Citrus Sinensis ID: 015222

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-
Protein Sequence
METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSASPNCLCKFYAITHCLLCSILCYC
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEccccccccEEEEcccccccccEEEEEEEcccccEEEEEEEcccHHHHHHHHHHHHHHHHHHHcccccccEEEEcccEEccccEEEEEccccccHHHHHHccccccccHHHHHHHHHHHHHHHHHHHHccccccccccccEEEEcccccccccccccccccccccccccccccccEEEEEccccccccccEEEEEccccccccEEEEccccccHHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHccccHHHHHHHcccccccccccccccccccccccHHHHHHHHHccccccccccccccHHHHHHHHHHHHHHHHHHHc
Secondary Structure Prediction (SSPRO)
cccHHHHcccccccccccccccccccccccccccccccccEEccccccccccccccccHHcccccccccccccccccccccEEEEEEEEccccEcccEEEEccccEEEEEccEccccEccEEEEEcccHHHHHHHHHHHHHHHHHccccEEEEEEccccccccccccEEEEEHcccccHHHHHHccccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEcccccccccccccccEEEEEEccccccccccccEcccccccccHHHHcccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccHHHcccccHHHHHHHHHccccccccccccHHHHHHHHHHHcccccccccHHHHHccHHHHHHccccccccccc
Coil and Loop (DISEMBL)
metqriiefphknmdkrprkrprltwdvppplpppkvlpalycvqefgnggmpnyacssmfygaiprtgsppwrpddkdghyVFAIGENLTPRYRILskmgegtfgqVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLArhdiggtrcvqirnwfDYRNHICIVFEKLGPSLYDFLrknsyrsfPIDLVRELGRQLLESVAFMHELRLIhtdlkpenILLVSAeyvkvpdykflsrsskdgsyfknlpkssaiklidfgsttfehqdhsyvvstrhyrapevilglgwnypcdlwsvGCILVELCSGEALFQTHENLEHLAMMERVlgplphhmvIRADRRAEKYFRrgarldwpdgatsrdSMRAVWKLLRLPvidlysaspnclckFYAITHCLLCSILCYC
Flexible Loop (DISEMBL)
metqriiefphknmdkrprkrprltwdvppplpppkVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQrlarhdiggtrcvqirnWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIhtdlkpenILLVSAEYVKVPDYKFlsrsskdgsyfknlpkssAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRgarldwpdgatsrdSMRAVWKLLRLPVIDLYSASPNCLCKFYAITHCLLCSILCYC
Low Complexity Region (SEG)
METQRIIEFPHKNMDKRPRKRPRLTWDvppplpppkvlpALYCVQEFGNGGMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSASPNCLCKFYAITHCLLCSILCYC
Disordered region (IsUnstruct)
***********************************KVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS**DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSASPNCLCKFYAITHCLLCSILCY*
Disordered Region (DISOPRED)
****************************************************************************DKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK**************LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARL****************************ASPNCLCKFYAITHCLLCSILCYC
Disordered Region (DISEMBL)
METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSASPNCLCKFYAITHCLLCSILCYC
Disordered Region (DISPRO)
**********************RLTWDVPPPLPPPKVLPALYCV*EFGNGG***YACS***YGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSASPNCLCKFYAITHCLLCSILCYC
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSASPNCLCKFYAITHCLLCSILCYC
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	411	2.2.26 [Sep-21-2011]
P51566	467	Serine/threonine-protein	yes	no	0.927	0.815	0.826	0.0
P51567	427	Serine/threonine-protein	no	no	0.912	0.878	0.707	1e-161
P51568	400	Serine/threonine-protein	no	no	0.900	0.925	0.623	1e-137
Q10156	690	Dual specificity protein	yes	no	0.717	0.427	0.480	1e-84
P49762	832	Serine/threonine-protein	no	no	0.720	0.355	0.485	4e-80
O35491	499	Dual specificity protein	yes	no	0.712	0.587	0.486	4e-80
P49760	499	Dual specificity protein	yes	no	0.712	0.587	0.486	6e-80
Q9HAZ1	481	Dual specificity protein	no	no	0.683	0.584	0.489	6e-78
O35493	481	Dual specificity protein	no	no	0.683	0.584	0.493	8e-78
Q63117	490	Dual specificity protein	no	no	0.681	0.571	0.474	3e-75

>sp|P51566|AFC1_ARATH Serine/threonine-protein kinase AFC1 OS=Arabidopsis thaliana GN=AFC1 PE=2 SV=2

 Score =  671 bits (1730), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 319/386 (82%), Positives = 354/386 (91%), Gaps = 5/386 (1%)

Query: 1   METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVL-----PALYCVQEFGNGGMPNY 55
           +ETQR +EFPH+ +DKRPRKRPRLTWD  PPL PP        P LY   EF +G +PN+
Sbjct: 17  LETQRNVEFPHRIVDKRPRKRPRLTWDAAPPLLPPPPPPTVFQPPLYYGPEFASGLVPNF 76

Query: 56  ACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNE 115
              +MFY  +PR GSPPWRPDDKDGHYVF +G+ LTPRY+ILSKMGEGTFGQV+ECFDN+
Sbjct: 77  VYPNMFYNGLPRQGSPPWRPDDKDGHYVFVVGDTLTPRYQILSKMGEGTFGQVLECFDNK 136

Query: 116 KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175
            KE+VAIK++RSINKYREAAMIEIDVLQRL RHD+GG+RCVQIRNWFDYRNHICIVFEKL
Sbjct: 137 NKEVVAIKVIRSINKYREAAMIEIDVLQRLTRHDVGGSRCVQIRNWFDYRNHICIVFEKL 196

Query: 176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
           GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA+MH+LRLIHTDLKPENILLVS+EY+K+
Sbjct: 197 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAYMHDLRLIHTDLKPENILLVSSEYIKI 256

Query: 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW 295
           PDYKFLSR +KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH+Y+VSTRHYRAPEVILG+GW
Sbjct: 257 PDYKFLSRPTKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHNYIVSTRHYRAPEVILGVGW 316

Query: 296 NYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRR 355
           NYPCDLWS+GCILVELCSGEALFQTHENLEHLAMMERVLGPLP HMV+RADRR+EKYFRR
Sbjct: 317 NYPCDLWSIGCILVELCSGEALFQTHENLEHLAMMERVLGPLPPHMVLRADRRSEKYFRR 376

Query: 356 GARLDWPDGATSRDSMRAVWKLLRLP 381
           GA+LDWP+GATSRDS++AVWKL RLP
Sbjct: 377 GAKLDWPEGATSRDSLKAVWKLPRLP 402

Activator of yeast transcription factor, STE12.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 1

>sp|P51567|AFC2_ARATH Serine/threonine-protein kinase AFC2 OS=Arabidopsis thaliana GN=AFC2 PE=1 SV=1

 Score =  568 bits (1464), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 273/386 (70%), Positives = 321/386 (83%), Gaps = 11/386 (2%)

Query: 1   METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGN------GGMPN 54
           ME +R+ EFPH +MD+RPRKR RL WDV P     +V   ++C QE GN       G P+
Sbjct: 1   MEMERVHEFPHTHMDRRPRKRARLGWDVLPQATKAQV--GMFCGQEIGNISSFASSGAPS 58

Query: 55  YACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDN 114
              SS+    + R GSPPWR DDKDGHY+F +G++LTPRY+I SKMGEGTFGQV+EC+D 
Sbjct: 59  DNSSSLCVKGVARNGSPPWREDDKDGHYIFELGDDLTPRYKIYSKMGEGTFGQVLECWDR 118

Query: 115 EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK 174
           E+KE+VA+KIVR + KYREAAMIEI++LQ+L +HD GG RCVQIRNWFDYRNHICIVFEK
Sbjct: 119 ERKEMVAVKIVRGVKKYREAAMIEIEMLQQLGKHDKGGNRCVQIRNWFDYRNHICIVFEK 178

Query: 175 LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234
           LG SLYDFLRKN+YRSFPIDLVRE+G QLLE VAFMH+LR+IHTDLKPENILLVS++YVK
Sbjct: 179 LGSSLYDFLRKNNYRSFPIDLVREIGWQLLECVAFMHDLRMIHTDLKPENILLVSSDYVK 238

Query: 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG 294
           +P+YK  SR  +D  Y K +PKSSAIK+IDFGSTT+E QD +Y+VSTRHYRAPEVILGLG
Sbjct: 239 IPEYKG-SRLQRDVCY-KRVPKSSAIKVIDFGSTTYERQDQTYIVSTRHYRAPEVILGLG 296

Query: 295 WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFR 354
           W+YPCD+WSVGCI+VELC+GEALFQTHENLEHLAMMERVLGP P  M+ + DR +EKY R
Sbjct: 297 WSYPCDVWSVGCIIVELCTGEALFQTHENLEHLAMMERVLGPFPQQMLKKVDRHSEKYVR 356

Query: 355 RGARLDWPDGATSRDSMRAVWKLLRL 380
           RG RLDWPDGATSRDS++AV KL RL
Sbjct: 357 RG-RLDWPDGATSRDSLKAVLKLPRL 381

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

>sp|P51568|AFC3_ARATH Serine/threonine-protein kinase AFC3 OS=Arabidopsis thaliana GN=AFC3 PE=2 SV=2

 Score =  489 bits (1258), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 247/396 (62%), Positives = 303/396 (76%), Gaps = 26/396 (6%)

Query: 12  KNMDK-RPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGS 70
           ++MDK R RKRPR+TWD  P  P  K       ++  G+ G               R  S
Sbjct: 7   ESMDKERVRKRPRMTWDEAPAEPEAKRA----VIKGHGSDG---------------RILS 47

Query: 71  PPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK 130
           PP R DD+DGHYVF++ +NLTPRY+ILSKMGEGTFG+V+EC+D + KE VAIKI+RSI K
Sbjct: 48  PPLRDDDRDGHYVFSLRDNLTPRYKILSKMGEGTFGRVLECWDRDTKEYVAIKIIRSIKK 107

Query: 131 YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRS 190
           YR+AAMIEIDVLQ+L + D G TRCVQ++NWFDYRNHICIVFEKLGPSL+DFL++N Y +
Sbjct: 108 YRDAAMIEIDVLQKLVKSDKGRTRCVQMKNWFDYRNHICIVFEKLGPSLFDFLKRNKYSA 167

Query: 191 FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250
           FP+ LVR+ G QLLESVA+MHEL+L+HTDLKPENILLVS+E VK+PD K   RS+ + ++
Sbjct: 168 FPLALVRDFGCQLLESVAYMHELQLVHTDLKPENILLVSSENVKLPDNK---RSAANETH 224

Query: 251 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310
           F+ LPKSSAIKLIDFGST  +++ H  +V TRHYR+PEVILGLGW+Y CDLWS+GCIL E
Sbjct: 225 FRCLPKSSAIKLIDFGSTVCDNRIHHSIVQTRHYRSPEVILGLGWSYQCDLWSIGCILFE 284

Query: 311 LCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS 370
           LC+GEALFQTH+NLEHLAMMER LGPLP HM  +A R AEKYFRRG RL+WP+GA SR+S
Sbjct: 285 LCTGEALFQTHDNLEHLAMMERALGPLPEHMTRKASRGAEKYFRRGCRLNWPEGANSRES 344

Query: 371 MRAVWKLLRLPVIDLYSAS-PNCLCKFYAITHCLLC 405
           +RAV +L RL   D+ S    N   +F  + + LL 
Sbjct: 345 IRAVKRLDRLK--DMVSKHVDNTRSRFADLLYGLLA 378

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

>sp|Q10156|LKH1_SCHPO Dual specificity protein kinase lkh1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=lkh1 PE=1 SV=3

 Score =  313 bits (802), Expect = 1e-84,   Method: Compositional matrix adjust.
 Identities = 148/308 (48%), Positives = 212/308 (68%), Gaps = 13/308 (4%)

Query: 76  DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA 135
           DD DGHY          RY ++  +G GTFG+V++C+D       AIK+ R+I KYREA+
Sbjct: 344 DDDDGHYKVVPNSKFANRYTVVRLLGHGTFGKVIQCYDQSTGRHCAIKVTRAIPKYREAS 403

Query: 136 MIEIDVLQRLARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
           +IE+ VLQ +A  D     +C+Q+R++FDYR HICIV +  G S++DFL+ N+Y  FP+ 
Sbjct: 404 LIELRVLQTIAHSDPTNENKCIQLRDYFDYRKHICIVTDLFGWSVFDFLKNNNYIPFPLK 463

Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVS--AEYVKVPDYKFLSRSSKDGSYFK 252
            ++ L +QL +SVAF+H L L+HTDLKPEN+LLVS  +  +++P Y+         +Y +
Sbjct: 464 HIQMLSQQLFKSVAFLHSLGLVHTDLKPENVLLVSNASRTIRLP-YR---------NYSQ 513

Query: 253 NLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312
            +  S  I+LIDFGS TFE + HS VVSTRHYRAPE+ILGLGW+YPCD+WS+GCILVEL 
Sbjct: 514 KVLNSCEIRLIDFGSATFEDEYHSSVVSTRHYRAPEIILGLGWSYPCDVWSIGCILVELF 573

Query: 313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMR 372
           +G+ALFQTHE+ EHL MME++LGP   +M+ R+ R ++++F+   ++ +P   T + S+ 
Sbjct: 574 TGQALFQTHEDSEHLCMMEKILGPFDRNMISRSSRTSQRFFKSDGKVRYPLSNTPKKSIN 633

Query: 373 AVWKLLRL 380
            +  L  L
Sbjct: 634 YLQSLQTL 641

Protein kinase that may act as a negative regulator of filamentous growth and flocculation. Appears to have a role in normal cell wall and septum formation and in cell seperation. May have antagonistic function in the regulation of beta-glucan distribution between the sites for cell wall and septum assembly.

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

>sp|P49762|DOA_DROME Serine/threonine-protein kinase Doa OS=Drosophila melanogaster GN=Doa PE=1 SV=2

 Score =  298 bits (764), Expect = 4e-80,   Method: Compositional matrix adjust.
 Identities = 150/309 (48%), Positives = 213/309 (68%), Gaps = 13/309 (4%)

Query: 76  DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA 135
           DD DGH ++  G+ L  RY+I++ +GEGTFG+VV+  D E+   +A+KI++++ KYREAA
Sbjct: 461 DDADGHLIYHTGDILHHRYKIMATLGEGTFGRVVKVKDMERDYCMALKIIKNVEKYREAA 520

Query: 136 MIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
            +EI+ L+++A+ D      CV++ +WFDY  H+CIVFE LG S++DFLR+N+Y  +P+D
Sbjct: 521 KLEINALEKIAQKDPHCDHLCVKMIDWFDYHGHMCIVFEMLGLSVFDFLRENNYEPYPLD 580

Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254
            VR +  QL  SV F+H+ RL HTDLKPENIL V ++Y    ++K ++R  +        
Sbjct: 581 QVRHMAYQLCYSVKFLHDNRLTHTDLKPENILFVDSDYTSHYNHK-INREVRRV------ 633

Query: 255 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
            K++ ++LIDFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL EL  G
Sbjct: 634 -KNTDVRLIDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCILFELYLG 692

Query: 315 EALFQTHENLEHLAMMERVLGPLPHHMV---IRADRRAEKYFRRGARLDWPDGATSRDSM 371
             LFQTH+N EHLAMMER+LG +P+ M        +   KYF  G +LDW + +++   +
Sbjct: 693 ITLFQTHDNREHLAMMERILGQIPYRMARNHTLYSKTKTKYFYHG-KLDWDEKSSAGRYV 751

Query: 372 RAVWKLLRL 380
           R   K L L
Sbjct: 752 RDHCKPLFL 760

Negative regulator of the copia retrotransposon element of the white (w) gene. In the eye, it is required for normal pigmentation, photoreceptor cell development and for organization of interommatidial bristles. Also essential for embryonic segmentation and differentiation of the nervous system. Functions in the control of alternative splicing by phosphorylating the argine/serine-rich splicing factors, SR proteins.

Drosophila melanogaster (taxid: 7227)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

>sp|O35491|CLK2_MOUSE Dual specificity protein kinase CLK2 OS=Mus musculus GN=Clk2 PE=1 SV=2

 Score =  298 bits (764), Expect = 4e-80,   Method: Compositional matrix adjust.
 Identities = 149/306 (48%), Positives = 212/306 (69%), Gaps = 13/306 (4%)

Query: 76  DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKK-ELVAIKIVRSINKYREA 134
           DD +GH ++ +G+ L  RY I+S +GEGTFG+VV+C D+ +    VA+KI++++ KY+EA
Sbjct: 144 DDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGTQVALKIIKNVEKYKEA 203

Query: 135 AMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
           A +EI+VL+++   D      CVQ+ +WFDY  H+CI FE LG S +DFL+ N+Y  +PI
Sbjct: 204 ARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPI 263

Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
             VR +  QL ++V F+H+ +L HTDLKPENIL V+++Y    +   L +   + S    
Sbjct: 264 HQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYN---LEKKRDERS---- 316

Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
             KS+A++++DFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E   
Sbjct: 317 -VKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYV 375

Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
           G  LFQTH+N EHLAMMER+LGP+P  M+ +   R +KYF RG RLDW +  ++   +R 
Sbjct: 376 GFTLFQTHDNREHLAMMERILGPVPSRMIRKT--RKQKYFYRG-RLDWDENTSAGRYVRE 432

Query: 374 VWKLLR 379
             K LR
Sbjct: 433 NCKPLR 438

Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Acts as a suppressor of hepatic gluconeogenesis and glucose output by repressing PPARGC1A transcriptional activity on gluconeogenic genes via its phosphorylation. Phosphorylates PPP2R5B thereby stimulating the assembly of PP2A phosphatase with the PPP2R5B-AKT1 complex leading to dephosphorylation of AKT1. Phosphorylates: PTPN1, SRSF1 and SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

>sp|P49760|CLK2_HUMAN Dual specificity protein kinase CLK2 OS=Homo sapiens GN=CLK2 PE=1 SV=1

 Score =  298 bits (763), Expect = 6e-80,   Method: Compositional matrix adjust.
 Identities = 149/306 (48%), Positives = 212/306 (69%), Gaps = 13/306 (4%)

Query: 76  DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKK-ELVAIKIVRSINKYREA 134
           DD +GH ++ +G+ L  RY I+S +GEGTFG+VV+C D+ +    VA+KI++++ KY+EA
Sbjct: 145 DDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEA 204

Query: 135 AMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
           A +EI+VL+++   D      CVQ+ +WFDY  H+CI FE LG S +DFL+ N+Y  +PI
Sbjct: 205 ARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPI 264

Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
             VR +  QL ++V F+H+ +L HTDLKPENIL V+++Y    +   L +   + S    
Sbjct: 265 HQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYN---LEKKRDERS---- 317

Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
             KS+A++++DFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E   
Sbjct: 318 -VKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYV 376

Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
           G  LFQTH+N EHLAMMER+LGP+P  M+ +   R +KYF RG RLDW +  ++   +R 
Sbjct: 377 GFTLFQTHDNREHLAMMERILGPIPSRMIRKT--RKQKYFYRG-RLDWDENTSAGRYVRE 433

Query: 374 VWKLLR 379
             K LR
Sbjct: 434 NCKPLR 439

Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Acts as a suppressor of hepatic gluconeogenesis and glucose output by repressing PPARGC1A transcriptional activity on gluconeogenic genes via its phosphorylation. Phosphorylates PPP2R5B thereby stimulating the assembly of PP2A phosphatase with the PPP2R5B-AKT1 complex leading to dephosphorylation of AKT1. Phosphorylates: PTPN1, SRSF1 and SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

>sp|Q9HAZ1|CLK4_HUMAN Dual specificity protein kinase CLK4 OS=Homo sapiens GN=CLK4 PE=1 SV=1

 Score =  291 bits (745), Expect = 6e-78,   Method: Compositional matrix adjust.
 Identities = 144/294 (48%), Positives = 203/294 (69%), Gaps = 13/294 (4%)

Query: 76  DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINKYREA 134
           DD++GH +   G+ L  RY I+  +GEG FG+VVEC D+    + VA+KIV+++ +YREA
Sbjct: 141 DDEEGHLICQSGDVLRARYEIVDTLGEGAFGKVVECIDHGMDGMHVAVKIVKNVGRYREA 200

Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
           A  EI VL+ L   D     RCVQ+  WFD+  H+CIVFE LG S YDF+++NS+  F I
Sbjct: 201 ARSEIQVLEHLNSTDPNSVFRCVQMLEWFDHHGHVCIVFELLGLSTYDFIKENSFLPFQI 260

Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
           D +R++  Q+ +S+ F+H  +L HTDLKPENIL V ++YV     K+ S+  +D    KN
Sbjct: 261 DHIRQMAYQICQSINFLHHNKLTHTDLKPENILFVKSDYV----VKYNSKMKRDERTLKN 316

Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
               + IK++DFGS T++ + HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E   
Sbjct: 317 ----TDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 372

Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATS 367
           G  +FQTH++ EHLAMMER+LGP+P HM+ +  +R  KYF    +LDW + +++
Sbjct: 373 GFTVFQTHDSKEHLAMMERILGPIPQHMIQKTRKR--KYFHHN-QLDWDEHSSA 423

Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates SRSF1 and SRSF3. Required for the regulation of alternative splicing of MAPT/TAU. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

>sp|O35493|CLK4_MOUSE Dual specificity protein kinase CLK4 OS=Mus musculus GN=Clk4 PE=1 SV=1

 Score =  291 bits (744), Expect = 8e-78,   Method: Compositional matrix adjust.
 Identities = 145/294 (49%), Positives = 203/294 (69%), Gaps = 13/294 (4%)

Query: 76  DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINKYREA 134
           DD++GH +   G+ L  RY I+  +GEG FG+VVEC D+    L VA+KIV+++ +YREA
Sbjct: 141 DDEEGHLICQSGDVLRARYEIVDTLGEGAFGKVVECIDHGMDGLHVAVKIVKNVGRYREA 200

Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
           A  EI VL+ L   D     RCVQ+  WFD+  H+CIVFE LG S YDF+++NS+  F I
Sbjct: 201 ARSEIQVLEHLNSTDPNSVFRCVQMLEWFDHHGHVCIVFELLGLSTYDFIKENSFLPFQI 260

Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
           D +R++  Q+ +S+ F+H  +L HTDLKPENIL V ++YV     K+ S+  +D    KN
Sbjct: 261 DHIRQMAYQICQSINFLHHNKLTHTDLKPENILFVKSDYV----VKYNSKMKRDERTLKN 316

Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
               + IK++DFGS T++ + HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E   
Sbjct: 317 ----TDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 372

Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATS 367
           G  +FQTH++ EHLAMMER+LGP+P HM+ +  +R  KYF    +LDW + +++
Sbjct: 373 GFTVFQTHDSKEHLAMMERILGPIPAHMIQKTRKR--KYFHHN-QLDWDEHSSA 423

Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates SRSF1 and SRSF3. Required for the regulation of alternative splicing of MAPT/TAU. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

>sp|Q63117|CLK3_RAT Dual specificity protein kinase CLK3 OS=Rattus norvegicus GN=Clk3 PE=2 SV=2

 Score =  282 bits (722), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 139/293 (47%), Positives = 204/293 (69%), Gaps = 13/293 (4%)

Query: 76  DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEK-KELVAIKIVRSINKYREA 134
           DDK+GH V  IG+ L  RY I+  +GEGTFG+VVEC D+ + K  VA+KI+R++ KYREA
Sbjct: 138 DDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA 197

Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
           A +EI+VL+++   D      CV + +WF++  H+CI FE LG + ++FL++N+++ +P+
Sbjct: 198 ARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPL 257

Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
             VR +  QL  ++ F+HE +L HTDLKPENIL V++E+  + +     +S ++ S    
Sbjct: 258 PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE---HKSCEEKSV--- 311

Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
             K+++I++ DFGS TF+H+ H+ +V+TRHYR PEVIL LGW  PCD+WS+GCIL E   
Sbjct: 312 --KNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 369

Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGAT 366
           G  LFQTHEN EHL MME++LGP+P HM+ R   R +KYF +G  L W + ++
Sbjct: 370 GFTLFQTHENREHLVMMEKILGPIPSHMIHRT--RKQKYFYKGG-LVWDENSS 419

Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Phosphorylates SRSF1 and SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	411
147800314	448	hypothetical protein VITISV_001943 [Viti	0.914	0.839	0.892	0.0
224138498	433	predicted protein [Populus trichocarpa]	0.912	0.866	0.878	0.0
225439856	429	PREDICTED: serine/threonine-protein kina	0.914	0.876	0.892	0.0
449439982	428	PREDICTED: serine/threonine-protein kina	0.927	0.890	0.881	0.0
449439980	433	PREDICTED: serine/threonine-protein kina	0.927	0.879	0.881	0.0
356505140	427	PREDICTED: serine/threonine-protein kina	0.909	0.875	0.842	0.0
356505138	444	PREDICTED: serine/threonine-protein kina	0.927	0.858	0.828	0.0
15231839	467	serine/threonine-protein kinase AFC1 [Ar	0.927	0.815	0.826	0.0
601787	467	protein kinase [Arabidopsis thaliana]	0.927	0.815	0.823	0.0
42572659	453	serine/threonine-protein kinase AFC1 [Ar	0.927	0.841	0.826	0.0

>gi|147800314|emb|CAN73108.1| hypothetical protein VITISV_001943 [Vitis vinifera]

 Score =  692 bits (1787), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 339/380 (89%), Positives = 363/380 (95%), Gaps = 4/380 (1%)

Query: 1   METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSM 60
           METQRI EFPHKNMDKRPRKRPRLTWD+PPPLPPPKV+P +YC QEF    + NY  SS+
Sbjct: 1   METQRITEFPHKNMDKRPRKRPRLTWDMPPPLPPPKVVPGMYCSQEF----VSNYPYSSL 56

Query: 61  FYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELV 120
           FY  + R GSPPWRPDDKDGHY+FAIGENLTPRYRI+SKMGEGTFGQV+ECFDN+KKE+V
Sbjct: 57  FYKGVTRNGSPPWRPDDKDGHYIFAIGENLTPRYRIISKMGEGTFGQVLECFDNDKKEVV 116

Query: 121 AIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
           AIKIVRSI+KYREAAMIEIDVLQ+LARHD+GGTRCVQIRNWFDYRNHICIVFEKLGPSLY
Sbjct: 117 AIKIVRSIHKYREAAMIEIDVLQKLARHDVGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 176

Query: 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240
           DFLRKNSYRSFPIDLVRELGRQLLESVAFMH+LRLIHTDLKPENILLVS++Y+KVPDYKF
Sbjct: 177 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHDLRLIHTDLKPENILLVSSDYIKVPDYKF 236

Query: 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 300
           LSR+ KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH+YVVSTRHYRAPEVILGLGWNYPCD
Sbjct: 237 LSRTIKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHNYVVSTRHYRAPEVILGLGWNYPCD 296

Query: 301 LWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLD 360
           LWSVGCIL+ELCSGEALFQTHENLEHLAMMERVLGPLP HMV+RADRRAEKYFRRGARLD
Sbjct: 297 LWSVGCILIELCSGEALFQTHENLEHLAMMERVLGPLPQHMVLRADRRAEKYFRRGARLD 356

Query: 361 WPDGATSRDSMRAVWKLLRL 380
           WP+GATSR+SMRAVWKL RL
Sbjct: 357 WPEGATSRESMRAVWKLPRL 376

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224138498|ref|XP_002322829.1| predicted protein [Populus trichocarpa] gi|222867459|gb|EEF04590.1| predicted protein [Populus trichocarpa]

 Score =  691 bits (1783), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 340/387 (87%), Positives = 358/387 (92%), Gaps = 12/387 (3%)

Query: 1   METQRIIEFPHKNMDKRPRKRPRLTWDVPPP----LPPPKVLPALYCVQEFGNGG--MPN 54
           METQRI EFPHKNMDKRPRKR RLTWD+PPP    L P KV+P ++C QEFGNG   +PN
Sbjct: 1   METQRITEFPHKNMDKRPRKRQRLTWDIPPPPPPFLAPAKVVPGMFCGQEFGNGNGVIPN 60

Query: 55  YACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDN 114
           Y    +FY    R GSPPWRPDDKDGHYVFAIG+NLTPRYRILSKMGEGTFGQV+ECFDN
Sbjct: 61  YG---LFYN---RNGSPPWRPDDKDGHYVFAIGDNLTPRYRILSKMGEGTFGQVLECFDN 114

Query: 115 EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK 174
           EKKELVAIKIVRSI+KYREAAM EIDVLQRLARHDIG TRCVQIRNWFDYRNHICIVFEK
Sbjct: 115 EKKELVAIKIVRSIHKYREAAMTEIDVLQRLARHDIGSTRCVQIRNWFDYRNHICIVFEK 174

Query: 175 LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234
           LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH+L LIHTDLKPENILLVS+EY+K
Sbjct: 175 LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHDLHLIHTDLKPENILLVSSEYIK 234

Query: 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG 294
           VPDYKFLSRS+KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG
Sbjct: 235 VPDYKFLSRSTKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG 294

Query: 295 WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFR 354
           WNYPCD+WSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLP HMV+RADRRAEKYFR
Sbjct: 295 WNYPCDIWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPQHMVVRADRRAEKYFR 354

Query: 355 RGARLDWPDGATSRDSMRAVWKLLRLP 381
           RG RLDWP+GATSR+SM+AV KL RLP
Sbjct: 355 RGMRLDWPEGATSRESMKAVMKLPRLP 381

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225439856|ref|XP_002278124.1| PREDICTED: serine/threonine-protein kinase AFC1 [Vitis vinifera] gi|297741539|emb|CBI32671.3| unnamed protein product [Vitis vinifera]

 Score =  691 bits (1782), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 339/380 (89%), Positives = 363/380 (95%), Gaps = 4/380 (1%)

Query: 1   METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSM 60
           METQRI EFPHKNMDKRPRKRPRLTWD+PPPLPPPKV+P +YC QEF    + NY  SS+
Sbjct: 1   METQRITEFPHKNMDKRPRKRPRLTWDMPPPLPPPKVVPGMYCSQEF----VSNYPYSSL 56

Query: 61  FYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELV 120
           FY  + R GSPPWRPDDKDGHY+FAIGENLTPRYRI+SKMGEGTFGQV+ECFDN+KKE+V
Sbjct: 57  FYKGVTRNGSPPWRPDDKDGHYIFAIGENLTPRYRIISKMGEGTFGQVLECFDNDKKEVV 116

Query: 121 AIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
           AIKIVRSI+KYREAAMIEIDVLQ+LARHD+GGTRCVQIRNWFDYRNHICIVFEKLGPSLY
Sbjct: 117 AIKIVRSIHKYREAAMIEIDVLQKLARHDVGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 176

Query: 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240
           DFLRKNSYRSFPIDLVRELGRQLLESVAFMH+LRLIHTDLKPENILLVS++Y+KVPDYKF
Sbjct: 177 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHDLRLIHTDLKPENILLVSSDYIKVPDYKF 236

Query: 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 300
           LSR+ KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH+YVVSTRHYRAPEVILGLGWNYPCD
Sbjct: 237 LSRTIKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHNYVVSTRHYRAPEVILGLGWNYPCD 296

Query: 301 LWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLD 360
           LWSVGCIL+ELCSGEALFQTHENLEHLAMMERVLGPLP HMV+RADRRAEKYFRRGARLD
Sbjct: 297 LWSVGCILIELCSGEALFQTHENLEHLAMMERVLGPLPQHMVLRADRRAEKYFRRGARLD 356

Query: 361 WPDGATSRDSMRAVWKLLRL 380
           WP+GATSR+SMRAVWKL RL
Sbjct: 357 WPEGATSRESMRAVWKLPRL 376

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449439982|ref|XP_004137764.1| PREDICTED: serine/threonine-protein kinase AFC1-like isoform 2 [Cucumis sativus]

 Score =  681 bits (1758), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 336/381 (88%), Positives = 357/381 (93%)

Query: 1   METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSM 60
           METQRIIEFPHKNMDKRPRKR RL WD+PPP+PPPKVLP  YC QEFGNG +PNYA  SM
Sbjct: 1   METQRIIEFPHKNMDKRPRKRQRLAWDMPPPVPPPKVLPPPYCGQEFGNGQVPNYAYPSM 60

Query: 61  FYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELV 120
           +    PR GSPPWRPD+KDGHYVF+IGE LTPRY ILSKMGEGTFGQV+EC D+EKKE+V
Sbjct: 61  YCRGAPRVGSPPWRPDNKDGHYVFSIGECLTPRYTILSKMGEGTFGQVLECLDSEKKEVV 120

Query: 121 AIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
           AIKIVRSI+KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY
Sbjct: 121 AIKIVRSISKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180

Query: 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240
           DFLRKNSYRSFPIDLVRE  RQLLESVAFMHELRLIHTDLKPENILLVS+E+++VPD+KF
Sbjct: 181 DFLRKNSYRSFPIDLVREFARQLLESVAFMHELRLIHTDLKPENILLVSSEFIRVPDHKF 240

Query: 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 300
           LSRS KDGSYFKNLPKS+AIKLIDFGSTT EHQDHSY+VSTRHYRAPEVILGLGWNYPCD
Sbjct: 241 LSRSVKDGSYFKNLPKSAAIKLIDFGSTTTEHQDHSYIVSTRHYRAPEVILGLGWNYPCD 300

Query: 301 LWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLD 360
           LWSVGCILVELCSGEALFQTHENLEHLAMME+VLGPLP HMV+RADRRAEKYFRRG +LD
Sbjct: 301 LWSVGCILVELCSGEALFQTHENLEHLAMMEKVLGPLPQHMVLRADRRAEKYFRRGMQLD 360

Query: 361 WPDGATSRDSMRAVWKLLRLP 381
           WP  ATSR+SMRAVWKLLRLP
Sbjct: 361 WPQSATSRESMRAVWKLLRLP 381

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449439980|ref|XP_004137763.1| PREDICTED: serine/threonine-protein kinase AFC1-like isoform 1 [Cucumis sativus]

 Score =  680 bits (1755), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 336/381 (88%), Positives = 357/381 (93%)

Query: 1   METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSM 60
           METQRIIEFPHKNMDKRPRKR RL WD+PPP+PPPKVLP  YC QEFGNG +PNYA  SM
Sbjct: 1   METQRIIEFPHKNMDKRPRKRQRLAWDMPPPVPPPKVLPPPYCGQEFGNGQVPNYAYPSM 60

Query: 61  FYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELV 120
           +    PR GSPPWRPD+KDGHYVF+IGE LTPRY ILSKMGEGTFGQV+EC D+EKKE+V
Sbjct: 61  YCRGAPRVGSPPWRPDNKDGHYVFSIGECLTPRYTILSKMGEGTFGQVLECLDSEKKEVV 120

Query: 121 AIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
           AIKIVRSI+KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY
Sbjct: 121 AIKIVRSISKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180

Query: 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240
           DFLRKNSYRSFPIDLVRE  RQLLESVAFMHELRLIHTDLKPENILLVS+E+++VPD+KF
Sbjct: 181 DFLRKNSYRSFPIDLVREFARQLLESVAFMHELRLIHTDLKPENILLVSSEFIRVPDHKF 240

Query: 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 300
           LSRS KDGSYFKNLPKS+AIKLIDFGSTT EHQDHSY+VSTRHYRAPEVILGLGWNYPCD
Sbjct: 241 LSRSVKDGSYFKNLPKSAAIKLIDFGSTTTEHQDHSYIVSTRHYRAPEVILGLGWNYPCD 300

Query: 301 LWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLD 360
           LWSVGCILVELCSGEALFQTHENLEHLAMME+VLGPLP HMV+RADRRAEKYFRRG +LD
Sbjct: 301 LWSVGCILVELCSGEALFQTHENLEHLAMMEKVLGPLPQHMVLRADRRAEKYFRRGMQLD 360

Query: 361 WPDGATSRDSMRAVWKLLRLP 381
           WP  ATSR+SMRAVWKLLRLP
Sbjct: 361 WPQSATSRESMRAVWKLLRLP 381

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356505140|ref|XP_003521350.1| PREDICTED: serine/threonine-protein kinase AFC1-like isoform 2 [Glycine max]

 Score =  677 bits (1748), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 321/381 (84%), Positives = 349/381 (91%), Gaps = 7/381 (1%)

Query: 1   METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSM 60
           METQRIIEFPH+NMDKRPRK+ RLTWD+        VLP +YC QE GNG +PN+A  S+
Sbjct: 1   METQRIIEFPHRNMDKRPRKKQRLTWDM-------HVLPTMYCKQEVGNGVVPNHAYPSL 53

Query: 61  FYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELV 120
           FY  +PR GSPPWRPDDKDGHYVFA+GENLTPRY+ILSKMGEGTFGQV+EC DNEK+E+V
Sbjct: 54  FYRGMPRNGSPPWRPDDKDGHYVFAVGENLTPRYKILSKMGEGTFGQVLECLDNEKEEIV 113

Query: 121 AIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
           AIK+VRSINKYREAA  EI+VL RLARHD+ G  CVQIRNWFDYRNHICIVFEKLGPSLY
Sbjct: 114 AIKVVRSINKYREAARTEIEVLLRLARHDVDGAHCVQIRNWFDYRNHICIVFEKLGPSLY 173

Query: 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240
           DFLRKNSYRSFPIDLVRE GRQLLESVAFMH+L LIHTDLKPENILL+S+E++KVPDYKF
Sbjct: 174 DFLRKNSYRSFPIDLVREFGRQLLESVAFMHDLCLIHTDLKPENILLISSEFIKVPDYKF 233

Query: 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 300
           LSR++KDGSYFKNLPKSSAIKLIDFGST+FEHQDHSYVVSTRHYRAPEVILGLGWNYPCD
Sbjct: 234 LSRNTKDGSYFKNLPKSSAIKLIDFGSTSFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 293

Query: 301 LWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLD 360
           LWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLP HMV+RADRRAEKYF+RG RL 
Sbjct: 294 LWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPPHMVVRADRRAEKYFKRGTRLS 353

Query: 361 WPDGATSRDSMRAVWKLLRLP 381
           WPD +TSR+SMRAVWKL RLP
Sbjct: 354 WPDSSTSRESMRAVWKLPRLP 374

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356505138|ref|XP_003521349.1| PREDICTED: serine/threonine-protein kinase AFC1-like isoform 1 [Glycine max]

 Score =  674 bits (1739), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 324/391 (82%), Positives = 353/391 (90%), Gaps = 10/391 (2%)

Query: 1   METQRIIEFPHKNMDKRPRKRPRLTWDV----------PPPLPPPKVLPALYCVQEFGNG 50
           METQRIIEFPH+NMDKRPRK+ RLTWD+          P P P  +VLP +YC QE GNG
Sbjct: 1   METQRIIEFPHRNMDKRPRKKQRLTWDMHVPPPPPPPPPLPPPKLQVLPTMYCKQEVGNG 60

Query: 51  GMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVE 110
            +PN+A  S+FY  +PR GSPPWRPDDKDGHYVFA+GENLTPRY+ILSKMGEGTFGQV+E
Sbjct: 61  VVPNHAYPSLFYRGMPRNGSPPWRPDDKDGHYVFAVGENLTPRYKILSKMGEGTFGQVLE 120

Query: 111 CFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170
           C DNEK+E+VAIK+VRSINKYREAA  EI+VL RLARHD+ G  CVQIRNWFDYRNHICI
Sbjct: 121 CLDNEKEEIVAIKVVRSINKYREAARTEIEVLLRLARHDVDGAHCVQIRNWFDYRNHICI 180

Query: 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 230
           VFEKLGPSLYDFLRKNSYRSFPIDLVRE GRQLLESVAFMH+L LIHTDLKPENILL+S+
Sbjct: 181 VFEKLGPSLYDFLRKNSYRSFPIDLVREFGRQLLESVAFMHDLCLIHTDLKPENILLISS 240

Query: 231 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVI 290
           E++KVPDYKFLSR++KDGSYFKNLPKSSAIKLIDFGST+FEHQDHSYVVSTRHYRAPEVI
Sbjct: 241 EFIKVPDYKFLSRNTKDGSYFKNLPKSSAIKLIDFGSTSFEHQDHSYVVSTRHYRAPEVI 300

Query: 291 LGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAE 350
           LGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLP HMV+RADRRAE
Sbjct: 301 LGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPPHMVVRADRRAE 360

Query: 351 KYFRRGARLDWPDGATSRDSMRAVWKLLRLP 381
           KYF+RG RL WPD +TSR+SMRAVWKL RLP
Sbjct: 361 KYFKRGTRLSWPDSSTSRESMRAVWKLPRLP 391

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15231839|ref|NP_190925.1| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] gi|42570490|ref|NP_850695.2| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] gi|79314891|ref|NP_001030853.1| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] gi|26454604|sp|P51566.2|AFC1_ARATH RecName: Full=Serine/threonine-protein kinase AFC1 gi|642132|dbj|BAA08215.1| protein kinase [Arabidopsis thaliana] gi|6729508|emb|CAB67664.1| protein kinase (AME2/AFC1) [Arabidopsis thaliana] gi|222424132|dbj|BAH20025.1| AT3G53570 [Arabidopsis thaliana] gi|332645589|gb|AEE79110.1| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] gi|332645590|gb|AEE79111.1| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] gi|332645591|gb|AEE79112.1| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana]

 Score =  671 bits (1730), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 319/386 (82%), Positives = 354/386 (91%), Gaps = 5/386 (1%)

Query: 1   METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVL-----PALYCVQEFGNGGMPNY 55
           +ETQR +EFPH+ +DKRPRKRPRLTWD  PPL PP        P LY   EF +G +PN+
Sbjct: 17  LETQRNVEFPHRIVDKRPRKRPRLTWDAAPPLLPPPPPPTVFQPPLYYGPEFASGLVPNF 76

Query: 56  ACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNE 115
              +MFY  +PR GSPPWRPDDKDGHYVF +G+ LTPRY+ILSKMGEGTFGQV+ECFDN+
Sbjct: 77  VYPNMFYNGLPRQGSPPWRPDDKDGHYVFVVGDTLTPRYQILSKMGEGTFGQVLECFDNK 136

Query: 116 KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175
            KE+VAIK++RSINKYREAAMIEIDVLQRL RHD+GG+RCVQIRNWFDYRNHICIVFEKL
Sbjct: 137 NKEVVAIKVIRSINKYREAAMIEIDVLQRLTRHDVGGSRCVQIRNWFDYRNHICIVFEKL 196

Query: 176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
           GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA+MH+LRLIHTDLKPENILLVS+EY+K+
Sbjct: 197 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAYMHDLRLIHTDLKPENILLVSSEYIKI 256

Query: 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW 295
           PDYKFLSR +KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH+Y+VSTRHYRAPEVILG+GW
Sbjct: 257 PDYKFLSRPTKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHNYIVSTRHYRAPEVILGVGW 316

Query: 296 NYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRR 355
           NYPCDLWS+GCILVELCSGEALFQTHENLEHLAMMERVLGPLP HMV+RADRR+EKYFRR
Sbjct: 317 NYPCDLWSIGCILVELCSGEALFQTHENLEHLAMMERVLGPLPPHMVLRADRRSEKYFRR 376

Query: 356 GARLDWPDGATSRDSMRAVWKLLRLP 381
           GA+LDWP+GATSRDS++AVWKL RLP
Sbjct: 377 GAKLDWPEGATSRDSLKAVWKLPRLP 402

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|601787|gb|AAA57117.1| protein kinase [Arabidopsis thaliana]

 Score =  669 bits (1727), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 318/386 (82%), Positives = 354/386 (91%), Gaps = 5/386 (1%)

Query: 1   METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVL-----PALYCVQEFGNGGMPNY 55
           +ETQR +EFPH+ +DKRPRKRPRLTWD  PPL PP        P LY   EF +G +PN+
Sbjct: 17  LETQRNVEFPHRIVDKRPRKRPRLTWDAAPPLLPPPPPPTVFQPPLYYGPEFASGLVPNF 76

Query: 56  ACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNE 115
              +MFY  +PR GSPPWRPDDKDGHYVF +G+ LTPRY++LSKMGEGTFGQV+ECFDN+
Sbjct: 77  VYPNMFYNGLPRQGSPPWRPDDKDGHYVFVVGDTLTPRYQMLSKMGEGTFGQVLECFDNK 136

Query: 116 KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175
            KE+VAIK++RSINKYREAAMIEIDVLQRL RHD+GG+RCVQIRNWFDYRNHICIVFEKL
Sbjct: 137 NKEVVAIKVIRSINKYREAAMIEIDVLQRLTRHDVGGSRCVQIRNWFDYRNHICIVFEKL 196

Query: 176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
           GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA+MH+LRLIHTDLKPENILLVS+EY+K+
Sbjct: 197 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAYMHDLRLIHTDLKPENILLVSSEYIKI 256

Query: 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW 295
           PDYKFLSR +KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH+Y+VSTRHYRAPEVILG+GW
Sbjct: 257 PDYKFLSRPTKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHNYIVSTRHYRAPEVILGVGW 316

Query: 296 NYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRR 355
           NYPCDLWS+GCILVELCSGEALFQTHENLEHLAMMERVLGPLP HMV+RADRR+EKYFRR
Sbjct: 317 NYPCDLWSIGCILVELCSGEALFQTHENLEHLAMMERVLGPLPPHMVLRADRRSEKYFRR 376

Query: 356 GARLDWPDGATSRDSMRAVWKLLRLP 381
           GA+LDWP+GATSRDS++AVWKL RLP
Sbjct: 377 GAKLDWPEGATSRDSLKAVWKLPRLP 402

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|42572659|ref|NP_974425.1| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] gi|332645588|gb|AEE79109.1| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana]

 Score =  669 bits (1727), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 319/386 (82%), Positives = 354/386 (91%), Gaps = 5/386 (1%)

Query: 1   METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVL-----PALYCVQEFGNGGMPNY 55
           +ETQR +EFPH+ +DKRPRKRPRLTWD  PPL PP        P LY   EF +G +PN+
Sbjct: 3   LETQRNVEFPHRIVDKRPRKRPRLTWDAAPPLLPPPPPPTVFQPPLYYGPEFASGLVPNF 62

Query: 56  ACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNE 115
              +MFY  +PR GSPPWRPDDKDGHYVF +G+ LTPRY+ILSKMGEGTFGQV+ECFDN+
Sbjct: 63  VYPNMFYNGLPRQGSPPWRPDDKDGHYVFVVGDTLTPRYQILSKMGEGTFGQVLECFDNK 122

Query: 116 KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175
            KE+VAIK++RSINKYREAAMIEIDVLQRL RHD+GG+RCVQIRNWFDYRNHICIVFEKL
Sbjct: 123 NKEVVAIKVIRSINKYREAAMIEIDVLQRLTRHDVGGSRCVQIRNWFDYRNHICIVFEKL 182

Query: 176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
           GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA+MH+LRLIHTDLKPENILLVS+EY+K+
Sbjct: 183 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAYMHDLRLIHTDLKPENILLVSSEYIKI 242

Query: 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW 295
           PDYKFLSR +KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH+Y+VSTRHYRAPEVILG+GW
Sbjct: 243 PDYKFLSRPTKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHNYIVSTRHYRAPEVILGVGW 302

Query: 296 NYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRR 355
           NYPCDLWS+GCILVELCSGEALFQTHENLEHLAMMERVLGPLP HMV+RADRR+EKYFRR
Sbjct: 303 NYPCDLWSIGCILVELCSGEALFQTHENLEHLAMMERVLGPLPPHMVLRADRRSEKYFRR 362

Query: 356 GARLDWPDGATSRDSMRAVWKLLRLP 381
           GA+LDWP+GATSRDS++AVWKL RLP
Sbjct: 363 GAKLDWPEGATSRDSLKAVWKLPRLP 388

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	411
TAIR|locus:2084006	467	FC1 "FUS3-complementing gene 1	0.927	0.815	0.810	4e-177
TAIR|locus:2121984	427	FC2 "FUS3-complementing gene 2	0.912	0.878	0.699	1.2e-147
TAIR|locus:2125622	400	AME3 [Arabidopsis thaliana (ta	0.822	0.845	0.671	7e-128
FB|FBgn0259220	832	Doa "Darkener of apricot" [Dro	0.688	0.340	0.493	4.6e-78
POMBASE|SPAC1D4.11c	690	lkh1 "dual specificity protein	0.759	0.452	0.472	4.8e-78
UNIPROTKB|F1LSM4	705	Scamp3 "Protein Scamp3" [Rattu	0.722	0.421	0.493	1e-77
UNIPROTKB|F1RLJ5	500	CLK2 "Uncharacterized protein"	0.712	0.586	0.496	2.7e-77
UNIPROTKB|E1B9Q2	500	CLK2 "Uncharacterized protein"	0.712	0.586	0.496	3.4e-77
UNIPROTKB|F1P919	612	CLK2 "Uncharacterized protein"	0.712	0.478	0.496	3.4e-77
UNIPROTKB|B1AVT0	497	CLK2 "Dual-specificity protein	0.712	0.589	0.496	3.4e-77

TAIR|locus:2084006 FC1 "FUS3-complementing gene 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1720 (610.5 bits), Expect = 4.0e-177, P = 4.0e-177
 Identities = 313/386 (81%), Positives = 348/386 (90%)

Query:     1 METQRIIEFPHKNMDKRPRKRPRLTWDXXXXXXX-----XXXXXALYCVQEFGNGGMPNY 55
             +ETQR +EFPH+ +DKRPRKRPRLTWD                  LY   EF +G +PN+
Sbjct:    17 LETQRNVEFPHRIVDKRPRKRPRLTWDAAPPLLPPPPPPTVFQPPLYYGPEFASGLVPNF 76

Query:    56 ACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNE 115
                +MFY  +PR GSPPWRPDDKDGHYVF +G+ LTPRY+ILSKMGEGTFGQV+ECFDN+
Sbjct:    77 VYPNMFYNGLPRQGSPPWRPDDKDGHYVFVVGDTLTPRYQILSKMGEGTFGQVLECFDNK 136

Query:   116 KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175
              KE+VAIK++RSINKYREAAMIEIDVLQRL RHD+GG+RCVQIRNWFDYRNHICIVFEKL
Sbjct:   137 NKEVVAIKVIRSINKYREAAMIEIDVLQRLTRHDVGGSRCVQIRNWFDYRNHICIVFEKL 196

Query:   176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
             GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA+MH+LRLIHTDLKPENILLVS+EY+K+
Sbjct:   197 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAYMHDLRLIHTDLKPENILLVSSEYIKI 256

Query:   236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW 295
             PDYKFLSR +KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH+Y+VSTRHYRAPEVILG+GW
Sbjct:   257 PDYKFLSRPTKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHNYIVSTRHYRAPEVILGVGW 316

Query:   296 NYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRR 355
             NYPCDLWS+GCILVELCSGEALFQTHENLEHLAMMERVLGPLP HMV+RADRR+EKYFRR
Sbjct:   317 NYPCDLWSIGCILVELCSGEALFQTHENLEHLAMMERVLGPLPPHMVLRADRRSEKYFRR 376

Query:   356 GARLDWPDGATSRDSMRAVWKLLRLP 381
             GA+LDWP+GATSRDS++AVWKL RLP
Sbjct:   377 GAKLDWPEGATSRDSLKAVWKLPRLP 402

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005739 "mitochondrion" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0045727 "positive regulation of translation" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=TAS

TAIR|locus:2121984 FC2 "FUS3-complementing gene 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1442 (512.7 bits), Expect = 1.2e-147, P = 1.2e-147
 Identities = 270/386 (69%), Positives = 317/386 (82%)

Query:     1 METQRIIEFPHKNMDKRPRKRPRLTWDXXXXXXXXXXXXALYCVQEFGN------GGMPN 54
             ME +R+ EFPH +MD+RPRKR RL WD             ++C QE GN       G P+
Sbjct:     1 MEMERVHEFPHTHMDRRPRKRARLGWDVLPQATKAQV--GMFCGQEIGNISSFASSGAPS 58

Query:    55 YACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDN 114
                SS+    + R GSPPWR DDKDGHY+F +G++LTPRY+I SKMGEGTFGQV+EC+D 
Sbjct:    59 DNSSSLCVKGVARNGSPPWREDDKDGHYIFELGDDLTPRYKIYSKMGEGTFGQVLECWDR 118

Query:   115 EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK 174
             E+KE+VA+KIVR + KYREAAMIEI++LQ+L +HD GG RCVQIRNWFDYRNHICIVFEK
Sbjct:   119 ERKEMVAVKIVRGVKKYREAAMIEIEMLQQLGKHDKGGNRCVQIRNWFDYRNHICIVFEK 178

Query:   175 LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234
             LG SLYDFLRKN+YRSFPIDLVRE+G QLLE VAFMH+LR+IHTDLKPENILLVS++YVK
Sbjct:   179 LGSSLYDFLRKNNYRSFPIDLVREIGWQLLECVAFMHDLRMIHTDLKPENILLVSSDYVK 238

Query:   235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG 294
             +P+YK  SR  +D  Y K +PKSSAIK+IDFGSTT+E QD +Y+VSTRHYRAPEVILGLG
Sbjct:   239 IPEYKG-SRLQRDVCY-KRVPKSSAIKVIDFGSTTYERQDQTYIVSTRHYRAPEVILGLG 296

Query:   295 WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFR 354
             W+YPCD+WSVGCI+VELC+GEALFQTHENLEHLAMMERVLGP P  M+ + DR +EKY R
Sbjct:   297 WSYPCDVWSVGCIIVELCTGEALFQTHENLEHLAMMERVLGPFPQQMLKKVDRHSEKYVR 356

Query:   355 RGARLDWPDGATSRDSMRAVWKLLRL 380
             RG RLDWPDGATSRDS++AV KL RL
Sbjct:   357 RG-RLDWPDGATSRDSLKAVLKLPRL 381

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0004672 "protein kinase activity" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0006397 "mRNA processing" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0045727 "positive regulation of translation" evidence=RCA

TAIR|locus:2125622 AME3 [Arabidopsis thaliana (taxid:3702)]

 Score = 1213 (432.1 bits), Expect = 7.0e-128, Sum P(2) = 7.0e-128
 Identities = 231/344 (67%), Positives = 283/344 (82%)

Query:    62 YGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVA 121
             +G+  R  SPP R DD+DGHYVF++ +NLTPRY+ILSKMGEGTFG+V+EC+D + KE VA
Sbjct:    39 HGSDGRILSPPLRDDDRDGHYVFSLRDNLTPRYKILSKMGEGTFGRVLECWDRDTKEYVA 98

Query:   122 IKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYD 181
             IKI+RSI KYR+AAMIEIDVLQ+L + D G TRCVQ++NWFDYRNHICIVFEKLGPSL+D
Sbjct:    99 IKIIRSIKKYRDAAMIEIDVLQKLVKSDKGRTRCVQMKNWFDYRNHICIVFEKLGPSLFD 158

Query:   182 FLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241
             FL++N Y +FP+ LVR+ G QLLESVA+MHEL+L+HTDLKPENILLVS+E VK+PD K  
Sbjct:   159 FLKRNKYSAFPLALVRDFGCQLLESVAYMHELQLVHTDLKPENILLVSSENVKLPDNK-- 216

Query:   242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDL 301
              RS+ + ++F+ LPKSSAIKLIDFGST  +++ H  +V TRHYR+PEVILGLGW+Y CDL
Sbjct:   217 -RSAANETHFRCLPKSSAIKLIDFGSTVCDNRIHHSIVQTRHYRSPEVILGLGWSYQCDL 275

Query:   302 WSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDW 361
             WS+GCIL ELC+GEALFQTH+NLEHLAMMER LGPLP HM  +A R AEKYFRRG RL+W
Sbjct:   276 WSIGCILFELCTGEALFQTHDNLEHLAMMERALGPLPEHMTRKASRGAEKYFRRGCRLNW 335

Query:   362 PDGATSRDSMRAVWKLLRLPVIDLYSAS-PNCLCKFYAITHCLL 404
             P+GA SR+S+RAV +L RL   D+ S    N   +F  + + LL
Sbjct:   336 PEGANSRESIRAVKRLDRLK--DMVSKHVDNTRSRFADLLYGLL 377

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0045727 "positive regulation of translation" evidence=RCA

FB|FBgn0259220 Doa "Darkener of apricot" [Drosophila melanogaster (taxid:7227)]

 Score = 762 (273.3 bits), Expect = 4.6e-78, Sum P(2) = 4.6e-78
 Identities = 146/296 (49%), Positives = 208/296 (70%)

Query:    76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA 135
             DD DGH ++  G+ L  RY+I++ +GEGTFG+VV+  D E+   +A+KI++++ KYREAA
Sbjct:   461 DDADGHLIYHTGDILHHRYKIMATLGEGTFGRVVKVKDMERDYCMALKIIKNVEKYREAA 520

Query:   136 MIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
              +EI+ L+++A+ D      CV++ +WFDY  H+CIVFE LG S++DFLR+N+Y  +P+D
Sbjct:   521 KLEINALEKIAQKDPHCDHLCVKMIDWFDYHGHMCIVFEMLGLSVFDFLRENNYEPYPLD 580

Query:   195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254
              VR +  QL  SV F+H+ RL HTDLKPENIL V ++Y    ++K ++R  +        
Sbjct:   581 QVRHMAYQLCYSVKFLHDNRLTHTDLKPENILFVDSDYTSHYNHK-INREVRR------- 632

Query:   255 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
              K++ ++LIDFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL EL  G
Sbjct:   633 VKNTDVRLIDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCILFELYLG 692

Query:   315 EALFQTHENLEHLAMMERVLGPLPHHMVIRA---DRRAEKYFRRGARLDWPDGATS 367
               LFQTH+N EHLAMMER+LG +P+ M        +   KYF  G +LDW + +++
Sbjct:   693 ITLFQTHDNREHLAMMERILGQIPYRMARNHTLYSKTKTKYFYHG-KLDWDEKSSA 747

GO:0007399 "nervous system development" evidence=NAS;IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004672 "protein kinase activity" evidence=ISS;IDA

GO:0007350 "blastoderm segmentation" evidence=NAS;IMP

GO:0048749 "compound eye development" evidence=NAS;IMP

GO:0005634 "nucleus" evidence=IC;IDA;NAS

GO:0048477 "oogenesis" evidence=IMP

GO:0007417 "central nervous system development" evidence=NAS

GO:0008362 "chitin-based embryonic cuticle biosynthetic process" evidence=NAS

GO:0045494 "photoreceptor cell maintenance" evidence=NAS

GO:0007548 "sex differentiation" evidence=IGI;IMP

GO:0004674 "protein serine/threonine kinase activity" evidence=NAS;IDA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=NAS

GO:0042051 "compound eye photoreceptor development" evidence=IEP;IMP;NAS

GO:0008407 "chaeta morphogenesis" evidence=NAS

GO:0000165 "MAPK cascade" evidence=IGI

GO:0005737 "cytoplasm" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=NAS

GO:0048102 "autophagic cell death" evidence=IEP

GO:0035071 "salivary gland cell autophagic cell death" evidence=IEP

GO:0030717 "karyosome formation" evidence=IMP

GO:0005524 "ATP binding" evidence=IEA

GO:0000381 "regulation of alternative mRNA splicing, via spliceosome" evidence=IMP

GO:0005783 "endoplasmic reticulum" evidence=IDA

GO:0009306 "protein secretion" evidence=IMP

GO:0005875 "microtubule associated complex" evidence=IDA

GO:0048854 "brain morphogenesis" evidence=IMP

GO:0001964 "startle response" evidence=IMP

GO:0031987 "locomotion involved in locomotory behavior" evidence=IMP

POMBASE|SPAC1D4.11c lkh1 "dual specificity protein kinase Lkh1" [Schizosaccharomyces pombe (taxid:4896)]

 Score = 785 (281.4 bits), Expect = 4.8e-78, P = 4.8e-78
 Identities = 154/326 (47%), Positives = 218/326 (66%)

Query:    68 TGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS 127
             T   P   DD DGHY          RY ++  +G GTFG+V++C+D       AIK+ R+
Sbjct:   336 TAFDPSTFDDDDGHYKVVPNSKFANRYTVVRLLGHGTFGKVIQCYDQSTGRHCAIKVTRA 395

Query:   128 INKYREAAMIEIDVLQRLARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKN 186
             I KYREA++IE+ VLQ +A  D     +C+Q+R++FDYR HICIV +  G S++DFL+ N
Sbjct:   396 IPKYREASLIELRVLQTIAHSDPTNENKCIQLRDYFDYRKHICIVTDLFGWSVFDFLKNN 455

Query:   187 SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS--AEYVKVPDYKFLSRS 244
             +Y  FP+  ++ L +QL +SVAF+H L L+HTDLKPEN+LLVS  +  +++P Y+     
Sbjct:   456 NYIPFPLKHIQMLSQQLFKSVAFLHSLGLVHTDLKPENVLLVSNASRTIRLP-YR----- 509

Query:   245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSV 304
                 +Y + +  S  I+LIDFGS TFE + HS VVSTRHYRAPE+ILGLGW+YPCD+WS+
Sbjct:   510 ----NYSQKVLNSCEIRLIDFGSATFEDEYHSSVVSTRHYRAPEIILGLGWSYPCDVWSI 565

Query:   305 GCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDG 364
             GCILVEL +G+ALFQTHE+ EHL MME++LGP   +M+ R+ R ++++F+   ++ +P  
Sbjct:   566 GCILVELFTGQALFQTHEDSEHLCMMEKILGPFDRNMISRSSRTSQRFFKSDGKVRYPLS 625

Query:   365 ATSRDSMRAVWKLLRLPVIDLYSASP 390
              T + S+  +  L  L  I   S SP
Sbjct:   626 NTPKKSINYLQSLQTLEQIFAVS-SP 650

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IMP;IDA

GO:0006468 "protein phosphorylation" evidence=IC

GO:0010590 "regulation of cytokinetic cell separation" evidence=IMP

GO:0032955 "regulation of barrier septum assembly" evidence=IMP

GO:0034599 "cellular response to oxidative stress" evidence=IMP

GO:0035556 "intracellular signal transduction" evidence=TAS

GO:0048026 "positive regulation of mRNA splicing, via spliceosome" evidence=IMP

GO:0051519 "activation of bipolar cell growth" evidence=IMP

GO:0060237 "regulation of fungal-type cell wall organization" evidence=IMP

GO:0060257 "negative regulation of flocculation" evidence=IMP

GO:0060258 "negative regulation of filamentous growth" evidence=IMP

UNIPROTKB|F1LSM4 Scamp3 "Protein Scamp3" [Rattus norvegicus (taxid:10116)]

 Score = 782 (280.3 bits), Expect = 1.0e-77, P = 1.0e-77
 Identities = 153/310 (49%), Positives = 215/310 (69%)

Query:    76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINKYREA 134
             DD +GH ++ +G+ L  RY I+S +GEGTFG+VV+C D+ +    VA+KI++++ KY+EA
Sbjct:    84 DDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEA 143

Query:   135 AMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
             A +EI+VL+++   D      CVQ+ +WFDY  H+CI FE LG S +DFL+ N+Y  +PI
Sbjct:   144 ARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPI 203

Query:   194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
               VR +  QL ++V F+H+ +L HTDLKPENIL V+++Y     Y  L +   + S    
Sbjct:   204 HQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELT--YN-LEKKRDERSV--- 257

Query:   254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
               KS+A++++DFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E   
Sbjct:   258 --KSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYV 315

Query:   314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
             G  LFQTH+N EHLAMMER+LGP+P  M IR  R+ +KYF RG RLDW +  ++   +R 
Sbjct:   316 GFTLFQTHDNREHLAMMERILGPVPSRM-IRKTRK-QKYFYRG-RLDWDENTSAGRYVRE 372

Query:   374 VWKLLRLPVI 383
               K LR P +
Sbjct:   373 NCKPLRDPAV 382

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0015031 "protein transport" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

UNIPROTKB|F1RLJ5 CLK2 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 778 (278.9 bits), Expect = 2.7e-77, P = 2.7e-77
 Identities = 152/306 (49%), Positives = 213/306 (69%)

Query:    76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINKYREA 134
             DD +GH ++ +G+ L  RY I+S +GEGTFG+VV+C D+ +    VA+KI++++ KY+EA
Sbjct:   145 DDAEGHLIYHVGDWLQERYEIISTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEA 204

Query:   135 AMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
             A +EI+VL+++   D      CVQ+ +WFDY  H+CI FE LG S +DFL+ N+Y  +PI
Sbjct:   205 ARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPI 264

Query:   194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
               VR +  QL ++V F+H+ +L HTDLKPENIL V+++Y     Y  L +   + S    
Sbjct:   265 HQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELT--YN-LEKKRDERSV--- 318

Query:   254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
               KS+A++++DFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E   
Sbjct:   319 --KSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYV 376

Query:   314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
             G  LFQTH+N EHLAMMER+LGP+P  M IR  R+ +KYF RG RLDW +  ++   +R 
Sbjct:   377 GFTLFQTHDNREHLAMMERILGPIPSRM-IRKTRK-QKYFYRG-RLDWDENTSAGRYVRE 433

Query:   374 VWKLLR 379
               K LR
Sbjct:   434 NCKPLR 439

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0045721 "negative regulation of gluconeogenesis" evidence=IEA

GO:0043484 "regulation of RNA splicing" evidence=IEA

GO:0032526 "response to retinoic acid" evidence=IEA

GO:0018108 "peptidyl-tyrosine phosphorylation" evidence=IEA

GO:0010212 "response to ionizing radiation" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|E1B9Q2 CLK2 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 777 (278.6 bits), Expect = 3.4e-77, P = 3.4e-77
 Identities = 152/306 (49%), Positives = 213/306 (69%)

Query:    76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINKYREA 134
             DD +GH ++ +G+ L  RY I+S +GEGTFG+VV+C D+ +    VA+KI++++ KY+EA
Sbjct:   145 DDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEA 204

Query:   135 AMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
             A +EI+VL+++   D      CVQ+ +WFDY  H+CI FE LG S +DFL+ N+Y  +PI
Sbjct:   205 ARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPI 264

Query:   194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
               VR +  QL ++V F+H+ +L HTDLKPENIL V+++Y     Y  L +   + S    
Sbjct:   265 HQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELT--YN-LEKKRDERSV--- 318

Query:   254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
               KS+A++++DFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E   
Sbjct:   319 --KSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYV 376

Query:   314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
             G  LFQTH+N EHLAMMER+LGP+P  M IR  R+ +KYF RG RLDW +  ++   +R 
Sbjct:   377 GFTLFQTHDNREHLAMMERILGPIPSRM-IRKTRK-QKYFYRG-RLDWDENTSAGRYVRE 433

Query:   374 VWKLLR 379
               K LR
Sbjct:   434 NCKPLR 439

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0045721 "negative regulation of gluconeogenesis" evidence=IEA

GO:0043484 "regulation of RNA splicing" evidence=IEA

GO:0032526 "response to retinoic acid" evidence=IEA

GO:0018108 "peptidyl-tyrosine phosphorylation" evidence=IEA

GO:0010212 "response to ionizing radiation" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|F1P919 CLK2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 777 (278.6 bits), Expect = 3.4e-77, P = 3.4e-77
 Identities = 152/306 (49%), Positives = 213/306 (69%)

Query:    76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINKYREA 134
             DD +GH ++ +G+ L  RY I+S +GEGTFG+VV+C D+ +    VA+KI++++ KY+EA
Sbjct:   257 DDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEA 316

Query:   135 AMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
             A +EI+VL+++   D      CVQ+ +WFDY  H+CI FE LG S +DFL+ N+Y  +PI
Sbjct:   317 ARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPI 376

Query:   194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
               VR +  QL ++V F+H+ +L HTDLKPENIL V+++Y     Y  L +   + S    
Sbjct:   377 HQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELT--YN-LEKKRDERSV--- 430

Query:   254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
               KS+A++++DFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E   
Sbjct:   431 --KSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYV 488

Query:   314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
             G  LFQTH+N EHLAMMER+LGP+P  M IR  R+ +KYF RG RLDW +  ++   +R 
Sbjct:   489 GFTLFQTHDNREHLAMMERILGPIPSRM-IRKTRK-QKYFYRG-RLDWDENTSAGRYVRE 545

Query:   374 VWKLLR 379
               K LR
Sbjct:   546 NCKPLR 551

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|B1AVT0 CLK2 "Dual-specificity protein kinase CLK2" [Homo sapiens (taxid:9606)]

 Score = 777 (278.6 bits), Expect = 3.4e-77, P = 3.4e-77
 Identities = 152/306 (49%), Positives = 213/306 (69%)

Query:    76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINKYREA 134
             DD +GH ++ +G+ L  RY I+S +GEGTFG+VV+C D+ +    VA+KI++++ KY+EA
Sbjct:   143 DDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEA 202

Query:   135 AMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
             A +EI+VL+++   D      CVQ+ +WFDY  H+CI FE LG S +DFL+ N+Y  +PI
Sbjct:   203 ARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPI 262

Query:   194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
               VR +  QL ++V F+H+ +L HTDLKPENIL V+++Y     Y  L +   + S    
Sbjct:   263 HQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELT--YN-LEKKRDERSV--- 316

Query:   254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
               KS+A++++DFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E   
Sbjct:   317 --KSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYV 374

Query:   314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
             G  LFQTH+N EHLAMMER+LGP+P  M IR  R+ +KYF RG RLDW +  ++   +R 
Sbjct:   375 GFTLFQTHDNREHLAMMERILGPIPSRM-IRKTRK-QKYFYRG-RLDWDENTSAGRYVRE 431

Query:   374 VWKLLR 379
               K LR
Sbjct:   432 NCKPLR 437

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P51567	AFC2_ARATH	2, ., 7, ., 1, 2, ., 1	0.7072	0.9124	0.8782	no	no
P51566	AFC1_ARATH	2, ., 7, ., 1, 2, ., 1	0.8264	0.9270	0.8158	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.12.1	0.991
3rd Layer	2.7.12	0.976
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.00160734 hypothetical protein (434 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	411
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-63
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	3e-62
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-50
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-44
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-40
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	8e-40
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-39
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-39
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-38
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-32
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-31
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	7e-31
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-30
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-30
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-30
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-30
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-28
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-28
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	8e-28
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-26
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-26
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-25
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-25
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-25
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-24
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-24
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-24
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-24
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-23
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-23
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-23
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-23
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-23
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-23
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-23
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-23
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	7e-23
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-22
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-22
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-22
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	9e-22
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-21
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-21
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-20
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-20
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-20
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-20
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	5e-20
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-20
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	9e-20
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-19
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-19
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-19
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-19
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-19
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	9e-19
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	9e-19
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-18
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-18
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-17
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-17
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-17
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	8e-17
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-16
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-16
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-16
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-16
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-16
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-16
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	8e-16
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-15
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-15
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-15
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-15
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-15
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-15
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-15
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-15
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-15
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	6e-15
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-15
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	7e-15
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-15
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	7e-15
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-14
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	6e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-14
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	8e-14
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	9e-14
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-13
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-13
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-13
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-13
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-13
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-13
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-13
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-13
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-12
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-12
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-12
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-12
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-12
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	8e-12
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-11
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-11
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-11
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	6e-11
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-11
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	7e-11
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-10
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-10
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-10
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-10
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-10
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-10
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-10
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-10
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-10
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	7e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-10
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	9e-10
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	9e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-09
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-09
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-09
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-09
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-09
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-09
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-09
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	6e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	7e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	9e-09
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-08
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-08
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-08
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-08
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-08
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-08
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-08
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-08
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-08
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-08
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-08
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-08
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-07
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-07
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-07
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-07
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-07
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-07
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-07
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-07
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-07
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-07
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-07
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	8e-07
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-06
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-06
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-06
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-06
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	8e-06
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	8e-06
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	8e-06
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-05
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-05
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-05
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-05
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-05
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-05
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-05
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-05
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-05
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	7e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	8e-05
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	8e-05
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	9e-05
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-04
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-04
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-04
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-04
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-04
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-04
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-04
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-04
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-04
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-04
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-04
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	8e-04
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	9e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.001
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	0.001
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	0.002
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	0.002
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	0.002
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.003
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  202 bits (517), Expect = 5e-63
 Identities = 80/253 (31%), Positives = 122/253 (48%), Gaps = 41/253 (16%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDIG 151
           Y IL K+GEG+FG+V    D +  +LVAIK+++   I K RE  + EI +L++L +H   
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKL-KHP-- 57

Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
               V++ + F+  + + +V E   G  L+D L+K        D  R   RQ+L ++ ++
Sbjct: 58  --NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR--GRLSEDEARFYLRQILSALEYL 113

Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H   ++H DLKPENILL                  +DG           +KL DFG    
Sbjct: 114 HSKGIVHRDLKPENILL-----------------DEDGH----------VKLADFGLARQ 146

Query: 271 EHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
                     V T  Y APEV+LG G+    D+WS+G IL EL +G+  F   + L    
Sbjct: 147 LDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLL--E 204

Query: 329 MMERVLGPLPHHM 341
           + +++  P P   
Sbjct: 205 LFKKIGKPKPPFP 217

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score =  207 bits (528), Expect = 3e-62
 Identities = 108/277 (38%), Positives = 165/277 (59%), Gaps = 27/277 (9%)

Query: 78  KDGHYVFAIGENL---TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA 134
           ++GH+   +GE++   T R++ILS +GEGTFG+VVE +D ++KE  A+KIVR++ KY   
Sbjct: 112 EEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRD 171

Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWF-DYRNHICIVFEKLGPSLYDFLRKNSYRSFP 192
           A IEI  ++++ + D       ++I+ +F +   H+CIV  K GP L D++ K+   S  
Sbjct: 172 AKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSH- 230

Query: 193 IDLVRELGRQLLESVA----FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248
               R L + + ++      F  EL L+HTDLKPENIL+ +++            +  D 
Sbjct: 231 ----RHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSD------------TVVDP 274

Query: 249 SYFKNLPKSSA-IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCI 307
              + LP     +++ D G    E    + +VSTRHYR+PEV+LGLGW Y  D+WS+GCI
Sbjct: 275 VTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCI 334

Query: 308 LVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIR 344
           + EL +G+ L+ TH+NLEHL +ME+ LG LP     R
Sbjct: 335 IYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGR 371

Length = 467

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  170 bits (434), Expect = 1e-50
 Identities = 75/255 (29%), Positives = 120/255 (47%), Gaps = 44/255 (17%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHD- 149
           Y +L K+G G+FG V +       ++VA+KI++     +K  + A  EI +L+RL  H  
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRL-SHPN 59

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I     V++ + F+ ++H+ +V E      L+D+L +        D  +++  Q+L  + 
Sbjct: 60  I-----VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG--GPLSEDEAKKIALQILRGLE 112

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-S 267
           ++H   +IH DLKPENILL                                +K+ DFG +
Sbjct: 113 YLHSNGIIHRDLKPENILLDENGV---------------------------VKIADFGLA 145

Query: 268 TTFEHQDHSY--VVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
                   S    V T  Y APEV+L G G+    D+WS+G IL EL +G+  F     L
Sbjct: 146 KKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENIL 205

Query: 325 EHLAMMERVLGPLPH 339
           + L ++ R+LGP   
Sbjct: 206 DQLQLIRRILGPPLE 220

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  153 bits (388), Expect = 2e-44
 Identities = 71/218 (32%), Positives = 105/218 (48%), Gaps = 39/218 (17%)

Query: 101 GEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           GEG FG V    D +  + VAIKI++    +   E  + EI++L++L  H       V++
Sbjct: 2   GEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHP----NIVKL 56

Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
              F+  NH+ +V E   G SL D L++N  +    D +  +  Q+LE + ++H   +IH
Sbjct: 57  YGVFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNGIIH 115

Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
            DLKPENILL S                              +KL DFG +     D S 
Sbjct: 116 RDLKPENILLDSDNGK--------------------------VKLADFGLSKLLTSDKSL 149

Query: 278 VVS---TRHYRAPEVILGLG-WNYPCDLWSVGCILVEL 311
           + +   T  Y APEV+LG G ++   D+WS+G IL EL
Sbjct: 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  144 bits (365), Expect = 4e-40
 Identities = 78/247 (31%), Positives = 120/247 (48%), Gaps = 33/247 (13%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHD 149
           RY+IL ++GEG  G V +  D E  E VA+K   + R        A+ EI  LQ      
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
           +     V++ + F + +   +V E +   L + LR +  R  P   V+   R LL+ VA+
Sbjct: 61  V-----VKLLDVFPHGSGFVLVMEYMPSDLSEVLR-DEERPLPEAQVKSYMRMLLKGVAY 114

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
           MH   ++H DLKP N+L+ +   +K+ D+  L+R   +                      
Sbjct: 115 MHANGIMHRDLKPANLLISADGVLKIADFG-LARLFSEE-----------------EPRL 156

Query: 270 FEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
           + HQ     V+TR YRAPE++ G   ++   DLW+VGCI  EL +G  LF    ++E LA
Sbjct: 157 YSHQ-----VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLA 211

Query: 329 MMERVLG 335
           ++ R LG
Sbjct: 212 IVFRTLG 218

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  143 bits (362), Expect = 8e-40
 Identities = 80/257 (31%), Positives = 132/257 (51%), Gaps = 35/257 (13%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHD 149
           +Y +L  +GEG +G V++C +    E+VAIK           ++ A+ E+ VL++L   +
Sbjct: 2   KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN 61

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
           I     V ++  F  +  + +VFE +  +L + L  +     P D VR    QLL+++A+
Sbjct: 62  I-----VNLKEAFRRKGRLYLVFEYVERTLLELLEASPG-GLPPDAVRSYIWQLLQAIAY 115

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
            H   +IH D+KPENIL+  +  +K+ D+ F           + L    A  L D+    
Sbjct: 116 CHSHNIIHRDIKPENILVSESGVLKLCDFGFA----------RALRARPASPLTDY---- 161

Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTHENLEHL 327
                    V+TR YRAPE+++G   NY  P D+W++GCI+ EL  GE LF    +++ L
Sbjct: 162 ---------VATRWYRAPELLVG-DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL 211

Query: 328 AMMERVLGPLPHHMVIR 344
            ++++ LGPLP      
Sbjct: 212 YLIQKCLGPLPPSHQEL 228

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  141 bits (357), Expect = 4e-39
 Identities = 77/251 (30%), Positives = 124/251 (49%), Gaps = 44/251 (17%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARHD 149
           Y  L K+GEGT+G V +  D +  E+VA+K +R ++   E     A+ EI +L+ L +H 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR-LDNEEEGIPSTALREISLLKEL-KHP 58

Query: 150 -IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
            I     V++ +       + +VFE     L  +L K        +L++ +  QLL  +A
Sbjct: 59  NI-----VKLLDVIHTERKLYLVFEYCDMDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLA 112

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-S 267
           + H  R++H DLKP+NIL+                 ++DG           +KL DFG +
Sbjct: 113 YCHSHRILHRDLKPQNILI-----------------NRDGV----------LKLADFGLA 145

Query: 268 TTFEHQDHSY--VVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
             F     +Y   V T  YRAPE++LG   ++   D+WSVGCI  E+ +G+ LF     +
Sbjct: 146 RAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI 205

Query: 325 EHLAMMERVLG 335
           + L  + ++LG
Sbjct: 206 DQLFKIFQILG 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  141 bits (357), Expect = 5e-39
 Identities = 71/245 (28%), Positives = 122/245 (49%), Gaps = 32/245 (13%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREA-AMIEIDVLQRLARHDIG 151
           Y+++ ++G+GTFG V    + E  ELVAIK + +    + E   + E+  L++L  H   
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHP-- 58

Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
               V+++  F   + +  VFE +  +LY  ++    + F   ++R +  Q+L+ +A +H
Sbjct: 59  --NIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
           +    H DLKPEN+L+   E VK+ D+  L+R  +    +                T + 
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFG-LAREIRSRPPY----------------TDY- 158

Query: 272 HQDHSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330
                  VSTR YRAPE++L     + P D+W++GCI+ EL +   LF     ++ L  +
Sbjct: 159 -------VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKI 211

Query: 331 ERVLG 335
             VLG
Sbjct: 212 CSVLG 216

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  139 bits (353), Expect = 1e-38
 Identities = 79/256 (30%), Positives = 120/256 (46%), Gaps = 41/256 (16%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHDI 150
           Y+ L K+GEGT+G V +  D    E+VAIK ++   +     + A+ EI +L+ L   +I
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                +++ + F ++  + +VFE +   LY  ++    R  P  L++    QLL+ +AF 
Sbjct: 61  -----IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFC 114

Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H   ++H DLKPEN+L                           +     +KL DFG    
Sbjct: 115 HSHGILHRDLKPENLL---------------------------INTEGVLKLADFGLARS 147

Query: 271 EHQDHSYV---VSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                      V TR YRAPE++LG  G++ P D+WSVGCI  EL S   LF     ++ 
Sbjct: 148 FGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ 207

Query: 327 LAMMERVLG-PLPHHM 341
           L  + R LG P P   
Sbjct: 208 LFKIFRTLGTPDPEVW 223

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  123 bits (311), Expect = 1e-32
 Identities = 74/249 (29%), Positives = 136/249 (54%), Gaps = 32/249 (12%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
           ++ +L  +GEG +G V++C   E KE+VAIK  +      + +E  + E+ +L+ L + +
Sbjct: 2   KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
           I     V+++  F  R  + +VFE +  ++ + L +      P + VR    QL++++ +
Sbjct: 62  I-----VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP-EKVRSYIYQLIKAIHW 115

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
            H+  ++H D+KPEN+L+   + +K+ D+ F +R+  +GS                    
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGF-ARNLSEGS-------------------- 154

Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329
             + +++  V+TR YR+PE++LG  +    D+WSVGCIL EL  G+ LF     ++ L  
Sbjct: 155 --NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFT 212

Query: 330 MERVLGPLP 338
           +++VLGPLP
Sbjct: 213 IQKVLGPLP 221

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  119 bits (300), Expect = 3e-31
 Identities = 63/226 (27%), Positives = 111/226 (49%), Gaps = 37/226 (16%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHDIGG 152
           + IL K+G+G FG+V +       + VAIK+++    + +E  + EI +L++    +I  
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNI-- 59

Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V+    +  ++ + IV E   G SL D L K++ ++     +  + ++LL+ + ++H
Sbjct: 60  ---VKYYGSYLKKDELWIVMEFCSGGSLKDLL-KSTNQTLTESQIAYVCKELLKGLEYLH 115

Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTF 270
              +IH D+K  NILL                 + DG           +KLIDFG S   
Sbjct: 116 SNGIIHRDIKAANILL-----------------TSDGE----------VKLIDFGLSAQL 148

Query: 271 EH-QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
              +  + +V T ++ APEVI G  ++Y  D+WS+G   +EL  G+
Sbjct: 149 SDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  119 bits (300), Expect = 7e-31
 Identities = 80/277 (28%), Positives = 124/277 (44%), Gaps = 54/277 (19%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI----EIDVLQRLARHD 149
           Y+IL K+GEGTF +V++    +  +  AIK       ++    +    EI  L+RL+ H 
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIK--CMKKHFKSLEQVNNLREIQALRRLSPHP 58

Query: 150 --IGGTRCVQIRNWFDYR-NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
             +     +     FD +   + +VFE +  +LY+ + K   R  P   V+    QLL+S
Sbjct: 59  NILRLIEVL-----FDRKTGRLALVFELMDMNLYELI-KGRKRPLPEKRVKSYMYQLLKS 112

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +  MH   + H D+KPENIL+                            K   +KL DFG
Sbjct: 113 LDHMHRNGIFHRDIKPENILI----------------------------KDDILKLADFG 144

Query: 267 S--TTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHEN 323
           S    +    ++  +STR YRAPE +L  G +    D+W+VGC+  E+ S   LF     
Sbjct: 145 SCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE 204

Query: 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLD 360
           L+ +A +  VLG  P       D    K FR+   ++
Sbjct: 205 LDQIAKIHDVLG-TP-------DAEVLKKFRKSRHMN 233

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  118 bits (298), Expect = 2e-30
 Identities = 77/262 (29%), Positives = 118/262 (45%), Gaps = 61/262 (23%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE---AAMIEIDVLQRLARHDI 150
           Y  ++++GEGT+GQV +  + +  ELVA+K +R  N+       A+ EI +LQ+L RH  
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-RHP- 58

Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLY--------DF---LRKNSYRSFPIDLVREL 199
                V++           IV  K   S+Y        D    L     + F    ++  
Sbjct: 59  ---NIVRL---------KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK-FTESQIKCY 105

Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
            +QLLE + ++H   ++H D+K  NIL+                 + DG           
Sbjct: 106 MKQLLEGLQYLHSNGILHRDIKGSNILI-----------------NNDGV---------- 138

Query: 260 IKLIDFG---STTFEH-QDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSG 314
           +KL DFG     T  +  D++  V T  YR PE++LG   +    D+WSVGCIL EL  G
Sbjct: 139 LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG 198

Query: 315 EALFQTHENLEHLAMMERVLGP 336
           + +FQ    LE L  +  + G 
Sbjct: 199 KPIFQGSTELEQLEKIFELCGS 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  119 bits (299), Expect = 3e-30
 Identities = 77/264 (29%), Positives = 116/264 (43%), Gaps = 51/264 (19%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHD 149
           YRIL K+GEG+FG+V    D +    VA+K++     S +K  E  + EI +L  L    
Sbjct: 2   YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYR-SFPIDLVRELGRQLLESV 207
                 V++ ++F     + +V E + G SL D L+K   +          +  Q+L ++
Sbjct: 59  ----NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
            ++H   +IH D+KPENILL                                +KLIDFG 
Sbjct: 115 EYLHSKGIIHRDIKPENILLD--------------------------RDGRVVKLIDFGL 148

Query: 267 --------STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPC---DLWSVGCILVELCSGE 315
                   ST+      S  V T  Y APEV+LGL   Y     D+WS+G  L EL +G 
Sbjct: 149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208

Query: 316 ALFQTHENLEHLAMMERVLGPLPH 339
             F+  +N    +   +++  LP 
Sbjct: 209 PPFEGEKNSSATSQTLKIILELPT 232

Length = 384

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  117 bits (295), Expect = 3e-30
 Identities = 80/276 (28%), Positives = 135/276 (48%), Gaps = 56/276 (20%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK---------IVRSINKYREAAMIEIDVLQ 143
           +Y  LSK+GEG++G V +C + E  ++VAIK         +++ I      A+ EI +L+
Sbjct: 2   KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKI------ALREIRMLK 55

Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
           +L   ++     V +   F  +  + +VFE    ++ + L KN  R  P  L++++  Q 
Sbjct: 56  QLKHPNL-----VNLIEVFRRKRKLHLVFEYCDHTVLNELEKNP-RGVPEHLIKKIIWQT 109

Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
           L++V F H+   IH D+KPENIL+                            K   IKL 
Sbjct: 110 LQAVNFCHKHNCIHRDVKPENILIT---------------------------KQGQIKLC 142

Query: 264 DFG-STTFEHQDHSYV--VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQ 319
           DFG +         Y   V+TR YRAPE+++G   +  P D+W++GC+  EL +G+ L+ 
Sbjct: 143 DFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP 202

Query: 320 THENLEHLAMMERVLGPL-PHHMVIRADRRAEKYFR 354
              +++ L ++ + LG L P H  I       ++F+
Sbjct: 203 GKSDVDQLYLIRKTLGDLIPRHQQI---FSTNQFFK 235

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  115 bits (291), Expect = 7e-30
 Identities = 64/245 (26%), Positives = 106/245 (43%), Gaps = 49/245 (20%)

Query: 101 GEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQ 157
           G G+FG V    D +  EL+A+K   +     +  EA   EI +L  L +H       V+
Sbjct: 9   GRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHP----NIVR 63

Query: 158 IR--NWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
                  + +N + I  E + G SL   L+K  +   P  ++R+  RQ+LE +A++H   
Sbjct: 64  YYGSERDEEKNTLNIFLEYVSGGSLSSLLKK--FGKLPEPVIRKYTRQILEGLAYLHSNG 121

Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG------ST 268
           ++H D+K  NIL+ S                              +KL DFG        
Sbjct: 122 IVHRDIKGANILVDS---------------------------DGVVKLADFGCAKRLGDI 154

Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
                  S V  T ++ APEVI G  +    D+WS+GC ++E+ +G+  +   E    +A
Sbjct: 155 ETGEGTGS-VRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW--SELGNPMA 211

Query: 329 MMERV 333
            + ++
Sbjct: 212 ALYKI 216

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  113 bits (285), Expect = 1e-28
 Identities = 79/255 (30%), Positives = 116/255 (45%), Gaps = 45/255 (17%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE---AAMI-EIDVLQRLARH- 148
           Y  L+++GEG +G V +  D      VA+K VR      E    + + EI +L++L    
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFE 59

Query: 149 --------DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG 200
                   D+    C   R   D    + +VFE +   L  +L K      P + +++L 
Sbjct: 60  HPNIVRLLDV----CHGPRT--DRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLM 113

Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
           RQLL  V F+H  R++H DLKP+NIL+ S   VK+ D+  L+R      Y   +  +S  
Sbjct: 114 RQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFG-LARI-----YSFEMALTS-- 165

Query: 261 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320
                            VV T  YRAPEV+L   +  P D+WSVGCI  EL     LF+ 
Sbjct: 166 -----------------VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRG 208

Query: 321 HENLEHLAMMERVLG 335
               + L  +  V+G
Sbjct: 209 TSEADQLDKIFDVIG 223

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  111 bits (280), Expect = 4e-28
 Identities = 63/233 (27%), Positives = 107/233 (45%), Gaps = 21/233 (9%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYR--EAAMIEIDVLQRLARHD 149
           ++    +GEG+F  VV   + E  +  AIKI+  R + K +  +   IE +VL RL  H 
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH- 61

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                 +++   F    ++  V E      L  ++RK  Y S      R    ++L ++ 
Sbjct: 62  ---PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALE 116

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           ++H   +IH DLKPENILL    ++K+ D+   K L  +S   S   N   ++ I     
Sbjct: 117 YLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES---NKGDATNIDSQIE 173

Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
            +        +  V T  Y +PE++         DLW++GCI+ ++ +G+  F
Sbjct: 174 KNRRR----FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  110 bits (277), Expect = 8e-28
 Identities = 69/247 (27%), Positives = 119/247 (48%), Gaps = 42/247 (17%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
           +Y I+ ++G+G+FG+V         +L  +K +   N   K RE A+ E+ +L++L  H 
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHP 59

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFL--RKNSYRSFPIDLVRELGRQLLES 206
                 ++    F+ +  +CIV E   G  L   +  +K   + FP + + +   QL  +
Sbjct: 60  ----NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           + ++H  +++H D+KP+NI L                 + +G           +KL DFG
Sbjct: 116 LKYLHSRKILHRDIKPQNIFL-----------------TSNGL----------VKLGDFG 148

Query: 267 -STTFEH-QDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
            S       D +  VV T +Y +PE+     +NY  D+WS+GC+L ELC+ +  F+  EN
Sbjct: 149 ISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFE-GEN 207

Query: 324 LEHLAMM 330
           L  LA+ 
Sbjct: 208 LLELALK 214

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  107 bits (268), Expect = 2e-26
 Identities = 75/251 (29%), Positives = 119/251 (47%), Gaps = 49/251 (19%)

Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDIGGT 153
           + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I   
Sbjct: 5   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI--- 61

Query: 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
             V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H  
Sbjct: 62  --VKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119

Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST----- 268
           R++H DLKP+N+L+                 + +G          AIKL DFG       
Sbjct: 120 RVLHRDLKPQNLLI-----------------NTEG----------AIKLADFGLARAFGV 152

Query: 269 ---TFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENL 324
              T+ H+     V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     +
Sbjct: 153 PVRTYTHE-----VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 207

Query: 325 EHLAMMERVLG 335
           + L  + R LG
Sbjct: 208 DQLFRIFRTLG 218

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  106 bits (266), Expect = 4e-26
 Identities = 81/259 (31%), Positives = 128/259 (49%), Gaps = 41/259 (15%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--IVRSINKY-REAAMIEIDVLQRLARHD 149
           +Y  L  +GEG++G V++C   E  ++VAIK  +    +K  ++ AM EI +L++L RH+
Sbjct: 2   KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHE 60

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
                 V +   F  +  + +VFE +  ++ D L K          VR+   Q+L  + F
Sbjct: 61  ----NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEF 115

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-ST 268
            H   +IH D+KPENIL VS                          +S  +KL DFG + 
Sbjct: 116 CHSHNIIHRDIKPENIL-VS--------------------------QSGVVKLCDFGFAR 148

Query: 269 TFEHQDHSYV--VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
           T       Y   V+TR YRAPE+++G   +    D+W+VGC++ E+ +GE LF    +++
Sbjct: 149 TLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID 208

Query: 326 HLAMMERVLGPL-PHHMVI 343
            L  + + LG L P H  I
Sbjct: 209 QLYHIIKCLGNLIPRHQEI 227

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  104 bits (262), Expect = 2e-25
 Identities = 74/253 (29%), Positives = 113/253 (44%), Gaps = 43/253 (16%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA------AMIEIDVLQRLA 146
           RY    K+GEGT+  V +  D E   +VAIK ++   +          A+ EI +LQ L 
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL- 59

Query: 147 RHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
           +H  I G   V     F ++++I +VFE +   L   ++  S    P D ++      L 
Sbjct: 60  KHPNIIGLLDV-----FGHKSNINLVFEFMETDLEKVIKDKSIVLTPAD-IKSYMLMTLR 113

Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
            + ++H   ++H DLKP N+L+ S   +K+ D+  L+RS                    F
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIASDGVLKLADFG-LARS--------------------F 152

Query: 266 GS--TTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHE 322
           GS      HQ     V TR YRAPE++ G   +    D+WSVGCI  EL           
Sbjct: 153 GSPNRKMTHQ-----VVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207

Query: 323 NLEHLAMMERVLG 335
           +++ L  +   LG
Sbjct: 208 DIDQLGKIFEALG 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 4e-25
 Identities = 70/230 (30%), Positives = 105/230 (45%), Gaps = 43/230 (18%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA---AMIEIDVLQRLARHD 149
            Y++   +G G FG V +  + E  + VAIK +       EA    M EID+L+ L   +
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 150 IGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I     V+     +  + + I+ E     SL   ++K  +  FP  LV     Q+L+ +A
Sbjct: 61  I-----VKYIGSIETSDSLYIILEYAENGSLRQIIKK--FGPFPESLVAVYVYQVLQGLA 113

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++HE  +IH D+K  NIL                  +KDG           +KL DFG  
Sbjct: 114 YLHEQGVIHRDIKAANILT-----------------TKDGV----------VKLADFGVA 146

Query: 269 T----FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           T        D S VV T ++ APEVI   G +   D+WS+GC ++EL +G
Sbjct: 147 TKLNDVSKDDAS-VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTG 195

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  103 bits (260), Expect = 6e-25
 Identities = 69/263 (26%), Positives = 109/263 (41%), Gaps = 59/263 (22%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--------YREAAMIEIDVLQR 144
           RY +L  +G G +G V    D      VAIK + ++           RE     I +L+ 
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILRE-----IKLLRH 55

Query: 145 LARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGR--- 201
           L   +I G   +      +  N + IV E +   L+  ++       P  L  +  +   
Sbjct: 56  LRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKS------PQPLTDDHIQYFL 109

Query: 202 -QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+L  + ++H   +IH DLKP NIL+                         N   +  +
Sbjct: 110 YQILRGLKYLHSANVIHRDLKPSNILV-------------------------N--SNCDL 142

Query: 261 KLIDFG-----STTFEHQDH--SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELC 312
           K+ DFG         + +     YVV TR YRAPE++L    +    D+WSVGCI  EL 
Sbjct: 143 KICDFGLARGVDPDEDEKGFLTEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL 201

Query: 313 SGEALFQTHENLEHLAMMERVLG 335
           + + LF   + ++ L ++  VLG
Sbjct: 202 TRKPLFPGRDYIDQLNLIVEVLG 224

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  101 bits (254), Expect = 1e-24
 Identities = 66/260 (25%), Positives = 111/260 (42%), Gaps = 56/260 (21%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI----EIDVLQRLARH 148
           R++  +K+G GTFG+V    + +  EL+A+K +R I       +     E+ VL+ L   
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIR-IQDNDPKTIKEIADEMKVLELLKHP 59

Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
           ++     V++     +R  + I F +   G +L + L     R     ++R    QLLE 
Sbjct: 60  NLVKYYGVEV-----HREKVYI-FMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEG 111

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +A++H   ++H D+KP NI L                             +  IKL DFG
Sbjct: 112 LAYLHSHGIVHRDIKPANIFLD---------------------------HNGVIKLGDFG 144

Query: 267 S-------TTFEHQDHSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCSG-- 314
                   TT   ++   +  T  Y APEVI G    G     D+WS+GC+++E+ +G  
Sbjct: 145 CAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Query: 315 --EALFQTHENLEHLAMMER 332
               L    + + H+    +
Sbjct: 205 PWSELDNEFQIMFHVGAGHK 224

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  101 bits (253), Expect = 2e-24
 Identities = 72/254 (28%), Positives = 122/254 (48%), Gaps = 49/254 (19%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDIG 151
           ++ L K+GEGT+  V +  +    E+VA+K +   +       A+ EI +++ L   +I 
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI- 60

Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYR-SFPIDLVRELGRQLLESVAFM 210
               V++ +     N + +VFE +   L  ++  +  R +   + V+    QLL+ +AF 
Sbjct: 61  ----VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116

Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG---- 266
           HE R++H DLKP+N+L+                 +K G           +KL DFG    
Sbjct: 117 HENRVLHRDLKPQNLLI-----------------NKRGE----------LKLADFGLARA 149

Query: 267 ----STTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
                 TF ++     V T  YRAP+V+LG   ++   D+WSVGCI+ E+ +G  LF   
Sbjct: 150 FGIPVNTFSNE-----VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT 204

Query: 322 ENLEHLAMMERVLG 335
            N + L  + R++G
Sbjct: 205 NNEDQLLKIFRIMG 218

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  102 bits (256), Expect = 2e-24
 Identities = 78/253 (30%), Positives = 120/253 (47%), Gaps = 60/253 (23%)

Query: 86  IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV-----------RSINKYREA 134
           I +++  +Y IL K+G+G +G V +  D   KE+VA+K +           R+   +RE 
Sbjct: 1   IDKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRT---FRE- 56

Query: 135 AMIEIDVLQRLARHD-IGGTRCVQIRNWFDYRNH--ICIVFEKLGPSLYDFLRKNSYRSF 191
               I  LQ L  H  I     V++ N     N   I +VFE +   L+  +R N     
Sbjct: 57  ----IMFLQELGDHPNI-----VKLLNVIKAENDKDIYLVFEYMETDLHAVIRAN----- 102

Query: 192 PIDLVRELGR-----QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246
              ++ ++ +     QLL+++ ++H   +IH DLKP NILL S   VK+ D+  L+RS  
Sbjct: 103 ---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFG-LARS-- 156

Query: 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW-NYPCDLWSVG 305
                           +       E+   +  V+TR YRAPE++LG        D+WSVG
Sbjct: 157 ----------------LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVG 200

Query: 306 CILVELCSGEALF 318
           CIL E+  G+ LF
Sbjct: 201 CILGEMLLGKPLF 213

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 99.1 bits (248), Expect = 6e-24
 Identities = 65/243 (26%), Positives = 111/243 (45%), Gaps = 47/243 (19%)

Query: 101 GEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMI--EIDVLQRLARHDIGGTRCV 156
           G+G+FG+V+     +  +L A+K+++   I K +E      E ++L R+  H       V
Sbjct: 2   GKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPF----IV 56

Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           ++   F     + +V E   G  L+  L K     F  +  R    +++ ++ ++H L +
Sbjct: 57  KLHYAFQTEEKLYLVLEYAPGGELFSHLSK--EGRFSEERARFYAAEIVLALEYLHSLGI 114

Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS----TTFE 271
           I+ DLKPENILL                   DG           IKL DFG     ++  
Sbjct: 115 IYRDLKPENILL-----------------DADGH----------IKLTDFGLAKELSSEG 147

Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 331
            + +++   T  Y APEV+LG G+    D WS+G +L E+ +G+  F   +  E   + E
Sbjct: 148 SRTNTF-CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYE 203

Query: 332 RVL 334
           ++L
Sbjct: 204 KIL 206

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 99.5 bits (248), Expect = 1e-23
 Identities = 76/252 (30%), Positives = 115/252 (45%), Gaps = 35/252 (13%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR---EAAMIEIDVLQRLARHDI 150
           Y  L K+GEGT+G+V +  D    +LVA+K  R           A+ EI +LQ L+   I
Sbjct: 3   YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLS-ESI 61

Query: 151 GGTRCVQIRNWFDYRNHICI--VFEKLGPSLYDFL---RKNSYRSFPIDLVRELGRQLLE 205
              R + + +  +      +  VFE L   L  F+    +   R  P   ++    QLL+
Sbjct: 62  YIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121

Query: 206 SVAFMHELRLIHTDLKPENILL-VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
            VA  H+  ++H DLKP+N+L+      +K+ D   L R+                  I 
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG-LGRAFS----------------IP 164

Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHEN 323
             S T E       + T  YRAPEV+LG   ++ P D+WSVGCI  E+   + LF     
Sbjct: 165 VKSYTHE-------IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE 217

Query: 324 LEHLAMMERVLG 335
           L+ L  + ++LG
Sbjct: 218 LQQLLHIFKLLG 229

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 98.9 bits (247), Expect = 1e-23
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 28/222 (12%)

Query: 103 GTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARHDIGGTRCVQI 158
           G +G+V         ++ AIK+++  +  R+      + E D+L +     +     V++
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYV-----VKL 58

Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
              F  + ++ +V E L G  L   L   +  S   D+ R    +++ ++ ++H   +IH
Sbjct: 59  YYSFQGKKNLYLVMEYLPGGDLASLLE--NVGSLDEDVARIYIAEIVLALEYLHSNGIIH 116

Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
            DLKP+NIL+ S  ++K+ D+      SK G   + +  +   K            +   
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGL----SKVGLVRRQINLNDDEK------------EDKR 160

Query: 278 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
           +V T  Y APEVILG G +   D WS+GCIL E   G   F 
Sbjct: 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH 202

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 99.4 bits (248), Expect = 2e-23
 Identities = 73/247 (29%), Positives = 109/247 (44%), Gaps = 40/247 (16%)

Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI----EIDVLQRLARHDIGG 152
           L+++GEGT+G V    D    E+VA+K VR ++  R+   I    EI +L  L   +I  
Sbjct: 12  LNRIGEGTYGIVYRARDTTSGEIVALKKVR-MDNERDGIPISSLREITLLLNLRHPNIVE 70

Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
            + V +    D    I +V E     L   L  N    F    V+ L  QLL  + ++HE
Sbjct: 71  LKEVVVGKHLD---SIFLVMEYCEQDLASLL-DNMPTPFSESQVKCLMLQLLRGLQYLHE 126

Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFE 271
             +IH DLK  N+LL                                +K+ DFG + T+ 
Sbjct: 127 NFIIHRDLKVSNLLLTD---------------------------KGCLKIADFGLARTYG 159

Query: 272 HQDHSY--VVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
                    V T  YRAPE++LG   +    D+W+VGCIL EL + + L      +E L 
Sbjct: 160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLD 219

Query: 329 MMERVLG 335
           ++ ++LG
Sbjct: 220 LIIQLLG 226

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 98.2 bits (245), Expect = 3e-23
 Identities = 74/256 (28%), Positives = 117/256 (45%), Gaps = 53/256 (20%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARHD 149
           Y+ + K+GEGT+G V +  D    E+VA+K +R +    E     A+ EI +L+ L  H 
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIR-LETEDEGVPSTAIREISLLKEL-NHP 58

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
                 V++ +     N + +VFE L   L  ++  +        L++    QLL+ +A+
Sbjct: 59  ----NIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST- 268
            H  R++H DLKP+N+L                           + +  A+KL DFG   
Sbjct: 115 CHSHRVLHRDLKPQNLL---------------------------IDREGALKLADFGLAR 147

Query: 269 -------TFEHQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQ 319
                  T+ H+     V T  YRAPE++LG    Y  P D+WS+GCI  E+ +   LF 
Sbjct: 148 AFGVPVRTYTHE-----VVTLWYRAPEILLG-SRQYSTPVDIWSIGCIFAEMVNRRPLFP 201

Query: 320 THENLEHLAMMERVLG 335
               ++ L  + R LG
Sbjct: 202 GDSEIDQLFRIFRTLG 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 98.5 bits (246), Expect = 3e-23
 Identities = 69/252 (27%), Positives = 118/252 (46%), Gaps = 44/252 (17%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARHD 149
           Y  L+++ EGT+G V    D +  E+VA+K ++ + K +E     ++ EI++L +L +H 
Sbjct: 7   YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK-MEKEKEGFPITSLREINILLKL-QHP 64

Query: 150 IGGTRCVQIRNWF--DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
                 V ++        + I +V E +   L   + +   + F    V+ L  QLL  V
Sbjct: 65  ----NIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLM-ETMKQPFLQSEVKCLMLQLLSGV 119

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
           A +H+  ++H DLK  N+LL                 +  G           +K+ DFG 
Sbjct: 120 AHLHDNWILHRDLKTSNLLL-----------------NNRG----------ILKICDFGL 152

Query: 267 STTFEHQDHSY--VVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHEN 323
           +  +      Y  +V T  YRAPE++LG   ++   D+WSVGCI  EL + + LF     
Sbjct: 153 AREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE 212

Query: 324 LEHLAMMERVLG 335
           ++ L  + ++LG
Sbjct: 213 IDQLNKIFKLLG 224

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 97.1 bits (242), Expect = 4e-23
 Identities = 71/258 (27%), Positives = 120/258 (46%), Gaps = 46/258 (17%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSIN-KYREAAMIEIDVLQRLARHD 149
            +++L K+G+G++G V +       +  A+K V   S++ K RE A+ EI +L  +   +
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSY--RSFPIDLVRELGRQLLE 205
           I     +  +  F   N +CIV E    G  L   + K     +  P   +  +  QLL 
Sbjct: 61  I-----ISYKEAFLDGNKLCIVMEYAPFG-DLSKAISKRKKKRKLIPEQEIWRIFIQLLR 114

Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
            +  +HE +++H DLK  NILLV+ + VK+ D   +S+  K     KN+ K+        
Sbjct: 115 GLQALHEQKILHRDLKSANILLVANDLVKIGDLG-ISKVLK-----KNMAKT-------- 160

Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
                        + T HY APEV  G  ++Y  D+WS+GC+L E+ +    F+   +++
Sbjct: 161 ------------QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA-RSMQ 207

Query: 326 HLAMMERVLG----PLPH 339
            L    +V      P+P 
Sbjct: 208 DLRY--KVQRGKYPPIPP 223

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 97.7 bits (244), Expect = 5e-23
 Identities = 64/230 (27%), Positives = 107/230 (46%), Gaps = 45/230 (19%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           Y+ L K+GEG  G+V +  D    + VAIK +R   + +E  + EI +++     +I   
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI--- 77

Query: 154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRE----LGRQLLESVA 208
             V   + +   + + +V E + G SL D + +N      + +       + R++L+ + 
Sbjct: 78  --VDYYDSYLVGDELWVVMEYMDGGSLTDIITQN-----FVRMNEPQIAYVCREVLQGLE 130

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-- 266
           ++H   +IH D+K +NILL                 SKDGS          +KL DFG  
Sbjct: 131 YLHSQNVIHRDIKSDNILL-----------------SKDGS----------VKLADFGFA 163

Query: 267 -STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
              T E    + VV T ++ APEVI    +    D+WS+G + +E+  GE
Sbjct: 164 AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 98.1 bits (245), Expect = 6e-23
 Identities = 73/251 (29%), Positives = 116/251 (46%), Gaps = 27/251 (10%)

Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRL 145
            ++ PRY+ LS +GEG +G V           VAIK +       + +  + EI +L+R 
Sbjct: 1   FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF 60

Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
              +I G   +     F+  N + IV E +   LY  ++     +   D ++    Q+L 
Sbjct: 61  KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSN---DHIQYFLYQILR 117

Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
            + ++H   ++H DLKP N+LL +   +K+ D+  L+R               A    D 
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFG-LAR--------------IADPEHDH 162

Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENL 324
                E+      V+TR YRAPE++L   G+    D+WSVGCIL E+ S   LF   + L
Sbjct: 163 TGFLTEY------VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL 216

Query: 325 EHLAMMERVLG 335
             L ++  VLG
Sbjct: 217 HQLNLILGVLG 227

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 97.3 bits (242), Expect = 7e-23
 Identities = 71/254 (27%), Positives = 112/254 (44%), Gaps = 36/254 (14%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE---AAMIEIDVLQRLARHD 149
           +Y  ++++G G +G V +  D      VA+K VR          + + E+ +L+RL   D
Sbjct: 1   QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60

Query: 150 IGGTR-----CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
                     C   R   D    + +VFE +   L  +L K      P + +++L RQ L
Sbjct: 61  HPNIVRLMDVCATSRT--DRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFL 118

Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
             + F+H   ++H DLKPENIL+ S   VK+ D+      ++  S               
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGL----ARIYSC-------------- 160

Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
                      + VV T  YRAPEV+L   +  P D+WSVGCI  E+   + LF  +   
Sbjct: 161 -------QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 213

Query: 325 EHLAMMERVLGPLP 338
           + L  +  ++G LP
Sbjct: 214 DQLGKIFDLIG-LP 226

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 97.1 bits (242), Expect = 1e-22
 Identities = 66/271 (24%), Positives = 119/271 (43%), Gaps = 40/271 (14%)

Query: 85  AIGENLTPRYRILSK-MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI------ 137
            +  +++ RY      +GEGT+G+V + +D    ++VAIK V+ I +             
Sbjct: 1   NMSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVK-IIEISNDVTKDRQLVG 59

Query: 138 ----------EIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK-- 185
                     E+ ++  +   +I G   V +   F     I +V + +     D L+K  
Sbjct: 60  MCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDF-----INLVMDIMA---SD-LKKVV 110

Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
           +         V+ +  Q+L  +  +H+   +H DL P NI + S    K+ D+  L+R  
Sbjct: 111 DRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG-LARRY 169

Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSV 304
               Y   L K   ++           ++ +  V T  YRAPE+++G   +++  D+WSV
Sbjct: 170 GYPPYSDTLSKDETMQR---------REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSV 220

Query: 305 GCILVELCSGEALFQTHENLEHLAMMERVLG 335
           GCI  EL +G+ LF     ++ L  +  +LG
Sbjct: 221 GCIFAELLTGKPLFPGENEIDQLGRIFELLG 251

Length = 335

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 97.2 bits (242), Expect = 2e-22
 Identities = 81/277 (29%), Positives = 135/277 (48%), Gaps = 51/277 (18%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY-REAAMI--EIDVLQRLARH- 148
           RY+I   +G+G++G V    D    E VAIK +  + ++  +A  I  EI +L RL RH 
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLL-RLLRHP 59

Query: 149 DIGGTRCVQIRNWF------DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGR- 201
           DI     V+I++        ++++ I +VFE +   L+  ++ N       DL  E  + 
Sbjct: 60  DI-----VEIKHIMLPPSRREFKD-IYVVFELMESDLHQVIKAND------DLTPEHHQF 107

Query: 202 ---QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              QLL ++ ++H   + H DLKP+NIL  +   +K+ D+  L+R +     F + P  +
Sbjct: 108 FLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFG-LARVA-----FNDTP--T 159

Query: 259 AIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEA 316
           AI   D+             V+TR YRAPE+       Y    D+WS+GCI  E+ +G+ 
Sbjct: 160 AIFWTDY-------------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 206

Query: 317 LFQTHENLEHLAMMERVLGPLPHHMVIRA-DRRAEKY 352
           LF     +  L ++  +LG      + R  + +A +Y
Sbjct: 207 LFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRY 243

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 95.6 bits (238), Expect = 3e-22
 Identities = 80/269 (29%), Positives = 127/269 (47%), Gaps = 48/269 (17%)

Query: 87  GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVL 142
           G+    ++ I+ ++GEGT+GQV +  D +  ELVA+K VR  N+ +E     A+ EI +L
Sbjct: 2   GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKIL 60

Query: 143 QRLARHDIGGTRCVQI----RNWFDYRNH---ICIVFEKLGPSLYDFLRKNSYRSFPIDL 195
           ++L   +I      +I    ++  D++       +VFE +   L   L ++    F  D 
Sbjct: 61  RQLNHRNI--VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL-ESGLVHFSEDH 117

Query: 196 VRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 255
           ++   +QLLE + + H+   +H D+K  NILL                            
Sbjct: 118 IKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---------------------------N 150

Query: 256 KSSAIKLIDFGSTTFEHQDHS--YV--VSTRHYRAPEVILGLGWNYPC-DLWSVGCILVE 310
               IKL DFG     + + S  Y   V T  YR PE++LG     P  D+WS GCIL E
Sbjct: 151 NKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE 210

Query: 311 LCSGEALFQTHENLEHLAMMERVLG-PLP 338
           L + + +FQ ++ L  L ++ R+ G P P
Sbjct: 211 LFTKKPIFQANQELAQLELISRLCGSPCP 239

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 94.8 bits (236), Expect = 9e-22
 Identities = 71/263 (26%), Positives = 122/263 (46%), Gaps = 54/263 (20%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARH 148
           +Y  L+K+G+GTFG+V +    + K++VA+K V   N+ +E     A+ EI +LQ L +H
Sbjct: 13  KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLL-KH 70

Query: 149 D-------IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGR 201
           +       I  T+         Y+    +VFE     L   L  N    F +  ++++ +
Sbjct: 71  ENVVNLIEICRTKATPYNR---YKGSFYLVFEFCEHDLAGLL-SNKNVKFTLSEIKKVMK 126

Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
            LL  + ++H  +++H D+K  NIL+                 +KDG           +K
Sbjct: 127 MLLNGLYYIHRNKILHRDMKAANILI-----------------TKDG----------ILK 159

Query: 262 LIDFG-----STTFEHQDHSYV--VSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELC 312
           L DFG     S +   + + Y   V T  YR PE++LG   +Y  P D+W  GCI+ E+ 
Sbjct: 160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG-ERDYGPPIDMWGAGCIMAEMW 218

Query: 313 SGEALFQTHENLEHLAMMERVLG 335
           +   + Q +     L ++ ++ G
Sbjct: 219 TRSPIMQGNTEQHQLTLISQLCG 241

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 93.5 bits (232), Expect = 2e-21
 Identities = 70/253 (27%), Positives = 117/253 (46%), Gaps = 38/253 (15%)

Query: 93  RYRILSKMGEGTFGQVVECFD-NEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLAR 147
           +Y  ++++GEG +G+V +  D       VA+K VR +    E    + + E+ VL+ L  
Sbjct: 2   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIREVAVLRHLET 60

Query: 148 HDIGGTR-----CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
            +          C   R   D    + +VFE +   L  +L K      P + ++++  Q
Sbjct: 61  FEHPNVVRLFDVCTVSRT--DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 118

Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           LL  + F+H  R++H DLKP+NIL+ S+  +K+ D+                      ++
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL-------------------ARI 159

Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322
             F          + VV T  YRAPEV+L   +  P DLWSVGCI  E+   + LF+   
Sbjct: 160 YSFQMAL------TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213

Query: 323 NLEHLAMMERVLG 335
           +++ L  +  V+G
Sbjct: 214 DVDQLGKILDVIG 226

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 91.8 bits (228), Expect = 3e-21
 Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 35/219 (15%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV------RSINKYREAAMIEIDVLQRLARHDIGGT 153
           +G+G FG+V  C+D +    +A+K V          K   A   EI +L+ L +H+    
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHE---- 64

Query: 154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
           R VQ          + I  E + G S+ D L+  +Y +    + R+  RQ+LE V ++H 
Sbjct: 65  RIVQYYGCLRDDETLSIFMEYMPGGSVKDQLK--AYGALTETVTRKYTRQILEGVEYLHS 122

Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
             ++H D+K  NIL  SA  VK+ D+     +SK         +   I      S T   
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFG----ASK---------RLQTICS----SGTGM- 164

Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
                V  T ++ +PEVI G G+    D+WSVGC +VE+
Sbjct: 165 ---KSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEM 200

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 91.6 bits (228), Expect = 1e-20
 Identities = 74/307 (24%), Positives = 133/307 (43%), Gaps = 45/307 (14%)

Query: 90  LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREA--AMIEIDVLQRLA 146
           +  RY+ +  +G G +G V    D    + VAIK I  + +    A   + E+ +L+   
Sbjct: 3   VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK 62

Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
             +I   R +      D++  + +V + +   L+  +  +  +    + +R    QLL  
Sbjct: 63  HDNIIAIRDILRPPGADFK-DVYVVMDLMESDLHHIIHSD--QPLTEEHIRYFLYQLLRG 119

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLI 263
           + ++H   +IH DLKP N+L+     +++ D+   + LS S  +  YF            
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT---------- 169

Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHE 322
                  E+      V+TR YRAPE++L L  +    D+WSVGCI  E+     LF    
Sbjct: 170 -------EY------VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN 216

Query: 323 NLEHLAMMERVLGPLPHHMV--IRADRRAEKY---FRRGARLDW----PDGATSRDSMRA 373
            +  L ++  VLG     ++  I +D R  KY     R   + W    P    S +++  
Sbjct: 217 YVHQLKLILSVLGSPSEEVLNRIGSD-RVRKYIQNLPRKQPVPWSKIFPK--ASPEALDL 273

Query: 374 VWKLLRL 380
           + ++L+ 
Sbjct: 274 LSQMLQF 280

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 90.4 bits (225), Expect = 1e-20
 Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 37/225 (16%)

Query: 101 GEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRCV 156
           G G FG+V       K    A+K V  R I +  +   I  E ++L+    H       V
Sbjct: 2   GVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILE-ECNHPF----IV 56

Query: 157 QIRNWFDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           ++   F  + +I ++ E  LG  L+  LR      F     R     ++ +  ++H   +
Sbjct: 57  KLYRTFKDKKYIYMLMEYCLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGI 114

Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           I+ DLKPEN+LL S  YVK+ D+ F                    K +  G  T+     
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGF-------------------AKKLKSGQKTWT---- 151

Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320
                T  Y APE+IL  G+++  D WS+G +L EL +G   F  
Sbjct: 152 --FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGE 194

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 90.6 bits (225), Expect = 2e-20
 Identities = 70/252 (27%), Positives = 120/252 (47%), Gaps = 44/252 (17%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR---EAAMIEIDVLQRLARHDI 150
           Y  + K+GEGT+G V +  + +  ++VA+K +R  ++       A+ EI +L+ L   +I
Sbjct: 2   YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61

Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSL---YDFLRKNSYRSFPIDLVRELGRQLLESV 207
                V +++     + + ++FE L   L    D L K  Y     +LV+    Q+L+ +
Sbjct: 62  -----VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQY--MDAELVKSYLYQILQGI 114

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
            F H  R++H DLKP+N+L+                                IKL DFG 
Sbjct: 115 LFCHSRRVLHRDLKPQNLLI---------------------------DNKGVIKLADFGL 147

Query: 267 --STTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHEN 323
             +     + +++ V T  YRAPEV+LG   ++ P D+WS+G I  E+ + + LF     
Sbjct: 148 ARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE 207

Query: 324 LEHLAMMERVLG 335
           ++ L  + R+LG
Sbjct: 208 IDQLFRIFRILG 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 89.5 bits (222), Expect = 4e-20
 Identities = 72/256 (28%), Positives = 122/256 (47%), Gaps = 50/256 (19%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARH 148
           +Y  + K+GEGT+G V +  D    E +A+K +R + +  E     A+ EI +L+ +   
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIR-LEQEDEGVPSTAIREISLLKEMQHG 61

Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           +I     V++++       + +VFE L   L   +  +   +    L++    Q+L  +A
Sbjct: 62  NI-----VRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           + H  R++H DLKP+N+L              + R             ++A+KL DFG  
Sbjct: 117 YCHSHRVLHRDLKPQNLL--------------IDRR------------TNALKLADFGLA 150

Query: 269 --------TFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQ 319
                   TF H+     V T  YRAPE++LG   ++ P D+WSVGCI  E+ + + LF 
Sbjct: 151 RAFGIPVRTFTHE-----VVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFP 205

Query: 320 THENLEHLAMMERVLG 335
               ++ L  + R+LG
Sbjct: 206 GDSEIDELFKIFRILG 221

Length = 294

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 90.1 bits (223), Expect = 5e-20
 Identities = 71/277 (25%), Positives = 127/277 (45%), Gaps = 54/277 (19%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ L+ +G G +G V   +D   ++ VA+K        ++ +   YRE     + +L+ 
Sbjct: 16  RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRE-----LRLLKH 70

Query: 145 LARHDIGG-----TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVREL 199
           +   ++ G     T    I N+    N + +V   +G  L + ++    +    + V+ L
Sbjct: 71  MKHENVIGLLDVFTPATSIENF----NEVYLVTNLMGADLNNIVK---CQKLSDEHVQFL 123

Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
             QLL  + ++H   +IH DLKP N+ +                            +   
Sbjct: 124 IYQLLRGLKYIHSAGIIHRDLKPSNVAV---------------------------NEDCE 156

Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALF 318
           ++++DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL  G+ALF
Sbjct: 157 LRILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216

Query: 319 QTHENLEHLA-MMERVLGPLPHHMVIRADRRAEKYFR 354
             ++ ++ L  +ME V  P P  +   +   A KY +
Sbjct: 217 PGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQ 253

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 88.8 bits (221), Expect = 5e-20
 Identities = 61/236 (25%), Positives = 101/236 (42%), Gaps = 55/236 (23%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR----LARH 148
            + +L  +G+G+FG+V +  D    ++VAIK++       E A  EI+ +Q+    L+  
Sbjct: 2   LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID-----LEEAEDEIEDIQQEIQFLS-- 54

Query: 149 DIGGTRCVQIRNWF-----DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQ 202
                R   I  ++       +  + I+ E   G S  D L+           +  + R+
Sbjct: 55  ---QCRSPYITKYYGSFLKGSK--LWIIMEYCGGGSCLDLLK---PGKLDETYIAFILRE 106

Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++HE   IH D+K  NILL                 S++G           +KL
Sbjct: 107 VLLGLEYLHEEGKIHRDIKAANILL-----------------SEEGD----------VKL 139

Query: 263 IDFGST---TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
            DFG +   T      +  V T  + APEVI   G++   D+WS+G   +EL  GE
Sbjct: 140 ADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGE 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 89.7 bits (223), Expect = 9e-20
 Identities = 62/236 (26%), Positives = 107/236 (45%), Gaps = 17/236 (7%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAA-MIEIDVLQRLARH 148
            + ++  +G G FG+V    D +  ++ A+K++R    I + + A    E D+L      
Sbjct: 2   DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSP 61

Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
            I     V++   F    H+ +V E + G  L + L +     FP +  R    +L+ ++
Sbjct: 62  WI-----VKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR--KDVFPEETARFYIAELVLAL 114

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR--SSKDGSYFKNLPKSSAIKLIDF 265
             +H+L  IH D+KP+NIL+ +  ++K+ D+    +   +KD  Y+ N   +   +    
Sbjct: 115 DSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174

Query: 266 GSTTFEHQDHSY---VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
                  Q        V T  Y APEV+ G  +   CD WS+G IL E+  G   F
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 87.8 bits (217), Expect = 3e-19
 Identities = 66/272 (24%), Positives = 122/272 (44%), Gaps = 47/272 (17%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE  ++      +
Sbjct: 18  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL------K 71

Query: 145 LARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
             +H+  IG           +  N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 72  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 128

Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+ +                            +   +K+
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAV---------------------------NEDCELKI 161

Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 162 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221

Query: 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYF 353
           ++++ L ++ R++G     ++ +    + + +
Sbjct: 222 DHIDQLKLILRLVGTPGAELLKKISSESARNY 253

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 87.4 bits (217), Expect = 3e-19
 Identities = 66/269 (24%), Positives = 117/269 (43%), Gaps = 55/269 (20%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
            Y IL K+GEGTFG+V +    +   +VA+K +  ++  ++     A+ EI +L++L   
Sbjct: 9   DYEILGKLGEGTFGEVYKARQIKTGRVVALKKI-LMHNEKDGFPITALREIKILKKLKHP 67

Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI---DLVRELG----- 200
           ++     V +         I +  E+  P      R + Y   P    DL   L      
Sbjct: 68  NV-----VPL---------IDMAVER--PDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK 111

Query: 201 ----------RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250
                      QLLE + ++HE  ++H D+K  NIL+ +   +K+ D+  L+R       
Sbjct: 112 LTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG-LARPYDGPPP 170

Query: 251 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCIL 308
             N            G T      ++ +V TR YR PE++LG    Y    D+W +GC+ 
Sbjct: 171 --NPKGGGG------GGTR----KYTNLVVTRWYRPPELLLGER-RYTTAVDIWGIGCVF 217

Query: 309 VELCSGEALFQTHENLEHLAMMERVLGPL 337
            E+ +   + Q   +++ L ++ ++ G  
Sbjct: 218 AEMFTRRPILQGKSDIDQLHLIFKLCGTP 246

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 85.9 bits (213), Expect = 4e-19
 Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 44/225 (19%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI------EIDVLQRLARHDIGGT 153
           +G G+FG V E  + +  +  A+K V   +  +           EI +L +L   +I   
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI--- 64

Query: 154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
             VQ        +++ I  E + G SL   L+K  Y SFP  ++R   RQ+L  + ++H+
Sbjct: 65  --VQYLGTEREEDNLYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHD 120

Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST--TF 270
              +H D+K  NIL+                   +G           +KL DFG      
Sbjct: 121 RNTVHRDIKGANILV-----------------DTNG----------VVKLADFGMAKQVV 153

Query: 271 EHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSG 314
           E         + ++ APEVI   G +    D+WS+GC ++E+ +G
Sbjct: 154 EFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATG 198

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 85.9 bits (213), Expect = 6e-19
 Identities = 74/253 (29%), Positives = 119/253 (47%), Gaps = 45/253 (17%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
           +Y  L K+GEGT+G V +  + E  E+VA+K VR ++   E    +A+ EI +L+ L   
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALREICLLKELKHK 59

Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK-NSYRSFPIDLVRELGRQLLESV 207
           +I     V++ +       + +VFE     L  +    N      I  V+    QLL+ +
Sbjct: 60  NI-----VRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEI--VKSFMFQLLKGL 112

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
           AF H   ++H DLKP+N+L+                 +K+G           +KL DFG 
Sbjct: 113 AFCHSHNVLHRDLKPQNLLI-----------------NKNGE----------LKLADFGL 145

Query: 267 --STTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELC-SGEALFQTHE 322
             +     + +S  V T  YR P+V+ G   ++   D+WS GCI  EL  +G  LF  ++
Sbjct: 146 ARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 205

Query: 323 NLEHLAMMERVLG 335
             + L  + R+LG
Sbjct: 206 VDDQLKRIFRLLG 218

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 86.9 bits (215), Expect = 6e-19
 Identities = 73/272 (26%), Positives = 119/272 (43%), Gaps = 45/272 (16%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINK--YREAAMIEIDVLQRLARHD 149
           RY  L ++G G +G V    D    E VAIK + R      + + A  E+ +L+ +   +
Sbjct: 16  RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75

Query: 150 IGGTRCVQI-----RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
           + G   V         + D        F  + P +   L+K        D V+ L  Q+L
Sbjct: 76  VIGLLDVFTSAVSGDEFQD--------FYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQML 127

Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
             + ++H   +IH DLKP N+ +                            +   +K++D
Sbjct: 128 CGLKYIHSAGIIHRDLKPGNLAV---------------------------NEDCELKILD 160

Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
           FG       + +  V TR YRAPEVIL  + +N   D+WSVGCI+ E+ +G+ LF+  + 
Sbjct: 161 FGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 220

Query: 324 LEHLAMMERVLG-PLPHHMVIRADRRAEKYFR 354
           L+ L  + +V G P P  +    D+ A+ Y +
Sbjct: 221 LDQLTQILKVTGVPGPEFVQKLEDKAAKSYIK 252

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 85.0 bits (211), Expect = 9e-19
 Identities = 57/230 (24%), Positives = 103/230 (44%), Gaps = 46/230 (20%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           + IL K+GEG++G V +    E  ++VAIK+V  + +  +  + EI +L++         
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQ--------C 55

Query: 154 RCVQIRNWFD---YRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
               I  ++        + IV E    G S+ D ++  + ++   + +  +  Q L+ + 
Sbjct: 56  DSPYIVKYYGSYFKNTDLWIVMEYCGAG-SVSDIMKITN-KTLTEEEIAAILYQTLKGLE 113

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-S 267
           ++H  + IH D+K  NILL                 +++G            KL DFG S
Sbjct: 114 YLHSNKKIHRDIKAGNILL-----------------NEEG----------QAKLADFGVS 146

Query: 268 TTFEH--QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
                     + V+ T  + APEVI  +G+N   D+WS+G   +E+  G+
Sbjct: 147 GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 85.0 bits (211), Expect = 9e-19
 Identities = 62/253 (24%), Positives = 110/253 (43%), Gaps = 44/253 (17%)

Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKI--VRSINKYREAAMIEIDVLQRLARHDIGG 152
             +  +G+G+ G V +       ++ A+K   V    ++R+  + E+  L+      +  
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYV-- 61

Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V+    F     I IV E + G SL D L+K      P  ++  + RQ+L+ + ++H
Sbjct: 62  ---VKCYGAFYKEGEISIVLEYMDGGSLADLLKK--VGKIPEPVLAYIARQILKGLDYLH 116

Query: 212 -ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STT 269
            +  +IH D+KP N+L+                 +  G           +K+ DFG S  
Sbjct: 117 TKRHIIHRDIKPSNLLI-----------------NSKGE----------VKIADFGISKV 149

Query: 270 FEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
            E+   Q +++V  T  Y +PE I G  ++Y  D+WS+G  L+E   G+  F        
Sbjct: 150 LENTLDQCNTFV-GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF 208

Query: 327 LAMMERVL-GPLP 338
             +M+ +  GP P
Sbjct: 209 FELMQAICDGPPP 221

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 68/256 (26%), Positives = 104/256 (40%), Gaps = 85/256 (33%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +GQV   FD +    VAIK         + +   YRE          R
Sbjct: 16  RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYREL---------R 66

Query: 145 LARHDIGGTRCVQIRNWFDYRNHIC------------------IVFEKLGPSLYDFLRKN 186
           L +H              D+ N I                   +V   +G  L + ++  
Sbjct: 67  LLKH-------------MDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC- 112

Query: 187 SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246
             +    D ++ L  Q+L  + ++H   +IH DLKP NI                     
Sbjct: 113 --QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNI--------------------- 149

Query: 247 DGSYFKNLPKSSAIKLIDFG---STTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLW 302
                  + +   +K++DFG    T  E   +   V+TR YRAPE++L  + +N   D+W
Sbjct: 150 ------AVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIW 200

Query: 303 SVGCILVELCSGEALF 318
           SVGCI+ EL +G+ LF
Sbjct: 201 SVGCIMAELLTGKTLF 216

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 40/227 (17%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHD 149
           ++I  K+G+G F  V +        +VA+K V+       K R+  + EID+L++L   +
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLR-----KNSYRSFPIDLVRELGRQLL 204
           +     ++    F   N + IV E L  +  D  R     K   R  P   + +   QL 
Sbjct: 64  V-----IKYLASFIENNELNIVLE-LADA-GDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116

Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
            ++  MH  R++H D+KP N+ + +   VK+ D          G +F     SS      
Sbjct: 117 SALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGL-------GRFF-----SS------ 158

Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
              TT  H     +V T +Y +PE I   G+N+  D+WS+GC+L E+
Sbjct: 159 --KTTAAHS----LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 85.2 bits (211), Expect = 3e-18
 Identities = 78/284 (27%), Positives = 119/284 (41%), Gaps = 67/284 (23%)

Query: 81  HYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSIN 129
            Y   +G++   +  RY+ L  +G G  G V   +D    + VAIK        +  +  
Sbjct: 2   FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKR 61

Query: 130 KYREAAMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNS 187
            YRE       VL +L  H   IG       +   +    + +V E +  +L   ++   
Sbjct: 62  AYREL------VLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ--- 112

Query: 188 YRSFPIDLVRE----LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243
                +DL  E    L  Q+L  +  +H   +IH DLKP NI++ S              
Sbjct: 113 -----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-------------- 153

Query: 244 SSKDGSYFKNLPKSSAIKLIDFG-----STTFEHQDHSYVVSTRHYRAPEVILGLGWNYP 298
                           +K++DFG      T+F      YVV TR+YRAPEVILG+G+   
Sbjct: 154 -------------DCTLKILDFGLARTAGTSFMMTP--YVV-TRYYRAPEVILGMGYKEN 197

Query: 299 CDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG-PLPHHM 341
            D+WSVGCI+ E+  G  LF   ++++    +   LG P    M
Sbjct: 198 VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 83.9 bits (207), Expect = 1e-17
 Identities = 71/257 (27%), Positives = 121/257 (47%), Gaps = 51/257 (19%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR------ 147
           Y++ + +G G+FG V E    +  E VAIK V    +Y+     E+ +++ L        
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR---ELLIMKNLNHINIIFL 124

Query: 148 HDIGGTRCVQI--RNWFDYRNHICIVFEKLGPSLYDFLRKNSY--RSFPIDLVRELGRQL 203
            D   T C +   +N F     + +V E +  +++ +++  +    + P+ LV+    QL
Sbjct: 125 KDYYYTECFKKNEKNIF-----LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL 179

Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
             ++A++H   + H DLKP+N+L+                           P +  +KL 
Sbjct: 180 CRALAYIHSKFICHRDLKPQNLLID--------------------------PNTHTLKLC 213

Query: 264 DFGSTT---FEHQDHSYVVSTRHYRAPEVILGLGWNYPC--DLWSVGCILVELCSGEALF 318
           DFGS        +  SY+ S R YRAPE++LG   NY    DLWS+GCI+ E+  G  +F
Sbjct: 214 DFGSAKNLLAGQRSVSYICS-RFYRAPELMLG-ATNYTTHIDLWSLGCIIAEMILGYPIF 271

Query: 319 QTHENLEHLAMMERVLG 335
               +++ L  + +VLG
Sbjct: 272 SGQSSVDQLVRIIQVLG 288

Length = 440

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 70/247 (28%), Positives = 120/247 (48%), Gaps = 37/247 (14%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA----MIEIDVLQRLARHD 149
           Y  L K+GEGT+  V +      + LVA+K +R   ++ E A    + E+ +L+ L   +
Sbjct: 7   YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRL--EHEEGAPCTAIREVSLLKNLKHAN 64

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
           I     V + +       + +VFE L   L  +L  N      +  V+    QLL  +++
Sbjct: 65  I-----VTLHDIIHTERCLTLVFEYLDSDLKQYL-DNCGNLMSMHNVKIFMFQLLRGLSY 118

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
            H+ +++H DLKP+N+L+     +K+ D+  L+R+       K++P  +           
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGELKLADFG-LARA-------KSVPTKT----------- 159

Query: 270 FEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
                +S  V T  YR P+V+LG   ++ P D+W VGCIL E+ +G  +F      E L 
Sbjct: 160 -----YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELH 214

Query: 329 MMERVLG 335
           ++ R+LG
Sbjct: 215 LIFRLLG 221

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 82.3 bits (203), Expect = 2e-17
 Identities = 70/258 (27%), Positives = 117/258 (45%), Gaps = 37/258 (14%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINK--YREAAMIEIDVLQRLARHD 149
           RYR L ++G G +G V    D      VAIK + R      + + A  E+ +L+ + +H+
Sbjct: 16  RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHE 74

Query: 150 --IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
             IG           D  +   +V   +G  L   ++   +     D ++ L  Q+L+ +
Sbjct: 75  NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK---HEKLSEDRIQFLVYQMLKGL 131

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
            ++H   +IH DLKP N L V+ +                            +K++DFG 
Sbjct: 132 KYIHAAGIIHRDLKPGN-LAVNED--------------------------CELKILDFGL 164

Query: 268 TTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                 + +  V TR YRAPEVIL  + +    D+WSVGCI+ E+ +G+ LF+ H++L+ 
Sbjct: 165 ARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ 224

Query: 327 LAMMERVLGPLPHHMVIR 344
           L  + +V G      V +
Sbjct: 225 LMEIMKVTGTPSKEFVQK 242

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 81.3 bits (201), Expect = 4e-17
 Identities = 71/246 (28%), Positives = 111/246 (45%), Gaps = 49/246 (19%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKI-----VRSINKYREAAMIEIDVLQRLARH 148
           ++IL+++G+G +GQV      +  E+VA+K      +  +N+ R   + E D+L    + 
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHV-LTERDILTT-TKS 60

Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
           +      V++   F    ++ +  E + G      L  N+      D  R    ++ E+V
Sbjct: 61  EW----LVKLLYAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFEAV 114

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
             +HEL  IH DLKPEN L+                    G           IKL DFG 
Sbjct: 115 DALHELGYIHRDLKPENFLI-----------------DASGH----------IKLTDFGL 147

Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE-LC-----SGEALFQT 320
           S       +S VV +  Y APEV+ G G+++  D WS+GC+L E LC     SG    +T
Sbjct: 148 SKGIVTYANS-VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET 206

Query: 321 HENLEH 326
            ENL++
Sbjct: 207 WENLKY 212

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 79.5 bits (196), Expect = 7e-17
 Identities = 70/269 (26%), Positives = 119/269 (44%), Gaps = 43/269 (15%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVR-----SINKYREAAMI-----EIDVLQRLARHD 149
           +G G+FG V    +    EL+A+K V      + +K R+ +M+     EI +L+ L   +
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I     VQ        +H+ I  E + G S+   L  N+Y +F   LVR   RQ+L+ + 
Sbjct: 68  I-----VQYLGSSLDADHLNIFLEYVPGGSVAALL--NNYGAFEETLVRNFVRQILKGLN 120

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           ++H   +IH D+K  NIL+ +   +K+ D+   K L  +S         P          
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS--------L 172

Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
             + F             + APEV+    +    D+WS+GC++VE+ +G+  F     L+
Sbjct: 173 QGSVF-------------WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ 219

Query: 326 HLAMM-ERVLGPLPHHMVIRADRRAEKYF 353
            +  + E     +P ++   A    EK F
Sbjct: 220 AIFKIGENASPEIPSNISSEAIDFLEKTF 248

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 8e-17
 Identities = 73/310 (23%), Positives = 119/310 (38%), Gaps = 90/310 (29%)

Query: 93  RYRILSKMGEGTFGQVVECF--DNEKKELVAIKIVRSINK---------YREAAMI-EID 140
           +Y I   +G GT+G+V +    + +  +  AIK  +   +          RE A++ E+ 
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 141 -----VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFL------RKNSYR 189
                 L  +        + V +   FDY  H             D        R+    
Sbjct: 61  HENVVSLVEVFLEH--ADKSVYLL--FDYAEH-------------DLWQIIKFHRQAKRV 103

Query: 190 SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249
           S P  +V+ L  Q+L  V ++H   ++H DLKP NIL++                  +G 
Sbjct: 104 SIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMG-----------------EG- 145

Query: 250 YFKNLPKSSAIKLIDFGSTTFEHQ------DHSYVVSTRHYRAPEVILGLG-WNYPCDLW 302
                P+   +K+ D G     +       D   VV T  YRAPE++LG   +    D+W
Sbjct: 146 -----PERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIW 200

Query: 303 SVGCILVELCSGEALFQTHE------NLEHLAMMER---VLGP-----------LPHHMV 342
           ++GCI  EL + E +F+  E      N      +ER   VLG            +P +  
Sbjct: 201 AIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDT 260

Query: 343 IRADRRAEKY 352
           +  D + + Y
Sbjct: 261 LMKDFKTKTY 270

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 67/280 (23%), Positives = 123/280 (43%), Gaps = 54/280 (19%)

Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLAR 147
           +L  RY  L  +G G+ G V    D++  + VA+K IV +  +  + A+ EI +++RL  
Sbjct: 2   DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDH 61

Query: 148 HDI---------GGTRCVQ-IRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVR 197
            +I          G+   + + +  +  + + IV E +   L + L +        +  R
Sbjct: 62  DNIVKVYEVLGPSGSDLTEDVGSLTELNS-VYIVQEYMETDLANVLEQGP---LSEEHAR 117

Query: 198 ELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 257
               QLL  + ++H   ++H DLKP N+ + + + V                        
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLV------------------------ 153

Query: 258 SAIKLIDFG-----STTFEHQDH-SYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVE 310
             +K+ DFG        + H+ + S  + T+ YR+P ++L    +    D+W+ GCI  E
Sbjct: 154 --LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAE 211

Query: 311 LCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAE 350
           + +G+ LF     LE    M+ +L  +P   V+R + R E
Sbjct: 212 MLTGKPLFAGAHELE---QMQLILESVP---VVREEDRNE 245

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 79/277 (28%), Positives = 126/277 (45%), Gaps = 39/277 (14%)

Query: 74  RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
           R    +  Y   IG++   +  RY+ L  +G G  G V   +D   +  VAIK + R   
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62

Query: 130 KYREA--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
               A  A  E+ VL +   H   IG       +   +    + IV E +  +L   ++ 
Sbjct: 63  NQTHAKRAYREL-VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM 121

Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
                   + +  L  Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++
Sbjct: 122 ----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA 176

Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
             G+ F   P                     YVV TR+YRAPEVILG+G+    D+WSVG
Sbjct: 177 --GTSFMMTP---------------------YVV-TRYYRAPEVILGMGYKENVDIWSVG 212

Query: 306 CILVELCSGEALFQTHENLEHL-AMMERVLGPLPHHM 341
           CI+ E+  G  LF   ++++    ++E++  P P  M
Sbjct: 213 CIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 77.3 bits (190), Expect = 3e-16
 Identities = 74/275 (26%), Positives = 125/275 (45%), Gaps = 43/275 (15%)

Query: 93  RYRILSKMGEGTFGQ---VVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD 149
           +Y +L  +GEG+FG+   V     ++K  +  I++ +S +   E +  E  +L ++   +
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAV-EDSRKEAVLLAKMKHPN 59

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I     V  +  F+   H+ IV E   G  L   ++    + FP D + +   Q+   V 
Sbjct: 60  I-----VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ 114

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
            +HE R++H D+K +NI              FL+++ K             +KL DFGS 
Sbjct: 115 HIHEKRVLHRDIKSKNI--------------FLTQNGK-------------VKLGDFGSA 147

Query: 269 TFEHQDHSYV---VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH--EN 323
                  +Y    V T +Y  PE+   + +N   D+WS+GCIL ELC+ +  FQ +  +N
Sbjct: 148 RLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN 207

Query: 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGAR 358
           L  L + +    PLP H         ++ F+R  R
Sbjct: 208 LI-LKVCQGSYKPLPSHYSYELRSLIKQMFKRNPR 241

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 78.7 bits (194), Expect = 4e-16
 Identities = 68/256 (26%), Positives = 111/256 (43%), Gaps = 44/256 (17%)

Query: 90  LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-----EIDVLQR 144
           +T RY  L  +G G FG V    D    + VAIK  + +  +    +      E+ +L+ 
Sbjct: 8   ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIK--KIMKPFSTPVLAKRTYRELKLLKH 65

Query: 145 LARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
           L   +I     + I    D    I  V E LG  L+  L     R      ++    Q+L
Sbjct: 66  LRHENIISLSDIFISPLED----IYFVTELLGTDLHRLLTS---RPLEKQFIQYFLYQIL 118

Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
             + ++H   ++H DLKP NIL+                            ++  +K+ D
Sbjct: 119 RGLKYVHSAGVVHRDLKPSNILI---------------------------NENCDLKICD 151

Query: 265 FG-STTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHE 322
           FG +   + Q   YV STR+YRAPE++L    ++   D+WS GCI  E+  G+ LF   +
Sbjct: 152 FGLARIQDPQMTGYV-STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210

Query: 323 NLEHLAMMERVLGPLP 338
           ++   +++  +LG  P
Sbjct: 211 HVNQFSIITDLLGTPP 226

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 78.2 bits (193), Expect = 5e-16
 Identities = 66/250 (26%), Positives = 117/250 (46%), Gaps = 30/250 (12%)

Query: 90  LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREA--AMIEIDVLQRLA 146
           +  +Y  +  +G G +G V    ++E  E VAIK I  + +   +A   + EI +L+ L 
Sbjct: 3   VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLD 62

Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
             ++   + +      +  N + IV+E +   L+  +R +  ++   D  +    QLL  
Sbjct: 63  HENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSS--QTLSDDHCQYFLYQLLRG 120

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           + ++H   ++H DLKP N+LL +   +K+ D+  L+R++ +   F               
Sbjct: 121 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFG-LARTTSEKGDFMT------------- 166

Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
                     YVV TR YRAPE++L    +    D+WSVGCI  EL   + LF   + + 
Sbjct: 167 ---------EYVV-TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH 216

Query: 326 HLAMMERVLG 335
            L ++  +LG
Sbjct: 217 QLKLITELLG 226

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 77.4 bits (190), Expect = 6e-16
 Identities = 62/231 (26%), Positives = 106/231 (45%), Gaps = 41/231 (17%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-EAAMIEIDVLQRLARHDIGG 152
           + I+ ++G+G FG+V +  + E   L A K++ + ++   E  M+EID+L      +I  
Sbjct: 7   WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI-- 64

Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
              V++ + F Y N++ I+ E       D +     R      +R + +Q LE++ ++HE
Sbjct: 65  ---VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121

Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG---STT 269
            ++IH DLK  NIL                  + DG           IKL DFG     T
Sbjct: 122 NKIIHRDLKAGNILF-----------------TLDGD----------IKLADFGVSAKNT 154

Query: 270 FEHQDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGE 315
              Q     + T ++ APEV++        ++Y  D+WS+G  L+E+   E
Sbjct: 155 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIE 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 76.7 bits (189), Expect = 7e-16
 Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 33/224 (14%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREAAMIEIDVLQRLARHD 149
            Y  +  +G+G FG+       E   LV  K V   R   K R  A+ EI +L  L   +
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I     +   N F   N + I  E   G +LYD + +   + F  ++V     Q++ +V+
Sbjct: 61  I-----IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVS 115

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H+  ++H D+K  NI L  A  +K+ D+     S   GS +               + 
Sbjct: 116 YIHKAGILHRDIKTLNIFLTKAGLIKLGDFGI---SKILGSEYS-------------MAE 159

Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312
           T        VV T +Y +PE+  G+ +N+  D+W++GC+L EL 
Sbjct: 160 T--------VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 76.7 bits (189), Expect = 8e-16
 Identities = 64/238 (26%), Positives = 100/238 (42%), Gaps = 43/238 (18%)

Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA--MIEIDVLQRL 145
            N    + I+ ++G+G FG+V +    E     A KI++ I    E    M+EID+L   
Sbjct: 1   VNPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQ-IESEEELEDFMVEIDILSEC 59

Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
            +H       V +   + Y N + I+ E       D +     R      +R + RQ+LE
Sbjct: 60  -KHP----NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLE 114

Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           ++ F+H  ++IH DLK  NILL                   DG           +KL DF
Sbjct: 115 ALNFLHSHKVIHRDLKAGNILLTL-----------------DGD----------VKLADF 147

Query: 266 GST---TFEHQDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGE 315
           G +       Q     + T ++ APEV+         ++Y  D+WS+G  L+EL   E
Sbjct: 148 GVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 77.0 bits (189), Expect = 9e-16
 Identities = 66/244 (27%), Positives = 120/244 (49%), Gaps = 35/244 (14%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE--AAMIEIDVLQRLARHDIG 151
           Y  L K+GEG++  V +       +LVA+K++R   +      A+ E  +L+ L   +I 
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI- 65

Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
               V + +    +  + +VFE +   L  ++ K+     P + V+    QLL  ++++H
Sbjct: 66  ----VLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHP-ENVKLFLFQLLRGLSYIH 120

Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
           +  ++H DLKP+N+L+     +K+ D+  L+R+       K++P           S T+ 
Sbjct: 121 QRYILHRDLKPQNLLISDTGELKLADFG-LARA-------KSVP-----------SHTYS 161

Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPC-DLWSVGCILVELCSGEALFQTHENLEHLAMM 330
           ++     V T  YR P+V+LG      C D+W VGCI VE+  G A F   ++++    +
Sbjct: 162 NE-----VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QL 214

Query: 331 ERVL 334
           ER+ 
Sbjct: 215 ERIF 218

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 62/260 (23%), Positives = 116/260 (44%), Gaps = 49/260 (18%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSI-------NKYREAAMIEIDVLQRLARHDI-- 150
           +G G F    +  D +   L+A+K V  +        +  EA   EI ++ RL    I  
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 151 --GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
             G T            +H  +  E + G S+   L K  Y +F   ++     QLL  +
Sbjct: 68  MLGATC---------EDSHFNLFVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGL 116

Query: 208 AFMHELRLIHTDLKPENILLVS-AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++HE ++IH D+K  N+L+ S  + +++ D+                   +A +L   G
Sbjct: 117 SYLHENQIIHRDVKGANLLIDSTGQRLRIADF------------------GAAARLAAKG 158

Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
           +   E Q    ++ T  + APEV+ G  +   CD+WSVGC+++E+ + +  +   ++  H
Sbjct: 159 TGAGEFQGQ--LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH 216

Query: 327 LAMMERVLG-----PLPHHM 341
           LA++ ++        +P H+
Sbjct: 217 LALIFKIASATTAPSIPEHL 236

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 76.0 bits (187), Expect = 1e-15
 Identities = 61/236 (25%), Positives = 107/236 (45%), Gaps = 43/236 (18%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHD 149
           +Y  + K+GEG+FG+ +     E  +   IK   I +   K RE +  E+ VL  +   +
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I     VQ +  F+   ++ IV +   G  LY  +       FP D + +   Q+  ++ 
Sbjct: 61  I-----VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-- 266
            +H+ +++H D+K +NI L                 +KDG           IKL DFG  
Sbjct: 116 HVHDRKILHRDIKSQNIFL-----------------TKDG----------TIKLGDFGIA 148

Query: 267 ---STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
              ++T E       + T +Y +PE+     +N   D+W++GC+L E+C+ +  F+
Sbjct: 149 RVLNSTVELA--RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 58/233 (24%), Positives = 107/233 (45%), Gaps = 45/233 (19%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-EAAMIEIDVLQRLARHDIGG 152
           + I+ ++G+G FG+V +  + E   L A K++ + ++   E  M+EI++L       I  
Sbjct: 14  WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYI-- 71

Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
              V++   F +   + I+ E       D +     R      ++ + RQ+LE++ ++H 
Sbjct: 72  ---VKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128

Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST---- 268
           +++IH DLK  N+LL                 + DG           IKL DFG +    
Sbjct: 129 MKIIHRDLKAGNVLL-----------------TLDGD----------IKLADFGVSAKNV 161

Query: 269 -TFEHQDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGE 315
            T + +D    + T ++ APEV++        ++Y  D+WS+G  L+E+   E
Sbjct: 162 KTLQRRDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 212

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 67/256 (26%), Positives = 109/256 (42%), Gaps = 40/256 (15%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREAAMIEIDVLQRLARHD 149
           +Y  +  +G G FG V  C     ++LV IK +   +     R AA  E  VL+ L+  +
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I     ++    F     + IV E   G +L ++++K        D +     Q+L ++ 
Sbjct: 61  I-----IEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH 115

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-S 267
            +H   ++H DLK +NILL   + V                          +K+ DFG S
Sbjct: 116 HVHTKLILHRDLKTQNILLDKHKMV--------------------------VKIGDFGIS 149

Query: 268 TTFEHQDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                +  +Y VV T  Y +PE+  G  +N   D+W++GC+L EL S +  F+   NL  
Sbjct: 150 KILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA-ANLPA 208

Query: 327 LAM--MERVLGPLPHH 340
           L +  M     P+   
Sbjct: 209 LVLKIMSGTFAPISDR 224

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 70/266 (26%), Positives = 111/266 (41%), Gaps = 63/266 (23%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREA--AMIEIDVLQRLA 146
           RY +  ++G+G+FG V    D +      +K+++ I        E   A  E  +L +L 
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60

Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLR--KNSYRSFPIDLVRELGRQL 203
              I     V+    F  R+  CI+ E   G  L   L   K++ ++   + V E   QL
Sbjct: 61  HPAI-----VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115

Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
           L  V +MH+ R++H DLK +NI L                            K++ +K+ 
Sbjct: 116 LLGVHYMHQRRILHRDLKAKNIFL----------------------------KNNLLKIG 147

Query: 264 DFG-----------STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312
           DFG           +TTF          T +Y +PE +   G++   D+WS+GCIL E+C
Sbjct: 148 DFGVSRLLMGSCDLATTF--------TGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMC 199

Query: 313 SGEALFQTHENLEHLAMMERVLGPLP 338
                F+    L    ++  V GP P
Sbjct: 200 CLAHAFEGQNFLS--VVLRIVEGPTP 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 75.5 bits (185), Expect = 2e-15
 Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 37/227 (16%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR------SINKYREAAMIEIDVLQRLAR 147
           +R+   +G+G FG+V  C+D +    +A+K V+        +K   A   EI +L+ L  
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63

Query: 148 HDIGGTRCVQIRNWF-DYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELGRQLL 204
                 R VQ      D       +F +  P  S+ D L+  SY +   ++ R+  RQ+L
Sbjct: 64  E-----RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK--SYGALTENVTRKYTRQIL 116

Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
           E V+++H   ++H D+K  NIL  S   VK+ D+                  S  ++ I 
Sbjct: 117 EGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFG----------------ASKRLQTIC 160

Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
              T  +      V  T ++ +PEVI G G+    D+WSVGC +VE+
Sbjct: 161 LSGTGMKS-----VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 72/253 (28%), Positives = 118/253 (46%), Gaps = 48/253 (18%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA---AMIEIDVLQRLAR--- 147
           Y+ L K+GEG++  V +       +LVA+K +R +     A   A+ E  +L+ L     
Sbjct: 7   YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIR-LEHEEGAPFTAIREASLLKDLKHANI 65

Query: 148 ---HDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
              HDI  T           +  + +VFE L   L  ++         +  VR    QLL
Sbjct: 66  VTLHDIIHT-----------KKTLTLVFEYLDTDLKQYMDDCG-GGLSMHNVRLFLFQLL 113

Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
             +A+ H+ R++H DLKP+N+L+     +K+ D+  L+R+       K++P         
Sbjct: 114 RGLAYCHQRRVLHRDLKPQNLLISERGELKLADFG-LARA-------KSVP--------- 156

Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
             S T+ ++     V T  YR P+V+LG   ++   D+W VGCI  E+ +G  LF    +
Sbjct: 157 --SKTYSNE-----VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD 209

Query: 324 -LEHLAMMERVLG 335
             + L  + RVLG
Sbjct: 210 VEDQLHKIFRVLG 222

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 68/247 (27%), Positives = 115/247 (46%), Gaps = 37/247 (14%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA----MIEIDVLQRLARHD 149
           Y  L K+GEGT+  V +        LVA+K +R   ++ E A    + E+ +L+ L   +
Sbjct: 8   YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRL--EHEEGAPCTAIREVSLLKDLKHAN 65

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
           I     V + +       + +VFE L   L  +L  +   S  +  V+    QLL  + +
Sbjct: 66  I-----VTLHDIIHTEKSLTLVFEYLDKDLKQYL-DDCGNSINMHNVKLFLFQLLRGLNY 119

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
            H  +++H DLKP+N+L+     +K+ D+  L+R+       K++P  +           
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFG-LARA-------KSIPTKT----------- 160

Query: 270 FEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
                +S  V T  YR P+++LG   ++   D+W VGCI  E+ +G  LF      E L 
Sbjct: 161 -----YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLH 215

Query: 329 MMERVLG 335
            + R+LG
Sbjct: 216 FIFRILG 222

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 68/250 (27%), Positives = 112/250 (44%), Gaps = 42/250 (16%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE---AAMIEIDVLQRLARHDI 150
           Y  L K+GEG++  V +       +LVA+K++ S+         A+ E  +L+ L   +I
Sbjct: 7   YLNLEKLGEGSYATVYKGISRINGQLVALKVI-SMKTEEGVPFTAIREASLLKGLKHANI 65

Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V + +    +  +  VFE +   L  ++ ++     P + VR    QLL  +A++
Sbjct: 66  -----VLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYN-VRLFMFQLLRGLAYI 119

Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG---S 267
           H   ++H DLKP+N+L+                     SY   L      KL DFG   +
Sbjct: 120 HGQHILHRDLKPQNLLI---------------------SYLGEL------KLADFGLARA 152

Query: 268 TTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQ-THENLE 325
            +   Q +S  V T  YR P+V+LG   ++   D+W  GCI +E+  G+  F    +  E
Sbjct: 153 KSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE 212

Query: 326 HLAMMERVLG 335
            L  +  VLG
Sbjct: 213 QLEKIWTVLG 222

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 74.6 bits (184), Expect = 4e-15
 Identities = 57/245 (23%), Positives = 106/245 (43%), Gaps = 42/245 (17%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDI 150
           Y +L  +G+G+FG V +       +++  K +   N   K ++  + E+++L+ L   +I
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61

Query: 151 GGTRCVQIRNWF-DYRNH-ICIVFEKL-GPSLYDFLRK--NSYRSFPIDLVRELGRQLLE 205
                V+  +   D  N  + IV E   G  L   ++K     +    + +  +  QLL 
Sbjct: 62  -----VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116

Query: 206 SVAFMHEL-----RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
           ++   H        ++H DLKP NI L +   VK+ D+  L++     S F         
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFG-LAKILGHDSSF--------- 166

Query: 261 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320
                 + T+        V T +Y +PE +  + ++   D+WS+GC++ ELC+    F  
Sbjct: 167 ------AKTY--------VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA 212

Query: 321 HENLE 325
              L+
Sbjct: 213 RNQLQ 217

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 74.1 bits (182), Expect = 5e-15
 Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 33/229 (14%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSIN-KYREAAMIEIDVLQRLARHDI 150
           + IL+K+G+G+FG V +      K + A+K +    +N + RE A+ E  VL +L    I
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 151 GGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
                ++    F  +  + IV E      L+  L+    R  P D V     Q+L  +A 
Sbjct: 62  -----IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
           +H  +++H D+K  N+ L + + VK+ D   +++   D + F N                
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLG-VAKLLSDNTNFANT--------------- 160

Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
                   +V T +Y +PE+     +N   D+W++G +L E C+G+  F
Sbjct: 161 --------IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPF 201

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 75.4 bits (185), Expect = 6e-15
 Identities = 47/134 (35%), Positives = 70/134 (52%), Gaps = 25/134 (18%)

Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++                
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA---------------- 173

Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
                 T F      YVV TR+YRAPEVILG+G+    D+WSVGCI+ EL  G  +FQ  
Sbjct: 174 -----CTNFMMT--PYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225

Query: 322 ENLEHLAMMERVLG 335
           ++++    +   LG
Sbjct: 226 DHIDQWNKVIEQLG 239

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 74.6 bits (183), Expect = 6e-15
 Identities = 67/247 (27%), Positives = 117/247 (47%), Gaps = 37/247 (14%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA----MIEIDVLQRLARHD 149
           Y  L K+GEGT+  V +      + LVA+K +R   ++ E A    + E+ +L+ L   +
Sbjct: 8   YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRL--EHEEGAPCTAIREVSLLKDLKHAN 65

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
           I     V + +       + +VFE L   L  ++  +      +  V+    Q+L  +A+
Sbjct: 66  I-----VTLHDIVHTDKSLTLVFEYLDKDLKQYM-DDCGNIMSMHNVKIFLYQILRGLAY 119

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
            H  +++H DLKP+N+L+     +K+ D+  L+R+       K++P  +           
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFG-LARA-------KSVPTKT----------- 160

Query: 270 FEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
                +S  V T  YR P+V+LG   ++   D+W VGCI  E+ SG  LF      + L 
Sbjct: 161 -----YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELH 215

Query: 329 MMERVLG 335
           ++ R+LG
Sbjct: 216 LIFRLLG 222

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 73.9 bits (182), Expect = 7e-15
 Identities = 63/241 (26%), Positives = 103/241 (42%), Gaps = 48/241 (19%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDI 150
            Y ++ ++G GT+G V +  D    ELVAIK++  +    +  +I  EI +L+   RH  
Sbjct: 4   DYELIQRIGSGTYGDVYKARDIATGELVAIKVI-KLEPGDDFEIIQQEISMLKE-CRHP- 60

Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
                V     +  R+ + IV E   G SL D  +           +  + R+ L+ +A+
Sbjct: 61  ---NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAY 116

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG--- 266
           +HE   IH D+K  NILL                 ++DG           +KL DFG   
Sbjct: 117 LHETGKIHRDIKGANILL-----------------TEDGD----------VKLADFGVSA 149

Query: 267 --STTFEHQDHSYVVSTRHYRAPEVI---LGLGWNYPCDLWSVGCILVELCSGE-ALFQT 320
             + T         + T ++ APEV       G++  CD+W++G   +EL   +  +F  
Sbjct: 150 QLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207

Query: 321 H 321
           H
Sbjct: 208 H 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 74.8 bits (184), Expect = 7e-15
 Identities = 64/244 (26%), Positives = 106/244 (43%), Gaps = 38/244 (15%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAA--MIEIDVLQRLARHDIGGTRC 155
           +G+GTFG+V+   +    +  A+KI++   I    E A  + E  VLQ   RH       
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQN-TRHPF----L 57

Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
             ++  F   + +C V E   G  L+  L +   R F  D  R  G +++ ++ ++H   
Sbjct: 58  TALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCD 115

Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           +++ DLK EN++L    ++K+ D+       K+G              I  G+T      
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGL----CKEG--------------ISDGATM----- 152

Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENLEHLAMMER 332
                 T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L  L +ME 
Sbjct: 153 -KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 211

Query: 333 VLGP 336
           +  P
Sbjct: 212 IRFP 215

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 76.3 bits (187), Expect = 7e-15
 Identities = 76/263 (28%), Positives = 124/263 (47%), Gaps = 40/263 (15%)

Query: 87  GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAA--MIEIDVL 142
           GE+    Y ++ K+G G FG+V        +E    K +  R + K RE +  +IE++V+
Sbjct: 8   GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVM 66

Query: 143 QRLARHDIGGTRCV-QIRNWFDYRNHICIVFEKLGPSLYDFLR--KNSYRSF-PID--LV 196
           + L   +I   R + +  N  + + +I + F   G    D  R  +  Y+ F  I+   +
Sbjct: 67  RELKHKNI--VRYIDRFLNKANQKLYILMEFCDAG----DLSRNIQKCYKMFGKIEEHAI 120

Query: 197 RELGRQLLESVAFMHEL-------RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249
            ++ RQLL ++A+ H L       R++H DLKP+NI L +           +    K  +
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG----------IRHIGKITA 170

Query: 250 YFKNLPKSSAIKLIDFG---STTFEHQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSV 304
              NL      K+ DFG   +   E   HS  V T +Y +PE++L    +Y    D+W++
Sbjct: 171 QANNLNGRPIAKIGDFGLSKNIGIESMAHS-CVGTPYYWSPELLLHETKSYDDKSDMWAL 229

Query: 305 GCILVELCSGEALFQTHENLEHL 327
           GCI+ ELCSG+  F    N   L
Sbjct: 230 GCIIYELCSGKTPFHKANNFSQL 252

Length = 1021

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 73.0 bits (180), Expect = 1e-14
 Identities = 53/233 (22%), Positives = 90/233 (38%), Gaps = 49/233 (21%)

Query: 95  RILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARH 148
            +  K+GEG FG+V +       + K+  VA+K ++     ++      E  ++++L  H
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL-DH 60

Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
                 +G   C +          + IV E    G  L D+LRKN  +   +  +     
Sbjct: 61  PNIVKLLGV--CTE-------EEPLMIVMEYMPGG-DLLDYLRKNRPKELSLSDLLSFAL 110

Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAI 260
           Q+   + ++     IH DL   N L+     VK+ D  F LSR   D  Y+K       I
Sbjct: 111 QIARGMEYLESKNFIHRDLAARNCLVGENLVVKISD--FGLSRDLYDDDYYKVKGGKLPI 168

Query: 261 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
           +                      + APE +    +    D+WS G +L E+ +
Sbjct: 169 R----------------------WMAPESLKEGKFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 66/228 (28%), Positives = 109/228 (47%), Gaps = 39/228 (17%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIV------RSINKYREAAMIEIDVLQRLAR 147
           +R+   +G G FG+V  C+D +    +A+K V      +  +K   A   EI +L+ L R
Sbjct: 4   WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-R 62

Query: 148 HDIGGTRCVQ----IRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
           HD    R VQ    +R+  + +  I + +   G S+ D L+  +Y +   ++ R   RQ+
Sbjct: 63  HD----RIVQYYGCLRDPEEKKLSIFVEYMP-GGSIKDQLK--AYGALTENVTRRYTRQI 115

Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
           L+ V+++H   ++H D+K  NIL  SA  VK+ D+                  S  I+ I
Sbjct: 116 LQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFG----------------ASKRIQTI 159

Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
               T  +      V  T ++ +PEVI G G+    D+WSV C +VE+
Sbjct: 160 CMSGTGIKS-----VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 71.3 bits (174), Expect = 5e-14
 Identities = 66/253 (26%), Positives = 115/253 (45%), Gaps = 39/253 (15%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVR------SINKYREAAMIEIDVLQRLARHDIGGT 153
           +G+G FG+V  C+D +    +A K V+        +K   A   EI +L+ L +H+    
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHE---- 64

Query: 154 RCVQIRNWF-DYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
           R VQ      D       +F +  P  S+ D L+  +Y +    + R+  RQ+LE ++++
Sbjct: 65  RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLK--AYGALTESVTRKYTRQILEGMSYL 122

Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H   ++H D+K  NIL  SA  VK+ D+                  S  ++ I    T  
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFG----------------ASKRLQTICMSGTGI 166

Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330
                  V  T ++ +PEVI G G+    D+WS+GC +VE+ + +  +  +E +  +  +
Sbjct: 167 RS-----VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI 221

Query: 331 --ERVLGPLPHHM 341
             +     LP H+
Sbjct: 222 ATQPTNPQLPSHI 234

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 72.4 bits (178), Expect = 6e-14
 Identities = 35/120 (29%), Positives = 59/120 (49%), Gaps = 14/120 (11%)

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS--RSSKDGSYFKNLPKSSAIKLIDFG 266
            +H+L  IH D+KP+N+LL +  ++K+ D+   +  + S    +++ L  +     +DF 
Sbjct: 116 SIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175

Query: 267 STTFEHQD--HSY----------VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           S     +    ++           V T  Y APEV L  G+N  CD WS+G I+ E+  G
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 71.2 bits (174), Expect = 6e-14
 Identities = 62/234 (26%), Positives = 106/234 (45%), Gaps = 40/234 (17%)

Query: 94  YRILSKMGEGTFGQVVEC---FDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHD 149
           ++I  K+G G F +V       D +   L  ++I   ++ K R+  + EID+L++L   +
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 150 IGGTRCVQIRNWFDYRNHICIVFE-----KLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
           +     ++  + F   N + IV E      L   +  F  K   R  P   V +   QL 
Sbjct: 64  V-----IKYLDSFIEDNELNIVLELADAGDLSQMIKYF--KKQKRLIPERTVWKYFVQLC 116

Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
            +V  MH  R++H D+KP N+ + +   VK+ D          G +F +           
Sbjct: 117 SAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL-------GRFFSS----------- 158

Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
              TT  H     +V T +Y +PE I   G+N+  D+WS+GC+L E+ + ++ F
Sbjct: 159 --KTTAAHS----LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 70.8 bits (174), Expect = 8e-14
 Identities = 59/261 (22%), Positives = 112/261 (42%), Gaps = 72/261 (27%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
            + ++  +GEGT+G+V +    +  +LVAIKI+  I    E    E ++L++ + H    
Sbjct: 7   IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNH---- 62

Query: 153 TRCVQIRNWFDY------RNHIC------IVFEKL-GPSLYDFLR--KNSYRSFPIDLVR 197
                  N   +      +N         +V E   G S+ D ++  +   +    + + 
Sbjct: 63  ------PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA 116

Query: 198 ELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 257
            + R+ L  +A++HE ++IH D+K +NILL                            K+
Sbjct: 117 YILRETLRGLAYLHENKVIHRDIKGQNILLT---------------------------KN 149

Query: 258 SAIKLIDFG----STTFEHQDHSYVVSTRHYRAPEVI-----LGLGWNYPCDLWSVGCIL 308
           + +KL+DFG      +   + +++ + T ++ APEVI         ++   D+WS+G   
Sbjct: 150 AEVKLVDFGVSAQLDSTLGRRNTF-IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITA 208

Query: 309 VELCSGE----------ALFQ 319
           +EL  G+          ALF+
Sbjct: 209 IELADGKPPLCDMHPMRALFK 229

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 71.7 bits (175), Expect = 9e-14
 Identities = 48/141 (34%), Positives = 75/141 (53%), Gaps = 26/141 (18%)

Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++  G+ F   P      
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA--GTSFMMTP------ 177

Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
                          YVV TR+YRAPEVILG+G+    D+WSVGCI+ E+   + LF   
Sbjct: 178 ---------------YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221

Query: 322 ENLEHL-AMMERVLGPLPHHM 341
           + ++    ++E++  P P  M
Sbjct: 222 DYIDQWNKVIEQLGTPCPEFM 242

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 67/259 (25%), Positives = 117/259 (45%), Gaps = 53/259 (20%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKY-------REAAMI-----EIDVLQRLAR 147
           +G+GT+G+V    +    E++A+K V  +          R+  M+     EI+ L+ L  
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVE-LPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
            +I     VQ   +     ++ I  E + G S+   LR   Y  F   LVR    Q+LE 
Sbjct: 68  LNI-----VQYLGFETTEEYLSIFLEYVPGGSIGSCLRT--YGRFEEQLVRFFTEQVLEG 120

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +A++H   ++H DLK +N+L+ +    K+ D+  +S+ S D   + N    S        
Sbjct: 121 LAYLHSKGILHRDLKADNLLVDADGICKISDFG-ISKKSDD--IYDNDQNMS------MQ 171

Query: 267 STTFEHQDHSYVVSTRHYRAPEVI--LGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
            + F             + APEVI     G++   D+WS+GC+++E+ +G    +   + 
Sbjct: 172 GSVF-------------WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR---RPWSDE 215

Query: 325 EHLAMM-----ERVLGPLP 338
           E +A M     +R   P+P
Sbjct: 216 EAIAAMFKLGNKRSAPPIP 234

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 70.3 bits (173), Expect = 1e-13
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 41/227 (18%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHD 149
           +  +  +G G+FG+V+        +  A+KI+    I K ++   +  E  +LQ + RH 
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHP 61

Query: 150 IGGTRCVQIRNWF-DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
                 V +   F D  N + +V E + G  L+  LRK+    FP  + R    Q++ ++
Sbjct: 62  F----LVNLYGSFQDDSN-LYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLAL 114

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
            ++H L +++ DLKPEN+LL S  Y+K+ D+ F                    K +   +
Sbjct: 115 EYLHSLDIVYRDLKPENLLLDSDGYIKITDFGF-------------------AKRVKGRT 155

Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
            T        +  T  Y APE+IL  G+    D W++G ++ E+ +G
Sbjct: 156 YT--------LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 40/225 (17%)

Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVR-SIN-KYREAAMIEIDVLQRLARHDIGGTR 154
           L ++G G  G V +       +++A+K +R  IN   ++  + E+D+L +          
Sbjct: 6   LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHK--------CN 57

Query: 155 C---VQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
               V     F     I I  E +     D + K      P  ++ ++   +L+ + ++H
Sbjct: 58  SPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117

Query: 212 E-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           E  ++IH D+KP NIL+ S   +K+ D+  +S                  +L++  + TF
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFG-VSG-----------------QLVNSLAKTF 159

Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
                   V T  Y APE I G  ++   D+WS+G  L+EL +G 
Sbjct: 160 --------VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 68.7 bits (169), Expect = 3e-13
 Identities = 55/233 (23%), Positives = 93/233 (39%), Gaps = 50/233 (21%)

Query: 95  RILSKMGEGTFGQVVECF----DNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARH 148
            +  K+GEG FG+V +        +KK  VA+K ++  +  +  E  + E  ++++L  H
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL-DH 60

Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
                 +G   C +          + IV E  + G  L  +LRKN  +    DL+     
Sbjct: 61  PNVVKLLGV--CTE-------EEPLYIVMEYMEGG-DLLSYLRKNRPKLSLSDLL-SFAL 109

Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAI 260
           Q+   + ++     IH DL   N L+     VK+ D  F LSR   D  Y++       I
Sbjct: 110 QIARGMEYLESKNFIHRDLAARNCLVGENLVVKISD--FGLSRDLYDDDYYRKRGGKLPI 167

Query: 261 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
           +                      + APE +    +    D+WS G +L E+ +
Sbjct: 168 R----------------------WMAPESLKEGKFTSKSDVWSFGVLLWEIFT 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 69.8 bits (171), Expect = 4e-13
 Identities = 42/147 (28%), Positives = 67/147 (45%), Gaps = 32/147 (21%)

Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
           D V+    Q+L  + ++H   ++H D+KP N+L+ S                        
Sbjct: 103 DHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNS------------------------ 138

Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYV----VSTRHYRAPEVILGLG-WNYPCDLWSVGCIL 308
              +  +K+ DFG    E  D S      V T++YRAPE+++G   +    D+WSVGCI 
Sbjct: 139 ---NCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIF 195

Query: 309 VELCSGEALFQTHENLEHLAMMERVLG 335
            EL     LFQ    ++ L ++  +LG
Sbjct: 196 AELLGRRILFQAQSPIQQLDLITDLLG 222

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 69.0 bits (169), Expect = 5e-13
 Identities = 72/279 (25%), Positives = 125/279 (44%), Gaps = 49/279 (17%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKK--ELVAIK-IVRSINKYREA--AMIEIDVLQRLAR 147
           RY ++ ++G+G +G V    + E    E VAIK I    +K   A  A+ E+ +L+    
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60

Query: 148 HD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNS------YRSFPIDLVRELG 200
           H  I     + I  +    N + +  E +   L+  +R         ++SF         
Sbjct: 61  HKNITCLYDMDIV-FPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIY------- 112

Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+L  + ++H   ++H DLKP N+L+ +   +K+ D+  L+R       F   P  +A 
Sbjct: 113 -QILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFG-LARG------FSENPGENAG 164

Query: 261 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPC----DLWSVGCILVELCSGEA 316
            + ++             V+TR YRAPE++L            D+WSVGCIL EL   + 
Sbjct: 165 FMTEY-------------VATRWYRAPEIMLS---FQSYTKAIDVWSVGCILAELLGRKP 208

Query: 317 LFQTHENLEHLAMMERVLGPLPHHMVIR-ADRRAEKYFR 354
           +F+  + ++ L  + +VLG      + R    +A+ Y R
Sbjct: 209 VFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIR 247

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 68.1 bits (166), Expect = 5e-13
 Identities = 62/232 (26%), Positives = 103/232 (44%), Gaps = 36/232 (15%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHD 149
           +RI  K+G G F +V           VA+K V+  +    K R   + EID+L++L   +
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLR--KNSYRSFPIDLVRELGRQLLES 206
           +     ++    F   N + IV E      L   ++  K   R  P   V +   QL  +
Sbjct: 64  V-----IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +  MH  R++H D+KP N+ + +   VK+ D          G +F +             
Sbjct: 119 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL-------GRFFSS------------- 158

Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
            TT  H     +V T +Y +PE I   G+N+  D+WS+GC+L E+ + ++ F
Sbjct: 159 KTTAAHS----LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 68.7 bits (168), Expect = 6e-13
 Identities = 48/153 (31%), Positives = 77/153 (50%), Gaps = 10/153 (6%)

Query: 162 FDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLK 221
           F+ + H+C+V E +       L KN   + P+D+ R    + + ++ ++H   ++H DLK
Sbjct: 70  FETKRHLCMVMEYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLK 128

Query: 222 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVST 281
           P+N+L+ S  ++K+ D+      SK G    +L  +     I+    T E  D   V  T
Sbjct: 129 PDNLLITSMGHIKLTDFGL----SKIG--LMSLTTNLYEGHIE--KDTREFLDKQ-VCGT 179

Query: 282 RHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
             Y APEVIL  G+  P D W++G IL E   G
Sbjct: 180 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 67.9 bits (166), Expect = 7e-13
 Identities = 67/250 (26%), Positives = 104/250 (41%), Gaps = 57/250 (22%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           +G+GT+G V    D   +  +AIK I    ++Y +    EI +   L   +I     VQ 
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNI-----VQY 70

Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLR-KNSYRSFPIDLVRELGRQLLESVAFMHELRLI 216
                      I  E++ G SL   LR K          +    +Q+LE + ++H+ +++
Sbjct: 71  LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIV 130

Query: 217 HTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-------- 268
           H D+K +N+L        V  Y                  S  +K+ DFG++        
Sbjct: 131 HRDIKGDNVL--------VNTY------------------SGVVKISDFGTSKRLAGINP 164

Query: 269 ---TFEHQDHSYVVSTRHYRAPEVI-LGL-GWNYPCDLWSVGCILVELCSGEALFQTHEN 323
              TF          T  Y APEVI  G  G+  P D+WS+GC +VE+ +G+  F   E 
Sbjct: 165 CTETF--------TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF--IEL 214

Query: 324 LEHLAMMERV 333
            E  A M +V
Sbjct: 215 GEPQAAMFKV 224

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 67.5 bits (166), Expect = 1e-12
 Identities = 53/235 (22%), Positives = 93/235 (39%), Gaps = 51/235 (21%)

Query: 95  RILSKMGEGTFGQVVECF----DNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARH 148
            +  K+GEG FG+V +          +  VA+K ++  +  + RE  + E  ++++L  H
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL-SH 60

Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
                 +G   C Q          + IV E    G  L DFLRK+      +  + ++  
Sbjct: 61  PNIVRLLGV--CTQ-------GEPLYIVTEYMPGG-DLLDFLRKHG-EKLTLKDLLQMAL 109

Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKS-SA 259
           Q+ + + ++     +H DL   N L+     VK+ D  F LSR   +  Y++        
Sbjct: 110 QIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISD--FGLSRDIYEDDYYRKRGGGKLP 167

Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           IK                      + APE +    +    D+WS G +L E+ + 
Sbjct: 168 IK----------------------WMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 68.2 bits (166), Expect = 1e-12
 Identities = 57/243 (23%), Positives = 103/243 (42%), Gaps = 36/243 (14%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCV 156
           +G+GTFG+V+   +    +  A+KI++    I K   A  +    + +  RH        
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPF----LT 58

Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
            ++  F  ++ +C V E + G  L+  L +   R F  D  R  G +++ ++ ++H  ++
Sbjct: 59  SLKYSFQTKDRLCFVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKI 116

Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           ++ DLK EN++L    ++K+ D+        D +  K                       
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF--------------------- 155

Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENLEHLAMMERV 333
                T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L  L +ME +
Sbjct: 156 ---CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI 212

Query: 334 LGP 336
             P
Sbjct: 213 KFP 215

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 67.1 bits (164), Expect = 1e-12
 Identities = 40/154 (25%), Positives = 69/154 (44%), Gaps = 31/154 (20%)

Query: 162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL 220
           F  ++++ +V E L G      ++       P D  ++   +++  V  +H+  +IH D+
Sbjct: 66  FQSKDYLYLVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123

Query: 221 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVS 280
           KPEN+L+    ++K+ D+  LSR+  +   F                           V 
Sbjct: 124 KPENLLIDQTGHLKLTDFG-LSRNGLENKKF---------------------------VG 155

Query: 281 TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           T  Y APE ILG+G +   D WS+GC++ E   G
Sbjct: 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 68/250 (27%), Positives = 108/250 (43%), Gaps = 44/250 (17%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAA--MIEIDVLQRLARHDIGGTRC 155
           +G+GTFG+V+   +       A+KI++   I    E A  + E  VLQ  +RH       
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPF----L 57

Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH-EL 213
             ++  F   + +C V E   G  L+  L +   R F  D  R  G +++ ++ ++H E 
Sbjct: 58  TALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK 115

Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
            +++ DLK EN++L    ++K+ D+       KDG+  K                TF   
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK----------------TF--- 156

Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENLEHLAMME 331
                  T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L  L +ME
Sbjct: 157 -----CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 211

Query: 332 -----RVLGP 336
                R L P
Sbjct: 212 EIRFPRTLSP 221

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 39/224 (17%)

Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR----LARHDIGG 152
           L ++G+G+FG+V +  DN  +++VAIKI+       E A  EI+ +Q+    L++ D   
Sbjct: 9   LERIGKGSFGEVFKGIDNRTQQVVAIKIID-----LEEAEDEIEDIQQEITVLSQCD--S 61

Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
               +    +     + I+ E L G S  D LR   +  F I     + +++L+ + ++H
Sbjct: 62  PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQI---ATMLKEILKGLDYLH 118

Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
             + IH D+K  N+LL     VK+ D+    + +            + IK   F  T F 
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-----------DTQIKRNTFVGTPF- 166

Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
                       + APEVI    ++   D+WS+G   +EL  GE
Sbjct: 167 ------------WMAPEVIQQSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 66.1 bits (161), Expect = 3e-12
 Identities = 61/244 (25%), Positives = 103/244 (42%), Gaps = 39/244 (15%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHD 149
           RY I+ K+GEG+FG++         E   IK   + +   K +EA+  E+ +L ++   +
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I     V     F     + IV E   G  L   + +     F  D +     Q+   + 
Sbjct: 61  I-----VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
            +H+ +++H D+K +NI              FLS++                KL DFG  
Sbjct: 116 HIHDRKILHRDIKSQNI--------------FLSKNGM------------VAKLGDFGIA 149

Query: 269 TFEHQDHSYV---VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
              +         V T +Y +PE+     +N   D+WS+GC+L ELC+ +  F+ + NL 
Sbjct: 150 RQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLH 208

Query: 326 HLAM 329
            L +
Sbjct: 209 QLVL 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 66/228 (28%), Positives = 98/228 (42%), Gaps = 47/228 (20%)

Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDIG--- 151
           L ++G+G+FG+V +  DN  KE+VAIKI+       E   I  EI VL +     I    
Sbjct: 9   LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68

Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
           G+     + W        I+ E L G S  D L+        I  +    R++L+ + ++
Sbjct: 69  GSYLKGTKLW--------IIMEYLGGGSALDLLKPGPLEETYIATIL---REILKGLDYL 117

Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF---GS 267
           H  R IH D+K  N+LL                 S+ G           +KL DF   G 
Sbjct: 118 HSERKIHRDIKAANVLL-----------------SEQGD----------VKLADFGVAGQ 150

Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
            T      +  V T  + APEVI    +++  D+WS+G   +EL  GE
Sbjct: 151 LTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 58/233 (24%), Positives = 101/233 (43%), Gaps = 32/233 (13%)

Query: 94  YRILSKMGEGTFGQVV-ECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           +  +  +G G+FG+V+   + NE    VAIK        ++  +  +   +++  + I  
Sbjct: 32  FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY-INH 90

Query: 153 TRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
             CV +   F   +++ +V E  +G   + FLR+N  + FP D+      Q++    ++ 
Sbjct: 91  PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQ 148

Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            L +++ DLKPEN+LL                  KDG           IK+ DFG     
Sbjct: 149 SLNIVYRDLKPENLLL-----------------DKDG----------FIKMTDFGFAKVV 181

Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
                 +  T  Y APE++L +G     D W++G  + E+  G   F  +E L
Sbjct: 182 DTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL 234

Length = 340

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 66.1 bits (161), Expect = 3e-12
 Identities = 65/259 (25%), Positives = 111/259 (42%), Gaps = 58/259 (22%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVR-------SINKYREAAMIEIDVLQRLARHDIG- 151
           +G+G +G V  C    + +L+A+K V        +  K  E    E+D+L+ L   +I  
Sbjct: 8   LGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 152 --GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
             GT C+         N I I  E + G S+   L  N +   P  +  +  +Q+L+ VA
Sbjct: 67  YLGT-CLD-------DNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVA 116

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H   ++H D+K  N++L+                            +  IKLIDFG  
Sbjct: 117 YLHNNCVVHRDIKGNNVMLMP---------------------------NGIIKLIDFGCA 149

Query: 269 -----TFEHQDHSYVVSTRH----YRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
                   H  HS ++ + H    + APEVI   G+    D+WS+GC + E+ +G+    
Sbjct: 150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLA 209

Query: 320 THENLEHLAMMERVLGPLP 338
           + + L  +  +    G +P
Sbjct: 210 SMDRLAAMFYIGAHRGLMP 228

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 63/244 (25%), Positives = 104/244 (42%), Gaps = 38/244 (15%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMI-EIDVLQRLARHDIGGTRC 155
           +G+GTFG+V+   +       A+KI+R    I K   A  + E  VLQ   RH       
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA-- 59

Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
             ++  F   + +C V E   G  L+  L +   R F  +  R  G +++ ++ ++H   
Sbjct: 60  --LKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD 115

Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           +++ D+K EN++L    ++K+ D+        DG+  K                TF    
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK----------------TF---- 155

Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENLEHLAMMER 332
                 T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L  L +ME 
Sbjct: 156 ----CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 211

Query: 333 VLGP 336
           +  P
Sbjct: 212 IRFP 215

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 66.4 bits (162), Expect = 4e-12
 Identities = 59/237 (24%), Positives = 97/237 (40%), Gaps = 47/237 (19%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRC 155
           +G G+FG+V         E  AIK ++       K  +    E  +L  L+   I     
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI----- 80

Query: 156 VQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
           V +   F   N +  + E  +G  L+  LRK     FP D+ +    +L+ +  ++H   
Sbjct: 81  VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKD 138

Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           +I+ DLKPEN+LL +  +VKV D+ F  +                              D
Sbjct: 139 IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP----------------------------D 170

Query: 275 HSYVV-STRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG------EALFQTHENL 324
            ++ +  T  Y APEVI   G     D W++G +L E  +G      +  F+ +E +
Sbjct: 171 RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI 227

Length = 329

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 65.5 bits (160), Expect = 6e-12
 Identities = 55/247 (22%), Positives = 102/247 (41%), Gaps = 47/247 (19%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDIG 151
           Y+ L  +G G +G V          +VA+KI+       + + I  E+ +L +L +    
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 152 GTRCVQIRNWFDYRN--HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                  + +  Y     + I+ E   G S+   ++        I ++    R++L ++ 
Sbjct: 63  NI----TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVII---REVLVALK 115

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY----KFLSRSSKDGSYFKNLPKSSAIKLID 264
           ++H++ +IH D+K  NIL+ +   VK+ D+         SSK                  
Sbjct: 116 YIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK------------------ 157

Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
              +TF        V T ++ APEVI  G  ++   D+WS+G  + E+ +G   +   + 
Sbjct: 158 --RSTF--------VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD- 206

Query: 324 LEHLAMM 330
               AMM
Sbjct: 207 -AFRAMM 212

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 65.1 bits (158), Expect = 8e-12
 Identities = 61/240 (25%), Positives = 106/240 (44%), Gaps = 34/240 (14%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHDIG 151
           +Y    K+G+G  G V    D    + VAIK +    + ++  +I EI V++ L   +I 
Sbjct: 20  KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI- 78

Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
               V   + F   + + +V E L G SL D + +       I  V    R+ L+++ F+
Sbjct: 79  ----VNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV---CRECLQALEFL 131

Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H  ++IH D+K +N+LL     VK+ D+ F ++                         T 
Sbjct: 132 HANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ------------------------ITP 167

Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330
           E    S +V T ++ APEV+    +    D+WS+G + +E+  GE  +     L  L ++
Sbjct: 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 56/230 (24%), Positives = 99/230 (43%), Gaps = 44/230 (19%)

Query: 97  LSKMGEGTFGQVVEC----FDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDI 150
           + ++GEG FG+V  C      +   E VA+K +      ++R     EI++L+ L   +I
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 151 GGTRCVQIRNWFD--YRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVREL--GRQLLE 205
                V+ +   +      + ++ E L   SL D+L+++  +   I+L R L    Q+ +
Sbjct: 69  -----VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ---INLKRLLLFSSQICK 120

Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR--SSKDGSYFKNLPKSSAIKLI 263
            + ++   R IH DL   NIL+ S + VK+ D+  L++        Y+   P  S I   
Sbjct: 121 GMDYLGSQRYIHRDLAARNILVESEDLVKISDFG-LAKVLPEDKDYYYVKEPGESPIF-- 177

Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                               + APE +    ++   D+WS G  L EL +
Sbjct: 178 --------------------WYAPECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 54/251 (21%), Positives = 102/251 (40%), Gaps = 50/251 (19%)

Query: 94  YRILSKMGEGTFGQV--VECFDNEKKELVAIKIVRSINKYR---EAAMIEIDVLQRLARH 148
           Y ++  +G G    V    C  N   E VAIK +  + K +   +    E+  + +    
Sbjct: 3   YELIEVIGVGATAVVYAAICLPN--NEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHP 59

Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLR-KNSYRSFPIDLVRELGRQLLES 206
           ++           F   + + +V   L G SL D ++           ++  + +++L+ 
Sbjct: 60  NVVKYYTS-----FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKG 114

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           + ++H    IH D+K  NILL                  +DGS          +K+ DFG
Sbjct: 115 LEYLHSNGQIHRDIKAGNILL-----------------GEDGS----------VKIADFG 147

Query: 267 --STTFEHQDHSY-----VVSTRHYRAPEVI-LGLGWNYPCDLWSVGCILVELCSGEALF 318
             ++  +  D +       V T  + APEV+    G+++  D+WS G   +EL +G A +
Sbjct: 148 VSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPY 207

Query: 319 QTHENLEHLAM 329
             +  ++ L +
Sbjct: 208 SKYPPMKVLML 218

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 63/240 (26%), Positives = 109/240 (45%), Gaps = 38/240 (15%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAA--MIEIDVLQRLARHDIGGTRC 155
           +G+G+FG+V+        +  A+K++  ++I K +E    M E +VL +  +H       
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPF----L 58

Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
           V +   F   + +  V + + G  L+  L++   RSFP    R    ++  ++ ++H L 
Sbjct: 59  VGLHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLN 116

Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           +I+ DLKPENILL S  +V + D+       K+G              I+   TT     
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGL----CKEG--------------IEHSKTT----- 153

Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVL 334
            S    T  Y APEV+    ++   D W +G +L E+  G   F + +  E   M + +L
Sbjct: 154 -STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE---MYDNIL 209

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 64.4 bits (156), Expect = 2e-11
 Identities = 65/246 (26%), Positives = 106/246 (43%), Gaps = 46/246 (18%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHDIG 151
           +Y    K+G+G  G V    D    + VAIK +    + ++  +I EI V++        
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE------- 72

Query: 152 GTRCVQIRNWFDYR---NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
             +   I N+ D     + + +V E L G SL D + +       I  V    R+ L+++
Sbjct: 73  -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQAL 128

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
            F+H  ++IH D+K +NILL                   DGS          +KL DFG 
Sbjct: 129 DFLHSNQVIHRDIKSDNILL-----------------GMDGS----------VKLTDFGF 161

Query: 267 --STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
               T E    S +V T ++ APEV+    +    D+WS+G + +E+  GE  +     L
Sbjct: 162 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221

Query: 325 EHLAMM 330
             L ++
Sbjct: 222 RALYLI 227

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 62/230 (26%), Positives = 100/230 (43%), Gaps = 44/230 (19%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           +Y    K+G+G  G V    D    + VAIK +    + ++  +I   ++ R  +H    
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHP--- 76

Query: 153 TRCVQIRNWFD---YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                I N+ D     + + +V E L G SL D + +       I  V    R+ L+++ 
Sbjct: 77  ----NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALE 129

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-- 266
           F+H  ++IH D+K +NILL                   DGS          +KL DFG  
Sbjct: 130 FLHSNQVIHRDIKSDNILL-----------------GMDGS----------VKLTDFGFC 162

Query: 267 -STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
              T E    S +V T ++ APEV+    +    D+WS+G + +E+  GE
Sbjct: 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 49/220 (22%), Positives = 90/220 (40%), Gaps = 40/220 (18%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           Y ++  +  G+ G+V       + + V +KI +     +   +IE  +LQ +    +   
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQ-----KGTTLIEAMLLQNVNHPSV--- 119

Query: 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
             +++++        C+V       LY +L K S R  PID    + +Q+LE + ++H  
Sbjct: 120 --IRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQ 176

Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
           R+IH D+K ENI +                                + + D G+  F   
Sbjct: 177 RIIHRDVKTENIFINDV---------------------------DQVCIGDLGAAQFPVV 209

Query: 274 DHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
             ++  +  T    APEV+    +N   D+WS G +L E+
Sbjct: 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 55/248 (22%), Positives = 103/248 (41%), Gaps = 47/248 (18%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-------EAAMIEIDVLQRLARHDIGG 152
           +G+G FG+V  C      ++ A K    ++K R       + A+ E  +L++++   I  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACK---KLDKKRLKKRKGEQMALNEKKILEKVSSRFI-- 55

Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V +   F+ ++ +C+V   + G  L   +       FP         Q++  +  +H
Sbjct: 56  ---VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH 112

Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
           + R+++ DLKPEN+LL     V++ D                     A++L   G     
Sbjct: 113 QRRIVYRDLKPENVLLDDHGNVRISDLGL------------------AVELKG-GKKI-- 151

Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH------ENLE 325
                    T  Y APEV+ G  +++  D +++GC L E+ +G + F+        E L+
Sbjct: 152 ---KGR-AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK 207

Query: 326 HLAMMERV 333
              +   V
Sbjct: 208 RRTLEMAV 215

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 52/226 (23%), Positives = 95/226 (42%), Gaps = 39/226 (17%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKI--VRSINKYREAAMI--EIDVLQRLARHD 149
              +  +G GTFG+V    D   +   A+K+  +  + + ++   +  E  VL+ ++   
Sbjct: 3   LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I            D +  + ++ E + G  L+ +LR  +   F          +++ ++ 
Sbjct: 63  IIRLFW----TEHD-QRFLYMLMEYVPGGELFSYLR--NSGRFSNSTGLFYASEIVCALE 115

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H   +++ DLKPENILL    ++K+ D+ F                  A KL D   T
Sbjct: 116 YLHSKEIVYRDLKPENILLDKEGHIKLTDFGF------------------AKKLRDRTWT 157

Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                    +  T  Y APEVI   G N   D W++G ++ E+  G
Sbjct: 158 ---------LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 64.0 bits (155), Expect = 2e-11
 Identities = 64/246 (26%), Positives = 106/246 (43%), Gaps = 46/246 (18%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHDIG 151
           +Y    K+G+G  G V    D    + VAI+ +    + ++  +I EI V++        
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE------- 73

Query: 152 GTRCVQIRNWFDYR---NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
             +   I N+ D     + + +V E L G SL D + +       I  V    R+ L+++
Sbjct: 74  -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQAL 129

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
            F+H  ++IH D+K +NILL                   DGS          +KL DFG 
Sbjct: 130 EFLHSNQVIHRDIKSDNILL-----------------GMDGS----------VKLTDFGF 162

Query: 267 --STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
               T E    S +V T ++ APEV+    +    D+WS+G + +E+  GE  +     L
Sbjct: 163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222

Query: 325 EHLAMM 330
             L ++
Sbjct: 223 RALYLI 228

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 35/241 (14%)

Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+GEG+ G V    +    + VA+K +    + R   +    V+ R   H+      V +
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHE----NVVDM 84

Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
            N +   + + +V E L G +L D +         I  V      +L +++++H   +IH
Sbjct: 85  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATV---CLSVLRALSYLHNQGVIH 141

Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
            D+K ++ILL S   +K+ D+ F ++ SK+      +PK  ++                 
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKE------VPKRKSL----------------- 178

Query: 278 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPL 337
            V T ++ APEVI  L +    D+WS+G +++E+  GE     + N   L  M R+   L
Sbjct: 179 -VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP---PYFNEPPLQAMRRIRDNL 234

Query: 338 P 338
           P
Sbjct: 235 P 235

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 68/261 (26%), Positives = 116/261 (44%), Gaps = 43/261 (16%)

Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI----GG 152
           +  +G G FG+V      + K L A+K +R     ++  ++   V    A  DI      
Sbjct: 6   IKTLGIGAFGEVCLARKVDTKALYAMKTLR-----KKDVLLRNQVAHVKAERDILAEADN 60

Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V++   F  ++++  V + + G  +   L +     FP DL R    +L  +V  +H
Sbjct: 61  EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI--FPEDLARFYIAELTCAVESVH 118

Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLS--RSSKDGSYFK--NLPKSSAIKLIDFGS 267
           ++  IH D+KP+NIL+    ++K+ D+   +  R + D  Y++  +  +  ++   DF +
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSM---DFSN 175

Query: 268 --------------------TTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSV 304
                                  +HQ    HS +V T +Y APEV+L  G+   CD WSV
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHS-LVGTPNYIAPEVLLRTGYTQLCDWWSV 234

Query: 305 GCILVELCSGEALFQTHENLE 325
           G IL E+  G+  F     LE
Sbjct: 235 GVILYEMLVGQPPFLAQTPLE 255

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 62.9 bits (153), Expect = 4e-11
 Identities = 62/266 (23%), Positives = 113/266 (42%), Gaps = 48/266 (18%)

Query: 94  YRILSKMGEGTFGQVVEC-FDNEKKELVAIKIV-----------RSINKYREAAMIEIDV 141
           Y +L  +G G FG V +    N  + L+A+K +           R  +K     + E+ +
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 142 LQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLR--KNSYRSFPIDLVRE 198
           ++   RH       V+    F   + + IV + + G  L +     K   + F  + +  
Sbjct: 62  IKEQLRH----PNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117

Query: 199 LGRQLLESVAFMH-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 257
           +  Q++ ++ ++H E R++H DL P NI+L   + V + D+  L++  +  S   +    
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFG-LAKQKQPESKLTS---- 172

Query: 258 SAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317
                               VV T  Y  PE++    +    D+W+ GCIL ++C+ +  
Sbjct: 173 --------------------VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212

Query: 318 FQTHENLEHLAM--MERVLGPLPHHM 341
           F +  N+  LA   +E V  PLP  M
Sbjct: 213 FYS-TNMLSLATKIVEAVYEPLPEGM 237

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 54/242 (22%), Positives = 104/242 (42%), Gaps = 58/242 (23%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           + ++  +G GT+GQV +    +  +L AIK++       E   +EI++L++ + H     
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHH----- 72

Query: 154 RCVQIRNWFDY------------RNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELG 200
                RN   Y             + + +V E  G  S+ D ++     +   D +  + 
Sbjct: 73  -----RNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYIC 127

Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
           R++L  +A +H  ++IH D+K +N+LL                            +++ +
Sbjct: 128 REILRGLAHLHAHKVIHRDIKGQNVLLT---------------------------ENAEV 160

Query: 261 KLIDFG-STTFEHQ--DHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELC 312
           KL+DFG S   +      +  + T ++ APEVI         ++Y  D+WS+G   +E+ 
Sbjct: 161 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMA 220

Query: 313 SG 314
            G
Sbjct: 221 EG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 62.4 bits (151), Expect = 6e-11
 Identities = 60/226 (26%), Positives = 99/226 (43%), Gaps = 43/226 (19%)

Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR----LARHDIGG 152
           L K+G+G+FG+V +  DN  +++VAIKI+       E A  EI+ +Q+    L++ D   
Sbjct: 9   LEKIGKGSFGEVFKGIDNRTQKVVAIKIID-----LEEAEDEIEDIQQEITVLSQCD--S 61

Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPID--LVRELGRQLLESVAF 209
               +    +     + I+ E L G S  D L        P+D   +  + R++L+ + +
Sbjct: 62  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDY 116

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
           +H  + IH D+K  N+LL     VK+ D+                           G  T
Sbjct: 117 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVA------------------------GQLT 152

Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
                 +  V T  + APEVI    ++   D+WS+G   +EL  GE
Sbjct: 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 62.9 bits (153), Expect = 7e-11
 Identities = 45/148 (30%), Positives = 74/148 (50%), Gaps = 21/148 (14%)

Query: 191 FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS--RSSKDG 248
           F  DL R    +L  ++  +H++  IH D+KP+NIL+    ++K+ D+   +  R + D 
Sbjct: 98  FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157

Query: 249 SYFK--NLPKSSAIKLIDFGS-------TTFE------HQD---HSYVVSTRHYRAPEVI 290
            Y++  +  +  +++  +  S          E      HQ    HS +V T +Y APEV+
Sbjct: 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHS-LVGTPNYIAPEVL 216

Query: 291 LGLGWNYPCDLWSVGCILVELCSGEALF 318
           L  G+   CD WSVG IL E+  G+  F
Sbjct: 217 LRTGYTQLCDWWSVGVILYEMLVGQPPF 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 54/229 (23%), Positives = 92/229 (40%), Gaps = 46/229 (20%)

Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRC 155
           LS++GEG  G V +C       + A+K + +         ++  +L+ L           
Sbjct: 6   LSRLGEGAGGSVTKCRLKNTGMIFALKTITT----DPNPDLQKQILRELEINKSCKSPYI 61

Query: 156 VQIRNWF--DYRNHICIVFEKLG----PSLYDFLRKNSYRSFPIDLVRELGR---QLLES 206
           V+    F  +  + I I  E        S+Y  ++K   R       + LG+    +L+ 
Sbjct: 62  VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGE----KVLGKIAESVLKG 117

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           ++++H  ++IH D+KP NILL                 ++ G           +KL DFG
Sbjct: 118 LSYLHSRKIIHRDIKPSNILL-----------------TRKG----------QVKLCDFG 150

Query: 267 -STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
            S    +        T  Y APE I G  ++   D+WS+G  L+E+   
Sbjct: 151 VSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQN 199

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 39/245 (15%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS--INKYR--EAAMIEIDVLQRLARHDIGGTRC 155
           +G+G+FG+V+        EL A+K+++   I +    E  M E  VL    +H       
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPF----L 58

Query: 156 VQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            Q+ + F  ++ +  V E +  G  ++   R      F     R    +++  + F+HE 
Sbjct: 59  TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHER 115

Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
            +I+ DLK +N+LL S  ++K+ D+       K+G              I  G TT    
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGM----CKEG--------------ILGGVTT---- 153

Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENLEHLAMME 331
             S    T  Y APE++    +    D W++G +L E+ +G++ F     + L    + +
Sbjct: 154 --STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED 211

Query: 332 RVLGP 336
            V  P
Sbjct: 212 EVRYP 216

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 58/227 (25%), Positives = 104/227 (45%), Gaps = 34/227 (14%)

Query: 92  PRYRI--LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD 149
           PR  +    K+GEG+ G V    D      VA+K +    + R   +    V+ R  +H 
Sbjct: 17  PRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHP 76

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                 V++ + +   + + +V E L G +L D +         I  V      +L++++
Sbjct: 77  ----NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATV---CLAVLKALS 129

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           F+H   +IH D+K ++ILL S   VK+ D+ F ++ SK+      +P+  ++        
Sbjct: 130 FLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE------VPRRKSL-------- 175

Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
                     V T ++ APEVI  L +    D+WS+G +++E+  GE
Sbjct: 176 ----------VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 61.1 bits (149), Expect = 2e-10
 Identities = 56/245 (22%), Positives = 108/245 (44%), Gaps = 33/245 (13%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSI---NKYREAAMIEIDVLQRLAR 147
            ++ +  +G+G  G+V         +L A+K++  + +   NK +     E ++L  L  
Sbjct: 2   HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVL-TEQEILATL-D 59

Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
           H         +   F    ++C+V +   G  L+  L++   +    ++ R    ++L +
Sbjct: 60  HPF----LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA 115

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDY----------KFLSRSSKDGSYFKNLPK 256
           + ++H L +++ DLKPENILL  + ++ + D+            +S++ + GS   ++  
Sbjct: 116 LEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175

Query: 257 SS---AIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                  +   F S +F        V T  Y APEVI G G     D W++G +L E+  
Sbjct: 176 IPSETFSEEPSFRSNSF--------VGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY 227

Query: 314 GEALF 318
           G   F
Sbjct: 228 GTTPF 232

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 58/225 (25%), Positives = 106/225 (47%), Gaps = 34/225 (15%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRC 155
           +G+GTFGQV +    + + + A+K++  + I   +E A    E ++L R    +      
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDE--SPFI 58

Query: 156 VQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
           V ++  F   + + +V +   G  L+  L+K     F  D  +    +L+ ++  +H+  
Sbjct: 59  VGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYD 116

Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           +++ DLKPENILL +  ++ + D+  LS++        NL  +         + TF    
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFG-LSKA--------NLTDNKT-------TNTF---- 156

Query: 275 HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALF 318
                 T  Y APEV+L   G+    D WS+G ++ E+C G + F
Sbjct: 157 ----CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF 197

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 63/251 (25%), Positives = 111/251 (44%), Gaps = 43/251 (17%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDI-- 150
           +  L  +G G FG+V      +   + A+KI+R      +A M+E + +  + A  DI  
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR------KADMLEKEQVAHIRAERDILV 56

Query: 151 --GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES- 206
              G   V++   F  + ++ ++ E L G  +   L K        D + E   Q   + 
Sbjct: 57  EADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK-------DTLSEEATQFYIAE 109

Query: 207 ----VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS--RSSKDGSYFKNL---PKS 257
               +  +H+L  IH D+KP+N+LL +  +VK+ D+   +  + +    +++NL   P S
Sbjct: 110 TVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPS 169

Query: 258 SAIKLIDFGSTTFEHQDHSY----------VVSTRHYRAPEVILGLGWNYPCDLWSVGCI 307
                  F +   + +  ++           V T  Y APEV +  G+N  CD WS+G I
Sbjct: 170 D----FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225

Query: 308 LVELCSGEALF 318
           + E+  G   F
Sbjct: 226 MYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 64/247 (25%), Positives = 111/247 (44%), Gaps = 39/247 (15%)

Query: 94  YRILSKMGEGTFGQV--VECFDNEKKELVAIKIVRSINKYREAAMI----EIDVLQRLAR 147
           +  +  +G+G FG+V  V+  D  K  + A+K +     +++  +     E DVL   A 
Sbjct: 3   FHTVKVIGKGAFGEVRLVQKKDTGK--IYAMKTLLKSEMFKKDQLAHVKAERDVL---AE 57

Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
            D      V +   F    ++ ++ E L G  L   L K  Y +F  D+ R    + + +
Sbjct: 58  SD--SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLA 113

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK--DGSYFKNLPKSSAIK--- 261
           +  +H+L  IH D+KP+NIL+    ++K+ D+   +   K  D +Y++ L +  + K   
Sbjct: 114 IEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173

Query: 262 ------LIDFGSTTFEHQDH-----------SY-VVSTRHYRAPEVILGLGWNYPCDLWS 303
                  +D  + T   +D            +Y  V T  Y APE+ L  G+   CD WS
Sbjct: 174 DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233

Query: 304 VGCILVE 310
           +G I+ E
Sbjct: 234 LGAIMFE 240

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 70/282 (24%), Positives = 116/282 (41%), Gaps = 70/282 (24%)

Query: 97  LSKMGEGTFGQVV---ECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDI 150
           L  +G+G+FG+V    +    +  +L A+K+++      + R    +E D+L        
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDIL-------- 52

Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLY---DFLRKNSYRSFPIDLVRELGRQLL--- 204
                 ++ + F  + H    F+  G  LY   DFLR         DL   L ++++   
Sbjct: 53  -----AEVNHPFIVKLHY--AFQTEG-KLYLILDFLRGG-------DLFTRLSKEVMFTE 97

Query: 205 ESVAF-----------MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
           E V F           +H L +I+ DLKPENILL    ++K+ D+  LS+ S D      
Sbjct: 98  EDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG-LSKESIDH----- 151

Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                            E + +S+   T  Y APEV+   G     D WS G ++ E+ +
Sbjct: 152 -----------------EKKAYSFC-GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 193

Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRR 355
           G   FQ  +  E + M+ +    +P  +   A       F+R
Sbjct: 194 GSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKR 235

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 59.7 bits (144), Expect = 4e-10
 Identities = 51/232 (21%), Positives = 106/232 (45%), Gaps = 38/232 (16%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH-DIGG 152
           + ++  +G GT+GQV +    +  +L AIK++       E    EI++L++ + H +I  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 153 TRCVQIR-NWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                I+ N     + + +V E  G  S+ D ++     +   + +  + R++L  ++ +
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127

Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H+ ++IH D+K +N+LL                            +++ +KL+DFG +  
Sbjct: 128 HQHKVIHRDIKGQNVLLT---------------------------ENAEVKLVDFGVSAQ 160

Query: 271 EHQD---HSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSG 314
             +     +  + T ++ APEVI         +++  DLWS+G   +E+  G
Sbjct: 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 59.8 bits (145), Expect = 5e-10
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 49/230 (21%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV-----RSINKYREAAMIEIDVLQRLAR 147
            +  L ++G G+FG V    D    E+VAIK +     +S  K+++  + E+  LQ+L R
Sbjct: 16  LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI-IKEVRFLQQL-R 73

Query: 148 HDIGGTRCVQIRNWFDYRNHIC-IVFEKLGPSLYDFL--RKNSYRSFPIDLVRELGRQLL 204
           H       ++ +  +  R H   +V E    S  D L   K   +   I  +       L
Sbjct: 74  H----PNTIEYKGCY-LREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICH---GAL 125

Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
           + +A++H    IH D+K  NILL                 ++ G+          +KL D
Sbjct: 126 QGLAYLHSHERIHRDIKAGNILL-----------------TEPGT----------VKLAD 158

Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVEL 311
           FGS +     +S+ V T ++ APEVIL +    ++   D+WS+G   +EL
Sbjct: 159 FGSASLVSPANSF-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 59.7 bits (144), Expect = 6e-10
 Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 32/218 (14%)

Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+GEG+ G V    +      VA+K++    + R   +    V+ R  +H       V++
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH----QNVVEM 83

Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
              +     + ++ E L G +L D + +       I  V E    +L+++ ++H   +IH
Sbjct: 84  YKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCE---SVLQALCYLHSQGVIH 140

Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
            D+K ++ILL     VK+ D+ F ++ SKD      +PK  ++                 
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKD------VPKRKSL----------------- 177

Query: 278 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
            V T ++ APEVI    +    D+WS+G +++E+  GE
Sbjct: 178 -VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 59.2 bits (143), Expect = 6e-10
 Identities = 62/240 (25%), Positives = 104/240 (43%), Gaps = 32/240 (13%)

Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           +++ K+G G FG+V     N   + VA+K ++      E+ + E  ++++L RHD    +
Sbjct: 9   QLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFLEEAQIMKKL-RHD----K 62

Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            VQ+         I IV E +   SL DFL+    R+  +  + ++  Q+   +A++  +
Sbjct: 63  LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 121

Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             IH DL+  NIL+      K+ D+  L+R  +D  Y         IK            
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFG-LARLIEDNEYTARQGAKFPIK------------ 168

Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE  L   +    D+WS G +L EL + G   +    N E L  +ER
Sbjct: 169 ----------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER 218

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 59.3 bits (143), Expect = 7e-10
 Identities = 59/239 (24%), Positives = 107/239 (44%), Gaps = 32/239 (13%)

Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+GEG+ G V         +LVA+K +    + R   +    V+ R  +H+      V++
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHE----NVVEM 82

Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
            N +   + + +V E L G +L D +         I  V      +L++++ +H   +IH
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV---CLAVLKALSVLHAQGVIH 139

Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
            D+K ++ILL     VK+ D+ F ++ SK+    K+L                       
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL----------------------- 176

Query: 278 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGP 336
            V T ++ APE+I  L +    D+WS+G +++E+  GE  +     L+ + M+   L P
Sbjct: 177 -VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP 234

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 59.2 bits (143), Expect = 9e-10
 Identities = 63/245 (25%), Positives = 109/245 (44%), Gaps = 38/245 (15%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS---IN-KYREAAMIEIDVLQRLARHDIGGTRC 155
           +G+G+FG+V+        +  A+K+++    +N K ++  M E +VL +  +H       
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPF----L 58

Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
           V +   F     +  V + + G  L+  L++   RSFP    R    ++  ++ ++H + 
Sbjct: 59  VGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSIN 116

Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           +++ DLKPENILL S  +V + D+       K+G           I   D  +TTF    
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGL----CKEG-----------IAQSD-TTTTF---- 156

Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF---QTHENLEHLAMME 331
                 T  Y APEVI    ++   D W +G +L E+  G   F      E  +++    
Sbjct: 157 ----CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP 212

Query: 332 RVLGP 336
            VL P
Sbjct: 213 LVLRP 217

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 59.6 bits (144), Expect = 9e-10
 Identities = 57/231 (24%), Positives = 94/231 (40%), Gaps = 44/231 (19%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           + IL     G  G    C DN+  E V IK  +     R     E  +L+ +    I   
Sbjct: 94  FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSI--- 145

Query: 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
             +Q++  F Y    C++  +    LY +L   + R+  I  +  + R +L ++ ++HE 
Sbjct: 146 --IQLKGTFTYNKFTCLILPRYKTDLYCYL--AAKRNIAICDILAIERSVLRAIQYLHEN 201

Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE-- 271
           R+IH D+K ENI                         F N P    + L DFG+  F   
Sbjct: 202 RIIHRDIKAENI-------------------------FINHPGD--VCLGDFGAACFPVD 234

Query: 272 -HQDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE-ALFQ 319
            + +  Y    T    APE++    +    D+WS G +L E+ +   +LF+
Sbjct: 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285

Length = 391

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 59.2 bits (143), Expect = 9e-10
 Identities = 58/241 (24%), Positives = 103/241 (42%), Gaps = 37/241 (15%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           + I+  +G G FG+V        + + A+KI   +NK+      E     R  R+ +   
Sbjct: 3   FEIIKVIGRGAFGEVAVVKMKHTERIYAMKI---LNKWEMLKRAETACF-REERNVLVNG 58

Query: 154 RCVQIRNW---FDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
            C  I      F   N++ +V +  +G  L   L K   R  P D+ R    +++ ++  
Sbjct: 59  DCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIHS 117

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
           +H+L  +H D+KP+N+LL    ++++ D+    + ++DG+                    
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV------------------- 158

Query: 270 FEHQDHSYVVSTRHYRAPEVIL----GLGWNYP-CDLWSVGCILVELCSGEALFQTHENL 324
                 S  V T  Y +PE++     G+G   P CD WS+G  + E+  GE  F     +
Sbjct: 159 ----QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214

Query: 325 E 325
           E
Sbjct: 215 E 215

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 52/237 (21%), Positives = 99/237 (41%), Gaps = 42/237 (17%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           + + S +G G FG+V    +    ++ A+K+++     +   + +  V       DI   
Sbjct: 3   FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMK-----KSVLLAQETVSFFEEERDILSI 57

Query: 154 R----CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRS-FPIDLVRELGRQLLESV 207
                  Q++  F  ++++ +V E   G  L   L  N Y   F  D+ +    +L+ ++
Sbjct: 58  SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL--NRYEDQFDEDMAQFYLAELVLAI 115

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
             +H++  +H D+KPEN+L+    ++K+ D+   +R + +      LP            
Sbjct: 116 HSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLP------------ 163

Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLG------WNYPCDLWSVGCILVELCSGEALF 318
                      V T  Y APEV+  +       +   CD WS+G I  E+  G + F
Sbjct: 164 -----------VGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 65/270 (24%), Positives = 108/270 (40%), Gaps = 53/270 (19%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRC 155
           +G+G+FG+V+      K E  A+K ++     I+   E  M+E  VL     +       
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPF----L 58

Query: 156 VQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRE--LGRQLLESVAFMH 211
             +   F  + H+  V E L  G  ++    K  +     DL R      +++  + F+H
Sbjct: 59  THLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRF-----DLYRATFYAAEIVCGLQFLH 113

Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG---ST 268
              +I+ DLK +N++L                  +DG           IK+ DFG     
Sbjct: 114 SKGIIYRDLKLDNVML-----------------DRDGH----------IKIADFGMCKEN 146

Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
            F     S    T  Y APE++ GL + +  D WS G +L E+  G++ F   +  E   
Sbjct: 147 VFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE--- 203

Query: 329 MMERVLGPLPHH---MVIRADRRAEKYFRR 355
           + E +    PH+   +   +    EK F R
Sbjct: 204 LFESIRVDTPHYPRWITKESKDILEKLFER 233

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 44/152 (28%), Positives = 74/152 (48%), Gaps = 25/152 (16%)

Query: 191 FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS--RSSKDG 248
           FP  L R    +L  ++  +H++  IH D+KP+NIL+    ++K+ D+   +  R + + 
Sbjct: 98  FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157

Query: 249 SYFK--NLPKSSAIKLIDF-----------------GSTTFEHQD---HSYVVSTRHYRA 286
            Y++  +  +  +++  D                     T +HQ    HS +V T +Y A
Sbjct: 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHS-LVGTPNYIA 216

Query: 287 PEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
           PEV+L  G+   CD WSVG IL E+  G+  F
Sbjct: 217 PEVLLRKGYTQLCDWWSVGVILFEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 57.8 bits (139), Expect = 2e-09
 Identities = 60/243 (24%), Positives = 102/243 (41%), Gaps = 49/243 (20%)

Query: 99  KMGEGTFGQVVECF--DNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           K+G GT+G V +    D + ++  A+K +        +A  EI +L+ L   ++   + V
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKV 66

Query: 157 QIRN-----W--FDYRNHI---CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
            + +     W  FDY  H     I F +   +             P  +V+ L  Q+L+ 
Sbjct: 67  FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKA------NKKPMQLPRSMVKSLLYQILDG 120

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           + ++H   ++H DLKP NIL++                          P+   +K+ D G
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEG-----------------------PERGRVKIADMG 157

Query: 267 STTFEHQ------DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQ 319
                +       D   VV T  YRAPE++LG   +    D+W++GCI  EL + E +F 
Sbjct: 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217

Query: 320 THE 322
             +
Sbjct: 218 CRQ 220

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 57.8 bits (139), Expect = 2e-09
 Identities = 69/294 (23%), Positives = 115/294 (39%), Gaps = 71/294 (24%)

Query: 99  KMGEGTFGQVVECF--DNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           K+G GT+G V +    D +     A+K +        +A  EI +L+ L   ++   + V
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKV 66

Query: 157 QIRN-----W--FDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDL----VRELGRQLLE 205
            + +     W  FDY  H           +  F R +     P+ L    V+ L  Q+L+
Sbjct: 67  FLSHADRKVWLLFDYAEHDLW-------HIIKFHRASKANKKPVQLPRGMVKSLLYQILD 119

Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
            + ++H   ++H DLKP NIL++                          P+   +K+ D 
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEG-----------------------PERGRVKIADM 156

Query: 266 GSTTFEHQ------DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALF 318
           G     +       D   VV T  YRAPE++LG   +    D+W++GCI  EL + E +F
Sbjct: 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Query: 319 QTHE------NLEHLAMMERV--------------LGPLPHHMVIRADRRAEKY 352
              +      N  H   ++R+              +  +P H  +  D R   Y
Sbjct: 217 HCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTY 270

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 62/248 (25%), Positives = 110/248 (44%), Gaps = 37/248 (14%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDI-- 150
           +  L  +G G FG+V      +   + A+KI+R      +A M+E + +  + A  DI  
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR------KADMLEKEQVGHIRAERDILV 56

Query: 151 --GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQL---- 203
                  V++   F  + ++ ++ E L G  +   L K        D + E   Q     
Sbjct: 57  EADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK-------DTLTEEETQFYIAE 109

Query: 204 -LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS--RSSKDGSYFKNLPKSSAI 260
            + ++  +H+L  IH D+KP+N+LL S  +VK+ D+   +  + +    +++NL  S   
Sbjct: 110 TVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169

Query: 261 KLIDFGSTTFEHQDHSY----------VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310
               F +   + +  ++           V T  Y APEV +  G+N  CD WS+G I+ E
Sbjct: 170 DFT-FQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228

Query: 311 LCSGEALF 318
           +  G   F
Sbjct: 229 MLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 51/227 (22%), Positives = 99/227 (43%), Gaps = 35/227 (15%)

Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDIGG 152
             +S +G G  G V +        ++A K+V   + +  R+  + E+ ++     H+   
Sbjct: 8   ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIM-----HECRS 62

Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH- 211
              V     F   N+IC+  E +     D + K      P++++ ++   ++E + +++ 
Sbjct: 63  PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYK-KGGPIPVEILGKIAVAVVEGLTYLYN 121

Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
             R++H D+KP NIL+ S   +K+ D+                    + +LI+  + TF 
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDF------------------GVSGELINSIADTF- 162

Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
                  V T  Y +PE I G  +    D+WS+G  ++EL  G+  F
Sbjct: 163 -------VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPF 202

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 56.9 bits (138), Expect = 3e-09
 Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 36/221 (16%)

Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           ++  K+G G FG+V     N   + VA+K ++      EA + E  ++++L RHD    +
Sbjct: 9   KLERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKL-RHD----K 62

Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            VQ+         I IV E +   SL DFL+    +   +  + ++  Q+ E +A++   
Sbjct: 63  LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR 122

Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA---IKLIDFGSTTF 270
             IH DL   NIL+      K+ D+  L+R  +D  Y     +  A   IK         
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFG-LARLIEDDEY---TAREGAKFPIK--------- 169

Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
                        + APE      +    D+WS G +L E+
Sbjct: 170 -------------WTAPEAANYGRFTIKSDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 64/241 (26%), Positives = 107/241 (44%), Gaps = 34/241 (14%)

Query: 95  RILSKMGEGTFGQV-VECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           R+  K+G+G FG+V +  ++   K  VAIK ++      EA + E  ++++L RHD    
Sbjct: 9   RLDVKLGQGCFGEVWMGTWNGTTK--VAIKTLKPGTMMPEAFLQEAQIMKKL-RHD---- 61

Query: 154 RCVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
           + V +         I IV E +G  SL DFL++   +   +  + ++  Q+ + +A++  
Sbjct: 62  KLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER 120

Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
           +  IH DL+  NIL+      K+ D+  L+R  +D  Y         IK           
Sbjct: 121 MNYIHRDLRAANILVGDNLVCKIADFG-LARLIEDNEYTARQGAKFPIK----------- 168

Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMME 331
                      + APE  L   +    D+WS G +L EL + G   +    N E L  +E
Sbjct: 169 -----------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE 217

Query: 332 R 332
           R
Sbjct: 218 R 218

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 60/243 (24%), Positives = 105/243 (43%), Gaps = 41/243 (16%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI----EIDVLQRLARHD 149
           + IL  +G G FG+V         ++ A+KI+      + A       E DVL       
Sbjct: 3   FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN----- 57

Query: 150 IGGTRCVQIRNW-FDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
            G  + +   ++ F   N++ +V +  +G  L   L K   R  P D+ R    +++ ++
Sbjct: 58  -GDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAI 115

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
             +H+L  +H D+KP+NIL+    ++++ D+                   S +KL++ G+
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGHIRLADF------------------GSCLKLMEDGT 157

Query: 268 TTFEHQDHSYVVSTRHYRAPEVIL----GLGWNYP-CDLWSVGCILVELCSGEALFQTHE 322
                   S  V T  Y +PE++     G G   P CD WS+G  + E+  GE  F    
Sbjct: 158 V-----QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212

Query: 323 NLE 325
            +E
Sbjct: 213 LVE 215

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 56.5 bits (136), Expect = 7e-09
 Identities = 54/225 (24%), Positives = 96/225 (42%), Gaps = 46/225 (20%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEID--VLQRLARHDIGGTRCVQ 157
           +G+G+FG+V++     K++   I  +++I K    +  E+   + +R     +     V 
Sbjct: 1   IGKGSFGKVMQV---RKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVP 57

Query: 158 IRNWFDYRNHICIVFEKL-GPSLYDFLRK----NSYRSFPIDLVRELGRQLLESVAFMHE 212
           ++  F     + +V   + G  L+  L++    +  R+      R    +LL ++  +H+
Sbjct: 58  LKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRA------RFYTAELLCALENLHK 111

Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
             +I+ DLKPENILL         DY                     I L DFG      
Sbjct: 112 FNVIYRDLKPENILL---------DY------------------QGHIALCDFGLCKLNM 144

Query: 273 QDHSYV---VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           +D         T  Y APE++LG G+    D W++G +L E+ +G
Sbjct: 145 KDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 56.4 bits (136), Expect = 9e-09
 Identities = 51/222 (22%), Positives = 104/222 (46%), Gaps = 37/222 (16%)

Query: 93  RYRILSKMGEGTFGQVVECF---DNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD 149
           +Y ILS +  G+ G+V  C    D ++K++    IV+++   +     EID+L+ ++   
Sbjct: 93  QYNILSSLTPGSEGEVFVCTKHGDEQRKKV----IVKAVTGGKTPGR-EIDILKTISHRA 147

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
           I     + + + + +++ +C+V  K    L+ ++ ++     P++    + R+LLE++A+
Sbjct: 148 I-----INLIHAYRWKSTVCMVMPKYKCDLFTYVDRSG--PLPLEQAITIQRRLLEALAY 200

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
           +H   +IH D+K ENI L   E   + D+                   +A KL    +  
Sbjct: 201 LHGRGIIHRDVKTENIFLDEPENAVLGDF------------------GAACKL---DAHP 239

Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
              Q + +   T    +PE++    +    D+WS G +L E+
Sbjct: 240 DTPQCYGW-SGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 70/289 (24%), Positives = 121/289 (41%), Gaps = 63/289 (21%)

Query: 93  RY-RILSKMGEGTFGQV-VECFD---NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRL 145
           RY + +  +GEG FG+V + C+D   +   E+VA+K ++     +       EI++L+ L
Sbjct: 4   RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL 63

Query: 146 ARHDI---------GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLV 196
              +I          G + +Q+           + +  LG SL D+L K+      ++L 
Sbjct: 64  YHENIVKYKGCCSEQGGKGLQL----------IMEYVPLG-SLRDYLPKHK-----LNLA 107

Query: 197 REL--GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254
           + L   +Q+ E +A++H    IH DL   N+LL +   VK+ D+  L+++  +G  +  +
Sbjct: 108 QLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFG-LAKAVPEGHEYYRV 166

Query: 255 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
            +       D  S  F             + A E +    ++Y  D+WS G  L EL   
Sbjct: 167 RE-------DGDSPVF-------------WYAVECLKENKFSYASDVWSFGVTLYEL--- 203

Query: 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPD 363
             L             E ++GP    M +    R  +   RG RL  P 
Sbjct: 204 --LTHCDSKQSPPKKFEEMIGPKQGQMTV---VRLIELLERGMRLPCPK 247

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 54/236 (22%), Positives = 98/236 (41%), Gaps = 39/236 (16%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAAMI--EIDVLQRLARHD 149
           + +L  +G+G FG+V      + K++ A+K +      +      +  E  +LQ L  H 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHP 60

Query: 150 IGGTRCVQIRNWFDYRNHICIVFE-KLGPSL-YDFLRKNSYRSFPIDLVRELGRQLLESV 207
                 V +   F    ++ +V +  LG  L Y   +K     F  + V+    +++ ++
Sbjct: 61  F----LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLAL 113

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
            ++H   +IH D+KP+NILL    +V + D+              N+    A K+    +
Sbjct: 114 EYLHSKGIIHRDIKPDNILLDEQGHVHITDF--------------NI----ATKVTP-DT 154

Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
            T           T  Y APEV+   G++   D WS+G    E   G+  ++ H  
Sbjct: 155 LTTS------TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 59/240 (24%), Positives = 102/240 (42%), Gaps = 51/240 (21%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           + I+  +G+GT+G+V +  + +     A+KI+  I+   E    E ++L+ L+ H     
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDH----P 75

Query: 154 RCVQIRNWF---DYRN--HICIVFEKL-GPSLYD----FLRKNSYRSFPIDLVRELGRQL 203
             V+    +   D +N   + +V E   G S+ D    FL++      PI  +  +  + 
Sbjct: 76  NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI--IAYILHEA 133

Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
           L  +  +H  + IH D+K  NILL +                              +KL+
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTT---------------------------EGGVKLV 166

Query: 264 DFGST---TFEHQDHSYVVSTRHYRAPEVI-----LGLGWNYPCDLWSVGCILVELCSGE 315
           DFG +   T      +  V T  + APEVI     L   ++  CD+WS+G   +EL  G+
Sbjct: 167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGD 226

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 50/231 (21%), Positives = 100/231 (43%), Gaps = 41/231 (17%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-------EAAMIEIDVLQRLARHDIGG 152
           +G+G FG+V         ++ A K    ++K R       + A++E ++L+++    I  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACK---KLDKKRLKKKSGEKMALLEKEILEKVNSPFI-- 55

Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V +   F+ + H+C+V   + G  L   +     R   ++ V     Q+   +  +H
Sbjct: 56  ---VNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH 112

Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            + +++ D+KPEN+LL      ++ D                     A++L D  + T  
Sbjct: 113 SMDIVYRDMKPENVLLDDQGNCRLSDLGL------------------AVELKDGKTITQR 154

Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322
                    T  Y APE++    ++YP D +++GC + E+ +G   F+ H+
Sbjct: 155 -------AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 55.2 bits (134), Expect = 1e-08
 Identities = 59/238 (24%), Positives = 95/238 (39%), Gaps = 60/238 (25%)

Query: 99  KMGEGTFGQVVECF---DNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHD---- 149
           K+GEG FG+V +      + K   VA+K ++     + R+  + E  V+++L  H     
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVVR 60

Query: 150 -IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
            +G   C +          + +V E  + G  L D+LRK+    FP      L  + L S
Sbjct: 61  LLGV--CTE-------EEPLYLVLEYMEGG-DLLDYLRKSR-PVFPSPEKSTLSLKDLLS 109

Query: 207 VA--------FMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKS 257
            A        ++   + +H DL   N L+     VK+ D  F LSR   D  Y++   K 
Sbjct: 110 FAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISD--FGLSRDVYDDDYYR---KK 164

Query: 258 SAIKLIDFGSTTFEHQDHSYVVSTRHYR--APEVILGLGWNYPCDLWSVGCILVELCS 313
           +  KL                      R  APE +    +    D+WS G +L E+ +
Sbjct: 165 TGGKL--------------------PIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 58/241 (24%), Positives = 103/241 (42%), Gaps = 33/241 (13%)

Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           ++L K+G G FG+V E   N     VA+K ++      +  + E  ++++L RH     +
Sbjct: 9   QLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKDFLAEAQIMKKL-RH----PK 62

Query: 155 CVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
            +Q+         I IV E  K G SL ++L+  + R+  +  + ++  Q+   +A++  
Sbjct: 63  LIQLYAVCTLEEPIYIVTELMKYG-SLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA 121

Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
              IH DL   N+L+      KV D+  L+R  K+  Y         IK           
Sbjct: 122 QNYIHRDLAARNVLVGENNICKVADFG-LARVIKEDIYEAREGAKFPIK----------- 169

Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMME 331
                      + APE  L   ++   D+WS G +L E+ + G   +    N E L  ++
Sbjct: 170 -----------WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218

Query: 332 R 332
           +
Sbjct: 219 Q 219

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 63/252 (25%), Positives = 106/252 (42%), Gaps = 60/252 (23%)

Query: 93  RYRILSKMGEGTFGQVVECF------DNEKKELVAI------KIVRSINKY-----REAA 135
            +R++  +  G FG++  C       + E +  V        K  R I K      R A 
Sbjct: 149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAI 208

Query: 136 MIE--IDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNS--YRSF 191
            +E  I  L RL   +I     ++I        +  ++ +K    LY F+   +  ++  
Sbjct: 209 QLENEILALGRLNHENI-----LKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDR 263

Query: 192 P-IDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250
           P +   R + +QLL +V ++H+ +LIH D+K ENI L                 + DG  
Sbjct: 264 PLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL-----------------NCDGK- 305

Query: 251 FKNLPKSSAIKLIDFGS-TTFEHQ----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
                    I L DFG+   FE +    D+ +V  T    +PE++ G G+    D+WS G
Sbjct: 306 ---------IVLGDFGTAMPFEKEREAFDYGWV-GTVATNSPEILAGDGYCEITDIWSCG 355

Query: 306 CILVELCSGEAL 317
            IL+++ S +  
Sbjct: 356 LILLDMLSHDFC 367

Length = 501

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 60/248 (24%), Positives = 107/248 (43%), Gaps = 47/248 (18%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-------EAAMIEIDVLQRLARHDIGG 152
           +G+G FG+V  C      +L A K    +NK R       E AM+E  +L ++    I  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACK---KLNKKRLKKRKGYEGAMVEKRILAKVHSRFI-- 55

Query: 153 TRCVQIRNWFDYRNHICIVFE-----KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
              V +   F  +  +C+V        L   +Y+   +N    FP         Q++  +
Sbjct: 56  ---VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENP--GFPEPRACFYTAQIISGL 110

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
             +H+ R+I+ DLKPEN+LL +   V++ D                     A++L D  S
Sbjct: 111 EHLHQRRIIYRDLKPENVLLDNDGNVRISDLGL------------------AVELKDGQS 152

Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH-ENLEH 326
            T  +        T  + APE++ G  +++  D +++G  L E+ +    F+   E +E+
Sbjct: 153 KTKGY------AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN 206

Query: 327 LAMMERVL 334
             + +R+L
Sbjct: 207 KELKQRIL 214

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 55.5 bits (133), Expect = 1e-08
 Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 43/223 (19%)

Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIV-----RSINKYREAAMIEIDVLQRLARHDIG 151
           L ++G G+FG V    D    E+VAIK +     +S  K+++  + E+  LQR+   +  
Sbjct: 30  LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI-IKEVKFLQRIKHPN-- 86

Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
               ++ +  +   +   +V E    S  D L  +      +++   +    L+ +A++H
Sbjct: 87  ---SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AITHGALQGLAYLH 142

Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
              +IH D+K  NILL                            +   +KL DFGS +  
Sbjct: 143 SHNMIHRDIKAGNILLT---------------------------EPGQVKLADFGSASIA 175

Query: 272 HQDHSYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVEL 311
              +S+ V T ++ APEVIL +    ++   D+WS+G   +EL
Sbjct: 176 SPANSF-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 55/232 (23%), Positives = 97/232 (41%), Gaps = 37/232 (15%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRC 155
           +G+G+FG+V         +  AIK ++     ++   E  M+E  VL     H       
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF----L 58

Query: 156 VQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRE--LGRQLLESVAFMHEL 213
             +   F  + ++  V E L      F  ++ ++    DL R      +++  + F+H  
Sbjct: 59  THLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLHSK 115

Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
            +++ DLK +NILL +  ++K+ D+     +                 L D  + TF   
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKEN----------------MLGDAKTCTF--- 156

Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
                  T  Y APE++LG  +N   D WS G +L E+  G++ F  H+  E
Sbjct: 157 -----CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 55.1 bits (132), Expect = 1e-08
 Identities = 64/240 (26%), Positives = 102/240 (42%), Gaps = 32/240 (13%)

Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           R+  K+G+G FG+V     N     VAIK ++      EA + E  V+++L RH+    +
Sbjct: 9   RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE----K 62

Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            VQ+         I IV E +   SL DFL+    +   +  + ++  Q+   +A++  +
Sbjct: 63  LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 121

Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL+  NIL+      KV D+  L+R  +D  Y         IK            
Sbjct: 122 NYVHRDLRAANILVGENLVCKVADFG-LARLIEDNEYTARQGAKFPIK------------ 168

Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE  L   +    D+WS G +L EL + G   +    N E L  +ER
Sbjct: 169 ----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 218

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 56/251 (22%), Positives = 110/251 (43%), Gaps = 38/251 (15%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
           +YR+L   G+G FG+V  C      ++ A K +  + I K +  +M   E  +L+++   
Sbjct: 4   QYRVL---GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60

Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
            +     V +   ++ ++ +C+V   + G  L   +       F          ++   +
Sbjct: 61  FV-----VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGL 115

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
             +H+ R+++ DLKPENILL    ++++ D               ++P+   IK    G 
Sbjct: 116 EDLHQERIVYRDLKPENILLDDHGHIRISDLGLAV----------HVPEGQTIK----GR 161

Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
                      V T  Y APEV+    + +  D W++GC+L E+ +G++ FQ  +     
Sbjct: 162 -----------VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR 210

Query: 328 AMMERVLGPLP 338
             +ER++  + 
Sbjct: 211 EEVERLVKEVQ 221

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 53/229 (23%), Positives = 92/229 (40%), Gaps = 49/229 (21%)

Query: 99  KMGEGTFGQVVEC-FDNEKKEL--VAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGT 153
           K+G+G+FG V    +     ++  VA+K ++S       +  + E  ++  L   ++   
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENL--- 58

Query: 154 RCVQIRNWFDYRNH-ICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
               IR +     H + +V E L P  SL D LRK++   F I  + +   Q+   + ++
Sbjct: 59  ----IRLYGVVLTHPLMMVTE-LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL 113

Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
              R IH DL   NILL S + VK+ D+  L R+                          
Sbjct: 114 ESKRFIHRDLAARNILLASDDKVKIGDFG-LMRALPQN---------------------- 150

Query: 271 EHQDHSYVVSTRHYR------APEVILGLGWNYPCDLWSVGCILVELCS 313
                 + V   H +      APE +    +++  D+W  G  L E+ +
Sbjct: 151 ----EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 55.1 bits (132), Expect = 2e-08
 Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 41/222 (18%)

Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIV----RSINKYREAAMIEIDVLQRLARHDIGG 152
           L ++G G+FG V    D    E+VAIK +    +  N+  +  + E+  LQ+L RH    
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RH---- 74

Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
              +Q R  +   +   +V E    S  D L  +      +++   +    L+ +A++H 
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AVTHGALQGLAYLHS 133

Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
             +IH D+K  NILL                            +   +KL DFGS +   
Sbjct: 134 HNMIHRDVKAGNILLS---------------------------EPGLVKLGDFGSASIMA 166

Query: 273 QDHSYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVEL 311
             + + V T ++ APEVIL +    ++   D+WS+G   +EL
Sbjct: 167 PANXF-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 59/243 (24%), Positives = 105/243 (43%), Gaps = 40/243 (16%)

Query: 99  KMGEGTFGQVVECFDNEKK--ELVAIKIVRSINK---YREAAMIEIDVLQRLARHDIGGT 153
           ++G G FG V +     KK  + VA+KI+++ N     ++  + E +V+Q+L    I   
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYI--V 59

Query: 154 RCVQI---RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
           R + I    +W      + +   +LGP L  FL+KN  +      + EL  Q+   + ++
Sbjct: 60  RMIGICEAESWM-----LVMELAELGP-LNKFLQKN--KHVTEKNITELVHQVSMGMKYL 111

Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
            E   +H DL   N+LLV+  Y K+ D+        D +Y+K                  
Sbjct: 112 EETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA----------------- 154

Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAM 329
             + H        + APE +    ++   D+WS G ++ E  S G+  ++  +  E   M
Sbjct: 155 --KTHGK--WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM 210

Query: 330 MER 332
           +E 
Sbjct: 211 IES 213

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 65/255 (25%), Positives = 105/255 (41%), Gaps = 62/255 (24%)

Query: 91  TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150
           T  + I+  +G+GT+G+V +  + +   L A+KI+  I+   E    E ++LQ L  H  
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNH-- 78

Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVREL---GRQLLESV 207
                V+    F Y+    +     G  L+  L   +  S   +LV+ L   G++L E++
Sbjct: 79  --PNVVKFYGMF-YKADKLV-----GGQLWLVLELCNGGSV-TELVKGLLICGQRLDEAM 129

Query: 208 ------------AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 255
                         +H  R+IH D+K  NILL +                          
Sbjct: 130 ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTT-------------------------- 163

Query: 256 KSSAIKLIDFGST---TFEHQDHSYVVSTRHYRAPEVI-----LGLGWNYPCDLWSVGCI 307
               +KL+DFG +   T      +  V T  + APEVI         ++  CD+WS+G  
Sbjct: 164 -EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGIT 222

Query: 308 LVELCSGE-ALFQTH 321
            +EL  G+  LF  H
Sbjct: 223 AIELGDGDPPLFDMH 237

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 59/251 (23%), Positives = 112/251 (44%), Gaps = 35/251 (13%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHDI 150
           Y  +  +G+G++G+V         +   IK   +  +  + R+AA  E  +L +L   +I
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61

Query: 151 GGTRCVQIRNW--FDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
              R     +W   D   +I + F + G  LY  L++   +  P + V E   Q+  ++ 
Sbjct: 62  VAYR----ESWEGEDGLLYIVMGFCE-GGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ 116

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++HE  ++H DLK +N+ L     +KV D   ++R  ++                D  ST
Sbjct: 117 YLHEKHILHRDLKTQNVFLTRTNIIKVGDLG-IARVLENQC--------------DMAST 161

Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE-NLEHL 327
                    ++ T +Y +PE+     +NY  D+W++GC + E+ + +  F   + N    
Sbjct: 162 ---------LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY 212

Query: 328 AMMERVLGPLP 338
            ++E  L P+P
Sbjct: 213 RIIEGKLPPMP 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 67/264 (25%), Positives = 106/264 (40%), Gaps = 57/264 (21%)

Query: 96  ILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
            L ++G GT GQV +    +   ++A+K + R+ NK  E   I +D+   L  HD     
Sbjct: 19  NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHD----- 72

Query: 155 C---VQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
           C   V+   +F   + + I  E +   L D L K      P D+   LG+  +  V  +H
Sbjct: 73  CPYIVKCYGYFITDSDVFICMELMSTCL-DKLLKRIQGPIPEDI---LGKMTVAIVKALH 128

Query: 212 ELR----LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
            L+    +IH D+KP NILL                             S  +KL DFG 
Sbjct: 129 YLKEKHGVIHRDVKPSNILL---------------------------DASGNVKLCDFGI 161

Query: 268 TTF--EHQDHSYVVSTRHYRAPEVI----LGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +    + +  +       Y APE I        ++   D+WS+G  LVEL +G+  F   
Sbjct: 162 SGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ--FPYK 219

Query: 322 ENLEHLAMMERVLGP----LPHHM 341
                  ++ ++L      LP + 
Sbjct: 220 NCKTEFEVLTKILQEEPPSLPPNE 243

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 63/245 (25%), Positives = 108/245 (44%), Gaps = 34/245 (13%)

Query: 92  PR--YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD 149
           PR   +++ K+G G FG+V   + N   + VAIK ++  +   EA + E +++++L +H 
Sbjct: 4   PRETLKLVKKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEAFLAEANLMKQL-QHP 61

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
               R V++      +  I I+ E +   SL DFL+        I+ + ++  Q+ E +A
Sbjct: 62  ----RLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMA 116

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           F+     IH DL+  NIL+      K+ D+  L+R  +D  Y         IK       
Sbjct: 117 FIERKNYIHRDLRAANILVSETLCCKIADFG-LARLIEDNEYTAREGAKFPIK------- 168

Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHL 327
                          + APE I    +    D+WS G +L E+ + G   +    N E +
Sbjct: 169 ---------------WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI 213

Query: 328 AMMER 332
             +ER
Sbjct: 214 QNLER 218

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 60/242 (24%), Positives = 96/242 (39%), Gaps = 41/242 (16%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRC 155
           +G+G+FG+V+        E  AIK ++      +   E  M+E  VL     H       
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPF----L 58

Query: 156 VQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
             +   F  + H+  V E L      F  ++S R F     R    +++  + F+H+  +
Sbjct: 59  THLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLHKKGI 117

Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE---H 272
           I+ DLK +N+LL                  KDG           IK+ DFG         
Sbjct: 118 IYRDLKLDNVLL-----------------DKDGH----------IKIADFGMCKENMNGE 150

Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENLEHLAMM 330
              S    T  Y APE++ G  +N   D WS G +L E+  G++ F  +  + L    + 
Sbjct: 151 GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN 210

Query: 331 ER 332
           +R
Sbjct: 211 DR 212

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 55/231 (23%), Positives = 102/231 (44%), Gaps = 35/231 (15%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAA--MIEIDVLQRLARHDIGGTRC 155
           +G+G+FG+V+      +++  A+K++  ++I K +E    M E +VL +  +H       
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF----L 58

Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
           V +   F   + +  V + + G  L+  L++   R F     R    ++  ++ ++H L 
Sbjct: 59  VGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN 116

Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           +++ DLKPENILL S  ++ + D+     +                  I+   TT     
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKEN------------------IEHNGTT----- 153

Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
            S    T  Y APEV+    ++   D W +G +L E+  G   F +    E
Sbjct: 154 -STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 53.5 bits (128), Expect = 4e-08
 Identities = 62/236 (26%), Positives = 107/236 (45%), Gaps = 32/236 (13%)

Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+G G FG+V     N K   VA+K ++  +   EA + E +V++ L +HD    + V++
Sbjct: 13  KLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHD----KLVKL 66

Query: 159 RNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
            +    +  I I+ E +   SL DFL+ +     P+  + +   Q+ E +AF+ +   IH
Sbjct: 67  -HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 125

Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
            DL+  NIL+ ++   K+ D+  L+R  +D  Y         IK                
Sbjct: 126 RDLRAANILVSASLVCKIADFG-LARVIEDNEYTAREGAKFPIK---------------- 168

Query: 278 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                 + APE I    +    D+WS G +L+E+ + G   +    N E +  +ER
Sbjct: 169 ------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 218

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 53.4 bits (128), Expect = 5e-08
 Identities = 59/234 (25%), Positives = 99/234 (42%), Gaps = 42/234 (17%)

Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           ++G G FG V   +  EK++ VAIK +R      E  + E  V+ +L+       + VQ+
Sbjct: 11  EIGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFIEEAQVMMKLSH-----PKLVQL 64

Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
                 R+ IC+VFE +    L D+LR      F  + +  +   + E +A++    +IH
Sbjct: 65  YGVCTERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIH 123

Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
            DL   N L                           + ++  +K+ DFG T F   D  Y
Sbjct: 124 RDLAARNCL---------------------------VGENQVVKVSDFGMTRFVLDDQ-Y 155

Query: 278 VVSTR-----HYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 325
             ST       + +PEV     ++   D+WS G ++ E+ S G+  ++   N E
Sbjct: 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE 209

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 53.5 bits (128), Expect = 6e-08
 Identities = 50/225 (22%), Positives = 103/225 (45%), Gaps = 37/225 (16%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAAMIEID--VLQRLARHD--IGGT 153
           +G G++ +V+     + + + A+K+V+   +N   +   ++ +  V ++ + H   +G  
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            C Q  +    R    I +   G  ++   R+   R  P +  R    ++  ++ ++HE 
Sbjct: 63  SCFQTES----RLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER 115

Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
            +I+ DLK +N+LL S  ++K+ DY       K+G              +  G TT    
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGM----CKEG--------------LRPGDTT---- 153

Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
             S    T +Y APE++ G  + +  D W++G ++ E+ +G + F
Sbjct: 154 --STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 52.6 bits (127), Expect = 1e-07
 Identities = 40/158 (25%), Positives = 67/158 (42%), Gaps = 30/158 (18%)

Query: 176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
              L+D L+K          V+++ RQL+E++  +H+  +IH D+K EN+L         
Sbjct: 93  DGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVL--------- 141

Query: 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW 295
                         Y +   +   I L D+G          Y   T  Y +PE I G  +
Sbjct: 142 --------------YDRAKDR---IYLCDYGLCKIIGTPSCY-DGTLDYFSPEKIKGHNY 183

Query: 296 NYPCDLWSVGCILVELCSGEALFQTHENLE-HLAMMER 332
           +   D W+VG +  EL +G+  F+  E+ E  L  + +
Sbjct: 184 DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLK 221

Length = 267

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 54/240 (22%), Positives = 106/240 (44%), Gaps = 31/240 (12%)

Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           +++ K+G G FG+V   + N   + VA+K ++      +A + E ++++ L +HD    +
Sbjct: 9   KLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFLEEANLMKTL-QHD----K 62

Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            V++         I I+ E +   SL DFL+ +      +  + +   Q+ E +A++   
Sbjct: 63  LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122

Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             IH DL+  N+L+  +   K+ D+  L+R  +D  Y         IK            
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFG-LARVIEDNEYTAREGAKFPIK------------ 169

Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE I    +    D+WS G +L E+ + G+  +    N + ++ ++R
Sbjct: 170 ----------WTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR 219

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 62/268 (23%), Positives = 109/268 (40%), Gaps = 73/268 (27%)

Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA--MIEIDVLQRLARHDIGGTR 154
           L ++G G FG V +        ++A+K +RS    +E    ++++DV+ R        + 
Sbjct: 9   LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMR-------SSD 61

Query: 155 CVQIRNWFDYRNH-----IC-----IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
           C  I  ++          IC     I  +K    +Y+ L+       P ++   LG+  +
Sbjct: 62  CPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSV----IPEEI---LGKIAV 114

Query: 205 ESVAFMH----ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            +V  ++    EL++IH D+KP NILL                            ++  I
Sbjct: 115 ATVKALNYLKEELKIIHRDVKPSNILL---------------------------DRNGNI 147

Query: 261 KLIDFG------STTFEHQDHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVEL 311
           KL DFG       +  + +D       R Y APE I      G++   D+WS+G  L E+
Sbjct: 148 KLCDFGISGQLVDSIAKTRD----AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203

Query: 312 CSGEALFQTHENL-EHLAMMERVLGPLP 338
            +G+  +    ++ + L  +  V G  P
Sbjct: 204 ATGKFPYPKWNSVFDQLTQV--VKGDPP 229

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 60/238 (25%), Positives = 104/238 (43%), Gaps = 41/238 (17%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAA--MIEIDVLQRLARHDIGGTRC 155
           +G+G+FG+V+           A+K++  ++I K +E    M E +VL +  +H       
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPF----L 58

Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
           V +   F     +  V + + G  L+  L++   R F     R    ++  ++ ++H L 
Sbjct: 59  VGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLN 116

Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           +I+ DLKPENILL S  +V + D+       K+G              ++   TT     
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGL----CKEG--------------VEPEETT----- 153

Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF------QTHENLEH 326
            S    T  Y APEV+    ++   D W +G +L E+  G   F      Q ++N+ H
Sbjct: 154 -STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH 210

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 52/222 (23%), Positives = 97/222 (43%), Gaps = 41/222 (18%)

Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIV----RSINKYREAAMIEIDVLQRLARHDIGG 152
           L ++G G+FG V    ++   E+VA+K +    +  N+  +  + E+  LQ+L   +   
Sbjct: 26  LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNT-- 83

Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
              ++ +  +   +   +V E    S  D L  +      +++   +    L+ +A++H 
Sbjct: 84  ---IEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AITHGALQGLAYLHS 139

Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
             +IH D+K  NILL                            +   +KL DFGS +   
Sbjct: 140 HNMIHRDIKAGNILLT---------------------------EPGQVKLADFGSASKSS 172

Query: 273 QDHSYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVEL 311
             +S+ V T ++ APEVIL +    ++   D+WS+G   +EL
Sbjct: 173 PANSF-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 51/235 (21%), Positives = 103/235 (43%), Gaps = 39/235 (16%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           + ++ ++G GT+G V +  +    EL AIK+++ +    + A+++ +++      D   +
Sbjct: 11  FELIQRIGSGTYGDVYKARNVNTGELAAIKVIK-LEPGEDFAVVQQEIIMM---KDCKHS 66

Query: 154 RCVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPID--LVRELGRQLLESVAFM 210
             V     +  R+ + I  E  G  SL D      + + P+    +  + R+ L+ + ++
Sbjct: 67  NIVAYFGSYLRRDKLWICMEFCGGGSLQDIY----HVTGPLSESQIAYVSRETLQGLYYL 122

Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H    +H D+K  NILL    +VK+ D+   ++ +   +  K+                 
Sbjct: 123 HSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF---------------- 166

Query: 271 EHQDHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGE-ALFQTH 321
                   + T ++ APEV       G+N  CD+W+VG   +EL   +  +F  H
Sbjct: 167 --------IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 64/268 (23%), Positives = 110/268 (41%), Gaps = 54/268 (20%)

Query: 94  YRILSKMGEGTFGQVV---ECFDNEKKELVAIKIVRSIN-----KYREAAMIEIDVLQRL 145
           + +L  +G G +G+V    +   ++  +L A+K+++        K  E    E  VL+ +
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61

Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
            R        V +   F     + ++ + + G  L+  L +  +  F    VR    +++
Sbjct: 62  RRCPF----LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH--FTESEVRVYIAEIV 115

Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
            ++  +H+L +I+ D+K ENILL                   +G           + L D
Sbjct: 116 LALDHLHQLGIIYRDIKLENILL-----------------DSEGH----------VVLTD 148

Query: 265 FG-STTF----EHQDHSYVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSGEAL 317
           FG S  F    E + +S+   T  Y APEVI G   G +   D WS+G +  EL +G + 
Sbjct: 149 FGLSKEFLAEEEERAYSF-CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Query: 318 FQTH-ENLEHLAMMERVLG---PLPHHM 341
           F    E      +  R+L    P P  M
Sbjct: 208 FTVDGEQNSQSEISRRILKSKPPFPKTM 235

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 46/221 (20%), Positives = 100/221 (45%), Gaps = 29/221 (13%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159
           +G G++ +V+     +  ++ A+K+V+    + +  +  +   + +          V + 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 160 NWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
           + F   + + +V E +  G  ++   R+   R  P +  R    ++  ++ F+HE  +I+
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERGIIY 119

Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
            DLK +N+LL +  ++K+ DY       K+G              +  G TT      S 
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGM----CKEG--------------LGPGDTT------ST 155

Query: 278 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
              T +Y APE++ G  + +  D W++G ++ E+ +G + F
Sbjct: 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 51.0 bits (122), Expect = 3e-07
 Identities = 51/231 (22%), Positives = 97/231 (41%), Gaps = 38/231 (16%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHD 149
           YR+L   G+G FG+V  C      ++ A K +  + I K +  AM   E  +L++     
Sbjct: 5   YRVL---GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK----- 56

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           +     V +   ++ ++ +C+V   + G  L   +       F  +       ++   + 
Sbjct: 57  VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLE 116

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
            +H  R+++ DLKPENILL    ++++ D   L+    +G   +                
Sbjct: 117 DLHRERIVYRDLKPENILLDDYGHIRISDLG-LAVEIPEGETIRGR-------------- 161

Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
                     V T  Y APEV+    + +  D W +GC++ E+  G++ F+
Sbjct: 162 ----------VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFR 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 63/244 (25%), Positives = 103/244 (42%), Gaps = 52/244 (21%)

Query: 95  RILSKMGEGTFGQVVEC-FD---NEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
           + + ++G+G FG V  C +D   +   E+VA+K ++ S  ++      EI++L+ L   +
Sbjct: 7   KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDN 66

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
           I   + V    +   R ++ +V E L P  SL D+L+K+  R     L+     Q+ + +
Sbjct: 67  IVKYKGV---CYSAGRRNLRLVMEYL-PYGSLRDYLQKHRERLDHRKLL-LYASQICKGM 121

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
            ++   R +H DL   NIL+ S   VK+                            DFG 
Sbjct: 122 EYLGSKRYVHRDLATRNILVESENRVKIG---------------------------DFGL 154

Query: 268 TTFEHQDHSYVV------STRHYRAPEVILGLGWNYPCDLWSVGCILVEL-------CSG 314
           T    QD  Y        S   + APE +    ++   D+WS G +L EL       CS 
Sbjct: 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSP 214

Query: 315 EALF 318
            A F
Sbjct: 215 PAEF 218

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 61/228 (26%), Positives = 99/228 (43%), Gaps = 38/228 (16%)

Query: 92  PR--YRILSKMGEGTFGQVVE-CFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLAR 147
           PR  + +  K+G G FG+V E  + N  +  VAIKI++S +  ++     E+  L+RL R
Sbjct: 4   PREEFTLERKLGSGYFGEVWEGLWKNRVR--VAIKILKSDDLLKQQDFQKEVQALKRL-R 60

Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLES 206
           H       + +         + I+ E +   SL  FLR    +  P+  + ++  Q+ E 
Sbjct: 61  HK----HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEG 116

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYV-KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           +A++ E   IH DL   NI LV  + V KV D+  L+R  K+  Y   L     I     
Sbjct: 117 MAYLEEQNSIHRDLAARNI-LVGEDLVCKVADFG-LARLIKEDVY---LSSDKKIPY--- 168

Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                             + APE      ++   D+WS G +L E+ +
Sbjct: 169 -----------------KWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 50.6 bits (121), Expect = 4e-07
 Identities = 51/224 (22%), Positives = 92/224 (41%), Gaps = 42/224 (18%)

Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARHDIGG 152
           +    +G G  G V + +    + ++A+K++      + ++  M E+++L +     I  
Sbjct: 4   QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYI-- 61

Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              +     F   N I I  E + G SL      + YR  P  ++  +   +++ + ++ 
Sbjct: 62  ---IGFYGAFFVENRISICTEFMDGGSL------DVYRKIPEHVLGRIAVAVVKGLTYLW 112

Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTF 270
            L+++H D+KP N+L+ +   V                           KL DFG ST  
Sbjct: 113 SLKILHRDVKPSNMLVNTRGQV---------------------------KLCDFGVSTQL 145

Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
            +      V T  Y APE I G  +    D+WS+G   +EL  G
Sbjct: 146 VNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALG 189

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 57/234 (24%), Positives = 94/234 (40%), Gaps = 48/234 (20%)

Query: 13  NMDKRPRKRPRLTWDVP---PPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTG 69
               RPR+RP LT  +P   P L  P  LP             P  + SS    +     
Sbjct: 19  TTKSRPRRRPDLTLPLPQRDPSLAVPLPLP-------------PPSSSSSSSSSSSASGS 65

Query: 70  SPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RS 127
           +P                 +L+   R+ +++G G  G V +        L A+K++    
Sbjct: 66  APSAAK-------------SLSELERV-NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH 111

Query: 128 INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNS 187
            +  R     EI++L R   H       V+  + FD+   I ++ E        F+   S
Sbjct: 112 EDTVRRQICREIEIL-RDVNH----PNVVKCHDMFDHNGEIQVLLE--------FMDGGS 158

Query: 188 YRSFPIDLVREL---GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
                I   + L    RQ+L  +A++H   ++H D+KP N+L+ SA+ VK+ D+
Sbjct: 159 LEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADF 212

Length = 353

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 50.0 bits (120), Expect = 5e-07
 Identities = 64/260 (24%), Positives = 100/260 (38%), Gaps = 78/260 (30%)

Query: 100 MGEGTFGQVVECFDNEK--KEL-VAIKIVR--SINKYREAAMIEIDVLQRLARHDIGGTR 154
           +G G FG VV+     K  KE+ VA+K ++   I   ++  + E  V+ +L         
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL--------- 53

Query: 155 CVQIRNWFDYRNHICIV----------------FEKLGPSLYDFLRKNSYRSFPIDLVRE 198
                      +H CIV                   LGP L  +L+K   R  P+  ++E
Sbjct: 54  -----------DHPCIVRLIGVCKGEPLMLVMELAPLGP-LLKYLKKR--REIPVSDLKE 99

Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
           L  Q+   +A++     +H DL   N+LLV+    K+ D+  +SR+   GS         
Sbjct: 100 LAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFG-MSRALGAGS--------- 149

Query: 259 AIKLIDFGSTTFEHQDHSYVVSTRHYR------APEVILGLGWNYPCDLWSVGCILVELC 312
                             Y  +T   R      APE I    ++   D+WS G  L E  
Sbjct: 150 -----------------DYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAF 192

Query: 313 S-GEALFQTHENLEHLAMME 331
           S G   +   +  E +AM+E
Sbjct: 193 SYGAKPYGEMKGAEVIAMLE 212

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 54/231 (23%), Positives = 95/231 (41%), Gaps = 36/231 (15%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRL--AR 147
           +R L+ +G G FG+V+     +  EL AIK ++          E+ M E  + +     R
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60

Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
           H       V +   F   +H+C V E    +  D +       F           ++  +
Sbjct: 61  HPF----LVNLFACFQTEDHVCFVMEYA--AGGDLMMHIHTDVFSEPRAVFYAACVVLGL 114

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
            ++HE ++++ DLK +N+LL +  +VK+ D+       K+G              + FG 
Sbjct: 115 QYLHENKIVYRDLKLDNLLLDTEGFVKIADFGL----CKEG--------------MGFGD 156

Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
            T      S    T  + APEV+    +    D W +G ++ E+  GE+ F
Sbjct: 157 RT------STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 50.7 bits (121), Expect = 8e-07
 Identities = 66/258 (25%), Positives = 94/258 (36%), Gaps = 65/258 (25%)

Query: 64  AIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK 123
           AI R   PP           FAI   LTP          G+ G V E    +  + V +K
Sbjct: 151 AISRGCKPPSEVAKVVAGLGFAIHRALTP----------GSEGCVFESSHPDYPQRVVVK 200

Query: 124 IVRSINKYREAAMIE----IDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSL 179
                +   EA ++       VL  L    +GG                C+V  K    L
Sbjct: 201 AGWYASSVHEARLLRRLSHPAVLALLDVRVVGGL--------------TCLVLPKYRSDL 246

Query: 180 YDFLRKNSYRSFPIDL--VRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
           Y +L     R  P+ L  V  + RQLL ++ ++H   +IH D+K EN+L+          
Sbjct: 247 YTYL---GARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---------- 293

Query: 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY-----VVSTRHYRAPEVILG 292
                          N P+   I L DFG+  F     S      +  T    APEV+ G
Sbjct: 294 ---------------NGPED--ICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAG 336

Query: 293 LGWNYPCDLWSVGCILVE 310
             +    D+WS G ++ E
Sbjct: 337 DPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 71/292 (24%), Positives = 120/292 (41%), Gaps = 56/292 (19%)

Query: 100 MGEGTFGQVVEC-FDNE---KKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDIGGT 153
           +GEG FG+V  C +D E     E VA+K ++  +     A +  EI++L+ L   +I   
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 154 R--CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL--GRQLLESVA 208
           +  C +     D  N I ++ E L   SL ++L +N  +   I+L ++L    Q+ + + 
Sbjct: 72  KGICTE-----DGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMD 123

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++   + +H DL   N+L+ S   VK+ D+        D  Y+        +K  D  S 
Sbjct: 124 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY-------TVK-DDLDSP 175

Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL---CSGEALFQTHENLE 325
            F             + APE ++   +    D+WS G  L EL   C  E+         
Sbjct: 176 VF-------------WYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES--------S 214

Query: 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR--DSMRAVW 375
            + +  +++GP    M +    R  +    G RL  P          MR  W
Sbjct: 215 PMTLFLKMIGPTHGQMTV---TRLVRVLEEGKRLPRPPNCPEEVYQLMRKCW 263

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 49.7 bits (118), Expect = 1e-06
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 37/222 (16%)

Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTR 154
           +S++G G  G V +        ++A K++    K   R   + E+ VL     H+     
Sbjct: 10  ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL-----HECNSPY 64

Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            V     F     I I  E + G SL   L++   +  P +++ ++   +L  +A++ E 
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREK 122

Query: 214 -RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
            +++H D+KP NIL+ S   +K+ D+                    + +LID  + +F  
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDF------------------GVSGQLIDSMANSF-- 162

Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                 V TR Y +PE + G  ++   D+WS+G  LVEL  G
Sbjct: 163 ------VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 53/226 (23%), Positives = 99/226 (43%), Gaps = 42/226 (18%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDIG 151
           Y ++ ++G GT+G V +  +    EL A+KI++ +    + ++I  EI +++     +I 
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK-LEPGDDFSLIQQEIFMVKECKHCNI- 68

Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPID--LVRELGRQLLESVA 208
               V     +  R  + I  E  G  SL D      + + P+    +  + R+ L+ +A
Sbjct: 69  ----VAYFGSYLSREKLWICMEYCGGGSLQDIY----HVTGPLSELQIAYVCRETLQGLA 120

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H    +H D+K  NILL     VK+ D+   ++ +   +  K+               
Sbjct: 121 YLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF-------------- 166

Query: 269 TFEHQDHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVEL 311
                     + T ++ APEV       G+N  CD+W+VG   +EL
Sbjct: 167 ----------IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 30/121 (24%), Positives = 53/121 (43%), Gaps = 27/121 (22%)

Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           +++ ++  +H +  IH D+KP+N+LL  + ++K+ D+    +   +G             
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV----------- 198

Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVELCSGEAL 317
                       D +  V T  Y +PEV+   G    +   CD WSVG  L E+  G+  
Sbjct: 199 ----------RCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Query: 318 F 318
           F
Sbjct: 247 F 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 51/232 (21%), Positives = 100/232 (43%), Gaps = 38/232 (16%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
           +YR+L   G+G FG+V  C      ++ A K +  + I K +  +M   E  +L+++   
Sbjct: 4   QYRVL---GKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60

Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
            +     V +   ++ ++ +C+V   + G  L   +       F  +       ++L  +
Sbjct: 61  FV-----VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGL 115

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
             +H    ++ DLKPENILL    ++++ D     +          +P+  +I+    G 
Sbjct: 116 EDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVK----------IPEGESIR----GR 161

Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
                      V T  Y APEV+    +    D W +GC++ E+  G++ F+
Sbjct: 162 -----------VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFR 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 36/114 (31%), Positives = 56/114 (49%), Gaps = 25/114 (21%)

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
           +H+  +I+ DLKPENILL +  +VK+ D+               L K S    I  G+ T
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDF--------------GLCKES----IHEGTVT 157

Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
                H++   T  Y APE+++  G     D WS+G ++ ++ +G   F T EN
Sbjct: 158 -----HTF-CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPF-TAEN 204

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 58/238 (24%), Positives = 102/238 (42%), Gaps = 45/238 (18%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-----EAAMI--EIDVLQRLA 146
           + IL  +G G FG+V         ++ A+KI   +NK+      E A    E DVL    
Sbjct: 3   FEILKVIGRGAFGEVAVVKMKNTGQVYAMKI---LNKWEMLKRAETACFREERDVLVNGD 59

Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
           R  I       +   F   N++ +V +  +G  L   L K   R  P D+ R    +++ 
Sbjct: 60  RRWI-----TNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVL 113

Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           ++  +H+L  +H D+KP+N+LL    ++++ D+                   S ++L+  
Sbjct: 114 AIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADF------------------GSCLRLLAD 155

Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLG-----WNYPCDLWSVGCILVELCSGEALF 318
           G+        +  V T  Y +PE++  +      +   CD WS+G  + E+  GE  F
Sbjct: 156 GTV-----QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 53/245 (21%), Positives = 100/245 (40%), Gaps = 60/245 (24%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHD 149
           YR+L   G+G FG+V  C      ++ A K +  + I K +  AM   E  +L++     
Sbjct: 5   YRVL---GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEK----- 56

Query: 150 IGGTRCVQIRNWFDYRNHICIVFE------------KLGPSLYDFLRKNSYRSFPIDLVR 197
           +     V +   ++ ++ +C+V               +G   +D  R   Y +       
Sbjct: 57  VNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA------- 109

Query: 198 ELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 257
               +L   +  +   R+++ DLKPENILL    ++++ D     +          +P+ 
Sbjct: 110 ----ELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQ----------IPEG 155

Query: 258 SAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317
             ++    G            V T  Y APEVI    + +  D W +GC++ E+  G++ 
Sbjct: 156 ETVR----GR-----------VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Query: 318 FQTHE 322
           F+  +
Sbjct: 201 FRKRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 47.9 bits (114), Expect = 4e-06
 Identities = 31/130 (23%), Positives = 60/130 (46%), Gaps = 24/130 (18%)

Query: 189 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248
           R  P +  R    ++  ++ F+HE  +I+ DLK +N+LL +  ++K+ DY       + G
Sbjct: 91  RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG 150

Query: 249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308
                             ++TF          T +Y APE++ G  + +  D W++G ++
Sbjct: 151 DT----------------TSTF--------CGTPNYIAPEILRGEDYGFSVDWWALGVLM 186

Query: 309 VELCSGEALF 318
            E+ +G + F
Sbjct: 187 FEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 47.2 bits (112), Expect = 6e-06
 Identities = 58/233 (24%), Positives = 100/233 (42%), Gaps = 36/233 (15%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRC 155
           +G+G+FG+V+     E   L A+K+++      +   E  M E  +L     H       
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPF----L 58

Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
            Q+   F   + +  V E + G  L   ++K+  R F     R    ++  ++ F+H+  
Sbjct: 59  TQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKG 116

Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           +I+ DLK +N+LL    + K+ D+       K+G              I  G TT     
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGM----CKEG--------------IFNGKTT----- 153

Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
            S    T  Y APE++  + +    D W++G +L E+  G A F+  EN + L
Sbjct: 154 -STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 46.8 bits (111), Expect = 7e-06
 Identities = 59/246 (23%), Positives = 108/246 (43%), Gaps = 35/246 (14%)

Query: 96  ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRC 155
            L ++G G FG VV+      +  VAIK+++  +   +  + E  V+ +L+   +     
Sbjct: 8   FLKELGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKL----- 61

Query: 156 VQIRNWFDYRNHICIVFEKLGPS-LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
           VQ+      +  I IV E +    L ++LR++  R  P  L+ E+ + + E +A++   +
Sbjct: 62  VQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLL-EMCKDVCEGMAYLESKQ 120

Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
            IH DL   N L+     VKV D+  LSR   D  Y  ++     ++             
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFG-LSRYVLDDEYTSSVGSKFPVR------------- 166

Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEA---LFQTHENLEHLAMM 330
                    +  PEV+L   ++   D+W+ G ++ E+ S G+     F   E +E ++  
Sbjct: 167 ---------WSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG 217

Query: 331 ERVLGP 336
            R+  P
Sbjct: 218 LRLYRP 223

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 53/229 (23%), Positives = 97/229 (42%), Gaps = 36/229 (15%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRC 155
           +G G FG+V  C   +  ++ A+K +      + +    A+ E  +L  ++  D     C
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
           +     F   + +C + + + G  L+  L ++    F    +R    +++  +  MH   
Sbjct: 62  MTYA--FHTPDKLCFILDLMNGGDLHYHLSQHGV--FSEKEMRFYATEIILGLEHMHNRF 117

Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           +++ DLKP NILL    +V++ D       SK        P +S                
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK------PHAS---------------- 155

Query: 275 HSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHE 322
               V T  Y APEV+  G  ++   D +S+GC+L +L  G + F+ H+
Sbjct: 156 ----VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 55/239 (23%), Positives = 103/239 (43%), Gaps = 32/239 (13%)

Query: 99  KMGEGTFGQVVE-CFDNEKKEL-VAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTR 154
           ++G G FG V +  +   KK++ VAIK++++ N+   R+  M E +++ +L    I    
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYI---- 57

Query: 155 CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
            V++    +    + ++    G  L  FL         +  V EL  Q+   + ++    
Sbjct: 58  -VRMIGVCEAEALMLVMEMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKN 115

Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
            +H DL   N+LLV+  Y K+ D+        D SY+K   +S        G    +   
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--ARS-------AGKWPLK--- 163

Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                    + APE I    ++   D+WS G  + E  S G+  ++  +  E ++ +E+
Sbjct: 164 ---------WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ 213

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 47.1 bits (112), Expect = 8e-06
 Identities = 58/231 (25%), Positives = 95/231 (41%), Gaps = 52/231 (22%)

Query: 100 MGEGTFGQVVE--CFDNEKKEL---VAIKIVRSINKY--REAAMIEIDVLQRLARHDIGG 152
           +G G FG+VVE   +   K +    VA+K+++       REA M E+ ++  L  H+   
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHE--- 99

Query: 153 TRCVQIRNWFDYRNH---ICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
                I N          I ++ E    G  L +FLR+       ++ +     Q+ + +
Sbjct: 100 ----NIVNLLGACTIGGPILVITEYCCYG-DLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
           AF+     IH DL   N+LL   + VK+ D+  L+R   +                    
Sbjct: 155 AFLASKNCIHRDLAARNVLLTHGKIVKICDFG-LARDIMN-------------------- 193

Query: 268 TTFEHQDHSYVV--STR---HYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                 D +YVV  + R    + APE I    + +  D+WS G +L E+ S
Sbjct: 194 ------DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 47.3 bits (112), Expect = 8e-06
 Identities = 52/234 (22%), Positives = 97/234 (41%), Gaps = 40/234 (17%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMI--EIDVLQRLARHD 149
           Y ++  +G G FG+V        +++ A+K++      K  ++A    E D++       
Sbjct: 45  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF----- 99

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                 VQ+   F    ++ +V E + G  L + +   S    P    R    +++ ++ 
Sbjct: 100 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAEVVLALD 156

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
            +H +  IH D+KP+N+LL  + ++K+ D+    + +K+G    +               
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-------------- 202

Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVELCSGEALF 318
                     V T  Y +PEV+   G    +   CD WSVG  L E+  G+  F
Sbjct: 203 ---------AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 54/246 (21%), Positives = 104/246 (42%), Gaps = 39/246 (15%)

Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYR----EAAMIEIDVLQRLARHDIGGTRC 155
           +G+G+FG+V+        E+ AIK+++     +    +  M E  +L   A+H       
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPF----L 58

Query: 156 VQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
             +   F  ++ +  V E +  G  ++   R    R F     R    ++  ++ F+H  
Sbjct: 59  TALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRH 115

Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
            +I+ DLK +NILL +  + K+ D+        +G                  +TTF   
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT----------------TTTF--- 156

Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT--HENLEHLAMME 331
                  T  Y APE++  L +    D W++G ++ E+ +G+  F+    ++L    + +
Sbjct: 157 -----CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD 211

Query: 332 RVLGPL 337
            VL P+
Sbjct: 212 DVLYPV 217

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 56/240 (23%), Positives = 96/240 (40%), Gaps = 52/240 (21%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMI--EIDVLQRLARHD 149
           Y ++  +G G FG+V        +++ A+K++      K  ++A    E D++       
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF----- 99

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                 VQ+   F    ++ +V E + G  L + +   S    P    +    +++ ++ 
Sbjct: 100 ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM---SNYDVPEKWAKFYTAEVVLALD 156

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS- 267
            +H + LIH D+KP+N+LL                            K   +KL DFG+ 
Sbjct: 157 AIHSMGLIHRDVKPDNMLL---------------------------DKHGHLKLADFGTC 189

Query: 268 -----TTFEHQDHSYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVELCSGEALF 318
                T     D +  V T  Y +PEV+   G    +   CD WSVG  L E+  G+  F
Sbjct: 190 MKMDETGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 40/151 (26%), Positives = 69/151 (45%), Gaps = 30/151 (19%)

Query: 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPE 223
             I I  E + G SL   L+K      P +++ ++   +L  + ++ E  +++H D+KP 
Sbjct: 72  GEISICMEHMDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPS 129

Query: 224 NILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRH 283
           NIL+ S   +K+ D+                    + +LID  + +F        V TR 
Sbjct: 130 NILVNSRGEIKLCDF------------------GVSGQLIDSMANSF--------VGTRS 163

Query: 284 YRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           Y +PE + G  +    D+WS+G  LVE+  G
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 52/228 (22%), Positives = 93/228 (40%), Gaps = 37/228 (16%)

Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGG 152
           L  +G+G+FG+V+        EL AIKI++      +   E  M+E  VL    +     
Sbjct: 5   LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPF-- 62

Query: 153 TRCVQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
               Q+ + F   + +  V E +  G  +Y   +   ++  P  +      ++   + F+
Sbjct: 63  --LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKE-PQAVF--YAAEISVGLFFL 117

Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H   +I+ DLK +N++L S  ++K+ D+        DG                  + TF
Sbjct: 118 HRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----------------VTTRTF 161

Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
                     T  Y APE+I    +    D W+ G +L E+ +G+  F
Sbjct: 162 --------CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 37/222 (16%)

Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTR 154
           +S++G G  G V +        ++A K++    K   R   + E+ VL     H+     
Sbjct: 10  ISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL-----HECNSPY 64

Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            V     F     I I  E + G SL   L+K      P  ++ ++   +++ + ++ E 
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREK 122

Query: 214 -RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
            +++H D+KP NIL+ S   +K+ D+                    + +LID  + +F  
Sbjct: 123 HKIMHRDVKPSNILVNSRGEIKLCDF------------------GVSGQLIDSMANSF-- 162

Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                 V TR Y +PE + G  ++   D+WS+G  LVE+  G
Sbjct: 163 ------VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 55/235 (23%), Positives = 103/235 (43%), Gaps = 39/235 (16%)

Query: 94  YRILSKMGEGTFGQVV---ECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR-LARHD 149
           + +L  +G G +G+V    +   ++  +L A+K+++     ++A  +E    +R +  H 
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                 V +   F     + ++ + + G  ++  L +     F  D VR    +++ ++ 
Sbjct: 62  RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEIILALE 119

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-S 267
            +H+L +++ D+K ENILL S  +V                            L DFG S
Sbjct: 120 HLHKLGIVYRDIKLENILLDSEGHV---------------------------VLTDFGLS 152

Query: 268 TTF--EHQDHSY-VVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALF 318
             F  E ++ +Y    T  Y APE+I G  G     D WS+G ++ EL +G + F
Sbjct: 153 KEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 40/152 (26%), Positives = 69/152 (45%), Gaps = 32/152 (21%)

Query: 170 IVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENIL 226
           I  E +  SL  F +K  +   + P D++ ++   +++++ ++H  L +IH D+KP N+L
Sbjct: 77  ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVL 136

Query: 227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRA 286
           +     VK+ D+               L  S A K ID G               + Y A
Sbjct: 137 INRNGQVKLCDF----------GISGYLVDSVA-KTIDAGC--------------KPYMA 171

Query: 287 PEVILG----LGWNYPCDLWSVGCILVELCSG 314
           PE I       G++   D+WS+G  ++EL +G
Sbjct: 172 PERINPELNQKGYDVKSDVWSLGITMIELATG 203

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 32/114 (28%), Positives = 51/114 (44%), Gaps = 27/114 (23%)

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
           MH   +++ DLKP NILL    +V++ D            + K  P +S           
Sbjct: 113 MHNRFVVYRDLKPANILLDEHGHVRISDLGLAC------DFSKKKPHAS----------- 155

Query: 270 FEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHE 322
                    V T  Y APEV+  G+ ++   D +S+GC+L +L  G + F+ H+
Sbjct: 156 ---------VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 56/239 (23%), Positives = 98/239 (41%), Gaps = 39/239 (16%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHD 149
           +  L  +G+G+FG+V+        EL AIKI++      +   E  M+E  VL    +  
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRS-FPIDLVRELGRQLLES 206
                  Q+ + F   + +  V E +  G  +Y   +   ++    +    E+   L   
Sbjct: 62  F----LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLF-- 115

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
             F+H   +I+ DLK +N++L S  ++K+ D+     +  DG   K              
Sbjct: 116 --FLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK-------------- 159

Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
             TF          T  Y APE+I    +    D W+ G +L E+ +G+A F+  +  E
Sbjct: 160 --TF--------CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 43.7 bits (103), Expect = 7e-05
 Identities = 53/238 (22%), Positives = 96/238 (40%), Gaps = 32/238 (13%)

Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           + ++G G FG VV       +  VAIK +       E  + E  V+ +L+       + V
Sbjct: 9   MKELGSGQFG-VVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSH-----PKLV 62

Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           Q+      +  + IV E +    L ++LR+        D++  + + + E + ++     
Sbjct: 63  QLYGVCTQQKPLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERNSF 121

Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           IH DL   N L+ S   VKV D+  ++R   D  Y  +      +K              
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFG-MTRYVLDDEYTSSSGAKFPVK-------------- 166

Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                   +  PEV     ++   D+WS G ++ E+ + G+  F+   N E + M+ R
Sbjct: 167 --------WSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR 216

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 43.3 bits (102), Expect = 8e-05
 Identities = 36/167 (21%), Positives = 66/167 (39%), Gaps = 30/167 (17%)

Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
           V +  +    + + +V +   G  L+  + K  + + P + V+    +++ ++  +H   
Sbjct: 48  VCLHKYIVSEDSVFLVLQHAEGGKLWSHISK--FLNIPEECVKRWAAEMVVALDALHREG 105

Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           ++  DL P NILL    ++++             +YF                +  E   
Sbjct: 106 IVCRDLNPNNILLDDRGHIQL-------------TYFSRW-------------SEVEDSC 139

Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
               V    Y APEV         CD WS+G IL EL +G+ L + H
Sbjct: 140 DGEAVE-NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECH 185

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 43.6 bits (103), Expect = 8e-05
 Identities = 58/246 (23%), Positives = 99/246 (40%), Gaps = 47/246 (19%)

Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEID------VLQRLARHDI 150
           L ++G G FG VV       K  VAIK++R      E AM E D      V+ +L+  ++
Sbjct: 9   LKELGSGQFG-VVHLGKWRGKIDVAIKMIR------EGAMSEDDFIEEAKVMMKLSHPNL 61

Query: 151 GGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                VQ+      +  I IV E    G  L ++LR+   +    + + ++   + E++ 
Sbjct: 62  -----VQLYGVCTKQRPIFIVTEYMANG-CLLNYLRERKGK-LGTEWLLDMCSDVCEAME 114

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++     IH DL   N L+     VKV D+  L+R   D  Y  +      +K       
Sbjct: 115 YLESNGFIHRDLAARNCLVGEDNVVKVSDFG-LARYVLDDQYTSSQGTKFPVK------- 166

Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
                          +  PEV     ++   D+WS G ++ E+ S   +   +E   +  
Sbjct: 167 ---------------WAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKM--PYERFSNSE 209

Query: 329 MMERVL 334
           ++E V 
Sbjct: 210 VVESVS 215

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 43.7 bits (103), Expect = 9e-05
 Identities = 39/142 (27%), Positives = 61/142 (42%), Gaps = 27/142 (19%)

Query: 178 SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
           +L  FLR+N  +   I LV  L R +   + ++ E+  +H DL   NIL+ S    KV D
Sbjct: 91  ALDSFLRQNDGQFTVIQLVGML-RGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSD 149

Query: 238 Y---KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG 294
           +   +FL   + D +Y  +L     I+                      + APE I    
Sbjct: 150 FGLSRFLEDDTSDPTYTSSLGGKIPIR----------------------WTAPEAIAYRK 187

Query: 295 WNYPCDLWSVGCILVELCS-GE 315
           +    D+WS G ++ E+ S GE
Sbjct: 188 FTSASDVWSYGIVMWEVMSYGE 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 46/191 (24%), Positives = 85/191 (44%), Gaps = 37/191 (19%)

Query: 92  PRYRIL--SKMGEGTFGQVVEC---------------FDNEKKELVAIKIVRS-INKY-R 132
           PR ++    K+GEG FG+V  C               FD  +  LVA+K++R+ + K  R
Sbjct: 3   PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDG-QPVLVAVKMLRADVTKTAR 61

Query: 133 EAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRK------ 185
              + EI ++ RL   +I     V + +     + +C++ E +    L  FL +      
Sbjct: 62  NDFLKEIKIMSRLKNPNIIRLLGVCVSD-----DPLCMITEYMENGDLNQFLSQREIEST 116

Query: 186 ----NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241
               N+  S  I  +  +  Q+   + ++  L  +H DL   N L+ +   +K+ D+  +
Sbjct: 117 FTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFG-M 175

Query: 242 SRSSKDGSYFK 252
           SR+   G Y++
Sbjct: 176 SRNLYSGDYYR 186

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 38/142 (26%), Positives = 58/142 (40%), Gaps = 37/142 (26%)

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
           +H+L +I+ D+K ENILL S                 +G           + L DFG + 
Sbjct: 121 LHKLGIIYRDIKLENILLDS-----------------NGH----------VVLTDFGLSK 153

Query: 270 FEHQDHSY----VVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSGEALFQTH-E 322
             H+D          T  Y AP+++ G   G +   D WS+G ++ EL +G + F    E
Sbjct: 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE 213

Query: 323 NLEHLAMMERVLG---PLPHHM 341
                 +  R+L    P P  M
Sbjct: 214 KNSQAEISRRILKSEPPYPQEM 235

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 28/168 (16%)

Query: 100 MGEGTFGQVVECF--DNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDIGGTR 154
           +GEG FGQV+      +  K   AIK+++   S N +R+ A  E++VL +L  H      
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAG-ELEVLCKLGHH----PN 64

Query: 155 CVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELG-------RQLLE 205
            + +    + R ++ I  E   P  +L DFLRK+          +E G       +QLL+
Sbjct: 65  IINLLGACENRGYLYIAIE-YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123

Query: 206 -------SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246
                   + ++ E + IH DL   N+L+      K+ D+  LSR  +
Sbjct: 124 FASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFG-LSRGEE 170

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 53/246 (21%), Positives = 96/246 (39%), Gaps = 65/246 (26%)

Query: 100 MGEGTFGQVVECFDNEKKEL-----VAIKIVR---SINKYREAAMIEIDVLQRLARHDI- 150
           +GEG FG+VV+      K       VA+K+++   S ++ R   + E ++L+++    + 
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELR-DLLSEFNLLKQVNHPHVI 66

Query: 151 ---GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLR---------------KNSY---- 188
              G   C Q     D    + + + K G SL  FLR               +NS     
Sbjct: 67  KLYGA--CSQ-----DGPLLLIVEYAKYG-SLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118

Query: 189 ---RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
              R+  +  +     Q+   + ++ E++L+H DL   N+L+     +K+ D+       
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVY 178

Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
           ++ SY K       +K +   S      DH Y   +                  D+WS G
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLF----DHIYTTQS------------------DVWSFG 216

Query: 306 CILVEL 311
            +L E+
Sbjct: 217 VLLWEI 222

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 50/231 (21%), Positives = 94/231 (40%), Gaps = 37/231 (16%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHD 149
           +  L  +G+G+FG+V+        EL AIKI++      +   E  M+E  VL    +  
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK-- 59

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
                  Q+ + F   + +  V E +  G  +Y   +   ++  P  +      ++   +
Sbjct: 60  --PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKE-PHAVF--YAAEIAIGL 114

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
            F+H   +I+ DLK +N++L +  ++K+ D+     +   G   +               
Sbjct: 115 FFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR--------------- 159

Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
            TF          T  Y APE+I    +    D W+ G +L E+ +G+  F
Sbjct: 160 -TF--------CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 42/141 (29%), Positives = 63/141 (44%), Gaps = 29/141 (20%)

Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           Q+L +V  +H   +IH D+K  NILL S   VK+ D+ F               K  A  
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF--------------SKMYAAT 196

Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
           + D    TF          T +Y APE+     ++   D++S+G +L EL + +  F   
Sbjct: 197 VSDDVGRTF--------CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG- 247

Query: 322 ENLEHLAMMERVLG----PLP 338
           EN+E +  M + L     PLP
Sbjct: 248 ENMEEV--MHKTLAGRYDPLP 266

Length = 496

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 51/218 (23%), Positives = 88/218 (40%), Gaps = 37/218 (16%)

Query: 98  SKMGEGTFGQVVE-CFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           + +G+G FG V+   +  +K   VA+K ++  +   +A + E  V+  L RH       V
Sbjct: 12  ATIGKGEFGDVMLGDYRGQK---VAVKCLKDDSTAAQAFLAEASVMTTL-RHP----NLV 63

Query: 157 QIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           Q+       N + IV E +   SL D+LR        +         + E + ++ E   
Sbjct: 64  QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF 123

Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           +H DL   N+L+      KV D+  L++ +  G     LP    +K              
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFG-LAKEASQGQDSGKLP----VK-------------- 164

Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                   + APE +    ++   D+WS G +L E+ S
Sbjct: 165 --------WTAPEALREKKFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 41.6 bits (97), Expect = 3e-04
 Identities = 42/168 (25%), Positives = 74/168 (44%), Gaps = 28/168 (16%)

Query: 100 MGEGTFGQVVECFDNEK--KELVAIKIVR---SINKYREAAMIEIDVLQRLARHDIGGTR 154
           +GEG FGQV++    +   +   AIK ++   S + +R+ A  E++VL +L  H      
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG-ELEVLCKLGHH----PN 57

Query: 155 CVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELG-------RQLLE 205
            + +    ++R ++ +  E   P  +L DFLRK+                     +QLL 
Sbjct: 58  IINLLGACEHRGYLYLAIE-YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116

Query: 206 -------SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246
                   + ++ + + IH DL   NIL+      K+ D+  LSR  +
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG-LSRGQE 163

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 41.8 bits (98), Expect = 4e-04
 Identities = 50/233 (21%), Positives = 96/233 (41%), Gaps = 48/233 (20%)

Query: 96  ILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDIGG 152
           +L ++G+G +G V +         +A+K +R     +K+ +  M E+D+L +     I  
Sbjct: 5   VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIM-ELDILHKAVSPYI-- 61

Query: 153 TRCVQIRNWFDYRN--HICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
              V     F      ++C+ +   G    LY      +    P D++R +   +++ + 
Sbjct: 62  ---VDFYGAFFIEGAVYMCMEYMDAGSLDKLYA--GGVATEGIPEDVLRRITYAVVKGLK 116

Query: 209 FMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
           F+ E   +IH D+KP N+L+     VK+ D+         G+   +L K++         
Sbjct: 117 FLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGV------SGNLVASLAKTN--------- 161

Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLG------WNYPCDLWSVGCILVELCSG 314
                      +  + Y APE I   G      +    D+WS+G  ++E+  G
Sbjct: 162 -----------IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALG 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 40.9 bits (96), Expect = 5e-04
 Identities = 64/227 (28%), Positives = 91/227 (40%), Gaps = 48/227 (21%)

Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHD-----IG 151
           K+G+G FG V +       E VA+K  RS      +   + E ++L++   H      IG
Sbjct: 2   KIGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIG 59

Query: 152 GTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
              CVQ       +  I IV E   G SL  FLRK   R      V++L +  L++ A M
Sbjct: 60  --VCVQ-------KQPIYIVMELVPGGSLLTFLRKKKNRL----TVKKLLQMSLDAAAGM 106

Query: 211 HELR---LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
             L     IH DL   N L+     +K+ D+  +SR  + G Y      S  +K I    
Sbjct: 107 EYLESKNCIHRDLAARNCLVGENNVLKISDFG-MSREEEGGIY----TVSDGLKQIPIKW 161

Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           T                 APE +    +    D+WS G +L E  S 
Sbjct: 162 T-----------------APEALNYGRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 34/133 (25%), Positives = 60/133 (45%), Gaps = 25/133 (18%)

Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           Q++ ++  +H  +++H DLK  NI L+    +K+ D+ F  + S   S            
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS------------ 224

Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
            +D  S+            T +Y APE+     ++   D+WS+G IL EL +    F+  
Sbjct: 225 -LDVASS---------FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274

Query: 322 ENLEHLAMMERVL 334
              E   +M++VL
Sbjct: 275 SQRE---IMQQVL 284

Length = 478

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 40.8 bits (95), Expect = 8e-04
 Identities = 36/133 (27%), Positives = 61/133 (45%), Gaps = 23/133 (17%)

Query: 179 LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
           L D++R+N  R    DL+     Q+ + ++++ E+RL+H DL   N+L+ S  +VK+ D+
Sbjct: 95  LLDYVRENKDRIGSQDLL-NWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDF 153

Query: 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYP 298
                                 +L+D   T + H D   V     + A E IL   + + 
Sbjct: 154 GL-------------------ARLLDIDETEY-HADGGKV--PIKWMALESILHRRFTHQ 191

Query: 299 CDLWSVGCILVEL 311
            D+WS G  + EL
Sbjct: 192 SDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 40.3 bits (94), Expect = 9e-04
 Identities = 54/233 (23%), Positives = 91/233 (39%), Gaps = 34/233 (14%)

Query: 100 MGEGTFGQVVEC---FDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTR 154
           +G G FG+V          K+  VAIK ++     K R+  + E  ++ + + H+I    
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNI---- 68

Query: 155 CVQIRNWFDYRNHICIVFEKLGPSLYD-FLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            +++           I+ E +     D +LR +        LV  L R +   + ++ ++
Sbjct: 69  -IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGML-RGIAAGMKYLSDM 126

Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL   NIL+ S    KV D+  LSR                  L D    T+   
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFG-LSRV-----------------LEDDPEGTYTTS 168

Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 325
                +    + APE I    +    D+WS G ++ E+ S GE  +    N E
Sbjct: 169 GGKIPI---RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE 218

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 36/148 (24%), Positives = 69/148 (46%), Gaps = 12/148 (8%)

Query: 96  ILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMI-EIDVLQRLARHDIG 151
           I+  +  G FG+V         +L A+K+V+    INK     +  E D L  L++    
Sbjct: 8   IVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA-LSKSPF- 65

Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
               V +       N++ +V E L G  +   L    Y  F  ++  +   ++  ++ ++
Sbjct: 66  ---IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY--FDEEMAVKYISEVALALDYL 120

Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDY 238
           H   +IH DLKP+N+L+ +  ++K+ D+
Sbjct: 121 HRHGIIHRDLKPDNMLISNEGHIKLTDF 148

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 40.1 bits (94), Expect = 0.001
 Identities = 29/87 (33%), Positives = 47/87 (54%), Gaps = 5/87 (5%)

Query: 168 ICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI 225
           + IV E   LG  L  +L+ N Y S  +  +     QL  ++A++   R +H D+   N+
Sbjct: 81  VWIVMELAPLG-ELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNV 138

Query: 226 LLVSAEYVKVPDYKFLSRSSKDGSYFK 252
           L+ S + VK+ D+  LSR  +D SY+K
Sbjct: 139 LVSSPDCVKLGDFG-LSRYLEDESYYK 164

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 57/248 (22%), Positives = 99/248 (39%), Gaps = 42/248 (16%)

Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+G G +G+V E    +    VA+K ++      E  + E  V++ +   ++     VQ+
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL-----VQL 67

Query: 159 RNWFDYRNHICIVFEKLG-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
                      I+ E +   +L D+LR+ + +     ++  +  Q+  ++ ++ +   IH
Sbjct: 68  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 127

Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
            DL   N L+     VKV D+  LSR     +Y  +      IK                
Sbjct: 128 RDLAARNCLVGENHLVKVADFG-LSRLMTGDTYTAHAGAKFPIK---------------- 170

Query: 278 VVSTRHYRAPEVILGLGWN---YPCDLWSVGCILVELCS-------GEALFQTHENLEHL 327
                 + APE    L +N      D+W+ G +L E+ +       G  L Q +E LE  
Sbjct: 171 ------WTAPE---SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG 221

Query: 328 AMMERVLG 335
             MER  G
Sbjct: 222 YRMERPEG 229

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 39.2 bits (92), Expect = 0.002
 Identities = 38/141 (26%), Positives = 56/141 (39%), Gaps = 28/141 (19%)

Query: 178 SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
           SL  FLR+N  +     LV  L R +   + ++ E+  +H DL   NIL+ S    KV D
Sbjct: 91  SLDKFLRENDGKFTVGQLVGML-RGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSD 149

Query: 238 YKFLSR--SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW 295
           +  LSR     + +Y     K                           + APE I    +
Sbjct: 150 FG-LSRRLEDSEATYTTKGGKIPI-----------------------RWTAPEAIAYRKF 185

Query: 296 NYPCDLWSVGCILVELCS-GE 315
               D+WS G ++ E+ S GE
Sbjct: 186 TSASDVWSFGIVMWEVMSYGE 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 38.7 bits (91), Expect = 0.002
 Identities = 24/67 (35%), Positives = 33/67 (49%), Gaps = 8/67 (11%)

Query: 162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL 220
            D  N I IV E + G  L D +  NS     ++L RE+GR     V  +H   +IH DL
Sbjct: 69  VDPENFI-IVMEYIEGEPLKDLI--NSNGMEELELSREIGRL----VGKLHSAGIIHGDL 121

Query: 221 KPENILL 227
              N++L
Sbjct: 122 TTSNMIL 128

Length = 211

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 38.4 bits (90), Expect = 0.003
 Identities = 21/61 (34%), Positives = 30/61 (49%), Gaps = 10/61 (16%)

Query: 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228
           IV E + G  L D L +        DL+RE+GR     V  +H+  ++H DL   NI+L 
Sbjct: 76  IVMEYIEGELLKDALEEARP-----DLLREVGRL----VGKLHKAGIVHGDLTTSNIILS 126

Query: 229 S 229
            
Sbjct: 127 G 127

Length = 204

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 39.3 bits (91), Expect = 0.004
 Identities = 15/46 (32%), Positives = 31/46 (67%)

Query: 193 IDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
           I++++ + RQ+L  +  +H + ++H D+KPEN+L+     VK+ D+
Sbjct: 308 INVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDF 353

Length = 507

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	411
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.98
PLN00181	793	protein SPA1-RELATED; Provisional	99.98
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.98
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.94
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.92
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.89
PRK10345	210	hypothetical protein; Provisional	99.89
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.86
smart00090	237	RIO RIO-like kinase.	99.85
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.84
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.83
PRK14879	211	serine/threonine protein kinase; Provisional	99.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.74
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.73
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.71
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.7
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.62
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.56
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.51
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.51
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.5
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.49
KOG3087	229	consensus Serine/threonine protein kinase [General	99.38
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.37
KOG1243	690	consensus Protein kinase [General function predict	99.34
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.26
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.25
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.18
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.13
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.08
PRK09902	216	hypothetical protein; Provisional	98.96
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.93
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.92
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.87
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.75
COG4248	637	Uncharacterized protein with protein kinase and he	98.72
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.7
PF01636	239	APH: Phosphotransferase enzyme family This family	98.68
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.65
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.54
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.54
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.51
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.47
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.37
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.26
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.23
PLN02876	822	acyl-CoA dehydrogenase	98.17
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.09
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.08
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.98
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.91
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.8
PRK05231	319	homoserine kinase; Provisional	97.8
KOG2270	520	consensus Serine/threonine protein kinase involved	97.77
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.76
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.75
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.73
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.44
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.41
PLN02236	344	choline kinase	97.34
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.28
PRK12396	409	5-methylribose kinase; Reviewed	97.2
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.19
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.19
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.15
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.1
PRK10593	297	hypothetical protein; Provisional	97.1
PRK11768	325	serine/threonine protein kinase; Provisional	96.94
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.94
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.82
PLN02756	418	S-methyl-5-thioribose kinase	96.79
PTZ00384	383	choline kinase; Provisional	96.5
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.38
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.07
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.04
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.97
COG2334	331	Putative homoserine kinase type II (protein kinase	95.86
PTZ00296	442	choline kinase; Provisional	95.82
PRK06148	1013	hypothetical protein; Provisional	95.79
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.7
PHA03111	444	Ser/Thr kinase; Provisional	95.34

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5e-59  Score=426.50  Aligned_cols=265  Identities=26%  Similarity=0.392  Sum_probs=236.3

Q ss_pred             CccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchh--------hhHHHHHHHHHHHHHhcCCCCCcceEEEe
Q 015222           88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--------YREAAMIEIDVLQRLARHDIGGTRCVQIR  159 (411)
Q Consensus        88 ~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~--------~~~~~~~E~~~l~~l~~~~i~~~~iv~~~  159 (411)
                      ..+.+.|.+.+.||+|+||.|-+|..+.||+.||||++++...        .....++|++||++|+||+|     |+++
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~I-----V~~~  242 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNI-----VRIK  242 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCE-----EEEe
Confidence            3467789999999999999999999999999999999975321        22345799999999999988     9999


Q ss_pred             eeeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCc
Q 015222          160 NWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY  238 (411)
Q Consensus       160 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df  238 (411)
                      ++|+..+..|+||||+ ||+|.+++-.++  .+.+..-+.+++|++.|+.|||++||+||||||+|||+..+.       
T Consensus       243 d~f~~~ds~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~-------  313 (475)
T KOG0615|consen  243 DFFEVPDSSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDA-------  313 (475)
T ss_pred             eeeecCCceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCC-------
Confidence            9999999999999999 999999999887  688999999999999999999999999999999999997753       


Q ss_pred             ccccccCCCCCccccCCCCCCeeEeecCCcccccC--CCcccccCCCccccceecCCC---CCccchhHHHHHHHHHHHh
Q 015222          239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVELCS  313 (411)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlGvil~ellt  313 (411)
                                       ....+||+|||+|+..+.  ...+.+||+.|.|||++.+..   +..++||||+||+||.+|+
T Consensus       314 -----------------e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLs  376 (475)
T KOG0615|consen  314 -----------------EDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLS  376 (475)
T ss_pred             -----------------cceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEec
Confidence                             456899999999998853  457789999999999998774   3358899999999999999


Q ss_pred             CCCCCCCCChHH-HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          314 GEALFQTHENLE-HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       314 g~~pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                      |.+||.+..... ..+.|.++...+-+..+..+++++.++|..||..|    |+.|+++.|+|+||||+.+...+
T Consensus       377 G~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~Vd----P~~R~s~~eaL~hpW~~~~~~~s  447 (475)
T KOG0615|consen  377 GYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVD----PENRPSADEALNHPWFKDAPCLS  447 (475)
T ss_pred             cCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeC----cccCcCHHHHhcChhhhcccccc
Confidence            999998876555 77888888888888888999999999999999999    99999999999999999887655

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-57  Score=411.66  Aligned_cols=308  Identities=59%  Similarity=1.017  Sum_probs=278.8

Q ss_pred             CCCCCCCCCCCCCCCceEEeeCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHH
Q 015222           66 PRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL  145 (411)
Q Consensus        66 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l  145 (411)
                      ++...+++.+++.+|++.+.+++.+.++|.++..+|+|.||.|-.+.+..++..||||+++...+.++....|+++|+++
T Consensus        63 ~~~~~~~~~~dD~dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki  142 (415)
T KOG0671|consen   63 ARLESRPGRPDDKDGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKI  142 (415)
T ss_pred             ccccCCCCCCCCCCceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHH
Confidence            56677888889999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hcCC-CCCcceEEEeeeeecCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 015222          146 ARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPEN  224 (411)
Q Consensus       146 ~~~~-i~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~N  224 (411)
                      .+.. -+...|+++.+||+..++.|||+|.+|-|+++++..++...++...++.++.||+++++|||+.+++|.||||+|
T Consensus       143 ~~~DP~g~~rcv~m~~wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPEN  222 (415)
T KOG0671|consen  143 NESDPNGKFRCVQMRDWFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPEN  222 (415)
T ss_pred             HhcCCCCceEEEeeehhhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChhe
Confidence            7765 345678999999999999999999999999999999988899999999999999999999999999999999999


Q ss_pred             EEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHH
Q 015222          225 ILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSV  304 (411)
Q Consensus       225 Ili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  304 (411)
                      ||+.+..+.+..+.+-.       ..+.+..++..++++|||.|+...+..++.+.|..|+|||++.+-+++.++||||+
T Consensus       223 ILfvss~~~~~~~~k~~-------~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSi  295 (415)
T KOG0671|consen  223 ILFVSSEYFKTYNPKKK-------VCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSI  295 (415)
T ss_pred             EEEeccceEEEeccCCc-------cceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceee
Confidence            99999887766554321       12223456778999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhh---------------------------------------
Q 015222          305 GCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRA---------------------------------------  345 (411)
Q Consensus       305 Gvil~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~---------------------------------------  345 (411)
                      ||||+||.+|...|++.++.+++++++++.+++|..+....                                       
T Consensus       296 GCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~  375 (415)
T KOG0671|consen  296 GCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQD  375 (415)
T ss_pred             eeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccC
Confidence            99999999999999999999999999999999998775544                                       


Q ss_pred             ---hhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          346 ---DRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       346 ---~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                         ...+-+++++||..|    |++|+|+.|+|.||||....
T Consensus       376 d~e~~~LfDLl~~mL~fD----P~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  376 DLEHVQLFDLLRRMLEFD----PARRITLREALSHPFFARLT  413 (415)
T ss_pred             cHHHhHHHHHHHHHHccC----ccccccHHHHhcCHHhhcCC
Confidence               123668999999999    99999999999999998653

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9e-57  Score=430.90  Aligned_cols=249  Identities=29%  Similarity=0.451  Sum_probs=231.9

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEecc----chhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      .+|...+.||+|||+.||++++..+|+.||+|++.+    ....++.+.+|++|.++|+|+||     |+++++|++.++
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnI-----V~f~~~FEDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNI-----VQFYHFFEDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcE-----EeeeeEeecCCc
Confidence            579999999999999999999999999999999976    45677889999999999999888     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|||+|+| .++|..+++++.  .++|.+++.++.||+.||.|||+++|+|||||..|+|++++                
T Consensus        93 VYivLELC~~~sL~el~Krrk--~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~----------------  154 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKRRK--PLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNEN----------------  154 (592)
T ss_pred             eEEEEEecCCccHHHHHHhcC--CCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCc----------------
Confidence            99999999 999999999665  89999999999999999999999999999999999998654                


Q ss_pred             CCCccccCCCCCCeeEeecCCccccc---CCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN  323 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~  323 (411)
                                 .+|||+|||+|....   +...+.+|||.|+|||++.....+..+||||+|||||.||.|++||+..+-
T Consensus       155 -----------~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v  223 (592)
T KOG0575|consen  155 -----------MNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV  223 (592)
T ss_pred             -----------CcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH
Confidence                       489999999998766   456789999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCc
Q 015222          324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~  382 (411)
                      .+.+..|......+|.    .++.+++++|.++|+.+    |.+|||+.+|+.|+||..
T Consensus       224 kety~~Ik~~~Y~~P~----~ls~~A~dLI~~lL~~~----P~~Rpsl~~vL~h~Ff~~  274 (592)
T KOG0575|consen  224 KETYNKIKLNEYSMPS----HLSAEAKDLIRKLLRPN----PSERPSLDEVLDHPFFKS  274 (592)
T ss_pred             HHHHHHHHhcCccccc----ccCHHHHHHHHHHhcCC----cccCCCHHHHhcCHhhhC
Confidence            9999999999999987    46788999999999999    999999999999999943

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-56  Score=403.04  Aligned_cols=259  Identities=22%  Similarity=0.372  Sum_probs=226.4

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEec--cchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC-eE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN-HI  168 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~--~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~-~~  168 (411)
                      .+.+.++.||+|+.|+||+|+++.|++.+|+|++.  .....++++.+|+++++..++++|     |.+|+.|...+ .+
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyI-----V~~ygaF~~~~~~i  153 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYI-----VGFYGAFYSNGEEI  153 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCe-----eeEeEEEEeCCceE
Confidence            46788899999999999999999999999999994  445677889999999999988877     99999999988 59


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+|||| +|+|.+++...+  .++|.....|+.+|++||.|||+ ++||||||||+||||++.|               
T Consensus       154 sI~mEYMDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG---------------  216 (364)
T KOG0581|consen  154 SICMEYMDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG---------------  216 (364)
T ss_pred             EeehhhcCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC---------------
Confidence            9999999 999999998775  79999999999999999999995 8999999999999998887               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC-CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCC--Ch
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH--EN  323 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~--~~  323 (411)
                                  .|||||||.+...... ..+++||..|||||.+.+..|+.++||||||++++|+.+|+.||...  ..
T Consensus       217 ------------eVKicDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~  284 (364)
T KOG0581|consen  217 ------------EVKICDFGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY  284 (364)
T ss_pred             ------------CEEeccccccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC
Confidence                        7899999998875444 46789999999999999999999999999999999999999999874  23


Q ss_pred             HHHHHHHHHHhCCCChhHHHh-hhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccCC
Q 015222          324 LEHLAMMERVLGPLPHHMVIR-ADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSA  388 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~~~~~-~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~  388 (411)
                      ...+..+..+....|+..... +++++++|+..||++|    |.+|++++|+++|||+........
T Consensus       285 ~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kd----p~~R~s~~qLl~Hpfi~~~~~~~v  346 (364)
T KOG0581|consen  285 LDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKD----PSERPSAKQLLQHPFIKKFEDPNV  346 (364)
T ss_pred             CCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCC----cccCCCHHHHhcCHHHhhcccccc
Confidence            344455555555455555554 8999999999999999    999999999999999997665443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-56  Score=401.97  Aligned_cols=260  Identities=24%  Similarity=0.404  Sum_probs=229.9

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++++.||+|+||+||.++.+.|++.+|+|++++..    ...+....|..||.+++||.|     |.++..|++.++
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFi-----v~l~ysFQt~~k   99 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFI-----VKLIYSFQTEEK   99 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcE-----eeeEEecccCCe
Confidence            57999999999999999999999999999999998643    345677889999999888877     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+|+||+ ||.|...|++.+  .+++..++.++..|+.||.|||++|||||||||+|||++.+|               
T Consensus       100 LylVld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~G---------------  162 (357)
T KOG0598|consen  100 LYLVLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQG---------------  162 (357)
T ss_pred             EEEEEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCC---------------
Confidence            99999999 999999999877  799999999999999999999999999999999999999888               


Q ss_pred             CCCccccCCCCCCeeEeecCCccccc---CCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN  323 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~  323 (411)
                                  +++|+|||+++...   ....+++||+.|||||++.+..|+.++|+||||+++|||++|.+||.+.+.
T Consensus       163 ------------Hi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~  230 (357)
T KOG0598|consen  163 ------------HIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV  230 (357)
T ss_pred             ------------cEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH
Confidence                        66777777776432   234557999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcH----HHHHHHHhcCCCCcccccCCCCCc
Q 015222          324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR----DSMRAVWKLLRLPVIDLYSASPNC  392 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R----~t~~~il~~~~~~~~~~~~~~~~~  392 (411)
                      ....+.|.+.....++.   -++.+++++++++|..+    |++|    -.+.++.+|+||..++|.......
T Consensus       231 ~~~~~~I~~~k~~~~p~---~ls~~ardll~~LL~rd----p~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~  296 (357)
T KOG0598|consen  231 KKMYDKILKGKLPLPPG---YLSEEARDLLKKLLKRD----PRQRLGGPGDAEEIKRHPFFKGINWEKLLAKK  296 (357)
T ss_pred             HHHHHHHhcCcCCCCCc---cCCHHHHHHHHHHhccC----HHHhcCCCCChHHhhcCcccccCCHHHHHhcC
Confidence            99999988876444433   25778999999999999    6677    589999999999999997764443

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=8.8e-55  Score=421.45  Aligned_cols=285  Identities=39%  Similarity=0.697  Sum_probs=260.3

Q ss_pred             CCCCCCceEEeeCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHh-cCCCCCc
Q 015222           75 PDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGT  153 (411)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~  153 (411)
                      .++.++.|.+..++.+..+|.|++.||+|+||.|.+|.+..|++.||||+++.......+.+.|+.+|..|+ |.+-...
T Consensus       169 ~~~~~~dY~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~  248 (586)
T KOG0667|consen  169 FDDEDGDYQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKY  248 (586)
T ss_pred             CCCCCCceeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCe
Confidence            556777899999999999999999999999999999999999999999999998888899999999999999 5555667


Q ss_pred             ceEEEeeeeecCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCccc
Q 015222          154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV  233 (411)
Q Consensus       154 ~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~  233 (411)
                      |+|+++++|.+.+|+|||+|+++.+|+++++.+....++...++.++.||+.||.+||+.||||+||||||||+.+.+  
T Consensus       249 n~Vrm~d~F~fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~--  326 (586)
T KOG0667|consen  249 NIVRMLDYFYFRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPK--  326 (586)
T ss_pred             eEEEeeeccccccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCC--
Confidence            999999999999999999999999999999999988999999999999999999999999999999999999997654  


Q ss_pred             ccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh
Q 015222          234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS  313 (411)
Q Consensus       234 ~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt  313 (411)
                                             ...+||+|||+|.+..+...+.+.+..|+|||++.|.+|+.+.||||||||++||++
T Consensus       327 -----------------------r~~vKVIDFGSSc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~t  383 (586)
T KOG0667|consen  327 -----------------------RSRIKVIDFGSSCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFT  383 (586)
T ss_pred             -----------------------cCceeEEecccccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhc
Confidence                                   348999999999999888888899999999999999999999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChhHHHh-------------------------------------------------
Q 015222          314 GEALFQTHENLEHLAMMERVLGPLPHHMVIR-------------------------------------------------  344 (411)
Q Consensus       314 g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~-------------------------------------------------  344 (411)
                      |.+.|.|.++.+++..|.++.|.+|..+...                                                 
T Consensus       384 G~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~  463 (586)
T KOG0667|consen  384 GEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGS  463 (586)
T ss_pred             CccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCC
Confidence            9999999999999999999998777654321                                                 


Q ss_pred             ----------hhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccCC
Q 015222          345 ----------ADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSA  388 (411)
Q Consensus       345 ----------~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~  388 (411)
                                ....+.+||.+||..|    |.+|+|..++++|||+........
T Consensus       464 ~~l~~~~~~~~~~~F~dflk~~L~~d----P~~R~tp~qal~Hpfl~~~~~~~~  513 (586)
T KOG0667|consen  464 RSLESGLPKADDKLFIDFLKRCLEWD----PAERITPAQALNHPFLTGTSLERR  513 (586)
T ss_pred             cccchhcccccHHHHHHHHHHHhccC----chhcCCHHHHhcCccccccccccc
Confidence                      1234678999999999    999999999999999996665443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-54  Score=409.19  Aligned_cols=272  Identities=22%  Similarity=0.315  Sum_probs=230.7

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      ..+|.+.+.||+|+|++|++|+++.+++.||||++.+..    ...+.+.+|-.+|.+|.    +||.|++++-.|+++.
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~----~hPgivkLy~TFQD~~  147 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLS----GHPGIVKLYFTFQDEE  147 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhh----CCCCeEEEEEEeeccc
Confidence            468999999999999999999999999999999997543    23345678999999995    3355599999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      .+|+|+||+ +|+|.++|.+.+  .|++..++.++.||+.||+|||++|||||||||+|||++.+|+++|+|||-++...
T Consensus       148 sLYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  148 SLYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS  225 (604)
T ss_pred             ceEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence            999999999 999999999987  89999999999999999999999999999999999999999877666666554333


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                      .......           .+-...........++||..|.+||++..+..++.+|||+||||||+|+.|.+||.+.++.-
T Consensus       226 ~~~~~~~-----------~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl  294 (604)
T KOG0592|consen  226 PSQKSQE-----------NPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL  294 (604)
T ss_pred             hhhcccc-----------CccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH
Confidence            2211000           00000001111245899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                      .+++|......+|+.+    ++.++++|+++|..|    |..|.|+++|.+||||.+++|..
T Consensus       295 iFqkI~~l~y~fp~~f----p~~a~dLv~KLLv~d----p~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  295 IFQKIQALDYEFPEGF----PEDARDLIKKLLVRD----PSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             HHHHHHHhcccCCCCC----CHHHHHHHHHHHccC----ccccccHHHHhhCcccccCChhh
Confidence            9999999999998876    477899999999999    99999999999999999999865

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-54  Score=381.30  Aligned_cols=260  Identities=22%  Similarity=0.372  Sum_probs=235.2

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++++.||.|+||.|.+++++.+|..+|+|++++..    +..+...+|..+|+.+.||.+     +++.+.|.+.+.
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFl-----v~l~~t~~d~~~  118 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFL-----VKLYGTFKDNSN  118 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCcee-----EEEEEeeccCCe
Confidence            57999999999999999999999999999999998643    455677889999999998877     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+||||. ||.|..++++.+  ++++..++.++.||+.||+|||+++|++|||||+|||++.+|               
T Consensus       119 lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G---------------  181 (355)
T KOG0616|consen  119 LYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNG---------------  181 (355)
T ss_pred             EEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCC---------------
Confidence            99999999 999999999876  899999999999999999999999999999999999998887               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH  326 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~  326 (411)
                                  .+||+|||+|+.......+.+|||.|+|||+++..+|+.++|.|||||++|||+.|.+||.+.+....
T Consensus       182 ------------~iKitDFGFAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i  249 (355)
T KOG0616|consen  182 ------------HIKITDFGFAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI  249 (355)
T ss_pred             ------------cEEEEeccceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH
Confidence                        67888899998888887889999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCC-CcHHHHHHHHhcCCCCcccccCCC
Q 015222          327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGA-TSRDSMRAVWKLLRLPVIDLYSAS  389 (411)
Q Consensus       327 ~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp-~~R~t~~~il~~~~~~~~~~~~~~  389 (411)
                      +++|......+|..+    +..++++|+++|+.|-.+|. ......++|..|+||.+++|....
T Consensus       250 Y~KI~~~~v~fP~~f----s~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~  309 (355)
T KOG0616|consen  250 YEKILEGKVKFPSYF----SSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAIL  309 (355)
T ss_pred             HHHHHhCcccCCccc----CHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHh
Confidence            999999988998875    56688888899888855552 223577899999999999987653

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-53  Score=389.89  Aligned_cols=261  Identities=26%  Similarity=0.414  Sum_probs=226.7

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      .++|.+.++||+|+||+||+|+++.++..||||.+.+.   .+..+.+..|+.+|+.++|+||     |.+++++++.++
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nI-----V~l~d~~~~~~~   83 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNI-----VRLLDCIEDDDF   83 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcce-----eeEEEEEecCCe
Confidence            46799999999999999999999999999999999754   3566778899999999998887     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+||||| ||+|.+|+++++  .+++..++.++.||+.||++||+++||||||||+||||+....              
T Consensus        84 i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~--------------  147 (429)
T KOG0595|consen   84 IYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTAR--------------  147 (429)
T ss_pred             EEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCC--------------
Confidence            99999999 999999999987  7999999999999999999999999999999999999977420              


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                             .+....+||+|||+|+......  .+.+|++.|||||++..+.|+.|+|+||+|+|||+|++|+.||...+..
T Consensus       148 -------~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~  220 (429)
T KOG0595|consen  148 -------NDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK  220 (429)
T ss_pred             -------CCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence                   1112589999999999876543  5689999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      +.+..+.+.....|. .....+....+++...+..+    +..|.+..+-+.|+++..-.
T Consensus       221 eL~~~~~k~~~~~~~-~~~~~s~~~~~Ll~~ll~~~----~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  221 ELLLYIKKGNEIVPV-LPAELSNPLRELLISLLQRN----PKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             HHHHHHhccccccCc-hhhhccCchhhhhhHHHhcC----ccccCchHHhhhhhhcccCc
Confidence            988877766544332 33445566668888888888    88999999999988877543

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.3e-53  Score=403.23  Aligned_cols=287  Identities=23%  Similarity=0.337  Sum_probs=233.7

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchh----hhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      .++|++++.||+|+||.||+|+.+.||..+|+|+++++..    ..+.+..|-.+|.....+.+     |+++-.|++.+
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~v-----VKLyYsFQD~~  214 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWV-----VKLYYSFQDKE  214 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcE-----EEEEEEecCCC
Confidence            4689999999999999999999999999999999987653    34556678888877656555     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      ++||||||+ ||++..+|.+.+  .|++..++.++.+++.|++.+|+.|+|||||||+|+|||..|++||+||||+.-..
T Consensus       215 ~LYLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  215 YLYLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             eeEEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhh
Confidence            999999999 999999999887  89999999999999999999999999999999999999999999999999985443


Q ss_pred             CCCCccc------cCCCCCCeeEeecCCc--cccc--C----------C---CcccccCCCccccceecCCCCCccchhH
Q 015222          246 KDGSYFK------NLPKSSAIKLIDFGST--TFEH--Q----------D---HSYVVSTRHYRAPEVILGLGWNYPCDLW  302 (411)
Q Consensus       246 ~~~~~~~------~~~~~~~~kl~Dfg~a--~~~~--~----------~---~~~~~gt~~y~aPE~~~~~~~~~~~Diw  302 (411)
                      .......      ........+-.||...  ....  .          .   ....+|||.|||||++.+..|+..+|+|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            3222110      0001112344455431  1100  0          0   1236899999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC--CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          303 SVGCILVELCSGEALFQTHENLEHLAMMERVLG--PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       303 SlGvil~elltg~~pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      |||||+||||.|.+||.+.+..+...+|.....  .+|..  ..++++++|+|.++|. |+.+|-. -..++||.+||||
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~--~~~s~eA~DLI~rll~-d~~~RLG-~~G~~EIK~HPfF  448 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE--VDLSDEAKDLITRLLC-DPENRLG-SKGAEEIKKHPFF  448 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc--CcccHHHHHHHHHHhc-CHHHhcC-cccHHHHhcCCcc
Confidence            999999999999999999999999999987664  44444  4567999999999998 8343333 3469999999999


Q ss_pred             CcccccCC
Q 015222          381 PVIDLYSA  388 (411)
Q Consensus       381 ~~~~~~~~  388 (411)
                      ++++|.-.
T Consensus       449 ~~v~W~~l  456 (550)
T KOG0605|consen  449 KGVDWDHL  456 (550)
T ss_pred             ccCCcchh
Confidence            99998654

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.1e-53  Score=377.23  Aligned_cols=256  Identities=28%  Similarity=0.516  Sum_probs=228.0

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      ++|+.+.++|+|+||+||+|+++.||+.||||++..+.   ...+-..+|+.+|++++|+|+     |.++++|.....+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NL-----VnLiEVFrrkrkl   76 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENL-----VNLIEVFRRKRKL   76 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchH-----HHHHHHHHhccee
Confidence            57999999999999999999999999999999996433   345677899999999999998     9999999999999


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      ++|+|||..++.+-|.+.. ..++.+.++.++.|++.|+.|+|++++|||||||+||||+.+|                 
T Consensus        77 hLVFE~~dhTvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~g-----------------  138 (396)
T KOG0593|consen   77 HLVFEYCDHTVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNG-----------------  138 (396)
T ss_pred             EEEeeecchHHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCC-----------------
Confidence            9999999888888888776 4699999999999999999999999999999999999998877                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                                .+||||||+|+.....   -+.++.|.+|+|||.+.|. .|+.++||||+||++.||++|++.|.+.++.
T Consensus       139 ----------vvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi  208 (396)
T KOG0593|consen  139 ----------VVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI  208 (396)
T ss_pred             ----------cEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH
Confidence                      7789999998876532   2346889999999999985 8999999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCChhHH---------------------------HhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          325 EHLAMMERVLGPLPHHMV---------------------------IRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~---------------------------~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      +++..|.+..|.+.++-.                           +.++..+.+|+++||.+|    |++|.+-++++.|
T Consensus       209 DQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~d----P~~R~sc~qll~H  284 (396)
T KOG0593|consen  209 DQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMD----PDDRLSCEQLLHH  284 (396)
T ss_pred             HHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCC----ccccccHHHHhcC
Confidence            999999998887654432                           234567889999999999    9999999999999


Q ss_pred             CCCCccc
Q 015222          378 LRLPVID  384 (411)
Q Consensus       378 ~~~~~~~  384 (411)
                      ++|.++.
T Consensus       285 ~yFd~~~  291 (396)
T KOG0593|consen  285 PYFDGFI  291 (396)
T ss_pred             hHHHHHH
Confidence            9996554

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.1e-53  Score=394.21  Aligned_cols=276  Identities=29%  Similarity=0.464  Sum_probs=236.1

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .-.+.|+.+++||+|+||.||+|++..+|+.||+|.++...   .......+|+.||++|.|+||     +++.+...+.
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNI-----ikL~eivt~~  188 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNI-----IKLEEIVTSK  188 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcc-----cceeeEEEec
Confidence            33467999999999999999999999999999999997543   345667899999999999988     9999988765


Q ss_pred             --CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          166 --NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       166 --~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                        ..+|+|+|||..+|..++.... ..|++.+++.+++||+.||+|||++||+|||||.+||||+++|            
T Consensus       189 ~~~siYlVFeYMdhDL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G------------  255 (560)
T KOG0600|consen  189 LSGSIYLVFEYMDHDLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNG------------  255 (560)
T ss_pred             CCceEEEEEecccchhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCC------------
Confidence              7999999999999999988754 4799999999999999999999999999999999999998887            


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccCC----CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALF  318 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf  318 (411)
                                     .+||+|||+|++....    .+..+-|.+|+|||+++|. .|+.++|+||.||||.||++|++.|
T Consensus       256 ---------------~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~  320 (560)
T KOG0600|consen  256 ---------------VLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPIL  320 (560)
T ss_pred             ---------------CEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCc
Confidence                           6788888888865433    2446789999999999998 7999999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCChhHHH-------------------------hhhhhhhhhhccCCccCCCCCCCcHHHHHH
Q 015222          319 QTHENLEHLAMMERVLGPLPHHMVI-------------------------RADRRAEKYFRRGARLDWPDGATSRDSMRA  373 (411)
Q Consensus       319 ~~~~~~~~~~~i~~~~~~~p~~~~~-------------------------~~~~~~~~li~~~l~~~~~~rp~~R~t~~~  373 (411)
                      .+.++.+++..|.+..|...+..|+                         ..+..+.+|+..+|.+|    |.+|.|+.+
T Consensus       321 ~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ld----P~kR~tA~~  396 (560)
T KOG0600|consen  321 QGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLD----PDKRGTASS  396 (560)
T ss_pred             CCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccC----ccccccHHH
Confidence            9999999999999999876665554                         24567888999999999    999999999


Q ss_pred             HHhcCCCCcccccCCCCCchhhHHHHHHHH
Q 015222          374 VWKLLRLPVIDLYSASPNCLCKFYAITHCL  403 (411)
Q Consensus       374 il~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (411)
                      +|++.|| ...+....|..|.. |...|.+
T Consensus       397 aL~seyF-~t~p~~~~p~~Lp~-y~~s~E~  424 (560)
T KOG0600|consen  397 ALQSEYF-TTEPLPCDPSSLPK-YPPSHEL  424 (560)
T ss_pred             HhcCccc-ccCCCCCCcccCCC-CCcchhH
Confidence            9999999 44444445554444 4444433

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-53  Score=394.79  Aligned_cols=259  Identities=31%  Similarity=0.486  Sum_probs=228.0

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHH--HHHHHHHHHHh-cCCCCCcceEEEeeeeecCC
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA--MIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~--~~E~~~l~~l~-~~~i~~~~iv~~~~~~~~~~  166 (411)
                      +.+||.++++||.|+||.||+|+.+.+++.||||.+++.-...++.  .+|+..|++|+ |+||     +++.+++.+.+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpni-----ikL~Evi~d~~   82 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNI-----IKLKEVIRDND   82 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcc-----hhhHHHhhccC
Confidence            4579999999999999999999999999999999998644333333  57999999998 8877     99999998877


Q ss_pred             -eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 -HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 -~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                       .+|+|||||..+|+++++.+ ...|++..++.|+.||++||+|+|.+|+.|||+||||||+...               
T Consensus        83 ~~L~fVfE~Md~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~---------------  146 (538)
T KOG0661|consen   83 RILYFVFEFMDCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGN---------------  146 (538)
T ss_pred             ceEeeeHHhhhhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEeccc---------------
Confidence             99999999999999999988 4789999999999999999999999999999999999999643               


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHE  322 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~  322 (411)
                                  ..+||+|||+|+......  +.++.|.+|+|||++... .|+.+.||||+|||++|+.+-++.|.|.+
T Consensus       147 ------------~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s  214 (538)
T KOG0661|consen  147 ------------DVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS  214 (538)
T ss_pred             ------------ceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc
Confidence                        378999999999876544  457899999999998765 78999999999999999999999999999


Q ss_pred             hHHHHHHHHHHhCCCChhH--------------------------HHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHh
Q 015222          323 NLEHLAMMERVLGPLPHHM--------------------------VIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK  376 (411)
Q Consensus       323 ~~~~~~~i~~~~~~~p~~~--------------------------~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~  376 (411)
                      +.+++.+|..+.|......                          .+..+.++.++|.+|++.|    |.+|||+.++|+
T Consensus       215 E~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WD----P~kRpTA~~al~  290 (538)
T KOG0661|consen  215 EIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWD----PDKRPTASQALQ  290 (538)
T ss_pred             HHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCC----CccCccHHHHhc
Confidence            9999999999888644322                          2235678889999999999    999999999999


Q ss_pred             cCCCCcccc
Q 015222          377 LLRLPVIDL  385 (411)
Q Consensus       377 ~~~~~~~~~  385 (411)
                      ||||+.-..
T Consensus       291 ~pffq~~~~  299 (538)
T KOG0661|consen  291 HPFFQVGRA  299 (538)
T ss_pred             Ccccccccc
Confidence            999997544

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-51  Score=394.56  Aligned_cols=254  Identities=28%  Similarity=0.425  Sum_probs=226.2

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc-----h-hhhHHHHHHHHHHHHHh-cCCCCCcceEEEeee
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-----N-KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNW  161 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~-~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~  161 (411)
                      ...++|.+.+.||+|+||+|++|.+..+++.||+|++++.     . ...+.+.+|+.+++++. |+||     ++++++
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI-----~~l~ev   88 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNI-----IRLLEV   88 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCE-----eEEEEE
Confidence            4457899999999999999999999999999999987653     1 23456678999999999 7766     999999


Q ss_pred             eecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                      +.....+|+||||+ ||+|.+++...+  ++.+..++.++.||+.|++|||++||+||||||+|||++.+.         
T Consensus        89 ~~t~~~~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~---------  157 (370)
T KOG0583|consen   89 FATPTKIYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE---------  157 (370)
T ss_pred             EecCCeEEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC---------
Confidence            99999999999999 899999999854  799999999999999999999999999999999999997651         


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCccccc---CCCcccccCCCccccceecCCC-CC-ccchhHHHHHHHHHHHhCC
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLG-WN-YPCDLWSVGCILVELCSGE  315 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwSlGvil~elltg~  315 (411)
                                       .++||+|||++....   ....+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+
T Consensus       158 -----------------~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~  220 (370)
T KOG0583|consen  158 -----------------GNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGR  220 (370)
T ss_pred             -----------------CCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCC
Confidence                             378999999888762   3446689999999999999987 86 8999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCc
Q 015222          316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~  382 (411)
                      .||...+.......|.+....+|..+.   +..+++++.+||..+    |.+|+++.++++|+||+.
T Consensus       221 ~PF~d~~~~~l~~ki~~~~~~~p~~~~---S~~~~~Li~~mL~~~----P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  221 LPFDDSNVPNLYRKIRKGEFKIPSYLL---SPEARSLIEKMLVPD----PSTRITLLEILEHPWFQK  280 (370)
T ss_pred             CCCCCccHHHHHHHHhcCCccCCCCcC---CHHHHHHHHHHcCCC----cccCCCHHHHhhChhhcc
Confidence            999998888888888887777777653   788999999999999    999999999999999997

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.6e-53  Score=369.73  Aligned_cols=252  Identities=27%  Similarity=0.386  Sum_probs=215.7

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEecc---chhhhHHHHHHHHHHHHHhcCCCCCcceEEEee-eeecCC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRN-WFDYRN  166 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~-~~~~~~  166 (411)
                      ...|+|+++||+|+||+||++.+..+|..||.|.++-   +.+.++....|+.+|++|+|+||     |++++ .|..++
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNI-----VqYy~~~f~~~~   92 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNI-----VQYYAHSFIEDN   92 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchH-----HHHHHHhhhccc
Confidence            3579999999999999999999999999999999873   34566778899999999999988     99988 455555


Q ss_pred             e-EEEEEccC-CCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceecCCCCCcEEEecCcccccCCc
Q 015222          167 H-ICIVFEKL-GPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHE--LR--LIHTDLKPENILLVSAEYVKVPDY  238 (411)
Q Consensus       167 ~-~~lv~e~~-~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~--~g--ivH~Dikp~NIli~~~~~~~l~df  238 (411)
                      . ++||||+| +|+|.+.++.  ...+.+++..+++++.|++.||..+|+  ..  |+||||||.||+++.+|       
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-------  165 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-------  165 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC-------
Confidence            5 99999999 9999999873  344679999999999999999999999  44  99999999999998777       


Q ss_pred             ccccccCCCCCccccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCC
Q 015222          239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE  315 (411)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~  315 (411)
                                          .+||+|||+++......   .+.+|||+||+||.+.+.+|+++|||||+||++|||+.-+
T Consensus       166 --------------------vvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~  225 (375)
T KOG0591|consen  166 --------------------VVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQ  225 (375)
T ss_pred             --------------------ceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcC
Confidence                                78999999998876554   4479999999999999999999999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHh
Q 015222          316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK  376 (411)
Q Consensus       316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~  376 (411)
                      +||.+.+-.+...+|.++..  |+-....++..+..+|..|+..|+..||+.-|-+.++..
T Consensus       226 ~PF~g~n~~~L~~KI~qgd~--~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  226 SPFYGDNLLSLCKKIEQGDY--PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             CCcccccHHHHHHHHHcCCC--CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            99999988888888887643  322334578889999999999997777766555555544

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.3e-49  Score=398.12  Aligned_cols=289  Identities=38%  Similarity=0.662  Sum_probs=237.1

Q ss_pred             CceEEeeCCcc---CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCC-Ccce
Q 015222           80 GHYVFAIGENL---TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG-GTRC  155 (411)
Q Consensus        80 ~~~~~~~~~~~---~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~-~~~i  155 (411)
                      +.+....++.+   .++|+++++||+|+||+||+|.+..+++.||||+++...........|+.+++.+.|.++. +.++
T Consensus       114 ~~~~~~~~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i  193 (467)
T PTZ00284        114 GHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPL  193 (467)
T ss_pred             CceeEecCCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcce
Confidence            34455555544   5789999999999999999999999999999999976555556677899999999987754 4568


Q ss_pred             EEEeeeeecC-CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEecCccc
Q 015222          156 VQIRNWFDYR-NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYV  233 (411)
Q Consensus       156 v~~~~~~~~~-~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dikp~NIli~~~~~~  233 (411)
                      +.++++|... +++|+|||+++++|.+++.+..  .+++..+..|+.||+.||+|||+ .|||||||||+|||++.++..
T Consensus       194 ~~i~~~~~~~~~~~~iv~~~~g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~  271 (467)
T PTZ00284        194 MKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTV  271 (467)
T ss_pred             eeeEEEEEcCCceEEEEEeccCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcc
Confidence            8999988764 5899999999999999998765  69999999999999999999998 599999999999999876632


Q ss_pred             ccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh
Q 015222          234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS  313 (411)
Q Consensus       234 ~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt  313 (411)
                      .  ++.....         ...+...+||+|||.+..........+||+.|+|||++.+..++.++|||||||++|||++
T Consensus       272 ~--~~~~~~~---------~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ellt  340 (467)
T PTZ00284        272 V--DPVTNRA---------LPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYT  340 (467)
T ss_pred             c--ccccccc---------cCCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHh
Confidence            1  1111000         0112346999999988766555566789999999999999999999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChhHHHh--------------------------------------hhhhhhhhhcc
Q 015222          314 GEALFQTHENLEHLAMMERVLGPLPHHMVIR--------------------------------------ADRRAEKYFRR  355 (411)
Q Consensus       314 g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~--------------------------------------~~~~~~~li~~  355 (411)
                      |+.||.+.+..+.+..+.+..+.+|..+...                                      .+..+.+||.+
T Consensus       341 G~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~  420 (467)
T PTZ00284        341 GKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYG  420 (467)
T ss_pred             CCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHH
Confidence            9999999888888888888877777654321                                      12346699999


Q ss_pred             CCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          356 GARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       356 ~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      ||..|    |.+|+|++|+|+||||.....
T Consensus       421 mL~~d----P~~R~ta~e~L~Hp~~~~~~~  446 (467)
T PTZ00284        421 LLHYD----RQKRLNARQMTTHPYVLKYYP  446 (467)
T ss_pred             hCCcC----hhhCCCHHHHhcCccccccCC
Confidence            99999    999999999999999997554

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.5e-51  Score=356.33  Aligned_cols=259  Identities=28%  Similarity=0.445  Sum_probs=228.3

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchh---hhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      .+|..+++||+|.||.||+|++..||+.||||.++..+.   ......+|++.|+.++|+||     +.++++|-+.+.+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nI-----i~LiD~F~~~~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNI-----IELIDVFPHKSNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcch-----hhhhhhccCCCce
Confidence            579999999999999999999999999999999985432   24567899999999999888     9999999999999


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      -||+||+..+|+..++... ..++...++.++.++++||+|||++.|+||||||.|+||+++|                 
T Consensus        77 ~lVfEfm~tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g-----------------  138 (318)
T KOG0659|consen   77 SLVFEFMPTDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDG-----------------  138 (318)
T ss_pred             EEEEEeccccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCC-----------------
Confidence            9999999999999998765 5799999999999999999999999999999999999999888                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                                .+||+|||+|+......   ...+-|.+|+|||++.|. .|+..+||||.|||+.||+.|.+.|.|.++.
T Consensus       139 ----------~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi  208 (318)
T KOG0659|consen  139 ----------QLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI  208 (318)
T ss_pred             ----------cEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH
Confidence                      67888888888765443   223679999999999887 7999999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCChhHHH------------------------hhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          325 EHLAMMERVLGPLPHHMVI------------------------RADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~------------------------~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      +++..|.+..|...++.|+                        ..+..+.+++.+|+.+|    |.+|.++.|+++|+||
T Consensus       209 dQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~yn----P~~Rita~qaL~~~yf  284 (318)
T KOG0659|consen  209 DQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYN----PKKRITASQALKHPYF  284 (318)
T ss_pred             HHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccC----chhcccHHHHhcchhh
Confidence            9999999988865443333                        24566789999999999    9999999999999999


Q ss_pred             CcccccC
Q 015222          381 PVIDLYS  387 (411)
Q Consensus       381 ~~~~~~~  387 (411)
                      .+.....
T Consensus       285 ~~~P~pt  291 (318)
T KOG0659|consen  285 KSLPLPT  291 (318)
T ss_pred             hcCCCCC
Confidence            9855443

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-51  Score=375.01  Aligned_cols=288  Identities=22%  Similarity=0.290  Sum_probs=240.1

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      +.|++++.||.|.-|+||+|+.+.++..+|+|++.+..    ....+++.|-+||+.+.||.+     +.+|..|+.++.
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFl-----PTLYa~fet~~~  151 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFL-----PTLYASFETDKY  151 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCcc-----chhhheeeccce
Confidence            57999999999999999999999999999999998643    334567789999999999988     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      .|+||||| ||+|..+++++....+++..++.++..++.||+|||-.|||+|||||+||||.++|++.|+||.++.+...
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            99999999 99999999999989999999999999999999999999999999999999999999999999998776643


Q ss_pred             CCCccccCC----CC-CC---eeE----------------eecCC--------cccccCCCcccccCCCccccceecCCC
Q 015222          247 DGSYFKNLP----KS-SA---IKL----------------IDFGS--------TTFEHQDHSYVVSTRHYRAPEVILGLG  294 (411)
Q Consensus       247 ~~~~~~~~~----~~-~~---~kl----------------~Dfg~--------a~~~~~~~~~~~gt~~y~aPE~~~~~~  294 (411)
                      ........+    .. ..   +.+                .|++.        |...+.....++||-.|.|||++.|..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence            221111100    00 00   001                12221        111222334579999999999999999


Q ss_pred             CCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHH
Q 015222          295 WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV  374 (411)
Q Consensus       295 ~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~i  374 (411)
                      .+.++|+|+|||++|||+.|..||.|.+..+.+..|......+|...  .++..++|+|+++|.+|+++|-..+-.+.||
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI  389 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI  389 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchHHh
Confidence            99999999999999999999999999999999999988777787764  6778999999999999944444444449999


Q ss_pred             HhcCCCCccccc
Q 015222          375 WKLLRLPVIDLY  386 (411)
Q Consensus       375 l~~~~~~~~~~~  386 (411)
                      .+||||++++|.
T Consensus       390 K~HpFF~gVnWa  401 (459)
T KOG0610|consen  390 KRHPFFEGVNWA  401 (459)
T ss_pred             hcCccccCCChh
Confidence            999999999986

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-50  Score=392.58  Aligned_cols=258  Identities=24%  Similarity=0.336  Sum_probs=223.3

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      .++|.+++.||+|+||+|++|..+.+++.+|||++++..    ...+..+.|..|+....    .||.++.++..|+..+
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~----~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELAN----RHPFLVNLFSCFQTKE  442 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhc----cCCeEeecccccccCC
Confidence            468999999999999999999999999999999998754    44567788999998886    4456699999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      ++|+||||+ ||++..+.+.   ..+++..++.++..|+.||+|||++||||||||.+|||+|.+|              
T Consensus       443 ~l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eG--------------  505 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEG--------------  505 (694)
T ss_pred             eEEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccC--------------
Confidence            999999999 8884444333   3699999999999999999999999999999999999999988              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccc---cCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE  322 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~  322 (411)
                                   .+||+|||+++..   +...++++|||.|||||++.+..|+.++|+|||||+|||||.|+.||.+.+
T Consensus       506 -------------h~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd  572 (694)
T KOG0694|consen  506 -------------HVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD  572 (694)
T ss_pred             -------------cEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence                         4566666666542   334567899999999999999999999999999999999999999999999


Q ss_pred             hHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHH-----HHHHHhcCCCCcccccCCCC
Q 015222          323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS-----MRAVWKLLRLPVIDLYSASP  390 (411)
Q Consensus       323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t-----~~~il~~~~~~~~~~~~~~~  390 (411)
                      +.+....|.......|..    ++.++..+++++|.++    |++|..     +.+|.+||||.+|+|.....
T Consensus       573 Eee~FdsI~~d~~~yP~~----ls~ea~~il~~ll~k~----p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~  637 (694)
T KOG0694|consen  573 EEEVFDSIVNDEVRYPRF----LSKEAIAIMRRLLRKN----PEKRLGSGERDAEDIKKHPFFRSIDWDDLLN  637 (694)
T ss_pred             HHHHHHHHhcCCCCCCCc----ccHHHHHHHHHHhccC----cccccCCCCCCchhhhhCCccccCCHHHHhh
Confidence            999999999887777655    4678889999999999    777765     48899999999999865433

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-51  Score=369.36  Aligned_cols=272  Identities=26%  Similarity=0.427  Sum_probs=238.2

Q ss_pred             CccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEecc---chhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        88 ~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      -.+..+|..++.||+|+||.|..|.++.+|+.||||.+..   .....+...+|+.+|+.++|+||     +.+.+++..
T Consensus        18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNI-----i~l~di~~p   92 (359)
T KOG0660|consen   18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENI-----IGLLDIFRP   92 (359)
T ss_pred             EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCc-----ceEEeeccc
Confidence            3456678889999999999999999999999999999862   33456778899999999999988     888888765


Q ss_pred             -----CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcc
Q 015222          165 -----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK  239 (411)
Q Consensus       165 -----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~  239 (411)
                           -+.+|+|+|+|+.+|.+.++.+.  .++++.+..++.||++||+|+|+.+|+||||||+|+|++.+.        
T Consensus        93 ~~~~~f~DvYiV~elMetDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c--------  162 (359)
T KOG0660|consen   93 PSRDKFNDVYLVFELMETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADC--------  162 (359)
T ss_pred             ccccccceeEEehhHHhhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCC--------
Confidence                 35799999999999999998875  699999999999999999999999999999999999987654        


Q ss_pred             cccccCCCCCccccCCCCCCeeEeecCCccccc-----CCCcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHh
Q 015222          240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH-----QDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCS  313 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~-----~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt  313 (411)
                                         .+||+|||+|+...     ...+..+.|.+|+|||++... .|+.+.||||+|||+.||++
T Consensus       163 -------------------~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~  223 (359)
T KOG0660|consen  163 -------------------DLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLT  223 (359)
T ss_pred             -------------------CEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHc
Confidence                               67999999998874     233567889999999998765 89999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChhHHH---------------------------hhhhhhhhhhccCCccCCCCCCC
Q 015222          314 GEALFQTHENLEHLAMMERVLGPLPHHMVI---------------------------RADRRAEKYFRRGARLDWPDGAT  366 (411)
Q Consensus       314 g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~---------------------------~~~~~~~~li~~~l~~~~~~rp~  366 (411)
                      |++.|.|.+..+++..|....|..+++...                           +.++.+.+++.+||..|    |.
T Consensus       224 gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fd----P~  299 (359)
T KOG0660|consen  224 GKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFD----PK  299 (359)
T ss_pred             CCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccC----cc
Confidence            999999999999999988888876654433                           34577899999999999    99


Q ss_pred             cHHHHHHHHhcCCCCcccccCCCCCchhhHH
Q 015222          367 SRDSMRAVWKLLRLPVIDLYSASPNCLCKFY  397 (411)
Q Consensus       367 ~R~t~~~il~~~~~~~~~~~~~~~~~~~~~~  397 (411)
                      +|+|++|+|+|||+........+|.|...|.
T Consensus       300 kRita~eAL~hPYl~~~hdp~dEP~~~~~~~  330 (359)
T KOG0660|consen  300 KRITAEEALAHPYLAPYHDPEDEPVCQPIFD  330 (359)
T ss_pred             ccCCHHHHhcChhhhhhcCCccCCCCCCCCc
Confidence            9999999999999999999999998777554

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.2e-51  Score=392.39  Aligned_cols=254  Identities=26%  Similarity=0.453  Sum_probs=230.4

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc----hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      +-|++.+.||.|+-|.|-+|++..||+.+|||++.+.    ......+.+|+-||+.+.|||+     ++++++++...+
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnV-----l~LydVwe~~~~   86 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNV-----LRLYDVWENKQH   86 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCe-----eeeeeeeccCce
Confidence            4589999999999999999999999999999999754    2345667899999999999988     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+|.||+ ||.|++++.+++  .+++.++.+++.||+.|+.|+|..+|+||||||+|+|++..+               
T Consensus        87 lylvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~---------------  149 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKN---------------  149 (786)
T ss_pred             EEEEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhccc---------------
Confidence            99999999 999999999887  899999999999999999999999999999999999987655               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCh
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEALFQTHEN  323 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~pf~~~~~  323 (411)
                                  ++||+|||+|.....+  ..+.||++.|+|||++.|.+|+ .++||||+|||||.||||+.||.+.+-
T Consensus       150 ------------nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi  217 (786)
T KOG0588|consen  150 ------------NIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI  217 (786)
T ss_pred             ------------CEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH
Confidence                        6899999999876544  3668999999999999999885 899999999999999999999999888


Q ss_pred             HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                      ...+.++.++...+|.    .++.+++++|++||..|    |++|.|++||++|||+....-..
T Consensus       218 r~LLlKV~~G~f~MPs----~Is~eaQdLLr~ml~VD----p~~RiT~~eI~kHP~l~g~~~~~  273 (786)
T KOG0588|consen  218 RVLLLKVQRGVFEMPS----NISSEAQDLLRRMLDVD----PSTRITTEEILKHPFLSGYTSLP  273 (786)
T ss_pred             HHHHHHHHcCcccCCC----cCCHHHHHHHHHHhccC----ccccccHHHHhhCchhhcCCCCC
Confidence            8999999998888884    46788999999999999    99999999999999998765433

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-52  Score=360.34  Aligned_cols=281  Identities=23%  Similarity=0.330  Sum_probs=244.7

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEecc---chhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .+.+.|++.+.||+|.|+.|+++.+..+|+.+|+|+++.   .....+.+.+|+.|-+.|+||+|     +++.+.+...
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~I-----vrL~~ti~~~   82 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI-----VRLHDSIQEE   82 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcE-----eehhhhhccc
Confidence            356789999999999999999999999999999999863   23456788999999999999888     9999999999


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      +..|+|+|++ |++|..-+-.+.  .+++..+-.+++||+.||.|+|.+||||||+||+|+|+.+..             
T Consensus        83 ~~~ylvFe~m~G~dl~~eIV~R~--~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~-------------  147 (355)
T KOG0033|consen   83 SFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKA-------------  147 (355)
T ss_pred             ceeEEEEecccchHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeecc-------------
Confidence            9999999999 999976555443  689999999999999999999999999999999999997643             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE  322 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~  322 (411)
                                 +.--+||+|||+|.......  ...+|||.|||||++...+|+..+|||+.|||||-|+.|.+||.+.+
T Consensus       148 -----------~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~  216 (355)
T KOG0033|consen  148 -----------KGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED  216 (355)
T ss_pred             -----------CCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc
Confidence                       44579999999998766332  34689999999999999999999999999999999999999999999


Q ss_pred             hHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccCC------CCCchhhH
Q 015222          323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSA------SPNCLCKF  396 (411)
Q Consensus       323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~------~~~~~~~~  396 (411)
                      ....++.|.+....+|...+..+++++++++++||..|    |++|.|+.|+|+|||+++-.-.+.      .-+|+.+|
T Consensus       217 ~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~d----P~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkf  292 (355)
T KOG0033|consen  217 QHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVN----PKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKF  292 (355)
T ss_pred             HHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccC----hhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHh
Confidence            99999999999999999889999999999999999999    999999999999999997543322      22355666


Q ss_pred             HHHHHHHh
Q 015222          397 YAITHCLL  404 (411)
Q Consensus       397 ~~~~~~~~  404 (411)
                      -+....+.
T Consensus       293 NarRKLKg  300 (355)
T KOG0033|consen  293 NARRKLKG  300 (355)
T ss_pred             hHHHHHHH
Confidence            55554443

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=7.9e-51  Score=384.75  Aligned_cols=253  Identities=25%  Similarity=0.390  Sum_probs=222.9

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      ++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+..   +..+.+.+|++|++.++|+||     +.++++|+...++
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpni-----v~m~esfEt~~~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNI-----VEMLESFETSAHL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcch-----hhHHHhhcccceE
Confidence            57999999999999999999999999999999997544   344667899999999999988     9999999999999


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      |+|+||+-|+|..++...+  .++|+.++.++.|++.||.|||+.+|+|||+||.|||++..|                 
T Consensus        77 ~vVte~a~g~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~-----------------  137 (808)
T KOG0597|consen   77 WVVTEYAVGDLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGG-----------------  137 (808)
T ss_pred             EEEehhhhhhHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCC-----------------
Confidence            9999999669999999876  799999999999999999999999999999999999987766                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                                .+|+||||+|+......   +...|||.|||||+..+++|+..+|+||||||+|||++|++||...+-.+
T Consensus       138 ----------~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~  207 (808)
T KOG0597|consen  138 ----------TLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ  207 (808)
T ss_pred             ----------ceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH
Confidence                      77888888888765543   34689999999999999999999999999999999999999998766666


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                      ..+.|.......|.    ..+..+.+|++.+|.+|    |.+|.++-+++.|+|.+.....
T Consensus       208 Lv~~I~~d~v~~p~----~~S~~f~nfl~gLL~kd----P~~RltW~~Ll~HpF~k~~~~~  260 (808)
T KOG0597|consen  208 LVKSILKDPVKPPS----TASSSFVNFLQGLLIKD----PAQRLTWTDLLGHPFWKGKINI  260 (808)
T ss_pred             HHHHHhcCCCCCcc----cccHHHHHHHHHHhhcC----hhhcccHHHHhcChHHhhhhhh
Confidence            66666654444443    56778999999999999    9999999999999998864433

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-49  Score=379.69  Aligned_cols=266  Identities=29%  Similarity=0.443  Sum_probs=241.0

Q ss_pred             CCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchh----hhHHHHHHHHHHHHHh-cCCCCCcceEEEeee
Q 015222           87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLA-RHDIGGTRCVQIRNW  161 (411)
Q Consensus        87 ~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~  161 (411)
                      ...+...|++.+.||+|.||.||+|+++.+|+.+|+|++.+...    ..+.+.+|+.+|+++. |+|+     +.+++.
T Consensus        30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpni-----v~l~~~  104 (382)
T KOG0032|consen   30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNI-----VQLKDA  104 (382)
T ss_pred             cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCE-----EEEEEE
Confidence            34566789999999999999999999999999999999975432    3468899999999998 7766     999999


Q ss_pred             eecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                      |++...+++|||+| ||.|.+.+...   .+++..+..++.||+.|++|||+.||+||||||+|+|+....         
T Consensus       105 ~e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~---------  172 (382)
T KOG0032|consen  105 FEDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKD---------  172 (382)
T ss_pred             EEcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeecccc---------
Confidence            99999999999999 99999999887   299999999999999999999999999999999999997643         


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccC--CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCC
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF  318 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf  318 (411)
                                    +.+..++++|||++.....  .....+||+.|+|||++.+..|+..+||||+||++|.|++|.+||
T Consensus       173 --------------~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF  238 (382)
T KOG0032|consen  173 --------------EGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPF  238 (382)
T ss_pred             --------------CCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCC
Confidence                          1235899999999998776  345689999999999999999999999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                      .+.+.......+.+....++...+..++..++++++++|..|    |.+|+++.++|+|||+.+.....
T Consensus       239 ~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~d----p~~R~ta~~~L~HpWi~~~~~~~  303 (382)
T KOG0032|consen  239 WGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFD----PRKRLTAAQALQHPWIKSIGEAT  303 (382)
T ss_pred             cCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccC----cccCCCHHHHhcCccccCCcccc
Confidence            999999999999998889999999999999999999999999    99999999999999999864433

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.3e-50  Score=358.73  Aligned_cols=258  Identities=26%  Similarity=0.404  Sum_probs=226.7

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec--C
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--R  165 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~--~  165 (411)
                      .+.|+.+.+|++|+||.||+|+++.|++.||+|.++-..   ...-...+|+.+|.+++|+||     |.+.++...  -
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NI-----V~vkEVVvG~~~  149 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNI-----VEVKEVVVGSNM  149 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCe-----eeeEEEEecccc
Confidence            467999999999999999999999999999999997443   233446789999999999888     888887764  3


Q ss_pred             CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          166 NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       166 ~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      +.+|+|||||..+|..++.... +.+...+++.++.|+++||+|||.+.|+|||||++|+|+.+.|              
T Consensus       150 d~iy~VMe~~EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G--------------  214 (419)
T KOG0663|consen  150 DKIYIVMEYVEHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKG--------------  214 (419)
T ss_pred             ceeeeeHHHHHhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCC--------------
Confidence            5799999999999999998776 6799999999999999999999999999999999999998887              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                                   .+||+|||+|+..+..   .+..+-|.+|+|||++.+. .|++++|+||+|||+.||+++++.|.|.
T Consensus       215 -------------~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~  281 (419)
T KOG0663|consen  215 -------------ILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK  281 (419)
T ss_pred             -------------cEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC
Confidence                         6789999999887766   4556789999999999987 7999999999999999999999999999


Q ss_pred             ChHHHHHHHHHHhCCCChhHHHh----------------------------hhhhhhhhhccCCccCCCCCCCcHHHHHH
Q 015222          322 ENLEHLAMMERVLGPLPHHMVIR----------------------------ADRRAEKYFRRGARLDWPDGATSRDSMRA  373 (411)
Q Consensus       322 ~~~~~~~~i~~~~~~~p~~~~~~----------------------------~~~~~~~li~~~l~~~~~~rp~~R~t~~~  373 (411)
                      ++.+++.+|.+..+.....+++.                            +++..-++++.+|.+|    |.+|.|+.+
T Consensus       282 sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~d----P~kR~tA~~  357 (419)
T KOG0663|consen  282 SEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYD----PGKRITAED  357 (419)
T ss_pred             chHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccC----ccccccHHH
Confidence            99999999999888655544332                            3366778999999999    999999999


Q ss_pred             HHhcCCCCcccc
Q 015222          374 VWKLLRLPVIDL  385 (411)
Q Consensus       374 il~~~~~~~~~~  385 (411)
                      .|+|.||.+...
T Consensus       358 ~L~h~~F~e~P~  369 (419)
T KOG0663|consen  358 GLKHEYFRETPL  369 (419)
T ss_pred             hhcccccccCCC
Confidence            999999998554

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-49  Score=363.56  Aligned_cols=267  Identities=22%  Similarity=0.292  Sum_probs=226.5

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      .+.|++.+.||.|.-++||+|+...+++.||||++.-.+  ...+.+.+|+..++.++||||     +.++..|..+..+
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNI-----v~~~~sFvv~~~L   99 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNI-----VTYHCSFVVDSEL   99 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCc-----ceEEEEEEeccee
Confidence            357999999999999999999999999999999997433  345788999999999999988     9999999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      |+||.|| +|++.+++...-...++|..+..|++++++||.|||.+|-||||||+.||||+++|.+||+|||.+      
T Consensus       100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvs------  173 (516)
T KOG0582|consen  100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVS------  173 (516)
T ss_pred             EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceee------
Confidence            9999999 999999999776677999999999999999999999999999999999999999998888777753      


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCC--CCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                                  ..|.|-|.....  ...+++||+.|||||++...  .|+.|+||||||++..||.+|..||.......
T Consensus       174 ------------a~l~~~G~R~~~--rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk  239 (516)
T KOG0582|consen  174 ------------ASLFDSGDRQVT--RFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK  239 (516)
T ss_pred             ------------eeecccCceeeE--eeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH
Confidence                        344454411111  11567999999999996543  79999999999999999999999999887776


Q ss_pred             HHHHHHHHhC------CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          326 HLAMMERVLG------PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       326 ~~~~i~~~~~------~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                      .+..-.+...      .++.+.....+..++.++..||.+|    |++|||+.++++|+||+.....
T Consensus       240 vLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kD----P~kRptAskLlkh~FFk~~k~~  302 (516)
T KOG0582|consen  240 VLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKD----PSKRPTASKLLKHAFFKKAKSK  302 (516)
T ss_pred             HHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcC----cccCCCHHHHhccHHHhhccch
Confidence            6544333222      2345556677788999999999999    9999999999999999986643

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-49  Score=371.42  Aligned_cols=253  Identities=24%  Similarity=0.321  Sum_probs=220.3

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....    ...+.+.+|+.+++++.|+||     +++++++.+.+.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~~   75 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFI-----IRLFWTEHDQRF   75 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcH-----hhhHhhhccCCe
Confidence            36999999999999999999999999999999986432    234567889999999988877     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+||||+ +++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.+|               
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~---------------  138 (291)
T cd05612          76 LYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG---------------  138 (291)
T ss_pred             EEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC---------------
Confidence            99999999 999999998765  699999999999999999999999999999999999997766               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH  326 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~  326 (411)
                                  .++|+|||++...........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.
T Consensus       139 ------------~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~  206 (291)
T cd05612         139 ------------HIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI  206 (291)
T ss_pred             ------------CEEEEecCcchhccCCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                        67888888887665555556799999999999998999999999999999999999999998887777


Q ss_pred             HHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH-----HHHHHHhcCCCCccccc
Q 015222          327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-----SMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       327 ~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~-----t~~~il~~~~~~~~~~~  386 (411)
                      ...+......+|..    .+..++++|.+||..|    |.+|+     +++++++|+||..+++.
T Consensus       207 ~~~i~~~~~~~~~~----~~~~~~~li~~~l~~d----p~~R~~~~~~~~~~~l~h~~~~~~~~~  263 (291)
T cd05612         207 YEKILAGKLEFPRH----LDLYAKDLIKKLLVVD----RTRRLGNMKNGADDVKNHRWFKSVDWD  263 (291)
T ss_pred             HHHHHhCCcCCCcc----CCHHHHHHHHHHcCCC----HHHccCCccCCHHHHhcCccccCCCHH
Confidence            77776655455443    4678899999999999    77777     59999999999987654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8e-50  Score=368.90  Aligned_cols=255  Identities=30%  Similarity=0.434  Sum_probs=210.9

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC--eE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN--HI  168 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~--~~  168 (411)
                      .+|...+.||+|+||+||++.+..+|+..|||.+.... ...+.+.+|+.+|.+++|++|     |++++......  .+
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~I-----V~~~G~~~~~~~~~~   91 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNI-----VQYYGSSSSRENDEY   91 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCE-----EeeCCccccccCeee
Confidence            45888899999999999999999999999999986542 124568899999999998777     99999755444  69


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec-CcccccCCcccccccCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS-AEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~-~~~~~l~df~~~~~~~~  246 (411)
                      +++|||+ +|+|.+++.+.++ .+++..++.+++||++||.|||++|||||||||+|||++. ++               
T Consensus        92 ~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~---------------  155 (313)
T KOG0198|consen   92 NIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNG---------------  155 (313)
T ss_pred             EeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCC---------------
Confidence            9999999 9999999999876 7999999999999999999999999999999999999987 45               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccC------CCcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ------DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQ  319 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~  319 (411)
                                  .+||+|||.+.....      ......||+.|||||++.++ ...+++|||||||++.||+||+.||.
T Consensus       156 ------------~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~  223 (313)
T KOG0198|consen  156 ------------DVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWS  223 (313)
T ss_pred             ------------eEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcch
Confidence                        567777776654431      12346899999999999963 34469999999999999999999998


Q ss_pred             CC-ChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          320 TH-ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       320 ~~-~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      .. ...+.+..+.... ..| .+...+++.+++||.+|+..+    |..|||+.++|+|||+.+...
T Consensus       224 ~~~~~~~~~~~ig~~~-~~P-~ip~~ls~~a~~Fl~~C~~~~----p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  224 EFFEEAEALLLIGRED-SLP-EIPDSLSDEAKDFLRKCFKRD----PEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             hhcchHHHHHHHhccC-CCC-CCCcccCHHHHHHHHHHhhcC----cccCcCHHHHhhChhhhcccc
Confidence            73 3333333333222 233 555668899999999999999    999999999999999987554

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=9e-49  Score=380.03  Aligned_cols=285  Identities=22%  Similarity=0.304  Sum_probs=221.3

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++++.||+|+||+||+|+++.+++.||||++++..    .....+.+|+.++..+.|++|     +++++.+.+.+.
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~i-----v~~~~~~~~~~~   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWV-----VKMFYSFQDKLN   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCc-----ceEEEEEecCCe
Confidence            46999999999999999999999999999999997532    233567789999999988877     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+||||+ +++|.+++.+..  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++.....
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            99999999 999999998765  799999999999999999999999999999999999999999888888887664432


Q ss_pred             CCCccccCCCCCCeeEeecCCcccc------------cCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFE------------HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG  314 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg  314 (411)
                      ...... ..........|+......            .......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       154 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G  232 (363)
T cd05628         154 AHRTEF-YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG  232 (363)
T ss_pred             cccccc-cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence            111000 000000011121111100            0011235799999999999999999999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhC--CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccCC
Q 015222          315 EALFQTHENLEHLAMMERVLG--PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSA  388 (411)
Q Consensus       315 ~~pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~  388 (411)
                      +.||.+.+..+....+.....  .+|..  ..+++.++++|.+++. +|.+ +..||+++++++||||.++++...
T Consensus       233 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~--~~~s~~~~~li~~l~~-~~~~-r~~r~~~~ei~~hp~f~~~~~~~~  304 (363)
T cd05628         233 YPPFCSETPQETYKKVMNWKETLIFPPE--VPISEKAKDLILRFCC-EWEH-RIGAPGVEEIKTNPFFEGVDWEHI  304 (363)
T ss_pred             CCCCCCCCHHHHHHHHHcCcCcccCCCc--CCCCHHHHHHHHHHcC-Chhh-cCCCCCHHHHhCCCCCCCCCHHHH
Confidence            999998887777776665322  23332  2367789999998764 4444 445899999999999999877554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-50  Score=380.53  Aligned_cols=255  Identities=25%  Similarity=0.386  Sum_probs=224.4

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchh-hhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      ..+|...++||+|+.|.||.|+...+++.||||.+..... ..+-+.+|+.+|+..+|+||     |.+++.|-..+.+|
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~Ni-----Vnfl~Sylv~deLW  346 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNI-----VNFLDSYLVGDELW  346 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHH-----HHHHHHhcccceeE
Confidence            4579999999999999999999999999999999986543 34567899999999999988     99999998889999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +||||+ ||+|.|.+....   ++|.++..|++++++||+|||.+||+|||||.+|||++.+|                 
T Consensus       347 VVMEym~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g-----------------  406 (550)
T KOG0578|consen  347 VVMEYMEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDG-----------------  406 (550)
T ss_pred             EEEeecCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCC-----------------
Confidence            999999 999999998764   99999999999999999999999999999999999998887                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccC---CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                                .+||+|||++.....   ...+.+|||+|||||+.....|++++||||||++++||+.|++||-..+...
T Consensus       407 ----------~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr  476 (550)
T KOG0578|consen  407 ----------SVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR  476 (550)
T ss_pred             ----------cEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH
Confidence                      567777776655433   3466899999999999999999999999999999999999999998777766


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      .+..|.. .+.........++..+++||.+||..|    +.+|+++.++|+||||+....
T Consensus       477 AlyLIa~-ng~P~lk~~~klS~~~kdFL~~cL~~d----v~~RasA~eLL~HpFl~~a~p  531 (550)
T KOG0578|consen  477 ALYLIAT-NGTPKLKNPEKLSPELKDFLDRCLVVD----VEQRASAKELLEHPFLKMAKP  531 (550)
T ss_pred             HHHHHhh-cCCCCcCCccccCHHHHHHHHHHhhcc----hhcCCCHHHHhcChhhhhcCC
Confidence            6665544 456666667788999999999999999    999999999999999965443

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=9.7e-49  Score=374.76  Aligned_cols=253  Identities=25%  Similarity=0.348  Sum_probs=219.3

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++.+.||+|+||.||+|+++.+++.||+|+++...    ...+.+.+|+.+++++.|+||     +++++.+.+++.
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~~   92 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI-----VNMMCSFQDENR   92 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCC-----CcEEEEEEcCCE
Confidence            57999999999999999999999999999999997532    234567889999999988877     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+||||+ +++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.+|               
T Consensus        93 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~---------------  155 (329)
T PTZ00263         93 VYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG---------------  155 (329)
T ss_pred             EEEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCC---------------
Confidence            99999999 999999998765  689999999999999999999999999999999999997766               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH  326 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~  326 (411)
                                  .+||+|||++...........||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.
T Consensus       156 ------------~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  223 (329)
T PTZ00263        156 ------------HVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI  223 (329)
T ss_pred             ------------CEEEeeccCceEcCCCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH
Confidence                        67888888887665555556899999999999999999999999999999999999999988877776


Q ss_pred             HHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH-----HHHHHHhcCCCCccccc
Q 015222          327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-----SMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       327 ~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~-----t~~~il~~~~~~~~~~~  386 (411)
                      ...+......+|.    ..+..++++|.+||..|    |.+|+     +++++++||||.+.++.
T Consensus       224 ~~~i~~~~~~~p~----~~~~~~~~li~~~L~~d----P~~R~~~~~~~~~~ll~hp~f~~~~~~  280 (329)
T PTZ00263        224 YEKILAGRLKFPN----WFDGRARDLVKGLLQTD----HTKRLGTLKGGVADVKNHPYFHGANWD  280 (329)
T ss_pred             HHHHhcCCcCCCC----CCCHHHHHHHHHHhhcC----HHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence            6666654444443    35677899999999999    66665     48999999999986544

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-49  Score=365.04  Aligned_cols=254  Identities=22%  Similarity=0.314  Sum_probs=215.1

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---------------hhhHHHHHHHHHHHHHhcCCCCCc
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------------KYREAAMIEIDVLQRLARHDIGGT  153 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---------------~~~~~~~~E~~~l~~l~~~~i~~~  153 (411)
                      ...+.|++++.||+|.||.|-+|++..+++.||||++.+..               ...+...+|+.||+++.|+|+   
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV---  170 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV---  170 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe---
Confidence            44578999999999999999999999999999999996432               123578899999999999887   


Q ss_pred             ceEEEeeeeec--CCeEEEEEccC-CCCHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 015222          154 RCVQIRNWFDY--RNHICIVFEKL-GPSLYDFLRKNSYRS-FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS  229 (411)
Q Consensus       154 ~iv~~~~~~~~--~~~~~lv~e~~-~~~L~~~l~~~~~~~-l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~  229 (411)
                        |+++++..+  .+.+|||+||| .|.+...   ..... +++.+++.++++++.||+|||.+|||||||||+|+||++
T Consensus       171 --V~LiEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  171 --VKLIEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSS  245 (576)
T ss_pred             --eEEEEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcC
Confidence              999999987  46899999999 7765432   22223 899999999999999999999999999999999999998


Q ss_pred             CcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC--------CcccccCCCccccceecCCC----CCc
Q 015222          230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--------HSYVVSTRHYRAPEVILGLG----WNY  297 (411)
Q Consensus       230 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--------~~~~~gt~~y~aPE~~~~~~----~~~  297 (411)
                      +|                           ++||+|||.+......        ....+|||.|+|||.+.++.    .+.
T Consensus       246 ~g---------------------------~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~  298 (576)
T KOG0585|consen  246 DG---------------------------TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGF  298 (576)
T ss_pred             CC---------------------------cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccch
Confidence            88                           5666667766543211        12268999999999998742    358


Q ss_pred             cchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          298 PCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       298 ~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      +.||||+||+||.|+.|+.||-+....+...+|......+|..  +.+.+.++++|.+||.+|    |++|.++.+|..|
T Consensus       299 a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~--pe~~e~~kDli~~lL~Kd----P~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  299 ALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPEN--PEINEDLKDLIKRLLEKD----PEQRITLPDIKLH  372 (576)
T ss_pred             hhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCCCc--ccccHHHHHHHHHHhhcC----hhheeehhhheec
Confidence            9999999999999999999999999999999998877777664  356788999999999999    9999999999999


Q ss_pred             CCCCcc
Q 015222          378 LRLPVI  383 (411)
Q Consensus       378 ~~~~~~  383 (411)
                      ||...-
T Consensus       373 pwvt~~  378 (576)
T KOG0585|consen  373 PWVTRD  378 (576)
T ss_pred             ceeccC
Confidence            999864

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.1e-50  Score=342.93  Aligned_cols=252  Identities=24%  Similarity=0.374  Sum_probs=229.8

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      .++|++.+.||+|-||.||+|+.+.++..||+|++-++.    .....+.+|++|.+.|+||||     .+++++|.+..
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpni-----lrlY~~fhd~~   95 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNI-----LRLYGYFHDSK   95 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccH-----Hhhhhheeccc
Confidence            367999999999999999999999999999999997543    334667889999999988888     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      .+|+++||. .|+|+..|+......+++..+..++.|++.||.|+|.++||||||||+|+|++.+|              
T Consensus        96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~--------------  161 (281)
T KOG0580|consen   96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAG--------------  161 (281)
T ss_pred             eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCC--------------
Confidence            999999999 99999999976666899999999999999999999999999999999999998877              


Q ss_pred             CCCCccccCCCCCCeeEeecCCccccc-CCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEH-QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                                   .+||+|||.+.... ....+.+||..|.+||+..+..++..+|+|++|++.||++.|.+||...+..
T Consensus       162 -------------~lkiAdfGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~  228 (281)
T KOG0580|consen  162 -------------ELKIADFGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS  228 (281)
T ss_pred             -------------CeeccCCCceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH
Confidence                         67888999887764 4456789999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCc
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~  382 (411)
                      +.++.|.+....+|.    .++..+.++|.+|+.++    |..|.+..++++|||+..
T Consensus       229 etYkrI~k~~~~~p~----~is~~a~dlI~~ll~~~----p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  229 ETYKRIRKVDLKFPS----TISGGAADLISRLLVKN----PIERLALTEVMDHPWIVA  278 (281)
T ss_pred             HHHHHHHHccccCCc----ccChhHHHHHHHHhccC----ccccccHHHHhhhHHHHh
Confidence            999999999888884    46788999999999999    999999999999999864

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2e-48  Score=365.11  Aligned_cols=264  Identities=21%  Similarity=0.309  Sum_probs=216.1

Q ss_pred             eEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        94 y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      |++.+.||+|+||.||+|.+..+++.||+|++....    .....+.+|+.+++++.|+++     +.+++.+.+++..+
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i-----v~~~~~~~~~~~~~   76 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFV-----VSLAYAYETKDALC   76 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcE-----EEEEEEEccCCeEE
Confidence            889999999999999999999999999999986432    223456789999999988776     99999999999999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++                 
T Consensus        77 lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~-----------------  139 (285)
T cd05631          77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG-----------------  139 (285)
T ss_pred             EEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-----------------
Confidence            999999 89999888765445699999999999999999999999999999999999997665                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH  326 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~  326 (411)
                                .++|+|||++......  .....||..|+|||++.+..++.++|||||||++|||++|+.||.+.+....
T Consensus       140 ----------~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~  209 (285)
T cd05631         140 ----------HIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK  209 (285)
T ss_pred             ----------CEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh
Confidence                      5788888877654322  2335789999999999999999999999999999999999999987655433


Q ss_pred             HHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHH-----HHHHHhcCCCCcccccCCCCCch
Q 015222          327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS-----MRAVWKLLRLPVIDLYSASPNCL  393 (411)
Q Consensus       327 ~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t-----~~~il~~~~~~~~~~~~~~~~~~  393 (411)
                      ...+.......+..+....+..+.+++++||+.|    |.+|++     +.++++|+||.++++....-+.+
T Consensus       210 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~----P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~  277 (285)
T cd05631         210 REEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKN----PKERLGCRGNGAAGVKQHPIFKNINFKRLEANML  277 (285)
T ss_pred             HHHHHHHhhcccccCCccCCHHHHHHHHHHhhcC----HHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcC
Confidence            3333332222223334456788999999999999    666664     99999999999988766554433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-47  Score=353.17  Aligned_cols=308  Identities=32%  Similarity=0.571  Sum_probs=254.8

Q ss_pred             CCCCCCceEEeeCCccC-CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCC---C
Q 015222           75 PDDKDGHYVFAIGENLT-PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD---I  150 (411)
Q Consensus        75 ~~~~~~~~~~~~~~~~~-~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~---i  150 (411)
                      ....+|++++.+|+.|. +||.+.++||.|.|++||+|.|..+.+.||+|+.+....+.+....|+.+|++++...   .
T Consensus        60 dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~  139 (590)
T KOG1290|consen   60 DYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDP  139 (590)
T ss_pred             hhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCC
Confidence            34557899999999999 9999999999999999999999999999999999998889999999999999998654   3


Q ss_pred             CCcceEEEeeeeec----CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcE
Q 015222          151 GGTRCVQIRNWFDY----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENI  225 (411)
Q Consensus       151 ~~~~iv~~~~~~~~----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dikp~NI  225 (411)
                      +..+||++++.|..    +.|+|+|+|++|.+|..+|....++.++...++.|++||+.||.|||. .||||.||||+||
T Consensus       140 ~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENv  219 (590)
T KOG1290|consen  140 GKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENV  219 (590)
T ss_pred             CCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCccee
Confidence            34578999999986    459999999999999999999998999999999999999999999997 5999999999999


Q ss_pred             EEecCcc-c-c-----------c------------------------CCc------------------------------
Q 015222          226 LLVSAEY-V-K-----------V------------------------PDY------------------------------  238 (411)
Q Consensus       226 li~~~~~-~-~-----------l------------------------~df------------------------------  238 (411)
                      |+..... + +           +                        .++                              
T Consensus       220 Ll~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~  299 (590)
T KOG1290|consen  220 LLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPN  299 (590)
T ss_pred             eeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccc
Confidence            9954310 0 0           0                        000                              


Q ss_pred             ----------ccc----cccC----------CCC---C---------------------------ccc------------
Q 015222          239 ----------KFL----SRSS----------KDG---S---------------------------YFK------------  252 (411)
Q Consensus       239 ----------~~~----~~~~----------~~~---~---------------------------~~~------------  252 (411)
                                +..    ....          ..+   +                           ...            
T Consensus       300 ~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~  379 (590)
T KOG1290|consen  300 QESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPL  379 (590)
T ss_pred             ccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccc
Confidence                      000    0000          000   0                           000            


Q ss_pred             ------cCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCC-----
Q 015222          253 ------NLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH-----  321 (411)
Q Consensus       253 ------~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~-----  321 (411)
                            .-....++||+|||-|.+.....+.-+.|..|+|||++.|..|++.+||||++|++|||+||...|...     
T Consensus       380 v~p~~~~~~~di~vKIaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y  459 (590)
T KOG1290|consen  380 VNPDIPLPECDIRVKIADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENY  459 (590)
T ss_pred             cCCCCCCCccceeEEEeeccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCC
Confidence                  011235799999999999888888788999999999999999999999999999999999999999754     


Q ss_pred             -ChHHHHHHHHHHhCCCChhHHH--------------------------------------hhhhhhhhhhccCCccCCC
Q 015222          322 -ENLEHLAMMERVLGPLPHHMVI--------------------------------------RADRRAEKYFRRGARLDWP  362 (411)
Q Consensus       322 -~~~~~~~~i~~~~~~~p~~~~~--------------------------------------~~~~~~~~li~~~l~~~~~  362 (411)
                       .+.++++.|.+.++.+|..+..                                      .....+.+||.-||+.+  
T Consensus       460 ~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~--  537 (590)
T KOG1290|consen  460 SRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFD--  537 (590)
T ss_pred             CccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcC--
Confidence             3578999999999988876533                                      12356789999999999  


Q ss_pred             CCCCcHHHHHHHHhcCCCCccccc
Q 015222          363 DGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       363 ~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                        |.+|+|+.+.|+|||+..+...
T Consensus       538 --PeKR~tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  538 --PEKRPTAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             --ccccccHHHHhcCccccCCCCC
Confidence              9999999999999999977653

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.2e-47  Score=360.47  Aligned_cols=252  Identities=29%  Similarity=0.463  Sum_probs=212.1

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      ++|++.++||.|+||+||+|++..+++.||+|+++...  .....+.+|+.++++++|+|+     +++++++..++..+
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~   79 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI-----VTLHDIIHTERCLT   79 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCE-----eeEEEEEcCCCeEE
Confidence            57999999999999999999999999999999987432  234567789999999988877     99999999999999


Q ss_pred             EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      +||||+.++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++                  
T Consensus        80 lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~------------------  140 (288)
T cd07871          80 LVFEYLDSDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG------------------  140 (288)
T ss_pred             EEEeCCCcCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC------------------
Confidence            999999779999987654 3589999999999999999999999999999999999998766                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecC-CCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                               .+||+|||++......   .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+
T Consensus       141 ---------~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~  211 (288)
T cd07871         141 ---------ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE  211 (288)
T ss_pred             ---------CEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                     5677777766543221   223467999999999876 468999999999999999999999999988877


Q ss_pred             HHHHHHHHhCCCChhHHH--------------------------hhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCC
Q 015222          326 HLAMMERVLGPLPHHMVI--------------------------RADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR  379 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~--------------------------~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~  379 (411)
                      .+..+.+..+..+...++                          ..+..+.++|.+||..|    |.+|+|++|+++|||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d----p~~R~t~~~~l~hp~  287 (288)
T cd07871         212 ELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYE----TKSRISAEAALRHSY  287 (288)
T ss_pred             HHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcC----cccCCCHHHHhcCCC
Confidence            777776665544333221                          24567889999999999    999999999999999


Q ss_pred             C
Q 015222          380 L  380 (411)
Q Consensus       380 ~  380 (411)
                      |
T Consensus       288 f  288 (288)
T cd07871         288 F  288 (288)
T ss_pred             C
Confidence            7

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=6.4e-48  Score=370.35  Aligned_cols=259  Identities=24%  Similarity=0.363  Sum_probs=220.3

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCC-cEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKK-ELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~-~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .++|++.+.||+|+||.||+|.++.++ ..||+|++....    ...+.+.+|+.+++.++|+||     +++++++.++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~I-----v~~~~~~~~~  103 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFC-----VNLYGSFKDE  103 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCC-----cceEEEEEeC
Confidence            467999999999999999999876655 689999986432    334567789999999988877     9999999999


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      +.+|+||||+ +++|.+++.+..  .+++..+..++.||+.||.|||++||+||||||+|||++.+|             
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-------------  168 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG-------------  168 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-------------
Confidence            9999999999 999999998765  699999999999999999999999999999999999997766             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                                    .++|+|||++...........||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..
T Consensus       169 --------------~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~  234 (340)
T PTZ00426        169 --------------FIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL  234 (340)
T ss_pred             --------------CEEEecCCCCeecCCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH
Confidence                          678888888776655555668999999999999988999999999999999999999999988777


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCC-CcHHHHHHHHhcCCCCcccccC
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGA-TSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp-~~R~t~~~il~~~~~~~~~~~~  387 (411)
                      .....+......+|.    ..+..+.++|++||+.++.+|+ ..|++++++++||||.++++..
T Consensus       235 ~~~~~i~~~~~~~p~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~  294 (340)
T PTZ00426        235 LIYQKILEGIIYFPK----FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVS  294 (340)
T ss_pred             HHHHHHhcCCCCCCC----CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence            766666655444443    3567789999999999955553 2346999999999999887543

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-48  Score=369.88  Aligned_cols=256  Identities=25%  Similarity=0.368  Sum_probs=218.6

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++.+.||+|+||.||+|++..+++.||||+++...    .....+.+|+.++..+.|++|     +++++++...+.
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----v~~~~~~~~~~~   75 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWL-----VKLLYAFQDDEY   75 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCC-----ccEEEEEEcCCE
Confidence            46999999999999999999999999999999997532    234567789999999988877     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      .|+||||+ +++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++               
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~---------------  138 (333)
T cd05600          76 LYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG---------------  138 (333)
T ss_pred             EEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC---------------
Confidence            99999999 999999998765  689999999999999999999999999999999999997766               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH  326 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~  326 (411)
                                  .+||+|||++...........||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.
T Consensus       139 ------------~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~  206 (333)
T cd05600         139 ------------HIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET  206 (333)
T ss_pred             ------------CEEEEeCcCCcccccccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH
Confidence                        67888888887665545556899999999999999999999999999999999999999998877776


Q ss_pred             HHHHHHHhCCC--Ch--hHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          327 LAMMERVLGPL--PH--HMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       327 ~~~i~~~~~~~--p~--~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      ...+......+  |.  .....++..+.++|.+||..+    |.+|+++.++++|+||.++.+
T Consensus       207 ~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~----~~rr~s~~~ll~h~~~~~~~~  265 (333)
T cd05600         207 WENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDP----SRRFGSLEDIKNHPFFKEVDW  265 (333)
T ss_pred             HHHHHhccccccCCCCCccccccCHHHHHHHHHHhhCh----hhhcCCHHHHHhCcccCCCCH
Confidence            66655432211  11  111245778999999998876    999999999999999998754

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.8e-48  Score=352.03  Aligned_cols=260  Identities=29%  Similarity=0.469  Sum_probs=224.6

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchh---hhHHHHHHHHHHHHHhcCC-CCCcceEEEeeeeecCC-
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHD-IGGTRCVQIRNWFDYRN-  166 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~~~~-i~~~~iv~~~~~~~~~~-  166 (411)
                      ..|+.+++||+|+||+||+|+++.+|+.||+|.++....   ......+|+.+++.|+|+| |     +.+++++...+ 
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~i-----v~L~dv~~~~~~   85 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHI-----VRLHDVIHTSNN   85 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcce-----EEEEeeeeeccc
Confidence            458888999999999999999999999999999985443   4566789999999999987 5     99999998876 


Q ss_pred             -----eEEEEEccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcc
Q 015222          167 -----HICIVFEKLGPSLYDFLRKNSY--RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK  239 (411)
Q Consensus       167 -----~~~lv~e~~~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~  239 (411)
                           .+++||||+..+|.+++.....  ..++...++.++.||+.||+|||++||+||||||.||||+++|        
T Consensus        86 ~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G--------  157 (323)
T KOG0594|consen   86 HRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG--------  157 (323)
T ss_pred             ccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC--------
Confidence                 8999999999999999987653  3688899999999999999999999999999999999998877        


Q ss_pred             cccccCCCCCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCC
Q 015222          240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGE  315 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~  315 (411)
                                         .+||+|||+|+...-.   .+..++|..|+|||++.+. .|+..+||||+|||++||++++
T Consensus       158 -------------------~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~  218 (323)
T KOG0594|consen  158 -------------------VLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRR  218 (323)
T ss_pred             -------------------cEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCC
Confidence                               6788888888765422   2345789999999999998 7999999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChhHHHh--------------------------hhhhhhhhhccCCccCCCCCCCcHH
Q 015222          316 ALFQTHENLEHLAMMERVLGPLPHHMVIR--------------------------ADRRAEKYFRRGARLDWPDGATSRD  369 (411)
Q Consensus       316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~--------------------------~~~~~~~li~~~l~~~~~~rp~~R~  369 (411)
                      ..|.+.++.+++..|-+..+......++.                          .+....+++.+||..+    |.+|.
T Consensus       219 ~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~----p~~R~  294 (323)
T KOG0594|consen  219 PLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYD----PAKRI  294 (323)
T ss_pred             CCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccC----cccCc
Confidence            99999999999999998887654332221                          1237888999999999    99999


Q ss_pred             HHHHHHhcCCCCcccccC
Q 015222          370 SMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       370 t~~~il~~~~~~~~~~~~  387 (411)
                      +++.++.|+||.....+.
T Consensus       295 Sa~~al~h~yf~~~~~~~  312 (323)
T KOG0594|consen  295 SAKGALTHPYFSELPEKS  312 (323)
T ss_pred             CHHHHhcChhhcccccch
Confidence            999999999999876543

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-48  Score=374.18  Aligned_cols=283  Identities=23%  Similarity=0.337  Sum_probs=218.1

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++++.||+|+||+||+|++..+++.||||+++...    .....+.+|+.+++.++|++|     +++++++.++++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~i-----v~~~~~~~~~~~   75 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWV-----VKLYYSFQDENY   75 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCC-----cceEEEEEcCCe
Confidence            46999999999999999999999999999999997532    234556789999999988777     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+||||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++.....
T Consensus        76 ~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             EEEEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            99999999 999999998765  699999999999999999999999999999999999999999888888887654432


Q ss_pred             CCCc--cccCCCCCCeeEeecCCcccccC------------CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHH
Q 015222          247 DGSY--FKNLPKSSAIKLIDFGSTTFEHQ------------DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC  312 (411)
Q Consensus       247 ~~~~--~~~~~~~~~~kl~Dfg~a~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell  312 (411)
                      ....  +.........-..++........            .....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence            2110  00000000000011111110000            011247999999999999989999999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHH---HHHHHhcCCCCccccc
Q 015222          313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS---MRAVWKLLRLPVIDLY  386 (411)
Q Consensus       313 tg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t---~~~il~~~~~~~~~~~  386 (411)
                      +|..||.+.+..+....+......++......+++.+.++|.+|+. +    |.+|++   +.++++|+||.++++.
T Consensus       234 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~----p~~R~~~~~~~~ll~h~~~~~~~~~  305 (364)
T cd05599         234 VGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-E----AERRLGNNGVNEIKSHPFFKGVDWE  305 (364)
T ss_pred             cCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-C----HhhcCCCCCHHHHhcCCCcCCCCHH
Confidence            9999999888776666555433222211112457789999999985 7    666665   9999999999987653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.1e-49  Score=343.58  Aligned_cols=259  Identities=25%  Similarity=0.377  Sum_probs=229.9

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---------hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeee
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW  161 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---------~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~  161 (411)
                      -.+|.-.+.||.|..++|-++.++.+|..+|+|++...         ....+....|+.||+++.    +||+|+.+.++
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~----GHP~II~l~D~   91 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVM----GHPYIIDLQDV   91 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhc----CCCcEEEeeee
Confidence            35788889999999999999999999999999999521         123455678999999985    45666999999


Q ss_pred             eecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                      |+....+++|+|.| .|.|+|+|...-  .+++...++|++|++.|++|||.++||||||||+|||++++.         
T Consensus        92 yes~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~---------  160 (411)
T KOG0599|consen   92 YESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNM---------  160 (411)
T ss_pred             ccCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecccc---------
Confidence            99999999999999 999999999876  799999999999999999999999999999999999986654         


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecC------CCCCccchhHHHHHHHHHHH
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILG------LGWNYPCDLWSVGCILVELC  312 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlGvil~ell  312 (411)
                                        +++|+|||+|.......  ...+|||.|+|||.+..      ..|+..+|+||+|||+|.|+
T Consensus       161 ------------------~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLL  222 (411)
T KOG0599|consen  161 ------------------NIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLL  222 (411)
T ss_pred             ------------------ceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHH
Confidence                              78889999888765544  45799999999999863      26899999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       313 tg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                      .|.+||-.....-.+..|..+...+....|.+++..++++|.++|+.|    |++|.|++|+|+||||..+...
T Consensus       223 aGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVd----p~~Ritake~LaHpff~q~~~~  292 (411)
T KOG0599|consen  223 AGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVD----PTKRITAKEALAHPFFIQIAQQ  292 (411)
T ss_pred             cCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeC----chhcccHHHHhcChHHHHHHHh
Confidence            999999888888888999999999999999999999999999999999    9999999999999999665543

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.3e-47  Score=360.03  Aligned_cols=257  Identities=27%  Similarity=0.413  Sum_probs=208.4

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      ++|++.++||+|+||.||+|+++.+++.||||+++...  .....+.+|+.+++.+.|+|+     +++++++.+.+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~   79 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI-----VLLHDIIHTKETLT   79 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCc-----CeEEEEEecCCeEE
Confidence            67999999999999999999999999999999987432  223456789999999988887     99999999999999


Q ss_pred             EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      +||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|                  
T Consensus        80 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~------------------  140 (303)
T cd07869          80 LVFEYVHTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG------------------  140 (303)
T ss_pred             EEEECCCcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC------------------
Confidence            999999889999887654 3689999999999999999999999999999999999998766                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCh-H
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHEN-L  324 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~-~  324 (411)
                               .+||+|||++......   .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+..+ .
T Consensus       141 ---------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  211 (303)
T cd07869         141 ---------ELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ  211 (303)
T ss_pred             ---------CEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH
Confidence                     5677777766543221   2234689999999998764 688999999999999999999999987544 3


Q ss_pred             HHHHHHHHHhCCCChh-----------------------HHH-----hhhhhhhhhhccCCccCCCCCCCcHHHHHHHHh
Q 015222          325 EHLAMMERVLGPLPHH-----------------------MVI-----RADRRAEKYFRRGARLDWPDGATSRDSMRAVWK  376 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~-----------------------~~~-----~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~  376 (411)
                      +.+..+....+.....                       +..     ..+..+.+++.+||+.|    |.+|+|++++++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d----p~~R~s~~~~l~  287 (303)
T cd07869         212 DQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCF----PKNRLSAQAALS  287 (303)
T ss_pred             HHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccC----chhccCHHHHhc
Confidence            3444443332221110                       000     12356889999999999    999999999999


Q ss_pred             cCCCCcccc
Q 015222          377 LLRLPVIDL  385 (411)
Q Consensus       377 ~~~~~~~~~  385 (411)
                      |+||.++.+
T Consensus       288 h~~f~~~~~  296 (303)
T cd07869         288 HEYFSDLPP  296 (303)
T ss_pred             CcccccCCh
Confidence            999998764

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.6e-47  Score=356.73  Aligned_cols=252  Identities=30%  Similarity=0.570  Sum_probs=210.6

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      ++|++.+.||+|+||.||+|+++.+++.||+|+++...   ...+.+.+|+.+++.++|+|+     +++++++..++..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~   75 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI-----VELKEAFRRRGKL   75 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccc-----cchhhhEecCCEE
Confidence            47999999999999999999999999999999997532   334567789999999998887     9999999999999


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      ++||||+.+++.+.+.... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++                 
T Consensus        76 ~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~-----------------  137 (287)
T cd07848          76 YLVFEYVEKNMLELLEEMP-NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND-----------------  137 (287)
T ss_pred             EEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-----------------
Confidence            9999999445545554432 3699999999999999999999999999999999999997766                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCC----CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                                .+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..
T Consensus       138 ----------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~  207 (287)
T cd07848         138 ----------VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI  207 (287)
T ss_pred             ----------cEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHH
Confidence                      5677777777654321    12346899999999999989999999999999999999999999988777


Q ss_pred             HHHHHHHHHhCCCChhHH----------------------------HhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHh
Q 015222          325 EHLAMMERVLGPLPHHMV----------------------------IRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK  376 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~----------------------------~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~  376 (411)
                      +.+..+....++.|....                            ...+..+.+++.+||+.|    |++|+|++++++
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~----P~~R~s~~~~l~  283 (287)
T cd07848         208 DQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLN----PTDRYLTEQCLN  283 (287)
T ss_pred             HHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCC----cccCCCHHHHhc
Confidence            776666666555443221                            124667899999999999    999999999999


Q ss_pred             cCCC
Q 015222          377 LLRL  380 (411)
Q Consensus       377 ~~~~  380 (411)
                      ||||
T Consensus       284 hp~f  287 (287)
T cd07848         284 HPAF  287 (287)
T ss_pred             CCCC
Confidence            9997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-48  Score=357.13  Aligned_cols=250  Identities=27%  Similarity=0.443  Sum_probs=225.4

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      ++..+|++.+.||+|.||.|-+|.+...|+.||||.++++.    ...-.+.+|++|++.|+||+|     +.++++|+.
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhI-----I~IyEVFEN  124 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHI-----IQIYEVFEN  124 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCce-----eehhhhhcC
Confidence            45678999999999999999999999999999999998643    334456789999999999988     999999999


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                      .+.+.|||||. +|.|+||+...+  .|++.+++.+++||.+|+.|+|.++++|||||.+|||++.++            
T Consensus       125 kdKIvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~------------  190 (668)
T KOG0611|consen  125 KDKIVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNN------------  190 (668)
T ss_pred             CceEEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCC------------
Confidence            99999999999 999999999887  799999999999999999999999999999999999987665            


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCC-CccchhHHHHHHHHHHHhCCCCCCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQT  320 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~pf~~  320 (411)
                                     ++||+|||++.......  .+++|++.|.+||++.|.+| ++.+|-|||||+||.|+.|..||.+
T Consensus       191 ---------------NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG  255 (668)
T KOG0611|consen  191 ---------------NIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG  255 (668)
T ss_pred             ---------------CeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC
Confidence                           78999999988765543  67899999999999999987 5999999999999999999999999


Q ss_pred             CChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCC
Q 015222          321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP  381 (411)
Q Consensus       321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~  381 (411)
                      .+....+..|.++...-|..     +..+..+|+-||..+    |+.|.|+.+|-.|-|+.
T Consensus       256 ~Dhk~lvrQIs~GaYrEP~~-----PSdA~gLIRwmLmVN----P~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  256 RDHKRLVRQISRGAYREPET-----PSDASGLIRWMLMVN----PERRATIEDIASHWWVN  307 (668)
T ss_pred             chHHHHHHHhhcccccCCCC-----CchHHHHHHHHHhcC----cccchhHHHHhhhheee
Confidence            99999999888876655543     456889999999999    99999999999999974

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.1e-47  Score=366.46  Aligned_cols=249  Identities=21%  Similarity=0.349  Sum_probs=210.8

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEc
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE  173 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e  173 (411)
                      +.||+|+||.||+|.++.+|+.||||+++...    .....+.+|+.+++++.|+++     +++++.+...+.+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i-----~~~~~~~~~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFL-----TALKYSFQTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCC-----CCEEEEEEcCCEEEEEEe
Confidence            46899999999999999999999999997532    233456789999999988887     999999999999999999


Q ss_pred             cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccc
Q 015222          174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK  252 (411)
Q Consensus       174 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~  252 (411)
                      |+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++                     
T Consensus        76 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~---------------------  132 (323)
T cd05571          76 YANGGELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG---------------------  132 (323)
T ss_pred             CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC---------------------
Confidence            99 999999998765  799999999999999999999999999999999999997766                     


Q ss_pred             cCCCCCCeeEeecCCccccc---CCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015222          253 NLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM  329 (411)
Q Consensus       253 ~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~  329 (411)
                            .+||+|||++....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......
T Consensus       133 ------~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~  206 (323)
T cd05571         133 ------HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL  206 (323)
T ss_pred             ------CEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHH
Confidence                  57777787765422   122345799999999999999999999999999999999999999988777666666


Q ss_pred             HHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH-----HHHHHHhcCCCCcccccCC
Q 015222          330 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-----SMRAVWKLLRLPVIDLYSA  388 (411)
Q Consensus       330 i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~-----t~~~il~~~~~~~~~~~~~  388 (411)
                      +......+|.    .++..+.++|.+||..|    |.+|+     ++.++++|+||.++++...
T Consensus       207 ~~~~~~~~p~----~~~~~~~~li~~~L~~d----P~~R~~~~~~~~~~ll~h~~f~~~~~~~~  262 (323)
T cd05571         207 ILMEEIRFPR----TLSPEAKSLLAGLLKKD----PKQRLGGGPEDAKEIMEHRFFASINWQDV  262 (323)
T ss_pred             HHcCCCCCCC----CCCHHHHHHHHHHccCC----HHHcCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence            5544444443    45778999999999999    77777     8999999999998765433

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5e-47  Score=364.07  Aligned_cols=261  Identities=28%  Similarity=0.455  Sum_probs=211.6

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC----
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR----  165 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~----  165 (411)
                      +|++.+.||+|+||.||+|++..+++.||||+++..   ......+.+|+.+++.++|+|+     +++++++...    
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~~~~~   75 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI-----VEIKHIMLPPSRRE   75 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCE-----eeecceEeccCCCC
Confidence            699999999999999999999999999999998642   2233457789999999988877     9988877532    


Q ss_pred             -CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 -NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 -~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                       ..+|+||||++++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++             
T Consensus        76 ~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-------------  140 (338)
T cd07859          76 FKDIYVVFELMESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC-------------  140 (338)
T ss_pred             CceEEEEEecCCCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-------------
Confidence             3589999999889999988765  699999999999999999999999999999999999998776             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCC------CcccccCCCccccceecC--CCCCccchhHHHHHHHHHHHhCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSGEA  316 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~  316 (411)
                                    .+||+|||++......      .....||+.|+|||++.+  ..++.++|||||||++|||++|+.
T Consensus       141 --------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~  206 (338)
T cd07859         141 --------------KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP  206 (338)
T ss_pred             --------------cEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCC
Confidence                          5666666666532211      123478999999999876  578999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChhHH---------------------------HhhhhhhhhhhccCCccCCCCCCCcHH
Q 015222          317 LFQTHENLEHLAMMERVLGPLPHHMV---------------------------IRADRRAEKYFRRGARLDWPDGATSRD  369 (411)
Q Consensus       317 pf~~~~~~~~~~~i~~~~~~~p~~~~---------------------------~~~~~~~~~li~~~l~~~~~~rp~~R~  369 (411)
                      ||.+.+....+..+....+..+....                           +..+..+.+++.+||+.+    |++||
T Consensus       207 pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----P~~Rp  282 (338)
T cd07859         207 LFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFD----PKDRP  282 (338)
T ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcC----cccCC
Confidence            99887766655555444443332211                           124556789999999998    99999


Q ss_pred             HHHHHHhcCCCCcccccCCCCC
Q 015222          370 SMRAVWKLLRLPVIDLYSASPN  391 (411)
Q Consensus       370 t~~~il~~~~~~~~~~~~~~~~  391 (411)
                      ++.++++||||.++......+.
T Consensus       283 t~~e~l~hp~f~~~~~~~~~~~  304 (338)
T cd07859         283 TAEEALADPYFKGLAKVEREPS  304 (338)
T ss_pred             CHHHHhcCchhhhcCccccccc
Confidence            9999999999998877655444

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.6e-47  Score=373.63  Aligned_cols=286  Identities=21%  Similarity=0.321  Sum_probs=218.0

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      .|++++.||+|+||+||+|++..+++.||||++....    .....+.+|+.+++.+.|++|     +++++.+.+.+++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~i-----v~l~~~~~~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWV-----VKLYYSFQDKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCe-----eeeEEEEecCCEE
Confidence            5899999999999999999999999999999997532    234567889999999988777     9999999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      |+||||+ +++|.+++.+..  .+++..++.++.||+.||+|||++||+||||||+||||+.+|.++|+|||++......
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             EEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            9999999 999999998765  6999999999999999999999999999999999999999999999999976533211


Q ss_pred             CC--cccc------CCCCC-----CeeEeecCCc-------cc-c--cCCCcccccCCCccccceecCCCCCccchhHHH
Q 015222          248 GS--YFKN------LPKSS-----AIKLIDFGST-------TF-E--HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSV  304 (411)
Q Consensus       248 ~~--~~~~------~~~~~-----~~kl~Dfg~a-------~~-~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  304 (411)
                      ..  .+..      .....     ....+.++..       .. .  .......+||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence            00  0000      00000     0000111100       00 0  001123579999999999999899999999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          305 GCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       305 Gvil~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      ||++|||++|..||...+..+....+..............++..+.++|.+++..  ..++..|+++.++++|+||.+++
T Consensus       235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~--~~~~~~R~~~~~~l~hp~f~~~~  312 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCS--AEERLGRNGADDIKAHPFFSEVD  312 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccC--cccccCCCCHHHHhcCcccCCCC
Confidence            9999999999999988776665555443222222112234678899999997643  34467799999999999999877


Q ss_pred             ccC
Q 015222          385 LYS  387 (411)
Q Consensus       385 ~~~  387 (411)
                      +..
T Consensus       313 ~~~  315 (381)
T cd05626         313 FSS  315 (381)
T ss_pred             hhH
Confidence            644

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.4e-47  Score=366.86  Aligned_cols=252  Identities=23%  Similarity=0.359  Sum_probs=202.4

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      ++|+++++||+|+||.||+|++..+++.||||++...  ......+.+|+.+++.++|+||     +++++++...+.++
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~  148 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNV-----VKCHDMFDHNGEIQ  148 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCc-----ceeeeEeccCCeEE
Confidence            4688899999999999999999999999999998643  2345678899999999988877     99999999999999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +||||+ +++|.+.      ...++..+..++.||+.||+|||++||+||||||+|||++.++                 
T Consensus       149 lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-----------------  205 (353)
T PLN00034        149 VLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK-----------------  205 (353)
T ss_pred             EEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-----------------
Confidence            999999 8888642      2467788899999999999999999999999999999998766                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecC-----CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSGEALFQT  320 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltg~~pf~~  320 (411)
                                .+||+|||++......   .....||..|+|||++..     ...+.++|||||||++|||++|+.||..
T Consensus       206 ----------~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~  275 (353)
T PLN00034        206 ----------NVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV  275 (353)
T ss_pred             ----------CEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence                      5677777776654322   233578999999999853     2345789999999999999999999975


Q ss_pred             CChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      ....+....+.......+.......+..+.++|.+||..+    |++||++.++++|+||.....
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~----P~~Rpt~~ell~hp~~~~~~~  336 (353)
T PLN00034        276 GRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQRE----PAKRWSAMQLLQHPFILRAQP  336 (353)
T ss_pred             CCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCC----hhhCcCHHHHhcCcccccCCc
Confidence            4333332222222222222233456778999999999988    999999999999999998643

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-47  Score=372.67  Aligned_cols=283  Identities=22%  Similarity=0.325  Sum_probs=216.1

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|+++++||+|+||.||+|.++.+++.||||++.+..    ...+.+.+|+.+++.+.|++|     +++++++.+.++
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i-----v~~~~~~~~~~~   75 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWV-----VSLYYSFQDAQY   75 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEEcCCe
Confidence            46999999999999999999999999999999986532    234567789999999888777     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+||||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             eEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            99999999 999999998754  699999999999999999999999999999999999999999999999988753322


Q ss_pred             CCC--ccccC----------CCCCCe-------------eEeecCCcccccCCCcccccCCCccccceecCCCCCccchh
Q 015222          247 DGS--YFKNL----------PKSSAI-------------KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDL  301 (411)
Q Consensus       247 ~~~--~~~~~----------~~~~~~-------------kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  301 (411)
                      ...  .+...          +....+             ++.+++.+...  .....+||+.|+|||++.+..++.++||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di  231 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRL--MAYSTVGTPDYIAPEIFLQQGYGQECDW  231 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc--cccccCCCccccCHHHHccCCCCCceee
Confidence            110  00000          000000             01111110000  0112479999999999999899999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCC
Q 015222          302 WSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP  381 (411)
Q Consensus       302 wSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~  381 (411)
                      |||||++|||++|..||.+.+..+.+..+......+.......++..++++|.+||. ++.+|+ .|+++.++++|+||.
T Consensus       232 wSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~-~r~~~~~~l~hp~~~  309 (377)
T cd05629         232 WSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRL-GRGGAHEIKSHPFFR  309 (377)
T ss_pred             EecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcC-CCCCHHHHhcCCCcC
Confidence            999999999999999998877766666555432222111112456789999999996 633332 257999999999999


Q ss_pred             cccc
Q 015222          382 VIDL  385 (411)
Q Consensus       382 ~~~~  385 (411)
                      ++++
T Consensus       310 ~~~~  313 (377)
T cd05629         310 GVDW  313 (377)
T ss_pred             CCCH
Confidence            8764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.6e-48  Score=351.04  Aligned_cols=256  Identities=26%  Similarity=0.453  Sum_probs=221.2

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC--C---e
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--N---H  167 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~--~---~  167 (411)
                      .|.-.+.+|.|+||.||+|....+++.||||.+-.+...   -.+|+++|+.+.|+||     |++.-+|...  .   +
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---knrEl~im~~l~HpNI-----V~L~~~f~~~~~~d~~~   96 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---KNRELQIMRKLDHPNI-----VRLLYFFSSSTESDEVY   96 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---CcHHHHHHHhcCCcCe-----eeEEEEEEecCCCchhH
Confidence            688999999999999999999999999999998655443   3459999999988888     9988877542  2   5


Q ss_pred             EEEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          168 ICIVFEKLGPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       168 ~~lv~e~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      ..+||||+..+|.++++..  .+..++.-.++-++.||++||.|||+.||+||||||.|||+|.+               
T Consensus        97 lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~---------------  161 (364)
T KOG0658|consen   97 LNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPD---------------  161 (364)
T ss_pred             HHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCC---------------
Confidence            6799999999999999842  23479999999999999999999999999999999999999864               


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHE  322 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~  322 (411)
                                 ...+||||||+|+.....  ..+...|..|+|||.+.|. .|+.+.||||.||++.||+-|++.|.|.+
T Consensus       162 -----------tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s  230 (364)
T KOG0658|consen  162 -----------TGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS  230 (364)
T ss_pred             -----------CCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC
Confidence                       347899999999876443  3456789999999999987 79999999999999999999999999999


Q ss_pred             hHHHHHHHHHHhCCCChhH-------------------------HHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          323 NLEHLAMMERVLGPLPHHM-------------------------VIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       323 ~~~~~~~i~~~~~~~p~~~-------------------------~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ..+++..|.++.|.+..+.                         ....+.++.+|+.++|..+    |.+|.++.+++.|
T Consensus       231 ~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~----P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  231 SVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYS----PSKRLSALEALAH  306 (364)
T ss_pred             HHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccC----hhhcCCHHHHhcc
Confidence            9999999999988755433                         2235678889999999999    9999999999999


Q ss_pred             CCCCccccc
Q 015222          378 LRLPVIDLY  386 (411)
Q Consensus       378 ~~~~~~~~~  386 (411)
                      ++|......
T Consensus       307 ~fFdelr~~  315 (364)
T KOG0658|consen  307 PFFDELRDP  315 (364)
T ss_pred             hhhHHhhCc
Confidence            999987655

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.9e-47  Score=372.01  Aligned_cols=282  Identities=24%  Similarity=0.347  Sum_probs=216.8

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      +|+++++||+|+||+||+|++..+++.||+|++.+..    .....+.+|+.+++++.|++|     +++++.+.+.+.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~i-----v~~~~~~~~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWV-----VRLYYSFQDKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcC-----CeEEEEEEeCCEE
Confidence            6999999999999999999999999999999997532    234567889999999988877     9999999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      |+||||+ +++|.+++.+..  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++......
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             EEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            9999999 999999998764  6899999999999999999999999999999999999999999999999986533211


Q ss_pred             C--CccccCCCCCCeeEeecCC---------------------ccc-ccCCCcccccCCCccccceecCCCCCccchhHH
Q 015222          248 G--SYFKNLPKSSAIKLIDFGS---------------------TTF-EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWS  303 (411)
Q Consensus       248 ~--~~~~~~~~~~~~kl~Dfg~---------------------a~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  303 (411)
                      .  ..+.. .........+|..                     +.. ........+||+.|+|||++.+..++.++||||
T Consensus       155 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS  233 (382)
T cd05625         155 HDSKYYQS-GDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS  233 (382)
T ss_pred             cccccccc-ccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence            0  00000 0000000001100                     000 000112357999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHH---HHHHHhcCCC
Q 015222          304 VGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS---MRAVWKLLRL  380 (411)
Q Consensus       304 lGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t---~~~il~~~~~  380 (411)
                      |||++|||++|+.||.+.+..+....+.......+......+++.+.++|.+++ .+    |.+|++   +.++++|+||
T Consensus       234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~----p~~R~~~~~~~ei~~hp~f  308 (382)
T cd05625         234 VGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RG----PEDRLGKNGADEIKAHPFF  308 (382)
T ss_pred             chHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cC----HhHcCCCCCHHHHhcCCCc
Confidence            999999999999999988776666555543322222222456788899998875 46    666655   9999999999


Q ss_pred             CcccccC
Q 015222          381 PVIDLYS  387 (411)
Q Consensus       381 ~~~~~~~  387 (411)
                      ..+++..
T Consensus       309 ~~~~~~~  315 (382)
T cd05625         309 KTIDFSS  315 (382)
T ss_pred             CCcChHH
Confidence            9876543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.5e-47  Score=373.21  Aligned_cols=283  Identities=23%  Similarity=0.321  Sum_probs=216.6

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++++.||+|+||.||+|++..+++.||||++.+..    .....+.+|+.+++.+.|++|     +++++.+.+++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~i-----v~~~~~~~~~~~   75 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWV-----VKLYYSFQDKDN   75 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCc-----ceEEEEEEcCCE
Confidence            36999999999999999999999999999999996432    234567789999999988877     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+||||+ +++|.+++.+..  .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus        76 ~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          76 LYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            99999999 999999998765  689999999999999999999999999999999999999999888888887643321


Q ss_pred             C--CCccccCCCCCCeeEeecCCc-------c-----------cccCCCcccccCCCccccceecCCCCCccchhHHHHH
Q 015222          247 D--GSYFKNLPKSSAIKLIDFGST-------T-----------FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC  306 (411)
Q Consensus       247 ~--~~~~~~~~~~~~~kl~Dfg~a-------~-----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  306 (411)
                      .  ...+... ........+....       .           .........+||+.|+|||++.+..++.++|||||||
T Consensus       154 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  232 (376)
T cd05598         154 THDSKYYQKG-DHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  232 (376)
T ss_pred             cccccccccc-cccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccc
Confidence            1  0000000 0000000000000       0           0000112357999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH---HHHHHHhcCCCCcc
Q 015222          307 ILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD---SMRAVWKLLRLPVI  383 (411)
Q Consensus       307 il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~---t~~~il~~~~~~~~  383 (411)
                      ++|||++|+.||.+.+..+....+.......+......++..+.++|.+|+ .+    |.+|+   ++.++++|+||..+
T Consensus       233 ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~----p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         233 ILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CG----AEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             eeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cC----HhhcCCCCCHHHHhCCCCcCCC
Confidence            999999999999988776665555433222222222346778889998865 46    88888   99999999999987


Q ss_pred             cccC
Q 015222          384 DLYS  387 (411)
Q Consensus       384 ~~~~  387 (411)
                      ++..
T Consensus       308 ~~~~  311 (376)
T cd05598         308 DFAS  311 (376)
T ss_pred             CHHH
Confidence            6433

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-47  Score=368.97  Aligned_cols=281  Identities=23%  Similarity=0.327  Sum_probs=217.8

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++.+.||+|+||+||+|++..+++.||||+++...    .....+..|+.++..+.|+++     +++++.+.++++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWI-----VKLYYSFQDEEH   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCc-----cchhhheecCCe
Confidence            47999999999999999999999999999999997532    334567889999999988777     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+||||+ +++|.+++.+..  .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             EEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            99999999 999999998764  799999999999999999999999999999999999999988777777776544332


Q ss_pred             CCCccccCCCCCC-eeEeecC----CcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          247 DGSYFKNLPKSSA-IKLIDFG----STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       247 ~~~~~~~~~~~~~-~kl~Dfg----~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                      ............. .......    .............||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            2100000000000 0000000    0000001122357899999999999999999999999999999999999999988


Q ss_pred             ChHHHHHHHHHHhC--CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHH-HHHHHhcCCCCccccc
Q 015222          322 ENLEHLAMMERVLG--PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS-MRAVWKLLRLPVIDLY  386 (411)
Q Consensus       322 ~~~~~~~~i~~~~~--~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t-~~~il~~~~~~~~~~~  386 (411)
                      +..+....+.....  .+|..  ..++..+.++|.+||. +    |.+|++ +.++++||||.++++.
T Consensus       234 ~~~~~~~~i~~~~~~~~~p~~--~~~~~~~~~li~~ll~-d----p~~R~~s~~~ll~hp~~~~~~~~  294 (350)
T cd05573         234 TLQETYNKIINWKESLRFPPD--PPVSPEAIDLICRLLC-D----PEDRLGSFEEIKSHPFFKGIDWE  294 (350)
T ss_pred             CHHHHHHHHhccCCcccCCCC--CCCCHHHHHHHHHHcc-C----hhhcCCCHHHHhcCCCcCCCCHH
Confidence            87666666655222  22222  2367889999999986 7    999999 9999999999987664

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.7e-47  Score=368.32  Aligned_cols=257  Identities=23%  Similarity=0.394  Sum_probs=210.4

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      .++|++++.||+|+||.||+|.+..+++.||+|....     ..+.+|+.++++++|+||     ++++++|...+..++
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~HpnI-----v~~~~~~~~~~~~~l  160 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAINHPSI-----IQLKGTFTYNKFTCL  160 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCCCCCC-----CCEeEEEEECCeeEE
Confidence            4689999999999999999999999999999997542     346789999999998887     999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       171 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      |||+++++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++                   
T Consensus       161 v~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~-------------------  219 (391)
T PHA03212        161 ILPRYKTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG-------------------  219 (391)
T ss_pred             EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCC-------------------
Confidence            99999889999987764  689999999999999999999999999999999999997766                   


Q ss_pred             cccCCCCCCeeEeecCCcccccC----CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCC----
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQ----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE----  322 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~----  322 (411)
                              .++|+|||++.....    ......||+.|+|||++.+..++.++|||||||++|||++|..||...+    
T Consensus       220 --------~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~  291 (391)
T PHA03212        220 --------DVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDG  291 (391)
T ss_pred             --------CEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccc
Confidence                    578888887754221    1223579999999999999899999999999999999999998874322    


Q ss_pred             ---hHHHHHHHHHHhCCCChhH-------------------------------HHhhhhhhhhhhccCCccCCCCCCCcH
Q 015222          323 ---NLEHLAMMERVLGPLPHHM-------------------------------VIRADRRAEKYFRRGARLDWPDGATSR  368 (411)
Q Consensus       323 ---~~~~~~~i~~~~~~~p~~~-------------------------------~~~~~~~~~~li~~~l~~~~~~rp~~R  368 (411)
                         ....+..+....+..|..+                               ....+..+.++|.+||..|    |.+|
T Consensus       292 ~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~d----P~~R  367 (391)
T PHA03212        292 DCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFD----AHHR  367 (391)
T ss_pred             cCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCC----hhhC
Confidence               2233333333333222111                               1124557889999999999    9999


Q ss_pred             HHHHHHHhcCCCCcccccCCCC
Q 015222          369 DSMRAVWKLLRLPVIDLYSASP  390 (411)
Q Consensus       369 ~t~~~il~~~~~~~~~~~~~~~  390 (411)
                      ||++|+++|+||.++.....+|
T Consensus       368 pta~elL~hp~f~~~~~~~~~~  389 (391)
T PHA03212        368 PSAEALLDFAAFQDIPDPYPNP  389 (391)
T ss_pred             CCHHHHhcChhhccCCCCCCCC
Confidence            9999999999999876654443

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.8e-46  Score=361.14  Aligned_cols=262  Identities=27%  Similarity=0.453  Sum_probs=211.8

Q ss_pred             ceEEeeCC---ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcc
Q 015222           81 HYVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR  154 (411)
Q Consensus        81 ~~~~~~~~---~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~  154 (411)
                      .|.+..++   .+.++|++.+.||+|+||.||+|.+..+++.||||++...   ......+.+|+.+++.++|+||    
T Consensus         7 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni----   82 (359)
T cd07876           7 FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI----   82 (359)
T ss_pred             cceecccchhhhhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCE----
Confidence            45555555   4568999999999999999999999999999999998643   2344567789999999988877    


Q ss_pred             eEEEeeeeecC------CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015222          155 CVQIRNWFDYR------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV  228 (411)
Q Consensus       155 iv~~~~~~~~~------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~  228 (411)
                       +++++++...      ..+|+||||++++|.+.+..    .+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus        83 -v~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~  157 (359)
T cd07876          83 -ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK  157 (359)
T ss_pred             -eeeeeeeccCCCccccceeEEEEeCCCcCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC
Confidence             9999988643      35799999998888887753    488999999999999999999999999999999999998


Q ss_pred             cCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHH
Q 015222          229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC  306 (411)
Q Consensus       229 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  306 (411)
                      .+|                           .+||+|||++......  .....||+.|+|||++.+..++.++|||||||
T Consensus       158 ~~~---------------------------~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~  210 (359)
T cd07876         158 SDC---------------------------TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC  210 (359)
T ss_pred             CCC---------------------------CEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHH
Confidence            766                           5677777777643222  23357899999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHH--------------------------------------Hhhhhh
Q 015222          307 ILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMV--------------------------------------IRADRR  348 (411)
Q Consensus       307 il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~--------------------------------------~~~~~~  348 (411)
                      ++|+|++|+.||.+.+..+.+..+.+..+..+..+.                                      ...++.
T Consensus       211 il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (359)
T cd07876         211 IMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQ  290 (359)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchh
Confidence            999999999999987766555444443333222111                                      112456


Q ss_pred             hhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCc
Q 015222          349 AEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       349 ~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~  382 (411)
                      ++++|.+||..|    |.+|+|+.|+++|||+..
T Consensus       291 ~~~li~~mL~~d----P~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         291 ARDLLSKMLVID----PDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHHHHHhccC----cccCCCHHHHhcCchhhh
Confidence            789999999999    999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-47  Score=336.48  Aligned_cols=267  Identities=24%  Similarity=0.371  Sum_probs=231.3

Q ss_pred             cCCCeEEE-eeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec----
Q 015222           90 LTPRYRIL-SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY----  164 (411)
Q Consensus        90 ~~~~y~i~-~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~----  164 (411)
                      +.++|.+- ++||-|-.|.|..+.++.|++.+|+|++....    ...+|+++.-..+    +|+|||.++++|+.    
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~----KARrEVeLHw~~s----~h~~iV~IidVyeNs~~~  130 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP----KARREVELHWMAS----GHPHIVSIIDVYENSYQG  130 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH----HHHhHhhhhhhhc----CCCceEEeehhhhhhccC
Confidence            45678775 57899999999999999999999999997654    3556777654443    45666999998864    


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                      ...+.+|||.+ ||.|++.++.++...++|.++..|++||..|+.|||+.+|.||||||+|+|....+            
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~------------  198 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTS------------  198 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCC------------
Confidence            46789999999 99999999999988899999999999999999999999999999999999987654            


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCccccc--CCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEH--QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                                  .+..+||+|||+|+...  ....+.+-|++|.|||++....|+...|+||+||++|-|++|.+||.+.
T Consensus       199 ------------~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~  266 (400)
T KOG0604|consen  199 ------------PNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN  266 (400)
T ss_pred             ------------CCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccccc
Confidence                        56689999999998766  3345678899999999999999999999999999999999999999875


Q ss_pred             Ch----HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccCCCCCc
Q 015222          322 EN----LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSASPNC  392 (411)
Q Consensus       322 ~~----~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~~~~~  392 (411)
                      ..    .....+|......||...|..+++.++++|+++|..+    |++|.|+.++++|||+.+.......|-+
T Consensus       267 hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~----PteRlTI~~~m~hpwi~~~~~vp~tpl~  337 (400)
T KOG0604|consen  267 HGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTE----PTERLTIEEVMDHPWINQYEAVPQTPLS  337 (400)
T ss_pred             CCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCC----chhheeHHHhhcCchhcccccCCCCCch
Confidence            43    3456778888889999999999999999999999999    9999999999999999987665555543

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=6.4e-47  Score=367.67  Aligned_cols=256  Identities=21%  Similarity=0.331  Sum_probs=212.7

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      .++|++.+.||+|+||.||+|+++.+++.||+|++.+..    .....+.+|+.+++.++|+++     +++++++.+++
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~i-----v~~~~~~~~~~  116 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWI-----VQLHYAFQDDK  116 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCc-----ceEEEEEecCC
Confidence            357999999999999999999999999999999996432    233446789999999988877     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      .+|+||||+ +++|.+++...   .+++..+..++.||+.||+|||++||+||||||+|||++.+|              
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~--------------  179 (370)
T cd05596         117 YLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--------------  179 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCC--------------
Confidence            999999999 99999998764   489999999999999999999999999999999999998766              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCC----CcccccCCCccccceecCC----CCCccchhHHHHHHHHHHHhCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL----GWNYPCDLWSVGCILVELCSGEAL  317 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlGvil~elltg~~p  317 (411)
                                   .+||+|||++......    .....||+.|+|||++.+.    .++.++|||||||++|||++|+.|
T Consensus       180 -------------~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~P  246 (370)
T cd05596         180 -------------HLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP  246 (370)
T ss_pred             -------------CEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCC
Confidence                         5677777776654321    1345799999999998754    478999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCc--HHHHHHHHhcCCCCcccc
Q 015222          318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATS--RDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~--R~t~~~il~~~~~~~~~~  385 (411)
                      |.+.+....+..+..............++..++++|.+||..+    |.+  |+++.++++|+||.+..+
T Consensus       247 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~----p~r~~R~s~~ell~h~~~~~~~~  312 (370)
T cd05596         247 FYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDR----EVRLGRNGVDEIKSHPFFKNDQW  312 (370)
T ss_pred             cCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccCh----hhccCCCCHHHHhcCcccCCCCh
Confidence            9988877666666543322211112246788999999999877    665  999999999999998654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.7e-46  Score=358.63  Aligned_cols=252  Identities=23%  Similarity=0.318  Sum_probs=212.7

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      +|++++.||+|+||.||+|.+..+++.||||++++..    ...+.+..|..++..+.|++    +++.+++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~----~i~~~~~~~~~~~~~   76 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP----FLTQLHSCFQTMDRL   76 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCC----ceeeeEEEEEcCCEE
Confidence            4899999999999999999999999999999997532    33455677888888887654    358889999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      |+||||+ +++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.+|                
T Consensus        77 ~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~----------------  138 (324)
T cd05587          77 YFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG----------------  138 (324)
T ss_pred             EEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC----------------
Confidence            9999999 999999998765  689999999999999999999999999999999999998766                


Q ss_pred             CCccccCCCCCCeeEeecCCccccc---CCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                                 .++|+|||++....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..
T Consensus       139 -----------~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~  207 (324)
T cd05587         139 -----------HIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED  207 (324)
T ss_pred             -----------CEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence                       56777777765321   1223457999999999999999999999999999999999999999988887


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHH-----HHHHhcCCCCcccc
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSM-----RAVWKLLRLPVIDL  385 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~-----~~il~~~~~~~~~~  385 (411)
                      +.+..+......+|.    .++..+.+++.+||..+    |.+|++.     +++++||||..+++
T Consensus       208 ~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~~----P~~R~~~~~~~~~~~~~hp~~~~~~~  265 (324)
T cd05587         208 ELFQSIMEHNVSYPK----SLSKEAVSICKGLLTKH----PAKRLGCGPTGERDIREHAFFRRIDW  265 (324)
T ss_pred             HHHHHHHcCCCCCCC----CCCHHHHHHHHHHhhcC----HHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            777777665555443    45778899999999999    6666654     89999999998765

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.4e-46  Score=350.62  Aligned_cols=256  Identities=29%  Similarity=0.490  Sum_probs=206.7

Q ss_pred             CCeEEEeeeccccceEEEEEEeCC-CCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee----
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD----  163 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~----  163 (411)
                      ++|++.+.||+|+||+||+|++.. +++.||+|+++...   .......+|+.+++.+..  ..|+|++++++++.    
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~hpniv~~~~~~~~~~~   78 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET--FEHPNVVRLFDVCTVSRT   78 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcc--cCCCCcceEEEEEecccC
Confidence            479999999999999999999854 56889999986432   223456678888877742  12344499998875    


Q ss_pred             -cCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccc
Q 015222          164 -YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       164 -~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                       ....+++||||++++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++           
T Consensus        79 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~-----------  147 (290)
T cd07862          79 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-----------  147 (290)
T ss_pred             CCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC-----------
Confidence             34579999999988999999876555699999999999999999999999999999999999998766           


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT  320 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~  320 (411)
                                      .++|+|||++......  .....||+.|+|||++.+..++.++|||||||++|||++|++||.+
T Consensus       148 ----------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  211 (290)
T cd07862         148 ----------------QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG  211 (290)
T ss_pred             ----------------CEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCC
Confidence                            5677777776543322  2335789999999999988999999999999999999999999999


Q ss_pred             CChHHHHHHHHHHhCCCCh-----------------------hHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          321 HENLEHLAMMERVLGPLPH-----------------------HMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       321 ~~~~~~~~~i~~~~~~~p~-----------------------~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      .+..+.+..+....+....                       .+.+..+..+.+++.+||+.+    |++||++.++++|
T Consensus       212 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----P~~R~s~~~~l~h  287 (290)
T cd07862         212 SSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN----PAKRISAYSALSH  287 (290)
T ss_pred             CCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccC----chhcCCHHHHhcC
Confidence            8887777777654432211                       122345677889999999999    9999999999999


Q ss_pred             CCC
Q 015222          378 LRL  380 (411)
Q Consensus       378 ~~~  380 (411)
                      |||
T Consensus       288 p~f  290 (290)
T cd07862         288 PYF  290 (290)
T ss_pred             CCC
Confidence            997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-49  Score=364.44  Aligned_cols=252  Identities=25%  Similarity=0.371  Sum_probs=221.3

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      ..|..++.||+|+||.||+|.+..+++.||+|++....  ...+.+++|+.+|.++++++|     .++|+.|..+..++
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~i-----t~yygsyl~g~~Lw   87 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNI-----TEYYGSYLKGTKLW   87 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchH-----HhhhhheeecccHH
Confidence            35888899999999999999999999999999997433  445778899999999999877     89999999999999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      ++|||| ||++.+.+....  .+.+..+..++++++.||.|||+++.+|||||+.|||+..+|                 
T Consensus        88 iiMey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g-----------------  148 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESG-----------------  148 (467)
T ss_pred             HHHHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccC-----------------
Confidence            999999 999999998875  568999999999999999999999999999999999998776                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                                .+||+|||.+......   ..+++||+.|||||++.+..|+.++||||||++.+||++|.+|+.......
T Consensus       149 ----------~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr  218 (467)
T KOG0201|consen  149 ----------DVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR  218 (467)
T ss_pred             ----------cEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce
Confidence                      6788888887654432   366899999999999998899999999999999999999999998877754


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      .+..|-   ...|+.+...+++.+++|+..||.++    |+.||++.++|+|.|++...
T Consensus       219 vlflIp---k~~PP~L~~~~S~~~kEFV~~CL~k~----P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  219 VLFLIP---KSAPPRLDGDFSPPFKEFVEACLDKN----PEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             EEEecc---CCCCCccccccCHHHHHHHHHHhhcC----cccCcCHHHHhhhHHHHhcC
Confidence            444433   34556666688899999999999999    99999999999999999833

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=6.9e-47  Score=366.48  Aligned_cols=282  Identities=22%  Similarity=0.335  Sum_probs=216.0

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++++.||+|+||.||+|.++.+++.||||+++...    .....+..|+.++..+.|+++     +++++.+.+.++
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----v~~~~~~~~~~~   75 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWV-----VKMFYSFQDKRN   75 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCE-----eeEEEEEEcCCE
Confidence            36999999999999999999999999999999997432    234567789999999887776     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+||||+ +++|.+++.+..  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++.....
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             EEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            99999999 999999998765  699999999999999999999999999999999999999999888888887654432


Q ss_pred             CCCc--cccCCCCCCeeEeecCCcccc------------cCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHH
Q 015222          247 DGSY--FKNLPKSSAIKLIDFGSTTFE------------HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC  312 (411)
Q Consensus       247 ~~~~--~~~~~~~~~~kl~Dfg~a~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell  312 (411)
                      ....  +....   ...-.++.+....            .......+||+.|+|||++.+..++.++|||||||++|||+
T Consensus       154 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~  230 (360)
T cd05627         154 AHRTEFYRNLT---HNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML  230 (360)
T ss_pred             ccccccccccc---cCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecc
Confidence            1100  00000   0000111110000            00112357999999999999999999999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhC--CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          313 SGEALFQTHENLEHLAMMERVLG--PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       313 tg~~pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                      +|+.||.+.+..+....+.....  .+|..  ..++..++++|.+++ .++.+|+. |.++.++++||||.++++..
T Consensus       231 tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~--~~~s~~~~~li~~l~-~~p~~R~~-~~~~~ei~~hp~f~~~~~~~  303 (360)
T cd05627         231 IGYPPFCSETPQETYRKVMNWKETLVFPPE--VPISEKAKDLILRFC-TDSENRIG-SNGVEEIKSHPFFEGVDWGH  303 (360)
T ss_pred             cCCCCCCCCCHHHHHHHHHcCCCceecCCC--CCCCHHHHHHHHHhc-cChhhcCC-CCCHHHHhcCCCCCCCCHHH
Confidence            99999998887776666654322  22322  235778999999876 47333332 23689999999999987543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.2e-46  Score=365.41  Aligned_cols=257  Identities=21%  Similarity=0.322  Sum_probs=211.4

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      .++|++.+.||+|+||.||+|+++.+++.||+|++.+..    .....+.+|+.+++.++|+++     +++++.+.+++
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~i-----v~~~~~~~~~~  116 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV-----VQLFCAFQDDK  116 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCE-----eeEEEEEEcCC
Confidence            468999999999999999999999999999999986422    233456789999999888877     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      .+|+||||+ +++|.+++...   .+++..+..++.||+.||+|||++||+||||||+|||++.++              
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~--------------  179 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG--------------  179 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC--------------
Confidence            999999999 99999999764   489999999999999999999999999999999999997766              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCC----CcccccCCCccccceecCCC----CCccchhHHHHHHHHHHHhCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVELCSGEAL  317 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlGvil~elltg~~p  317 (411)
                                   .+||+|||++......    .....||+.|+|||++.+..    ++.++|||||||++|||++|+.|
T Consensus       180 -------------~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~P  246 (370)
T cd05621         180 -------------HLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP  246 (370)
T ss_pred             -------------CEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCC
Confidence                         6788888877654322    13457999999999997643    78999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      |.+.+....+..+......+.......++..+++++.+||..+ .. +..|+++.++++||||.+..
T Consensus       247 f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~-~~-r~~R~~~~e~l~hp~~~~~~  311 (370)
T cd05621         247 FYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDR-EV-RLGRNGVEEIKQHPFFKNDQ  311 (370)
T ss_pred             CCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCc-hh-ccCCCCHHHHhcCcccCCCC
Confidence            9988877777666653322221112346788999999998733 22 23488999999999998754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.4e-46  Score=357.35  Aligned_cols=247  Identities=21%  Similarity=0.341  Sum_probs=208.1

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEc
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE  173 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e  173 (411)
                      +.||+|+||.||+|++..+|+.||+|+++...    .....+.+|+.+++.+.|+++     +++++.+...+.+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----~~~~~~~~~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL-----TALKYAFQTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCC-----cceeeEEecCCEEEEEEe
Confidence            46899999999999999999999999997532    233456789999999988887     999999999999999999


Q ss_pred             cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccc
Q 015222          174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK  252 (411)
Q Consensus       174 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~  252 (411)
                      |+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++                     
T Consensus        76 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~---------------------  132 (323)
T cd05595          76 YANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG---------------------  132 (323)
T ss_pred             CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC---------------------
Confidence            99 999999887765  699999999999999999999999999999999999998776                     


Q ss_pred             cCCCCCCeeEeecCCcccccC---CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015222          253 NLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM  329 (411)
Q Consensus       253 ~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~  329 (411)
                            .+||+|||++.....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....
T Consensus       133 ------~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~  206 (323)
T cd05595         133 ------HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL  206 (323)
T ss_pred             ------CEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence                  456666666543211   12235789999999999998999999999999999999999999988777766666


Q ss_pred             HHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH-----HHHHHHhcCCCCccccc
Q 015222          330 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-----SMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       330 i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~-----t~~~il~~~~~~~~~~~  386 (411)
                      +......+|.    .+++.+.++|.+||+.|    |.+|+     ++.++++|+||.++.+.
T Consensus       207 ~~~~~~~~p~----~~~~~~~~li~~~L~~d----P~~R~~~~~~~~~~~l~h~~~~~~~~~  260 (323)
T cd05595         207 ILMEEIRFPR----TLSPEAKSLLAGLLKKD----PKQRLGGGPSDAKEVMEHRFFLSINWQ  260 (323)
T ss_pred             HhcCCCCCCC----CCCHHHHHHHHHHccCC----HHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence            6544444443    45778899999999999    77776     89999999999987653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-47  Score=355.06  Aligned_cols=260  Identities=24%  Similarity=0.409  Sum_probs=233.8

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .+.+-|.+.+.||+|.|.+|-+|++.-||+.||||++.+..   .....+.+|+..++.+.|+||     |++|++....
T Consensus        15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNi-----VRLYEViDTQ   89 (864)
T KOG4717|consen   15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNI-----VRLYEVIDTQ   89 (864)
T ss_pred             ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCe-----eeeeehhccc
Confidence            45567999999999999999999999999999999997644   345678899999999999988     9999999999


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      ..+|||+|+- +|+|+|||.++. ..+.++.+++++.||+.|+.|+|+..+|||||||+||.+..               
T Consensus        90 TKlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE---------------  153 (864)
T KOG4717|consen   90 TKLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE---------------  153 (864)
T ss_pred             ceEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee---------------
Confidence            9999999999 999999999876 57999999999999999999999999999999999998744               


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccC--CCcccccCCCccccceecCCCCC-ccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                                 +-+-|||+|||++.....  ...+.+|+..|-|||++.|..|+ +++||||||||||-|++|++||+..
T Consensus       154 -----------KlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeA  222 (864)
T KOG4717|consen  154 -----------KLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEA  222 (864)
T ss_pred             -----------ecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccc
Confidence                       334688899998865433  34678999999999999999887 8899999999999999999999999


Q ss_pred             ChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccCC
Q 015222          322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSA  388 (411)
Q Consensus       322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~  388 (411)
                      ++.+.+.+|......+|...    +.+++++|..||..|    |.+|.++++|..++|++.++....
T Consensus       223 NDSETLTmImDCKYtvPshv----S~eCrdLI~sMLvRd----PkkRAslEeI~s~~Wlq~~D~~~s  281 (864)
T KOG4717|consen  223 NDSETLTMIMDCKYTVPSHV----SKECRDLIQSMLVRD----PKKRASLEEIVSTSWLQAGDRGLS  281 (864)
T ss_pred             cchhhhhhhhcccccCchhh----hHHHHHHHHHHHhcC----chhhccHHHHhccccccCCCCCcc
Confidence            99999999999999998764    678899999999999    999999999999999999886554

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-46  Score=356.16  Aligned_cols=244  Identities=25%  Similarity=0.390  Sum_probs=207.4

Q ss_pred             eccccceEEEEEEeCCCCcEEEEEEeccc----hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC
Q 015222          100 MGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL  175 (411)
Q Consensus       100 lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~  175 (411)
                      ||+|+||.||+|++..+++.||+|+++..    ......+.+|+.+++++.|+||     +++++++...+..|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFI-----VPLKFSFQSPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcE-----eceeeEEecCCeEEEEEcCC
Confidence            79999999999999999999999999743    2334556789999999988776     99999999999999999999


Q ss_pred             -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccC
Q 015222          176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL  254 (411)
Q Consensus       176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~  254 (411)
                       +++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++                       
T Consensus        76 ~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~-----------------------  130 (312)
T cd05585          76 NGGELFHHLQREG--RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG-----------------------  130 (312)
T ss_pred             CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC-----------------------
Confidence             999999998764  699999999999999999999999999999999999997766                       


Q ss_pred             CCCCCeeEeecCCcccccC---CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015222          255 PKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME  331 (411)
Q Consensus       255 ~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~  331 (411)
                          .++|+|||++.....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.
T Consensus       131 ----~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~  206 (312)
T cd05585         131 ----HIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL  206 (312)
T ss_pred             ----cEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH
Confidence                578888887764321   1233579999999999999999999999999999999999999999877776666655


Q ss_pred             HHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH---HHHHHHhcCCCCcccc
Q 015222          332 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD---SMRAVWKLLRLPVIDL  385 (411)
Q Consensus       332 ~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~---t~~~il~~~~~~~~~~  385 (411)
                      .....+|    ..++..+.++|.+||..|    |.+|+   ++.++++||||.+..+
T Consensus       207 ~~~~~~~----~~~~~~~~~li~~~L~~d----p~~R~~~~~~~e~l~hp~~~~~~~  255 (312)
T cd05585         207 QEPLRFP----DGFDRDAKDLLIGLLSRD----PTRRLGYNGAQEIKNHPFFSQLSW  255 (312)
T ss_pred             cCCCCCC----CcCCHHHHHHHHHHcCCC----HHHcCCCCCHHHHHcCCCcCCCCH
Confidence            4433443    346778999999999999    88885   6899999999998643

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2e-46  Score=358.59  Aligned_cols=247  Identities=21%  Similarity=0.347  Sum_probs=208.3

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEc
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE  173 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e  173 (411)
                      +.||+|+||.||+|++..+++.||+|++.+..    .....+.+|+.+++.+.|+++     +++++.+...+.+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFL-----TSLKYSFQTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCC-----cceEEEEEcCCEEEEEEe
Confidence            46899999999999999999999999997532    234567789999999988877     999999999999999999


Q ss_pred             cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccc
Q 015222          174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK  252 (411)
Q Consensus       174 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~  252 (411)
                      |+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++                     
T Consensus        76 y~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~---------------------  132 (328)
T cd05593          76 YVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG---------------------  132 (328)
T ss_pred             CCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC---------------------
Confidence            99 999999887764  699999999999999999999999999999999999998766                     


Q ss_pred             cCCCCCCeeEeecCCcccccC---CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015222          253 NLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM  329 (411)
Q Consensus       253 ~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~  329 (411)
                            .+||+|||++.....   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....
T Consensus       133 ------~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  206 (328)
T cd05593         133 ------HIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL  206 (328)
T ss_pred             ------cEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH
Confidence                  567777777654221   12335799999999999998999999999999999999999999988777666655


Q ss_pred             HHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH-----HHHHHHhcCCCCccccc
Q 015222          330 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-----SMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       330 i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~-----t~~~il~~~~~~~~~~~  386 (411)
                      +......+|.    .++..+.++|.+||..+    |.+|+     ++.++++|+||...++.
T Consensus       207 ~~~~~~~~p~----~~~~~~~~li~~~L~~d----P~~R~~~~~~~~~~il~h~~~~~~~~~  260 (328)
T cd05593         207 ILMEDIKFPR----TLSADAKSLLSGLLIKD----PNKRLGGGPDDAKEIMRHSFFTGVNWQ  260 (328)
T ss_pred             hccCCccCCC----CCCHHHHHHHHHHcCCC----HHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence            5444344443    45778899999999999    66665     89999999999887654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-46  Score=350.48  Aligned_cols=263  Identities=21%  Similarity=0.305  Sum_probs=215.8

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      .|++.+.||+|+||+||++.+..+++.||+|++....    .....+.+|+.+++.++|+++     +.+++.+..++.+
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFV-----VSLAYAYETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCE-----eeeeeeecCCCeE
Confidence            4899999999999999999999999999999986432    223446789999999988777     9999999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      |+||||+ +++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||++++++                
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~----------------  139 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG----------------  139 (285)
T ss_pred             EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC----------------
Confidence            9999999 89999988765445699999999999999999999999999999999999997665                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                                 .++|+|||++.......  ....|+..|+|||++.+..++.++|||||||++|||++|+.||.+.+...
T Consensus       140 -----------~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~  208 (285)
T cd05605         140 -----------HIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV  208 (285)
T ss_pred             -----------CEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh
Confidence                       57777777776543222  23478999999999998899999999999999999999999998866544


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH-----HHHHHHhcCCCCcccccCCCCC
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-----SMRAVWKLLRLPVIDLYSASPN  391 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~-----t~~~il~~~~~~~~~~~~~~~~  391 (411)
                      ....+.......+.......+..+.+++.+|+..|    |.+|+     ++.++++|+||...++......
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~  275 (285)
T cd05605         209 KREEVERRVKEDQEEYSEKFSEAARSICRQLLTKD----PGFRLGCRGEGAEEVKAHPFFRTANFKRLEAG  275 (285)
T ss_pred             HHHHHHHHhhhcccccCcccCHHHHHHHHHHccCC----HHHhcCCCCCCHHHHhcCcCccCCCHHHHhhC
Confidence            44333332222223333456778899999999998    99999     9999999999998776654433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8.7e-47  Score=361.48  Aligned_cols=256  Identities=22%  Similarity=0.325  Sum_probs=213.3

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++.+.||+|+||+||+|+++.+++.||+|+++...    .....+.+|+.+++.+.|+++     +++++++.+.+.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i-----~~~~~~~~~~~~   75 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWI-----PQLQYAFQDKDN   75 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCC-----cceeeEEecCCe
Confidence            46999999999999999999999999999999997543    244567789999998888777     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      .|+||||+ +++|.+++.+.. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|               
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~---------------  139 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG---------------  139 (330)
T ss_pred             EEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC---------------
Confidence            99999999 999999998763 3699999999999999999999999999999999999998766               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceec------CCCCCccchhHHHHHHHHHHHhCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVIL------GLGWNYPCDLWSVGCILVELCSGEA  316 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlGvil~elltg~~  316 (411)
                                  .+||+|||++.......    ....||+.|+|||++.      +..++.++|||||||++|||++|+.
T Consensus       140 ------------~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~  207 (330)
T cd05601         140 ------------HIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS  207 (330)
T ss_pred             ------------CEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCC
Confidence                        56777777765443221    2246899999999987      4467899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhC--CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          317 LFQTHENLEHLAMMERVLG--PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       317 pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                      ||...+....+..+.....  .+|.  ...++..+.++|.+||. +    |.+|+++.++++|+||..+++..
T Consensus       208 Pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~~~~~~~li~~ll~-~----p~~R~t~~~l~~h~~~~~~~~~~  273 (330)
T cd05601         208 PFHEGTSAKTYNNIMNFQRFLKFPE--DPKVSSDFLDLIQSLLC-G----QKERLGYEGLCCHPFFSKIDWNN  273 (330)
T ss_pred             CCCCCCHHHHHHHHHcCCCccCCCC--CCCCCHHHHHHHHHHcc-C----hhhCCCHHHHhCCCCcCCCCHHH
Confidence            9988777666666554322  2222  12467788999999986 7    99999999999999999876543

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=7.1e-46  Score=367.72  Aligned_cols=259  Identities=24%  Similarity=0.402  Sum_probs=210.7

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec----
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY----  164 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~----  164 (411)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++....   ....+|+.+++.++|+|+     +++++++..    
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~ni-----v~l~~~~~~~~~~  134 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINI-----IFLKDYYYTECFK  134 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCC-----cceeeeEeecccc
Confidence            34568999999999999999999999999999999886432   234569999999998888     888777632    


Q ss_pred             ----CCeEEEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCc
Q 015222          165 ----RNHICIVFEKLGPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY  238 (411)
Q Consensus       165 ----~~~~~lv~e~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df  238 (411)
                          ...+++||||++++|.+++...  ....+++..++.++.||+.||+|||++||+||||||+|||++.++       
T Consensus       135 ~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~-------  207 (440)
T PTZ00036        135 KNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT-------  207 (440)
T ss_pred             cCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCC-------
Confidence                2357899999988898887632  234699999999999999999999999999999999999997543       


Q ss_pred             ccccccCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCC
Q 015222          239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGE  315 (411)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~  315 (411)
                                         ..+||+|||++......  .....||+.|+|||++.+. .++.++|||||||++|||++|.
T Consensus       208 -------------------~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~  268 (440)
T PTZ00036        208 -------------------HTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGY  268 (440)
T ss_pred             -------------------CceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence                               25788888888754322  2345789999999998765 6899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChhH-------------------------HHhhhhhhhhhhccCCccCCCCCCCcHHH
Q 015222          316 ALFQTHENLEHLAMMERVLGPLPHHM-------------------------VIRADRRAEKYFRRGARLDWPDGATSRDS  370 (411)
Q Consensus       316 ~pf~~~~~~~~~~~i~~~~~~~p~~~-------------------------~~~~~~~~~~li~~~l~~~~~~rp~~R~t  370 (411)
                      +||.+.+..+.+..+.+..+..+...                         ....+.++.+||.+||..+    |.+|+|
T Consensus       269 ~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~d----P~~R~t  344 (440)
T PTZ00036        269 PIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYE----PLKRLN  344 (440)
T ss_pred             CCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCC----hhHCcC
Confidence            99999888777777766554332211                         1124567899999999999    999999


Q ss_pred             HHHHHhcCCCCcccc
Q 015222          371 MRAVWKLLRLPVIDL  385 (411)
Q Consensus       371 ~~~il~~~~~~~~~~  385 (411)
                      +.++++||||.++..
T Consensus       345 a~e~l~hp~f~~~~~  359 (440)
T PTZ00036        345 PIEALADPFFDDLRD  359 (440)
T ss_pred             HHHHhCChhHHhhhc
Confidence            999999999987653

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.2e-45  Score=350.34  Aligned_cols=256  Identities=27%  Similarity=0.444  Sum_probs=213.7

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      ++|++.++||+|+||.||+|+++.+++.||+|.++...  .....+.+|+.++++++|+|+     +++++++..++..+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~   80 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI-----VTLHDIVHTDKSLT   80 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCc-----ceEEEEEeeCCeEE
Confidence            57999999999999999999999999999999987432  233456789999999988887     99999999999999


Q ss_pred             EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      +||||+.++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++                  
T Consensus        81 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~------------------  141 (309)
T cd07872          81 LVFEYLDKDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERG------------------  141 (309)
T ss_pred             EEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC------------------
Confidence            999999779999887654 3589999999999999999999999999999999999998766                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                               .++|+|||++......   .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+
T Consensus       142 ---------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~  212 (309)
T cd07872         142 ---------ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED  212 (309)
T ss_pred             ---------CEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence                     5677777766543221   1234678999999998764 68999999999999999999999999888777


Q ss_pred             HHHHHHHHhCCCChhHH--------------------------HhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCC
Q 015222          326 HLAMMERVLGPLPHHMV--------------------------IRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR  379 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~--------------------------~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~  379 (411)
                      .+..+.+..+..+...+                          ..++..+.++|.+||..+    |.+|+|+.++++|+|
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d----p~~R~t~~e~l~h~~  288 (309)
T cd07872         213 ELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYE----SKKRISAEEAMKHAY  288 (309)
T ss_pred             HHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCC----hhhCCCHHHHhcChh
Confidence            77666665543332221                          234667889999999999    999999999999999


Q ss_pred             CCccc
Q 015222          380 LPVID  384 (411)
Q Consensus       380 ~~~~~  384 (411)
                      |..+.
T Consensus       289 ~~~~~  293 (309)
T cd07872         289 FRSLG  293 (309)
T ss_pred             hhhcc
Confidence            99865

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5e-46  Score=358.10  Aligned_cols=259  Identities=25%  Similarity=0.451  Sum_probs=214.4

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC-
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR-  165 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~-  165 (411)
                      +.++|++++.||+|+||+||+|.+..+++.||||++....   .....+.+|+.++++++|+||     +++++++... 
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~   87 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV-----IGLLDVFTPAT   87 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCch-----hhhhhhhcccc
Confidence            4578999999999999999999999999999999987532   233556789999999988887     8888877532 


Q ss_pred             -----CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          166 -----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       166 -----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                           ...|++|++++++|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++.++         
T Consensus        88 ~~~~~~~~~~~~~~~~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~---------  155 (343)
T cd07878          88 SIENFNEVYLVTNLMGADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC---------  155 (343)
T ss_pred             cccccCcEEEEeecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCC---------
Confidence                 467999999999999887653   599999999999999999999999999999999999998766         


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecC-CCCCccchhHHHHHHHHHHHhCCCCCC
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQ  319 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~pf~  319 (411)
                                        .+||+|||++...........||..|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus       156 ------------------~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  217 (343)
T cd07878         156 ------------------ELRILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFP  217 (343)
T ss_pred             ------------------CEEEcCCccceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCC
Confidence                              5777888877766555555689999999999987 478999999999999999999999998


Q ss_pred             CCChHHHHHHHHHHhCCCChhHHH---------------------------hhhhhhhhhhccCCccCCCCCCCcHHHHH
Q 015222          320 THENLEHLAMMERVLGPLPHHMVI---------------------------RADRRAEKYFRRGARLDWPDGATSRDSMR  372 (411)
Q Consensus       320 ~~~~~~~~~~i~~~~~~~p~~~~~---------------------------~~~~~~~~li~~~l~~~~~~rp~~R~t~~  372 (411)
                      +.+..+.+..+....+..+.....                           ..++.+.++|.+||..|    |.+|+|+.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~d----p~~R~s~~  293 (343)
T cd07878         218 GNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLD----SDKRISAS  293 (343)
T ss_pred             CCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCC----hhhCCCHH
Confidence            877766666665544433322211                           23445789999999999    99999999


Q ss_pred             HHHhcCCCCcccccC
Q 015222          373 AVWKLLRLPVIDLYS  387 (411)
Q Consensus       373 ~il~~~~~~~~~~~~  387 (411)
                      ++++||||.......
T Consensus       294 ell~hp~~~~~~~~~  308 (343)
T cd07878         294 EALAHPYFSQYHDPE  308 (343)
T ss_pred             HHhcCcchhccCCCc
Confidence            999999999876544

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.7e-46  Score=354.90  Aligned_cols=258  Identities=23%  Similarity=0.318  Sum_probs=209.1

Q ss_pred             eEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        94 y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      |++++.||+|+||.||+|.+..+++.||||++++..    ...+.+.+|+.++..+.  .+.|+|++++++++...+..|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~--~l~hp~i~~~~~~~~~~~~~~   78 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN--SERHPFLVNLFACFQTEDHVC   78 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc--ccCCCChhceeeEEEcCCEEE
Confidence            788999999999999999999999999999997532    23345666776665443  223455599999999999999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +||||+ +++|..++...   .+++..+..++.||+.||+|||++||+||||||+|||++.++                 
T Consensus        79 lv~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~-----------------  138 (324)
T cd05589          79 FVMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG-----------------  138 (324)
T ss_pred             EEEcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-----------------
Confidence            999999 99999888653   599999999999999999999999999999999999998776                 


Q ss_pred             CccccCCCCCCeeEeecCCccccc---CCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                                .+||+|||++....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+
T Consensus       139 ----------~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~  208 (324)
T cd05589         139 ----------FVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE  208 (324)
T ss_pred             ----------cEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH
Confidence                      56777777655321   12234579999999999999899999999999999999999999999888877


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH-HHHHHHhcCCCCcccccC
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-SMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~-t~~~il~~~~~~~~~~~~  387 (411)
                      ....+.......|.    .++..+.++|.+||..||.+||...+ ++.++++|+||.++.+..
T Consensus       209 ~~~~i~~~~~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~  267 (324)
T cd05589         209 VFDSIVNDEVRYPR----FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDD  267 (324)
T ss_pred             HHHHHHhCCCCCCC----CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHH
Confidence            77776665544443    35677899999999999444433221 799999999999876543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.5e-46  Score=355.70  Aligned_cols=247  Identities=23%  Similarity=0.309  Sum_probs=207.7

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeecCCeEEEEE
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF  172 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~~~~~~lv~  172 (411)
                      +.||+|+||+||+|+++.+++.||||++++..    ...+.+..|..++..+ .|+++     +++++++...+.+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i-----v~~~~~~~~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL-----TQLYCCFQTPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCch-----hceeeEEEcCCEEEEEE
Confidence            46899999999999999999999999997532    2334566788888766 35555     99999999999999999


Q ss_pred             ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCcc
Q 015222          173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF  251 (411)
Q Consensus       173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~  251 (411)
                      ||+ +++|.+++.+..  .+++..+..++.||+.||+|||++||+||||||+|||++.++                    
T Consensus        76 Ey~~~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~--------------------  133 (320)
T cd05590          76 EFVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG--------------------  133 (320)
T ss_pred             cCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC--------------------
Confidence            999 899999988765  699999999999999999999999999999999999998776                    


Q ss_pred             ccCCCCCCeeEeecCCccccc---CCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015222          252 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA  328 (411)
Q Consensus       252 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~  328 (411)
                             .++|+|||++....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+...
T Consensus       134 -------~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~  206 (320)
T cd05590         134 -------HCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFE  206 (320)
T ss_pred             -------cEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH
Confidence                   56777777665421   12234579999999999999899999999999999999999999999888877777


Q ss_pred             HHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHH------HHHHhcCCCCccccc
Q 015222          329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSM------RAVWKLLRLPVIDLY  386 (411)
Q Consensus       329 ~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~------~~il~~~~~~~~~~~  386 (411)
                      .+.......|.    .++..+.+++.+||..|    |.+|+++      +++++|+||.++.+.
T Consensus       207 ~i~~~~~~~~~----~~~~~~~~li~~~L~~d----P~~R~~~~~~~~~~~~~~h~~f~~~~~~  262 (320)
T cd05590         207 AILNDEVVYPT----WLSQDAVDILKAFMTKN----PTMRLGSLTLGGEEAILRHPFFKELDWE  262 (320)
T ss_pred             HHhcCCCCCCC----CCCHHHHHHHHHHcccC----HHHCCCCCCCCCHHHHHcCCCcCCCCHH
Confidence            76654444443    35678899999999999    8888887      999999999987653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3e-46  Score=358.02  Aligned_cols=251  Identities=24%  Similarity=0.370  Sum_probs=202.9

Q ss_pred             CeEEEeeeccccceEEEEEEeC---CCCcEEEEEEeccch-----hhhHHHHHHHHHHHHHh-cCCCCCcceEEEeeeee
Q 015222           93 RYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~---~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~~~  163 (411)
                      +|++.+.||+|+||+||+|++.   .+++.||+|++++..     ...+.+..|+.+++.+. |+++     +.+++++.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i-----~~~~~~~~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL-----VTLHYAFQ   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCc-----ccEEEEEe
Confidence            4899999999999999999864   578999999997432     23355678999999885 4555     99999999


Q ss_pred             cCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccc
Q 015222          164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                      .++.+++||||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+|           
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~-----------  142 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG-----------  142 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC-----------
Confidence            999999999999 999999998765  699999999999999999999999999999999999998766           


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCcccccCC----CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCC
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEAL  317 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p  317 (411)
                                      .++|+|||++......    .....||+.|+|||++.+. .++.++|||||||++|||++|..|
T Consensus       143 ----------------~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p  206 (332)
T cd05614         143 ----------------HVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP  206 (332)
T ss_pred             ----------------CEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCC
Confidence                            5677777776543211    1235799999999999875 478999999999999999999999


Q ss_pred             CCCCCh----HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH-----HHHHHHhcCCCCcccc
Q 015222          318 FQTHEN----LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-----SMRAVWKLLRLPVIDL  385 (411)
Q Consensus       318 f~~~~~----~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~-----t~~~il~~~~~~~~~~  385 (411)
                      |.....    ......+......++    ..++..+.+++.+||+.|    |++|+     +++++++|+||.+..+
T Consensus       207 f~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~d----p~~R~~~~~~~~~~~l~h~~~~~~~~  275 (332)
T cd05614         207 FTLEGERNTQSEVSRRILKCDPPFP----SFIGPEAQDLLHKLLRKD----PKKRLGAGPQGASEIKEHPFFKGLDW  275 (332)
T ss_pred             CCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHcCCC----HHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence            975432    222222322222333    346778899999999999    77777     8999999999998654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.8e-45  Score=355.82  Aligned_cols=253  Identities=28%  Similarity=0.449  Sum_probs=210.1

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC-
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR-  165 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~-  165 (411)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++...   ......+.+|+.+++.+.|+|+     +++++++... 
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----i~~~~~~~~~~   96 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI-----IGLLNVFTPQK   96 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCc-----cccceeecccc
Confidence            468999999999999999999999999999999998643   2334567789999999988887     8888776542 


Q ss_pred             -----CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          166 -----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       166 -----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                           ..+|+||||++++|.+.+..    .+++..+..++.|++.||+|||++||+||||||+|||++.++         
T Consensus        97 ~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~---------  163 (364)
T cd07875          97 SLEEFQDVYIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC---------  163 (364)
T ss_pred             cccccCeEEEEEeCCCCCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC---------
Confidence                 46899999998889888754    488999999999999999999999999999999999997766         


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCC
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF  318 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf  318 (411)
                                        .+||+|||++.......  ....||..|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus       164 ------------------~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf  225 (364)
T cd07875         164 ------------------TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF  225 (364)
T ss_pred             ------------------cEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCC
Confidence                              67888888876544322  3357899999999999999999999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCChhHHHh--------------------------------------hhhhhhhhhccCCccC
Q 015222          319 QTHENLEHLAMMERVLGPLPHHMVIR--------------------------------------ADRRAEKYFRRGARLD  360 (411)
Q Consensus       319 ~~~~~~~~~~~i~~~~~~~p~~~~~~--------------------------------------~~~~~~~li~~~l~~~  360 (411)
                      .+.+..+.+..+....+.....+...                                      .+..++++|.+||..|
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d  305 (364)
T cd07875         226 PGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID  305 (364)
T ss_pred             CCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcC
Confidence            98887777666655444333222111                                      1345789999999999


Q ss_pred             CCCCCCcHHHHHHHHhcCCCCc
Q 015222          361 WPDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       361 ~~~rp~~R~t~~~il~~~~~~~  382 (411)
                          |.+|||+.++++||||..
T Consensus       306 ----P~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         306 ----ASKRISVDEALQHPYINV  323 (364)
T ss_pred             ----cccCCCHHHHhcCccccc
Confidence                999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.1e-46  Score=355.75  Aligned_cols=250  Identities=23%  Similarity=0.360  Sum_probs=206.8

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHH-HHHHHhcCCCCCcceEEEeeeeecCCeEEEEE
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEID-VLQRLARHDIGGTRCVQIRNWFDYRNHICIVF  172 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~  172 (411)
                      +.||+|+||+||+|+++.+++.||||++....    .....+..|.. +++.++|+++     +++++.+...+..|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~i-----v~~~~~~~~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFL-----VGLHYSFQTADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCC-----CCeeEEEEeCCEEEEEE
Confidence            46899999999999999999999999997432    12233344444 4456666666     99999999999999999


Q ss_pred             ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCcc
Q 015222          173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF  251 (411)
Q Consensus       173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~  251 (411)
                      ||+ +++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.+|                    
T Consensus        76 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~--------------------  133 (323)
T cd05575          76 DYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG--------------------  133 (323)
T ss_pred             cCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC--------------------
Confidence            999 999999998765  699999999999999999999999999999999999998766                    


Q ss_pred             ccCCCCCCeeEeecCCcccccC---CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015222          252 KNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA  328 (411)
Q Consensus       252 ~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~  328 (411)
                             .+||+|||++.....   ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+...
T Consensus       134 -------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~  206 (323)
T cd05575         134 -------HVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD  206 (323)
T ss_pred             -------cEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHH
Confidence                   567777777654221   1233578999999999999999999999999999999999999999877766666


Q ss_pred             HHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       329 ~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      .+.......+    ...+..+.++|.+||+.||.+||+.++.+.++++|+||..+.+
T Consensus       207 ~i~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~  259 (323)
T cd05575         207 NILNKPLRLK----PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW  259 (323)
T ss_pred             HHHcCCCCCC----CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence            6554433333    3457789999999999998888888888899999999988664

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=9.5e-46  Score=353.26  Aligned_cols=254  Identities=23%  Similarity=0.308  Sum_probs=211.3

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      +|++.+.||+|+||.||+|++..+++.||||++++..    ...+....|..++..+.|+    ++++.+++++...+.+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~----~~i~~~~~~~~~~~~~   76 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP----PFLTQLHSCFQTMDRL   76 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCC----CeEeeEEEEEecCCEE
Confidence            4899999999999999999999999999999997532    2233455677777766533    4568899999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      |+||||+ +++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++                
T Consensus        77 ~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~----------------  138 (323)
T cd05616          77 YFVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG----------------  138 (323)
T ss_pred             EEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC----------------
Confidence            9999999 999999988765  699999999999999999999999999999999999998776                


Q ss_pred             CCccccCCCCCCeeEeecCCccccc---CCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                                 .+||+|||++....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..
T Consensus       139 -----------~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~  207 (323)
T cd05616         139 -----------HIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED  207 (323)
T ss_pred             -----------cEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH
Confidence                       56777777665422   1223457899999999999999999999999999999999999999988887


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHH-----HHHHHhcCCCCcccccC
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS-----MRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t-----~~~il~~~~~~~~~~~~  387 (411)
                      +....+......+|.    ..+..+.+++.+||+.+    |.+|++     ..++++|+||..+++..
T Consensus       208 ~~~~~i~~~~~~~p~----~~s~~~~~li~~~l~~~----p~~R~~~~~~~~~~i~~h~~~~~~~~~~  267 (323)
T cd05616         208 ELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKH----PGKRLGCGPEGERDIKEHAFFRYIDWEK  267 (323)
T ss_pred             HHHHHHHhCCCCCCC----cCCHHHHHHHHHHcccC----HHhcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence            777777665555554    45778999999999999    556654     58999999999877544

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5.7e-46  Score=361.05  Aligned_cols=258  Identities=21%  Similarity=0.339  Sum_probs=212.6

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      .++|++.+.||+|+||.||+|+++.+++.||+|++.+..    .....+.+|+.+++.++|+++     +++++.+..++
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~i-----v~~~~~~~~~~  116 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV-----VQLFYAFQDDR  116 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEEcCC
Confidence            478999999999999999999999999999999986422    233456789999999988877     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      .+|+||||+ +++|.+++...   .+++..+..++.||+.||+|||++||+||||||+|||++.+|              
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~--------------  179 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--------------  179 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCC--------------
Confidence            999999999 99999998765   489999999999999999999999999999999999997766              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCC----CcccccCCCccccceecCCC----CCccchhHHHHHHHHHHHhCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVELCSGEAL  317 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlGvil~elltg~~p  317 (411)
                                   .+||+|||++......    .....||+.|+|||++.+..    ++.++|||||||++|||++|..|
T Consensus       180 -------------~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~P  246 (371)
T cd05622         180 -------------HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP  246 (371)
T ss_pred             -------------CEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCC
Confidence                         6788888877654322    22457999999999997643    78999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      |.+.+.......+......++......++..++++|..||. ++.. ...|+++.++++|+||.+..+
T Consensus       247 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~-~~~~-r~~r~~~~ei~~h~~~~~~~~  312 (371)
T cd05622         247 FYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLT-DREV-RLGRNGVEEIKRHLFFKNDQW  312 (371)
T ss_pred             CCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcC-Chhh-hcCCCCHHHHhcCcccCCCCh
Confidence            99888777776666543322222234578889999999997 4222 223789999999999988543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=6.8e-46  Score=353.12  Aligned_cols=247  Identities=23%  Similarity=0.349  Sum_probs=204.7

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeecCCeEEEEE
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF  172 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~~~~~~lv~  172 (411)
                      +.||+|+||.||+|+++.+++.||+|+++...    ........|..++..+ .|+++     +++++++.+.+++|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i-----~~~~~~~~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFL-----THLYCTFQTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCc-----cCeeEEEEeCCEEEEEE
Confidence            47999999999999999999999999997532    2334456677777654 45555     99999999999999999


Q ss_pred             ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCcc
Q 015222          173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF  251 (411)
Q Consensus       173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~  251 (411)
                      ||+ +++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++                    
T Consensus        76 E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~--------------------  133 (316)
T cd05620          76 EFLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG--------------------  133 (316)
T ss_pred             CCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC--------------------
Confidence            999 999999988764  689999999999999999999999999999999999998776                    


Q ss_pred             ccCCCCCCeeEeecCCcccc---cCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015222          252 KNLPKSSAIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA  328 (411)
Q Consensus       252 ~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~  328 (411)
                             .++|+|||++...   ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+...
T Consensus       134 -------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~  206 (316)
T cd05620         134 -------HIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE  206 (316)
T ss_pred             -------CEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence                   5667777765432   122234578999999999999999999999999999999999999999887777666


Q ss_pred             HHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHH-HHHHhcCCCCccccc
Q 015222          329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSM-RAVWKLLRLPVIDLY  386 (411)
Q Consensus       329 ~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~-~~il~~~~~~~~~~~  386 (411)
                      .+......+|.    .++..++++|.+||..|    |++|+++ .++++|+||..+++.
T Consensus       207 ~~~~~~~~~~~----~~~~~~~~li~~~l~~d----P~~R~~~~~~~~~h~~f~~~~~~  257 (316)
T cd05620         207 SIRVDTPHYPR----WITKESKDILEKLFERD----PTRRLGVVGNIRGHPFFKTINWT  257 (316)
T ss_pred             HHHhCCCCCCC----CCCHHHHHHHHHHccCC----HHHcCCChHHHHcCCCcCCCCHH
Confidence            66554444443    35678899999999999    9999987 588899999987654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2e-45  Score=355.64  Aligned_cols=263  Identities=26%  Similarity=0.434  Sum_probs=212.2

Q ss_pred             ceEEeeCC---ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcc
Q 015222           81 HYVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR  154 (411)
Q Consensus        81 ~~~~~~~~---~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~  154 (411)
                      .+.+..++   .+.++|++.+.||+|+||.||+|.+..+++.||||++...   ......+.+|+.+++.++|+|+    
T Consensus         3 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni----   78 (355)
T cd07874           3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI----   78 (355)
T ss_pred             ceeeccCchhhhhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCch----
Confidence            34555555   3568999999999999999999999999999999998743   2334567789999999998887    


Q ss_pred             eEEEeeeeecC------CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015222          155 CVQIRNWFDYR------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV  228 (411)
Q Consensus       155 iv~~~~~~~~~------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~  228 (411)
                       +++++++...      ...|+||||+.++|.+.+..    .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus        79 -v~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~  153 (355)
T cd07874          79 -ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK  153 (355)
T ss_pred             -hceeeeeeccccccccceeEEEhhhhcccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEC
Confidence             8888887543      35799999998788888754    488999999999999999999999999999999999997


Q ss_pred             cCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHH
Q 015222          229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC  306 (411)
Q Consensus       229 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  306 (411)
                      .++                           .+||+|||++......  .....||..|+|||++.+..++.++|||||||
T Consensus       154 ~~~---------------------------~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~  206 (355)
T cd07874         154 SDC---------------------------TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC  206 (355)
T ss_pred             CCC---------------------------CEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHH
Confidence            766                           5788888877654332  23357899999999999989999999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHH--------------------------------------Hhhhhh
Q 015222          307 ILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMV--------------------------------------IRADRR  348 (411)
Q Consensus       307 il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~--------------------------------------~~~~~~  348 (411)
                      ++|+|++|+.||.+.+..+....+....+.....+.                                      ...+..
T Consensus       207 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (355)
T cd07874         207 IMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ  286 (355)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchH
Confidence            999999999999987766555544433332221111                                      112345


Q ss_pred             hhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcc
Q 015222          349 AEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVI  383 (411)
Q Consensus       349 ~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~  383 (411)
                      +.++|.+||..|    |.+|||+.++++||||...
T Consensus       287 ~~~li~~mL~~d----P~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         287 ARDLLSKMLVID----PAKRISVDEALQHPYINVW  317 (355)
T ss_pred             HHHHHHHHhcCC----chhcCCHHHHhcCcchhcc
Confidence            789999999999    9999999999999999744

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-46  Score=353.29  Aligned_cols=246  Identities=26%  Similarity=0.384  Sum_probs=202.2

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC-eE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN-HI  168 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~-~~  168 (411)
                      ...+.+.||.|+||+||+|.++.+.. ||||++....   ...+.+.+|+.+|.+++||||     |++++++.... .+
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~-vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNI-----V~f~G~~~~~~~~~  115 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDV-VAVKIISDPDFDDESRKAFRREASLLSRLRHPNI-----VQFYGACTSPPGSL  115 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCcee-EEEEEecchhcChHHHHHHHHHHHHHHhCCCCCe-----eeEEEEEcCCCCce
Confidence            45566779999999999998764332 9999997533   225689999999999999988     99999999877 79


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR-LIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g-ivH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      ++||||+ +|+|.+++.+.....++...+..++.||++||+|||+++ ||||||||+|||++.++               
T Consensus       116 ~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~---------------  180 (362)
T KOG0192|consen  116 CIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG---------------  180 (362)
T ss_pred             EEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC---------------
Confidence            9999999 999999998843458999999999999999999999999 99999999999997653               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccC---CCcccccCCCccccceec--CCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVIL--GLGWNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                                 .++||+|||+++....   ..+...||+.|||||++.  ...|+.++||||||++||||+||+.||.+.
T Consensus       181 -----------~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~  249 (362)
T KOG0192|consen  181 -----------KTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDL  249 (362)
T ss_pred             -----------CEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCC
Confidence                       2688899998877653   334468999999999999  558999999999999999999999999998


Q ss_pred             ChHHHHHHHHHH--hCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          322 ENLEHLAMMERV--LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       322 ~~~~~~~~i~~~--~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ...+....+...  ...+|.    .+++.+..++.+    ||..+|..||++.+++..+
T Consensus       250 ~~~~~~~~v~~~~~Rp~~p~----~~~~~l~~l~~~----CW~~dp~~RP~f~ei~~~l  300 (362)
T KOG0192|consen  250 APVQVASAVVVGGLRPPIPK----ECPPHLSSLMER----CWLVDPSRRPSFLEIVSRL  300 (362)
T ss_pred             CHHHHHHHHHhcCCCCCCCc----cCCHHHHHHHHH----hCCCCCCcCCCHHHHHHHH
Confidence            875544444322  122232    256667777776    5777799999999998754

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=6.5e-46  Score=354.08  Aligned_cols=248  Identities=21%  Similarity=0.289  Sum_probs=207.4

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeecCCeEEEEE
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF  172 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~~~~~~lv~  172 (411)
                      +.||+|+||.||+|+++.+++.||||+++...    ...+.+..|..++..+ .|+++     +++++++...+.+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i-----~~~~~~~~~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFL-----TALHCCFQTKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCc-----cceeeEEEcCCeEEEEE
Confidence            46899999999999999999999999997532    2334566788888765 45555     99999999999999999


Q ss_pred             ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCcc
Q 015222          173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF  251 (411)
Q Consensus       173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~  251 (411)
                      ||+ +++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.+|                    
T Consensus        76 E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~--------------------  133 (321)
T cd05591          76 EYVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG--------------------  133 (321)
T ss_pred             eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC--------------------
Confidence            999 899999988765  699999999999999999999999999999999999998766                    


Q ss_pred             ccCCCCCCeeEeecCCcccccC---CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015222          252 KNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA  328 (411)
Q Consensus       252 ~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~  328 (411)
                             .++|+|||++.....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+.
T Consensus       134 -------~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~  206 (321)
T cd05591         134 -------HCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE  206 (321)
T ss_pred             -------CEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHH
Confidence                   567777777654221   1233578999999999999899999999999999999999999999888877777


Q ss_pred             HHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH-------HHHHHHhcCCCCcccccC
Q 015222          329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-------SMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       329 ~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~-------t~~~il~~~~~~~~~~~~  387 (411)
                      .+......+|.    ..+..+.++|.+||..+    |.+|+       ++.++++|+||..+++..
T Consensus       207 ~i~~~~~~~p~----~~~~~~~~ll~~~L~~d----p~~R~~~~~~~~~~~~~~~hp~~~~~~~~~  264 (321)
T cd05591         207 SILHDDVLYPV----WLSKEAVSILKAFMTKN----PNKRLGCVASQGGEDAIKQHPFFKEIDWVL  264 (321)
T ss_pred             HHHcCCCCCCC----CCCHHHHHHHHHHhccC----HHHcCCCCCCCCCHHHHhcCCccCCCCHHH
Confidence            77665444443    25678899999999999    66776       999999999998876543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.3e-46  Score=356.68  Aligned_cols=247  Identities=21%  Similarity=0.340  Sum_probs=207.8

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEc
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE  173 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e  173 (411)
                      +.||+|+||.||+|.+..+++.||+|+++...    .....+.+|+.+++.+.|++|     +++++++...+.+|+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i-----~~~~~~~~~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL-----TALKYSFQTHDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCC-----CceEEEEEcCCEEEEEEe
Confidence            46899999999999999999999999997532    233456678899998888877     999999999999999999


Q ss_pred             cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEecCcccccCCcccccccCCCCCcc
Q 015222          174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF  251 (411)
Q Consensus       174 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~  251 (411)
                      |+ +++|.+++....  .+++..++.++.||+.||+|||+ +||+||||||+|||++.+|                    
T Consensus        76 ~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~--------------------  133 (325)
T cd05594          76 YANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG--------------------  133 (325)
T ss_pred             CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC--------------------
Confidence            99 999999887765  69999999999999999999997 7999999999999998766                    


Q ss_pred             ccCCCCCCeeEeecCCcccccC---CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015222          252 KNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA  328 (411)
Q Consensus       252 ~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~  328 (411)
                             .+||+|||++.....   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...
T Consensus       134 -------~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~  206 (325)
T cd05594         134 -------HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE  206 (325)
T ss_pred             -------CEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHH
Confidence                   567777777654221   1233579999999999999899999999999999999999999998877766666


Q ss_pred             HHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH-----HHHHHHhcCCCCccccc
Q 015222          329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-----SMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       329 ~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~-----t~~~il~~~~~~~~~~~  386 (411)
                      .+......+|.    .++..+.++|.+||+.|    |.+|+     ++.++++|+||.++.+.
T Consensus       207 ~i~~~~~~~p~----~~~~~~~~li~~~L~~d----P~~R~~~~~~~~~~il~h~~~~~~~~~  261 (325)
T cd05594         207 LILMEEIRFPR----TLSPEAKSLLSGLLKKD----PKQRLGGGPDDAKEIMQHKFFAGIVWQ  261 (325)
T ss_pred             HHhcCCCCCCC----CCCHHHHHHHHHHhhcC----HHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence            65544444443    35678899999999999    77775     99999999999987654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.4e-45  Score=344.39  Aligned_cols=255  Identities=28%  Similarity=0.472  Sum_probs=207.1

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec-----
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-----  164 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~-----  164 (411)
                      +|++.+.||+|+||+||+|+++.+++.||+|.++...   .......+|+.+++.+.+  +.|+|++++++++..     
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~h~ni~~~~~~~~~~~~~~   78 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEA--FDHPNIVRLMDVCATSRTDR   78 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhh--cCCCCeeeeeeeeccccCCC
Confidence            5999999999999999999999999999999987432   223356678888887742  234555999998764     


Q ss_pred             CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          165 RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       165 ~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      ...+++|||++.++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++             
T Consensus        79 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-------------  145 (288)
T cd07863          79 ETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-------------  145 (288)
T ss_pred             CceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-------------
Confidence            3468999999977999999876545699999999999999999999999999999999999998766             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE  322 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~  322 (411)
                                    .++|+|||++......  .....||..|+|||++.+..++.++|||||||++|+|++|.+||.+..
T Consensus       146 --------------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~  211 (288)
T cd07863         146 --------------QVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS  211 (288)
T ss_pred             --------------CEEECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC
Confidence                          5677777776654322  223468999999999998899999999999999999999999998887


Q ss_pred             hHHHHHHHHHHhCCCC-----------------------hhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCC
Q 015222          323 NLEHLAMMERVLGPLP-----------------------HHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR  379 (411)
Q Consensus       323 ~~~~~~~i~~~~~~~p-----------------------~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~  379 (411)
                      ..+.+..+....+...                       ....+.++..+.++|.+||..|    |.+||++.+++.|||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d----P~~R~t~~~~l~hp~  287 (288)
T cd07863         212 EADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFN----PHKRISAFRALQHPF  287 (288)
T ss_pred             HHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccC----cccCCCHHHHhcCCC
Confidence            7766666655432111                       1122345677889999999999    999999999999999


Q ss_pred             C
Q 015222          380 L  380 (411)
Q Consensus       380 ~  380 (411)
                      |
T Consensus       288 f  288 (288)
T cd07863         288 F  288 (288)
T ss_pred             C
Confidence            7

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6.8e-46  Score=354.55  Aligned_cols=250  Identities=22%  Similarity=0.316  Sum_probs=206.8

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHH-HHHHHhcCCCCCcceEEEeeeeecCCeEEEEE
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEID-VLQRLARHDIGGTRCVQIRNWFDYRNHICIVF  172 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~  172 (411)
                      +.||+|+||+||+|.++.+|+.||+|++....    .....+..|.. +++.+.|+||     +++++.+...+..|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~i-----v~~~~~~~~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFL-----VGLHYSFQTTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCC-----ccEEEEEecCCEEEEEE
Confidence            46899999999999999999999999997532    22233444544 3555666666     99999999999999999


Q ss_pred             ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCcc
Q 015222          173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF  251 (411)
Q Consensus       173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~  251 (411)
                      ||+ +++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.+|                    
T Consensus        76 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~--------------------  133 (325)
T cd05604          76 DFVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG--------------------  133 (325)
T ss_pred             cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC--------------------
Confidence            999 999999887654  799999999999999999999999999999999999998766                    


Q ss_pred             ccCCCCCCeeEeecCCccccc---CCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015222          252 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA  328 (411)
Q Consensus       252 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~  328 (411)
                             .++|+|||++....   .......||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+...
T Consensus       134 -------~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~  206 (325)
T cd05604         134 -------HVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD  206 (325)
T ss_pred             -------CEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHH
Confidence                   56777777765421   12234579999999999999999999999999999999999999999887776666


Q ss_pred             HHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       329 ~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      .+.......+    ...+..+.++|.+||+.||.+||+.|+++.++++|+||..+.+
T Consensus       207 ~~~~~~~~~~----~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~  259 (325)
T cd05604         207 NILHKPLVLR----PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW  259 (325)
T ss_pred             HHHcCCccCC----CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence            6554332222    2456778899999999999999999999999999999997654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.9e-45  Score=351.02  Aligned_cols=257  Identities=24%  Similarity=0.360  Sum_probs=210.3

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      .++|++++.||+|+||.||+|++..++..||+|++...  ....+.+.+|++++++++|+|+     +++++++..++.+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~   78 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI-----VGFYGAFYSDGEI   78 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCC-----CeEEEEEEECCEE
Confidence            46899999999999999999999999999999998753  2345678899999999988887     9999999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      ++||||+ +++|.+++....  .+++..+..++.|++.||.|||++ +|+||||||+|||++.++               
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~---------------  141 (331)
T cd06649          79 SICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG---------------  141 (331)
T ss_pred             EEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC---------------
Confidence            9999999 899999998765  689999999999999999999986 699999999999998776               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccC-CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                                  .++|+|||++..... ......||..|+|||++.+..++.++|||||||++|||++|+.||...+..+
T Consensus       142 ------------~~kl~Dfg~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~  209 (331)
T cd06649         142 ------------EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE  209 (331)
T ss_pred             ------------cEEEccCcccccccccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                        567777776654322 2234578999999999999899999999999999999999999997655443


Q ss_pred             HHHHHHHH-------------------------------------------h-CCCChhHHHhhhhhhhhhhccCCccCC
Q 015222          326 HLAMMERV-------------------------------------------L-GPLPHHMVIRADRRAEKYFRRGARLDW  361 (411)
Q Consensus       326 ~~~~i~~~-------------------------------------------~-~~~p~~~~~~~~~~~~~li~~~l~~~~  361 (411)
                      ....+...                                           . ...+.......+..+.+||.+||..| 
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~-  288 (331)
T cd06649         210 LEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKN-  288 (331)
T ss_pred             HHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCC-
Confidence            32221110                                           0 00011111134667899999999999 


Q ss_pred             CCCCCcHHHHHHHHhcCCCCcccc
Q 015222          362 PDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       362 ~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                         |++|||+.++++|+||.....
T Consensus       289 ---P~~Rpt~~ell~h~~~~~~~~  309 (331)
T cd06649         289 ---PAERADLKMLMNHTFIKRSEV  309 (331)
T ss_pred             ---cccCCCHHHHhcChHHhhccc
Confidence               999999999999999987543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.1e-45  Score=349.78  Aligned_cols=247  Identities=25%  Similarity=0.343  Sum_probs=203.6

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeecCCeEEEEE
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF  172 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~~~~~~lv~  172 (411)
                      +.||+|+||.||+|++..+++.||||+++...    ...+....|..++..+ .|++|     +++++++..++.+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i-----~~~~~~~~~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFL-----THLFCTFQTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCc-----cceeeEEEcCCEEEEEE
Confidence            46999999999999999999999999997532    2233445566666543 45554     99999999999999999


Q ss_pred             ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCcc
Q 015222          173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF  251 (411)
Q Consensus       173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~  251 (411)
                      ||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++                    
T Consensus        76 e~~~gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~--------------------  133 (316)
T cd05592          76 EYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG--------------------  133 (316)
T ss_pred             cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC--------------------
Confidence            999 999999998765  699999999999999999999999999999999999997766                    


Q ss_pred             ccCCCCCCeeEeecCCccccc---CCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015222          252 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA  328 (411)
Q Consensus       252 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~  328 (411)
                             .+||+|||++....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+...
T Consensus       134 -------~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~  206 (316)
T cd05592         134 -------HIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD  206 (316)
T ss_pred             -------CEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence                   56777777775432   12234579999999999999899999999999999999999999999888777776


Q ss_pred             HHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHH-HHHHhcCCCCccccc
Q 015222          329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSM-RAVWKLLRLPVIDLY  386 (411)
Q Consensus       329 ~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~-~~il~~~~~~~~~~~  386 (411)
                      .+......+|.    .++..+.+++.+||..+    |.+|+++ .++++|+||..+++.
T Consensus       207 ~i~~~~~~~~~----~~~~~~~~ll~~~l~~~----P~~R~~~~~~l~~h~~~~~~~~~  257 (316)
T cd05592         207 SILNDRPHFPR----WISKEAKDCLSKLFERD----PTKRLGVDGDIRQHPFFRGIDWE  257 (316)
T ss_pred             HHHcCCCCCCC----CCCHHHHHHHHHHccCC----HHHcCCChHHHHcCcccCCCCHH
Confidence            66554444443    35677899999999998    8888875 588899999987653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.1e-45  Score=349.65  Aligned_cols=247  Identities=23%  Similarity=0.342  Sum_probs=205.0

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeecCCeEEEEE
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF  172 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~~~~~~lv~  172 (411)
                      +.||+|+||.||+|++..+++.||||+++...    ........|..++..+ .|+++     +++++++.+.+.+++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i-----v~~~~~~~~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL-----THLYCTFQTKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcC-----cceEEEEEeCCEEEEEE
Confidence            46999999999999999999999999997532    2234455677777654 56655     99999999999999999


Q ss_pred             ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCcc
Q 015222          173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF  251 (411)
Q Consensus       173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~  251 (411)
                      ||+ +++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++                    
T Consensus        76 ey~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~--------------------  133 (316)
T cd05619          76 EYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG--------------------  133 (316)
T ss_pred             eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC--------------------
Confidence            999 999999998754  689999999999999999999999999999999999998766                    


Q ss_pred             ccCCCCCCeeEeecCCccccc---CCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015222          252 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA  328 (411)
Q Consensus       252 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~  328 (411)
                             .++|+|||++....   .......||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+...
T Consensus       134 -------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~  206 (316)
T cd05619         134 -------HIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQ  206 (316)
T ss_pred             -------CEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence                   56777777665321   12234578999999999999899999999999999999999999999887777666


Q ss_pred             HHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHH-HHHhcCCCCccccc
Q 015222          329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMR-AVWKLLRLPVIDLY  386 (411)
Q Consensus       329 ~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~-~il~~~~~~~~~~~  386 (411)
                      .+......+|.    ..+..+.++|.+||..+    |.+|+++. ++++|+||..+++.
T Consensus       207 ~i~~~~~~~~~----~~~~~~~~li~~~l~~~----P~~R~~~~~~l~~h~~~~~~~~~  257 (316)
T cd05619         207 SIRMDNPCYPR----WLTREAKDILVKLFVRE----PERRLGVKGDIRQHPFFREIDWS  257 (316)
T ss_pred             HHHhCCCCCCc----cCCHHHHHHHHHHhccC----HhhcCCChHHHHcCcccCCCCHH
Confidence            65544333332    35678899999999999    88888886 89999999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2e-45  Score=343.90  Aligned_cols=252  Identities=20%  Similarity=0.301  Sum_probs=202.8

Q ss_pred             eccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC
Q 015222          100 MGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL  175 (411)
Q Consensus       100 lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~  175 (411)
                      ||+|+||+||+|.++.+++.||+|++....    ...+.+..|+.+++.++|+++     +++.+++..++..|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i-----~~~~~~~~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFI-----VSLAYAFQTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcE-----eeeeEEEcCCCeEEEEEeCC
Confidence            699999999999999999999999986432    123456789999999988776     99999999999999999999


Q ss_pred             -CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccc
Q 015222          176 -GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK  252 (411)
Q Consensus       176 -~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~  252 (411)
                       +++|.+++...  ....+++..+..++.||+.||+|||++||+||||||+||+++.++                     
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~---------------------  134 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG---------------------  134 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC---------------------
Confidence             99999887542  224689999999999999999999999999999999999997766                     


Q ss_pred             cCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015222          253 NLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM  329 (411)
Q Consensus       253 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~  329 (411)
                            .++|+|||++......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus       135 ------~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~  208 (280)
T cd05608         135 ------NVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE  208 (280)
T ss_pred             ------CEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHH
Confidence                  5777888877543322   2234789999999999999999999999999999999999999986543322222


Q ss_pred             HHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH-----HHHHHHhcCCCCcccccC
Q 015222          330 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-----SMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       330 i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~-----t~~~il~~~~~~~~~~~~  387 (411)
                      +.......+..+...++..+.+++.+||+.+    |++|+     +++++++|+||+++.+..
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----P~~R~~~~~~~~~~~l~h~~~~~~~~~~  267 (280)
T cd05608         209 LKQRILNDSVTYPDKFSPASKSFCEALLAKD----PEKRLGFRDGNCDGLRTHPLFRDLNWRQ  267 (280)
T ss_pred             HHHhhcccCCCCcccCCHHHHHHHHHHhcCC----HHHhcCCCCCCHHHHhcChhhhcCCHhH
Confidence            2222112222333456788999999999999    77776     899999999999877654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-47  Score=351.90  Aligned_cols=283  Identities=20%  Similarity=0.306  Sum_probs=248.7

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc----hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      .+.|+.-+.||+||||.|+-++-+.||+.+|+|.+.+.    ........+|-.||++++.+.|     |.+--.|+..+
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~Fi-----VslaYAfeTkd  258 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFI-----VSLAYAFETKD  258 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcE-----EEEeeeecCCC
Confidence            45788999999999999999999999999999988642    2445667889999999988866     99888899999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      .+|+||..| ||+|.-.|...+...+++..++.++.+|+.||++||..+||.|||||+|||+|+.|              
T Consensus       259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~G--------------  324 (591)
T KOG0986|consen  259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHG--------------  324 (591)
T ss_pred             ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCC--------------
Confidence            999999999 99999888887777899999999999999999999999999999999999998877              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN  323 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~  323 (411)
                                   +++|+|+|+|.......  ...+||.+|||||++.++.|+...|+|||||+||||+.|+.||.....
T Consensus       325 -------------hvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke  391 (591)
T KOG0986|consen  325 -------------HVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE  391 (591)
T ss_pred             -------------CeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence                         67888888887654433  345899999999999999999999999999999999999999998877


Q ss_pred             HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcH-HHHHHHHhcCCCCcccccCCCCCchh-hHHHHHH
Q 015222          324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR-DSMRAVWKLLRLPVIDLYSASPNCLC-KFYAITH  401 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R-~t~~~il~~~~~~~~~~~~~~~~~~~-~~~~~~~  401 (411)
                      ...-+.+.+.....+..++...+++++++++.+|.+|+.+|-..| -.++++.+||+|++++|....-+.+. +|.+..+
T Consensus       392 Kvk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~  471 (591)
T KOG0986|consen  392 KVKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPG  471 (591)
T ss_pred             hhhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCcc
Confidence            776767777777888888889999999999999999988887777 78999999999999999998888777 6666666


Q ss_pred             HHhh
Q 015222          402 CLLC  405 (411)
Q Consensus       402 ~~~~  405 (411)
                      ...|
T Consensus       472 aVya  475 (591)
T KOG0986|consen  472 AVYA  475 (591)
T ss_pred             ccch
Confidence            5554

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3e-45  Score=349.70  Aligned_cols=257  Identities=22%  Similarity=0.294  Sum_probs=211.2

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      +|++.+.||+|+||+||+|+++.+++.||+|++.+..    ...+.+..|..++..+.|++    +++++++++...+.+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~----~i~~~~~~~~~~~~~   76 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP----FLTQLHSCFQTVDRL   76 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCC----chhheeeEEecCCEE
Confidence            4788999999999999999999999999999997532    22345667888888876643    347888999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      |+||||+ +++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++                
T Consensus        77 ~lv~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~----------------  138 (323)
T cd05615          77 YFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG----------------  138 (323)
T ss_pred             EEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC----------------
Confidence            9999999 999999998765  699999999999999999999999999999999999998766                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccC---CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                                 .++|+|||++.....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..
T Consensus       139 -----------~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~  207 (323)
T cd05615         139 -----------HIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED  207 (323)
T ss_pred             -----------CEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence                       567777777654321   123356899999999999989999999999999999999999999988877


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcH-HHHHHHHhcCCCCccccc
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR-DSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R-~t~~~il~~~~~~~~~~~  386 (411)
                      .....+.......|.    ..+..+.+++.+||..+|.+|+... ...+++++|+||..+++.
T Consensus       208 ~~~~~i~~~~~~~p~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~  266 (323)
T cd05615         208 ELFQSIMEHNVSYPK----SLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWD  266 (323)
T ss_pred             HHHHHHHhCCCCCCc----cCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHH
Confidence            777777665544443    3567889999999999944433322 236899999999998753

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-45  Score=351.15  Aligned_cols=258  Identities=26%  Similarity=0.383  Sum_probs=210.7

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++.+.||+|+||+||++++..+++.||+|++.+..    ...+.+.+|+.+++.+.|++|     +.+++++..+++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWI-----TNLHYAFQDENN   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCC-----CceEEEEecCCe
Confidence            47999999999999999999999999999999997422    233457789999998888877     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+||||+ +++|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|               
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~---------------  139 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG---------------  139 (331)
T ss_pred             EEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC---------------
Confidence            99999999 999999997643 3699999999999999999999999999999999999997766               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecC-----CCCCccchhHHHHHHHHHHHhCCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSGEAL  317 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltg~~p  317 (411)
                                  .++|+|||++.......    ....||+.|+|||++.+     ..++.++|||||||++|+|++|+.|
T Consensus       140 ------------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~P  207 (331)
T cd05597         140 ------------HIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP  207 (331)
T ss_pred             ------------CEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCC
Confidence                        67888888775433221    22468999999999873     3578899999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhC--CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          318 FQTHENLEHLAMMERVLG--PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      |.+.+..+....+.....  .++.. ...++..+++++.+||..  +..+..|++++++++|+||.+.++
T Consensus       208 f~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~~~li~~ll~~--~~~r~~r~~~~~~l~hp~~~~~~~  274 (331)
T cd05597         208 FYAESLVETYGKIMNHKEHFQFPPD-VTDVSEEAKDLIRRLICS--PETRLGRNGLQDFKDHPFFEGIDW  274 (331)
T ss_pred             CCCCCHHHHHHHHHcCCCcccCCCc-cCCCCHHHHHHHHHHccC--cccccCCCCHHHHhcCCCCCCCCH
Confidence            988777666665544322  22222 234678899999998854  333556899999999999988654

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.8e-45  Score=350.00  Aligned_cols=247  Identities=22%  Similarity=0.344  Sum_probs=207.2

Q ss_pred             EeeeccccceEEEEEEeC---CCCcEEEEEEeccch-----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           97 LSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        97 ~~~lG~G~~g~V~~a~~~---~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      ++.||+|+||.||+|++.   .+++.||+|+++...     .....+.+|+.+++.+.|+||     +++++.+..++.+
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i-----v~~~~~~~~~~~~   75 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI-----VDLIYAFQTGGKL   75 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCch-----hceeeEEecCCeE
Confidence            368999999999999864   478899999997532     223456789999999988877     9999999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      |+||||+ +++|.+++.+..  .+++..+..++.||+.||+|||++||+||||||+|||++.+|                
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~----------------  137 (323)
T cd05584          76 YLILEYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG----------------  137 (323)
T ss_pred             EEEEeCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC----------------
Confidence            9999999 899999998765  688999999999999999999999999999999999998766                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccC---CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                                 .+||+|||++.....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..
T Consensus       138 -----------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~  206 (323)
T cd05584         138 -----------HVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK  206 (323)
T ss_pred             -----------CEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH
Confidence                       567777777653221   123357899999999999988999999999999999999999999988877


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH-----HHHHHHhcCCCCcccc
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-----SMRAVWKLLRLPVIDL  385 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~-----t~~~il~~~~~~~~~~  385 (411)
                      ..+..+......+|.    ..+..+.++|.+||+.+    |++|+     ++.++++|+||....+
T Consensus       207 ~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~----p~~R~~~~~~~~~~l~~h~~~~~~~~  264 (323)
T cd05584         207 KTIDKILKGKLNLPP----YLTPEARDLLKKLLKRN----PSSRLGAGPGDAAEVQSHPFFRHVNW  264 (323)
T ss_pred             HHHHHHHcCCCCCCC----CCCHHHHHHHHHHcccC----HhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            766666655444443    35677899999999999    77777     8999999999987654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.6e-45  Score=352.48  Aligned_cols=247  Identities=20%  Similarity=0.321  Sum_probs=200.0

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeecCCeEEEEE
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF  172 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~~~~~~lv~  172 (411)
                      +.||+|+||.||+|++..+++.||+|++++..    .....+..|..++..+ +|++|     +++++++.+.+.+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~I-----v~~~~~~~~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFL-----VGLHSCFQTESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCC-----CceEEEEEcCCEEEEEE
Confidence            46899999999999999999999999997532    2334567889998888 46666     99999999999999999


Q ss_pred             ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCcc
Q 015222          173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF  251 (411)
Q Consensus       173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~  251 (411)
                      ||+ +++|.+++.+..  .+++..++.++.||+.||+|||++||+||||||+|||++.++                    
T Consensus        76 e~~~~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~--------------------  133 (329)
T cd05588          76 EFVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG--------------------  133 (329)
T ss_pred             eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC--------------------
Confidence            999 999999987664  799999999999999999999999999999999999998766                    


Q ss_pred             ccCCCCCCeeEeecCCcccc---cCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCC------
Q 015222          252 KNLPKSSAIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE------  322 (411)
Q Consensus       252 ~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~------  322 (411)
                             .++|+|||++...   ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....      
T Consensus       134 -------~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~  206 (329)
T cd05588         134 -------HIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD  206 (329)
T ss_pred             -------CEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccccc
Confidence                   5677777766532   112234579999999999999999999999999999999999999996321      


Q ss_pred             --hH-HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHH------HHHHHhcCCCCccccc
Q 015222          323 --NL-EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS------MRAVWKLLRLPVIDLY  386 (411)
Q Consensus       323 --~~-~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t------~~~il~~~~~~~~~~~  386 (411)
                        .. .....+......+|    ..++..+.++|.+||+.|    |.+|++      +.++++|+||.++++.
T Consensus       207 ~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~d----P~~R~~~~~~~~~~~i~~hp~~~~~~~~  271 (329)
T cd05588         207 QNTEDYLFQVILEKQIRIP----RSLSVKASSVLKGFLNKD----PKERLGCHPQTGFRDIKSHPFFRNIDWD  271 (329)
T ss_pred             ccchHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhccC----HHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence              11 12222333222333    345677899999999999    666665      8999999999987653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.4e-45  Score=355.37  Aligned_cols=254  Identities=25%  Similarity=0.379  Sum_probs=210.2

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC---
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN---  166 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~---  166 (411)
                      +|++.++||+|+||.||+|.+..+++.||||++...   ......+.+|+.+++.++|+||     +++++++...+   
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~   75 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNV-----LSALDILQPPHIDP   75 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCc-----CCHhheecCCCccc
Confidence            478899999999999999999999999999998642   2234567889999999998887     99999988766   


Q ss_pred             --eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          167 --HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       167 --~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                        ..|+||||++++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++             
T Consensus        76 ~~~~~lv~e~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~-------------  140 (372)
T cd07853          76 FEEIYVVTELMQSDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC-------------  140 (372)
T ss_pred             cceEEEEeeccccCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC-------------
Confidence              899999999889999887654  699999999999999999999999999999999999998776             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCC----CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQ  319 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~  319 (411)
                                    .+||+|||++......    .....+|..|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus       141 --------------~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  206 (372)
T cd07853         141 --------------VLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ  206 (372)
T ss_pred             --------------CEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCC
Confidence                          5667777766543221    1224678999999999875 58999999999999999999999999


Q ss_pred             CCChHHHHHHHHHHhCCCChhH----------------------------HHhhhhhhhhhhccCCccCCCCCCCcHHHH
Q 015222          320 THENLEHLAMMERVLGPLPHHM----------------------------VIRADRRAEKYFRRGARLDWPDGATSRDSM  371 (411)
Q Consensus       320 ~~~~~~~~~~i~~~~~~~p~~~----------------------------~~~~~~~~~~li~~~l~~~~~~rp~~R~t~  371 (411)
                      +.+..+.+..+....+..+...                            ....++.+.++|.+||..|    |.+|||+
T Consensus       207 ~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~d----P~~R~t~  282 (372)
T cd07853         207 AQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFD----PDKRISA  282 (372)
T ss_pred             CCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCC----hhhCcCH
Confidence            8887777776665544332211                            1123567889999999999    9999999


Q ss_pred             HHHHhcCCCCccc
Q 015222          372 RAVWKLLRLPVID  384 (411)
Q Consensus       372 ~~il~~~~~~~~~  384 (411)
                      .++++|+||.+..
T Consensus       283 ~e~l~hp~~~~~~  295 (372)
T cd07853         283 ADALAHPYLDEGR  295 (372)
T ss_pred             HHHhcCHhhCCCc
Confidence            9999999998754

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3e-45  Score=348.98  Aligned_cols=246  Identities=23%  Similarity=0.326  Sum_probs=206.9

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHh-cCCCCCcceEEEeeeeecCCeEEEEE
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNHICIVF  172 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~~~~~~~~~lv~  172 (411)
                      +.||+|+||+||+|.+..+++.||||++++..    .....+..|..+++.+. |+++     +++++++...+.+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i-----~~~~~~~~~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFL-----TQLHSCFQTKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCc-----cceeeEEEcCCEEEEEE
Confidence            46999999999999999999999999997532    23345667888888773 5555     99999999999999999


Q ss_pred             ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCcc
Q 015222          173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF  251 (411)
Q Consensus       173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~  251 (411)
                      ||+ +++|.+++.+..  .+++..+..++.||+.||.|||++||+||||||+|||++.++                    
T Consensus        76 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~--------------------  133 (318)
T cd05570          76 EYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG--------------------  133 (318)
T ss_pred             cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC--------------------
Confidence            999 999999988764  699999999999999999999999999999999999998766                    


Q ss_pred             ccCCCCCCeeEeecCCccccc---CCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015222          252 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA  328 (411)
Q Consensus       252 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~  328 (411)
                             .++|+|||++....   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...
T Consensus       134 -------~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~  206 (318)
T cd05570         134 -------HIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ  206 (318)
T ss_pred             -------cEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHH
Confidence                   56777777665321   11233568999999999999999999999999999999999999999887777666


Q ss_pred             HHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHH-----HHHHhcCCCCcccc
Q 015222          329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSM-----RAVWKLLRLPVIDL  385 (411)
Q Consensus       329 ~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~-----~~il~~~~~~~~~~  385 (411)
                      .+......+|.    ..+..+.++|.+||..|    |.+|+++     .++++|+||.++++
T Consensus       207 ~i~~~~~~~~~----~~~~~~~~li~~~l~~d----P~~R~s~~~~~~~~ll~~~~~~~~~~  260 (318)
T cd05570         207 SILEDEVRYPR----WLSKEAKSILKSFLTKN----PEKRLGCLPTGEQDIKGHPFFREIDW  260 (318)
T ss_pred             HHHcCCCCCCC----cCCHHHHHHHHHHccCC----HHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            66554444443    45678899999999999    9999998     99999999998765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.7e-45  Score=349.45  Aligned_cols=250  Identities=22%  Similarity=0.340  Sum_probs=205.6

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccchh----hhHHHHHHHH-HHHHHhcCCCCCcceEEEeeeeecCCeEEEEE
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEID-VLQRLARHDIGGTRCVQIRNWFDYRNHICIVF  172 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~----~~~~~~~E~~-~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~  172 (411)
                      +.||+|+||+||+|++..+++.||+|++.....    ....+..|.. +++.+.|++|     +++++++...+.+|+||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~I-----v~~~~~~~~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL-----VGLHFSFQTADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCC-----CceeEEEEcCCeEEEEE
Confidence            469999999999999999999999999975321    1223333433 4566666666     99999999999999999


Q ss_pred             ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCcc
Q 015222          173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF  251 (411)
Q Consensus       173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~  251 (411)
                      ||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++                    
T Consensus        76 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~--------------------  133 (325)
T cd05602          76 DYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG--------------------  133 (325)
T ss_pred             eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC--------------------
Confidence            999 899999998754  688999999999999999999999999999999999997766                    


Q ss_pred             ccCCCCCCeeEeecCCccccc---CCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015222          252 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA  328 (411)
Q Consensus       252 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~  328 (411)
                             .++|+|||++....   .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+.
T Consensus       134 -------~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  206 (325)
T cd05602         134 -------HIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD  206 (325)
T ss_pred             -------CEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHH
Confidence                   56777777765421   12234579999999999999999999999999999999999999999887777666


Q ss_pred             HHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       329 ~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      .+.......+    ..++..+.++|.+||+.||.+|++..+.+.++++|+||..+++
T Consensus       207 ~i~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~  259 (325)
T cd05602         207 NILNKPLQLK----PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW  259 (325)
T ss_pred             HHHhCCcCCC----CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence            6654333332    3567889999999999998888888888889999999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.8e-45  Score=342.26  Aligned_cols=258  Identities=22%  Similarity=0.344  Sum_probs=210.0

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+....    .....+.+|+.++++++|+++     +.+++.+.+++..
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i-----~~~~~~~~~~~~~   75 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFV-----VSLAYAYETKDAL   75 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCe-----eeeeEEEecCCEE
Confidence            3788899999999999999999999999999986432    223446679999999988877     9999999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      |+||||+ +++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++.++                
T Consensus        76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~----------------  139 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG----------------  139 (285)
T ss_pred             EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC----------------
Confidence            9999999 89999998765545699999999999999999999999999999999999997665                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                                 .++|+|||++.......  ....||..|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus       140 -----------~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~  208 (285)
T cd05630         140 -----------HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI  208 (285)
T ss_pred             -----------CEEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc
Confidence                       57788888776543222  23478999999999999899999999999999999999999998754322


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHH-----HHHHHhcCCCCccccc
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS-----MRAVWKLLRLPVIDLY  386 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t-----~~~il~~~~~~~~~~~  386 (411)
                      ............+.......+..+.+++.+||+.|    |.+|++     ++++++|+||..+++.
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----p~~R~s~~~~~~~~~~~h~~~~~~~~~  270 (285)
T cd05630         209 KREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKD----PKERLGCQGGGAREVKEHPLFKQINFK  270 (285)
T ss_pred             hHHHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcC----HHHccCCCCCchHHHHcChhhhccCHH
Confidence            22222222222222333456778899999999999    999998     9999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-46  Score=353.74  Aligned_cols=250  Identities=28%  Similarity=0.487  Sum_probs=223.9

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEecc---chhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe-
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH-  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~-  167 (411)
                      ++|.+++++|+|+||.+++++++..+..||+|.+.-   ....++.+.+|+.+++++.||||     |.+.+.|..++. 
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~i-----v~y~ds~~~~~~~   78 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNI-----VEYKDSFEEDGQL   78 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCe-----eeeccchhcCCce
Confidence            579999999999999999999999999999999963   33455678899999999999988     999999998887 


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +||||+|| ||+|.+.+.+.....++++.+..++.|++.|+.|||+++|+|||||+.|||++.++               
T Consensus        79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~---------------  143 (426)
T KOG0589|consen   79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK---------------  143 (426)
T ss_pred             EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC---------------
Confidence            99999999 99999999987777899999999999999999999999999999999999987765               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN  323 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~  323 (411)
                                  .|+|+|||+|+......   .+.+||+.||+||++.+.+|+.|+|||||||++|||++-+++|.+.+.
T Consensus       144 ------------~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m  211 (426)
T KOG0589|consen  144 ------------KVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM  211 (426)
T ss_pred             ------------ceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch
Confidence                        67889999988766543   557999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHHh-CCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCC
Q 015222          324 LEHLAMMERVL-GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP  381 (411)
Q Consensus       324 ~~~~~~i~~~~-~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~  381 (411)
                      .....+|.+.. .++|.    .++.+++.+++.||..+    |..||++.++|.+|.+.
T Consensus       212 ~~Li~ki~~~~~~Plp~----~ys~el~~lv~~~l~~~----P~~RPsa~~LL~~P~l~  262 (426)
T KOG0589|consen  212 SELILKINRGLYSPLPS----MYSSELRSLVKSMLRKN----PEHRPSALELLRRPHLL  262 (426)
T ss_pred             HHHHHHHhhccCCCCCc----cccHHHHHHHHHHhhcC----CccCCCHHHHhhChhhh
Confidence            88888888776 34443    45778999999999999    99999999999997766

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.5e-45  Score=350.49  Aligned_cols=259  Identities=24%  Similarity=0.360  Sum_probs=210.5

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++.+.||+|+||+||+++++.+++.||+|++.+..    .....+.+|..++..+.|++|     +.+++++.+.+.
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~l~~~~~~~~~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWI-----TTLHYAFQDENY   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEcCCE
Confidence            47999999999999999999999999999999987532    223446778888888877766     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      .|+||||+ +++|.+++.+.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++               
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~---------------  139 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG---------------  139 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC---------------
Confidence            99999999 999999998743 3689999999999999999999999999999999999997766               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecC-----CCCCccchhHHHHHHHHHHHhCCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSGEAL  317 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltg~~p  317 (411)
                                  .+||+|||++.......    ....||+.|+|||++.+     ..++.++|||||||++|||++|+.|
T Consensus       140 ------------~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~P  207 (331)
T cd05624         140 ------------HIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP  207 (331)
T ss_pred             ------------CEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCC
Confidence                        56777777775443221    22469999999999876     4678999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhC--CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          318 FQTHENLEHLAMMERVLG--PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                      |.+.+..+.+..+.....  .+|... ..+++.+++++.+||..+ .+ ...|++++++++|+||.++++.
T Consensus       208 f~~~~~~~~~~~i~~~~~~~~~p~~~-~~~~~~~~~li~~ll~~~-~~-~~~~~~~~~~~~h~~f~~~~~~  275 (331)
T cd05624         208 FYAESLVETYGKIMNHEERFQFPSHI-TDVSEEAKDLIQRLICSR-ER-RLGQNGIEDFKKHAFFEGIDWE  275 (331)
T ss_pred             ccCCCHHHHHHHHHcCCCcccCCCcc-ccCCHHHHHHHHHHccCc-hh-hcCCCCHHHHhcCCCcCCCCHH
Confidence            998777666666554322  233322 356788999999998754 22 2336799999999999987653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-45  Score=353.17  Aligned_cols=252  Identities=22%  Similarity=0.344  Sum_probs=205.4

Q ss_pred             eccccceEEEEEEeCCCCcEEEEEEeccchh----hhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC
Q 015222          100 MGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL  175 (411)
Q Consensus       100 lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~  175 (411)
                      ||+|+||+||+|+++.+++.||||++.+...    .......|..++..+...  .|++++.+++.+...+.+|+||||+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~--~~p~i~~~~~~~~~~~~~~lv~e~~   78 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLD--ESPFIVGLKFSFQTDSDLYLVTDYM   78 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccC--CCCcCcceEEEEecCCeEEEEEcCC
Confidence            7999999999999999999999999864321    222344566666655311  2345599999999999999999999


Q ss_pred             -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccC
Q 015222          176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL  254 (411)
Q Consensus       176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~  254 (411)
                       +++|.+++.+..  .+++..++.++.||+.||+|||++||+||||||+|||++.++                       
T Consensus        79 ~~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~-----------------------  133 (330)
T cd05586          79 SGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG-----------------------  133 (330)
T ss_pred             CCChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-----------------------
Confidence             999999988765  699999999999999999999999999999999999998766                       


Q ss_pred             CCCCCeeEeecCCcccccC---CCcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 015222          255 PKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM  330 (411)
Q Consensus       255 ~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i  330 (411)
                          .++|+|||++.....   ......||..|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus       134 ----~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i  209 (330)
T cd05586         134 ----HIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI  209 (330)
T ss_pred             ----CEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH
Confidence                567777877654221   12345799999999999765 5899999999999999999999999987777766666


Q ss_pred             HHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          331 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       331 ~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      ......++..   .+++.+.++|.+||..+|.+||+.++++.++++|+||.+.++
T Consensus       210 ~~~~~~~~~~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~  261 (330)
T cd05586         210 AFGKVRFPKN---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDW  261 (330)
T ss_pred             HcCCCCCCCc---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCH
Confidence            5544444432   357788999999999998888888889999999999988653

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.6e-44  Score=341.23  Aligned_cols=256  Identities=28%  Similarity=0.451  Sum_probs=212.2

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      ++|++.++||+|+||.||+|.++.+++.||+|.++...  .....+.+|+.+++.+.|+||     +++++++...+..+
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-----~~~~~~~~~~~~~~   80 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI-----VTLHDIIHTEKSLT   80 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCc-----ceEEEEEecCCeEE
Confidence            57999999999999999999999999999999986432  233457789999999988887     99999999999999


Q ss_pred             EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      +||||+.++|.+++.... ..+++..+..++.||+.||+|||+.||+|+||||+|||++.++                  
T Consensus        81 lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~------------------  141 (301)
T cd07873          81 LVFEYLDKDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG------------------  141 (301)
T ss_pred             EEEeccccCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCC------------------
Confidence            999999889999987654 3689999999999999999999999999999999999998766                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                               .++|+|||++......   .....+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+
T Consensus       142 ---------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~  212 (301)
T cd07873         142 ---------ELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE  212 (301)
T ss_pred             ---------cEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                     5677777766543221   1224578899999998765 58899999999999999999999999887776


Q ss_pred             HHHHHHHHhCCCChh--------------------------HHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCC
Q 015222          326 HLAMMERVLGPLPHH--------------------------MVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR  379 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~--------------------------~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~  379 (411)
                      ....+....+.....                          ....+++.++++|.+||..+    |.+|+|+.++++|+|
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~d----p~~R~t~~eil~h~~  288 (301)
T cd07873         213 QLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFE----GRKRISAEEAMKHPY  288 (301)
T ss_pred             HHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCC----cccCcCHHHHhcCcc
Confidence            666655544322211                          11235667889999999999    999999999999999


Q ss_pred             CCccc
Q 015222          380 LPVID  384 (411)
Q Consensus       380 ~~~~~  384 (411)
                      |....
T Consensus       289 f~~~~  293 (301)
T cd07873         289 FHCLG  293 (301)
T ss_pred             ccccc
Confidence            98765

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.3e-45  Score=347.81  Aligned_cols=251  Identities=22%  Similarity=0.317  Sum_probs=206.2

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHH-HHHHHhcCCCCCcceEEEeeeeecCCeEEEEE
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEID-VLQRLARHDIGGTRCVQIRNWFDYRNHICIVF  172 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~  172 (411)
                      +.||+|+||.||+|++..+++.||+|++.+..    .....+..|.. +++.+.|+|+     +++++.+.+.+..|+||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~i-----v~~~~~~~~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFL-----VGLHYSFQTAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCc-----cceeeEEEcCCEEEEEE
Confidence            47999999999999999999999999997432    22233444443 5667777766     99999999999999999


Q ss_pred             ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCcc
Q 015222          173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF  251 (411)
Q Consensus       173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~  251 (411)
                      ||+ +++|.+.+....  .+++..+..++.||+.||+|||++||+||||||+|||++.+|                    
T Consensus        76 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~--------------------  133 (321)
T cd05603          76 DYVNGGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG--------------------  133 (321)
T ss_pred             cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC--------------------
Confidence            999 899998887654  689999999999999999999999999999999999998776                    


Q ss_pred             ccCCCCCCeeEeecCCcccccC---CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015222          252 KNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA  328 (411)
Q Consensus       252 ~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~  328 (411)
                             .+||+|||++.....   ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+...
T Consensus       134 -------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  206 (321)
T cd05603         134 -------HVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD  206 (321)
T ss_pred             -------CEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHH
Confidence                   567777776654211   1233578999999999998899999999999999999999999999877666665


Q ss_pred             HHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       329 ~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                      .+......+|    ...+..+.++|.+||+.++.+|++.++++.++++|+||..+++.
T Consensus       207 ~i~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~  260 (321)
T cd05603         207 NILHKPLQLP----GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWD  260 (321)
T ss_pred             HHhcCCCCCC----CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHH
Confidence            5554333333    34567789999999999988888888889999999999877653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.7e-44  Score=354.88  Aligned_cols=250  Identities=24%  Similarity=0.384  Sum_probs=199.8

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      ...|.+.+.||+|+||.||+|.+..+++.||||....     ....+|+.++++++|+||     +++++++..++..++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~HpnI-----v~l~~~~~~~~~~~l  237 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLSHPAV-----LALLDVRVVGGLTCL  237 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCCCCCC-----CcEEEEEEECCEEEE
Confidence            4579999999999999999999999999999996432     335679999999998887     999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       171 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      |||++.++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++                   
T Consensus       238 v~e~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~-------------------  297 (461)
T PHA03211        238 VLPKYRSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE-------------------  297 (461)
T ss_pred             EEEccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC-------------------
Confidence            99999889999987653 3699999999999999999999999999999999999997766                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCC---
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE---  322 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~---  322 (411)
                              .++|+|||++......     .....||..|+|||++.+..++.++|||||||+||||++|..|+-...   
T Consensus       298 --------~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~  369 (461)
T PHA03211        298 --------DICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGD  369 (461)
T ss_pred             --------CEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCccc
Confidence                    5677777766543221     123469999999999999999999999999999999999876543211   


Q ss_pred             -----hHHHHHHHHHHhC---CCChh----H--------------------H---HhhhhhhhhhhccCCccCCCCCCCc
Q 015222          323 -----NLEHLAMMERVLG---PLPHH----M--------------------V---IRADRRAEKYFRRGARLDWPDGATS  367 (411)
Q Consensus       323 -----~~~~~~~i~~~~~---~~p~~----~--------------------~---~~~~~~~~~li~~~l~~~~~~rp~~  367 (411)
                           ..+....+.....   .++..    +                    +   ...+..+.++|.+||..|    |.+
T Consensus       370 ~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~D----P~~  445 (461)
T PHA03211        370 ERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFD----GAR  445 (461)
T ss_pred             ccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccC----hhh
Confidence                 1222233322211   11110    0                    0   123457889999999999    999


Q ss_pred             HHHHHHHHhcCCCCc
Q 015222          368 RDSMRAVWKLLRLPV  382 (411)
Q Consensus       368 R~t~~~il~~~~~~~  382 (411)
                      |||+.|+|+|+||++
T Consensus       446 RPsa~elL~hp~f~~  460 (461)
T PHA03211        446 RPSAAELLRLPLFQS  460 (461)
T ss_pred             CcCHHHHhhCcccCC
Confidence            999999999999975

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.4e-45  Score=350.23  Aligned_cols=246  Identities=20%  Similarity=0.318  Sum_probs=199.3

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeecCCeEEEEE
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF  172 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~~~~~~lv~  172 (411)
                      +.||+|+||.||+|+++.+++.||+|++++..    .....+..|+.++.++ .|+++     +++++++...+.+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~i-----v~~~~~~~~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL-----VGLHSCFQTESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcC-----CceeeEEEeCCEEEEEE
Confidence            46999999999999999999999999997532    2334567788888776 56666     99999999999999999


Q ss_pred             ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCcc
Q 015222          173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF  251 (411)
Q Consensus       173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~  251 (411)
                      ||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++                    
T Consensus        76 E~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~--------------------  133 (329)
T cd05618          76 EYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG--------------------  133 (329)
T ss_pred             eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC--------------------
Confidence            999 999999887664  699999999999999999999999999999999999998766                    


Q ss_pred             ccCCCCCCeeEeecCCccccc---CCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCC------
Q 015222          252 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE------  322 (411)
Q Consensus       252 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~------  322 (411)
                             .+||+|||++....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||....      
T Consensus       134 -------~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~  206 (329)
T cd05618         134 -------HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD  206 (329)
T ss_pred             -------CEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcc
Confidence                   57777777765421   12234579999999999999999999999999999999999999995211      


Q ss_pred             ---hHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHH------HHHHHhcCCCCcccc
Q 015222          323 ---NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS------MRAVWKLLRLPVIDL  385 (411)
Q Consensus       323 ---~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t------~~~il~~~~~~~~~~  385 (411)
                         .......+......+|    ...+..+.++|.+||+.|    |.+|++      +.++++||||.++++
T Consensus       207 ~~~~~~~~~~i~~~~~~~p----~~~~~~~~~ll~~~L~~d----P~~R~~~~~~~~~~~i~~hp~f~~~~~  270 (329)
T cd05618         207 QNTEDYLFQVILEKQIRIP----RSLSVKAASVLKSFLNKD----PKERLGCHPQTGFADIQGHPFFRNVDW  270 (329)
T ss_pred             cccHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhcCC----HHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence               1112222333223333    345677899999999999    666666      689999999998765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.1e-45  Score=346.66  Aligned_cols=279  Identities=32%  Similarity=0.589  Sum_probs=249.5

Q ss_pred             CCCCCCCceEEeeCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCC-CC
Q 015222           74 RPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI-GG  152 (411)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i-~~  152 (411)
                      ..++..|+|.+.+|+.+..+|.|....|+|-||+|.+|.+...|..||||+++.+....+.-..|++||++|+...- ..
T Consensus       414 NWdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk  493 (752)
T KOG0670|consen  414 NWDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDK  493 (752)
T ss_pred             CcccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhh
Confidence            45777899999999999999999999999999999999999999999999999888777888899999999987554 34


Q ss_pred             cceEEEeeeeecCCeEEEEEccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCc
Q 015222          153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE  231 (411)
Q Consensus       153 ~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~  231 (411)
                      .||++++..|.+.+|+|||+|-+.-+|.++|.+.+ +..|....++.++.|+..||..|-..||+|.||||+||||+.. 
T Consensus       494 ~Hclrl~r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~-  572 (752)
T KOG0670|consen  494 FHCLRLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNES-  572 (752)
T ss_pred             hHHHHHHHHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccC-
Confidence            68899999999999999999999999999998765 3468899999999999999999999999999999999999763 


Q ss_pred             ccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-cccccCCCccccceecCCCCCccchhHHHHHHHHH
Q 015222          232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE  310 (411)
Q Consensus       232 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e  310 (411)
                                               ...+||||||.|....... +.+.-+..|.|||++.|.+|+...|+||.||+|||
T Consensus       573 -------------------------k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYE  627 (752)
T KOG0670|consen  573 -------------------------KNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYE  627 (752)
T ss_pred             -------------------------cceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEE
Confidence                                     4479999999998876554 33556778999999999999999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHh----------------------------------------------
Q 015222          311 LCSGEALFQTHENLEHLAMMERVLGPLPHHMVIR----------------------------------------------  344 (411)
Q Consensus       311 lltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~----------------------------------------------  344 (411)
                      |.||+..|.|.++.+++..+..+.|.+|..+...                                              
T Consensus       628 lYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~  707 (752)
T KOG0670|consen  628 LYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIA  707 (752)
T ss_pred             eeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhc
Confidence            9999999999999999999999999998766431                                              


Q ss_pred             ----------hhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCc
Q 015222          345 ----------ADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       345 ----------~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~  382 (411)
                                .-..+++||.+||.+|    |++|.|..++|+||||..
T Consensus       708 ~q~~~deq~~~~~~~rdLLdkml~Ld----P~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  708 VQRLPDEQPKIVQQLRDLLDKMLILD----PEKRITVNQALKHPFITE  751 (752)
T ss_pred             cCCCCchhHHHHHHHHHHHHHHhccC----hhhcCCHHHHhcCCcccC
Confidence                      1135789999999999    999999999999999974

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5e-46  Score=353.33  Aligned_cols=244  Identities=23%  Similarity=0.337  Sum_probs=206.9

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF  172 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~  172 (411)
                      .++.+++||+|.||.||+|.+..+. .||+|.++......+.+.+|+++|++|+|+++     |++++++..++.+||||
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~~-~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~l-----V~l~gV~~~~~piyIVt  280 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGST-KVAVKTIKEGSMSPEAFLREAQIMKKLRHEKL-----VKLYGVCTKQEPIYIVT  280 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCCC-cccceEEeccccChhHHHHHHHHHHhCcccCe-----EEEEEEEecCCceEEEE
Confidence            3556789999999999999887553 59999998877777889999999999999988     99999999988999999


Q ss_pred             ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCcc
Q 015222          173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF  251 (411)
Q Consensus       173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~  251 (411)
                      ||+ .|+|.++|+......+...+...++.||++|++||+++++|||||-..||||+++.                    
T Consensus       281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~--------------------  340 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDL--------------------  340 (468)
T ss_pred             EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCc--------------------
Confidence            999 99999999986667899999999999999999999999999999999999998766                    


Q ss_pred             ccCCCCCCeeEeecCCcccccCCCcc----cccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHH
Q 015222          252 KNLPKSSAIKLIDFGSTTFEHQDHSY----VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEH  326 (411)
Q Consensus       252 ~~~~~~~~~kl~Dfg~a~~~~~~~~~----~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~  326 (411)
                             .+||+|||+|+....+...    ..-...|.|||.+..+.++.+||||||||+||||+| |+.||.+.+..+.
T Consensus       341 -------~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev  413 (468)
T KOG0197|consen  341 -------VVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV  413 (468)
T ss_pred             -------eEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH
Confidence                   6777888888754433322    122567999999999999999999999999999999 9999999999999


Q ss_pred             HHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHh
Q 015222          327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK  376 (411)
Q Consensus       327 ~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~  376 (411)
                      ++.+.++..-..       ++.+.+.|-..|..||..+|+.|||++.+..
T Consensus       414 ~~~le~GyRlp~-------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  414 LELLERGYRLPR-------PEGCPDEVYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             HHHHhccCcCCC-------CCCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence            999988643221       1234445555666779999999999996653

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=6.4e-45  Score=348.82  Aligned_cols=259  Identities=25%  Similarity=0.363  Sum_probs=210.1

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++.++||+|+||+||+++++.+++.||+|++.+..    .....+.+|+.++..+.|+++     +.+++.+.+.+.
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~   75 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWI-----TTLHYAFQDENN   75 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCE-----eeEEEEEecCCE
Confidence            46999999999999999999999999999999996422    223446778888888777666     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+||||+ +++|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++               
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~---------------  139 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG---------------  139 (332)
T ss_pred             EEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC---------------
Confidence            99999999 999999998743 3689999999999999999999999999999999999997766               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC----CcccccCCCccccceec-----CCCCCccchhHHHHHHHHHHHhCCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGEAL  317 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltg~~p  317 (411)
                                  .++|+|||++......    .....||+.|+|||++.     ...++.++|||||||++|||++|+.|
T Consensus       140 ------------~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~P  207 (332)
T cd05623         140 ------------HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP  207 (332)
T ss_pred             ------------CEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCC
Confidence                        5677777776543211    12347999999999986     34688999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhC--CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          318 FQTHENLEHLAMMERVLG--PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                      |.+.+..+.+..+.....  .+|.. ...++..+++++.+||..+  ..+..|+++.++++|+||.++++.
T Consensus       208 f~~~~~~~~~~~i~~~~~~~~~p~~-~~~~s~~~~~li~~ll~~~--~~r~~r~~~~~~~~h~~f~~~~~~  275 (332)
T cd05623         208 FYAESLVETYGKIMNHKERFQFPAQ-VTDVSEDAKDLIRRLICSR--EHRLGQNGIEDFKQHPFFTGIDWD  275 (332)
T ss_pred             CCCCCHHHHHHHHhCCCccccCCCc-cccCCHHHHHHHHHHccCh--hhhcCCCCHHHHhCCCCcCCCCHH
Confidence            998877777666654322  22322 2356788999999998654  224457899999999999988754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.5e-44  Score=337.36  Aligned_cols=259  Identities=20%  Similarity=0.300  Sum_probs=213.8

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      .|++.+.||+|+||+||+|.+..+++.||+|++....    .....+.+|+.++++++|+++     +.+.+.+..++..
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i-----~~~~~~~~~~~~~   75 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFV-----VNLAYAYETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCc-----eeEEEEEecCCEE
Confidence            3788899999999999999999999999999986432    223456789999999988877     9999999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      |+||||+ +++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||++++++                
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~----------------  139 (285)
T cd05632          76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG----------------  139 (285)
T ss_pred             EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC----------------
Confidence            9999999 89999888765545799999999999999999999999999999999999997655                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                                 .++|+|||++......  .....|+..|+|||++.+..++.++|||||||++|+|++|..||.+.....
T Consensus       140 -----------~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~  208 (285)
T cd05632         140 -----------HIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV  208 (285)
T ss_pred             -----------CEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                       5788888877543322  123578999999999998899999999999999999999999998776655


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHH-----HHHHHhcCCCCcccccC
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS-----MRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t-----~~~il~~~~~~~~~~~~  387 (411)
                      ....+..........+....+..+.+++.+|++.+    |.+|++     +.++++|+||.+..+..
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----P~~R~~~~~~~~~~l~~~~~~~~~~~~~  271 (285)
T cd05632         209 KREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKD----PKQRLGCQEEGAGEVKRHPFFRNMNFKR  271 (285)
T ss_pred             HHHHHHHhhhccccccCccCCHHHHHHHHHHccCC----HhHcCCCcccChHHHHcChhhhcCCHHH
Confidence            44444433333233334456778899999999999    777777     89999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.6e-45  Score=349.50  Aligned_cols=247  Identities=26%  Similarity=0.395  Sum_probs=209.0

Q ss_pred             eeeccccceEEEEEEe---CCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           98 SKMGEGTFGQVVECFD---NEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~---~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      +.||+|+||.||++++   ..+|+.||+|+++...   .......+|+.++++++|+||     +++++++..++.+|+|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI-----VKLHYAFQTEGKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCc-----ccEEEEEEcCCEEEEE
Confidence            6799999999999986   3578999999997533   233456779999999988877     9999999999999999


Q ss_pred             EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      |||+ +++|.+++.+..  .+++..++.++.||+.||+|||++||+||||||+|||++.++                   
T Consensus        77 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-------------------  135 (318)
T cd05582          77 LDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-------------------  135 (318)
T ss_pred             EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCC-------------------
Confidence            9999 899999997754  699999999999999999999999999999999999997766                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL  327 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~  327 (411)
                              .++|+|||++......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+..
T Consensus       136 --------~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~  207 (318)
T cd05582         136 --------HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM  207 (318)
T ss_pred             --------cEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH
Confidence                    5778888877654322   23357899999999999888999999999999999999999999988877777


Q ss_pred             HHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHH-----HHHHHhcCCCCccccc
Q 015222          328 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS-----MRAVWKLLRLPVIDLY  386 (411)
Q Consensus       328 ~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t-----~~~il~~~~~~~~~~~  386 (411)
                      ..+.+....+|.    .++..+.++|.+||+.|    |.+|++     +.++++|+||..+.+.
T Consensus       208 ~~i~~~~~~~p~----~~~~~~~~li~~~l~~~----P~~R~~a~~~~~~~~~~~~~~~~~~~~  263 (318)
T cd05582         208 TMILKAKLGMPQ----FLSPEAQSLLRALFKRN----PANRLGAGPDGVEEIKRHPFFSTIDWN  263 (318)
T ss_pred             HHHHcCCCCCCC----CCCHHHHHHHHHHhhcC----HhHcCCCCCCCHHHHhCCCCcCCCCHH
Confidence            766655544443    35677899999999999    888887     8889999999987543

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-46  Score=351.22  Aligned_cols=262  Identities=26%  Similarity=0.369  Sum_probs=229.6

Q ss_pred             CCeEE--EeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           92 PRYRI--LSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        92 ~~y~i--~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      .-|+|  .+.||+|.||+||-|.++.+|+.||||++.+..   +....+.+|+.||+.+.||+|     |.+.-.|+..+
T Consensus       562 tvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGi-----V~le~M~ET~e  636 (888)
T KOG4236|consen  562 TVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGI-----VNLECMFETPE  636 (888)
T ss_pred             HHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCe-----eEEEEeecCCc
Confidence            34665  378999999999999999999999999997532   455778899999999999988     99999999999


Q ss_pred             eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          167 HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       167 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      .+++|||.+.|+..+.+......+|++...+.++.||+.||.|||-++|+|+||||+|||+.+.                
T Consensus       637 rvFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~----------------  700 (888)
T KOG4236|consen  637 RVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASA----------------  700 (888)
T ss_pred             eEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccC----------------
Confidence            9999999997787777766666789999999999999999999999999999999999999764                


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                              +...++||||||+|+++.+.  ....+||+.|+|||++.++.|+..-|+||.|||+|.-++|..||...++ 
T Consensus       701 --------~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-  771 (888)
T KOG4236|consen  701 --------SPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-  771 (888)
T ss_pred             --------CCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-
Confidence                    35568999999999998755  3567999999999999999999999999999999999999999975443 


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccCC
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSA  388 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~  388 (411)
                       +-..|++..--.|...|..++.++.++|..+|+..    -.+|.++...+.|+|+++-..|..
T Consensus       772 -IndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVk----m~kRysvdk~lsh~Wlq~yq~w~D  830 (888)
T KOG4236|consen  772 -INDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVK----MRKRYSVDKSLSHPWLQDYQTWLD  830 (888)
T ss_pred             -hhHHhhccccccCCCchhhcCHHHHHHHHHHHHHH----HHHhcchHhhccchhhhcchHHHH
Confidence             44555555556777888999999999999999999    889999999999999998776654

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-44  Score=349.35  Aligned_cols=250  Identities=24%  Similarity=0.404  Sum_probs=199.7

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      .+|++++.||+|+||.||+|++..+++.||+|+....     ....|+.++++++|+||     +++++++...+..++|
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~lv  135 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSV-----IRMKDTLVSGAITCMV  135 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCC-----cChhheEEeCCeeEEE
Confidence            4799999999999999999999999999999986432     23468999999988877     9999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCcc
Q 015222          172 FEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF  251 (411)
Q Consensus       172 ~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~  251 (411)
                      ||++.++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++                    
T Consensus       136 ~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~--------------------  194 (357)
T PHA03209        136 LPHYSSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD--------------------  194 (357)
T ss_pred             EEccCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--------------------
Confidence            9999889999987654 4699999999999999999999999999999999999997766                    


Q ss_pred             ccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhC-CCCCCCCCh-----
Q 015222          252 KNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG-EALFQTHEN-----  323 (411)
Q Consensus       252 ~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg-~~pf~~~~~-----  323 (411)
                             .++|+|||++......  .....||..|+|||++.+..++.++|||||||++|||+++ ..+|.....     
T Consensus       195 -------~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~  267 (357)
T PHA03209        195 -------QVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEY  267 (357)
T ss_pred             -------CEEEecCccccccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHH
Confidence                   5778888877643222  2335789999999999999999999999999999999985 444543211     


Q ss_pred             ----HHHHHHHHHHhCCCChhHH------------------------------HhhhhhhhhhhccCCccCCCCCCCcHH
Q 015222          324 ----LEHLAMMERVLGPLPHHMV------------------------------IRADRRAEKYFRRGARLDWPDGATSRD  369 (411)
Q Consensus       324 ----~~~~~~i~~~~~~~p~~~~------------------------------~~~~~~~~~li~~~l~~~~~~rp~~R~  369 (411)
                          ...+..+....+..|..+.                              ...+..+.++|.+||+.|    |.+||
T Consensus       268 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~d----P~~Rp  343 (357)
T PHA03209        268 VKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFD----AAMRP  343 (357)
T ss_pred             HHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCC----cccCc
Confidence                1122222222222221111                              123456677999999999    99999


Q ss_pred             HHHHHHhcCCCCcc
Q 015222          370 SMRAVWKLLRLPVI  383 (411)
Q Consensus       370 t~~~il~~~~~~~~  383 (411)
                      |+.|+++||||+++
T Consensus       344 ta~e~l~hp~f~~~  357 (357)
T PHA03209        344 SAEEILNYPMFAQL  357 (357)
T ss_pred             CHHHHhcCchhccC
Confidence            99999999999874

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.9e-44  Score=345.64  Aligned_cols=256  Identities=23%  Similarity=0.358  Sum_probs=208.8

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      .++|++.++||+|+||.||+|.+..++..||+|++...  ......+.+|+++++.+.|+||     +++++++..++++
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~   78 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI-----VGFYGAFYSDGEI   78 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcc-----cceeEEEEECCEE
Confidence            47899999999999999999999999999999998743  2344668899999999988877     9999999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      ++||||+ +++|.+++....  .+++..+..++.||+.||.|||+. +|+|+||||+|||++.+|               
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~---------------  141 (333)
T cd06650          79 SICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG---------------  141 (333)
T ss_pred             EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC---------------
Confidence            9999999 999999998765  689999999999999999999985 799999999999998766               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC-CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                                  .+||+|||++...... .....||..|+|||++.+..++.++|||||||++|+|++|+.||...+..+
T Consensus       142 ------------~~kL~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~  209 (333)
T cd06650         142 ------------EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE  209 (333)
T ss_pred             ------------CEEEeeCCcchhhhhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH
Confidence                        5778888877643222 234578999999999998889999999999999999999999997654433


Q ss_pred             HHHHHH-----------------------------------------HHhC-CCChhHHHhhhhhhhhhhccCCccCCCC
Q 015222          326 HLAMME-----------------------------------------RVLG-PLPHHMVIRADRRAEKYFRRGARLDWPD  363 (411)
Q Consensus       326 ~~~~i~-----------------------------------------~~~~-~~p~~~~~~~~~~~~~li~~~l~~~~~~  363 (411)
                      ....+.                                         .... ..+.......+.++.+++.+||+.|   
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~---  286 (333)
T cd06650         210 LELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKN---  286 (333)
T ss_pred             HHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCC---
Confidence            221110                                         0000 0000001124567889999999999   


Q ss_pred             CCCcHHHHHHHHhcCCCCccc
Q 015222          364 GATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       364 rp~~R~t~~~il~~~~~~~~~  384 (411)
                       |++||++.++++|+||+...
T Consensus       287 -P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         287 -PAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             -cccCcCHHHHhhCHHHhcCc
Confidence             99999999999999998754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=9e-45  Score=347.04  Aligned_cols=248  Identities=20%  Similarity=0.305  Sum_probs=200.3

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHh-cCCCCCcceEEEeeeeecCCeEEEEE
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNHICIVF  172 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~~~~~~~~~lv~  172 (411)
                      +.||+|+||+||+|++..+++.||+|++++..    ...+.+.+|+.++.++. |++     ++.+++++...+.+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~-----i~~~~~~~~~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPF-----LVGLHSCFQTTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCC-----EeeEEEEEEeCCEEEEEE
Confidence            47999999999999999999999999997532    23445678888888884 554     499999999999999999


Q ss_pred             ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCcc
Q 015222          173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF  251 (411)
Q Consensus       173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~  251 (411)
                      ||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++                    
T Consensus        76 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~--------------------  133 (327)
T cd05617          76 EYVNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG--------------------  133 (327)
T ss_pred             eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCC--------------------
Confidence            999 999999887664  699999999999999999999999999999999999998776                    


Q ss_pred             ccCCCCCCeeEeecCCccccc---CCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCC------
Q 015222          252 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE------  322 (411)
Q Consensus       252 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~------  322 (411)
                             .+||+|||++....   ......+||+.|+|||++.+..++.++|||||||++|||++|..||....      
T Consensus       134 -------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~  206 (327)
T cd05617         134 -------HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN  206 (327)
T ss_pred             -------CEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc
Confidence                   56777777765421   12234579999999999999999999999999999999999999996422      


Q ss_pred             hHH-HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHH------HHHHHhcCCCCcccccC
Q 015222          323 NLE-HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS------MRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       323 ~~~-~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t------~~~il~~~~~~~~~~~~  387 (411)
                      ..+ ....+......+    ....+..+.+++.+||+.|    |.+|++      +.++++|+||..+++..
T Consensus       207 ~~~~~~~~~~~~~~~~----p~~~~~~~~~li~~~L~~d----P~~R~~~~~~~~~~~i~~h~~f~~~~~~~  270 (327)
T cd05617         207 TEDYLFQVILEKPIRI----PRFLSVKASHVLKGFLNKD----PKERLGCQPQTGFSDIKSHTFFRSIDWDL  270 (327)
T ss_pred             cHHHHHHHHHhCCCCC----CCCCCHHHHHHHHHHhccC----HHHcCCCCCCCCHHHHHcCCCCCCCCHHH
Confidence            112 222222222223    3346678899999999999    666665      68999999999887543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.5e-44  Score=340.07  Aligned_cols=251  Identities=24%  Similarity=0.434  Sum_probs=195.4

Q ss_pred             EeeeccccceEEEEEEeC--CCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec--CCeEEEEE
Q 015222           97 LSKMGEGTFGQVVECFDN--EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--RNHICIVF  172 (411)
Q Consensus        97 ~~~lG~G~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~--~~~~~lv~  172 (411)
                      .++||+|+||+||+|+++  .+++.||+|.+.... ......+|+.++++++|+|+     +++++++..  +..+|+||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNV-----ISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCC-----cceeeeEecCCCcEEEEEE
Confidence            358999999999999975  467899999987543 23457789999999998887     999988854  46789999


Q ss_pred             ccCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          173 EKLGPSLYDFLRKNS-------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       173 e~~~~~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      ||++++|.+++....       ...+++..++.++.||+.||+|||++||+||||||+|||+..++              
T Consensus        80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~--------------  145 (317)
T cd07868          80 DYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG--------------  145 (317)
T ss_pred             eccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCC--------------
Confidence            999889999886431       12589999999999999999999999999999999999995432              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCC------CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALF  318 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf  318 (411)
                               +.+..+||+|||++......      .....||+.|+|||++.+. .++.++|||||||++|||++|++||
T Consensus       146 ---------~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f  216 (317)
T cd07868         146 ---------PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF  216 (317)
T ss_pred             ---------CCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCc
Confidence                     13347899999988764332      1235789999999999875 6899999999999999999999999


Q ss_pred             CCCCh---------HHHHHHHHHHhCCCChhHHH----------------------------------hhhhhhhhhhcc
Q 015222          319 QTHEN---------LEHLAMMERVLGPLPHHMVI----------------------------------RADRRAEKYFRR  355 (411)
Q Consensus       319 ~~~~~---------~~~~~~i~~~~~~~p~~~~~----------------------------------~~~~~~~~li~~  355 (411)
                      .+...         .+.+..+....+..+...+.                                  ..+..+.++|.+
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~  296 (317)
T cd07868         217 HCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQK  296 (317)
T ss_pred             cCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHH
Confidence            75432         22333333333222111111                                  113457789999


Q ss_pred             CCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          356 GARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       356 ~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      ||..|    |.+|+|++|+++||||
T Consensus       297 mL~~d----P~~R~t~~e~l~hp~f  317 (317)
T cd07868         297 LLTMD----PIKRITSEQAMQDPYF  317 (317)
T ss_pred             HhccC----cccCCCHHHHhcCCCC
Confidence            99999    9999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.6e-44  Score=348.13  Aligned_cols=257  Identities=23%  Similarity=0.373  Sum_probs=205.8

Q ss_pred             CCccCCCeEEEeeeccccceEEEEEEeC--CCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           87 GENLTPRYRILSKMGEGTFGQVVECFDN--EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        87 ~~~~~~~y~i~~~lG~G~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      ...+..+|++++.||+|+||.||+|...  .+++.||+|.+...    ....+|+.++++++|++|     +++++++..
T Consensus        87 ~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~i-----v~~~~~~~~  157 (392)
T PHA03207         87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAI-----INLIHAYRW  157 (392)
T ss_pred             chhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCc-----cceeeeEee
Confidence            3345678999999999999999999764  45678999998643    234679999999998887     999999999


Q ss_pred             CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          165 RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       165 ~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      .+..|+|||+++++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++             
T Consensus       158 ~~~~~lv~e~~~~~l~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~-------------  222 (392)
T PHA03207        158 KSTVCMVMPKYKCDLFTYVDRSG--PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE-------------  222 (392)
T ss_pred             CCEEEEEehhcCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-------------
Confidence            99999999999889999996544  799999999999999999999999999999999999998776             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ  319 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~  319 (411)
                                    .++|+|||++.......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       223 --------------~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~  288 (392)
T PHA03207        223 --------------NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLF  288 (392)
T ss_pred             --------------CEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence                          56677777665432221     23579999999999999899999999999999999999999997


Q ss_pred             CCCh---HHHHHHHHHHhCCCChhHH------------------------------HhhhhhhhhhhccCCccCCCCCCC
Q 015222          320 THEN---LEHLAMMERVLGPLPHHMV------------------------------IRADRRAEKYFRRGARLDWPDGAT  366 (411)
Q Consensus       320 ~~~~---~~~~~~i~~~~~~~p~~~~------------------------------~~~~~~~~~li~~~l~~~~~~rp~  366 (411)
                      +...   ...+..+.+..+..+..+.                              ...+..+.++|.+||..+    |.
T Consensus       289 ~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~d----p~  364 (392)
T PHA03207        289 GKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFD----QE  364 (392)
T ss_pred             CCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccC----hh
Confidence            6532   2333333333222111100                              123456788999999999    99


Q ss_pred             cHHHHHHHHhcCCCCcccc
Q 015222          367 SRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       367 ~R~t~~~il~~~~~~~~~~  385 (411)
                      +||++.+++.||||....+
T Consensus       365 ~Rpsa~e~l~~p~f~~~~~  383 (392)
T PHA03207        365 FRPSAQDILSLPLFTKEPI  383 (392)
T ss_pred             hCCCHHHHhhCchhhccch
Confidence            9999999999999987554

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.6e-44  Score=334.21  Aligned_cols=256  Identities=21%  Similarity=0.333  Sum_probs=201.5

Q ss_pred             eccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC
Q 015222          100 MGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL  175 (411)
Q Consensus       100 lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~  175 (411)
                      ||+|+||.||+++++.+|+.||+|.+....    ........|++++++++|+++     ++++++++.+.+.|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i-----~~~~~~~~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFI-----VNLAYAFESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcE-----EEEEEEEecCCeEEEEEecC
Confidence            799999999999999999999999986422    123345669999999988776     99999999999999999999


Q ss_pred             -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccC
Q 015222          176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL  254 (411)
Q Consensus       176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~  254 (411)
                       +++|.+++.......+++..+..++.||+.||+|||+.||+||||||+||+++.++                       
T Consensus        76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-----------------------  132 (277)
T cd05607          76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG-----------------------  132 (277)
T ss_pred             CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC-----------------------
Confidence             99999988766555689999999999999999999999999999999999997766                       


Q ss_pred             CCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHH
Q 015222          255 PKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH-LAMME  331 (411)
Q Consensus       255 ~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-~~~i~  331 (411)
                          .++|+|||++.......  ....||..|+|||++.+..++.++|||||||++|||++|+.||........ .....
T Consensus       133 ----~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~  208 (277)
T cd05607         133 ----NCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR  208 (277)
T ss_pred             ----CEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHH
Confidence                56777777765543222  234689999999999998999999999999999999999999976533211 11111


Q ss_pred             HHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          332 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       332 ~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                      .............++..+.+++.+||+.+|.+||+.+..+++++.|+||+.+++..
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~  264 (277)
T cd05607         209 RTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPR  264 (277)
T ss_pred             HhhccccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHH
Confidence            21111111112356788999999999999554444444448899999999887543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-45  Score=323.50  Aligned_cols=266  Identities=24%  Similarity=0.358  Sum_probs=227.7

Q ss_pred             CCeEEE-eeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           92 PRYRIL-SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        92 ~~y~i~-~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      +-|++. +.||+|+|+.|--+....++..+|||++.+.. ..+..+.+|++++.+..    +|+||++++++|+++..+|
T Consensus        77 d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cq----gh~nilqLiefFEdd~~FY  152 (463)
T KOG0607|consen   77 DMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQ----GHKNILQLIEFFEDDTRFY  152 (463)
T ss_pred             HHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhc----CCccHHHHHHHhcccceEE
Confidence            345553 57899999999999999999999999997654 45677889999998875    4466699999999999999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      ||||.+ ||+|...|+++.  .+++.++.++.++|+.||.|||.+||.||||||+|||-.+.+                 
T Consensus       153 LVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn-----------------  213 (463)
T KOG0607|consen  153 LVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPN-----------------  213 (463)
T ss_pred             EEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCC-----------------
Confidence            999999 999999999876  699999999999999999999999999999999999987654                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccC----------CCcccccCCCccccceec---CC--CCCccchhHHHHHHHHHHHh
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQ----------DHSYVVSTRHYRAPEVIL---GL--GWNYPCDLWSVGCILVELCS  313 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~----------~~~~~~gt~~y~aPE~~~---~~--~~~~~~DiwSlGvil~ellt  313 (411)
                             .-.-+|||||.+..-...          ...+.+|+..|||||+..   +.  .|+.+.|.||||||||-||+
T Consensus       214 -------~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLs  286 (463)
T KOG0607|consen  214 -------KVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLS  286 (463)
T ss_pred             -------CcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHh
Confidence                   223688888877653221          123468999999999864   32  58999999999999999999


Q ss_pred             CCCCCCCCC---------------hHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          314 GEALFQTHE---------------NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       314 g~~pf~~~~---------------~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      |.+||.+.-               ....++.|+.+...+|+.-|..++.++++++..+|..+    +..|.++.++++||
T Consensus       287 GYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrd----a~~rlsa~~vlnhP  362 (463)
T KOG0607|consen  287 GYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRD----AKQRLSAAQVLNHP  362 (463)
T ss_pred             CCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhcc----HHhhhhhhhccCCc
Confidence            999998652               24567888999999999999999999999999999999    99999999999999


Q ss_pred             CCCcccccCCCCC
Q 015222          379 RLPVIDLYSASPN  391 (411)
Q Consensus       379 ~~~~~~~~~~~~~  391 (411)
                      |++.+....+.|.
T Consensus       363 w~~~~~~ekalpt  375 (463)
T KOG0607|consen  363 WVQRCAPEKALPT  375 (463)
T ss_pred             cccccchhccCCC
Confidence            9998887755444

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-47  Score=334.52  Aligned_cols=255  Identities=22%  Similarity=0.365  Sum_probs=217.7

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF  172 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~  172 (411)
                      -|.++++||+|+||.||+|.++++|+.||||.+.. ....+++.+|+.|+++...+.+     |++|+.|-....++|||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC~S~yV-----VKYYGSYFK~sDLWIVM  107 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQCKSKYV-----VKYYGSYFKHSDLWIVM  107 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHcCCchh-----hhhhhhhccCCceEeeh
Confidence            48899999999999999999999999999999854 3456778999999999988776     99999988888999999


Q ss_pred             ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCcc
Q 015222          173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF  251 (411)
Q Consensus       173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~  251 (411)
                      ||| .|++.|.++.+. ..|++.++..+++..+.||+|||...-||||||..|||++-+|                    
T Consensus       108 EYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G--------------------  166 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG--------------------  166 (502)
T ss_pred             hhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc--------------------
Confidence            999 899999998655 5799999999999999999999999999999999999998887                    


Q ss_pred             ccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015222          252 KNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA  328 (411)
Q Consensus       252 ~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~  328 (411)
                             ..||+|||.|......   .++..||+.|||||++..-.|+.++||||||++..||..|++||.+-.....+.
T Consensus       167 -------~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF  239 (502)
T KOG0574|consen  167 -------IAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF  239 (502)
T ss_pred             -------hhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE
Confidence                   5677777777654433   356789999999999999999999999999999999999999998766654443


Q ss_pred             HHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       329 ~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                      .|-. .++....-...+++++.+|++.||.+.    |++|.|+.++++|+|+++....
T Consensus       240 MIPT-~PPPTF~KPE~WS~~F~DFi~~CLiK~----PE~R~TA~~L~~H~FiknA~g~  292 (502)
T KOG0574|consen  240 MIPT-KPPPTFKKPEEWSSEFNDFIRSCLIKK----PEERKTALRLCEHTFIKNAPGC  292 (502)
T ss_pred             eccC-CCCCCCCChHhhhhHHHHHHHHHhcCC----HHHHHHHHHHhhhhhhcCCCcc
Confidence            3322 112222334567889999999999999    9999999999999999986543

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.1e-43  Score=333.73  Aligned_cols=255  Identities=25%  Similarity=0.401  Sum_probs=218.3

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....    ...+.+.+|+++++++.|+|+     +++++++..++.
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~   75 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFL-----VNLYGSFQDDSN   75 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCc-----cceeeEEEcCCe
Confidence            46999999999999999999999999999999986432    344667889999999988877     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      .++||||+ +++|.+++....  .+++..+..++.||+.||.|||+.||+|+||+|+|||++.++               
T Consensus        76 ~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~---------------  138 (290)
T cd05580          76 LYLVMEYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG---------------  138 (290)
T ss_pred             EEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC---------------
Confidence            99999999 999999998765  799999999999999999999999999999999999997766               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH  326 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~  326 (411)
                                  .++|+|||++...........|++.|+|||.+.+...+.++||||||+++|+|++|+.||...+..+.
T Consensus       139 ------------~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~  206 (290)
T cd05580         139 ------------YIKITDFGFAKRVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI  206 (290)
T ss_pred             ------------CEEEeeCCCccccCCCCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                        57888888777655555556789999999999888899999999999999999999999988776555


Q ss_pred             HHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH-----HHHHHHhcCCCCcccccCC
Q 015222          327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-----SMRAVWKLLRLPVIDLYSA  388 (411)
Q Consensus       327 ~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~-----t~~~il~~~~~~~~~~~~~  388 (411)
                      ...+......+|.    ..+..+.++|.+||..+    |.+|+     +++++++|+||..+.+...
T Consensus       207 ~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~----p~~R~~~~~~~~~~l~~~~~~~~~~~~~~  265 (290)
T cd05580         207 YEKILEGKVRFPS----FFSPDAKDLIRNLLQVD----LTKRLGNLKNGVNDIKNHPWFAGIDWIAL  265 (290)
T ss_pred             HHHHhcCCccCCc----cCCHHHHHHHHHHccCC----HHHccCcccCCHHHHHcCcccccCCHHHH
Confidence            5555544434443    34678899999999999    66666     9999999999998875443

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.6e-43  Score=341.97  Aligned_cols=262  Identities=27%  Similarity=0.457  Sum_probs=214.0

Q ss_pred             ceEEeeCC---ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcc
Q 015222           81 HYVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTR  154 (411)
Q Consensus        81 ~~~~~~~~---~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~  154 (411)
                      ++++.+|+   .+.++|++.+.||+|+||.||+|.+..+++.||||++...   ......+.+|+.++++++|+|+    
T Consensus         2 ~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i----   77 (353)
T cd07850           2 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNI----   77 (353)
T ss_pred             ceeecccchhhhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCC----
Confidence            45666766   4578999999999999999999999999999999998642   2334556789999999988887    


Q ss_pred             eEEEeeeeecC------CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015222          155 CVQIRNWFDYR------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV  228 (411)
Q Consensus       155 iv~~~~~~~~~------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~  228 (411)
                       +++++++...      .+.|+||||+.++|.+.+...    +++..+..++.||+.||+|||++||+||||||+||+++
T Consensus        78 -v~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~  152 (353)
T cd07850          78 -IGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK  152 (353)
T ss_pred             -cceeeeeccCCCccccCcEEEEEeccCCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC
Confidence             8888887543      367999999988999988652    88999999999999999999999999999999999998


Q ss_pred             cCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCCCccchhHHHHH
Q 015222          229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGC  306 (411)
Q Consensus       229 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  306 (411)
                      .++                           .++|+|||++.......  ....++..|+|||++.+..++.++|||||||
T Consensus       153 ~~~---------------------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~  205 (353)
T cd07850         153 SDC---------------------------TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC  205 (353)
T ss_pred             CCC---------------------------CEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHH
Confidence            766                           56777777766543322  2346788999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHHH---------------------------------------hhhh
Q 015222          307 ILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVI---------------------------------------RADR  347 (411)
Q Consensus       307 il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~---------------------------------------~~~~  347 (411)
                      ++|+|++|+.||...+.......+....+..+..+..                                       ..++
T Consensus       206 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (353)
T cd07850         206 IMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKAS  285 (353)
T ss_pred             HHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchh
Confidence            9999999999999887766666655544443332211                                       1244


Q ss_pred             hhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCc
Q 015222          348 RAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       348 ~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~  382 (411)
                      .+.++|.+||..|    |++||++.++|+|+||..
T Consensus       286 ~~~~li~~~L~~d----P~~R~t~~eiL~~~~~~~  316 (353)
T cd07850         286 QARDLLSKMLVID----PEKRISVDDALQHPYINV  316 (353)
T ss_pred             HHHHHHHHHcCCC----hhhCcCHHHHhcChhHhh
Confidence            5789999999999    999999999999998874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.9e-44  Score=331.47  Aligned_cols=249  Identities=32%  Similarity=0.519  Sum_probs=205.8

Q ss_pred             eEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHH---HHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA---AMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        94 y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~---~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      |++.+.||+|+||+||++.+..+++.||+|++.........   ..+|+.+++++.|+++     +++++++.+.+..++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i-----~~~~~~~~~~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNI-----VQILDVFQDDNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTB-----CHEEEEEEESSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccc-----ccccccccccccccc
Confidence            89999999999999999999999999999999865533332   3459999999988887     999999999999999


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      |||++ +++|.+++....  .+++..+..++.||+.||++||++||+|+||||+||+++.++                  
T Consensus        76 v~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~------------------  135 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENG------------------  135 (260)
T ss_dssp             EEEEETTEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTS------------------
T ss_pred             cccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccc------------------
Confidence            99999 669999998544  699999999999999999999999999999999999998766                  


Q ss_pred             ccccCCCCCCeeEeecCCcccc---cCCCcccccCCCccccceec-CCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                               .++|+|||.+...   ........+|..|+|||++. +..++.++||||||+++|+|++|..||......+
T Consensus       136 ---------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~  206 (260)
T PF00069_consen  136 ---------EVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD  206 (260)
T ss_dssp             ---------EEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH
T ss_pred             ---------ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchh
Confidence                     5677777777542   22223457899999999998 7789999999999999999999999999875444


Q ss_pred             HHHHHHHHhCCCChhHH---HhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          326 HLAMMERVLGPLPHHMV---IRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~---~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      ....+.+..........   ......+.+++.+||..+    |++||++.++++||||
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~----p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  207 QLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKD----PEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSS----GGGSTTHHHHHTSGGG
T ss_pred             hhhhhhhcccccccccccccchhHHHHHHHHHHHccCC----hhHCcCHHHHhcCCCC
Confidence            44444443322111111   112378999999999999    9999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.1e-43  Score=330.63  Aligned_cols=252  Identities=29%  Similarity=0.459  Sum_probs=203.4

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      +|++.+.||+|++|.||+|++..+++.||+|+++...   .....+.+|+.+++++.|+++     +++++++..++..|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI-----VCLQDVLMQESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCE-----eeeEEEEeeCCeEE
Confidence            4899999999999999999999999999999986432   234567889999999987776     99999999999999


Q ss_pred             EEEccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKLGPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +||||+.++|.+++.... ...+++..++.++.||+.||+|||++||+|+||||+||+++.+|                 
T Consensus        76 ~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-----------------  138 (285)
T cd07861          76 LIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKG-----------------  138 (285)
T ss_pred             EEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCC-----------------
Confidence            999999779999887543 24689999999999999999999999999999999999998877                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                                .++|+|||++.......   ....+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..
T Consensus       139 ----------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~  208 (285)
T cd07861         139 ----------VIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI  208 (285)
T ss_pred             ----------cEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence                      45666666554332111   223568899999998765 5789999999999999999999999887665


Q ss_pred             HHHHHHHHHhCCCChh-------------------------HHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCC
Q 015222          325 EHLAMMERVLGPLPHH-------------------------MVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR  379 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~-------------------------~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~  379 (411)
                      +....+.+..+.....                         ....++.++.++|.+||..|    |.+|||+.++++|+|
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d----P~~Rpt~~~ll~~~~  284 (285)
T cd07861         209 DQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYD----PAKRISAKKALNHPY  284 (285)
T ss_pred             HHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCC----hhhCCCHHHHhcCCC
Confidence            5444433332221111                         11235677889999999999    999999999999999


Q ss_pred             C
Q 015222          380 L  380 (411)
Q Consensus       380 ~  380 (411)
                      |
T Consensus       285 ~  285 (285)
T cd07861         285 F  285 (285)
T ss_pred             C
Confidence            7

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-46  Score=329.49  Aligned_cols=262  Identities=23%  Similarity=0.386  Sum_probs=224.9

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      -++|..++.||+|.||.|.+++.+.+++.+|+|++++.-    ........|-.+|+..+||.+     ..+.-.|+..+
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFL-----t~LKYsFQt~d  241 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFL-----TSLKYSFQTQD  241 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHH-----HHhhhhhccCc
Confidence            357889999999999999999999999999999998643    223344568889999888876     77777888999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      ++|+||||. ||.|.-.|.+..  .+++..++.+...|+.||.|||+++||.||||.+|+|++.+|              
T Consensus       242 rlCFVMeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDG--------------  305 (516)
T KOG0690|consen  242 RLCFVMEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDG--------------  305 (516)
T ss_pred             eEEEEEEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCC--------------
Confidence            999999999 999998888765  799999999999999999999999999999999999998888              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccc---cCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE  322 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~  322 (411)
                                   ++||+|||+++..   .....+++|||.|+|||++....|+.++|+|.+||++|||++|+.||...+
T Consensus       306 -------------HIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d  372 (516)
T KOG0690|consen  306 -------------HIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD  372 (516)
T ss_pred             -------------ceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc
Confidence                         5566666666532   234567899999999999999999999999999999999999999999988


Q ss_pred             hHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcH-----HHHHHHHhcCCCCcccccCCCCCchh
Q 015222          323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR-----DSMRAVWKLLRLPVIDLYSASPNCLC  394 (411)
Q Consensus       323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R-----~t~~~il~~~~~~~~~~~~~~~~~~~  394 (411)
                      .....+.|......+|..    ++++++.++..+|.+|    |.+|     ..++||.+|.||..++|.....+-+.
T Consensus       373 h~kLFeLIl~ed~kFPr~----ls~eAktLLsGLL~kd----P~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~  441 (516)
T KOG0690|consen  373 HEKLFELILMEDLKFPRT----LSPEAKTLLSGLLKKD----PKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIE  441 (516)
T ss_pred             hhHHHHHHHhhhccCCcc----CCHHHHHHHHHHhhcC----hHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccC
Confidence            888888887777777765    5778999999999999    6665     46899999999999999877555444

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-43  Score=336.86  Aligned_cols=289  Identities=19%  Similarity=0.286  Sum_probs=220.8

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+....    ...+.+..|+.+++.+.|+++     +++++.+.+++.
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~   75 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFL-----PTLYASFQTETY   75 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCc-----hhheeeeecCCE
Confidence            47999999999999999999999999999999997533    234567889999999988777     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      .|+||||+ +++|.+++.+.....+++..+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            99999999 89999999876555799999999999999999999999999999999999999999888888887654433


Q ss_pred             CCCccccCCCCCC-----eeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          247 DGSYFKNLPKSSA-----IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       247 ~~~~~~~~~~~~~-----~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                      .............     .+...=..............||..|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            2211100000000     00000000000111122357899999999999888999999999999999999999999887


Q ss_pred             ChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                      +....+..+.......+..  ...+..+.+++.+|+..++.+||+.+-+++++++|+||.+.++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~  299 (316)
T cd05574         236 NRDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWAL  299 (316)
T ss_pred             chHHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhh
Confidence            7766665554433333322  226788999999999999444444444499999999999877544

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=9.5e-44  Score=356.81  Aligned_cols=254  Identities=22%  Similarity=0.232  Sum_probs=208.2

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      ..++|++.+.||+|+||+||+|++..+++.||||++...   ......+.+|+.++..+.|+++     +++++.+...+
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~i-----v~~~~~~~~~~  104 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSI-----VKCHEDFAKKD  104 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcE-----EEeecceeccc
Confidence            346999999999999999999999999999999998643   2334567789988888877766     88777664321


Q ss_pred             --------eEEEEEccC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCccccc
Q 015222          167 --------HICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV  235 (411)
Q Consensus       167 --------~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l  235 (411)
                              .+++||||+ +|+|.+++....  ...+++..+..++.||+.||+|||++||+||||||+|||++.++    
T Consensus       105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~----  180 (496)
T PTZ00283        105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG----  180 (496)
T ss_pred             ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC----
Confidence                    478999999 999999987532  34689999999999999999999999999999999999998766    


Q ss_pred             CCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCCCccchhHHHHHHHHH
Q 015222          236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE  310 (411)
Q Consensus       236 ~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e  310 (411)
                                             .+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++||
T Consensus       181 -----------------------~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilye  237 (496)
T PTZ00283        181 -----------------------LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYE  237 (496)
T ss_pred             -----------------------CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHH
Confidence                                   5778888877643221     234579999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCc
Q 015222          311 LCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       311 lltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~  382 (411)
                      |++|+.||.+.+..+.+..+......   .+...++..+.+++.+||..+    |.+||++.++++|+|++.
T Consensus       238 LltG~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~L~~d----P~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        238 LLTLKRPFDGENMEEVMHKTLAGRYD---PLPPSISPEMQEIVTALLSSD----PKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             HHHCCCCCCCCCHHHHHHHHhcCCCC---CCCCCCCHHHHHHHHHHcccC----hhhCcCHHHHHhCHHHHH
Confidence            99999999987776665554432221   122346778999999999888    999999999999999775

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.6e-43  Score=331.34  Aligned_cols=251  Identities=27%  Similarity=0.442  Sum_probs=202.9

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      +|++.+.||+|+||.||+|++..+|+.||+|.++...   .....+.+|+.++++++|+|+     +++++++.+.+..+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i-----~~~~~~~~~~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI-----VRLYDVLHSDKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCe-----eeHHHHhccCCceE
Confidence            5899999999999999999999999999999986432   223456789999999988877     99999999999999


Q ss_pred             EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      +|+||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++                  
T Consensus        76 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~------------------  136 (284)
T cd07839          76 LVFEYCDQDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG------------------  136 (284)
T ss_pred             EEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC------------------
Confidence            999999889999887643 3699999999999999999999999999999999999998776                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCC-CCCChH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALF-QTHENL  324 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf-~~~~~~  324 (411)
                               .++|+|||++......   .....++..|+|||++.+. .++.++|||||||++|+|++|..|| .+.+..
T Consensus       137 ---------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~  207 (284)
T cd07839         137 ---------ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD  207 (284)
T ss_pred             ---------cEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH
Confidence                     4566666665543221   1223578899999998775 4789999999999999999988875 555555


Q ss_pred             HHHHHHHHHhCCCChh-------------------------HHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCC
Q 015222          325 EHLAMMERVLGPLPHH-------------------------MVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR  379 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~-------------------------~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~  379 (411)
                      +.+..+.+..+..+..                         ....++..+.++|.+||+.+    |.+|||+.++++|+|
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----P~~R~t~~~il~h~~  283 (284)
T cd07839         208 DQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCN----PVQRISAEEALQHPY  283 (284)
T ss_pred             HHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCC----hhhcCCHHHHhcCCC
Confidence            5555554433322211                         11235678889999999999    999999999999999


Q ss_pred             C
Q 015222          380 L  380 (411)
Q Consensus       380 ~  380 (411)
                      |
T Consensus       284 f  284 (284)
T cd07839         284 F  284 (284)
T ss_pred             C
Confidence            7

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.6e-44  Score=357.66  Aligned_cols=265  Identities=22%  Similarity=0.322  Sum_probs=197.9

Q ss_pred             EeeCCccCCCeEEEeeeccccceEEEEEEeCCCC-cEEEEE------------------EeccchhhhHHHHHHHHHHHH
Q 015222           84 FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKK-ELVAIK------------------IVRSINKYREAAMIEIDVLQR  144 (411)
Q Consensus        84 ~~~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~-~~vavK------------------~~~~~~~~~~~~~~E~~~l~~  144 (411)
                      ...++.+.++|+++++||+|+||+||+|..+... ..+++|                  .+.........+.+|+.++++
T Consensus       140 ~~~~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~  219 (501)
T PHA03210        140 LKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGR  219 (501)
T ss_pred             cccchhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHh
Confidence            3445567789999999999999999998764322 222222                  222222344567889999999


Q ss_pred             HhcCCCCCcceEEEeeeeecCCeEEEEEccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 015222          145 LARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNS---YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLK  221 (411)
Q Consensus       145 l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dik  221 (411)
                      ++|+||     +++++++.+.+..|+||++++++|.+++....   ........++.++.||+.||+|||++||||||||
T Consensus       220 l~HpnI-----v~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLK  294 (501)
T PHA03210        220 LNHENI-----LKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIK  294 (501)
T ss_pred             CCCCCc-----CcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            998887     99999999999999999999889998876532   1123466788999999999999999999999999


Q ss_pred             CCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecCCCCCc
Q 015222          222 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNY  297 (411)
Q Consensus       222 p~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~  297 (411)
                      |+|||++.+|                           .+||+|||++.......    ....||..|+|||++.+..++.
T Consensus       295 P~NILl~~~~---------------------------~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  347 (501)
T PHA03210        295 LENIFLNCDG---------------------------KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCE  347 (501)
T ss_pred             HHHEEECCCC---------------------------CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCc
Confidence            9999997766                           57888888876543321    2357999999999999999999


Q ss_pred             cchhHHHHHHHHHHHhCCCC-CCCC--ChHHHHHHHHHHhC----CCCh-----------------------hH-HHhhh
Q 015222          298 PCDLWSVGCILVELCSGEAL-FQTH--ENLEHLAMMERVLG----PLPH-----------------------HM-VIRAD  346 (411)
Q Consensus       298 ~~DiwSlGvil~elltg~~p-f~~~--~~~~~~~~i~~~~~----~~p~-----------------------~~-~~~~~  346 (411)
                      ++|||||||++|||++|..+ |...  .....+..+.....    .+|.                       .+ ....+
T Consensus       348 ~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  427 (501)
T PHA03210        348 ITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLP  427 (501)
T ss_pred             HHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCC
Confidence            99999999999999998754 4332  22222222222111    1111                       00 01234


Q ss_pred             hhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          347 RRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       347 ~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      ..+.++|.+||..|    |.+||++.|+++||||....
T Consensus       428 ~~~~~li~kmL~~D----P~~Rpsa~elL~hp~f~~~~  461 (501)
T PHA03210        428 ADFEYPLVKMLTFD----WHLRPGAAELLALPLFSAEE  461 (501)
T ss_pred             hHHHHHHHHHhccC----cccCcCHHHHhhChhhhcCC
Confidence            45677899999999    99999999999999998765

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.9e-43  Score=354.17  Aligned_cols=252  Identities=21%  Similarity=0.206  Sum_probs=210.2

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCC-CcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEK-KELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      ..|.+.+.||+|+||.||+|.+..+ ++.||+|.+.... .....+.+|+.+++.+.|+||     +++++++..++++|
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpni-----v~~~~~~~~~~~~~  141 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGI-----VKHFDDFKSDDKLL  141 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCE-----eEEEEEEEECCEEE
Confidence            4599999999999999999998887 7889999875433 334556789999999988887     99999999999999


Q ss_pred             EEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          170 IVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +||||+ +++|.+++...  ....+++..+..++.||+.||+|||++||+||||||+|||++.++               
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~---------------  206 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG---------------  206 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC---------------
Confidence            999999 99999988642  223689999999999999999999999999999999999998766               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                                  .+||+|||++......     ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus       207 ------------~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~  274 (478)
T PTZ00267        207 ------------IIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP  274 (478)
T ss_pred             ------------cEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence                        5677777777654322     23356999999999999989999999999999999999999999887


Q ss_pred             ChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCc
Q 015222          322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~  382 (411)
                      +..+.+..+......   .....++..+.++|.+||..+    |..||++.+++.|+|+..
T Consensus       275 ~~~~~~~~~~~~~~~---~~~~~~s~~~~~li~~~L~~d----P~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        275 SQREIMQQVLYGKYD---PFPCPVSSGMKALLDPLLSKN----PALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             CHHHHHHHHHhCCCC---CCCccCCHHHHHHHHHHhccC----hhhCcCHHHHHhCHHHHH
Confidence            776666655543221   112345678999999999988    999999999999998864

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-45  Score=351.87  Aligned_cols=257  Identities=23%  Similarity=0.395  Sum_probs=221.8

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEec-cchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      +.|.|+..||.|+||.||+|..+.++-..|-|++. +.....+++.-|++||..+.||+|     +++++.|..++.++|
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~i-----vkLl~ayy~enkLwi  106 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVI-----VKLLSAYYFENKLWI  106 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHH-----HHHHHHHhccCceEE
Confidence            46899999999999999999999999989999986 455667889999999999988877     999999999999999


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      ..||| ||-+...+..-+ +.|.+.++..+++|++.||.|||+++|||||||..|||++-+|                  
T Consensus       107 liEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldG------------------  167 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDG------------------  167 (1187)
T ss_pred             EEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecC------------------
Confidence            99999 777777776554 5799999999999999999999999999999999999999888                  


Q ss_pred             ccccCCCCCCeeEeecCCccccc---CCCcccccCCCccccceec-----CCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                               .++|+|||.+....   .....++|||+|||||+..     ..+|+.++||||||++|.||..+.+|....
T Consensus       168 ---------dirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel  238 (1187)
T KOG0579|consen  168 ---------DIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL  238 (1187)
T ss_pred             ---------cEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc
Confidence                     67888888765432   3345689999999999875     457999999999999999999999999988


Q ss_pred             ChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                      +....+.+|.+..++- .-.+..++..+.||+.+||.++    |..||++.++++|||+.++.-.
T Consensus       239 npMRVllKiaKSePPT-LlqPS~Ws~~F~DfLk~cL~Kn----p~~Rp~aaqll~Hpfv~~~~Sn  298 (1187)
T KOG0579|consen  239 NPMRVLLKIAKSEPPT-LLQPSHWSRSFSDFLKRCLVKN----PRNRPPAAQLLKHPFVQNAPSN  298 (1187)
T ss_pred             chHHHHHHHhhcCCCc-ccCcchhhhHHHHHHHHHHhcC----CccCCCHHHHhhCcccccCCcc
Confidence            8888887777654321 1223456788999999999999    9999999999999999987654

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.4e-43  Score=338.80  Aligned_cols=249  Identities=22%  Similarity=0.308  Sum_probs=193.9

Q ss_pred             CCCeEEEeeeccccceEEEEEEe-----CCCCcEEEEEEeccch--hhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeee
Q 015222           91 TPRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWF  162 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~-----~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~  162 (411)
                      .++|++.++||+|+||.||+|.+     ..+++.||||+++...  .....+.+|+.+++.+ .|+||     +++++++
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni-----v~~~~~~   80 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV-----VNLLGAC   80 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcce-----eeEEeEe
Confidence            36899999999999999999975     2445789999997432  3345688999999999 67766     9999987


Q ss_pred             ecC-CeEEEEEccC-CCCHHHHHHhcC-----------------------------------------------------
Q 015222          163 DYR-NHICIVFEKL-GPSLYDFLRKNS-----------------------------------------------------  187 (411)
Q Consensus       163 ~~~-~~~~lv~e~~-~~~L~~~l~~~~-----------------------------------------------------  187 (411)
                      ... +.+++||||+ +|+|.+++....                                                     
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence            654 5689999999 999999997532                                                     


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccCCCCCCe
Q 015222          188 -------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI  260 (411)
Q Consensus       188 -------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  260 (411)
                             ...+++..+..++.||+.||+|||++||+||||||+|||++.++                           .+
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~---------------------------~~  213 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN---------------------------VV  213 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC---------------------------cE
Confidence                   12478889999999999999999999999999999999998766                           56


Q ss_pred             eEeecCCcccccCC-----CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 015222          261 KLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERVL  334 (411)
Q Consensus       261 kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~  334 (411)
                      ||+|||++......     .....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+...... 
T Consensus       214 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-  292 (338)
T cd05102         214 KICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-  292 (338)
T ss_pred             EEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-
Confidence            77777766543221     112345678999999999899999999999999999997 99999876543333222211 


Q ss_pred             CCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          335 GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       335 ~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      +.. .......+..+.+++.+|+..+    |.+||++.++++.
T Consensus       293 ~~~-~~~~~~~~~~l~~li~~cl~~d----p~~RPs~~el~~~  330 (338)
T cd05102         293 GTR-MRAPENATPEIYRIMLACWQGD----PKERPTFSALVEI  330 (338)
T ss_pred             CCC-CCCCCCCCHHHHHHHHHHccCC----hhhCcCHHHHHHH
Confidence            111 1122345677889999998888    9999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.4e-43  Score=328.00  Aligned_cols=252  Identities=21%  Similarity=0.394  Sum_probs=204.9

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeec-----
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY-----  164 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~-----  164 (411)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.........+..|+.+++++ .|+|+     +++++++..     
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i-----~~~~~~~~~~~~~~   79 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNI-----ATYYGAFIKKNPPG   79 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCe-----eeEeeEEeecCCCC
Confidence            4679999999999999999999999999999999976655566788899999988 46666     999998864     


Q ss_pred             -CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccc
Q 015222          165 -RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       165 -~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                       ...+|+||||+ +++|.+++.......+++..+..++.|++.||+|||++||+|+||||+||+++.++           
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~-----------  148 (272)
T cd06637          80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-----------  148 (272)
T ss_pred             CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCC-----------
Confidence             34789999999 88999999875545799999999999999999999999999999999999997766           


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCcccccC---CCcccccCCCccccceecC-----CCCCccchhHHHHHHHHHHHhC
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSG  314 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltg  314 (411)
                                      .++|+|||++.....   ......|+..|+|||++.+     ..++.++|||||||++|||++|
T Consensus       149 ----------------~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g  212 (272)
T cd06637         149 ----------------EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG  212 (272)
T ss_pred             ----------------CEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhC
Confidence                            567777777654322   1233578999999999863     3588899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       315 ~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      ..||...........+...  ..+.......+..+.+++.+|+..+    |.+||++.++++|+||
T Consensus       213 ~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~----p~~Rpt~~~il~~~~~  272 (272)
T cd06637         213 APPLCDMHPMRALFLIPRN--PAPRLKSKKWSKKFQSFIESCLVKN----HSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCccccCHHHHHHHHhcC--CCCCCCCCCcCHHHHHHHHHHcCCC----hhhCCCHHHHhhCCCC
Confidence            9999766554443333221  1111122345678899999998888    9999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-45  Score=346.15  Aligned_cols=254  Identities=22%  Similarity=0.287  Sum_probs=219.5

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEecc----chhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      +.|.-++.||.|+||.||-|++..+.+.||||.+.-    ....-.++.+|+..|++++|||+     +.+.++|..+..
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPnt-----ieYkgCyLre~T  100 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNT-----IEYKGCYLREHT  100 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCc-----ccccceeeccch
Confidence            357888999999999999999999999999999962    23344678899999999999988     999999999999


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          168 ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       168 ~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      .|||||||-|+-.|++.-.. .++.+.++..|+.+.++||.|||+.+.||||||..|||+++.|                
T Consensus       101 aWLVMEYClGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g----------------  163 (948)
T KOG0577|consen  101 AWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG----------------  163 (948)
T ss_pred             HHHHHHHHhccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC----------------
Confidence            99999999878888887654 4799999999999999999999999999999999999998877                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecC---CCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                                 .|||+|||+|..... ..+++|||+|||||++..   +.|+-++||||||++..||...++|+-..+..
T Consensus       164 -----------~VKLaDFGSAsi~~P-AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM  231 (948)
T KOG0577|consen  164 -----------LVKLADFGSASIMAP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM  231 (948)
T ss_pred             -----------eeeeccccchhhcCc-hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH
Confidence                       678888888876543 455799999999999974   47999999999999999999999998888888


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      ..+..|.....+.  --...+++.+..|+..||++-    |..|||..+++.|+|+..-.+
T Consensus       232 SALYHIAQNesPt--Lqs~eWS~~F~~Fvd~CLqKi----pqeRptse~ll~H~fv~R~Rp  286 (948)
T KOG0577|consen  232 SALYHIAQNESPT--LQSNEWSDYFRNFVDSCLQKI----PQERPTSEELLKHRFVLRERP  286 (948)
T ss_pred             HHHHHHHhcCCCC--CCCchhHHHHHHHHHHHHhhC----cccCCcHHHHhhcchhccCCC
Confidence            7777776643322  224567888999999999999    999999999999999986544

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-43  Score=322.81  Aligned_cols=249  Identities=28%  Similarity=0.428  Sum_probs=206.6

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch------hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      +.|++.+.||+|++|.||+|.+..+++.||+|.+....      .....+.+|+.++++++|+++     +++++++..+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~   76 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI-----VQYYGCLRDD   76 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCe-----eeeEEEEccC
Confidence            46899999999999999999999999999999986432      123467789999999988877     9999999999


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      +..++||||+ +++|.+++....  .+++..+..++.|++.||.|||+.||+|+||||+||+++.++             
T Consensus        77 ~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~-------------  141 (263)
T cd06625          77 ETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG-------------  141 (263)
T ss_pred             CeEEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-------------
Confidence            9999999999 899999998765  689999999999999999999999999999999999998766             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCCC------cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF  318 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf  318 (411)
                                    .++|+|||.+.......      ....|+..|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       142 --------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~  207 (263)
T cd06625         142 --------------NVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPW  207 (263)
T ss_pred             --------------CEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCc
Confidence                          56777777665432111      2345788999999999989999999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      ...+.......+...  ..........+..+.+++.+|+..+    |.+||++.++++|+||
T Consensus       208 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~----p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         208 AEFEAMAAIFKIATQ--PTNPQLPSHVSPDARNFLRRTFVEN----AKKRPSAEELLRHFFV  263 (263)
T ss_pred             cccchHHHHHHHhcc--CCCCCCCccCCHHHHHHHHHHhhcC----cccCCCHHHHhhCCCC
Confidence            876555444433322  1222233456778899999999888    9999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.6e-42  Score=319.30  Aligned_cols=249  Identities=24%  Similarity=0.385  Sum_probs=209.3

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      +|.+.+.||+|++|.||+|.+..+++.|++|.+...   ......+.+|+.+++.++|+|+     +++++.+...+..+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI-----IRYYESFLDKGKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCe-----ehheeeeccCCEEE
Confidence            488999999999999999999999999999998642   3455677889999999988877     99999999999999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +||||+ +++|.+++.......+++..+..++.||+.||.|||+.||+|+||||+||+++.++                 
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~-----------------  138 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD-----------------  138 (256)
T ss_pred             EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC-----------------
Confidence            999999 99999999876445799999999999999999999999999999999999998776                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                                .++|+|||++.......   ....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+
T Consensus       139 ----------~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~  208 (256)
T cd08529         139 ----------NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA  208 (256)
T ss_pred             ----------CEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                      56677777665433221   23467889999999999899999999999999999999999998877655


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      ....+....  .+ .....++..+.+++.+|++.+    |++||++.++++|+|+
T Consensus       209 ~~~~~~~~~--~~-~~~~~~~~~~~~~i~~~l~~~----p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         209 LILKIIRGV--FP-PVSQMYSQQLAQLIDQCLTKD----YRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHHHcCC--CC-CCccccCHHHHHHHHHHccCC----cccCcCHHHHhhCCCC
Confidence            555444322  21 122256778899999998888    9999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=7.8e-43  Score=330.94  Aligned_cols=257  Identities=24%  Similarity=0.371  Sum_probs=207.5

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      ++|++.+.||+|+||.||++.+..++..||+|.++..  ......+.+|+++++++.|+|+     +++++.+..++.++
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~   75 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYI-----VGFYGAFYSDGEIS   75 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEeeCCEEE
Confidence            3699999999999999999999999999999998643  2334567889999999988887     99999999999999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      +||||+ +++|.+++.+..  .+++..+..++.||+.||.|||+ .+++|+||||+|||++.++                
T Consensus        76 lv~ey~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~----------------  137 (308)
T cd06615          76 ICMEHMDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG----------------  137 (308)
T ss_pred             EEeeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC----------------
Confidence            999999 899999998764  68999999999999999999998 5999999999999998776                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCC-CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH  326 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~  326 (411)
                                 .++|+|||++...... .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+....
T Consensus       138 -----------~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~  206 (308)
T cd06615         138 -----------EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL  206 (308)
T ss_pred             -----------cEEEccCCCcccccccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH
Confidence                       4677777766543221 2345789999999999888899999999999999999999999976543332


Q ss_pred             HHHHHHHhCCC----------------------------------ChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHH
Q 015222          327 LAMMERVLGPL----------------------------------PHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMR  372 (411)
Q Consensus       327 ~~~i~~~~~~~----------------------------------p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~  372 (411)
                      ...+.......                                  |......++..+.+++.+||..+    |++||++.
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----P~~Rpt~~  282 (308)
T cd06615         207 EAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKN----PKERADLK  282 (308)
T ss_pred             HHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCC----hhhCcCHH
Confidence            22221110000                                  00000124567889999999999    99999999


Q ss_pred             HHHhcCCCCccccc
Q 015222          373 AVWKLLRLPVIDLY  386 (411)
Q Consensus       373 ~il~~~~~~~~~~~  386 (411)
                      ++++|+||.+....
T Consensus       283 ~ll~~~~~~~~~~~  296 (308)
T cd06615         283 ELTKHPFIKRAELE  296 (308)
T ss_pred             HHhcChhhhhcccc
Confidence            99999999876544

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.5e-42  Score=324.93  Aligned_cols=251  Identities=30%  Similarity=0.534  Sum_probs=203.9

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      ++|++.+.||+|+||.||+|.++.+++.||+|++....   ...+.+.+|+.+++++.|+|+     +++++++...+..
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~~~   75 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNL-----VNLIEVFRRKRKL   75 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCE-----eeeeeEEeeCCEE
Confidence            47999999999999999999999999999999986432   234557789999999988776     9999999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      ++||||+ ++.|..++....  .+++..++.++.||+.||+|||+.||+|+||||+||+++.++                
T Consensus        76 ~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~----------------  137 (286)
T cd07847          76 HLVFEYCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG----------------  137 (286)
T ss_pred             EEEEeccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC----------------
Confidence            9999999 666665554433  689999999999999999999999999999999999998766                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCh
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHEN  323 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~  323 (411)
                                 .++|+|||++.......   ....++..|+|||++.+. .++.++|||||||++|+|++|..||.+.+.
T Consensus       138 -----------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~  206 (286)
T cd07847         138 -----------QIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD  206 (286)
T ss_pred             -----------cEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                       56677777665443222   234578899999998764 688999999999999999999999998777


Q ss_pred             HHHHHHHHHHhCCCCh---------------------------hHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHh
Q 015222          324 LEHLAMMERVLGPLPH---------------------------HMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK  376 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~---------------------------~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~  376 (411)
                      .+....+....+....                           ......+..+.+++.+|+..+    |++||++.+++.
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----p~~Rp~~~eil~  282 (286)
T cd07847         207 VDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMD----PTERLSCEELLE  282 (286)
T ss_pred             HHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCC----ccccCCHHHHhc
Confidence            6665555443221111                           112345677889999999888    999999999999


Q ss_pred             cCCC
Q 015222          377 LLRL  380 (411)
Q Consensus       377 ~~~~  380 (411)
                      |+||
T Consensus       283 ~~~f  286 (286)
T cd07847         283 HPYF  286 (286)
T ss_pred             CCCC
Confidence            9997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.1e-42  Score=329.88  Aligned_cols=260  Identities=28%  Similarity=0.407  Sum_probs=211.8

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchh---hhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC--
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--  165 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~--  165 (411)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|+++....   ......+|+.++++++|+++     +++++++...  
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~   80 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI-----VELKEVVVGKHL   80 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCC-----cceEEEEecCCC
Confidence            3679999999999999999999999999999999864321   22345679999999998887     9999988654  


Q ss_pred             CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          166 NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       166 ~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      +.+++||||++++|.+++.... ..+++..+..++.||+.||+|||+.|++||||||+||+++.++              
T Consensus        81 ~~~~lv~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~--------------  145 (309)
T cd07845          81 DSIFLVMEYCEQDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG--------------  145 (309)
T ss_pred             CeEEEEEecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--------------
Confidence            5789999999879999887643 4689999999999999999999999999999999999998776              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                                   .++|+|||.+......   .....++..|+|||++.+. .++.++|||||||++|||++|+.||.+.
T Consensus       146 -------------~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~  212 (309)
T cd07845         146 -------------CLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK  212 (309)
T ss_pred             -------------CEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence                         5666666666543322   1223457889999998764 6899999999999999999999999988


Q ss_pred             ChHHHHHHHHHHhCCCChhHH--------------------------HhhhhhhhhhhccCCccCCCCCCCcHHHHHHHH
Q 015222          322 ENLEHLAMMERVLGPLPHHMV--------------------------IRADRRAEKYFRRGARLDWPDGATSRDSMRAVW  375 (411)
Q Consensus       322 ~~~~~~~~i~~~~~~~p~~~~--------------------------~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il  375 (411)
                      +..+.+..+....+..+...+                          ...++.+.++|.+||..|    |.+||++.+++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~d----p~~R~t~~~il  288 (309)
T cd07845         213 SEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYD----PKKRATAEEAL  288 (309)
T ss_pred             CHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCC----hhhCcCHHHHh
Confidence            888877777665432222111                          124677889999999999    99999999999


Q ss_pred             hcCCCCcccccC
Q 015222          376 KLLRLPVIDLYS  387 (411)
Q Consensus       376 ~~~~~~~~~~~~  387 (411)
                      +|+||.......
T Consensus       289 ~h~~f~~~~~~~  300 (309)
T cd07845         289 ESSYFKEKPLPC  300 (309)
T ss_pred             cChhhccCCCCC
Confidence            999999777654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.5e-42  Score=324.88  Aligned_cols=252  Identities=31%  Similarity=0.496  Sum_probs=206.9

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      .|++++.||.|++|.||+|++..+++.||||.++...   .....+.+|++++++++|+|+     +++++++.+++..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI-----VKLLDVIHTENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCC-----cchhhhcccCCcEE
Confidence            4899999999999999999999999999999986432   223567889999999998887     99999999999999


Q ss_pred             EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      +||||+.++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+||+++.++                  
T Consensus        76 ~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~------------------  137 (284)
T cd07860          76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG------------------  137 (284)
T ss_pred             EEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC------------------
Confidence            99999977999998876555799999999999999999999999999999999999998766                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCCC-CCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                               .++|+|||.+.......   ....++..|+|||++.+.. ++.++|||||||++|+|+||+.||.+.+..+
T Consensus       138 ---------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~  208 (284)
T cd07860         138 ---------AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID  208 (284)
T ss_pred             ---------CEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence                     56777777665432221   2235688899999987754 6889999999999999999999998877665


Q ss_pred             HHHHHHHHhCCCChh-------------------------HHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          326 HLAMMERVLGPLPHH-------------------------MVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~-------------------------~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      ....+.+..+..+..                         ....++..+.++|.+|++.|    |++||+++++++||||
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         209 QLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYD----PNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCC----cccCCCHHHHhcCCCC
Confidence            555544433322211                         11234567888999999998    9999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8e-43  Score=362.16  Aligned_cols=280  Identities=25%  Similarity=0.401  Sum_probs=218.4

Q ss_pred             eeCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeee
Q 015222           85 AIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW  161 (411)
Q Consensus        85 ~~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~  161 (411)
                      ..++.+.++|+++++||+|+||+||+|.+..+++.||+|++...   ......+..|+.++++|.|++|     ++++++
T Consensus         6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNI-----Vrl~d~   80 (1021)
T PTZ00266          6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI-----VRYIDR   80 (1021)
T ss_pred             cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCc-----CeEEEE
Confidence            34566678999999999999999999999999999999998642   2345668889999999998887     999998


Q ss_pred             eec--CCeEEEEEccC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-------CceecCCCCCcEEEec
Q 015222          162 FDY--RNHICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHEL-------RLIHTDLKPENILLVS  229 (411)
Q Consensus       162 ~~~--~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~-------givH~Dikp~NIli~~  229 (411)
                      |..  ...+||||||+ +++|.++|....  ...+++..++.|+.||+.||.|||+.       +||||||||+||||+.
T Consensus        81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s  160 (1021)
T PTZ00266         81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST  160 (1021)
T ss_pred             EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence            854  46799999999 899999997531  23699999999999999999999984       4999999999999976


Q ss_pred             CcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCC--CCCccchhHHHH
Q 015222          230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGL--GWNYPCDLWSVG  305 (411)
Q Consensus       230 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG  305 (411)
                      ... .+.+....         ....+....+||+|||++......  .....||+.|+|||++.+.  .++.++||||||
T Consensus       161 ~~~-~lg~i~~~---------~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG  230 (1021)
T PTZ00266        161 GIR-HIGKITAQ---------ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALG  230 (1021)
T ss_pred             Ccc-cccccccc---------ccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHH
Confidence            421 11110000         011234456999999998765432  2345799999999998653  588999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          306 CILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       306 vil~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      ||||||++|..||...+....+.........++   ....+..+.+||..||..+    |.+||++.++|.|+|+..+..
T Consensus       231 ~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lp---i~~~S~eL~dLI~~~L~~d----PeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        231 CIIYELCSGKTPFHKANNFSQLISELKRGPDLP---IKGKSKELNILIKNLLNLS----AKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             HHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCC---cCCCCHHHHHHHHHHhcCC----hhHCcCHHHHhccHHHhhcCC
Confidence            999999999999987665444333322222222   1335678999999999999    999999999999999987755


Q ss_pred             c
Q 015222          386 Y  386 (411)
Q Consensus       386 ~  386 (411)
                      .
T Consensus       304 p  304 (1021)
T PTZ00266        304 P  304 (1021)
T ss_pred             C
Confidence            4

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.9e-43  Score=336.69  Aligned_cols=260  Identities=18%  Similarity=0.243  Sum_probs=202.8

Q ss_pred             EEeeeccc--cceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           96 ILSKMGEG--TFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        96 i~~~lG~G--~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      ++++||+|  +|++||++.++.+|+.||+|+++..   ....+.+.+|+.+++.++|+||     +++++++..++..++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpni-----v~~~~~~~~~~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNI-----VPYRATFIADNELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCe-----eeEEEEEEECCEEEE
Confidence            56789999  7899999999999999999999753   2344567789999999988887     999999999999999


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      ||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+++.||+...       
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~-------  149 (327)
T cd08227          77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL-------  149 (327)
T ss_pred             EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhh-------
Confidence            99999 8999999976544469999999999999999999999999999999999999998877777765322       


Q ss_pred             ccccCCCCCCeeEeecCCcccc-cCCCcccccCCCccccceecC--CCCCccchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFE-HQDHSYVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSGEALFQTHENLEH  326 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~  326 (411)
                                 .+.++|..... ........++..|+|||++.+  ..++.++|||||||++|||++|+.||........
T Consensus       150 -----------~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  218 (327)
T cd08227         150 -----------SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM  218 (327)
T ss_pred             -----------ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH
Confidence                       22222221111 111122356778999999976  3689999999999999999999999986554333


Q ss_pred             HHHHHHHhCCCC--------------------------------------------hhHHHhhhhhhhhhhccCCccCCC
Q 015222          327 LAMMERVLGPLP--------------------------------------------HHMVIRADRRAEKYFRRGARLDWP  362 (411)
Q Consensus       327 ~~~i~~~~~~~p--------------------------------------------~~~~~~~~~~~~~li~~~l~~~~~  362 (411)
                      ......  +..+                                            .......+..+.+++.+||..|  
T Consensus       219 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d--  294 (327)
T cd08227         219 LLEKLN--GTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRN--  294 (327)
T ss_pred             HHHHhc--CCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhC--
Confidence            222211  1111                                            0011224567889999999999  


Q ss_pred             CCCCcHHHHHHHHhcCCCCccc
Q 015222          363 DGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       363 ~rp~~R~t~~~il~~~~~~~~~  384 (411)
                        |.+|||++++++|+||+++.
T Consensus       295 --P~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         295 --PDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             --chhcCCHHHHhcChhhhhcc
Confidence              99999999999999998765

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.5e-42  Score=318.37  Aligned_cols=249  Identities=22%  Similarity=0.349  Sum_probs=205.8

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec-CCeE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-RNHI  168 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~-~~~~  168 (411)
                      +|++.+.||+|++|.||++.++.+++.||+|.+....   ...+.+.+|+.+++++.|+++     +++++.+.. +..+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~   75 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI-----VAYRESWEGEDGLL   75 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCe-----eeeeeeecCCCCEE
Confidence            4899999999999999999999999999999986432   334567889999999988877     888887764 4578


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      |+||||+ +++|.+++.......+++..+..++.|++.||++||+.||+|+||||+||+++.++                
T Consensus        76 ~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~----------------  139 (257)
T cd08223          76 YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN----------------  139 (257)
T ss_pred             EEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC----------------
Confidence            9999999 89999999875545689999999999999999999999999999999999998766                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                                 .++|+|||++......   .....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus       140 -----------~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~  208 (257)
T cd08223         140 -----------IIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN  208 (257)
T ss_pred             -----------cEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH
Confidence                       5677777766543221   22346889999999999989999999999999999999999999877665


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      .....+.....  + ......+..+.+++.+|++.+    |..||++.++++||||
T Consensus       209 ~~~~~~~~~~~--~-~~~~~~~~~~~~li~~~l~~~----p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         209 SLVYRIIEGKL--P-PMPKDYSPELGELIATMLSKR----PEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHHHhcCC--C-CCccccCHHHHHHHHHHhccC----cccCCCHHHHhcCCCC
Confidence            55444433222  1 122356778999999999998    9999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2e-42  Score=324.03  Aligned_cols=252  Identities=33%  Similarity=0.513  Sum_probs=209.3

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      +|++.+.||+|+||.||+|.+..+++.||+|++....   .....+.+|+.+++++.|+++     +++++++..++..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYV-----VKLLDVFPHGSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCC-----cceeeEEecCCeeE
Confidence            5899999999999999999999999999999987432   334678899999999988777     99999999999999


Q ss_pred             EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      +||||++++|.+++.... ..+++..++.++.||+.||+|||+.||+|+||||+||+++.++                  
T Consensus        76 ~v~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~------------------  136 (286)
T cd07832          76 LVMEYMPSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG------------------  136 (286)
T ss_pred             EEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC------------------
Confidence            999999999999987654 4699999999999999999999999999999999999998766                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCC----CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                               .++|+|||.+......    .....|+..|+|||++.+. .++.++|||||||++|||++|.+||.+.+..
T Consensus       137 ---------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~  207 (286)
T cd07832         137 ---------VLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI  207 (286)
T ss_pred             ---------cEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH
Confidence                     5677777766544322    2234688999999998765 5689999999999999999999999887776


Q ss_pred             HHHHHHHHHhCCCCh--------------------------hHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          325 EHLAMMERVLGPLPH--------------------------HMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~--------------------------~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      +.+..+....+....                          ......+..+.++|.+||..+    |.+||+++++++|+
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----p~~R~~~~~~l~h~  283 (286)
T cd07832         208 EQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYD----PSKRLSAAEALRHP  283 (286)
T ss_pred             HHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccC----hhhCCCHHHHhhCc
Confidence            666655543332211                          111234677889999999998    99999999999999


Q ss_pred             CCC
Q 015222          379 RLP  381 (411)
Q Consensus       379 ~~~  381 (411)
                      ||.
T Consensus       284 ~~~  286 (286)
T cd07832         284 YFT  286 (286)
T ss_pred             CcC
Confidence            984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-42  Score=333.52  Aligned_cols=262  Identities=29%  Similarity=0.501  Sum_probs=207.4

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC--
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--  165 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~--  165 (411)
                      +.++|++.++||+|+||.||+|.+..+|+.||||++...  ......+.+|+.++++++|+|+     +++++++...  
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~   77 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI-----IGILDIIRPPSF   77 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCc-----Cchhheeecccc
Confidence            457899999999999999999999999999999998642  2344567789999999998887     8888765433  


Q ss_pred             ---CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccc
Q 015222          166 ---NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       166 ---~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                         .+.|+||||++++|.+++...   .+++..++.++.||+.||+|||+.||+||||||+|||++.++.          
T Consensus        78 ~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~----------  144 (336)
T cd07849          78 ESFNDVYIVQELMETDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD----------  144 (336)
T ss_pred             cccceEEEEehhcccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC----------
Confidence               468999999988999888654   5999999999999999999999999999999999999987774          


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCcccccCC------CcccccCCCccccceecC-CCCCccchhHHHHHHHHHHHhCC
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGE  315 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~  315 (411)
                                       ++|+|||++......      .....||..|+|||.+.+ ..++.++|||||||++|+|++|+
T Consensus       145 -----------------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~  207 (336)
T cd07849         145 -----------------LKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR  207 (336)
T ss_pred             -----------------EEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence                             555555555432211      122468899999998765 46899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChh---------------------------HHHhhhhhhhhhhccCCccCCCCCCCcH
Q 015222          316 ALFQTHENLEHLAMMERVLGPLPHH---------------------------MVIRADRRAEKYFRRGARLDWPDGATSR  368 (411)
Q Consensus       316 ~pf~~~~~~~~~~~i~~~~~~~p~~---------------------------~~~~~~~~~~~li~~~l~~~~~~rp~~R  368 (411)
                      .||.+.+.......+....+..+..                           ..+..+..+.+++.+||+.+    |.+|
T Consensus       208 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d----P~~R  283 (336)
T cd07849         208 PLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFN----PHKR  283 (336)
T ss_pred             CCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCC----hhhC
Confidence            9998776655554444433322111                           11234667889999999888    9999


Q ss_pred             HHHHHHHhcCCCCcccccCCCC
Q 015222          369 DSMRAVWKLLRLPVIDLYSASP  390 (411)
Q Consensus       369 ~t~~~il~~~~~~~~~~~~~~~  390 (411)
                      |++.++++|+||......+..|
T Consensus       284 pt~~e~l~hp~~~~~~~~~~~~  305 (336)
T cd07849         284 ITVEEALAHPYLEQYHDPSDEP  305 (336)
T ss_pred             cCHHHHhcCccccccCCCCCcc
Confidence            9999999999999776554433

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-44  Score=366.68  Aligned_cols=255  Identities=24%  Similarity=0.345  Sum_probs=215.9

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      .++|.|++.||+|+||.|.+++++.|++.||+|++++..    .....|..|-.+|..-+.+     -|+.++-.|.+++
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~-----Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSE-----WIVQLHYAFQDER  148 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcH-----HHHHHHHHhcCcc
Confidence            358999999999999999999999999999999998632    2345567788887765544     4499999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      ++|+||||+ ||+|..++.+..  .++++.++.++..|+.||.-||+.|+|||||||+||||+..|++            
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHi------------  214 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHI------------  214 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcE------------
Confidence            999999999 999999999886  79999999999999999999999999999999999999988855            


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCC----CcccccCCCccccceecC-----CCCCccchhHHHHHHHHHHHhCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSGEA  316 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltg~~  316 (411)
                                     ||+|||.+-....+    ....+|||.|+|||++..     +.|++.+|+||+||++|||+.|..
T Consensus       215 ---------------kLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~T  279 (1317)
T KOG0612|consen  215 ---------------KLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGET  279 (1317)
T ss_pred             ---------------eeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCC
Confidence                           55555544333211    234689999999999963     468999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHH--hCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHH---HHHHHhcCCCCccccc
Q 015222          317 LFQTHENLEHLAMMERV--LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS---MRAVWKLLRLPVIDLY  386 (411)
Q Consensus       317 pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t---~~~il~~~~~~~~~~~  386 (411)
                      ||...+-.+.+.+|...  ...||...  .++.+++++|.+.+.-     |..|..   ++++..||||.+++|.
T Consensus       280 PFYadslveTY~KIm~hk~~l~FP~~~--~VSeeakdLI~~ll~~-----~e~RLgrngiedik~HpFF~g~~W~  347 (1317)
T KOG0612|consen  280 PFYADSLVETYGKIMNHKESLSFPDET--DVSEEAKDLIEALLCD-----REVRLGRNGIEDIKNHPFFEGIDWD  347 (1317)
T ss_pred             cchHHHHHHHHHHHhchhhhcCCCccc--ccCHHHHHHHHHHhcC-----hhhhcccccHHHHHhCccccCCChh
Confidence            99999888999888876  45677443  4899999999988643     677777   9999999999999983

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=7.5e-43  Score=326.27  Aligned_cols=254  Identities=21%  Similarity=0.331  Sum_probs=204.0

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      ++|++++.||+|+||.||+|.+..+++.||+|++...  ......+.+|+.+++++.|+++     +++++.+...+..+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~   75 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYI-----IGFYGAFFVENRIS   75 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCe-----eeEEEEEEECCEEE
Confidence            3688999999999999999999999999999998643  2344568889999999988877     99999999999999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +||||+ +++|..+      ..+++..+..++.|++.||+|||+.||+|+||||+|||++.++                 
T Consensus        76 lv~e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~-----------------  132 (279)
T cd06619          76 ICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG-----------------  132 (279)
T ss_pred             EEEecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC-----------------
Confidence            999999 8888654      1478899999999999999999999999999999999998766                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccC-CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH--
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE--  325 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~--  325 (411)
                                .++|+|||++..... ......||..|+|||++.+..++.++|||||||++|+|++|+.||......+  
T Consensus       133 ----------~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~  202 (279)
T cd06619         133 ----------QVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS  202 (279)
T ss_pred             ----------CEEEeeCCcceecccccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc
Confidence                      577788887764332 2334578999999999999899999999999999999999999996532211  


Q ss_pred             --HHHHHHHHhCCCChh-HHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          326 --HLAMMERVLGPLPHH-MVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       326 --~~~~i~~~~~~~p~~-~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                        ............+.. .....+..+.+++.+|+..+    |.+||+++++++|+||...+...
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----P~~Rp~~~eil~~~~~~~~~~~~  263 (279)
T cd06619         203 LMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQ----PKERPAPENLMDHPFIVQYNDGN  263 (279)
T ss_pred             cchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCC----hhhCCCHHHHhcCcccccccCcc
Confidence              111111111111111 12235667899999999988    99999999999999998875443

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.1e-42  Score=329.08  Aligned_cols=250  Identities=24%  Similarity=0.450  Sum_probs=191.9

Q ss_pred             eeeccccceEEEEEEeCC--CCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec--CCeEEEEEc
Q 015222           98 SKMGEGTFGQVVECFDNE--KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--RNHICIVFE  173 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~--~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~--~~~~~lv~e  173 (411)
                      .+||+|+||+||+|+++.  ++..||+|.+.... ....+.+|+.+++.++|+|+     +++++++..  +...++|||
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNV-----IALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCe-----eeEEEEEeccCCCeEEEEEe
Confidence            589999999999999654  56889999987543 23457789999999988877     999998743  568899999


Q ss_pred             cCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          174 KLGPSLYDFLRKNS-------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       174 ~~~~~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      |++++|.+++....       ...+++..++.++.||+.||.|||++||+||||||+|||+..++               
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~---------------  145 (317)
T cd07867          81 YAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG---------------  145 (317)
T ss_pred             eeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCC---------------
Confidence            99889998875321       12588999999999999999999999999999999999995432               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC------CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQ  319 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~  319 (411)
                              +.+..+||+|||++......      .....||+.|+|||++.+. .++.++|||||||++|||+||++||.
T Consensus       146 --------~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~  217 (317)
T cd07867         146 --------PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH  217 (317)
T ss_pred             --------CCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence                    23347889999988754332      1235789999999999874 58999999999999999999999997


Q ss_pred             CCChH---------HHHHHHHHHhCCCChhHH----------------------------------HhhhhhhhhhhccC
Q 015222          320 THENL---------EHLAMMERVLGPLPHHMV----------------------------------IRADRRAEKYFRRG  356 (411)
Q Consensus       320 ~~~~~---------~~~~~i~~~~~~~p~~~~----------------------------------~~~~~~~~~li~~~  356 (411)
                      .....         ..+..+....+......+                                  ...+..+.+++.+|
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  297 (317)
T cd07867         218 CRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKL  297 (317)
T ss_pred             cccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHH
Confidence            54321         122222222221111000                                  01234577899999


Q ss_pred             CccCCCCCCCcHHHHHHHHhcCCC
Q 015222          357 ARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       357 l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      |..|    |.+|||+.|+++||||
T Consensus       298 l~~d----P~~R~t~~e~l~hp~f  317 (317)
T cd07867         298 LTMD----PTKRITSEQALQDPYF  317 (317)
T ss_pred             hccC----cccccCHHHHhcCCCC
Confidence            9999    9999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.1e-42  Score=326.17  Aligned_cols=255  Identities=24%  Similarity=0.380  Sum_probs=209.3

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|.+.... ...+.+.+|+.+++.+.|+|+     +++++.+..+.+.|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v-----~~~~~~~~~~~~~~   93 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI-----VNYLDSYLVGDELW   93 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCE-----eeEEEEEEeCCEEE
Confidence            368999999999999999999999999999999987433 334667789999999888776     99999999999999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +||||+ +++|.+++...   .+++..+..++.|++.||.|||+.||+|+||||+|||++.++                 
T Consensus        94 lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~-----------------  153 (296)
T cd06654          94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-----------------  153 (296)
T ss_pred             EeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-----------------
Confidence            999999 99999998754   489999999999999999999999999999999999997766                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                                .++|+|||.+......   .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+...
T Consensus       154 ----------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~  223 (296)
T cd06654         154 ----------SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR  223 (296)
T ss_pred             ----------CEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                      5677777766543221   123468899999999998889999999999999999999999998766544


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      ....+... ...+......++..+.+++.+|+..+    |..||++.++++|+|+.....
T Consensus       224 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~----p~~Rpt~~eil~~~~~~~~~~  278 (296)
T cd06654         224 ALYLIATN-GTPELQNPEKLSAIFRDFLNRCLDMD----VEKRGSAKELLQHQFLKIAKP  278 (296)
T ss_pred             hHHHHhcC-CCCCCCCccccCHHHHHHHHHHCcCC----cccCcCHHHHhhChhhhccCC
Confidence            43333221 11111222346677899999998888    999999999999999987543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.5e-42  Score=333.07  Aligned_cols=265  Identities=26%  Similarity=0.468  Sum_probs=213.4

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC-
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR-  165 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~-  165 (411)
                      +.++|++.+.||+|+||+||+|++..+++.||||.+...   ......+.+|+.+++.+.|+|+     +++++++... 
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----~~~~~~~~~~~   77 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV-----IAIKDIMPPPH   77 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCc-----cchHHheeccc
Confidence            456899999999999999999999999999999998642   2234556789999999988887     8888877643 


Q ss_pred             ----CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccc
Q 015222          166 ----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL  241 (411)
Q Consensus       166 ----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~  241 (411)
                          ...|+||||++++|.+++....  .+++..+..++.||+.||.|||++|++||||||+||+++.++          
T Consensus        78 ~~~~~~~~lv~e~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~----------  145 (337)
T cd07858          78 REAFNDVYIVYELMDTDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC----------  145 (337)
T ss_pred             ccccCcEEEEEeCCCCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC----------
Confidence                3589999999889999987654  699999999999999999999999999999999999998766          


Q ss_pred             cccCCCCCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecC-CCCCccchhHHHHHHHHHHHhCCCC
Q 015222          242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEAL  317 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p  317 (411)
                                       .++|+|||++......   .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.|
T Consensus       146 -----------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  208 (337)
T cd07858         146 -----------------DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPL  208 (337)
T ss_pred             -----------------CEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCC
Confidence                             5667777766543322   123467889999998875 4689999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCh---------------------------hHHHhhhhhhhhhhccCCccCCCCCCCcHHH
Q 015222          318 FQTHENLEHLAMMERVLGPLPH---------------------------HMVIRADRRAEKYFRRGARLDWPDGATSRDS  370 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~~~p~---------------------------~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t  370 (411)
                      |.+.+.......+....+..+.                           ......+..+.+++.+||+.+    |++||+
T Consensus       209 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----P~~Rps  284 (337)
T cd07858         209 FPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFD----PSKRIT  284 (337)
T ss_pred             CCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCC----hhhccC
Confidence            9887665555555444332221                           112345677889999999999    999999


Q ss_pred             HHHHHhcCCCCcccccCCCCCc
Q 015222          371 MRAVWKLLRLPVIDLYSASPNC  392 (411)
Q Consensus       371 ~~~il~~~~~~~~~~~~~~~~~  392 (411)
                      ++++++|+||..+......+-.
T Consensus       285 ~~ell~h~~~~~~~~~~~~~~~  306 (337)
T cd07858         285 VEEALAHPYLASLHDPSDEPVC  306 (337)
T ss_pred             HHHHHcCcchhhhcCcccCccC
Confidence            9999999999887666555443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2e-42  Score=326.24  Aligned_cols=255  Identities=25%  Similarity=0.378  Sum_probs=211.3

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      .+|++.+.||.|+||.||+|.+..+++.||+|.+.... ...+.+.+|+.+++.+.|+|+     +.+++++...+.+++
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~~l   93 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI-----VNFLDSFLVGDELFV   93 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCce-----eeeeeeEecCceEEE
Confidence            57999999999999999999999999999999986432 334667889999999988877     999999999999999


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      ||||+ +++|.+++...   .+++..+..++.|++.||+|||+.|++|+||||+||+++.++                  
T Consensus        94 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~------------------  152 (296)
T cd06655          94 VMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG------------------  152 (296)
T ss_pred             EEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC------------------
Confidence            99999 99999988764   489999999999999999999999999999999999998766                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH  326 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~  326 (411)
                               .++|+|||++......   .....|+..|+|||.+.+..++.++|||||||++|+|++|..||.+.+....
T Consensus       153 ---------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~  223 (296)
T cd06655         153 ---------SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA  223 (296)
T ss_pred             ---------CEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                     4666777765543222   1234688899999999988899999999999999999999999988776555


Q ss_pred             HHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       327 ~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                      ...+.... ..+......++..+.++|.+|+..+    |.+||++.++++|+||......
T Consensus       224 ~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~d----p~~Rpt~~~il~~~~~~~~~~~  278 (296)
T cd06655         224 LYLIATNG-TPELQNPEKLSPIFRDFLNRCLEMD----VEKRGSAKELLQHPFLKLAKPL  278 (296)
T ss_pred             HHHHHhcC-CcccCCcccCCHHHHHHHHHHhhcC----hhhCCCHHHHhhChHhhhcccc
Confidence            44443321 1111223346678889999998888    9999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.8e-42  Score=325.77  Aligned_cols=258  Identities=22%  Similarity=0.397  Sum_probs=208.7

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      .+.|+++++||.|+||.||+|++..+++.||+|++.... ...+.+.+|+.+++.+.|+++     +++++.+..++..|
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~   85 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYI-----VKLLGAFYWDGKLW   85 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcE-----eeeEEEEEeCCeEE
Confidence            367999999999999999999999999999999987543 345667889999999988877     99999999999999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +||||+ +++|..++.+.. ..+++..+..++.||+.||+|||+.||+||||||+||+++.++                 
T Consensus        86 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~-----------------  147 (292)
T cd06644          86 IMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG-----------------  147 (292)
T ss_pred             EEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC-----------------
Confidence            999999 889988876543 3689999999999999999999999999999999999997766                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecC-----CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSGEALFQT  320 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltg~~pf~~  320 (411)
                                .++|+|||.+......   .....++..|+|||++.+     ..++.++|||||||++|+|++|..||..
T Consensus       148 ----------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  217 (292)
T cd06644         148 ----------DIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE  217 (292)
T ss_pred             ----------CEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc
Confidence                      5677777766543221   223467889999999853     3578899999999999999999999987


Q ss_pred             CChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                      .+.......+.....+ .......++..+.+++.+|+..+    |++||++.++++|+|+..+...
T Consensus       218 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~----p~~Rp~~~~il~~~~~~~~~~~  278 (292)
T cd06644         218 LNPMRVLLKIAKSEPP-TLSQPSKWSMEFRDFLKTALDKH----PETRPSAAQLLEHPFVSSVTSN  278 (292)
T ss_pred             ccHHHHHHHHhcCCCc-cCCCCcccCHHHHHHHHHHhcCC----cccCcCHHHHhcCccccccccc
Confidence            6655544444322111 11112345667889999998888    9999999999999999876653

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.4e-43  Score=327.72  Aligned_cols=259  Identities=19%  Similarity=0.315  Sum_probs=212.7

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      ++|++++.||+|+||.||+|.+..+++.||+|.++..  ......+.+|+.+++++.|+|+     +++++.+...+..+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~~~   75 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYI-----VDFYGAFFIEGAVY   75 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcH-----HhhhhheecCCeEE
Confidence            3689999999999999999999999999999988642  2334567889999999988877     99999999999999


Q ss_pred             EEEccC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          170 IVFEKL-GPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +||||+ +++|.+++.... ...+++..+..++.||+.||.|||+ .||+|+||||+||+++.++               
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~---------------  140 (286)
T cd06622          76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG---------------  140 (286)
T ss_pred             EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC---------------
Confidence            999999 889999887642 2368999999999999999999997 5999999999999997765               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccC-CCcccccCCCccccceecCC------CCCccchhHHHHHHHHHHHhCCCCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGL------GWNYPCDLWSVGCILVELCSGEALFQ  319 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlGvil~elltg~~pf~  319 (411)
                                  .++|+|||.+..... ......|+..|+|||++.+.      .++.++|||||||++|+|++|+.||.
T Consensus       141 ------------~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~  208 (286)
T cd06622         141 ------------QVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP  208 (286)
T ss_pred             ------------CEEEeecCCcccccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence                        578888887764422 22334678899999998654      35889999999999999999999998


Q ss_pred             CCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                      ..........+.......+......++..+.+++.+|+..+    |.+||++.++++|+||......
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         209 PETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKI----PNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             CcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccC----cccCCCHHHHhcChhhhhccCC
Confidence            76555555444444333344444557888999999999888    9999999999999999876643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=324.40  Aligned_cols=260  Identities=22%  Similarity=0.299  Sum_probs=217.6

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      .+|..+..||+|+||.|.+|..+.+.+.+|||++++.-    ...+-.+.|-.+|.....+    |.+++++..|+.-+.
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kp----pFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP----PFLVQLHSCFQTMDR  424 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCC----chHHHHHHHhhhhhh
Confidence            57899999999999999999999999999999998643    2233345677776655444    456999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+||||+ ||+|.-.+++-+  ++.+..+..++..|+-||-|||++|||.||||.+|||++.+|               
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG---------------  487 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG---------------  487 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC---------------
Confidence            99999999 999999998876  799999999999999999999999999999999999999888               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccc---cCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN  323 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~  323 (411)
                                  ++||+|||++...   .....+++|||.|+|||++..++|+.++|+||+||+||||+.|++||.+.++
T Consensus       488 ------------HiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE  555 (683)
T KOG0696|consen  488 ------------HIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE  555 (683)
T ss_pred             ------------ceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence                        5667777766542   2345668999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH-HHHHHHhcCCCCcccccCC
Q 015222          324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-SMRAVWKLLRLPVIDLYSA  388 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~-t~~~il~~~~~~~~~~~~~  388 (411)
                      .+..+.|.......|..+    +.++..++...|.+.|.+|-..-+ .-++|..|+||..++|.-.
T Consensus       556 ~elF~aI~ehnvsyPKsl----SkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~  617 (683)
T KOG0696|consen  556 DELFQAIMEHNVSYPKSL----SKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKL  617 (683)
T ss_pred             HHHHHHHHHccCcCcccc----cHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHH
Confidence            999999998888887765    556667777777777544432222 2367889999999998654

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.1e-42  Score=333.54  Aligned_cols=265  Identities=24%  Similarity=0.440  Sum_probs=216.0

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec---
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY---  164 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~---  164 (411)
                      .++|++.+.||+|+||.||+|.++.+++.||+|++....   .....+.+|+.++++++|+++     +++++++..   
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~   78 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNI-----IAIRDILRPPGA   78 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCc-----cCHHHhccccCC
Confidence            468999999999999999999999999999999987532   334567789999999998877     888887753   


Q ss_pred             -CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          165 -RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       165 -~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                       ...+++||||++++|.+++....  .+++..++.++.||+.||.|||++||+||||||+||+++.+|            
T Consensus        79 ~~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~------------  144 (334)
T cd07855          79 DFKDVYVVMDLMESDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC------------  144 (334)
T ss_pred             CCceEEEEEehhhhhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC------------
Confidence             45789999999879999987654  599999999999999999999999999999999999998877            


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccCC-------CcccccCCCccccceecC-CCCCccchhHHHHHHHHHHHhCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-------HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGE  315 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~  315 (411)
                                     .++|+|||++......       .....|+..|+|||.+.+ ..++.++|||||||++|||++|+
T Consensus       145 ---------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~  209 (334)
T cd07855         145 ---------------ELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR  209 (334)
T ss_pred             ---------------cEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCC
Confidence                           4566666655432211       123468889999999866 36899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChhH---------------------------HHhhhhhhhhhhccCCccCCCCCCCcH
Q 015222          316 ALFQTHENLEHLAMMERVLGPLPHHM---------------------------VIRADRRAEKYFRRGARLDWPDGATSR  368 (411)
Q Consensus       316 ~pf~~~~~~~~~~~i~~~~~~~p~~~---------------------------~~~~~~~~~~li~~~l~~~~~~rp~~R  368 (411)
                      .||.+.+....+..+....+..+...                           ....+..+.++|.+||+.+    |.+|
T Consensus       210 ~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----P~~R  285 (334)
T cd07855         210 QLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFD----PEER  285 (334)
T ss_pred             CccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCC----hhhC
Confidence            99988776666555555444333222                           1335677899999999999    9999


Q ss_pred             HHHHHHHhcCCCCcccccCCCCCch
Q 015222          369 DSMRAVWKLLRLPVIDLYSASPNCL  393 (411)
Q Consensus       369 ~t~~~il~~~~~~~~~~~~~~~~~~  393 (411)
                      |++.+++.|+||.....+...+.+-
T Consensus       286 pt~~~~l~~~~~~~~~~~~~~~~~~  310 (334)
T cd07855         286 ITVEQALQHPFLAQYHDPDDEPTCP  310 (334)
T ss_pred             cCHHHHHhChhhhhccCCcccccCC
Confidence            9999999999999888888777763

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-42  Score=319.15  Aligned_cols=249  Identities=22%  Similarity=0.325  Sum_probs=202.7

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccchh----hhHHHHHHHHHHH-HHhcCCCCCcceEEEeeeeecCCeEEEEE
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQ-RLARHDIGGTRCVQIRNWFDYRNHICIVF  172 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~-~l~~~~i~~~~iv~~~~~~~~~~~~~lv~  172 (411)
                      +.||+|+||.||+|.+..+++.||+|++.....    .......|..++. ...|+     |++++++.+..++..|+||
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~-----~i~~~~~~~~~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESP-----YVAKLYYSFQSKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCC-----CeeeeeeeEEcCCeEEEEE
Confidence            578999999999999999999999999875321    1122333433332 23444     5599999999999999999


Q ss_pred             ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCcc
Q 015222          173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF  251 (411)
Q Consensus       173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~  251 (411)
                      ||+ +++|.+++....  .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++                    
T Consensus        77 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~--------------------  134 (260)
T cd05611          77 EYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG--------------------  134 (260)
T ss_pred             eccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--------------------
Confidence            999 999999998765  689999999999999999999999999999999999997765                    


Q ss_pred             ccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015222          252 KNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME  331 (411)
Q Consensus       252 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~  331 (411)
                             .++|+|||++..... .....|+..|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.
T Consensus       135 -------~~~l~dfg~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~  206 (260)
T cd05611         135 -------HLKLTDFGLSRNGLE-NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL  206 (260)
T ss_pred             -------cEEEeecccceeccc-cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence                   577888887665432 233468889999999998889999999999999999999999998877766666655


Q ss_pred             HHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH---HHHHHHhcCCCCcccc
Q 015222          332 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD---SMRAVWKLLRLPVIDL  385 (411)
Q Consensus       332 ~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~---t~~~il~~~~~~~~~~  385 (411)
                      ......+......++..+.+++.+||..+    |+.|+   ++++++.||||.++.|
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~----p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         207 SRRINWPEEVKEFCSPEAVDLINRLLCMD----PAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             hcccCCCCcccccCCHHHHHHHHHHccCC----HHHccCCCcHHHHHcChHhhcCCC
Confidence            54444444444567888999999999999    88888   5689999999998775

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.9e-42  Score=325.60  Aligned_cols=273  Identities=22%  Similarity=0.308  Sum_probs=211.1

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++++.||+|+||.||++.+..+++.||+|.+....    .....+.+|+.+++.+.|+|+     +++++.+..+++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~   75 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFV-----VSMFCSFETKRH   75 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCe-----eeeEEEEecCCE
Confidence            36999999999999999999999999999999987542    234567789999999888776     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +++||||+ +++|.+++....  .+++..+..++.|++.||+|||++|++||||||+||+++.++.++++|||+.+....
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          76 LCMVMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             EEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            99999999 899999997765  689999999999999999999999999999999999998887665555554321100


Q ss_pred             CCCccccCCCCCCeeEeecCCcccc-cCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFE-HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                      ..          ...+.+....... ........|+..|+|||.+.+..++.++|||||||++|||++|..||.+.+..+
T Consensus       154 ~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~  223 (305)
T cd05609         154 SL----------TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE  223 (305)
T ss_pred             Cc----------cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            00          0000000000000 001112357889999999998889999999999999999999999998877766


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHH---HHHHHhcCCCCccccc
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS---MRAVWKLLRLPVIDLY  386 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t---~~~il~~~~~~~~~~~  386 (411)
                      ....+.......|... ...+..+.+++.+|++.+    |.+||+   +.++++|+||...++.
T Consensus       224 ~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~----P~~R~~~~~~~~ll~~~~~~~~~~~  282 (305)
T cd05609         224 LFGQVISDDIEWPEGD-EALPADAQDLISRLLRQN----PLERLGTGGAFEVKQHRFFLGLDWN  282 (305)
T ss_pred             HHHHHHhcccCCCCcc-ccCCHHHHHHHHHHhccC----hhhccCccCHHHHHhCccccCCCHH
Confidence            6665554433333321 246778899999999999    778876   8999999999876653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.1e-42  Score=326.55  Aligned_cols=252  Identities=26%  Similarity=0.454  Sum_probs=203.9

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC---
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR---  165 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~---  165 (411)
                      ++|++.++||+|+||.||+|.+..+++.||||.+....   .....+.+|+.+++++.|+++     +++++++...   
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~   86 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENV-----VNLIEICRTKATP   86 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCc-----cceEEEEeccccc
Confidence            57999999999999999999999999999999986432   223445679999999999888     8888877553   


Q ss_pred             -----CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          166 -----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       166 -----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                           ...++||||++++|.+++.... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.        
T Consensus        87 ~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--------  157 (310)
T cd07865          87 YNRYKGSFYLVFEFCEHDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI--------  157 (310)
T ss_pred             ccCCCceEEEEEcCCCcCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCc--------
Confidence                 3569999999889998887653 36899999999999999999999999999999999999987774        


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccCC-------CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHH
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-------HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELC  312 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell  312 (411)
                                         ++|+|||.+......       .....++..|+|||.+.+. .++.++||||||+++|||+
T Consensus       158 -------------------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~  218 (310)
T cd07865         158 -------------------LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMW  218 (310)
T ss_pred             -------------------EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHH
Confidence                               555566555432211       1223578889999988765 4789999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChhHHHh----------------------------hhhhhhhhhccCCccCCCCC
Q 015222          313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIR----------------------------ADRRAEKYFRRGARLDWPDG  364 (411)
Q Consensus       313 tg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~----------------------------~~~~~~~li~~~l~~~~~~r  364 (411)
                      +|+.||.+.+.......+....+.++....+.                            .+..+.++|.+||..+    
T Consensus       219 t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~----  294 (310)
T cd07865         219 TRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLD----  294 (310)
T ss_pred             hCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCC----
Confidence            99999998887777777777666554433221                            1345678999999888    


Q ss_pred             CCcHHHHHHHHhcCCC
Q 015222          365 ATSRDSMRAVWKLLRL  380 (411)
Q Consensus       365 p~~R~t~~~il~~~~~  380 (411)
                      |.+||++.++++|+||
T Consensus       295 P~~R~t~~e~l~h~~f  310 (310)
T cd07865         295 PAKRIDADTALNHDFF  310 (310)
T ss_pred             hhhccCHHHHhcCCCC
Confidence            9999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.2e-42  Score=327.98  Aligned_cols=258  Identities=25%  Similarity=0.380  Sum_probs=211.5

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+.... ...+.+.+|+.+++.+.|+++     +++++++..+++.+
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~~~~   92 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNI-----VNYLDSYLVGDELW   92 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCE-----eeEEEEEecCCEEE
Confidence            478999999999999999999999999999999986433 334567789999999888877     99999999999999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +||||+ +++|.+++.+.   .+++..+..++.|++.||.|||+.||+||||||+|||++.++                 
T Consensus        93 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~-----------------  152 (297)
T cd06656          93 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG-----------------  152 (297)
T ss_pred             EeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-----------------
Confidence            999999 99999998764   489999999999999999999999999999999999998766                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                                .++|+|||.+......   .....+++.|+|||.+.+..++.++|||||||++|+|++|..||.+.+...
T Consensus       153 ----------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~  222 (297)
T cd06656         153 ----------SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR  222 (297)
T ss_pred             ----------CEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch
Confidence                      5666667665543222   123467889999999999889999999999999999999999998765544


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccCC
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSA  388 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~  388 (411)
                      ....+.. .+..+.......+..+.+++.+|+..+    |..||++.++++|+||........
T Consensus       223 ~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~----p~~Rps~~~il~~~~~~~~~~~~~  280 (297)
T cd06656         223 ALYLIAT-NGTPELQNPERLSAVFRDFLNRCLEMD----VDRRGSAKELLQHPFLKLAKPLSS  280 (297)
T ss_pred             heeeecc-CCCCCCCCccccCHHHHHHHHHHccCC----hhhCcCHHHHhcCchhcccccccc
Confidence            3332222 122222223446677889999998888    999999999999999998766543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-42  Score=323.19  Aligned_cols=252  Identities=29%  Similarity=0.453  Sum_probs=201.7

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      ++|++.+.||+|++|.||+|.++.+++.||||.+....  .....+.+|+.++++++|+++     +++++++.+.+..+
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~   79 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI-----VTLHDIIHTKKTLT   79 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcce-----eeEEEEEecCCeEE
Confidence            67999999999999999999999999999999986432  223456789999999988877     99999999999999


Q ss_pred             EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      +||||+.++|.+++.+.. ..+++..++.++.||+.||.|||++||+||||||+||+++++|                  
T Consensus        80 lv~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~------------------  140 (291)
T cd07844          80 LVFEYLDTDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG------------------  140 (291)
T ss_pred             EEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCC------------------
Confidence            999999779999987654 3689999999999999999999999999999999999998776                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCC-hH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHE-NL  324 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~-~~  324 (411)
                               .++|+|||.+......   .....++..|+|||++.+. .++.++|||||||++|+|++|+.||.+.. ..
T Consensus       141 ---------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~  211 (291)
T cd07844         141 ---------ELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE  211 (291)
T ss_pred             ---------CEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH
Confidence                     4566666665433211   1123467889999998764 68999999999999999999999997665 33


Q ss_pred             HHHHHHHHHhCCCChhHH--------------------------Hhhh--hhhhhhhccCCccCCCCCCCcHHHHHHHHh
Q 015222          325 EHLAMMERVLGPLPHHMV--------------------------IRAD--RRAEKYFRRGARLDWPDGATSRDSMRAVWK  376 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~--------------------------~~~~--~~~~~li~~~l~~~~~~rp~~R~t~~~il~  376 (411)
                      +.+..+.+..+......+                          ...+  ..+.+++.+||..+    |..||++.++++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~----p~~Rps~~e~l~  287 (291)
T cd07844         212 DQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYE----PKKRISAAEAMK  287 (291)
T ss_pred             HHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccC----cccccCHHHHhc
Confidence            444433333222111111                          1122  56779999999999    999999999999


Q ss_pred             cCCC
Q 015222          377 LLRL  380 (411)
Q Consensus       377 ~~~~  380 (411)
                      |+||
T Consensus       288 ~~~f  291 (291)
T cd07844         288 HPYF  291 (291)
T ss_pred             CCCC
Confidence            9997

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.4e-42  Score=324.69  Aligned_cols=258  Identities=27%  Similarity=0.413  Sum_probs=209.7

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchh------hhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK------YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      +|++.+.||+|+||.||+|.+..+++.||||.++....      ....+..|+.++++++|+++     +++++++.+.+
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNI-----IGLLDVFGHKS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCC-----hhhhheeecCC
Confidence            58999999999999999999999999999999975432      23456789999999988877     99999999999


Q ss_pred             eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          167 HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       167 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      ..++||||++++|.+++.... ..+++..+..++.||++||.|||++||+|+||||+||+++.+|               
T Consensus        76 ~~~lv~e~~~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~---------------  139 (298)
T cd07841          76 NINLVFEFMETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG---------------  139 (298)
T ss_pred             EEEEEEcccCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC---------------
Confidence            999999999889999997654 3699999999999999999999999999999999999998777               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHE  322 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~  322 (411)
                                  .++|+|||++......   .....++..|+|||.+.+. .++.++|||||||++|||++|.+||.+.+
T Consensus       140 ------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~  207 (298)
T cd07841         140 ------------VLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS  207 (298)
T ss_pred             ------------CEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence                        4566666666543322   1223567889999998654 67899999999999999999999998877


Q ss_pred             hHHHHHHHHHHhCCCChhH------------------------HHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          323 NLEHLAMMERVLGPLPHHM------------------------VIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       323 ~~~~~~~i~~~~~~~p~~~------------------------~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ..+.+..+....+......                        ....+..+.+++.+||..+    |.+||++.++++|+
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----P~~R~s~~e~l~~~  283 (298)
T cd07841         208 DIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLN----PNKRITARQALEHP  283 (298)
T ss_pred             cHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCC----cccCcCHHHHhhCc
Confidence            7666555544332221111                        1234567889999999998    99999999999999


Q ss_pred             CCCcccccC
Q 015222          379 RLPVIDLYS  387 (411)
Q Consensus       379 ~~~~~~~~~  387 (411)
                      ||.+....-
T Consensus       284 ~~~~~~~~~  292 (298)
T cd07841         284 YFSNDPAPT  292 (298)
T ss_pred             cccCCCCCC
Confidence            999866544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.9e-42  Score=323.85  Aligned_cols=252  Identities=23%  Similarity=0.399  Sum_probs=205.5

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHh-cCCCCCcceEEEeeeee------
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFD------  163 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~~~------  163 (411)
                      .+.|++.+.||.|+||.||+|.+..+++.||+|++.........+..|+.+++++. |+|+     +++++++.      
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i-----~~~~~~~~~~~~~~   89 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNI-----ATYYGAFIKKSPPG   89 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcE-----EEEeeehhcccccC
Confidence            36799999999999999999999999999999998766555567788999999884 5555     99999874      


Q ss_pred             cCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccc
Q 015222          164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                      ..+.+|++|||+ +++|.+++.......+++..+..++.||+.||.|||+.||+|+||||+||+++.++           
T Consensus        90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~-----------  158 (282)
T cd06636          90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA-----------  158 (282)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-----------
Confidence            246899999999 88999999876555689999999999999999999999999999999999997765           


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCcccccC---CCcccccCCCccccceec-----CCCCCccchhHHHHHHHHHHHhC
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSG  314 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltg  314 (411)
                                      .++|+|||.+.....   ......|+..|+|||++.     +..++.++|||||||++|||++|
T Consensus       159 ----------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g  222 (282)
T cd06636         159 ----------------EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG  222 (282)
T ss_pred             ----------------CEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhC
Confidence                            577888887664332   123356899999999986     34688899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       315 ~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      ..||...........+.+.  ..+......++..+.++|.+|+..+    |.+||++.++++|+||
T Consensus       223 ~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~~----p~~Rp~~~ell~~~~~  282 (282)
T cd06636         223 APPLCDMHPMRALFLIPRN--PPPKLKSKKWSKKFIDFIEGCLVKN----YLSRPSTEQLLKHPFI  282 (282)
T ss_pred             CCCccccCHHhhhhhHhhC--CCCCCcccccCHHHHHHHHHHhCCC----hhhCcCHHHHhcCCCC
Confidence            9999776554444333222  1222222346778999999999999    9999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.8e-42  Score=323.86  Aligned_cols=259  Identities=29%  Similarity=0.463  Sum_probs=212.0

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      ++|++.+.||+|++|+||+|.++.+++.||+|.+....   ...+.+.+|+.+++++.|+++     +++++++...+..
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI-----VRLQDVVHSEKRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCE-----eeEEEEEecCCeE
Confidence            57999999999999999999999999999999986432   233567789999999988877     9999999999999


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      |+||||++++|.+++.......+++..+..++.||+.||+|||++||+|+||||+||+++.++                 
T Consensus        77 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~-----------------  139 (294)
T PLN00009         77 YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT-----------------  139 (294)
T ss_pred             EEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCC-----------------
Confidence            999999987999988766544578899999999999999999999999999999999997533                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                               ..+||+|||++.......   ....+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+..
T Consensus       140 ---------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~  210 (294)
T PLN00009        140 ---------NALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI  210 (294)
T ss_pred             ---------CEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence                     257888888776543221   224678899999998764 5789999999999999999999999887776


Q ss_pred             HHHHHHHHHhCCCChh-------------------------HHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCC
Q 015222          325 EHLAMMERVLGPLPHH-------------------------MVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR  379 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~-------------------------~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~  379 (411)
                      +.+..+....+.....                         .....+..+.+++.+||..+    |++||++.++++|+|
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~----P~~Rps~~~~l~~~~  286 (294)
T PLN00009        211 DELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLD----PSKRITARAALEHEY  286 (294)
T ss_pred             HHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCC----hhhCcCHHHHhcCch
Confidence            6655554433221111                         11245677889999999999    999999999999999


Q ss_pred             CCcccc
Q 015222          380 LPVIDL  385 (411)
Q Consensus       380 ~~~~~~  385 (411)
                      |.+++.
T Consensus       287 ~~~~~~  292 (294)
T PLN00009        287 FKDLGD  292 (294)
T ss_pred             HhHHhc
Confidence            998763

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=8.5e-42  Score=326.58  Aligned_cols=268  Identities=28%  Similarity=0.448  Sum_probs=220.9

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec-C
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-R  165 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~-~  165 (411)
                      +.++|++.+.||.|+||.||+|.+..+++.||+|++...   ....+.+..|+.+++.+.|+|+     +++++++.. .
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~~   82 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENI-----ISLSDIFISPL   82 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCe-----eeEeeeEecCC
Confidence            567899999999999999999999999999999987542   2334667789999999988877     999998865 5


Q ss_pred             CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          166 NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       166 ~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      +..++||||++++|.+++...   .+++..+..++.||+.||+|||++||+|+||||+||+++.++              
T Consensus        83 ~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~--------------  145 (328)
T cd07856          83 EDIYFVTELLGTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC--------------  145 (328)
T ss_pred             CcEEEEeehhccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC--------------
Confidence            689999999988999888754   488999999999999999999999999999999999997665              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecC-CCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                                   .++|+|||.+...........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..
T Consensus       146 -------------~~~l~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~  212 (328)
T cd07856         146 -------------DLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV  212 (328)
T ss_pred             -------------CEEeCccccccccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence                         5677777777655444444577889999999876 47899999999999999999999999887765


Q ss_pred             HHHHHHHHHhCCCChhHH---------------------------HhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          325 EHLAMMERVLGPLPHHMV---------------------------IRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~---------------------------~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      .....+.+..+..+..+.                           ...+..+.++|.+|+..+    |.+||++.+++.|
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----P~~R~t~~ell~~  288 (328)
T cd07856         213 NQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFD----PQKRISAAEALAH  288 (328)
T ss_pred             HHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCC----hhhCCCHHHHhcC
Confidence            555555444443332221                           234567889999999888    9999999999999


Q ss_pred             CCCCcccccCCCCCchhhH
Q 015222          378 LRLPVIDLYSASPNCLCKF  396 (411)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~  396 (411)
                      +|+.....+-.+|.+.++|
T Consensus       289 ~~~~~~~~~~~~~~~~~~~  307 (328)
T cd07856         289 PYLAPYHDPTDEPVAEEKF  307 (328)
T ss_pred             CccccccCCccccCchhhc
Confidence            9999888877777766666

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=8.8e-42  Score=320.88  Aligned_cols=252  Identities=26%  Similarity=0.408  Sum_probs=201.3

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....  .....+.+|+.+++.+.|+|+     +++++++..++..|
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----~~~~~~~~~~~~~~   79 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANI-----VLLHDIIHTKETLT   79 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCE-----eEEEEEEecCCeEE
Confidence            57999999999999999999999999999999986432  223456789999999988877     99999999999999


Q ss_pred             EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      +||||++++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++                  
T Consensus        80 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~------------------  140 (291)
T cd07870          80 FVFEYMHTDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG------------------  140 (291)
T ss_pred             EEEecccCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC------------------
Confidence            999999888888876543 3578899999999999999999999999999999999997766                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCh-H
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHEN-L  324 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~-~  324 (411)
                               .++|+|||++......   .....++..|+|||++.+. .++.++|||||||++|+|++|..||.+.+. .
T Consensus       141 ---------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~  211 (291)
T cd07870         141 ---------ELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF  211 (291)
T ss_pred             ---------cEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH
Confidence                     5677777776543221   2234578899999998764 588999999999999999999999976543 2


Q ss_pred             HHHHHHHHHhCCCChhHHH----------------------------hhhhhhhhhhccCCccCCCCCCCcHHHHHHHHh
Q 015222          325 EHLAMMERVLGPLPHHMVI----------------------------RADRRAEKYFRRGARLDWPDGATSRDSMRAVWK  376 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~----------------------------~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~  376 (411)
                      +.+..+....+..+.....                            ..+..+.+++.+|+..+    |++|||+.+++.
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~d----p~~R~t~~~~l~  287 (291)
T cd07870         212 EQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMF----PKDRISAQDALL  287 (291)
T ss_pred             HHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcC----cccCcCHHHHhc
Confidence            3333333322211111100                            11356789999999999    999999999999


Q ss_pred             cCCC
Q 015222          377 LLRL  380 (411)
Q Consensus       377 ~~~~  380 (411)
                      |+||
T Consensus       288 h~~~  291 (291)
T cd07870         288 HPYF  291 (291)
T ss_pred             CCCC
Confidence            9997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.6e-43  Score=337.54  Aligned_cols=255  Identities=26%  Similarity=0.360  Sum_probs=224.5

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      -.+.|.+.+.||+|.|+.|.+|++..++..||||++.+..   .......+|+++++.|+||||     |+++.+.+...
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnI-----vkl~~v~~t~~  128 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNI-----VKLFSVIETEA  128 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcce-----eeeeeeeeecc
Confidence            3467999999999999999999999999999999998644   334557899999999999988     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      .+|+||||+ +|.+++++.+++  .+.+..++.++.|+++|++|||+++|||||||++|||++.+               
T Consensus       129 ~lylV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~---------------  191 (596)
T KOG0586|consen  129 TLYLVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDEN---------------  191 (596)
T ss_pred             eeEEEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccc---------------
Confidence            999999999 999999999987  78889999999999999999999999999999999998654               


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCC-CccchhHHHHHHHHHHHhCCCCCCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQTHE  322 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~pf~~~~  322 (411)
                                  .++||+|||++.+....  ..+.+|++.|+|||++.+..| ++.+|+||+|++||.|+.|..||.+.+
T Consensus       192 ------------mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~  259 (596)
T KOG0586|consen  192 ------------MNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN  259 (596)
T ss_pred             ------------cceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc
Confidence                        36899999999876543  356899999999999999876 599999999999999999999999987


Q ss_pred             hHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                      -.+.-.........+|..+    +.+++++|+++|..+    |.+|.+++++.+|.|+......
T Consensus       260 lk~Lr~rvl~gk~rIp~~m----s~dce~lLrk~lvl~----Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  260 LKELRPRVLRGKYRIPFYM----SCDCEDLLRKFLVLN----PSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             cccccchheeeeeccccee----echhHHHHHHhhccC----ccccCCHHHhhhhcccchhhhh
Confidence            7766666666555666554    567889999999999    9999999999999999865544

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-42  Score=332.40  Aligned_cols=263  Identities=26%  Similarity=0.461  Sum_probs=217.5

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .+.++|++.+.||+|++|.||+|++..+++.||+|++...   ......+.+|+.+++++.|+++     +++++++...
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~   86 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV-----IGLLDVFTPA   86 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCH-----HHHHHHhhcc
Confidence            3467899999999999999999999999999999998642   2234556789999999988877     8888877655


Q ss_pred             Ce------EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcc
Q 015222          166 NH------ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK  239 (411)
Q Consensus       166 ~~------~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~  239 (411)
                      +.      .++|+||++++|.+++...   .+++..+..++.||+.||+|||+.||+|+||||+||+++.++        
T Consensus        87 ~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~--------  155 (343)
T cd07851          87 SSLEDFQDVYLVTHLMGADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC--------  155 (343)
T ss_pred             ccccccccEEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--------
Confidence            43      8999999999999998764   599999999999999999999999999999999999998766        


Q ss_pred             cccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCC
Q 015222          240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALF  318 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf  318 (411)
                                         .++|+|||.+...........++..|+|||.+.+. .++.++|||||||++|+|++|+.||
T Consensus       156 -------------------~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf  216 (343)
T cd07851         156 -------------------ELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF  216 (343)
T ss_pred             -------------------CEEEccccccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence                               57777887776655444555788899999998764 6789999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCChhH---------------------------HHhhhhhhhhhhccCCccCCCCCCCcHHHH
Q 015222          319 QTHENLEHLAMMERVLGPLPHHM---------------------------VIRADRRAEKYFRRGARLDWPDGATSRDSM  371 (411)
Q Consensus       319 ~~~~~~~~~~~i~~~~~~~p~~~---------------------------~~~~~~~~~~li~~~l~~~~~~rp~~R~t~  371 (411)
                      .+.+..+.+..+....+..++.+                           ....+..+.++|.+||..+    |.+|||+
T Consensus       217 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~----P~~Rpt~  292 (343)
T cd07851         217 PGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLD----PDKRITA  292 (343)
T ss_pred             CCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCC----hhhCCCH
Confidence            88877776666665544333222                           1234677889999999988    9999999


Q ss_pred             HHHHhcCCCCcccccCCCC
Q 015222          372 RAVWKLLRLPVIDLYSASP  390 (411)
Q Consensus       372 ~~il~~~~~~~~~~~~~~~  390 (411)
                      .++++|+||.+.......+
T Consensus       293 ~ell~h~~~~~~~~~~~~~  311 (343)
T cd07851         293 AEALAHPYLAEYHDPEDEP  311 (343)
T ss_pred             HHHhcCCCccccCCCcccc
Confidence            9999999999877665444

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.9e-42  Score=323.06  Aligned_cols=254  Identities=31%  Similarity=0.468  Sum_probs=204.0

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhc-CCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLAR-HDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~-~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++.+.||+|+||.||+|.+..+++.||||+++...   .....+.+|+.+++.+.| +++     +++++++...+.
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i-----~~~~~~~~~~~~   75 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI-----VRLLDVEHVEEK   75 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCc-----cceeeeEeecCC
Confidence            46999999999999999999999999999999986432   223567789999999964 565     999988876555


Q ss_pred             -----EEEEEccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec-CcccccCCc
Q 015222          168 -----ICIVFEKLGPSLYDFLRKNS---YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS-AEYVKVPDY  238 (411)
Q Consensus       168 -----~~lv~e~~~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~-~~~~~l~df  238 (411)
                           .|+||||+.++|.+++....   ...+++..++.++.||+.||.|||++||+||||||+||+++. ++       
T Consensus        76 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~-------  148 (295)
T cd07837          76 NGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKG-------  148 (295)
T ss_pred             CCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCC-------
Confidence                 89999999779999887542   235899999999999999999999999999999999999976 44       


Q ss_pred             ccccccCCCCCccccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhC
Q 015222          239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSG  314 (411)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg  314 (411)
                                          .++|+|||.+.......   ....+++.|+|||++.+. .++.++|||||||++|+|++|
T Consensus       149 --------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g  208 (295)
T cd07837         149 --------------------LLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK  208 (295)
T ss_pred             --------------------eEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcC
Confidence                                57778887766432211   223568889999988764 679999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCCh------------------------hHHHhhhhhhhhhhccCCccCCCCCCCcHHH
Q 015222          315 EALFQTHENLEHLAMMERVLGPLPH------------------------HMVIRADRRAEKYFRRGARLDWPDGATSRDS  370 (411)
Q Consensus       315 ~~pf~~~~~~~~~~~i~~~~~~~p~------------------------~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t  370 (411)
                      ..||.+.+..+.+..+.......+.                        ...+..+..+.++|.+||..+    |.+||+
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~----P~~R~~  284 (295)
T cd07837         209 QPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYD----PAKRIS  284 (295)
T ss_pred             CCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCC----hhhcCC
Confidence            9999987776666555443221111                        112346778899999999998    999999


Q ss_pred             HHHHHhcCCCC
Q 015222          371 MRAVWKLLRLP  381 (411)
Q Consensus       371 ~~~il~~~~~~  381 (411)
                      +.+++.|+||+
T Consensus       285 ~~eil~~~~~~  295 (295)
T cd07837         285 AKAALTHPYFD  295 (295)
T ss_pred             HHHHhcCCCcC
Confidence            99999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-43  Score=333.04  Aligned_cols=264  Identities=22%  Similarity=0.321  Sum_probs=208.6

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEecc---chhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      ...+...+.+.||+|+||+||+|++..   .||||+++.   .....+.|.+|+..+++-+|.||     +-+.+++...
T Consensus       389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NI-----lLFMG~~~~p  460 (678)
T KOG0193|consen  389 IPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENI-----LLFMGACMNP  460 (678)
T ss_pred             cCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhh-----eeeehhhcCC
Confidence            344566788999999999999997753   399999974   34567889999999999999988     9999999877


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      +. .||+.+| |.+|+.+++... .+|.....+.|++||++|+.|||.++|||||||..|||+.+++             
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~-------------  525 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL-------------  525 (678)
T ss_pred             ce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC-------------
Confidence            66 9999999 889999998665 4799999999999999999999999999999999999997766             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCccccc-----CCCcccccCCCccccceecCC---CCCccchhHHHHHHHHHHHhCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEH-----QDHSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSGEA  316 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~-----~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlGvil~elltg~~  316 (411)
                                    .|||+|||++....     .......|...|||||++..+   +|++.+|||||||++|||++|..
T Consensus       526 --------------kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~l  591 (678)
T KOG0193|consen  526 --------------KVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGEL  591 (678)
T ss_pred             --------------cEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcC
Confidence                          67788888775432     222335688899999999743   79999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhC-CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHh----cCC-CCcccccCCCC
Q 015222          317 LFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK----LLR-LPVIDLYSASP  390 (411)
Q Consensus       317 pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~----~~~-~~~~~~~~~~~  390 (411)
                      ||......+++.++-++.. +.......+.++++++++..|+.++    +++||.+.+|+.    ++. ++.+.-....|
T Consensus       592 Pysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~----~~eRP~F~~il~~l~~l~~~~pki~RS~S~P  667 (678)
T KOG0193|consen  592 PYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFD----REERPLFPQLLSKLEELLPSLPKINRSASEP  667 (678)
T ss_pred             CcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcC----cccCccHHHHHHHHHHhhhcccccccCcCcc
Confidence            9997666666665555422 3334445566778888888887777    666666666655    443 45555444455


Q ss_pred             Cch
Q 015222          391 NCL  393 (411)
Q Consensus       391 ~~~  393 (411)
                      +.+
T Consensus       668 ~~~  670 (678)
T KOG0193|consen  668 VLL  670 (678)
T ss_pred             chh
Confidence            443

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.7e-42  Score=329.64  Aligned_cols=264  Identities=26%  Similarity=0.460  Sum_probs=216.4

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++....   ...+.+.+|+.++++++|+|+     +++++++...
T Consensus        14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i-----v~~~~~~~~~   88 (345)
T cd07877          14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV-----IGLLDVFTPA   88 (345)
T ss_pred             hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcc-----cceeeeeeec
Confidence            35678999999999999999999999999999999987432   234567789999999988887     8888877532


Q ss_pred             ------CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcc
Q 015222          166 ------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK  239 (411)
Q Consensus       166 ------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~  239 (411)
                            +..|+++++++++|.+++...   .+++..++.++.||+.||+|||++||+||||||+||+++.++        
T Consensus        89 ~~~~~~~~~~lv~~~~~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~--------  157 (345)
T cd07877          89 RSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC--------  157 (345)
T ss_pred             ccccccccEEEEehhcccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC--------
Confidence                  457899999999999888654   489999999999999999999999999999999999998766        


Q ss_pred             cccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecC-CCCCccchhHHHHHHHHHHHhCCCCC
Q 015222          240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALF  318 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~pf  318 (411)
                                         .++|+|||++...........|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||
T Consensus       158 -------------------~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  218 (345)
T cd07877         158 -------------------ELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF  218 (345)
T ss_pred             -------------------CEEEecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCC
Confidence                               5778888877765554455678999999999876 46889999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCChhHHH---------------------------hhhhhhhhhhccCCccCCCCCCCcHHHH
Q 015222          319 QTHENLEHLAMMERVLGPLPHHMVI---------------------------RADRRAEKYFRRGARLDWPDGATSRDSM  371 (411)
Q Consensus       319 ~~~~~~~~~~~i~~~~~~~p~~~~~---------------------------~~~~~~~~li~~~l~~~~~~rp~~R~t~  371 (411)
                      ...+....+..+....+..+.....                           ..+..+.++|.+||..+    |.+|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d----p~~R~t~  294 (345)
T cd07877         219 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD----SDKRITA  294 (345)
T ss_pred             CCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCC----hhhcCCH
Confidence            8877666655555544333222211                           23556789999999999    9999999


Q ss_pred             HHHHhcCCCCcccccCCCCC
Q 015222          372 RAVWKLLRLPVIDLYSASPN  391 (411)
Q Consensus       372 ~~il~~~~~~~~~~~~~~~~  391 (411)
                      .+++.|+||.+...+...|.
T Consensus       295 ~e~l~h~~f~~~~~~~~~~~  314 (345)
T cd07877         295 AQALAHAYFAQYHDPDDEPV  314 (345)
T ss_pred             HHHhcChhhhhcCCCCcccc
Confidence            99999999998777776664

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.8e-42  Score=323.39  Aligned_cols=256  Identities=21%  Similarity=0.320  Sum_probs=205.0

Q ss_pred             eccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC
Q 015222          100 MGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL  175 (411)
Q Consensus       100 lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~  175 (411)
                      ||+|+||+||+|.+..+++.||+|++....    .....+..|+.++++++|+++     +++++.+...+..|+||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFI-----VSLAYAFETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCE-----eeeeeEEecCCeEEEEEecC
Confidence            699999999999999999999999986422    233455689999999987766     99999999999999999999


Q ss_pred             -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccC
Q 015222          176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL  254 (411)
Q Consensus       176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~  254 (411)
                       +++|.+++.+.....+++..+..++.|++.||.|||+.|++|+||||+||+++.++                       
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~-----------------------  132 (277)
T cd05577          76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG-----------------------  132 (277)
T ss_pred             CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-----------------------
Confidence             89999999876545799999999999999999999999999999999999998766                       


Q ss_pred             CCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 015222          255 PKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER  332 (411)
Q Consensus       255 ~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~  332 (411)
                          .++|+|||.+......  .....++..|+|||++.+..++.++|||||||++|+|++|+.||...........+..
T Consensus       133 ----~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  208 (277)
T cd05577         133 ----NVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR  208 (277)
T ss_pred             ----CEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh
Confidence                5677777766543221  1234678899999999888899999999999999999999999977554222222222


Q ss_pred             HhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH-HHHHHHhcCCCCcccccC
Q 015222          333 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-SMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       333 ~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~-t~~~il~~~~~~~~~~~~  387 (411)
                      .....+.......+..+.++|.+||..+|.+||+.+. ++.++++|+||.++++..
T Consensus       209 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~  264 (277)
T cd05577         209 RTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRR  264 (277)
T ss_pred             ccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhh
Confidence            2222233333456788999999999999555555554 999999999999888643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9.2e-43  Score=323.28  Aligned_cols=250  Identities=22%  Similarity=0.340  Sum_probs=202.2

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      ++|++.+.||+|+||.||+|++..+++.||+|+++... .....+.+|+.+++.+.|+++     +++++.+...+..++
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~i-----i~~~~~~~~~~~~~l   83 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI-----VAYFGSYLRRDKLWI   83 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCe-----eeEEEEEEeCCEEEE
Confidence            57999999999999999999999999999999987543 233457789999999988877     999999999999999


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      ||||+ +++|.+++...+  .+++..+..++.|++.||+|||+.||+|+||||+||+++.++                  
T Consensus        84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~------------------  143 (267)
T cd06645          84 CMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG------------------  143 (267)
T ss_pred             EEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC------------------
Confidence            99999 889999987765  699999999999999999999999999999999999998766                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceec---CCCCCccchhHHHHHHHHHHHhCCCCCCCCCh
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGEALFQTHEN  323 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltg~~pf~~~~~  323 (411)
                               .++|+|||++......   .....|+..|+|||++.   +..++.++|||||||++|+|++|..||.....
T Consensus       144 ---------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~  214 (267)
T cd06645         144 ---------HVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP  214 (267)
T ss_pred             ---------CEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc
Confidence                     4666666665433221   12346899999999975   44688999999999999999999999976554


Q ss_pred             HHHHHHHHHHhCCCCh-hHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCC
Q 015222          324 LEHLAMMERVLGPLPH-HMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR  379 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~-~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~  379 (411)
                      ......+.......+. .....++..+.+++.+||..+    |.+||++.++++|+|
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----P~~R~~~~~ll~~~~  267 (267)
T cd06645         215 MRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKN----PKKRPTAEKLLQHPF  267 (267)
T ss_pred             hhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCC----chhCcCHHHHhcCCC
Confidence            4433333222111111 111235667889999999998    999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.8e-42  Score=329.81  Aligned_cols=261  Identities=27%  Similarity=0.460  Sum_probs=215.0

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      +.++|++.+.||+|+||.||+|.+..++..||||++...   ......+.+|+.+++++.|+|+     +++++++....
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~   87 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV-----IGLLDVFTPDL   87 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCc-----cceeeeecCCc
Confidence            567899999999999999999999999999999998642   2234567789999999998887     89988886543


Q ss_pred             ------eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          167 ------HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       167 ------~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                            .+++||||++++|.+++...   .+++..++.++.||+.||+|||+.||+||||||+||+++.++         
T Consensus        88 ~~~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~---------  155 (343)
T cd07880          88 SLDRFHDFYLVMPFMGTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC---------  155 (343)
T ss_pred             cccccceEEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC---------
Confidence                  46999999988999888753   599999999999999999999999999999999999997765         


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCC
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQ  319 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~  319 (411)
                                        .++|+|||++...........+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.
T Consensus       156 ------------------~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~  217 (343)
T cd07880         156 ------------------ELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK  217 (343)
T ss_pred             ------------------CEEEeecccccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence                              57888888877655544555788999999998763 68899999999999999999999998


Q ss_pred             CCChHHHHHHHHHHhCCCChhH---------------------------HHhhhhhhhhhhccCCccCCCCCCCcHHHHH
Q 015222          320 THENLEHLAMMERVLGPLPHHM---------------------------VIRADRRAEKYFRRGARLDWPDGATSRDSMR  372 (411)
Q Consensus       320 ~~~~~~~~~~i~~~~~~~p~~~---------------------------~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~  372 (411)
                      +.+.......+.+.....+..+                           ....+..+.++|.+||+.+    |.+|||+.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d----P~~R~t~~  293 (343)
T cd07880         218 GHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLD----AESRITAA  293 (343)
T ss_pred             CCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCC----hhhCCCHH
Confidence            8776655555544433332221                           1234566889999999999    99999999


Q ss_pred             HHHhcCCCCcccccCCC
Q 015222          373 AVWKLLRLPVIDLYSAS  389 (411)
Q Consensus       373 ~il~~~~~~~~~~~~~~  389 (411)
                      +++.|+||+........
T Consensus       294 ~~l~~~~~~~~~~~~~~  310 (343)
T cd07880         294 EALAHPYFEEFHDPEDE  310 (343)
T ss_pred             HHhcCccHhhhcCcccc
Confidence            99999999987655433

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.4e-42  Score=322.01  Aligned_cols=251  Identities=23%  Similarity=0.330  Sum_probs=202.3

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+|+.+++++.|+++     +++++++..++..+
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----i~~~~~~~~~~~~~   82 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI-----VAYFGSYLSREKLW   82 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCe-----eeeeEEEEeCCEEE
Confidence            457999999999999999999999999999999987432 334567789999999988877     99999999999999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +||||+ +++|.+++....  .+++..+..++.|++.||+|||+.||+||||||+||+++.++                 
T Consensus        83 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~-----------------  143 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNG-----------------  143 (267)
T ss_pred             EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-----------------
Confidence            999999 889999987654  689999999999999999999999999999999999997766                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceec---CCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGEALFQTHE  322 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltg~~pf~~~~  322 (411)
                                .++|+|||++......   .....|+..|+|||.+.   ...++.++|||||||++|||++|..||....
T Consensus       144 ----------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~  213 (267)
T cd06646         144 ----------DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLH  213 (267)
T ss_pred             ----------CEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence                      4677777766543221   22346889999999985   3357889999999999999999999997554


Q ss_pred             hHHHHHHHHHHhCCCCh-hHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCC
Q 015222          323 NLEHLAMMERVLGPLPH-HMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR  379 (411)
Q Consensus       323 ~~~~~~~i~~~~~~~p~-~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~  379 (411)
                      ..+....+.......+. .....++..+.+++++||..+    |++||+++++++|+|
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----P~~Rp~~~~il~~l~  267 (267)
T cd06646         214 PMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKN----PKKRPTAERLLTHLF  267 (267)
T ss_pred             hhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCC----hhhCcCHHHHhcCCC
Confidence            43333222221111111 111245678999999999888    999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.5e-42  Score=321.13  Aligned_cols=253  Identities=21%  Similarity=0.319  Sum_probs=196.8

Q ss_pred             eeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEcc
Q 015222           99 KMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK  174 (411)
Q Consensus        99 ~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~  174 (411)
                      .||+|+||.||++.+..+++.||+|.+.+..    .......+|..+++.+.+.  .|++++.+++.+..++..++||||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~i~~~~~~~~~~~~~~lv~e~   78 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG--DCPFIVCMTYAFHTPDKLCFILDL   78 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhC--CCCcEeEEEEEEecCCeEEEEEec
Confidence            4899999999999999999999999986432    1122334455555544322  346669999999999999999999


Q ss_pred             C-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCcccc
Q 015222          175 L-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN  253 (411)
Q Consensus       175 ~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~  253 (411)
                      + +++|.+++..+.  .+++..+..++.|++.||+|||++||+|+||||+|||++.++                      
T Consensus        79 ~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~----------------------  134 (279)
T cd05633          79 MNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG----------------------  134 (279)
T ss_pred             CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC----------------------
Confidence            9 999999988765  699999999999999999999999999999999999997766                      


Q ss_pred             CCCCCCeeEeecCCcccccC-CCcccccCCCccccceecC-CCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015222          254 LPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME  331 (411)
Q Consensus       254 ~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~  331 (411)
                           .++|+|||++..... ......||..|+|||.+.+ ..++.++|||||||++|+|++|..||........ ..+.
T Consensus       135 -----~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~  208 (279)
T cd05633         135 -----HVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEID  208 (279)
T ss_pred             -----CEEEccCCcceeccccCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHH
Confidence                 567777776653322 1223468999999999874 4689999999999999999999999976433221 1122


Q ss_pred             HHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH-----HHHHHHhcCCCCcccccC
Q 015222          332 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-----SMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       332 ~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~-----t~~~il~~~~~~~~~~~~  387 (411)
                      ......+.......+..+.++|.+||..|    |++|+     +++++++|+||.++.+..
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~----p~~R~~~~~~~~~~~~~h~~~~~~~~~~  265 (279)
T cd05633         209 RMTLTVNVELPDSFSPELKSLLEGLLQRD----VSKRLGCLGRGAQEVKEHVFFKGIDWQQ  265 (279)
T ss_pred             HHhhcCCcCCccccCHHHHHHHHHHhcCC----HHHhcCCCCCCHHHHHhCccccCCCHhH
Confidence            22222333344556788999999999999    88888     699999999999977544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-42  Score=321.84  Aligned_cols=253  Identities=25%  Similarity=0.361  Sum_probs=211.8

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      ++|++.+.||.|+||.||+|.+..+++.||+|++....  .....+.+|+.+++.+.|+|+     +++++++..+...+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~   75 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYI-----TKYYGSFLKGSKLW   75 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCe-----eeeeEEEEECCeEE
Confidence            47899999999999999999999999999999987432  334567889999999988877     99999999999999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +|+||+ +++|.+++...   .+++..+..++.|++.||.|||++|++|+||+|+||++++++                 
T Consensus        76 ~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-----------------  135 (274)
T cd06609          76 IIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG-----------------  135 (274)
T ss_pred             EEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-----------------
Confidence            999999 88999998865   589999999999999999999999999999999999998766                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                                .++|+|||.+......   .....|+..|+|||.+.+..++.++|||||||++|+|++|..||...+...
T Consensus       136 ----------~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~  205 (274)
T cd06609         136 ----------DVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR  205 (274)
T ss_pred             ----------CEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH
Confidence                      5677777776654332   233578889999999998889999999999999999999999998766555


Q ss_pred             HHHHHHHHhCCCChhHHHh-hhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          326 HLAMMERVLGPLPHHMVIR-ADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~-~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                      ....+.....+   ..... .+..+.+++.+|+..+    |.+||+++++++|+||.+....
T Consensus       206 ~~~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~~----p~~Rpt~~~il~~~~~~~~~~~  260 (274)
T cd06609         206 VLFLIPKNNPP---SLEGNKFSKPFKDFVSLCLNKD----PKERPSAKELLKHKFIKKAKKT  260 (274)
T ss_pred             HHHHhhhcCCC---CCcccccCHHHHHHHHHHhhCC----hhhCcCHHHHhhChhhcCCCcc
Confidence            54444433221   11122 6677899999998888    9999999999999999885543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=8.8e-42  Score=314.60  Aligned_cols=249  Identities=27%  Similarity=0.383  Sum_probs=209.7

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      +|++++.||.|+||.||.+++..+++.|++|.+...   ......+.+|+.++++++|+|+     +++++++.+.+..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI-----IAYYNHFMDDNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCe-----eEEEeEEecCCeEE
Confidence            599999999999999999999999999999988642   3445667889999999988776     99999999999999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      ++|||+ +++|.+++.+.....+++..+..++.|++.||.|||+.|++|+||||+||+++.++                 
T Consensus        76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~-----------------  138 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG-----------------  138 (256)
T ss_pred             EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCC-----------------
Confidence            999999 89999999876445789999999999999999999999999999999999998776                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                                .+||+|||.+.......   ....|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+
T Consensus       139 ----------~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~  208 (256)
T cd08221         139 ----------LIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN  208 (256)
T ss_pred             ----------CEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH
Confidence                      45666666655432222   23568899999999998889999999999999999999999998877766


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      ....+....  .+. .....+..+.+++.+|+..+    |..||++.++++|+|+
T Consensus       209 ~~~~~~~~~--~~~-~~~~~~~~~~~~i~~~l~~~----p~~R~s~~~ll~~~~l  256 (256)
T cd08221         209 LVVKIVQGN--YTP-VVSVYSSELISLVHSLLQQD----PEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHHHcCC--CCC-CccccCHHHHHHHHHHcccC----cccCCCHHHHhhCcCC
Confidence            666554322  221 12456778899999998888    9999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-42  Score=324.68  Aligned_cols=255  Identities=25%  Similarity=0.400  Sum_probs=209.2

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      ++|++.+.||.|+||.||+|.+..++..||+|++.... ...+.+..|+.++++++|+++     +++++.+..++..|+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~l   79 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNI-----VGLYEAYFYENKLWI   79 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCce-----eEEEEEEecCCeEEE
Confidence            57999999999999999999999899999999987433 344567889999999988777     999999999999999


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      ||||+ +++|.+++.+.. ..+++..++.++.|++.||.|||++||+|+||||+||+++.++                  
T Consensus        80 v~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~------------------  140 (280)
T cd06611          80 LIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG------------------  140 (280)
T ss_pred             EeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCC------------------
Confidence            99999 889999987654 3699999999999999999999999999999999999998766                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceec-----CCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                               .++|+|||.+......   .....|++.|+|||++.     +..++.++|||||||++|+|++|+.||...
T Consensus       141 ---------~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~  211 (280)
T cd06611         141 ---------DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL  211 (280)
T ss_pred             ---------CEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence                     5677777765543221   23346899999999985     335788999999999999999999999887


Q ss_pred             ChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      +..+.+..+.....+ .......++..+.+++.+|+..+    |.+||++.++++|+|+.+..
T Consensus       212 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~----p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         212 NPMRVLLKILKSEPP-TLDQPSKWSSSFNDFLKSCLVKD----PDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             CHHHHHHHHhcCCCC-CcCCcccCCHHHHHHHHHHhccC----hhhCcCHHHHhcChhhcccc
Confidence            665555444432211 11112345678899999998888    99999999999999998763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=6.8e-42  Score=320.68  Aligned_cols=256  Identities=22%  Similarity=0.374  Sum_probs=203.6

Q ss_pred             CccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeee---
Q 015222           88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD---  163 (411)
Q Consensus        88 ~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~---  163 (411)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++.........+.+|+.+++.+ .|+|+     +++++++.   
T Consensus        14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i-----~~~~~~~~~~~   88 (286)
T cd06638          14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNV-----VKFYGMYYKKD   88 (286)
T ss_pred             CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCe-----eeeeeeeeecc
Confidence            3456799999999999999999999999999999999876555556678899999999 47766     99998873   


Q ss_pred             --cCCeEEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCc
Q 015222          164 --YRNHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY  238 (411)
Q Consensus       164 --~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df  238 (411)
                        .++..++||||+ +++|.+++...  ....+++..+..++.|++.||.|||+.+|+||||||+||+++.++       
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-------  161 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG-------  161 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC-------
Confidence              356799999999 99999987632  224689999999999999999999999999999999999998766       


Q ss_pred             ccccccCCCCCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecC-----CCCCccchhHHHHHHHHH
Q 015222          239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVE  310 (411)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~e  310 (411)
                                          .++|+|||++......   .....|+..|+|||++..     ..++.++|||||||++||
T Consensus       162 --------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~e  221 (286)
T cd06638         162 --------------------GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIE  221 (286)
T ss_pred             --------------------CEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHH
Confidence                                4677777776543221   223468999999999853     357899999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          311 LCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       311 lltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      |++|+.||...+....+..+..... .........+..+.+++.+|+..+    |++||++.++++|+||
T Consensus       222 l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~----p~~Rps~~ell~~~~~  286 (286)
T cd06638         222 LGDGDPPLADLHPMRALFKIPRNPP-PTLHQPELWSNEFNDFIRKCLTKD----YEKRPTVSDLLQHVFI  286 (286)
T ss_pred             HhcCCCCCCCCchhHHHhhccccCC-CcccCCCCcCHHHHHHHHHHccCC----cccCCCHHHHhhcccC
Confidence            9999999987655444333322211 111111224567899999998888    9999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.4e-42  Score=319.35  Aligned_cols=247  Identities=26%  Similarity=0.400  Sum_probs=202.7

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----------hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeee
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF  162 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----------~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~  162 (411)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+....          ...+.+.+|+.+++++.|+++     +++++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~   75 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENI-----VQYLGSS   75 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCe-----eeEEEEE
Confidence            4788899999999999999999999999999886422          122567789999999988877     9999999


Q ss_pred             ecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccc
Q 015222          163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL  241 (411)
Q Consensus       163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~  241 (411)
                      ...+..++||||+ +++|.+++....  .+++..+..++.|++.||+|||+.|++||||||+||++++++.         
T Consensus        76 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~---------  144 (267)
T cd06628          76 LDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG---------  144 (267)
T ss_pred             EeCCccEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC---------
Confidence            9999999999999 889999998764  6899999999999999999999999999999999999987774         


Q ss_pred             cccCCCCCccccCCCCCCeeEeecCCcccccC---------CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHH
Q 015222          242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---------DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC  312 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell  312 (411)
                                        ++|+|||.+.....         ......|+..|+|||.+.+..++.++|||||||++|+|+
T Consensus       145 ------------------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~  206 (267)
T cd06628         145 ------------------IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEML  206 (267)
T ss_pred             ------------------EEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHh
Confidence                              45555554443321         112245788999999999888999999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       313 tg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      +|+.||.+.+....+..+..   ..........+..+.++|.+|+..+    |.+||++.++++|+||
T Consensus       207 ~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~----p~~Rp~~~~il~~~~~  267 (267)
T cd06628         207 TGKHPFPDCTQLQAIFKIGE---NASPEIPSNISSEAIDFLEKTFEID----HNKRPTAAELLKHPFL  267 (267)
T ss_pred             hCCCCCCCccHHHHHHHHhc---cCCCcCCcccCHHHHHHHHHHccCC----chhCcCHHHHhhCCCC
Confidence            99999987655444433332   1122223346778899999998888    9999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1e-41  Score=318.64  Aligned_cols=249  Identities=30%  Similarity=0.485  Sum_probs=203.6

Q ss_pred             eEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHh-cCCCCCcceEEEeeeeecC--CeE
Q 015222           94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYR--NHI  168 (411)
Q Consensus        94 y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~~~~~--~~~  168 (411)
                      |++.++||+|+||.||+|.+..+++.||+|+++...  .......+|+.++.++. |+|+     +++++++.+.  +.+
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i-----~~~~~~~~~~~~~~~   75 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI-----LRLIEVLFDRKTGRL   75 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCc-----cceEEEEecCCCCcE
Confidence            688999999999999999999999999999987532  22233456888888875 6666     9999999887  899


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      ++||||+.++|.+++.... ..+++..+..++.||+.||+|||+.||+||||||+||+++. +                 
T Consensus        76 ~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~-----------------  136 (282)
T cd07831          76 ALVFELMDMNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-D-----------------  136 (282)
T ss_pred             EEEEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-C-----------------
Confidence            9999999779999887643 36899999999999999999999999999999999999976 5                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecC-CCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                                .++|+|||.+.......  ....++..|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+
T Consensus       137 ----------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~  206 (282)
T cd07831         137 ----------ILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD  206 (282)
T ss_pred             ----------CeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH
Confidence                      57778887776543222  23467889999997754 457899999999999999999999999887777


Q ss_pred             HHHHHHHHhCCCChh-------------------------HHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          326 HLAMMERVLGPLPHH-------------------------MVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~-------------------------~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      ....+....+..+..                         .....+..+.++|.+||+.+    |.+||++.++++|+||
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----P~~R~~~~~~l~~~~~  282 (282)
T cd07831         207 QIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYD----PDERITAKQALRHPYF  282 (282)
T ss_pred             HHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccC----cccccCHHHHhhCCCC
Confidence            666665544433321                         12245678999999999999    9999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.4e-42  Score=317.08  Aligned_cols=250  Identities=24%  Similarity=0.383  Sum_probs=208.0

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+..... .+.+.+|+.++++++|+++     +++++++......|++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i-----~~~~~~~~~~~~~~l~   76 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYI-----VKYYGSYFKNTDLWIV   76 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcE-----eeeeeeeecCCcEEEE
Confidence            579999999999999999999999899999999976543 6778899999999977776     9999999999999999


Q ss_pred             EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      +||+ +++|.+++.... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++                   
T Consensus        77 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~-------------------  136 (256)
T cd06612          77 MEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG-------------------  136 (256)
T ss_pred             EecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCC-------------------
Confidence            9999 889999987644 4689999999999999999999999999999999999998766                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL  327 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~  327 (411)
                              .++|+|||++.......   ....|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.....
T Consensus       137 --------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~  208 (256)
T cd06612         137 --------QAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI  208 (256)
T ss_pred             --------cEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh
Confidence                    56777777666543222   2345788999999999889999999999999999999999999876554443


Q ss_pred             HHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          328 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       328 ~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      ..+.... .........++..+.+++.+|+..+    |.+||++.++++|+||
T Consensus       209 ~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~----P~~Rps~~~il~~~~~  256 (256)
T cd06612         209 FMIPNKP-PPTLSDPEKWSPEFNDFVKKCLVKD----PEERPSAIQLLQHPFI  256 (256)
T ss_pred             hhhccCC-CCCCCchhhcCHHHHHHHHHHHhcC----hhhCcCHHHHhcCCCC
Confidence            3322211 1111123345678899999998888    9999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.7e-42  Score=321.94  Aligned_cols=254  Identities=25%  Similarity=0.417  Sum_probs=207.3

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc-hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      -|++.+.||+|+||.||+|.+..++..+|+|.+... ....+.+.+|+.+++.+.|+|+     +++++++..++..++|
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----i~~~~~~~~~~~~~~v   80 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI-----VKLLDAFYYENNLWIL   80 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCe-----eeEEEEEeeCCEEEEE
Confidence            378899999999999999999999999999998643 3445667889999999988877     9999999999999999


Q ss_pred             EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      |||+ +++|..++.+.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++                   
T Consensus        81 ~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~-------------------  140 (282)
T cd06643          81 IEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG-------------------  140 (282)
T ss_pred             EEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC-------------------
Confidence            9999 889988876533 3699999999999999999999999999999999999998766                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceec-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGEALFQTHE  322 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltg~~pf~~~~  322 (411)
                              .++|+|||++......   .....|+..|+|||++.     +..++.++|||||||++|+|++|+.||...+
T Consensus       141 --------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~  212 (282)
T cd06643         141 --------DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN  212 (282)
T ss_pred             --------CEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC
Confidence                    5666666665443221   22346889999999984     3457889999999999999999999998877


Q ss_pred             hHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      ..+....+....... ......++..+.++|.+|++.+    |.+||++.++++|+|+....
T Consensus       213 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~----p~~Rp~~~~il~~~~~~~~~  269 (282)
T cd06643         213 PMRVLLKIAKSEPPT-LAQPSRWSSEFKDFLKKCLEKN----VDARWTTTQLLQHPFVTVNS  269 (282)
T ss_pred             HHHHHHHHhhcCCCC-CCCccccCHHHHHHHHHHccCC----hhhCcCHHHHhcCCCEeccC
Confidence            666555554432211 1112346678999999998888    99999999999999998643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-43  Score=286.99  Aligned_cols=255  Identities=28%  Similarity=0.461  Sum_probs=220.5

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      +|.-.++||+|.||+||+|+++++++.||+|.++...   .......+|+-+|+.++|.||     |++++....++.+-
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhkni-----vrl~dvlhsdkklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI-----VRLHDVLHSDKKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcce-----eehhhhhccCceeE
Confidence            5777899999999999999999999999999997433   344678899999999999988     99999999999999


Q ss_pred             EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      +|+|||..+|..+...-. ..++.+.++.++.|+++||.|+|++++.|||+||.|+||+.+|                  
T Consensus        78 lvfe~cdqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ng------------------  138 (292)
T KOG0662|consen   78 LVFEFCDQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNG------------------  138 (292)
T ss_pred             EeHHHhhHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCC------------------
Confidence            999999999999988765 4699999999999999999999999999999999999998877                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCC-CCCccchhHHHHHHHHHHHh-CCCCCCCCChH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCS-GEALFQTHENL  324 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~  324 (411)
                               .+||+|||+++..+-..   +..+-|..|++|.++.|. -|++..|+||.|||+.|+.. |++.|.+.+..
T Consensus       139 ---------elkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd  209 (292)
T KOG0662|consen  139 ---------ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD  209 (292)
T ss_pred             ---------cEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH
Confidence                     67778888777655443   224668999999999887 58999999999999999998 99999999999


Q ss_pred             HHHHHHHHHhCCCChhHH-------------------------HhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCC
Q 015222          325 EHLAMMERVLGPLPHHMV-------------------------IRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR  379 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~-------------------------~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~  379 (411)
                      +++..|.+..+...++.+                         +.++..-+++++++|..+    |..|.+++++++||+
T Consensus       210 dqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cn----p~qrisaeaalqhpy  285 (292)
T KOG0662|consen  210 DQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCN----PAQRISAEAALQHPY  285 (292)
T ss_pred             HHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccC----cccccCHHHHhcCcc
Confidence            999999988875443322                         234455678999999888    999999999999999


Q ss_pred             CCccc
Q 015222          380 LPVID  384 (411)
Q Consensus       380 ~~~~~  384 (411)
                      |.+..
T Consensus       286 f~d~s  290 (292)
T KOG0662|consen  286 FSDFS  290 (292)
T ss_pred             ccccC
Confidence            98764

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.4e-42  Score=322.58  Aligned_cols=238  Identities=13%  Similarity=0.162  Sum_probs=196.6

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccchhh----hHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec----CCeEE
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY----REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY----RNHIC  169 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~----~~~~~  169 (411)
                      ..||+|++|.||+|..  +|+.||||+++.....    .+.+.+|+.++++++|+||     +++++++.+    ...++
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-----v~~~g~~~~~~~~~~~~~   98 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNI-----LKIYGFIIDIVDDLPRLS   98 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCE-----EEEeeeEEecccCCCceE
Confidence            5789999999999976  6889999999754332    3566799999999998877     999998876    35789


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      +||||+ +|+|.+++....  .+++.....++.|++.||.|||+ .+++||||||+|||++.++                
T Consensus        99 lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~----------------  160 (283)
T PHA02988         99 LILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY----------------  160 (283)
T ss_pred             EEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC----------------
Confidence            999999 999999998764  68999999999999999999998 4999999999999998766                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecC--CCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                                 .+||+|||++...........||..|+|||++.+  ..++.++|||||||++|||++|+.||.+.+..+
T Consensus       161 -----------~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~  229 (283)
T PHA02988        161 -----------KLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE  229 (283)
T ss_pred             -----------cEEEcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH
Confidence                       5777888877654444444578999999999976  579999999999999999999999999887766


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ....+......++  .....+..+.+++.+|++.+    |..||++.++++.
T Consensus       230 ~~~~i~~~~~~~~--~~~~~~~~l~~li~~cl~~d----p~~Rps~~ell~~  275 (283)
T PHA02988        230 IYDLIINKNNSLK--LPLDCPLEIKCIVEACTSHD----SIKRPNIKEILYN  275 (283)
T ss_pred             HHHHHHhcCCCCC--CCCcCcHHHHHHHHHHhcCC----cccCcCHHHHHHH
Confidence            6665543322222  22245778999999998888    9999999999864

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=9.2e-42  Score=314.47  Aligned_cols=249  Identities=24%  Similarity=0.387  Sum_probs=209.2

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      +|++.+.||+|+||.||++.+..+++.||+|.+...   ......+.+|+.+++++.|+++     +++++++...++.+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI-----VQYQESFEENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCe-----eeeEeeecCCCeEE
Confidence            599999999999999999999999999999998642   2344577889999999988777     99999999999999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +||||+ +++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+|||++.++                 
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~-----------------  138 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-----------------  138 (256)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-----------------
Confidence            999999 89999999875545689999999999999999999999999999999999997765                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                                .++|+|||.+.......   ....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+
T Consensus       139 ----------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~  208 (256)
T cd08218         139 ----------TIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN  208 (256)
T ss_pred             ----------CEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH
Confidence                      56777777766543322   22467889999999998889999999999999999999999998777666


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      ....+....  .+. .....+..+.++|.+|++.+    |++||++.++++|+||
T Consensus       209 ~~~~~~~~~--~~~-~~~~~~~~~~~li~~~l~~~----p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         209 LVLKIIRGS--YPP-VSSHYSYDLRNLVSQLFKRN----PRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHHhcCC--CCC-CcccCCHHHHHHHHHHhhCC----hhhCcCHHHHhhCcCC
Confidence            555543322  211 22345677899999998888    9999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-41  Score=314.16  Aligned_cols=251  Identities=24%  Similarity=0.349  Sum_probs=207.8

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|++.... ...+.+.+|+.++++++|+++     +++++.+.+++.+|+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI-----VAYFGSYLRRDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCCh-----hceEEEEEeCCEEEE
Confidence            57999999999999999999999999999999987533 345678899999999988887     999999999999999


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      +|||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++                  
T Consensus        78 ~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~------------------  138 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG------------------  138 (262)
T ss_pred             EEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCC------------------
Confidence            99999 889999987752 3699999999999999999999999999999999999998766                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCC---CCCccchhHHHHHHHHHHHhCCCCCCCCCh
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSGEALFQTHEN  323 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlGvil~elltg~~pf~~~~~  323 (411)
                               .++|+|||.+......   .....++..|+|||.+.+.   .++.++|||||||++|+|++|..||...+.
T Consensus       139 ---------~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~  209 (262)
T cd06613         139 ---------DVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP  209 (262)
T ss_pred             ---------CEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence                     5677777766543321   2334688899999999877   789999999999999999999999988766


Q ss_pred             HHHHHHHHHHhCCC-ChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCC
Q 015222          324 LEHLAMMERVLGPL-PHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR  379 (411)
Q Consensus       324 ~~~~~~i~~~~~~~-p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~  379 (411)
                      .+....+....... ........+..+.+++.+|+..+    |..||++.+++.|+|
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----p~~Rpt~~~il~~~~  262 (262)
T cd06613         210 MRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKD----PKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCC----hhhCCCHHHHhcCCC
Confidence            55544443331111 11122345677899999998888    999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1e-41  Score=319.60  Aligned_cols=252  Identities=32%  Similarity=0.614  Sum_probs=206.5

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++..   ....+.+.+|+++++++.|+++     +++++++..++..
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~   75 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENI-----VNLKEAFRRKGRL   75 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCe-----eehhheEEECCEE
Confidence            4799999999999999999999999999999998643   2345678899999999988877     9999999999999


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      ++||||+++++.+.+.... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++                 
T Consensus        76 ~iv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~-----------------  137 (288)
T cd07833          76 YLVFEYVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG-----------------  137 (288)
T ss_pred             EEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-----------------
Confidence            9999999545554444333 3589999999999999999999999999999999999997766                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCh
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHEN  323 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~  323 (411)
                                .++|+|||.+.......    ....++..|+|||++.+. .++.++||||||+++|+|++|+.||.+.+.
T Consensus       138 ----------~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~  207 (288)
T cd07833         138 ----------VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD  207 (288)
T ss_pred             ----------CEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence                      57777777766543322    234678899999999888 889999999999999999999999988777


Q ss_pred             HHHHHHHHHHhCCCChhH----------------------------HHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHH
Q 015222          324 LEHLAMMERVLGPLPHHM----------------------------VIRADRRAEKYFRRGARLDWPDGATSRDSMRAVW  375 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~~----------------------------~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il  375 (411)
                      .+.+..+....+.++...                            ...++..+.+++.+|+..+    |++||++++++
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----p~~Rps~~~il  283 (288)
T cd07833         208 IDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMD----PKERLTCDELL  283 (288)
T ss_pred             HHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccC----chhcccHHHHh
Confidence            666655555443332211                            1112677889999998888    99999999999


Q ss_pred             hcCCC
Q 015222          376 KLLRL  380 (411)
Q Consensus       376 ~~~~~  380 (411)
                      +|+||
T Consensus       284 ~~~~f  288 (288)
T cd07833         284 QHPYF  288 (288)
T ss_pred             cCCCC
Confidence            99997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=345.78  Aligned_cols=251  Identities=27%  Similarity=0.358  Sum_probs=204.3

Q ss_pred             eEEeeCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEecc-chhhhHHHHHHHHHHHHHh-cCCCCCcceEEEe
Q 015222           82 YVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS-INKYREAAMIEIDVLQRLA-RHDIGGTRCVQIR  159 (411)
Q Consensus        82 ~~~~~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~  159 (411)
                      ..+.+|.   -+++|.+.|.+|||+.||+|++...+..||+|.+-. +....+.+.+|+++|+.|. |+||     |.++
T Consensus        30 ~~~~Vg~---~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nI-----V~yi  101 (738)
T KOG1989|consen   30 QTFTVGS---HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNI-----VSYI  101 (738)
T ss_pred             eEEEECC---EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCce-----eeEe
Confidence            3445554   378999999999999999999999889999998853 4456678889999999997 5555     9999


Q ss_pred             ee-eec------CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEec
Q 015222          160 NW-FDY------RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVS  229 (411)
Q Consensus       160 ~~-~~~------~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dikp~NIli~~  229 (411)
                      +. ...      .-.++|.|||| ||+|.|++..+....|++.++++|+.|+++|+.+||..+  |||||||-|||||+.
T Consensus       102 dss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~  181 (738)
T KOG1989|consen  102 DSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSA  181 (738)
T ss_pred             ccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcC
Confidence            93 221      13689999999 799999999776667999999999999999999999998  999999999999988


Q ss_pred             CcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCc------------ccccCCCccccceec---CCC
Q 015222          230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS------------YVVSTRHYRAPEVIL---GLG  294 (411)
Q Consensus       230 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~------------~~~gt~~y~aPE~~~---~~~  294 (411)
                      +|                           ..||||||++........            ....|+.|+|||++.   +.+
T Consensus       182 ~g---------------------------~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~p  234 (738)
T KOG1989|consen  182 DG---------------------------NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLP  234 (738)
T ss_pred             CC---------------------------CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCC
Confidence            77                           678888998765332221            134699999999974   568


Q ss_pred             CCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHH
Q 015222          295 WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV  374 (411)
Q Consensus       295 ~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~i  374 (411)
                      ++.|+|||+|||+||-|+....||++...    ..|......+|..  +.++..+++||+.||+.+    |.+||++-++
T Consensus       235 I~eKsDIWALGclLYkLCy~t~PFe~sg~----laIlng~Y~~P~~--p~ys~~l~~LI~~mL~~n----P~~RPnI~Qv  304 (738)
T KOG1989|consen  235 IGEKSDIWALGCLLYKLCYFTTPFEESGK----LAILNGNYSFPPF--PNYSDRLKDLIRTMLQPN----PDERPNIYQV  304 (738)
T ss_pred             CcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEeccccCCCC--ccHHHHHHHHHHHHhccC----cccCCCHHHH
Confidence            99999999999999999999999986544    2344555666664  567889999999999999    6666666666


Q ss_pred             Hhc
Q 015222          375 WKL  377 (411)
Q Consensus       375 l~~  377 (411)
                      +.+
T Consensus       305 ~~~  307 (738)
T KOG1989|consen  305 LEE  307 (738)
T ss_pred             HHH
Confidence            654

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-42  Score=318.46  Aligned_cols=253  Identities=24%  Similarity=0.381  Sum_probs=205.1

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeecC----
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYR----  165 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~~----  165 (411)
                      .++|++.+.||+|+||.||+|.++.+++.|++|++.......+.+.+|+.+++++ .|+|+     +++++++...    
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i-----~~~~~~~~~~~~~~   79 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNI-----ATFYGAFIKKNPPG   79 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCCh-----heEEEEEEecCCCC
Confidence            4789999999999999999999999999999999987666667788999999998 57776     9999998653    


Q ss_pred             --CeEEEEEccC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          166 --NHICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       166 --~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                        ..+++||||+ +++|.+++....  ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++         
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~---------  150 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA---------  150 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC---------
Confidence              4589999999 889999987533  34789999999999999999999999999999999999998766         


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecC-----CCCCccchhHHHHHHHHHHH
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELC  312 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~ell  312 (411)
                                        .++|+|||.+......   .....|+..|+|||++..     ..++.++|||||||++|+|+
T Consensus       151 ------------------~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~  212 (275)
T cd06608         151 ------------------EVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELA  212 (275)
T ss_pred             ------------------eEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHH
Confidence                              5667777766543221   123468899999998854     24678999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       313 tg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      +|+.||........+..+...... .......++..+.+++.+||..|    |++|||+.++++|||+
T Consensus       213 ~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~d----p~~Rpt~~~ll~~~~~  275 (275)
T cd06608         213 DGKPPLCDMHPMRALFKIPRNPPP-TLKSPENWSKKFNDFISECLIKN----YEQRPFMEELLEHPFI  275 (275)
T ss_pred             hCCCCccccchHHHHHHhhccCCC-CCCchhhcCHHHHHHHHHHhhcC----hhhCcCHHHHhcCCCC
Confidence            999999876555444444332111 11112235678999999999999    9999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=7e-42  Score=321.89  Aligned_cols=252  Identities=28%  Similarity=0.434  Sum_probs=206.3

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC--C
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--N  166 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~--~  166 (411)
                      ++|++.+.||.|+||.||+|.+..+++.||+|.++...   .....+.+|+.+++++.|+|+     +++++++...  +
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----~~~~~~~~~~~~~   79 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNI-----VTVKEVVVGSNLD   79 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCE-----EEEEEEEEecCCC
Confidence            47999999999999999999999999999999997432   223345689999999988777     9999988776  8


Q ss_pred             eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          167 HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       167 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      ..|+||||++++|.+++.... ..+++..++.++.||+.||+|||++||+|+||||+||+++.++               
T Consensus        80 ~~~lv~e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~---------------  143 (293)
T cd07843          80 KIYMVMEYVEHDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRG---------------  143 (293)
T ss_pred             cEEEEehhcCcCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC---------------
Confidence            999999999779999987654 3689999999999999999999999999999999999998766               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHE  322 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~  322 (411)
                                  .++|+|||.+......   .....++..|+|||.+.+. .++.++|||||||++|+|++|..||...+
T Consensus       144 ------------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~  211 (293)
T cd07843         144 ------------ILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS  211 (293)
T ss_pred             ------------cEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                        5677777766654332   1234578899999998765 46899999999999999999999999887


Q ss_pred             hHHHHHHHHHHhCCCChhHH--------------------------Hh--hhhhhhhhhccCCccCCCCCCCcHHHHHHH
Q 015222          323 NLEHLAMMERVLGPLPHHMV--------------------------IR--ADRRAEKYFRRGARLDWPDGATSRDSMRAV  374 (411)
Q Consensus       323 ~~~~~~~i~~~~~~~p~~~~--------------------------~~--~~~~~~~li~~~l~~~~~~rp~~R~t~~~i  374 (411)
                      ..+.+..+....+......+                          ..  .++.+.++|.+||+.+    |++||++.|+
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----p~~R~t~~el  287 (293)
T cd07843         212 EIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYD----PAKRISAEDA  287 (293)
T ss_pred             hHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccC----ccccCCHHHH
Confidence            77666665544332211111                          11  3667889999999988    9999999999


Q ss_pred             HhcCCC
Q 015222          375 WKLLRL  380 (411)
Q Consensus       375 l~~~~~  380 (411)
                      ++|+||
T Consensus       288 l~~~~f  293 (293)
T cd07843         288 LKHPYF  293 (293)
T ss_pred             hcCCCC
Confidence            999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=7.7e-42  Score=323.43  Aligned_cols=251  Identities=20%  Similarity=0.291  Sum_probs=196.4

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCC----------------CCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNE----------------KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGG  152 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~----------------~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~  152 (411)
                      .++|++.++||+|+||.||+|.+..                ++..||+|++...  ......+.+|+.++.++.|+||  
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--   81 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI--   81 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCe--
Confidence            3689999999999999999998543                3457999998753  2345678899999999988777  


Q ss_pred             cceEEEeeeeecCCeEEEEEccC-CCCHHHHHHhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 015222          153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSY-----------------RSFPIDLVRELGRQLLESVAFMHELR  214 (411)
Q Consensus       153 ~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-----------------~~l~~~~~~~i~~qi~~aL~~LH~~g  214 (411)
                         +++++++.+.+..++||||+ +++|.+++.....                 ..+++..+..++.||+.||.|||+.|
T Consensus        82 ---v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~  158 (304)
T cd05096          82 ---IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN  158 (304)
T ss_pred             ---eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence               99999999999999999999 9999999865321                 24677889999999999999999999


Q ss_pred             ceecCCCCCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccce
Q 015222          215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEV  289 (411)
Q Consensus       215 ivH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~  289 (411)
                      |+||||||+|||++.++                           .+||+|||++.......     ....++..|+|||+
T Consensus       159 ivH~dlkp~Nill~~~~---------------------------~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~  211 (304)
T cd05096         159 FVHRDLATRNCLVGENL---------------------------TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWEC  211 (304)
T ss_pred             ccccCcchhheEEcCCc---------------------------cEEECCCccceecccCceeEecCcCCCCccccCHHH
Confidence            99999999999998766                           56666666665432211     12345778999999


Q ss_pred             ecCCCCCccchhHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhC----CCChhHHHhhhhhhhhhhccCCccCCCC
Q 015222          290 ILGLGWNYPCDLWSVGCILVELCS--GEALFQTHENLEHLAMMERVLG----PLPHHMVIRADRRAEKYFRRGARLDWPD  363 (411)
Q Consensus       290 ~~~~~~~~~~DiwSlGvil~ellt--g~~pf~~~~~~~~~~~i~~~~~----~~p~~~~~~~~~~~~~li~~~l~~~~~~  363 (411)
                      +.+..++.++|||||||++|||++  +..||.+.+..+.+..+.....    .........++..+.+++.+|+..+   
T Consensus       212 ~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~---  288 (304)
T cd05096         212 ILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRD---  288 (304)
T ss_pred             HhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCC---
Confidence            988899999999999999999987  6788987766665554433211    1111111234567889999998888   


Q ss_pred             CCCcHHHHHHHHhc
Q 015222          364 GATSRDSMRAVWKL  377 (411)
Q Consensus       364 rp~~R~t~~~il~~  377 (411)
                       |.+||++.++.+.
T Consensus       289 -p~~RPs~~~i~~~  301 (304)
T cd05096         289 -CRERPSFSDIHAF  301 (304)
T ss_pred             -chhCcCHHHHHHH
Confidence             9999999999654

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.6e-41  Score=317.67  Aligned_cols=252  Identities=29%  Similarity=0.488  Sum_probs=206.1

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      +|++.++||.|++|.||+|++..+++.||||+++...  .....+.+|+.++++++|+|+     +++++++.+.+..++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI-----VRLHDVIHTENKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCE-----eeeeeeEeeCCcEEE
Confidence            5899999999999999999999999999999987533  234566789999999988877     999999999999999


Q ss_pred             EEccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          171 VFEKLGPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       171 v~e~~~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      ||||+.++|.+++.... ...+++..+..++.||+.||+|||+.|++|+||||+||++++++                  
T Consensus        76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~------------------  137 (284)
T cd07836          76 VFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG------------------  137 (284)
T ss_pred             EEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC------------------
Confidence            99999779999887543 23589999999999999999999999999999999999998766                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                               .++|+|||.+......   .....++..|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+
T Consensus       138 ---------~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~  208 (284)
T cd07836         138 ---------ELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED  208 (284)
T ss_pred             ---------cEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence                     5677777766543221   1224578899999998764 57899999999999999999999999877666


Q ss_pred             HHHHHHHHhCCCCh-------------------------hHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          326 HLAMMERVLGPLPH-------------------------HMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       326 ~~~~i~~~~~~~p~-------------------------~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      ....+.+.......                         .+.+..+..+.+++.+|++.+    |.+||++.++++|+||
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~----p~~R~~~~~~l~~~~f  284 (284)
T cd07836         209 QLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLN----PELRISAHDALQHPWF  284 (284)
T ss_pred             HHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCC----cccCCCHHHHhcCCCC
Confidence            65554433221111                         112345677889999999998    9999999999999997

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.6e-41  Score=319.11  Aligned_cols=255  Identities=24%  Similarity=0.372  Sum_probs=204.3

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeecC---
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYR---  165 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~~---  165 (411)
                      ..++|++.+.||+|+||.||+|.+..+++.+|+|++.........+.+|+.+++++ .|+|+     +++++++...   
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni-----~~~~~~~~~~~~~   94 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNV-----VKFYGMFYKADKL   94 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCe-----EEEEEEEEecccc
Confidence            45789999999999999999999999999999999976555556778899999988 56665     9999987643   


Q ss_pred             --CeEEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          166 --NHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       166 --~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                        +..++||||+ +++|.+++...  ....+++..++.++.|++.||+|||+.||+|+||||+||+++.++         
T Consensus        95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~---------  165 (291)
T cd06639          95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG---------  165 (291)
T ss_pred             CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC---------
Confidence              4689999999 89999988642  224689999999999999999999999999999999999997765         


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCC-----CCCccchhHHHHHHHHHHH
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-----GWNYPCDLWSVGCILVELC  312 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlGvil~ell  312 (411)
                                        .++|+|||.+......   .....|+..|+|||++...     .++.++|||||||++|||+
T Consensus       166 ------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~  227 (291)
T cd06639         166 ------------------GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELG  227 (291)
T ss_pred             ------------------CEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHh
Confidence                              5677777776643321   2234688899999998653     3689999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCC
Q 015222          313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP  381 (411)
Q Consensus       313 tg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~  381 (411)
                      +|+.||...+....+..+.+.... ...........+.+++.+|+..+    |++||++.++++|+||+
T Consensus       228 ~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~----p~~Rps~~~il~~~~~~  291 (291)
T cd06639         228 DGDPPLFDMHPVKTLFKIPRNPPP-TLLHPEKWCRSFNHFISQCLIKD----FEARPSVTHLLEHPFIK  291 (291)
T ss_pred             hCCCCCCCCcHHHHHHHHhcCCCC-CCCcccccCHHHHHHHHHHhhcC----hhhCcCHHHHhcCcccC
Confidence            999999877665554444332111 11112234567889999998888    99999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=9e-42  Score=319.73  Aligned_cols=251  Identities=29%  Similarity=0.493  Sum_probs=203.8

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      ++|++.++||+|+||.||+|.+..+++.||+|++....   ...+.+.+|+++++.++|+++     +++++++..++..
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~   75 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENL-----VNLIEVFRRKKRL   75 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcch-----hhHHHhcccCCeE
Confidence            46999999999999999999999999999999986432   234567789999999988877     9999999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      |+||||+ +++|.++.....  .+++..+..++.||+.||.|||+.||+|+||+|+||++++++                
T Consensus        76 ~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~----------------  137 (286)
T cd07846          76 YLVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG----------------  137 (286)
T ss_pred             EEEEecCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC----------------
Confidence            9999999 767776655443  589999999999999999999999999999999999997766                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCh
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHEN  323 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~  323 (411)
                                 .++|+|||++.......   ....++..|+|||++.+. .++.++|||||||++|||++|+.||.+.+.
T Consensus       138 -----------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~  206 (286)
T cd07846         138 -----------VVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD  206 (286)
T ss_pred             -----------cEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch
Confidence                       56777777765432221   224678899999998764 578899999999999999999999987776


Q ss_pred             HHHHHHHHHHhCCCChh---------------------------HHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHh
Q 015222          324 LEHLAMMERVLGPLPHH---------------------------MVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK  376 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~---------------------------~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~  376 (411)
                      .+....+....+.+...                           ..+.++..+.+++.+|+..+    |.+||++.++++
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----P~~Rp~~~~il~  282 (286)
T cd07846         207 IDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRID----PDDRPSSSQLLH  282 (286)
T ss_pred             HHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCC----cccchhHHHHhc
Confidence            66555554433322211                           11234567888999998888    999999999999


Q ss_pred             cCCC
Q 015222          377 LLRL  380 (411)
Q Consensus       377 ~~~~  380 (411)
                      |+||
T Consensus       283 ~~~~  286 (286)
T cd07846         283 HEFF  286 (286)
T ss_pred             CCCC
Confidence            9997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7.9e-42  Score=316.48  Aligned_cols=253  Identities=21%  Similarity=0.329  Sum_probs=206.2

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      ++|++.+.||.|+||+||+|.+..++..||+|++....  .....+.+|+.+++.+.|+++     +++++.+...+..+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~   75 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNV-----VKYYTSFVVGDELW   75 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCE-----EEEEEEEeeCCEEE
Confidence            46999999999999999999999999999999986432  345678899999999988776     99999999999999


Q ss_pred             EEEccC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSY-RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      +|||++ +++|.+++..... ..+++..+..++.||+.||.|||+.||+|+||||+||++++++                
T Consensus        76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~----------------  139 (267)
T cd06610          76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG----------------  139 (267)
T ss_pred             EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC----------------
Confidence            999999 9999999986532 4689999999999999999999999999999999999998766                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCC-------CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCC
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQD-------HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQ  319 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~  319 (411)
                                 .++|+|||.+......       .....|+..|+|||++... .++.++|+|||||++|+|++|+.||.
T Consensus       140 -----------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~  208 (267)
T cd06610         140 -----------SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYS  208 (267)
T ss_pred             -----------CEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcc
Confidence                       4566666655433221       1234688999999998877 78999999999999999999999998


Q ss_pred             CCChHHHHHHHHHHhC-CCChhH-HHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          320 THENLEHLAMMERVLG-PLPHHM-VIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       320 ~~~~~~~~~~i~~~~~-~~p~~~-~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      ..+............. ..+... ....+..+.+++.+|+..+    |++||++.++++||||
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         209 KYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKD----PSKRPTAEELLKHKFF  267 (267)
T ss_pred             ccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCC----hhhCcCHHHHhhCCCC
Confidence            7666544444333211 111111 1245677899999998888    9999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=6.6e-42  Score=317.18  Aligned_cols=257  Identities=24%  Similarity=0.350  Sum_probs=201.7

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-------hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      +|++.+.||+|+||.||+|.+ .+++.+|+|.++...       .....+.+|++++++++|+|+     +++++++.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI-----VQYLGTCLDD   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCE-----eeEeeEeecC
Confidence            488899999999999999986 478889999886322       223557789999999988877     9999999999


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      +..++||||+ +++|.+++.+..  .+++..+..++.|++.||+|||+.||+|+||||+||++++++.++++|||+....
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  152 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL  152 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence            9999999999 999999998764  6899999999999999999999999999999999999988775544444433221


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                      .....                  ............|+..|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus       153 ~~~~~------------------~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~  214 (265)
T cd06631         153 AWVGL------------------HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL  214 (265)
T ss_pred             hhccc------------------cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH
Confidence            11000                  000001112246889999999999888999999999999999999999999876655


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      .....+.......+ ......+..+.++|.+|+..+    |.+||++.++++|+||
T Consensus       215 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~----p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         215 AAMFYIGAHRGLMP-RLPDSFSAAAIDFVTSCLTRD----QHERPSALQLLRHDFL  265 (265)
T ss_pred             HHHHHhhhccCCCC-CCCCCCCHHHHHHHHHHhcCC----cccCCCHHHHhcCCCC
Confidence            54444433322222 123346778899999999888    9999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5e-42  Score=328.46  Aligned_cols=259  Identities=27%  Similarity=0.428  Sum_probs=215.6

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC---
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN---  166 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~---  166 (411)
                      +|++.+.||.|+||.||+|++..+++.||||++...   ....+.+.+|+.+++.++|+++     +++++++...+   
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~   75 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI-----IGLLDILRPPSPED   75 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcch-----hhhhhhhcccCccc
Confidence            689999999999999999999999999999998753   2345678889999999988877     99999887764   


Q ss_pred             --eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          167 --HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       167 --~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                        .+|+||||++++|.+++....  .+++..++.++.||+.||+|||+.||+|+||||+|||++.++             
T Consensus        76 ~~~~~lv~e~~~~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~-------------  140 (330)
T cd07834          76 FNDVYIVTELMETDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC-------------  140 (330)
T ss_pred             ccceEEEecchhhhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-------------
Confidence              899999999879999987654  799999999999999999999999999999999999998776             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCC------CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEAL  317 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p  317 (411)
                                    .++|+|||.+......      .....++..|+|||++.+. .++.++|||||||++|+|++|+.|
T Consensus       141 --------------~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~p  206 (330)
T cd07834         141 --------------DLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPL  206 (330)
T ss_pred             --------------CEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCC
Confidence                          4566666655543322      2234678899999999988 889999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChhHH---------------------------HhhhhhhhhhhccCCccCCCCCCCcHHH
Q 015222          318 FQTHENLEHLAMMERVLGPLPHHMV---------------------------IRADRRAEKYFRRGARLDWPDGATSRDS  370 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~~~p~~~~---------------------------~~~~~~~~~li~~~l~~~~~~rp~~R~t  370 (411)
                      |.+.+..+.+..+....+..+....                           ...+..+.++|.+||+.+    |.+||+
T Consensus       207 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----P~~Rpt  282 (330)
T cd07834         207 FPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFD----PKKRIT  282 (330)
T ss_pred             cCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCC----hhhCCC
Confidence            9998887777776665554333221                           124567889999999888    999999


Q ss_pred             HHHHHhcCCCCcccccCCC
Q 015222          371 MRAVWKLLRLPVIDLYSAS  389 (411)
Q Consensus       371 ~~~il~~~~~~~~~~~~~~  389 (411)
                      +.++++|+||.++..+...
T Consensus       283 ~~~ll~~~~~~~~~~~~~~  301 (330)
T cd07834         283 ADEALAHPYLAQLHDPEDE  301 (330)
T ss_pred             HHHHHhCccHHhhcccccC
Confidence            9999999999987776543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=7.4e-42  Score=316.66  Aligned_cols=247  Identities=18%  Similarity=0.275  Sum_probs=205.2

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      ..|.+.++||+|+||.||+|.++.+++.||+|++.........+.+|+.+++++.|+++     +++++++..++.+++|
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv   80 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL-----VQLLGVCTREPPFYII   80 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCCh-----hheEEEEcCCCCcEEE
Confidence            46999999999999999999999999999999998665556778899999999988877     9999999999999999


Q ss_pred             EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      |||+ +++|.+++.......+++..+..++.|++.||+|||++|++||||||+||++++++                   
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~-------------------  141 (263)
T cd05052          81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-------------------  141 (263)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-------------------
Confidence            9999 89999999876555689999999999999999999999999999999999998776                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCCCc----ccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQDHS----YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE  325 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~  325 (411)
                              .++|+|||.+........    ...++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+
T Consensus       142 --------~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~  213 (263)
T cd05052         142 --------LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ  213 (263)
T ss_pred             --------cEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence                    456666665554332211    1233567999999998899999999999999999998 999998877666


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ....+...   .........+..+.+++.+|+..+    |++||++.++++.
T Consensus       214 ~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~~----p~~Rp~~~~l~~~  258 (263)
T cd05052         214 VYELLEKG---YRMERPEGCPPKVYELMRACWQWN----PSDRPSFAEIHQA  258 (263)
T ss_pred             HHHHHHCC---CCCCCCCCCCHHHHHHHHHHccCC----cccCCCHHHHHHH
Confidence            55554432   122223456778999999998888    9999999999765

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-44  Score=337.43  Aligned_cols=243  Identities=23%  Similarity=0.359  Sum_probs=197.5

Q ss_pred             EeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC-
Q 015222           97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-  175 (411)
Q Consensus        97 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~-  175 (411)
                      ++-||.|+.|.||+|+.  .++.||||.++.      .-..+++-|++|+|+||     +.+.+++.....+||||||| 
T Consensus       129 LeWlGSGaQGAVF~Grl--~netVAVKKV~e------lkETdIKHLRkLkH~NI-----I~FkGVCtqsPcyCIiMEfCa  195 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRL--HNETVAVKKVRE------LKETDIKHLRKLKHPNI-----ITFKGVCTQSPCYCIIMEFCA  195 (904)
T ss_pred             hhhhccCcccceeeeec--cCceehhHHHhh------hhhhhHHHHHhccCcce-----eeEeeeecCCceeEEeeeccc
Confidence            56799999999999965  477899998753      23347888999999988     99999999999999999999 


Q ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccCC
Q 015222          176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP  255 (411)
Q Consensus       176 ~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~  255 (411)
                      .|.|...|+...  .+.......+.++|+.|+.|||.+.|||||||.-||||..++                        
T Consensus       196 ~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d------------------------  249 (904)
T KOG4721|consen  196 QGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD------------------------  249 (904)
T ss_pred             cccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc------------------------
Confidence            999999999876  789999999999999999999999999999999999998766                        


Q ss_pred             CCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 015222          256 KSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV  333 (411)
Q Consensus       256 ~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~  333 (411)
                         .|||+|||.++.....  .-.++||..|||||++.+.+.+.|+|||||||||||||||..||.+-+...++.-+-..
T Consensus       250 ---~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsN  326 (904)
T KOG4721|consen  250 ---VVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSN  326 (904)
T ss_pred             ---eEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCC
Confidence               6899999988765443  23479999999999999999999999999999999999999999876554443322211


Q ss_pred             hCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          334 LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       334 ~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                      ...+  .....+++-++-++++|    |...|..||++++++.|+-+..-++.+
T Consensus       327 sL~L--pvPstcP~GfklL~Kqc----w~sKpRNRPSFrqil~HldIa~pell~  374 (904)
T KOG4721|consen  327 SLHL--PVPSTCPDGFKLLLKQC----WNSKPRNRPSFRQILLHLDIASPELLS  374 (904)
T ss_pred             cccc--cCcccCchHHHHHHHHH----HhcCCCCCccHHHHHHHHhhcCHHHhc
Confidence            1111  11223444555555554    777799999999999998776554433

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.9e-41  Score=314.19  Aligned_cols=249  Identities=27%  Similarity=0.434  Sum_probs=199.7

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch------hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec-
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-  164 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~-  164 (411)
                      .+|++.+.||+|+||.||+|.+..+++.||||.+....      ...+.+.+|+.+++++.|+++     +++++++.+ 
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~   76 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERI-----VQYYGCLRDP   76 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCe-----eeEEeEeccC
Confidence            46999999999999999999999999999999885321      234567789999999988877     999998866 


Q ss_pred             -CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccc
Q 015222          165 -RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       165 -~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                       ...+++||||+ +++|.+++.+..  .+++..+..++.|++.||+|||++||+|+||||+||+++.++.          
T Consensus        77 ~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~----------  144 (265)
T cd06652          77 MERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN----------  144 (265)
T ss_pred             CCceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC----------
Confidence             35788999999 899999998764  5899999999999999999999999999999999999987774          


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCcccccC------CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCC
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ------DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA  316 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~  316 (411)
                                       ++|+|||.+.....      ......|+..|+|||++.+..++.++|||||||++|+|++|+.
T Consensus       145 -----------------~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~  207 (265)
T cd06652         145 -----------------VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKP  207 (265)
T ss_pred             -----------------EEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCC
Confidence                             55555555543211      1223458889999999998889999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCC
Q 015222          317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP  381 (411)
Q Consensus       317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~  381 (411)
                      ||...+.......+..  ...........+..+.++|.+|+. +    |..||++.++++|+|+.
T Consensus       208 p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~-~----p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         208 PWAEFEAMAAIFKIAT--QPTNPVLPPHVSDHCRDFLKRIFV-E----AKLRPSADELLRHTFVH  265 (265)
T ss_pred             CCCccchHHHHHHHhc--CCCCCCCchhhCHHHHHHHHHHhc-C----hhhCCCHHHHhcCcccC
Confidence            9987655444433221  111122334566778899999873 5    89999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-41  Score=317.79  Aligned_cols=251  Identities=30%  Similarity=0.493  Sum_probs=205.4

Q ss_pred             eEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        94 y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      |++.+.||.|++|.||+|.++.+|..||+|++....   .....+.+|+.+++.++|+++     +++++++.+++..|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i-----v~~~~~~~~~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI-----VRLLDVVHSENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCc-----cCHhheeccCCeEEE
Confidence            678899999999999999999999999999986432   233567789999999988877     999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       171 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      +|||++++|.+++.......+++..+..++.|++.||+|||++|++|+||+|+||+++.++                   
T Consensus        76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~-------------------  136 (283)
T cd07835          76 VFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG-------------------  136 (283)
T ss_pred             EEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-------------------
Confidence            9999988999999876545689999999999999999999999999999999999998766                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEH  326 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~  326 (411)
                              .++|+|||.+.......   ....++..|+|||++.+. .++.++|||||||++|+|++|+.||...+....
T Consensus       137 --------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  208 (283)
T cd07835         137 --------ALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ  208 (283)
T ss_pred             --------cEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                    56777777765432211   223568899999988765 578999999999999999999999988776655


Q ss_pred             HHHHHHHhCCCCh-------------------------hHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          327 LAMMERVLGPLPH-------------------------HMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       327 ~~~i~~~~~~~p~-------------------------~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      +..+.+.......                         .....++..+.++|.+|++.+    |.+||+++++++|+||
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----P~~Rpt~~~il~~~~~  283 (283)
T cd07835         209 LFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYD----PAKRISAKAALQHPYF  283 (283)
T ss_pred             HHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCC----hhhCcCHHHHhcCCCC
Confidence            5544433222111                         112344567889999999998    9999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=6.7e-42  Score=317.60  Aligned_cols=247  Identities=19%  Similarity=0.267  Sum_probs=198.5

Q ss_pred             CCCeEEEeeeccccceEEEEEEeC---CCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~---~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .++|++.+.||+|+||.||+|.++   ..+..||+|+++...  .....+.+|+.++++++|+|+     +++++++..+
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~   78 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNI-----VRLEGVITRG   78 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCc-----CeEEEEEecC
Confidence            357999999999999999999865   456789999987542  334567889999999988877     9999999999


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      ++.++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++|++||||||+|||++.++.            
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~------------  145 (266)
T cd05064          79 NTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLV------------  145 (266)
T ss_pred             CCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCc------------
Confidence            9999999999 889999998753 36899999999999999999999999999999999999987764            


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQ  319 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~  319 (411)
                                     ++++|||.+.......    ....++..|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus       146 ---------------~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~  210 (266)
T cd05064         146 ---------------CKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYW  210 (266)
T ss_pred             ---------------EEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcC
Confidence                           5555555443321111    11234678999999999999999999999999999875 999999


Q ss_pred             CCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      +.+..+.+..+...... +  ....++..+.+++.+|++.+    |.+||++.++++.
T Consensus       211 ~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~li~~c~~~~----p~~RP~~~~i~~~  261 (266)
T cd05064         211 DMSGQDVIKAVEDGFRL-P--APRNCPNLLHQLMLDCWQKE----RGERPRFSQIHSI  261 (266)
T ss_pred             cCCHHHHHHHHHCCCCC-C--CCCCCCHHHHHHHHHHcCCC----chhCCCHHHHHHH
Confidence            88777766665543221 1  22346677888999887777    9999999988763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-41  Score=326.75  Aligned_cols=258  Identities=27%  Similarity=0.464  Sum_probs=210.1

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC-
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR-  165 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~-  165 (411)
                      +.++|.+.+.||+|+||.||+|.+..+++.||||++...   ......+.+|+.+++.+.|+|+     +++++++... 
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----v~~~~~~~~~~   87 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV-----IGLLDVFTSAV   87 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCc-----cchhheecccc
Confidence            357899999999999999999999999999999998643   2234557789999999988887     8888887653 


Q ss_pred             -----CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          166 -----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       166 -----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                           ..+++||||+..+|.+++.    ..+++..+..++.|++.||+|||+.||+||||||+||+++.++         
T Consensus        88 ~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~---------  154 (342)
T cd07879          88 SGDEFQDFYLVMPYMQTDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC---------  154 (342)
T ss_pred             cCCCCceEEEEecccccCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC---------
Confidence                 3579999999778877653    2589999999999999999999999999999999999997766         


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecC-CCCCccchhHHHHHHHHHHHhCCCCCC
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQ  319 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~pf~  319 (411)
                                        .++|+|||++...........++..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus       155 ------------------~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~  216 (342)
T cd07879         155 ------------------ELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK  216 (342)
T ss_pred             ------------------CEEEeeCCCCcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC
Confidence                              6788888887765544445578889999999876 468999999999999999999999999


Q ss_pred             CCChHHHHHHHHHHhCCCChhH---------------------------HHhhhhhhhhhhccCCccCCCCCCCcHHHHH
Q 015222          320 THENLEHLAMMERVLGPLPHHM---------------------------VIRADRRAEKYFRRGARLDWPDGATSRDSMR  372 (411)
Q Consensus       320 ~~~~~~~~~~i~~~~~~~p~~~---------------------------~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~  372 (411)
                      +.+....+..+....+..+..+                           .+..+..+.++|.+||+.|    |.+||++.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d----P~~R~~~~  292 (342)
T cd07879         217 GKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELD----VDKRLTAT  292 (342)
T ss_pred             CCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCC----hhhCcCHH
Confidence            8776665555544332221111                           1234566889999999988    99999999


Q ss_pred             HHHhcCCCCcccccC
Q 015222          373 AVWKLLRLPVIDLYS  387 (411)
Q Consensus       373 ~il~~~~~~~~~~~~  387 (411)
                      +++.|+||.......
T Consensus       293 e~l~h~~f~~~~~~~  307 (342)
T cd07879         293 EALEHPYFDSFRDAD  307 (342)
T ss_pred             HHhcCcchhhccccc
Confidence            999999999887643

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.8e-41  Score=314.57  Aligned_cols=248  Identities=27%  Similarity=0.408  Sum_probs=199.3

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch------hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec--
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--  164 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~--  164 (411)
                      .|++.+.||+|+||.||+|.+..++..||+|++....      .....+.+|+.+++++.|+++     +++++++.+  
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~   77 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI-----VQYYGCLRDRA   77 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCe-----eeEEEEEEcCC
Confidence            6899999999999999999999999999999986321      233567789999999988877     999998765  


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                      ++.++++|||+ +++|.+++....  .+++..+..++.||+.||+|||++||+|+||||+||+++.++            
T Consensus        78 ~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~------------  143 (266)
T cd06651          78 EKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG------------  143 (266)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC------------
Confidence            46789999999 889999998765  589999999999999999999999999999999999997766            


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccC------CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ------DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL  317 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p  317 (411)
                                     .++|+|||++.....      ......++..|+|||.+.+..++.++|||||||++|||++|+.|
T Consensus       144 ---------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~p  208 (266)
T cd06651         144 ---------------NVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP  208 (266)
T ss_pred             ---------------CEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCC
Confidence                           466666666543221      11224578899999999988899999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCC
Q 015222          318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP  381 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~  381 (411)
                      |...+.......+...  .....+....++.+++++ +|+..+    |++||+++++++||||+
T Consensus       209 f~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li-~~~~~~----p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         209 WAEYEAMAAIFKIATQ--PTNPQLPSHISEHARDFL-GCIFVE----ARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             ccccchHHHHHHHhcC--CCCCCCchhcCHHHHHHH-HHhcCC----hhhCcCHHHHhcCcccc
Confidence            9876554444333221  112223344567778888 455455    99999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1e-41  Score=317.06  Aligned_cols=250  Identities=24%  Similarity=0.410  Sum_probs=205.4

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-----------hhhHHHHHHHHHHHHHhcCCCCCcceEEEeee
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNW  161 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-----------~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~  161 (411)
                      +|.+.+.||.|+||.||+|.+..+++.||+|.++...           ...+.+..|+.+++.+.|+++     ++++++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~   76 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNI-----VQYLGF   76 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCc-----ceEEEE
Confidence            5889999999999999999999999999999885321           112456789999999988877     999999


Q ss_pred             eecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                      +...+..++||||+ +++|.+++.+..  .+++..+..++.||+.||.|||++|++|+||||+||+++.++         
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~---------  145 (272)
T cd06629          77 ETTEEYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG---------  145 (272)
T ss_pred             eccCCceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCC---------
Confidence            99999999999999 999999998764  689999999999999999999999999999999999998766         


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCC--CCccchhHHHHHHHHHHHh
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLG--WNYPCDLWSVGCILVELCS  313 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~ellt  313 (411)
                                        .++|+|||.+......     .....|+..|+|||.+.+..  ++.++|+||||+++|+|++
T Consensus       146 ------------------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~  207 (272)
T cd06629         146 ------------------ICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFA  207 (272)
T ss_pred             ------------------eEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHh
Confidence                              5666666666543221     12246788999999988754  8899999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHH--hCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          314 GEALFQTHENLEHLAMMERV--LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       314 g~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      |..||...+..+.+..+...  ...++......++..+.+++.+|+..+    |..||++.++++|+|+
T Consensus       208 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----p~~Rps~~~il~~~~~  272 (272)
T cd06629         208 GRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTIN----PDNRPTARELLQHPFI  272 (272)
T ss_pred             CCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCC----hhhCCCHHHHhhCCCC
Confidence            99999765554444332221  234444555567888999999999998    9999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.1e-41  Score=315.15  Aligned_cols=244  Identities=26%  Similarity=0.383  Sum_probs=204.5

Q ss_pred             eccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC
Q 015222          100 MGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL  175 (411)
Q Consensus       100 lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~  175 (411)
                      ||.|+||.||+|++..+++.||+|++....    ...+.+.+|+.+++.+.|+++     +++++.+.+++..++||||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFI-----VKLYRTFKDKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCE-----eeeeeeEEcCCccEEEEecC
Confidence            699999999999999999999999996432    344678889999999988877     99999999999999999999


Q ss_pred             -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccC
Q 015222          176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL  254 (411)
Q Consensus       176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~  254 (411)
                       +++|.+++.+..  .+++..+..++.||+.||+|||++|++|+||||+||+++.++                       
T Consensus        76 ~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~-----------------------  130 (262)
T cd05572          76 LGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG-----------------------  130 (262)
T ss_pred             CCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC-----------------------
Confidence             899999998764  589999999999999999999999999999999999998766                       


Q ss_pred             CCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCC--hHHHHHHH
Q 015222          255 PKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE--NLEHLAMM  330 (411)
Q Consensus       255 ~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~--~~~~~~~i  330 (411)
                          .++|+|||.+......  .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+  ..+....+
T Consensus       131 ----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  206 (262)
T cd05572         131 ----YVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI  206 (262)
T ss_pred             ----CEEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHH
Confidence                5777888877654432  233468889999999988889999999999999999999999998766  44444444


Q ss_pred             HH--HhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHH-----HHHHHhcCCCCcccc
Q 015222          331 ER--VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS-----MRAVWKLLRLPVIDL  385 (411)
Q Consensus       331 ~~--~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t-----~~~il~~~~~~~~~~  385 (411)
                      ..  .....|.    ..+..+.+++.+|+..+    |.+|++     ++++++|+||.+.++
T Consensus       207 ~~~~~~~~~~~----~~~~~~~~~i~~~l~~~----p~~R~~~~~~~~~~l~~~~~~~~~~~  260 (262)
T cd05572         207 LKGNGKLEFPN----YIDKAAKDLIKQLLRRN----PEERLGNLKGGIKDIKKHKWFNGFDW  260 (262)
T ss_pred             hccCCCCCCCc----ccCHHHHHHHHHHccCC----hhhCcCCcccCHHHHhcChhhhCCCC
Confidence            32  1222332    23678999999999888    888888     999999999998755

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.6e-41  Score=311.22  Aligned_cols=250  Identities=25%  Similarity=0.346  Sum_probs=209.4

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+...   ......+.+|+.+++.++|+++     +++++.+..++..+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI-----IEYYENFLEDKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCch-----hheeeeEecCCEEE
Confidence            589999999999999999999999999999998643   2345667889999999988877     99999999899999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +||||+ +++|.+++.......+++..+..++.|++.||+|||++||+|+||||+||+++.++                 
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~-----------------  138 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHK-----------------  138 (256)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-----------------
Confidence            999999 88999999876545689999999999999999999999999999999999997543                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH  326 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~  326 (411)
                               ..++|+|||.+.......  ....|+..|+|||.+.+..++.++||||||+++|+|++|..||.+.+....
T Consensus       139 ---------~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~  209 (256)
T cd08220         139 ---------MVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL  209 (256)
T ss_pred             ---------CEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH
Confidence                     246888888776554322  235688899999999988899999999999999999999999988766555


Q ss_pred             HHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       327 ~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      ...+......   ......+..+.+++.+|+..+    |..||++.++++|||+
T Consensus       210 ~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~----p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         210 VLKIMSGTFA---PISDRYSPDLRQLILSMLNLD----PSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHHHhcCCC---CCCCCcCHHHHHHHHHHccCC----hhhCCCHHHHhhCCCC
Confidence            4444332111   122245677899999998888    9999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.1e-41  Score=314.92  Aligned_cols=254  Identities=24%  Similarity=0.396  Sum_probs=210.7

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      +|++.+.||+|++|.||+|.+..+++.||+|++....  .....+.+|+.++.+++|+++     +++++++...+..++
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~l   76 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYV-----VKCYGAFYKEGEISI   76 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCe-----eeEEEEEccCCeEEE
Confidence            6899999999999999999999999999999987543  346778899999999988777     999999999999999


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      ||||+ +++|.+++....  .+++..+..++.||+.||+|||+ .|++|+||+|+||+++.++                 
T Consensus        77 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~-----------------  137 (264)
T cd06623          77 VLEYMDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG-----------------  137 (264)
T ss_pred             EEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC-----------------
Confidence            99999 899999998764  69999999999999999999999 9999999999999998766                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                                .++|+|||.+.......   ....++..|+|||.+.+..++.++||||||+++|+|++|..||.......
T Consensus       138 ----------~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~  207 (264)
T cd06623         138 ----------EVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS  207 (264)
T ss_pred             ----------CEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC
Confidence                      56777777665543222   23467889999999998889999999999999999999999998764212


Q ss_pred             HHHHHHHHhCCCChhHHHh-hhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          326 HLAMMERVLGPLPHHMVIR-ADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~-~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      ................... ++..+.++|.+|+..+    |+.||++.++++|+|+++.+
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~----p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         208 FFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKD----PKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             HHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCC----hhhCCCHHHHHhCHHHHhcc
Confidence            2222222222222222333 6778999999999988    99999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.2e-41  Score=315.81  Aligned_cols=252  Identities=23%  Similarity=0.406  Sum_probs=206.5

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-------hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      +|++.+.||+|+||.||+|.+..+++.||+|++....       ...+.+.+|+.++++++|+++     +++++++.+.
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI-----IRMLGATCED   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCce-----ehhhceeccC
Confidence            4788899999999999999999999999999986422       234677889999999988877     9999999999


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      +..++||||+ +++|.+++.+..  .+++..+..++.||+.||.|||++|++|+||||+||+++.++             
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~-------------  140 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTG-------------  140 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-------------
Confidence            9999999999 899999998755  689999999999999999999999999999999999997654             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCC-------CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL  317 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p  317 (411)
                                   ..++|+|||.+......       .....|+..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus       141 -------------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p  207 (268)
T cd06630         141 -------------QRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP  207 (268)
T ss_pred             -------------CEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCC
Confidence                         14677777776543321       1234678899999999888899999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHh-CCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCC
Q 015222          318 FQTHENLEHLAMMERVL-GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP  381 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~  381 (411)
                      |...+.......+.+.. ...........+..+.+++.+|+..+    |+.||++.++++|+||.
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~----p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         208 WNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQ----PEDRPPSRELLKHPVFR  268 (268)
T ss_pred             CCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCC----cccCcCHHHHhcCcccC
Confidence            97654433333332221 12222333456778999999999999    99999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.6e-41  Score=326.58  Aligned_cols=265  Identities=23%  Similarity=0.399  Sum_probs=208.0

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC---
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR---  165 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~---  165 (411)
                      +..+|++.+.||.|+||.||+|.+..+++.||+|++.... ...+.+.+|+++++.++|+++     +++++.+...   
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i-----~~~~~~~~~~~~~   77 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNI-----VKVYEVLGPSGSD   77 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcc-----hhhHhhhcccccc
Confidence            3578999999999999999999999999999999986433 344667889999999988887     8887665543   


Q ss_pred             -----------CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccc
Q 015222          166 -----------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK  234 (411)
Q Consensus       166 -----------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~  234 (411)
                                 ...|+||||++++|.+++...   .+++..++.++.||+.||+|||+.||+||||||+||+++.++   
T Consensus        78 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~---  151 (342)
T cd07854          78 LTEDVGSLTELNSVYIVQEYMETDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED---  151 (342)
T ss_pred             cccccccccccceEEEEeecccccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC---
Confidence                       468999999987999888654   589999999999999999999999999999999999997533   


Q ss_pred             cCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC------CcccccCCCccccceecC-CCCCccchhHHHHHH
Q 015222          235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCI  307 (411)
Q Consensus       235 l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvi  307 (411)
                                             ..++|+|||.+......      .....|+..|+|||++.+ ..++.++|||||||+
T Consensus       152 -----------------------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvi  208 (342)
T cd07854         152 -----------------------LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCI  208 (342)
T ss_pred             -----------------------ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHH
Confidence                                   24677777776543221      112357889999998765 468899999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCC--------------------------ChhHHHhhhhhhhhhhccCCccCC
Q 015222          308 LVELCSGEALFQTHENLEHLAMMERVLGPL--------------------------PHHMVIRADRRAEKYFRRGARLDW  361 (411)
Q Consensus       308 l~elltg~~pf~~~~~~~~~~~i~~~~~~~--------------------------p~~~~~~~~~~~~~li~~~l~~~~  361 (411)
                      +|+|++|+.||.+.+..+....+.......                          ........+..+.+++.+||..+ 
T Consensus       209 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d-  287 (342)
T cd07854         209 FAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFN-  287 (342)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCC-
Confidence            999999999998776655444333221100                          01112345677889999999999 


Q ss_pred             CCCCCcHHHHHHHHhcCCCCcccccCCCCCc
Q 015222          362 PDGATSRDSMRAVWKLLRLPVIDLYSASPNC  392 (411)
Q Consensus       362 ~~rp~~R~t~~~il~~~~~~~~~~~~~~~~~  392 (411)
                         |.+||++.++++|+||+....+...|--
T Consensus       288 ---P~~R~t~~ell~h~~~~~~~~~~~~~~~  315 (342)
T cd07854         288 ---PMDRLTAEEALMHPYMSCYSCPFDEPVS  315 (342)
T ss_pred             ---chhccCHHHHhCCCccccccCCccccCC
Confidence               9999999999999999977665444443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-43  Score=336.80  Aligned_cols=251  Identities=24%  Similarity=0.349  Sum_probs=211.2

Q ss_pred             eeccccceEEEEEEeCCCCcEEEEEEec-cchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC-C
Q 015222           99 KMGEGTFGQVVECFDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-G  176 (411)
Q Consensus        99 ~lG~G~~g~V~~a~~~~~~~~vavK~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~-~  176 (411)
                      .||+|.||+||-|+|..|...+|||.+. +.....+.+.+|+.+.++|+|.||     |++++.+..++++-|.||-+ |
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNI-----VrYLGs~senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNI-----VRYLGSVSENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhH-----HHHhhccCCCCeEEEEeecCCC
Confidence            7999999999999999999999999986 444566778899999999999998     99999999999999999999 9


Q ss_pred             CCHHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccC
Q 015222          177 PSLYDFLRKNSYRSF--PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL  254 (411)
Q Consensus       177 ~~L~~~l~~~~~~~l--~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~  254 (411)
                      |+|.++++..- .++  .+..+..+.+||++||.|||++.|||||||-+||||+-                         
T Consensus       657 GSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT-------------------------  710 (1226)
T KOG4279|consen  657 GSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT-------------------------  710 (1226)
T ss_pred             CcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee-------------------------
Confidence            99999998654 355  78999999999999999999999999999999999964                         


Q ss_pred             CCCCCeeEeecCCcccccC---CCcccccCCCccccceecCC--CCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015222          255 PKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM  329 (411)
Q Consensus       255 ~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~  329 (411)
                       -.+.+||+|||.++....   -..++.||..|||||++..+  .|+.++|||||||++.||.||++||......+ ..+
T Consensus       711 -ySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq-AAM  788 (1226)
T KOG4279|consen  711 -YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ-AAM  788 (1226)
T ss_pred             -ccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-Hhh
Confidence             234789999998876432   23557899999999999876  69999999999999999999999997654322 233


Q ss_pred             HHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          330 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       330 i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                      ..-+.....+.++..++.+++.||.+|+..+    |..||+++++|..||++.-...
T Consensus       789 FkVGmyKvHP~iPeelsaeak~FilrcFepd----~~~R~sA~~LL~DpFlq~~~kk  841 (1226)
T KOG4279|consen  789 FKVGMYKVHPPIPEELSAEAKNFILRCFEPD----PCDRPSAKDLLQDPFLQHNNKK  841 (1226)
T ss_pred             hhhcceecCCCCcHHHHHHHHHHHHHHcCCC----cccCccHHHhccCcccccCCCC
Confidence            3333333333444556788999999999999    9999999999999999976433

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=6.3e-42  Score=316.05  Aligned_cols=246  Identities=23%  Similarity=0.329  Sum_probs=205.2

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      +|++.+.||.|+||.||+|.+..+++.||+|++....    ...+.+.+|++++++++|+|+     +++++.+..++..
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFL-----VNLWYSFQDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCCh-----HHHHHhhcCCCeE
Confidence            4899999999999999999999999999999997432    345678889999999988887     9999999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      ++||||+ +++|.+++....  .+++..+..++.||+.||.|||++|++|+||||+||++++++                
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~----------------  137 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQKV--KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQG----------------  137 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCC----------------
Confidence            9999999 999999998763  699999999999999999999999999999999999998766                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh--
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN--  323 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~--  323 (411)
                                 .++|+|||.+......  .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.  
T Consensus       138 -----------~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  206 (258)
T cd05578         138 -----------HVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI  206 (258)
T ss_pred             -----------CEEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH
Confidence                       5677777766544322  2234678899999999988899999999999999999999999987664  


Q ss_pred             -HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHH--HHHHhcCCC
Q 015222          324 -LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSM--RAVWKLLRL  380 (411)
Q Consensus       324 -~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~--~~il~~~~~  380 (411)
                       ..............|    ...+..+.++|.+|+..+    |.+|+++  +++++|+||
T Consensus       207 ~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~~l~~~----p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         207 RDQIRAKQETADVLYP----ATWSTEAIDAINKLLERD----PQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHHHHHhccccccCc----ccCcHHHHHHHHHHccCC----hhHcCCccHHHHhcCCCC
Confidence             222222221222333    345678899999999999    7788888  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=7.1e-42  Score=332.68  Aligned_cols=248  Identities=23%  Similarity=0.299  Sum_probs=195.0

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCC-----CcEEEEEEeccch--hhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeee
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~-----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~  163 (411)
                      ++|++.+.||+|+||.||+|++..+     +..||||+++...  ...+.+.+|+.+++.+ .|+||     +++++.+.
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nI-----v~~~~~~~  112 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNI-----VNLLGACT  112 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCce-----eeEeeEec
Confidence            4799999999999999999986543     3579999997432  3345678899999999 67777     99999999


Q ss_pred             cCCeEEEEEccC-CCCHHHHHHhcC-------------------------------------------------------
Q 015222          164 YRNHICIVFEKL-GPSLYDFLRKNS-------------------------------------------------------  187 (411)
Q Consensus       164 ~~~~~~lv~e~~-~~~L~~~l~~~~-------------------------------------------------------  187 (411)
                      ..+.+++||||+ +|+|.+++....                                                       
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            999999999999 999999986431                                                       


Q ss_pred             -------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccC
Q 015222          188 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL  254 (411)
Q Consensus       188 -------------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~  254 (411)
                                   ...+++..++.++.||+.||+|||++||+||||||+|||++.++                       
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~-----------------------  249 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR-----------------------  249 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC-----------------------
Confidence                         12478889999999999999999999999999999999998766                       


Q ss_pred             CCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 015222          255 PKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLA  328 (411)
Q Consensus       255 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~  328 (411)
                          .++|+|||++.......     ....++..|+|||++.+..++.++|||||||++|||++ |+.||..........
T Consensus       250 ----~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~  325 (374)
T cd05106         250 ----VAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY  325 (374)
T ss_pred             ----eEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHH
Confidence                46666666665432211     11234567999999998899999999999999999997 999998765544333


Q ss_pred             HHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       329 ~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      .+......  .......+..+.+++.+|++.+    |.+||++.++++.
T Consensus       326 ~~~~~~~~--~~~~~~~~~~l~~li~~cl~~d----p~~RPs~~~l~~~  368 (374)
T cd05106         326 KMVKRGYQ--MSRPDFAPPEIYSIMKMCWNLE----PTERPTFSQISQL  368 (374)
T ss_pred             HHHHcccC--ccCCCCCCHHHHHHHHHHcCCC----hhhCcCHHHHHHH
Confidence            33322111  1112234678899999998888    9999999998864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.5e-41  Score=325.95  Aligned_cols=276  Identities=24%  Similarity=0.393  Sum_probs=212.1

Q ss_pred             cCCCeEE-EeeeccccceEEEEEEeCCCCcEEEEEEeccchhhh---------------HHHHHHHHHHHHHhcCCCCCc
Q 015222           90 LTPRYRI-LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR---------------EAAMIEIDVLQRLARHDIGGT  153 (411)
Q Consensus        90 ~~~~y~i-~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~---------------~~~~~E~~~l~~l~~~~i~~~  153 (411)
                      +.++|.. .+.||.|+||+||+|.+..+++.||||+++......               ..+.+|+.+++.+.|+++   
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i---   82 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENI---   82 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcce---
Confidence            4567875 467999999999999999999999999986432211               246789999999988777   


Q ss_pred             ceEEEeeeeecCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCccc
Q 015222          154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV  233 (411)
Q Consensus       154 ~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~  233 (411)
                        +++++++..++..++||||+.++|.+++....  .+++..+..++.||+.||+|||+.||+|+||||+||+++.++.+
T Consensus        83 --v~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~  158 (335)
T PTZ00024         83 --MGLVDVYVEGDFINLVMDIMASDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC  158 (335)
T ss_pred             --eeeeEEEecCCcEEEEEeccccCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCE
Confidence              99999999999999999999889999987654  69999999999999999999999999999999999999988877


Q ss_pred             ccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCC-CCCccchhHHHHHHHHHHH
Q 015222          234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELC  312 (411)
Q Consensus       234 ~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell  312 (411)
                      +++|||++.....+....        ..-.+.+.  ..........++..|+|||.+.+. .++.++|||||||++|+|+
T Consensus       159 kl~dfg~~~~~~~~~~~~--------~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~  228 (335)
T PTZ00024        159 KIADFGLARRYGYPPYSD--------TLSKDETM--QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL  228 (335)
T ss_pred             EECCccceeecccccccc--------cccccccc--cccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHH
Confidence            777776554332111000        00000000  000111223568889999998765 4789999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChh------------------------HHHhhhhhhhhhhccCCccCCCCCCCcH
Q 015222          313 SGEALFQTHENLEHLAMMERVLGPLPHH------------------------MVIRADRRAEKYFRRGARLDWPDGATSR  368 (411)
Q Consensus       313 tg~~pf~~~~~~~~~~~i~~~~~~~p~~------------------------~~~~~~~~~~~li~~~l~~~~~~rp~~R  368 (411)
                      +|..||.+.+..+.+..+....+..+..                        .....+..+.++|.+||..+    |++|
T Consensus       229 tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----P~~R  304 (335)
T PTZ00024        229 TGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLN----PLER  304 (335)
T ss_pred             hCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCC----chhc
Confidence            9999999888777776665544322211                        11233567889999999999    9999


Q ss_pred             HHHHHHHhcCCCCccccc
Q 015222          369 DSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       369 ~t~~~il~~~~~~~~~~~  386 (411)
                      |++.+++.|+||+.....
T Consensus       305 ~s~~~~l~~~~~~~~~~~  322 (335)
T PTZ00024        305 ISAKEALKHEYFKSDPLP  322 (335)
T ss_pred             cCHHHHhcCcccCCCCCC
Confidence            999999999999976544

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.9e-41  Score=312.27  Aligned_cols=247  Identities=26%  Similarity=0.374  Sum_probs=205.2

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      +|++.++||+|+||.||++.+..+++.||+|.++..  ....+.+.+|+.+++.+.|+|+     +++++.+.+++.+|+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI-----VAFKESFEADGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEEECCEEEE
Confidence            589999999999999999999999999999998632  3345667889999999988877     999999999999999


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      ||||+ +++|.+++.......+++..+..++.||+.||.|||++||+|+||||+||++++++                  
T Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~------------------  137 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG------------------  137 (255)
T ss_pred             EEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCC------------------
Confidence            99999 89999998765545689999999999999999999999999999999999997766                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH  326 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~  326 (411)
                               .++|+|||.+......   .....|+..|+|||++.+..++.++||||||+++|+|++|..||...+....
T Consensus       138 ---------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~  208 (255)
T cd08219         138 ---------KVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL  208 (255)
T ss_pred             ---------cEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH
Confidence                     5677777766543322   1235688999999999988899999999999999999999999987766555


Q ss_pred             HHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       327 ~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ...+.......   ....++..+.+++.+|++.+    |.+||++.+++...
T Consensus       209 ~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~----P~~Rp~~~~il~~~  253 (255)
T cd08219         209 ILKVCQGSYKP---LPSHYSYELRSLIKQMFKRN----PRSRPSATTILSRG  253 (255)
T ss_pred             HHHHhcCCCCC---CCcccCHHHHHHHHHHHhCC----cccCCCHHHHhhcc
Confidence            55444322211   12345677899999998888    99999999998643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4.5e-42  Score=323.26  Aligned_cols=256  Identities=22%  Similarity=0.349  Sum_probs=209.4

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      +.|.....||+|+||.||++.+..++..||||.+.... ...+.+.+|+.+++.+.|+|+     +++++.+..++..++
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----i~~~~~~~~~~~~~l   96 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENV-----VDMYNSYLVGDELWV   96 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcH-----HHHHHheecCCeEEE
Confidence            45666788999999999999999999999999986432 345567889999999988877     999999999999999


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      ||||+ +++|.+++...   .+++..+..++.||+.||+|||++||+||||||+||+++.++                  
T Consensus        97 v~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~------------------  155 (292)
T cd06658          97 VMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG------------------  155 (292)
T ss_pred             EEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC------------------
Confidence            99999 88999988653   489999999999999999999999999999999999998766                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH  326 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~  326 (411)
                               .++|+|||++......   .....|+..|+|||.+.+..++.++|||||||++|||++|..||.+.+....
T Consensus       156 ---------~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~  226 (292)
T cd06658         156 ---------RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA  226 (292)
T ss_pred             ---------CEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                     5666666665432211   1234688999999999888899999999999999999999999988776665


Q ss_pred             HHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       327 ~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                      +..+........ ......+..+.+++.+|+..+    |.+||+++++++|+||......+
T Consensus       227 ~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~----P~~Rpt~~~il~~~~~~~~~~~~  282 (292)
T cd06658         227 MRRIRDNLPPRV-KDSHKVSSVLRGFLDLMLVRE----PSQRATAQELLQHPFLKLAGPPS  282 (292)
T ss_pred             HHHHHhcCCCcc-ccccccCHHHHHHHHHHccCC----hhHCcCHHHHhhChhhhccCCcc
Confidence            555444322211 112245677889999998888    99999999999999999776554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-41  Score=321.14  Aligned_cols=256  Identities=27%  Similarity=0.452  Sum_probs=200.5

Q ss_pred             CeEEEeeeccccceEEEEEEeCC--CCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC-
Q 015222           93 RYRILSKMGEGTFGQVVECFDNE--KKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR-  165 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~--~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~-  165 (411)
                      +|++.++||+|+||.||+|.+..  +++.||+|++....    ...+...+|+.+++.++|+++     +++++++.+. 
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~   75 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENV-----VSLVEVFLEHA   75 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCc-----cceEEEEeCCC
Confidence            58999999999999999999988  89999999997532    334567789999999998887     9999999887 


Q ss_pred             -CeEEEEEccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccc
Q 015222          166 -NHICIVFEKLGPSLYDFLRKNS---YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL  241 (411)
Q Consensus       166 -~~~~lv~e~~~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~  241 (411)
                       +.+++||||++++|.+++....   ...+++..++.++.||+.||+|||++||+||||||+|||++.++          
T Consensus        76 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~----------  145 (316)
T cd07842          76 DKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEG----------  145 (316)
T ss_pred             CceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCC----------
Confidence             8899999999888888876432   13689999999999999999999999999999999999998722          


Q ss_pred             cccCCCCCccccCCCCCCeeEeecCCcccccCC------CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhC
Q 015222          242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSG  314 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg  314 (411)
                                   +.+..+||+|||++......      .....+|..|+|||++.+. .++.++|||||||++|+|++|
T Consensus       146 -------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~  212 (316)
T cd07842         146 -------------PERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTL  212 (316)
T ss_pred             -------------CccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhc
Confidence                         12336777777766643322      1234678899999988764 589999999999999999999


Q ss_pred             CCCCCCCChHH---------HHHHHHHHhCCCChh---------------------------HH----H--hhhhhhhhh
Q 015222          315 EALFQTHENLE---------HLAMMERVLGPLPHH---------------------------MV----I--RADRRAEKY  352 (411)
Q Consensus       315 ~~pf~~~~~~~---------~~~~i~~~~~~~p~~---------------------------~~----~--~~~~~~~~l  352 (411)
                      +.||.+.....         .+..+....+.....                           ..    .  ..+..+.++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (316)
T cd07842         213 EPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDL  292 (316)
T ss_pred             CCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHH
Confidence            99998654322         222222221111110                           00    0  345578899


Q ss_pred             hccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          353 FRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       353 i~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      +.+||..+    |.+|||+.++++|+||
T Consensus       293 i~~~l~~~----P~~Rps~~eil~~~~f  316 (316)
T cd07842         293 LRKLLEYD----PTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHHhcCC----cccCcCHHHHhcCCCC
Confidence            99999998    9999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.6e-41  Score=320.28  Aligned_cols=257  Identities=22%  Similarity=0.277  Sum_probs=209.7

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....    .....+.+|+.+++.++|+|+     +++++++.+.
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-----v~~~~~~~~~   87 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNT-----IEYKGCYLRE   87 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCE-----EEEEEEEEeC
Confidence            3467999999999999999999999999999999986322    233567789999999988877     9999999999


Q ss_pred             CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          166 NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       166 ~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      +..++||||+.++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++              
T Consensus        88 ~~~~lv~e~~~g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~--------------  152 (307)
T cd06607          88 HTAWLVMEYCLGSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPG--------------  152 (307)
T ss_pred             CeEEEEHHhhCCCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCC--------------
Confidence            9999999999888888876543 3689999999999999999999999999999999999997766              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceec---CCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGEALFQTHE  322 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltg~~pf~~~~  322 (411)
                                   .++|+|||++...... ....|+..|+|||++.   ...++.++||||||+++|||++|+.||.+.+
T Consensus       153 -------------~~kL~dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~  218 (307)
T cd06607         153 -------------TVKLADFGSASLVSPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN  218 (307)
T ss_pred             -------------CEEEeecCcceecCCC-CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc
Confidence                         6788888877654332 2346888999999985   3468899999999999999999999998766


Q ss_pred             hHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                      .......+...  ..+......++..+.+++.+|+..+    |.+||++.+++.|+|+......
T Consensus       219 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~----p~~Rp~~~~il~~~~~~~~~~~  276 (307)
T cd06607         219 AMSALYHIAQN--DSPTLSSNDWSDYFRNFVDSCLQKI----PQDRPSSEELLKHRFVLRERPP  276 (307)
T ss_pred             HHHHHHHHhcC--CCCCCCchhhCHHHHHHHHHHhcCC----hhhCcCHHHHhcChhhcccCCc
Confidence            65544433321  1222222345677899999998888    9999999999999999976543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.3e-41  Score=311.97  Aligned_cols=248  Identities=26%  Similarity=0.431  Sum_probs=202.2

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchh---hhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      +|++.+.||+|+||.||+|.+..+++.||+|+++....   ....+..|+.+++.++|+++     +++++.+...+..+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i-----~~~~~~~~~~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNL-----VKYYGVEVHREKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCCh-----hheeeeEecCCEEE
Confidence            69999999999999999999999999999999975433   56778899999999988877     99999998899999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +|+||+ +++|.+++....  .+++..+..++.|++.||.|||+.||+|+||||+||+++.++                 
T Consensus        76 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~-----------------  136 (264)
T cd06626          76 IFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG-----------------  136 (264)
T ss_pred             EEEecCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-----------------
Confidence            999999 899999998754  588999999999999999999999999999999999998776                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCCC-------cccccCCCccccceecCCC---CCccchhHHHHHHHHHHHhCCCCC
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQDH-------SYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVELCSGEALF  318 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlGvil~elltg~~pf  318 (411)
                                .++|+|||.+.......       ....++..|+|||++.+..   ++.++||||||+++|+|++|+.||
T Consensus       137 ----------~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf  206 (264)
T cd06626         137 ----------VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW  206 (264)
T ss_pred             ----------CEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCc
Confidence                      45666666554432211       1245788999999998766   889999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHh--CCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          319 QTHENLEHLAMMERVL--GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       319 ~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      ...+............  ..+|.  ....+..+.++|.+|+..+    |.+||++.+++.|+|+
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~----p~~R~~~~~i~~~~~~  264 (264)
T cd06626         207 SELDNEFQIMFHVGAGHKPPIPD--SLQLSPEGKDFLDRCLESD----PKKRPTASELLQHPFV  264 (264)
T ss_pred             cCCcchHHHHHHHhcCCCCCCCc--ccccCHHHHHHHHHHccCC----cccCCCHHHHhcCCCC
Confidence            7654332222211111  12222  1234677889999998888    9999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.3e-41  Score=317.48  Aligned_cols=253  Identities=24%  Similarity=0.371  Sum_probs=209.6

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      ..|+.+++||.|+||.||+|.+..++..||+|++...  ......+.+|+.+++++.|+++     +++++.+.+++..+
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~   78 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV-----TKYYGSYLKGTKLW   78 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEECCEEE
Confidence            4588899999999999999999999999999998743  2344667889999999988777     99999999999999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +||||+ +++|.+++...   .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++                 
T Consensus        79 lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~-----------------  138 (277)
T cd06640          79 IIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG-----------------  138 (277)
T ss_pred             EEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC-----------------
Confidence            999999 89999998754   589999999999999999999999999999999999998766                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                                .++|+|||++......   .....++..|+|||++.+..++.++|+|||||++|||++|..||...+...
T Consensus       139 ----------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~  208 (277)
T cd06640         139 ----------DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR  208 (277)
T ss_pred             ----------CEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh
Confidence                      4666666666443221   122457889999999998889999999999999999999999998776655


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                      ....+..   ..+.......+..+.+++.+|+..+    |..||++.++++|+|+.+....
T Consensus       209 ~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~----p~~Rp~~~~il~~~~~~~~~~~  262 (277)
T cd06640         209 VLFLIPK---NNPPTLTGEFSKPFKEFIDACLNKD----PSFRPTAKELLKHKFIVKNAKK  262 (277)
T ss_pred             Hhhhhhc---CCCCCCchhhhHHHHHHHHHHcccC----cccCcCHHHHHhChHhhhcchh
Confidence            4443322   2223334456677889999998888    9999999999999999876653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.7e-41  Score=315.97  Aligned_cols=256  Identities=18%  Similarity=0.363  Sum_probs=200.7

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHH-HHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDV-LQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~-l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|+++...  .....+..|+.+ ++.+.|+|+     +++++++..++..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i-----v~~~~~~~~~~~~   75 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYT-----VTFYGALFREGDV   75 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCe-----eeeeEEEecCCcE
Confidence            36999999999999999999999999999999987532  223344556655 444455555     9999999999999


Q ss_pred             EEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          169 CIVFEKLGPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       169 ~lv~e~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      |+||||+.++|.+++...  ....+++..++.++.||+.||+|||++ +++||||||+||+++.++              
T Consensus        76 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~--------------  141 (283)
T cd06617          76 WICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG--------------  141 (283)
T ss_pred             EEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC--------------
Confidence            999999988998888652  224689999999999999999999997 999999999999997766              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecC----CCCCccchhHHHHHHHHHHHhCCCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILG----LGWNYPCDLWSVGCILVELCSGEALFQ  319 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvil~elltg~~pf~  319 (411)
                                   .+||+|||.+.......  ....|+..|+|||++.+    ..++.++|||||||++|+|++|+.||.
T Consensus       142 -------------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  208 (283)
T cd06617         142 -------------QVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD  208 (283)
T ss_pred             -------------CEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCC
Confidence                         57777777776543221  22468889999999865    356899999999999999999999997


Q ss_pred             CCC-hHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          320 THE-NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       320 ~~~-~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      ... ..+.+..+..  ...+......++..+.+++.+||..+    |..||++.++++|+||.....
T Consensus       209 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~----p~~Rp~~~~il~~~~~~~~~~  269 (283)
T cd06617         209 SWKTPFQQLKQVVE--EPSPQLPAEKFSPEFQDFVNKCLKKN----YKERPNYPELLQHPFFELHLS  269 (283)
T ss_pred             ccccCHHHHHHHHh--cCCCCCCccccCHHHHHHHHHHccCC----hhhCcCHHHHhcCchhhhccc
Confidence            532 2233333222  11121112346778999999999988    999999999999999998653

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.6e-41  Score=330.45  Aligned_cols=248  Identities=23%  Similarity=0.326  Sum_probs=195.7

Q ss_pred             CCeEEEeeeccccceEEEEEEe-----CCCCcEEEEEEeccch--hhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeee
Q 015222           92 PRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~-----~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~  163 (411)
                      ++|++.+.||+|+||.||+|++     ..++..||||+++...  ...+.+.+|+.+++.+ .|+||     +++++++.
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnI-----v~l~~~~~  109 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINI-----VNLLGACT  109 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcce-----eeeeeeec
Confidence            4799999999999999999974     3456789999997432  3445678899999999 67766     99999999


Q ss_pred             cCCeEEEEEccC-CCCHHHHHHhcC-------------------------------------------------------
Q 015222          164 YRNHICIVFEKL-GPSLYDFLRKNS-------------------------------------------------------  187 (411)
Q Consensus       164 ~~~~~~lv~e~~-~~~L~~~l~~~~-------------------------------------------------------  187 (411)
                      ..+..++||||+ +|+|.+++....                                                       
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            999999999999 999999987532                                                       


Q ss_pred             ------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          188 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       188 ------------------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                                        ...+++..+..++.||+.||+|||++||+||||||+|||++.++                  
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~------------------  251 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR------------------  251 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC------------------
Confidence                              12478889999999999999999999999999999999998765                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCh
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHEN  323 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~  323 (411)
                               .++|+|||++.......     ....++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus       252 ---------~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~  322 (375)
T cd05104         252 ---------ITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV  322 (375)
T ss_pred             ---------cEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc
Confidence                     46677777665432221     11234567999999999999999999999999999998 9999987654


Q ss_pred             HHHHHH-HHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          324 LEHLAM-MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       324 ~~~~~~-i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ...... +.......   .....+..+.+++.+|++.+    |++||++.++++..
T Consensus       323 ~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~d----P~~RPs~~eil~~l  371 (375)
T cd05104         323 DSKFYKMIKEGYRML---SPECAPSEMYDIMKSCWDAD----PLKRPTFKQIVQLI  371 (375)
T ss_pred             hHHHHHHHHhCccCC---CCCCCCHHHHHHHHHHccCC----hhHCcCHHHHHHHH
Confidence            433332 22221111   11234567899999998888    99999999998764

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.7e-41  Score=313.74  Aligned_cols=246  Identities=21%  Similarity=0.340  Sum_probs=202.9

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      ++|++.++||+|+||.||+|.+. ++..||+|.+.......+.+.+|+.+++.++|+++     +++++.+...+..+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv   79 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKL-----VRLYAVVTKEEPIYII   79 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCe-----eeEEEEEcCCCCcEEE
Confidence            57999999999999999999865 45679999987655556788899999999988877     9999999999999999


Q ss_pred             EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      |||+ +++|.+++.+.....+++..+..++.|++.||+|||+.|++||||||+||+++.++                   
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~-------------------  140 (261)
T cd05072          80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL-------------------  140 (261)
T ss_pred             EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC-------------------
Confidence            9999 89999999876555789999999999999999999999999999999999998776                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE  325 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~  325 (411)
                              .++|+|||.+.......    ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+
T Consensus       141 --------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~  212 (261)
T cd05072         141 --------MCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD  212 (261)
T ss_pred             --------cEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH
Confidence                    45666666665433221    12245678999999988889999999999999999998 999998877666


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ....+..... .+  .....+..+.+++.+|+..+    |++||+++++.+.
T Consensus       213 ~~~~~~~~~~-~~--~~~~~~~~~~~li~~~l~~~----p~~Rp~~~~i~~~  257 (261)
T cd05072         213 VMSALQRGYR-MP--RMENCPDELYDIMKTCWKEK----AEERPTFDYLQSV  257 (261)
T ss_pred             HHHHHHcCCC-CC--CCCCCCHHHHHHHHHHccCC----cccCcCHHHHHHH
Confidence            6655544321 11  12346678899999999888    9999999998764

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.4e-41  Score=317.98  Aligned_cols=248  Identities=23%  Similarity=0.294  Sum_probs=202.7

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCC-----cEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKK-----ELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~-----~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      ++|++.+.||+|+||.||+|.+...+     ..||+|.++...  .....+.+|+.+++++.|+++     +++++++..
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i-----~~~~~~~~~   79 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI-----VCLLGVCTK   79 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCccc-----ceEEEEEcC
Confidence            46899999999999999999876655     689999986432  344567889999999988877     999999998


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKNSY--------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS  229 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~  229 (411)
                      .+..+++|||+ +++|.+++.....              ..+++..+..++.||+.||.|||++||+|+||||+||++++
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~  159 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE  159 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence            89999999999 8999999976421              35888999999999999999999999999999999999987


Q ss_pred             CcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCCCccchhHHH
Q 015222          230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSV  304 (411)
Q Consensus       230 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  304 (411)
                      ++                           .++|+|||++......     .....+++.|+|||.+.+..++.++|||||
T Consensus       160 ~~---------------------------~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~sl  212 (283)
T cd05048         160 GL---------------------------TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSF  212 (283)
T ss_pred             CC---------------------------cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHH
Confidence            66                           4666666666543211     122356788999999998899999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          305 GCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       305 Gvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ||++|||++ |..||.+.+..+....+.....   .......+..+.+++.+|++.+    |.+||++.++++++
T Consensus       213 G~il~el~~~g~~p~~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~~l~~~c~~~~----p~~Rp~~~~i~~~l  280 (283)
T cd05048         213 GVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQL---LPCPEDCPARVYALMIECWNEI----PARRPRFKDIHTRL  280 (283)
T ss_pred             HHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc---CCCcccCCHHHHHHHHHHccCC----hhhCcCHHHHHHHH
Confidence            999999998 9999998877766655543221   1123456788999999998887    99999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.8e-41  Score=311.63  Aligned_cols=249  Identities=25%  Similarity=0.388  Sum_probs=200.5

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc----hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++.+.||+|+||.||+|++..+++.||||.++..    ......+.+|+.+++.++|+++     +++++++...+.
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNV-----IKYLDSFIEDNE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcce-----eeeeeeEEECCe
Confidence            4799999999999999999999999999999987532    2334567889999999988877     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          168 ICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      .++||||+ +++|.+++...  ....+++..+..++.||+.||.|||++||+|+||||+||+++.++             
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~-------------  143 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG-------------  143 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCC-------------
Confidence            99999999 88999888632  223589999999999999999999999999999999999998766             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                                    .++|+|||.+.......   ....|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       144 --------------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~  209 (267)
T cd08228         144 --------------VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             --------------CEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence                          56777777665543221   2346888999999999888999999999999999999999999654


Q ss_pred             Ch--HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          322 EN--LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       322 ~~--~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ..  .+....+..  ...+.......+..+.+++.+|+..+    |++||++.++++..
T Consensus       210 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~~----p~~Rp~~~~vl~~~  262 (267)
T cd08228         210 KMNLFSLCQKIEQ--CDYPPLPTEHYSEKLRELVSMCIYPD----PDQRPDIGYVHQIA  262 (267)
T ss_pred             cccHHHHHHHHhc--CCCCCCChhhcCHHHHHHHHHHCCCC----cccCcCHHHHHHHH
Confidence            32  222222222  22333333456677889999887777    99999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=7e-41  Score=320.89  Aligned_cols=264  Identities=25%  Similarity=0.412  Sum_probs=209.6

Q ss_pred             CeEEEeeeccccceEEEEEEeCCC--CcEEEEEEeccc---hhhhHHHHHHHHHHHHHh-cCCCCCcceEEEeeeeec--
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEK--KELVAIKIVRSI---NKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDY--  164 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~~~~--  164 (411)
                      +|++.+.||+|+||.||+|.+..+  +..||+|++...   ....+.+.+|+.+++++. |+|+     +++++....  
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----v~~~~~~~~~~   75 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNI-----TCLYDMDIVFP   75 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCCh-----heeeeeeeecc
Confidence            589999999999999999999888  889999998642   223456778999999984 6766     888875432  


Q ss_pred             --CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccc
Q 015222          165 --RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       165 --~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                        ...++++||+++++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.          
T Consensus        76 ~~~~~~~~~~e~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~----------  143 (332)
T cd07857          76 GNFNELYLYEELMEADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE----------  143 (332)
T ss_pred             ccCCcEEEEEecccCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC----------
Confidence              35689999999889999987654  6999999999999999999999999999999999999988774          


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCcccccC-------CCcccccCCCccccceecC-CCCCccchhHHHHHHHHHHHhC
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-------DHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSG  314 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg  314 (411)
                                       ++|+|||.+.....       ......||..|+|||++.+ ..++.++|||||||++|+|++|
T Consensus       144 -----------------~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g  206 (332)
T cd07857         144 -----------------LKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR  206 (332)
T ss_pred             -----------------EEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence                             55555555543221       1123468999999998776 4689999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChhH---------------------------HHhhhhhhhhhhccCCccCCCCCCCc
Q 015222          315 EALFQTHENLEHLAMMERVLGPLPHHM---------------------------VIRADRRAEKYFRRGARLDWPDGATS  367 (411)
Q Consensus       315 ~~pf~~~~~~~~~~~i~~~~~~~p~~~---------------------------~~~~~~~~~~li~~~l~~~~~~rp~~  367 (411)
                      ..||.+.+....+..+....+..+...                           ....+..+.+++.+||+.+    |.+
T Consensus       207 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----P~~  282 (332)
T cd07857         207 KPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFD----PTK  282 (332)
T ss_pred             CcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCC----ccc
Confidence            999988776666655555444332211                           1123567889999999988    999


Q ss_pred             HHHHHHHHhcCCCCcccccCCCCCchh
Q 015222          368 RDSMRAVWKLLRLPVIDLYSASPNCLC  394 (411)
Q Consensus       368 R~t~~~il~~~~~~~~~~~~~~~~~~~  394 (411)
                      ||++.++++|+|+.........|.|-.
T Consensus       283 R~t~~~ll~~~~~~~~~~~~~~~~~~~  309 (332)
T cd07857         283 RISVEEALEHPYLAIWHDPDDEPVCQK  309 (332)
T ss_pred             CCCHHHHhcChhhhhhcCccccccccc
Confidence            999999999999998877777777644

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-41  Score=318.37  Aligned_cols=255  Identities=22%  Similarity=0.345  Sum_probs=207.1

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      ++|++++.||+|+||+||++.+..+++.||+|++...  ......+.+|+++++.++|+++     +++++.+...+.++
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~   79 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYI-----VSFYGAFLNENNIC   79 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCc-----ceEeeeEecCCEEE
Confidence            5799999999999999999999999999999998643  2345678899999999988877     99999999999999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      +||||+ +++|.+++.+.+  .+++..+..++.|++.||.|||+ .|++|+||||+||+++.++                
T Consensus        80 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~----------------  141 (284)
T cd06620          80 MCMEFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG----------------  141 (284)
T ss_pred             EEEecCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC----------------
Confidence            999999 899999987754  68999999999999999999997 5999999999999997766                


Q ss_pred             CCccccCCCCCCeeEeecCCccccc-CCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH--
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEH-QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL--  324 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~--  324 (411)
                                 .++|+|||++.... .......|+..|+|||++.+..++.++|||||||++|+|++|..||......  
T Consensus       142 -----------~~~l~d~gl~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~  210 (284)
T cd06620         142 -----------QIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD  210 (284)
T ss_pred             -----------cEEEccCCcccchhhhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhh
Confidence                       56777777665432 1223357899999999998889999999999999999999999999865432  


Q ss_pred             ------HHHHHHHHHhCCCChhH-HHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          325 ------EHLAMMERVLGPLPHHM-VIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       325 ------~~~~~i~~~~~~~p~~~-~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                            .....+.......+..+ ....+..+.+++.+|+..+    |.+||++.++++|+||....
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d----p~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         211 GQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKD----PTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             hhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCC----cccCcCHHHHhcCccccccc
Confidence                  11122222221111111 1235677899999998888    99999999999999997643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.3e-42  Score=306.37  Aligned_cols=264  Identities=25%  Similarity=0.421  Sum_probs=218.6

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCC----cEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKK----ELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~----~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      ..|+++++||+|+||.||+|..++++    +.+|||.++...   .......+|+.+++.++|+|+     +.+..+|..
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nv-----i~Lv~Vfl~   98 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNV-----ISLVKVFLS   98 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcc-----hhHHHHHhc
Confidence            47999999999999999999766654    378999997543   334567899999999999988     888888866


Q ss_pred             -CCeEEEEEccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          165 -RNHICIVFEKLGPSLYDFLRKNS---YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       165 -~~~~~lv~e~~~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                       +..+++++||...+|++.++-+.   ...++...++.|+.||+.|+.|||++=|+||||||.||||..+|         
T Consensus        99 ~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdg---------  169 (438)
T KOG0666|consen   99 HDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDG---------  169 (438)
T ss_pred             cCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccC---------
Confidence             78999999999999999997432   24689999999999999999999999999999999999998875         


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccCCCc------ccccCCCccccceecCC-CCCccchhHHHHHHHHHHHh
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS------YVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCS  313 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~------~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt  313 (411)
                                    ...+.|||+|||+++.......      ..+-|.+|+|||++.|. .|+.+.||||+|||+.||+|
T Consensus       170 --------------perG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLt  235 (438)
T KOG0666|consen  170 --------------PERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLT  235 (438)
T ss_pred             --------------CccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHc
Confidence                          3466899999999998765432      24679999999999987 79999999999999999999


Q ss_pred             CCCCCCCCCh---------HHHHHHHHHHhCCCChhHHHh---------------------------------hhhhhhh
Q 015222          314 GEALFQTHEN---------LEHLAMMERVLGPLPHHMVIR---------------------------------ADRRAEK  351 (411)
Q Consensus       314 g~~pf~~~~~---------~~~~~~i~~~~~~~p~~~~~~---------------------------------~~~~~~~  351 (411)
                      -++.|.+.+.         .+++..|.++.|......++.                                 -++.+-+
T Consensus       236 l~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~  315 (438)
T KOG0666|consen  236 LEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALD  315 (438)
T ss_pred             cCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHH
Confidence            9999986532         356667777766543322221                                 1234778


Q ss_pred             hhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          352 YFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       352 li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                      ++.++|..|    |.+|.|++++++|++|.....+.
T Consensus       316 LL~klL~yD----P~kRIta~qAleh~yF~~d~lpp  347 (438)
T KOG0666|consen  316 LLQKLLTYD----PIKRITAEQALEHPYFTEDPLPP  347 (438)
T ss_pred             HHHHHhccC----chhhccHHHHhcccccccCCCCC
Confidence            999999999    99999999999999999887663

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-41  Score=313.57  Aligned_cols=250  Identities=30%  Similarity=0.483  Sum_probs=204.7

Q ss_pred             eEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC--CeE
Q 015222           94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--NHI  168 (411)
Q Consensus        94 y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~--~~~  168 (411)
                      |++.++||.|+||.||+|.+..+++.||+|++...   ......+.+|+.+++.+.|+++     +++++++...  +..
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~~   75 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI-----VRLKEIVTSKGKGSI   75 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCe-----eeheeeEecCCCCcE
Confidence            78899999999999999999999999999999754   2334567789999999988776     9999999887  899


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      ++||||++++|.+++.... ..+++..++.++.||+.||+|||+.|++|+||||+||++++++                 
T Consensus        76 ~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~-----------------  137 (287)
T cd07840          76 YMVFEYMDHDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG-----------------  137 (287)
T ss_pred             EEEeccccccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCC-----------------
Confidence            9999999779999887653 3699999999999999999999999999999999999998776                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCC----CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCh
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHEN  323 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~  323 (411)
                                .++|+|||.+......    .....++..|+|||.+.+. .++.++||||||+++|||++|+.||...+.
T Consensus       138 ----------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~  207 (287)
T cd07840         138 ----------VLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE  207 (287)
T ss_pred             ----------CEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence                      5666666666544332    1223567889999987764 688999999999999999999999998877


Q ss_pred             HHHHHHHHHHhCCCChhH--------------------------HHh-hhhhhhhhhccCCccCCCCCCCcHHHHHHHHh
Q 015222          324 LEHLAMMERVLGPLPHHM--------------------------VIR-ADRRAEKYFRRGARLDWPDGATSRDSMRAVWK  376 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~~--------------------------~~~-~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~  376 (411)
                      ...+..+....+..+...                          ... .+..+.+++.+|+..+    |.+||++.++++
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~----P~~Rp~~~~~l~  283 (287)
T cd07840         208 LEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLD----PKKRISADQALQ  283 (287)
T ss_pred             HHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCC----hhhCcCHHHHhh
Confidence            666665555433221111                          111 2667888999998888    999999999999


Q ss_pred             cCCC
Q 015222          377 LLRL  380 (411)
Q Consensus       377 ~~~~  380 (411)
                      |+||
T Consensus       284 ~~~~  287 (287)
T cd07840         284 HEYF  287 (287)
T ss_pred             CcCC
Confidence            9997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=9.4e-42  Score=315.93  Aligned_cols=254  Identities=24%  Similarity=0.393  Sum_probs=208.0

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      ++|++.+.||.|+||.||+|.++.+++.||+|.+...  ......+.+|+++++++.|+++     +++++.+...+..+
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~~~   75 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYI-----VGFYGAFYNNGDIS   75 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCch-----hhhheeeecCCEEE
Confidence            3688899999999999999999999999999998754  2445667889999999988877     99999999999999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      ++|||+ +++|.+++.... ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++                
T Consensus        76 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~----------------  138 (265)
T cd06605          76 ICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG----------------  138 (265)
T ss_pred             EEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC----------------
Confidence            999999 799999998753 478999999999999999999999 9999999999999998765                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCC-CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCC--hH
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE--NL  324 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~--~~  324 (411)
                                 .++|+|||.+...... .....++..|+|||.+.+..++.++|||||||++|+|++|..||...+  ..
T Consensus       139 -----------~~~l~d~g~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  207 (265)
T cd06605         139 -----------QIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD  207 (265)
T ss_pred             -----------CEEEeecccchhhHHHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc
Confidence                       6788888877654322 122578889999999999899999999999999999999999997542  11


Q ss_pred             HHHHHHHHHhCCCChhHHH-hhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCc
Q 015222          325 EHLAMMERVLGPLPHHMVI-RADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~-~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~  382 (411)
                      .....+.......+..... .++..+.++|.+|+..+    |.+||++.+++.||||+.
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----p~~Rpt~~~ll~~~~~~~  262 (265)
T cd06605         208 GIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKD----PRERPSYKELLEHPFIKK  262 (265)
T ss_pred             cHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCC----chhCcCHHHHhhCchhhc
Confidence            1222222222222222222 26778999999998888    999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4e-41  Score=348.85  Aligned_cols=144  Identities=22%  Similarity=0.380  Sum_probs=131.2

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|+++++||+|+||.||+|.+..+++.||||+++...    .....+..|+.+++.++|++|     +++++.+...++
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~I-----v~~~~~~~~~~~   78 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFI-----VHLYYSLQSANN   78 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCc-----CeEEEEEEECCE
Confidence            67999999999999999999999999999999997532    234667889999999988877     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccc
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                      +|+||||+ +++|.+++....  .+++..++.++.||+.||+|||++|||||||||+||||+.++.++|+|||+++
T Consensus        79 ~~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          79 VYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999 999999998754  68999999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.7e-41  Score=312.21  Aligned_cols=250  Identities=23%  Similarity=0.341  Sum_probs=197.2

Q ss_pred             CCCeEEEeee--ccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           91 TPRYRILSKM--GEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        91 ~~~y~i~~~l--G~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      .++|++.+.+  |+|+||.||++.++.+++.+|+|++.......    .|+.....+.    .|+|++++++.+...+..
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~----~h~~iv~~~~~~~~~~~~   84 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMK----DNPNFIKLYYSVTTLKGH   84 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhh----cCCCEEEEEEEEecCCee
Confidence            3567777776  99999999999999999999999986532211    1333322222    245569999999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      |+||||+ +++|.+++....  .+++..+..++.||+.||.|||+.|++||||||+||+++.++                
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~----------------  146 (267)
T PHA03390         85 VLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK----------------  146 (267)
T ss_pred             EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC----------------
Confidence            9999999 999999998765  799999999999999999999999999999999999997654                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHH-
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH-  326 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~-  326 (411)
                                ..++|+|||.+...... ....|+..|+|||++.+..++.++|||||||++|+|++|..||........ 
T Consensus       147 ----------~~~~l~dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~  215 (267)
T PHA03390        147 ----------DRIYLCDYGLCKIIGTP-SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD  215 (267)
T ss_pred             ----------CeEEEecCccceecCCC-ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh
Confidence                      15678888877654332 234688999999999998999999999999999999999999985543321 


Q ss_pred             HHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHH-HHHHHhcCCCCc
Q 015222          327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS-MRAVWKLLRLPV  382 (411)
Q Consensus       327 ~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t-~~~il~~~~~~~  382 (411)
                      ...+.... ..+.......+..+.++|.+||+.+    |.+|++ ++++++|+||.+
T Consensus       216 ~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~----p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        216 LESLLKRQ-QKKLPFIKNVSKNANDFVQSMLKYN----INYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHHHHHhh-cccCCcccccCHHHHHHHHHHhccC----hhhCCchHHHHhcCCcccC
Confidence            12222211 2222333467889999999999999    999985 799999999975

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4.1e-41  Score=323.14  Aligned_cols=268  Identities=31%  Similarity=0.455  Sum_probs=212.9

Q ss_pred             CccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeee
Q 015222           88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        88 ~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~  163 (411)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||+|.+...   ......+.+|+.+++++ +|+|+     +++++++.
T Consensus         3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni-----~~~~~~~~   77 (337)
T cd07852           3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNI-----VKLLNVIK   77 (337)
T ss_pred             chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCc-----cceeeeec
Confidence            34668899999999999999999999999999999988532   23345567899999999 88877     99999876


Q ss_pred             c--CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccc
Q 015222          164 Y--RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL  241 (411)
Q Consensus       164 ~--~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~  241 (411)
                      .  ....|+||||++++|.+++...   .+++..+..++.||+.||.|||+.||+|+||||+||+++.++          
T Consensus        78 ~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~----------  144 (337)
T cd07852          78 AENDKDIYLVFEYMETDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDC----------  144 (337)
T ss_pred             cCCCceEEEEecccccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC----------
Confidence            4  3478999999977999988764   588999999999999999999999999999999999998877          


Q ss_pred             cccCCCCCccccCCCCCCeeEeecCCcccccCC--------CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHH
Q 015222          242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--------HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELC  312 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell  312 (411)
                                       .++|+|||.+......        .....||..|+|||++.+. .++.++|||||||++|+|+
T Consensus       145 -----------------~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~  207 (337)
T cd07852         145 -----------------RVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEML  207 (337)
T ss_pred             -----------------cEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHH
Confidence                             4566666655433211        1224688999999988664 6789999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCCh---------------------------hHHHhhhhhhhhhhccCCccCCCCCC
Q 015222          313 SGEALFQTHENLEHLAMMERVLGPLPH---------------------------HMVIRADRRAEKYFRRGARLDWPDGA  365 (411)
Q Consensus       313 tg~~pf~~~~~~~~~~~i~~~~~~~p~---------------------------~~~~~~~~~~~~li~~~l~~~~~~rp  365 (411)
                      +|+.||.+....+....+....+..+.                           ...+..+..+.+++.+|++.+    |
T Consensus       208 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~----P  283 (337)
T cd07852         208 LGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFN----P  283 (337)
T ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCC----c
Confidence            999999887766655554443332221                           111234667889999998888    9


Q ss_pred             CcHHHHHHHHhcCCCCcccccCCCCCchh
Q 015222          366 TSRDSMRAVWKLLRLPVIDLYSASPNCLC  394 (411)
Q Consensus       366 ~~R~t~~~il~~~~~~~~~~~~~~~~~~~  394 (411)
                      ++||++.++++|+|+.+.......+....
T Consensus       284 ~~Rps~~~il~~~~~~~~~~~~~~~~~~~  312 (337)
T cd07852         284 NKRLTAEEALEHPYVAQFHNPSDEPVLPY  312 (337)
T ss_pred             ccccCHHHHhhChhhhhhccCCCCCCCCC
Confidence            99999999999999998876655554433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=5.2e-41  Score=314.90  Aligned_cols=255  Identities=24%  Similarity=0.369  Sum_probs=209.3

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      .|...+.||+|++|.||++.+..+++.||+|+++... ...+.+.+|+.+++.+.|+++     +++++++...+..++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~v-----v~~~~~~~~~~~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI-----VEMYSSYLVGDELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCCh-----heEEEEEEcCCeEEEE
Confidence            4666789999999999999999999999999986433 334567889999999988877     9999999999999999


Q ss_pred             EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      +||+ +++|.+++...   .+++..+..++.||+.||+|||++||+||||||+||+++.++                   
T Consensus        95 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~-------------------  152 (285)
T cd06648          95 MEFLEGGALTDIVTHT---RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG-------------------  152 (285)
T ss_pred             EeccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC-------------------
Confidence            9999 99999998873   589999999999999999999999999999999999998776                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL  327 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~  327 (411)
                              .++|+|||.+......   .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+..+..
T Consensus       153 --------~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~  224 (285)
T cd06648         153 --------RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM  224 (285)
T ss_pred             --------cEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH
Confidence                    5566666655432221   12246889999999998888999999999999999999999999877766665


Q ss_pred             HHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          328 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       328 ~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                      ..+......... .....+..+.+++.+|+..+    |.+||++.++++|+|+.+.....
T Consensus       225 ~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~----p~~Rpt~~~il~~~~~~~~~~~~  279 (285)
T cd06648         225 KRIRDNLPPKLK-NLHKVSPRLRSFLDRMLVRD----PAQRATAAELLNHPFLAKAGPPS  279 (285)
T ss_pred             HHHHhcCCCCCc-ccccCCHHHHHHHHHHcccC----hhhCcCHHHHccCcccccCCCcc
Confidence            555443221111 11235678999999999888    99999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.6e-41  Score=309.44  Aligned_cols=245  Identities=22%  Similarity=0.317  Sum_probs=200.3

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      ++|++.+.||+|+||.||+|..+. +..+|+|.+.........+.+|+.+++++.|+++     +++++++...+..++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKL-----VQLYGVCTQQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCc-----eeEEEEEccCCCEEEE
Confidence            468999999999999999998754 4579999987655556778899999999988877     9999999999999999


Q ss_pred             EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      |||+ +++|.+++.... ..+++..+..++.|++.||+|||++||+|+||||+||+++.++                   
T Consensus        78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-------------------  137 (256)
T cd05114          78 TEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG-------------------  137 (256)
T ss_pred             EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC-------------------
Confidence            9999 899999987644 2589999999999999999999999999999999999998766                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE  325 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~  325 (411)
                              .++|+|||.+.......    ....++..|+|||++.+..++.++||||||+++|||++ |+.||...+..+
T Consensus       138 --------~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~  209 (256)
T cd05114         138 --------VVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE  209 (256)
T ss_pred             --------eEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence                    45666666655432111    11234568999999998899999999999999999999 999998887777


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      .+..+.+......+   ...+..+.+++.+|+..+    |.+||++.++++.
T Consensus       210 ~~~~i~~~~~~~~~---~~~~~~~~~li~~c~~~~----p~~Rps~~~l~~~  254 (256)
T cd05114         210 VVEMISRGFRLYRP---KLASMTVYEVMYSCWHEK----PEGRPTFAELLRA  254 (256)
T ss_pred             HHHHHHCCCCCCCC---CCCCHHHHHHHHHHccCC----cccCcCHHHHHHh
Confidence            76666553322111   224567888999987777    9999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=299.73  Aligned_cols=249  Identities=22%  Similarity=0.270  Sum_probs=198.9

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec-----
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-----  164 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~-----  164 (411)
                      ++||+|.++||+|||+-||+++...+++.+|+|.+.... +..+..++|++..++++|+|+     ++++++...     
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~v-----l~l~dh~l~~~~D~   94 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNV-----LRLVDHQLREEKDG   94 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcch-----HHHHHHHHHhhccC
Confidence            469999999999999999999999999999999987544 677888999999999999887     888876543     


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEecCcccccCCcc
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYK  239 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dikp~NIli~~~~~~~l~df~  239 (411)
                      ....||+++|. .|+|.+.+...  ++..+++.++..|+.+|++||++||+..  ++||||||.|||+.+.+        
T Consensus        95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~--------  166 (302)
T KOG2345|consen   95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG--------  166 (302)
T ss_pred             ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC--------
Confidence            34699999999 99999998743  3346999999999999999999999998  99999999999997765        


Q ss_pred             cccccCCCCCccccCCCCCCeeEeecCCcccccCC------------CcccccCCCccccceecCC---CCCccchhHHH
Q 015222          240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------------HSYVVSTRHYRAPEVILGL---GWNYPCDLWSV  304 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------------~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSl  304 (411)
                                         .++|.|||+++...-.            ......|..|+|||.+.-.   ..+.++|||||
T Consensus       167 -------------------~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSL  227 (302)
T KOG2345|consen  167 -------------------LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSL  227 (302)
T ss_pred             -------------------ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhh
Confidence                               6788888877643211            1123578999999999744   57899999999


Q ss_pred             HHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          305 GCILVELCSGEALFQTHEN--LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       305 Gvil~elltg~~pf~~~~~--~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ||+||+|+.|..||+..-.  ....-.+......+|..-  .+++.+.++|+.||+.|    |.+||++.+++.+
T Consensus       228 GCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~--~yse~l~~lik~mlqvd----P~qRP~i~~ll~~  296 (302)
T KOG2345|consen  228 GCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSS--RYSEALHQLIKSMLQVD----PNQRPTIPELLSK  296 (302)
T ss_pred             hHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCC--CccHHHHHHHHHHhcCC----cccCCCHHHHHHH
Confidence            9999999999999953111  000111122223344432  37888999999999999    8888888888865

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-42  Score=299.19  Aligned_cols=256  Identities=23%  Similarity=0.354  Sum_probs=208.3

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      ++.+++..||.|+-|+||+++.+.+|...|||.+.+..  +..+.+...+.++..-.    ..|.||+.+++|..+..++
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~----dcpyIV~c~GyFi~n~dV~  167 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSH----DCPYIVQCFGYFITNTDVF  167 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhcc----CCCeeeeeeeEEeeCchHH
Confidence            34567889999999999999999999999999997543  33445555666554432    2356699999999999999


Q ss_pred             EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +.||.|+..+..++.+.. ..++|..+-++...++.||.||-++ ||+|||+||+|||++..|                 
T Consensus       168 IcMelMs~C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-----------------  229 (391)
T KOG0983|consen  168 ICMELMSTCAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-----------------  229 (391)
T ss_pred             HHHHHHHHHHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-----------------
Confidence            999999777777776654 5799999999999999999999975 899999999999998877                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCC---CCCccchhHHHHHHHHHHHhCCCCCCCC-C
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSGEALFQTH-E  322 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlGvil~elltg~~pf~~~-~  322 (411)
                                ++||||||++......  .+...|-+.|||||.+.-.   .|+..+||||||++|+||.||+.||.+. .
T Consensus       230 ----------niKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t  299 (391)
T KOG0983|consen  230 ----------NIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT  299 (391)
T ss_pred             ----------CEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc
Confidence                      7899999988765433  3446899999999999744   6899999999999999999999999985 4


Q ss_pred             hHHHHHHHHHHhCC-CChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          323 NLEHLAMMERVLGP-LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       323 ~~~~~~~i~~~~~~-~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      +.+.+.++.+..++ +|..  ...+..+.+|+..||.+|    +.+||...++++|+|+..-..
T Consensus       300 dFe~ltkvln~ePP~L~~~--~gFSp~F~~fv~~CL~kd----~r~RP~Y~~Ll~h~Fi~~ye~  357 (391)
T KOG0983|consen  300 DFEVLTKVLNEEPPLLPGH--MGFSPDFQSFVKDCLTKD----HRKRPKYNKLLEHPFIKRYET  357 (391)
T ss_pred             cHHHHHHHHhcCCCCCCcc--cCcCHHHHHHHHHHhhcC----cccCcchHHHhcCcceeecch
Confidence            56777776664332 2222  237888999999999999    889999999999999986543

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5.2e-41  Score=317.19  Aligned_cols=256  Identities=30%  Similarity=0.496  Sum_probs=207.8

Q ss_pred             CccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        88 ~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      +...++|++.+.||+|+||.||+|.++.+++.||+|+++...   .....+.+|+.++++++|+|+     +++++++.+
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i-----~~~~~~~~~   77 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI-----VNLKEIVTD   77 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCe-----eeeeheecC
Confidence            345578999999999999999999999999999999997432   233456789999999988877     999888765


Q ss_pred             CC----------eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccc
Q 015222          165 RN----------HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK  234 (411)
Q Consensus       165 ~~----------~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~  234 (411)
                      ..          .+++||||++++|.+++.... ..+++..+..++.||+.||+|||+.||+|+||||+||++++++   
T Consensus        78 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~---  153 (302)
T cd07864          78 KQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG---  153 (302)
T ss_pred             cchhhhccccCCcEEEEEcccCccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC---
Confidence            44          899999999778888887653 3689999999999999999999999999999999999998766   


Q ss_pred             cCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecCC-CCCccchhHHHHHHHH
Q 015222          235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILV  309 (411)
Q Consensus       235 l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~  309 (411)
                                              .+||+|||.+.......    ....++..|+|||++.+. .++.++|||||||++|
T Consensus       154 ------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~  209 (302)
T cd07864         154 ------------------------QIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG  209 (302)
T ss_pred             ------------------------cEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHH
Confidence                                    56666666665432221    123457789999988754 5789999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCChhH--------------------------HHhhhhhhhhhhccCCccCCCC
Q 015222          310 ELCSGEALFQTHENLEHLAMMERVLGPLPHHM--------------------------VIRADRRAEKYFRRGARLDWPD  363 (411)
Q Consensus       310 elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~--------------------------~~~~~~~~~~li~~~l~~~~~~  363 (411)
                      ||++|+.||...+..+.+..+.+..+..+...                          ....+..+.+++.+||..+   
T Consensus       210 el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~---  286 (302)
T cd07864         210 ELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLD---  286 (302)
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCC---
Confidence            99999999998887777777766544322211                          1234678899999999888   


Q ss_pred             CCCcHHHHHHHHhcCCC
Q 015222          364 GATSRDSMRAVWKLLRL  380 (411)
Q Consensus       364 rp~~R~t~~~il~~~~~  380 (411)
                       |++||++.+++.|+||
T Consensus       287 -P~~Rp~~~~il~~~~~  302 (302)
T cd07864         287 -PSKRCTAEEALNSPWL  302 (302)
T ss_pred             -hhhCCCHHHHhcCCCC
Confidence             9999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.8e-41  Score=316.64  Aligned_cols=247  Identities=19%  Similarity=0.269  Sum_probs=202.1

Q ss_pred             CCeEEEeeeccccceEEEEEEeCC-----CCcEEEEEEeccchh--hhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      ++|.+.+.||+|+||.||+|.+..     +++.||||+++....  ..+.+.+|+++++.+.|+++     +++++++..
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~   79 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI-----VKFYGVCTE   79 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCc-----hheeeEEec
Confidence            468999999999999999998753     357899999975432  35678899999999988877     999999999


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCc
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKNS------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE  231 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~  231 (411)
                      .+..++||||+ +++|.+++...+            ...+++..+..++.||+.||.|||++|++||||||+||+++.++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~  159 (280)
T cd05049          80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL  159 (280)
T ss_pred             CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC
Confidence            99999999999 999999997643            13578899999999999999999999999999999999998776


Q ss_pred             ccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCCCccchhHHHHH
Q 015222          232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC  306 (411)
Q Consensus       232 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  306 (411)
                                                 .++|+|||++......     .....+++.|+|||++.+..++.++|||||||
T Consensus       160 ---------------------------~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  212 (280)
T cd05049         160 ---------------------------VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGV  212 (280)
T ss_pred             ---------------------------eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHH
Confidence                                       4566666655432211     12234577899999999999999999999999


Q ss_pred             HHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          307 ILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       307 il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ++|||++ |..||.+.+..+....+.......+   ....+..+.+++.+|+..+    |.+||++.++++.
T Consensus       213 il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~----p~~Rp~~~eil~~  277 (280)
T cd05049         213 VLWEIFTYGKQPWYGLSNEEVIECITQGRLLQR---PRTCPSEVYDIMLGCWKRD----PQQRINIKDIHER  277 (280)
T ss_pred             HHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcCCC----cccCCCHHHHHHH
Confidence            9999998 9999988777776666554332222   2346778999999998888    9999999999865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=7.2e-41  Score=312.81  Aligned_cols=253  Identities=20%  Similarity=0.276  Sum_probs=195.2

Q ss_pred             eeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEcc
Q 015222           99 KMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK  174 (411)
Q Consensus        99 ~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~  174 (411)
                      .||+|+||.||+|.+..+++.||+|++....    ........|..+++.+.+.  .|++++.+++.+...+..++||||
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~v~e~   78 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG--DCPFIVCMSYAFHTPDKLSFILDL   78 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhC--CCCcEeeeeeeeecCCEEEEEEec
Confidence            4799999999999999999999999986432    1122334455555544432  346669999999999999999999


Q ss_pred             C-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCcccc
Q 015222          175 L-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN  253 (411)
Q Consensus       175 ~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~  253 (411)
                      + |++|.+++....  .+++..++.++.|++.||.|||+.+|+||||||+||+++.++                      
T Consensus        79 ~~g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~----------------------  134 (278)
T cd05606          79 MNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG----------------------  134 (278)
T ss_pred             CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC----------------------
Confidence            9 999999887654  699999999999999999999999999999999999997766                      


Q ss_pred             CCCCCCeeEeecCCcccccC-CCcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015222          254 LPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME  331 (411)
Q Consensus       254 ~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~  331 (411)
                           .++|+|||++..... ......|+..|+|||++.++ .++.++||||+||++|+|++|+.||.+...........
T Consensus       135 -----~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~  209 (278)
T cd05606         135 -----HVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR  209 (278)
T ss_pred             -----CEEEccCcCccccCccCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH
Confidence                 466777776653322 22335789999999999755 68999999999999999999999998763222111111


Q ss_pred             HHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH-----HHHHHHhcCCCCcccccC
Q 015222          332 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-----SMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       332 ~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~-----t~~~il~~~~~~~~~~~~  387 (411)
                      . ....+..+....+..+.+++.+||..+    |..|+     ++.++++|+||..+.+..
T Consensus       210 ~-~~~~~~~~~~~~s~~~~~li~~~l~~~----p~~R~~~~~~~~~~ll~~~~~~~~~~~~  265 (278)
T cd05606         210 M-TLTMAVELPDSFSPELRSLLEGLLQRD----VNRRLGCLGRGAQEVKEHPFFRSLDWQM  265 (278)
T ss_pred             H-hhccCCCCCCcCCHHHHHHHHHHhhcC----HHhccCCCCCCHHHHHhCccccCCCchH
Confidence            1 111122223345788999999999999    77777     999999999999877544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.7e-41  Score=309.69  Aligned_cols=248  Identities=25%  Similarity=0.410  Sum_probs=204.9

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch------hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      +|+..+.||+|+||.||+|.+..+++.||+|.+....      ...+.+.+|+.+++.++|+++     +++++++...+
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI-----VQYLGTEREED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCc-----hheeeeEecCC
Confidence            5788899999999999999999899999999986432      244667889999999988877     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      .++++|||+ +++|.+++.+..  .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++              
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~--------------  139 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG--------------  139 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--------------
Confidence            999999999 889999998764  689999999999999999999999999999999999997766              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCC-CCccchhHHHHHHHHHHHhCCCCCCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHE  322 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~pf~~~~  322 (411)
                                   .+||+|||.+......  .....|+..|+|||.+.... ++.++|+|||||++|+|++|+.||....
T Consensus       140 -------------~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~  206 (258)
T cd06632         140 -------------VVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE  206 (258)
T ss_pred             -------------CEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence                         5677777766543322  23356889999999998776 8999999999999999999999998766


Q ss_pred             hHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      ..+....+... ... .......+..+.+++.+|+..+    |..||++.+++.|+|+
T Consensus       207 ~~~~~~~~~~~-~~~-~~~~~~~~~~~~~li~~~l~~~----p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         207 GVAAVFKIGRS-KEL-PPIPDHLSDEAKDFILKCLQRD----PSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHHHHHHhc-ccC-CCcCCCcCHHHHHHHHHHhhcC----cccCcCHHHHhcCCCC
Confidence            54444433321 111 1223446678899999998888    9999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1e-40  Score=308.29  Aligned_cols=249  Identities=23%  Similarity=0.390  Sum_probs=206.3

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec--CCe
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--RNH  167 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~--~~~  167 (411)
                      +|++.+.||.|+||.||+|.+..+++.||+|++...   ....+.+..|+++++.+.|+++     +++++++..  +..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~   75 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI-----VRYYDRIIDRSNQT   75 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCcc-----ceeeeeeecCCCCE
Confidence            589999999999999999999999999999998643   2344567789999999988877     999887653  467


Q ss_pred             EEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCceecCCCCCcEEEecCcccccCCcc
Q 015222          168 ICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMH-----ELRLIHTDLKPENILLVSAEYVKVPDYK  239 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH-----~~givH~Dikp~NIli~~~~~~~l~df~  239 (411)
                      .+++|||+ +++|.+++...  ....+++..++.++.||+.||.|||     +.+|+|+||||+||+++.++        
T Consensus        76 ~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~--------  147 (265)
T cd08217          76 LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN--------  147 (265)
T ss_pred             EEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC--------
Confidence            89999999 89999998753  2346899999999999999999999     89999999999999998766        


Q ss_pred             cccccCCCCCccccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCC
Q 015222          240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA  316 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~  316 (411)
                                         .++|+|||++.......   ....|+..|+|||++.+..++.++||||||+++|+|++|+.
T Consensus       148 -------------------~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~  208 (265)
T cd08217         148 -------------------NVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSP  208 (265)
T ss_pred             -------------------CEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCC
Confidence                               56777777666543322   23468999999999998889999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      ||...+..+....+.....   ..+....+..+.+++.+|+..+    |.+||+++++++|||+
T Consensus       209 p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~~~l~~~----p~~Rp~~~~il~~~~~  265 (265)
T cd08217         209 PFTARNQLQLASKIKEGKF---RRIPYRYSSELNEVIKSMLNVD----PDKRPSTEELLQLPLI  265 (265)
T ss_pred             cccCcCHHHHHHHHhcCCC---CCCccccCHHHHHHHHHHccCC----cccCCCHHHHhhCCCC
Confidence            9988775555554443321   2233456778999999999988    9999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.2e-41  Score=317.59  Aligned_cols=261  Identities=25%  Similarity=0.374  Sum_probs=211.6

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc-hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      .++|++.+.||+|+||.||++.+..++..||+|.+... ....+.+.+|+.+++.+.|+++     +++++.+...+..|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i-----~~~~~~~~~~~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNI-----VNYLDSYLVGDELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCe-----eehhheeeeCCcEE
Confidence            36899999999999999999999989999999998643 2334667889999998888776     99999999999999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +|+||+ +++|.+++.+.   .+++..+..++.|++.||.|||++|++|+||||+||+++.++                 
T Consensus        93 lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~-----------------  152 (293)
T cd06647          93 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-----------------  152 (293)
T ss_pred             EEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC-----------------
Confidence            999999 99999998765   488999999999999999999999999999999999997766                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                                .++|+|||++......   .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+
T Consensus       153 ----------~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~  222 (293)
T cd06647         153 ----------SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR  222 (293)
T ss_pred             ----------CEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence                      5667777765433221   123468889999999988889999999999999999999999998766544


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccCCCCC
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSASPN  391 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~~~~  391 (411)
                      .+..+... +..........+..+.+++.+|+..+    |..||++.+++.|+||......+..|-
T Consensus       223 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~----p~~Rp~~~~il~h~~~~~~~~~~~~~~  283 (293)
T cd06647         223 ALYLIATN-GTPELQNPEKLSAIFRDFLNRCLEMD----VEKRGSAKELLQHPFLKIAKPLSSLTP  283 (293)
T ss_pred             heeehhcC-CCCCCCCccccCHHHHHHHHHHccCC----hhhCcCHHHHhcCHHHhcCcccccccc
Confidence            43332221 11111122345667889999998888    999999999999999998776555443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.9e-41  Score=312.02  Aligned_cols=246  Identities=26%  Similarity=0.399  Sum_probs=205.6

Q ss_pred             eccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC
Q 015222          100 MGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL  175 (411)
Q Consensus       100 lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~  175 (411)
                      ||.|+||.||+|++..+++.||+|++....    ...+.+.+|+.+++++.|+|+     +++++.+..++..|+||||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYV-----VKLYYSFQGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcch-----hHHHHheecCcEEEEEEecC
Confidence            689999999999999999999999986533    345667889999999988877     99999999999999999999


Q ss_pred             -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccC
Q 015222          176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL  254 (411)
Q Consensus       176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~  254 (411)
                       +++|.+++.+..  .+++..+..++.||+.||.|||++|++|+||+|+||+++.++                       
T Consensus        76 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~-----------------------  130 (265)
T cd05579          76 PGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG-----------------------  130 (265)
T ss_pred             CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCC-----------------------
Confidence             889999998765  699999999999999999999999999999999999998777                       


Q ss_pred             CCCCCeeEeecCCcccccCC-----------CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh
Q 015222          255 PKSSAIKLIDFGSTTFEHQD-----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN  323 (411)
Q Consensus       255 ~~~~~~kl~Dfg~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~  323 (411)
                          .++|+|||++......           .....++..|+|||.+.+...+.++||||||+++|+|++|..||.....
T Consensus       131 ----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~  206 (265)
T cd05579         131 ----HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP  206 (265)
T ss_pred             ----CEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence                4566666655432211           1234678899999999888899999999999999999999999988777


Q ss_pred             HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHH---HHHHhcCCCCcccc
Q 015222          324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSM---RAVWKLLRLPVIDL  385 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~---~~il~~~~~~~~~~  385 (411)
                      .+....+.......+...  ..+..+.+++.+|++.+    |.+||++   .++++|+||.+++|
T Consensus       207 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~~l~~~----p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         207 EEIFQNILNGKIEWPEDV--EVSDEAIDLISKLLVPD----PEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             HHHHHHHhcCCcCCCccc--cCCHHHHHHHHHHhcCC----HhhcCCCccHHHHhcCccccCCCC
Confidence            766666555333333321  24778899999999888    9999999   99999999998765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=6e-41  Score=312.79  Aligned_cols=270  Identities=23%  Similarity=0.318  Sum_probs=215.0

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc----hhhhHHHHHHHHHHHHHh-cCCCCCcceEEEeeeeecCC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~~~~~~  166 (411)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...    ......+.+|+.+++++. |+|+     +++++++...+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i-----~~~~~~~~~~~   75 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI-----IKLYYTFQDEE   75 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCc-----hhHHHHhcCCc
Confidence            4699999999999999999999999999999998752    233456778999999987 7666     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      ..++|||++ +++|.+++.+..  .+++..+..++.|++.||.|||+.|++|+||||+||+++.+|.++++|||+.....
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            999999999 999999998765  69999999999999999999999999999999999999998877777777655443


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                      ..........    ....++..............|+..|+|||++.+..++.++||||||+++++|++|+.||...+...
T Consensus       154 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  229 (280)
T cd05581         154 PNSSPESNKG----DATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL  229 (280)
T ss_pred             CccccccCCC----CCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence            3221100000    000111111111122233567899999999988889999999999999999999999999877666


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHH----HHHHhcCCC
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSM----RAVWKLLRL  380 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~----~~il~~~~~  380 (411)
                      .+..+......++..    ++..+.+++.+||..+    |.+||++    +++++|+||
T Consensus       230 ~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~~----p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         230 TFQKILKLEYSFPPN----FPPDAKDLIEKLLVLD----PQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHHHHHhcCCCCCCc----cCHHHHHHHHHHhcCC----HhhCCCcccCHHHHhcCCCC
Confidence            666655544455543    4677899999999988    8899999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=9.8e-41  Score=313.43  Aligned_cols=255  Identities=20%  Similarity=0.300  Sum_probs=201.7

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCC-----CCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~  163 (411)
                      .++|++.+.||+|+||.||+|.++.     .+..||+|.+....  .....+.+|+.+++.+.|+++     +++++++.
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~   79 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV-----VRLLGVVS   79 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCe-----eeEEEEEc
Confidence            4689999999999999999997653     34579999986433  233456789999999988776     99999999


Q ss_pred             cCCeEEEEEccC-CCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccc
Q 015222          164 YRNHICIVFEKL-GPSLYDFLRKNS--------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK  234 (411)
Q Consensus       164 ~~~~~~lv~e~~-~~~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~  234 (411)
                      ..+..|+||||+ +++|.+++.+..        ...++...+..++.||+.||.|||++||+||||||+|||++.++   
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~---  156 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF---  156 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC---
Confidence            889999999999 999999997532        12346778899999999999999999999999999999998766   


Q ss_pred             cCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchhHHHHHHHH
Q 015222          235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV  309 (411)
Q Consensus       235 l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  309 (411)
                                              .++|+|||+++......     ....++..|+|||.+.+..++.++|||||||++|
T Consensus       157 ------------------------~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~  212 (288)
T cd05061         157 ------------------------TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW  212 (288)
T ss_pred             ------------------------cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHH
Confidence                                    56677777665332211     1124567799999999889999999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHHh-CCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHh------cCCCC
Q 015222          310 ELCS-GEALFQTHENLEHLAMMERVL-GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK------LLRLP  381 (411)
Q Consensus       310 ellt-g~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~------~~~~~  381 (411)
                      ||++ |..||.+.+..+....+.... ...+    ...+..+.+++.+|++.+    |.+||++.++++      |+||.
T Consensus       213 el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~----p~~Rps~~~ll~~l~~~~~~~~~  284 (288)
T cd05061         213 EITSLAEQPYQGLSNEQVLKFVMDGGYLDQP----DNCPERVTDLMRMCWQFN----PKMRPTFLEIVNLLKDDLHPSFP  284 (288)
T ss_pred             HHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCCHHHHHHHHHHcCCC----hhHCcCHHHHHHHHHhhcCCCCC
Confidence            9998 899998877666555443321 1122    234678999999999999    777777877776      89999


Q ss_pred             cccc
Q 015222          382 VIDL  385 (411)
Q Consensus       382 ~~~~  385 (411)
                      ++++
T Consensus       285 ~~~~  288 (288)
T cd05061         285 EVSF  288 (288)
T ss_pred             CCCC
Confidence            8875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.8e-41  Score=309.08  Aligned_cols=250  Identities=24%  Similarity=0.363  Sum_probs=207.3

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      +|++.+.||+|+||.||+|.++.++..||+|.+....   ...+.+.+|+.+++.++|+++     +++++.+...+..+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i-----~~~~~~~~~~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI-----VTFFASFQENGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCCh-----hhhhheeccCCeEE
Confidence            5899999999999999999999999999999986432   344567789999999988877     99999999999999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +|+||+ +++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.                
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~----------------  139 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM----------------  139 (257)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC----------------
Confidence            999999 999999998765456899999999999999999999999999999999999976542                


Q ss_pred             CccccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                                .++|+|||.+.......   ....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+
T Consensus       140 ----------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  209 (257)
T cd08225         140 ----------VAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ  209 (257)
T ss_pred             ----------eEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence                      35777777765543322   22468889999999988889999999999999999999999998766555


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      ....+...  .. .......+..+.+++.+|+..+    |++||++.++++|+||
T Consensus       210 ~~~~~~~~--~~-~~~~~~~~~~~~~~i~~~l~~~----p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         210 LVLKICQG--YF-APISPNFSRDLRSLISQLFKVS----PRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHHhcc--cC-CCCCCCCCHHHHHHHHHHhccC----hhhCcCHHHHhhCCCC
Confidence            44333221  11 1122345677999999998888    9999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.8e-41  Score=346.96  Aligned_cols=262  Identities=18%  Similarity=0.230  Sum_probs=193.3

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc----hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++.++||+|+||.||+|++..+++.||||+++..    ....+.+.+|+.+++++.|+|+     +++++++.+++.
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNI-----Vkl~~v~~d~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGI-----VPVYSICSDGDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCc-----CeEEEEEeeCCE
Confidence            5899999999999999999999999999999998743    2335668889999999988887     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNS---------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD  237 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~d  237 (411)
                      .|+||||+ |++|.+++....         ...++...+..++.||+.||+|||++||+||||||+|||++.+|.++++|
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD  156 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD  156 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence            99999999 999999986421         12356678899999999999999999999999999999999888777777


Q ss_pred             cccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCC
Q 015222          238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL  317 (411)
Q Consensus       238 f~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p  317 (411)
                      ||++...........      ......-+............+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus       157 FGLAk~i~~~~~~~~------~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P  230 (932)
T PRK13184        157 WGAAIFKKLEEEDLL------DIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP  230 (932)
T ss_pred             cCcceeccccccccc------ccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence            766544321110000      00000000000000111235799999999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCC
Q 015222          318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGA  365 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp  365 (411)
                      |...+....... .....+........++..+.+++.+||..+|.+|+
T Consensus       231 F~~~~~~ki~~~-~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~  277 (932)
T PRK13184        231 YRRKKGRKISYR-DVILSPIEVAPYREIPPFLSQIAMKALAVDPAERY  277 (932)
T ss_pred             CCCcchhhhhhh-hhccChhhccccccCCHHHHHHHHHHccCChhhCc
Confidence            987544332221 11111111111235677789999999999944443

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=6.2e-41  Score=312.93  Aligned_cols=252  Identities=19%  Similarity=0.259  Sum_probs=204.2

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCC-----CCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~  163 (411)
                      .++|++.+.||+|+||.||+|.+..     ++..||+|.+....  .....+.+|+.+++.+.|+++     +++++++.
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~   79 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI-----VRLIGVSF   79 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEc
Confidence            3579999999999999999999987     77889999986432  334567889999999988776     99999998


Q ss_pred             cCCeEEEEEccC-CCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCC
Q 015222          164 YRNHICIVFEKL-GPSLYDFLRKNSY-----RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD  237 (411)
Q Consensus       164 ~~~~~~lv~e~~-~~~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~d  237 (411)
                      +.+..++||||+ +++|.+++.....     ..+++..+..++.||+.||+|||++|++||||||+||+++.++      
T Consensus        80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~------  153 (277)
T cd05036          80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG------  153 (277)
T ss_pred             cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccC------
Confidence            888999999999 9999999976531     2589999999999999999999999999999999999998654      


Q ss_pred             cccccccCCCCCccccCCCCCCeeEeecCCcccccCCCc-----ccccCCCccccceecCCCCCccchhHHHHHHHHHHH
Q 015222          238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS-----YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC  312 (411)
Q Consensus       238 f~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell  312 (411)
                                        ....++|+|||++........     ...++..|+|||++.+..++.++|||||||++|||+
T Consensus       154 ------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~  215 (277)
T cd05036         154 ------------------PGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIF  215 (277)
T ss_pred             ------------------CCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHH
Confidence                              223578888888775432211     123356799999999889999999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          313 S-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       313 t-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      + |..||.+.+..+....+.....   .......+..+.+++.+|++.+    |+.||++.++++|.
T Consensus       216 ~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i~~cl~~~----p~~Rps~~~vl~~l  275 (277)
T cd05036         216 SLGYMPYPGRTNQEVMEFVTGGGR---LDPPKGCPGPVYRIMTDCWQHT----PEDRPNFATILERI  275 (277)
T ss_pred             cCCCCCCCCCCHHHHHHHHHcCCc---CCCCCCCCHHHHHHHHHHcCCC----cccCcCHHHHHHHh
Confidence            7 9999988776665544433211   1122345677889999999888    99999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=6.7e-41  Score=310.22  Aligned_cols=246  Identities=24%  Similarity=0.331  Sum_probs=199.3

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      .++|++.++||+|+||.||+|.+..++ .||+|+++......+.+.+|+++++++.|+++     +++++.+. .+..++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i-----~~~~~~~~-~~~~~l   77 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKL-----VQLYAVVS-EEPIYI   77 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhCCCCCc-----ceEEEEEC-CCCcEE
Confidence            367999999999999999999887664 59999998655555678899999999988877     88888775 456899


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      ||||+ +++|.+++.+.....+++..+..++.|++.||+|||+.||+|+||||+||+++.++                  
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~------------------  139 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL------------------  139 (262)
T ss_pred             EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCC------------------
Confidence            99999 88999999875444689999999999999999999999999999999999998766                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCCCc----ccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQDHS----YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL  324 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~  324 (411)
                               .++|+|||.+........    ...++..|+|||+..+..++.++|||||||++|+|++ |..||.+....
T Consensus       140 ---------~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~  210 (262)
T cd05071         140 ---------VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR  210 (262)
T ss_pred             ---------cEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH
Confidence                     466677776654332221    2245678999999988899999999999999999999 89999887766


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      +....+.... ..  ......+..+.+++.+|++.+    |++||++.++++.
T Consensus       211 ~~~~~~~~~~-~~--~~~~~~~~~l~~li~~~l~~~----p~~Rp~~~~~~~~  256 (262)
T cd05071         211 EVLDQVERGY-RM--PCPPECPESLHDLMCQCWRKE----PEERPTFEYLQAF  256 (262)
T ss_pred             HHHHHHhcCC-CC--CCccccCHHHHHHHHHHccCC----cccCCCHHHHHHH
Confidence            6555544321 11  123456778899999999988    8888899988754

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-40  Score=312.40  Aligned_cols=259  Identities=22%  Similarity=0.327  Sum_probs=204.7

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec--CCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--RNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~--~~~  167 (411)
                      ++|++.+.||.|++|.||+|.+..+++.||+|.+....  .....+.+|+++++++.|+||     +++++++..  .+.
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~~   75 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI-----VKYYGAFLDESSSS   75 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCe-----eeeeeEEEccCCCe
Confidence            46999999999999999999999999999999987533  345678899999999988877     999998754  347


Q ss_pred             EEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          168 ICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      +|+||||+ +++|.+++...  ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++             
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~-------------  142 (287)
T cd06621          76 IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG-------------  142 (287)
T ss_pred             EEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCC-------------
Confidence            89999999 89999887642  234689999999999999999999999999999999999998766             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCC-CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCC-
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE-  322 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~-  322 (411)
                                    .++|+|||++...... .....++..|+|||.+.+..++.++|||||||++|+|++|..||.... 
T Consensus       143 --------------~~~l~dfg~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  208 (287)
T cd06621         143 --------------QVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGE  208 (287)
T ss_pred             --------------eEEEeeccccccccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccC
Confidence                          5677777776543322 123457888999999998899999999999999999999999997652 


Q ss_pred             ----hHHHHHHHHHHhC-CCChhHH--HhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          323 ----NLEHLAMMERVLG-PLPHHMV--IRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       323 ----~~~~~~~i~~~~~-~~p~~~~--~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                          ..+....+..... .++....  ..+++.+.+++.+|+..+    |++|||+.++++|+|+.+....
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----p~~Rpt~~eil~~~~~~~~~~~  275 (287)
T cd06621         209 PPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKD----PTRRPTPWDMLEHPWIKAQMKK  275 (287)
T ss_pred             CCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCC----cccCCCHHHHHhCccccccccc
Confidence                1222222222111 1111110  123567889999998888    9999999999999999776544

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-40  Score=308.34  Aligned_cols=247  Identities=21%  Similarity=0.332  Sum_probs=202.6

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      .++|++.+.||+|+||.||+|.+.. ++.||+|.++......+.+.+|+.+++++.|+++     +++++++...+..++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~l   78 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKL-----IQLYAVCTLEEPIYI   78 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCc-----cceeEEEecCCCeee
Confidence            3679999999999999999998754 5679999998665556778899999999988877     999999999999999


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      ||||+ +++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++                  
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~------------------  140 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN------------------  140 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCC------------------
Confidence            99999 99999999876545789999999999999999999999999999999999998776                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCCC-cc---cccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQDH-SY---VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL  324 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~---~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~  324 (411)
                               .++|+|||++....... ..   ...+..|+|||.+.+..++.++||||||+++|||++ |+.||.+.+..
T Consensus       141 ---------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  211 (261)
T cd05068         141 ---------ICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA  211 (261)
T ss_pred             ---------CEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence                     45666666665433211 11   122457999999998899999999999999999999 99999887776


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ..+..+..... .+  .....+..+.+++.+|++.+    |.+||++.++.+.
T Consensus       212 ~~~~~~~~~~~-~~--~~~~~~~~~~~li~~~l~~~----P~~Rp~~~~l~~~  257 (261)
T cd05068         212 EVLQQVDQGYR-MP--CPPGCPKELYDIMLDCWKED----PDDRPTFETLQWK  257 (261)
T ss_pred             HHHHHHHcCCC-CC--CCCcCCHHHHHHHHHHhhcC----cccCCCHHHHHHH
Confidence            66655543321 11  12345678899999999888    9999999998764

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-41  Score=312.80  Aligned_cols=250  Identities=32%  Similarity=0.540  Sum_probs=208.1

Q ss_pred             eEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        94 y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      |++.+.||.|++|.||+|.+..+++.+|+|.+....   .....+.+|+.++++++|+++     +++++++.+++..++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI-----IKLLDVFRHKGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCc-----chHHHhhccCCCEEE
Confidence            678899999999999999999999999999986533   234667889999999988877     999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       171 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      ||||+.++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++                   
T Consensus        76 v~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-------------------  135 (283)
T cd05118          76 VFEFMDTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG-------------------  135 (283)
T ss_pred             EEeccCCCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC-------------------
Confidence            99999779999888754 4699999999999999999999999999999999999997766                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEH  326 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~  326 (411)
                              .++|+|||.+.......   ....++..|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+..+.
T Consensus       136 --------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~  207 (283)
T cd05118         136 --------VLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ  207 (283)
T ss_pred             --------cEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                    56777777665543322   224578889999999877 789999999999999999999999988877666


Q ss_pred             HHHHHHHhCCCC--------------------------hhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          327 LAMMERVLGPLP--------------------------HHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       327 ~~~i~~~~~~~p--------------------------~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      +..+....+...                          .......+..+.++|.+|+..+    |.+||++.+++.|+||
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~----P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         208 LFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYD----PHKRITAEQALAHPYF  283 (283)
T ss_pred             HHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccC----cccCcCHHHHhhCCCC
Confidence            555544322211                          1223346778999999999988    9999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-43  Score=329.20  Aligned_cols=260  Identities=25%  Similarity=0.380  Sum_probs=223.4

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      .+++++..||-|+||.|-++........+|+|++++..    ...+.+..|-.||.....+.|     |++|..|.+..+
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fI-----vrLYrTfrd~ky  494 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFI-----VRLYRTFRDSKY  494 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHH-----HHHHHHhccchh
Confidence            46778889999999999999877666678999998643    456777889999999887766     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+.||-| ||.|+..|++++  .|.+..++.++..++.|++|||++|||+|||||+|+|++.+|+              
T Consensus       495 vYmLmEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy--------------  558 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY--------------  558 (732)
T ss_pred             hhhhHHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc--------------
Confidence            99999999 999999999887  7999999999999999999999999999999999999998885              


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                                   +||.|||+|+......  -+++|||.|.|||++.+...+.++|.||||+++|||++|.+||.+.+..
T Consensus       559 -------------~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm  625 (732)
T KOG0614|consen  559 -------------LKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM  625 (732)
T ss_pred             -------------eEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH
Confidence                         5677777776654443  4589999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHH-----HHHHHhcCCCCcccccCCCCC
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS-----MRAVWKLLRLPVIDLYSASPN  391 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t-----~~~il~~~~~~~~~~~~~~~~  391 (411)
                      ..+..|.++...+  +++..+...+.++++++-+.+    |++|..     +.+|.+|.||.+.+|......
T Consensus       626 ktYn~ILkGid~i--~~Pr~I~k~a~~Lik~LCr~~----P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~  691 (732)
T KOG0614|consen  626 KTYNLILKGIDKI--EFPRRITKTATDLIKKLCRDN----PTERLGYQKGGINDIKKHRWFEGFDWEGLRSR  691 (732)
T ss_pred             HHHHHHHhhhhhh--hcccccchhHHHHHHHHHhcC----cHhhhccccCChHHHHhhhhhhcCChhhhhhc
Confidence            9998888765432  233456677888888887777    777765     899999999999998765443

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.2e-40  Score=315.80  Aligned_cols=267  Identities=23%  Similarity=0.387  Sum_probs=204.8

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec---
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY---  164 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~---  164 (411)
                      .++|++.++||+|+||.||+|.++.+++.||||++....   .......+|+++++.++|+++     +++++++..   
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~   81 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNV-----VPLIDMAVERPD   81 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCc-----cchhhheecccc
Confidence            478999999999999999999999999999999986432   223456789999999998888     888877643   


Q ss_pred             -----CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcc
Q 015222          165 -----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK  239 (411)
Q Consensus       165 -----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~  239 (411)
                           ...+++||||++++|.+.+.... ..+++..+..++.||++||.|||++||+|+||||+||++++++.++++|||
T Consensus        82 ~~~~~~~~~~lv~~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          82 KSKRKRGSVYMVTPYMDHDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             cccccCceEEEEEecCCcCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCc
Confidence                 33579999999888888877543 369999999999999999999999999999999999999988876666666


Q ss_pred             cccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCC
Q 015222          240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALF  318 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf  318 (411)
                      ++..........            ..+. ...........|++.|+|||.+.+. .++.++|||||||++|||++|++||
T Consensus       161 ~~~~~~~~~~~~------------~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~  227 (311)
T cd07866         161 LARPYDGPPPNP------------KGGG-GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL  227 (311)
T ss_pred             cchhccCCCccc------------ccCC-cccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC
Confidence            554332211100            0000 0000111234678899999988764 5899999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCChhH--------------------------HHhhhhhhhhhhccCCccCCCCCCCcHHHHH
Q 015222          319 QTHENLEHLAMMERVLGPLPHHM--------------------------VIRADRRAEKYFRRGARLDWPDGATSRDSMR  372 (411)
Q Consensus       319 ~~~~~~~~~~~i~~~~~~~p~~~--------------------------~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~  372 (411)
                      .+.+.......+....+..++..                          .......+.++|.+||..+    |.+|||+.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~----p~~R~t~~  303 (311)
T cd07866         228 QGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLD----PYKRLTAS  303 (311)
T ss_pred             CCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccC----cccCcCHH
Confidence            98887776666655433222111                          1123356779999999999    99999999


Q ss_pred             HHHhcCCC
Q 015222          373 AVWKLLRL  380 (411)
Q Consensus       373 ~il~~~~~  380 (411)
                      +++.|+||
T Consensus       304 ell~~~~f  311 (311)
T cd07866         304 DALEHPYF  311 (311)
T ss_pred             HHhcCCCC
Confidence            99999997

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.5e-41  Score=318.94  Aligned_cols=253  Identities=21%  Similarity=0.352  Sum_probs=207.7

Q ss_pred             eEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEE
Q 015222           94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF  172 (411)
Q Consensus        94 y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~  172 (411)
                      |....+||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.+.|+|+     +++++.+..++..++||
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i-----~~~~~~~~~~~~~~iv~   97 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNV-----VEMYKSYLVGEELWVLM   97 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCch-----hhhhhheeeCCeEEEEE
Confidence            555668999999999999999999999999986432 334567789999999888777     99999999999999999


Q ss_pred             ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCcc
Q 015222          173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF  251 (411)
Q Consensus       173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~  251 (411)
                      ||+ +++|.+++...   .+++..+..++.|++.||.|||++||+|+||||+||+++.++                    
T Consensus        98 e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~--------------------  154 (297)
T cd06659          98 EFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG--------------------  154 (297)
T ss_pred             ecCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC--------------------
Confidence            999 88999887653   489999999999999999999999999999999999998766                    


Q ss_pred             ccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015222          252 KNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA  328 (411)
Q Consensus       252 ~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~  328 (411)
                             .++|+|||++......   .....|+..|+|||++.+..++.++|||||||++|||++|+.||...+..+.+.
T Consensus       155 -------~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~  227 (297)
T cd06659         155 -------RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK  227 (297)
T ss_pred             -------cEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence                   5677777766533221   223568899999999998889999999999999999999999998777666555


Q ss_pred             HHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       329 ~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                      .+...... ........+..+.+++.+|+..+    |.+||++.++++|+||.+....
T Consensus       228 ~~~~~~~~-~~~~~~~~~~~l~~~i~~~l~~~----P~~Rps~~~ll~~~~~~~~~~~  280 (297)
T cd06659         228 RLRDSPPP-KLKNAHKISPVLRDFLERMLTRE----PQERATAQELLDHPFLLQTGLP  280 (297)
T ss_pred             HHhccCCC-CccccCCCCHHHHHHHHHHhcCC----cccCcCHHHHhhChhhccCCCc
Confidence            44432211 11222345677899999999888    9999999999999999976643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=8.1e-41  Score=309.08  Aligned_cols=247  Identities=23%  Similarity=0.336  Sum_probs=202.5

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      ..++|+++++||+|+||.||+|..+ +++.||+|.+.......+.+.+|+.+++++.|+++     +++++++. .+..+
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~-~~~~~   76 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRL-----VRLYAVVT-QEPIY   76 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCe-----eeEEEEEc-cCCcE
Confidence            4578999999999999999999865 46779999998766666788899999999988877     88888774 46789


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      ++|||+ +++|.+++.......+++..+..++.|++.||+|||+.|++|+||||+||++++++                 
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-----------------  139 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETL-----------------  139 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCC-----------------
Confidence            999999 89999999876555789999999999999999999999999999999999998766                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCh
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHEN  323 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~  323 (411)
                                .++|+|||.+.......    ....++..|+|||++.+..++.++||||||+++|||++ |+.||.+.+.
T Consensus       140 ----------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  209 (260)
T cd05067         140 ----------CCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN  209 (260)
T ss_pred             ----------CEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh
Confidence                      56677777665443111    12345678999999998889999999999999999999 9999988777


Q ss_pred             HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      .+....+......   ......+..+.+++.+|++.+    |++||+++++++.
T Consensus       210 ~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~----p~~Rp~~~~l~~~  256 (260)
T cd05067         210 PEVIQNLERGYRM---PRPDNCPEELYELMRLCWKEK----PEERPTFEYLRSV  256 (260)
T ss_pred             HHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHccCC----hhhCCCHHHHHHH
Confidence            6666655443221   122345678999999999888    9999999998864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3e-40  Score=309.33  Aligned_cols=254  Identities=30%  Similarity=0.471  Sum_probs=204.7

Q ss_pred             eEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe---
Q 015222           94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH---  167 (411)
Q Consensus        94 y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~---  167 (411)
                      |++.+.||+|+||.||+|+++.+++.||+|+++...   .....+.+|+.+++++.  .+.|++++++++++...+.   
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~h~~i~~~~~~~~~~~~~~~   78 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLE--SFEHPNIVRLLDVCHGPRTDRE   78 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhh--ccCCCCcceEEEEEeeccCCCC
Confidence            788999999999999999999889999999997432   22345667888888774  2234455999999987666   


Q ss_pred             --EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          168 --ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       168 --~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                        .+++|||++++|.+++.......+++..++.++.||+.||.|||+.|++|+||||+||+++.++              
T Consensus        79 ~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~--------------  144 (287)
T cd07838          79 LKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG--------------  144 (287)
T ss_pred             ceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC--------------
Confidence              9999999977999998875544699999999999999999999999999999999999998766              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN  323 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~  323 (411)
                                   .++|+|||.+.......  ....++..|+|||++.+..++.++|||||||++|+|++|.+||.+.+.
T Consensus       145 -------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~  211 (287)
T cd07838         145 -------------QVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE  211 (287)
T ss_pred             -------------CEEEeccCcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh
Confidence                         56777777665543221  223578899999999998999999999999999999999999998887


Q ss_pred             HHHHHHHHHHhCC-----------------------CChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          324 LEHLAMMERVLGP-----------------------LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       324 ~~~~~~i~~~~~~-----------------------~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      .+.+..+......                       .+.......+..+.+++.+|++.+    |.+||++.+++.|+||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d----p~~Rp~~~~il~~~~~  287 (287)
T cd07838         212 ADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFN----PHKRISAFEALQHPYF  287 (287)
T ss_pred             HHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccC----CccCCCHHHHhcCcCC
Confidence            7766665443211                       112222345677889999999888    9999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6e-41  Score=309.98  Aligned_cols=247  Identities=23%  Similarity=0.340  Sum_probs=200.0

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      ..++|++.++||+|+||.||+|.+. ++..||+|.++......+.+.+|+.++++++|+++     +++++++. .+..+
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i-----~~~~~~~~-~~~~~   76 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKL-----VQLYAVVS-EEPIY   76 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCce-----EEEEeEEC-CCCcE
Confidence            3468999999999999999999866 45669999998655556778899999999998877     99988875 45689


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      ++|||+ +++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||++++++                 
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~-----------------  139 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL-----------------  139 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc-----------------
Confidence            999999 89999999876545689999999999999999999999999999999999998766                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCh
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHEN  323 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~  323 (411)
                                .++|+|||.+.......    ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+.
T Consensus       140 ----------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~  209 (260)
T cd05070         140 ----------VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN  209 (260)
T ss_pred             ----------eEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence                      45666666665432221    11234567999999988889999999999999999999 9999988777


Q ss_pred             HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      .+....+....   +.......+..+.+++.+|+..+    |.+|||+.++.+.
T Consensus       210 ~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~----p~~Rpt~~~l~~~  256 (260)
T cd05070         210 REVLEQVERGY---RMPCPQDCPISLHELMLQCWKKD----PEERPTFEYLQSF  256 (260)
T ss_pred             HHHHHHHHcCC---CCCCCCcCCHHHHHHHHHHcccC----cccCcCHHHHHHH
Confidence            66666554321   11122355678999999999999    8888888888753

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-41  Score=313.26  Aligned_cols=253  Identities=20%  Similarity=0.337  Sum_probs=205.8

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      .|++.+.||+|+||.||+|.+..+++.||+|+++..  ......+.+|+.+++.+.+  ..|++++++++++..+...|+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~--~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQ--SQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhcc--CCCCCeeeEeeeeeeCCEEEE
Confidence            488899999999999999999999999999998643  2344567889999999974  234566999999999999999


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      ||||+ +++|.+++...   .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++                  
T Consensus        80 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~------------------  138 (277)
T cd06917          80 IMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG------------------  138 (277)
T ss_pred             EEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC------------------
Confidence            99999 89999998764   589999999999999999999999999999999999998766                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                               .++|+|||.+......   .....|+..|+|||.+.++ .++.++|+|||||++|+|++|..||.+.+...
T Consensus       139 ---------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~  209 (277)
T cd06917         139 ---------NVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR  209 (277)
T ss_pred             ---------CEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence                     5677777766544322   2234688899999998754 57899999999999999999999998765544


Q ss_pred             HHHHHHHHhCCCChhHHH-hhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          326 HLAMMERVLGPLPHHMVI-RADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~-~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      ....+...   .+..+.. ..+..+.+++.+|+..+    |.+||++.++++|+|+++..
T Consensus       210 ~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~~----p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         210 AMMLIPKS---KPPRLEDNGYSKLLREFVAACLDEE----PKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             hhhccccC---CCCCCCcccCCHHHHHHHHHHcCCC----cccCcCHHHHhhChHhhccc
Confidence            33322221   1222222 25678899999998888    99999999999999998755

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=8.5e-41  Score=308.46  Aligned_cols=246  Identities=22%  Similarity=0.329  Sum_probs=199.7

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      ++|++.+.||+|+||+||+|.+.. +..||+|.++......+.+.+|+.+++++.|+++     +++++++...+..++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv   77 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKL-----VQLYGVCTKQRPIYIV   77 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCe-----eeEEEEEccCCCcEEE
Confidence            469999999999999999998754 3459999987655556678899999999988776     9999999988899999


Q ss_pred             EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      |||+ +++|.+++.... ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++                   
T Consensus        78 ~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~-------------------  137 (256)
T cd05113          78 TEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG-------------------  137 (256)
T ss_pred             EEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-------------------
Confidence            9999 899999998654 2689999999999999999999999999999999999998766                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE  325 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~  325 (411)
                              .+||+|||.+.......    ....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+
T Consensus       138 --------~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~  209 (256)
T cd05113         138 --------CVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE  209 (256)
T ss_pred             --------CEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence                    45666666554332211    11234567999999998889999999999999999999 999998877666


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ....+........   ....+..+.+++.+|+..+    |.+||++.+++++.
T Consensus       210 ~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~----p~~Rp~~~~ll~~~  255 (256)
T cd05113         210 TVEKVSQGLRLYR---PHLASEKVYAIMYSCWHEK----AEERPTFQQLLSSI  255 (256)
T ss_pred             HHHHHhcCCCCCC---CCCCCHHHHHHHHHHcCCC----cccCCCHHHHHHhh
Confidence            6555544332221   1234677889999998888    99999999998753

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.6e-41  Score=322.35  Aligned_cols=263  Identities=16%  Similarity=0.173  Sum_probs=199.6

Q ss_pred             eeeccc--cceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEE
Q 015222           98 SKMGEG--TFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF  172 (411)
Q Consensus        98 ~~lG~G--~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~  172 (411)
                      ..||+|  +||+||+|.+..+++.||+|++....   ...+.+.+|+.+++.++|+||     ++++++|..++..++||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~ni-----v~~~~~~~~~~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNI-----MTSWTVFTTGSWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCc-----ceEeeeEecCCceEEEE
Confidence            456666  99999999999999999999987432   234667889999888888877     99999999999999999


Q ss_pred             ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCcc
Q 015222          173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF  251 (411)
Q Consensus       173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~  251 (411)
                      ||+ +++|.+++.+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+++.||+........+   
T Consensus        79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~---  155 (328)
T cd08226          79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG---  155 (328)
T ss_pred             ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccC---
Confidence            999 8899999987654569999999999999999999999999999999999999988877666665322111100   


Q ss_pred             ccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCC--CCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015222          252 KNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM  329 (411)
Q Consensus       252 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~  329 (411)
                                    +.............++..|+|||++.+.  .++.++|||||||++|+|++|..||.+....+....
T Consensus       156 --------------~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~  221 (328)
T cd08226         156 --------------QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQ  221 (328)
T ss_pred             --------------ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHH
Confidence                          0000000011112356679999999774  578999999999999999999999987655443322


Q ss_pred             HHHHhCCC-------------------------------------------ChhHHHhhhhhhhhhhccCCccCCCCCCC
Q 015222          330 MERVLGPL-------------------------------------------PHHMVIRADRRAEKYFRRGARLDWPDGAT  366 (411)
Q Consensus       330 i~~~~~~~-------------------------------------------p~~~~~~~~~~~~~li~~~l~~~~~~rp~  366 (411)
                      ........                                           ........+..+.+++.+||..+    |.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d----P~  297 (328)
T cd08226         222 KLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQD----PE  297 (328)
T ss_pred             HhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCC----cc
Confidence            22111000                                           01112235567889999999999    99


Q ss_pred             cHHHHHHHHhcCCCCccccc
Q 015222          367 SRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       367 ~R~t~~~il~~~~~~~~~~~  386 (411)
                      +|||+.++++|+||.++...
T Consensus       298 ~Rpta~e~l~~~~~~~~~~~  317 (328)
T cd08226         298 KRPSASSLLSHAFFKQVKEQ  317 (328)
T ss_pred             cCCCHHHHhhCHHHHHHHHh
Confidence            99999999999999876653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=9.3e-42  Score=318.42  Aligned_cols=251  Identities=25%  Similarity=0.398  Sum_probs=206.2

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      +.|++.+.||+|+||.||+|.+..+++.||+|++...  ....+.+.+|+.+++++.|+++     +++++.+..++..|
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~   78 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI-----TRYYGSYLKGTKLW   78 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCcc-----HhhhcccccCCceE
Confidence            4578889999999999999999999999999998743  2344567889999999988877     99999999999999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +||||+ +++|.+++...   .+++..+..++.||+.||.|||++|++|+||+|+||+++.++                 
T Consensus        79 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~-----------------  138 (277)
T cd06642          79 IIMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG-----------------  138 (277)
T ss_pred             EEEEccCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCC-----------------
Confidence            999999 89999988653   589999999999999999999999999999999999998766                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                                .++|+|||++.......   ....|+..|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       139 ----------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~  208 (277)
T cd06642         139 ----------DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR  208 (277)
T ss_pred             ----------CEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh
Confidence                      46677777665433221   22467889999999999889999999999999999999999998665544


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      ....+...   .+.......+..+.+++.+|+..+    |+.||++.++++|+|+....
T Consensus       209 ~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~----p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         209 VLFLIPKN---SPPTLEGQYSKPFKEFVEACLNKD----PRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             HHhhhhcC---CCCCCCcccCHHHHHHHHHHccCC----cccCcCHHHHHHhHHHHHHh
Confidence            44333221   122223345677889999998888    99999999999999987644

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=9e-41  Score=307.23  Aligned_cols=240  Identities=21%  Similarity=0.309  Sum_probs=193.7

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL  175 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~  175 (411)
                      +.||+|+||.||+|+++.+++.||+|.+...  ......+.+|+++++++.|+++     +++++++...+..++||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI-----VRLIGVCTQKQPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEcCCCCeEEEEeec
Confidence            4689999999999999999999999988643  2345678899999999988877     99999999999999999999


Q ss_pred             -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccC
Q 015222          176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL  254 (411)
Q Consensus       176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~  254 (411)
                       +++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.                      
T Consensus        76 ~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~----------------------  132 (252)
T cd05084          76 QGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV----------------------  132 (252)
T ss_pred             cCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc----------------------
Confidence             899999997654 35899999999999999999999999999999999999987764                      


Q ss_pred             CCCCCeeEeecCCcccccCCCc-----ccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 015222          255 PKSSAIKLIDFGSTTFEHQDHS-----YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLA  328 (411)
Q Consensus       255 ~~~~~~kl~Dfg~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~  328 (411)
                           ++|+|||.+........     ...++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+...
T Consensus       133 -----~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~  207 (252)
T cd05084         133 -----LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE  207 (252)
T ss_pred             -----EEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH
Confidence                 55555555543221110     1122456999999998899999999999999999998 999998766655544


Q ss_pred             HHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       329 ~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      .+....   +.......+..+.+++.+|+..+    |++||++.++++.
T Consensus       208 ~~~~~~---~~~~~~~~~~~~~~li~~~l~~~----p~~Rps~~~~~~~  249 (252)
T cd05084         208 AIEQGV---RLPCPELCPDAVYRLMERCWEYD----PGQRPSFSTVHQE  249 (252)
T ss_pred             HHHcCC---CCCCcccCCHHHHHHHHHHcCCC----hhhCcCHHHHHHH
Confidence            444321   11223345678899999999999    9999999999864

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-40  Score=309.66  Aligned_cols=251  Identities=29%  Similarity=0.517  Sum_probs=204.7

Q ss_pred             eEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchh--hhHHHHHHHHHHHHHh-cCCCCCcceEEEeeeeecCCeEEE
Q 015222           94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        94 y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      |++.+.||+|++|+||+|.+..+++.||||.+.....  ......+|+..++++. |+++     +++++++.+++..++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i-----~~~~~~~~~~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI-----VKLKEVFRENDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCc-----hhHHHHhhcCCcEEE
Confidence            6789999999999999999999999999999865322  2233456888888887 7766     999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       171 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      ||||++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++.++                   
T Consensus        76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~-------------------  136 (283)
T cd07830          76 VFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE-------------------  136 (283)
T ss_pred             EEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-------------------
Confidence            9999988999998876545789999999999999999999999999999999999998766                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHL  327 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~  327 (411)
                              .++|+|||.+.......  ....++..|+|||++.+. .++.++||||||+++|+|++|+.||...+..+.+
T Consensus       137 --------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~  208 (283)
T cd07830         137 --------VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQL  208 (283)
T ss_pred             --------CEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHH
Confidence                    66777777776543321  234678899999988654 6799999999999999999999999887776666


Q ss_pred             HHHHHHhCCCChhH--------------------------HHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          328 AMMERVLGPLPHHM--------------------------VIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       328 ~~i~~~~~~~p~~~--------------------------~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      ..+....+......                          ....+..+.+++++|+..+    |.+||++++++.|+||
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~----p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         209 YKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWD----PKKRPTASQALQHPYF  283 (283)
T ss_pred             HHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccC----cccCCCHHHHhhCCCC
Confidence            65554443322211                          1122466889999998888    9999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.1e-40  Score=307.48  Aligned_cols=244  Identities=21%  Similarity=0.312  Sum_probs=199.7

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeee-ecCCeEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF-DYRNHICI  170 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~-~~~~~~~l  170 (411)
                      ++|++.+.||+|+||.||++...  +..||+|.++... ..+.+.+|+.+++++.|+++     +++++++ ..++..++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~~l   77 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNL-----VQLLGVIVEEKGGLYI   77 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCe-----eeEEEEEEcCCCceEE
Confidence            47999999999999999999754  7779999986543 34568889999999988877     9999865 45568999


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      ||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+||+++.++                  
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~------------------  139 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN------------------  139 (256)
T ss_pred             EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCC------------------
Confidence            99999 88999999876645689999999999999999999999999999999999998776                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLA  328 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~  328 (411)
                               .++|+|||++...........++..|+|||++.+..++.++|||||||++|+|++ |+.||...+..+...
T Consensus       140 ---------~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~  210 (256)
T cd05082         140 ---------VAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP  210 (256)
T ss_pred             ---------cEEecCCccceeccccCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence                     5677777776654433333445678999999998889999999999999999998 999998776666555


Q ss_pred             HHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       329 ~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      .+.+..   +.......+..+.+++.+|+..+    |.+||++.++++.
T Consensus       211 ~~~~~~---~~~~~~~~~~~~~~li~~~l~~~----p~~Rpt~~~l~~~  252 (256)
T cd05082         211 RVEKGY---KMDAPDGCPPVVYDVMKQCWHLD----AATRPSFLQLREQ  252 (256)
T ss_pred             HHhcCC---CCCCCCCCCHHHHHHHHHHhcCC----hhhCcCHHHHHHH
Confidence            554322   22223456778899999999888    9999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.1e-40  Score=307.67  Aligned_cols=248  Identities=25%  Similarity=0.361  Sum_probs=196.9

Q ss_pred             EEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEcc
Q 015222           96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK  174 (411)
Q Consensus        96 i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~  174 (411)
                      ....||+|+||.||+|.+..++..||+|.+.... ...+.+.+|+.+++.++|+|+     +++++++..++..++||||
T Consensus        12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~~lv~e~   86 (268)
T cd06624          12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNI-----VQYLGSDSENGFFKIFMEQ   86 (268)
T ss_pred             ceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCe-----eeeeeeeccCCEEEEEEec
Confidence            3468999999999999999999999999886543 345678899999999988877     9999999999999999999


Q ss_pred             C-CCCHHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCcc
Q 015222          175 L-GPSLYDFLRKNSYRSF--PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF  251 (411)
Q Consensus       175 ~-~~~L~~~l~~~~~~~l--~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~  251 (411)
                      + +++|.+++.... ..+  ++..+..++.||+.||.|||++||+||||||+||+++.+                     
T Consensus        87 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~---------------------  144 (268)
T cd06624          87 VPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTY---------------------  144 (268)
T ss_pred             CCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC---------------------
Confidence            9 899999998653 234  788899999999999999999999999999999999652                     


Q ss_pred             ccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCC--CCCccchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 015222          252 KNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGEALFQTHENLEH  326 (411)
Q Consensus       252 ~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~  326 (411)
                           ...++|+|||.+......   .....|+..|+|||++.+.  .++.++||||||+++|+|++|..||........
T Consensus       145 -----~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~  219 (268)
T cd06624         145 -----SGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA  219 (268)
T ss_pred             -----CCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh
Confidence                 125788888877643221   1224578999999998765  378999999999999999999999976443221


Q ss_pred             HHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       327 ~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      ........ .....+....++.+.+++.+|+..+    |.+||++.+++.||||
T Consensus       220 ~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~----p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         220 AMFKVGMF-KIHPEIPESLSAEAKNFILRCFEPD----PDKRASAHDLLQDPFL  268 (268)
T ss_pred             hHhhhhhh-ccCCCCCcccCHHHHHHHHHHcCCC----chhCCCHHHHHhCCCC
Confidence            11111111 1111223345677899999998888    9999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.1e-40  Score=312.09  Aligned_cols=248  Identities=21%  Similarity=0.311  Sum_probs=199.1

Q ss_pred             CCeEEEeeeccccceEEEEEEeC----CCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDN----EKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~----~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      +.|++.+.||+|+||+||+|.+.    .++..||+|.+....  .....+.+|+.+++++.|+|+     +++++++..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNI-----VCLLGVVTQE   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCe-----eeEEEEEecC
Confidence            46899999999999999999853    456789999997432  233567889999999988877     9999999999


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNS---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS  229 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~  229 (411)
                      +..|+||||+ +++|.+++....               ...+++..+..++.|++.||+|||++||+||||||+|||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~  159 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE  159 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence            9999999999 899999986332               124788999999999999999999999999999999999987


Q ss_pred             CcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCCCccchhHHH
Q 015222          230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSV  304 (411)
Q Consensus       230 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  304 (411)
                      ++                           .++|+|||++......     .....++..|+|||++.+..++.++|||||
T Consensus       160 ~~---------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  212 (283)
T cd05090         160 QL---------------------------HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSF  212 (283)
T ss_pred             CC---------------------------cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHH
Confidence            66                           5677777766543221     122345678999999988889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          305 GCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       305 Gvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ||++|||++ |..||.+.+..+....+.... ..  ......+..+.+++.+|++.+    |++||++.+++++.
T Consensus       213 G~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~li~~cl~~~----p~~Rp~~~~i~~~l  280 (283)
T cd05090         213 GVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ-LL--PCSEDCPPRMYSLMTECWQEG----PSRRPRFKDIHTRL  280 (283)
T ss_pred             HHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-cC--CCCCCCCHHHHHHHHHHcccC----cccCcCHHHHHHHh
Confidence            999999998 999998876655555444322 11  122345678889999998888    99999999998765

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1e-40  Score=315.63  Aligned_cols=248  Identities=21%  Similarity=0.262  Sum_probs=196.6

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCc--EEEEEEeccc--hhhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeecCC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKE--LVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~--~vavK~~~~~--~~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      ++|++.+.||+|+||.||+|.++.++.  .+|+|.++..  ......+.+|+.++.++ .|+++     +++++++..++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~i-----v~~~~~~~~~~   81 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI-----INLLGACEHRG   81 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCc-----ceEEEEECCCC
Confidence            479999999999999999999887775  4577776542  23445678899999999 67776     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCc
Q 015222          167 HICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE  231 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~  231 (411)
                      .+++||||+ +++|.+++.+..              ...+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  161 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence            999999999 899999997543              12578999999999999999999999999999999999998766


Q ss_pred             ccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCc--ccccCCCccccceecCCCCCccchhHHHHHHHH
Q 015222          232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS--YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV  309 (411)
Q Consensus       232 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  309 (411)
                                                 .++|+|||++........  ...++..|+|||++.+..++.++|||||||++|
T Consensus       162 ---------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  214 (303)
T cd05088         162 ---------------------------VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW  214 (303)
T ss_pred             ---------------------------cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHH
Confidence                                       567777776653221111  123356799999998888999999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          310 ELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       310 ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ||+| |..||.+.+..+....+...   .........+..+.+++.+|++.+    |.+||++.+++++.
T Consensus       215 ellt~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~----p~~Rp~~~~il~~l  277 (303)
T cd05088         215 EIVSLGGTPYCGMTCAELYEKLPQG---YRLEKPLNCDDEVYDLMRQCWREK----PYERPSFAQILVSL  277 (303)
T ss_pred             HHHhcCCCCcccCChHHHHHHHhcC---CcCCCCCCCCHHHHHHHHHHcCCC----hhhCcCHHHHHHHH
Confidence            9998 99999877666555444322   111112235677899999999998    88888888888764

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.5e-40  Score=307.30  Aligned_cols=246  Identities=24%  Similarity=0.347  Sum_probs=199.7

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      .++|++.++||+|+||.||+|.+..++ .||+|.+.......+.+.+|+.+++++.|+++     +++++++. .+..++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~-~~~~~~   77 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKL-----VPLYAVVS-EEPIYI   77 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCccHHHHHHHHHHHHhCCCCCe-----eeEEEEEc-CCCcEE
Confidence            367999999999999999999886654 59999987655556778899999999988877     88888875 456899


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      ||||+ +++|.+++.......+++..+..++.||+.||.|||+.||+|+||||+||++++++                  
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~------------------  139 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL------------------  139 (260)
T ss_pred             EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC------------------
Confidence            99999 88999999876545689999999999999999999999999999999999998766                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL  324 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~  324 (411)
                               .++|+|||.+.......    ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....
T Consensus       140 ---------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  210 (260)
T cd05069         140 ---------VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR  210 (260)
T ss_pred             ---------eEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence                     56777777665432221    12245678999999988889999999999999999999 99999887776


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      +....+.... ..  ......+..+.+++.+|++.+    |.+||+++++++.
T Consensus       211 ~~~~~~~~~~-~~--~~~~~~~~~~~~li~~~l~~~----p~~Rp~~~~i~~~  256 (260)
T cd05069         211 EVLEQVERGY-RM--PCPQGCPESLHELMKLCWKKD----PDERPTFEYIQSF  256 (260)
T ss_pred             HHHHHHHcCC-CC--CCCcccCHHHHHHHHHHccCC----cccCcCHHHHHHH
Confidence            6655554321 11  122346778999999999888    8899999988764

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.2e-40  Score=302.34  Aligned_cols=248  Identities=26%  Similarity=0.438  Sum_probs=209.0

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchh-hhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      .|++.+.||+|++|.||++.+..+++.|++|++..... ....+.+|+.+++.+.|+++     +++++++...+..+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNI-----VKYYGSYLKKDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCE-----eEEEEEEecCCeEEEE
Confidence            48899999999999999999999999999999976543 56778899999999987776     9999999999999999


Q ss_pred             EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      +||+ +++|.+++.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++                   
T Consensus        76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~-------------------  135 (253)
T cd05122          76 MEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG-------------------  135 (253)
T ss_pred             EecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC-------------------
Confidence            9999 799999988763 3689999999999999999999999999999999999997765                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA  328 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~  328 (411)
                              .++|+|||.+.......  ....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+..+...
T Consensus       136 --------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~  207 (253)
T cd05122         136 --------EVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF  207 (253)
T ss_pred             --------eEEEeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH
Confidence                    67888888776654443  45578899999999998889999999999999999999999998775555544


Q ss_pred             HHHHHhCCCChh-HHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCC
Q 015222          329 MMERVLGPLPHH-MVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR  379 (411)
Q Consensus       329 ~i~~~~~~~p~~-~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~  379 (411)
                      .+...  ..+.. ....++..+.++|.+|+..+    |++||++.++++|+|
T Consensus       208 ~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~~----p~~R~t~~~~l~~~~  253 (253)
T cd05122         208 KIATN--GPPGLRNPEKWSDEFKDFLKKCLQKN----PEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHHhc--CCCCcCcccccCHHHHHHHHHHccCC----hhhCCCHHHHhcCCC
Confidence            44331  11111 11223677899999999888    999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=9e-41  Score=308.16  Aligned_cols=245  Identities=20%  Similarity=0.279  Sum_probs=200.3

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      .+|++.+.||+|+||.||+|.++ ++..+|+|++.........+.+|+.+++++.|+++     +++++++...+..|+|
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~lv   77 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNL-----VQLYGVCTKQRPIFIV   77 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCE-----EEEEEEEcCCCceEEE
Confidence            35889999999999999999876 45679999987655555678889999999988776     9999999999999999


Q ss_pred             EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      |||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||++++++                   
T Consensus        78 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~-------------------  137 (256)
T cd05059          78 TEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN-------------------  137 (256)
T ss_pred             EecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCC-------------------
Confidence            9999 999999998654 2689999999999999999999999999999999999998776                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCCCc----ccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQDHS----YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE  325 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~  325 (411)
                              .++|+|||.+........    ...++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+
T Consensus       138 --------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~  209 (256)
T cd05059         138 --------VVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE  209 (256)
T ss_pred             --------cEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH
Confidence                    466777776654322211    1123457999999998899999999999999999999 899998877766


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ....+.....   .......+..+.+++.+|+..+    |.+||++.++++.
T Consensus       210 ~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~----p~~Rpt~~~~l~~  254 (256)
T cd05059         210 VVESVSAGYR---LYRPKLAPTEVYTIMYSCWHEK----PEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHHHcCCc---CCCCCCCCHHHHHHHHHHhcCC----hhhCcCHHHHHHH
Confidence            6655543321   1122346778999999999888    9999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.6e-40  Score=311.54  Aligned_cols=260  Identities=25%  Similarity=0.368  Sum_probs=214.8

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      ...+.|++.+.||+|++|.||+|.+..++..||+|++.......+.+.+|+++++.++|+|+     +++++.+...+..
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~   90 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI-----VDYYDSYLVGDEL   90 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCe-----eEEEEEEEECCEE
Confidence            45567999999999999999999999889999999998655456678889999999988877     9999999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      ++|+||+ +++|.+++.... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++                
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~----------------  153 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG----------------  153 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCC----------------
Confidence            9999999 799999998764 3699999999999999999999999999999999999998776                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                                 .++|+|||.+......   .....++..|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus       154 -----------~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~  222 (286)
T cd06614         154 -----------SVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL  222 (286)
T ss_pred             -----------CEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH
Confidence                       4566666655433221   12345788999999999888999999999999999999999999877665


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                      .....+... ...+......++..+.++|.+|++.+    |..||++.++++|+||......
T Consensus       223 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~----p~~Rpt~~~il~~~~~~~~~~~  279 (286)
T cd06614         223 RALFLITTK-GIPPLKNPEKWSPEFKDFLNKCLVKD----PEKRPSAEELLQHPFLKKACPK  279 (286)
T ss_pred             HHHHHHHhc-CCCCCcchhhCCHHHHHHHHHHhccC----hhhCcCHHHHhhChHhhccCch
Confidence            544443322 11111222336778999999999998    9999999999999999985443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.8e-40  Score=309.79  Aligned_cols=249  Identities=18%  Similarity=0.243  Sum_probs=198.7

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCC-----CCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeee
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF  162 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~  162 (411)
                      ..++|++.+.||+|+||.||+|.++.     ++..||+|++....  .....+.+|+.+++.+.|+|+     +++++++
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----v~~~~~~   78 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV-----VRLLGVV   78 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCe-----eeEEEEE
Confidence            45789999999999999999998652     35679999986432  234567789999999888776     9999999


Q ss_pred             ecCCeEEEEEccC-CCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCccc
Q 015222          163 DYRNHICIVFEKL-GPSLYDFLRKNSY--------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV  233 (411)
Q Consensus       163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~  233 (411)
                      ..++..++||||+ +++|.+++.+...        ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++  
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~--  156 (277)
T cd05062          79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF--  156 (277)
T ss_pred             cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC--
Confidence            9999999999999 8999999975321        2357788999999999999999999999999999999998766  


Q ss_pred             ccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchhHHHHHHH
Q 015222          234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL  308 (411)
Q Consensus       234 ~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  308 (411)
                                               .++|+|||++.......     ....++..|+|||++.+..++.++|||||||++
T Consensus       157 -------------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l  211 (277)
T cd05062         157 -------------------------TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL  211 (277)
T ss_pred             -------------------------CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHH
Confidence                                     56667777665332211     112456789999999988999999999999999


Q ss_pred             HHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          309 VELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       309 ~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      |||++ |..||.+.+..+....+.......   .....+..+.+++.+|++.+    |.+||++.+++++
T Consensus       212 ~el~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~----p~~Rps~~e~l~~  274 (277)
T cd05062         212 WEIATLAEQPYQGMSNEQVLRFVMEGGLLD---KPDNCPDMLFELMRMCWQYN----PKMRPSFLEIISS  274 (277)
T ss_pred             HHHHcCCCCCCCCCCHHHHHHHHHcCCcCC---CCCCCCHHHHHHHHHHcCCC----hhhCcCHHHHHHH
Confidence            99999 799998877666555544322111   12345677899999999988    9999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.9e-41  Score=312.04  Aligned_cols=246  Identities=24%  Similarity=0.337  Sum_probs=203.3

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchh-hhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      .+|++.++||.|+||.||+|.+.. ++.||+|++..... ....+..|+.+++.++|+++     +++++++.+.+..++
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~l   79 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHL-----ISLFAVCSVGEPVYI   79 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcch-----hheeeeEecCCCeEE
Confidence            469999999999999999999888 88899999976543 45678889999999988877     999999999999999


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      ||||+ +++|.+++.......+++..+..++.||+.||+|||++||+|+||||+||+++.++                  
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~------------------  141 (261)
T cd05148          80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL------------------  141 (261)
T ss_pred             EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCc------------------
Confidence            99999 88999999876556789999999999999999999999999999999999998777                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE  325 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~  325 (411)
                               .++|+|||.+.......   ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+..+
T Consensus       142 ---------~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~  212 (261)
T cd05148         142 ---------VCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE  212 (261)
T ss_pred             ---------eEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence                     45666666554432211   12235678999999998899999999999999999998 899998877766


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      .+..+..... .  ......+..+.+++.+|+..+    |.+||++.++++.
T Consensus       213 ~~~~~~~~~~-~--~~~~~~~~~~~~~i~~~l~~~----p~~Rpt~~~l~~~  257 (261)
T cd05148         213 VYDQITAGYR-M--PCPAKCPQEIYKIMLECWAAE----PEDRPSFKALREE  257 (261)
T ss_pred             HHHHHHhCCc-C--CCCCCCCHHHHHHHHHHcCCC----chhCcCHHHHHHH
Confidence            6666553211 1  112355677889999999888    8899999988764

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-40  Score=305.18  Aligned_cols=246  Identities=21%  Similarity=0.297  Sum_probs=204.5

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      ++|++.+.||.|+||.||+|...  ++.||+|.++......+.+.+|+.+++.+.|+++     +++++++.+.+..++|
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~~v   78 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNL-----VQLLGVVLQGNPLYIV   78 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcce-----eeeEEEEcCCCCeEEE
Confidence            57999999999999999999764  7889999998665556778899999999988877     9999999988999999


Q ss_pred             EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      |||+ +++|.+++.......+++..+..++.|++.||.|||++||+|+||||+||+++.++                   
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~-------------------  139 (256)
T cd05039          79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL-------------------  139 (256)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCC-------------------
Confidence            9999 88999999876545699999999999999999999999999999999999998766                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAM  329 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~  329 (411)
                              .++|+|||.+...........++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....
T Consensus       140 --------~~~l~d~g~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~  211 (256)
T cd05039         140 --------VAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH  211 (256)
T ss_pred             --------CEEEcccccccccccccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence                    5677777777655433333344667999999988889999999999999999997 9999987766655544


Q ss_pred             HHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          330 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       330 i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      +....   ........+..+.+++.+|+..+    |++||++.++++..
T Consensus       212 ~~~~~---~~~~~~~~~~~~~~li~~~l~~~----p~~Rp~~~~l~~~l  253 (256)
T cd05039         212 VEKGY---RMEAPEGCPPEVYKVMKDCWELD----PAKRPTFKQLREQL  253 (256)
T ss_pred             HhcCC---CCCCccCCCHHHHHHHHHHhccC----hhhCcCHHHHHHHH
Confidence            44321   11222345778999999999998    99999999988653

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=6e-41  Score=314.66  Aligned_cols=254  Identities=22%  Similarity=0.343  Sum_probs=201.9

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHh-cCCCCCcceEEEeeeeecCCeEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      +|+..+.||+|+||.||++.+..+++.||+|.+....  .....+.+|+.++.++. |+++     +++++++...+..+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i-----v~~~~~~~~~~~~~   79 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYI-----VKFYGALFREGDCW   79 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCE-----eeeeeEEecCCcEE
Confidence            5677889999999999999999999999999987432  34556788999999886 6666     99999998889999


Q ss_pred             EEEccCCCCHHHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          170 IVFEKLGPSLYDFLR---KNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       170 lv~e~~~~~L~~~l~---~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      ++|||++++|.++..   ......+++..+..++.|++.||+|||+. ||+||||||+||+++.++              
T Consensus        80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~--------------  145 (288)
T cd06616          80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG--------------  145 (288)
T ss_pred             EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC--------------
Confidence            999999777766543   22234699999999999999999999975 999999999999997765              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCC---CCCccchhHHHHHHHHHHHhCCCCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSGEALFQT  320 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlGvil~elltg~~pf~~  320 (411)
                                   .++|+|||++......  .....|+..|+|||++.+.   .++.++|||||||++|+|++|+.||..
T Consensus       146 -------------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  212 (288)
T cd06616         146 -------------NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK  212 (288)
T ss_pred             -------------cEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence                         5778888877543222  2234688999999999876   689999999999999999999999976


Q ss_pred             CChHHHHHHHHHHhC----CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          321 HENLEHLAMMERVLG----PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       321 ~~~~~~~~~i~~~~~----~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      ...  ....+.+...    ..+.......+..+.+++.+|+..+    |++||+++++++|+||....
T Consensus       213 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~----p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         213 WNS--VFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKD----ESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             cch--HHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCC----hhhCcCHHHHhcChhhhchh
Confidence            542  2222332221    1222222346778999999999988    99999999999999998744

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3e-40  Score=306.29  Aligned_cols=247  Identities=22%  Similarity=0.300  Sum_probs=200.5

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCC---CcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~---~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      ++|++.+.||+|+||.||+|.++.+   ...||||+++..  ......+.+|+.++++++|+++     +++++++...+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~   78 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI-----IRLEGVVTKSR   78 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCc-----ceEeEEEecCC
Confidence            5799999999999999999998654   457999998643  2344567889999999988877     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      ..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||++||+|+||||+|||++.++              
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~--------------  143 (266)
T cd05033          79 PVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNL--------------  143 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC--------------
Confidence            999999999 899999998754 3689999999999999999999999999999999999998776              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQ  319 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~  319 (411)
                                   .++|+|||++.......     ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus       144 -------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~  210 (266)
T cd05033         144 -------------VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYW  210 (266)
T ss_pred             -------------CEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCC
Confidence                         45666666555442111     11234578999999998899999999999999999998 999998


Q ss_pred             CCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      .....+....+...... +  .....+..+.+++.+|++.+    |++||++.+++++.
T Consensus       211 ~~~~~~~~~~~~~~~~~-~--~~~~~~~~l~~li~~cl~~~----p~~Rp~~~ei~~~l  262 (266)
T cd05033         211 DMSNQDVIKAVEDGYRL-P--PPMDCPSALYQLMLDCWQKD----RNERPTFSQIVSTL  262 (266)
T ss_pred             CCCHHHHHHHHHcCCCC-C--CCCCCCHHHHHHHHHHcCCC----cccCcCHHHHHHHH
Confidence            77766665555443211 1  12345778899999998888    99999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-41  Score=319.75  Aligned_cols=252  Identities=25%  Similarity=0.374  Sum_probs=199.4

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEec---cchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~---~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      ..|+++++||+||.+.||++.... .+.||+|.+.   .+......+.+|+..|.+|+.+    .+||++++|-..++++
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~----~~IIqL~DYEv~d~~l  435 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGH----DKIIQLYDYEVTDGYL  435 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCC----ceEEEEeeeeccCceE
Confidence            469999999999999999997544 3456766654   3445667789999999999743    5669999999999999


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      |+|||+-..+|..+|++... .++.-.++.+..|++.|+.+.|..||||.||||.|+|+..                   
T Consensus       436 YmvmE~Gd~DL~kiL~k~~~-~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-------------------  495 (677)
T KOG0596|consen  436 YMVMECGDIDLNKILKKKKS-IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-------------------  495 (677)
T ss_pred             EEEeecccccHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-------------------
Confidence            99999999999999998762 3444589999999999999999999999999999999854                   


Q ss_pred             CccccCCCCCCeeEeecCCcccccCCCcc-----cccCCCccccceecCCC-----------CCccchhHHHHHHHHHHH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSY-----VVSTRHYRAPEVILGLG-----------WNYPCDLWSVGCILVELC  312 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~-----~~gt~~y~aPE~~~~~~-----------~~~~~DiwSlGvil~ell  312 (411)
                               +.+||+|||+|.....+.+.     -+||+.|||||.+....           .++++||||||||||+|+
T Consensus       496 ---------G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMv  566 (677)
T KOG0596|consen  496 ---------GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMV  566 (677)
T ss_pred             ---------eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHH
Confidence                     26899999999876655433     58999999999996432           568999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCC-hhHHHhhh-hhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcc
Q 015222          313 SGEALFQTHENLEHLAMMERVLGPLP-HHMVIRAD-RRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVI  383 (411)
Q Consensus       313 tg~~pf~~~~~~~~~~~i~~~~~~~p-~~~~~~~~-~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~  383 (411)
                      .|+.||....  ..+.++..+..+-. -++....+ .++.++++.||..|    |.+|+++.++|+|||+.-+
T Consensus       567 YgktPf~~~~--n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rd----PkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  567 YGKTPFGQII--NQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARD----PKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             hcCCchHHHH--HHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcC----cccCCCcHHHhcCcccccc
Confidence            9999997532  23333333322211 01111111 23889999999999    9999999999999999863

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.5e-40  Score=316.43  Aligned_cols=246  Identities=21%  Similarity=0.289  Sum_probs=195.1

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCc----EEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKE----LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~----~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .+|++.+.||+|+||.||+|++..+++    .||+|+++..  ....+.+.+|+.+++.+.|+|+     +++++++...
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----v~~~g~~~~~   81 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV-----CRLLGICLTS   81 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEcCC
Confidence            579999999999999999999876665    3899998643  2445678889999999988887     9999988764


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                       ..++|+||+ +|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++             
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~-------------  146 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQ-------------  146 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCC-------------
Confidence             577999999 999999998754 3588999999999999999999999999999999999997766             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCCCc-----ccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS-----YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALF  318 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf  318 (411)
                                    .+||+|||++........     ...++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus       147 --------------~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~  212 (316)
T cd05108         147 --------------HVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY  212 (316)
T ss_pred             --------------cEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence                          567777777665432211     1234667999999999899999999999999999998 99999


Q ss_pred             CCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      .+....+....+... ...+.  ....+..+.+++.+|+..+    |..||++.+++.+.
T Consensus       213 ~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~li~~cl~~~----p~~Rps~~~l~~~l  265 (316)
T cd05108         213 DGIPASEISSILEKG-ERLPQ--PPICTIDVYMIMVKCWMID----ADSRPKFRELIIEF  265 (316)
T ss_pred             CCCCHHHHHHHHhCC-CCCCC--CCCCCHHHHHHHHHHccCC----hhhCcCHHHHHHHH
Confidence            876665544333322 22221  1234567888899888877    88888998888763

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.5e-40  Score=310.31  Aligned_cols=250  Identities=24%  Similarity=0.380  Sum_probs=207.3

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      -|++.+.||+|+||.||+|.+..+++.||||++....  .....+.+|+.+++++.|+++     +++++.+..++..++
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~~l   79 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV-----TKYYGSYLKDTKLWI   79 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCE-----eEEEEEEEeCCeEEE
Confidence            4788999999999999999999999999999986432  334567889999999988776     999999999999999


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      ||||+ +++|.+++...   .+++..+..++.|++.||.|||+.|++|+||||+||+++.++                  
T Consensus        80 v~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~------------------  138 (277)
T cd06641          80 IMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG------------------  138 (277)
T ss_pred             EEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCC------------------
Confidence            99999 88999998754   589999999999999999999999999999999999997766                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH  326 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~  326 (411)
                               .++|+|||++......   .....|+..|+|||.+.+..++.++|+|||||++|+|++|..||........
T Consensus       139 ---------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  209 (277)
T cd06641         139 ---------EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV  209 (277)
T ss_pred             ---------CEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH
Confidence                     5677777766543322   1234678899999999888899999999999999999999999987665554


Q ss_pred             HHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       327 ~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      ...+...   .+.......+..+.+++.+|+..+    |.+||++.++++|+||.+..
T Consensus       210 ~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~~----p~~Rp~~~~~l~~~~~~~~~  260 (277)
T cd06641         210 LFLIPKN---NPPTLEGNYSKPLKEFVEACLNKE----PSFRPTAKELLKHKFIVRFA  260 (277)
T ss_pred             HHHHhcC---CCCCCCcccCHHHHHHHHHHccCC----hhhCcCHHHHHhCHHHhhhh
Confidence            4443322   122233345677899999998888    99999999999999999854

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=5.8e-40  Score=312.51  Aligned_cols=272  Identities=21%  Similarity=0.273  Sum_probs=214.9

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      ...|...+.||+|+||.||+|.+..++..||+|++....    .....+.+|+.+++.+.|+++     +++++++..++
T Consensus        24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~   98 (317)
T cd06635          24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNS-----IEYKGCYLREH   98 (317)
T ss_pred             hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCE-----EEEEEEEeeCC
Confidence            345889999999999999999999999999999986432    233467789999999988876     99999999999


Q ss_pred             eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          167 HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       167 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      ..++||||+.++|.+++.... ..+++..+..++.||+.||.|||++||+||||+|+||+++.++               
T Consensus        99 ~~~lv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~---------------  162 (317)
T cd06635          99 TAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG---------------  162 (317)
T ss_pred             eEEEEEeCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC---------------
Confidence            999999999778888876543 3689999999999999999999999999999999999997766               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceec---CCCCCccchhHHHHHHHHHHHhCCCCCCCCCh
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGEALFQTHEN  323 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltg~~pf~~~~~  323 (411)
                                  .++|+|||++..... .....|+..|+|||++.   +..++.++|||||||++|||++|..||...+.
T Consensus       163 ------------~~kl~dfg~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~  229 (317)
T cd06635         163 ------------QVKLADFGSASIASP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA  229 (317)
T ss_pred             ------------CEEEecCCCccccCC-cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH
Confidence                        567777777654332 23346888999999974   34688999999999999999999999987766


Q ss_pred             HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccCCCCCchhhHHHHHHH
Q 015222          324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSASPNCLCKFYAITHC  402 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (411)
                      ......+.....  +.......+..+++++.+|++.+    |.+||++.++++|+|+..........+...+.-.....
T Consensus       230 ~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~----p~~Rpt~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (317)
T cd06635         230 MSALYHIAQNES--PTLQSNEWSDYFRNFVDSCLQKI----PQDRPTSEELLKHMFVLRERPETVLIDLIQRTKDAVRE  302 (317)
T ss_pred             HHHHHHHHhccC--CCCCCccccHHHHHHHHHHccCC----cccCcCHHHHHhChhhhccCcccchhhHHHHHHHHHHH
Confidence            555555444322  11122345677899999998888    99999999999999997765544333333343333333

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.7e-40  Score=324.70  Aligned_cols=249  Identities=20%  Similarity=0.245  Sum_probs=195.7

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCC-----CcEEEEEEeccch--hhhHHHHHHHHHHHHHh-cCCCCCcceEEEeeee
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWF  162 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~-----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~~  162 (411)
                      .++|++.++||+|+||.||+|.+...     +..||||+++...  ...+.+.+|+.+++++. |+||     +++++++
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnI-----v~l~~~~  110 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNI-----VNLLGAC  110 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCe-----eeEEEEE
Confidence            35789999999999999999987433     3479999997432  33467889999999996 7766     9999999


Q ss_pred             ecCCeEEEEEccC-CCCHHHHHHhcC------------------------------------------------------
Q 015222          163 DYRNHICIVFEKL-GPSLYDFLRKNS------------------------------------------------------  187 (411)
Q Consensus       163 ~~~~~~~lv~e~~-~~~L~~~l~~~~------------------------------------------------------  187 (411)
                      ...+..|+||||| +|+|.+++.++.                                                      
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            9999999999999 999999986531                                                      


Q ss_pred             ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 015222          188 ----------------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL  227 (411)
Q Consensus       188 ----------------------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli  227 (411)
                                                              ...+++..+..++.||+.||+|||+.||+||||||+|||+
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill  270 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence                                                    1247788899999999999999999999999999999999


Q ss_pred             ecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchhH
Q 015222          228 VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLW  302 (411)
Q Consensus       228 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Diw  302 (411)
                      +.++                           .+||+|||++.......     ....++..|+|||++.+..++.++|||
T Consensus       271 ~~~~---------------------------~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw  323 (400)
T cd05105         271 AQGK---------------------------IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVW  323 (400)
T ss_pred             eCCC---------------------------EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHH
Confidence            8765                           56777777765432211     223567889999999988999999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          303 SVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       303 SlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ||||++|||++ |..||...................  ......+..+.+++.+|+..+    |++||++.++.+.
T Consensus       324 SlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~d----P~~RPt~~~l~~~  393 (400)
T cd05105         324 SYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM--AKPDHATQEVYDIMVKCWNSE----PEKRPSFLHLSDI  393 (400)
T ss_pred             HHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCC--CCCccCCHHHHHHHHHHCccC----HhHCcCHHHHHHH
Confidence            99999999997 999998754433332222211111  122346678899999998888    8899998888764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.6e-40  Score=310.53  Aligned_cols=247  Identities=19%  Similarity=0.277  Sum_probs=199.7

Q ss_pred             CCeEEEeeeccccceEEEEEEeC-----CCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .+|.+.+.||+|+||.||++.+.     .++..+|+|.+.... ...+.+.+|+.+++++.|+++     +++++++...
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~   79 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI-----VKFYGVCVEG   79 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEecC
Confidence            47999999999999999999853     345679999987533 345678899999999988887     9999999999


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNS-----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV  233 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~  233 (411)
                      +..++||||+ +++|.+++....           ...+++..+..++.||+.||+|||++|++||||||+|||+++++  
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~--  157 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL--  157 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC--
Confidence            9999999999 899999997543           12489999999999999999999999999999999999998776  


Q ss_pred             ccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchhHHHHHHH
Q 015222          234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL  308 (411)
Q Consensus       234 ~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  308 (411)
                                               .++|+|||.+.......     ....++..|+|||++.+..++.++|||||||++
T Consensus       158 -------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il  212 (288)
T cd05093         158 -------------------------LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVL  212 (288)
T ss_pred             -------------------------cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHH
Confidence                                     45666666655332211     123457789999999988999999999999999


Q ss_pred             HHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          309 VELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       309 ~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      |+|++ |..||.+.+..+....+.......   .....+..+.+++.+|++.+    |.+||++.++++.
T Consensus       213 ~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~li~~~l~~~----p~~Rpt~~~v~~~  275 (288)
T cd05093         213 WEIFTYGKQPWYQLSNNEVIECITQGRVLQ---RPRTCPKEVYDLMLGCWQRE----PHMRLNIKEIHSL  275 (288)
T ss_pred             HHHHhCCCCCCCCCCHHHHHHHHHcCCcCC---CCCCCCHHHHHHHHHHccCC----hhhCCCHHHHHHH
Confidence            99998 999998877766666555432211   12245677899999999988    8899999988654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=6.2e-40  Score=303.95  Aligned_cols=248  Identities=25%  Similarity=0.395  Sum_probs=199.8

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc----hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++..    ....+.+.+|+++++++.|+++     +++++.+...+.
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i-----~~~~~~~~~~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNV-----IKYLASFIENNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCe-----eeeeeeeecCCe
Confidence            5799999999999999999999999999999988632    2335678899999999988877     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          168 ICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      .++||||+ +++|.+++...  ....+++..+..++.||+.||.|||+.||+|+||||+||+++.++             
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~-------------  143 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG-------------  143 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCC-------------
Confidence            99999999 89999998753  234589999999999999999999999999999999999998766             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                                    .++|+|||.+......   .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus       144 --------------~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  209 (267)
T cd08224         144 --------------VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             --------------cEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence                          5667777766543222   12346788999999999888999999999999999999999999654


Q ss_pred             Ch--HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          322 EN--LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       322 ~~--~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ..  .+....+..  +..+.......+..+.++|.+|+..+    |+.||++.++++.
T Consensus       210 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~cl~~~----p~~Rp~~~~il~~  261 (267)
T cd08224         210 KMNLYSLCKKIEK--CDYPPLPADHYSEELRDLVSRCINPD----PEKRPDISYVLQV  261 (267)
T ss_pred             CccHHHHHhhhhc--CCCCCCChhhcCHHHHHHHHHHcCCC----cccCCCHHHHHHH
Confidence            32  122222222  12222222356678899999998888    9999999988764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1e-40  Score=320.18  Aligned_cols=249  Identities=20%  Similarity=0.274  Sum_probs=193.8

Q ss_pred             CCeEEEeeeccccceEEEEEEeCC-----CCcEEEEEEeccch--hhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeee
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~  163 (411)
                      ++|++.+.||+|+||.||+|.+..     +++.||+|+++...  ...+.+..|+.+++++ .|+|+     +++++++.
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~ni-----v~~~~~~~   81 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNV-----VNLLGACT   81 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcch-----hheeeeEe
Confidence            589999999999999999997543     45789999987432  2345677899999999 66766     99998775


Q ss_pred             c-CCeEEEEEccC-CCCHHHHHHhcCC-----------------------------------------------------
Q 015222          164 Y-RNHICIVFEKL-GPSLYDFLRKNSY-----------------------------------------------------  188 (411)
Q Consensus       164 ~-~~~~~lv~e~~-~~~L~~~l~~~~~-----------------------------------------------------  188 (411)
                      . +..++++|||+ +++|.+++.....                                                     
T Consensus        82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            4 46789999999 9999999864321                                                     


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeE
Q 015222          189 ------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL  262 (411)
Q Consensus       189 ------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl  262 (411)
                            ..+++..+..++.||+.||+|||++||+||||||+|||++.++                           .++|
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~---------------------------~vkL  214 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN---------------------------VVKI  214 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC---------------------------cEEE
Confidence                  2578999999999999999999999999999999999998766                           5677


Q ss_pred             eecCCcccccCC-----CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 015222          263 IDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGP  336 (411)
Q Consensus       263 ~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~  336 (411)
                      +|||++......     .....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+.........
T Consensus       215 ~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~  294 (337)
T cd05054         215 CDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR  294 (337)
T ss_pred             eccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC
Confidence            777776653221     122345678999999999999999999999999999998 99999875544433322221111


Q ss_pred             CChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          337 LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       337 ~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                        .......+..+.+++.+|++.+    |++||++.++++|.
T Consensus       295 --~~~~~~~~~~~~~l~~~cl~~~----p~~RPs~~ell~~l  330 (337)
T cd05054         295 --MRAPEYATPEIYSIMLDCWHNN----PEDRPTFSELVEIL  330 (337)
T ss_pred             --CCCCccCCHHHHHHHHHHccCC----hhhCcCHHHHHHHH
Confidence              1112245667889999998888    99999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.5e-40  Score=312.04  Aligned_cols=247  Identities=21%  Similarity=0.267  Sum_probs=196.8

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCc--EEEEEEeccc--hhhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeecCC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKE--LVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~--~vavK~~~~~--~~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      ++|++.+.||+|+||.||+|.++.++.  .+++|.++..  ....+.+.+|+.++.++ .|+++     +++++++...+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i-----v~~~~~~~~~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI-----INLLGACENRG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCch-----hheEEEEccCC
Confidence            479999999999999999999877764  4788888642  23445678899999999 56666     99999999889


Q ss_pred             eEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCc
Q 015222          167 HICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE  231 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~  231 (411)
                      ..++||||+ +++|.+++....              ...+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~  156 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL  156 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC
Confidence            999999999 899999997542              12488999999999999999999999999999999999997766


Q ss_pred             ccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcc--cccCCCccccceecCCCCCccchhHHHHHHHH
Q 015222          232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILV  309 (411)
Q Consensus       232 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  309 (411)
                                                 .+||+|||++.........  ...+..|+|||++.+..++.++|||||||++|
T Consensus       157 ---------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~  209 (297)
T cd05089         157 ---------------------------ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLW  209 (297)
T ss_pred             ---------------------------eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHH
Confidence                                       5667777766532211111  12345799999999889999999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          310 ELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       310 ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ||++ |..||.+.+..+....+.....   ......++..+.+++.+|++.+    |.+||++.++++.
T Consensus       210 el~t~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~----p~~Rp~~~~i~~~  271 (297)
T cd05089         210 EIVSLGGTPYCGMTCAELYEKLPQGYR---MEKPRNCDDEVYELMRQCWRDR----PYERPPFAQISVQ  271 (297)
T ss_pred             HHHcCCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCCHHHHHHHHHHcCCC----hhhCcCHHHHHHH
Confidence            9997 9999988777666555443221   1122346678899999998888    8889999998765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.4e-40  Score=308.53  Aligned_cols=248  Identities=25%  Similarity=0.381  Sum_probs=199.1

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc----hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++.+.||+|+||.||+|.+..+++.||||.+...    ......+.+|+.+++.+.|+|+     +++++++..++.
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV-----IKYYASFIEDNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCch-----hhhhheeEeCCe
Confidence            4689999999999999999999999999999988642    2334567889999999988877     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          168 ICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      .+++|||+ +++|.+++...  ....+++..++.++.||+.||.|||++|++|+||||+||+++.++             
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-------------  143 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-------------  143 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-------------
Confidence            99999999 88999988742  224689999999999999999999999999999999999998766             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                                    .++|+|||++.......   ....|+..|+|||.+.+..++.++||||||+++|+|++|..||.+.
T Consensus       144 --------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  209 (267)
T cd08229         144 --------------VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             --------------CEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence                          56677777655433221   2346888999999999888999999999999999999999999754


Q ss_pred             ChH--HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          322 ENL--EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       322 ~~~--~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ...  +....+...  ..+.......+..+.+++.+|+..+    |.+|||+.++++.
T Consensus       210 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~----p~~Rpt~~~i~~~  261 (267)
T cd08229         210 KMNLYSLCKKIEQC--DYPPLPSDHYSEELRQLVNMCINPD----PEKRPDITYVYDV  261 (267)
T ss_pred             cchHHHHhhhhhcC--CCCCCCcccccHHHHHHHHHhcCCC----cccCCCHHHHHHH
Confidence            332  222222221  2222222346678999999998888    9999999987753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-40  Score=304.34  Aligned_cols=248  Identities=25%  Similarity=0.398  Sum_probs=200.8

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc------hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .+|++.+.||+|+||.||+|++..+++.||+|++...      ......+.+|+.++++++|+++     +++++++.+.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i-----~~~~~~~~~~   76 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI-----VQYYGCLRDP   76 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCc-----ceEEEEEEcC
Confidence            4699999999999999999999999999999987532      2234567889999999998887     9999988653


Q ss_pred             --CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccc
Q 015222          166 --NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       166 --~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                        +.++++|||+ +++|.+++....  .+++..+..++.||+.||.|||++|++|+||||+||+++.++.          
T Consensus        77 ~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~----------  144 (264)
T cd06653          77 EEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN----------  144 (264)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC----------
Confidence              5789999999 899999998765  5899999999999999999999999999999999999987764          


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCcccccC------CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCC
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ------DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA  316 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~  316 (411)
                                       ++|+|||++.....      ......|+..|+|||.+.+..++.++|||||||++|+|++|+.
T Consensus       145 -----------------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~  207 (264)
T cd06653         145 -----------------VKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKP  207 (264)
T ss_pred             -----------------EEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence                             55555555543211      1123468889999999998889999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      ||...........+.  ..+.+..+....++.+.+++.+|+. +    +..||++.+++.|||.
T Consensus       208 p~~~~~~~~~~~~~~--~~~~~~~~p~~~~~~~~~~i~~~l~-~----~~~r~~~~~~~~~~~~  264 (264)
T cd06653         208 PWAEYEAMAAIFKIA--TQPTKPMLPDGVSDACRDFLKQIFV-E----EKRRPTAEFLLRHPFV  264 (264)
T ss_pred             CCCccCHHHHHHHHH--cCCCCCCCCcccCHHHHHHHHHHhc-C----cccCccHHHHhcCCCC
Confidence            998765544433322  2222333445567889999999977 3    7899999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5.3e-40  Score=312.19  Aligned_cols=253  Identities=21%  Similarity=0.285  Sum_probs=208.1

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      +.|...++||+|+||+||+|.+..+++.||+|++....    .....+.+|+.+++.++|+++     +++++++.+.+.
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~   95 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNT-----IEYKGCYLKEHT   95 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCC-----ccEEEEEEeCCE
Confidence            45788889999999999999999999999999986422    233457789999999988877     999999999999


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          168 ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       168 ~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      .|+||||+.++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++                
T Consensus        96 ~~lv~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~----------------  158 (313)
T cd06633          96 AWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG----------------  158 (313)
T ss_pred             EEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC----------------
Confidence            99999999888988887644 3689999999999999999999999999999999999997766                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceec---CCCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                                 .++|+|||++..... .....|+..|+|||++.   +..++.++|||||||++|+|++|..||...+..
T Consensus       159 -----------~~kL~dfg~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~  226 (313)
T cd06633         159 -----------QVKLADFGSASKSSP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM  226 (313)
T ss_pred             -----------CEEEeecCCCcccCC-CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH
Confidence                       567777777654322 23457889999999985   346889999999999999999999999877665


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      .....+...  ..+......++..+++++.+|++.+    |.+||++.+++.|+||....
T Consensus       227 ~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~----P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         227 SALYHIAQN--DSPTLQSNEWTDSFRGFVDYCLQKI----PQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             HHHHHHHhc--CCCCCCccccCHHHHHHHHHHccCC----hhhCcCHHHHhcCcccCCCc
Confidence            555544332  2232233345667899999999999    99999999999999999744

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-40  Score=308.93  Aligned_cols=247  Identities=20%  Similarity=0.295  Sum_probs=200.1

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCC-----CcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~-----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~  163 (411)
                      .++|++.+.||+|+||.||+|.++..     +..||+|.+....  .....+.+|+.+++.+.|+++     +++++++.
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~   79 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV-----VRLLGVVS   79 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCce-----eEEEEEEc
Confidence            46899999999999999999988654     3789999986443  334567789999999988877     99999999


Q ss_pred             cCCeEEEEEccC-CCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccc
Q 015222          164 YRNHICIVFEKL-GPSLYDFLRKNS--------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK  234 (411)
Q Consensus       164 ~~~~~~lv~e~~-~~~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~  234 (411)
                      .....++||||+ +++|.+++....        ...+++..+..++.||+.||.|||+.||+||||||+|||++.++   
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~---  156 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL---  156 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCC---
Confidence            999999999999 899999997532        12468889999999999999999999999999999999998776   


Q ss_pred             cCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCCCccchhHHHHHHHH
Q 015222          235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV  309 (411)
Q Consensus       235 l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  309 (411)
                                              .++|+|||++......     .....++..|+|||.+.+..++.++|||||||++|
T Consensus       157 ------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  212 (277)
T cd05032         157 ------------------------TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLW  212 (277)
T ss_pred             ------------------------CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHH
Confidence                                    4566666665533221     12235678899999998888999999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHHh-CCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          310 ELCS-GEALFQTHENLEHLAMMERVL-GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       310 ellt-g~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ||++ |..||.+.+..+....+.... ...|    ...+..+.+++.+|+..+    |++|||+.++++.
T Consensus       213 el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~----p~~Rpt~~~l~~~  274 (277)
T cd05032         213 EMATLAEQPYQGLSNEEVLKFVIDGGHLDLP----ENCPDKLLELMRMCWQYN----PKMRPTFLEIVSS  274 (277)
T ss_pred             HhhccCCCCCccCCHHHHHHHHhcCCCCCCC----CCCCHHHHHHHHHHcCCC----hhhCCCHHHHHHH
Confidence            9998 999998877766665555221 1222    234678899999998888    9999999999864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-40  Score=304.80  Aligned_cols=245  Identities=24%  Similarity=0.334  Sum_probs=203.1

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      .++|++.++||+|+||.||+|.+. +++.||||.+.......+.+.+|+.+++++.|+++     +++++++......++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~~   78 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKL-----VQLYAVCSEEEPIYI   78 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCE-----eeeeeeeecCCceEE
Confidence            468999999999999999999976 45779999998766666778999999999988776     999999998899999


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      ||||+ +++|.+++.......+++..+..++.||+.||.|||++|++|+||||+||++++++                  
T Consensus        79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~------------------  140 (261)
T cd05034          79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL------------------  140 (261)
T ss_pred             EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC------------------
Confidence            99999 89999999876555799999999999999999999999999999999999998776                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL  324 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~  324 (411)
                               .++|+|||.+.......    ....++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+.+..
T Consensus       141 ---------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  211 (261)
T cd05034         141 ---------VCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR  211 (261)
T ss_pred             ---------CEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence                     56667777665433211    11234568999999998889999999999999999998 99999887776


Q ss_pred             HHHHHHHHHhC-CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHh
Q 015222          325 EHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK  376 (411)
Q Consensus       325 ~~~~~i~~~~~-~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~  376 (411)
                      ..+..+..... ..+    ...+..+.+++.+|+..+    |.+||+++++.+
T Consensus       212 ~~~~~~~~~~~~~~~----~~~~~~~~~~i~~~l~~~----p~~Rp~~~~l~~  256 (261)
T cd05034         212 EVLEQVERGYRMPRP----PNCPEELYDLMLQCWDKD----PEERPTFEYLQS  256 (261)
T ss_pred             HHHHHHHcCCCCCCC----CCCCHHHHHHHHHHcccC----cccCCCHHHHHH
Confidence            66666554321 122    234677899999999988    888889988875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.4e-40  Score=309.93  Aligned_cols=257  Identities=23%  Similarity=0.348  Sum_probs=201.7

Q ss_pred             CeEEEeeeccccceEEEEEEeC---CCCcEEEEEEeccch-----hhhHHHHHHHHHHHHHh-cCCCCCcceEEEeeeee
Q 015222           93 RYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~---~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~~~  163 (411)
                      .|++.+.||.|+||.||+|.+.   .+|+.||+|+++...     ...+.+.+|+.+++++. |+++     +.+++.+.
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i-----~~~~~~~~   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL-----VTLHYAFQ   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCCh-----hceeeEee
Confidence            4899999999999999999875   478999999987432     23456778999999995 5555     99999999


Q ss_pred             cCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccc
Q 015222          164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                      .++..|+||||+ +++|.+++....  .+++..+..++.||+.||.|||+.|++||||||+|||++.++           
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-----------  142 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG-----------  142 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC-----------
Confidence            999999999999 899999998765  689999999999999999999999999999999999997766           


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCcccccCC----CcccccCCCccccceecCC--CCCccchhHHHHHHHHHHHhCCC
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGEA  316 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~  316 (411)
                                      .++|+|||++......    .....|+..|+|||.+.+.  .++.++||||||+++|+|++|..
T Consensus       143 ----------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~  206 (290)
T cd05613         143 ----------------HVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGAS  206 (290)
T ss_pred             ----------------CEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCC
Confidence                            5677777766543221    1234688999999998763  47889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH-----HHHHHHhcCCCCcccccC
Q 015222          317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-----SMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~-----t~~~il~~~~~~~~~~~~  387 (411)
                      ||...........+...............+..+.+++.+|+..+    |..|+     ++.++++|+||..+.+..
T Consensus       207 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~----p~~R~~~~~~~~~~l~~~~~~~~~~~~~  278 (290)
T cd05613         207 PFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKD----PKKRLGCGPSDADEIKKHPFFQKINWDD  278 (290)
T ss_pred             CCCcCCccccHHHHHHHhhccCCCCCccCCHHHHHHHHHHhcCC----HHHhcCCCCCCHHHHHcCcccccCCHHH
Confidence            99754322222222211111111122345677889999999888    77775     899999999999987543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4.6e-40  Score=302.55  Aligned_cols=248  Identities=29%  Similarity=0.438  Sum_probs=206.7

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC--Ce
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--NH  167 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~--~~  167 (411)
                      +|++.+.||+|++|.||+|.+..+++.|++|++....   ...+.+.+|+.+++++.|+++     +++++.+...  +.
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~   75 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNI-----VRYYGSERDEEKNT   75 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCE-----eeEEEEEecCCCCe
Confidence            4889999999999999999999999999999997544   446778899999999988776     9999999888  89


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      .++|||++ +++|.+++....  .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++               
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~---------------  138 (260)
T cd06606          76 LNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG---------------  138 (260)
T ss_pred             EEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC---------------
Confidence            99999999 999999998765  799999999999999999999999999999999999998766               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                                  .++|+|||.+......     .....++..|+|||.+.+...+.++||||||+++|+|++|..||...
T Consensus       139 ------------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (260)
T cd06606         139 ------------VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL  206 (260)
T ss_pred             ------------CEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence                        5666677666554333     23356888999999999888999999999999999999999999876


Q ss_pred             Ch-HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          322 EN-LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       322 ~~-~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      +. ......+..  ......+....+..+.+++.+|+..+    |.+||++.++++|+||
T Consensus       207 ~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~i~~~l~~~----p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         207 GNPMAALYKIGS--SGEPPEIPEHLSEEAKDFLRKCLRRD----PKKRPTADELLQHPFL  260 (260)
T ss_pred             CchHHHHHhccc--cCCCcCCCcccCHHHHHHHHHhCcCC----hhhCCCHHHHhhCCCC
Confidence            52 222222221  11222233445788999999999888    9999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2e-40  Score=314.37  Aligned_cols=273  Identities=22%  Similarity=0.267  Sum_probs=219.0

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc----hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      ...|++.+.||+|+||.||+|+++.+++.||+|.+...    ......+.+|+.+++.+.|+++     +++++++...+
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~   88 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT-----IQYRGCYLREH   88 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCc-----ccEEEEEEcCC
Confidence            35688899999999999999999999999999998632    2233457789999999988877     99999999999


Q ss_pred             eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          167 HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       167 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      ..++||||+.++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++               
T Consensus        89 ~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~---------------  152 (308)
T cd06634          89 TAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG---------------  152 (308)
T ss_pred             eeEEEEEccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC---------------
Confidence            999999999778888876543 3589999999999999999999999999999999999997766               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceec---CCCCCccchhHHHHHHHHHHHhCCCCCCCCCh
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGEALFQTHEN  323 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltg~~pf~~~~~  323 (411)
                                  .++|+|||++..... .....|+..|+|||.+.   ...++.++|||||||++|+|++|..||...+.
T Consensus       153 ------------~~kl~dfg~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~  219 (308)
T cd06634         153 ------------LVKLGDFGSASIMAP-ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA  219 (308)
T ss_pred             ------------cEEECCcccceeecC-cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH
Confidence                        567777776654332 22346888999999975   34678999999999999999999999977665


Q ss_pred             HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccCCCCCchhhHHHHHHHH
Q 015222          324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSASPNCLCKFYAITHCL  403 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (411)
                      .+....+...  ..+.......+..+.++|.+|+..+    |.+||++.++++|+|+.........+...+.++.....+
T Consensus       220 ~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~~----P~~Rp~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (308)
T cd06634         220 MSALYHIAQN--ESPALQSGHWSEYFRNFVDSCLQKI----PQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVREL  293 (308)
T ss_pred             HHHHHHHhhc--CCCCcCcccccHHHHHHHHHHhhCC----cccCCCHHHHhhCccccccCChhHHHHHHHHHHHHHHHH
Confidence            5544443332  2222223356677899999998888    999999999999999999877777777777666544443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-41  Score=321.59  Aligned_cols=259  Identities=24%  Similarity=0.315  Sum_probs=197.9

Q ss_pred             EEeeCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhh-hHHHHHHHHHHHHHhcCCCCCcceEEEeee
Q 015222           83 VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY-REAAMIEIDVLQRLARHDIGGTRCVQIRNW  161 (411)
Q Consensus        83 ~~~~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~  161 (411)
                      .+..-...++.|.-...||+|+||.||+|....+ ..||||.+...... ..+|.+|+.++.+++|+|+     |++++|
T Consensus        66 s~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nl-----v~LlGy  139 (361)
T KOG1187|consen   66 SYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNL-----VKLLGY  139 (361)
T ss_pred             eHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCc-----ccEEEE
Confidence            3333344567888889999999999999987654 88999988765544 5669999999999999888     999999


Q ss_pred             eecCC-eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCcEEEecCcccccC
Q 015222          162 FDYRN-HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR---LIHTDLKPENILLVSAEYVKVP  236 (411)
Q Consensus       162 ~~~~~-~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dikp~NIli~~~~~~~l~  236 (411)
                      |.+.+ +.+||+||+ +|+|.++|.......++|....+|+.++++||+|||+..   |||||||++|||+|.+      
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~------  213 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED------  213 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC------
Confidence            99888 599999999 999999998765337899999999999999999999853   9999999999998654      


Q ss_pred             CcccccccCCCCCccccCCCCCCeeEeecCCcccccC-CCcc--c-ccCCCccccceecCCCCCccchhHHHHHHHHHHH
Q 015222          237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-DHSY--V-VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC  312 (411)
Q Consensus       237 df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~--~-~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell  312 (411)
                                           .++||+|||+|..... ....  . .||..|+|||.+..+..+.++|||||||+|.||+
T Consensus       214 ---------------------~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllEli  272 (361)
T KOG1187|consen  214 ---------------------FNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELI  272 (361)
T ss_pred             ---------------------CCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHH
Confidence                                 4788888888876554 3222  2 7999999999999989999999999999999999


Q ss_pred             hCCCCCCCCC---hHHHHHH----HHH--HhCCCChhHH-Hh-----hhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          313 SGEALFQTHE---NLEHLAM----MER--VLGPLPHHMV-IR-----ADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       313 tg~~pf~~~~---~~~~~~~----i~~--~~~~~p~~~~-~~-----~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ||+.+.....   .......    +.+  ...-+.+.+. ..     .-..+..+-.+|++.+    |..||++.++.+.
T Consensus       273 tgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~----~~~RP~m~~Vv~~  348 (361)
T KOG1187|consen  273 TGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPD----PKERPTMSQVVKE  348 (361)
T ss_pred             hCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcC----CCcCcCHHHHHHH
Confidence            9998887432   1111111    111  0001111111 11     1122445556777777    7888888887665


Q ss_pred             C
Q 015222          378 L  378 (411)
Q Consensus       378 ~  378 (411)
                      +
T Consensus       349 L  349 (361)
T KOG1187|consen  349 L  349 (361)
T ss_pred             H
Confidence            5

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.6e-40  Score=311.51  Aligned_cols=251  Identities=21%  Similarity=0.341  Sum_probs=200.7

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCC----------------cEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCc
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKK----------------ELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGT  153 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~----------------~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~  153 (411)
                      ++|++.++||+|+||.||+|.+..++                ..||+|++....  ...+.+.+|+.+++++.|+++   
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i---   81 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNI---   81 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCE---
Confidence            57999999999999999999876544                568999987532  345678889999999988877   


Q ss_pred             ceEEEeeeeecCCeEEEEEccC-CCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 015222          154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNS---------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPE  223 (411)
Q Consensus       154 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~  223 (411)
                        +++++++..++..+++||++ +++|.+++....         ...+++..++.++.|++.||.|||++||+|+||||+
T Consensus        82 --~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~  159 (296)
T cd05051          82 --ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR  159 (296)
T ss_pred             --eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence              99999999999999999999 899999997643         125899999999999999999999999999999999


Q ss_pred             cEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCCCcc
Q 015222          224 NILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYP  298 (411)
Q Consensus       224 NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~  298 (411)
                      ||+++.++                           .++|+|||.+......     .....++..|+|||.+.+..++.+
T Consensus       160 Nili~~~~---------------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  212 (296)
T cd05051         160 NCLVGKNY---------------------------TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK  212 (296)
T ss_pred             ceeecCCC---------------------------ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCcc
Confidence            99998776                           5566666665533211     122345778999999998889999


Q ss_pred             chhHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHh----CCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHH
Q 015222          299 CDLWSVGCILVELCS--GEALFQTHENLEHLAMMERVL----GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMR  372 (411)
Q Consensus       299 ~DiwSlGvil~ellt--g~~pf~~~~~~~~~~~i~~~~----~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~  372 (411)
                      +|||||||++|||++  |..||...+..+.+.......    ...........+..+.+++.+|+..+    |.+||++.
T Consensus       213 ~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~----p~~Rpt~~  288 (296)
T cd05051         213 SDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRD----EEDRPTFR  288 (296)
T ss_pred             chhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccC----hhcCCCHH
Confidence            999999999999998  788998777666655554431    11111112235578999999999888    99999999


Q ss_pred             HHHhcC
Q 015222          373 AVWKLL  378 (411)
Q Consensus       373 ~il~~~  378 (411)
                      ++++.+
T Consensus       289 el~~~L  294 (296)
T cd05051         289 EIHLFL  294 (296)
T ss_pred             HHHHHh
Confidence            997654

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.8e-43  Score=300.53  Aligned_cols=259  Identities=24%  Similarity=0.421  Sum_probs=215.6

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEecc---chhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec---
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY---  164 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~---  164 (411)
                      .+.|+-..+||+|.||.||+|+.+++|+.||+|++--   .........+|+.+|..|+|+|+     +.+++.+..   
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv-----~nliEic~tk~T   90 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENV-----VNLIEICRTKAT   90 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhH-----HHHHHHHhhccC
Confidence            3578888999999999999999999999999987642   22345677899999999999988     555555432   


Q ss_pred             -----CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcc
Q 015222          165 -----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK  239 (411)
Q Consensus       165 -----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~  239 (411)
                           ...+|+||++|..+|..++.... .+++..++++++.+++.||.|+|...|+|||+|++|+||+.+|        
T Consensus        91 p~~r~r~t~ylVf~~cehDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dg--------  161 (376)
T KOG0669|consen   91 PTNRDRATFYLVFDFCEHDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDG--------  161 (376)
T ss_pred             CcccccceeeeeHHHhhhhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCc--------
Confidence                 34699999999999999997654 4799999999999999999999999999999999999998888        


Q ss_pred             cccccCCCCCccccCCCCCCeeEeecCCcccccCC-------CcccccCCCccccceecCC-CCCccchhHHHHHHHHHH
Q 015222          240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-------HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVEL  311 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~el  311 (411)
                                         .+||+|||+++.....       .+..+-|.+|++||.+.|. .|+++.|||..|||+.||
T Consensus       162 -------------------ilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeM  222 (376)
T KOG0669|consen  162 -------------------ILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEM  222 (376)
T ss_pred             -------------------eEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHH
Confidence                               5566666666433221       1234569999999999987 799999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhh-------------------------------hhhhhhhhccCCccC
Q 015222          312 CSGEALFQTHENLEHLAMMERVLGPLPHHMVIRA-------------------------------DRRAEKYFRRGARLD  360 (411)
Q Consensus       312 ltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~-------------------------------~~~~~~li~~~l~~~  360 (411)
                      .+|.+.|.+.++...+..|....+.+..+.|++.                               ++.+.+++.++|..|
T Consensus       223 wtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~D  302 (376)
T KOG0669|consen  223 WTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLD  302 (376)
T ss_pred             HccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccC
Confidence            9999999999999999999888887655544432                               236778999999999


Q ss_pred             CCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          361 WPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       361 ~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                          |.+|+++.++++|.||+.-...
T Consensus       303 ----P~kR~~ad~alnh~~F~kdp~p  324 (376)
T KOG0669|consen  303 ----PTKRIDADQALNHDFFWKDPMP  324 (376)
T ss_pred             ----cccCcchHhhhchhhhhcCCcc
Confidence                9999999999999999865443

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=6.7e-40  Score=301.48  Aligned_cols=249  Identities=27%  Similarity=0.459  Sum_probs=208.1

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      +|++.+.||.|+||.||++.+..+++.||+|++....   .....+.+|+++++.++|+++     +++.+.+..++..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~-----~~~~~~~~~~~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI-----IKYYESFEEKGKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCCh-----hheEEEEecCCEEE
Confidence            5899999999999999999999999999999997532   455668889999999988877     99999998889999


Q ss_pred             EEEccC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          170 IVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|||++ +++|.+++....  ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++               
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~---------------  140 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG---------------  140 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCC---------------
Confidence            999999 889999998652  34799999999999999999999999999999999999998766               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN  323 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~  323 (411)
                                  .++|+|||.+......   .....|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.
T Consensus       141 ------------~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~  208 (258)
T cd08215         141 ------------LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL  208 (258)
T ss_pred             ------------cEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH
Confidence                        5666666666543322   1234688899999999888899999999999999999999999987765


Q ss_pred             HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      .+.........   ........+..+.+++.+||..+    |+.||++.++++|+||
T Consensus       209 ~~~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~~----p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         209 LELALKILKGQ---YPPIPSQYSSELRNLVSSLLQKD----PEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHHhcCC---CCCCCCCCCHHHHHHHHHHcCCC----hhhCcCHHHHhcCCCC
Confidence            55554443321   11122256778899999999998    9999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-40  Score=303.78  Aligned_cols=242  Identities=21%  Similarity=0.318  Sum_probs=201.2

Q ss_pred             eeeccccceEEEEEEeCCC---CcEEEEEEeccchhh--hHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEE
Q 015222           98 SKMGEGTFGQVVECFDNEK---KELVAIKIVRSINKY--REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF  172 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~---~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~  172 (411)
                      +.||+|+||.||+|.+...   +..||+|++......  .+.+.+|+.+++.+.|+++     +++++++.....+++||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNV-----VRLLGVCTEEEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCCh-----heeeeeecCCCceEEEE
Confidence            4789999999999999866   889999999754433  5778899999999988777     99999999999999999


Q ss_pred             ccC-CCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          173 EKL-GPSLYDFLRKNS-------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       173 e~~-~~~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      ||+ +++|.+++....       ...+++..+..++.||+.||+|||++||+|+||||+||+++.++             
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~-------------  142 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL-------------  142 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC-------------
Confidence            999 999999998751       24799999999999999999999999999999999999998776             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALF  318 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf  318 (411)
                                    .++|+|||.+......     .....++..|+|||.+.+..++.++|||||||++|+|++ |..||
T Consensus       143 --------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~  208 (262)
T cd00192         143 --------------VVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY  208 (262)
T ss_pred             --------------cEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCC
Confidence                          5666777666554332     223457889999999998889999999999999999999 69999


Q ss_pred             CCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ...+..+....+....   .......++..+.+++.+|+..+    |..||++.+++++.
T Consensus       209 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~----p~~Rps~~~l~~~l  261 (262)
T cd00192         209 PGLSNEEVLEYLRKGY---RLPKPEYCPDELYELMLSCWQLD----PEDRPTFSELVERL  261 (262)
T ss_pred             CCCCHHHHHHHHHcCC---CCCCCccCChHHHHHHHHHccCC----cccCcCHHHHHHhh
Confidence            9887766666555421   11223345778999999998888    99999999999864

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.8e-40  Score=310.94  Aligned_cols=249  Identities=22%  Similarity=0.323  Sum_probs=198.1

Q ss_pred             CCCeEEEeeeccccceEEEEEEe-----CCCCcEEEEEEeccch--hhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeee
Q 015222           91 TPRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWF  162 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~-----~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~  162 (411)
                      .++|++.+.||+|+||.||+|.+     ..++..||+|+++...  ...+.+.+|+.+++++ .|+|+     +++++++
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----v~~~~~~  108 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI-----VNLLGAC  108 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCc-----ceEEEEE
Confidence            35799999999999999999975     3345689999987532  3345678899999999 68777     9999999


Q ss_pred             ecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccc
Q 015222          163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL  241 (411)
Q Consensus       163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~  241 (411)
                      ...+..++||||+ +++|.+++.......+++..+..++.||+.||+|||++||+|+||||+|||++.++          
T Consensus       109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~----------  178 (302)
T cd05055         109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK----------  178 (302)
T ss_pred             ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC----------
Confidence            9999999999999 89999999865534589999999999999999999999999999999999997766          


Q ss_pred             cccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CC
Q 015222          242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GE  315 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~  315 (411)
                                       .++|+|||++.......     ....++..|+|||++.+..++.++|||||||++|||++ |.
T Consensus       179 -----------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~  241 (302)
T cd05055         179 -----------------IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGS  241 (302)
T ss_pred             -----------------eEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCC
Confidence                             45666666655332211     12245678999999998899999999999999999998 99


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      .||.+....+.........  .+.......+..+.+++.+|+..+    |++||++.++++.
T Consensus       242 ~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~----p~~Rpt~~ell~~  297 (302)
T cd05055         242 NPYPGMPVDSKFYKLIKEG--YRMAQPEHAPAEIYDIMKTCWDAD----PLKRPTFKQIVQL  297 (302)
T ss_pred             CCcCCCCchHHHHHHHHcC--CcCCCCCCCCHHHHHHHHHHcCCC----chhCcCHHHHHHH
Confidence            9998766554443332211  111112235678999999999988    9999999998864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-40  Score=306.93  Aligned_cols=250  Identities=30%  Similarity=0.505  Sum_probs=207.5

Q ss_pred             eEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        94 y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      |++.+.||+|++|.||+|.+..+++.||+|++...   ....+.+..|+.+++.+.|+++     +++++++.+.+..++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI-----VKLLDVIHTERKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCH-----HHHHhhhhcCCceEE
Confidence            67788999999999999999999999999999754   3344667789999999988777     999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       171 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      ||||++++|.+++.+.. ..+++..+..++.|++.||+|||++||+||||+|+||++++++                   
T Consensus        76 v~e~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~-------------------  135 (282)
T cd07829          76 VFEYCDMDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG-------------------  135 (282)
T ss_pred             EecCcCcCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC-------------------
Confidence            99999779999998763 3699999999999999999999999999999999999998766                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEH  326 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~  326 (411)
                              .++|+|||.+.......   ....++..|+|||.+.+. .++.++|||||||++|||++|..||.+.+..+.
T Consensus       136 --------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~  207 (282)
T cd07829         136 --------VLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ  207 (282)
T ss_pred             --------CEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence                    56777777665443222   223457789999998877 789999999999999999999999998877766


Q ss_pred             HHHHHHHhCCCChhH-------------------------HHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          327 LAMMERVLGPLPHHM-------------------------VIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       327 ~~~i~~~~~~~p~~~-------------------------~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      +..+....+......                         .+..+..+.++|.+||..+    |++||++.+++.||||
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~----P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         208 LFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYN----PAKRISAKEALKHPYF  282 (282)
T ss_pred             HHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccC----cccCCCHHHHhhCcCC
Confidence            666555433222211                         1233567899999999998    9999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-40  Score=300.83  Aligned_cols=247  Identities=27%  Similarity=0.411  Sum_probs=208.0

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      +|++.+.||+|++|.||+|.+..+++.||+|.+....   ...+.+.+|+++++++.|+++     +++++++...+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI-----VKYIGSIETSDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCc-----cEEEEEEEeCCEEE
Confidence            5899999999999999999999999999999997554   355678899999999988877     99999999899999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      ++||++ +++|.+++....  .+++..+..++.|++.||.|||+.||+|+||||+||+++.++                 
T Consensus        76 ~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-----------------  136 (254)
T cd06627          76 IILEYAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG-----------------  136 (254)
T ss_pred             EEEecCCCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC-----------------
Confidence            999999 889999998764  799999999999999999999999999999999999997765                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                                .++|+|||.+.......   ....++..|+|||...+..++.++||||||+++|+|++|..||...+...
T Consensus       137 ----------~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~  206 (254)
T cd06627         137 ----------VVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA  206 (254)
T ss_pred             ----------CEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence                      56777777766544332   23467889999999988888999999999999999999999998766544


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      ....+..  ... .......+..+.+++.+||..+    |++||++.+++.|+||
T Consensus       207 ~~~~~~~--~~~-~~~~~~~~~~~~~~i~~~l~~~----p~~R~~~~~~l~~~~~  254 (254)
T cd06627         207 ALFRIVQ--DDH-PPLPEGISPELKDFLMQCFQKD----PNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHHHhc--cCC-CCCCCCCCHHHHHHHHHHHhCC----hhhCcCHHHHhcCCCC
Confidence            4443332  111 1223456778899999999988    9999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4e-40  Score=312.17  Aligned_cols=249  Identities=18%  Similarity=0.278  Sum_probs=197.6

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCC-------CCcEEEEEEeccc--hhhhHHHHHHHHHHHHH-hcCCCCCcceEEEee
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNE-------KKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRN  160 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~-------~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~  160 (411)
                      .++|.+.+.||+|+||.||+|.+..       +...||+|.++..  ......+..|+.+++.+ .|+++     +++++
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i-----~~~~~   91 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI-----INLLG   91 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCE-----eeEEE
Confidence            3689999999999999999998643       2356999999753  23345677899999998 57666     99999


Q ss_pred             eeecCCeEEEEEccC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 015222          161 WFDYRNHICIVFEKL-GPSLYDFLRKNSY--------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI  225 (411)
Q Consensus       161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NI  225 (411)
                      ++...+..|+||||+ +++|.+++.....              ..+++..+..++.||+.||+|||++|++||||||+||
T Consensus        92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni  171 (307)
T cd05098          92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  171 (307)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence            999999999999999 8999999986431              2488899999999999999999999999999999999


Q ss_pred             EEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccch
Q 015222          226 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCD  300 (411)
Q Consensus       226 li~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~D  300 (411)
                      |++.++                           .++|+|||.+.......     ....++..|+|||++.+..++.++|
T Consensus       172 ll~~~~---------------------------~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  224 (307)
T cd05098         172 LVTEDN---------------------------VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD  224 (307)
T ss_pred             EEcCCC---------------------------cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHH
Confidence            998766                           45666666665432211     1123456899999999888999999


Q ss_pred             hHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          301 LWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       301 iwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ||||||++|||++ |..||.+....+....+....   ........+..+.+++.+|+..+    |..||++.+++++.
T Consensus       225 vwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~----p~~Rps~~evl~~l  296 (307)
T cd05098         225 VWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH---RMDKPSNCTNELYMMMRDCWHAV----PSQRPTFKQLVEDL  296 (307)
T ss_pred             HHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCC---CCCCCCcCCHHHHHHHHHHcccC----hhhCcCHHHHHHHH
Confidence            9999999999998 999998766655555444322   11222345678889999999888    99999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-41  Score=298.91  Aligned_cols=273  Identities=18%  Similarity=0.310  Sum_probs=215.0

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc----hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      .++|.++..||+|+|..|.+++.+.|.+.+|+|++++.    .+..+..+.|-.+..+..    .+|.+|.++.+|..+.
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~as----n~pflvglhscfqtes  324 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS----NNPFLVGLHSCFQTES  324 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhcc----CCCeEEehhhhhcccc
Confidence            36799999999999999999999999999999999853    234455566766666553    3366699999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      .+++|.||+ ||+|.-.++++.  +++++.++.+...|+.||.|||++|||.||||.+|+|++.+|++|++|+|+.+..-
T Consensus       325 rlffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  325 RLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             eEEEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence            999999999 999988888775  79999999999999999999999999999999999999999855555554433222


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCC-----
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT-----  320 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~-----  320 (411)
                      .+                        ....++++|||.|+|||++.+..|++.+|+|+|||+++||+.|+.||.-     
T Consensus       403 ~~------------------------gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n  458 (593)
T KOG0695|consen  403 GP------------------------GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDN  458 (593)
T ss_pred             CC------------------------CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCC
Confidence            21                        2234668999999999999999999999999999999999999999962     


Q ss_pred             --CChH-HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH--HHHHHHhcCCCCcccccCCCCCchhh
Q 015222          321 --HENL-EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD--SMRAVWKLLRLPVIDLYSASPNCLCK  395 (411)
Q Consensus       321 --~~~~-~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~--t~~~il~~~~~~~~~~~~~~~~~~~~  395 (411)
                        .+.. -.++.|.+....+|..++..    +...++..|++||.+|-..+|  .+.++..|+||..++|...+.+...+
T Consensus       459 ~d~ntedylfqvilekqiriprslsvk----as~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~p  534 (593)
T KOG0695|consen  459 PDMNTEDYLFQVILEKQIRIPRSLSVK----ASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLP  534 (593)
T ss_pred             cccchhHHHHHHHhhhcccccceeehh----hHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCC
Confidence              1222 23344555555666665444    455556666677655555554  47899999999999998877776654


Q ss_pred             HH
Q 015222          396 FY  397 (411)
Q Consensus       396 ~~  397 (411)
                      .+
T Consensus       535 pf  536 (593)
T KOG0695|consen  535 PF  536 (593)
T ss_pred             CC
Confidence            43

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=6.1e-40  Score=308.59  Aligned_cols=247  Identities=19%  Similarity=0.294  Sum_probs=198.4

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCC-----CcEEEEEEeccch--hhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeee
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~-----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~  163 (411)
                      ++|++.+.||+|+||.||++.+...     ...||+|.+....  .....+.+|+.+++++ +|+++     +++++++.
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----~~~~~~~~   86 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI-----INLLGVCT   86 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCe-----eeEEEEEc
Confidence            5799999999999999999987644     3789999987532  3335677899999998 67766     99999999


Q ss_pred             cCCeEEEEEccC-CCCHHHHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015222          164 YRNHICIVFEKL-GPSLYDFLRKN--------------SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV  228 (411)
Q Consensus       164 ~~~~~~lv~e~~-~~~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~  228 (411)
                      .++.++++|||+ +++|.+++...              ....+++..+..++.||+.||.|||+.||+||||||+|||++
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~  166 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT  166 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence            999999999999 99999999752              234689999999999999999999999999999999999998


Q ss_pred             cCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchhHH
Q 015222          229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWS  303 (411)
Q Consensus       229 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwS  303 (411)
                      .++                           .++|+|||.+.......     ....++..|+|||++.+..++.++||||
T Consensus       167 ~~~---------------------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  219 (293)
T cd05053         167 EDH---------------------------VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWS  219 (293)
T ss_pred             CCC---------------------------eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceee
Confidence            776                           55666666665433211     1123456799999998889999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          304 VGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       304 lGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      |||++|||++ |..||.+....+....+......   ......+..+.+++.+|+..+    |.+|||+.+++++
T Consensus       220 lG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~----p~~Rps~~eil~~  287 (293)
T cd05053         220 FGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRM---EKPQNCTQELYHLMRDCWHEV----PSQRPTFKQLVED  287 (293)
T ss_pred             hhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC---CCCCCCCHHHHHHHHHHcccC----cccCcCHHHHHHH
Confidence            9999999998 99999887766655554432211   122245677889999998888    9999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.2e-40  Score=310.59  Aligned_cols=252  Identities=23%  Similarity=0.365  Sum_probs=206.3

Q ss_pred             eEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEE
Q 015222           94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF  172 (411)
Q Consensus        94 y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~  172 (411)
                      |....+||+|+||.||++.+..+++.||||++.... .....+.+|+.+++.+.|+++     +++++.+...++.++||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~~lv~   96 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV-----VEMYNSYLVGDELWVVM   96 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcch-----hheeeEEEeCCEEEEEE
Confidence            444578999999999999999999999999986432 345567889999999988877     99999999999999999


Q ss_pred             ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCcc
Q 015222          173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF  251 (411)
Q Consensus       173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~  251 (411)
                      ||+ +++|.+++...   .+++..+..++.|++.||+|||+.|++|+||||+||+++.++                    
T Consensus        97 e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~--------------------  153 (292)
T cd06657          97 EFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG--------------------  153 (292)
T ss_pred             ecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--------------------
Confidence            999 88999887553   489999999999999999999999999999999999998776                    


Q ss_pred             ccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015222          252 KNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA  328 (411)
Q Consensus       252 ~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~  328 (411)
                             .++|+|||++......   .....|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+...
T Consensus       154 -------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~  226 (292)
T cd06657         154 -------RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK  226 (292)
T ss_pred             -------CEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence                   4566666655433221   123467889999999988889999999999999999999999998877666555


Q ss_pred             HHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       329 ~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      .+......... .....+..+.+++.+|+..+    |.+||++.++++|+||.....
T Consensus       227 ~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~----P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         227 MIRDNLPPKLK-NLHKVSPSLKGFLDRLLVRD----PAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             HHHhhCCcccC-CcccCCHHHHHHHHHHHhCC----cccCcCHHHHhcChHHhccCC
Confidence            55443221111 12345677889999999888    999999999999999998774

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.3e-39  Score=301.00  Aligned_cols=247  Identities=23%  Similarity=0.337  Sum_probs=199.4

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      ..++|++.++||+|+||.||+|.+. .+..||+|.+.......+.+.+|+.+++++.|+++     +++++.+.. ...+
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~-~~~~   76 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKL-----VKLHAVVTK-EPIY   76 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCc-----ceEEEEEcC-CCeE
Confidence            4578999999999999999999865 44569999987665556778899999999988887     899888877 7789


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      ++|||+ +++|.+++.+.....+++..+..++.||+.||.|||+.|++|+||||+||+++.++                 
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~-----------------  139 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-----------------  139 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-----------------
Confidence            999999 88999999876555688999999999999999999999999999999999998766                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCh
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHEN  323 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~  323 (411)
                                .++|+|||.+.......    ....++..|+|||++.+..++.++|||||||++|++++ |..||.+.+.
T Consensus       140 ----------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~  209 (260)
T cd05073         140 ----------VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN  209 (260)
T ss_pred             ----------cEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH
Confidence                      45666666554332111    11235667999999998889999999999999999999 9999988776


Q ss_pred             HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      .+....+.....   .......+..+.+++.+|++.+    |.+||++.++++.
T Consensus       210 ~~~~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~~----p~~Rp~~~~l~~~  256 (260)
T cd05073         210 PEVIRALERGYR---MPRPENCPEELYNIMMRCWKNR----PEERPTFEYIQSV  256 (260)
T ss_pred             HHHHHHHhCCCC---CCCcccCCHHHHHHHHHHcccC----cccCcCHHHHHHH
Confidence            655554443221   1122346678899999999888    8889888888753

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=7.9e-40  Score=307.72  Aligned_cols=247  Identities=20%  Similarity=0.289  Sum_probs=199.0

Q ss_pred             CCeEEEeeeccccceEEEEEEeCC-----CCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .+|.+.+.||+|+||.||+|.+..     ++..|++|.+.... ...+.+.+|+.+++++.|+++     +++++++...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI-----VKFYGVCGDG   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCc-----ceEEEEEccC
Confidence            469999999999999999998543     45679999986443 334568899999999988877     9999999999


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecC
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA  230 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~  230 (411)
                      +..++||||+ +++|.+++....              ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN  159 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence            9999999999 999999997643              1248899999999999999999999999999999999999877


Q ss_pred             cccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCCCccchhHHHH
Q 015222          231 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVG  305 (411)
Q Consensus       231 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  305 (411)
                      +                           .++|+|||++......     .....++..|+|||++.+..++.++||||||
T Consensus       160 ~---------------------------~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  212 (291)
T cd05094         160 L---------------------------LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFG  212 (291)
T ss_pred             C---------------------------cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHH
Confidence            6                           4566666665433221     1223567889999999998999999999999


Q ss_pred             HHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          306 CILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       306 vil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      |++|||++ |..||...+..+....+......   ......+..+.+++.+|+..+    |.+||++.++++.
T Consensus       213 ~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~----P~~Rpt~~~v~~~  278 (291)
T cd05094         213 VILWEIFTYGKQPWFQLSNTEVIECITQGRVL---ERPRVCPKEVYDIMLGCWQRE----PQQRLNIKEIYKI  278 (291)
T ss_pred             HHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCC---CCCccCCHHHHHHHHHHcccC----hhhCcCHHHHHHH
Confidence            99999999 99999887776665554432221   122345677899999999888    8888888888764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=8.9e-40  Score=301.24  Aligned_cols=246  Identities=24%  Similarity=0.366  Sum_probs=200.5

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      .+|++.+.||+|+||.||+|.+.. +..+|+|++.........+.+|+++++++.|+++     +++++++......++|
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~~v   77 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKL-----VQLYGVCTERSPICLV   77 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCe-----eeEEEEEccCCceEEE
Confidence            469999999999999999998754 6679999987655555678899999999988776     9999999998999999


Q ss_pred             EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      |||+ +++|.+++.... ..++++.+..++.|++.||+|||+.|++|+||||+||+++.++                   
T Consensus        78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~-------------------  137 (256)
T cd05112          78 FEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ-------------------  137 (256)
T ss_pred             EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC-------------------
Confidence            9999 899999987654 3588999999999999999999999999999999999997766                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE  325 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~  325 (411)
                              .++|+|||.+.......    ....++..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus       138 --------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  209 (256)
T cd05112         138 --------VVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE  209 (256)
T ss_pred             --------eEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence                    45666666655332211    11234568999999998899999999999999999998 999998877766


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ....+.........   ...+..+.+++.+|+..+    |++||++.+++++.
T Consensus       210 ~~~~~~~~~~~~~~---~~~~~~~~~l~~~~l~~~----p~~Rp~~~~~l~~l  255 (256)
T cd05112         210 VVETINAGFRLYKP---RLASQSVYELMQHCWKER----PEDRPSFSLLLHQL  255 (256)
T ss_pred             HHHHHhCCCCCCCC---CCCCHHHHHHHHHHcccC----hhhCCCHHHHHHhh
Confidence            66665543222211   124677889999998888    99999999998753

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=9.6e-40  Score=305.14  Aligned_cols=246  Identities=21%  Similarity=0.281  Sum_probs=195.7

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCc----EEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKE----LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~----~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      .++|+++++||+|+||+||+|++..+++    .||+|+++..  ......+.+|+.+++.+.|+++     +.+++++..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~   80 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV-----CRLLGICLT   80 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCC-----ceEEEEEcC
Confidence            3579999999999999999999877765    4899998643  2345667889999998888777     888888764


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                       ...+++|||+ +|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+++++            
T Consensus        81 -~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~------------  146 (279)
T cd05109          81 -STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN------------  146 (279)
T ss_pred             -CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC------------
Confidence             4578999999 999999997653 3689999999999999999999999999999999999997766            


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccCCCc-----ccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS-----YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEAL  317 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p  317 (411)
                                     .+||+|||++........     ...++..|+|||.+.+..++.++|||||||++|||++ |..|
T Consensus       147 ---------------~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p  211 (279)
T cd05109         147 ---------------HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP  211 (279)
T ss_pred             ---------------cEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence                           467777776654432211     1234678999999998899999999999999999998 9999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      |...........+.... ..+.  ....+..+.+++.+|+..|    |+.||++.+++..
T Consensus       212 ~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~li~~~l~~d----p~~Rp~~~~l~~~  264 (279)
T cd05109         212 YDGIPAREIPDLLEKGE-RLPQ--PPICTIDVYMIMVKCWMID----SECRPRFRELVDE  264 (279)
T ss_pred             CCCCCHHHHHHHHHCCC-cCCC--CccCCHHHHHHHHHHcCCC----hhhCcCHHHHHHH
Confidence            98766655544444322 1111  2345677889999998888    9999999998854

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.4e-40  Score=309.83  Aligned_cols=248  Identities=19%  Similarity=0.234  Sum_probs=199.5

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCC-----CcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~-----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      .+|++.++||+|+||.||+|.+..+     ++.||||+++...  ...+.+.+|+.++..+.|++|     +++++++..
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i-----v~~~~~~~~   79 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI-----VCLLGVVTK   79 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCc-----CeEEEEEcC
Confidence            3588899999999999999987543     5789999997433  234567889999999888877     999999999


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS  229 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~  229 (411)
                      .+..++++||+ +++|.+++....              ...+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus        80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~  159 (283)
T cd05091          80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD  159 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence            99999999999 899999985321              124788899999999999999999999999999999999977


Q ss_pred             CcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchhHHH
Q 015222          230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSV  304 (411)
Q Consensus       230 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  304 (411)
                      ++                           .+||+|||++.......     ....+++.|+|||++.+..++.++|||||
T Consensus       160 ~~---------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  212 (283)
T cd05091         160 KL---------------------------NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSY  212 (283)
T ss_pred             CC---------------------------ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHH
Confidence            65                           46666776655432111     12345778999999988889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          305 GCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       305 Gvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ||++|||++ |..||.+....+....+.......   .....+..+.+++.+|++.+    |.+||++.++++..
T Consensus       213 G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~~~~~li~~cl~~~----p~~RP~~~~i~~~l  280 (283)
T cd05091         213 GVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLP---CPDDCPAWVYTLMLECWNEF----PSRRPRFKDIHSRL  280 (283)
T ss_pred             HHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC---CCCCCCHHHHHHHHHHhCCC----cccCCCHHHHHHHh
Confidence            999999998 999998877777666655433211   12346677889999998888    99999999998764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-40  Score=320.63  Aligned_cols=243  Identities=25%  Similarity=0.366  Sum_probs=204.1

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHh-cCCCCCcceEEEeeeeecCCeE
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      +.+.|.+...+|.|+|+.|-.+.+..+++..++|++.+.   .....+|+.++.... |+|+     +++.+.+.++.+.
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~~~h~ni-----v~~~~v~~~~~~~  391 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLVRDHPNI-----VKSHDVYEDGKEI  391 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccc---ccccccccchhhhhcCCCcc-----eeecceecCCcee
Confidence            457899999999999999999999999999999999765   233455776666554 4554     9999999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe-cCcccccCCcccccccCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV-SAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~-~~~~~~l~df~~~~~~~~  246 (411)
                      |+|||++ |+-|.+.+....   .....+..|+.+|+.|+.|||++|||||||||+|||++ +.|               
T Consensus       392 ~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g---------------  453 (612)
T KOG0603|consen  392 YLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAG---------------  453 (612)
T ss_pred             eeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCC---------------
Confidence            9999999 888888777664   33378888999999999999999999999999999994 554               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH-H
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL-E  325 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~-~  325 (411)
                                  +++|+|||.+........+.+-|..|.|||++....|+.++||||||++||+||+|+.||...... +
T Consensus       454 ------------~lrltyFG~a~~~~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e  521 (612)
T KOG0603|consen  454 ------------HLRLTYFGFWSELERSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE  521 (612)
T ss_pred             ------------cEEEEEechhhhCchhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH
Confidence                        789999998887766544456688999999999889999999999999999999999999887665 2


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      ....+.    ..  .+...+++.++++|+.||+.+    |..|+++.+++.|+|+
T Consensus       522 i~~~i~----~~--~~s~~vS~~AKdLl~~LL~~d----P~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  522 IHTRIQ----MP--KFSECVSDEAKDLLQQLLQVD----PALRLGADEIGAHPWF  566 (612)
T ss_pred             HHHhhc----CC--ccccccCHHHHHHHHHhccCC----hhhCcChhhhccCcch
Confidence            222222    11  122678999999999999999    9999999999999999

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=9e-40  Score=301.66  Aligned_cols=237  Identities=23%  Similarity=0.314  Sum_probs=190.9

Q ss_pred             eeccccceEEEEEEe--CCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEc
Q 015222           99 KMGEGTFGQVVECFD--NEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE  173 (411)
Q Consensus        99 ~lG~G~~g~V~~a~~--~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e  173 (411)
                      +||+|+||.||+|.+  ..++..||+|+++...   ...+.+.+|+.+++.+.|+++     +++++++. .+..++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~-~~~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYI-----VRMIGICE-AESWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEc-CCCcEEEEe
Confidence            689999999999965  4567899999986432   345678889999999988877     89988875 456799999


Q ss_pred             cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccc
Q 015222          174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK  252 (411)
Q Consensus       174 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~  252 (411)
                      |+ +++|.+++....  .+++..+..++.|++.||+|||++||+||||||+||+++.++                     
T Consensus        76 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~---------------------  132 (257)
T cd05116          76 LAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH---------------------  132 (257)
T ss_pred             cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC---------------------
Confidence            99 889999997654  689999999999999999999999999999999999997766                     


Q ss_pred             cCCCCCCeeEeecCCcccccCCC------cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 015222          253 NLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE  325 (411)
Q Consensus       253 ~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~  325 (411)
                            .++|+|||++.......      ....++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+
T Consensus       133 ------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  206 (257)
T cd05116         133 ------YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE  206 (257)
T ss_pred             ------eEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence                  46667777665433221      11234578999999988889999999999999999998 999998877766


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ....+.+....   ......+..+.++|.+|++.+    |..||++.+|.+.
T Consensus       207 ~~~~i~~~~~~---~~~~~~~~~l~~li~~~~~~~----p~~Rp~~~~i~~~  251 (257)
T cd05116         207 VTQMIESGERM---ECPQRCPPEMYDLMKLCWTYG----VDERPGFAVVELR  251 (257)
T ss_pred             HHHHHHCCCCC---CCCCCCCHHHHHHHHHHhccC----chhCcCHHHHHHH
Confidence            66666543221   122346778999999998888    8899999888754

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.4e-40  Score=306.56  Aligned_cols=248  Identities=22%  Similarity=0.317  Sum_probs=188.7

Q ss_pred             CCCe-EEEeeeccccceEEEEEE----eCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee
Q 015222           91 TPRY-RILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        91 ~~~y-~i~~~lG~G~~g~V~~a~----~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~  163 (411)
                      .++| ++++.||+|+||+||++.    ...++..||+|+++...  .....+.+|+.+++.+.|+++     +++++++.
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~   76 (283)
T cd05080           2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI-----VKYKGCCS   76 (283)
T ss_pred             ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEe
Confidence            4566 999999999999998765    34567899999997543  345677889999999988877     99998876


Q ss_pred             c--CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          164 Y--RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       164 ~--~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                      .  ...+++||||+ +++|.+++...   .+++..+..++.|++.||+|||++||+||||||+|||++.++         
T Consensus        77 ~~~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~---------  144 (283)
T cd05080          77 EQGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR---------  144 (283)
T ss_pred             cCCCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC---------
Confidence            5  34689999999 99999999775   499999999999999999999999999999999999998766         


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccCCC------cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhC
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG  314 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg  314 (411)
                                        .++|+|||++.......      ....++..|+|||.+.+..++.++|||||||++|||++|
T Consensus       145 ------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg  206 (283)
T cd05080         145 ------------------LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTH  206 (283)
T ss_pred             ------------------cEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhC
Confidence                              46666666665433221      112356679999999888899999999999999999999


Q ss_pred             CCCCCCCChHH--HH---------HHHHH-HhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          315 EALFQTHENLE--HL---------AMMER-VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       315 ~~pf~~~~~~~--~~---------~~i~~-~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ..||.......  ..         ..... .............+..+.+++.+|++.+    |+.||+++++++.
T Consensus       207 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~----p~~Rps~~~i~~~  277 (283)
T cd05080         207 CDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETE----AKFRPTFRSLIPI  277 (283)
T ss_pred             CCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccC----hhhCCCHHHHHHH
Confidence            99986533210  00         00000 0000000011234567889999998888    9999999998863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.7e-40  Score=305.35  Aligned_cols=245  Identities=22%  Similarity=0.292  Sum_probs=196.6

Q ss_pred             eeeccccceEEEEEEeCCCCc-------EEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           98 SKMGEGTFGQVVECFDNEKKE-------LVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~-------~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      +.||+|+||.||+|.++.++.       .||+|.+.... ...+.+.+|+.+++.+.|+|+     +++++++..++..+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----v~~~~~~~~~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHL-----VLNYGVCVCGDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCCh-----hheeeEEEeCCCcE
Confidence            468999999999999866544       48889886433 334567889999999888877     99999999888999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++..++.+++         
T Consensus        76 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~---------  145 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPP---------  145 (258)
T ss_pred             EEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCc---------
Confidence            999999 899999998754 368999999999999999999999999999999999999988866655554         


Q ss_pred             CccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhC-CCCCCCCChHHH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSG-EALFQTHENLEH  326 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg-~~pf~~~~~~~~  326 (411)
                                .++++|||.+..... .....++..|+|||++.+. .++.++|||||||++|||++| ..||...+....
T Consensus       146 ----------~~~l~d~g~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~  214 (258)
T cd05078         146 ----------FIKLSDPGISITVLP-KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK  214 (258)
T ss_pred             ----------eEEecccccccccCC-chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH
Confidence                      579999998865433 2335688899999999874 589999999999999999998 577766555443


Q ss_pred             HHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       327 ~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      .... .....+|..    .+..+.+++.+|++.+    |.+||+++++++.
T Consensus       215 ~~~~-~~~~~~~~~----~~~~~~~li~~~l~~~----p~~Rps~~~il~~  256 (258)
T cd05078         215 LQFY-EDRHQLPAP----KWTELANLINQCMDYE----PDFRPSFRAIIRD  256 (258)
T ss_pred             HHHH-HccccCCCC----CcHHHHHHHHHHhccC----hhhCCCHHHHHHh
Confidence            3322 222333332    3356789999998888    9999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1e-39  Score=300.70  Aligned_cols=243  Identities=20%  Similarity=0.267  Sum_probs=197.9

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      ++|++.+.||+|+||.||++.  .+++.||+|+++... ..+.+.+|+.++++++|+++     +++++++... ..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~-~~~~v   76 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNL-----VRLLGVILHN-GLYIV   76 (254)
T ss_pred             HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCc-----CeEEEEEcCC-CcEEE
Confidence            569999999999999999985  467889999986533 34568889999999988877     9999888654 57999


Q ss_pred             EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      |||+ +++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++                   
T Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~-------------------  137 (254)
T cd05083          77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG-------------------  137 (254)
T ss_pred             EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-------------------
Confidence            9999 89999999876555689999999999999999999999999999999999997766                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAM  329 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~  329 (411)
                              .++|+|||++............+..|+|||.+.+..++.++|||||||++|+|++ |+.||...+..+....
T Consensus       138 --------~~kl~Dfg~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  209 (254)
T cd05083         138 --------VAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC  209 (254)
T ss_pred             --------cEEECCCccceeccccCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence                    5677777766544332223344567999999988899999999999999999998 9999988777665555


Q ss_pred             HHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          330 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       330 i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      +.+.....   .....+..+.+++.+|++.+    |..||+++++++.
T Consensus       210 ~~~~~~~~---~~~~~~~~~~~li~~~l~~~----p~~Rp~~~~l~~~  250 (254)
T cd05083         210 VEKGYRME---PPEGCPADVYVLMTSCWETE----PKKRPSFHKLREK  250 (254)
T ss_pred             HhCCCCCC---CCCcCCHHHHHHHHHHcCCC----hhhCcCHHHHHHH
Confidence            54432111   12345678889999998888    9999999998865

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.3e-40  Score=308.99  Aligned_cols=250  Identities=22%  Similarity=0.318  Sum_probs=196.4

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCC--------------cEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcce
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKK--------------ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRC  155 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~--------------~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~i  155 (411)
                      ++|++.+.||+|+||.||+|++..++              ..||+|+++..  ......+.+|+++++++.|+++     
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i-----   79 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNI-----   79 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCc-----
Confidence            58999999999999999999875432              35899998753  2344568899999999998877     


Q ss_pred             EEEeeeeecCCeEEEEEccC-CCCHHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 015222          156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSY----------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPEN  224 (411)
Q Consensus       156 v~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~N  224 (411)
                      +++++++...+..++||||+ +++|.+++.....          ..+++..+..++.|++.||+|||++|++|+||||+|
T Consensus        80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N  159 (295)
T cd05097          80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN  159 (295)
T ss_pred             CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhh
Confidence            99999999999999999999 8999999865321          136888999999999999999999999999999999


Q ss_pred             EEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccc
Q 015222          225 ILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPC  299 (411)
Q Consensus       225 Ili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~  299 (411)
                      |+++.++                           .+||+|||++.......     ....++..|+|||++.+..++.++
T Consensus       160 ill~~~~---------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  212 (295)
T cd05097         160 CLVGNHY---------------------------TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTAS  212 (295)
T ss_pred             EEEcCCC---------------------------cEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchh
Confidence            9998766                           45666666654332111     122456789999999988999999


Q ss_pred             hhHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhCC----CChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHH
Q 015222          300 DLWSVGCILVELCS--GEALFQTHENLEHLAMMERVLGP----LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA  373 (411)
Q Consensus       300 DiwSlGvil~ellt--g~~pf~~~~~~~~~~~i~~~~~~----~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~  373 (411)
                      |||||||++|+|++  |..||...+..+.+..+......    .........+..+.+++.+|+..+    |.+||++.+
T Consensus       213 DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~----p~~RPs~~~  288 (295)
T cd05097         213 DVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRD----IKDRPTFNK  288 (295)
T ss_pred             hHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCC----chhCcCHHH
Confidence            99999999999998  77899877766655544332110    101112234577999999999888    999999999


Q ss_pred             HHhc
Q 015222          374 VWKL  377 (411)
Q Consensus       374 il~~  377 (411)
                      +++.
T Consensus       289 i~~~  292 (295)
T cd05097         289 IHHF  292 (295)
T ss_pred             HHHH
Confidence            9764

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.9e-40  Score=305.54  Aligned_cols=244  Identities=25%  Similarity=0.379  Sum_probs=193.5

Q ss_pred             EEEeeeccccceEEEEEEeC----CCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           95 RILSKMGEGTFGQVVECFDN----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        95 ~i~~~lG~G~~g~V~~a~~~----~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      .+.+.||.|.||.||+|...    ..+..|+||+++..  ....+.+.+|++.+++++|+||     +++++++...+..
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----~~~~g~~~~~~~~   76 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNI-----VKLYGFCIENEPL   76 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTB-----E-EEEEEESSSSE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccc-----ccccccccccccc
Confidence            56789999999999999988    45678999999643  2346788999999999999888     9999999988889


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      ++||||+ +++|.+++.......+++..+..|+.||+.||.|||+++|+|+||+++|||++.++                
T Consensus        77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~----------------  140 (259)
T PF07714_consen   77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG----------------  140 (259)
T ss_dssp             EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT----------------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----------------
Confidence            9999999 88999999987445799999999999999999999999999999999999998877                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTH  321 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~  321 (411)
                                 .+||+|||++......     .....+...|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       141 -----------~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~  209 (259)
T PF07714_consen  141 -----------QVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY  209 (259)
T ss_dssp             -----------EEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred             -----------ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence                       5666677666544211     112345678999999998889999999999999999999 78999988


Q ss_pred             ChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      +..+....+.+.....   ....++..+.+++.+|+..+    |.+||+++++++.
T Consensus       210 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~C~~~~----p~~RPs~~~i~~~  258 (259)
T PF07714_consen  210 DNEEIIEKLKQGQRLP---IPDNCPKDIYSLIQQCWSHD----PEKRPSFQEILQE  258 (259)
T ss_dssp             CHHHHHHHHHTTEETT---SBTTSBHHHHHHHHHHT-SS----GGGS--HHHHHHH
T ss_pred             ccccccccccccccce---eccchhHHHHHHHHHHcCCC----hhhCcCHHHHHhc
Confidence            7777776664433211   12345667788888886666    9999999999864

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.9e-41  Score=321.84  Aligned_cols=253  Identities=22%  Similarity=0.337  Sum_probs=214.9

Q ss_pred             CCe-EEEeeeccccceEEEEEEeCCCCcEEEEEEec-----cchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           92 PRY-RILSKMGEGTFGQVVECFDNEKKELVAIKIVR-----SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        92 ~~y-~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~-----~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      +|| +....||+|+|-+||+|.|..+|..||.-.++     +.....+.+..|+.+|+.|+|+||     +++++++.+.
T Consensus        39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NI-----irfy~SW~d~  113 (632)
T KOG0584|consen   39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNI-----IRFYDSWVDT  113 (632)
T ss_pred             CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCce-----eeeeeheecC
Confidence            344 45678999999999999999999988865443     334455889999999999999988     9999998875


Q ss_pred             C--eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEecCcccccCCccc
Q 015222          166 N--HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       166 ~--~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                      .  .+.+|+|++ .|+|..|+.+.+  .++...++.|++||+.||.|||++.  |||||||-+||||+.           
T Consensus       114 ~n~~in~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG-----------  180 (632)
T KOG0584|consen  114 DNKTINFITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNG-----------  180 (632)
T ss_pred             CCceeeeeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcC-----------
Confidence            4  589999999 999999999887  7999999999999999999999985  999999999999964           


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccCCC-cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ  319 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~  319 (411)
                                     ..+.|||+|+|+|....... ...+|||.|||||+.. ..|+..+||||||+.+.||+|+.+||.
T Consensus       181 ---------------~~G~VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs  244 (632)
T KOG0584|consen  181 ---------------NLGEVKIGDLGLATLLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS  244 (632)
T ss_pred             ---------------CcCceeecchhHHHHhhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh
Confidence                           34589999999999876554 4469999999999998 689999999999999999999999998


Q ss_pred             CCCh-HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          320 THEN-LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       320 ~~~~-~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      .... .++++++.  .|..|..+..--++++++||.+||..     .+.|+++.|+|+|+||...+.
T Consensus       245 EC~n~AQIYKKV~--SGiKP~sl~kV~dPevr~fIekCl~~-----~~~R~sa~eLL~d~Ff~~d~g  304 (632)
T KOG0584|consen  245 ECTNPAQIYKKVT--SGIKPAALSKVKDPEVREFIEKCLAT-----KSERLSAKELLKDPFFDEDGG  304 (632)
T ss_pred             hhCCHHHHHHHHH--cCCCHHHhhccCCHHHHHHHHHHhcC-----chhccCHHHHhhChhhccccc
Confidence            6544 34444443  45667777777788999999999876     578999999999999997643

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.2e-39  Score=304.73  Aligned_cols=247  Identities=20%  Similarity=0.289  Sum_probs=198.7

Q ss_pred             CCeEEEeeeccccceEEEEEEeC-----CCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .+|++.++||+|+||.||+|...     .++..||+|.+.... ...+.+.+|+.+++.+.|+|+     +++++++.+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHI-----VRFYGVCTEG   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCC-----ceEEEEEecC
Confidence            57899999999999999999743     356789999886433 445678899999999988877     9999999999


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSY-------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE  231 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~  231 (411)
                      +..+++|||+ +++|.+++.....             ..+++..+..++.||+.||+|||+.||+||||||+|||+++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence            9999999999 9999999976431             2488999999999999999999999999999999999998766


Q ss_pred             ccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchhHHHHH
Q 015222          232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGC  306 (411)
Q Consensus       232 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  306 (411)
                                                 .++|+|||++.......     ....+++.|+|||.+.+..++.++|||||||
T Consensus       160 ---------------------------~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  212 (280)
T cd05092         160 ---------------------------VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGV  212 (280)
T ss_pred             ---------------------------CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHH
Confidence                                       45666666654322111     1234567899999999989999999999999


Q ss_pred             HHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          307 ILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       307 il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ++|||++ |..||......+....+......   .....++..+.+++.+|+..+    |.+||++.++++.
T Consensus       213 il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~----P~~Rp~~~~l~~~  277 (280)
T cd05092         213 VLWEIFTYGKQPWYQLSNTEAIECITQGREL---ERPRTCPPEVYAIMQGCWQRE----PQQRMVIKDIHSR  277 (280)
T ss_pred             HHHHHHcCCCCCCccCCHHHHHHHHHcCccC---CCCCCCCHHHHHHHHHHccCC----hhhCCCHHHHHHH
Confidence            9999998 99999877766655555433221   112345677899999998888    9999999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.6e-39  Score=297.71  Aligned_cols=249  Identities=26%  Similarity=0.418  Sum_probs=207.1

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      +|++.++||+|+||.||++.+..+++.+|+|.+....   .....+.+|+.+++.++|+++     +++++++......+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI-----ISYKEAFLDGNKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCc-----hhhhhhhccCCEEE
Confidence            5899999999999999999999999999999987532   334566789999999988877     99999999899999


Q ss_pred             EEEccC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          170 IVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +||||+ +++|.+++.+..  ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++               
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~---------------  140 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND---------------  140 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC---------------
Confidence            999999 899999987621  24689999999999999999999999999999999999998765               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC-CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                                  .++|+|||++...... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+
T Consensus       141 ------------~~kl~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~  208 (256)
T cd08530         141 ------------LVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD  208 (256)
T ss_pred             ------------cEEEeeccchhhhccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                        5677777776654332 222457889999999998889999999999999999999999998877655


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      ....+....  .+. .....+..+.+++.+|+..+    |..||++.++++||++
T Consensus       209 ~~~~~~~~~--~~~-~~~~~~~~~~~li~~~l~~~----p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         209 LRYKVQRGK--YPP-IPPIYSQDLQNFIRSMLQVK----PKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHhcCC--CCC-CchhhCHHHHHHHHHHcCCC----cccCCCHHHHhcCCCC
Confidence            544443322  221 22356778999999999999    9999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=9.9e-40  Score=306.49  Aligned_cols=252  Identities=24%  Similarity=0.350  Sum_probs=199.5

Q ss_pred             CeEEEeeeccccceEEEEEEeC---CCCcEEEEEEeccch-----hhhHHHHHHHHHHHHHh-cCCCCCcceEEEeeeee
Q 015222           93 RYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~---~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~~~  163 (411)
                      +|++.+.||+|+||.||+|++.   .+++.||||+++...     ...+.+.+|+.++.++. |+++     +++++.+.
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i-----~~~~~~~~   75 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL-----VTLHYAFQ   75 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcch-----hhhheeee
Confidence            4889999999999999999864   467889999987432     23455778999999995 5665     89999999


Q ss_pred             cCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccc
Q 015222          164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                      .++..++||||+ +++|.+++....  .+++..++.++.|++.||.|||+.|++||||||+||+++.++           
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~-----------  142 (288)
T cd05583          76 TDTKLHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG-----------  142 (288)
T ss_pred             cCCEEEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-----------
Confidence            999999999999 889999987654  689999999999999999999999999999999999997765           


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecCCC--CCccchhHHHHHHHHHHHhCCC
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLG--WNYPCDLWSVGCILVELCSGEA  316 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~elltg~~  316 (411)
                                      .++|+|||++.......    ....|+..|+|||.+.+..  .+.++||||||+++|+|++|..
T Consensus       143 ----------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~  206 (288)
T cd05583         143 ----------------HVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGAS  206 (288)
T ss_pred             ----------------CEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCC
Confidence                            56777777765432221    2246888999999987764  7899999999999999999999


Q ss_pred             CCCCCChH----HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHH---HHHHHhcCCCCccccc
Q 015222          317 LFQTHENL----EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS---MRAVWKLLRLPVIDLY  386 (411)
Q Consensus       317 pf~~~~~~----~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t---~~~il~~~~~~~~~~~  386 (411)
                      ||......    +....+.......+    ...+..+.+++.+|++.+    |+.|||   +.++++|+||+++.+.
T Consensus       207 p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~----p~~R~t~~~~~~~l~~~~~~~~~~~  275 (288)
T cd05583         207 PFTVDGEQNSQSEISRRILKSKPPFP----KTMSAEARDFIQKLLEKD----PKKRLGANGADEIKNHPFFQGIDWD  275 (288)
T ss_pred             CcccCcccchHHHHHHHHHccCCCCC----cccCHHHHHHHHHHhcCC----HhhccCcchHHHHhcCcccccCCHH
Confidence            99643322    22222222222222    335677899999999999    777776   6778999999998864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.9e-39  Score=301.19  Aligned_cols=246  Identities=21%  Similarity=0.318  Sum_probs=198.0

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCc---EEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~---~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      ++|+..+.||+|+||.||+|.++.++.   .||+|.++..  ....+.+..|+.+++++.|+++     +++.+++...+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~   79 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNI-----IRLEGVVTKFK   79 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCe-----eEEEEEEccCC
Confidence            578999999999999999999876654   7999998753  2345667889999999988776     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      ..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++              
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~--------------  144 (268)
T cd05063          80 PAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL--------------  144 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC--------------
Confidence            999999999 889999997653 3689999999999999999999999999999999999998766              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCCCc------ccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS------YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALF  318 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf  318 (411)
                                   .++|+|||++........      ....+..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus       145 -------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~  211 (268)
T cd05063         145 -------------ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY  211 (268)
T ss_pred             -------------cEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCC
Confidence                         456666665543322111      1123457999999998889999999999999999998 99999


Q ss_pred             CCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ...+..+....+.... ..|.  ....+..+.+++.+|+..+    |..||++.++++.
T Consensus       212 ~~~~~~~~~~~i~~~~-~~~~--~~~~~~~~~~li~~c~~~~----p~~Rp~~~~i~~~  263 (268)
T cd05063         212 WDMSNHEVMKAINDGF-RLPA--PMDCPSAVYQLMLQCWQQD----RARRPRFVDIVNL  263 (268)
T ss_pred             CcCCHHHHHHHHhcCC-CCCC--CCCCCHHHHHHHHHHcCCC----cccCcCHHHHHHH
Confidence            8777766666555432 2221  2245677889999998888    8899999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.8e-39  Score=298.98  Aligned_cols=245  Identities=22%  Similarity=0.304  Sum_probs=201.2

Q ss_pred             eEEEeeeccccceEEEEEEeCCCC----cEEEEEEeccchh--hhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           94 YRILSKMGEGTFGQVVECFDNEKK----ELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        94 y~i~~~lG~G~~g~V~~a~~~~~~----~~vavK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      +++.+.||.|+||.||+|.+...+    ..||+|+++....  ..+.+..|+.+++.+.|+++     +++++++.+.+.
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNI-----VKLLGVCTEEEP   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCch-----heEEEEEcCCCe
Confidence            357789999999999999998766    8999999975443  46678899999999988777     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      .+++|||+ +++|.+++.......+++..+..++.||+.||+|||+.|++|+||||+||++++++               
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~---------------  140 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL---------------  140 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC---------------
Confidence            99999999 89999999875533389999999999999999999999999999999999998776               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCCc----ccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHS----YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTH  321 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~  321 (411)
                                  .++|+|||.+........    ...++..|+|||.+.+..++.++|||||||++|+|++ |..||...
T Consensus       141 ------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~  208 (258)
T smart00219      141 ------------VVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM  208 (258)
T ss_pred             ------------eEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence                        456666666554332211    1236788999999988889999999999999999998 89999887


Q ss_pred             ChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      +..+....+.......   .....+..+.+++.+|+..+    |.+|||+.++++.
T Consensus       209 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~~~l~~~----p~~Rpt~~~ll~~  257 (258)
T smart00219      209 SNEEVLEYLKKGYRLP---KPENCPPEIYKLMLQCWAED----PEDRPTFSELVEI  257 (258)
T ss_pred             CHHHHHHHHhcCCCCC---CCCcCCHHHHHHHHHHCcCC----hhhCcCHHHHHhh
Confidence            7766666655433221   12236778899999999999    9999999999864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.6e-39  Score=303.84  Aligned_cols=245  Identities=20%  Similarity=0.229  Sum_probs=189.8

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCc----EEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKE----LVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      ++|++.+.||+|+||+||+|.+..+++    .|++|.+....  .....+..|+.+++++.|+|+     +++++++. +
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~i-----v~~~~~~~-~   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYI-----VRLLGICP-G   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCc-----ceEEEEEC-C
Confidence            579999999999999999999877776    47778775322  233556677778887777766     99999875 4


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      ...++++||+ +++|.+++.... ..+++..+..++.||+.||+|||++|++||||||+|||++.++             
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~-------------  146 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS-------------  146 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-------------
Confidence            5678899999 999999998654 3689999999999999999999999999999999999998766             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALF  318 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf  318 (411)
                                    .+||+|||.+......     .....++..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus       147 --------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~  212 (279)
T cd05111         147 --------------IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPY  212 (279)
T ss_pred             --------------cEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCC
Confidence                          5566666666543211     122346778999999998899999999999999999998 99999


Q ss_pred             CCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      .+.........+.........   ...+..+.+++.+|+..+    |..||++.++++.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~c~~~~----p~~Rps~~el~~~  264 (279)
T cd05111         213 AGMRPHEVPDLLEKGERLAQP---QICTIDVYMVMVKCWMID----ENVRPTFKELANE  264 (279)
T ss_pred             CCCCHHHHHHHHHCCCcCCCC---CCCCHHHHHHHHHHcCCC----cccCcCHHHHHHH
Confidence            887665544444332211111   123456777888887777    8888999988764

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.5e-39  Score=307.72  Aligned_cols=249  Identities=17%  Similarity=0.265  Sum_probs=198.7

Q ss_pred             CCCeEEEeeeccccceEEEEEEeC-------CCCcEEEEEEeccc--hhhhHHHHHHHHHHHHH-hcCCCCCcceEEEee
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDN-------EKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRN  160 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~-------~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~  160 (411)
                      .++|++.+.||+|+||.||+|++.       .++..||+|.+...  ......+.+|+.+++.+ .|+|+     +++++
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----~~~~~   88 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI-----INLLG   88 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCc-----hheeE
Confidence            467999999999999999999753       23457999998743  23446788999999999 67776     99999


Q ss_pred             eeecCCeEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 015222          161 WFDYRNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI  225 (411)
Q Consensus       161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NI  225 (411)
                      ++...+..++||||+ +++|.+++.+..              ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni  168 (304)
T cd05101          89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV  168 (304)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence            999999999999999 889999998642              12478888999999999999999999999999999999


Q ss_pred             EEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCCCccch
Q 015222          226 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCD  300 (411)
Q Consensus       226 li~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~D  300 (411)
                      |++.++                           .++|+|||.+......     .....++..|+|||++.+..++.++|
T Consensus       169 li~~~~---------------------------~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  221 (304)
T cd05101         169 LVTENN---------------------------VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD  221 (304)
T ss_pred             EEcCCC---------------------------cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhh
Confidence            998766                           4566666666543221     11224567899999999888999999


Q ss_pred             hHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          301 LWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       301 iwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ||||||++|+|++ |..||.+.+..+....+.....   .......+..+.+++.+|+..+    |..||++.++++.+
T Consensus       222 i~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~----p~~Rps~~e~l~~l  293 (304)
T cd05101         222 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR---MDKPANCTNELYMMMRDCWHAI----PSHRPTFKQLVEDL  293 (304)
T ss_pred             HHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc---CCCCCCCCHHHHHHHHHHcccC----hhhCCCHHHHHHHH
Confidence            9999999999998 8999988777666655543221   1112346678899999998888    88899999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-40  Score=318.76  Aligned_cols=283  Identities=23%  Similarity=0.305  Sum_probs=222.6

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      -|..++.||-|+||.|.+++...|...+|+|.+++.+    ........|-.||.....+-+     |+++-.|.+.+.+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WV-----VrLyySFQDkdnL  704 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWV-----VRLYYSFQDKDNL  704 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcce-----EEEEEEeccCCce
Confidence            4788999999999999999999999999999997643    233445678888888766655     9999999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC-
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK-  246 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~-  246 (411)
                      |+||+|+ ||++..+|-+.+  .|.|+.++.++..+..|+++.|..|+|||||||+|||||.+|++||+||||+.-+.. 
T Consensus       705 YFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  705 YFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             EEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceec
Confidence            9999999 999999998876  799999999999999999999999999999999999999999999999999876654 


Q ss_pred             -CCCccccCCCC------CCeeEeecCCccc-cc---------CCCcccccCCCccccceecCCCCCccchhHHHHHHHH
Q 015222          247 -DGSYFKNLPKS------SAIKLIDFGSTTF-EH---------QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV  309 (411)
Q Consensus       247 -~~~~~~~~~~~------~~~kl~Dfg~a~~-~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  309 (411)
                       +.++|.+.+..      ..-..+|-+-+.. ..         -.....+||+.|+|||++....|+..+|+||.|||||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence             34444422110      0111122221110 00         0113368999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH---HHHHHHhcCCCCccccc
Q 015222          310 ELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD---SMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       310 elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~---t~~~il~~~~~~~~~~~  386 (411)
                      ||+.|++||...+..+...++.+....+....-.+++.++.++|.++.. .    ++.|.   .++++..|+||+.|++.
T Consensus       863 em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-s----ad~RLGkng~d~vKaHpfFkgIDfs  937 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-S----ADSRLGKNGADQVKAHPFFKGIDFS  937 (1034)
T ss_pred             HHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-C----hhhhhcccchhhhhcCccccccchH
Confidence            9999999999887766655555444433333445778888888887632 2    44553   46789999999999987


Q ss_pred             C
Q 015222          387 S  387 (411)
Q Consensus       387 ~  387 (411)
                      +
T Consensus       938 s  938 (1034)
T KOG0608|consen  938 S  938 (1034)
T ss_pred             h
Confidence            6

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.9e-39  Score=301.71  Aligned_cols=244  Identities=16%  Similarity=0.210  Sum_probs=191.7

Q ss_pred             EEEeeeccccceEEEEEEeCCCCc--EEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec-----
Q 015222           95 RILSKMGEGTFGQVVECFDNEKKE--LVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-----  164 (411)
Q Consensus        95 ~i~~~lG~G~~g~V~~a~~~~~~~--~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~-----  164 (411)
                      .+.+.||+|+||.||+|.+..++.  .||+|.++..   ....+.+.+|+.+++.++|+|+     +++++++..     
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~   76 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV-----MRLIGVCLQTVESE   76 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEccCCccc
Confidence            467899999999999999887765  6999998643   3345667889999999988887     888886532     


Q ss_pred             -CCeEEEEEccC-CCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCc
Q 015222          165 -RNHICIVFEKL-GPSLYDFLRKN----SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY  238 (411)
Q Consensus       165 -~~~~~lv~e~~-~~~L~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df  238 (411)
                       ....+++|||+ +++|.+++...    ....+++..+..++.||+.||+|||++||+||||||+|||++.++       
T Consensus        77 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-------  149 (272)
T cd05075          77 GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM-------  149 (272)
T ss_pred             CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC-------
Confidence             23579999999 89999987532    123589999999999999999999999999999999999997766       


Q ss_pred             ccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh
Q 015222          239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS  313 (411)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt  313 (411)
                                          .++|+|||++.......     ....+++.|+|||.+.+..++.++|||||||++|||++
T Consensus       150 --------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~  209 (272)
T cd05075         150 --------------------NVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT  209 (272)
T ss_pred             --------------------CEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHc
Confidence                                46666666665433221     12245678999999999899999999999999999999


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          314 -GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       314 -g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                       |+.||.+.+..+....+...... +  .....+..+.+++.+|+..+    |.+||++.+++++
T Consensus       210 ~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~li~~~l~~~----p~~Rps~~~l~~~  267 (272)
T cd05075         210 RGQTPYPGVENSEIYDYLRQGNRL-K--QPPDCLDGLYSLMSSCWLLN----PKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCCC-C--CCCCCCHHHHHHHHHHcCCC----cccCcCHHHHHHH
Confidence             89999887766655555443221 1  12245667889999998888    9999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=348.54  Aligned_cols=253  Identities=27%  Similarity=0.381  Sum_probs=210.4

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEecc---chhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .+.-+|+-..+||.|.||.||-|.+..+|+..|+|-++-   ..+....+.+|..++..++|+|+     |+++++-.+.
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNl-----V~YyGVEvHR 1306 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNL-----VRYYGVEVHR 1306 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccc-----cccCceeecH
Confidence            344578888999999999999999999999999998863   23445667889999999999988     9999999999


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      +.++|.|||| +|+|.+.+...+  ..++-..+.+..|++.||.|||+.|||||||||+||+++.+|             
T Consensus      1307 ekv~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g------------- 1371 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG------------- 1371 (1509)
T ss_pred             HHHHHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC-------------
Confidence            9999999999 999999998765  577888889999999999999999999999999999999888             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCCC-------cccccCCCccccceecCC---CCCccchhHHHHHHHHHHHhC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-------SYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSG  314 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlGvil~elltg  314 (411)
                                    .+|++|||.|.......       ....||+.|||||++.+.   .-..++||||||||+.||+||
T Consensus      1372 --------------~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tG 1437 (1509)
T KOG4645|consen 1372 --------------LIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATG 1437 (1509)
T ss_pred             --------------cEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecC
Confidence                          45666666665433222       346899999999999875   356899999999999999999


Q ss_pred             CCCCCCCChH-HHHHHHHHH-hCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcc
Q 015222          315 EALFQTHENL-EHLAMMERV-LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVI  383 (411)
Q Consensus       315 ~~pf~~~~~~-~~~~~i~~~-~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~  383 (411)
                      +.||...+.. .++..+..+ .+++|..    ++.+.++||.+||..|    |+.|-++.|+++|.|-+.-
T Consensus      1438 krPW~~~dne~aIMy~V~~gh~Pq~P~~----ls~~g~dFle~Cl~~d----P~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1438 KRPWAELDNEWAIMYHVAAGHKPQIPER----LSSEGRDFLEHCLEQD----PKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred             CCchhhccchhHHHhHHhccCCCCCchh----hhHhHHHHHHHHHhcC----chhhhHHHHHHHhhccccc
Confidence            9999876543 333333332 2345554    7888999999999999    9999999999999987653

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-39  Score=301.20  Aligned_cols=246  Identities=16%  Similarity=0.213  Sum_probs=194.5

Q ss_pred             eEEEeeeccccceEEEEEEeCCC---CcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC-
Q 015222           94 YRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN-  166 (411)
Q Consensus        94 y~i~~~lG~G~~g~V~~a~~~~~---~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~-  166 (411)
                      |++.+.||+|+||.||+|.+..+   +..||+|+++...   .....+.+|+.+++.+.|+++     +++++++.... 
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~   75 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV-----MKLIGVCFEASS   75 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCe-----eeEEeeeccCCc
Confidence            57889999999999999987653   4789999987432   334567889999999988877     99998775544 


Q ss_pred             -----eEEEEEccC-CCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccC
Q 015222          167 -----HICIVFEKL-GPSLYDFLRKNS----YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP  236 (411)
Q Consensus       167 -----~~~lv~e~~-~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~  236 (411)
                           ..+++|||+ +++|..++....    ...+++..+..++.|++.||.|||++||+||||||+||++++++     
T Consensus        76 ~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~-----  150 (273)
T cd05035          76 LQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM-----  150 (273)
T ss_pred             cccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC-----
Confidence                 489999999 999999985432    23689999999999999999999999999999999999997766     


Q ss_pred             CcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchhHHHHHHHHHH
Q 015222          237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL  311 (411)
Q Consensus       237 df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el  311 (411)
                                            .+||+|||.+.......     ....++..|+|||.+.+..++.++|||||||++|||
T Consensus       151 ----------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el  208 (273)
T cd05035         151 ----------------------TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI  208 (273)
T ss_pred             ----------------------eEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHH
Confidence                                  45666666665432221     112346689999999888899999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          312 CS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       312 lt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ++ |..||.+.+..+....+....   ........+..+.+++.+|++.+    |.+||++.+++++.
T Consensus       209 ~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~----p~~Rp~~~e~~~~l  269 (273)
T cd05035         209 ATRGQTPYPGVENHEIYDYLRHGN---RLKQPEDCLDELYDLMYSCWRAD----PKDRPTFTKLREVL  269 (273)
T ss_pred             HhCCCCCCCCCCHHHHHHHHHcCC---CCCCCcCCCHHHHHHHHHHcCCC----hhhCcCHHHHHHHH
Confidence            99 999998877666555444322   11223456778999999998888    99999999998753

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.3e-39  Score=302.25  Aligned_cols=246  Identities=22%  Similarity=0.319  Sum_probs=197.7

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCC---cEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKK---ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~---~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      .+|++.+.||+|+||.||+|.++.++   ..||+|.++..  ....+.+.+|+.+++++.|+|+     +++++++..++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~   78 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNI-----IHLEGVVTKSK   78 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEecCC
Confidence            57999999999999999999986554   37999998643  2345678889999999988877     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      ..|+||||+ +++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+|||++.++              
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~--------------  143 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL--------------  143 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC--------------
Confidence            999999999 899999998754 3689999999999999999999999999999999999998766              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCCCc------ccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS------YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALF  318 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf  318 (411)
                                   .++|+|||.+........      ...++..|+|||.+.+..++.++|||||||++||+++ |..||
T Consensus       144 -------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~  210 (267)
T cd05066         144 -------------VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY  210 (267)
T ss_pred             -------------eEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCc
Confidence                         456666665544322111      1123567999999998899999999999999999887 99999


Q ss_pred             CCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ...+..+....+.+.. ..+  .....+..+.+++.+|++.+    |..||++.++++.
T Consensus       211 ~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~li~~~l~~~----p~~Rp~~~~i~~~  262 (267)
T cd05066         211 WEMSNQDVIKAIEEGY-RLP--APMDCPAALHQLMLDCWQKD----RNERPKFEQIVSI  262 (267)
T ss_pred             ccCCHHHHHHHHhCCC-cCC--CCCCCCHHHHHHHHHHcccC----chhCCCHHHHHHH
Confidence            8877666555554432 112  12345677899999999888    8888888888754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.3e-39  Score=306.93  Aligned_cols=248  Identities=19%  Similarity=0.295  Sum_probs=197.4

Q ss_pred             CCeEEEeeeccccceEEEEEEeCC-------CCcEEEEEEeccch--hhhHHHHHHHHHHHHH-hcCCCCCcceEEEeee
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNE-------KKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNW  161 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~-------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~  161 (411)
                      ++|.+.++||+|+||.||+|++..       ....||+|.++...  .....+..|+.+++++ .|+|+     ++++++
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----v~~~~~   86 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNI-----INLLGV   86 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCe-----eeEEEE
Confidence            589999999999999999998632       34579999987532  3345677899999988 47766     999999


Q ss_pred             eecCCeEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015222          162 FDYRNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL  226 (411)
Q Consensus       162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIl  226 (411)
                      +.+++.+++||||+ +++|.+++....              ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  166 (314)
T cd05099          87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL  166 (314)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence            99889999999999 899999997642              135889999999999999999999999999999999999


Q ss_pred             EecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchh
Q 015222          227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDL  301 (411)
Q Consensus       227 i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di  301 (411)
                      ++.++                           .+||+|||.++......     ....++..|+|||++.+..++.++||
T Consensus       167 l~~~~---------------------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  219 (314)
T cd05099         167 VTEDN---------------------------VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDV  219 (314)
T ss_pred             EcCCC---------------------------cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchh
Confidence            98766                           56777777665433211     11234467999999998899999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          302 WSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       302 wSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      |||||++|+|++ |..||.+.+..+....+.....   .......+..+.+++.+|+..+    |..||++.++++..
T Consensus       220 wslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~----p~~Rps~~~ll~~l  290 (314)
T cd05099         220 WSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHR---MDKPSNCTHELYMLMRECWHAV----PTQRPTFKQLVEAL  290 (314)
T ss_pred             hHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCHHHHHHHHHHcCCC----cccCcCHHHHHHHH
Confidence            999999999999 9999988776666655544221   1112345667889999999999    88889999888754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=7e-41  Score=333.07  Aligned_cols=247  Identities=22%  Similarity=0.349  Sum_probs=206.9

Q ss_pred             CCeEEEeeeccccceEEEEEEeCC-----CCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      .+-+..++||+|.||+||+|+...     ....||||.++...  ..+.+|++|++++..++|+||     |++++++..
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nI-----VrLlGVC~~  560 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNI-----VRLLGVCRE  560 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCe-----EEEEEEEcc
Confidence            456778999999999999997643     34689999998543  467899999999999999988     999999999


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhcC--------CCC----CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCc
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKNS--------YRS----FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE  231 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~~--------~~~----l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~  231 (411)
                      ++.+|+|+||| .|+|.+||....        ...    |+..+...|+.||+.|++||-++.+|||||-..|+||+++ 
T Consensus       561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~-  639 (774)
T KOG1026|consen  561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN-  639 (774)
T ss_pred             CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc-
Confidence            99999999999 999999997542        122    8899999999999999999999999999999999999764 


Q ss_pred             ccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccc-----cCCCccccceecCCCCCccchhHHHHH
Q 015222          232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVV-----STRHYRAPEVILGLGWNYPCDLWSVGC  306 (411)
Q Consensus       232 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~-----gt~~y~aPE~~~~~~~~~~~DiwSlGv  306 (411)
                                                ..|||+|||+++.......+.+     -.+.|||||.|..++|+++|||||+||
T Consensus       640 --------------------------l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GV  693 (774)
T KOG1026|consen  640 --------------------------LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGV  693 (774)
T ss_pred             --------------------------eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhh
Confidence                                      4788888888876554443322     257899999999999999999999999


Q ss_pred             HHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          307 ILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       307 il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      +|||+++ |+.||.+.++.+.++.+..... ++  ...+++.++..++..|    |.+.|.+||++.||-..
T Consensus       694 vLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L~--~Pe~CP~~vY~LM~~C----W~~~P~~RPsF~eI~~~  758 (774)
T KOG1026|consen  694 VLWEIFSYGKQPYYGLSNQEVIECIRAGQL-LS--CPENCPTEVYSLMLEC----WNENPKRRPSFKEIHSR  758 (774)
T ss_pred             hhhhhhccccCcccccchHHHHHHHHcCCc-cc--CCCCCCHHHHHHHHHH----hhcCcccCCCHHHHHHH
Confidence            9999999 9999999999999999987643 21  2234555666666555    88889999999998654

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.6e-39  Score=306.33  Aligned_cols=255  Identities=22%  Similarity=0.335  Sum_probs=199.2

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHh-cCCCCCcceEEEeeeeecCCeE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      +.|++.+.||+|+||.||+|.+..+++.||||+++...  .....+..|+.++.+.. |++     ++++++++......
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~-----i~~~~~~~~~~~~~   89 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPY-----IVKCYGYFITDSDV   89 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCc-----hHhhheeeecCCeE
Confidence            57999999999999999999999999999999997532  23344556776665554 555     49999999999999


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      |+||||++++|.+++.... ..+++..+..++.||+.||+|||+ .||+||||+|+||+++.++                
T Consensus        90 ~~v~e~~~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~----------------  152 (296)
T cd06618          90 FICMELMSTCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG----------------  152 (296)
T ss_pred             EEEeeccCcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC----------------
Confidence            9999999888888876643 378999999999999999999997 5999999999999997766                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCC----CCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                                 .++|+|||.+......  .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||...
T Consensus       153 -----------~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  221 (296)
T cd06618         153 -----------NVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC  221 (296)
T ss_pred             -----------CEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence                       5677777766543221  12235788999999997654    789999999999999999999999764


Q ss_pred             Ch-HHHHHHHHHHh-CCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          322 EN-LEHLAMMERVL-GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       322 ~~-~~~~~~i~~~~-~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      .. .+.+..+.... ...+.  ....+..+.+++.+|+..+    |..||++.++++|+|+.....
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~----p~~Rp~~~~il~~~~~~~~~~  281 (296)
T cd06618         222 KTEFEVLTKILQEEPPSLPP--NEGFSPDFCSFVDLCLTKD----HRKRPKYRELLQHPFIRRYET  281 (296)
T ss_pred             hhHHHHHHHHhcCCCCCCCC--CCCCCHHHHHHHHHHccCC----hhhCCCHHHHhcChhhhccch
Confidence            33 23333222211 11111  1135677899999999988    999999999999999997554

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.4e-39  Score=318.11  Aligned_cols=248  Identities=21%  Similarity=0.285  Sum_probs=194.9

Q ss_pred             CCeEEEeeeccccceEEEEEEeC-----CCCcEEEEEEeccch--hhhHHHHHHHHHHHHHh-cCCCCCcceEEEeeeee
Q 015222           92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~~~  163 (411)
                      ++|.+.++||+|+||.||+|++.     .+++.||||+++...  ...+.+.+|+.++.++. |+|+     +++++.+.
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~ni-----v~~~~~~~  111 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNI-----VNLLGACT  111 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCe-----EEEEEEEc
Confidence            46889999999999999999864     345689999997532  23346788999999997 7766     99999999


Q ss_pred             cCCeEEEEEccC-CCCHHHHHHhcCC------------------------------------------------------
Q 015222          164 YRNHICIVFEKL-GPSLYDFLRKNSY------------------------------------------------------  188 (411)
Q Consensus       164 ~~~~~~lv~e~~-~~~L~~~l~~~~~------------------------------------------------------  188 (411)
                      ..+..++||||+ +|+|.+++.+...                                                      
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            999999999999 9999999975421                                                      


Q ss_pred             ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015222          189 ------------------------------------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL  226 (411)
Q Consensus       189 ------------------------------------------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIl  226 (411)
                                                                ..+++..+..++.||+.||+|||+.||+||||||+|||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL  271 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL  271 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence                                                      23677788999999999999999999999999999999


Q ss_pred             EecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCCCccchh
Q 015222          227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDL  301 (411)
Q Consensus       227 i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di  301 (411)
                      ++.++                           .++|+|||++......     .....++..|+|||.+.+..++.++||
T Consensus       272 l~~~~---------------------------~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv  324 (401)
T cd05107         272 ICEGK---------------------------LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDV  324 (401)
T ss_pred             EeCCC---------------------------EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHH
Confidence            98765                           5677777776543211     122356788999999998889999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          302 WSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       302 wSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      |||||++|||++ |..||......+............  ......+..+.+++.+|+..+    |.+||++.++++.
T Consensus       325 wslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~l~~li~~cl~~~----P~~RPs~~ell~~  395 (401)
T cd05107         325 WSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM--AKPAHASDEIYEIMQKCWEEK----FEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCC----hhHCcCHHHHHHH
Confidence            999999999998 899998765544433322211111  112345678889999887777    9999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-39  Score=297.81  Aligned_cols=239  Identities=27%  Similarity=0.426  Sum_probs=202.5

Q ss_pred             eccccceEEEEEEeCCCCcEEEEEEeccchh----hhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC
Q 015222          100 MGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL  175 (411)
Q Consensus       100 lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~  175 (411)
                      ||.|+||.||++.+..+++.||+|++.....    ....+..|+.+++++.|+++     +++++.++.++..|+|||++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI-----VKLHYAFQTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcH-----HHHHHHeecCCeeEEEEecC
Confidence            6999999999999998899999999875432    34577889999999998877     99999999999999999999


Q ss_pred             -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccC
Q 015222          176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL  254 (411)
Q Consensus       176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~  254 (411)
                       +++|.+++....  .+++..+..++.|++.||.|||+.+++|+||||+||+++.++                       
T Consensus        76 ~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~-----------------------  130 (250)
T cd05123          76 PGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG-----------------------  130 (250)
T ss_pred             CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC-----------------------
Confidence             999999998765  689999999999999999999999999999999999997766                       


Q ss_pred             CCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015222          255 PKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME  331 (411)
Q Consensus       255 ~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~  331 (411)
                          .++|+|||.+......   .....++..|+|||.+.+...+.++|+||||+++|+|++|..||...+..+....+.
T Consensus       131 ----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~  206 (250)
T cd05123         131 ----HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL  206 (250)
T ss_pred             ----cEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence                5788888877654332   234567889999999988888999999999999999999999998777655555554


Q ss_pred             HHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHH---HHHHhcCCC
Q 015222          332 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSM---RAVWKLLRL  380 (411)
Q Consensus       332 ~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~---~~il~~~~~  380 (411)
                      .....++..    .+..+.+++.+|+..+    |..||++   +++++|+||
T Consensus       207 ~~~~~~~~~----~~~~l~~~i~~~l~~~----p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         207 KDPLRFPEF----LSPEARDLISGLLQKD----PTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             cCCCCCCCC----CCHHHHHHHHHHhcCC----HhhCCCcccHHHHHhCCCC
Confidence            433333333    3677899999999998    8888888   999999997

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.6e-39  Score=308.88  Aligned_cols=255  Identities=19%  Similarity=0.196  Sum_probs=191.6

Q ss_pred             cceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC-CCCH
Q 015222          104 TFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSL  179 (411)
Q Consensus       104 ~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L  179 (411)
                      ++|.||.+++..+++.||||+++..   ....+.+.+|+.+++.++|+|+     +++++++...+..+++|||+ +++|
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i-----~~~~~~~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI-----LPYVTSFIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcch-----hhhhheeecCCeEEEEEeccCCCCH
Confidence            4456666677779999999998743   3445678899999999988877     99999999999999999999 8999


Q ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccCCCCCC
Q 015222          180 YDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA  259 (411)
Q Consensus       180 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~  259 (411)
                      .+++.......+++..+..++.||+.||+|||++||+||||||+||+++.+|.++++||+........+..        .
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~--------~  158 (314)
T cd08216          87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR--------Q  158 (314)
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccc--------c
Confidence            99998765456899999999999999999999999999999999999998886666666543222111000        0


Q ss_pred             eeEeecCCcccccCCCcccccCCCccccceecCC--CCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC--
Q 015222          260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG--  335 (411)
Q Consensus       260 ~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~--  335 (411)
                               ...........++..|+|||++.+.  .++.++|||||||++|||++|..||........+........  
T Consensus       159 ---------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  229 (314)
T cd08216         159 ---------RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPC  229 (314)
T ss_pred             ---------cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCcc
Confidence                     0000111223567889999998764  588999999999999999999999987654433221111000  


Q ss_pred             ----------------------------CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          336 ----------------------------PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       336 ----------------------------~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                                                  ..+.......+..+.+++.+||..+    |++||+++++++||||..+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         230 LLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRD----PESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             ccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcC----CCcCcCHHHHhcCchHhhhc
Confidence                                        0111112234567888999998888    99999999999999998765

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.5e-39  Score=300.70  Aligned_cols=246  Identities=23%  Similarity=0.350  Sum_probs=197.4

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCc---EEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~---~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      +.|++.+.||+|+||.||+|.++.+++   .||||+++..  ......+..|+.+++.+.|+|+     +++++++..++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----~~~~~~~~~~~   78 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI-----IHLEGVVTKSR   78 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCc-----ceEEEEECCCC
Confidence            468999999999999999999887664   6999998753  3345678899999999988877     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      ..++||||+ +++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++              
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~--------------  143 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL--------------  143 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC--------------
Confidence            999999999 889999987654 3689999999999999999999999999999999999997766              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCCCc-----c-c--ccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS-----Y-V--VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEA  316 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~-----~-~--~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~  316 (411)
                                   .++|+|||.+........     . .  ..+..|+|||.+.+..++.++|||||||++|||++ |..
T Consensus       144 -------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~  210 (269)
T cd05065         144 -------------VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER  210 (269)
T ss_pred             -------------cEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCC
Confidence                         456666665543322110     0 1  12457999999998899999999999999999887 999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ||...+..+....+.... ..|  .....+..+.+++.+|+..+    |.+||++.+++..
T Consensus       211 p~~~~~~~~~~~~i~~~~-~~~--~~~~~~~~~~~li~~~l~~~----p~~Rp~~~~i~~~  264 (269)
T cd05065         211 PYWDMSNQDVINAIEQDY-RLP--PPMDCPTALHQLMLDCWQKD----RNARPKFGQIVST  264 (269)
T ss_pred             CCCCCCHHHHHHHHHcCC-cCC--CcccCCHHHHHHHHHHcCCC----hhhCcCHHHHHHH
Confidence            998877766666554322 111  12345667888999998888    8899999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-39  Score=298.37  Aligned_cols=238  Identities=22%  Similarity=0.288  Sum_probs=191.0

Q ss_pred             eeeccccceEEEEEEeCCCC---cEEEEEEeccchh--hhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEE
Q 015222           98 SKMGEGTFGQVVECFDNEKK---ELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF  172 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~---~~vavK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~  172 (411)
                      ++||+|+||.||+|.+..++   ..||+|.+.....  ..+.+.+|+.+++.+.|+++     +++++++. .+..++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~-~~~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCI-----VRLIGVCK-GEPLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCe-----eeEEEEEc-CCceEEEE
Confidence            47999999999999876554   7899999975443  45678889999999988776     99998876 45789999


Q ss_pred             ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCcc
Q 015222          173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF  251 (411)
Q Consensus       173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~  251 (411)
                      ||+ +++|.+++....  .+++..+..++.|++.||+|||+.|++|+||||+|||++.++                    
T Consensus        75 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~--------------------  132 (257)
T cd05060          75 ELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH--------------------  132 (257)
T ss_pred             EeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCC--------------------
Confidence            999 899999998765  689999999999999999999999999999999999998877                    


Q ss_pred             ccCCCCCCeeEeecCCcccccCCCc------ccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChH
Q 015222          252 KNLPKSSAIKLIDFGSTTFEHQDHS------YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL  324 (411)
Q Consensus       252 ~~~~~~~~~kl~Dfg~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~  324 (411)
                             .++|+|||.+........      ...++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..
T Consensus       133 -------~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~  205 (257)
T cd05060         133 -------QAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA  205 (257)
T ss_pred             -------cEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH
Confidence                   456666665554322211      1123467999999998899999999999999999998 99999887766


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      +....+.....   .......+..+.+++.+|+..+    |.+||++.++++.
T Consensus       206 ~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~----p~~Rp~~~~l~~~  251 (257)
T cd05060         206 EVIAMLESGER---LPRPEECPQEIYSIMLSCWKYR----PEDRPTFSELEST  251 (257)
T ss_pred             HHHHHHHcCCc---CCCCCCCCHHHHHHHHHHhcCC----hhhCcCHHHHHHH
Confidence            55555443321   1222345678899999999998    8899999988764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.8e-39  Score=298.07  Aligned_cols=242  Identities=22%  Similarity=0.294  Sum_probs=194.7

Q ss_pred             eeeccccceEEEEEEeCC-CC--cEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEE
Q 015222           98 SKMGEGTFGQVVECFDNE-KK--ELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF  172 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~-~~--~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~  172 (411)
                      +.||+|++|.||+|.+.. .+  ..||||.+....  ...+.+.+|+.++++++|+|+     +++++.+.. ...++||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~-~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENL-----IRLYGVVLT-HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCc-----cceeEEEcC-CeEEEEE
Confidence            468999999999999865 33  369999997543  345678899999999988887     999999887 8999999


Q ss_pred             ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCcc
Q 015222          173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF  251 (411)
Q Consensus       173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~  251 (411)
                      ||+ +++|.+++.......+++..++.++.|++.||+|||++|++|+||||+||+++.++.+                  
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~------------------  136 (257)
T cd05040          75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKV------------------  136 (257)
T ss_pred             EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEE------------------
Confidence            999 9999999987643468999999999999999999999999999999999999887744                  


Q ss_pred             ccCCCCCCeeEeecCCcccccCC------CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChH
Q 015222          252 KNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL  324 (411)
Q Consensus       252 ~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~  324 (411)
                               ||+|||++......      .....++..|+|||.+.+..++.++|||||||++|||++ |..||...+..
T Consensus       137 ---------kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  207 (257)
T cd05040         137 ---------KIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS  207 (257)
T ss_pred             ---------EeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH
Confidence                     55555554433221      112356778999999998899999999999999999999 99999877777


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      +....+.......+  .....+..+.+++.+|+..+    |++||++.++++..
T Consensus       208 ~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~----p~~Rps~~~~~~~l  255 (257)
T cd05040         208 QILKKIDKEGERLE--RPEACPQDIYNVMLQCWAHN----PADRPTFAALREFL  255 (257)
T ss_pred             HHHHHHHhcCCcCC--CCccCCHHHHHHHHHHCCCC----cccCCCHHHHHHHh
Confidence            66666554222221  12345678889999998888    99999999998653

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.6e-39  Score=300.37  Aligned_cols=248  Identities=27%  Similarity=0.412  Sum_probs=200.7

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch------hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      +|.+.++||+|+||.||++.+..++..+++|+++...      .....+..|+.+++.++|+|+     +++++++.+..
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI-----VKFHASFLERD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcH-----HHHHHHHhcCC
Confidence            6999999999999999999998887778788775321      223456678889998888877     99999999889


Q ss_pred             eEEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          167 HICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                      ..++||||+ +++|.+++...  ....+++..++.++.|++.||.|||+.|++|+||||+||++++ +            
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~------------  142 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-N------------  142 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-C------------
Confidence            999999999 88999988642  2246999999999999999999999999999999999999964 2            


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT  320 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~  320 (411)
                                     .++|+|||.+......   .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||..
T Consensus       143 ---------------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~  207 (260)
T cd08222         143 ---------------LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG  207 (260)
T ss_pred             ---------------CEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                           4677777776543222   1234678899999999888889999999999999999999999987


Q ss_pred             CChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      .+.......+..  +. ........+..+.+++.+|+..+    |++||++.++++|+||
T Consensus       208 ~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~li~~~l~~~----p~~Rp~~~~il~~~~~  260 (260)
T cd08222         208 QNFLSVVLRIVE--GP-TPSLPETYSRQLNSIMQSMLNKD----PSLRPSAAEILRNPFI  260 (260)
T ss_pred             ccHHHHHHHHHc--CC-CCCCcchhcHHHHHHHHHHhcCC----hhhCcCHHHHhhCCCC
Confidence            655444443332  22 22233456778899999998888    9999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.9e-39  Score=304.38  Aligned_cols=257  Identities=17%  Similarity=0.211  Sum_probs=183.5

Q ss_pred             eCCccCCCeEEEeeeccccceEEEEEEeCCC---CcEEEEEEeccchhhh--HH-------HHHHHHHHHHHhcCCCCCc
Q 015222           86 IGENLTPRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSINKYR--EA-------AMIEIDVLQRLARHDIGGT  153 (411)
Q Consensus        86 ~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~---~~~vavK~~~~~~~~~--~~-------~~~E~~~l~~l~~~~i~~~  153 (411)
                      +.+...++|++.+.||+|+||+||+|.+..+   +..+|+|+........  +.       ...++..+.  ...++.|+
T Consensus         6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~--~~~~~~h~   83 (294)
T PHA02882          6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWK--NIHNIDHL   83 (294)
T ss_pred             eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHH--HhccCCCC
Confidence            3455668999999999999999999998887   6778888754222110  00       011122222  22345666


Q ss_pred             ceEEEeeeeecCC----eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 015222          154 RCVQIRNWFDYRN----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS  229 (411)
Q Consensus       154 ~iv~~~~~~~~~~----~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~  229 (411)
                      +++.+++......    ..+++|+++..++.+.+....  ..++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus        84 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~  161 (294)
T PHA02882         84 GIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDG  161 (294)
T ss_pred             CCCcEEEeeeEecCCceEEEEEEehhccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence            7788888655432    568899998778888776643  4678889999999999999999999999999999999977


Q ss_pred             CcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccC----------CCcccccCCCccccceecCCCCCccc
Q 015222          230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ----------DHSYVVSTRHYRAPEVILGLGWNYPC  299 (411)
Q Consensus       230 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~  299 (411)
                      ++                           .++|+|||+|+....          ......||+.|+|||++.+..++.++
T Consensus       162 ~~---------------------------~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~  214 (294)
T PHA02882        162 NN---------------------------RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRG  214 (294)
T ss_pred             CC---------------------------cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHH
Confidence            66                           566777776654321          11224699999999999999999999


Q ss_pred             hhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHH-HhCCC--ChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHH
Q 015222          300 DLWSVGCILVELCSGEALFQTHENL-EHLAMMER-VLGPL--PHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVW  375 (411)
Q Consensus       300 DiwSlGvil~elltg~~pf~~~~~~-~~~~~i~~-~~~~~--p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il  375 (411)
                      |||||||++|||++|+.||.+.... +....... ....+  +.......++.+.+++..|+..+    |.+||++.+++
T Consensus       215 DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~rp~~~~l~  290 (294)
T PHA02882        215 DLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLS----YEEKPDYDALI  290 (294)
T ss_pred             HHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCC----CCCCCCHHHHH
Confidence            9999999999999999999876332 22211110 00000  11112334667888888888887    99999999987


Q ss_pred             hc
Q 015222          376 KL  377 (411)
Q Consensus       376 ~~  377 (411)
                      +.
T Consensus       291 ~~  292 (294)
T PHA02882        291 KI  292 (294)
T ss_pred             Hh
Confidence            63

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.8e-39  Score=309.13  Aligned_cols=249  Identities=18%  Similarity=0.276  Sum_probs=197.7

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCC-------CcEEEEEEeccc--hhhhHHHHHHHHHHHHH-hcCCCCCcceEEEeee
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEK-------KELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNW  161 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~-------~~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~  161 (411)
                      .+|++.+.||+|+||.||+|++...       +..||+|+++..  ....+.+.+|+.+++++ .|+||     ++++++
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----v~~~~~   86 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNI-----INLLGA   86 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCe-----eeeeEE
Confidence            5799999999999999999986432       236999988743  23456788899999999 67776     999999


Q ss_pred             eecCCeEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015222          162 FDYRNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL  226 (411)
Q Consensus       162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIl  226 (411)
                      +..++..+++|||+ +++|.+++.+..              ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil  166 (334)
T cd05100          87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL  166 (334)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEE
Confidence            99999999999999 889999997642              134788899999999999999999999999999999999


Q ss_pred             EecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchh
Q 015222          227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDL  301 (411)
Q Consensus       227 i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di  301 (411)
                      ++.++                           .++|+|||+++......     ....++..|+|||++.+..++.++||
T Consensus       167 l~~~~---------------------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  219 (334)
T cd05100         167 VTEDN---------------------------VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV  219 (334)
T ss_pred             EcCCC---------------------------cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhh
Confidence            98766                           45666666655432211     11234567999999999899999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCC
Q 015222          302 WSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR  379 (411)
Q Consensus       302 wSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~  379 (411)
                      |||||++|||++ |..||.+.+..+....+.....   .......+..+.+++.+|++.+    |.+||++.+++++..
T Consensus       220 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~----p~~Rps~~ell~~l~  291 (334)
T cd05100         220 WSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR---MDKPANCTHELYMIMRECWHAV----PSQRPTFKQLVEDLD  291 (334)
T ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCHHHHHHHHHHcccC----hhhCcCHHHHHHHHH
Confidence            999999999998 8999988776666555543221   1122345667889999999888    888889999888753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.4e-39  Score=297.22  Aligned_cols=239  Identities=23%  Similarity=0.311  Sum_probs=188.9

Q ss_pred             eeccccceEEEEEEeC--CCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEcc
Q 015222           99 KMGEGTFGQVVECFDN--EKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK  174 (411)
Q Consensus        99 ~lG~G~~g~V~~a~~~--~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~  174 (411)
                      .||+|+||.||+|.+.  .++..||+|++....  ...+.+.+|+.+++++.|+++     +++++++. .+..++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----i~~~~~~~-~~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYI-----VRMIGVCE-AEALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCe-----EEEEEEEc-CCCeEEEEEe
Confidence            4899999999999765  455679999987543  334668899999999988877     99999876 4578999999


Q ss_pred             C-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCcccc
Q 015222          175 L-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN  253 (411)
Q Consensus       175 ~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~  253 (411)
                      + +++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||++.++                      
T Consensus        76 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~----------------------  132 (257)
T cd05115          76 ASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH----------------------  132 (257)
T ss_pred             CCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC----------------------
Confidence            9 899999987543 3689999999999999999999999999999999999998766                      


Q ss_pred             CCCCCCeeEeecCCcccccCCC------cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHH
Q 015222          254 LPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEH  326 (411)
Q Consensus       254 ~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~  326 (411)
                           .++|+|||++.......      ....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.
T Consensus       133 -----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  207 (257)
T cd05115         133 -----YAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV  207 (257)
T ss_pred             -----cEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH
Confidence                 45666666655332211      11123568999999988889999999999999999996 9999988777666


Q ss_pred             HHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       327 ~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ...+.....   .......+..+.+++.+|+..+    |.+||++.++.+..
T Consensus       208 ~~~~~~~~~---~~~~~~~~~~l~~li~~c~~~~----~~~Rp~~~~i~~~l  252 (257)
T cd05115         208 MSFIEQGKR---LDCPAECPPEMYALMKDCWIYK----WEDRPNFAKVEERM  252 (257)
T ss_pred             HHHHHCCCC---CCCCCCCCHHHHHHHHHHcCCC----hhhCcCHHHHHHHH
Confidence            555544321   1122345678889999998888    88889999987653

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3e-39  Score=304.49  Aligned_cols=251  Identities=21%  Similarity=0.304  Sum_probs=195.0

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCC----------------CCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNE----------------KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGG  152 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~----------------~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~  152 (411)
                      .++|++.++||+|+||.||+|.+..                ++..||+|+++..  ......+.+|+.+++.+.|+++  
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i--   81 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNI--   81 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCc--
Confidence            3579999999999999999986543                3457999999743  2345678899999999988877  


Q ss_pred             cceEEEeeeeecCCeEEEEEccC-CCCHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 015222          153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSY---------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKP  222 (411)
Q Consensus       153 ~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp  222 (411)
                         +++++++...+..++||||+ +++|.+++.....         ..+++..+..++.||+.||+|||+.||+|+||||
T Consensus        82 ---~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp  158 (296)
T cd05095          82 ---IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLAT  158 (296)
T ss_pred             ---ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCCh
Confidence               99999999999999999999 8999999976431         2467789999999999999999999999999999


Q ss_pred             CcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCc
Q 015222          223 ENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNY  297 (411)
Q Consensus       223 ~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~  297 (411)
                      +|||++.++                           .++|+|||++.......     ....++..|+|||...++.++.
T Consensus       159 ~Nili~~~~---------------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~  211 (296)
T cd05095         159 RNCLVGKNY---------------------------TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTT  211 (296)
T ss_pred             heEEEcCCC---------------------------CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccc
Confidence            999998766                           56667777665432211     1123467899999988888999


Q ss_pred             cchhHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhC----CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHH
Q 015222          298 PCDLWSVGCILVELCS--GEALFQTHENLEHLAMMERVLG----PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSM  371 (411)
Q Consensus       298 ~~DiwSlGvil~ellt--g~~pf~~~~~~~~~~~i~~~~~----~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~  371 (411)
                      ++|||||||++|||++  |..||...+..+..........    ..........+..+.+++.+|+..+    |.+||++
T Consensus       212 ~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~----p~~Rp~~  287 (296)
T cd05095         212 ASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRN----AKERPSF  287 (296)
T ss_pred             hhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCC----cccCCCH
Confidence            9999999999999998  7899987666555443322110    0000011234567889999998888    9999999


Q ss_pred             HHHHhc
Q 015222          372 RAVWKL  377 (411)
Q Consensus       372 ~~il~~  377 (411)
                      .++++.
T Consensus       288 ~~i~~~  293 (296)
T cd05095         288 QEIHAT  293 (296)
T ss_pred             HHHHHH
Confidence            998764

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.2e-39  Score=303.35  Aligned_cols=246  Identities=17%  Similarity=0.276  Sum_probs=195.8

Q ss_pred             CeEEEeeeccccceEEEEEEeCC-----CCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           93 RYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      +|++.+.||+|+||.||+|.+..     ....||+|.+....  .....+.+|+.+++.+.|+|+     +++++.+..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV-----IKLYGACSQD   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCE-----eeEEEEEecC
Confidence            48899999999999999998753     23579999886433  234567889999999988776     9999999999


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNS----------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKP  222 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp  222 (411)
                      +..+++|||+ +++|.+++....                      ...+++..+..++.|++.||+|||+.||+||||||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp  155 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAA  155 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhh
Confidence            9999999999 899999986431                      12478899999999999999999999999999999


Q ss_pred             CcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCc
Q 015222          223 ENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNY  297 (411)
Q Consensus       223 ~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~  297 (411)
                      +|||+++++                           .++|+|||++.......     ....++..|+|||.+.+..++.
T Consensus       156 ~nill~~~~---------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~  208 (290)
T cd05045         156 RNVLVAEGR---------------------------KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTT  208 (290)
T ss_pred             heEEEcCCC---------------------------cEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcch
Confidence            999997766                           56677777665432211     1224567899999998888999


Q ss_pred             cchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHh
Q 015222          298 PCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK  376 (411)
Q Consensus       298 ~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~  376 (411)
                      ++||||||+++|||++ |..||.+....+....+.......   .....+..+.+++.+|++.+    |.+||++.++++
T Consensus       209 ~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~~cl~~~----P~~Rp~~~~i~~  281 (290)
T cd05045         209 QSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRME---RPENCSEEMYNLMLTCWKQE----PDKRPTFADISK  281 (290)
T ss_pred             HhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC---CCCCCCHHHHHHHHHHccCC----cccCCCHHHHHH
Confidence            9999999999999998 999998877666555444322111   12345678889999999888    889999999875


Q ss_pred             c
Q 015222          377 L  377 (411)
Q Consensus       377 ~  377 (411)
                      .
T Consensus       282 ~  282 (290)
T cd05045         282 E  282 (290)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4.5e-39  Score=299.84  Aligned_cols=250  Identities=19%  Similarity=0.272  Sum_probs=200.6

Q ss_pred             CCeEEEeeeccccceEEEEEEeCC-----CCcEEEEEEeccchh--hhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      ++|++++.||+|+||.||+|+.+.     +.+.||+|.+.....  ..+.+.+|+.+++++.|+++     +++++++.+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNV-----VRLLGLCRE   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcce-----eeeEEEECC
Confidence            579999999999999999999754     346799999864332  35678899999999988877     999999999


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccC
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKNSY-------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP  236 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~  236 (411)
                      .+..++||||+ +++|.+++.....       ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.    
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~----  155 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE----  155 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc----
Confidence            89999999999 8999999976541       15899999999999999999999999999999999999988774    


Q ss_pred             CcccccccCCCCCccccCCCCCCeeEeecCCcccccCC----CcccccCCCccccceecCCCCCccchhHHHHHHHHHHH
Q 015222          237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC  312 (411)
Q Consensus       237 df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell  312 (411)
                                             ++|+|||.+......    .....++..|+|||.+.+..++.++|||||||++|+|+
T Consensus       156 -----------------------~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  212 (275)
T cd05046         156 -----------------------VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVF  212 (275)
T ss_pred             -----------------------EEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHH
Confidence                                   555566555432111    12235567899999998888899999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCC
Q 015222          313 S-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR  379 (411)
Q Consensus       313 t-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~  379 (411)
                      + |..||...........+.......+  .....+..+.+++.+|+..+    |..||++.++++..+
T Consensus       213 ~~~~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~~i~~~l~~~----p~~Rp~~~~~l~~l~  274 (275)
T cd05046         213 TQGELPFYGLSDEEVLNRLQAGKLELP--VPEGCPSRLYKLMTRCWAVN----PKDRPSFSELVSALG  274 (275)
T ss_pred             hCCCCCccccchHHHHHHHHcCCcCCC--CCCCCCHHHHHHHHHHcCCC----cccCCCHHHHHHHhc
Confidence            9 8999987666665555443222221  12345678899999999988    999999999987653

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.1e-39  Score=302.60  Aligned_cols=248  Identities=21%  Similarity=0.298  Sum_probs=189.8

Q ss_pred             CeEEEeeeccccceEEEEEEe----CCCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC-
Q 015222           93 RYRILSKMGEGTFGQVVECFD----NEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR-  165 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~----~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~-  165 (411)
                      -|++++.||+|+||.||+|..    ..++..||+|.++..  ......+.+|+.+++.+.|+|+     +++++++... 
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~   79 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI-----VKYKGICTEDG   79 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCe-----eeeeeEEecCC
Confidence            479999999999999999974    457889999998743  2344678899999999988877     9999888764 


Q ss_pred             -CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          166 -NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       166 -~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                       ...++||||+ +++|.+++.+.. ..+++..+..++.||+.||+|||++||+||||||+||+++.++            
T Consensus        80 ~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~------------  146 (284)
T cd05079          80 GNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH------------  146 (284)
T ss_pred             CCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC------------
Confidence             5789999999 999999997654 3589999999999999999999999999999999999998776            


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccCCC------cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL  317 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p  317 (411)
                                     .++|+|||++.......      ....++..|+|||++.+..++.++|||||||++|||+++..|
T Consensus       147 ---------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~  211 (284)
T cd05079         147 ---------------QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDS  211 (284)
T ss_pred             ---------------CEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCC
Confidence                           45666666655432211      123567789999999988899999999999999999998776


Q ss_pred             CCCCCh-----------HHHHH-HHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          318 FQTHEN-----------LEHLA-MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       318 f~~~~~-----------~~~~~-~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      +.....           ..... .+...............+..+.+++.+|++.+    |.+||+++++++.
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----p~~Rpt~~~il~~  279 (284)
T cd05079         212 ESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQ----PSKRTTFQNLIEG  279 (284)
T ss_pred             CccccchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCC----cccCcCHHHHHHH
Confidence            532110           00000 01111111111112345678999999999999    9999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4.5e-39  Score=302.00  Aligned_cols=247  Identities=18%  Similarity=0.267  Sum_probs=197.6

Q ss_pred             CCeEEEeeeccccceEEEEEEeCC-----CCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      ++|++.+.||+|+||.||+|.+..     ++..||+|++....  .....+.+|+.+++++.|+++     +++++++.+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i-----v~~~~~~~~   79 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNI-----VKLLGVCAV   79 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCch-----heEEEEEcC
Confidence            579999999999999999998753     67889999987432  334668889999999988877     999999999


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhcC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKNS--------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPE  223 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~~--------------------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~  223 (411)
                      ++..++||||+ +++|.+++....                    ...+++..+..++.||+.||.|||++|++||||||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~  159 (288)
T cd05050          80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR  159 (288)
T ss_pred             CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence            89999999999 889999997532                    124788899999999999999999999999999999


Q ss_pred             cEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCCCcc
Q 015222          224 NILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYP  298 (411)
Q Consensus       224 NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~  298 (411)
                      |||++.++                           .++|+|||.+......     .....++..|+|||.+.+..++.+
T Consensus       160 nil~~~~~---------------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  212 (288)
T cd05050         160 NCLVGENM---------------------------VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE  212 (288)
T ss_pred             heEecCCC---------------------------ceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCch
Confidence            99998776                           4566666655432211     111234567999999998899999


Q ss_pred             chhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          299 CDLWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       299 ~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      +|||||||++|||++ |..||.+.+..+....+...... +  .....+..+.+++.+|+..+    |.+||++.|+++.
T Consensus       213 ~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~l~~li~~~l~~~----p~~Rpt~~el~~~  285 (288)
T cd05050         213 SDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVL-S--CPDNCPLELYNLMRLCWSKL----PSDRPSFASINRI  285 (288)
T ss_pred             hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC-C--CCCCCCHHHHHHHHHHcccC----cccCCCHHHHHHH
Confidence            999999999999998 88999877776665555433211 1  11245677899999999988    9999999998764

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.7e-39  Score=310.31  Aligned_cols=247  Identities=21%  Similarity=0.295  Sum_probs=190.0

Q ss_pred             CCeEEEeeeccccceEEEEEEe-----CCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHh-cCCCCCcceEEEeeeee
Q 015222           92 PRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~-----~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~~~  163 (411)
                      ++|++.+.||+|+||.||+|.+     ..+++.||||+++...  .....+.+|+.++.++. |+|+     +++++++.
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni-----v~~~~~~~   81 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV-----VNLLGACT   81 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccH-----hhhcceee
Confidence            6899999999999999999985     3467899999997532  33456788999999995 4555     99998775


Q ss_pred             c-CCeEEEEEccC-CCCHHHHHHhcCC-----------------------------------------------------
Q 015222          164 Y-RNHICIVFEKL-GPSLYDFLRKNSY-----------------------------------------------------  188 (411)
Q Consensus       164 ~-~~~~~lv~e~~-~~~L~~~l~~~~~-----------------------------------------------------  188 (411)
                      . ++.+++||||+ +++|.+++.....                                                     
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence            4 45789999999 9999999875320                                                     


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccCCC
Q 015222          189 ------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK  256 (411)
Q Consensus       189 ------------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~  256 (411)
                                  ..+++..+..++.||+.||+|||++||+||||||+|||++.++                         
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~-------------------------  216 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN-------------------------  216 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC-------------------------
Confidence                        1367788899999999999999999999999999999997765                         


Q ss_pred             CCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHH-H
Q 015222          257 SSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLA-M  329 (411)
Q Consensus       257 ~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~-~  329 (411)
                        .++|+|||++.......     ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.......... .
T Consensus       217 --~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~  294 (343)
T cd05103         217 --VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  294 (343)
T ss_pred             --cEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH
Confidence              56777777665432211     11235677999999988899999999999999999997 999997754433222 2


Q ss_pred             HHHHhC-CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          330 MERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       330 i~~~~~-~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      +..... ..|    ...+..+.+++.+|++.+    |.+||++.++++|.
T Consensus       295 ~~~~~~~~~~----~~~~~~~~~~~~~cl~~~----p~~Rps~~eil~~l  336 (343)
T cd05103         295 LKEGTRMRAP----DYTTPEMYQTMLDCWHGE----PSQRPTFSELVEHL  336 (343)
T ss_pred             HhccCCCCCC----CCCCHHHHHHHHHHccCC----hhhCcCHHHHHHHH
Confidence            222111 111    124556788888887777    99999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-39  Score=298.45  Aligned_cols=241  Identities=21%  Similarity=0.266  Sum_probs=189.5

Q ss_pred             eeeccccceEEEEEEeCCCCc--EEEEEEeccc--hhhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeecCCeEEEEE
Q 015222           98 SKMGEGTFGQVVECFDNEKKE--LVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF  172 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~--~vavK~~~~~--~~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~~~~~~lv~  172 (411)
                      +.||+|+||.||+|++..++.  .+|+|.++..  ....+.+.+|+.+++++ .|+++     +++++++...+..++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----v~~~~~~~~~~~~~lv~   75 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI-----INLLGACEHRGYLYLAI   75 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCe-----eeEEEEEecCCCceEEE
Confidence            368999999999999988775  4688988742  33456788899999999 56666     99999999999999999


Q ss_pred             ccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCC
Q 015222          173 EKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD  237 (411)
Q Consensus       173 e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~d  237 (411)
                      ||+ +++|.+++....              ...+++..+..++.|++.||+|||+.|++||||||+|||++.++      
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~------  149 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY------  149 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC------
Confidence            999 899999997542              12478999999999999999999999999999999999998766      


Q ss_pred             cccccccCCCCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-C
Q 015222          238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-G  314 (411)
Q Consensus       238 f~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g  314 (411)
                                           .++|+|||++.......  .....+..|+|||++.+..++.++|||||||++|||++ |
T Consensus       150 ---------------------~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g  208 (270)
T cd05047         150 ---------------------VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG  208 (270)
T ss_pred             ---------------------eEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCC
Confidence                                 45666666654222111  11123567999999988889999999999999999997 9


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       315 ~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ..||.+.+..+....+....   ........+..+.+++.+|+..+    |.+||++.++++.
T Consensus       209 ~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~----p~~Rps~~~il~~  264 (270)
T cd05047         209 GTPYCGMTCAELYEKLPQGY---RLEKPLNCDDEVYDLMRQCWREK----PYERPSFAQILVS  264 (270)
T ss_pred             CCCccccCHHHHHHHHhCCC---CCCCCCcCCHHHHHHHHHHcccC----hhhCCCHHHHHHH
Confidence            99998776655555443321   11112235667889999998888    8899999998864

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=9e-39  Score=297.06  Aligned_cols=246  Identities=22%  Similarity=0.280  Sum_probs=197.2

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCC---CcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~---~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .++|.+.+.||+|+||.||+|.+...   ...||||.....  ....+.+.+|+.+++++.|+|+     +++++++.+ 
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~-   78 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI-----VKLIGVITE-   78 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCch-----hceeEEEcC-
Confidence            35699999999999999999987654   356999988743  3445678899999999988877     999998875 


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      +..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||+.|++|+||||+|||++.++             
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~-------------  144 (270)
T cd05056          79 NPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD-------------  144 (270)
T ss_pred             CCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC-------------
Confidence            5578999999 899999997654 3589999999999999999999999999999999999998766             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQ  319 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~  319 (411)
                                    .++|+|||++.......    ....++..|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus       145 --------------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~  210 (270)
T cd05056         145 --------------CVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQ  210 (270)
T ss_pred             --------------CeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCC
Confidence                          46666666665432221    11234567999999988889999999999999999996 999998


Q ss_pred             CCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      +.+..+....+.+....   ......+..+.+++.+|+..+    |.+||++.++++.
T Consensus       211 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~----P~~Rpt~~~~~~~  261 (270)
T cd05056         211 GVKNNDVIGRIENGERL---PMPPNCPPTLYSLMTKCWAYD----PSKRPRFTELKAQ  261 (270)
T ss_pred             CCCHHHHHHHHHcCCcC---CCCCCCCHHHHHHHHHHcCCC----hhhCcCHHHHHHH
Confidence            87776666555443221   112345678999999999888    8888999888765

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-38  Score=298.29  Aligned_cols=244  Identities=21%  Similarity=0.303  Sum_probs=194.9

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCc----EEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKE----LVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .+|++.+.||+|+||.||+|.++.+++    .||+|.+....  .....+.+|+.+++++.|+|+     +++++++.. 
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~-   80 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHV-----VRLLGICLS-   80 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEec-
Confidence            579999999999999999999877664    58999887543  344677889999999988877     999998876 


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      ...++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+|+||||+||+++.++             
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~-------------  146 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ-------------  146 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCC-------------
Confidence            7899999999 999999998754 3589999999999999999999999999999999999998766             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCCCc-----ccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS-----YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALF  318 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf  318 (411)
                                    .++|+|||.+........     ...++..|+|||.+.+..++.++|||||||++|||++ |+.||
T Consensus       147 --------------~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~  212 (279)
T cd05057         147 --------------HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPY  212 (279)
T ss_pred             --------------eEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCC
Confidence                          456666666554332211     1123567999999988889999999999999999999 99999


Q ss_pred             CCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHh
Q 015222          319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK  376 (411)
Q Consensus       319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~  376 (411)
                      .+....+....+..... .+.  ....+..+.+++.+|+..+    |..||++.++++
T Consensus       213 ~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~l~~~----p~~Rp~~~~l~~  263 (279)
T cd05057         213 EGIPAVEIPDLLEKGER-LPQ--PPICTIDVYMVLVKCWMID----AESRPTFKELIN  263 (279)
T ss_pred             CCCCHHHHHHHHhCCCC-CCC--CCCCCHHHHHHHHHHcCCC----hhhCCCHHHHHH
Confidence            88776665555543221 111  1234567888999998888    888888888764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.6e-39  Score=298.13  Aligned_cols=244  Identities=20%  Similarity=0.279  Sum_probs=189.1

Q ss_pred             eeccccceEEEEEEeCCC------------------------CcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCc
Q 015222           99 KMGEGTFGQVVECFDNEK------------------------KELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGT  153 (411)
Q Consensus        99 ~lG~G~~g~V~~a~~~~~------------------------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~  153 (411)
                      .||+|+||.||+|....+                        ...||+|++.... .....+.+|+.+++.+.|+|+   
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~ni---   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHL---   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCe---
Confidence            689999999999974321                        2458999986433 234567778889988888777   


Q ss_pred             ceEEEeeeeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcc
Q 015222          154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY  232 (411)
Q Consensus       154 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~  232 (411)
                        +++++++......++||||+ +++|.+++.+.. ..+++..+..++.||+.||+|||++||+||||||+|||++..+.
T Consensus        79 --v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          79 --AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             --eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCc
Confidence              99999999999999999999 899998887643 36899999999999999999999999999999999999987542


Q ss_pred             cccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecC-CCCCccchhHHHHHHHHHH
Q 015222          233 VKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVEL  311 (411)
Q Consensus       233 ~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~el  311 (411)
                      .                    ......++++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++|||
T Consensus       156 ~--------------------~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el  214 (274)
T cd05076         156 A--------------------EGTSPFIKLSDPGVSFTALSR-EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI  214 (274)
T ss_pred             c--------------------cCccceeeecCCccccccccc-cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHH
Confidence            1                    012235799999987543222 22357888999999876 4689999999999999999


Q ss_pred             H-hCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          312 C-SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       312 l-tg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      + +|..||......+....+.. ....|.    .....+.+++.+|++.+    |+.||++.++++++
T Consensus       215 ~~~g~~p~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~li~~cl~~~----p~~Rps~~~il~~L  273 (274)
T cd05076         215 CFDGEVPLKERTPSEKERFYEK-KHRLPE----PSCKELATLISQCLTYE----PTQRPSFRTILRDL  273 (274)
T ss_pred             HhCCCCCccccChHHHHHHHHh-ccCCCC----CCChHHHHHHHHHcccC----hhhCcCHHHHHHhh
Confidence            5 69999987665544333222 222332    13356788999998877    99999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.3e-39  Score=294.43  Aligned_cols=228  Identities=20%  Similarity=0.267  Sum_probs=181.4

Q ss_pred             ccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC-CCCHHH
Q 015222          103 GTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYD  181 (411)
Q Consensus       103 G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~  181 (411)
                      |.+|.||+|+++.+++.||+|.+.....    ..+|...+....|     +|++++++++...+..++||||+ +++|.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~~~-----~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   74 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPHCV-----PNMVCLHKYIVSEDSVFLVLQHAEGGKLWS   74 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhcCC-----CceeehhhheecCCeEEEEEecCCCCCHHH
Confidence            8999999999999999999999976432    2234444433334     45599999999999999999999 899999


Q ss_pred             HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccCCCCCCee
Q 015222          182 FLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK  261 (411)
Q Consensus       182 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~k  261 (411)
                      ++.+..  .+++..+..++.|++.||+|||++||+||||||+||+++.++                           .++
T Consensus        75 ~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~---------------------------~~~  125 (237)
T cd05576          75 HISKFL--NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG---------------------------HIQ  125 (237)
T ss_pred             HHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC---------------------------CEE
Confidence            998765  599999999999999999999999999999999999998766                           567


Q ss_pred             EeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Q 015222          262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHM  341 (411)
Q Consensus       262 l~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~  341 (411)
                      |+|||.+...........++..|+|||.+.+..++.++||||+||++|||++|..||.......  ..  .....+|   
T Consensus       126 l~df~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--~~--~~~~~~~---  198 (237)
T cd05576         126 LTYFSRWSEVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI--NT--HTTLNIP---  198 (237)
T ss_pred             EecccchhccccccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--cc--ccccCCc---
Confidence            7777766544443334456778999999988889999999999999999999999886432210  00  0001122   


Q ss_pred             HHhhhhhhhhhhccCCccCCCCCCCcHHHH-----HHHHhcCCC
Q 015222          342 VIRADRRAEKYFRRGARLDWPDGATSRDSM-----RAVWKLLRL  380 (411)
Q Consensus       342 ~~~~~~~~~~li~~~l~~~~~~rp~~R~t~-----~~il~~~~~  380 (411)
                       ..++..+.++|.+||+.|    |.+|+++     +++++||||
T Consensus       199 -~~~~~~~~~li~~~l~~d----p~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         199 -EWVSEEARSLLQQLLQFN----PTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             -ccCCHHHHHHHHHHccCC----HHHhcCCCccchHHHHcCCCC
Confidence             345677899999999999    8888774     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.1e-38  Score=295.50  Aligned_cols=245  Identities=20%  Similarity=0.217  Sum_probs=188.1

Q ss_pred             eeeccccceEEEEEEeCC------------CCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           98 SKMGEGTFGQVVECFDNE------------KKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~------------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      +.||+|+||.||+|+...            ....||+|++.... .....+.+|+.+++.+.|+|+     +++++++..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~i-----v~~~~~~~~   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHI-----VLLYGVCVR   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCE-----eeEEEEEec
Confidence            468999999999997532            23368999886533 234466778889999988777     999999998


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                      ....++||||+ +++|..++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++..          
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~----------  144 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGID----------  144 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCcc----------
Confidence            88999999999 889988887543 368999999999999999999999999999999999999876521          


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceec-CCCCCccchhHHHHHHHHHHH-hCCCCCCCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELC-SGEALFQTH  321 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~ell-tg~~pf~~~  321 (411)
                                ......++++|||.+...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||...
T Consensus       145 ----------~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  213 (262)
T cd05077         145 ----------GECGPFIKLSDPGIPITVLSR-QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK  213 (262)
T ss_pred             ----------CCCCceeEeCCCCCCccccCc-ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence                      012234899999988654322 2346788999999987 457899999999999999998 589999765


Q ss_pred             ChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ...+.... ........    ...+..+.+++.+|++.+    |.+||++.+++++.
T Consensus       214 ~~~~~~~~-~~~~~~~~----~~~~~~~~~li~~cl~~d----p~~Rp~~~~il~~~  261 (262)
T cd05077         214 TLAEKERF-YEGQCMLV----TPSCKELADLMTHCMNYD----PNQRPFFRAIMRDI  261 (262)
T ss_pred             chhHHHHH-HhcCccCC----CCChHHHHHHHHHHcCCC----hhhCcCHHHHHHhc
Confidence            54333221 11111111    122456788999998888    99999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=313.90  Aligned_cols=246  Identities=23%  Similarity=0.343  Sum_probs=198.0

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCc---E-EEEEEecc----chhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKE---L-VAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~---~-vavK~~~~----~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      +-.+.++||+|+||.||+|..+..+.   . ||||..+.    ......++.+|++++++++|+||     |+++|+..+
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NV-----Vr~yGVa~~  232 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNV-----VRFYGVAVL  232 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCE-----EEEEEEEcC
Confidence            33456899999999999998876432   3 89999874    24566788999999999999888     999999999


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                      +..+++|||+| ||+|.++|++... .++..+...++.+.+.||+|||++++|||||-.+|+|++.++            
T Consensus       233 ~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~------------  299 (474)
T KOG0194|consen  233 EEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKG------------  299 (474)
T ss_pred             CCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCC------------
Confidence            99999999999 9999999998873 699999999999999999999999999999999999998766            


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccCC--Cc-ccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HS-YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQ  319 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~-~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~  319 (411)
                                     .+||+|||+++....-  .. ...-...|+|||.+....|++++|||||||++||+++ |..||.
T Consensus       300 ---------------~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~  364 (474)
T KOG0194|consen  300 ---------------VVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYP  364 (474)
T ss_pred             ---------------eEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCC
Confidence                           4577777776654311  11 1123568999999999999999999999999999999 899999


Q ss_pred             CCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      +....+....+.......+..  ...+..+..++.+|    |...|+.|+++.++.+.
T Consensus       365 g~~~~~v~~kI~~~~~r~~~~--~~~p~~~~~~~~~c----~~~~p~~R~tm~~i~~~  416 (474)
T KOG0194|consen  365 GMKNYEVKAKIVKNGYRMPIP--SKTPKELAKVMKQC----WKKDPEDRPTMSTIKKK  416 (474)
T ss_pred             CCCHHHHHHHHHhcCccCCCC--CCCHHHHHHHHHHh----ccCChhhccCHHHHHHH
Confidence            999988888885433222211  13344455555555    55559999999988764

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=7e-39  Score=297.46  Aligned_cols=246  Identities=18%  Similarity=0.283  Sum_probs=195.1

Q ss_pred             eeeccccceEEEEEEeCCCC------cEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           98 SKMGEGTFGQVVECFDNEKK------ELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~------~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      +.||+|+||.||+|+++...      +.||+|.+....  .....+.+|+.+++.+.|+++     +++++++...+..+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI-----VKLLGVCLLNEPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCe-----eeEeeeecCCCCeE
Confidence            36899999999999886544      689999886433  345677889999999988877     99999999889999


Q ss_pred             EEEccC-CCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          170 IVFEKL-GPSLYDFLRKNS-----YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                      +||||+ +++|.+++.+..     ...+++..+..++.||+.||+|||+++++|+||||+||+++.++            
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~------------  143 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKG------------  143 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCC------------
Confidence            999999 899999997532     23478899999999999999999999999999999999998754            


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEAL  317 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p  317 (411)
                                .+....++|+|||++.......     ....++..|+|||.+.+..++.++|||||||++|||++ |..|
T Consensus       144 ----------~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p  213 (269)
T cd05044         144 ----------YDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP  213 (269)
T ss_pred             ----------CCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCC
Confidence                      1123357788888775432211     12345678999999999899999999999999999998 9999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      |...+..+....+....   ........+..+.+++.+|+..+    |.+||++.++++.
T Consensus       214 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~----p~~Rp~~~~i~~~  266 (269)
T cd05044         214 YPALNNQEVLQHVTAGG---RLQKPENCPDKIYQLMTNCWAQD----PSERPTFDRIQEI  266 (269)
T ss_pred             CcccCHHHHHHHHhcCC---ccCCcccchHHHHHHHHHHcCCC----cccCCCHHHHHHH
Confidence            98777666555443321   11122345677889999998888    9999999998764

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.3e-38  Score=292.47  Aligned_cols=239  Identities=22%  Similarity=0.301  Sum_probs=191.8

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL  175 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~  175 (411)
                      +.||+|+||.||+|... ++..||+|+++...  .....+.+|+.+++.+.|+|+     +++++++...+..++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNI-----VKLIGVCTQRQPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCc-----CeEEEEEecCCccEEEEECC
Confidence            36899999999999864 67889999987532  334567889999999988877     99999999999999999999


Q ss_pred             -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccC
Q 015222          176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL  254 (411)
Q Consensus       176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~  254 (411)
                       +++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++                       
T Consensus        75 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~-----------------------  130 (250)
T cd05085          75 PGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN-----------------------  130 (250)
T ss_pred             CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC-----------------------
Confidence             999999987654 3588999999999999999999999999999999999998776                       


Q ss_pred             CCCCCeeEeecCCcccccCCC----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 015222          255 PKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAM  329 (411)
Q Consensus       255 ~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~  329 (411)
                          .++|+|||++.......    ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.........
T Consensus       131 ----~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~  206 (250)
T cd05085         131 ----VLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ  206 (250)
T ss_pred             ----eEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence                45666666654332211    11234567999999998889999999999999999998 9999988766655554


Q ss_pred             HHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          330 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       330 i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      +....   ........+..+.+++.+|+..+    |+.||++.++++.
T Consensus       207 ~~~~~---~~~~~~~~~~~~~~li~~~l~~~----p~~Rp~~~~l~~~  247 (250)
T cd05085         207 VEKGY---RMSCPQKCPDDVYKVMQRCWDYK----PENRPKFSELQKE  247 (250)
T ss_pred             HHcCC---CCCCCCCCCHHHHHHHHHHcccC----cccCCCHHHHHHH
Confidence            44321   11222345678899999999988    9999999998865

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-38  Score=292.89  Aligned_cols=240  Identities=23%  Similarity=0.331  Sum_probs=193.6

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL  175 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~  175 (411)
                      ++||+|+||.||+|.+.. ++.||+|++....  .....+.+|+.+++++.|+++     +++++++...+..++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNI-----VKLIGVCVQKQPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCe-----EEEEEEEecCCCeEEEEEcC
Confidence            478999999999999887 8999999987533  245678899999999988877     99999999999999999999


Q ss_pred             -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccC
Q 015222          176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL  254 (411)
Q Consensus       176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~  254 (411)
                       +++|.+++.... ..+++..+..++.|++.||+|||++|++||||||+|||++.++                       
T Consensus        75 ~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~-----------------------  130 (251)
T cd05041          75 PGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN-----------------------  130 (251)
T ss_pred             CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC-----------------------
Confidence             899999997654 3688999999999999999999999999999999999998776                       


Q ss_pred             CCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 015222          255 PKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLA  328 (411)
Q Consensus       255 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~  328 (411)
                          .++|+|||.+.......     ....++..|+|||.+.+..++.++|||||||++|||++ |..||..........
T Consensus       131 ----~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~  206 (251)
T cd05041         131 ----VLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE  206 (251)
T ss_pred             ----cEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH
Confidence                45666666655432111     11123567999999998899999999999999999999 899998776655554


Q ss_pred             HHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          329 MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       329 ~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      .+..... .  ......+..+.+++.+|+..+    |.+||++.++++..
T Consensus       207 ~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~----p~~Rp~~~ell~~l  249 (251)
T cd05041         207 RIESGYR-M--PAPQLCPEEIYRLMLQCWAYD----PENRPSFSEIYNEL  249 (251)
T ss_pred             HHhcCCC-C--CCCccCCHHHHHHHHHHhccC----hhhCcCHHHHHHHh
Confidence            4433211 1  112345678899999998888    99999999998753

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.6e-38  Score=297.04  Aligned_cols=248  Identities=18%  Similarity=0.225  Sum_probs=197.0

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCC----CCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNE----KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~----~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      .++|++.+.||+|+||.||+|.+..    ++..||+|++...  ....+.+.+|+.+++.+.|+|+     +++++++..
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----~~~~~~~~~   79 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI-----LPILHVCIE   79 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEec
Confidence            4689999999999999999999876    3578999998743  2345667889999999988888     999987655


Q ss_pred             -CCeEEEEEccC-CCCHHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccC
Q 015222          165 -RNHICIVFEKL-GPSLYDFLRKNSY------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP  236 (411)
Q Consensus       165 -~~~~~lv~e~~-~~~L~~~l~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~  236 (411)
                       +...++++||+ +++|.+++.....      ..+++..+..++.||+.||+|||+.|++|+||||+||+++.++     
T Consensus        80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~-----  154 (280)
T cd05043          80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL-----  154 (280)
T ss_pred             CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC-----
Confidence             57889999999 8999999976431      3589999999999999999999999999999999999998766     


Q ss_pred             CcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchhHHHHHHHHHH
Q 015222          237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL  311 (411)
Q Consensus       237 df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el  311 (411)
                                            .+||+|||+++......     ....++..|+|||++.+..++.++|||||||++||+
T Consensus       155 ----------------------~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el  212 (280)
T cd05043         155 ----------------------QVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWEL  212 (280)
T ss_pred             ----------------------cEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHH
Confidence                                  45666666655332111     112456779999999988899999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          312 CS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       312 lt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ++ |+.||...+..+....+.... ..  ......++.+.+++.+|+..+    |+.||++.++++.
T Consensus       213 ~~~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~li~~~l~~~----p~~Rps~~~~~~~  272 (280)
T cd05043         213 MTLGQTPYVEIDPFEMAAYLKDGY-RL--AQPINCPDELFAVMACCWALD----PEERPSFSQLVQC  272 (280)
T ss_pred             hcCCCCCcCcCCHHHHHHHHHcCC-CC--CCCCcCCHHHHHHHHHHcCCC----hhhCCCHHHHHHH
Confidence            99 999998776655544443321 11  112345677889999998888    9999999998864

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-38  Score=297.70  Aligned_cols=247  Identities=24%  Similarity=0.328  Sum_probs=187.6

Q ss_pred             CCeEEEeeeccccceEEEEEE----eCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec--
Q 015222           92 PRYRILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--  164 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~----~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~--  164 (411)
                      ++|++++.||+|+||.||+|.    +..+++.||+|.+.... ...+.+.+|+.+++++.|+|+     +++++++..  
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~   78 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI-----VKYKGVCYSAG   78 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCe-----eEEEEEEccCC
Confidence            479999999999999999997    45678899999987543 334677899999999988877     999887643  


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                      ...+++||||+ +++|.+++.+.. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.           
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~-----------  146 (284)
T cd05081          79 RRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR-----------  146 (284)
T ss_pred             CCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCe-----------
Confidence            45789999999 999999997653 35899999999999999999999999999999999999987764           


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccCCCc------ccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS------YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL  317 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p  317 (411)
                                      ++|+|||++........      ...++..|+|||++.+..++.++|||||||++|||++|..+
T Consensus       147 ----------------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~  210 (284)
T cd05081         147 ----------------VKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDK  210 (284)
T ss_pred             ----------------EEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCc
Confidence                            55666665554322111      11234569999999988899999999999999999998877


Q ss_pred             CCCCChHH---------------HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          318 FQTHENLE---------------HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       318 f~~~~~~~---------------~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      +.......               .+..+......++  .....+..+.+++.+|+..+    |+.|||+.++++.
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~----p~~Rpt~~ei~~~  279 (284)
T cd05081         211 SCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLP--APPGCPAEIYAIMKECWNND----PSQRPSFSELALQ  279 (284)
T ss_pred             CCCcchhhhhhcccccccccchHHHHHHHhcCCcCC--CCCCCCHHHHHHHHHHccCC----hhhCCCHHHHHHH
Confidence            64322110               0000111111111  11235667889999998888    9999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.4e-38  Score=293.48  Aligned_cols=243  Identities=21%  Similarity=0.267  Sum_probs=192.0

Q ss_pred             eeeccccceEEEEEEeCCCC----------cEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           98 SKMGEGTFGQVVECFDNEKK----------ELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~----------~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      +.||+|+||.||+|.+..++          ..|++|++.........+.+|+.+++.+.|+++     +++++++.. ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~-~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHL-----VKLYGVCVR-DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcch-----hheeeEEec-CC
Confidence            46899999999999998776          458889887554446778899999999988877     999998877 77


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      .++||||+ +++|.+++..... .+++..+..++.||+.||+|||++||+||||||+|||++.++..             
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~-------------  140 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLN-------------  140 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccc-------------
Confidence            89999999 9999999987542 68999999999999999999999999999999999999876510             


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCC--CCCccchhHHHHHHHHHHHh-CCCCCCCCCh
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCS-GEALFQTHEN  323 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ellt-g~~pf~~~~~  323 (411)
                             ......++|+|||++..... .....++..|+|||++.+.  .++.++|||||||++|+|++ |..||...+.
T Consensus       141 -------~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~  212 (259)
T cd05037         141 -------EGYVPFIKLSDPGIPITVLS-REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS  212 (259)
T ss_pred             -------cCCceeEEeCCCCccccccc-ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc
Confidence                   01223589999998876543 2234677889999999876  78999999999999999999 6888877654


Q ss_pred             HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      .+...... .....+..    ....+.+++.+|+..+    |.+||++.++++.
T Consensus       213 ~~~~~~~~-~~~~~~~~----~~~~~~~li~~~l~~~----p~~Rpt~~~il~~  257 (259)
T cd05037         213 SEKERFYQ-DQHRLPMP----DCAELANLINQCWTYD----PTKRPSFRAILRD  257 (259)
T ss_pred             hhHHHHHh-cCCCCCCC----CchHHHHHHHHHhccC----hhhCCCHHHHHHh
Confidence            33333222 11112111    1257889999998888    9999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.9e-39  Score=298.57  Aligned_cols=249  Identities=21%  Similarity=0.304  Sum_probs=194.0

Q ss_pred             CCeEEEeeeccccceEEEEEEeC----CCCcEEEEEEeccchh--hhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec-
Q 015222           92 PRYRILSKMGEGTFGQVVECFDN----EKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-  164 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~----~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~-  164 (411)
                      ..|++.+.||+|+||.||+|...    .+++.||||++.....  ..+.+.+|+++++.+.|+++     +++++++.. 
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i-----~~~~~~~~~~   78 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI-----VKYKGVCEKP   78 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCCh-----heEEeeeecC
Confidence            46889999999999999999864    3478999999986544  36778999999999988877     999998877 


Q ss_pred             -CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccc
Q 015222          165 -RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       165 -~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                       +...++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+|+||||+||+++.++           
T Consensus        79 ~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~-----------  146 (284)
T cd05038          79 GGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED-----------  146 (284)
T ss_pred             CCCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-----------
Confidence             56899999999 899999998754 3589999999999999999999999999999999999998766           


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCcccccCCCc------ccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCC
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS------YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA  316 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~  316 (411)
                                      .++|+|||.+........      ...++..|+|||.+.+..++.++|||||||++|||++|..
T Consensus       147 ----------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~  210 (284)
T cd05038         147 ----------------LVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGD  210 (284)
T ss_pred             ----------------CEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCC
Confidence                            567777776665432211      1234567999999988899999999999999999999999


Q ss_pred             CCCCCChHH-----------HHHHHHH-HhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          317 LFQTHENLE-----------HLAMMER-VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       317 pf~~~~~~~-----------~~~~i~~-~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ||.......           ....+.. .............+..+.+++.+|+..+    |..||++.++++.
T Consensus       211 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~----p~~Rpt~~ei~~~  279 (284)
T cd05038         211 PSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAE----PQDRPSFADLILI  279 (284)
T ss_pred             CcccccchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccC----hhhCCCHHHHHHH
Confidence            986543211           0111111 1111111112234567889999998888    8888999998864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-39  Score=317.95  Aligned_cols=255  Identities=23%  Similarity=0.396  Sum_probs=219.3

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec-----C
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-----R  165 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~-----~  165 (411)
                      .+.|+|.+.||.|.+|.||+++.+.+++.+|+|++.......++++.|.++|+.+.|+    +|++.++++|..     +
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~h----pnv~~fyg~~~k~~~~~~   93 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHH----PNVATFYGAFIKKDPGNG   93 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCC----CCcceEEEEEEEecCCCC
Confidence            3579999999999999999999999999999999988888888899999999988643    556999988764     5


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      +.+||||||| ||+..|+++...+..+.|+.+..|++.++.||.+||...++|||||-.|||++.+|             
T Consensus        94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~-------------  160 (953)
T KOG0587|consen   94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA-------------  160 (953)
T ss_pred             CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC-------------
Confidence            6899999999 99999999877778899999999999999999999999999999999999998877             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCC-----CCCccchhHHHHHHHHHHHhCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-----GWNYPCDLWSVGCILVELCSGEA  316 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlGvil~elltg~~  316 (411)
                                    .|||+|||.+...+.+   ..+.+||+.|||||++...     .|+..+|+||||++..||..|.+
T Consensus       161 --------------~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~P  226 (953)
T KOG0587|consen  161 --------------EVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAP  226 (953)
T ss_pred             --------------cEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCC
Confidence                          7899999988765443   4567999999999999753     47789999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChh-HHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCc
Q 015222          317 LFQTHENLEHLAMMERVLGPLPHH-MVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       317 pf~~~~~~~~~~~i~~~~~~~p~~-~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~  382 (411)
                      |+.+......+-.|-+  .+.|.- -+..++..+.+||..||.+|    ..+||+..++++|||+..
T Consensus       227 Pl~DmHPmraLF~IpR--NPPPkLkrp~kWs~~FndFIs~cL~Kd----~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  227 PLCDMHPMRALFLIPR--NPPPKLKRPKKWSKKFNDFISTCLVKD----YEQRPSTEELLKHPFITE  287 (953)
T ss_pred             CccCcchhhhhccCCC--CCCccccchhhHHHHHHHHHHHHHhhc----cccCcchhhhccCCcccc
Confidence            9987666554443332  222222 25678899999999999999    999999999999999993

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=5.4e-40  Score=279.90  Aligned_cols=257  Identities=23%  Similarity=0.455  Sum_probs=213.7

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC--Ce
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--NH  167 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~--~~  167 (411)
                      -.++|++.+++|+|.|+.||.|.+..+++.++||+++....  +.+.+|+.||+.|.    +++||++++++..+.  ..
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk--kKIkREikIL~nL~----gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK--KKIKREIKILQNLR----GGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH--HHHHHHHHHHHhcc----CCCCeeehhhhhcCccccC
Confidence            34789999999999999999999999999999999986543  66889999999997    334559999998874  57


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      ..+|+||+ +.+...+..     .++...++.++.+++.||.|+|++||+|||+||.|++|+...               
T Consensus       110 paLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~---------------  169 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHEL---------------  169 (338)
T ss_pred             chhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhh---------------
Confidence            88999999 666555433     588899999999999999999999999999999999998743               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCCcc--cccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCC-CCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALF-QTHE  322 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf-~~~~  322 (411)
                                 ..++|+|+|+|.+.+.....  .+.+..|.-||++..- .|+.+-|+|||||+|..|+..+.|| .|.+
T Consensus       170 -----------rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d  238 (338)
T KOG0668|consen  170 -----------RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD  238 (338)
T ss_pred             -----------ceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC
Confidence                       37899999999988766543  5678889999999875 6899999999999999999987775 6778


Q ss_pred             hHHHHHHHHHHhCC-------------CChhHHH--------------------hhhhhhhhhhccCCccCCCCCCCcHH
Q 015222          323 NLEHLAMMERVLGP-------------LPHHMVI--------------------RADRRAEKYFRRGARLDWPDGATSRD  369 (411)
Q Consensus       323 ~~~~~~~i~~~~~~-------------~p~~~~~--------------------~~~~~~~~li~~~l~~~~~~rp~~R~  369 (411)
                      +.+++.+|.++.|.             +++.+..                    -.++++.+|+.++|+.|    ...|+
T Consensus       239 N~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYD----HqeRl  314 (338)
T KOG0668|consen  239 NYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYD----HQERL  314 (338)
T ss_pred             CHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhc----ccccc
Confidence            88888888777653             2222211                    13478899999999999    99999


Q ss_pred             HHHHHHhcCCCCcccccC
Q 015222          370 SMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       370 t~~~il~~~~~~~~~~~~  387 (411)
                      |++|++.||||..+....
T Consensus       315 TakEam~HpyF~~~~~~~  332 (338)
T KOG0668|consen  315 TAKEAMAHPYFAPVREAE  332 (338)
T ss_pred             chHHHhcCchHHHHHHHh
Confidence            999999999998765443

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.5e-38  Score=293.92  Aligned_cols=244  Identities=20%  Similarity=0.272  Sum_probs=183.1

Q ss_pred             eeeccccceEEEEEEeCC--CCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEc
Q 015222           98 SKMGEGTFGQVVECFDNE--KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE  173 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~--~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e  173 (411)
                      ++||+|+||.||+|....  ....+|+|.+....  .....+.+|+.+++.++|+|+     +++++.+.+.+..++|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~ni-----i~~~~~~~~~~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNV-----LQCLGQCIESIPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCc-----ceEEEEECCCCceEEEEE
Confidence            368999999999996533  34578999876432  334567789999999888877     999999999999999999


Q ss_pred             cC-CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          174 KL-GPSLYDFLRKNSY---RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       174 ~~-~~~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      |+ +++|.+++.....   ...++..+..++.||+.||+|||++||+||||||+|||++.++                  
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~------------------  137 (269)
T cd05042          76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL------------------  137 (269)
T ss_pred             eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC------------------
Confidence            99 8999999976532   2356788899999999999999999999999999999998766                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecC-------CCCCccchhHHHHHHHHHHHh-CCC
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILG-------LGWNYPCDLWSVGCILVELCS-GEA  316 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~ellt-g~~  316 (411)
                               .+||+|||++......     .....++..|+|||++..       ..++.++|||||||++|||++ |..
T Consensus       138 ---------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~  208 (269)
T cd05042         138 ---------SVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQ  208 (269)
T ss_pred             ---------cEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCC
Confidence                     5667777766432211     122345678999998743       356889999999999999999 889


Q ss_pred             CCCCCChHHHHHHHHHHh-CCCCh-hHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          317 LFQTHENLEHLAMMERVL-GPLPH-HMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       317 pf~~~~~~~~~~~i~~~~-~~~p~-~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ||......+.+..+.... ..++. ......+....+++..|+ .+    |++||+++++++..
T Consensus       209 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~d----p~~Rpt~~~v~~~l  267 (269)
T cd05042         209 PYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LD----PETRPTAEEVHELL  267 (269)
T ss_pred             CCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cC----cccccCHHHHHHHh
Confidence            998777666555443322 12221 222345556666666654 24    99999999998753

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.4e-38  Score=293.09  Aligned_cols=243  Identities=19%  Similarity=0.251  Sum_probs=182.1

Q ss_pred             eeeccccceEEEEEEeC--CCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEc
Q 015222           98 SKMGEGTFGQVVECFDN--EKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE  173 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~--~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e  173 (411)
                      +.||+|+||.||+|...  .++..+|+|.++...  .....+.+|+.++++++|+|+     +++++++.+....++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNL-----LQCLGQCTEVTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEcCCCCcEEEEE
Confidence            36899999999999864  355679999987543  233467889999999988877     999999998889999999


Q ss_pred             cC-CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          174 KL-GPSLYDFLRKNS---YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       174 ~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      |+ +++|.+++....   ....++..+..++.|++.||+|||+.|++|+||||+||+++.++                  
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~------------------  137 (269)
T cd05087          76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL------------------  137 (269)
T ss_pred             CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC------------------
Confidence            99 899999997542   12456778889999999999999999999999999999998766                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCC-------CCCccchhHHHHHHHHHHHh-CCC
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGL-------GWNYPCDLWSVGCILVELCS-GEA  316 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwSlGvil~ellt-g~~  316 (411)
                               .++|+|||.+......     .....|+..|+|||++.+.       .++.++|||||||++|||++ |+.
T Consensus       138 ---------~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~  208 (269)
T cd05087         138 ---------TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQ  208 (269)
T ss_pred             ---------cEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCC
Confidence                     4566666655432211     1123567889999998643       35789999999999999996 999


Q ss_pred             CCCCCChHHHHHHHHHH-hCCCC-hhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          317 LFQTHENLEHLAMMERV-LGPLP-HHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       317 pf~~~~~~~~~~~i~~~-~~~~p-~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ||...+..+........ ....+ .......++.+.+++..|    |. +|++||++++++..
T Consensus       209 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c----~~-~P~~Rpt~~~l~~~  266 (269)
T cd05087         209 PYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFC----WL-QPEQRPSAEEVHLL  266 (269)
T ss_pred             CCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHH----hc-CcccCCCHHHHHHH
Confidence            99876665544332221 11121 111223445566777766    42 39999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-39  Score=313.96  Aligned_cols=202  Identities=29%  Similarity=0.415  Sum_probs=175.9

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC----
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR----  165 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~----  165 (411)
                      .-|...+.||+|+||.||+++++.+|+.||||.++..  ....+...+|+++|++++|+||     |+++++-+..    
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NI-----Vk~f~iee~~~~~~   87 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNI-----VKLFDIEETKFLGL   87 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhh-----hhhcccCCccccCc
Confidence            3467778999999999999999999999999999853  3556778899999999999888     9998876653    


Q ss_pred             --CeEEEEEccC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccc
Q 015222          166 --NHICIVFEKL-GPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL  241 (411)
Q Consensus       166 --~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~  241 (411)
                        ....+||||| ||+|...|.+-. ...|++.++..++.++..||.|||++|||||||||+||++-..+          
T Consensus        88 ~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Ge----------  157 (732)
T KOG4250|consen   88 VTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGE----------  157 (732)
T ss_pred             ccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC----------
Confidence              3678999999 999999998532 24699999999999999999999999999999999999985532          


Q ss_pred             cccCCCCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecC-CCCCccchhHHHHHHHHHHHhCCCCC
Q 015222          242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALF  318 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~pf  318 (411)
                                   ++....||+|||.|+..+++.  ...+||..|.+||++.. +.|+..+|.|||||++|+..||..||
T Consensus       158 -------------dgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF  224 (732)
T KOG4250|consen  158 -------------DGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPF  224 (732)
T ss_pred             -------------CCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCC
Confidence                         345578999999999876654  55799999999999995 78999999999999999999999999


Q ss_pred             CCC
Q 015222          319 QTH  321 (411)
Q Consensus       319 ~~~  321 (411)
                      ...
T Consensus       225 ~p~  227 (732)
T KOG4250|consen  225 IPF  227 (732)
T ss_pred             CcC
Confidence            654

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.7e-38  Score=298.14  Aligned_cols=246  Identities=22%  Similarity=0.280  Sum_probs=192.2

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCc----EEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKE----LVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      ++|++.+.||+|+||.||+|.+..+++    .||+|.+....  .....+.+|+.+++.+.|+|+     +++++++.. 
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~ni-----v~~~~~~~~-   80 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL-----VRLLGVCLS-   80 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCc-----ccEEEEEcC-
Confidence            578999999999999999999887775    57889886432  223457789999999988887     999998865 


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      ...++++||+ +|+|.+++.... ..+++..+..++.|++.||+|||++||+|+||||+||+++.++             
T Consensus        81 ~~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~-------------  146 (303)
T cd05110          81 PTIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPN-------------  146 (303)
T ss_pred             CCceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCC-------------
Confidence            4567999999 899999987654 3589999999999999999999999999999999999997665             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALF  318 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf  318 (411)
                                    .+||+|||++.......     ....++..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus       147 --------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~  212 (303)
T cd05110         147 --------------HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY  212 (303)
T ss_pred             --------------ceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence                          46777777665433221     11235678999999998899999999999999999998 99999


Q ss_pred             CCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      .+....+....+... ..++.  ....+..+.+++.+|+..+    |+.||++.++++..
T Consensus       213 ~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~li~~c~~~~----p~~Rp~~~~l~~~l  265 (303)
T cd05110         213 DGIPTREIPDLLEKG-ERLPQ--PPICTIDVYMVMVKCWMID----ADSRPKFKELAAEF  265 (303)
T ss_pred             CCCCHHHHHHHHHCC-CCCCC--CCCCCHHHHHHHHHHcCCC----hhhCcCHHHHHHHH
Confidence            876654444433322 22221  1234566788888888777    88888888877654

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5.6e-38  Score=291.49  Aligned_cols=248  Identities=22%  Similarity=0.389  Sum_probs=196.2

Q ss_pred             CeEEEeeeccccceEEEEEEeCC-CCcEEEEEEeccch-----------hhhHHHHHHHHHHHH-HhcCCCCCcceEEEe
Q 015222           93 RYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSIN-----------KYREAAMIEIDVLQR-LARHDIGGTRCVQIR  159 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~-~~~~vavK~~~~~~-----------~~~~~~~~E~~~l~~-l~~~~i~~~~iv~~~  159 (411)
                      .|++.+.||+|+||.||+|.+.. +++.+|+|.+....           .....+..|+.++.+ +.|+|+     ++++
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i-----~~~~   75 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNI-----VRYY   75 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCe-----eeEE
Confidence            38889999999999999999987 67899999885321           122345567776664 555555     9999


Q ss_pred             eeeecCCeEEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEecCccccc
Q 015222          160 NWFDYRNHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKV  235 (411)
Q Consensus       160 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dikp~NIli~~~~~~~l  235 (411)
                      +++..++..++||||+ +++|.+++...  ....+++..++.++.|++.||.|||+ .|++|+||||+||+++.++    
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~----  151 (269)
T cd08528          76 KTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD----  151 (269)
T ss_pred             eeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC----
Confidence            9999999999999999 88999988542  23468999999999999999999996 7899999999999997766    


Q ss_pred             CCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh
Q 015222          236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS  313 (411)
Q Consensus       236 ~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt  313 (411)
                                             .++|+|||.+......  .....|+..|+|||.+.+..++.++||||||+++|+|++
T Consensus       152 -----------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~  208 (269)
T cd08528         152 -----------------------KVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT  208 (269)
T ss_pred             -----------------------cEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHh
Confidence                                   5677777776654332  233568889999999998889999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       314 g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      |+.||...+.......+.........  ....+..+.+++.+|+..|    |+.||++.++..+.
T Consensus       209 g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~----p~~Rp~~~e~~~~~  267 (269)
T cd08528         209 LQPPFYSTNMLSLATKIVEAVYEPLP--EGMYSEDVTDVITSCLTPD----AEARPDIIQVSAMI  267 (269)
T ss_pred             CCCcccccCHHHHHHHHhhccCCcCC--cccCCHHHHHHHHHHCCCC----CccCCCHHHHHHHh
Confidence            99999877666555554443222111  1245678899999998888    99999999988653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5.4e-38  Score=290.36  Aligned_cols=240  Identities=16%  Similarity=0.211  Sum_probs=184.2

Q ss_pred             eeeccccceEEEEEEeCC---CCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee-cCCeEEEE
Q 015222           98 SKMGEGTFGQVVECFDNE---KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD-YRNHICIV  171 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~-~~~~~~lv  171 (411)
                      +.||+|+||.||+|.+..   .+..||+|.+...  ....+.+.+|+.+++.+.|+|+     +++++++. .++..++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~~~lv   75 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNV-----LSLLGICLPSEGSPLVV   75 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCc-----ceEEEEeecCCCCcEEE
Confidence            468999999999998653   3457999998542  2345667789999999888877     99998654 45678999


Q ss_pred             EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      |||+ +++|.+++.+.. ..+++..+..++.||+.||.|||+.||+||||||+|||+++++                   
T Consensus        76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~-------------------  135 (262)
T cd05058          76 LPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF-------------------  135 (262)
T ss_pred             EecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-------------------
Confidence            9999 899999997654 3467888899999999999999999999999999999998776                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCC-------CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQD-------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHE  322 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~  322 (411)
                              .+||+|||++......       .....++..|+|||.+.+..++.++|||||||++|||++ |.+||...+
T Consensus       136 --------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~  207 (262)
T cd05058         136 --------TVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD  207 (262)
T ss_pred             --------cEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence                    4566666655432211       112345678999999988899999999999999999999 577787766


Q ss_pred             hHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ..+....+.......   .....+..+.+++.+|+..+    |++||++.++++.
T Consensus       208 ~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~----p~~Rp~~~~il~~  255 (262)
T cd05058         208 SFDITVYLLQGRRLL---QPEYCPDPLYEVMLSCWHPK----PEMRPTFSELVSR  255 (262)
T ss_pred             HHHHHHHHhcCCCCC---CCCcCCHHHHHHHHHHcCCC----hhhCCCHHHHHHH
Confidence            555444443321111   11234567889999998888    9999999998864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=301.96  Aligned_cols=252  Identities=23%  Similarity=0.330  Sum_probs=204.8

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      -.++..+.++||+|.||.|.+|+- ..+..||||+++...  ..+.++.+|+++|.+|+||||     +.+++++..++.
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNI-----veLvGVC~~DeP  609 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNI-----VELLGVCVQDDP  609 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCe-----eEEEeeeecCCc
Confidence            346788999999999999999974 446899999998543  445789999999999999988     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+||||+ .|+|.+|+.++....+......+|+.||+.|++||.+.++|||||.+.|+|++.++               
T Consensus       610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~---------------  674 (807)
T KOG1094|consen  610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEF---------------  674 (807)
T ss_pred             hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcc---------------
Confidence            99999999 99999999988644455667778999999999999999999999999999986554               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCCcc-----cccCCCccccceecCCCCCccchhHHHHHHHHHHHh--CCCCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY-----VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS--GEALFQ  319 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt--g~~pf~  319 (411)
                                  ++||+|||+++........     .+-...|||+|.+..+++++++|+|+||+++||+++  ...||.
T Consensus       675 ------------~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~  742 (807)
T KOG1094|consen  675 ------------TIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYS  742 (807)
T ss_pred             ------------cEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchh
Confidence                        7899999998855443322     234689999999999999999999999999999876  789999


Q ss_pred             CCChHHHHHHHHHHhCCCChhH----HHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          320 THENLEHLAMMERVLGPLPHHM----VIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       320 ~~~~~~~~~~i~~~~~~~p~~~----~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ..++.+..+........-+...    ..-++..+-+++.+|    |.-+-.+||+++++..++
T Consensus       743 ~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~C----w~~es~~RPsFe~lh~~l  801 (807)
T KOG1094|consen  743 QLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRC----WRRESEQRPSFEQLHLFL  801 (807)
T ss_pred             hhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHH----hchhhhcCCCHHHHHHHH
Confidence            9888888777666554322221    122344455566555    555599999999987653

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=326.87  Aligned_cols=247  Identities=20%  Similarity=0.295  Sum_probs=202.2

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCC-----cEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKK-----ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~-----~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~  163 (411)
                      ...-+..+.||+|.||.||.|......     ..||||.+++.  .....+|.+|..+++.++|+||     +++++++-
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNi-----v~liGv~l  765 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNI-----VSLIGVCL  765 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcce-----eeEEEeec
Confidence            356788899999999999999876433     34999999865  4566788999999999999988     99999999


Q ss_pred             cCCeEEEEEccC-CCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCC
Q 015222          164 YRNHICIVFEKL-GPSLYDFLRKNS-----YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD  237 (411)
Q Consensus       164 ~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~d  237 (411)
                      +....+|++||| ||+|..||++..     ...++..+...++.||++|++||+++++|||||-.+|+|++...      
T Consensus       766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r------  839 (1025)
T KOG1095|consen  766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERR------  839 (1025)
T ss_pred             CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccC------
Confidence            999999999999 999999999762     24689999999999999999999999999999999999987654      


Q ss_pred             cccccccCCCCCccccCCCCCCeeEeecCCcccccCCCccc-----ccCCCccccceecCCCCCccchhHHHHHHHHHHH
Q 015222          238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV-----VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC  312 (411)
Q Consensus       238 f~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~-----~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell  312 (411)
                                           .+||+|||+|+.......+.     .-...|||||.+..+.++.++|||||||+|||++
T Consensus       840 ---------------------~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEif  898 (1025)
T KOG1095|consen  840 ---------------------VVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIF  898 (1025)
T ss_pred             ---------------------cEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHH
Confidence                                 78888888888443332221     1235799999999999999999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHh
Q 015222          313 S-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK  376 (411)
Q Consensus       313 t-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~  376 (411)
                      | |..||.+.++.+.+....+.- .++.  ...+++.+-    +.|..||...|+.||++..+++
T Consensus       899 slG~~PY~~~~n~~v~~~~~~gg-RL~~--P~~CP~~ly----~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  899 SLGATPYPSRSNFEVLLDVLEGG-RLDP--PSYCPEKLY----QLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             hCCCCCCCCcchHHHHHHHHhCC-ccCC--CCCCChHHH----HHHHHHccCChhhCccHHHHHh
Confidence            9 999999999988887655532 2221  122333344    4555668888999999999998

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.3e-37  Score=289.09  Aligned_cols=244  Identities=20%  Similarity=0.248  Sum_probs=183.7

Q ss_pred             eeeccccceEEEEEEeCCC--CcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEc
Q 015222           98 SKMGEGTFGQVVECFDNEK--KELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE  173 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~--~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e  173 (411)
                      ++||+|+||.||+|.....  ...+++|.++...  ...+.+.+|+.+++.++|+|+     +++++.+......|+|||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~i-----v~~~~~~~~~~~~~lv~e   75 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNI-----LQCLGQCVEAIPYLLVFE   75 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcch-----hheEEEecCCCccEEEEe
Confidence            3689999999999975433  3456777766432  345678889999999988877     999999999899999999


Q ss_pred             cC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          174 KL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       174 ~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      |+ +++|.+++.+..  ...+++..+..++.||+.||+|||+.+|+||||||+|||++.++                   
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~-------------------  136 (268)
T cd05086          76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL-------------------  136 (268)
T ss_pred             cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc-------------------
Confidence            99 899999997642  23467778899999999999999999999999999999997766                   


Q ss_pred             cccCCCCCCeeEeecCCcccccC-----CCcccccCCCccccceecC-------CCCCccchhHHHHHHHHHHHh-CCCC
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILG-------LGWNYPCDLWSVGCILVELCS-GEAL  317 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~ellt-g~~p  317 (411)
                              .++|+|||++.....     ......|+..|+|||++..       ..++.++|||||||++|||++ |..|
T Consensus       137 --------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p  208 (268)
T cd05086         137 --------TVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP  208 (268)
T ss_pred             --------cEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCC
Confidence                    466677776543211     1123467889999999853       245789999999999999997 6889


Q ss_pred             CCCCChHHHHHHHHHHhC-C-CChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          318 FQTHENLEHLAMMERVLG-P-LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~-~-~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      |...+..+.+..+..... . +.+.+....++.+.+++..|+ .+    |.+||+++++++.+
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~----P~~Rp~~~~i~~~l  266 (268)
T cd05086         209 YSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LS----PEKRATAEEVHRLL  266 (268)
T ss_pred             CCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hC----cccCCCHHHHHHHh
Confidence            987777666655433321 1 122222335566677777664 33    99999999998654

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=8.1e-39  Score=326.45  Aligned_cols=274  Identities=25%  Similarity=0.316  Sum_probs=197.5

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee---
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD---  163 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~---  163 (411)
                      ....+|+.++.||+||||.||+++++-+|+.||||.+...  ......+.+|+..|.+|+|+|+     |+++..+.   
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNV-----VRYysAWVEs~  550 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNV-----VRYYSAWVEST  550 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcce-----eeeehhhhccC
Confidence            3456788999999999999999999999999999999754  4455667899999999999998     22221000   


Q ss_pred             --------------------------------------------------------------------------------
Q 015222          164 --------------------------------------------------------------------------------  163 (411)
Q Consensus       164 --------------------------------------------------------------------------------  163 (411)
                                                                                                      
T Consensus       551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~  630 (1351)
T KOG1035|consen  551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL  630 (1351)
T ss_pred             CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------cC--------CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHH
Q 015222          164 ----------------------------YR--------NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES  206 (411)
Q Consensus       164 ----------------------------~~--------~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~a  206 (411)
                                                  .+        -.+||-|||| ...|.+++.++... -....+++++++|+.|
T Consensus       631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEG  709 (1351)
T KOG1035|consen  631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEG  709 (1351)
T ss_pred             ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHH
Confidence                                        00        2479999999 55556666665411 1478899999999999


Q ss_pred             HHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccc-cCCCcccccCCCcc
Q 015222          207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE-HQDHSYVVSTRHYR  285 (411)
Q Consensus       207 L~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~-~~~~~~~~gt~~y~  285 (411)
                      |.|+|++|||||||||.||++++++.+||+|||++.......       ........+.+.-.-. ....+..+||..|+
T Consensus       710 LaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~-------~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYv  782 (1351)
T KOG1035|consen  710 LAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENL-------ESIDQDLSFSTNRAGSNDGDLTSQVGTALYV  782 (1351)
T ss_pred             HHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhh-------hhHhhccCccccccCCCCcccccccceeeee
Confidence            999999999999999999999999888888887765421100       0001111111111111 11335578999999


Q ss_pred             ccceecCCC---CCccchhHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCC
Q 015222          286 APEVILGLG---WNYPCDLWSVGCILVELCSGEALFQTH-ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDW  361 (411)
Q Consensus       286 aPE~~~~~~---~~~~~DiwSlGvil~elltg~~pf~~~-~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~  361 (411)
                      |||++.+..   |+.|+||||||||||||+.   ||... +....+..+.++..+.+..+...--..-..+|+.||+.| 
T Consensus       783 APEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hd-  858 (1351)
T KOG1035|consen  783 APELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHD-  858 (1351)
T ss_pred             cHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCC-
Confidence            999998764   9999999999999999984   67542 223344444433334443333334455678999999999 


Q ss_pred             CCCCCcHHHHHHHHhcCCCCc
Q 015222          362 PDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       362 ~~rp~~R~t~~~il~~~~~~~  382 (411)
                         |++|||+.|+|++-|++-
T Consensus       859 ---P~kRPtA~eLL~s~llpp  876 (1351)
T KOG1035|consen  859 ---PSKRPTATELLNSELLPP  876 (1351)
T ss_pred             ---CccCCCHHHHhhccCCCc
Confidence               999999999999999984

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-39  Score=298.41  Aligned_cols=261  Identities=26%  Similarity=0.395  Sum_probs=209.9

Q ss_pred             eeCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--------hhhHHHHHHHHHHHHHhcCCCCCcceE
Q 015222           85 AIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--------KYREAAMIEIDVLQRLARHDIGGTRCV  156 (411)
Q Consensus        85 ~~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--------~~~~~~~~E~~~l~~l~~~~i~~~~iv  156 (411)
                      .-...++++|-++..||+|||+.||+|.|....+.||||+-....        ...+...+|..|.+.|.|+.|     |
T Consensus       456 kDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRI-----V  530 (775)
T KOG1151|consen  456 KDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRI-----V  530 (775)
T ss_pred             ccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCccee-----e
Confidence            344567789999999999999999999999999999999975332        233456778888888877766     9


Q ss_pred             EEeeeeec-CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CceecCCCCCcEEEecCcc
Q 015222          157 QIRNWFDY-RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL--RLIHTDLKPENILLVSAEY  232 (411)
Q Consensus       157 ~~~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--givH~Dikp~NIli~~~~~  232 (411)
                      ++|++|.- .+.+|-|+||| |.+|.-||+.+.  .+++.+++.|+.||+.||.||.+.  .|||-||||.|||+.+.. 
T Consensus       531 KlYDyfslDtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gt-  607 (775)
T KOG1151|consen  531 KLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGT-  607 (775)
T ss_pred             eeeeeeeeccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCc-
Confidence            99999975 56899999999 889988888776  799999999999999999999987  499999999999997643 


Q ss_pred             cccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC----------cccccCCCccccceecCC----CCCcc
Q 015222          233 VKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----------SYVVSTRHYRAPEVILGL----GWNYP  298 (411)
Q Consensus       233 ~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----------~~~~gt~~y~aPE~~~~~----~~~~~  298 (411)
                                             ..+.+||+|||++.+.+...          +...||.+|++||.+.-+    ..+.+
T Consensus       608 -----------------------acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnK  664 (775)
T KOG1151|consen  608 -----------------------ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNK  664 (775)
T ss_pred             -----------------------ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccc
Confidence                                   33468888888887755432          235799999999988644    47899


Q ss_pred             chhHHHHHHHHHHHhCCCCCCCCChHH-HHHH--H-HHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHH
Q 015222          299 CDLWSVGCILVELCSGEALFQTHENLE-HLAM--M-ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV  374 (411)
Q Consensus       299 ~DiwSlGvil~elltg~~pf~~~~~~~-~~~~--i-~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~i  374 (411)
                      +||||+|||+|..+.|+.||...-... ++..  | ......||..  +.++.++++||++||++.    -..|....++
T Consensus       665 VDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~K--PvVsseAkaFIRRCLaYR----KeDR~DV~qL  738 (775)
T KOG1151|consen  665 VDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPK--PVVSSEAKAFIRRCLAYR----KEDRIDVQQL  738 (775)
T ss_pred             eeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCC--CccCHHHHHHHHHHHHhh----hhhhhhHHHH
Confidence            999999999999999999997643332 2221  1 1122345543  457889999999999998    8899999999


Q ss_pred             HhcCCCCc
Q 015222          375 WKLLRLPV  382 (411)
Q Consensus       375 l~~~~~~~  382 (411)
                      -.+|+|.-
T Consensus       739 A~dpyllP  746 (775)
T KOG1151|consen  739 ACDPYLLP  746 (775)
T ss_pred             ccCccccc
Confidence            99998764

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.4e-37  Score=289.29  Aligned_cols=245  Identities=15%  Similarity=0.204  Sum_probs=191.0

Q ss_pred             eEEEeeeccccceEEEEEEeCC---CCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC-
Q 015222           94 YRILSKMGEGTFGQVVECFDNE---KKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN-  166 (411)
Q Consensus        94 y~i~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~-  166 (411)
                      |++.+.||+|+||.||+|.+..   +++.||||++...   ....+.+.+|+.+++++.|+++     +++++++...+ 
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~   75 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNV-----IKLIGVSLRSRA   75 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCc-----ceEEEEEccCCC
Confidence            6778899999999999998653   5789999998743   2345567889999999988877     99999875432 


Q ss_pred             -----eEEEEEccC-CCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccC
Q 015222          167 -----HICIVFEKL-GPSLYDFLRKNS----YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP  236 (411)
Q Consensus       167 -----~~~lv~e~~-~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~  236 (411)
                           ..++++||+ +++|.+++....    ...+++..+..++.||+.||+|||++||+||||||+||+++.++     
T Consensus        76 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~-----  150 (273)
T cd05074          76 KGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM-----  150 (273)
T ss_pred             CCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC-----
Confidence                 357899999 899998875321    12578999999999999999999999999999999999997665     


Q ss_pred             CcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchhHHHHHHHHHH
Q 015222          237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL  311 (411)
Q Consensus       237 df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el  311 (411)
                                            .++|+|||.+.......     ....++..|++||.+.+..++.++|||||||++|+|
T Consensus       151 ----------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el  208 (273)
T cd05074         151 ----------------------TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEI  208 (273)
T ss_pred             ----------------------CEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHH
Confidence                                  56677777665432211     123456789999999988899999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          312 CS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       312 lt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ++ |+.||.+.+..+....+..... .  ......+..+.+++.+|+..+    |+.||++.++++.
T Consensus       209 ~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~l~~~~l~~~----p~~Rps~~~~~~~  268 (273)
T cd05074         209 MTRGQTPYAGVENSEIYNYLIKGNR-L--KQPPDCLEDVYELMCQCWSPE----PKCRPSFQHLRDQ  268 (273)
T ss_pred             hhCCCCCCCCCCHHHHHHHHHcCCc-C--CCCCCCCHHHHHHHHHHcCCC----hhhCcCHHHHHHH
Confidence            99 9999987766555444433211 1  111245577899999998888    9999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.5e-37  Score=313.34  Aligned_cols=256  Identities=18%  Similarity=0.230  Sum_probs=174.1

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCC----CcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeee-----
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEK----KELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW-----  161 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~-----  161 (411)
                      .++|++.++||+|+||.||+|++..+    +..||||.+......      |..+..++.+...  .++..+...     
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~------e~~~~e~l~~~~~--~~~~~~~~~~~~~~  202 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV------EIWMNERVRRACP--NSCADFVYGFLEPV  202 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh------HHHHHHHHHhhch--hhHHHHHHhhhccc
Confidence            46899999999999999999999988    899999987643221      2222222222110  000111111     


Q ss_pred             -eecCCeEEEEEccC-CCCHHHHHHhcCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 015222          162 -FDYRNHICIVFEKL-GPSLYDFLRKNSYR------------------SFPIDLVRELGRQLLESVAFMHELRLIHTDLK  221 (411)
Q Consensus       162 -~~~~~~~~lv~e~~-~~~L~~~l~~~~~~------------------~l~~~~~~~i~~qi~~aL~~LH~~givH~Dik  221 (411)
                       ...+...++||||+ +++|.+++......                  ......+..++.||+.||+|||++||+|||||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK  282 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK  282 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence             23456899999999 88999998754311                  11234567899999999999999999999999


Q ss_pred             CCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC----CcccccCCCccccceecCC----
Q 015222          222 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL----  293 (411)
Q Consensus       222 p~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~----  293 (411)
                      |+|||++.+                          +..+||+|||+|......    .....+|+.|+|||++...    
T Consensus       283 P~NILl~~~--------------------------~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~  336 (566)
T PLN03225        283 PQNIIFSEG--------------------------SGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTP  336 (566)
T ss_pred             HHHEEEeCC--------------------------CCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCC
Confidence            999999752                          126788888888654322    2346789999999976432    


Q ss_pred             ------------------CCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC------------CChhHH-
Q 015222          294 ------------------GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGP------------LPHHMV-  342 (411)
Q Consensus       294 ------------------~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~------------~p~~~~-  342 (411)
                                        .++.++|||||||+||||+++..++..  ....+.......+.            ...... 
T Consensus       337 ~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  414 (566)
T PLN03225        337 SAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRR  414 (566)
T ss_pred             CCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhh
Confidence                              234567999999999999997766532  22222211111111            000000 


Q ss_pred             -----HhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          343 -----IRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       343 -----~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                           ........+||.+||..|    |.+|||+.++++||||.+....
T Consensus       415 ~~~~~d~~~~~~~dLi~~mL~~d----P~kR~ta~e~L~Hpff~~~~~~  459 (566)
T PLN03225        415 GFEVLDLDGGAGWELLKSMMRFK----GRQRISAKAALAHPYFDREGLL  459 (566)
T ss_pred             hhhhccccchHHHHHHHHHccCC----cccCCCHHHHhCCcCcCCCCcc
Confidence                 001123448999999999    9999999999999999986654

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=283.11  Aligned_cols=252  Identities=25%  Similarity=0.399  Sum_probs=208.8

Q ss_pred             EEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC-----Ce
Q 015222           96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR-----NH  167 (411)
Q Consensus        96 i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~-----~~  167 (411)
                      -.+.||.|+||.||.++|..+|+.||+|.+...   -...+.+.+|+..|...+|.|+     ...+++..-.     ..
T Consensus        57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNV-----LSaLDILQPph~dfFqE  131 (449)
T KOG0664|consen   57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNV-----LSLLDILQPANPSFFQE  131 (449)
T ss_pred             CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccH-----HHHHHhcCCCCchHHHH
Confidence            346899999999999999999999999988532   2345678889999999999887     6666554322     35


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          168 ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       168 ~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      +|+++|++..+|...+-.-.  .++.+.++-++.||++||+|||+.||.||||||.|+|++++                 
T Consensus       132 iYV~TELmQSDLHKIIVSPQ--~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSN-----------------  192 (449)
T KOG0664|consen  132 LYVLTELMQSDLHKIIVSPQ--ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSN-----------------  192 (449)
T ss_pred             HHHHHHHHHhhhhheeccCC--CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccC-----------------
Confidence            78999999889988877654  79999999999999999999999999999999999998764                 


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHE  322 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~  322 (411)
                                ..+||||||+++..+.+.    +..+-|-+|+|||++.|. .|+.++||||.|||+.||+..+..|...+
T Consensus       193 ----------CvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~  262 (449)
T KOG0664|consen  193 ----------CILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG  262 (449)
T ss_pred             ----------ceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC
Confidence                      478999999998765443    335678899999999987 79999999999999999999999999999


Q ss_pred             hHHHHHHHHHHhCCCChhHHHh------------------------------hhhhhhhhhccCCccCCCCCCCcHHHHH
Q 015222          323 NLEHLAMMERVLGPLPHHMVIR------------------------------ADRRAEKYFRRGARLDWPDGATSRDSMR  372 (411)
Q Consensus       323 ~~~~~~~i~~~~~~~p~~~~~~------------------------------~~~~~~~li~~~l~~~~~~rp~~R~t~~  372 (411)
                      ..+.++.|....+....+-...                              -..+...++.+++..+    |.+|.+..
T Consensus       263 PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d----~dkris~~  338 (449)
T KOG0664|consen  263 PIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFD----PDKRISVE  338 (449)
T ss_pred             hHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCC----CcccccHh
Confidence            9999999988887655432221                              1234567788888888    99999999


Q ss_pred             HHHhcCCCCcccc
Q 015222          373 AVWKLLRLPVIDL  385 (411)
Q Consensus       373 ~il~~~~~~~~~~  385 (411)
                      +.+.|+++.....
T Consensus       339 ~A~~~~~~~e~R~  351 (449)
T KOG0664|consen  339 EALQHRYLEEGRL  351 (449)
T ss_pred             hhcccccccccce
Confidence            9999999887654

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.9e-37  Score=303.58  Aligned_cols=264  Identities=20%  Similarity=0.287  Sum_probs=191.3

Q ss_pred             CCCeEEEeeeccccceEEEEEEeC----------------CCCcEEEEEEeccchh---------------hhHHHHHHH
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDN----------------EKKELVAIKIVRSINK---------------YREAAMIEI  139 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~----------------~~~~~vavK~~~~~~~---------------~~~~~~~E~  139 (411)
                      .++|++.++||+|+||+||+|.+.                ..++.||||.+.....               ..+....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            568999999999999999999752                2346799999864321               112334578


Q ss_pred             HHHHHHhcCCCCCcceEEEeeeeec--------CCeEEEEEccC-CCCHHHHHHhcC----------------------C
Q 015222          140 DVLQRLARHDIGGTRCVQIRNWFDY--------RNHICIVFEKL-GPSLYDFLRKNS----------------------Y  188 (411)
Q Consensus       140 ~~l~~l~~~~i~~~~iv~~~~~~~~--------~~~~~lv~e~~-~~~L~~~l~~~~----------------------~  188 (411)
                      .++.++.|+++.+.+++++++++..        .+..++||||+ +++|.+++....                      .
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            8888898888878888888887753        35689999999 999999987431                      0


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCc
Q 015222          189 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST  268 (411)
Q Consensus       189 ~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a  268 (411)
                      ..+++..++.++.|++.||.|||+.+|+||||||+|||++.++                           .++|+|||++
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~---------------------------~~kL~DFGla  356 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG---------------------------QVKIIDFGAA  356 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCC---------------------------cEEEEeCcCc
Confidence            1245678899999999999999999999999999999997665                           5677777776


Q ss_pred             ccccCCC----cccccCCCccccceecCCC--------------------CC--ccchhHHHHHHHHHHHhCCC-CCCCC
Q 015222          269 TFEHQDH----SYVVSTRHYRAPEVILGLG--------------------WN--YPCDLWSVGCILVELCSGEA-LFQTH  321 (411)
Q Consensus       269 ~~~~~~~----~~~~gt~~y~aPE~~~~~~--------------------~~--~~~DiwSlGvil~elltg~~-pf~~~  321 (411)
                      .......    ....+|+.|+|||++....                    ++  .+.||||+||++|+|++|.. ||.+.
T Consensus       357 ~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~  436 (507)
T PLN03224        357 VDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANI  436 (507)
T ss_pred             cccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccch
Confidence            5432211    1124478999999986432                    11  34799999999999999875 77542


Q ss_pred             ChHH--------HHHHHHHH-hCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCc
Q 015222          322 ENLE--------HLAMMERV-LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       322 ~~~~--------~~~~i~~~-~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~  382 (411)
                      ....        .+...... ............++...+++.++|..++.. +.+|+|+.|+|+||||..
T Consensus       437 ~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~-~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        437 RLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQA-NRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             hhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCC-cccCCCHHHHhCCCCcCC
Confidence            2111        01111111 112222234556788999999999987333 478999999999999964

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-38  Score=278.32  Aligned_cols=250  Identities=28%  Similarity=0.445  Sum_probs=214.7

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC--
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--  165 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~--  165 (411)
                      ..||.-++.+|.|.- .|-.|.|.-+++.||+|.+...   ....+...+|...+..++|+|+     ++++.+|.-.  
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~ni-----i~l~n~ftP~~~   89 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNI-----ISLLNVFTPQKT   89 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccce-----eeeeeccCcccc
Confidence            468999999999998 7888999999999999987532   2345667889999999999888     9999998643  


Q ss_pred             ----CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccc
Q 015222          166 ----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL  241 (411)
Q Consensus       166 ----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~  241 (411)
                          ..+|+|||++..+|.+.+.-    .++-+.+..|+.|++.|++|||+.||+||||||+||++..++          
T Consensus        90 l~~~~e~y~v~e~m~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~----------  155 (369)
T KOG0665|consen   90 LEEFQEVYLVMELMDANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDC----------  155 (369)
T ss_pred             HHHHHhHHHHHHhhhhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchh----------
Confidence                36899999999999999883    477889999999999999999999999999999999997766          


Q ss_pred             cccCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 015222          242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ  319 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~  319 (411)
                                       .+||.|||+|+.....  .+.++.|..|.|||++.+..+...+||||+||++.||++|+..|.
T Consensus       156 -----------------~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~  218 (369)
T KOG0665|consen  156 -----------------TLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP  218 (369)
T ss_pred             -----------------heeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence                             6788888888765544  355788999999999999999999999999999999999999999


Q ss_pred             CCChHHHHHHHHHHhCCCChhHHHhh--------------------------------------hhhhhhhhccCCccCC
Q 015222          320 THENLEHLAMMERVLGPLPHHMVIRA--------------------------------------DRRAEKYFRRGARLDW  361 (411)
Q Consensus       320 ~~~~~~~~~~i~~~~~~~p~~~~~~~--------------------------------------~~~~~~li~~~l~~~~  361 (411)
                      |.+..++..++.+..+...+++..+.                                      ...+++++.+||..+ 
T Consensus       219 g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~-  297 (369)
T KOG0665|consen  219 GKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVID-  297 (369)
T ss_pred             CchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccC-
Confidence            99988888888877776655543321                                      245889999999999 


Q ss_pred             CCCCCcHHHHHHHHhcCCCC
Q 015222          362 PDGATSRDSMRAVWKLLRLP  381 (411)
Q Consensus       362 ~~rp~~R~t~~~il~~~~~~  381 (411)
                         |+.|.+++++|+||+++
T Consensus       298 ---pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  298 ---PEKRISVDDALRHPYIK  314 (369)
T ss_pred             ---hhhcccHHHHhcCCeee
Confidence               99999999999999986

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-39  Score=279.86  Aligned_cols=258  Identities=22%  Similarity=0.344  Sum_probs=203.4

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      +..+-+..||.|+||+|++-.++.+|+..|||.++...  +...++..|.+...+-.  +  .++||++++..-.++..|
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~--~--cp~IVkfyGa~F~EGdcW  139 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSS--N--CPNIVKFYGALFSEGDCW  139 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhc--C--CcHHHHHhhhhhcCCcee
Confidence            34566789999999999999999999999999998543  45566677777655432  2  266699999988889999


Q ss_pred             EEEccCCCCHHHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          170 IVFEKLGPSLYDFLR---KNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       170 lv~e~~~~~L~~~l~---~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      +.||+|..||..+..   ......++|..+-.|+...+.||.||-+ ..||||||||+|||++..|              
T Consensus       140 iCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G--------------  205 (361)
T KOG1006|consen  140 ICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG--------------  205 (361)
T ss_pred             eeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC--------------
Confidence            999999888766543   2223479999999999999999999996 4899999999999998877              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCC--CCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                                   .+||||||.+......  .+.-.|-..|||||.+...  .|+.+||+||||++|||+.||+.||.+.
T Consensus       206 -------------~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w  272 (361)
T KOG1006|consen  206 -------------DVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW  272 (361)
T ss_pred             -------------CEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH
Confidence                         7888999987654322  2334788899999999754  5899999999999999999999999876


Q ss_pred             ChHHHHHHHHHHhCCCChhHH-----HhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          322 ENLEHLAMMERVLGPLPHHMV-----IRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       322 ~~~~~~~~i~~~~~~~p~~~~-----~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                      +.  .++.+..+...-|+.+.     -..+..+..||..||.+|    -+.||...++++++|...-...
T Consensus       273 ~s--vfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd----~~~Rpky~~Lk~~~fyr~y~~~  336 (361)
T KOG1006|consen  273 DS--VFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKD----RSDRPKYDDLKKFPFYRMYAVE  336 (361)
T ss_pred             HH--HHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcc----cccCcchhhhhcCchhhhhhhc
Confidence            54  44444443322222111     235678899999999999    8899999999999998865443

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-36  Score=254.25  Aligned_cols=210  Identities=21%  Similarity=0.404  Sum_probs=170.8

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      +....+..||+|++|.|-+.++..+|...|+|.++..  ........+|+.+..+.    ...|..|.+++.+.....++
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~----~~CPf~V~FyGa~~regdvw  121 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRT----VDCPFTVHFYGALFREGDVW  121 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccC----CCCCeEEEeehhhhccccEE
Confidence            3456678999999999999999999999999998743  34445555666665443    34466799999988899999


Q ss_pred             EEEccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          170 IVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       170 lv~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +.||.|..||..+..+  ..+..++|..+-+|+..++.||.|||++ .|||||+||+||||+.+|               
T Consensus       122 IcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G---------------  186 (282)
T KOG0984|consen  122 ICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG---------------  186 (282)
T ss_pred             EeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC---------------
Confidence            9999999899877653  1235799999999999999999999986 899999999999998887               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCC-cc-cccCCCccccceecCC----CCCccchhHHHHHHHHHHHhCCCCCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH-SY-VVSTRHYRAPEVILGL----GWNYPCDLWSVGCILVELCSGEALFQT  320 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~-~~gt~~y~aPE~~~~~----~~~~~~DiwSlGvil~elltg~~pf~~  320 (411)
                                  ++|+||||.+.+..... .+ ..|...|||||.+..+    .|+-+|||||||++++||.+++.||..
T Consensus       187 ------------qVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  187 ------------QVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             ------------cEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence                        78999999887754432 22 4688899999998643    689999999999999999999999975


Q ss_pred             C-ChHHHHHHHHH
Q 015222          321 H-ENLEHLAMMER  332 (411)
Q Consensus       321 ~-~~~~~~~~i~~  332 (411)
                      . +..+++..+.+
T Consensus       255 w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  255 WGTPFQQLKQVVE  267 (282)
T ss_pred             cCCHHHHHHHHhc
Confidence            4 55666665554

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-36  Score=288.69  Aligned_cols=244  Identities=19%  Similarity=0.299  Sum_probs=207.9

Q ss_pred             eEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEc
Q 015222           94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE  173 (411)
Q Consensus        94 y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e  173 (411)
                      .....+||-|.||.||.|.++...-.||||.++.+....++|..|+.+++.++|+|+     |+++++|..+..+|||+|
T Consensus       269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNL-----VqLLGVCT~EpPFYIiTE  343 (1157)
T KOG4278|consen  269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL-----VQLLGVCTHEPPFYIITE  343 (1157)
T ss_pred             eeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccH-----HHHhhhhccCCCeEEEEe
Confidence            445679999999999999999999999999999888888999999999999999988     999999999999999999


Q ss_pred             cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccc
Q 015222          174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK  252 (411)
Q Consensus       174 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~  252 (411)
                      || .|+|.+||++.....++.-....++.||..|++||..+++|||||-..|+|++.+.                     
T Consensus       344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnh---------------------  402 (1157)
T KOG4278|consen  344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH---------------------  402 (1157)
T ss_pred             cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccc---------------------
Confidence            99 99999999987766788888999999999999999999999999999999987655                     


Q ss_pred             cCCCCCCeeEeecCCcccccCCCcc-ccc---CCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 015222          253 NLPKSSAIKLIDFGSTTFEHQDHSY-VVS---TRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHL  327 (411)
Q Consensus       253 ~~~~~~~~kl~Dfg~a~~~~~~~~~-~~g---t~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~  327 (411)
                            .||++|||+++....+..+ -.|   .+.|.|||-+..+.++.++|||+|||+|||+.| |-.||.+.+..+.+
T Consensus       403 ------iVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY  476 (1157)
T KOG4278|consen  403 ------IVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY  476 (1157)
T ss_pred             ------eEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHH
Confidence                  6788888888876655433 223   568999999999999999999999999999999 99999999888877


Q ss_pred             HHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHh
Q 015222          328 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK  376 (411)
Q Consensus       328 ~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~  376 (411)
                      ..+++...--   -...+++.+-++++.|    |+-.|+.||++.++.+
T Consensus       477 ~LLEkgyRM~---~PeGCPpkVYeLMraC----W~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  477 GLLEKGYRMD---GPEGCPPKVYELMRAC----WNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             HHHhcccccc---CCCCCCHHHHHHHHHH----hcCCcccCccHHHHHH
Confidence            7776543211   1123445555666555    6666999999998864

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.2e-35  Score=268.38  Aligned_cols=238  Identities=32%  Similarity=0.502  Sum_probs=194.9

Q ss_pred             cceEEEEEEeCCCCcEEEEEEeccchhh--hHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC-CCCHH
Q 015222          104 TFGQVVECFDNEKKELVAIKIVRSINKY--REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLY  180 (411)
Q Consensus       104 ~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~  180 (411)
                      +||.||+|.+..+++.||+|++......  .+.+.+|+..+++++|+++     +++++++......+++||++ +++|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i-----~~~~~~~~~~~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNI-----VRLYDVFEDEDKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcH-----HHHHhheeeCCEEEEEEeCCCCCCHH
Confidence            5899999999999999999999754322  5778899999999988777     99999998889999999999 66999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccCCCCCCe
Q 015222          181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI  260 (411)
Q Consensus       181 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  260 (411)
                      +++....  .+++..+..++.+++.+|.+||+.|++|+||+|+||+++.++                           .+
T Consensus        76 ~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~---------------------------~~  126 (244)
T smart00220       76 DLLKKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG---------------------------HV  126 (244)
T ss_pred             HHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC---------------------------cE
Confidence            9998765  389999999999999999999999999999999999997765                           56


Q ss_pred             eEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHHhCCC
Q 015222          261 KLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT-HENLEHLAMMERVLGPL  337 (411)
Q Consensus       261 kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~-~~~~~~~~~i~~~~~~~  337 (411)
                      +|+|||.+......  .....++..|+|||.+.+..++.++||||||+++|+|++|..||.. .+.......+.......
T Consensus       127 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~  206 (244)
T smart00220      127 KLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF  206 (244)
T ss_pred             EEccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC
Confidence            77777777655442  3345678899999999888899999999999999999999999987 33333333333322222


Q ss_pred             ChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          338 PHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       338 p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      .. .....+..+.+++.+|+..+    |.+||++.++++|+||
T Consensus       207 ~~-~~~~~~~~~~~~i~~~l~~~----p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      207 PP-PEWKISPEAKDLIRKLLVKD----PEKRLTAEEALQHPFF  244 (244)
T ss_pred             cc-ccccCCHHHHHHHHHHccCC----chhccCHHHHhhCCCC
Confidence            11 11115677889999998888    9999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=294.06  Aligned_cols=248  Identities=21%  Similarity=0.327  Sum_probs=204.0

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCC---cEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKK---ELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      +.++.++||+|.||+|++|.+...+   ..||||.++...  ....+|.+|+.+|.+|.|+++     +++|++..+ ..
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hl-----iRLyGvVl~-qp  184 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHL-----IRLYGVVLD-QP  184 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcce-----eEEeeeecc-ch
Confidence            4566789999999999999987643   468999998544  356889999999999999887     999999987 77


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +.+|||++ .|+|.+.|++.....|-......++.||+.|+.||.++++|||||-..|||+....               
T Consensus       185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr---------------  249 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR---------------  249 (1039)
T ss_pred             hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc---------------
Confidence            88999999 99999999985556788899999999999999999999999999999999987644               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCCcccc------cCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVV------STRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQ  319 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~------gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~  319 (411)
                                  .|||+|||+.+........++      -...|.|||.+....++.++|+|++||++|||++ |+.||.
T Consensus       250 ------------tVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~  317 (1039)
T KOG0199|consen  250 ------------TVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWV  317 (1039)
T ss_pred             ------------eeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCC
Confidence                        678888888877655543322      2457999999999999999999999999999999 999999


Q ss_pred             CCChHHHHHHHHHHhC-CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCC
Q 015222          320 THENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP  381 (411)
Q Consensus       320 ~~~~~~~~~~i~~~~~-~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~  381 (411)
                      +....++++.+.+... +.|.    .+++.+-+++    ..||...|..||++..|.+...+.
T Consensus       318 G~~g~qIL~~iD~~erLpRPk----~csedIY~im----k~cWah~paDRptFsair~~~~l~  372 (1039)
T KOG0199|consen  318 GCRGIQILKNIDAGERLPRPK----YCSEDIYQIM----KNCWAHNPADRPTFSAIREDLVLA  372 (1039)
T ss_pred             CCCHHHHHHhccccccCCCCC----CChHHHHHHH----HHhccCCccccccHHHHHHhHHHH
Confidence            9999999998884321 2222    2344444444    455888899999999997554443

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-36  Score=285.11  Aligned_cols=196  Identities=26%  Similarity=0.478  Sum_probs=172.9

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhH---------HHHHHHHHHHHHhcCCCCCcceEEEeeeee
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE---------AAMIEIDVLQRLARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~---------~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~  163 (411)
                      .|..++.+|+|+||.|++|.++.....|+||.+.+..-..+         .+-.|++||..++.+  .|+||++++++|+
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~--sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKH--SHENILKLLDFFE  639 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhc--Cccchhhhhheee
Confidence            59999999999999999999999999999999976543222         234599999999833  3455599999999


Q ss_pred             cCCeEEEEEccC--CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccc
Q 015222          164 YRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL  241 (411)
Q Consensus       164 ~~~~~~lv~e~~--~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~  241 (411)
                      +++++||+||--  |-+|++++..+.  .++|.+++.|++|++.|+++||++||||||||-+|+.++.+|          
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g----------  707 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG----------  707 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC----------
Confidence            999999999987  669999999876  799999999999999999999999999999999999998877          


Q ss_pred             cccCCCCCccccCCCCCCeeEeecCCcccccCC-CcccccCCCccccceecCCCC-CccchhHHHHHHHHHHHhCCCCCC
Q 015222          242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQ  319 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~pf~  319 (411)
                                       -+||+|||.|...... ...++||..|+|||++.|.+| +..-|||+||++||.++....||.
T Consensus       708 -----------------~~klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  708 -----------------FVKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             -----------------eEEEeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence                             6799999998876544 466899999999999999876 688999999999999999999985

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=274.42  Aligned_cols=265  Identities=20%  Similarity=0.277  Sum_probs=194.0

Q ss_pred             CCCceEEeeCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHH--HHhcCCCCCcce
Q 015222           78 KDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQ--RLARHDIGGTRC  155 (411)
Q Consensus        78 ~~~~~~~~~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~--~l~~~~i~~~~i  155 (411)
                      ++...++.+...+...-++.+.||+|.||.||+|.++  |+.||||++...++  ..+.+|.+|.+  .|+|+||     
T Consensus       197 SGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE--~SWfrEtEIYqTvmLRHENI-----  267 (513)
T KOG2052|consen  197 SGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE--RSWFRETEIYQTVMLRHENI-----  267 (513)
T ss_pred             CCCCchhHhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEecccch--hhhhhHHHHHHHHHhccchh-----
Confidence            3345566667778889999999999999999999665  78899999976443  44555666655  4678887     


Q ss_pred             EEEeeeeecC----CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCC
Q 015222          156 VQIRNWFDYR----NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL--------RLIHTDLKP  222 (411)
Q Consensus       156 v~~~~~~~~~----~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------givH~Dikp  222 (411)
                      ..+++.-..+    ..++||++|- .|||+|||.+.   .++.+...+++..++.||++||..        .|.|||||.
T Consensus       268 LgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKS  344 (513)
T KOG2052|consen  268 LGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKS  344 (513)
T ss_pred             hhhhhccccCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccc
Confidence            7777654332    2689999999 99999999996   499999999999999999999952        499999999


Q ss_pred             CcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCC----CCC--
Q 015222          223 ENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL----GWN--  296 (411)
Q Consensus       223 ~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~----~~~--  296 (411)
                      .||||..+|.+-|+|+|++.+...+..                    ..+...+..+||..|||||++...    .+.  
T Consensus       345 KNILVKkn~~C~IADLGLAv~h~~~t~--------------------~idi~~N~rVGTKRYMAPEvLdetin~~~Fesy  404 (513)
T KOG2052|consen  345 KNILVKKNGTCCIADLGLAVRHDSDTD--------------------TIDIPPNPRVGTKRYMAPEVLDETINMKHFESY  404 (513)
T ss_pred             ccEEEccCCcEEEeeceeeEEecccCC--------------------cccCCCCCccceeeccChHHhhhhcChhhhhhh
Confidence            999998888554444444333332211                    111223456899999999999753    122  


Q ss_pred             ccchhHHHHHHHHHHHhC----------CCCCCCC----ChHHHHHH---HHHHhCCCChhHHHhhhhhhhhhhccCCcc
Q 015222          297 YPCDLWSVGCILVELCSG----------EALFQTH----ENLEHLAM---MERVLGPLPHHMVIRADRRAEKYFRRGARL  359 (411)
Q Consensus       297 ~~~DiwSlGvil~elltg----------~~pf~~~----~~~~~~~~---i~~~~~~~p~~~~~~~~~~~~~li~~~l~~  359 (411)
                      ..+||||||.|+||++..          +.||.+.    ...+.+..   +.+..+.+|..+.   +..+..-+.++|.-
T Consensus       405 k~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~---s~~~l~~m~klMke  481 (513)
T KOG2052|consen  405 KRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWK---SDPALRVMAKLMKE  481 (513)
T ss_pred             hHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccc---cCHHHHHHHHHHHH
Confidence            568999999999999853          5788653    22333333   3444556666653   34455666777888


Q ss_pred             CCCCCCCcHHHHHHHHhc
Q 015222          360 DWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       360 ~~~~rp~~R~t~~~il~~  377 (411)
                      ||..+|+.|.|+-.+.+.
T Consensus       482 CW~~Np~aRltALriKKt  499 (513)
T KOG2052|consen  482 CWYANPAARLTALRIKKT  499 (513)
T ss_pred             hhcCCchhhhHHHHHHHH
Confidence            899999999999877653

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=299.85  Aligned_cols=254  Identities=22%  Similarity=0.216  Sum_probs=195.6

Q ss_pred             eEEEeeeccccceE-EEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEE
Q 015222           94 YRILSKMGEGTFGQ-VVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF  172 (411)
Q Consensus        94 y~i~~~lG~G~~g~-V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~  172 (411)
                      |.-.+.+|.|+.|+ ||+|..  .|+.||||.+-.  .....+++|+..|+.-.    .|+|||++++.-.++.+.||..
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~--e~~~~A~rEi~lL~eSD----~H~NviRyyc~E~d~qF~YIal  582 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLE--EFFDFAQREIQLLQESD----EHPNVIRYYCSEQDRQFLYIAL  582 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhh--HhHHHHHHHHHHHHhcc----CCCceEEEEeeccCCceEEEEe
Confidence            33456789999885 799954  578999998743  34456789999998764    2355599999999999999999


Q ss_pred             ccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          173 EKLGPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       173 e~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      |.|..+|.+++...  ..........+.++.|++.||++||+.+||||||||.||||+...                   
T Consensus       583 ELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~-------------------  643 (903)
T KOG1027|consen  583 ELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPS-------------------  643 (903)
T ss_pred             hHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccC-------------------
Confidence            99999999999874  211122255688999999999999999999999999999998632                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCCC------cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCh
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHEN  323 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~  323 (411)
                         .+...+++|+|||+++......      ....||.+|+|||++....-+.++|||||||++|..++ |..||...- 
T Consensus       644 ---~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~-  719 (903)
T KOG1027|consen  644 ---ADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL-  719 (903)
T ss_pred             ---CCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH-
Confidence               1234578999999988755443      34579999999999999888889999999999999999 599997532 


Q ss_pred             HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                       +.-..|......+-. +......++.++|.+|++.+    |..||++.++|.||+|++..
T Consensus       720 -~R~~NIl~~~~~L~~-L~~~~d~eA~dLI~~ml~~d----P~~RPsa~~VL~HPlFW~~e  774 (903)
T KOG1027|consen  720 -ERQANILTGNYTLVH-LEPLPDCEAKDLISRMLNPD----PQLRPSATDVLNHPLFWDSE  774 (903)
T ss_pred             -HhhhhhhcCccceee-eccCchHHHHHHHHHhcCCC----cccCCCHHHHhCCCccCChH
Confidence             222333333222111 11111128999999999999    99999999999999999754

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=296.99  Aligned_cols=247  Identities=22%  Similarity=0.328  Sum_probs=208.1

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCC---cEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKK---ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~---~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      ..-.|.+.||.|.||.|++|+.+..|   ..||||.++..  .+.+.+|..|+.||-+..||||     +++.++....+
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNI-----IrLEGVVTks~  703 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNI-----IRLEGVVTKSK  703 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcE-----EEEEEEEecCc
Confidence            35678899999999999999988766   47999999854  4667889999999999999988     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      .+.||+||| +|+|..||+.+.+ .|+..+...+++.|+.|++||-+.|+|||||-..||||+++               
T Consensus       704 PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsn---------------  767 (996)
T KOG0196|consen  704 PVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSN---------------  767 (996)
T ss_pred             eeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccc---------------
Confidence            999999999 9999999998874 59999999999999999999999999999999999998654               


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCCCcc----ccc--CCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY----VVS--TRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALF  318 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~----~~g--t~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf  318 (411)
                                  ...|++|||+++..+++...    .-|  ...|.|||.+...+++.+|||||+|++|||.++ |..||
T Consensus       768 ------------LvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY  835 (996)
T KOG0196|consen  768 ------------LVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY  835 (996)
T ss_pred             ------------eEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence                        47788888888876544321    112  468999999999999999999999999999888 99999


Q ss_pred             CCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      -+.++.+.+..|++...-.|+   .+++..+-.+..    -||+++=..||.+.+|+.++
T Consensus       836 WdmSNQdVIkaIe~gyRLPpP---mDCP~aL~qLMl----dCWqkdR~~RP~F~qiV~~l  888 (996)
T KOG0196|consen  836 WDMSNQDVIKAIEQGYRLPPP---MDCPAALYQLML----DCWQKDRNRRPKFAQIVSTL  888 (996)
T ss_pred             cccchHHHHHHHHhccCCCCC---CCCcHHHHHHHH----HHHHHHhhcCCCHHHHHHHH
Confidence            999999999999887543322   234444444444    45777699999999998753

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-35  Score=283.25  Aligned_cols=240  Identities=22%  Similarity=0.348  Sum_probs=198.3

Q ss_pred             EEEeeeccccceEEEEEEeCCC----CcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           95 RILSKMGEGTFGQVVECFDNEK----KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        95 ~i~~~lG~G~~g~V~~a~~~~~----~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      ...+.||+|.||.||+|.....    .-.||||..+.+  ....+.|..|..+++.+.||+|     +++++++.+ ...
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphI-----ikLIGv~~e-~P~  465 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHI-----IKLIGVCVE-QPM  465 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcch-----hheeeeeec-cce
Confidence            3456899999999999986432    346999999753  3557889999999999988887     999999985 678


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      +||||++ -|.|..||+.+. ..++......++.||+.||.|||+..+|||||-..|||+.+..                
T Consensus       466 WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~----------------  528 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ----------------  528 (974)
T ss_pred             eEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc----------------
Confidence            9999999 999999999876 4699999999999999999999999999999999999997654                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCCCcc--ccc--CCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSY--VVS--TRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHE  322 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~g--t~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~  322 (411)
                                 .|||+|||++++.+....+  ..|  .+.|||||.+.-..++.+||||-|||.+||++. |..||.+-.
T Consensus       529 -----------CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk  597 (974)
T KOG4257|consen  529 -----------CVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK  597 (974)
T ss_pred             -----------eeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc
Confidence                       7899999999987765432  122  568999999999999999999999999999998 999999988


Q ss_pred             hHHHHHHHHHHhC-CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHh
Q 015222          323 NLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK  376 (411)
Q Consensus       323 ~~~~~~~i~~~~~-~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~  376 (411)
                      +.+.+..++++.. +.|    +++++.+-.+..+|.+++    |.+||.+.++..
T Consensus       598 NsDVI~~iEnGeRlP~P----~nCPp~LYslmskcWaye----P~kRPrftei~~  644 (974)
T KOG4257|consen  598 NSDVIGHIENGERLPCP----PNCPPALYSLMSKCWAYE----PSKRPRFTEIKA  644 (974)
T ss_pred             ccceEEEecCCCCCCCC----CCCChHHHHHHHHHhccC----cccCCcHHHHHH
Confidence            8888877776543 233    345566666666665555    888888877654

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.5e-34  Score=314.10  Aligned_cols=241  Identities=16%  Similarity=0.204  Sum_probs=180.0

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      ..|...+.||+|+||.||+|++..++..||||.++.....   ...|++++++++|+||     +++++++.+.+..|+|
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnI-----v~~~~~~~~~~~~~lv  761 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNI-----VKLIGLCRSEKGAYLI  761 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCc-----ceEEEEEEcCCCCEEE
Confidence            3566778999999999999999999999999998643322   2346888888888877     9999999999999999


Q ss_pred             EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH---ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      |||+ +++|.++++.     +++..+..++.||+.||+|||   +.+|+||||||+||+++.++.               
T Consensus       762 ~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~---------------  821 (968)
T PLN00113        762 HEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE---------------  821 (968)
T ss_pred             EeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc---------------
Confidence            9999 9999999953     789999999999999999999   669999999999999976652               


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh--HH
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN--LE  325 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~--~~  325 (411)
                                  .++. ||.+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....  ..
T Consensus       822 ------------~~~~-~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~  887 (968)
T PLN00113        822 ------------PHLR-LSLPGLLCT-DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS  887 (968)
T ss_pred             ------------eEEE-ecccccccc-CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCc
Confidence                        2332 343322211 1223688999999999999999999999999999999999999854211  11


Q ss_pred             HHHHHHHHh----------CCCCh--hHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          326 HLAMMERVL----------GPLPH--HMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       326 ~~~~i~~~~----------~~~p~--~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      .........          .....  .........+.+++.+|++.+    |++||++.++++..
T Consensus       888 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~----P~~RPt~~evl~~L  948 (968)
T PLN00113        888 IVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATD----PTARPCANDVLKTL  948 (968)
T ss_pred             HHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCC----chhCcCHHHHHHHH
Confidence            111111000          00000  011112234556777776666    99999999998774

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-35  Score=274.59  Aligned_cols=244  Identities=22%  Similarity=0.298  Sum_probs=184.0

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC----e
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN----H  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~----~  167 (411)
                      ...++.+.||+|.||.||+|..  +++.||||++..  ...+.+++|-+|.+..   +..|+||+++++.-+...    .
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~--~~kqs~~~Ek~Iy~lp---~m~h~nIl~Fi~~ekr~t~~~~e  282 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE--QEKQSFQNEKNIYSLP---GMKHENILQFIGAEKRGTADRME  282 (534)
T ss_pred             CchhhHHHhhcCccceeehhhc--cCceeEEEecCH--HHHHHHHhHHHHHhcc---CccchhHHHhhchhccCCccccc
Confidence            3567889999999999999954  568999999964  3345677777776543   445555699988766544    8


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---------CCceecCCCCCcEEEecCcccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE---------LRLIHTDLKPENILLVSAEYVKVPD  237 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---------~givH~Dikp~NIli~~~~~~~l~d  237 (411)
                      ++||++|. .|+|.+||..+.   +++....+|+..+++||+|||+         ..|+|||||..||||.+++      
T Consensus       283 ywLVt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl------  353 (534)
T KOG3653|consen  283 YWLVTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL------  353 (534)
T ss_pred             eeEEeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC------
Confidence            99999999 999999999875   9999999999999999999997         2599999999999998877      


Q ss_pred             cccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCC-CCC-----ccchhHHHHH
Q 015222          238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGL-GWN-----YPCDLWSVGC  306 (411)
Q Consensus       238 f~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~-----~~~DiwSlGv  306 (411)
                                           +..|+|||+|.......     ...+||..|||||++.+. .+.     .+.||||+|.
T Consensus       354 ---------------------TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgL  412 (534)
T KOG3653|consen  354 ---------------------TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGL  412 (534)
T ss_pred             ---------------------cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHH
Confidence                                 56777777776543222     235899999999999875 333     5689999999


Q ss_pred             HHHHHHhCCC------------CCCCC-------ChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCc
Q 015222          307 ILVELCSGEA------------LFQTH-------ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATS  367 (411)
Q Consensus       307 il~elltg~~------------pf~~~-------~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~  367 (411)
                      |||||++...            ||+..       ++...+....+..+.+|..+...   ...+.+...+.-||+++++.
T Consensus       413 VLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h---~~~~~l~et~EeCWDhDaeA  489 (534)
T KOG3653|consen  413 VLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH---AGMAVLCETIEECWDHDAEA  489 (534)
T ss_pred             HHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC---ccHHHHHHHHHHHcCCchhh
Confidence            9999998643            34310       12222333345566777777654   23445555556668888999


Q ss_pred             HHHHHHHH
Q 015222          368 RDSMRAVW  375 (411)
Q Consensus       368 R~t~~~il  375 (411)
                      |.|+.=+-
T Consensus       490 RLTA~Cv~  497 (534)
T KOG3653|consen  490 RLTAGCVE  497 (534)
T ss_pred             hhhhHHHH
Confidence            99987553

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-35  Score=280.61  Aligned_cols=255  Identities=23%  Similarity=0.331  Sum_probs=214.7

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      .++|+.+..+|.|+||.||+|+++.+++..|+|+++-.. ....-.+.|+-+++..+|+||     +.+++.+.....++
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~ni-----vay~gsylr~dklw   88 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNI-----VAYFGSYLRRDKLW   88 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcCh-----HHHHhhhhhhcCcE
Confidence            468999999999999999999999999999999998543 334556789999999999988     99999999999999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      ++|||| ||+|.+..+-.+  .+++.++..+.+..++||+|||++|-+|||||-.|||+++.|                 
T Consensus        89 icMEycgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~g-----------------  149 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEG-----------------  149 (829)
T ss_pred             EEEEecCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccC-----------------
Confidence            999999 899999877665  799999999999999999999999999999999999998888                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccC---CCcccccCCCccccceec---CCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGEALFQTHE  322 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltg~~pf~~~~  322 (411)
                                .+|++|||.+..+..   ....+.||++|||||+..   .+.|...+|||++|++..||-.-++|-....
T Consensus       150 ----------DvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh  219 (829)
T KOG0576|consen  150 ----------DVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH  219 (829)
T ss_pred             ----------ceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc
Confidence                      556666666544332   234578999999999875   3479999999999999999999998876666


Q ss_pred             hHHHHHHHHHHhCCCCh-hHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcc
Q 015222          323 NLEHLAMMERVLGPLPH-HMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVI  383 (411)
Q Consensus       323 ~~~~~~~i~~~~~~~p~-~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~  383 (411)
                      ....+..+.+-....|. .-...+++.+.+|++.+|.++    |.+||+++.+|.|+++...
T Consensus       220 pmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altkn----pKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  220 PMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKN----PKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             hHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCC----CccCCChhhheeceeeccc
Confidence            66666666654433332 223456788999999999999    9999999999999998864

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=2.5e-33  Score=258.81  Aligned_cols=282  Identities=22%  Similarity=0.324  Sum_probs=201.5

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCC---CCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNE---KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .+.+.|.++++||+|+|++||+|.+..   .++.||+|.+..... ...+.+|++.|..+.    ++.||+++.+.+..+
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~g----G~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLG----GSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhc----cchhhhcchhhhccC
Confidence            456789999999999999999999887   788999999875433 355888999999986    334569999999999


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecC-cccccCCcccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA-EYVKVPDYKFLSR  243 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~-~~~~l~df~~~~~  243 (411)
                      +..++||||+ .....+++..     ++...++.++..++.||.++|.+|||||||||+|+|.+.. +.-.|.|||++-+
T Consensus       108 d~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR  182 (418)
T ss_pred             CeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence            9999999999 7777777664     6788999999999999999999999999999999999865 5667889998763


Q ss_pred             cCCCC----Ccc-c--cCCCCCCeeEeecCCcc---c---c---c----CCCcccccCCCccccceecCC-CCCccchhH
Q 015222          244 SSKDG----SYF-K--NLPKSSAIKLIDFGSTT---F---E---H----QDHSYVVSTRHYRAPEVILGL-GWNYPCDLW  302 (411)
Q Consensus       244 ~~~~~----~~~-~--~~~~~~~~kl~Dfg~a~---~---~---~----~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diw  302 (411)
                      .....    ... .  ....-..-..-.+..+.   .   .   .    .......||++|+|||++... .-++++|||
T Consensus       183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw  262 (418)
T KOG1167|consen  183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW  262 (418)
T ss_pred             HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence            21110    000 0  00000000000011110   0   0   0    011235799999999999876 568999999


Q ss_pred             HHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHh------------CC---------------------C-----------
Q 015222          303 SVGCILVELCSGEALFQTH-ENLEHLAMMERVL------------GP---------------------L-----------  337 (411)
Q Consensus       303 SlGvil~elltg~~pf~~~-~~~~~~~~i~~~~------------~~---------------------~-----------  337 (411)
                      |.|||+.-+++++.||-.. ++.+.+..+..+.            +.                     +           
T Consensus       263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~  342 (418)
T KOG1167|consen  263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP  342 (418)
T ss_pred             eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence            9999999999999998432 2222222111111            11                     0           


Q ss_pred             ---ChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          338 ---PHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       338 ---p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                         +.......+..+-+++++||..|    |.+|.|++++|+|+||...+
T Consensus       343 n~~~~~~~d~~~~~~~dlLdk~le~n----p~kRitAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  343 NTEREIGSDVFPALLLDLLDKCLELN----PQKRITAEDALKHPFFDEAD  388 (418)
T ss_pred             ceeeccccccccHHHHHHHHHHccCC----hhhcccHHHHhcCcCCcchh
Confidence               00011112336788999999999    99999999999999999544

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2e-33  Score=245.32  Aligned_cols=256  Identities=24%  Similarity=0.299  Sum_probs=198.2

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeee-eecCCeE
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW-FDYRNHI  168 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~-~~~~~~~  168 (411)
                      +.+.|.|.+.||+|.||.+-+|+++.++..+|+|.+........+|.+|..---.|.||    .||+.-|+. |+..+.+
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H----~hIi~tY~vaFqt~d~Y   97 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPH----QHIIDTYEVAFQTSDAY   97 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccc----hhhhHHHHHHhhcCceE
Confidence            45789999999999999999999999999999999988777788888888665555432    344666654 6777899


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      +++|||+ -|+|..-+...+   +.|...+.++.|+++||.|+|++++||||||.+||||-..+                
T Consensus        98 vF~qE~aP~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~d----------------  158 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDAD----------------  158 (378)
T ss_pred             EEeeccCccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCC----------------
Confidence            9999999 899988877654   88999999999999999999999999999999999996532                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCC-----CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-----GWNYPCDLWSVGCILVELCSGEALFQTHE  322 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlGvil~elltg~~pf~~~~  322 (411)
                               ..++||||||.++..+......--+..|.+||+....     ...+.+|||.||+++|.++||++||+...
T Consensus       159 ---------f~rvKlcDFG~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~  229 (378)
T KOG1345|consen  159 ---------FYRVKLCDFGLTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS  229 (378)
T ss_pred             ---------ccEEEeeecccccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh
Confidence                     3389999999998776655555557789999987532     35789999999999999999999998432


Q ss_pred             hH-HHHHHHH----HHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcH---HHHHHHHhcCCCCc
Q 015222          323 NL-EHLAMME----RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR---DSMRAVWKLLRLPV  382 (411)
Q Consensus       323 ~~-~~~~~i~----~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R---~t~~~il~~~~~~~  382 (411)
                      .. ..+....    +.....|. .....++.+..++++-|..+    +..|   -+++......|...
T Consensus       230 ~~d~~Y~~~~~w~~rk~~~~P~-~F~~fs~~a~r~Fkk~lt~~----~~drcki~~~kk~rk~~w~E~  292 (378)
T KOG1345|consen  230 IMDKPYWEWEQWLKRKNPALPK-KFNPFSEKALRLFKKSLTPR----FKDRCKIWTAKKMRKCLWKEK  292 (378)
T ss_pred             ccCchHHHHHHHhcccCccCch-hhcccCHHHHHHHHHhcCCc----ccccchhHHHHHHHHHHHHHh
Confidence            21 1222222    22223343 34567788888999998888    5555   55555555556543

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.98  E-value=4e-33  Score=295.69  Aligned_cols=210  Identities=17%  Similarity=0.177  Sum_probs=161.5

Q ss_pred             EEEeeeee-------cCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015222          156 VQIRNWFD-------YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV  228 (411)
Q Consensus       156 v~~~~~~~-------~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~  228 (411)
                      ..++++|.       ....++++||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||||+
T Consensus        36 ~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~  114 (793)
T PLN00181         36 RSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMS  114 (793)
T ss_pred             HHhhcccCCccccccccchhhhhhccCCccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEc
Confidence            55566552       234678889988889999997543 4699999999999999999999999999999999999999


Q ss_pred             cCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC-------------------CcccccCCCccccce
Q 015222          229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-------------------HSYVVSTRHYRAPEV  289 (411)
Q Consensus       229 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------------------~~~~~gt~~y~aPE~  289 (411)
                      ..|.+|++|||+++....        +....+|++|||+++.....                   ....+||+.|||||+
T Consensus       115 ~~~~~k~~d~~~~~~~~~--------~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        115 SFNHVSFIESASCSDSGS--------DEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             ccCcEEEeeccccCcccc--------cccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            999999999998765432        23457899999998753210                   011468999999999


Q ss_pred             ecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH
Q 015222          290 ILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD  369 (411)
Q Consensus       290 ~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~  369 (411)
                      +.+..++.++|||||||+||||++|..|+....  ..+..+...  ..|...... .....+++.+||..+    |.+||
T Consensus       187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~L~~~----P~~Rp  257 (793)
T PLN00181        187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHR--VLPPQILLN-WPKEASFCLWLLHPE----PSCRP  257 (793)
T ss_pred             hccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHh--hcChhhhhc-CHHHHHHHHHhCCCC----hhhCc
Confidence            999999999999999999999999999875422  122222211  123222222 233557788888888    99999


Q ss_pred             HHHHHHhcCCCCcc
Q 015222          370 SMRAVWKLLRLPVI  383 (411)
Q Consensus       370 t~~~il~~~~~~~~  383 (411)
                      ++.++++|+||...
T Consensus       258 s~~eil~h~~~~~~  271 (793)
T PLN00181        258 SMSELLQSEFINEP  271 (793)
T ss_pred             ChHHHhhchhhhhh
Confidence            99999999999864

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=1.1e-32  Score=271.43  Aligned_cols=241  Identities=20%  Similarity=0.245  Sum_probs=190.7

Q ss_pred             eEEEeeeccccceEEEEEEeCCCC----cEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           94 YRILSKMGEGTFGQVVECFDNEKK----ELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        94 y~i~~~lG~G~~g~V~~a~~~~~~----~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      .+..++||+|+||+||+|.+...|    .+||||++....  +...++.+|+-++.++.|+|+     +++++++.... 
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl-----~RLLgvc~~s~-  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNL-----LRLLGVCMLST-  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchH-----HHHhhhcccch-
Confidence            445679999999999999986555    478999987543  446788999999999998887     99999987654 


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +-||++|+ .|+|.|+++.++ ..+.......|..||++||.|||++++|||||-..||||..-.               
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~---------------  835 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPN---------------  835 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCC---------------
Confidence            88999999 999999999876 4688899999999999999999999999999999999997655               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCCcc-----cccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY-----VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQT  320 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~  320 (411)
                                  .+||.|||+++........     ..-.+.|||-|.+....|+.++|||||||++||++| |..|+.+
T Consensus       836 ------------hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g  903 (1177)
T KOG1025|consen  836 ------------HVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG  903 (1177)
T ss_pred             ------------eEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC
Confidence                        5677777777765443322     122567999999999999999999999999999999 9999999


Q ss_pred             CChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHH
Q 015222          321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVW  375 (411)
Q Consensus       321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il  375 (411)
                      ....++-..++.... ++.  .+..+-.+--++.+|+..|    +..||+++++.
T Consensus       904 i~~~eI~dlle~geR-Lsq--PpiCtiDVy~~mvkCwmid----~~~rp~fkel~  951 (1177)
T KOG1025|consen  904 IPAEEIPDLLEKGER-LSQ--PPICTIDVYMVMVKCWMID----ADSRPTFKELA  951 (1177)
T ss_pred             CCHHHhhHHHhcccc-CCC--CCCccHHHHHHHHHHhccC----cccCccHHHHH
Confidence            888777666655432 211  1223344555566665555    77777776654

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2e-31  Score=272.73  Aligned_cols=245  Identities=21%  Similarity=0.360  Sum_probs=189.8

Q ss_pred             CCeEEEeeeccccceEEEEEEeCC-------CCcEEEEEEeccch--hhhHHHHHHHHHHHHHh-cCCCCCcceEEEeee
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNE-------KKELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNW  161 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~-------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~  161 (411)
                      ++..+.+.||+|.||.|++|.-..       ....||||.++...  ...+.+..|+++++.+. |+|+     +.+++.
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~ni-----v~llG~  370 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNI-----VNLLGA  370 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcch-----hhheee
Confidence            344667799999999999997431       14579999997433  45677889999999986 5554     999999


Q ss_pred             eecCCeEEEEEccC-CCCHHHHHHhcC------------C--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015222          162 FDYRNHICIVFEKL-GPSLYDFLRKNS------------Y--RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL  226 (411)
Q Consensus       162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~------------~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIl  226 (411)
                      +...+.+++|+||+ .|+|.++++...            .  ..++..+...++.||+.|++||++.++|||||-..|||
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVL  450 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVL  450 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEE
Confidence            99999999999999 999999998765            1  13889999999999999999999999999999999999


Q ss_pred             EecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcc----ccc--CCCccccceecCCCCCccch
Q 015222          227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY----VVS--TRHYRAPEVILGLGWNYPCD  300 (411)
Q Consensus       227 i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~----~~g--t~~y~aPE~~~~~~~~~~~D  300 (411)
                      +..+.                           .+||+|||+|+........    ..|  ...|||||.+....|+.++|
T Consensus       451 i~~~~---------------------------~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSD  503 (609)
T KOG0200|consen  451 ITKNK---------------------------VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSD  503 (609)
T ss_pred             ecCCC---------------------------EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccch
Confidence            97765                           6788888888754333222    122  23499999999999999999


Q ss_pred             hHHHHHHHHHHHh-CCCCCCCCC-hHHHHHHHHHHhC-CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHh
Q 015222          301 LWSVGCILVELCS-GEALFQTHE-NLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK  376 (411)
Q Consensus       301 iwSlGvil~ellt-g~~pf~~~~-~~~~~~~i~~~~~-~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~  376 (411)
                      ||||||+|||+++ |..||.+.. ..+.++.+..+.. ..|.    .+++++-+++    ..||+.+|++||++.++.+
T Consensus       504 VWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~----~c~~eiY~iM----~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  504 VWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPE----HCSDEIYDLM----KSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             hhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCC----CCCHHHHHHH----HHHhCCCcccCCCHHHHHH
Confidence            9999999999999 999999855 4444444444322 2222    2334444444    4557777999999998875

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=9.5e-31  Score=235.49  Aligned_cols=206  Identities=37%  Similarity=0.569  Sum_probs=172.5

Q ss_pred             eEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchh--hhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        94 y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      |.+.+.||.|++|.||++.+..+++.+|+|.+.....  ..+.+.+|++.++.+.|+++     +++++++......+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i-----~~~~~~~~~~~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNI-----VKLYGVFEDPEPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCh-----hhheeeeecCCceEEE
Confidence            5678999999999999999998899999999975433  46778889999999987776     9999998888999999


Q ss_pred             EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      +|++ +++|.+++..... .+++..+..++.+++.+|.+||+.|++|+||+|+||+++.++                   
T Consensus        76 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~-------------------  135 (225)
T smart00221       76 MEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG-------------------  135 (225)
T ss_pred             EeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-------------------
Confidence            9999 7799999987651 188999999999999999999999999999999999997655                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCCC----cccccCCCcccccee-cCCCCCccchhHHHHHHHHHHHhCCCCCCC-CChH
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVI-LGLGWNYPCDLWSVGCILVELCSGEALFQT-HENL  324 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~elltg~~pf~~-~~~~  324 (411)
                              .++|+|||.+.......    ....++..|++||.+ ....++.++||||||+++++|++|+.||.. .+..
T Consensus       136 --------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~  207 (225)
T smart00221      136 --------LVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT  207 (225)
T ss_pred             --------CEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence                    67788888776654432    345678899999998 566788899999999999999999999976 3333


Q ss_pred             -HHHHHHHH
Q 015222          325 -EHLAMMER  332 (411)
Q Consensus       325 -~~~~~i~~  332 (411)
                       .....+..
T Consensus       208 ~~~~~~~~~  216 (225)
T smart00221      208 SLLSDVWSF  216 (225)
T ss_pred             HHHHHHHhc
Confidence             44444443

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=2e-30  Score=229.98  Aligned_cols=207  Identities=36%  Similarity=0.573  Sum_probs=179.0

Q ss_pred             eccccceEEEEEEeCCCCcEEEEEEeccchh--hhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC-C
Q 015222          100 MGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-G  176 (411)
Q Consensus       100 lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~-~  176 (411)
                      ||+|++|.||++.+..+++.+++|++.....  ..+.+.+|+..++.+.|+++     +++++++......+++||++ +
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i-----~~~~~~~~~~~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNI-----VKLYGVFEDENHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCe-----eeEeeeeecCCeEEEEEecCCC
Confidence            6899999999999988899999999986544  35678899999999988666     99999999889999999999 6


Q ss_pred             CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec-CcccccCCcccccccCCCCCccccCC
Q 015222          177 PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS-AEYVKVPDYKFLSRSSKDGSYFKNLP  255 (411)
Q Consensus       177 ~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~-~~~~~l~df~~~~~~~~~~~~~~~~~  255 (411)
                      ++|.+++.... ..++...+..++.+++.+|++||+.|++|+||+|.||+++. ++                        
T Consensus        76 ~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~------------------------  130 (215)
T cd00180          76 GSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG------------------------  130 (215)
T ss_pred             CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC------------------------
Confidence            99999998753 35899999999999999999999999999999999999976 44                        


Q ss_pred             CCCCeeEeecCCcccccCC---CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015222          256 KSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME  331 (411)
Q Consensus       256 ~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~  331 (411)
                         .++|+|||.+......   .....+...|++||.+... .++.++|+|++|+++++|                    
T Consensus       131 ---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------  187 (215)
T cd00180         131 ---KVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------  187 (215)
T ss_pred             ---cEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------
Confidence               6788888877655443   2335678899999999887 788999999999999999                    


Q ss_pred             HHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          332 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       332 ~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                                     ..+.+++.+|+..+    |+.||++.++++++
T Consensus       188 ---------------~~~~~~l~~~l~~~----p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ---------------PELKDLIRKMLQKD----PEKRPSAKEILEHL  215 (215)
T ss_pred             ---------------HHHHHHHHHHhhCC----cccCcCHHHHhhCC
Confidence                           45778889998888    99999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-28  Score=232.94  Aligned_cols=209  Identities=28%  Similarity=0.360  Sum_probs=172.1

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCC-cEEEEEEeccchhh-hHHHHHHHHHHHHHhcCCCCCcceEEEeeee-ecCCeEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKK-ELVAIKIVRSINKY-REAAMIEIDVLQRLARHDIGGTRCVQIRNWF-DYRNHIC  169 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~-~~vavK~~~~~~~~-~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~-~~~~~~~  169 (411)
                      +|++.++||+|+||.||+|.+..++ ..+|+|+....... ...+..|+.++..+.. .....++..+++.. ..+.+.|
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~-~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEK-KNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhh-hcCCCCCCEEEEeccCCCceeE
Confidence            8999999999999999999988775 67899988654322 2267889999999985 22234568888888 5778999


Q ss_pred             EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      +||+.+|.+|.++........++..++..|+.|++.+|++||+.|++||||||+|++++..+                  
T Consensus        98 iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~------------------  159 (322)
T KOG1164|consen   98 IVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSS------------------  159 (322)
T ss_pred             EEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCC------------------
Confidence            99999999999998766667899999999999999999999999999999999999997643                  


Q ss_pred             ccccCCCCCCeeEeecCCcc--ccc-CC----------CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCC
Q 015222          250 YFKNLPKSSAIKLIDFGSTT--FEH-QD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA  316 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~--~~~-~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~  316 (411)
                          ......+.|.|||+++  ... ..          .....||..|+++....+...+.+.|+||++.++.||+.|..
T Consensus       160 ----~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~L  235 (322)
T KOG1164|consen  160 ----RSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSL  235 (322)
T ss_pred             ----CcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCC
Confidence                0112368888888887  210 10          123569999999999999999999999999999999999999


Q ss_pred             CCCCCChH
Q 015222          317 LFQTHENL  324 (411)
Q Consensus       317 pf~~~~~~  324 (411)
                      ||.+....
T Consensus       236 PW~~~~~~  243 (322)
T KOG1164|consen  236 PWEALEMT  243 (322)
T ss_pred             CCcccccc
Confidence            99776543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=8.6e-29  Score=213.04  Aligned_cols=249  Identities=23%  Similarity=0.331  Sum_probs=195.0

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      ..++|+++++||.|+||.+|+|....+|+.||||+-.... ....+..|..+...|.+-    ..+..+..++...++-.
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~hpqL~yEskvY~iL~~g----~GiP~i~~y~~e~~ynv   87 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KHPQLLYESKVYRILQGG----VGIPHIRHYGTEKDYNV   87 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-CCcchhHHHHHHHHhccC----CCCchhhhhccccccce
Confidence            3578999999999999999999999999999999865432 334567789999988753    22356666777788899


Q ss_pred             EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      +||+++|.+|.++..-.. +.++..++.-++-|++.-++|+|.+++|||||||+|+|.+-+-                  
T Consensus        88 lVMdLLGPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgr------------------  148 (341)
T KOG1163|consen   88 LVMDLLGPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGR------------------  148 (341)
T ss_pred             eeeeccCccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeecccc------------------
Confidence            999999999999987554 4799999999999999999999999999999999999986543                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCC----------CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ  319 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~  319 (411)
                            ....+.|+|||+|+...+.          .....||..|++--...+..-+...|+=|+|.+|..+..|..||+
T Consensus       149 ------h~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQ  222 (341)
T KOG1163|consen  149 ------HCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQ  222 (341)
T ss_pred             ------ccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccc
Confidence                  2346889999998754322          234679999999888888788899999999999999999999999


Q ss_pred             CCChH---HHHHHHHHHhCCCC-hhHHHhhhhhhhhhhccCCccCCCCCCCcH
Q 015222          320 THENL---EHLAMMERVLGPLP-HHMVIRADRRAEKYFRRGARLDWPDGATSR  368 (411)
Q Consensus       320 ~~~~~---~~~~~i~~~~~~~p-~~~~~~~~~~~~~li~~~l~~~~~~rp~~R  368 (411)
                      +....   +..++|.+..-..| +.+-...+.++..++.-|-..-+.+.|+-+
T Consensus       223 glka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~  275 (341)
T KOG1163|consen  223 GLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM  275 (341)
T ss_pred             ccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence            87554   44444444433333 334445566677777777666666767653

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-29  Score=230.68  Aligned_cols=247  Identities=16%  Similarity=0.177  Sum_probs=186.1

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCC-----CcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeee
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF  162 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~-----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~  162 (411)
                      ...|++....+.+|.||.||.|.+++.     .+.|-+|.++...  .....+..|.-.+..+.|+|+     ..+.++.
T Consensus       282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nl-----l~V~~V~  356 (563)
T KOG1024|consen  282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNL-----LSVLGVS  356 (563)
T ss_pred             hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCc-----cceeEEE
Confidence            346788889999999999999977643     2456677665432  233444556666666666655     8887765


Q ss_pred             e-cCCeEEEEEccC-CCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccc
Q 015222          163 D-YRNHICIVFEKL-GPSLYDFLRKN------SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK  234 (411)
Q Consensus       163 ~-~~~~~~lv~e~~-~~~L~~~l~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~  234 (411)
                      . +....++++.+. -|+|..|+...      ..+.++..+...++.|++.|++|||+.||||.||-..|.+|++.    
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~----  432 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ----  432 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh----
Confidence            4 456788999999 88999999822      23457778889999999999999999999999999999998754    


Q ss_pred             cCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccc-----cCCCccccceecCCCCCccchhHHHHHHHH
Q 015222          235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVV-----STRHYRAPEVILGLGWNYPCDLWSVGCILV  309 (411)
Q Consensus       235 l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~-----gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  309 (411)
                                             .++||+|-.+++..-.......     ....|||||.+.+..|+.++|+|||||+||
T Consensus       433 -----------------------LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllW  489 (563)
T KOG1024|consen  433 -----------------------LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLW  489 (563)
T ss_pred             -----------------------eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHH
Confidence                                   4778888877775443333222     356799999999999999999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHHhC-CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHh
Q 015222          310 ELCS-GEALFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK  376 (411)
Q Consensus       310 ellt-g~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~  376 (411)
                      ||+| |+.||..-+..+....+..+.. .-|.    ++++++-.    .|..||.-.|++||+++|+..
T Consensus       490 ELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~----NCPDeLf~----vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  490 ELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPF----NCPDELFT----VMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             HHHhcCCCCccccCHHHHHHHHhccceecCCC----CCcHHHHH----HHHHHHhcCcccCCCHHHHHH
Confidence            9999 9999999999888777766432 1111    23333333    345667777999999999875

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=4.8e-28  Score=217.34  Aligned_cols=260  Identities=23%  Similarity=0.301  Sum_probs=202.8

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      .-.|+|.++||+|+||++++|.+..+++.||||.-.. ......+..|....+.|...    ++|..++-+...+.+-.|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-kS~APQLrdEYr~YKlL~g~----~GIP~vYYFGqeG~~NiL  101 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-KSEAPQLRDEYRTYKLLGGT----EGIPQVYYFGQEGKYNIL  101 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccc-cCCcchHHHHHHHHHHHcCC----CCCCceeeeccccchhhh
Confidence            3479999999999999999999999999999997532 33345577788888888632    344677767777788999


Q ss_pred             EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       171 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      |||++|.+|.|+..-.+ +.|+...+..++.|++.-++|+|++.+|.|||||+|+||+.-+                   
T Consensus       102 VidLLGPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~-------------------  161 (449)
T KOG1165|consen  102 VIDLLGPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPG-------------------  161 (449)
T ss_pred             hhhhhCcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCC-------------------
Confidence            99999999999988665 6899999999999999999999999999999999999998755                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCCC----------cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQDH----------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT  320 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~  320 (411)
                         ..+...+.|+|||+|+......          ....||..||+--...|..-+..-|+=|||-+++..|-|..||.+
T Consensus       162 ---~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG  238 (449)
T KOG1165|consen  162 ---TKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG  238 (449)
T ss_pred             ---CCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence               2344578999999998754332          346799999999999999999999999999999999999999987


Q ss_pred             C---ChHHHHHHHHHHhCC-CChhHHHhhhhhhhhhhccCCccCCCCCCCc---HHHHHHHHhcC
Q 015222          321 H---ENLEHLAMMERVLGP-LPHHMVIRADRRAEKYFRRGARLDWPDGATS---RDSMRAVWKLL  378 (411)
Q Consensus       321 ~---~~~~~~~~i~~~~~~-~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~---R~t~~~il~~~  378 (411)
                      .   +..+.+++|-..... ....+-...+.++..+++-.-+.++.+.|+-   |-.+.++|...
T Consensus       239 LKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~  303 (449)
T KOG1165|consen  239 LKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL  303 (449)
T ss_pred             ccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence            5   445555555443332 2333444555566666655555565555653   55566666543

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=1.4e-28  Score=213.61  Aligned_cols=164  Identities=23%  Similarity=0.261  Sum_probs=126.4

Q ss_pred             CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccCCC
Q 015222          177 PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK  256 (411)
Q Consensus       177 ~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~  256 (411)
                      |+|.+++..++ ..+++..++.++.||+.||+|||+++      ||+|||++.++                         
T Consensus         1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~-------------------------   48 (176)
T smart00750        1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDG-------------------------   48 (176)
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCcc-------------------------
Confidence            68999998654 36999999999999999999999999      99999998766                         


Q ss_pred             CCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhC
Q 015222          257 SSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL-EHLAMMERVLG  335 (411)
Q Consensus       257 ~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~-~~~~~i~~~~~  335 (411)
                        .+++  ||++.......  ..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+..+.....
T Consensus        49 --~~~~--fG~~~~~~~~~--~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  122 (176)
T smart00750       49 --LLKL--DGSVAFKTPEQ--SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP  122 (176)
T ss_pred             --ceee--ccceEeecccc--CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc
Confidence              4455  67665543322  26899999999999999999999999999999999999999765432 22333322222


Q ss_pred             CC-Ch--hHHHhhhh--hhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCc
Q 015222          336 PL-PH--HMVIRADR--RAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       336 ~~-p~--~~~~~~~~--~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~  382 (411)
                      .. +.  ......+.  .+.+++.+|+..+    |..||++.++++|+|+..
T Consensus       123 ~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~----p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      123 ADDPRDRSNLESVSAARSFADFMRVCASRL----PQRREAANHYLAHCRALF  170 (176)
T ss_pred             cCCccccccHHHHHhhhhHHHHHHHHHhcc----cccccCHHHHHHHHHHHH
Confidence            11 11  11223333  6899999998888    999999999999998753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=4.2e-28  Score=245.54  Aligned_cols=262  Identities=22%  Similarity=0.315  Sum_probs=198.3

Q ss_pred             CCCe-EEEeeeccccceEEEEEEeCCCCcEEEEEEec----cch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeee
Q 015222           91 TPRY-RILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF  162 (411)
Q Consensus        91 ~~~y-~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~----~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~  162 (411)
                      .+.| .....+|.|++|.|+.+......+.++.|.++    ...   .....+..|+-+-..+.|+++     +..+..+
T Consensus       316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~-----~e~l~~~  390 (601)
T KOG0590|consen  316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNI-----IETLDIV  390 (601)
T ss_pred             ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCch-----hhhHHHH
Confidence            3445 45678999999999888887776666666554    111   111224456666667777766     6666666


Q ss_pred             ecCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccc
Q 015222          163 DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       163 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                      .+.....-+||||.++|+.++....  .+...++..+++||+.|++|+|+.||.|||||++|+++...|           
T Consensus       391 ~~~~~~~~~mE~~~~Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g-----------  457 (601)
T KOG0590|consen  391 QEIDGILQSMEYCPYDLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENG-----------  457 (601)
T ss_pred             hhcccchhhhhcccHHHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCC-----------
Confidence            5555455559999449999998864  688999999999999999999999999999999999998877           


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCcccccCC-------CcccccCCCccccceecCCCCC-ccchhHHHHHHHHHHHhC
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-------HSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSG  314 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg  314 (411)
                                      .+||+|||.+......       ....+|+..|+|||++.+..|+ ...||||.|++++.|.+|
T Consensus       458 ----------------~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~  521 (601)
T KOG0590|consen  458 ----------------ILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILG  521 (601)
T ss_pred             ----------------ceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecC
Confidence                            5677777766543221       2336899999999999999987 568999999999999999


Q ss_pred             CCCCCCCChHHHH-----HHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccCCC
Q 015222          315 EALFQTHENLEHL-----AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSAS  389 (411)
Q Consensus       315 ~~pf~~~~~~~~~-----~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~~  389 (411)
                      +.||......+..     .........-+..+...++.+.+.+|.+||+.+    |.+|.|+++|++.+||+.+......
T Consensus       522 ~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~----P~~R~ti~~i~~d~W~~~i~~c~v~  597 (601)
T KOG0590|consen  522 RFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLD----PTKRITIEQILNDEWIRSIECCHVD  597 (601)
T ss_pred             CCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCC----hhheecHHHHhhChHhhhcceEEec
Confidence            9999764433221     111111123355667778889999999999999    9999999999999999999876655


Q ss_pred             C
Q 015222          390 P  390 (411)
Q Consensus       390 ~  390 (411)
                      +
T Consensus       598 ~  598 (601)
T KOG0590|consen  598 P  598 (601)
T ss_pred             c
Confidence            4

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=2.5e-26  Score=218.87  Aligned_cols=159  Identities=19%  Similarity=0.171  Sum_probs=121.5

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCC-CCcEEEEEEeccc------hhhhHHHHHHHHHHHHHhcCCCCCcceE-EEeee
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSI------NKYREAAMIEIDVLQRLARHDIGGTRCV-QIRNW  161 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~-~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~~~~i~~~~iv-~~~~~  161 (411)
                      +.++|++.+.||+|+||+||+|+++. +++.||||++...      ......+.+|+.+|+++.|+++     + .++++
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~i-----v~~l~~~   90 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGV-----VPQLLAT   90 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCC-----CcEEEEc
Confidence            45789999999999999999999876 6788899986532      2235668899999999999887     4 44432


Q ss_pred             eecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCcEEEecCcccccCCcc
Q 015222          162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL-KPENILLVSAEYVKVPDYK  239 (411)
Q Consensus       162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Di-kp~NIli~~~~~~~l~df~  239 (411)
                          +..|+||||+ |++|.. +..     ..   ...++.|+++||.|||++||+|||| ||+|||++.++        
T Consensus        91 ----~~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~--------  149 (365)
T PRK09188         91 ----GKDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG--------  149 (365)
T ss_pred             ----CCcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC--------
Confidence                4579999999 888863 211     11   1467899999999999999999999 99999997666        


Q ss_pred             cccccCCCCCccccCCCCCCeeEeecCCcccccCC-----------CcccccCCCccccceecCC
Q 015222          240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----------HSYVVSTRHYRAPEVILGL  293 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~  293 (411)
                                         .++|+|||+|+.....           -.+..+++.|+|||.+...
T Consensus       150 -------------------~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        150 -------------------EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             -------------------CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence                               4666666666543221           1345688899999998643

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.94  E-value=4.2e-25  Score=208.80  Aligned_cols=251  Identities=31%  Similarity=0.453  Sum_probs=194.1

Q ss_pred             eEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchh----hhHHHHHHHHHHHHHhcC-CCCCcceEEEeeeeecCCeE
Q 015222           94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARH-DIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        94 y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~~~-~i~~~~iv~~~~~~~~~~~~  168 (411)
                      |.+.+.||.|+||.||++.+.   ..+++|.+.....    ....+.+|+.++..+.|+ ++     +.+.+.+......
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i-----~~~~~~~~~~~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI-----VKLYDFFQDEGSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcce-----eeEEEEEecCCEE
Confidence            788999999999999999887   7799999975432    366788999999999888 45     9999999877788


Q ss_pred             EEEEccC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSY-RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +++++++ ++++.+++..... ..++...+..++.|++.++.|+|+.|++||||||+||+++..+.              
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~--------------  139 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR--------------  139 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC--------------
Confidence            9999999 8999977765431 15899999999999999999999999999999999999976551              


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC---------CcccccCCCccccceecC---CCCCccchhHHHHHHHHHHHhC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---------HSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCSG  314 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---------~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~elltg  314 (411)
                                  .++++|||.+......         .....||..|+|||.+.+   ..++...|+||+|++++++++|
T Consensus       140 ------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~  207 (384)
T COG0515         140 ------------VVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTG  207 (384)
T ss_pred             ------------eEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhC
Confidence                        4677777776543222         245689999999999988   5788999999999999999999


Q ss_pred             CCCCCCCCh----HHHHHHHHHHhCC-CChhHHHhh----hhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCc
Q 015222          315 EALFQTHEN----LEHLAMMERVLGP-LPHHMVIRA----DRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       315 ~~pf~~~~~----~~~~~~i~~~~~~-~p~~~~~~~----~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~  382 (411)
                      ..||.....    ......+...... .........    ...+.+++.+++..+    |..|.+..+...+.+...
T Consensus       208 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~r~~~~~~~~~~~~~~  280 (384)
T COG0515         208 LPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKD----PKNRLSSSSDLSHDLLAH  280 (384)
T ss_pred             CCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcC----chhcCCHHHHhhchHhhC
Confidence            999887663    3444444433322 222222111    246788888888887    777777777666644443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.5e-26  Score=224.29  Aligned_cols=239  Identities=24%  Similarity=0.345  Sum_probs=190.6

Q ss_pred             eccccceEEEEEEe---CCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHh-cCCCCCcceEEEeeeeecCCeEEEEE
Q 015222          100 MGEGTFGQVVECFD---NEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNHICIVF  172 (411)
Q Consensus       100 lG~G~~g~V~~a~~---~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~~~~~~~~~lv~  172 (411)
                      +|+|.||.|++++.   ...+..+|+|+.++..   ........|..++..++ |+.+     +.+...|+.+...++++
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~-----v~lhyafqt~~kl~l~l   76 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFL-----VKLHYAFQTDGKLYLIL   76 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCce-----eeeeeeeccccchhHhh
Confidence            69999999997753   3456779999886432   11224455777777776 4544     99999999999999999


Q ss_pred             ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCcc
Q 015222          173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF  251 (411)
Q Consensus       173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~  251 (411)
                      ++. |+.|...+....  .+.+.....+...++.|++++|+.||+|||+|++||+++.+|+                   
T Consensus        77 d~~rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh-------------------  135 (612)
T KOG0603|consen   77 DFLRGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH-------------------  135 (612)
T ss_pred             hhcccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc-------------------
Confidence            999 889988887765  6888899999999999999999999999999999999998884                   


Q ss_pred             ccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 015222          252 KNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME  331 (411)
Q Consensus       252 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~  331 (411)
                              +++.|||.++..-..... +||..|||||++.  ....++|.||||+++|||+||..||.+    +....|.
T Consensus       136 --------i~~tdfglske~v~~~~~-cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il  200 (612)
T KOG0603|consen  136 --------IKLTDFGLSKEAVKEKIA-CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRIL  200 (612)
T ss_pred             --------cccCCchhhhHhHhhhhc-ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHh
Confidence                    566666666544333222 8999999999998  567899999999999999999999987    6777777


Q ss_pred             HHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH-----HHHHHHhcCCCCcccccC
Q 015222          332 RVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-----SMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       332 ~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~-----t~~~il~~~~~~~~~~~~  387 (411)
                      +....+|..++    ..+++++..++..+    |..|.     .+.++++|++|+.+++..
T Consensus       201 ~~~~~~p~~l~----~~a~~~~~~l~~r~----p~nrLg~~~~~~~eik~h~f~~~i~~~~  253 (612)
T KOG0603|consen  201 KAELEMPRELS----AEARSLFRQLFKRN----PENRLGAGPDGVDEIKQHEFFQSIDWNE  253 (612)
T ss_pred             hhccCCchhhh----HHHHHHHHHHHhhC----HHHHhccCcchhHHHhccchheeeeHhh
Confidence            77777777765    45666777777777    55554     458999999999999873

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.92  E-value=7e-26  Score=230.01  Aligned_cols=250  Identities=21%  Similarity=0.276  Sum_probs=184.5

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHH---HHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAM---IEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~---~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      .|...+.||.+.|=+|.+|++.+.  .|+||++-+..  ...+.+.   +|++ ...+++|     |++.+..+...+..
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG--~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~p-----n~lPfqk~~~t~kA   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREG--LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAP-----NCLPFQKVLVTDKA   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCc--eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCC-----cccchHHHHHhhHH
Confidence            688899999999999999976543  39999985432  2223333   3333 3334444     55888888777888


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          168 ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       168 ~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      .|+|-+|...+|+|.+..+.  .+..-+.+.|+.||+.||..+|..||+|||||.+||||++.+.+.|+||...+-.-.+
T Consensus        96 AylvRqyvkhnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP  173 (1431)
T KOG1240|consen   96 AYLVRQYVKHNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP  173 (1431)
T ss_pred             HHHHHHHHhhhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCC
Confidence            99999999999999999876  6888899999999999999999999999999999999999999999999755433221


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCC----------C-CCccchhHHHHHHHHHHHh-CC
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL----------G-WNYPCDLWSVGCILVELCS-GE  315 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwSlGvil~ellt-g~  315 (411)
                      ..           -=+||+.-.....      .-..|+|||.+...          . .+++.||||+||+++||++ |+
T Consensus       174 eD-----------NPadf~fFFDTSr------RRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~  236 (1431)
T KOG1240|consen  174 ED-----------NPADFTFFFDTSR------RRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGR  236 (1431)
T ss_pred             CC-----------CcccceEEEecCC------ceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCC
Confidence            11           1146654222111      12359999998641          2 6789999999999999999 89


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChhHHHhh-hhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          316 ALFQTHENLEHLAMMERVLGPLPHHMVIRA-DRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~-~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      +||.    ..++-.+..+....++.....+ +..++++|..|++.|    |++|.++++.|+.
T Consensus       237 PlF~----LSQL~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rd----Ps~RlSAedyL~~  291 (1431)
T KOG1240|consen  237 PLFT----LSQLLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRD----PSKRLSAEDYLQK  291 (1431)
T ss_pred             Cccc----HHHHHhHhccCccCHHHHHHhCcCccHHHHHHHHHccC----chhccCHHHHHHh
Confidence            9994    2333334433333333333333 346889999999999    9999999999976

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=2.2e-24  Score=191.54  Aligned_cols=177  Identities=14%  Similarity=0.153  Sum_probs=127.3

Q ss_pred             CCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhH----------HHHHHHHHHHHHhcCCCCCcceE
Q 015222           87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----------AAMIEIDVLQRLARHDIGGTRCV  156 (411)
Q Consensus        87 ~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~----------~~~~E~~~l~~l~~~~i~~~~iv  156 (411)
                      .+.+.++|++++.||.|+||.||++.+  ++..+|||+++......+          .+.+|+..+.++.|+++..+...
T Consensus        26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~  103 (232)
T PRK10359         26 DDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF  103 (232)
T ss_pred             HHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence            345688999999999999999999755  466799999974322111          25789999999999998444322


Q ss_pred             EE---eeeeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcc
Q 015222          157 QI---RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY  232 (411)
Q Consensus       157 ~~---~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~  232 (411)
                      ..   ...+...+..++||||+ |.+|.++.      .+++.    ...+++.+|..+|+.|++|||+||+||+++.+| 
T Consensus       104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMP------EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             eeecccccccccCCeEEEEEEECCccHHHhh------hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-
Confidence            11   11122245689999999 78998763      23332    456999999999999999999999999997543 


Q ss_pred             cccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHH
Q 015222          233 VKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC  312 (411)
Q Consensus       233 ~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell  312 (411)
                                                 ++|+|||.+.........         -.+.....|+.++||||||+++.-+.
T Consensus       173 ---------------------------i~liDfg~~~~~~e~~a~---------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 ---------------------------LRIIDLSGKRCTAQRKAK---------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             ---------------------------EEEEECCCcccccchhhH---------HHHHHHhHhcccccccceeEeehHHH
Confidence                                       688888876544222111         11334446778999999999986553

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.91  E-value=4.3e-25  Score=224.09  Aligned_cols=243  Identities=22%  Similarity=0.314  Sum_probs=177.5

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      ..+|..++.|..|+||.||.++++.+.+.+|+|+=++ +.          |++.     |     ..+      .+..+.
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~l----------ilRn-----i-----lt~------a~npfv  134 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-NL----------ILRN-----I-----LTF------AGNPFV  134 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhccccc-ch----------hhhc-----c-----ccc------cCCcce
Confidence            3579999999999999999999999999999965222 11          1111     1     111      111222


Q ss_pred             EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       171 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      |     |+-...++.-+  .++..        ++.+++|||+.||+|||+||+|.+|+.-|++|++|||+.+..-.....
T Consensus       135 v-----gDc~tllk~~g--~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  135 V-----GDCATLLKNIG--PLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             e-----chhhhhcccCC--CCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence            2     34344444433  34433        278999999999999999999999999998888888875433211100


Q ss_pred             cccCCCCCCeeEeecCCccccc-CCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEH-QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM  329 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~  329 (411)
                              ..+=+  ++..... ......+||+.|+|||++..+.|+..+|+|++|+|+||.+-|..||.+.+.++.+..
T Consensus       200 --------nl~eg--~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~  269 (1205)
T KOG0606|consen  200 --------NLKEG--HIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ  269 (1205)
T ss_pred             --------hhhhc--chHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhh
Confidence                    00000  0000000 112346899999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          330 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       330 i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                      ........|+. ....+.+++++|.++|+.++..|-..- .+-++.+|.+|+.++|.+
T Consensus       270 visd~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~-ga~evk~h~ff~~LDw~~  325 (1205)
T KOG0606|consen  270 VISDDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRLGTG-GALEVKQHGFFQLLDWKS  325 (1205)
T ss_pred             hhhhhcccccc-CcCCCHHHHHHHHHHHHhChHhhcccc-hhhhhhhccceeecccch
Confidence            88888888887 566788999999999999955444433 788899999999999974

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=7.2e-24  Score=185.89  Aligned_cols=138  Identities=22%  Similarity=0.229  Sum_probs=107.1

Q ss_pred             EeeeccccceEEEEEEeCCCCcEEEEEEeccchh---h------------------------hHHHHHHHHHHHHHhcCC
Q 015222           97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---Y------------------------REAAMIEIDVLQRLARHD  149 (411)
Q Consensus        97 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~---~------------------------~~~~~~E~~~l~~l~~~~  149 (411)
                      .+.||+|+||.||+|.+. +|+.||||+++....   .                        ......|+.++.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999987 899999999975321   0                        112345999999999988


Q ss_pred             CCCcceEEEeeeeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCcEEE
Q 015222          150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM-HELRLIHTDLKPENILL  227 (411)
Q Consensus       150 i~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~givH~Dikp~NIli  227 (411)
                      +..|.++..      .+ .++||||+ |+++.......  ..+++..+..++.|++.+|.++ |+.||+||||||+|||+
T Consensus        81 v~~p~~~~~------~~-~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli  151 (190)
T cd05147          81 IPCPEPILL------KS-HVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLY  151 (190)
T ss_pred             CCCCcEEEe------cC-CEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence            755554321      12 37999999 65665443333  2689999999999999999999 79999999999999999


Q ss_pred             ecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCccccc
Q 015222          228 VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH  272 (411)
Q Consensus       228 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~  272 (411)
                      +. +                           .++|+|||+|....
T Consensus       152 ~~-~---------------------------~v~LiDFG~a~~~~  168 (190)
T cd05147         152 HD-G---------------------------KLYIIDVSQSVEHD  168 (190)
T ss_pred             EC-C---------------------------cEEEEEccccccCC
Confidence            63 3                           58999999887543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=1e-22  Score=179.15  Aligned_cols=137  Identities=20%  Similarity=0.151  Sum_probs=106.0

Q ss_pred             EeeeccccceEEEEEEeCCCCcEEEEEEeccchhh---------------------------hHHHHHHHHHHHHHhcCC
Q 015222           97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY---------------------------REAAMIEIDVLQRLARHD  149 (411)
Q Consensus        97 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~E~~~l~~l~~~~  149 (411)
                      .+.||+|+||.||+|.+. +|+.||||+++.....                           ......|...+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            568999999999999987 8999999999753210                           122357899999999998


Q ss_pred             CCCcceEEEeeeeecCCeEEEEEccC-CCCHHHH-HHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEE
Q 015222          150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDF-LRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENIL  226 (411)
Q Consensus       150 i~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~-l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dikp~NIl  226 (411)
                      +..|..+..     .  ..++||||+ |+++... +..   ..++...+..++.|++.+|.++|+ .||+||||||+|||
T Consensus        81 i~~p~~~~~-----~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIl  150 (190)
T cd05145          81 VPVPEPILL-----K--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNIL  150 (190)
T ss_pred             CCCceEEEe-----c--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEE
Confidence            744443321     1  248999999 5544333 433   258889999999999999999999 99999999999999


Q ss_pred             EecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCccccc
Q 015222          227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH  272 (411)
Q Consensus       227 i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~  272 (411)
                      ++ ++                           .++|+|||++....
T Consensus       151 l~-~~---------------------------~~~liDFG~a~~~~  168 (190)
T cd05145         151 YH-DG---------------------------KPYIIDVSQAVELD  168 (190)
T ss_pred             EE-CC---------------------------CEEEEEcccceecC
Confidence            97 44                           67888888877543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=2.4e-23  Score=191.26  Aligned_cols=207  Identities=21%  Similarity=0.245  Sum_probs=154.1

Q ss_pred             CCcceEEEeeeeec---------------------------CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHH
Q 015222          151 GGTRCVQIRNWFDY---------------------------RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQL  203 (411)
Q Consensus       151 ~~~~iv~~~~~~~~---------------------------~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi  203 (411)
                      .|||||.+...|.+                           ...+|+||.-+..+|.+++..+.   .+.....-++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~---~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH---RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC---CchHHHHHHHHHH
Confidence            67888999988753                           24689999999999999998865   7788889999999


Q ss_pred             HHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccC---------C
Q 015222          204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---------D  274 (411)
Q Consensus       204 ~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---------~  274 (411)
                      ++|+.|||.+||.|||+|.+||||.-+.                       |.-..+.|+|||.+-..+.         .
T Consensus       351 LEav~hL~~hgvAhRDlKSDNiL~Eldd-----------------------D~~P~LVvaDFGCcLAd~~hGlqlpy~S~  407 (598)
T KOG4158|consen  351 LEAVTHLHKHGVAHRDLKSDNILLELDD-----------------------DEIPQLVVADFGCCLADDNHGLQLPYESD  407 (598)
T ss_pred             HHHHHHHHHccchhhcccccceEEEecC-----------------------CCCcEEEEcccceeeeccccccccccccc
Confidence            9999999999999999999999996543                       2344678888886543222         1


Q ss_pred             CcccccCCCccccceecCCC-----CC-ccchhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCChhHHHhhh
Q 015222          275 HSYVVSTRHYRAPEVILGLG-----WN-YPCDLWSVGCILVELCSGEALFQTHENLE--HLAMMERVLGPLPHHMVIRAD  346 (411)
Q Consensus       275 ~~~~~gt~~y~aPE~~~~~~-----~~-~~~DiwSlGvil~elltg~~pf~~~~~~~--~~~~i~~~~~~~p~~~~~~~~  346 (411)
                      .-..-|...-||||+....+     .+ .++|.|+.|.+.||+++...||.+..+..  ....-+...+.+|    ..++
T Consensus       408 ~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp----~~vp  483 (598)
T KOG4158|consen  408 EVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALP----SRVP  483 (598)
T ss_pred             cccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCc----ccCC
Confidence            12235778899999987542     12 58999999999999999999998743221  1111122233343    4467


Q ss_pred             hhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          347 RRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       347 ~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                      ..+++++..+|+.|+++|++-+..+.-+--.+|-..-+...
T Consensus       484 p~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~vka  524 (598)
T KOG4158|consen  484 PVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMGEDVKA  524 (598)
T ss_pred             hHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCchHHHH
Confidence            78899999999999888888888777665566665533333

>PRK10345 hypothetical protein; Provisional

Probab=99.89  E-value=4.8e-22  Score=176.02  Aligned_cols=126  Identities=21%  Similarity=0.253  Sum_probs=103.3

Q ss_pred             EeeeccccceEEEEEEeCCCCcEEEEEEeccc-hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC---eEE-EE
Q 015222           97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN---HIC-IV  171 (411)
Q Consensus        97 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~---~~~-lv  171 (411)
                      .+.||+|+||.||.  +..++.. +||++... ....+.+.+|+.+++.+.|.+..|+||++++++++++.   .++ +|
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            46899999999995  6777665 69988653 23456789999999999998888999999999998863   434 78


Q ss_pred             EccC---CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHHHhCCceecCCCCCcEEEecC
Q 015222          172 FEKL---GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV-AFMHELRLIHTDLKPENILLVSA  230 (411)
Q Consensus       172 ~e~~---~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL-~~LH~~givH~Dikp~NIli~~~  230 (411)
                      |||+   +++|.+++.+.   .+++.  ..++.|++.++ +|||+++|+||||||+|||++..
T Consensus        84 ~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~  141 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRI  141 (210)
T ss_pred             ecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEecc
Confidence            9994   58999999764   36665  35688888888 99999999999999999999754

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.88  E-value=6.7e-23  Score=187.46  Aligned_cols=237  Identities=19%  Similarity=0.214  Sum_probs=141.9

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHh----------cCCCCCc-ceEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLA----------RHDIGGT-RCVQ  157 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~----------~~~i~~~-~iv~  157 (411)
                      .+...+.||.|+++.||.+++..|++.+|||++....    ...+.+.+|.-....+.          |-.+.-| -+++
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3567789999999999999999999999999985322    22333444432222211          1011000 1122


Q ss_pred             Eee---eeecC---C-----eEEEEEccCCCCHHHHHH---hcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 015222          158 IRN---WFDYR---N-----HICIVFEKLGPSLYDFLR---KNSYR--SFPIDLVRELGRQLLESVAFMHELRLIHTDLK  221 (411)
Q Consensus       158 ~~~---~~~~~---~-----~~~lv~e~~~~~L~~~l~---~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dik  221 (411)
                      +.+   ++...   .     ..+++|+-+.++|.+++.   .....  .+.......+..|+++.+++||+.||||+|||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~  172 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK  172 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence            211   11111   1     247888888889988865   22211  12233345566899999999999999999999


Q ss_pred             CCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCC--------
Q 015222          222 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL--------  293 (411)
Q Consensus       222 p~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~--------  293 (411)
                      |+|++++.+|                           .+.|+||+.....+........+..|.+||.....        
T Consensus       173 ~~nfll~~~G---------------------------~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~  225 (288)
T PF14531_consen  173 PENFLLDQDG---------------------------GVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNA  225 (288)
T ss_dssp             GGGEEE-TTS----------------------------EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEE
T ss_pred             eeeEEEcCCC---------------------------CEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccc
Confidence            9999999888                           56666666554433332222345779999977432        


Q ss_pred             CCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcH
Q 015222          294 GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR  368 (411)
Q Consensus       294 ~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R  368 (411)
                      .++.+.|.|+||+++|.|.+|..||...........      .+. ... +.++.++.+|..+|+.+    |.+|
T Consensus       226 ~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~------~f~-~C~-~~Pe~v~~LI~~lL~~~----~~~R  288 (288)
T PF14531_consen  226 PYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW------DFS-RCR-DMPEPVQFLIRGLLQRN----PEDR  288 (288)
T ss_dssp             EE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG------GGT-TSS----HHHHHHHHHHT-SS----GGGS
T ss_pred             eeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc------cch-hcC-CcCHHHHHHHHHHccCC----cccC
Confidence            478999999999999999999999975433211110      010 011 45677889999999998    5554

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=7.7e-22  Score=171.73  Aligned_cols=182  Identities=15%  Similarity=0.121  Sum_probs=133.2

Q ss_pred             EEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhH-----HHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE-----AAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        95 ~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~-----~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      .+...|++|+||+||++..  .+..++.+.+........     .+.+|+++|++|.|+    +++.+++++    +..+
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~----~~vP~ll~~----~~~~   74 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGL----PRTPRLLHW----DGRH   74 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCC----CCCCEEEEE----cCEE
Confidence            3567899999999998854  677788887765544333     578999999999763    223666664    3469


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCcEEEecCcccccCCcccccccCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL-KPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Di-kp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      ++|||+ |.+|.+.+..        . ...++.|++.+|+++|++||+|||| ||+|||++.+|                
T Consensus        75 lvmeyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g----------------  129 (218)
T PRK12274         75 LDRSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG----------------  129 (218)
T ss_pred             EEEeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC----------------
Confidence            999999 8888654321        1 1357789999999999999999999 79999997766                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCCCc----------------ccccCCCccccceecCC-CCC-ccchhHHHHHHHH
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHS----------------YVVSTRHYRAPEVILGL-GWN-YPCDLWSVGCILV  309 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~----------------~~~gt~~y~aPE~~~~~-~~~-~~~DiwSlGvil~  309 (411)
                                 .++|+|||++........                ....++.|++|+...-. ..+ ...+.++.|+-+|
T Consensus       130 -----------~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~  198 (218)
T PRK12274        130 -----------SPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVY  198 (218)
T ss_pred             -----------CEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHH
Confidence                       567777777764432221                01357788888765432 334 5678999999999


Q ss_pred             HHHhCCCCCCCCC
Q 015222          310 ELCSGEALFQTHE  322 (411)
Q Consensus       310 elltg~~pf~~~~  322 (411)
                      .++|+..++-+..
T Consensus       199 ~~~~~~~~~~~~~  211 (218)
T PRK12274        199 RFVTRRVLHWEDN  211 (218)
T ss_pred             HHHhccCCccccC
Confidence            9999999875543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=1.2e-21  Score=202.80  Aligned_cols=200  Identities=26%  Similarity=0.396  Sum_probs=156.7

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      ..+|.|.+.||+|+||+||+|...+ |+.||||+-+....+.-  ..-.+++.+|+ +.+ .+.+..+...+...+.-+|
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEf--YI~~q~~~RLk-~~~-~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEF--YICLQVMERLK-PQM-LPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceee--eehHHHHHhhc-hhh-hcchHHHHHHHccCCccee
Confidence            4579999999999999999999877 99999999876544321  11223444444 111 1223566666666788899


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      |+||. -|+|.+++...+  .+++..+..++.|++.-++.||..||||+||||+|.||...-   ..|            
T Consensus       772 v~ey~~~Gtlld~~N~~~--~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~---~~~------------  834 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLINTNK--VMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREI---CAD------------  834 (974)
T ss_pred             eeeccccccHHHhhccCC--CCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeeccc---CCC------------
Confidence            99999 999999999554  799999999999999999999999999999999999996532   111            


Q ss_pred             ccccCCCCCCeeEeecCCccccc---C--CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCC
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEH---Q--DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL  317 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~---~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p  317 (411)
                           +++..++|+|||.+....   .  .....++|-.+-.+|+..|.+++..+|.|.|+.+++.||.|+..
T Consensus       835 -----~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  835 -----SDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             -----CcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence                 124579999999875421   1  22345789999999999999999999999999999999998654

>smart00090 RIO RIO-like kinase

Probab=99.85  E-value=8.8e-21  Score=171.94  Aligned_cols=142  Identities=24%  Similarity=0.182  Sum_probs=109.0

Q ss_pred             CeEEEeeeccccceEEEEEE-eCCCCcEEEEEEeccchh-------------------------hhHHHHHHHHHHHHHh
Q 015222           93 RYRILSKMGEGTFGQVVECF-DNEKKELVAIKIVRSINK-------------------------YREAAMIEIDVLQRLA  146 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~-~~~~~~~vavK~~~~~~~-------------------------~~~~~~~E~~~l~~l~  146 (411)
                      -|++.+.||+|+||.||+|. +..+|+.||||+++....                         ....+.+|+.+++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            38899999999999999998 677899999999874321                         1123568999999998


Q ss_pred             cCCCCCcceEEEeeeeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCc
Q 015222          147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR-LIHTDLKPEN  224 (411)
Q Consensus       147 ~~~i~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g-ivH~Dikp~N  224 (411)
                      +..+..   ..++++   . ..++||||+ |.+|........  .+....+..++.||+.+|++||+.| |+||||||+|
T Consensus       109 ~~~i~~---p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~N  179 (237)
T smart00090      109 EAGVPV---PKPIAW---R-RNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYN  179 (237)
T ss_pred             hcCCCC---CeeeEe---c-CceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhh
Confidence            754422   233332   2 348999999 667766543322  4666778899999999999999999 9999999999


Q ss_pred             EEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccc
Q 015222          225 ILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE  271 (411)
Q Consensus       225 Ili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~  271 (411)
                      |+++ ++                           .++|+|||.+...
T Consensus       180 Ili~-~~---------------------------~i~LiDFg~a~~~  198 (237)
T smart00090      180 ILVH-DG---------------------------KVVIIDVSQSVEL  198 (237)
T ss_pred             EEEE-CC---------------------------CEEEEEChhhhcc
Confidence            9997 43                           6789999987643

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.84  E-value=2.6e-22  Score=176.00  Aligned_cols=241  Identities=16%  Similarity=0.182  Sum_probs=182.8

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      ...++-+|.+...|..|+|++.  |..++.|+++..   ......|..|.-.|+...||||     ..+++.+....++.
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpni-----lpvlgacnsppnlv  263 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNI-----LPVLGACNSPPNLV  263 (448)
T ss_pred             hhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCch-----hhhhhhccCCCCce
Confidence            4556778999999999999775  455788887632   2345678889999999989888     99999999999999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      ++..|+ -|+|+..++.......+..++.+++.++++|+.|||+..  |.---|....++|+++-..             
T Consensus       264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedlta-------------  330 (448)
T KOG0195|consen  264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTA-------------  330 (448)
T ss_pred             EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhh-------------
Confidence            999999 999999999887667888999999999999999999975  4455688899999876432             


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCC---ccchhHHHHHHHHHHHhCCCCCCCCCh
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWN---YPCDLWSVGCILVELCSGEALFQTHEN  323 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwSlGvil~elltg~~pf~~~~~  323 (411)
                                  ++..+|--++...    ....-.+.||+||.++..+-+   .++|+|||++++|||.|...||...+.
T Consensus       331 ------------rismad~kfsfqe----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp  394 (448)
T KOG0195|consen  331 ------------RISMADTKFSFQE----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP  394 (448)
T ss_pred             ------------heecccceeeeec----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc
Confidence                        2333343222211    112346889999999887543   689999999999999999999999888


Q ss_pred             HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHH
Q 015222          324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVW  375 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il  375 (411)
                      .+.-.++.-  ..+...+.+.++.....++.-|++.|    |.+||.+..+.
T Consensus       395 mecgmkial--eglrv~ippgis~hm~klm~icmned----pgkrpkfdmiv  440 (448)
T KOG0195|consen  395 MECGMKIAL--EGLRVHIPPGISRHMNKLMNICMNED----PGKRPKFDMIV  440 (448)
T ss_pred             hhhhhhhhh--ccccccCCCCccHHHHHHHHHHhcCC----CCcCCCcceeh
Confidence            776544431  12222333455667777888787777    88888777654

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.83  E-value=1.6e-21  Score=186.04  Aligned_cols=251  Identities=21%  Similarity=0.245  Sum_probs=163.2

Q ss_pred             CeEEEeeeccccceEEEEEEeCCC---CcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEee-------e
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRN-------W  161 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~---~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~-------~  161 (411)
                      .+.+.+..+.++++.+....-...   .+.++-|..+... .......+++..+....|++.     ..+.+       .
T Consensus       245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~-----s~~~d~~~s~~~~  319 (516)
T KOG1033|consen  245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNR-----SILEDLRPSLFES  319 (516)
T ss_pred             cccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCc-----ccccCCCCchhhh
Confidence            455566666666666665543333   2334444333322 223334455555555555543     22222       1


Q ss_pred             e-----ecCCeEEEEEccC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccc
Q 015222          162 F-----DYRNHICIVFEKL-GPSLYDFLRKN-SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK  234 (411)
Q Consensus       162 ~-----~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~  234 (411)
                      +     ....++||.|++| ..+|.++|.+. .....+......++.|++.|++|   +|.+|+|+||.||++..++.+|
T Consensus       320 ~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~k  396 (516)
T KOG1033|consen  320 SKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLK  396 (516)
T ss_pred             ccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhh
Confidence            1     1134689999999 99999999743 33457778899999999999999   9999999999999988777555


Q ss_pred             cCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-
Q 015222          235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-  313 (411)
Q Consensus       235 l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-  313 (411)
                      |.|||+.........                  ........+..+||..||+||++.+..|+.++||||||++|+||+. 
T Consensus       397 IgDFgl~ts~~~~~~------------------~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~  458 (516)
T KOG1033|consen  397 IGDFGLVTSQDKDET------------------VAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQ  458 (516)
T ss_pred             hhhhhheeecccCCc------------------ccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHH
Confidence            555544322222110                  0000112344689999999999999999999999999999999997 


Q ss_pred             CCCCCCCCChHHHHHHHHH-HhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          314 GEALFQTHENLEHLAMMER-VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       314 g~~pf~~~~~~~~~~~i~~-~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      -...|      +....... ..+.+|+.+..+.+ .-..|+..++...    |..||++.+.--|.|.
T Consensus       459 f~T~~------er~~t~~d~r~g~ip~~~~~d~p-~e~~ll~~lls~~----p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  459 FSTQF------ERIATLTDIRDGIIPPEFLQDYP-EEYTLLQQLLSPS----PEERPSAIEVALHEFL  515 (516)
T ss_pred             hccHH------HHHHhhhhhhcCCCChHHhhcCc-HHHHHHHHhcCCC----cccCchHHHHhhhhhc
Confidence            33333      22222222 24577766666554 3457888999888    8888887777777664

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=3.2e-19  Score=159.52  Aligned_cols=132  Identities=25%  Similarity=0.307  Sum_probs=105.5

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccch---------hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      +.||+|++|.||+|.+  .+..|++|+.....         .....+.+|+.++..+.++++..|.+     ++.+.+..
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~-----~~~~~~~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAV-----YFVDPENF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeE-----EEEeCCCC
Confidence            5789999999999976  66779999865321         11245678999999999988744433     33345678


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      ++||||+ |++|.+++....     . ....++.+++.+|.++|+.|++|+|++|+|||++ ++                
T Consensus        75 ~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~----------------  131 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG----------------  131 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC----------------
Confidence            8999999 889999987543     2 7889999999999999999999999999999997 33                


Q ss_pred             CCccccCCCCCCeeEeecCCccc
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTF  270 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~  270 (411)
                                 .++|+|||.+..
T Consensus       132 -----------~~~liDf~~a~~  143 (211)
T PRK14879        132 -----------KIYLIDFGLAEF  143 (211)
T ss_pred             -----------CEEEEECCcccC
Confidence                       578899988764

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=1.4e-18  Score=153.94  Aligned_cols=136  Identities=25%  Similarity=0.249  Sum_probs=103.5

Q ss_pred             eEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchh-----------------------hhHHHHHHHHHHHHHhcCCC
Q 015222           94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-----------------------YREAAMIEIDVLQRLARHDI  150 (411)
Q Consensus        94 y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~E~~~l~~l~~~~i  150 (411)
                      |.+.+.||+|+||.||++... +|+.||||+++....                       .......|..++..+.+.++
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            888899999999999999875 789999998764220                       11235678999999988754


Q ss_pred             CCcceEEEeeeeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 015222          151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS  229 (411)
Q Consensus       151 ~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~  229 (411)
                      .-   ...++    ....++||||+ |++|.+....        .....++.+++.++.++|+.||+||||||+||+++.
T Consensus        96 ~v---~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~  160 (198)
T cd05144          96 PV---PKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDD  160 (198)
T ss_pred             CC---Cceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcC
Confidence            22   33332    23458999999 8788654321        345678899999999999999999999999999976


Q ss_pred             CcccccCCcccccccCCCCCccccCCCCCCeeEeecCCccccc
Q 015222          230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH  272 (411)
Q Consensus       230 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~  272 (411)
                      ++                           .++|+|||.+....
T Consensus       161 ~~---------------------------~~~liDfg~~~~~~  176 (198)
T cd05144         161 DE---------------------------KIYIIDWPQMVSTD  176 (198)
T ss_pred             CC---------------------------cEEEEECCccccCC
Confidence            55                           67888888775443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=1.4e-18  Score=153.96  Aligned_cols=128  Identities=23%  Similarity=0.252  Sum_probs=99.7

Q ss_pred             eeccccceEEEEEEeCCCCcEEEEEEeccch---------hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           99 KMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        99 ~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      .||+|+||.||+|..  ++..|++|+.....         .....+.+|+.++..+.++++..|.+   +.  ...+..+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~---~~--~~~~~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVV---YD--VDPDNKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEE---EE--EECCCCE
Confidence            379999999999974  56789999864321         11255678999999999887644332   22  2345678


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +||||+ |++|.+++....   .      .++.|++.+|.+||+.|++|+|++|+||+++ ++                 
T Consensus        74 lv~e~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~-----------------  126 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD-----------------  126 (199)
T ss_pred             EEEEEECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC-----------------
Confidence            999999 899998876532   1      7899999999999999999999999999997 44                 


Q ss_pred             CccccCCCCCCeeEeecCCccc
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTF  270 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~  270 (411)
                                .++++|||.+..
T Consensus       127 ----------~~~liDfg~a~~  138 (199)
T TIGR03724       127 ----------KLYLIDFGLGKY  138 (199)
T ss_pred             ----------cEEEEECCCCcC
Confidence                      678889988764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.77  E-value=6.1e-19  Score=171.46  Aligned_cols=197  Identities=18%  Similarity=0.241  Sum_probs=145.3

Q ss_pred             CcceEEEeeeeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-eecCCCCCcEEEec
Q 015222          152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL-IHTDLKPENILLVS  229 (411)
Q Consensus       152 ~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi-vH~Dikp~NIli~~  229 (411)
                      |.|+.++++...++...++|.+|| .|+|.|.+.... ..++......++++|+.||+|||...| .|+.++..|.+++.
T Consensus         6 h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~   84 (484)
T KOG1023|consen    6 HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDS   84 (484)
T ss_pred             hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeee
Confidence            444599999999999999999999 999999998744 578889999999999999999998766 89999999999876


Q ss_pred             CcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccC-----CCcccccCCCccccceecCC---C----CCc
Q 015222          230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGL---G----WNY  297 (411)
Q Consensus       230 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~---~----~~~  297 (411)
                      .-                           .+||+|||+......     ......-..-|.|||.+.+.   .    .+.
T Consensus        85 ~w---------------------------~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~  137 (484)
T KOG1023|consen   85 RW---------------------------VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQ  137 (484)
T ss_pred             eE---------------------------EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccc
Confidence            54                           667777776655432     11112234569999999874   1    467


Q ss_pred             cchhHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHH-HhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHH
Q 015222          298 PCDLWSVGCILVELCSGEALFQTH----ENLEHLAMMER-VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMR  372 (411)
Q Consensus       298 ~~DiwSlGvil~elltg~~pf~~~----~~~~~~~~i~~-~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~  372 (411)
                      +.||||||++++|+++...||...    +..+.+..+.+ ....+.+.+....  ++.+-+..+++.||.+.|..||+++
T Consensus       138 ~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~  215 (484)
T KOG1023|consen  138 KGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIE  215 (484)
T ss_pred             cCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHH
Confidence            899999999999999999999763    22344444444 2222222222111  3333444555667999999999999


Q ss_pred             HHHhcC
Q 015222          373 AVWKLL  378 (411)
Q Consensus       373 ~il~~~  378 (411)
                      ++....
T Consensus       216 ~i~~~~  221 (484)
T KOG1023|consen  216 QIRSKL  221 (484)
T ss_pred             HHHhhh
Confidence            987654

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=7.9e-18  Score=171.04  Aligned_cols=142  Identities=23%  Similarity=0.226  Sum_probs=107.0

Q ss_pred             EeeCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEec-cc---h-----hhhHHHHHHHHHHHHHhcCCCCCcc
Q 015222           84 FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-SI---N-----KYREAAMIEIDVLQRLARHDIGGTR  154 (411)
Q Consensus        84 ~~~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~-~~---~-----~~~~~~~~E~~~l~~l~~~~i~~~~  154 (411)
                      ..........|...+.||+|+||+||++.+....  +++|+.. +.   .     ...+.+.+|+++++.+.|+++    
T Consensus       325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i----  398 (535)
T PRK09605        325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGV----  398 (535)
T ss_pred             eccccccccccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCC----
Confidence            3334444556678899999999999999765443  4444321 11   0     123557789999999999887    


Q ss_pred             eEEEeeeeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCccc
Q 015222          155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV  233 (411)
Q Consensus       155 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~  233 (411)
                       +....+..+.+..++||||+ |++|.+++.          ....++.|++.+|.+||+.||+||||||+|||++ ++  
T Consensus       399 -~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~--  464 (535)
T PRK09605        399 -PTPVIYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD--  464 (535)
T ss_pred             -CeeEEEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC--
Confidence             44444444556678999999 999998875          3467899999999999999999999999999993 33  


Q ss_pred             ccCCcccccccCCCCCccccCCCCCCeeEeecCCccc
Q 015222          234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF  270 (411)
Q Consensus       234 ~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~  270 (411)
                                               .++|+|||+++.
T Consensus       465 -------------------------~~~liDFGla~~  476 (535)
T PRK09605        465 -------------------------RLYLIDFGLGKY  476 (535)
T ss_pred             -------------------------cEEEEeCccccc
Confidence                                     678999998875

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.74  E-value=2.1e-17  Score=144.89  Aligned_cols=135  Identities=26%  Similarity=0.249  Sum_probs=94.8

Q ss_pred             EeeeccccceEEEEEEeCCCCcEEEEEEeccchhh---hH----------------------HHHHHHHHHHHHhcCCCC
Q 015222           97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY---RE----------------------AAMIEIDVLQRLARHDIG  151 (411)
Q Consensus        97 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~----------------------~~~~E~~~l~~l~~~~i~  151 (411)
                      .+.||+|+||+||+|.+. +++.||||+++.....   ..                      ....|...+..+.+..+.
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999876 7899999998743211   11                      113577777777665432


Q ss_pred             CcceEEEeeeeecCCeEEEEEccC-CCCHH-HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEe
Q 015222          152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLY-DFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLV  228 (411)
Q Consensus       152 ~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~-~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dikp~NIli~  228 (411)
                      -   .+.+..    ...++||||+ ++++. ..+....   .. ..+..++.+++.++.++|. .||+|+||||+||+++
T Consensus        81 ~---~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~  149 (187)
T cd05119          81 V---PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD  149 (187)
T ss_pred             C---CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence            2   222222    2358999999 53322 1122111   11 6678999999999999999 9999999999999997


Q ss_pred             cCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccc
Q 015222          229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE  271 (411)
Q Consensus       229 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~  271 (411)
                       ++                           .++|+|||.+...
T Consensus       150 -~~---------------------------~~~liDfg~a~~~  164 (187)
T cd05119         150 -DG---------------------------KVYIIDVPQAVEI  164 (187)
T ss_pred             -CC---------------------------cEEEEECcccccc
Confidence             54                           5788888877643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=1.5e-19  Score=183.49  Aligned_cols=254  Identities=19%  Similarity=0.236  Sum_probs=191.9

Q ss_pred             CeEEEeeeccccceEEEEEEeCC-CCcEEEEEEeccch---hhhHHHHHHHHHHHHHh-cCCCCCcceEEEeeeeecCCe
Q 015222           93 RYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSIN---KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      .|.+.+.||+|+|+.|-++.... ....+|.|.+....   ...+....|..+-+.+. |.|+     +.+++...+.+.
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~-----~~~~~~~~~~~~   95 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNT-----VHMIEPSSSPRS   95 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccc-----cccCCccCCCcc
Confidence            57888889999999998887643 34567777765332   33344455777777776 5555     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEecCc-ccccCCccccccc
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLVSAE-YVKVPDYKFLSRS  244 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~givH~Dikp~NIli~~~~-~~~l~df~~~~~~  244 (411)
                      .++++++. |+++.+.+........+...+..++.|+..+|.|+| ..++.|+||||+|.+++..+ ..           
T Consensus        96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l-----------  164 (601)
T KOG0590|consen   96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSAL-----------  164 (601)
T ss_pred             cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcc-----------
Confidence            99999999 999998884222225778889999999999999999 99999999999999998776 44           


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccC-C-----Cccccc-CCCccccceecCC-CCCccchhHHHHHHHHHHHhCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-D-----HSYVVS-TRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEA  316 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~-----~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~  316 (411)
                                      ++.|||+|..... .     ....+| ++.|+|||...+. ...+..|+||.|+++..+++|..
T Consensus       165 ----------------~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~  228 (601)
T KOG0590|consen  165 ----------------KIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGEL  228 (601)
T ss_pred             ----------------cCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCC
Confidence                            5555555543322 1     122467 9999999999985 55789999999999999999999


Q ss_pred             CCCCCChHHHH-HHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCc
Q 015222          317 LFQTHENLEHL-AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       317 pf~~~~~~~~~-~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~  382 (411)
                      |+......... .........+-...+...+....+++.+++..+    |..|.+.+++..++|+..
T Consensus       229 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~----~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  229 PWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKEN----PSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             CccccccccccceeecccccccccCccccCChhhhhcccccccCC----chhccccccccccccccc
Confidence            98754433211 111111122234455677788899999998866    999999999999999998

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.71  E-value=2e-16  Score=143.75  Aligned_cols=134  Identities=19%  Similarity=0.190  Sum_probs=98.2

Q ss_pred             eeec-cccceEEEEEEeCCCCcEEEEEEeccch--------------hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeee
Q 015222           98 SKMG-EGTFGQVVECFDNEKKELVAIKIVRSIN--------------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF  162 (411)
Q Consensus        98 ~~lG-~G~~g~V~~a~~~~~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~  162 (411)
                      ..|| .||.|+||.+...  +..++||.+....              .....+.+|+.++.+|.+.++.-|   ..+++.
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP---~pl~~~  111 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVP---RPIAAR  111 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCc---eeEeee
Confidence            3566 7888888888653  6779999885311              123457789999999999886433   333332


Q ss_pred             ec-CC---eEEEEEccC-C-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccC
Q 015222          163 DY-RN---HICIVFEKL-G-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP  236 (411)
Q Consensus       163 ~~-~~---~~~lv~e~~-~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~  236 (411)
                      .. ..   ..++|||++ | .+|.+++...   .+++..    +.||+.+|.+||++||+||||||+|||++.++     
T Consensus       112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~-----  179 (239)
T PRK01723        112 VVRHGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDG-----  179 (239)
T ss_pred             eeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC-----
Confidence            22 12   346999999 5 5899888653   356543    57899999999999999999999999997654     


Q ss_pred             CcccccccCCCCCccccCCCCCCeeEeecCCccc
Q 015222          237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF  270 (411)
Q Consensus       237 df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~  270 (411)
                                            .++|+|||.+..
T Consensus       180 ----------------------~v~LIDfg~~~~  191 (239)
T PRK01723        180 ----------------------KFWLIDFDRGEL  191 (239)
T ss_pred             ----------------------CEEEEECCCccc
Confidence                                  688999997764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=2.5e-17  Score=160.31  Aligned_cols=267  Identities=19%  Similarity=0.212  Sum_probs=196.4

Q ss_pred             CccCCCeEEEeeecc--ccceEEEEEEe--CCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEee
Q 015222           88 ENLTPRYRILSKMGE--GTFGQVVECFD--NEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRN  160 (411)
Q Consensus        88 ~~~~~~y~i~~~lG~--G~~g~V~~a~~--~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~  160 (411)
                      +.+...+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-+..   ......-.+|+.-...+.    .|.+.++.+.
T Consensus       110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~----~~~~~v~~~~  185 (524)
T KOG0601|consen  110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKID----SHENPVRDSP  185 (524)
T ss_pred             chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccC----ccccccccCc
Confidence            345567889999999  99999999998  889999999984321   112222233444433332    2455688888


Q ss_pred             eeecCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHHHhCCceecCCCCCcEEEecC-ccccc
Q 015222          161 WFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE----SVAFMHELRLIHTDLKPENILLVSA-EYVKV  235 (411)
Q Consensus       161 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~----aL~~LH~~givH~Dikp~NIli~~~-~~~~l  235 (411)
                      .++..+..++-+|+|+.+|..+..... ..++...++.++.+..+    ||.++|+.+++|-|+||+||++..+ ...++
T Consensus       186 ~~e~~~~lfiqtE~~~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~  264 (524)
T KOG0601|consen  186 AWEGSGILFIQTELCGESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKL  264 (524)
T ss_pred             ccccCCcceeeeccccchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeec
Confidence            899999999999999999999887654 35889999999999999    9999999999999999999999888 77777


Q ss_pred             CCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCC
Q 015222          236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE  315 (411)
Q Consensus       236 ~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~  315 (411)
                      +||+++.                  +|.|.+++...... ....|...|++||...+ -++.+.||||+|.++.+..+|.
T Consensus       265 ~df~~v~------------------~i~~~~~~~~~~~~-~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~  324 (524)
T KOG0601|consen  265 TDFGLVS------------------KISDGNFSSVFKVS-KRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGS  324 (524)
T ss_pred             CCcceeE------------------EccCCccccceeee-ecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhc
Confidence            7777543                  33333333222211 12245667999999876 7789999999999999999987


Q ss_pred             CCCCCC--ChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccCC
Q 015222          316 ALFQTH--ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSA  388 (411)
Q Consensus       316 ~pf~~~--~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~  388 (411)
                      .++...  +.-..+.     .+.+|.++....+..+...+..|+..+    +-.|++.+.+.++.++.....+-.
T Consensus       325 ~~~~~g~~~~W~~~r-----~~~ip~e~~~~~s~~l~~~~~~~~d~~----~~~~~~~q~~~~l~~i~s~~~~~~  390 (524)
T KOG0601|consen  325 HLPSVGKNSSWSQLR-----QGYIPLEFCEGGSSSLRSVTSQMLDED----PRLRLTAQILTALNVIHSKLFVHL  390 (524)
T ss_pred             ccccCCCCCCccccc-----cccCchhhhcCcchhhhhHHHHhcCcc----hhhhhHHHHHhccccccchhhhcc
Confidence            776544  2212111     122566666566666666888888877    999999999999998886554443

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=4.4e-16  Score=130.83  Aligned_cols=121  Identities=25%  Similarity=0.272  Sum_probs=97.5

Q ss_pred             EEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC
Q 015222           96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL  175 (411)
Q Consensus        96 i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~  175 (411)
                      +++.||.|.++.||++....  ..+++|....... ...+..|+.+++.+.+.+   .++.+++.++...+..+++|||+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~---~~~p~~~~~~~~~~~~~~v~e~~   75 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARKG---LPVPKVLASGESDGWSYLLMEWI   75 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcC---CCCCeEEEEcCCCCccEEEEEec
Confidence            45789999999999998754  6799999865443 567889999999998862   23477777777778899999999


Q ss_pred             -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCcEEEecCc
Q 015222          176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL---RLIHTDLKPENILLVSAE  231 (411)
Q Consensus       176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dikp~NIli~~~~  231 (411)
                       +..+..+         +......++.+++.+|.+||..   +++|+|++|+||+++..+
T Consensus        76 ~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~  126 (155)
T cd05120          76 EGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK  126 (155)
T ss_pred             CCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc
Confidence             6655443         4566677899999999999985   799999999999997644

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.62  E-value=1.3e-16  Score=162.92  Aligned_cols=296  Identities=18%  Similarity=0.150  Sum_probs=207.3

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      +.+.+.+-+-+|.++.++.+.-..+|...++|+..........-.+++.--+.+.+ ...+|.++...-.+......+|+
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i-~p~~P~v~~~~~s~~~rsP~~L~  882 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILI-TPRSPAVVRSFPSFPCRSPLPLV  882 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccc-cCCCCceecccCCCCCCCCcchh
Confidence            45778889999999999999877778777777665433221111111110011110 01123334443334556789999


Q ss_pred             EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      ++|+ +++|...++..+  ..+.+-++.....+.+++++||+..++|+|++|.|+|+..+|+.+++||+..+....-...
T Consensus       883 ~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~  960 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT  960 (1205)
T ss_pred             hHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence            9999 889999988766  5777888888999999999999999999999999999999999999999865544322111


Q ss_pred             cccCCCCCCeeEeecCCccccc-------CCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEH-------QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN  323 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~  323 (411)
                      .........+..-+++-+....       .......||+.|.+||...+......+|+|++|++++|.++|.+||.....
T Consensus       961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen  961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred             CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence            0000000011111222111110       112346799999999999999999999999999999999999999999888


Q ss_pred             HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHH---HHHhcCCCCcccccCCCCCchhhH
Q 015222          324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMR---AVWKLLRLPVIDLYSASPNCLCKF  396 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~---~il~~~~~~~~~~~~~~~~~~~~~  396 (411)
                      ......+.....+.|.. ....+.++++++.+.+..+    +.+|..+.   ++-.|++|+.++|... ...+|.|
T Consensus      1041 q~~f~ni~~~~~~~p~g-~~~~s~~aq~~~~~ll~~~----~~qr~~a~~~~e~k~~~~~~~~~~~~l-~~q~~~~ 1110 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPWPEG-PEEGSYEAQDLINRLLTEE----PTQRLGAKGAAEVKGHPFFQDVDWENL-ALQKAEF 1110 (1205)
T ss_pred             hhhhhccccCCCCCCCC-ccccChhhhhhhhhhhccC----chhccCcccccccccCCccCCCCcccc-ccccCcc
Confidence            88888777765555543 2346778999999999888    89998888   8999999999987553 3334444

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.56  E-value=6.1e-14  Score=138.29  Aligned_cols=128  Identities=17%  Similarity=0.183  Sum_probs=85.9

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccchhh-----------------------------------------hHHHH
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY-----------------------------------------REAAM  136 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-----------------------------------------~~~~~  136 (411)
                      +.||.|++|.||+|+.+ +|+.||||+.+..-..                                         .-++.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            57999999999999865 6889999998642100                                         00234


Q ss_pred             HHHHHHHHHhcCCCCCcceEEEeeee-ecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHH-HHHHHHhC
Q 015222          137 IEIDVLQRLARHDIGGTRCVQIRNWF-DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE-SVAFMHEL  213 (411)
Q Consensus       137 ~E~~~l~~l~~~~i~~~~iv~~~~~~-~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~-aL~~LH~~  213 (411)
                      +|+..+.++....-.+++ +.+-.++ +.....++||||+ |++|.++...... ...   ...++.+++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~-v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPG-VYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCC-EEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhC
Confidence            566666666543222222 3333333 2234579999999 8899887654221 122   3456666665 47889999


Q ss_pred             CceecCCCCCcEEEecCc
Q 015222          214 RLIHTDLKPENILLVSAE  231 (411)
Q Consensus       214 givH~Dikp~NIli~~~~  231 (411)
                      |++|+|+||.||+++.+|
T Consensus       277 g~~H~D~hPgNilv~~~g  294 (437)
T TIGR01982       277 GFFHADLHPGNIFVLKDG  294 (437)
T ss_pred             CceeCCCCcccEEECCCC
Confidence            999999999999997766

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.51  E-value=3.4e-13  Score=117.53  Aligned_cols=137  Identities=19%  Similarity=0.223  Sum_probs=99.8

Q ss_pred             eeeccccceEEEEEEeCC------CCcEEEEEEeccch-----------------------hhhHH----HHHHHHHHHH
Q 015222           98 SKMGEGTFGQVVECFDNE------KKELVAIKIVRSIN-----------------------KYREA----AMIEIDVLQR  144 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~------~~~~vavK~~~~~~-----------------------~~~~~----~~~E~~~l~~  144 (411)
                      ..||.|--+.||.|....      .+..+|||+++...                       .....    ..+|...|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999997653      35789999985210                       01122    3489999999


Q ss_pred             HhcCCCCCcceEEEeeeeecCCeEEEEEccCCC-CHH-HHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCC
Q 015222          145 LARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP-SLY-DFLRKNSYRSFPIDLVRELGRQLLESVAFM-HELRLIHTDLK  221 (411)
Q Consensus       145 l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~~~-~L~-~~l~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~givH~Dik  221 (411)
                      +...++.-|..+   ++    ..-+|||||+++ .+. ..+...   .++...+..+..+++.+|..| |+.||||+||+
T Consensus        83 l~~~Gv~vP~pi---~~----~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVV---VL----KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEE---Ee----cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            999887555444   32    446899999954 332 223221   356667788899999999998 89999999999


Q ss_pred             CCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCccccc
Q 015222          222 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH  272 (411)
Q Consensus       222 p~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~  272 (411)
                      +.|||+.. |                           .+.|+|||.+....
T Consensus       153 ~~NIL~~~-~---------------------------~v~iIDF~qav~~~  175 (197)
T cd05146         153 EYNMLWHD-G---------------------------KVWFIDVSQSVEPT  175 (197)
T ss_pred             HHHEEEEC-C---------------------------cEEEEECCCceeCC
Confidence            99999963 2                           57899999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.51  E-value=5.8e-15  Score=133.44  Aligned_cols=242  Identities=17%  Similarity=0.201  Sum_probs=160.1

Q ss_pred             EEEEEEeCCCCcEEEEEEec----cchh-hhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC-----CeEEEEEccC-
Q 015222          107 QVVECFDNEKKELVAIKIVR----SINK-YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR-----NHICIVFEKL-  175 (411)
Q Consensus       107 ~V~~a~~~~~~~~vavK~~~----~~~~-~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~-----~~~~lv~e~~-  175 (411)
                      .||++.+...|.+|+--.++    +... ..+....-..-|.++.|.|+     ++++.|+.+.     ....+++||+ 
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnl-----vkfH~yw~d~K~~e~~rviFiteyms  155 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNL-----VKFHKYWTDKKYEEKPRVIFITEYMS  155 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHH-----HHHHHhhcccccccccceEEEEeccc
Confidence            46777777777666544332    1111 11222223344556667766     9999888764     3578999999 


Q ss_pred             CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEecCcccccCCcccccccCCCCCcc
Q 015222          176 GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF  251 (411)
Q Consensus       176 ~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~  251 (411)
                      .|+|.++|++..  ...+....-++++.||+.||.|||+..  |+|+++..+-|++..+|.+|+..-....         
T Consensus       156 sgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s---------  226 (458)
T KOG1266|consen  156 SGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDS---------  226 (458)
T ss_pred             chhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccc---------
Confidence            999999998532  346888889999999999999999985  9999999999999988755442110000         


Q ss_pred             ccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCC-CCCCChHHHHHHH
Q 015222          252 KNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL-FQTHENLEHLAMM  330 (411)
Q Consensus       252 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p-f~~~~~~~~~~~i  330 (411)
                          -...++.+       .........+-++|.|||.=..-..+.++|||+||+...||..|..- -.+.+..+.-..+
T Consensus       227 ----~h~s~~~~-------~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~i  295 (458)
T KOG1266|consen  227 ----THPSVNST-------REAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENI  295 (458)
T ss_pred             ----cchhhhhh-------hHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhh
Confidence                00000000       00111123456789999987666778899999999999999887654 3333333333334


Q ss_pred             HHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          331 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       331 ~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      .+......       ...-++++.+|++-.    |..||++++++.||-+-++.
T Consensus       296 a~~i~~le-------n~lqr~~i~kcl~~e----P~~rp~ar~llfHpllfeVh  338 (458)
T KOG1266|consen  296 ANVIIGLE-------NGLQRGSITKCLEGE----PNGRPDARLLLFHPLLFEVH  338 (458)
T ss_pred             hhheeecc-------CccccCcCcccccCC----CCCCcchhhhhcCceeeecc
Confidence            33322221       223457888898888    99999999999999877665

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.50  E-value=1.7e-13  Score=117.98  Aligned_cols=114  Identities=18%  Similarity=0.128  Sum_probs=84.2

Q ss_pred             EeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC-
Q 015222           97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-  175 (411)
Q Consensus        97 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~-  175 (411)
                      ++.|+.|.++.||+++..  ++.|++|+............+|+.+++.+.+.++    +.+++.+..  ...++|||++ 
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~----~P~~~~~~~--~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGI----GPKLYYFDP--ETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCC----CCceEEEeC--CCCeEEEEecC
Confidence            467899999999999764  7789999986544333456789999999987654    234444333  2347999999 


Q ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eecCCCCCcEEEe
Q 015222          176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL-----IHTDLKPENILLV  228 (411)
Q Consensus       176 ~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi-----vH~Dikp~NIli~  228 (411)
                      |.++.+.    .   .   ....++.+++.+|..||+.++     +|+|++|.||+++
T Consensus        75 G~~l~~~----~---~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~  122 (170)
T cd05151          75 GSELLTE----D---F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD  122 (170)
T ss_pred             CCccccc----c---c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE
Confidence            7666542    0   1   123456899999999999885     9999999999997

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.49  E-value=2.7e-13  Score=135.46  Aligned_cols=130  Identities=17%  Similarity=0.216  Sum_probs=84.3

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-----------------------------------hhhH----
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----------------------------------KYRE----  133 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-----------------------------------~~~~----  133 (411)
                      .|.. +.||+|++|.||+|+.+.+|+.||||+.+..-                                   +..+    
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4665 78999999999999998889999999997431                                   0011    


Q ss_pred             --HHHHHHHHHHHHhcCCCCCcceEEEeeeeec-CCeEEEEEccC-CCCHHHHH--HhcCC--CCCCHHHHHHHHHHHHH
Q 015222          134 --AAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-RNHICIVFEKL-GPSLYDFL--RKNSY--RSFPIDLVRELGRQLLE  205 (411)
Q Consensus       134 --~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~-~~~~~lv~e~~-~~~L~~~l--~~~~~--~~l~~~~~~~i~~qi~~  205 (411)
                        ++.+|+..+.++..... +...+.+-.++.+ ....++||||+ |+.+.++-  ...+.  ..+.+..+..++.|+  
T Consensus       200 ElD~~~Ea~N~~~~~~~f~-~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        200 ELDLMREAANASQLRRNFE-DSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             hhCHHHHHHHHHHHHHHcc-CCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence              23445555666653221 2222444343332 45678999999 88998753  22220  023334444444444  


Q ss_pred             HHHHHHhCCceecCCCCCcEEEecCc
Q 015222          206 SVAFMHELRLIHTDLKPENILLVSAE  231 (411)
Q Consensus       206 aL~~LH~~givH~Dikp~NIli~~~~  231 (411)
                           +..|++|+|+||.||+++.+|
T Consensus       277 -----f~~GffHaDpHPGNIlv~~~g  297 (537)
T PRK04750        277 -----FRDGFFHADMHPGNIFVSYDP  297 (537)
T ss_pred             -----HhCCeeeCCCChHHeEEecCC
Confidence                 458999999999999998765

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.38  E-value=1.3e-11  Score=103.74  Aligned_cols=145  Identities=24%  Similarity=0.209  Sum_probs=110.1

Q ss_pred             EEeeeccccceEEEEEEeCCCCcEEEEEEec-c--------chhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVR-S--------INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        96 i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~-~--------~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      .+..|-+|+-+.|+++.  ..|+..+||.=- +        ..-......+|+.+|.++..-.|..|.+     +|.+..
T Consensus        11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l-----~~~D~~   83 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRL-----IFIDTY   83 (229)
T ss_pred             cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceE-----EEEecC
Confidence            56788899999999995  457777787531 1        1123456778999999998888744433     334455


Q ss_pred             eEEEEEccCCC--CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          167 HICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       167 ~~~lv~e~~~~--~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      .-+|+|||+.|  ++.+++...............++++|-..+.-||..+|||+||..+||++.++|             
T Consensus        84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~-------------  150 (229)
T KOG3087|consen   84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDG-------------  150 (229)
T ss_pred             CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCC-------------
Confidence            66899999955  899999876544444444478899999999999999999999999999998876             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccc
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFE  271 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~  271 (411)
                                 ....+.++|||++...
T Consensus       151 -----------~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen  151 -----------NQITPILIDFGLSSVS  166 (229)
T ss_pred             -----------CcCceEEEeecchhcc
Confidence                       4456789999988653

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.37  E-value=4.2e-13  Score=131.10  Aligned_cols=249  Identities=18%  Similarity=0.100  Sum_probs=168.5

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeC-CCCcEEEEEEeccch---hhhHHHHHHHHHHHHHh-cCCCCCcceEEEeeeeec
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDN-EKKELVAIKIVRSIN---KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~~~~  164 (411)
                      ...+|..+..||.|.|+.|+.+... .++..+++|.+.+..   ........|+.+...+. |.++     +.....+..
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~-----~g~~~~W~~  337 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPS-----VGKNSSWSQ  337 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhccccc-----CCCCCCccc
Confidence            4467889999999999999988755 677889999875432   12222345666666654 3333     666666666


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                      ....|+-.||| ++++...+.-.  ..+.+...+++..|++.++.++|+..++|+|+||+||++.++|            
T Consensus       338 ~r~~~ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~------------  403 (524)
T KOG0601|consen  338 LRQGYIPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG------------  403 (524)
T ss_pred             cccccCchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch------------
Confidence            66777999999 88776665332  3688899999999999999999999999999999999998763            


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCcc--ccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYR--APEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                                    ...+++|||.............+...+.  +++......+..++|++|||..+.+.++|...-...
T Consensus       404 --------------~~~~~~~~~~~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~  469 (524)
T KOG0601|consen  404 --------------FFSKLGDFGCWTRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG  469 (524)
T ss_pred             --------------hhhhccccccccccceecccccccccccccchhhccccccccccccccccccccccccCcccCccc
Confidence                          1346666666543222222222333344  555555667889999999999999999986543322


Q ss_pred             ChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCc
Q 015222          322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~  382 (411)
                      ..   ...+.....+...    .....+..+.+.++..+    +..|+.+.++..|.-|..
T Consensus       470 ~~---~~~i~~~~~p~~~----~~~~~~q~~~kv~~~~~----~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  470 VQ---SLTIRSGDTPNLP----GLKLQLQVLLKVMINPD----RKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             cc---ceeeecccccCCC----chHHhhhhhhhhhcCCc----cccchhhhhhcccchhhh
Confidence            21   1222222111111    11245667777777777    888899988888776654

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.34  E-value=8.5e-12  Score=123.26  Aligned_cols=182  Identities=17%  Similarity=0.271  Sum_probs=130.2

Q ss_pred             eEEEeeeccccceEEE-EEEeCCCCcEEEEEEeccchh-hhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           94 YRILSKMGEGTFGQVV-ECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        94 y~i~~~lG~G~~g~V~-~a~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      |.+ ...+-++.+ +| .|..+.++.+|.|.+++.... ..+...+-++.|+.++||+|     +++++.++.++.+|||
T Consensus        15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~I-----l~yL~t~e~~~~~ylv   87 (690)
T KOG1243|consen   15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNI-----LSYLDTTEEEGTLYLV   87 (690)
T ss_pred             ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchh-----hhhhhhhcccCceEEE
Confidence            444 333334433 34 466788889999999875443 34556778899999999988     9999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          172 FEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       172 ~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      +|-+. .|..++.+     +....+...+.||+.||.||| +.+++|++|.-+.|+|+..|..||.+|.+++..+.-+. 
T Consensus        88 TErV~-Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-  160 (690)
T KOG1243|consen   88 TERVR-PLETVLKE-----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-  160 (690)
T ss_pred             eeccc-cHHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-
Confidence            99883 35566665     336778888999999999998 56899999999999999999766666655433322110 


Q ss_pred             cccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhC
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG  314 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg  314 (411)
                                             ......--..|..|+.+....  -..|.|-|||+++|++.|
T Consensus       161 -----------------------~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  161 -----------------------PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             -----------------------ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence                                   001111112356666554322  457999999999999999

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.26  E-value=4.2e-11  Score=107.57  Aligned_cols=108  Identities=17%  Similarity=0.157  Sum_probs=77.2

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccchh--hhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC---CeEEEEE
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR---NHICIVF  172 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~---~~~~lv~  172 (411)
                      +.|+.|..+.||++.... |+.+++|+......  ....+..|+.+++.+.+.++..|   +++.+....   +..++||
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp---~~~~~~~~~~~~~~~~~v~   79 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVP---KVLALCEDPSVLGTPFYVM   79 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCC---CEEEECCCCCccCCceEEE
Confidence            678999999999998643 57899999865433  35678899999999988655334   344444332   3678999


Q ss_pred             ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 015222          173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE  212 (411)
Q Consensus       173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  212 (411)
                      ||+ |.++.+.+..   ..+++.....++.+++.+|..||+
T Consensus        80 e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~  117 (223)
T cd05154          80 ERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHS  117 (223)
T ss_pred             EEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhC
Confidence            999 7777665432   146677777777888888877773

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.25  E-value=1.2e-10  Score=98.44  Aligned_cols=130  Identities=22%  Similarity=0.223  Sum_probs=93.9

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEec-cc--------hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVR-SI--------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~-~~--------~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      ..+++|+-+.+|.+..  -|..+++|.=- +.        .-..+...+|+.++.++....+..|   .+++  .+.+..
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P---~v~d--vD~~~~   74 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVP---IVYD--VDPDNG   74 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCC---eEEE--EcCCCC
Confidence            3578899999999855  34456777532 11        1233556789999999998877333   3333  344567


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      .|+|||+ |..|.+.+....         ..++..+-.-+.-||..||||+||.++||++...                 
T Consensus        75 ~I~me~I~G~~lkd~l~~~~---------~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-----------------  128 (204)
T COG3642          75 LIVMEYIEGELLKDALEEAR---------PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-----------------  128 (204)
T ss_pred             EEEEEEeCChhHHHHHHhcc---------hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-----------------
Confidence            8999999 667777887641         3455666666778999999999999999999654                 


Q ss_pred             CCccccCCCCCCeeEeecCCcccc
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFE  271 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~  271 (411)
                                 .+.++|||++...
T Consensus       129 -----------~i~~IDfGLg~~s  141 (204)
T COG3642         129 -----------RIYFIDFGLGEFS  141 (204)
T ss_pred             -----------cEEEEECCccccc
Confidence                       4899999998743

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.18  E-value=1.3e-09  Score=100.37  Aligned_cols=140  Identities=18%  Similarity=0.051  Sum_probs=98.2

Q ss_pred             EEEEEeCCCCcEEEEEEeccchh------------hhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec--CCeEEEEEc
Q 015222          108 VVECFDNEKKELVAIKIVRSINK------------YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--RNHICIVFE  173 (411)
Q Consensus       108 V~~a~~~~~~~~vavK~~~~~~~------------~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~--~~~~~lv~e  173 (411)
                      |+++..  .|+.|.||.......            ....+.+|...+.++...+|..|..|-+...-..  ...-++|||
T Consensus        38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte  115 (268)
T PRK15123         38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE  115 (268)
T ss_pred             EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence            555532  466788886643221            1124789999999999999877765554321111  235789999


Q ss_pred             cC-CC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCcc
Q 015222          174 KL-GP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF  251 (411)
Q Consensus       174 ~~-~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~  251 (411)
                      ++ +. +|.+++........+......++.+++..+.-||..||+|+|+++.|||++.+...                  
T Consensus       116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~------------------  177 (268)
T PRK15123        116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPG------------------  177 (268)
T ss_pred             eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccC------------------
Confidence            99 43 79999864322346677888999999999999999999999999999999752000                  


Q ss_pred             ccCCCCCCeeEeecCCcc
Q 015222          252 KNLPKSSAIKLIDFGSTT  269 (411)
Q Consensus       252 ~~~~~~~~~kl~Dfg~a~  269 (411)
                        .++...+.|+||+.+.
T Consensus       178 --~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        178 --REEDLKLSVIDLHRAQ  193 (268)
T ss_pred             --CCCCceEEEEECCccc
Confidence              0123478999999765

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.13  E-value=1.8e-10  Score=100.09  Aligned_cols=127  Identities=28%  Similarity=0.336  Sum_probs=81.5

Q ss_pred             EEEEEEeCCCCcEEEEEEeccch---------------------------hhhHHHHHHHHHHHHHhcCCCCCcceEEEe
Q 015222          107 QVVECFDNEKKELVAIKIVRSIN---------------------------KYREAAMIEIDVLQRLARHDIGGTRCVQIR  159 (411)
Q Consensus       107 ~V~~a~~~~~~~~vavK~~~~~~---------------------------~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~  159 (411)
                      .||.|.. ..|..+|||+.+...                           .......+|...|.++...++.-|   +++
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP---~p~   76 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVP---KPY   76 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS-----EE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCC---cEE
Confidence            3888876 456789999985210                           112446789999999988876444   333


Q ss_pred             eeeecCCeEEEEEccCC--CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-HHhCCceecCCCCCcEEEecCcccccC
Q 015222          160 NWFDYRNHICIVFEKLG--PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF-MHELRLIHTDLKPENILLVSAEYVKVP  236 (411)
Q Consensus       160 ~~~~~~~~~~lv~e~~~--~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~-LH~~givH~Dikp~NIli~~~~~~~l~  236 (411)
                      ++.    .-+|||||++  |.....+....   ++.+....++.+++..+.. +|+.||+|+||.+.|||++.+      
T Consensus        77 ~~~----~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~------  143 (188)
T PF01163_consen   77 DYN----RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG------  143 (188)
T ss_dssp             EEE----TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT------
T ss_pred             EEe----CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc------
Confidence            332    2369999996  64444444332   2245567788888886555 679999999999999999754      


Q ss_pred             CcccccccCCCCCccccCCCCCCeeEeecCCccccc
Q 015222          237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH  272 (411)
Q Consensus       237 df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~  272 (411)
                                            .+.|+|||.+....
T Consensus       144 ----------------------~~~iIDf~qav~~~  157 (188)
T PF01163_consen  144 ----------------------KVYIIDFGQAVDSS  157 (188)
T ss_dssp             ----------------------CEEE--GTTEEETT
T ss_pred             ----------------------eEEEEecCcceecC
Confidence                                  58899999876543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.08  E-value=1.7e-11  Score=121.53  Aligned_cols=167  Identities=14%  Similarity=0.258  Sum_probs=118.3

Q ss_pred             HHHHHHHHHHhC-CceecCCCCCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCccccc
Q 015222          202 QLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVS  280 (411)
Q Consensus       202 qi~~aL~~LH~~-givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~g  280 (411)
                      +++.||.|+|.. ++||++|.|++|.++..|.+|++.|+++........        .-...-|+++...       ..-
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~--------~p~~~yd~~lp~~-------~~~  171 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE--------YPFSEYDPPLPLL-------LQP  171 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc--------cccccCCCCCChh-------hcc
Confidence            344999999965 899999999999999999888777776543332221        1122233333221       223


Q ss_pred             CCCccccceecCCCCCccchhHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCcc
Q 015222          281 TRHYRAPEVILGLGWNYPCDLWSVGCILVELC-SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARL  359 (411)
Q Consensus       281 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell-tg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~  359 (411)
                      ...|.|||.+.+...+.++|+|||||++|.+. .|+..+...........-......--.....+++.++++-+.+++..
T Consensus       172 ~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~  251 (700)
T KOG2137|consen  172 HLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNG  251 (700)
T ss_pred             CcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcC
Confidence            55799999999988899999999999999999 57777766544333322222222222233456778899999999999


Q ss_pred             CCCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          360 DWPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       360 ~~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                      +    ...||++.+++..+||.+.....
T Consensus       252 ~----~~~rp~~~~l~~~~ff~D~~~~a  275 (700)
T KOG2137|consen  252 D----SAVRPTLDLLLSIPFFSDPGLKA  275 (700)
T ss_pred             C----cccCcchhhhhcccccCCchhhh
Confidence            9    88999999999999999865443

>PRK09902 hypothetical protein; Provisional

Probab=98.96  E-value=3.7e-08  Score=86.21  Aligned_cols=128  Identities=13%  Similarity=0.118  Sum_probs=96.6

Q ss_pred             ccccceEEEEEEeCCCCcEEEEEEecc----c---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec--CCeEEEE
Q 015222          101 GEGTFGQVVECFDNEKKELVAIKIVRS----I---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--RNHICIV  171 (411)
Q Consensus       101 G~G~~g~V~~a~~~~~~~~vavK~~~~----~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~--~~~~~lv  171 (411)
                      |+||.+-|+.....  |+.+=+|.-..    .   ......+.+|+..|++|...++.-|.++ ..+.-..  .-..+||
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            67888999887543  33577776531    0   2356778999999999999988655544 2222211  2357899


Q ss_pred             EccCC--CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCc
Q 015222          172 FEKLG--PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE  231 (411)
Q Consensus       172 ~e~~~--~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~  231 (411)
                      +|-++  .+|.+++........+......++.+++..+.-||+.|+.|+|+-+.|||++.+|
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g  165 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG  165 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC
Confidence            99885  6999998775534567888889999999999999999999999999999997544

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.93  E-value=3.5e-08  Score=95.27  Aligned_cols=167  Identities=18%  Similarity=0.255  Sum_probs=123.8

Q ss_pred             cceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec----CCeEEEEEccC--C
Q 015222          104 TFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY----RNHICIVFEKL--G  176 (411)
Q Consensus       104 ~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~----~~~~~lv~e~~--~  176 (411)
                      .-.+.|++....+|..|++|.+.-.. ........-+++++++.|.|+     |++.++|..    +..+++|++|.  .
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~Nv-----V~frevf~t~tF~D~SlvlvYDYyP~s  362 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNV-----VPFREVFLTYTFGDLSLVLVYDYYPSS  362 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCce-----eehhhhhhhhccCcceEEEEEecCCCC
Confidence            34578999999999999999994222 112233445788999999887     999998873    45799999998  6


Q ss_pred             CCHHHHHHhc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          177 PSLYDFLRKN-------------SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       177 ~~L~~~l~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                      ++|.++.-..             .+.+.++..+|.++.||..||.++|+.|+.-+-|.|.+||++.+.            
T Consensus       363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~------------  430 (655)
T KOG3741|consen  363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM------------  430 (655)
T ss_pred             chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc------------
Confidence            6888875321             124578899999999999999999999999999999999986543            


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA  316 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~  316 (411)
                                     +++|..-|.......+..           |.+.+   -.+-|.=.||.+++.|.||..
T Consensus       431 ---------------RIriS~C~i~Dvl~~d~~-----------~~le~---~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  431 ---------------RIRISGCGIMDVLQEDPT-----------EPLES---QQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             ---------------eEEEecccceeeecCCCC-----------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence                           566666665544332220           11111   245688999999999999854

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.92  E-value=1.7e-08  Score=89.81  Aligned_cols=113  Identities=29%  Similarity=0.328  Sum_probs=87.8

Q ss_pred             hHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec-CCeEEEEEccC-C-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Q 015222          132 REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-RNHICIVFEKL-G-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVA  208 (411)
Q Consensus       132 ~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~-~~~~~lv~e~~-~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~  208 (411)
                      .....+|...+..|...+|.-|..+-+...-.. ....++|+|++ + .+|.+++....  ..+......++.+++..+.
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIA  132 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHH
Confidence            456788999999999999876665554332111 13568999999 4 37999988754  3667788899999999999


Q ss_pred             HHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCccc
Q 015222          209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF  270 (411)
Q Consensus       209 ~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~  270 (411)
                      -||+.||+|+|+++.|||++.++                        +...+.|+||+-+..
T Consensus       133 ~lH~~gi~H~Dl~~~NILv~~~~------------------------~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  133 KLHDAGIYHGDLNPSNILVDPDD------------------------GQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHCcCCCCCCCcccEEEeCCC------------------------CceeEEEEcchhcee
Confidence            99999999999999999998754                        234678888886653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.87  E-value=2.6e-08  Score=89.38  Aligned_cols=123  Identities=28%  Similarity=0.293  Sum_probs=89.1

Q ss_pred             eEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc-----------------------hhhhHHHHHHHHHHHHHhcCCC
Q 015222           94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-----------------------NKYREAAMIEIDVLQRLARHDI  150 (411)
Q Consensus        94 y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----------------------~~~~~~~~~E~~~l~~l~~~~i  150 (411)
                      +.+..+||-|--|.||.|.+. .|.++|||.=+-.                       ...+..+++|.++|++|...+.
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            456789999999999999876 6778999975310                       0134557889999999976633


Q ss_pred             CCcceEEEeeeeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 015222          151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS  229 (411)
Q Consensus       151 ~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~  229 (411)
                      .-   .+.++    -+...+|||++ |..|...       ++..+.+..++..|+.-+.-+-..||||+|+.+=||+++.
T Consensus       172 ~V---P~P~~----~nRHaVvMe~ieG~eL~~~-------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~  237 (304)
T COG0478         172 KV---PKPIA----WNRHAVVMEYIEGVELYRL-------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE  237 (304)
T ss_pred             CC---CCccc----cccceeeeehcccceeecc-------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec
Confidence            11   23222    35678999999 6555432       2234556666777777777666899999999999999988


Q ss_pred             Cc
Q 015222          230 AE  231 (411)
Q Consensus       230 ~~  231 (411)
                      +|
T Consensus       238 dg  239 (304)
T COG0478         238 DG  239 (304)
T ss_pred             CC
Confidence            77

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.75  E-value=1.7e-07  Score=82.49  Aligned_cols=131  Identities=17%  Similarity=0.230  Sum_probs=87.4

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhh----------HHHHHHHHHHHHHhcCCCCCcc---e
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR----------EAAMIEIDVLQRLARHDIGGTR---C  155 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~----------~~~~~E~~~l~~l~~~~i~~~~---i  155 (411)
                      .+.++|.+.+.+-......|.+..  -.|+.+++|..+......          ....+++..+.++...+...++   +
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl  105 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL  105 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence            457889999999888888887764  456789999986432111          2234455556666555443221   2


Q ss_pred             EEEeeeeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCc
Q 015222          156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE  231 (411)
Q Consensus       156 v~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~  231 (411)
                      +...-.+......+++|||+ |..|.++..      +++    .+...|.+++.-||+.|+.|+|..|.|++++.++
T Consensus       106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~  172 (229)
T PF06176_consen  106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG  172 (229)
T ss_pred             eeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc
Confidence            22222233345678999999 777766532      333    2446677889999999999999999999997553

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.72  E-value=5.7e-08  Score=91.65  Aligned_cols=194  Identities=16%  Similarity=0.195  Sum_probs=121.3

Q ss_pred             EeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHH-hcCCCCCcceEEEee--eeec-CCeEEEEE
Q 015222           97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRN--WFDY-RNHICIVF  172 (411)
Q Consensus        97 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~--~~~~-~~~~~lv~  172 (411)
                      ...||+|+-+.+|-.-..   ...+-|++....-..+.-  -+..|... .|+.+. ..++--..  +.-+ +..+.+.|
T Consensus        16 gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aq--k~a~la~~p~~p~~~-~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          16 GRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQ--KVAELAATPDAPLLN-YRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CccccCCccceeeecchh---hchhheeecCCCchHHHH--HHHHhccCCCCcchh-hhhcccHHHhhCCCccceeEEec
Confidence            357899999999965322   224568876433221111  11112111 122110 00110000  0111 23478899


Q ss_pred             ccC-CC-CHHHHHH----hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          173 EKL-GP-SLYDFLR----KNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       173 e~~-~~-~L~~~l~----~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      ..+ |. .+.+++.    ++......+....++++.|+.+...||..|.+-+|+.++|+|+++++.+.|.|-.       
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsD-------  162 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSD-------  162 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccc-------
Confidence            988 43 4444443    3334457889999999999999999999999999999999999998866655421       


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceec-----CCCCCccchhHHHHHHHHHHHhC-CCCCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSG-EALFQT  320 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltg-~~pf~~  320 (411)
                                  ...|+|-|.-      ....+|...|.+||.-.     +..-+...|.|.|||++|+|+.| +.||.+
T Consensus       163 ------------sfqi~~ng~~------~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG  224 (637)
T COG4248         163 ------------SFQINANGTL------HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG  224 (637)
T ss_pred             ------------ceeeccCCce------EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence                        1222222211      12247888999999765     33456789999999999999985 999976


Q ss_pred             C
Q 015222          321 H  321 (411)
Q Consensus       321 ~  321 (411)
                      .
T Consensus       225 I  225 (637)
T COG4248         225 I  225 (637)
T ss_pred             c
Confidence            3

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.70  E-value=2.8e-07  Score=81.95  Aligned_cols=136  Identities=19%  Similarity=0.161  Sum_probs=95.0

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccchh-------------------------hhHHHHHHHHHHHHHhcCCCCC
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------------------------YREAAMIEIDVLQRLARHDIGG  152 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-------------------------~~~~~~~E~~~l~~l~~~~i~~  152 (411)
                      ..|..|--+.||+|.. .++..||+|+++....                         ......+|..-|+++...++..
T Consensus        54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            3556677778999974 5678899999863211                         1122357999999998877633


Q ss_pred             cceEEEeeeeecCCeEEEEEccCCCC--HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEec
Q 015222          153 TRCVQIRNWFDYRNHICIVFEKLGPS--LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVS  229 (411)
Q Consensus       153 ~~iv~~~~~~~~~~~~~lv~e~~~~~--L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dikp~NIli~~  229 (411)
                         .+.+.+.    .-.|||||+|..  -.-.|..-   .+..+++..+..++++.+.-|-. .|+||+||..=|||+. 
T Consensus       133 ---P~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-  201 (268)
T COG1718         133 ---PEPIAFR----NNVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-  201 (268)
T ss_pred             ---CCceeec----CCeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-
Confidence               3333332    347999999544  11122221   24444788889999999988887 8999999999999997 


Q ss_pred             CcccccCCcccccccCCCCCccccCCCCCCeeEeecCCccccc
Q 015222          230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH  272 (411)
Q Consensus       230 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~  272 (411)
                      +|                           .+.++|||.|....
T Consensus       202 ~~---------------------------~p~iID~~QaV~~~  217 (268)
T COG1718         202 DG---------------------------EPYIIDVSQAVTID  217 (268)
T ss_pred             CC---------------------------eEEEEECccccccC
Confidence            33                           68999999887554

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.68  E-value=4.2e-07  Score=82.02  Aligned_cols=82  Identities=21%  Similarity=0.268  Sum_probs=59.3

Q ss_pred             EeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC-
Q 015222           97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-  175 (411)
Q Consensus        97 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~-  175 (411)
                      ++.|+.|..+.||++....  ..+++|+.... .....+..|..+++.+....+..|.++............+++|+++ 
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            4788999999999998765  47999998665 5567788999999999988763344333222223345689999999 


Q ss_pred             CCCHHH
Q 015222          176 GPSLYD  181 (411)
Q Consensus       176 ~~~L~~  181 (411)
                      |..+..
T Consensus        79 g~~~~~   84 (239)
T PF01636_consen   79 GRPLDD   84 (239)
T ss_dssp             SEEHHH
T ss_pred             cccccc
Confidence            777766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.65  E-value=2.1e-07  Score=92.90  Aligned_cols=136  Identities=18%  Similarity=0.225  Sum_probs=85.0

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccchh-----------------------------------h------hHHHH
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-----------------------------------Y------REAAM  136 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-----------------------------------~------~~~~~  136 (411)
                      +.|+.++-|.||+|+.+. |+.||||+.+..-.                                   .      .-++.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            578999999999999765 89999999753110                                   0      01134


Q ss_pred             HHHHHHHHHhcCCCCCcceEEEeeee-ecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHH-HHHHHhC
Q 015222          137 IEIDVLQRLARHDIGGTRCVQIRNWF-DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES-VAFMHEL  213 (411)
Q Consensus       137 ~E~~~l~~l~~~~i~~~~iv~~~~~~-~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~a-L~~LH~~  213 (411)
                      +|..-+.++.+..-..+. +++-.++ +..+.-.++|||+ |..+.+...-.. ..++...+.   ..++++ +..+-..
T Consensus       210 ~EA~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia---~~~~~~f~~q~~~d  284 (517)
T COG0661         210 REAANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELA---ELLVRAFLRQLLRD  284 (517)
T ss_pred             HHHHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHH---HHHHHHHHHHHHhc
Confidence            566666676654333333 3333333 3456678999999 778888743222 235533332   222222 3344458


Q ss_pred             CceecCCCCCcEEEecCcccccCCcc
Q 015222          214 RLIHTDLKPENILLVSAEYVKVPDYK  239 (411)
Q Consensus       214 givH~Dikp~NIli~~~~~~~l~df~  239 (411)
                      |+.|.|.+|.||++..+|.+.+.|||
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfG  310 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFG  310 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCc
Confidence            99999999999999988744333333

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.54  E-value=3.7e-06  Score=73.74  Aligned_cols=124  Identities=17%  Similarity=0.305  Sum_probs=94.8

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccch-----------------hhhHHHHHHHHHHHHHh-cCCCCCcceEEEe
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----------------KYREAAMIEIDVLQRLA-RHDIGGTRCVQIR  159 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-----------------~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~  159 (411)
                      ..||+|+.-.||.-  .. .....||+++...                 .......+|+.....+. ..++.+.++.+++
T Consensus         7 ~~i~~G~~R~cy~H--P~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQH--PD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEEC--CC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            47899999999954  33 3347899987544                 23466778999888888 8888888999999


Q ss_pred             eeeecCCeEEEEEccC-C------CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCc
Q 015222          160 NWFDYRNHICIVFEKL-G------PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE  231 (411)
Q Consensus       160 ~~~~~~~~~~lv~e~~-~------~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~  231 (411)
                      ++.+++.-..+|+|.+ .      .+|.+++....   ++. ....   .+-.-.+||-+.+|+.+|++|.||++...+
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~  155 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRD  155 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecC
Confidence            9999998889999975 2      37888886653   655 3333   333334688899999999999999998754

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.54  E-value=7e-09  Score=102.30  Aligned_cols=243  Identities=14%  Similarity=0.029  Sum_probs=159.6

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF  172 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~  172 (411)
                      .|...+.+++|+++.+++.+...+...+ .+++...    ....-++++|.+++|||.    .+..++.++.+.+.+++|
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~n~P~~----~v~~~~d~~~E~~~~i~~  313 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKVNNPNP----VVRYLEDYDGEDYLWIPM  313 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHccCCCC----cccccccCCcccccchhh
Confidence            4556677899999999999877666555 7776543    345558899999999982    267777777788999999


Q ss_pred             ccC-CC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          173 EKL-GP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       173 e~~-~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      +++ ++ +......... ..+.+.+...+.+.-.++|++||+.-=+|+|    ||+..+                     
T Consensus       314 ~i~s~~rs~~~~~~~se-~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~---------------------  367 (829)
T KOG0576|consen  314 RICSTGRSSALEMTVSE-IALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE---------------------  367 (829)
T ss_pred             hhhcCCccccccCChhh-HhhhhhhhhhhhhhhcccccccccccccCcc----cccccc---------------------
Confidence            999 44 2222111111 1244455566677778899999998878998    887544                     


Q ss_pred             cccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA  328 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~  328 (411)
                             ...++.||+........  ..+..+|+.++|||+...+.+....|.||+|+--.++.-|.+|-...  .....
T Consensus       368 -------~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~  438 (829)
T KOG0576|consen  368 -------EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSP--PAVLP  438 (829)
T ss_pred             -------cccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCC--ccccC
Confidence                   25688888877665544  55678999999999999999999999999999877887777765331  00000


Q ss_pred             HHHHHhCCCChhHH-Hhhhhhh-hhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          329 MMERVLGPLPHHMV-IRADRRA-EKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       329 ~i~~~~~~~p~~~~-~~~~~~~-~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      .+..... .+.-.. ..++... .++...|+..-    |..++....++.+.+|....
T Consensus       439 ~~g~~p~-s~~L~~~~aw~~~~~~~~~~~~~~g~----P~~pkv~mgacfsKvfngCp  491 (829)
T KOG0576|consen  439 MIGNGPN-SPMLTDKSAWSPVFHRDFPAPCLNGL----PPTPKVHMGACFSKVFNGCP  491 (829)
T ss_pred             CCCCCCC-ccccchhhhcCcccccCCcccccCCC----CCCCcchhhHHHHHHhccCc
Confidence            0000000 000000 0011111 13555555555    77777777787777776543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.51  E-value=1.7e-06  Score=77.92  Aligned_cols=72  Identities=17%  Similarity=0.218  Sum_probs=52.9

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC-C
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-G  176 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~-~  176 (411)
                      ..||.|..+.||+.    .+..+++|+..... ......+|.++++.+...++..|   +.+.+.+..+...+|||++ |
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP---~~~~~~~~~~~~glv~e~i~G   78 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTP---HPFDLVEDGGRLGLIYELIVG   78 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCC---ceEEEEecCCeeeeeeeecCC
Confidence            57899999999984    24457899986533 34557889999999987666444   4455556667788999999 5


Q ss_pred             C
Q 015222          177 P  177 (411)
Q Consensus       177 ~  177 (411)
                      .
T Consensus        79 ~   79 (226)
T TIGR02172        79 K   79 (226)
T ss_pred             c
Confidence            4

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.47  E-value=3.8e-06  Score=73.11  Aligned_cols=118  Identities=21%  Similarity=0.289  Sum_probs=85.8

Q ss_pred             CCeEEEeeeccccc-eEEEEEEeCCCCcEEEEEEecc----c--------h----------hhhHHHHHHHHHHHHHhcC
Q 015222           92 PRYRILSKMGEGTF-GQVVECFDNEKKELVAIKIVRS----I--------N----------KYREAAMIEIDVLQRLARH  148 (411)
Q Consensus        92 ~~y~i~~~lG~G~~-g~V~~a~~~~~~~~vavK~~~~----~--------~----------~~~~~~~~E~~~l~~l~~~  148 (411)
                      .+++.++.||.|.. |.||+++.  .|+.+|||+++.    .        .          .....+..|.+...+|+..
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            57899999999999 99999965  577999999431    0        0          1234577899999999877


Q ss_pred             CCCCcceEEEeeeeecC------------------CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Q 015222          149 DIGGTRCVQIRNWFDYR------------------NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF  209 (411)
Q Consensus       149 ~i~~~~iv~~~~~~~~~------------------~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~  209 (411)
                      +-.+.-.++.++|..-.                  ....||.||. ...           .++...    +.+|++-|..
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~~----~~~~~~dl~~  179 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIRD----IPQMLRDLKI  179 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchhH----HHHHHHHHHH
Confidence            55333358888887321                  1346788876 322           133333    4567778889


Q ss_pred             HHhCCceecCCCCCcEE
Q 015222          210 MHELRLIHTDLKPENIL  226 (411)
Q Consensus       210 LH~~givH~Dikp~NIl  226 (411)
                      +|..||+-+|+|+.|..
T Consensus       180 ~~k~gI~~~Dv~~~ny~  196 (207)
T PF13095_consen  180 LHKLGIVPRDVKPRNYR  196 (207)
T ss_pred             HHHCCeeeccCcccccc
Confidence            99999999999999987

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.37  E-value=4e-06  Score=70.71  Aligned_cols=133  Identities=24%  Similarity=0.269  Sum_probs=89.9

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF  172 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~  172 (411)
                      .-++.+.||+|++|.||++.+.  |..+|+|+-+. +..+..++.|+++|..+.-.++    ..+++.+-.    .++.|
T Consensus        23 ~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~-ds~r~~l~kEakiLeil~g~~~----~p~vy~yg~----~~i~m   91 (201)
T COG2112          23 ELRVEKELAKGTTSVVYLGEWR--GGEVALKVRRR-DSPRRNLEKEAKILEILAGEGV----TPEVYFYGE----DFIRM   91 (201)
T ss_pred             hhhhhhhhhcccccEEEEeecc--CceEEEEEecC-CcchhhHHHHHHHHHHhhhcCC----CceEEEech----hhhhh
Confidence            3456789999999999999764  56899998653 4556788999999999987765    134444433    34559


Q ss_pred             ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC-CCcEEEecCcccccCCcccccccCCCCCc
Q 015222          173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLK-PENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dik-p~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      ||+ |..|.+.-...     .    ++-...++.+-.-|-..||-|+.|. |..++|..++                   
T Consensus        92 e~i~G~~L~~~~~~~-----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~-------------------  143 (201)
T COG2112          92 EYIDGRPLGKLEIGG-----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR-------------------  143 (201)
T ss_pred             hhhcCcchhhhhhcc-----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCC-------------------
Confidence            999 76887654321     1    2223445555455667899999886 4444443322                   


Q ss_pred             cccCCCCCCeeEeecCCccccc
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEH  272 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~  272 (411)
                              .+.|+||..|+...
T Consensus       144 --------~~~iIDFd~At~k~  157 (201)
T COG2112         144 --------DVYIIDFDSATFKK  157 (201)
T ss_pred             --------cEEEEEccchhhcc
Confidence                    67899999887443

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.26  E-value=1.4e-05  Score=73.03  Aligned_cols=75  Identities=15%  Similarity=0.092  Sum_probs=51.6

Q ss_pred             eeccccc-eEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC-C
Q 015222           99 KMGEGTF-GQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-G  176 (411)
Q Consensus        99 ~lG~G~~-g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~-~  176 (411)
                      .|-.|.+ +.||++...  +..+.||+.....  .....+|+.+++.+... +.   +.+++.+....+..++|||++ |
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~-~~---vP~v~~~~~~~~~~~lv~e~i~G   76 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGK-LP---VPEVIDYGSDDGRAWLLTSAVPG   76 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhc-CC---CCeEEEEEecCCccEEEEEeeCC
Confidence            4445555 789998653  3578899875433  34567899999999755 43   345666666556789999999 7


Q ss_pred             CCHHH
Q 015222          177 PSLYD  181 (411)
Q Consensus       177 ~~L~~  181 (411)
                      .+|.+
T Consensus        77 ~~l~~   81 (244)
T cd05150          77 VPAAA   81 (244)
T ss_pred             ccHhH
Confidence            66653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.23  E-value=9.9e-06  Score=73.55  Aligned_cols=76  Identities=14%  Similarity=0.073  Sum_probs=46.6

Q ss_pred             eeeccccce-EEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcC-CCCCcceEEEeeeeecCCeEEEEEccC
Q 015222           98 SKMGEGTFG-QVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH-DIGGTRCVQIRNWFDYRNHICIVFEKL  175 (411)
Q Consensus        98 ~~lG~G~~g-~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~-~i~~~~iv~~~~~~~~~~~~~lv~e~~  175 (411)
                      +.|+.|+.. .||+..     ..+++|+... ......+.+|.+++..+... .+..|.++..-..-+.....+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRLG-----DDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEcC-----CceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            567767666 599762     2477888654 23345788999999999753 444444333211111123458899998


Q ss_pred             -CCCH
Q 015222          176 -GPSL  179 (411)
Q Consensus       176 -~~~L  179 (411)
                       |.++
T Consensus        77 ~G~~l   81 (235)
T cd05155          77 EGETA   81 (235)
T ss_pred             cCCCC
Confidence             6555

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PLN02876 acyl-CoA dehydrogenase

Probab=98.17  E-value=2.4e-05  Score=83.96  Aligned_cols=78  Identities=15%  Similarity=0.126  Sum_probs=53.6

Q ss_pred             EeeeccccceEEEEEEeCCCC--cEEEEEEeccch--hhhHHHHHHHHHHHHHh-cCCCCCcceEEEeeeeecC---CeE
Q 015222           97 LSKMGEGTFGQVVECFDNEKK--ELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYR---NHI  168 (411)
Q Consensus        97 ~~~lG~G~~g~V~~a~~~~~~--~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~~~~~---~~~  168 (411)
                      ++.++.|.++.+|+......+  ..+++|+.....  .....+.+|+.+++.+. |.++..|   +++.++.+.   +..
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP---~v~~~~~d~~v~G~~  119 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVP---KVYCLCTDASVIGTA  119 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCC---cEEEEecCCCcCCCc
Confidence            577899999999998765432  357788764322  22356789999999997 5666444   444444442   467


Q ss_pred             EEEEccC-CC
Q 015222          169 CIVFEKL-GP  177 (411)
Q Consensus       169 ~lv~e~~-~~  177 (411)
                      |+|||++ |.
T Consensus       120 flVME~v~G~  129 (822)
T PLN02876        120 FYIMEYLEGR  129 (822)
T ss_pred             eEEEEecCCc
Confidence            8999999 54

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.09  E-value=5.4e-05  Score=68.59  Aligned_cols=75  Identities=15%  Similarity=0.329  Sum_probs=49.9

Q ss_pred             EeeeccccceEEEEEEeCC-CCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC
Q 015222           97 LSKMGEGTFGQVVECFDNE-KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL  175 (411)
Q Consensus        97 ~~~lG~G~~g~V~~a~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~  175 (411)
                      ++.|..|-...+|++.... .++.|++|+............+|+.+++.+...++ .   .+++..+..    .++|||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl-~---P~v~~~~~~----~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGL-A---PKLYATFQN----GLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCC-C---CeEEEEeCC----cEEEEee
Confidence            4677788888999996543 35679999876433322344579999999987765 2   334433321    3799999


Q ss_pred             -CCCH
Q 015222          176 -GPSL  179 (411)
Q Consensus       176 -~~~L  179 (411)
                       |.++
T Consensus        75 ~G~~l   79 (235)
T cd05157          75 PGRTL   79 (235)
T ss_pred             CCCcC
Confidence             6554

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.08  E-value=3.6e-05  Score=76.89  Aligned_cols=146  Identities=16%  Similarity=0.172  Sum_probs=88.4

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccch--------------------------------hhhH------HHHHHH
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--------------------------------KYRE------AAMIEI  139 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--------------------------------~~~~------~~~~E~  139 (411)
                      +.||.-+.|.||+|+.+. |+.||||+-+..-                                +..+      ++.+|+
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            579999999999999776 9999999965311                                0011      123344


Q ss_pred             HHHHHH----hcCCCCCcceEEEeeeee-cCCeEEEEEccC-CCCHHH--HHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 015222          140 DVLQRL----ARHDIGGTRCVQIRNWFD-YRNHICIVFEKL-GPSLYD--FLRKNSYRSFPIDLVRELGRQLLESVAFMH  211 (411)
Q Consensus       140 ~~l~~l----~~~~i~~~~iv~~~~~~~-~~~~~~lv~e~~-~~~L~~--~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH  211 (411)
                      +-..+.    .|-+.  ..-|.+-.++. ....-.|+|||+ |..+.|  .+.+.+   ++...+..-+.+..  ++-+-
T Consensus       246 ~Nae~~~~~f~~~~~--~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g---i~~~~i~~~l~~~~--~~qIf  318 (538)
T KOG1235|consen  246 KNAERFRENFKDFSL--LTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG---ISPHDILNKLVEAY--LEQIF  318 (538)
T ss_pred             HhHHHHHHHHHhccc--ccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC---CCHHHHHHHHHHHH--HHHHH
Confidence            333333    33221  01122333322 234678999999 765544  455544   66664444333332  23344


Q ss_pred             hCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC
Q 015222          212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD  274 (411)
Q Consensus       212 ~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~  274 (411)
                      ..|++|+|=+|.||++..++                       ..+..+.+-|||+.......
T Consensus       319 ~~GffHaDPHPGNilv~~~~-----------------------~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  319 KTGFFHADPHPGNILVRPNP-----------------------EGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             hcCCccCCCCCCcEEEecCC-----------------------CCCccEEEEcccccccccHH
Confidence            57899999999999998542                       13457899999987765443

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.98  E-value=0.00022  Score=69.38  Aligned_cols=75  Identities=20%  Similarity=0.217  Sum_probs=52.0

Q ss_pred             EeeeccccceEEEEEEeCCCCcEEEEEEeccc--------hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        97 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--------~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      .+.||.|.+..||++.+...++.|+||.-...        ....+....|.+.|+.+....  ..++.+++.+  +.+..
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~--p~~VPkV~~~--D~~~~  106 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYV--PDLVPKVYHY--DEELA  106 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhC--CCCCCeEEEE--CCCCC
Confidence            46899999999999998655468999984311        123456777888998875421  1234566655  33567


Q ss_pred             EEEEccC
Q 015222          169 CIVFEKL  175 (411)
Q Consensus       169 ~lv~e~~  175 (411)
                      ++|||++
T Consensus       107 ~lVME~L  113 (401)
T PRK09550        107 VTVMEDL  113 (401)
T ss_pred             EEEEecC
Confidence            8999999

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.91  E-value=0.00012  Score=68.91  Aligned_cols=79  Identities=14%  Similarity=0.123  Sum_probs=52.3

Q ss_pred             EeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEee---eeecCCeEEEEEc
Q 015222           97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN---WFDYRNHICIVFE  173 (411)
Q Consensus        97 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~---~~~~~~~~~lv~e  173 (411)
                      ++.|..|....+|+...  .+..+++|+...  ........|+.++..+.+.++.-+.++...+   +....+..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            56777788789998854  234689999865  3345677899999999877664333332211   1233456789999


Q ss_pred             cC-CCCH
Q 015222          174 KL-GPSL  179 (411)
Q Consensus       174 ~~-~~~L  179 (411)
                      ++ |..+
T Consensus        95 ~i~G~~~  101 (296)
T cd05153          95 FLAGEHL  101 (296)
T ss_pred             eCCCCCC
Confidence            99 6543

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.80  E-value=0.00023  Score=67.15  Aligned_cols=75  Identities=17%  Similarity=0.198  Sum_probs=49.9

Q ss_pred             EeeeccccceEEEEEEeCC------CCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           97 LSKMGEGTFGQVVECFDNE------KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        97 ~~~lG~G~~g~V~~a~~~~------~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      ++.|..|-...||++....      .++.+++|+............+|..+++.+...++ .   .+++..+..    .+
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~-~---P~~~~~~~~----~~   74 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNL-G---PKLYGIFPN----GR   74 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCC-C---CceEEEeCC----Cc
Confidence            3556667777899887543      25789999987654444567789999999987765 2   344444432    35


Q ss_pred             EEccC-CCCH
Q 015222          171 VFEKL-GPSL  179 (411)
Q Consensus       171 v~e~~-~~~L  179 (411)
                      |+||+ |..+
T Consensus        75 v~e~i~G~~l   84 (302)
T cd05156          75 IEEFIPSRTL   84 (302)
T ss_pred             hhheeCCCcC
Confidence            78888 5554

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.80  E-value=0.00059  Score=64.91  Aligned_cols=77  Identities=14%  Similarity=0.098  Sum_probs=50.5

Q ss_pred             EeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEee---eeecCCeEEEEEc
Q 015222           97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN---WFDYRNHICIVFE  173 (411)
Q Consensus        97 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~---~~~~~~~~~lv~e  173 (411)
                      ++.|+.|....+|+.... +| .+++|++.  ....+....|..++..|...++..|.++.-.+   +....+..+++++
T Consensus        27 ~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTT-QG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeC-CC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            456777887899998643 33 58999876  22334556688889998877775555443211   1223567899999


Q ss_pred             cC-CC
Q 015222          174 KL-GP  177 (411)
Q Consensus       174 ~~-~~  177 (411)
                      ++ |.
T Consensus       103 ~l~G~  107 (319)
T PRK05231        103 FLEGK  107 (319)
T ss_pred             ecCCC
Confidence            99 54

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.77  E-value=0.0004  Score=65.47  Aligned_cols=139  Identities=24%  Similarity=0.270  Sum_probs=99.9

Q ss_pred             EEeeeccccceEEEEEEeCCCCcEEEEEEeccc---------------------------hhhhHHHHHHHHHHHHHhcC
Q 015222           96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---------------------------NKYREAAMIEIDVLQRLARH  148 (411)
Q Consensus        96 i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---------------------------~~~~~~~~~E~~~l~~l~~~  148 (411)
                      |-..|..|--+.||.|.. .+|..+|||+++.+                           ....-.+..|+.-|++|+..
T Consensus       148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            345677888889999974 56777999998521                           01123356799999999999


Q ss_pred             CCCCcceEEEeeeeecCCeEEEEEccCCCCH--HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcE
Q 015222          149 DIGGTRCVQIRNWFDYRNHICIVFEKLGPSL--YDFLRKNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENI  225 (411)
Q Consensus       149 ~i~~~~iv~~~~~~~~~~~~~lv~e~~~~~L--~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~givH~Dikp~NI  225 (411)
                      +|..|--+-+.       ...|||+|+|.+=  .-.|...   .++...+..+-.|++.-+.-|- ..++||.||.-=|+
T Consensus       227 GIP~PePIlLk-------~hVLVM~FlGrdgw~aPkLKd~---~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~  296 (520)
T KOG2270|consen  227 GIPCPEPILLK-------NHVLVMEFLGRDGWAAPKLKDA---SLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNL  296 (520)
T ss_pred             CCCCCCceeee-------cceEeeeeccCCCCcCcccccc---cCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhh
Confidence            88776544442       3469999995432  2233332   4888888888899988887765 46999999999999


Q ss_pred             EEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccC
Q 015222          226 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ  273 (411)
Q Consensus       226 li~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~  273 (411)
                      |+-..                            .+.++|.+.+...+.
T Consensus       297 LyhdG----------------------------~lyiIDVSQSVE~DH  316 (520)
T KOG2270|consen  297 LYHDG----------------------------KLYIIDVSQSVEHDH  316 (520)
T ss_pred             eEECC----------------------------EEEEEEccccccCCC
Confidence            98543                            688999887765443

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.76  E-value=0.00044  Score=65.42  Aligned_cols=80  Identities=14%  Similarity=0.051  Sum_probs=51.5

Q ss_pred             EEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEee---eeecCCeEEEE
Q 015222           95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN---WFDYRNHICIV  171 (411)
Q Consensus        95 ~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~---~~~~~~~~~lv  171 (411)
                      ..++.++.|....+|++.. .++ .+++|+..... ..+....|.+++..|...++..+.++...+   +....+..+++
T Consensus        25 ~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l  101 (307)
T TIGR00938        25 LSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL  101 (307)
T ss_pred             eeccccCCccccceEEEEe-CCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence            3456777887789998864 334 57889876532 234566788899999877664444443221   11234678999


Q ss_pred             EccC-CC
Q 015222          172 FEKL-GP  177 (411)
Q Consensus       172 ~e~~-~~  177 (411)
                      |+++ |.
T Consensus       102 ~e~i~G~  108 (307)
T TIGR00938       102 VEFLQGL  108 (307)
T ss_pred             EEeCCCC
Confidence            9998 53

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.75  E-value=0.00014  Score=77.19  Aligned_cols=204  Identities=20%  Similarity=0.265  Sum_probs=124.8

Q ss_pred             HHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 015222          134 AAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE  212 (411)
Q Consensus       134 ~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  212 (411)
                      ....|...+..+.|.|++.+....+...+.. -...+..++| ..++...++...  ..+...++.+..+++.||.|+|+
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHH
Confidence            3445777788888888743333333222221 1223445677 778888887765  68889999999999999999999


Q ss_pred             CCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEe--ecCCcccccCCCcc--cccCCCccccc
Q 015222          213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI--DFGSTTFEHQDHSY--VVSTRHYRAPE  288 (411)
Q Consensus       213 ~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~--Dfg~a~~~~~~~~~--~~gt~~y~aPE  288 (411)
                      ...       .|+.+.....     +            ....+....+.++  ||+.+.........  ..-+..+.++|
T Consensus       305 ~~l-------~~v~L~~s~~-----~------------~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e  360 (1351)
T KOG1035|consen  305 LSL-------EHVVLSASSS-----K------------ESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADE  360 (1351)
T ss_pred             hcc-------ceeEEecccc-----c------------ccccCccceeecchhhhcccccCCCcccchhhcCcccccccc
Confidence            843       4444432210     0            0001223344444  77776655443322  23455688888


Q ss_pred             eecCCCCCc--cchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhh-hhhhhhhccCCccCCCCCC
Q 015222          289 VILGLGWNY--PCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRAD-RRAEKYFRRGARLDWPDGA  365 (411)
Q Consensus       289 ~~~~~~~~~--~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~-~~~~~li~~~l~~~~~~rp  365 (411)
                      ......++.  ..|+|.+|..+..+..|..+-.-.      .....        +..... ....+.+.+|+.-+    .
T Consensus       361 ~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~------~~~~~--------~l~~~~~~~~~d~~~~~~~~~----~  422 (1351)
T KOG1035|consen  361 DLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKS------AVPVS--------LLDVLSTSELLDALPKCLDED----S  422 (1351)
T ss_pred             ccccccchhhhhhHHHHHHHHHhhhhhcCcccccc------cchhh--------hhccccchhhhhhhhhhcchh----h
Confidence            887765554  479999999999998876543211      11111        111111 13456667776666    8


Q ss_pred             CcHHHHHHHHhcCCCCc
Q 015222          366 TSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       366 ~~R~t~~~il~~~~~~~  382 (411)
                      +.|.++.+++.|+++.-
T Consensus       423 ~~Rl~~~~ll~~~f~~~  439 (1351)
T KOG1035|consen  423 EERLSALELLTHPFLRF  439 (1351)
T ss_pred             hhccchhhhhhchhccc
Confidence            99999999999998763

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.73  E-value=0.00023  Score=65.53  Aligned_cols=71  Identities=13%  Similarity=0.073  Sum_probs=45.6

Q ss_pred             eeccccceEEEEEEeCCCCcEEEEEEeccchhhh-HHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC-C
Q 015222           99 KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-EAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-G  176 (411)
Q Consensus        99 ~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~-~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~-~  176 (411)
                      .+..|-.+.+|+..  .+++.+++|+........ -...+|..+++.+...++ .|.++.   ...    -++||||+ |
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~-~P~~i~---~~~----~~~v~e~i~G   72 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGL-APKPIL---VNE----HWLLVEWLEG   72 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCC-CCceEE---EeC----CEEEEEeccC
Confidence            34567778899886  446678899865432221 235779999999987665 344332   222    26899999 6


Q ss_pred             CCH
Q 015222          177 PSL  179 (411)
Q Consensus       177 ~~L  179 (411)
                      ..+
T Consensus        73 ~~~   75 (256)
T TIGR02721        73 EVI   75 (256)
T ss_pred             ccc
Confidence            544

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.44  E-value=0.00019  Score=66.44  Aligned_cols=130  Identities=20%  Similarity=0.222  Sum_probs=90.5

Q ss_pred             eEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-----------------------hhhHHHHHHHHHHHHHhcCCC
Q 015222           94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----------------------KYREAAMIEIDVLQRLARHDI  150 (411)
Q Consensus        94 y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-----------------------~~~~~~~~E~~~l~~l~~~~i  150 (411)
                      +.+.++||-|--+.||.+-+. .|.+.++|+-+...                       -.+-.+.+|...|+.|..+..
T Consensus        94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            677889999999999999764 46678888643100                       122345789999999987765


Q ss_pred             CCcceEEEeeeeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 015222          151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS  229 (411)
Q Consensus       151 ~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~  229 (411)
                      .-|   +.++    .+..|+|||++ |..|.+.-+-     .   .+..+...+..-+--|-..|+||+|..-=||+|.+
T Consensus       173 pVP---kpiD----~~RH~Vvmelv~g~Pl~~v~~v-----~---d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  173 PVP---KPID----HNRHCVVMELVDGYPLRQVRHV-----E---DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKD  237 (465)
T ss_pred             CCC---Cccc----ccceeeHHHhhcccceeeeeec-----C---ChHHHHHHHHHHHHHHHHcCceecccchheeEEec
Confidence            332   2222    35678999999 7777654322     1   22334444555556777899999999999999998


Q ss_pred             CcccccCCcc
Q 015222          230 AEYVKVPDYK  239 (411)
Q Consensus       230 ~~~~~l~df~  239 (411)
                      ++.++++||-
T Consensus       238 d~~i~vIDFP  247 (465)
T KOG2268|consen  238 DDKIVVIDFP  247 (465)
T ss_pred             CCCEEEeech
Confidence            8877777764

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.41  E-value=0.0026  Score=60.75  Aligned_cols=82  Identities=21%  Similarity=0.187  Sum_probs=51.5

Q ss_pred             eeccccceEEEEEEeCCCCcEEEEEEecc--------chhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           99 KMGEGTFGQVVECFDNEKKELVAIKIVRS--------INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        99 ~lG~G~~g~V~~a~~~~~~~~vavK~~~~--------~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      .||.|.-..||++.+..+++.|+||.-..        -....++...|...|+....- . ...+.+++.  .+.+...+
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~-~-P~~vP~vy~--~D~e~~~~   77 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEH-V-PHLVPRIFH--FDTEMAVT   77 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhcc-C-ccccCeEEE--Ecccccee
Confidence            57999999999999765446799997531        122345566788888776432 1 113344443  23456679


Q ss_pred             EEccC--CCCHHHHHH
Q 015222          171 VFEKL--GPSLYDFLR  184 (411)
Q Consensus       171 v~e~~--~~~L~~~l~  184 (411)
                      |||++  ...|.+.|.
T Consensus        78 vMEdL~~~~ilR~~Li   93 (370)
T TIGR01767        78 VMEDLSHHKIARKGLI   93 (370)
T ss_pred             hHhhCccchHHHHHHH
Confidence            99998  334545443

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02236 choline kinase

Probab=97.34  E-value=0.0034  Score=60.37  Aligned_cols=76  Identities=16%  Similarity=0.065  Sum_probs=49.1

Q ss_pred             EEeeeccccceEEEEEEeCC----CCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           96 ILSKMGEGTFGQVVECFDNE----KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        96 i~~~lG~G~~g~V~~a~~~~----~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      -+..|-.|-...+|++....    .++.|++|+........-...+|..+++.+...+++    .++++.+..+    .|
T Consensus        40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~----P~~~~~~~~g----~v  111 (344)
T PLN02236         40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQG----PRLLGRFPNG----RV  111 (344)
T ss_pred             EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCC----CceEEEECCc----eE
Confidence            34455557788999986432    346799999865433333346799999999887762    3444555332    47


Q ss_pred             EccC-CCCH
Q 015222          172 FEKL-GPSL  179 (411)
Q Consensus       172 ~e~~-~~~L  179 (411)
                      .+|+ +.+|
T Consensus       112 ~efi~g~~l  120 (344)
T PLN02236        112 EEFIHARTL  120 (344)
T ss_pred             EEeeCCCCC
Confidence            8888 5454

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.28  E-value=0.0013  Score=64.58  Aligned_cols=83  Identities=19%  Similarity=0.244  Sum_probs=56.5

Q ss_pred             ccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh--------hHHHhhhhhhhhhhccCCccCCCCCCCcH
Q 015222          297 YPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPH--------HMVIRADRRAEKYFRRGARLDWPDGATSR  368 (411)
Q Consensus       297 ~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~p~--------~~~~~~~~~~~~li~~~l~~~~~~rp~~R  368 (411)
                      +|+||||+|.++.|+..|...+......+.+..+.+.......        .+....+....++..+|+-..    |..|
T Consensus       110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~----~~ir  185 (725)
T KOG1093|consen  110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLE----PIIR  185 (725)
T ss_pred             cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccc----cccc
Confidence            5999999999999999999998877777777666654322111        122233444555556665444    8888


Q ss_pred             HHHHHHHhcCCCCcc
Q 015222          369 DSMRAVWKLLRLPVI  383 (411)
Q Consensus       369 ~t~~~il~~~~~~~~  383 (411)
                      |...+..+++-|..+
T Consensus       186 ~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  186 PLPMELSKRCSFTEV  200 (725)
T ss_pred             cchhHHhcCccHHHH
Confidence            888777777766654

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.20  E-value=0.0039  Score=60.32  Aligned_cols=83  Identities=23%  Similarity=0.237  Sum_probs=53.7

Q ss_pred             EeeeccccceEEEEEEeCCCCcEEEEEEecc----c---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRS----I---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        97 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~----~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      .+.||.|.-..||++.+...++.|+||.-..    .   ....++...|.++|+....-..  ..+.+++.+  +.+...
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P--~~VP~vy~~--D~e~~~  109 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAP--GLVPKVYLF--DSVMNC  109 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCC--CcCCeEEEE--CcHHhh
Confidence            6788999999999998854456799997531    1   2344666778889887754211  123455433  345677


Q ss_pred             EEEccC-C-CCHHHHH
Q 015222          170 IVFEKL-G-PSLYDFL  183 (411)
Q Consensus       170 lv~e~~-~-~~L~~~l  183 (411)
                      +|||++ . ..|.+.|
T Consensus       110 ~vMEdL~~~~ilR~~L  125 (409)
T PRK12396        110 CVMEDLSDHTILRTAL  125 (409)
T ss_pred             HHHHhCcccHHHHHHH
Confidence            899998 3 3444444

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.19  E-value=0.001  Score=58.08  Aligned_cols=94  Identities=21%  Similarity=0.176  Sum_probs=68.6

Q ss_pred             HHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC-CCCHHHH---HHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 015222          136 MIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDF---LRKNSYRSFPIDLVRELGRQLLESVAFMH  211 (411)
Q Consensus       136 ~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~---l~~~~~~~l~~~~~~~i~~qi~~aL~~LH  211 (411)
                      ..|.-+++.+.+..    ++.+++|++-.    ++|.||. .+++...   +...  ..-++..+.+|+.++++.+++|+
T Consensus         7 ~~E~lll~~l~~~~----~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~   76 (188)
T PF12260_consen    7 NNEPLLLQLLQGSE----PFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELD   76 (188)
T ss_pred             ccHHHHHHHcCCCC----CCCCeeeECCC----EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHh
Confidence            34777888887642    45899998843    5688998 4555421   1111  14679999999999999999999


Q ss_pred             h---CCceecCCCCCcEEEecCcccccCCcc
Q 015222          212 E---LRLIHTDLKPENILLVSAEYVKVPDYK  239 (411)
Q Consensus       212 ~---~givH~Dikp~NIli~~~~~~~l~df~  239 (411)
                      .   ..+.-.|++++|+-++++|.+|+.|..
T Consensus        77 ~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld  107 (188)
T PF12260_consen   77 HGPLGFFYLCDVSPDNFGVNDDGRLKLIDLD  107 (188)
T ss_pred             cCCCCcEEEeecchHHeEEeCCCcEEEEech
Confidence            7   348889999999999988755554443

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.19  E-value=0.0048  Score=58.98  Aligned_cols=74  Identities=12%  Similarity=0.240  Sum_probs=46.9

Q ss_pred             eeeccccceEEEEEEeCCC---CcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEcc
Q 015222           98 SKMGEGTFGQVVECFDNEK---KELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK  174 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~---~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~  174 (411)
                      +.|..|-...+|++.....   +..|++|+........-...+|..+++.+...++.    .+++.++.. +   +|.+|
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~----P~~l~~~~~-G---~i~~f   91 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFG----AKLLGVFGN-G---MIQSF   91 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCC----CceeEEeCC-c---Eeehh
Confidence            4444477778898865432   34799998865443333456799999999887773    344544432 2   47888


Q ss_pred             C-CCCH
Q 015222          175 L-GPSL  179 (411)
Q Consensus       175 ~-~~~L  179 (411)
                      + |..|
T Consensus        92 i~g~~l   97 (330)
T PLN02421         92 INARTL   97 (330)
T ss_pred             hcCCCC
Confidence            7 5443

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.15  E-value=0.0049  Score=57.29  Aligned_cols=46  Identities=24%  Similarity=0.098  Sum_probs=30.3

Q ss_pred             eccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhc
Q 015222          100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR  147 (411)
Q Consensus       100 lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~  147 (411)
                      .++|-...|+.+. ...|+.+++|.-+.. .......+|..+|+.+..
T Consensus        19 ~~~g~~~~v~~i~-~~~g~~~VlR~p~~~-~~~~~l~rE~~vL~~L~~   64 (276)
T cd05152          19 NESGLDFQVVFAK-DTDGVPWVLRIPRRP-DVSERAAAEKRVLALVRK   64 (276)
T ss_pred             cCCcceeEEEEEE-cCCCCeEEEEecCCH-HHHHHHHHHHHHHHHHHh
Confidence            3455555666653 234677889987532 234567889999999975

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.10  E-value=0.0001  Score=80.10  Aligned_cols=151  Identities=13%  Similarity=0.018  Sum_probs=106.2

Q ss_pred             HHHHHHHHHHhcCCCCCcceEEEeeeeec--CCeEEEEEccC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHH
Q 015222          136 MIEIDVLQRLARHDIGGTRCVQIRNWFDY--RNHICIVFEKL-GPSLYDFLRKNSY--RSFPIDLVRELGRQLLESVAFM  210 (411)
Q Consensus       136 ~~E~~~l~~l~~~~i~~~~iv~~~~~~~~--~~~~~lv~e~~-~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~L  210 (411)
                      ..|...++...|.++     .....-...  ....+.+++++ +|.+.+.+-+...  ..+...-+.....+.+.+..-+
T Consensus      1277 l~e~de~~~~~h~~~-----~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ 1351 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLT-----EVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVI 1351 (2724)
T ss_pred             hhhhhhhhhhhceee-----ecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchh
Confidence            344445555666654     333222221  34568999999 9999999875432  2344455555555657777777


Q ss_pred             HhC-----CceecCCCCCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC---cccccCC
Q 015222          211 HEL-----RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTR  282 (411)
Q Consensus       211 H~~-----givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~  282 (411)
                      |++     -.+|+++|+-|.+|..+.                           .++++++|+.+......   ...++++
T Consensus      1352 ls~tnlg~T~v~~~Lkf~lpmIVtny---------------------------~v~~gk~gLdKIknp~~sf~Gl~l~sp 1404 (2724)
T KOG1826|consen 1352 LSLTNLGNTNVSKSLKFTLPMIVTNY---------------------------NVKLGKGGLDKIKNPVLSFFGLELCSP 1404 (2724)
T ss_pred             hhcccCCccchhhhhhhhccceecCC---------------------------cccccccccccccCchHhhhhhhhCCH
Confidence            764     278999999999986554                           67777777777433222   3357788


Q ss_pred             CccccceecCCCCCccchhHHHHHHHHHHHhCCCCC
Q 015222          283 HYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF  318 (411)
Q Consensus       283 ~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf  318 (411)
                      .|++|++...-.++.++|||+.|+.+|++..|..+|
T Consensus      1405 ~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1405 IYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             HHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence            999999998888998899999999999998888776

>PRK10593 hypothetical protein; Provisional

Probab=97.10  E-value=0.0043  Score=58.35  Aligned_cols=106  Identities=17%  Similarity=0.138  Sum_probs=73.1

Q ss_pred             EEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCC-CCCcceEEEeeeee---cCCeEEE
Q 015222           95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD-IGGTRCVQIRNWFD---YRNHICI  170 (411)
Q Consensus        95 ~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~-i~~~~iv~~~~~~~---~~~~~~l  170 (411)
                      .-.+.||.|..+.||+..... + .+.+|+.+. ......+..|...|+.|.... +..   .++++++.   ..+..++
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpV---P~V~~~~~~~~~~g~~~L   90 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQ-G-NPMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRM---PTVYGVMTHEQSPGPDVL   90 (297)
T ss_pred             heeeecCCccceeEEEEEcCC-C-CEEEEEecc-cccchHHHHHHHHHHHHccCCCCCc---CcEEEEeccCCcCCCeEE
Confidence            345789999999999985432 3 477787543 223467889999999997643 433   44554443   3467899


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL  213 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  213 (411)
                      |||++ |.++.+.       ..+......+..+++++|.-||+.
T Consensus        91 VmE~i~G~~~~~~-------~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         91 LLERLRGVSVEAP-------ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             EEeccCCEecCCC-------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence            99999 7666541       133445567778888999999984

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.94  E-value=0.036  Score=52.87  Aligned_cols=74  Identities=16%  Similarity=0.095  Sum_probs=46.9

Q ss_pred             ccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEee--eeecCCeEEEEEccC-CC
Q 015222          103 GTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN--WFDYRNHICIVFEKL-GP  177 (411)
Q Consensus       103 G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~--~~~~~~~~~lv~e~~-~~  177 (411)
                      +.-..||+... .++..+++|+.+........+..|+..+..|....+.-+-.+..-+  ....++..+.+++++ |.
T Consensus        36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~  112 (325)
T PRK11768         36 SYENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGR  112 (325)
T ss_pred             cccceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCC
Confidence            34457888864 3456699999875444566778899999999876653211111112  123356788899998 44

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.94  E-value=0.025  Score=53.48  Aligned_cols=67  Identities=10%  Similarity=0.237  Sum_probs=42.1

Q ss_pred             EEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEee---eeecCCeEEEEEccC-CCC
Q 015222          107 QVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN---WFDYRNHICIVFEKL-GPS  178 (411)
Q Consensus       107 ~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~---~~~~~~~~~lv~e~~-~~~  178 (411)
                      .||++.. ..| .+++|++...   ......|+.++..|...++.-+.++...+   +...++..+++++++ |.+
T Consensus        11 ~v~~v~t-~~g-~~~LK~~~~~---~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~   81 (313)
T TIGR02906        11 NVYKVET-DSG-NKCLKKINYP---PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGRE   81 (313)
T ss_pred             cEEEEEe-CCC-CeEEEEcCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcC
Confidence            4888763 233 5889987532   24456688888888877764344443321   122356789999999 533

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.82  E-value=0.011  Score=55.59  Aligned_cols=77  Identities=13%  Similarity=0.039  Sum_probs=44.3

Q ss_pred             EEEeeeccccceEEEEEEeCCCCcEEEEEEec--cchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC--CeEEE
Q 015222           95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--NHICI  170 (411)
Q Consensus        95 ~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~--~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~--~~~~l  170 (411)
                      .+++.+..|....+|...+.  ++.+++..-.  ..........+|..+++.+..-.+..   ...++.+..+  +..+.
T Consensus        28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~---p~~~~~~~~~~~g~pf~  102 (321)
T COG3173          28 LIVEEISGGWSNDTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPV---PRAFGLCGEGYLGTPFY  102 (321)
T ss_pred             ceeeeccCCcccceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCC---cccccccccCCCCCceE
Confidence            34455544444455655443  6778887211  11234455677888888886644422   3344444444  37799


Q ss_pred             EEccC-C
Q 015222          171 VFEKL-G  176 (411)
Q Consensus       171 v~e~~-~  176 (411)
                      ||+++ |
T Consensus       103 v~~~veG  109 (321)
T COG3173         103 VMEWVEG  109 (321)
T ss_pred             EEEEecc
Confidence            99999 5

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.79  E-value=0.026  Score=55.03  Aligned_cols=74  Identities=16%  Similarity=0.149  Sum_probs=48.1

Q ss_pred             EEeeeccccceEEEEEEeCCCCcEEEEEEecc-----ch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRS-----IN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        96 i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-----~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ..+.||.|....||+..+.  +..|+||.-..     ..   ........|...|+.+....  ..++.+++.+..  +.
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~--p~~VPkVy~~de--d~  109 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLC--PDHVPEVYHFDR--TM  109 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcC--CCCCCeEEEECC--CC
Confidence            3678899999999999863  44589997541     11   13344555777777765321  123466666665  44


Q ss_pred             EEEEEccC
Q 015222          168 ICIVFEKL  175 (411)
Q Consensus       168 ~~lv~e~~  175 (411)
                      .+++||++
T Consensus       110 ~vlvME~L  117 (418)
T PLN02756        110 ALIGMRYL  117 (418)
T ss_pred             CEEEEeec
Confidence            67889999

>PTZ00384 choline kinase; Provisional

Probab=96.50  E-value=0.062  Score=52.36  Aligned_cols=76  Identities=20%  Similarity=0.244  Sum_probs=46.6

Q ss_pred             EEeeeccccceEEEEEEeCCCC------cEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           96 ILSKMGEGTFGQVVECFDNEKK------ELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        96 i~~~lG~G~~g~V~~a~~~~~~------~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      .++.|..|-...+|++......      +.|++++........-...+|..+++.+...+++    .++++.+..    +
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glg----P~l~~~f~~----g  125 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFG----PKIIGRFGD----F  125 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCC----CeEEEecCC----E
Confidence            3455655888899998654321      2255555432222223346699999999887762    466666643    5


Q ss_pred             EEEccC-CCCH
Q 015222          170 IVFEKL-GPSL  179 (411)
Q Consensus       170 lv~e~~-~~~L  179 (411)
                      +|.||+ |.+|
T Consensus       126 ~l~efIeGr~l  136 (383)
T PTZ00384        126 TIQEWVEGNTM  136 (383)
T ss_pred             EEEEEeccccC
Confidence            888988 5544

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.38  E-value=0.0098  Score=52.89  Aligned_cols=54  Identities=20%  Similarity=0.183  Sum_probs=35.1

Q ss_pred             CcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC-CCC
Q 015222          117 KELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPS  178 (411)
Q Consensus       117 ~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~-~~~  178 (411)
                      ++.|+||+........-....|..+++.+...+++    .++++.+..+    .|.+|+ |.+
T Consensus         2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~----p~~~~~~~~g----~v~e~i~g~~   56 (211)
T PF01633_consen    2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLG----PKIIYFFENG----RVEEFIEGRT   56 (211)
T ss_dssp             TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSS----S-EEEEETTE----EEEE--SSEE
T ss_pred             CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCC----CeEEEEcCCC----cEEEEecccc
Confidence            46789999887655566777899999999887762    4555555432    455777 444

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.07  E-value=0.043  Score=51.21  Aligned_cols=75  Identities=16%  Similarity=0.213  Sum_probs=50.1

Q ss_pred             EEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEcc
Q 015222           95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK  174 (411)
Q Consensus        95 ~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~  174 (411)
                      +-.+.++.|....+|+..  .+++.+.||+-.  ......+..|..-|+.|...+-  ..+.+++.+....+..+|||||
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~--~~vP~vi~~G~~~~~~fLlle~   93 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANP--IRVPKVIAWGEYDDDAFLLLEF   93 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTT--SBS--EEEEEE-SSCCEEEEE-
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCC--CCCCeEEEEEeecCCceEEEEe
Confidence            345678889999999886  667789999865  4445678889999999954322  3456777777766677999999


Q ss_pred             C
Q 015222          175 L  175 (411)
Q Consensus       175 ~  175 (411)
                      +
T Consensus        94 l   94 (288)
T PF03881_consen   94 L   94 (288)
T ss_dssp             -
T ss_pred             e
Confidence            8

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.04  E-value=0.027  Score=49.71  Aligned_cols=112  Identities=16%  Similarity=0.184  Sum_probs=70.3

Q ss_pred             ccceEEEEEEeCCCCcEEEEEEeccchh--hhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC-CCCH
Q 015222          103 GTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSL  179 (411)
Q Consensus       103 G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L  179 (411)
                      |+.++.-.+..+- | +..+|.+.....  ....+..+.+++.++  ++|     +++..-  ....+.++.|.| ....
T Consensus        73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~~~~~y~nky~v~Arm--hGi-----lrL~ND--n~~~yGvIlE~Cy~~~i  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCINDALYFNKYRVFARM--HGI-----LRLKND--NNYKYGVILERCYKIKI  141 (308)
T ss_pred             CCceEEEEecccc-c-hhhhhhccCCCcccchhhhhhhhhHHHHh--hhe-----eEeecC--CCceeEEEEeeccCccc
Confidence            4455555554333 3 355666654332  334567788899888  344     887743  445688999998 3221


Q ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCceecCCCCCcEEEecCcccccCCccc
Q 015222          180 YDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE--LRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       180 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                                 ..    ..++.-=+.+|.-.|+  .+.+|+|-.|+|||-+..|++|+.|.+.
T Consensus       142 -----------~~----~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  142 -----------NF----SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             -----------ch----hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence                       11    1111222467888894  4799999999999999988777766653

The function of this family is unknown.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.97  E-value=0.034  Score=53.53  Aligned_cols=61  Identities=25%  Similarity=0.367  Sum_probs=45.5

Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEecCc
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLVSAE  231 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~givH~Dikp~NIli~~~~  231 (411)
                      ..++-+|. |-++..++....   .+++..++++.--.+||--+- -.+++|.|+.|.||++.-..
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~  382 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK  382 (565)
T ss_pred             ceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence            45555677 889999988764   666777777777777765443 46899999999999996543

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.86  E-value=0.16  Score=48.39  Aligned_cols=78  Identities=19%  Similarity=0.149  Sum_probs=50.3

Q ss_pred             eeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcc-eEEEeee--eecCC--eEEEEEc
Q 015222           99 KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR-CVQIRNW--FDYRN--HICIVFE  173 (411)
Q Consensus        99 ~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~-iv~~~~~--~~~~~--~~~lv~e  173 (411)
                      .|.+ .-..||+....+ |+ +++|+.+.. .....+..|...+..|...++.-+- +...-+-  ....+  +.+-+++
T Consensus        33 ~l~s-~eN~~f~~~~~~-g~-~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~  108 (331)
T COG2334          33 GLNS-EENSNFRVQTED-GR-YILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE  108 (331)
T ss_pred             cccc-ccCceEEEEecC-CC-eEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence            4444 456788886543 33 499999887 6777888899999999887763321 1111111  11234  7888999


Q ss_pred             cC-CCCHH
Q 015222          174 KL-GPSLY  180 (411)
Q Consensus       174 ~~-~~~L~  180 (411)
                      |+ |..+.
T Consensus       109 ~l~G~~~~  116 (331)
T COG2334         109 YLPGRPLE  116 (331)
T ss_pred             ecCCcCcC
Confidence            99 65555

>PTZ00296 choline kinase; Provisional

Probab=95.82  E-value=0.11  Score=51.57  Aligned_cols=74  Identities=20%  Similarity=0.172  Sum_probs=49.1

Q ss_pred             EEeeeccccceEEEEEEeCCC--------CcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           96 ILSKMGEGTFGQVVECFDNEK--------KELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        96 i~~~lG~G~~g~V~~a~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      -++.|..|-...+|++.....        ++.|.+++........-....|..+++.+...+++    .++++.+..   
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~----P~l~~~f~g---  181 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIA----PQLLNTFSG---  181 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCC----CceEEEeCC---
Confidence            456666677778898875421        46799999865444333456799999999888773    345555532   


Q ss_pred             EEEEEccC-CC
Q 015222          168 ICIVFEKL-GP  177 (411)
Q Consensus       168 ~~lv~e~~-~~  177 (411)
                       +.|.||+ |.
T Consensus       182 -g~I~efi~g~  191 (442)
T PTZ00296        182 -GRIEEWLYGD  191 (442)
T ss_pred             -CEEEEeeCCc
Confidence             3467887 54

>PRK06148 hypothetical protein; Provisional

Probab=95.79  E-value=0.14  Score=56.33  Aligned_cols=81  Identities=16%  Similarity=0.137  Sum_probs=48.9

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcC--CCCCcceEEEee-----eeec-CC--e
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH--DIGGTRCVQIRN-----WFDY-RN--H  167 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~--~i~~~~iv~~~~-----~~~~-~~--~  167 (411)
                      +.|+ |..-.+|+... .+|..+++|+.+.. ........|...|..|...  .+.-|.++...+     .... ++  +
T Consensus        31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~-~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTT-DDGADYILKIVNPS-EPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEe-CCCCeEEEEEcCCc-cchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            4564 44567888763 45667999999754 2334555677788777653  554555554332     1111 22  5


Q ss_pred             EEEEEccC-CCCHHH
Q 015222          168 ICIVFEKL-GPSLYD  181 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~  181 (411)
                      .+.+++|+ |..+.+
T Consensus       108 ~vrLl~~l~G~~l~~  122 (1013)
T PRK06148        108 LLRLLSWLPGTPLAE  122 (1013)
T ss_pred             EEEEEeccCCCcHHh
Confidence            77889999 666654

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.70  E-value=0.17  Score=47.77  Aligned_cols=66  Identities=14%  Similarity=0.225  Sum_probs=40.1

Q ss_pred             ccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEee------eeecCCeEEEEEccC
Q 015222          103 GTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN------WFDYRNHICIVFEKL  175 (411)
Q Consensus       103 G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~------~~~~~~~~~lv~e~~  175 (411)
                      |.-+.||++.- ..| .+++|.+...   .+.+...+.++..|...++.  .++.++.      +...++..+++|+++
T Consensus        17 ~~~~~v~~v~T-~~G-~~~Lk~~~~~---~~~l~~~~~~~~~L~~~G~~--~~~~~~~t~~G~~~~~~~~~~~~L~~wi   88 (309)
T TIGR02904        17 QVTGKLFKVYT-DQG-VFALKKLYAD---RNTIESFVSQIQVLSEKGFS--RIVPVYPTKDGSYYLFHGHFLYYLMPWL   88 (309)
T ss_pred             cccCcEEEEEe-CCC-CEEEEEeccc---hHhHHHHHHHHHHHHHcCCC--cCCceeecCCCCeeeEECCEEEEEeCCc
Confidence            33568998854 344 5889988632   33445566777788766652  2233321      223356679999998

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PHA03111 Ser/Thr kinase; Provisional

Probab=95.34  E-value=0.019  Score=53.62  Aligned_cols=73  Identities=19%  Similarity=0.183  Sum_probs=45.7

Q ss_pred             HHHHHHHHHHHHHHHHHHHh----CCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCc
Q 015222          193 IDLVRELGRQLLESVAFMHE----LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST  268 (411)
Q Consensus       193 ~~~~~~i~~qi~~aL~~LH~----~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a  268 (411)
                      .+.++.++.||+.-.-..-+    ...+|-||||+||||-+........++-..-.         ..+-...+|.||.+|
T Consensus       278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~v---------F~Epi~~~LnDFDfS  348 (444)
T PHA03111        278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYV---------FNEPIKACLNDFDFS  348 (444)
T ss_pred             HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEE---------eccchhhhhcccCHH
Confidence            46678888898765433433    36999999999999977653322222211000         123447789999988


Q ss_pred             ccccCC
Q 015222          269 TFEHQD  274 (411)
Q Consensus       269 ~~~~~~  274 (411)
                      ...+-.
T Consensus       349 qv~~i~  354 (444)
T PHA03111        349 QVANII  354 (444)
T ss_pred             HHccch
Confidence            765543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	411
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		4e-81
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		6e-77
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		7e-77
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		1e-76
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-72
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		2e-71
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		1e-62
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-47
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-47
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-47
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		4e-46
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		5e-46
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		2e-45
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		4e-39
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		5e-39
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		2e-38
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		6e-32
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		6e-32
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-23
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-23
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-23
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-22
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-22
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-22
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-22
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-22
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-22
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-22
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-22
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		6e-22
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-22
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-22
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-22
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-22
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		6e-22
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-22
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-22
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		7e-22
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-22
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-22
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-22
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		7e-22
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-22
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		7e-22
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		8e-22
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		8e-22
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		8e-22
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-22
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		9e-22
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		9e-22
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-21
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-21
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-21
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-21
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-21
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		8e-21
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		8e-21
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		9e-21
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-20
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-20
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-20
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-20
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-20
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-20
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-20
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-20
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-20
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-20
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-20
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-20
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-20
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-20
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-20
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-20
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-20
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-20
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-20
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-20
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-20
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-20
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-20
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-20
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-20
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-20
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		8e-20
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-19
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-18
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-18
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-18
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-18
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-18
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-18
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		2e-18
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-18
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-18
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-18
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-18
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-18
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-18
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-18
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-18
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-18
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-18
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-18
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-18
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-18
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-18
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-18
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-18
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-18
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-18
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-18
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-18
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-18
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-18
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-18
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-18
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-18
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-18
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-18
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-18
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-18
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-18
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-18
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-18
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-18
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-18
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-18
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-18
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-18
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-18
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-18
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-18
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-18
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-18
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-18
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-18
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-18
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-18
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-18
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		7e-18
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		8e-18
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-17
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-17
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-17
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-17
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-17
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-17
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-17
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-17
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-17
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-17
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-17
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-17
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-17
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-17
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-17
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-17
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-17
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-17
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-17
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-17
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-17
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-17
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-17
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-17
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-17
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-17
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-17
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-17
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-17
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-17
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-17
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-17
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-17
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-17
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-17
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-17
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-17
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-17
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		6e-17
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-17
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		7e-17
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-17
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-17
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-17
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		9e-17
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-16
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-16
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-16
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-16
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-16
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-16
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-16
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-16
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-16
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-16
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		9e-16
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-15
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		3e-15
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-15
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-15
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-15
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-15
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-15
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-15
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-15
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-15
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		6e-15
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-15
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		7e-15
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-14
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-14
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-14
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-14
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-14
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-14
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-14
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-14
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-14
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-14
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-14
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-14
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-14
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		8e-14
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-14
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		8e-14
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		8e-14
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		8e-14
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		8e-14
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-14
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		9e-14
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		9e-14
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		9e-14
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-13
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-13
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-13
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-13
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-13
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-13
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-13
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-13
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-13
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-13
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-13
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-13
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-13
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-13
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-13
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-13
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-13
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-13
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-13
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-13
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-13
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-13
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-13
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-13
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-13
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-13
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-13
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-13
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-13
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-13
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-13
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-13
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		6e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-13
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		8e-13
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-13
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		8e-13
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		8e-13
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		8e-13
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		8e-13
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		8e-13
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		9e-13
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		9e-13
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		9e-13
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		9e-13
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		9e-13
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		9e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-12
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-12
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-12
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-12
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-12
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-12
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-12
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-12
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-12
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-12
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-12
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-12
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-12
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-12
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-12
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-12
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-12
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-12
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-12
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-12
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		7e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-12
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		7e-12
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		7e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		8e-12
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-12
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-11
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-11
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-11
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-11
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-11
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-11
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-11
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-11
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-11
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-11
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-11
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-11
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-11
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-11
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-11
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-11
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-11
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-11
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-11
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-11
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-11
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-11
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-11
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-11
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-11
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-11
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-11
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-11
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-11
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-11
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-11
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-11
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-11
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-11
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-11
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-11
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-11
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-11
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		5e-11
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-11
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-11
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-11
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-11
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-11
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		5e-11
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		6e-11
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-11
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		7e-11
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-11
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		7e-11
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-11
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		7e-11
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		8e-11
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		8e-11
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		8e-11
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-11
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		9e-11
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-11
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-10
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-10
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-10
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		1e-10
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-10
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-10
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-10
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-10
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-10
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-10
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-10
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-10
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-10
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-10
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-10
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-10
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-10
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-10
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-10
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-10
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-10
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-10
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-10
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-10
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-10
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-10
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-10
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		5e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-10
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		5e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		7e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-10
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		7e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		8e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		8e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		9e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-09
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-09
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-09
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		1e-09
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		1e-09
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-09
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-09
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-09
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-09
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-09
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-09
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-09
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-09
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-09
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-09
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-09
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		6e-09
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-09
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		6e-09
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-09
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-09
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		6e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-09
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		7e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		7e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		7e-09
3soa_A	444	Full-Length Human Camkii Length = 444		7e-09
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		8e-09
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		8e-09
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		8e-09
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-09
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		8e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		8e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		8e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		9e-09
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		9e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		9e-09
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		9e-09
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		9e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-08
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-08
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-08
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-08
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-08
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-08
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		1e-08
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-08
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-08
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-08
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-08
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-08
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-08
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-08
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-08
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-08
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-08
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-08
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-08
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-08
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-08
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-08
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-08
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-08
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-08
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-08
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-08
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-08
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		3e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-08
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-08
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-08
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-08
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-08
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-08
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-08
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-08
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		6e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		6e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		6e-08
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-08
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-08
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		7e-08
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		7e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		7e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		7e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		8e-08
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		8e-08
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		8e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		9e-08
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		9e-08
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		9e-08
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-07
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-07
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-07
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-07
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-07
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-07
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-07
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-07
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-07
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-07
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-07
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-07
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-07
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-07
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-07
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-07
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-07
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-07
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-07
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-07
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-07
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-07
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-07
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-07
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-07
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-07
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-07
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-07
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-07
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-07
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-07
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-07
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-07
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-07
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-07
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-07
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-07
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-07
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-07
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-07
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-07
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-07
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-07
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-07
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-07
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-07
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-07
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-07
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-07
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-07
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-07
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-07
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-07
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-07
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-07
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-07
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-07
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-07
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-07
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-07
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-07
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		6e-07
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-07
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-07
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		7e-07
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		7e-07
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		7e-07
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-07
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		7e-07
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		7e-07
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		7e-07
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-07
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-07
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-07
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		8e-07
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		8e-07
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-07
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-07
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-07
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-07
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		9e-07
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		9e-07
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-06
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-06
2v62_A	345	Structure Of Vaccinia-Related Kinase 2 Length = 345		1e-06
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-06
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-06
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-06
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-06
2csn_A	297	Binary Complex Of Casein Kinase-1 With Cki7 Length		2e-06
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-06
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-06
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-06
1eh4_A	298	Binary Complex Of Casein Kinase-1 From S. Pombe Wit		2e-06
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-06
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-06
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-06
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-06
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-06
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		2e-06
2c47_A	313	Structure Of Casein Kinase 1 Gamma 2 Length = 313		3e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-06
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-06
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-06
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-06
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-06
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-06
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-06
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-06
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-06
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-06
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-06
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-06
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-06
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-06
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-06
2izr_A	330	Structure Of Casein Kinase Gamma 3 In Complex With		4e-06
2chl_A	351	Structure Of Casein Kinase 1 Gamma 3 Length = 351		5e-06
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-06
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		5e-06
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-06
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		6e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		7e-06
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		7e-06
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		7e-06
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		8e-06
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		8e-06
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-06
2cmw_A	310	Structure Of Human Casein Kinase 1 Gamma-1 In Compl		9e-06
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-05
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-05
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-05
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-05
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-05
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-05
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-05
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-05
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-05
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-05
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-05
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-05
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-05
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-05
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-05
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-05
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-05
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-05
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-05
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-05
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-05
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-05
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-05
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-05
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-05
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-05
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-05
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-05
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-05
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-05
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-05
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-05
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-05
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-05
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-05
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-05
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-05
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-05
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-05
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-05
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-05
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		5e-05
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-05
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-05
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-05
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-05
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-05
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		5e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-05
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-05
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-05
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-05
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-05
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-05
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		7e-05
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		7e-05
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-05
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		8e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		8e-05
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		9e-05
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		9e-05
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-04
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-04
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-04
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-04
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-04
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-04
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-04
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-04
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-04
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-04
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-04
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-04
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-04
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-04
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-04
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-04
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-04
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-04
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-04
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-04
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-04
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-04
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-04
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-04
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-04
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-04
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-04
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-04
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-04
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-04
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-04
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-04
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-04
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-04
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-04
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-04
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		6e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		6e-04
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-04
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-04
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		7e-04
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		9e-04
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		9e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		9e-04

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score =  298 bits (763), Expect = 4e-81,   Method: Compositional matrix adjust.
 Identities = 149/306 (48%), Positives = 212/306 (69%), Gaps = 13/306 (4%)
Query: 76  DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKK-ELVAIKIVRSINKYREA 134
           DD +GH ++ +G+ L  RY I+S +GEGTFG+VV+C D+ +    VA+KI++++ KY+EA
Sbjct: 17  DDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEA 76
Query: 135 AMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
           A +EI+VL+++   D      CVQ+ +WFDY  H+CI FE LG S +DFL+ N+Y  +PI
Sbjct: 77  ARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPI 136
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
             VR +  QL ++V F+H+ +L HTDLKPENIL V+++Y    +   L +   + S    
Sbjct: 137 HQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYN---LEKKRDERSV--- 190
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
             KS+A++++DFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E   
Sbjct: 191 --KSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYV 248
Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
           G  LFQTH+N EHLAMMER+LGP+P  M+ +   R +KYF RG RLDW +  ++   +R 
Sbjct: 249 GFTLFQTHDNREHLAMMERILGPIPSRMIRKT--RKQKYFYRG-RLDWDENTSAGRYVRE 305
Query: 374 VWKLLR 379
             K LR
Sbjct: 306 NCKPLR 311

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score =  284 bits (727), Expect = 6e-77,   Method: Compositional matrix adjust.
 Identities = 139/293 (47%), Positives = 204/293 (69%), Gaps = 13/293 (4%)
Query: 76  DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEK-KELVAIKIVRSINKYREA 134
           DDK+GH V  IG+ L  RY I+  +GEGTFG+VVEC D+ + K  VA+KI+R++ KYREA
Sbjct: 35  DDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA 94
Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
           A +EI+VL+++   D      CV + +WF++  H+CI FE LG + ++FL++N+++ +P+
Sbjct: 95  ARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPL 154
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
             VR +  QL  ++ F+HE +L HTDLKPENIL V++E+  + +     +S ++ S    
Sbjct: 155 PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE---HKSCEEKSV--- 208
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
             K+++I++ DFGS TF+H+ H+ +V+TRHYR PEVIL LGW  PCD+WS+GCIL E   
Sbjct: 209 --KNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 266
Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGAT 366
           G  LFQTHEN EHL MME++LGP+P HM+ R   R +KYF +G  L W + ++
Sbjct: 267 GFTLFQTHENREHLVMMEKILGPIPSHMIHRT--RKQKYFYKGG-LVWDENSS 316

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score =  284 bits (726), Expect = 7e-77,   Method: Compositional matrix adjust.
 Identities = 139/293 (47%), Positives = 204/293 (69%), Gaps = 13/293 (4%)
Query: 76  DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEK-KELVAIKIVRSINKYREA 134
           DDK+GH V  IG+ L  RY I+  +GEGTFG+VVEC D+ + K  VA+KI+R++ KYREA
Sbjct: 12  DDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA 71
Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
           A +EI+VL+++   D      CV + +WF++  H+CI FE LG + ++FL++N+++ +P+
Sbjct: 72  ARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPL 131
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
             VR +  QL  ++ F+HE +L HTDLKPENIL V++E+  + +     +S ++ S    
Sbjct: 132 PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE---HKSCEEKSV--- 185
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
             K+++I++ DFGS TF+H+ H+ +V+TRHYR PEVIL LGW  PCD+WS+GCIL E   
Sbjct: 186 --KNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 243
Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGAT 366
           G  LFQTHEN EHL MME++LGP+P HM+ R   R +KYF +G  L W + ++
Sbjct: 244 GFTLFQTHENREHLVMMEKILGPIPSHMIHRT--RKQKYFYKGG-LVWDENSS 293

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score =  283 bits (725), Expect = 1e-76,   Method: Compositional matrix adjust.
 Identities = 139/293 (47%), Positives = 204/293 (69%), Gaps = 13/293 (4%)
Query: 76  DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEK-KELVAIKIVRSINKYREA 134
           DDK+GH V  IG+ L  RY I+  +GEGTFG+VVEC D+ + K  VA+KI+R++ KYREA
Sbjct: 3   DDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA 62
Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
           A +EI+VL+++   D      CV + +WF++  H+CI FE LG + ++FL++N+++ +P+
Sbjct: 63  ARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPL 122
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
             VR +  QL  ++ F+HE +L HTDLKPENIL V++E+  + +     +S ++ S    
Sbjct: 123 PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE---HKSCEEKSV--- 176
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
             K+++I++ DFGS TF+H+ H+ +V+TRHYR PEVIL LGW  PCD+WS+GCIL E   
Sbjct: 177 --KNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234
Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGAT 366
           G  LFQTHEN EHL MME++LGP+P HM+ R   R +KYF +G  L W + ++
Sbjct: 235 GFTLFQTHENREHLVMMEKILGPIPSHMIHRT--RKQKYFYKGG-LVWDENSS 284

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score =  270 bits (690), Expect = 1e-72,   Method: Compositional matrix adjust.
 Identities = 138/289 (47%), Positives = 194/289 (67%), Gaps = 13/289 (4%)
Query: 81  HYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKK-ELVAIKIVRSINKYREAAMIEI 139
           H +   G+ L+ RY I+  +GEG FG+VVEC D++     VA+KIV+++++Y EAA  EI
Sbjct: 3   HLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEI 62
Query: 140 DVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRE 198
            VL+ L   D   T RCVQ+  WF++  HICIVFE LG S YDF+++N +  F +D +R+
Sbjct: 63  QVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRK 122
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
           +  Q+ +SV F+H  +L HTDLKPENIL V ++Y +  + K      +D     N     
Sbjct: 123 MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI----KRDERTLIN----P 174
Query: 259 AIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
            IK++DFGS T++ + HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E   G  +F
Sbjct: 175 DIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234
Query: 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATS 367
            TH++ EHLAMMER+LGPLP HM+ +  +R  KYF    RLDW + +++
Sbjct: 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKR--KYFHHD-RLDWDEHSSA 280

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score =  266 bits (680), Expect = 2e-71,   Method: Compositional matrix adjust.
 Identities = 136/289 (47%), Positives = 192/289 (66%), Gaps = 13/289 (4%)
Query: 81  HYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKK-ELVAIKIVRSINKYREAAMIEI 139
           H +   G+ L+ RY I+  +GEG FG+VVEC D++     VA+KIV+++++Y EAA  EI
Sbjct: 3   HLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEI 62
Query: 140 DVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRE 198
            VL+ L   D   T RCVQ+  WF++  HICIVFE LG S YDF+++N +  F +D +R+
Sbjct: 63  QVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRK 122
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
           +  Q+ +SV F+H  +L HTDLKPENIL V ++Y +  + K      +D     N     
Sbjct: 123 MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI----KRDERTLIN----P 174
Query: 259 AIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
            IK++DFGS T++ + HS +V  RHYRAPEVIL LGW+ PCD+WS+GCIL+E   G  +F
Sbjct: 175 DIKVVDFGSATYDDEHHSTLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234
Query: 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATS 367
            TH++ EHLAMMER+LGPLP HM+ +  +R  KYF    RLDW + +++
Sbjct: 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKR--KYFHHD-RLDWDEHSSA 280

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score =  237 bits (604), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 130/339 (38%), Positives = 200/339 (58%), Gaps = 21/339 (6%)
Query: 73  WRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR 132
           ++ DD+  H+ +  G  L   + ++ KMG+GTFG+V+ C   + K+  A+K+VR+I KY 
Sbjct: 16  FQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT 75
Query: 133 EAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFP 192
            +A IE D+L+++   DI     V+    F Y +H+C++FE LGPSLY+ + +N+Y  F 
Sbjct: 76  RSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFH 135
Query: 193 IDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 252
           I+ ++    ++L+++ ++ ++ L HTDLKPENILL    + K        R   DG   +
Sbjct: 136 IEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSL---ITVRRVTDGKKIQ 192
Query: 253 NL-PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
               KS+ IKLIDFG  TF+   H  +++TR YRAPEVIL LGW+   D+WS GC+L EL
Sbjct: 193 IYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252
Query: 312 CSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADR-RAEKYFRRGA-RLDWPDGATSRD 369
            +G  LF+THE++EHLAMME ++ P+P +M+  A +    KY  +   +L WP+ A+S +
Sbjct: 253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSIN 312
Query: 370 SMRAVWKLLRLPVIDLYSASPNCLCKFYAITHCLLCSIL 408
           S++ V K               CL  +  I H L C  L
Sbjct: 313 SIKHVKK---------------CLPLYKIIKHELFCDFL 336

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 101/278 (36%), Positives = 157/278 (56%), Gaps = 27/278 (9%)
Query: 76  DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA 135
           DD  G YV    +++  RY +L  +G+G+FGQVV+ +D++  + VA+K+VR+  ++   A
Sbjct: 81  DDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA 140
Query: 136 MIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
             EI +L+ L + D   T   + +   F +RNHIC+ FE L  +LY+ ++KN ++ F + 
Sbjct: 141 AEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLP 200
Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254
           LVR+    +L+ +  +H+ R+IH DLKPENILL                           
Sbjct: 201 LVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQ------------------------ 236
Query: 255 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
              S IK+IDFGS+ +EHQ     + +R YRAPEVILG  +  P D+WS+GCIL EL +G
Sbjct: 237 -GRSGIKVIDFGSSCYEHQRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295
Query: 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKY 352
             L    +  + LA M  +LG +P   ++ A +RA+ +
Sbjct: 296 YPLLPGEDEGDQLACMIELLG-MPSQKLLDASKRAKNF 332

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  186 bits (473), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 101/278 (36%), Positives = 157/278 (56%), Gaps = 27/278 (9%)
Query: 76  DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA 135
           DD  G YV    +++  RY +L  +G+G+FGQVV+ +D++  + VA+K+VR+  ++   A
Sbjct: 81  DDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA 140
Query: 136 MIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
             EI +L+ L + D   T   + +   F +RNHIC+ FE L  +LY+ ++KN ++ F + 
Sbjct: 141 AEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLP 200
Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254
           LVR+    +L+ +  +H+ R+IH DLKPENILL                           
Sbjct: 201 LVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQ------------------------ 236
Query: 255 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
              S IK+IDFGS+ +EHQ     + +R YRAPEVILG  +  P D+WS+GCIL EL +G
Sbjct: 237 -GRSGIKVIDFGSSCYEHQRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295
Query: 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKY 352
             L    +  + LA M  +LG +P   ++ A +RA+ +
Sbjct: 296 YPLLPGEDEGDQLACMIELLG-MPSQKLLDASKRAKNF 332

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  186 bits (471), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 101/278 (36%), Positives = 156/278 (56%), Gaps = 27/278 (9%)
Query: 76  DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA 135
           DD  G YV    +++  RY +L  +G+G FGQVV+ +D++  + VA+K+VR+  ++   A
Sbjct: 81  DDDQGSYVQVPHDHVAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA 140
Query: 136 MIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
             EI +L+ L + D   T   + +   F +RNHIC+ FE L  +LY+ ++KN ++ F + 
Sbjct: 141 AEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLP 200
Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254
           LVR+    +L+ +  +H+ R+IH DLKPENILL                           
Sbjct: 201 LVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQ------------------------ 236
Query: 255 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
              S IK+IDFGS+ +EHQ     + +R YRAPEVILG  +  P D+WS+GCIL EL +G
Sbjct: 237 -GRSGIKVIDFGSSCYEHQRVYXXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295
Query: 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKY 352
             L    +  + LA M  +LG +P   ++ A +RA+ +
Sbjct: 296 YPLLPGEDEGDQLACMIELLG-MPXQKLLDASKRAKNF 332

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score =  182 bits (461), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 103/282 (36%), Positives = 161/282 (57%), Gaps = 34/282 (12%)
Query: 87  GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA 146
           GE    RY I S +G+G+FGQVV+ +D  ++E VAIKI+++   +   A IE+ +L+ + 
Sbjct: 49  GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMN 108
Query: 147 RHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
           +HD       V ++  F +RNH+C+VFE L  +LYD LR  ++R   ++L R+  +Q+  
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 206 SVAFMH--ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
           ++ F+   EL +IH DLKPENILL +                         PK SAIK++
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCN-------------------------PKRSAIKIV 203
Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
           DFGS+    Q     + +R YR+PEV+LG+ ++   D+WS+GCILVE+ +GE LF     
Sbjct: 204 DFGSSCQLGQRIYQXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263
Query: 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGA 365
           ++ +  +  VLG  P H++ +A  +A K+F +      PDG 
Sbjct: 264 VDQMNKIVEVLGIPPAHILDQAP-KARKFFEK-----LPDGT 299

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score =  181 bits (460), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 103/282 (36%), Positives = 161/282 (57%), Gaps = 34/282 (12%)
Query: 87  GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA 146
           GE    RY I S +G+G+FGQVV+ +D  ++E VAIKI+++   +   A IE+ +L+ + 
Sbjct: 30  GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMN 89
Query: 147 RHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
           +HD       V ++  F +RNH+C+VFE L  +LYD LR  ++R   ++L R+  +Q+  
Sbjct: 90  KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 149
Query: 206 SVAFMH--ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
           ++ F+   EL +IH DLKPENILL +                         PK SAIK++
Sbjct: 150 ALLFLATPELSIIHCDLKPENILLCN-------------------------PKRSAIKIV 184
Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
           DFGS+    Q     + +R YR+PEV+LG+ ++   D+WS+GCILVE+ +GE LF     
Sbjct: 185 DFGSSCQLGQRIYQXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 244
Query: 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGA 365
           ++ +  +  VLG  P H++ +A  +A K+F +      PDG 
Sbjct: 245 VDQMNKIVEVLGIPPAHILDQAP-KARKFFEK-----LPDGT 280

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score =  180 bits (456), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 102/282 (36%), Positives = 160/282 (56%), Gaps = 34/282 (12%)
Query: 87  GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA 146
           GE    RY I S +G+G+FGQVV+ +D  ++E VAIKI+++   +   A IE+ +L+ + 
Sbjct: 49  GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMN 108
Query: 147 RHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
           +HD       V ++  F +RNH+C+VFE L  +LYD LR  ++R   ++L R+  +Q+  
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 206 SVAFMH--ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
           ++ F+   EL +IH DLKPENILL +                         PK  AIK++
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCN-------------------------PKRXAIKIV 203
Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
           DFGS+    Q     + +R YR+PEV+LG+ ++   D+WS+GCILVE+ +GE LF     
Sbjct: 204 DFGSSCQLGQRIYQXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263
Query: 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGA 365
           ++ +  +  VLG  P H++ +A  +A K+F +      PDG 
Sbjct: 264 VDQMNKIVEVLGIPPAHILDQAP-KARKFFEK-----LPDGT 299

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score =  159 bits (401), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 95/320 (29%), Positives = 170/320 (53%), Gaps = 38/320 (11%)
Query: 75  PDD--KDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR 132
           P+D  K G+++  IG+    RY ++ K+G G F  V   +D + K+ VA+K+V+S   Y 
Sbjct: 2   PNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT 61
Query: 133 EAAMIEIDVLQRLARHDIGGTR---CVQIRNWFDYR----NHICIVFEKLGPSLYDFLRK 185
           E A+ EI +L+ +   D         VQ+ + F        HIC+VFE LG  L  ++ K
Sbjct: 62  ETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIK 121
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILL-VSAEYVK-----VPDY 238
           ++Y+  P+  V+++ +Q+L+ + ++H + R+IHTD+KPENILL V+ +Y++       ++
Sbjct: 122 SNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEW 181
Query: 239 KFLSRSSKDGSYFKNLPKSSA----------------IKLIDFGSTTFEHQDHSYVVSTR 282
           +        GS     P ++                 +K+ D G+  + H+  +  + TR
Sbjct: 182 QRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTR 241
Query: 283 HYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE------HLAMMERVLGP 336
            YR+ EV++G G+N P D+WS  C+  EL +G+ LF+ H   E      H+A++  +LG 
Sbjct: 242 QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGK 301
Query: 337 LPHHMVIRADRRAEKYFRRG 356
           +P  +++      E + ++G
Sbjct: 302 VPRKLIVAGKYSKEFFTKKG 321

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score =  158 bits (399), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 95/320 (29%), Positives = 170/320 (53%), Gaps = 38/320 (11%)
Query: 75  PDD--KDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR 132
           P+D  K G+++  IG+    RY ++ K+G G F  V   +D + K+ VA+K+V+S   Y 
Sbjct: 18  PNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT 77
Query: 133 EAAMIEIDVLQRLARHDIGGTR---CVQIRNWFDYR----NHICIVFEKLGPSLYDFLRK 185
           E A+ EI +L+ +   D         VQ+ + F        HIC+VFE LG  L  ++ K
Sbjct: 78  ETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIK 137
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILL-VSAEYVK-----VPDY 238
           ++Y+  P+  V+++ +Q+L+ + ++H + R+IHTD+KPENILL V+ +Y++       ++
Sbjct: 138 SNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEW 197
Query: 239 KFLSRSSKDGSYFKNLPKSSA----------------IKLIDFGSTTFEHQDHSYVVSTR 282
           +        GS     P ++                 +K+ D G+  + H+  +  + TR
Sbjct: 198 QRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTR 257
Query: 283 HYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE------HLAMMERVLGP 336
            YR+ EV++G G+N P D+WS  C+  EL +G+ LF+ H   E      H+A++  +LG 
Sbjct: 258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGK 317
Query: 337 LPHHMVIRADRRAEKYFRRG 356
           +P  +++      E + ++G
Sbjct: 318 VPRKLIVAGKYSKEFFTKKG 337

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 94/313 (30%), Positives = 161/313 (51%), Gaps = 34/313 (10%)
Query: 78  KDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI 137
           K G++   IG+    RY ++ K+G G F  V  C+D + K  VA+K+V+S   Y E A+ 
Sbjct: 17  KGGYHPVKIGDLFNGRYHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALD 76
Query: 138 EIDVLQRLARHDIGGTR---CVQIRNWFDYRN----HICIVFEKLGPSLYDFLRKNSYRS 190
           EI +L+ +   D         VQ+ + F        H+C+VFE LG  L  ++ K++Y+ 
Sbjct: 77  EIKLLKCVRESDPSDPNKDMVVQLIDDFKISGMNGIHVCMVFEVLGHHLLKWIIKSNYQG 136
Query: 191 FPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILL-VSAEYVK-----VPDYKFLSR 243
            P+  V+ + RQ+L+ + ++H + ++IHTD+KPENIL+ V   YV+       +++    
Sbjct: 137 LPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGA 196
Query: 244 SSKDGSYFKNLPKSSA--------------IKLIDFGSTTFEHQDHSYVVSTRHYRAPEV 289
               GS     P +                +K+ D G+  + H+  +  + TR YR+ EV
Sbjct: 197 PPPSGSAVSTAPAADLLVNPLDPRNADKIRVKIADLGNACWVHKHFTEDIQTRQYRSIEV 256
Query: 290 ILGLGWNYPCDLWSVGCILVELCSGEALFQTHE------NLEHLAMMERVLGPLPHHMVI 343
           ++G G++ P D+WS  C+  EL +G+ LF+ H       + +H+A +  +LG +P H  +
Sbjct: 257 LIGAGYSTPADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSIPRHFAL 316
Query: 344 RADRRAEKYFRRG 356
                 E + RRG
Sbjct: 317 SGKYSREFFNRRG 329

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score =  135 bits (339), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 95/312 (30%), Positives = 158/312 (50%), Gaps = 51/312 (16%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD--- 149
           RY ++ K+G G F  V    D      VA+KIVR    Y EAA  EI +LQR+   D   
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 79
Query: 150 ---IGGTRCVQIRNWFDYRN----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
              +G    +++ + F+++     H+ +VFE LG +L   ++K  +R  P+  V+++ +Q
Sbjct: 80  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 203 LLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           LL  + +MH    +IHTD+KPEN+L+   E V  P+               NL +   IK
Sbjct: 140 LLLGLDYMHRRCGIIHTDIKPENVLM---EIVDSPE---------------NLIQ---IK 178
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
           + D G+  +  + ++  + TR YR+PEV+LG  W    D+WS  C++ EL +G+ LF+  
Sbjct: 179 IADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 238
Query: 322 E------NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVW 375
           E      + +H+A +  +LG LP ++ +R  +    +F             SR  +R + 
Sbjct: 239 EGHSYTKDDDHIAQIIELLGELPSYL-LRNGKYTRTFF------------NSRGLLRNIS 285
Query: 376 KLLRLPVIDLYS 387
           KL   P+ D+ +
Sbjct: 286 KLKFWPLEDVLT 297

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score =  135 bits (339), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 95/312 (30%), Positives = 158/312 (50%), Gaps = 51/312 (16%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD--- 149
           RY ++ K+G G F  V    D      VA+KIVR    Y EAA  EI +LQR+   D   
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 79
Query: 150 ---IGGTRCVQIRNWFDYRN----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
              +G    +++ + F+++     H+ +VFE LG +L   ++K  +R  P+  V+++ +Q
Sbjct: 80  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 203 LLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           LL  + +MH    +IHTD+KPEN+L+   E V  P+               NL +   IK
Sbjct: 140 LLLGLDYMHRRCGIIHTDIKPENVLM---EIVDSPE---------------NLIQ---IK 178
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
           + D G+  +  + ++  + TR YR+PEV+LG  W    D+WS  C++ EL +G+ LF+  
Sbjct: 179 IADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 238
Query: 322 E------NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVW 375
           E      + +H+A +  +LG LP ++ +R  +    +F             SR  +R + 
Sbjct: 239 EGHSYTKDDDHIAQIIELLGELPSYL-LRNGKYTRTFF------------NSRGLLRNIS 285
Query: 376 KLLRLPVIDLYS 387
           KL   P+ D+ +
Sbjct: 286 KLKFWPLEDVLT 297

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 75/248 (30%), Positives = 125/248 (50%), Gaps = 37/248 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L DF+  ++    P+ L++    QLL+ +AF 
Sbjct: 65  -----VKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-- 268
           H  R++H DLKPEN+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 120 HSHRVLHRDLKPENLLINTEGAIKLADFG-LARA--------------------FGVPVR 158
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
           T+ H+     V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L
Sbjct: 159 TYXHE-----VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213
Query: 328 AMMERVLG 335
             + R LG
Sbjct: 214 FRIFRTLG 221

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 74/248 (29%), Positives = 125/248 (50%), Gaps = 37/248 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L DF+  ++    P+ L++    QLL+ +AF 
Sbjct: 68  -----VKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-- 268
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPVR 161
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
           T+ H+     V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L
Sbjct: 162 TYXHE-----VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 216
Query: 328 AMMERVLG 335
             + R LG
Sbjct: 217 FRIFRTLG 224

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 74/248 (29%), Positives = 125/248 (50%), Gaps = 37/248 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L DF+  ++    P+ L++    QLL+ +AF 
Sbjct: 67  -----VKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-- 268
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPVR 160
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
           T+ H+     V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L
Sbjct: 161 TYXHE-----VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 215
Query: 328 AMMERVLG 335
             + R LG
Sbjct: 216 FRIFRTLG 223

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 74/248 (29%), Positives = 124/248 (50%), Gaps = 37/248 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 68  -----VKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-- 268
           H  R++H DLKPEN+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 123 HSHRVLHRDLKPENLLINTEGAIKLADFG-LARA--------------------FGVPVR 161
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
           T+ H+     V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L
Sbjct: 162 TYXHE-----VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 216
Query: 328 AMMERVLG 335
             + R LG
Sbjct: 217 FRIFRTLG 224

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 74/248 (29%), Positives = 124/248 (50%), Gaps = 37/248 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 66  -----VKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-- 268
           H  R++H DLKPEN+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 121 HSHRVLHRDLKPENLLINTEGAIKLADFG-LARA--------------------FGVPVR 159
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
           T+ H+     V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L
Sbjct: 160 TYXHE-----VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 214
Query: 328 AMMERVLG 335
             + R LG
Sbjct: 215 FRIFRTLG 222

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 74/248 (29%), Positives = 124/248 (50%), Gaps = 37/248 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 67  -----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-- 268
           H  R++H DLKPEN+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 122 HSHRVLHRDLKPENLLINTEGAIKLADFG-LARA--------------------FGVPVR 160
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
           T+ H+     V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L
Sbjct: 161 TYXHE-----VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 215
Query: 328 AMMERVLG 335
             + R LG
Sbjct: 216 FRIFRTLG 223

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 74/248 (29%), Positives = 124/248 (50%), Gaps = 37/248 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 66  -----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-- 268
           H  R++H DLKPEN+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 121 HSHRVLHRDLKPENLLINTEGAIKLADFG-LARA--------------------FGVPVR 159
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
           T+ H+     V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L
Sbjct: 160 TYXHE-----VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 214
Query: 328 AMMERVLG 335
             + R LG
Sbjct: 215 FRIFRTLG 222

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 124/246 (50%), Gaps = 33/246 (13%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 72  -----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 127 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPV- 164
Query: 271 EHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329
             + +++ V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L  
Sbjct: 165 --RTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 222
Query: 330 MERVLG 335
           + R LG
Sbjct: 223 IFRTLG 228

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 124/246 (50%), Gaps = 33/246 (13%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 65  -----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPV- 157
Query: 271 EHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329
             + +++ V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L  
Sbjct: 158 --RTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 215
Query: 330 MERVLG 335
           + R LG
Sbjct: 216 IFRTLG 221

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 124/246 (50%), Gaps = 33/246 (13%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 72  -----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 127 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPV- 164
Query: 271 EHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329
             + +++ V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L  
Sbjct: 165 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 222
Query: 330 MERVLG 335
           + R LG
Sbjct: 223 IFRTLG 228

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 124/246 (50%), Gaps = 33/246 (13%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 66  -----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPV- 158
Query: 271 EHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329
             + +++ V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L  
Sbjct: 159 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 216
Query: 330 MERVLG 335
           + R LG
Sbjct: 217 IFRTLG 222

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 124/246 (50%), Gaps = 33/246 (13%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 65  -----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPV- 157
Query: 271 EHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329
             + +++ V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L  
Sbjct: 158 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 215
Query: 330 MERVLG 335
           + R LG
Sbjct: 216 IFRTLG 221

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 124/246 (50%), Gaps = 33/246 (13%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 65  -----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPV- 157
Query: 271 EHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329
             + +++ V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L  
Sbjct: 158 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 215
Query: 330 MERVLG 335
           + R LG
Sbjct: 216 IFRTLG 221

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 124/246 (50%), Gaps = 33/246 (13%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 64  -----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPV- 156
Query: 271 EHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329
             + +++ V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L  
Sbjct: 157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 214
Query: 330 MERVLG 335
           + R LG
Sbjct: 215 IFRTLG 220

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 124/246 (50%), Gaps = 33/246 (13%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 69  -----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 124 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPV- 161
Query: 271 EHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329
             + +++ V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L  
Sbjct: 162 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 219
Query: 330 MERVLG 335
           + R LG
Sbjct: 220 IFRTLG 225

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 124/246 (50%), Gaps = 33/246 (13%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 64  -----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPV- 156
Query: 271 EHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329
             + +++ V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L  
Sbjct: 157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 214
Query: 330 MERVLG 335
           + R LG
Sbjct: 215 IFRTLG 220

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 124/248 (50%), Gaps = 37/248 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 68  -----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-- 268
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPVR 161
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
           T+ H+     V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L
Sbjct: 162 TYXHE-----VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 216
Query: 328 AMMERVLG 335
             + R LG
Sbjct: 217 FRIFRTLG 224

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 124/248 (50%), Gaps = 37/248 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 68  -----VKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-- 268
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPVR 161
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
           T+ H+     V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L
Sbjct: 162 TYXHE-----VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 216
Query: 328 AMMERVLG 335
             + R LG
Sbjct: 217 FRIFRTLG 224

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 124/248 (50%), Gaps = 37/248 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 69  -----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-- 268
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 124 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPVR 162
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
           T+ H+     V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L
Sbjct: 163 TYXHE-----VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 217
Query: 328 AMMERVLG 335
             + R LG
Sbjct: 218 FRIFRTLG 225

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 124/248 (50%), Gaps = 37/248 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE +   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 68  -----VKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-- 268
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPVR 161
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
           T+ H+     V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L
Sbjct: 162 TYXHE-----VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 216
Query: 328 AMMERVLG 335
             + R LG
Sbjct: 217 FRIFRTLG 224

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 124/248 (50%), Gaps = 37/248 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 68  -----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-- 268
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPVR 161
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
           T+ H+     V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L
Sbjct: 162 TYXHE-----VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 216
Query: 328 AMMERVLG 335
             + R LG
Sbjct: 217 FRIFRTLG 224

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 124/248 (50%), Gaps = 37/248 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 67  -----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-- 268
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPVR 160
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
           T+ H+     V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L
Sbjct: 161 TYXHE-----VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 215
Query: 328 AMMERVLG 335
             + R LG
Sbjct: 216 FRIFRTLG 223

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 124/248 (50%), Gaps = 37/248 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 67  -----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-- 268
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPVR 160
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
           T+ H+     V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L
Sbjct: 161 TYXHE-----VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 215
Query: 328 AMMERVLG 335
             + R LG
Sbjct: 216 FRIFRTLG 223

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 124/248 (50%), Gaps = 37/248 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 64  -----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-- 268
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPVR 157
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
           T+ H+     V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L
Sbjct: 158 TYXHE-----VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212
Query: 328 AMMERVLG 335
             + R LG
Sbjct: 213 FRIFRTLG 220

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 124/248 (50%), Gaps = 37/248 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 66  -----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-- 268
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPVR 159
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
           T+ H+     V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L
Sbjct: 160 TYXHE-----VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 214
Query: 328 AMMERVLG 335
             + R LG
Sbjct: 215 FRIFRTLG 222

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 124/248 (50%), Gaps = 37/248 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 65  -----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-- 268
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPVR 158
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
           T+ H+     V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L
Sbjct: 159 TYXHE-----VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213
Query: 328 AMMERVLG 335
             + R LG
Sbjct: 214 FRIFRTLG 221

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 124/248 (50%), Gaps = 37/248 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 65  -----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-- 268
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPVR 158
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
           T+ H+     V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L
Sbjct: 159 TYXHE-----VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213
Query: 328 AMMERVLG 335
             + R LG
Sbjct: 214 FRIFRTLG 221

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 124/248 (50%), Gaps = 37/248 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 66  -----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-- 268
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPVR 159
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
           T+ H+     V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L
Sbjct: 160 TYXHE-----VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 214
Query: 328 AMMERVLG 335
             + R LG
Sbjct: 215 FRIFRTLG 222

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 124/246 (50%), Gaps = 33/246 (13%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE +   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 64  -----VKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPV- 156
Query: 271 EHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329
             + +++ V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L  
Sbjct: 157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 214
Query: 330 MERVLG 335
           + R LG
Sbjct: 215 IFRTLG 220

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 124/248 (50%), Gaps = 37/248 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 64  -----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-- 268
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPVR 157
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
           T+ H+     V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L
Sbjct: 158 TYXHE-----VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212
Query: 328 AMMERVLG 335
             + R LG
Sbjct: 213 FRIFRTLG 220

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 124/248 (50%), Gaps = 37/248 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 65  -----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-- 268
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPVR 158
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
           T+ H+     V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L
Sbjct: 159 TYXHE-----VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213
Query: 328 AMMERVLG 335
             + R LG
Sbjct: 214 FRIFRTLG 221

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 124/248 (50%), Gaps = 37/248 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 65  -----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-- 268
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPVR 158
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
           T+ H+     V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L
Sbjct: 159 TYXHE-----VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213
Query: 328 AMMERVLG 335
             + R LG
Sbjct: 214 FRIFRTLG 221

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 124/246 (50%), Gaps = 33/246 (13%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +I
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ ++F 
Sbjct: 65  -----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFC 119
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPV- 157
Query: 271 EHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329
             + +++ V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L  
Sbjct: 158 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 215
Query: 330 MERVLG 335
           + R LG
Sbjct: 216 IFRTLG 221

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 114/262 (43%), Gaps = 43/262 (16%)
Query: 83  VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEID 140
           VF +G    PRY  LS +GEG +G V   +DN  K  VAIK +       Y +  + EI 
Sbjct: 38  VFDVG----PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIK 93
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG 200
           +L R    +I G   +      +    + +V   +G  LY  L+     +   D +    
Sbjct: 94  ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSN---DHICYFL 150
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+L  + ++H   ++H DLKP N+LL +                           +  +
Sbjct: 151 YQILRGLKYIHSANVLHRDLKPSNLLLNT---------------------------TXDL 183
Query: 261 KLIDFGSTTFEHQDHSYV------VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCS 313
           K+ DFG       DH +       V+TR YRAPE++L   G+    D+WSVGCIL E+ S
Sbjct: 184 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 243
Query: 314 GEALFQTHENLEHLAMMERVLG 335
              +F     L+ L  +  +LG
Sbjct: 244 NRPIFPGKHYLDQLNHILGILG 265

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 123/246 (50%), Gaps = 33/246 (13%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+  +R           A+ EI +L+ L   +I
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 65  -----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPV- 157
Query: 271 EHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329
             + +++ V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L  
Sbjct: 158 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 215
Query: 330 MERVLG 335
           + R LG
Sbjct: 216 IFRTLG 221

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 123/246 (50%), Gaps = 33/246 (13%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           ++ + K+GEGT+G V +  +    E+VA+  +R           A+ EI +L+ L   +I
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF 
Sbjct: 64  -----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H  R++H DLKP+N+L+ +   +K+ D+  L+R+                    FG    
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFG-LARA--------------------FGVPV- 156
Query: 271 EHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329
             + +++ V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L  
Sbjct: 157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 214
Query: 330 MERVLG 335
           + R LG
Sbjct: 215 IFRTLG 220

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 114/262 (43%), Gaps = 43/262 (16%)
Query: 83  VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEID 140
           VF +G    PRY  LS +GEG +G V   +DN  K  VAIK +       Y +  + EI 
Sbjct: 22  VFDVG----PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIK 77
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG 200
           +L R    +I G   +      +    + IV + +   LY  L+     +   D +    
Sbjct: 78  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFL 134
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+L  + ++H   ++H DLKP N+LL +                           +  +
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNT---------------------------TXDL 167
Query: 261 KLIDFGSTTFEHQDHSYV------VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCS 313
           K+ DFG       DH +       V+TR YRAPE++L   G+    D+WSVGCIL E+ S
Sbjct: 168 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227
Query: 314 GEALFQTHENLEHLAMMERVLG 335
              +F     L+ L  +  +LG
Sbjct: 228 NRPIFPGKHYLDQLNHILGILG 249

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 129/259 (49%), Gaps = 35/259 (13%)
Query: 90  LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINK--YREAAMIEIDVLQRLA 146
           +  +Y  + K+GEG++G V +C + +  ++VAIK  + S +    ++ A+ EI +L++L 
Sbjct: 1   MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK 60
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
             ++     V +   F  +  + +VFE    ++   L +   R  P  LV+ +  Q L++
Sbjct: 61  HPNL-----VNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQA 114
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           V F H+   IH D+KPENIL+     +K+ D+ F    +    Y+ +             
Sbjct: 115 VNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD------------- 161
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
                       V+TR YR+PE+++G   +  P D+W++GC+  EL SG  L+    +++
Sbjct: 162 -----------EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD 210
Query: 326 HLAMMERVLGPL-PHHMVI 343
            L ++ + LG L P H  +
Sbjct: 211 QLYLIRKTLGDLIPRHQQV 229

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 114/262 (43%), Gaps = 43/262 (16%)
Query: 83  VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEID 140
           VF +G    PRY  LS +GEG +G V   +DN  K  VAIK +       Y +  + EI 
Sbjct: 18  VFDVG----PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIK 73
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG 200
           +L R    +I G   +      +    + IV + +   LY  L+     +   D +    
Sbjct: 74  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFL 130
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+L  + ++H   ++H DLKP N+LL +                           +  +
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNT---------------------------TXDL 163
Query: 261 KLIDFGSTTFEHQDHSYV------VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCS 313
           K+ DFG       DH +       V+TR YRAPE++L   G+    D+WSVGCIL E+ S
Sbjct: 164 KIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 223
Query: 314 GEALFQTHENLEHLAMMERVLG 335
              +F     L+ L  +  +LG
Sbjct: 224 NRPIFPGKHYLDQLNHILGILG 245

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 114/262 (43%), Gaps = 43/262 (16%)
Query: 83  VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEID 140
           VF +G    PRY  LS +GEG +G V   +DN  K  VAIK +       Y +  + EI 
Sbjct: 18  VFDVG----PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIK 73
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG 200
           +L R    +I G   +      +    + IV + +   LY  L+     +   D +    
Sbjct: 74  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFL 130
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+L  + ++H   ++H DLKP N+LL +                           +  +
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNT---------------------------TXDL 163
Query: 261 KLIDFGSTTFEHQDHSYV------VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCS 313
           K+ DFG       DH +       V+TR YRAPE++L   G+    D+WSVGCIL E+ S
Sbjct: 164 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 223
Query: 314 GEALFQTHENLEHLAMMERVLG 335
              +F     L+ L  +  +LG
Sbjct: 224 NRPIFPGKHYLDQLNHILGILG 245

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 117/259 (45%), Gaps = 34/259 (13%)
Query: 86  IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI------EI 139
           +G   T RY  ++++G G +G V +  D      VA+K VR  N       +      E+
Sbjct: 3   LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREV 62
Query: 140 DVLQRL-ARHDIGGTRCVQI--RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLV 196
            +L+RL A       R + +   +  D    + +VFE +   L  +L K      P + +
Sbjct: 63  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI 122
Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256
           ++L RQ L  + F+H   ++H DLKPENIL+ S   VK+ D+      ++  SY   L  
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL----ARIYSYQMAL-- 176
Query: 257 SSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 316
                              + VV T  YRAPEV+L   +  P D+WSVGCI  E+   + 
Sbjct: 177 -------------------TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217
Query: 317 LFQTHENLEHLAMMERVLG 335
           LF  +   + L  +  ++G
Sbjct: 218 LFCGNSEADQLGKIFDLIG 236

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 114/262 (43%), Gaps = 43/262 (16%)
Query: 83  VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEID 140
           VF +G    PRY  LS +GEG +G V   +DN  K  VAIK +       Y +  + EI 
Sbjct: 18  VFDVG----PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIK 73
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG 200
           +L R    +I G   +      +    + IV + +   LY  L+     +   D +    
Sbjct: 74  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFL 130
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+L  + ++H   ++H DLKP N+LL +                           +  +
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNT---------------------------TXDL 163
Query: 261 KLIDFGSTTFEHQDHSYV------VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCS 313
           K+ DFG       DH +       V+TR YRAPE++L   G+    D+WSVGCIL E+ S
Sbjct: 164 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 223
Query: 314 GEALFQTHENLEHLAMMERVLG 335
              +F     L+ L  +  +LG
Sbjct: 224 NRPIFPGKHYLDQLNHILGILG 245

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 114/262 (43%), Gaps = 43/262 (16%)
Query: 83  VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEID 140
           VF +G    PRY  LS +GEG +G V   +DN  K  VAIK +       Y +  + EI 
Sbjct: 38  VFDVG----PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIK 93
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG 200
           +L R    +I G   +      +    + IV + +   LY  L+     +   D +    
Sbjct: 94  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFL 150
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+L  + ++H   ++H DLKP N+LL +                           +  +
Sbjct: 151 YQILRGLKYIHSANVLHRDLKPSNLLLNT---------------------------TCDL 183
Query: 261 KLIDFGSTTFEHQDHSYV------VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCS 313
           K+ DFG       DH +       V+TR YRAPE++L   G+    D+WSVGCIL E+ S
Sbjct: 184 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 243
Query: 314 GEALFQTHENLEHLAMMERVLG 335
              +F     L+ L  +  +LG
Sbjct: 244 NRPIFPGKHYLDQLNHILGILG 265

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 114/262 (43%), Gaps = 43/262 (16%)
Query: 83  VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEID 140
           VF +G    PRY  LS +GEG +G V   +DN  K  VAIK +       Y +  + EI 
Sbjct: 18  VFDVG----PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIK 73
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG 200
           +L R    +I G   +      +    + IV + +   LY  L+     +   D +    
Sbjct: 74  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFL 130
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+L  + ++H   ++H DLKP N+LL +                           +  +
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNT---------------------------TCDL 163
Query: 261 KLIDFGSTTFEHQDHSYV------VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCS 313
           K+ DFG       DH +       V+TR YRAPE++L   G+    D+WSVGCIL E+ S
Sbjct: 164 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 223
Query: 314 GEALFQTHENLEHLAMMERVLG 335
              +F     L+ L  +  +LG
Sbjct: 224 NRPIFPGKHYLDQLNHILGILG 245

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 114/262 (43%), Gaps = 43/262 (16%)
Query: 83  VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEID 140
           VF +G    PRY  LS +GEG +G V   +DN  K  VAIK +       Y +  + EI 
Sbjct: 20  VFDVG----PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIK 75
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG 200
           +L R    +I G   +      +    + IV + +   LY  L+     +   D +    
Sbjct: 76  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFL 132
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+L  + ++H   ++H DLKP N+LL +                           +  +
Sbjct: 133 YQILRGLKYIHSANVLHRDLKPSNLLLNT---------------------------TCDL 165
Query: 261 KLIDFGSTTFEHQDHSYV------VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCS 313
           K+ DFG       DH +       V+TR YRAPE++L   G+    D+WSVGCIL E+ S
Sbjct: 166 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 225
Query: 314 GEALFQTHENLEHLAMMERVLG 335
              +F     L+ L  +  +LG
Sbjct: 226 NRPIFPGKHYLDQLNHILGILG 247

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 114/262 (43%), Gaps = 43/262 (16%)
Query: 83  VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEID 140
           VF +G    PRY  LS +GEG +G V   +DN  K  VAIK +       Y +  + EI 
Sbjct: 22  VFDVG----PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK 77
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG 200
           +L R    +I G   +      +    + IV + +   LY  L+     +   D +    
Sbjct: 78  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFL 134
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+L  + ++H   ++H DLKP N+LL +                           +  +
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNT---------------------------TXDL 167
Query: 261 KLIDFGSTTFEHQDHSYV------VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCS 313
           K+ DFG       DH +       V+TR YRAPE++L   G+    D+WSVGCIL E+ S
Sbjct: 168 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227
Query: 314 GEALFQTHENLEHLAMMERVLG 335
              +F     L+ L  +  +LG
Sbjct: 228 NRPIFPGKHYLDQLNHILGILG 249

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 114/262 (43%), Gaps = 43/262 (16%)
Query: 83  VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEID 140
           VF +G    PRY  LS +GEG +G V   +DN  K  VAIK +       Y +  + EI 
Sbjct: 22  VFDVG----PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK 77
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG 200
           +L R    +I G   +      +    + IV + +   LY  L+     +   D +    
Sbjct: 78  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFL 134
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+L  + ++H   ++H DLKP N+LL +                           +  +
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNT---------------------------TCDL 167
Query: 261 KLIDFGSTTFEHQDHSYV------VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCS 313
           K+ DFG       DH +       V+TR YRAPE++L   G+    D+WSVGCIL E+ S
Sbjct: 168 KICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227
Query: 314 GEALFQTHENLEHLAMMERVLG 335
              +F     L+ L  +  +LG
Sbjct: 228 NRPIFPGKHYLDQLNHILGILG 249

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 114/262 (43%), Gaps = 43/262 (16%)
Query: 83  VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEID 140
           VF +G    PRY  LS +GEG +G V   +DN  K  VAIK +       Y +  + EI 
Sbjct: 23  VFDVG----PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK 78
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG 200
           +L R    +I G   +      +    + IV + +   LY  L+     +   D +    
Sbjct: 79  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFL 135
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+L  + ++H   ++H DLKP N+LL +                           +  +
Sbjct: 136 YQILRGLKYIHSANVLHRDLKPSNLLLNT---------------------------TCDL 168
Query: 261 KLIDFGSTTFEHQDHSYV------VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCS 313
           K+ DFG       DH +       V+TR YRAPE++L   G+    D+WSVGCIL E+ S
Sbjct: 169 KICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 228
Query: 314 GEALFQTHENLEHLAMMERVLG 335
              +F     L+ L  +  +LG
Sbjct: 229 NRPIFPGKHYLDQLNHILGILG 250

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 114/262 (43%), Gaps = 43/262 (16%)
Query: 83  VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEID 140
           VF +G    PRY  LS +GEG +G V   +DN  K  VAIK +       Y +  + EI 
Sbjct: 23  VFDVG----PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK 78
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG 200
           +L R    +I G   +      +    + IV + +   LY  L+     +   D +    
Sbjct: 79  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFL 135
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+L  + ++H   ++H DLKP N+LL +                           +  +
Sbjct: 136 YQILRGLKYIHSANVLHRDLKPSNLLLNT---------------------------TCDL 168
Query: 261 KLIDFGSTTFEHQDHSYV------VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCS 313
           K+ DFG       DH +       V+TR YRAPE++L   G+    D+WSVGCIL E+ S
Sbjct: 169 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 228
Query: 314 GEALFQTHENLEHLAMMERVLG 335
              +F     L+ L  +  +LG
Sbjct: 229 NRPIFPGKHYLDQLNHILGILG 250

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 114/262 (43%), Gaps = 43/262 (16%)
Query: 83  VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEID 140
           VF +G    PRY  LS +GEG +G V   +DN  K  VAIK +       Y +  + EI 
Sbjct: 24  VFDVG----PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK 79
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG 200
           +L R    +I G   +      +    + IV + +   LY  L+     +   D +    
Sbjct: 80  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFL 136
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+L  + ++H   ++H DLKP N+LL +                           +  +
Sbjct: 137 YQILRGLKYIHSANVLHRDLKPSNLLLNT---------------------------TCDL 169
Query: 261 KLIDFGSTTFEHQDHSYV------VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCS 313
           K+ DFG       DH +       V+TR YRAPE++L   G+    D+WSVGCIL E+ S
Sbjct: 170 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 229
Query: 314 GEALFQTHENLEHLAMMERVLG 335
              +F     L+ L  +  +LG
Sbjct: 230 NRPIFPGKHYLDQLNHILGILG 251

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 114/262 (43%), Gaps = 43/262 (16%)
Query: 83  VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEID 140
           VF +G    PRY  LS +GEG +G V   +DN  K  VAIK +       Y +  + EI 
Sbjct: 15  VFDVG----PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK 70
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG 200
           +L R    +I G   +      +    + IV + +   LY  L+     +   D +    
Sbjct: 71  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFL 127
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+L  + ++H   ++H DLKP N+LL +                           +  +
Sbjct: 128 YQILRGLKYIHSANVLHRDLKPSNLLLNT---------------------------TCDL 160
Query: 261 KLIDFGSTTFEHQDHSYV------VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCS 313
           K+ DFG       DH +       V+TR YRAPE++L   G+    D+WSVGCIL E+ S
Sbjct: 161 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 220
Query: 314 GEALFQTHENLEHLAMMERVLG 335
              +F     L+ L  +  +LG
Sbjct: 221 NRPIFPGKHYLDQLNHILGILG 242

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 114/262 (43%), Gaps = 43/262 (16%)
Query: 83  VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEID 140
           VF +G    PRY  LS +GEG +G V   +DN  K  VAIK +       Y +  + EI 
Sbjct: 22  VFDVG----PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK 77
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG 200
           +L R    +I G   +      +    + IV + +   LY  L+     +   D +    
Sbjct: 78  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFL 134
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+L  + ++H   ++H DLKP N+LL +                           +  +
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNT---------------------------TCDL 167
Query: 261 KLIDFGSTTFEHQDHSYV------VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCS 313
           K+ DFG       DH +       V+TR YRAPE++L   G+    D+WSVGCIL E+ S
Sbjct: 168 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227
Query: 314 GEALFQTHENLEHLAMMERVLG 335
              +F     L+ L  +  +LG
Sbjct: 228 NRPIFPGKHYLDQLNHILGILG 249

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 114/262 (43%), Gaps = 43/262 (16%)
Query: 83  VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEID 140
           VF +G    PRY  LS +GEG +G V   +DN  K  VAIK +       Y +  + EI 
Sbjct: 20  VFDVG----PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIK 75
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG 200
           +L      +I G   +      +    + IV + +   LY  L+     +   D +    
Sbjct: 76  ILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFL 132
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+L  + ++H   ++H DLKP N+LL +                           +S +
Sbjct: 133 YQILRGLKYIHSANVLHRDLKPSNLLLNT---------------------------TSDL 165
Query: 261 KLIDFGSTTFEHQDHSYV------VSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCS 313
           K+ DFG       DH +       V+TR YRAPE++L   G+    D+WSVGCIL E+ S
Sbjct: 166 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 225
Query: 314 GEALFQTHENLEHLAMMERVLG 335
              +F     L+ L  +  +LG
Sbjct: 226 NRPIFPGKHYLDQLNHILGILG 247

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 114/262 (43%), Gaps = 43/262 (16%)
Query: 83  VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEID 140
           VF +G    PRY  LS +GEG +G V   +DN  K  VAIK +       Y +  + EI 
Sbjct: 26  VFDVG----PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIK 81
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG 200
           +L R    +I G   +      +    + IV + +   LY  L+     +   D +    
Sbjct: 82  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFL 138
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+L  + ++H   ++H DLKP N+LL +                           +  +
Sbjct: 139 YQILRGLKYIHSANVLHRDLKPSNLLLNT---------------------------TCDL 171
Query: 261 KLIDFGSTTFEHQDHSYV------VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCS 313
           K+ DFG       DH +       V+TR YRAPE++L   G+    D+WSVGCIL E+ S
Sbjct: 172 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 231
Query: 314 GEALFQTHENLEHLAMMERVLG 335
              +F     L+ L  +  +LG
Sbjct: 232 NRPIFPGKHYLDQLNHILGILG 253

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 114/262 (43%), Gaps = 43/262 (16%)
Query: 83  VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEID 140
           VF +G    PRY  LS +GEG +G V   +DN  K  VAIK +       Y +  + EI 
Sbjct: 18  VFDVG----PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIK 73
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG 200
           +L R    +I G   +      +    + IV + +   LY  L+     +   D +    
Sbjct: 74  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFL 130
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+L  + ++H   ++H DLKP N+LL +                           +  +
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNT---------------------------TCDL 163
Query: 261 KLIDFGSTTFEHQDHSYV------VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCS 313
           K+ DFG       DH +       V+TR YRAPE++L   G+    D+WSVGCIL E+ S
Sbjct: 164 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 223
Query: 314 GEALFQTHENLEHLAMMERVLG 335
              +F     L+ L  +  +LG
Sbjct: 224 NRPIFPGKHYLDQLNHILGILG 245

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 114/262 (43%), Gaps = 43/262 (16%)
Query: 83  VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEID 140
           VF +G    PRY  LS +GEG +G V   +DN  K  VAIK +       Y +  + EI 
Sbjct: 16  VFDVG----PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK 71
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG 200
           +L R    +I G   +      +    + IV + +   LY  L+     +   D +    
Sbjct: 72  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFL 128
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+L  + ++H   ++H DLKP N+LL +                           +  +
Sbjct: 129 YQILRGLKYIHSANVLHRDLKPSNLLLNT---------------------------TCDL 161
Query: 261 KLIDFGSTTFEHQDHSYV------VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCS 313
           K+ DFG       DH +       V+TR YRAPE++L   G+    D+WSVGCIL E+ S
Sbjct: 162 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 221
Query: 314 GEALFQTHENLEHLAMMERVLG 335
              +F     L+ L  +  +LG
Sbjct: 222 NRPIFPGKHYLDQLNHILGILG 243

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 113/251 (45%), Gaps = 31/251 (12%)
Query: 91  TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE---AAMIEIDVLQRL-A 146
           T RY  ++++G G +G V +  D      VA+K VR  N       + + E+ +L+RL A
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEA 62
Query: 147 RHDIGGTRCVQI--RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
                  R + +   +  D    + +VFE +   L  +L K      P + +++L RQ L
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
             + F+H   ++H DLKPENIL+ S   VK+ D+      S   + F             
Sbjct: 123 RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFP------------ 170
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
                        VV T  YRAPEV+L   +  P D+WSVGCI  E+   + LF  +   
Sbjct: 171 -------------VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 217
Query: 325 EHLAMMERVLG 335
           + L  +  ++G
Sbjct: 218 DQLGKIFDLIG 228

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 114/262 (43%), Gaps = 43/262 (16%)
Query: 83  VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEID 140
           VF +G    PRY  LS +GEG +G V   +DN  K  VAIK +       Y +  + EI 
Sbjct: 16  VFDVG----PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK 71
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG 200
           +L R    +I G   +      +    + IV + +   LY  L+     +   D +    
Sbjct: 72  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFL 128
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+L  + ++H   ++H DLKP N+LL +                           +  +
Sbjct: 129 YQILRGLKYIHSANVLHRDLKPSNLLLNT---------------------------TCDL 161
Query: 261 KLIDFGSTTFEHQDHSYV------VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCS 313
           K+ DFG       DH +       V+TR YRAPE++L   G+    D+WSVGCIL E+ S
Sbjct: 162 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 221
Query: 314 GEALFQTHENLEHLAMMERVLG 335
              +F     L+ L  +  +LG
Sbjct: 222 NRPIFPGKHYLDQLNHILGILG 243

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 114/262 (43%), Gaps = 43/262 (16%)
Query: 83  VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEID 140
           VF +G    PRY  LS +GEG +G V   +DN  K  VAIK +       Y +  + EI 
Sbjct: 22  VFDVG----PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK 77
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG 200
           +L R    +I G   +      +    + IV + +   LY  L+     +   D +    
Sbjct: 78  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSN---DHICYFL 134
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+L  + ++H   ++H DLKP N+LL +                           +  +
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNT---------------------------TCDL 167
Query: 261 KLIDFGSTTFEHQDHSYV------VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCS 313
           K+ DFG       DH +       V+TR YRAPE++L   G+    D+WSVGCIL E+ S
Sbjct: 168 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227
Query: 314 GEALFQTHENLEHLAMMERVLG 335
              +F     L+ L  +  +LG
Sbjct: 228 NRPIFPGKHYLDQLNHILGILG 249

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 114/262 (43%), Gaps = 43/262 (16%)
Query: 83  VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEID 140
           VF +G    PRY  LS +GEG +G V   +DN  K  VAI+ +       Y +  + EI 
Sbjct: 22  VFDVG----PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIK 77
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG 200
           +L R    +I G   +      +    + IV + +   LY  L+     +   D +    
Sbjct: 78  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFL 134
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+L  + ++H   ++H DLKP N+LL +                           +  +
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNT---------------------------TCDL 167
Query: 261 KLIDFGSTTFEHQDHSYV------VSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCS 313
           K+ DFG       DH +       V+TR YRAPE++L   G+    D+WSVGCIL E+ S
Sbjct: 168 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227
Query: 314 GEALFQTHENLEHLAMMERVLG 335
              +F     L+ L  +  +LG
Sbjct: 228 NRPIFPGKHYLDQLNHILGILG 249

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 116/251 (46%), Gaps = 31/251 (12%)
Query: 91  TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE---AAMIEIDVLQRL-A 146
           T RY  ++++G G +G V +  D      VA+K VR  N       + + E+ +L+RL A
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEA 62
Query: 147 RHDIGGTRCVQI--RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
                  R + +   +  D    + +VFE +   L  +L K      P + +++L RQ L
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
             + F+H   ++H DLKPENIL+ S   VK+ D+      ++  SY   L          
Sbjct: 123 RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL----ARIYSYQMAL---------- 168
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
                      + VV T  YRAPEV+L   +  P D+WSVGCI  E+   + LF  +   
Sbjct: 169 -----------APVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 217
Query: 325 EHLAMMERVLG 335
           + L  +  ++G
Sbjct: 218 DQLGKIFDLIG 228

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 118/255 (46%), Gaps = 42/255 (16%)
Query: 93  RYRILSKMGEGTFGQVVECFD-NEKKELVAIKIVR--------SINKYREAAMIEIDVLQ 143
           +Y  ++++GEG +G+V +  D       VA+K VR         ++  RE A++    L+
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH--LE 69
Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
                ++     V   +  D    + +VFE +   L  +L K      P + ++++  QL
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
           L  + F+H  R++H DLKP+NIL+ S                           S  IKL 
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTS---------------------------SGQIKLA 162
Query: 264 DFGST---TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320
           DFG     +F+    S VV T  YRAPEV+L   +  P DLWSVGCI  E+   + LF+ 
Sbjct: 163 DFGLARIYSFQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 221
Query: 321 HENLEHLAMMERVLG 335
             +++ L  +  V+G
Sbjct: 222 SSDVDQLGKILDVIG 236

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 118/255 (46%), Gaps = 42/255 (16%)
Query: 93  RYRILSKMGEGTFGQVVECFD-NEKKELVAIKIVR--------SINKYREAAMIEIDVLQ 143
           +Y  ++++GEG +G+V +  D       VA+K VR         ++  RE A++    L+
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH--LE 69
Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
                ++     V   +  D    + +VFE +   L  +L K      P + ++++  QL
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
           L  + F+H  R++H DLKP+NIL+ S                           S  IKL 
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTS---------------------------SGQIKLA 162
Query: 264 DFGST---TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320
           DFG     +F+    S VV T  YRAPEV+L   +  P DLWSVGCI  E+   + LF+ 
Sbjct: 163 DFGLARIYSFQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 221
Query: 321 HENLEHLAMMERVLG 335
             +++ L  +  V+G
Sbjct: 222 SSDVDQLGKILDVIG 236

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 118/255 (46%), Gaps = 42/255 (16%)
Query: 93  RYRILSKMGEGTFGQVVECFD-NEKKELVAIKIVR--------SINKYREAAMIEIDVLQ 143
           +Y  ++++GEG +G+V +  D       VA+K VR         ++  RE A++    L+
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH--LE 69
Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
                ++     V   +  D    + +VFE +   L  +L K      P + ++++  QL
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
           L  + F+H  R++H DLKP+NIL+ S                           S  IKL 
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTS---------------------------SGQIKLA 162
Query: 264 DFGST---TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320
           DFG     +F+    S VV T  YRAPEV+L   +  P DLWSVGCI  E+   + LF+ 
Sbjct: 163 DFGLARIYSFQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 221
Query: 321 HENLEHLAMMERVLG 335
             +++ L  +  V+G
Sbjct: 222 SSDVDQLGKILDVIG 236

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 115/251 (45%), Gaps = 31/251 (12%)
Query: 91  TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE---AAMIEIDVLQRL-A 146
           T RY  ++++G G +G V +  D      VA+K VR  N       + + E+ +L+RL A
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEA 62
Query: 147 RHDIGGTRCVQI--RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
                  R + +   +  D    + +VFE +   L  +L K      P + +++L RQ L
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
             + F+H   ++H DLKPENIL+ S   VK+ D+      ++  SY   L          
Sbjct: 123 RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL----ARIYSYQMAL---------- 168
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
                        VV T  YRAPEV+L   +  P D+WSVGCI  E+   + LF  +   
Sbjct: 169 -----------DPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 217
Query: 325 EHLAMMERVLG 335
           + L  +  ++G
Sbjct: 218 DQLGKIFDLIG 228

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 113/262 (43%), Gaps = 43/262 (16%)
Query: 83  VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEID 140
           VF +G    PRY  LS +GEG +G V   +DN  K  VAIK +       Y +  + EI 
Sbjct: 20  VFDVG----PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIK 75
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG 200
           +L      +I G   +      +    + IV + +   LY  L+     +   D +    
Sbjct: 76  ILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFL 132
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+L  + ++H   ++H DLKP N+LL +                           +  +
Sbjct: 133 YQILRGLKYIHSANVLHRDLKPSNLLLNT---------------------------TCDL 165
Query: 261 KLIDFGSTTFEHQDHSYV------VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCS 313
           K+ DFG       DH +       V+TR YRAPE++L   G+    D+WSVGCIL E+ S
Sbjct: 166 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 225
Query: 314 GEALFQTHENLEHLAMMERVLG 335
              +F     L+ L  +  +LG
Sbjct: 226 NRPIFPGKHYLDQLNHILGILG 247

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 114/256 (44%), Gaps = 39/256 (15%)
Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLA 146
           ++ PRY  L  +GEG +G V   +D+ +K  VAIK +       Y +  + EI +L R  
Sbjct: 40  DVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFR 99
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
             ++ G R +   +  +    + IV + +   LY  L+     +   D +     Q+L  
Sbjct: 100 HENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSN---DHICYFLYQILRG 156
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           + ++H   ++H DLKP N+L+ +                           +  +K+ DFG
Sbjct: 157 LKYIHSANVLHRDLKPSNLLINT---------------------------TCDLKICDFG 189
Query: 267 STTFEHQDHSYV------VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQ 319
                  +H +       V+TR YRAPE++L   G+    D+WSVGCIL E+ S   +F 
Sbjct: 190 LARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 249
Query: 320 THENLEHLAMMERVLG 335
               L+ L  +  +LG
Sbjct: 250 GKHYLDQLNHILGILG 265

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 123/252 (48%), Gaps = 36/252 (14%)
Query: 91  TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARH 148
           + +++ L K+G GT+  V +  +      VA+K V+  S       A+ EI +++ L   
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHE 63
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK----NSYRSFPIDLVRELGRQLL 204
           +I     V++ +     N + +VFE +   L  ++      N+ R   ++LV+    QLL
Sbjct: 64  NI-----VRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
           + +AF HE +++H DLKP+N+L+     +K+ D+               L ++  I +  
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDF--------------GLARAFGIPVNT 164
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHEN 323
           F S           V T  YRAP+V++G   ++   D+WS GCIL E+ +G+ LF    +
Sbjct: 165 FSSE----------VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND 214
Query: 324 LEHLAMMERVLG 335
            E L ++  ++G
Sbjct: 215 EEQLKLIFDIMG 226

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 77
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++         D V+ L  Q
Sbjct: 78  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVKSQKLTD---DHVQFLIYQ 133
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + + S +K+
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDSELKI 166
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 167 LDFGLCRHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 227 DHIDQLKLILRLVG 240

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 121/247 (48%), Gaps = 30/247 (12%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR---EAAMIEIDVLQRLARHD 149
           RYR ++K+GEGT+G+V +  D    E VAIK +R  ++       A+ E+ +L+ L   +
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRN 94
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
           I     +++++   + + + ++FE     L  ++ KN   S  + +++    QL+  V F
Sbjct: 95  I-----IELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVS--MRVIKSFLYQLINGVNF 147
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
            H  R +H DLKP+N+LL  ++  + P  K        G +   L ++  I +  F    
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKI-------GDF--GLARAFGIPIRQF---- 194
Query: 270 FEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
                 ++ + T  YR PE++LG   ++   D+WS+ CI  E+     LF     ++ L 
Sbjct: 195 ------THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF 248
Query: 329 MMERVLG 335
            +  VLG
Sbjct: 249 KIFEVLG 255

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 121/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 79
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 80  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 135
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + + S +K+
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDSELKI 168
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 169 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 228
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 229 DHIDQLKLILRLVG 242

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 124/258 (48%), Gaps = 45/258 (17%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHD 149
           +Y  L  +GEG++G V++C + +   +VAIK     +     ++ AM EI +L++L   +
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 150 IGG--TRCVQIRNW---FDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
           +      C + + W   F++ +H  +   +L P+  D+            +V++   Q++
Sbjct: 86  LVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDY-----------QVVQKYLFQII 134
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
             + F H   +IH D+KPENIL+  +  VK+ D+ F    +  G  + +           
Sbjct: 135 NGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD----------- 183
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
                         V+TR YRAPE+++G + +    D+W++GC++ E+  GE LF    +
Sbjct: 184 -------------EVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD 230
Query: 324 LEHLAMMERVLGPL-PHH 340
           ++ L  +   LG L P H
Sbjct: 231 IDQLYHIMMCLGNLIPRH 248

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 121/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 83
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 84  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 139
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + + S +K+
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDSELKI 172
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 173 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 232
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 233 DHIDQLKLILRLVG 246

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 119/254 (46%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 77
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++         D V+ L  Q
Sbjct: 78  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVKXQKLTD---DHVQFLIYQ 133
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDXELKI 166
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 167 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 227 DHIDQLKLILRLVG 240

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/320 (25%), Positives = 131/320 (40%), Gaps = 66/320 (20%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVL----- 142
           E  + +Y +   +G G+FG V E FD E  +  A+K V    +Y+   +  + VL     
Sbjct: 3   ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNI 62
Query: 143 ------------------QRLARHDIGGTRCVQIRNWF-------DYRNHICIVFEKLGP 177
                             Q    H+  G +   + N             ++ ++ E +  
Sbjct: 63  IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122
Query: 178 SLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
           +L+  L+    S RS P++L+     QL  +V F+H L + H D+KP+N+L+ S      
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS------ 176
Query: 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT--FEHQDHSYVVSTRHYRAPEVILGL 293
                               K + +KL DFGS       +     + +R YRAPE++LG 
Sbjct: 177 --------------------KDNTLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGA 216
Query: 294 GWNYPC-DLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEK 351
               P  DLWS+GC+  EL  G+ LF    +++ L  + +++G P    M+       E 
Sbjct: 217 TEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEV 276
Query: 352 YFRRGARLDW----PDGATS 367
            F      DW    P+G  S
Sbjct: 277 RFPTLKAKDWRKILPEGTPS 296

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 73
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 74  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 129
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 162
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 163 LDFGLARHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 223 DHIDQLKLILRLVG 236

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 73
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 74  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 129
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 162
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 163 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 223 DHIDQLKLILRLVG 236

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 77
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 78  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 133
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 166
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 167 LDFGLARHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 227 DHIDQLKLILRLVG 240

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 119/254 (46%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 77
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++         D V+ L  Q
Sbjct: 78  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVKXQKLTD---DHVQFLIYQ 133
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 166
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 167 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 227 DHIDQLKLILRLVG 240

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 77
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 78  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 133
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 166
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 167 LDFGLARHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 227 DHIDQLKLILRLVG 240

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 97
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 98  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 153
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 154 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 186
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 187 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 246
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 247 DHIDQLKLILRLVG 260

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 123/253 (48%), Gaps = 27/253 (10%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMI--EIDVLQRLARHD 149
           +Y ++ K+G+G +G V +  D    E+VA+K I  +     +A     EI +L  L+ H+
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 150 IGGTRCVQIRNWF--DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
                 V + N    D    + +VF+ +   L+  +R N         V     QL++ +
Sbjct: 70  ----NIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYV---VYQLIKVI 122
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
            ++H   L+H D+KP NILL +  +VKV D+  LSRS      F N+ + +    +    
Sbjct: 123 KYLHSGGLLHRDMKPSNILLNAECHVKVADFG-LSRS------FVNIRRVTNNIPLSINE 175
Query: 268 TTFEHQDHSYV----VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHE 322
            T    D   +    V+TR YRAPE++LG   +    D+WS+GCIL E+  G+ +F    
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235
Query: 323 NLEHLAMMERVLG 335
            +  L   ER++G
Sbjct: 236 TMNQL---ERIIG 245

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 42  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 96
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 97  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 152
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 153 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 185
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 186 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 245
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 246 DHIDQLKLILRLVG 259

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 83
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 84  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 139
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 172
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 173 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 232
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 233 DHIDQLKLILRLVG 246

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 77
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 78  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 133
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 166
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 167 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 227 DHIDQLKLILRLVG 240

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 28  RYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 82
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 83  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 138
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDXELKI 171
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 172 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 231
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 232 DHIDQLKLILRLVG 245

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 119/254 (46%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 73
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++         D V+ L  Q
Sbjct: 74  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVKCAKLTD---DHVQFLIYQ 129
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 162
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 163 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 223 DHIDQLKLILRLVG 236

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 82
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 83  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 138
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDXELKI 171
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 172 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 231
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 232 DHIDQLKLILRLVG 245

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 88
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 89  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 144
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 145 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDXELKI 177
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 178 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 237
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 238 DHIDQLKLILRLVG 251

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 119/254 (46%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 97
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 98  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 153
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 154 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 186
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       +    V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 187 LDFGLARHTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 246
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 247 DHIDQLKLILRLVG 260

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 77
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 78  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 133
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 166
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 167 LDFGLARHTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 227 DHIDQLKLILRLVG 240

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 77
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 78  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 133
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 166
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 167 LDFGLARHTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 227 DHIDQLKLILRLVG 240

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 73
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 74  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 129
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 162
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 163 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 223 DHIDQLKLILRLVG 236

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 74
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 75  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 130
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 131 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 163
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 164 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 223
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 224 DHIDQLKLILRLVG 237

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 79
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 80  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 135
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 168
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 169 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 228
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 229 DHIDQLKLILRLVG 242

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 21  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 75
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 76  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 131
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 132 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 164
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 165 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 224
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 225 DHIDQLKLILRLVG 238

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 89
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 90  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 145
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 146 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 178
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 179 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 238
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 239 DHIDQLKLILRLVG 252

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 82
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 83  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 138
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 171
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 172 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 231
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 232 DHIDQLKLILRLVG 245

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 89
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 90  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 145
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 146 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 178
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 179 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 238
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 239 DHIDQLKLILRLVG 252

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 74
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 75  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 130
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 131 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 163
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 164 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 223
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 224 DHIDQLKLILRLVG 237

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 77
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 78  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 133
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 166
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 167 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 227 DHIDQLKLILRLVG 240

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRE-----LRLLKH 89
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 90  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 145
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 146 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 178
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 179 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 238
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 239 DHIDQLKLILRLVG 252

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 84
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 85  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 140
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 173
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 174 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 234 DHIDQLKLILRLVG 247

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 88
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 89  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 144
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 145 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 177
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 178 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 237
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 238 DHIDQLKLILRLVG 251

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 77
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 78  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 133
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 166
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 167 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 227 DHIDQLKLILRLVG 240

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 79
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 80  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 135
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 168
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 169 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 228
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 229 DHIDQLKLILRLVG 242

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 79
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 80  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 135
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 168
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 169 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 228
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 229 DHIDQLKLILRLVG 242

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 42  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 96
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 97  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 152
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 153 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 185
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 186 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 245
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 246 DHIDQLKLILRLVG 259

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 84
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 85  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 140
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 173
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 174 LDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 234 DHIDQLKLILRLVG 247

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 100
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 101 MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 156
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 157 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 189
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 190 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 249
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 250 DHIDQLKLILRLVG 263

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 83
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 84  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 139
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 172
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 173 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 232
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 233 DHIDQLKLILRLVG 246

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 97
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 98  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 153
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 154 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 186
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 187 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 246
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 247 DHIDQLKLILRLVG 260

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 84
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 85  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 140
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 173
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 174 LDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 234 DHIDQLKLILRLVG 247

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 83
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 84  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 139
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 172
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 173 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 232
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 233 DHIDQLKLILRLVG 246

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 77
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 78  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 133
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 166
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 167 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 227 DHIDQLKLILRLVG 240

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ L+ +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 33  RYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 87
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 88  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 143
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 144 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 176
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 177 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 236
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 237 DHIDQLKLILRLVG 250

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 77
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 78  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 133
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 166
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 167 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 227 DHIDQLKLILRLVG 240

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 77
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 78  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 133
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 166
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 167 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 227 DHIDQLKLILRLVG 240

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 84
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 85  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 140
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 173
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 174 LDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 234 DHIDQLKLILRLVG 247

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 77
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 78  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 133
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 166
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 167 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 227 DHIDQLKLILRLVG 240

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 82
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 83  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 138
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 171
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 172 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 231
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 232 DHIDQLKLILRLVG 245

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 22  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 76
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 77  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 132
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 133 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 165
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 166 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 225
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 226 DHIDQLKLILRLVG 239

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 77
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 78  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 133
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 166
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 167 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 227 DHIDQLKLILRLVG 240

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 117/263 (44%), Gaps = 47/263 (17%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   +D +    +A+K        I+ +   YRE  ++      +
Sbjct: 52  RYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLL------K 105
Query: 145 LARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
             +H+  IG           +  N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 106 HMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 162
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 163 ILRGLKYIHSADIIHRDLKPSNLA---------------------------VNEDCELKI 195
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 196 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGT 255
Query: 322 ENLEHLAMMERVLGPLPHHMVIR 344
           +++  L  + R+ G  P  ++ R
Sbjct: 256 DHINQLQQIMRLTGTPPASVISR 278

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 119/254 (46%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 100
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 101 MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 156
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 157 ILRGLKYIHSADIIHRDLKPSNLA---------------------------VNEDCELKI 189
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +DFG       +    V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 190 LDFGLARHTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 249
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 250 DHIDQLKLILRLVG 263

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 120/260 (46%), Gaps = 46/260 (17%)
Query: 87  GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA 146
           GE     Y     +G G+FG V +    E  E VAIK V    +++   +     + R+ 
Sbjct: 35  GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNREL----QIMRIV 89
Query: 147 RHDIGGTRCVQIRNWF----DYRNHI--CIVFEKLGPSLYDFLRKNSY--RSFPIDLVRE 198
           +H       V ++ +F    D ++ +   +V E +  ++Y   R  +   ++ P+ L++ 
Sbjct: 90  KH----PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKL 145
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              QLL S+A++H + + H D+KP+N+LL                           P S 
Sbjct: 146 YMYQLLRSLAYIHSIGICHRDIKPQNLLLD--------------------------PPSG 179
Query: 259 AIKLIDFGSTTF--EHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGE 315
            +KLIDFGS       + +   + +R+YRAPE+I G   +    D+WS GC++ EL  G+
Sbjct: 180 VLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
Query: 316 ALFQTHENLEHLAMMERVLG 335
            LF     ++ L  + +VLG
Sbjct: 240 PLFPGESGIDQLVEIIKVLG 259

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 131/303 (43%), Gaps = 50/303 (16%)
Query: 63  GAIPRTGSPPWRPDDKDGHY---VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL 119
           G +PR      R   K G Y   V      L   Y   + +G G +G V    D    E 
Sbjct: 13  GLVPRGSMSLIR---KKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEK 69
Query: 120 VAIK-IVRSINK--YREAAMIEIDVLQRLARHDIGG-----TRCVQIRNWFDYRNHICIV 171
           VAIK + R      + + A  E+ +L+ +   ++ G     T    +RN++D        
Sbjct: 70  VAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD-------- 121
Query: 172 FEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231
           F  + P +   L+K     F  + ++ L  Q+L+ + ++H   ++H DLKP N+      
Sbjct: 122 FYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNL------ 175
Query: 232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL 291
                                 + +   +K++DFG       + +  V TR YRAPEVIL
Sbjct: 176 ---------------------AVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVIL 214
Query: 292 G-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAE 350
             + +N   D+WSVGCI+ E+ +G+ LF+  + L+ L  + +V G      V + + +A 
Sbjct: 215 SWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 274
Query: 351 KYF 353
           K +
Sbjct: 275 KSY 277

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/234 (30%), Positives = 123/234 (52%), Gaps = 43/234 (18%)
Query: 90  LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKY--REAAMIEIDVLQRL 145
            + RY+    +G+G+FG+V+ C D    +  A+K++  R + +   +E+ + E+ +L++L
Sbjct: 47  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEK-LGPSLYDFL--RKNSYRSFPIDLVRELGRQ 202
              +I     +++  +F+ + +  +V E   G  L+D +  RK   R   +D  R + RQ
Sbjct: 107 DHPNI-----MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK---RFSEVDAARII-RQ 157
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + +MH+ +++H DLKPEN+LL S               SKD +          I++
Sbjct: 158 VLSGITYMHKNKIVHRDLKPENLLLES--------------KSKDAN----------IRI 193
Query: 263 IDFG-STTFE-HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           IDFG ST FE  +     + T +Y APEV+ G  ++  CD+WS G IL  L SG
Sbjct: 194 IDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 246

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 123/254 (48%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 77
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 78  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 133
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+ +     +K+ D+ +L+R + D               
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDF-YLARHTDD--------------- 177
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
                      + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 178 -----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 227 DHIDQLKLILRLVG 240

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/234 (30%), Positives = 123/234 (52%), Gaps = 43/234 (18%)
Query: 90  LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKY--REAAMIEIDVLQRL 145
            + RY+    +G+G+FG+V+ C D    +  A+K++  R + +   +E+ + E+ +L++L
Sbjct: 48  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEK-LGPSLYDFL--RKNSYRSFPIDLVRELGRQ 202
              +I     +++  +F+ + +  +V E   G  L+D +  RK   R   +D  R + RQ
Sbjct: 108 DHPNI-----MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK---RFSEVDAARII-RQ 158
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + +MH+ +++H DLKPEN+LL S               SKD +          I++
Sbjct: 159 VLSGITYMHKNKIVHRDLKPENLLLES--------------KSKDAN----------IRI 194
Query: 263 IDFG-STTFE-HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           IDFG ST FE  +     + T +Y APEV+ G  ++  CD+WS G IL  L SG
Sbjct: 195 IDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 247

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 122/268 (45%), Gaps = 40/268 (14%)
Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRL 145
               RY I+  +G+G+FG+V++C D   ++  A+K++      NK     + E+++L++L
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
              +I     +++    +  +   IV E   G  L+D + K   + F       + +Q+ 
Sbjct: 79  DHPNI-----MKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVF 131
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
             + +MH+  ++H DLKPENILL S E                        K   IK+ID
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKE------------------------KDCDIKIID 167
Query: 265 FGSTTFEHQDHSYV--VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322
           FG +T   Q+      + T +Y APEV+ G  ++  CD+WS G IL  L SG   F    
Sbjct: 168 FGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN 226
Query: 323 NLEHLAMME--RVLGPLPHHMVIRADRR 348
             + L  +E  +    LP    I  D +
Sbjct: 227 EYDILKRVETGKYAFDLPQWRTISDDAK 254

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 122/268 (45%), Gaps = 40/268 (14%)
Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRL 145
               RY I+  +G+G+FG+V++C D   ++  A+K++      NK     + E+++L++L
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
              +I     +++    +  +   IV E   G  L+D + K   + F       + +Q+ 
Sbjct: 79  DHPNI-----MKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVF 131
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
             + +MH+  ++H DLKPENILL S E                        K   IK+ID
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKE------------------------KDCDIKIID 167
Query: 265 FGSTTFEHQDHSYV--VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322
           FG +T   Q+      + T +Y APEV+ G  ++  CD+WS G IL  L SG   F    
Sbjct: 168 FGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN 226
Query: 323 NLEHLAMME--RVLGPLPHHMVIRADRR 348
             + L  +E  +    LP    I  D +
Sbjct: 227 EYDILKRVETGKYAFDLPQWRTISDDAK 254

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 120/254 (47%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 77
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 78  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 133
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 166
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +D+G       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 167 LDYGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 227 DHIDQLKLILRLVG 240

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 120/265 (45%), Gaps = 44/265 (16%)
Query: 98  SKMGEGTFGQVVECFDNEKKELVAIK-IVRSINK--YREAAMIEIDVLQRLARHDIGG-- 152
           + +G G +G V    D    E VAIK + R      + + A  E+ +L+ +   ++ G  
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 153 ---TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
              T    +RN++D        F  + P +   L+K     F  + ++ L  Q+L+ + +
Sbjct: 90  DVFTPASSLRNFYD--------FYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKY 141
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
           +H   ++H DLKP N+                            + +   +K++DFG   
Sbjct: 142 IHSAGVVHRDLKPGNL---------------------------AVNEDCELKILDFGLAR 174
Query: 270 FEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
               + +  V TR YRAPEVIL  + +N   D+WSVGCI+ E+ +G+ LF+  + L+ L 
Sbjct: 175 HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT 234
Query: 329 MMERVLGPLPHHMVIRADRRAEKYF 353
            + +V G      V + + +A K +
Sbjct: 235 QILKVTGVPGTEFVQKLNDKAAKSY 259

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 127/250 (50%), Gaps = 39/250 (15%)
Query: 90  LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKY--REAAMIEIDVLQRL 145
            + RY+    +G+G+FG+V+ C D    +  A+K++  R + +   +E+ + E+ +L++L
Sbjct: 30  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 89
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
              +I     +++  +F+ + +  +V E   G  L+D +     R   +D  R + RQ+L
Sbjct: 90  DHPNI-----MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARII-RQVL 142
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
             + +MH+ +++H DLKPEN+LL S               SKD +          I++ID
Sbjct: 143 SGITYMHKNKIVHRDLKPENLLLES--------------KSKDAN----------IRIID 178
Query: 265 FG-STTFE-HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322
           FG ST FE  +     + T +Y APEV+ G  ++  CD+WS G IL  L SG   F    
Sbjct: 179 FGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGAN 237
Query: 323 NLEHLAMMER 332
             + L  +E+
Sbjct: 238 EYDILKKVEK 247

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 110/228 (48%), Gaps = 38/228 (16%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA-AMIEIDVLQRLARHDIGGTRCVQI 158
           +GEG+F    +C   +  +  A+KI   I+K  EA    EI  L+    H       V++
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKI---ISKRMEANTQKEITALKLCEGH----PNIVKL 71
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
              F  + H  +V E L G  L++ ++K  +  F       + R+L+ +V+ MH++ ++H
Sbjct: 72  HEVFHDQLHTFLVMELLNGGELFERIKKKKH--FSETEASYIMRKLVSAVSHMHDVGVVH 129
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
            DLKPEN+L                        F +   +  IK+IDFG    +  D+  
Sbjct: 130 RDLKPENLL------------------------FTDENDNLEIKIIDFGFARLKPPDNQP 165
Query: 278 VVS---TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322
           + +   T HY APE++   G++  CDLWS+G IL  + SG+  FQ+H+
Sbjct: 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 117/250 (46%), Gaps = 37/250 (14%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR------SINKYREAAMIEIDVLQRLA 146
           RY  L  +GEG F  V +  D    ++VAIK ++      + +     A+ EI +LQ L+
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
             +I G     + + F ++++I +VF+ +   L   ++ NS    P   ++      L+ 
Sbjct: 71  HPNIIG-----LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTP-SHIKAYMLMTLQG 124
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           + ++H+  ++H DLKP N+LL     +K+ D+               L KS       FG
Sbjct: 125 LEYLHQHWILHRDLKPNNLLLDENGVLKLADF--------------GLAKS-------FG 163
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
           S    ++ + + V TR YRAPE++ G   +    D+W+VGCIL EL           +L+
Sbjct: 164 SP---NRAYXHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD 220
Query: 326 HLAMMERVLG 335
            L  +   LG
Sbjct: 221 QLTRIFETLG 230

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 121/232 (52%), Gaps = 39/232 (16%)
Query: 90  LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKY--REAAMIEIDVLQRL 145
            + RY+    +G+G+FG+V+ C D    +  A+K++  R + +   +E+ + E+ +L++L
Sbjct: 24  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
              +I     +++  +F+ + +  +V E   G  L+D +     R   +D  R + RQ+L
Sbjct: 84  DHPNI-----MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAAR-IIRQVL 136
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
             + +MH+ +++H DLKPEN+LL S               SKD +          I++ID
Sbjct: 137 SGITYMHKNKIVHRDLKPENLLLES--------------KSKDAN----------IRIID 172
Query: 265 FG-STTFE-HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           FG ST FE  +     + T +Y APEV+ G  ++  CD+WS G IL  L SG
Sbjct: 173 FGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 223

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 117/247 (47%), Gaps = 45/247 (18%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159
           +G G+FG V +    +  ELVAIK V    +++     E+ ++++L   +I     V++R
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHCNI-----VRLR 113
Query: 160 NWFDYRN------HICIVFEKLGPSLYDFLR--KNSYRSFPIDLVRELGRQLLESVAFMH 211
            +F          ++ +V + +  ++Y   R    + ++ P+  V+    QL  S+A++H
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT-- 269
              + H D+KP+N+LL                           P ++ +KL DFGS    
Sbjct: 174 SFGICHRDIKPQNLLLD--------------------------PDTAVLKLCDFGSAKQL 207
Query: 270 FEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
              + +   + +R+YRAPE+I G   +    D+WS GC+L EL  G+ +F     ++ L 
Sbjct: 208 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 329 MMERVLG 335
            + +VLG
Sbjct: 268 EIIKVLG 274

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 117/247 (47%), Gaps = 45/247 (18%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159
           +G G+FG V +    +  ELVAIK V    +++     E+ ++++L   +I     V++R
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHCNI-----VRLR 117
Query: 160 NWFDYRN------HICIVFEKLGPSLYDFLR--KNSYRSFPIDLVRELGRQLLESVAFMH 211
            +F          ++ +V + +  ++Y   R    + ++ P+  V+    QL  S+A++H
Sbjct: 118 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 177
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT-- 269
              + H D+KP+N+LL                           P ++ +KL DFGS    
Sbjct: 178 SFGICHRDIKPQNLLLD--------------------------PDTAVLKLCDFGSAKQL 211
Query: 270 FEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
              + +   + +R+YRAPE+I G   +    D+WS GC+L EL  G+ +F     ++ L 
Sbjct: 212 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 271
Query: 329 MMERVLG 335
            + +VLG
Sbjct: 272 EIIKVLG 278

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 118/248 (47%), Gaps = 47/248 (18%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159
           +G G+FG V +    +  ELVAIK V    +++     E+ ++++L   +I     V++R
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHCNI-----VRLR 113
Query: 160 NWFDYRN------HICIVFEKLGPSLYDFLR--KNSYRSFPIDLVRELGRQLLESVAFMH 211
            +F          ++ +V + +  ++Y   R    + ++ P+  V+    QL  S+A++H
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST--- 268
              + H D+KP+N+LL                           P ++ +KL DFGS    
Sbjct: 174 SFGICHRDIKPQNLLLD--------------------------PDTAVLKLCDFGSAKQL 207
Query: 269 TFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
                + SY+ S R+YRAPE+I G   +    D+WS GC+L EL  G+ +F     ++ L
Sbjct: 208 VRGEPNVSYICS-RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 266
Query: 328 AMMERVLG 335
             + +VLG
Sbjct: 267 VEIIKVLG 274

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 118/248 (47%), Gaps = 47/248 (18%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159
           +G G+FG V +    +  ELVAIK V    +++     E+ ++++L   +I     V++R
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHCNI-----VRLR 115
Query: 160 NWFDYRN------HICIVFEKLGPSLYDFLR--KNSYRSFPIDLVRELGRQLLESVAFMH 211
            +F          ++ +V + +  ++Y   R    + ++ P+  V+    QL  S+A++H
Sbjct: 116 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 175
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST--- 268
              + H D+KP+N+LL                           P ++ +KL DFGS    
Sbjct: 176 SFGICHRDIKPQNLLLD--------------------------PDTAVLKLCDFGSAKQL 209
Query: 269 TFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
                + SY+ S R+YRAPE+I G   +    D+WS GC+L EL  G+ +F     ++ L
Sbjct: 210 VRGEPNVSYICS-RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 268
Query: 328 AMMERVLG 335
             + +VLG
Sbjct: 269 VEIIKVLG 276

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 118/248 (47%), Gaps = 47/248 (18%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159
           +G G+FG V +    +  ELVAIK V    +++     E+ ++++L   +I     V++R
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHCNI-----VRLR 107
Query: 160 NWFDYRN------HICIVFEKLGPSLYDFLR--KNSYRSFPIDLVRELGRQLLESVAFMH 211
            +F          ++ +V + +  ++Y   R    + ++ P+  V+    QL  S+A++H
Sbjct: 108 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 167
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST--- 268
              + H D+KP+N+LL                           P ++ +KL DFGS    
Sbjct: 168 SFGICHRDIKPQNLLLD--------------------------PDTAVLKLCDFGSAKQL 201
Query: 269 TFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
                + SY+ S R+YRAPE+I G   +    D+WS GC+L EL  G+ +F     ++ L
Sbjct: 202 VRGEPNVSYICS-RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 260
Query: 328 AMMERVLG 335
             + +VLG
Sbjct: 261 VEIIKVLG 268

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 117/247 (47%), Gaps = 45/247 (18%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159
           +G G+FG V +    +  ELVAIK V    +++     E+ ++++L   +I     V++R
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHCNI-----VRLR 83
Query: 160 NWFDYRN------HICIVFEKLGPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMH 211
            +F          ++ +V + +  ++Y   R  S   ++ P+  V+    QL  S+A++H
Sbjct: 84  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 143
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT-- 269
              + H D+KP+N+LL                           P ++ +KL DFGS    
Sbjct: 144 SFGICHRDIKPQNLLLD--------------------------PDTAVLKLCDFGSAKQL 177
Query: 270 FEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
              + +   + +R+YRAPE+I G   +    D+WS GC+L EL  G+ +F     ++ L 
Sbjct: 178 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 237
Query: 329 MMERVLG 335
            + +VLG
Sbjct: 238 EIIKVLG 244

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 117/247 (47%), Gaps = 45/247 (18%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159
           +G G+FG V +    +  ELVAIK V    +++     E+ ++++L   +I     V++R
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHCNI-----VRLR 98
Query: 160 NWFDYRN------HICIVFEKLGPSLYDFLR--KNSYRSFPIDLVRELGRQLLESVAFMH 211
            +F          ++ +V + +  ++Y   R    + ++ P+  V+    QL  S+A++H
Sbjct: 99  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 158
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT-- 269
              + H D+KP+N+LL                           P ++ +KL DFGS    
Sbjct: 159 SFGICHRDIKPQNLLLD--------------------------PDTAVLKLCDFGSAKQL 192
Query: 270 FEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
              + +   + +R+YRAPE+I G   +    D+WS GC+L EL  G+ +F     ++ L 
Sbjct: 193 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 252
Query: 329 MMERVLG 335
            + +VLG
Sbjct: 253 EIIKVLG 259

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 117/247 (47%), Gaps = 45/247 (18%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159
           +G G+FG V +    +  ELVAIK V    +++     E+ ++++L   +I     V++R
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHCNI-----VRLR 91
Query: 160 NWFDYRN------HICIVFEKLGPSLYDFLR--KNSYRSFPIDLVRELGRQLLESVAFMH 211
            +F          ++ +V + +  ++Y   R    + ++ P+  V+    QL  S+A++H
Sbjct: 92  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 151
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT-- 269
              + H D+KP+N+LL                           P ++ +KL DFGS    
Sbjct: 152 SFGICHRDIKPQNLLLD--------------------------PDTAVLKLCDFGSAKQL 185
Query: 270 FEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
              + +   + +R+YRAPE+I G   +    D+WS GC+L EL  G+ +F     ++ L 
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 329 MMERVLG 335
            + +VLG
Sbjct: 246 EIIKVLG 252

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 117/247 (47%), Gaps = 45/247 (18%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159
           +G G+FG V +    +  ELVAIK V    +++     E+ ++++L   +I     V++R
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHCNI-----VRLR 91
Query: 160 NWFDYRN------HICIVFEKLGPSLYDFLR--KNSYRSFPIDLVRELGRQLLESVAFMH 211
            +F          ++ +V + +  ++Y   R    + ++ P+  V+    QL  S+A++H
Sbjct: 92  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 151
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT-- 269
              + H D+KP+N+LL                           P ++ +KL DFGS    
Sbjct: 152 SFGICHRDIKPQNLLLD--------------------------PDTAVLKLCDFGSAKQL 185
Query: 270 FEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
              + +   + +R+YRAPE+I G   +    D+WS GC+L EL  G+ +F     ++ L 
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 329 MMERVLG 335
            + +VLG
Sbjct: 246 EIIKVLG 252

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 118/248 (47%), Gaps = 47/248 (18%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159
           +G G+FG V +    +  ELVAIK V    +++     E+ ++++L   +I     V++R
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHCNI-----VRLR 158
Query: 160 NWFDYRN------HICIVFEKLGPSLYDFLR--KNSYRSFPIDLVRELGRQLLESVAFMH 211
            +F          ++ +V + +  ++Y   R    + ++ P+  V+    QL  S+A++H
Sbjct: 159 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 218
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST--- 268
              + H D+KP+N+LL                           P ++ +KL DFGS    
Sbjct: 219 SFGICHRDIKPQNLLLD--------------------------PDTAVLKLCDFGSAKQL 252
Query: 269 TFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
                + SY+ S R+YRAPE+I G   +    D+WS GC+L EL  G+ +F     ++ L
Sbjct: 253 VRGEPNVSYICS-RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 311
Query: 328 AMMERVLG 335
             + +VLG
Sbjct: 312 VEIIKVLG 319

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 117/247 (47%), Gaps = 45/247 (18%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159
           +G G+FG V +    +  ELVAIK V    +++     E+ ++++L   +I     V++R
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHCNI-----VRLR 87
Query: 160 NWFDYRN------HICIVFEKLGPSLYDFLR--KNSYRSFPIDLVRELGRQLLESVAFMH 211
            +F          ++ +V + +  ++Y   R    + ++ P+  V+    QL  S+A++H
Sbjct: 88  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 147
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT-- 269
              + H D+KP+N+LL                           P ++ +KL DFGS    
Sbjct: 148 SFGICHRDIKPQNLLLD--------------------------PDTAVLKLCDFGSAKQL 181
Query: 270 FEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
              + +   + +R+YRAPE+I G   +    D+WS GC+L EL  G+ +F     ++ L 
Sbjct: 182 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 241
Query: 329 MMERVLG 335
            + +VLG
Sbjct: 242 EIIKVLG 248

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 118/248 (47%), Gaps = 47/248 (18%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159
           +G G+FG V +    +  ELVAIK V    +++     E+ ++++L   +I     V++R
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHCNI-----VRLR 84
Query: 160 NWFDYRN------HICIVFEKLGPSLYDFLR--KNSYRSFPIDLVRELGRQLLESVAFMH 211
            +F          ++ +V + +  ++Y   R    + ++ P+  V+    QL  S+A++H
Sbjct: 85  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 144
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST--- 268
              + H D+KP+N+LL                           P ++ +KL DFGS    
Sbjct: 145 SFGICHRDIKPQNLLLD--------------------------PDTAVLKLCDFGSAKQL 178
Query: 269 TFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
                + SY+ S R+YRAPE+I G   +    D+WS GC+L EL  G+ +F     ++ L
Sbjct: 179 VRGEPNVSYICS-RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 237
Query: 328 AMMERVLG 335
             + +VLG
Sbjct: 238 VEIIKVLG 245

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 117/247 (47%), Gaps = 45/247 (18%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159
           +G G+FG V +    +  ELVAIK V    +++     E+ ++++L   +I     V++R
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHCNI-----VRLR 79
Query: 160 NWFDYRN------HICIVFEKLGPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMH 211
            +F          ++ +V + +  ++Y   R  S   ++ P+  V+    QL  S+A++H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT-- 269
              + H D+KP+N+LL                           P ++ +KL DFGS    
Sbjct: 140 SFGICHRDIKPQNLLLD--------------------------PDTAVLKLCDFGSAKQL 173
Query: 270 FEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
              + +   + +R+YRAPE+I G   +    D+WS GC+L EL  G+ +F     ++ L 
Sbjct: 174 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 329 MMERVLG 335
            + +VLG
Sbjct: 234 EIIKVLG 240

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 117/247 (47%), Gaps = 45/247 (18%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159
           +G G+FG V +    +  ELVAIK V    +++     E+ ++++L   +I     V++R
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHCNI-----VRLR 79
Query: 160 NWFDYRN------HICIVFEKLGPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMH 211
            +F          ++ +V + +  ++Y   R  S   ++ P+  V+    QL  S+A++H
Sbjct: 80  YFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT-- 269
              + H D+KP+N+LL                           P ++ +KL DFGS    
Sbjct: 140 SFGICHRDIKPQNLLLD--------------------------PDTAVLKLCDFGSAKQL 173
Query: 270 FEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
              + +   + +R+YRAPE+I G   +    D+WS GC+L EL  G+ +F     ++ L 
Sbjct: 174 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 329 MMERVLG 335
            + +VLG
Sbjct: 234 EIIKVLG 240

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 117/247 (47%), Gaps = 45/247 (18%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159
           +G G+FG V +    +  ELVAIK V    +++     E+ ++++L   +I     V++R
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHCNI-----VRLR 92
Query: 160 NWFDYRN------HICIVFEKLGPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMH 211
            +F          ++ +V + +  ++Y   R  S   ++ P+  V+    QL  S+A++H
Sbjct: 93  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 152
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT-- 269
              + H D+KP+N+LL                           P ++ +KL DFGS    
Sbjct: 153 SFGICHRDIKPQNLLLD--------------------------PDTAVLKLCDFGSAKQL 186
Query: 270 FEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
              + +   + +R+YRAPE+I G   +    D+WS GC+L EL  G+ +F     ++ L 
Sbjct: 187 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 246
Query: 329 MMERVLG 335
            + +VLG
Sbjct: 247 EIIKVLG 253

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 117/247 (47%), Gaps = 45/247 (18%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159
           +G G+FG V +    +  ELVAIK V    +++     E+ ++++L   +I     V++R
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHCNI-----VRLR 80
Query: 160 NWFDYRN------HICIVFEKLGPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMH 211
            +F          ++ +V + +  ++Y   R  S   ++ P+  V+    QL  S+A++H
Sbjct: 81  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 140
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT-- 269
              + H D+KP+N+LL                           P ++ +KL DFGS    
Sbjct: 141 SFGICHRDIKPQNLLLD--------------------------PDTAVLKLCDFGSAKQL 174
Query: 270 FEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
              + +   + +R+YRAPE+I G   +    D+WS GC+L EL  G+ +F     ++ L 
Sbjct: 175 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 234
Query: 329 MMERVLG 335
            + +VLG
Sbjct: 235 EIIKVLG 241

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 117/247 (47%), Gaps = 45/247 (18%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159
           +G G+FG V +    +  ELVAIK V    +++     E+ ++++L   +I     V++R
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHCNI-----VRLR 79
Query: 160 NWFDYRN------HICIVFEKLGPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMH 211
            +F          ++ +V + +  ++Y   R  S   ++ P+  V+    QL  S+A++H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT-- 269
              + H D+KP+N+LL                           P ++ +KL DFGS    
Sbjct: 140 SFGICHRDIKPQNLLLD--------------------------PDTAVLKLCDFGSAKQL 173
Query: 270 FEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
              + +   + +R+YRAPE+I G   +    D+WS GC+L EL  G+ +F     ++ L 
Sbjct: 174 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 329 MMERVLG 335
            + +VLG
Sbjct: 234 EIIKVLG 240

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 117/247 (47%), Gaps = 45/247 (18%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159
           +G G+FG V +    +  ELVAIK V    +++     E+ ++++L   +I     V++R
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHCNI-----VRLR 79
Query: 160 NWFDYRN------HICIVFEKLGPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMH 211
            +F          ++ +V + +  ++Y   R  S   ++ P+  V+    QL  S+A++H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT-- 269
              + H D+KP+N+LL                           P ++ +KL DFGS    
Sbjct: 140 SFGICHRDIKPQNLLLD--------------------------PDTAVLKLCDFGSAKQL 173
Query: 270 FEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
              + +   + +R+YRAPE+I G   +    D+WS GC+L EL  G+ +F     ++ L 
Sbjct: 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 329 MMERVLG 335
            + +VLG
Sbjct: 234 EIIKVLG 240

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 38/232 (16%)
Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRL 145
               RY I+  +G+G+FG+V++C D   ++  A+K++      NK     + E+++L++L
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
              +I     +++    +  +   IV E   G  L+D + K   + F       + +Q+ 
Sbjct: 79  DHPNI-----MKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVF 131
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
             + +MH+  ++H DLKPENILL S E                        K   IK+ID
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKE------------------------KDCDIKIID 167
Query: 265 FGSTTFEHQDHSYV--VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           FG +T   Q+      + T +Y APEV+ G  ++  CD+WS G IL  L SG
Sbjct: 168 FGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSG 218

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 116/247 (46%), Gaps = 45/247 (18%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159
           +G G+FG V +    +  ELVAIK V     ++     E+ ++++L   +I     V++R
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR---ELQIMRKLDHCNI-----VRLR 79
Query: 160 NWFDYRN------HICIVFEKLGPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMH 211
            +F          ++ +V + +  ++Y   R  S   ++ P+  V+    QL  S+A++H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT-- 269
              + H D+KP+N+LL                           P ++ +KL DFGS    
Sbjct: 140 SFGICHRDIKPQNLLLD--------------------------PDTAVLKLCDFGSAKQL 173
Query: 270 FEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
              + +   + +R+YRAPE+I G   +    D+WS GC+L EL  G+ +F     ++ L 
Sbjct: 174 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 329 MMERVLG 335
            + +VLG
Sbjct: 234 EIIKVLG 240

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 120/254 (47%), Gaps = 21/254 (8%)
Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLA 146
           N++  +++ S +GEG +G V         E+VAIK +   +K  +    + EI +L+   
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK 67
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
             +I     +Q  + F+  N + I+ E +   L+   R  S +    D ++    Q L +
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTDLH---RVISTQMLSDDHIQYFIYQTLRA 124
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           V  +H   +IH DLKP N+L+ S   +KV D+  L+R   + +   + P      +++F 
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFG-LARIIDESAADNSEPTGQQSGMVEF- 182
Query: 267 STTFEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
                       V+TR YRAPEV+L    ++   D+WS GCIL EL     +F   +   
Sbjct: 183 ------------VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH 230
Query: 326 HLAMMERVLGPLPH 339
            L ++  ++G  PH
Sbjct: 231 QLLLIFGIIG-TPH 243

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 119/254 (46%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 77
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 78  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 133
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 166
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           + FG       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 167 LGFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 227 DHIDQLKLILRLVG 240

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 125/277 (45%), Gaps = 54/277 (19%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           R + L  +G G +G V   +D   ++ VA+K        ++ +   YRE     + +L+ 
Sbjct: 29  RLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRE-----LRLLKH 83
Query: 145 LARHDIGG-----TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVREL 199
           L   ++ G     T    I ++    + + +V   +G  L + ++  +      + V+ L
Sbjct: 84  LKHENVIGLLDVFTPATSIEDF----SEVYLVTTLMGADLNNIVKSQALSD---EHVQFL 136
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
             QLL  + ++H   +IH DLKP N+                            + + S 
Sbjct: 137 VYQLLRGLKYIHSAGIIHRDLKPSNV---------------------------AVNEDSE 169
Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALF 318
           ++++DFG      ++ +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL  G+ALF
Sbjct: 170 LRILDFGLARQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALF 229
Query: 319 QTHENLEHLA-MMERVLGPLPHHMVIRADRRAEKYFR 354
              + ++ L  +ME V  P P  +   +   A  Y +
Sbjct: 230 PGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQ 266

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 119/254 (46%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 77
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 78  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 133
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 166
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +D G       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 167 LDAGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 227 DHIDQLKLILRLVG 240

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 116/269 (43%), Gaps = 37/269 (13%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINK--YREAAMIEIDVLQRLARHD- 149
           YR L  +G G +G V    D      VAIK + R      + + A  E+ +L+ + RH+ 
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHEN 85
Query: 150 -IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
            IG           D      +V   +G  L   ++   +     D ++ L  Q+L+ + 
Sbjct: 86  VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK---HEKLGEDRIQFLVYQMLKGLR 142
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H   +IH DLKP N+                            + +   +K++DFG  
Sbjct: 143 YIHAAGIIHRDLKPGNL---------------------------AVNEDCELKILDFGLA 175
Query: 269 TFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
                +    V TR YRAPEVIL  + +    D+WSVGCI+ E+ +G+ LF+  ++L+ L
Sbjct: 176 RQADSEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL 235
Query: 328 AMMERVLGPLPHHMVIRADRRAEKYFRRG 356
             + +V G  P   V R      K + +G
Sbjct: 236 KEIMKVTGTPPAEFVQRLQSDEAKNYMKG 264

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 116/247 (46%), Gaps = 45/247 (18%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159
           +G G+FG V +    +  ELVAIK V     ++     E+ ++++L   +I     V++R
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR---ELQIMRKLDHCNI-----VRLR 79
Query: 160 NWFDYRN------HICIVFEKLGPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMH 211
            +F          ++ +V + +  ++Y   R  S   ++ P+  V+    QL  S+A++H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT-- 269
              + H D+KP+N+LL                           P ++ +KL DFGS    
Sbjct: 140 SFGICHRDIKPQNLLLD--------------------------PDTAVLKLCDFGSAKQL 173
Query: 270 FEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
              + +   + +R+YRAPE+I G   +    D+WS GC+L EL  G+ +F     ++ L 
Sbjct: 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 329 MMERVLG 335
            + +VLG
Sbjct: 234 EIIKVLG 240

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 116/247 (46%), Gaps = 45/247 (18%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159
           +G G+FG V +    +  ELVAIK V     ++     E+ ++++L   +I     V++R
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR---ELQIMRKLDHCNI-----VRLR 79
Query: 160 NWFDYRN------HICIVFEKLGPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMH 211
            +F          ++ +V + +  ++Y   R  S   ++ P+  V+    QL  S+A++H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT-- 269
              + H D+KP+N+LL                           P ++ +KL DFGS    
Sbjct: 140 SFGICHRDIKPQNLLLD--------------------------PDTAVLKLCDFGSAKQL 173
Query: 270 FEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
              + +   + +R+YRAPE+I G   +    D+WS GC+L EL  G+ +F     ++ L 
Sbjct: 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 329 MMERVLG 335
            + +VLG
Sbjct: 234 EIIKVLG 240

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 119/254 (46%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 77
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 78  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 133
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 166
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +D G       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 167 LDGGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 227 DHIDQLKLILRLVG 240

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 119/254 (46%), Gaps = 47/254 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           RY+ LS +G G +G V   FD +    VA+K        I+ +   YRE     + +L+ 
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKH 77
Query: 145 LARHDIGGTRCV--QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           +   ++ G   V    R+  ++ N + +V   +G  L + ++    +    D V+ L  Q
Sbjct: 78  MKHENVIGLLDVFTPARSLEEF-NDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 133
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + ++H   +IH DLKP N+                            + +   +K+
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCELKI 166
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTH 321
           +D G       + +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL +G  LF   
Sbjct: 167 LDRGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226
Query: 322 ENLEHLAMMERVLG 335
           ++++ L ++ R++G
Sbjct: 227 DHIDQLKLILRLVG 240

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 126/259 (48%), Gaps = 38/259 (14%)
Query: 80  GHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMI 137
           G ++ +   +L+  Y+ + K+G G +G+V+ C D       AIKI+R  S++    + ++
Sbjct: 25  GMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLL 84
Query: 138 EIDVLQRLARHDIGGTRCVQIRNWF-DYRNHICIVFEKLGPSLYD-FLRKNSYRSFPIDL 195
           E   + +L  H       +++ ++F D RN+  ++    G  L+D  + +  +      +
Sbjct: 85  EEVAVLKLLDH----PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV 140
Query: 196 VRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 255
           +    +Q+L  V ++H+  ++H DLKPEN+LL S E                        
Sbjct: 141 II---KQVLSGVTYLHKHNIVHRDLKPENLLLESKE------------------------ 173
Query: 256 KSSAIKLIDFG-STTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
           K + IK++DFG S  FE+Q      + T +Y APEV L   ++  CD+WS+G IL  L +
Sbjct: 174 KDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLA 232
Query: 314 GEALFQTHENLEHLAMMER 332
           G   F    + E L  +E+
Sbjct: 233 GYPPFGGQTDQEILRKVEK 251

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 118/257 (45%), Gaps = 27/257 (10%)
Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLA 146
           N++  +++ S +GEG +G V         E+VAIK +   +K  +    + EI +L+   
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK 67
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
             +I     +Q  + F+  N + I+ E +   L+   R  S +    D ++    Q L +
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTDLH---RVISTQMLSDDHIQYFIYQTLRA 124
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLI 263
           V  +H   +IH DLKP N+L+ S   +KV D+   + +  S+ D S              
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS-------------- 170
Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHE 322
                T +    +  V+TR YRAPEV+L    ++   D+WS GCIL EL     +F   +
Sbjct: 171 ---EPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227
Query: 323 NLEHLAMMERVLGPLPH 339
               L ++  ++G  PH
Sbjct: 228 YRHQLLLIFGIIG-TPH 243

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 118/257 (45%), Gaps = 27/257 (10%)
Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLA 146
           N++  +++ S +GEG +G V         E+VAIK +   +K  +    + EI +L+   
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK 67
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
             +I     +Q  + F+  N + I+ E +   L+   R  S +    D ++    Q L +
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTDLH---RVISTQMLSDDHIQYFIYQTLRA 124
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLI 263
           V  +H   +IH DLKP N+L+ S   +KV D+   + +  S+ D S              
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS-------------- 170
Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHE 322
                T +    +  V+TR YRAPEV+L    ++   D+WS GCIL EL     +F   +
Sbjct: 171 ---EPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227
Query: 323 NLEHLAMMERVLGPLPH 339
               L ++  ++G  PH
Sbjct: 228 YRHQLLLIFGIIG-TPH 243

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 126/277 (45%), Gaps = 54/277 (19%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           R + L  +G G +G V   +D   ++ VA+K        ++ +   YRE     + +L+ 
Sbjct: 29  RLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRE-----LRLLKH 83
Query: 145 LARHDIGG-----TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVREL 199
           L   ++ G     T    I ++    + + +V   +G  L + ++    ++   + V+ L
Sbjct: 84  LKHENVIGLLDVFTPATSIEDF----SEVYLVTTLMGADLNNIVK---CQALSDEHVQFL 136
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
             QLL  + ++H   +IH DLKP N+                            + + S 
Sbjct: 137 VYQLLRGLKYIHSAGIIHRDLKPSNV---------------------------AVNEDSE 169
Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALF 318
           ++++DFG      ++ +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL  G+ALF
Sbjct: 170 LRILDFGLARQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALF 229
Query: 319 QTHENLEHLA-MMERVLGPLPHHMVIRADRRAEKYFR 354
              + ++ L  +ME V  P P  +   +   A  Y +
Sbjct: 230 PGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQ 266

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 122/254 (48%), Gaps = 38/254 (14%)
Query: 81  HYVFAIGENLTPRYRILSK---MGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAM 136
           H +    +     +  +SK   +G G FGQV +C +      +A KI+++   K +E   
Sbjct: 75  HRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK 134
Query: 137 IEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDL 195
            EI V+ +L   ++     +Q+ + F+ +N I +V E + G  L+D +   SY    +D 
Sbjct: 135 NEISVMNQLDHANL-----IQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT 189
Query: 196 VRELGRQLLESVAFMHELRLIHTDLKPENILLVS--AEYVKVPDYKFLSRSSKDGSYFKN 253
           +  + +Q+ E +  MH++ ++H DLKPENIL V+  A+ +K+ D+  L+R  K     K 
Sbjct: 190 ILFM-KQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFG-LARRYKPREKLK- 246
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                    ++FG              T  + APEV+     ++P D+WSVG I   L S
Sbjct: 247 ---------VNFG--------------TPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLS 283
Query: 314 GEALFQTHENLEHL 327
           G + F    + E L
Sbjct: 284 GLSPFLGDNDAETL 297

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 118/253 (46%), Gaps = 47/253 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDN--EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150
           +Y  L K+GEGT+G V +  +N  E   L  I++ +         + EI +L+ L   +I
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFL-------RKNSYRSFPIDLVRELGRQL 203
                V++ +    +  + +VFE L   L   L          + +SF +        QL
Sbjct: 63  -----VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLL--------QL 109
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
           L  +A+ H+ R++H DLKP+N+L+     +K+ D+  L+R+                   
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFG-LARA------------------- 149
Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHE 322
            FG      + +++ V T  YRAP+V++G   ++   D+WSVGCI  E+ +G  LF    
Sbjct: 150 -FGIPV---RKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205
Query: 323 NLEHLAMMERVLG 335
             + L  + R+LG
Sbjct: 206 EADQLMRIFRILG 218

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 122/255 (47%), Gaps = 41/255 (16%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQR 144
           + L  +Y+ L K+GEGT+G V +  D++ + +VA+K +R           A+ EI +L+ 
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPSTAIREISLLKE 75
Query: 145 LARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
           L   +I     V + +       + +VFE +   L   L +N         ++    QLL
Sbjct: 76  LHHPNI-----VSLIDVIHSERCLTLVFEFMEKDLKKVLDENK-TGLQDSQIKIYLYQLL 129
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
             VA  H+ R++H DLKP+N+L+ S                 DG          A+KL D
Sbjct: 130 RGVAHCHQHRILHRDLKPQNLLINS-----------------DG----------ALKLAD 162
Query: 265 FG---STTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQT 320
           FG   +     + +++ V T  YRAP+V++G   ++   D+WS+GCI  E+ +G+ LF  
Sbjct: 163 FGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPG 222
Query: 321 HENLEHLAMMERVLG 335
             + + L  +  +LG
Sbjct: 223 VTDDDQLPKIFSILG 237

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 118/253 (46%), Gaps = 47/253 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDN--EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150
           +Y  L K+GEGT+G V +  +N  E   L  I++ +         + EI +L+ L   +I
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFL-------RKNSYRSFPIDLVRELGRQL 203
                V++ +    +  + +VFE L   L   L          + +SF +        QL
Sbjct: 63  -----VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLL--------QL 109
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
           L  +A+ H+ R++H DLKP+N+L+     +K+ D+  L+R+                   
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFG-LARA------------------- 149
Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHE 322
            FG      + +++ V T  YRAP+V++G   ++   D+WSVGCI  E+ +G  LF    
Sbjct: 150 -FGIPV---RKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVS 205
Query: 323 NLEHLAMMERVLG 335
             + L  + R+LG
Sbjct: 206 EADQLMRIFRILG 218

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 122/255 (47%), Gaps = 41/255 (16%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQR 144
           + L  +Y+ L K+GEGT+G V +  D++ + +VA+K +R           A+ EI +L+ 
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPSTAIREISLLKE 75
Query: 145 LARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
           L   +I     V + +       + +VFE +   L   L +N         ++    QLL
Sbjct: 76  LHHPNI-----VSLIDVIHSERCLTLVFEFMEKDLKKVLDENK-TGLQDSQIKIYLYQLL 129
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
             VA  H+ R++H DLKP+N+L+ S                 DG          A+KL D
Sbjct: 130 RGVAHCHQHRILHRDLKPQNLLINS-----------------DG----------ALKLAD 162
Query: 265 FG---STTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQT 320
           FG   +     + +++ V T  YRAP+V++G   ++   D+WS+GCI  E+ +G+ LF  
Sbjct: 163 FGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPG 222
Query: 321 HENLEHLAMMERVLG 335
             + + L  +  +LG
Sbjct: 223 VTDDDQLPKIFSILG 237

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 121/234 (51%), Gaps = 43/234 (18%)
Query: 90  LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKY--REAAMIEIDVLQRL 145
            + RY+    +G+G+FG+V+ C D    +  A+K++  R + +   +E+ + E+ +L++L
Sbjct: 24  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEK-LGPSLYDFL--RKNSYRSFPIDLVRELGRQ 202
              +I      ++  +F+ + +  +V E   G  L+D +  RK   R   +D  R + RQ
Sbjct: 84  DHPNI-----XKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK---RFSEVDAAR-IIRQ 134
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  + + H+ +++H DLKPEN+LL S               SKD +          I++
Sbjct: 135 VLSGITYXHKNKIVHRDLKPENLLLES--------------KSKDAN----------IRI 170
Query: 263 IDFG-STTFE-HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           IDFG ST FE  +     + T +Y APEV+ G  ++  CD+WS G IL  L SG
Sbjct: 171 IDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 223

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 118/253 (46%), Gaps = 47/253 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDN--EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150
           +Y  L K+GEGT+G V +  +N  E   L  I++ +         + EI +L+ L   +I
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFL-------RKNSYRSFPIDLVRELGRQL 203
                V++ +    +  + +VFE L   L   L          + +SF +        QL
Sbjct: 63  -----VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLL--------QL 109
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
           L  +A+ H+ R++H DLKP+N+L+     +K+ D+  L+R+                   
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFG-LARA------------------- 149
Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHE 322
            FG      + +++ + T  YRAP+V++G   ++   D+WSVGCI  E+ +G  LF    
Sbjct: 150 -FGIPV---RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205
Query: 323 NLEHLAMMERVLG 335
             + L  + R+LG
Sbjct: 206 EADQLMRIFRILG 218

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/277 (24%), Positives = 125/277 (45%), Gaps = 54/277 (19%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
           R + L  +G G +G V   +D   ++ VA+K        ++ +   YRE     + +L+ 
Sbjct: 21  RLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRE-----LRLLKH 75
Query: 145 LARHDIGG-----TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVREL 199
           L   ++ G     T    I ++    + + +V   +G  L + ++    ++   + V+ L
Sbjct: 76  LKHENVIGLLDVFTPATSIEDF----SEVYLVTTLMGADLNNIVK---CQALSDEHVQFL 128
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
             QLL  + ++H   +IH DLKP N+                            + +   
Sbjct: 129 VYQLLRGLKYIHSAGIIHRDLKPSNV---------------------------AVNEDCE 161
Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALF 318
           ++++DFG      ++ +  V+TR YRAPE++L  + +N   D+WSVGCI+ EL  G+ALF
Sbjct: 162 LRILDFGLARQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALF 221
Query: 319 QTHENLEHLA-MMERVLGPLPHHMVIRADRRAEKYFR 354
              + ++ L  +ME V  P P  +   +   A  Y +
Sbjct: 222 PGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQ 258

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 127/277 (45%), Gaps = 39/277 (14%)
Query: 74  RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
           R    +  Y   IG++   +  RY+ L  +G G  G V   +D   +  VAIK + R   
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 130 KYREA--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
               A  A  E+ VL ++  H   IG       +   +    + IV E +  +L   ++ 
Sbjct: 63  NQTHAKRAYREL-VLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ- 120
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
                   + +  L  Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++
Sbjct: 121 ---MELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFG-LARTA 176
Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
             G+ F   P                     YVV TR+YRAPEVILG+G+    D+WSVG
Sbjct: 177 --GTSFMMTP---------------------YVV-TRYYRAPEVILGMGYKENVDIWSVG 212
Query: 306 CILVELCSGEALFQTHENLEHL-AMMERVLGPLPHHM 341
           CI+ E+  G  LF   ++++    ++E++  P P  M
Sbjct: 213 CIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM 249

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 127/277 (45%), Gaps = 39/277 (14%)
Query: 74  RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
           R    +  Y   IG++   +  RY+ L  +G G  G V   +D   +  VAIK + R   
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 130 KYREA--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
               A  A  E+ VL ++  H   IG       +   +    + IV E +  +L   ++ 
Sbjct: 63  NQTHAKRAYREL-VLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ- 120
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
                   + +  L  Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++
Sbjct: 121 ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFG-LARTA 176
Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
             G+ F   P                     YVV TR+YRAPEVILG+G+    D+WSVG
Sbjct: 177 --GTSFMMTP---------------------YVV-TRYYRAPEVILGMGYKENVDIWSVG 212
Query: 306 CILVELCSGEALFQTHENLEHL-AMMERVLGPLPHHM 341
           CI+ E+  G  LF   ++++    ++E++  P P  M
Sbjct: 213 CIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM 249

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 126/282 (44%), Gaps = 49/282 (17%)
Query: 74  RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV----- 125
           R    +  Y   IG++   +  RY+ L  +G G  G VV  +D   +  VAIK +     
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQ 62
Query: 126 ---RSINKYREAAMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
               +   YRE       VL ++  H   IG       +   +    + IV E +  +L 
Sbjct: 63  NQTHAKRAYREL------VLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLS 116
Query: 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240
             ++         + +  L  Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  
Sbjct: 117 QVIQ----MELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFG- 171
Query: 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 300
           L+R++  G+ F   P                     YVV TR+YRAPEVILG+G+    D
Sbjct: 172 LARTA--GTSFMMTP---------------------YVV-TRYYRAPEVILGMGYKENVD 207
Query: 301 LWSVGCILVELCSGEALFQTHENLEHL-AMMERVLGPLPHHM 341
           +WSVG I+ E+  G  LF   ++++    ++E++  P P  M
Sbjct: 208 IWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM 249

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 126/277 (45%), Gaps = 39/277 (14%)
Query: 74  RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
           R    +  Y   IG++   +  RY+ L  +G G  G V   +D   +  VAIK + R   
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 130 KYREA--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
               A  A  E+ VL +   H   IG       +   +    + IV E +  +L   ++ 
Sbjct: 63  NQTHAKRAYREL-VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ- 120
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
                   + +  L  Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++
Sbjct: 121 ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFG-LARTA 176
Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
             G+ F   P                     YVV TR+YRAPEVILG+G+    D+WSVG
Sbjct: 177 --GTSFMMTP---------------------YVV-TRYYRAPEVILGMGYKENVDIWSVG 212
Query: 306 CILVELCSGEALFQTHENLEHL-AMMERVLGPLPHHM 341
           CI+ E+  G  LF   ++++    ++E++  P P  M
Sbjct: 213 CIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM 249

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 121/248 (48%), Gaps = 42/248 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           Y+++ K+G G + +V E  +    E V +KI++ + K +     EI +L+ L     GG 
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKR--EIKILENLR----GGP 92
Query: 154 RCVQIRNWFD--YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
             + + +           +VFE +  +  DF  K  Y++     +R    ++L+++ + H
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            + ++H D+KP N++ +  E+ K                         ++LID+G   F 
Sbjct: 149 SMGIMHRDVKPHNVM-IDHEHRK-------------------------LRLIDWGLAEFY 182
Query: 272 H--QDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELC-SGEALFQTHENLEHL 327
           H  Q+++  V++R+++ PE+++    ++Y  D+WS+GC+L  +    E  F  H+N + L
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242
Query: 328 AMMERVLG 335
             + +VLG
Sbjct: 243 VRIAKVLG 250

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 106/230 (46%), Gaps = 13/230 (5%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAI-KIVRSINKYREAAMI--EIDVLQRLARHD 149
           RY I   +G G++G V E +D  +K +VAI KI+R      +   I  EI +L RL    
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDH 113
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDL-VRELGRQLLESVA 208
           +     + I    +  + + +V E          R   Y +   +L ++ L   LL  V 
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLT---ELHIKTLLYNLLVGVK 170
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           ++H   ++H DLKP N L+     VKV D+   + +       S     P+   + L+ F
Sbjct: 171 YVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCS 313
             T    +  +  V TR YRAPE+IL L  NY    D+WS+GCI  EL +
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELIL-LQENYTEAIDVWSIGCIFAELLN 279

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 111/245 (45%), Gaps = 39/245 (15%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDI 150
           Y IL ++G G FG V  C +     +   K + +   ++KY      EI ++ +L     
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY--TVKNEISIMNQLHH--- 107
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
              + + + + F+ +  + ++ E L G  L+D +    Y+    +++  + RQ  E +  
Sbjct: 108 --PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYM-RQACEGLKH 164
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
           MHE  ++H D+KPENI+  +                          K+S++K+IDFG  T
Sbjct: 165 MHEHSIVHLDIKPENIMCETK-------------------------KASSVKIIDFGLAT 199
Query: 270 FEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
             + D       +T  + APE++      +  D+W++G +   L SG + F   ++LE L
Sbjct: 200 KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL 259
Query: 328 AMMER 332
             ++R
Sbjct: 260 QNVKR 264

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 125/267 (46%), Gaps = 48/267 (17%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           R+++    G+GTFG V    +      VAIK V    ++R     E+ ++Q LA   +  
Sbjct: 24  RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR---ELQIMQDLAV--LHH 78
Query: 153 TRCVQIRNWF------DYRN-HICIVFEKLGPSLYDFLRKNSYR---SFPIDLVRELGRQ 202
              VQ++++F      D R+ ++ +V E +  +L+   R N YR   + P  L++    Q
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCR-NYYRRQVAPPPILIKVFLFQ 137
Query: 203 LLESVAFMH--ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
           L+ S+  +H   + + H D+KP N+L+  A                DG+          +
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEA----------------DGT----------L 171
Query: 261 KLIDFGSTTFEHQDHSYV--VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEAL 317
           KL DFGS          V  + +R+YRAPE+I G   +    D+WSVGCI  E+  GE +
Sbjct: 172 KLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPI 231
Query: 318 FQTHENLEHLAMMERVLGPLPHHMVIR 344
           F+   +   L  + RVLG  P   V+R
Sbjct: 232 FRGDNSAGQLHEIVRVLG-CPSREVLR 257

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 126/277 (45%), Gaps = 39/277 (14%)
Query: 74  RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
           R    +  Y   IG++   +  RY+ L  +G G  G V   +D   +  VAIK + R   
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 130 KYREA--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
               A  A  E+ VL +   H   IG       +   +    + IV E +  +L   ++ 
Sbjct: 63  NQTHAKRAYREL-VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ- 120
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
                   + +  L  Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++
Sbjct: 121 ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA 176
Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
             G+ F   P                     YVV TR+YRAPEVILG+G+    D+WSVG
Sbjct: 177 --GTSFMMTP---------------------YVV-TRYYRAPEVILGMGYKENVDIWSVG 212
Query: 306 CILVELCSGEALFQTHENLEHL-AMMERVLGPLPHHM 341
           CI+ E+  G  LF   ++++    ++E++  P P  M
Sbjct: 213 CIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM 249

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 125/282 (44%), Gaps = 49/282 (17%)
Query: 74  RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV----- 125
           R    +  Y   IG++   +  RY+ L  +G G  G V   +D   +  VAIK +     
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 126 ---RSINKYREAAMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
               +   YRE       VL ++  H   IG       +   +    + IV E +  +L 
Sbjct: 63  NQTHAKRAYREL------VLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLS 116
Query: 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240
             ++         + +  L  Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  
Sbjct: 117 QVIQ----MELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFG- 171
Query: 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 300
           L+R++  G+ F   P                     YVV TR+YRAPEVILG+G+    D
Sbjct: 172 LARTA--GTSFMMTP---------------------YVV-TRYYRAPEVILGMGYKENVD 207
Query: 301 LWSVGCILVELCSGEALFQTHENLEHL-AMMERVLGPLPHHM 341
           +WSVG I+ E+  G  LF   ++++    ++E++  P P  M
Sbjct: 208 IWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM 249

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 126/277 (45%), Gaps = 39/277 (14%)
Query: 74  RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
           R    +  Y   IG++   +  RY+ L  +G G  G V   +D   +  VAIK + R   
Sbjct: 4   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 63
Query: 130 KYREA--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
               A  A  E+ VL +   H   IG       +   +    + IV E +  +L   ++ 
Sbjct: 64  NQTHAKRAYREL-VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ- 121
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
                   + +  L  Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++
Sbjct: 122 ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA 177
Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
             G+ F   P                     YVV TR+YRAPEVILG+G+    D+WSVG
Sbjct: 178 --GTSFMMTP---------------------YVV-TRYYRAPEVILGMGYKENVDIWSVG 213
Query: 306 CILVELCSGEALFQTHENLEHL-AMMERVLGPLPHHM 341
           CI+ E+  G  LF   ++++    ++E++  P P  M
Sbjct: 214 CIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 74  RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
           R    +  Y   IG++   +  RY+ L  +G G  G V   +D   +  VAIK + R   
Sbjct: 5   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 64
Query: 130 KYREA--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
               A  A  E+ VL +   H   IG       +   +    + IV E +  +L   ++ 
Sbjct: 65  NQTHAKRAYREL-VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ- 122
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
                   + +  L  Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++
Sbjct: 123 ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA 178
Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
             G+ F  +P                       V TR+YRAPEVILG+G+    D+WSVG
Sbjct: 179 --GTSFMMVP----------------------FVVTRYYRAPEVILGMGYKENVDIWSVG 214
Query: 306 CILVELCSGEALFQTHENLEHL-AMMERVLGPLPHHM 341
           CI+ E+  G  LF   ++++    ++E++  P P  M
Sbjct: 215 CIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 251

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 126/277 (45%), Gaps = 39/277 (14%)
Query: 74  RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
           R    +  Y   IG++   +  RY+ L  +G G  G V   +D   +  VAIK + R   
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 130 KYREA--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
               A  A  E+ VL +   H   IG       +   +    + IV E +  +L   ++ 
Sbjct: 63  NQTHAKRAYREL-VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ- 120
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
                   + +  L  Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++
Sbjct: 121 ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA 176
Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
             G+ F   P                     YVV TR+YRAPEVILG+G+    D+WSVG
Sbjct: 177 --GTSFMMTP---------------------YVV-TRYYRAPEVILGMGYKENVDIWSVG 212
Query: 306 CILVELCSGEALFQTHENLEHL-AMMERVLGPLPHHM 341
           CI+ E+  G  LF   ++++    ++E++  P P  M
Sbjct: 213 CIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 74  RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
           R    +  Y   IG++   +  RY+ L  +G G  G V   +D   +  VAIK + R   
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 130 KYREA--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
               A  A  E+ VL +   H   IG       +   +    + IV E +  +L   ++ 
Sbjct: 63  NQTHAKRAYREL-VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ- 120
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
                   + +  L  Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++
Sbjct: 121 ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA 176
Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
             G+ F   P+                      V TR+YRAPEVILG+G+    D+WSVG
Sbjct: 177 --GTSFMMTPE----------------------VVTRYYRAPEVILGMGYKENVDIWSVG 212
Query: 306 CILVELCSGEALFQTHENLEHL-AMMERVLGPLPHHM 341
           CI+ E+  G  LF   ++++    ++E++  P P  M
Sbjct: 213 CIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 126/277 (45%), Gaps = 39/277 (14%)
Query: 74  RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
           R    +  Y   IG++   +  RY+ L  +G G  G V   +D   +  VAIK + R   
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 130 KYREA--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
               A  A  E+ VL +   H   IG       +   +    + IV E +  +L   ++ 
Sbjct: 63  NQTHAKRAYREL-VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ- 120
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
                   + +  L  Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++
Sbjct: 121 ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA 176
Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
             G+ F   P                     YVV TR+YRAPEVILG+G+    D+WSVG
Sbjct: 177 --GTSFMMTP---------------------YVV-TRYYRAPEVILGMGYKENVDIWSVG 212
Query: 306 CILVELCSGEALFQTHENLEHL-AMMERVLGPLPHHM 341
           CI+ E+  G  LF   ++++    ++E++  P P  M
Sbjct: 213 CIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM 249

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 116/251 (46%), Gaps = 41/251 (16%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR---EAAMIEIDVLQRLARHD 149
           +Y  L K+GEGT+G V +  + E  E+VA+K VR  +       +A+ EI +L+ L   +
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
           I     V++ +       + +VFE     L  +    +    P ++V+    QLL+ + F
Sbjct: 63  I-----VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP-EIVKSFLFQLLKGLGF 116
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG--- 266
            H   ++H DLKP+N+L+                            ++  +KL +FG   
Sbjct: 117 CHSRNVLHRDLKPQNLLI---------------------------NRNGELKLANFGLAR 149
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELC-SGEALFQTHENL 324
           +     + +S  V T  YR P+V+ G   ++   D+WS GCI  EL  +G  LF  ++  
Sbjct: 150 AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209
Query: 325 EHLAMMERVLG 335
           + L  + R+LG
Sbjct: 210 DQLKRIFRLLG 220

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 115/251 (45%), Gaps = 41/251 (16%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR---EAAMIEIDVLQRLARHD 149
           +Y  L K+GEGT+G V +  + E  E+VA+K VR  +       +A+ EI +L+ L   +
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
           I     V++ +       + +VFE     L  +    +    P ++V+    QLL+ + F
Sbjct: 63  I-----VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP-EIVKSFLFQLLKGLGF 116
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG--- 266
            H   ++H DLKP+N+L+                            ++  +KL DFG   
Sbjct: 117 CHSRNVLHRDLKPQNLLIN---------------------------RNGELKLADFGLAR 149
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELC-SGEALFQTHENL 324
           +     + +S  V T  YR P+V+ G   ++   D+WS GCI  EL  +   LF  ++  
Sbjct: 150 AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVD 209
Query: 325 EHLAMMERVLG 335
           + L  + R+LG
Sbjct: 210 DQLKRIFRLLG 220

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 117/245 (47%), Gaps = 33/245 (13%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE--AAMIEIDVLQRLARHDIG 151
           Y  L K+GEGT+  V +        LVA+K +R  ++      A+ E+ +L+ L   +I 
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI- 62
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
               V + +       + +VFE L   L  +L  +      +  V+    QLL  +A+ H
Sbjct: 63  ----VTLHDIIHTEKSLTLVFEYLDKDLKQYL-DDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
             +++H DLKP+N+L+     +K+ D+  L+R+       K++P           + T++
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFG-LARA-------KSIP-----------TKTYD 158
Query: 272 HQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330
           ++     V T  YR P+++LG   ++   D+W VGCI  E+ +G  LF      E L  +
Sbjct: 159 NE-----VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFI 213
Query: 331 ERVLG 335
            R+LG
Sbjct: 214 FRILG 218

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 113/256 (44%), Gaps = 45/256 (17%)
Query: 80  GHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREA- 134
           G ++    + L   Y +   +G G  G+V   F+ +  + VAIKI+     +I   REA 
Sbjct: 4   GSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREAD 63
Query: 135 ----AMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRS 190
                  EI++L++L    I     ++I+N+FD  ++  ++    G  L+D +  N  + 
Sbjct: 64  PALNVETEIEILKKLNHPCI-----IKIKNFFDAEDYYIVLELMEGGELFDKVVGN--KR 116
Query: 191 FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250
                 +    Q+L +V ++HE  +IH DLKPEN+LL S E                   
Sbjct: 117 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE------------------- 157
Query: 251 FKNLPKSSAIKLIDFGSTTF--EHQDHSYVVSTRHYRAPEVILGL---GWNYPCDLWSVG 305
                +   IK+ DFG +    E      +  T  Y APEV++ +   G+N   D WS+G
Sbjct: 158 -----EDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 212
Query: 306 CILVELCSGEALFQTH 321
            IL    SG   F  H
Sbjct: 213 VILFICLSGYPPFSEH 228

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 111/237 (46%), Gaps = 40/237 (16%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR 147
           + L+  + + S++G G    V  C     ++  A+K+++     ++    EI VL RL+ 
Sbjct: 49  DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-KKIVRTEIGVLLRLSH 107
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSF--PIDLVRELGRQLL 204
            +I     ++++  F+    I +V E + G  L+D + +  Y S     D V+    Q+L
Sbjct: 108 PNI-----IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK----QIL 158
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
           E+VA++HE  ++H DLKPEN+L  +      PD                    + +K+ D
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATP----APD--------------------APLKIAD 194
Query: 265 FG-STTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL-VELCSGEALF 318
           FG S   EHQ     V  T  Y APE++ G  +    D+WSVG I  + LC  E  +
Sbjct: 195 FGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFY 251

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 74  RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
           R    +  Y   IG++   +  RY+ L  +G G  G V   +D   +  VAIK + R   
Sbjct: 8   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 67
Query: 130 KYREA--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
               A  A  E+ VL +   H   IG       +   +    + IV E +  +L   ++ 
Sbjct: 68  NQTHAKRAYREL-VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ- 125
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
                   + +  L  Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++
Sbjct: 126 ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA 181
Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
             G+ F   P                     YVV TR+YRAPEVILG+G+    DLWSVG
Sbjct: 182 --GTSFMMTP---------------------YVV-TRYYRAPEVILGMGYKENVDLWSVG 217
Query: 306 CILVELCSGEALFQTHENLEHL-AMMERVLGPLPHHM 341
           CI+ E+   + LF   + ++    ++E++  P P  M
Sbjct: 218 CIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFM 254

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 36/224 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDV-LQRLARHDI 150
           Y+I+  +GEG+FG+V   +     + VA+KI+  + + K      IE ++   RL RH  
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH-- 67
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                +++ +    ++ I +V E  G  L+D++ +    S      R   +Q++ +V + 
Sbjct: 68  --PHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSE--QEARRFFQQIISAVEYC 123
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H  +++H DLKPEN+LL     VK+ D+  LS    DG++ K                  
Sbjct: 124 HRHKIVHRDLKPENLLLDEHLNVKIADFG-LSNIMTDGNFLKT----------------- 165
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCIL-VELC 312
                     + +Y APEVI G  +  P  D+WS G IL V LC
Sbjct: 166 -------SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLC 202

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 36/224 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDV-LQRLARHDI 150
           Y+I+  +GEG+FG+V   +     + VA+KI+  + + K      IE ++   RL RH  
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH-- 63
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                +++ +    ++ I +V E  G  L+D++ +    S      R   +Q++ +V + 
Sbjct: 64  --PHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSE--QEARRFFQQIISAVEYC 119
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H  +++H DLKPEN+LL     VK+ D+  LS    DG++ K                  
Sbjct: 120 HRHKIVHRDLKPENLLLDEHLNVKIADFG-LSNIMTDGNFLKT----------------- 161
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCIL-VELC 312
                     + +Y APEVI G  +  P  D+WS G IL V LC
Sbjct: 162 -------SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLC 198

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 36/224 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDV-LQRLARHDI 150
           Y+I+  +GEG+FG+V   +     + VA+KI+  + + K      IE ++   RL RH  
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH-- 73
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                +++ +    ++ I +V E  G  L+D++ +    S      R   +Q++ +V + 
Sbjct: 74  --PHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSE--QEARRFFQQIISAVEYC 129
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H  +++H DLKPEN+LL     VK+ D+  LS    DG++ K                  
Sbjct: 130 HRHKIVHRDLKPENLLLDEHLNVKIADFG-LSNIMTDGNFLKT----------------- 171
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCIL-VELC 312
                     + +Y APEVI G  +  P  D+WS G IL V LC
Sbjct: 172 -------SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLC 208

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 119/253 (47%), Gaps = 41/253 (16%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQ 143
           + L+ RY+ + K+G G +G+V+ C D       AIKI++    +      A + E+ VL+
Sbjct: 17  QGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLK 76
Query: 144 RLARHDIGGTRCVQIRNWF-DYRNHICIVFEKLGPSLYD-FLRKNSYRSFPIDLVRELGR 201
           +L   +I     +++  +F D RN+  ++    G  L+D  + +  +      ++    +
Sbjct: 77  QLDHPNI-----MKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIM---K 128
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           Q+L    ++H+  ++H DLKPEN+LL S               S+D          + IK
Sbjct: 129 QVLSGTTYLHKHNIVHRDLKPENLLLES--------------KSRD----------ALIK 164
Query: 262 LIDFG-STTFE-HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
           ++DFG S  FE        + T +Y APEV L   ++  CD+WS G IL  L  G   F 
Sbjct: 165 IVDFGLSAHFEVGGKMKERLGTAYYIAPEV-LRKKYDEKCDVWSCGVILYILLCGYPPFG 223
Query: 320 THENLEHLAMMER 332
              + E L  +E+
Sbjct: 224 GQTDQEILKRVEK 236

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 124/272 (45%), Gaps = 39/272 (14%)
Query: 79  DGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREA 134
           +  Y   IG++   +  RY+ L  +G G  G V   +D   +  VAIK + R       A
Sbjct: 2   NNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA 61
Query: 135 --AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRS 190
             A  E+ VL +   H   IG       +   +    + IV E +  +L   ++      
Sbjct: 62  KRAYREL-VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ----ME 116
Query: 191 FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250
              + +  L  Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++  G+ 
Sbjct: 117 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA--GTS 173
Query: 251 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310
           F   P                     YVV TR+YRAPEVILG+G+    DLWSVGCI+ E
Sbjct: 174 FMMTP---------------------YVV-TRYYRAPEVILGMGYKENVDLWSVGCIMGE 211
Query: 311 LCSGEALFQTHENLEHL-AMMERVLGPLPHHM 341
           +   + LF   + ++    ++E++  P P  M
Sbjct: 212 MVCHKILFPGRDYIDQWNKVIEQLGTPCPEFM 243

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 110/241 (45%), Gaps = 46/241 (19%)
Query: 96  ILSK-MGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREA-----AMIEIDVLQRL 145
           I+SK +G G  G+V   F+ +  + VAIKI+     +I   REA        EI++L++L
Sbjct: 13  IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
               I     ++I+N+FD  ++  ++    G  L+D +  N  +       +    Q+L 
Sbjct: 73  NHPCI-----IKIKNFFDAEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLL 125
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           +V ++HE  +IH DLKPEN+LL S E                        +   IK+ DF
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQE------------------------EDCLIKITDF 161
Query: 266 GSTTF--EHQDHSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSGEALFQT 320
           G +    E      +  T  Y APEV++ +   G+N   D WS+G IL    SG   F  
Sbjct: 162 GHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221
Query: 321 H 321
           H
Sbjct: 222 H 222

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 36/224 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDV-LQRLARHDI 150
           Y+I+  +GEG+FG+V   +     + VA+KI+  + + K      IE ++   RL RH  
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH-- 72
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                +++ +    ++ I +V E  G  L+D++ +    S      R   +Q++ +V + 
Sbjct: 73  --PHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSE--QEARRFFQQIISAVEYC 128
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H  +++H DLKPEN+LL     VK+ D+  LS    DG++ K                  
Sbjct: 129 HRHKIVHRDLKPENLLLDEHLNVKIADFG-LSNIMTDGNFLKT----------------- 170
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCIL-VELC 312
                     + +Y APEVI G  +  P  D+WS G IL V LC
Sbjct: 171 -------SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLC 207

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 110/241 (45%), Gaps = 46/241 (19%)
Query: 96  ILSK-MGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREA-----AMIEIDVLQRL 145
           I+SK +G G  G+V   F+ +  + VAIKI+     +I   REA        EI++L++L
Sbjct: 12  IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 71
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
               I     ++I+N+FD  ++  ++    G  L+D +  N  +       +    Q+L 
Sbjct: 72  NHPCI-----IKIKNFFDAEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLL 124
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           +V ++HE  +IH DLKPEN+LL S E                        +   IK+ DF
Sbjct: 125 AVQYLHENGIIHRDLKPENVLLSSQE------------------------EDCLIKITDF 160
Query: 266 GSTTF--EHQDHSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSGEALFQT 320
           G +    E      +  T  Y APEV++ +   G+N   D WS+G IL    SG   F  
Sbjct: 161 GHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 220
Query: 321 H 321
           H
Sbjct: 221 H 221

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 110/241 (45%), Gaps = 46/241 (19%)
Query: 96  ILSK-MGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREA-----AMIEIDVLQRL 145
           I+SK +G G  G+V   F+ +  + VAIKI+     +I   REA        EI++L++L
Sbjct: 13  IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
               I     ++I+N+FD  ++  ++    G  L+D +  N  +       +    Q+L 
Sbjct: 73  NHPCI-----IKIKNFFDAEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLL 125
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           +V ++HE  +IH DLKPEN+LL S E                        +   IK+ DF
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQE------------------------EDCLIKITDF 161
Query: 266 GSTTF--EHQDHSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSGEALFQT 320
           G +    E      +  T  Y APEV++ +   G+N   D WS+G IL    SG   F  
Sbjct: 162 GHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221
Query: 321 H 321
           H
Sbjct: 222 H 222

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 110/241 (45%), Gaps = 46/241 (19%)
Query: 96  ILSK-MGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREA-----AMIEIDVLQRL 145
           I+SK +G G  G+V   F+ +  + VAIKI+     +I   REA        EI++L++L
Sbjct: 13  IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
               I     ++I+N+FD  ++  ++    G  L+D +  N  +       +    Q+L 
Sbjct: 73  NHPCI-----IKIKNFFDAEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLL 125
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           +V ++HE  +IH DLKPEN+LL S E                        +   IK+ DF
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQE------------------------EDCLIKITDF 161
Query: 266 GSTTF--EHQDHSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSGEALFQT 320
           G +    E      +  T  Y APEV++ +   G+N   D WS+G IL    SG   F  
Sbjct: 162 GHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221
Query: 321 H 321
           H
Sbjct: 222 H 222

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 120/271 (44%), Gaps = 36/271 (13%)
Query: 84  FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEID 140
           F +  ++   Y I+  +G G +G V         + VAIK + +   +    +  + E+ 
Sbjct: 47  FDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELK 106
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYR--NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRE 198
           +L+     +I   + + +R    Y     + +V + +   L+  +  +S +   ++ VR 
Sbjct: 107 ILKHFKHDNIIAIKDI-LRPTVPYGEFKSVYVVLDLMESDLHQII--HSSQPLTLEHVRY 163
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLP 255
              QLL  + +MH  ++IH DLKP N+L+     +K+ D+   + L  S  +  YF    
Sbjct: 164 FLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFM--- 220
Query: 256 KSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSG 314
                               +  V+TR YRAPE++L L  +    DLWSVGCI  E+ + 
Sbjct: 221 --------------------TEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLAR 260
Query: 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRA 345
             LF     +  L ++  VLG  P   VI+A
Sbjct: 261 RQLFPGKNYVHQLQLIMMVLG-TPSPAVIQA 290

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 110/241 (45%), Gaps = 43/241 (17%)
Query: 86  IGENLTPR--YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-EAAMIEIDVL 142
           +  +L P   + I+ ++G+G FG+V +  + E   L A K++ + ++   E  M+EID+L
Sbjct: 29  VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDIL 88
Query: 143 QRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
                 +I     V++ + F Y N++ I+ E       D +     R      ++ + +Q
Sbjct: 89  ASCDHPNI-----VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 143
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
            L+++ ++H+ ++IH DLK  NIL                  + DG           IKL
Sbjct: 144 TLDALNYLHDNKIIHRDLKAGNILF-----------------TLDGD----------IKL 176
Query: 263 IDFG---STTFEHQDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSG 314
            DFG     T   Q     + T ++ APEV++        ++Y  D+WS+G  L+E+   
Sbjct: 177 ADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEI 236
Query: 315 E 315
           E
Sbjct: 237 E 237

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 110/241 (45%), Gaps = 43/241 (17%)
Query: 86  IGENLTPR--YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-EAAMIEIDVL 142
           +  +L P   + I+ ++G+G FG+V +  + E   L A K++ + ++   E  M+EID+L
Sbjct: 29  VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDIL 88
Query: 143 QRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
                 +I     V++ + F Y N++ I+ E       D +     R      ++ + +Q
Sbjct: 89  ASCDHPNI-----VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 143
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
            L+++ ++H+ ++IH DLK  NIL                  + DG           IKL
Sbjct: 144 TLDALNYLHDNKIIHRDLKAGNILF-----------------TLDGD----------IKL 176
Query: 263 IDFG---STTFEHQDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSG 314
            DFG     T   Q     + T ++ APEV++        ++Y  D+WS+G  L+E+   
Sbjct: 177 ADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEI 236
Query: 315 E 315
           E
Sbjct: 237 E 237

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 124/277 (44%), Gaps = 39/277 (14%)
Query: 74  RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
           R    +  Y   IG++   +  RY+ L  +G G  G V   +D   +  VAIK + R   
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 130 KYREA--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
               A  A  E+ VL +   H   IG       +   +    + IV E +  +L   ++ 
Sbjct: 63  NQTHAKRAYREL-VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ- 120
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
                   + +  L  Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++
Sbjct: 121 ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA 176
Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
             G+ F   P+                      V TR+YRAPEVILG+G+    DLWSVG
Sbjct: 177 --GTSFMMEPE----------------------VVTRYYRAPEVILGMGYKENVDLWSVG 212
Query: 306 CILVELCSGEALFQTHENLEHL-AMMERVLGPLPHHM 341
           CI+ E+   + LF   + ++    ++E++  P P  M
Sbjct: 213 CIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFM 249

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 110/241 (45%), Gaps = 43/241 (17%)
Query: 86  IGENLTPR--YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-EAAMIEIDVL 142
           +  +L P   + I+ ++G+G FG+V +  + E   L A K++ + ++   E  M+EID+L
Sbjct: 29  VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDIL 88
Query: 143 QRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
                 +I     V++ + F Y N++ I+ E       D +     R      ++ + +Q
Sbjct: 89  ASCDHPNI-----VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 143
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
            L+++ ++H+ ++IH DLK  NIL                  + DG           IKL
Sbjct: 144 TLDALNYLHDNKIIHRDLKAGNILF-----------------TLDGD----------IKL 176
Query: 263 IDFG---STTFEHQDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSG 314
            DFG     T   Q     + T ++ APEV++        ++Y  D+WS+G  L+E+   
Sbjct: 177 ADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEI 236
Query: 315 E 315
           E
Sbjct: 237 E 237

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 120/271 (44%), Gaps = 36/271 (13%)
Query: 84  FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEID 140
           F +  ++   Y I+  +G G +G V         + VAIK + +   +    +  + E+ 
Sbjct: 46  FDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELK 105
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYR--NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRE 198
           +L+     +I   + + +R    Y     + +V + +   L+  +  +S +   ++ VR 
Sbjct: 106 ILKHFKHDNIIAIKDI-LRPTVPYGEFKSVYVVLDLMESDLHQII--HSSQPLTLEHVRY 162
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLP 255
              QLL  + +MH  ++IH DLKP N+L+     +K+ D+   + L  S  +  YF    
Sbjct: 163 FLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFM--- 219
Query: 256 KSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSG 314
                               +  V+TR YRAPE++L L  +    DLWSVGCI  E+ + 
Sbjct: 220 --------------------TEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLAR 259
Query: 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRA 345
             LF     +  L ++  VLG  P   VI+A
Sbjct: 260 RQLFPGKNYVHQLQLIMMVLG-TPSPAVIQA 289

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 110/241 (45%), Gaps = 46/241 (19%)
Query: 96  ILSK-MGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREA-----AMIEIDVLQRL 145
           I+SK +G G  G+V   F+ +  + VAI+I+     +I   REA        EI++L++L
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
               I     ++I+N+FD  ++  ++    G  L+D +  N  +       +    Q+L 
Sbjct: 198 NHPCI-----IKIKNFFDAEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLL 250
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           +V ++HE  +IH DLKPEN+LL S E                        +   IK+ DF
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQE------------------------EDCLIKITDF 286
Query: 266 GSTTF--EHQDHSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSGEALFQT 320
           G +    E      +  T  Y APEV++ +   G+N   D WS+G IL    SG   F  
Sbjct: 287 GHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 346
Query: 321 H 321
           H
Sbjct: 347 H 347

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 114/261 (43%), Gaps = 48/261 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLARHDIG 151
           RY+ L  +G G  G V   +D      VAIK + R       A         + A  ++ 
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---------KRAYRELV 68
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYD------FLRKNSYRSFPIDLVRE----LGR 201
             +CV  +N     N      +K      D       +  N  +   ++L  E    L  
Sbjct: 69  LMKCVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLY 126
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++  G+ F   P      
Sbjct: 127 QMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFG-LARTA--GTSFMMTP------ 177
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
                          YVV TR+YRAPEVILG+G+    D+WSVGCI+ E+   + LF   
Sbjct: 178 ---------------YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221
Query: 322 ENLEHL-AMMERVLGPLPHHM 341
           + ++    ++E++  P P  M
Sbjct: 222 DYIDQWNKVIEQLGTPCPEFM 242

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 116/259 (44%), Gaps = 42/259 (16%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHD 149
           +Y  L+K+G+GTFG+V +    +  + VA+K V   N+   +   A+ EI +LQ L   +
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 150 IGGTRCVQIRNWFDY---RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
           +     +       Y   +  I +VF+     L   L  N    F +  ++ + + LL  
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNG 137
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           + ++H  +++H D+K  N+L+                 ++DG           +KL DFG
Sbjct: 138 LYYIHRNKILHRDMKAANVLI-----------------TRDG----------VLKLADFG 170
Query: 267 -----STTFEHQDHSYV--VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALF 318
                S     Q + Y   V T  YR PE++LG   +  P DLW  GCI+ E+ +   + 
Sbjct: 171 LARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 230
Query: 319 QTHENLEHLAMMERVLGPL 337
           Q +     LA++ ++ G +
Sbjct: 231 QGNTEQHQLALISQLCGSI 249

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 114/261 (43%), Gaps = 48/261 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLARHDIG 151
           RY+ L  +G G  G V   +D      VAIK + R       A         + A  ++ 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---------KRAYRELV 75
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYD------FLRKNSYRSFPIDLVRE----LGR 201
             +CV  +N     N      +K      D       +  N  +   ++L  E    L  
Sbjct: 76  LMKCVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLY 133
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++  G+ F   P      
Sbjct: 134 QMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFG-LARTA--GTSFMMTP------ 184
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
                          YVV TR+YRAPEVILG+G+    D+WSVGCI+ E+   + LF   
Sbjct: 185 ---------------YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 228
Query: 322 ENLEHL-AMMERVLGPLPHHM 341
           + ++    ++E++  P P  M
Sbjct: 229 DYIDQWNKVIEQLGTPCPEFM 249

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 110/241 (45%), Gaps = 46/241 (19%)
Query: 96  ILSK-MGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREA-----AMIEIDVLQRL 145
           I+SK +G G  G+V   F+ +  + VAI+I+     +I   REA        EI++L++L
Sbjct: 152 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 211
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
               I     ++I+N+FD  ++  ++    G  L+D +  N  +       +    Q+L 
Sbjct: 212 NHPCI-----IKIKNFFDAEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLL 264
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           +V ++HE  +IH DLKPEN+LL S E                        +   IK+ DF
Sbjct: 265 AVQYLHENGIIHRDLKPENVLLSSQE------------------------EDCLIKITDF 300
Query: 266 GSTTF--EHQDHSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSGEALFQT 320
           G +    E      +  T  Y APEV++ +   G+N   D WS+G IL    SG   F  
Sbjct: 301 GHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 360
Query: 321 H 321
           H
Sbjct: 361 H 361

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 116/259 (44%), Gaps = 42/259 (16%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHD 149
           +Y  L+K+G+GTFG+V +    +  + VA+K V   N+   +   A+ EI +LQ L   +
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 77
Query: 150 IGGTRCVQIRNWFDY---RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
           +     +       Y   +  I +VF+     L   L  N    F +  ++ + + LL  
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNG 136
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           + ++H  +++H D+K  N+L+                 ++DG           +KL DFG
Sbjct: 137 LYYIHRNKILHRDMKAANVLI-----------------TRDG----------VLKLADFG 169
Query: 267 -----STTFEHQDHSYV--VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALF 318
                S     Q + Y   V T  YR PE++LG   +  P DLW  GCI+ E+ +   + 
Sbjct: 170 LARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 229
Query: 319 QTHENLEHLAMMERVLGPL 337
           Q +     LA++ ++ G +
Sbjct: 230 QGNTEQHQLALISQLCGSI 248

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 115/255 (45%), Gaps = 36/255 (14%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREA--AMIEIDVLQRLARHD 149
           RY+ L  +G G  G V   +D      VAIK + R       A  A  E+ VL +   H 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL-VLMKXVNHK 83
Query: 150 --IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
             I        +   +    + +V E +  +L   ++         + +  L  Q+L  +
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ----MELDHERMSYLLYQMLXGI 139
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
             +H   +IH DLKP NI++ S   +K+ D+  L+R++  G+ F   P            
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDXTLKILDFG-LARTA--GTSFMMTP------------ 184
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
                    YVV TR+YRAPEVILG+G+    D+WSVGCI+ E+   + LF   + ++  
Sbjct: 185 ---------YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 234
Query: 328 -AMMERVLGPLPHHM 341
             ++E++  P P  M
Sbjct: 235 NKVIEQLGTPCPEFM 249

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 116/259 (44%), Gaps = 42/259 (16%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHD 149
           +Y  L+K+G+GTFG+V +    +  + VA+K V   N+   +   A+ EI +LQ L   +
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 150 IGGTRCVQIRNWFDY---RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
           +     +       Y   +  I +VF+     L   L  N    F +  ++ + + LL  
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNG 137
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           + ++H  +++H D+K  N+L+                 ++DG           +KL DFG
Sbjct: 138 LYYIHRNKILHRDMKAANVLI-----------------TRDG----------VLKLADFG 170
Query: 267 -----STTFEHQDHSYV--VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALF 318
                S     Q + Y   V T  YR PE++LG   +  P DLW  GCI+ E+ +   + 
Sbjct: 171 LARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 230
Query: 319 QTHENLEHLAMMERVLGPL 337
           Q +     LA++ ++ G +
Sbjct: 231 QGNTEQHQLALISQLCGSI 249

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 122/301 (40%), Gaps = 46/301 (15%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEID 140
           EN+   Y    ++G G F  V +C +       A K ++            RE    E+ 
Sbjct: 7   ENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
           +L+ +   ++     + +   ++ +  + ++ E + G  L+DFL +    S   +   E 
Sbjct: 67  ILKEIQHPNV-----ITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
            +Q+L  V ++H L++ H DLKPENI+L+                       +N+PK   
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLD----------------------RNVPKPR- 156
Query: 260 IKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           IK+IDFG     H+     +   +  T  + APE++         D+WS+G I   L SG
Sbjct: 157 IKIIDFG---LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
Query: 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 374
            + F      E LA +  V               A+ + RR    D     T +DS++  
Sbjct: 214 ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273
Query: 375 W 375
           W
Sbjct: 274 W 274

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 122/301 (40%), Gaps = 46/301 (15%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEID 140
           EN+   Y    ++G G F  V +C +       A K ++            RE    E+ 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
           +L+ +   ++     + +   ++ +  + ++ E + G  L+DFL +    S   +   E 
Sbjct: 66  ILKEIQHPNV-----ITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 118
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
            +Q+L  V ++H L++ H DLKPENI+L+                       +N+PK   
Sbjct: 119 LKQILNGVYYLHSLQIAHFDLKPENIMLLD----------------------RNVPKPR- 155
Query: 260 IKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           IK+IDFG     H+     +   +  T  + APE++         D+WS+G I   L SG
Sbjct: 156 IKIIDFG---LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212
Query: 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 374
            + F      E LA +  V               A+ + RR    D     T +DS++  
Sbjct: 213 ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 272
Query: 375 W 375
           W
Sbjct: 273 W 273

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 122/301 (40%), Gaps = 46/301 (15%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEID 140
           EN+   Y    ++G G F  V +C +       A K ++            RE    E+ 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
           +L+ +   ++     + +   ++ +  + ++ E + G  L+DFL +    S   +   E 
Sbjct: 66  ILKEIQHPNV-----ITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 118
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
            +Q+L  V ++H L++ H DLKPENI+L+                       +N+PK   
Sbjct: 119 LKQILNGVYYLHSLQIAHFDLKPENIMLLD----------------------RNVPKPR- 155
Query: 260 IKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           IK+IDFG     H+     +   +  T  + APE++         D+WS+G I   L SG
Sbjct: 156 IKIIDFG---LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212
Query: 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 374
            + F      E LA +  V               A+ + RR    D     T +DS++  
Sbjct: 213 ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 272
Query: 375 W 375
           W
Sbjct: 273 W 273

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 122/301 (40%), Gaps = 46/301 (15%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEID 140
           EN+   Y    ++G G F  V +C +       A K ++            RE    E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
           +L+ +   ++     + +   ++ +  + ++ E + G  L+DFL +    S   +   E 
Sbjct: 67  ILKEIQHPNV-----ITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
            +Q+L  V ++H L++ H DLKPENI+L+                       +N+PK   
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLD----------------------RNVPKPR- 156
Query: 260 IKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           IK+IDFG     H+     +   +  T  + APE++         D+WS+G I   L SG
Sbjct: 157 IKIIDFG---LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
Query: 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 374
            + F      E LA +  V               A+ + RR    D     T +DS++  
Sbjct: 214 ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273
Query: 375 W 375
           W
Sbjct: 274 W 274

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 122/301 (40%), Gaps = 46/301 (15%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEID 140
           EN+   Y    ++G G F  V +C +       A K ++            RE    E+ 
Sbjct: 7   ENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
           +L+ +   ++     + +   ++ +  + ++ E + G  L+DFL +    S   +   E 
Sbjct: 67  ILKEIQHPNV-----ITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
            +Q+L  V ++H L++ H DLKPENI+L+                       +N+PK   
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLD----------------------RNVPKPR- 156
Query: 260 IKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           IK+IDFG     H+     +   +  T  + APE++         D+WS+G I   L SG
Sbjct: 157 IKIIDFG---LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
Query: 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 374
            + F      E LA +  V               A+ + RR    D     T +DS++  
Sbjct: 214 ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273
Query: 375 W 375
           W
Sbjct: 274 W 274

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 122/301 (40%), Gaps = 46/301 (15%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEID 140
           EN+   Y    ++G G F  V +C +       A K ++            RE    E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
           +L+ +   ++     + +   ++ +  + ++ E + G  L+DFL +    S   +   E 
Sbjct: 67  ILKEIQHPNV-----ITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
            +Q+L  V ++H L++ H DLKPENI+L+                       +N+PK   
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLD----------------------RNVPKPR- 156
Query: 260 IKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           IK+IDFG     H+     +   +  T  + APE++         D+WS+G I   L SG
Sbjct: 157 IKIIDFG---LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
Query: 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 374
            + F      E LA +  V               A+ + RR    D     T +DS++  
Sbjct: 214 ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273
Query: 375 W 375
           W
Sbjct: 274 W 274

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 122/301 (40%), Gaps = 46/301 (15%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEID 140
           EN+   Y    ++G G F  V +C +       A K ++            RE    E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
           +L+ +   ++     + +   ++ +  + ++ E + G  L+DFL +    S   +   E 
Sbjct: 67  ILKEIQHPNV-----ITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
            +Q+L  V ++H L++ H DLKPENI+L+                       +N+PK   
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLD----------------------RNVPKPR- 156
Query: 260 IKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           IK+IDFG     H+     +   +  T  + APE++         D+WS+G I   L SG
Sbjct: 157 IKIIDFG---LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
Query: 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 374
            + F      E LA +  V               A+ + RR    D     T +DS++  
Sbjct: 214 ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273
Query: 375 W 375
           W
Sbjct: 274 W 274

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 122/301 (40%), Gaps = 46/301 (15%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEID 140
           EN+   Y    ++G G F  V +C +       A K ++            RE    E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
           +L+ +   ++     + +   ++ +  + ++ E + G  L+DFL +    S   +   E 
Sbjct: 67  ILKEIQHPNV-----ITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
            +Q+L  V ++H L++ H DLKPENI+L+                       +N+PK   
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLD----------------------RNVPKPR- 156
Query: 260 IKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           IK+IDFG     H+     +   +  T  + APE++         D+WS+G I   L SG
Sbjct: 157 IKIIDFG---LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
Query: 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 374
            + F      E LA +  V               A+ + RR    D     T +DS++  
Sbjct: 214 ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273
Query: 375 W 375
           W
Sbjct: 274 W 274

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 108/256 (42%), Gaps = 51/256 (19%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLARHDIG 151
           RY+ L  +G G  G V   FD      VA+K + R       A         + A  ++ 
Sbjct: 23  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA---------KRAYRELV 73
Query: 152 GTRCVQIRNWFDYRN------------HICIVFEKLGPSLYDFLRKNSYRSFPIDLVREL 199
             +CV  +N     N             + +V E +  +L   +    +     + +  L
Sbjct: 74  LLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI----HMELDHERMSYL 129
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
             Q+L  +  +H   +IH DLKP NI++ S   +K+ D+     +S +   F   P    
Sbjct: 130 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTN---FMMTP---- 182
Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
                            YVV TR+YRAPEVILG+G+    D+WSVGCI+ EL  G  +FQ
Sbjct: 183 -----------------YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 224
Query: 320 THENLEHLAMMERVLG 335
             ++++    +   LG
Sbjct: 225 GTDHIDQWNKVIEQLG 240

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 116/259 (44%), Gaps = 42/259 (16%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHD 149
           +Y  L+K+G+GTFG+V +    +  + VA+K V   N+   +   A+ EI +LQ L   +
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 150 IGGTRCVQIRNWFDY---RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
           +     +       Y   +  I +VF+     L   L  N    F +  ++ + + LL  
Sbjct: 79  VVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNG 137
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           + ++H  +++H D+K  N+L+                 ++DG           +KL DFG
Sbjct: 138 LYYIHRNKILHRDMKAANVLI-----------------TRDG----------VLKLADFG 170
Query: 267 -----STTFEHQDHSYV--VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALF 318
                S     Q + Y   V T  YR PE++LG   +  P DLW  GCI+ E+ +   + 
Sbjct: 171 LARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 230
Query: 319 QTHENLEHLAMMERVLGPL 337
           Q +     LA++ ++ G +
Sbjct: 231 QGNTEQHQLALISQLCGSI 249

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 122/301 (40%), Gaps = 46/301 (15%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEID 140
           EN+   Y    ++G G F  V +C +       A K ++            RE    E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
           +L+ +   ++     + +   ++ +  + ++ E + G  L+DFL +    S   +   E 
Sbjct: 67  ILKEIQHPNV-----ITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEF 119
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
            +Q+L  V ++H L++ H DLKPENI+L+                       +N+PK   
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLD----------------------RNVPKPR- 156
Query: 260 IKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           IK+IDFG     H+     +   +  T  + APE++         D+WS+G I   L SG
Sbjct: 157 IKIIDFG---LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
Query: 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 374
            + F      E LA +  V               A+ + RR    D     T +DS++  
Sbjct: 214 ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273
Query: 375 W 375
           W
Sbjct: 274 W 274

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 116/252 (46%), Gaps = 41/252 (16%)
Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQR 144
            L+ RY+ + K+G G +G+V+ C D       AIKI++    +      A + E+ VL++
Sbjct: 1   GLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQ 60
Query: 145 LARHDIGGTRCVQIRNWF-DYRNHICIVFEKLGPSLYD-FLRKNSYRSFPIDLVRELGRQ 202
           L   +I     +++  +F D RN+  ++    G  L+D  + +  +      ++    +Q
Sbjct: 61  LDHPNI-----MKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIM---KQ 112
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L    ++H+  ++H DLKPEN+LL S                          + + IK+
Sbjct: 113 VLSGTTYLHKHNIVHRDLKPENLLLESK------------------------SRDALIKI 148
Query: 263 IDFG-STTFE-HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320
           +DFG S  FE        + T +Y APEV L   ++  CD+WS G IL  L  G   F  
Sbjct: 149 VDFGLSAHFEVGGKMKERLGTAYYIAPEV-LRKKYDEKCDVWSCGVILYILLCGYPPFGG 207
Query: 321 HENLEHLAMMER 332
             + E L  +E+
Sbjct: 208 QTDQEILKRVEK 219

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 122/301 (40%), Gaps = 46/301 (15%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEID 140
           EN+   Y    ++G G F  V +C +       A K ++            RE    E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
           +L+ +   ++     + +   ++ +  + ++ E + G  L+DFL +    S   +   E 
Sbjct: 67  ILKEIQHPNV-----ITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
            +Q+L  V ++H L++ H DLKPENI+L+                       +N+PK   
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLD----------------------RNVPKPR- 156
Query: 260 IKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           IK+IDFG     H+     +   +  T  + APE++         D+WS+G I   L SG
Sbjct: 157 IKIIDFG---LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
Query: 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 374
            + F      E LA +  V               A+ + RR    D     T +DS++  
Sbjct: 214 ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273
Query: 375 W 375
           W
Sbjct: 274 W 274

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 122/301 (40%), Gaps = 46/301 (15%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEID 140
           EN+   Y    ++G G F  V +C +       A K ++            RE    E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
           +L+ +   ++     + +   ++ +  + ++ E + G  L+DFL +    S   +   E 
Sbjct: 67  ILKEIQHPNV-----ITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
            +Q+L  V ++H L++ H DLKPENI+L+                       +N+PK   
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLD----------------------RNVPKPR- 156
Query: 260 IKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           IK+IDFG     H+     +   +  T  + APE++         D+WS+G I   L SG
Sbjct: 157 IKIIDFG---LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
Query: 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 374
            + F      E LA +  V               A+ + RR    D     T +DS++  
Sbjct: 214 ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273
Query: 375 W 375
           W
Sbjct: 274 W 274

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 122/301 (40%), Gaps = 46/301 (15%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEID 140
           EN+   Y    ++G G F  V +C +       A K ++            RE    E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
           +L+ +   ++     + +   ++ +  + ++ E + G  L+DFL +    S   +   E 
Sbjct: 67  ILKEIQHPNV-----ITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
            +Q+L  V ++H L++ H DLKPENI+L+                       +N+PK   
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLD----------------------RNVPKPR- 156
Query: 260 IKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           IK+IDFG     H+     +   +  T  + APE++         D+WS+G I   L SG
Sbjct: 157 IKIIDFG---LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
Query: 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 374
            + F      E LA +  V               A+ + RR    D     T +DS++  
Sbjct: 214 ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273
Query: 375 W 375
           W
Sbjct: 274 W 274

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 124/277 (44%), Gaps = 39/277 (14%)
Query: 74  RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
           R    +  Y   IG++   +  RY+ L  +G G  G V   +D   +  VAIK + R   
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 130 KYREA--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
               A  A  E+ VL +   H   IG       +   +    + IV E +  +L   ++ 
Sbjct: 63  NQTHAKRAYREL-VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ- 120
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
                   + +  L  Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++
Sbjct: 121 ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA 176
Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
             G+ F   P+                      V TR+YRAPEVILG+G+    D+WSVG
Sbjct: 177 --GTSFMMEPE----------------------VVTRYYRAPEVILGMGYKENVDIWSVG 212
Query: 306 CILVELCSGEALFQTHENLEHL-AMMERVLGPLPHHM 341
           CI+ E+   + LF   + ++    ++E++  P P  M
Sbjct: 213 CIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFM 249

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 122/301 (40%), Gaps = 46/301 (15%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEID 140
           EN+   Y    ++G G F  V +C +       A K ++            RE    E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
           +L+ +   ++     + +   ++ +  + ++ E + G  L+DFL +    S   +   E 
Sbjct: 67  ILKEIQHPNV-----ITLHEVYENKTDVILIGELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
            +Q+L  V ++H L++ H DLKPENI+L+                       +N+PK   
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLD----------------------RNVPKPR- 156
Query: 260 IKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           IK+IDFG     H+     +   +  T  + APE++         D+WS+G I   L SG
Sbjct: 157 IKIIDFG---LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
Query: 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 374
            + F      E LA +  V               A+ + RR    D     T +DS++  
Sbjct: 214 ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273
Query: 375 W 375
           W
Sbjct: 274 W 274

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 122/301 (40%), Gaps = 46/301 (15%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEID 140
           EN+   Y    ++G G F  V +C +       A K ++            RE    E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
           +L+ +   ++     + +   ++ +  + ++ E + G  L+DFL +    S   +   E 
Sbjct: 67  ILKEIQHPNV-----ITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
            +Q+L  V ++H L++ H DLKPENI+L+                       +N+PK   
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLD----------------------RNVPKPR- 156
Query: 260 IKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           IK+IDFG     H+     +   +  T  + APE++         D+WS+G I   L SG
Sbjct: 157 IKIIDFG---LAHKIDFGNEFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
Query: 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 374
            + F      E LA +  V               A+ + RR    D     T +DS++  
Sbjct: 214 ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273
Query: 375 W 375
           W
Sbjct: 274 W 274

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 104/226 (46%), Gaps = 43/226 (19%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-----EAAMIEIDVLQRLARHDIGGT 153
           K+G G FG V      E++     +++++INK R     E    EI+VL+ L   +I   
Sbjct: 29  KLGSGAFGDVHLV---EERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNI--- 82
Query: 154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPID--LVRELGRQLLESVAFM 210
             ++I   F+  +++ IV E   G  L + +     R   +    V EL +Q++ ++A+ 
Sbjct: 83  --IKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STT 269
           H   ++H DLKPENIL                        F++    S IK+IDFG +  
Sbjct: 141 HSQHVVHKDLKPENIL------------------------FQDTSPHSPIKIIDFGLAEL 176
Query: 270 FEHQDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           F+  +HS     T  Y APEV       + CD+WS G ++  L +G
Sbjct: 177 FKSDEHSTNAAGTALYMAPEV-FKRDVTFKCDIWSAGVVMYFLLTG 221

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 115/255 (45%), Gaps = 36/255 (14%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREA--AMIEIDVLQRLARHD 149
           RY+ L  +G G  G V   +D      VAIK + R       A  A  E+ VL +   H 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL-VLMKXVNHK 83
Query: 150 --IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
             I        +   +    + +V E +  +L   ++         + +  L  Q+L  +
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ----MELDHERMSYLLYQMLCGI 139
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
             +H   +IH DLKP NI++ S   +K+ D+  L+R++  G+ F   P            
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDXTLKILDFG-LARTA--GTSFMMTP------------ 184
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
                    YVV TR+YRAPEVILG+G+    D+WSVGCI+ E+   + LF   + ++  
Sbjct: 185 ---------YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 234
Query: 328 -AMMERVLGPLPHHM 341
             ++E++  P P  M
Sbjct: 235 NKVIEQLGTPCPEFM 249

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 127/306 (41%), Gaps = 60/306 (19%)
Query: 51  GMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRI-------LSKMGEG 103
           G+   A + M +    R+GSP      ++     A      P++R+       L  +G+G
Sbjct: 109 GLKKQAAAEMDF----RSGSPSDNSGAEEMEVSLA-----KPKHRVTMNEFEYLKLLGKG 159
Query: 104 TFGQVVECFDNEKKELVAIKIVRS--INKYREAA--MIEIDVLQRLARHDIGGTRCVQIR 159
           TFG+V+   +       A+KI++   I    E A  + E  VLQ  +RH         ++
Sbjct: 160 TFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPF----LTALK 214
Query: 160 NWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIH 217
             F   + +C V E   G  L+  L +   R F  D  R  G +++ ++ ++H E  +++
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVY 272
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
            DLK EN++L    ++K+ D+       KDG+  K                         
Sbjct: 273 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF----------------------- 309
Query: 278 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENLEHLAMME---- 331
              T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L  L +ME    
Sbjct: 310 -CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF 368
Query: 332 -RVLGP 336
            R LGP
Sbjct: 369 PRTLGP 374

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 114/267 (42%), Gaps = 52/267 (19%)
Query: 81  HYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV----------RSINK 130
           H      EN  P+      +G G    V  C      +  A+KI+            + +
Sbjct: 10  HSTHGFYENYEPK----EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQE 65
Query: 131 YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPS-LYDFLRKNSYR 189
            REA + E+D+L++++ H       +Q+++ ++      +VF+ +    L+D+L +    
Sbjct: 66  LREATLKEVDILRKVSGH----PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-- 119
Query: 190 SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249
           +      R++ R LLE +  +H+L ++H DLKPENILL     +K+ D+ F  +      
Sbjct: 120 TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ------ 173
Query: 250 YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVI-LGLGWNYP-----CDLWS 303
                        +D G    E      V  T  Y APE+I   +  N+P      D+WS
Sbjct: 174 -------------LDPGEKLRE------VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWS 214
Query: 304 VGCILVELCSGEALFQTHENLEHLAMM 330
            G I+  L +G   F   + +  L M+
Sbjct: 215 TGVIMYTLLAGSPPFWHRKQMLMLRMI 241

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/294 (22%), Positives = 124/294 (42%), Gaps = 44/294 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRLA 146
           Y I  ++G G F  V +C +       A K ++            RE    E+ +L+++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
            H++     + + + ++ R  + ++ E + G  L+DFL +    S   +      +Q+L+
Sbjct: 74  HHNV-----ITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILD 126
Query: 206 SVAFMHELRLIHTDLKPENILLVSAE----YVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
            V ++H  ++ H DLKPENI+L+       ++K+ D+  L+   +DG  FKN+       
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG-LAHEIEDGVEFKNI------- 178
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
              FG+  F               APE++         D+WS+G I   L SG + F   
Sbjct: 179 ---FGTPEF--------------VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221
Query: 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVW 375
              E LA +  V          +    A+ + R+    +     T ++++R  W
Sbjct: 222 TKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/294 (22%), Positives = 124/294 (42%), Gaps = 44/294 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRLA 146
           Y I  ++G G F  V +C +       A K ++            RE    E+ +L+++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
            H++     + + + ++ R  + ++ E + G  L+DFL +    S   +      +Q+L+
Sbjct: 74  HHNV-----ITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILD 126
Query: 206 SVAFMHELRLIHTDLKPENILLVSAE----YVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
            V ++H  ++ H DLKPENI+L+       ++K+ D+  L+   +DG  FKN+       
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG-LAHEIEDGVEFKNI------- 178
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
              FG              T  + APE++         D+WS+G I   L SG + F   
Sbjct: 179 ---FG--------------TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221
Query: 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVW 375
              E LA +  V          +    A+ + R+    +     T ++++R  W
Sbjct: 222 TKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 35/230 (15%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR--HDIG 151
           Y +   +G+G F  V  C + E  +  A+KIV  + K+  +  +  + L+R A   H + 
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIV-DVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPID--LVRELGRQLLESVA 208
               V++   +     + +VFE + G  L   + K +   F     +     RQ+LE++ 
Sbjct: 85  HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           + H+  +IH D+KPEN+LL S E                         S+ +KL DFG  
Sbjct: 145 YCHDNNIIHRDVKPENVLLASKE------------------------NSAPVKLGDFG-V 179
Query: 269 TFEHQDHSYV----VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
             +  +   V    V T H+ APEV+    +  P D+W  G IL  L SG
Sbjct: 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 75/141 (53%), Gaps = 26/141 (18%)
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++  G+ F   P      
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFG-LARTA--GTSFMMTP------ 184
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
                          YVV TR+YRAPEVILG+G+    D+WSVGCI+ E+   + LF   
Sbjct: 185 ---------------YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 228
Query: 322 ENLEHL-AMMERVLGPLPHHM 341
           + ++    ++E++  P P  M
Sbjct: 229 DYIDQWNKVIEQLGTPCPEFM 249

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 115/263 (43%), Gaps = 52/263 (19%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLARHDIG 151
           RY+ L  +G G  G V   +D      VAIK + R       A         + A  ++ 
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---------KRAYRELV 113
Query: 152 GTRCVQIRNWFDYRN------------HICIVFEKLGPSLYDFLRKNSYRSFPIDLVREL 199
             +CV  +N     N             + +V E +  +L   ++         + +  L
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYL 169
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
             Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++  G+ F   P    
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA--GTSFMMTP---- 222
Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
                            YVV TR+YRAPEVILG+G+    D+WSVGCI+ E+   + LF 
Sbjct: 223 -----------------YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 264
Query: 320 THENLEHL-AMMERVLGPLPHHM 341
             + ++    ++E++  P P  M
Sbjct: 265 GRDYIDQWNKVIEQLGTPCPEFM 287

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 113/260 (43%), Gaps = 52/260 (20%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV----------RSINKYREAAMI 137
           EN  P+      +G G    V  C      +  A+KI+            + + REA + 
Sbjct: 4   ENYEPK----EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 59
Query: 138 EIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPS-LYDFLRKNSYRSFPIDLV 196
           E+D+L++++ H       +Q+++ ++      +VF+ +    L+D+L +    +      
Sbjct: 60  EVDILRKVSGH----PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKET 113
Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256
           R++ R LLE +  +H+L ++H DLKPENILL     +K+ D+ F  +             
Sbjct: 114 RKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ------------- 160
Query: 257 SSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVI-LGLGWNYP-----CDLWSVGCILVE 310
                 +D G    E      V  T  Y APE+I   +  N+P      D+WS G I+  
Sbjct: 161 ------LDPGEKLRE------VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT 208
Query: 311 LCSGEALFQTHENLEHLAMM 330
           L +G   F   + +  L M+
Sbjct: 209 LLAGSPPFWHRKQMLMLRMI 228

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 101/223 (45%), Gaps = 32/223 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           + +L K+GEG++G V +    E  ++VAIK V   +  +E  + EI ++Q+         
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEI-IKEISIMQQC-----DSP 84
Query: 154 RCVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
             V+    +     + IV E  G  S+ D +R  + ++   D +  + +  L+ + ++H 
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHF 143
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
           +R IH D+K  NILL +  + K+ D+                           G  T   
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVA------------------------GQLTDXM 179
Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
              + V+ T  + APEVI  +G+N   D+WS+G   +E+  G+
Sbjct: 180 AKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/294 (22%), Positives = 123/294 (41%), Gaps = 44/294 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRLA 146
           Y I  ++G G F  V +C +       A K ++            RE    E+ +L+++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
            H++     + + + ++ R  + ++ E + G  L+DFL +    S   +      +Q+L+
Sbjct: 74  HHNV-----ITLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILD 126
Query: 206 SVAFMHELRLIHTDLKPENILLVSAE----YVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
            V ++H  ++ H DLKPENI+L+       ++K+ D+  L+   +DG  FKN+       
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG-LAHEIEDGVEFKNI------- 178
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
              FG              T  + APE++         D+WS+G I   L SG + F   
Sbjct: 179 ---FG--------------TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221
Query: 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVW 375
              E LA +  V               A+ + R+    +     T ++++R  W
Sbjct: 222 TKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/294 (22%), Positives = 123/294 (41%), Gaps = 44/294 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRLA 146
           Y I  ++G G F  V +C +       A K ++            RE    E+ +L+++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
            H++     + + + ++ R  + ++ E + G  L+DFL +    S   +      +Q+L+
Sbjct: 74  HHNV-----ITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILD 126
Query: 206 SVAFMHELRLIHTDLKPENILLVSAE----YVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
            V ++H  ++ H DLKPENI+L+       ++K+ D+  L+   +DG  FKN+       
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG-LAHEIEDGVEFKNI------- 178
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
              FG+  F               APE++         D+WS+G I   L SG + F   
Sbjct: 179 ---FGTPEF--------------VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221
Query: 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVW 375
              E LA +  V               A+ + R+    +     T ++++R  W
Sbjct: 222 TKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/294 (22%), Positives = 123/294 (41%), Gaps = 44/294 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRLA 146
           Y I  ++G G F  V +C +       A K ++            RE    E+ +L+++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
            H++     + + + ++ R  + ++ E + G  L+DFL +    S   +      +Q+L+
Sbjct: 74  HHNV-----ITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILD 126
Query: 206 SVAFMHELRLIHTDLKPENILLVSAE----YVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
            V ++H  ++ H DLKPENI+L+       ++K+ D+  L+   +DG  FKN+       
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG-LAHEIEDGVEFKNI------- 178
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
              FG+  F               APE++         D+WS+G I   L SG + F   
Sbjct: 179 ---FGTPEF--------------VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221
Query: 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVW 375
              E LA +  V               A+ + R+    +     T ++++R  W
Sbjct: 222 TKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 52/297 (17%)
Query: 69  GSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI 128
           G   +R +D + HY   +GE L          G G F  V +C      +  A K ++  
Sbjct: 1   GMSTFRQEDVEDHY--EMGEEL----------GSGQFAIVRKCRQKGTGKEYAAKFIKKR 48
Query: 129 -------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLY 180
                     RE    E+++L+ + RH       + + + F+ +  + ++ E + G  L+
Sbjct: 49  RLSSSRRGVSREEIEREVNILREI-RH----PNIITLHDIFENKTDVVLILELVSGGELF 103
Query: 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240
           DFL +    S   D   +  +Q+L+ V ++H  R+ H DLKPENI+L+            
Sbjct: 104 DFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLD----------- 150
Query: 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYP 298
                      KN+P +  IKLIDFG        + +  +  T  + APE++        
Sbjct: 151 -----------KNVP-NPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLE 198
Query: 299 CDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRR 355
            D+WS+G I   L SG + F      E L  +  V               A+ + RR
Sbjct: 199 ADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRR 255

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 115/263 (43%), Gaps = 52/263 (19%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLARHDIG 151
           RY+ L  +G G  G V   +D      VAIK + R       A         + A  ++ 
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---------KRAYRELV 113
Query: 152 GTRCVQIRNWFDYRN------------HICIVFEKLGPSLYDFLRKNSYRSFPIDLVREL 199
             +CV  +N     N             + +V E +  +L   ++         + +  L
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYL 169
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
             Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++  G+ F   P    
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA--GTSFMMTP---- 222
Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
                            YVV TR+YRAPEVILG+G+    D+WSVGCI+ E+   + LF 
Sbjct: 223 -----------------YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 264
Query: 320 THENLEHL-AMMERVLGPLPHHM 341
             + ++    ++E++  P P  M
Sbjct: 265 GRDYIDQWNKVIEQLGTPCPEFM 287

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 128/297 (43%), Gaps = 44/297 (14%)
Query: 81  HYVFAIGENLTP-RYRILSKMGEGTFGQVV---ECFDNEKKELVAIKIVRSIN---KYRE 133
           H+V A  E   P  + +L  +G+G+FG+V    +    +   L A+K+++      + R 
Sbjct: 16  HHVKAGSEKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRV 75
Query: 134 AAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFP 192
              +E D+L      D+     V++   F     + ++ + L G  L+  L K     F 
Sbjct: 76  RTKMERDILA-----DVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM--FT 128
Query: 193 IDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 252
            + V+    +L   +  +H L +I+ DLKPENILL    ++K+ D+  LS+ + D     
Sbjct: 129 EEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG-LSKEAID----- 182
Query: 253 NLPKSSAIKLIDFGSTTFEHQDHSYVV-STRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
                              H+  +Y    T  Y APEV+   G ++  D WS G ++ E+
Sbjct: 183 -------------------HEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEM 223
Query: 312 CSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRR--GARL-DWPDGA 365
            +G   FQ  +  E + ++ +    +P  +   A       F+R    RL   PDGA
Sbjct: 224 LTGSLPFQGKDRKETMTLILKAKLGMPQFLSTEAQSLLRALFKRNPANRLGSGPDGA 280

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 114/261 (43%), Gaps = 48/261 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLARHDIG 151
           RY+ L  +G G  G V   +D      VAIK + R       A         + A  ++ 
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---------KRAYRELV 76
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYD------FLRKNSYRSFPIDLVRE----LGR 201
             +CV  +N     N      +K      D       +  N  +   ++L  E    L  
Sbjct: 77  LMKCVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 134
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++  G+ F   P      
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA--GTSFMMTP------ 185
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
                          YVV TR+YRAPEVILG+G+    D+WSVGCI+ E+   + LF   
Sbjct: 186 ---------------YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 229
Query: 322 ENLEHL-AMMERVLGPLPHHM 341
           + ++    ++E++  P P  M
Sbjct: 230 DYIDQWNKVIEQLGTPCPEFM 250

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 109/263 (41%), Gaps = 47/263 (17%)
Query: 81  HYVFAIGENLTPR------------YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI 128
           +YVF I +   P+            Y I  ++G G FG V    +       A K V + 
Sbjct: 134 NYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP 193
Query: 129 NKY-REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKN 186
           ++  +E    EI  +  L RH       V + + F+  N + +++E + G  L++ +  +
Sbjct: 194 HESDKETVRKEIQTMSVL-RHPT----LVNLHDAFEDDNEMVMIYEFMSGGELFEKV-AD 247
Query: 187 SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246
            +     D   E  RQ+ + +  MHE   +H DLKPENI+  +                 
Sbjct: 248 EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK---------------- 291
Query: 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVS--TRHYRAPEVILGLGWNYPCDLWSV 304
                    +S+ +KLIDFG T       S  V+  T  + APEV  G    Y  D+WSV
Sbjct: 292 ---------RSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSV 342
Query: 305 GCILVELCSGEALFQTHENLEHL 327
           G +   L SG + F    + E L
Sbjct: 343 GVLSYILLSGLSPFGGENDDETL 365

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 114/261 (43%), Gaps = 48/261 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLARHDIG 151
           RY+ L  +G G  G V   +D      VAIK + R       A         + A  ++ 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---------KRAYRELV 75
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYD------FLRKNSYRSFPIDLVRE----LGR 201
             +CV  +N     N      +K      D       +  N  +   ++L  E    L  
Sbjct: 76  LMKCVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 133
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++  G+ F   P      
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA--GTSFMMTP------ 184
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
                          YVV TR+YRAPEVILG+G+    D+WSVGCI+ E+   + LF   
Sbjct: 185 ---------------YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 228
Query: 322 ENLEHL-AMMERVLGPLPHHM 341
           + ++    ++E++  P P  M
Sbjct: 229 DYIDQWNKVIEQLGTPCPEFM 249

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 110/256 (42%), Gaps = 51/256 (19%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLARHDIG 151
           RY+ L  +G G  G V   FD      VA+K + R       A         + A  ++ 
Sbjct: 25  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA---------KRAYRELV 75
Query: 152 GTRCVQIRNWFDYRN------------HICIVFEKLGPSLYDFLRKNSYRSFPIDLVREL 199
             +CV  +N     N             + +V E +  +L   +    +     + +  L
Sbjct: 76  LLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI----HMELDHERMSYL 131
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
             Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++              
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA-------------- 176
Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
               +F  T +        V TR+YRAPEVILG+G+    D+WSVGCI+ EL  G  +FQ
Sbjct: 177 --CTNFMMTPY--------VVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQ 226
Query: 320 THENLEHLAMMERVLG 335
             ++++    +   LG
Sbjct: 227 GTDHIDQWNKVIEQLG 242

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 114/261 (43%), Gaps = 48/261 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLARHDIG 151
           RY+ L  +G G  G V   +D      VAIK + R       A         + A  ++ 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---------KRAYRELV 75
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYD------FLRKNSYRSFPIDLVRE----LGR 201
             +CV  +N     N      +K      D       +  N  +   ++L  E    L  
Sbjct: 76  LMKCVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 133
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++  G+ F   P      
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA--GTSFMMTP------ 184
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
                          YVV TR+YRAPEVILG+G+    D+WSVGCI+ E+   + LF   
Sbjct: 185 ---------------YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 228
Query: 322 ENLEHL-AMMERVLGPLPHHM 341
           + ++    ++E++  P P  M
Sbjct: 229 DYIDQWNKVIEQLGTPCPEFM 249

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 114/261 (43%), Gaps = 48/261 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLARHDIG 151
           RY+ L  +G G  G V   +D      VAIK + R       A         + A  ++ 
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---------KRAYRELV 76
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYD------FLRKNSYRSFPIDLVRE----LGR 201
             +CV  +N     N      +K      D       +  N  +   ++L  E    L  
Sbjct: 77  LMKCVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 134
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++  G+ F   P      
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA--GTSFMMTP------ 185
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
                          YVV TR+YRAPEVILG+G+    D+WSVGCI+ E+   + LF   
Sbjct: 186 ---------------YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 229
Query: 322 ENLEHL-AMMERVLGPLPHHM 341
           + ++    ++E++  P P  M
Sbjct: 230 DYIDQWNKVIEQLGTPCPEFM 250

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 114/261 (43%), Gaps = 48/261 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLARHDIG 151
           RY+ L  +G G  G V   +D      VAIK + R       A         + A  ++ 
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---------KRAYRELV 69
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYD------FLRKNSYRSFPIDLVRE----LGR 201
             +CV  +N     N      +K      D       +  N  +   ++L  E    L  
Sbjct: 70  LMKCVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 127
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++  G+ F   P      
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA--GTSFMMTP------ 178
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
                          YVV TR+YRAPEVILG+G+    D+WSVGCI+ E+   + LF   
Sbjct: 179 ---------------YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 222
Query: 322 ENLEHL-AMMERVLGPLPHHM 341
           + ++    ++E++  P P  M
Sbjct: 223 DYIDQWNKVIEQLGTPCPEFM 243

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 114/261 (43%), Gaps = 48/261 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLARHDIG 151
           RY+ L  +G G  G V   +D      VAIK + R       A         + A  ++ 
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---------KRAYRELV 69
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYD------FLRKNSYRSFPIDLVRE----LGR 201
             +CV  +N     N      +K      D       +  N  +   ++L  E    L  
Sbjct: 70  LMKCVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 127
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++  G+ F   P      
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA--GTSFMMTP------ 178
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
                          YVV TR+YRAPEVILG+G+    D+WSVGCI+ E+   + LF   
Sbjct: 179 ---------------YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 222
Query: 322 ENLEHL-AMMERVLGPLPHHM 341
           + ++    ++E++  P P  M
Sbjct: 223 DYIDQWNKVIEQLGTPCPEFM 243

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 109/263 (41%), Gaps = 47/263 (17%)
Query: 81  HYVFAIGENLTPR------------YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI 128
           +YVF I +   P+            Y I  ++G G FG V    +       A K V + 
Sbjct: 28  NYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP 87
Query: 129 NKY-REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKN 186
           ++  +E    EI  +  L RH       V + + F+  N + +++E + G  L++ +  +
Sbjct: 88  HESDKETVRKEIQTMSVL-RHPT----LVNLHDAFEDDNEMVMIYEFMSGGELFEKV-AD 141
Query: 187 SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246
            +     D   E  RQ+ + +  MHE   +H DLKPENI+  +                 
Sbjct: 142 EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK---------------- 185
Query: 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVS--TRHYRAPEVILGLGWNYPCDLWSV 304
                    +S+ +KLIDFG T       S  V+  T  + APEV  G    Y  D+WSV
Sbjct: 186 ---------RSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSV 236
Query: 305 GCILVELCSGEALFQTHENLEHL 327
           G +   L SG + F    + E L
Sbjct: 237 GVLSYILLSGLSPFGGENDDETL 259

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 114/261 (43%), Gaps = 48/261 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLARHDIG 151
           RY+ L  +G G  G V   +D      VAIK + R       A         + A  ++ 
Sbjct: 24  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---------KRAYRELV 74
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYD------FLRKNSYRSFPIDLVRE----LGR 201
             +CV  +N     N      +K      D       +  N  +   ++L  E    L  
Sbjct: 75  LMKCVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 132
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++  G+ F   P      
Sbjct: 133 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA--GTSFMMTP------ 183
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
                          YVV TR+YRAPEVILG+G+    D+WSVGCI+ E+   + LF   
Sbjct: 184 ---------------YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 227
Query: 322 ENLEHL-AMMERVLGPLPHHM 341
           + ++    ++E++  P P  M
Sbjct: 228 DYIDQWNKVIEQLGTPCPEFM 248

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 121/290 (41%), Gaps = 56/290 (19%)
Query: 67  RTGSPPWRPDDKDGHYVFAIGENLTPRYRI-------LSKMGEGTFGQVVECFDNEKKEL 119
           R+GSP      ++     A      P++R+       L  +G+GTFG+V+   +      
Sbjct: 124 RSGSPSDNSGAEEMEVSLA-----KPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRY 178
Query: 120 VAIKIVRS--INKYREAA--MIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175
            A+KI++   I    E A  + E  VLQ  +RH         ++  F   + +C V E  
Sbjct: 179 YAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPF----LTALKYSFQTHDRLCFVMEYA 233
Query: 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLVSAEYV 233
            G  L+  L +   R F  D  R  G +++ ++ ++H E  +++ DLK EN++L    ++
Sbjct: 234 NGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHI 291
Query: 234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL 293
           K+ D+       KDG+  K                            T  Y APEV+   
Sbjct: 292 KITDFGLCKEGIKDGATMKTF------------------------CGTPEYLAPEVLEDN 327
Query: 294 GWNYPCDLWSVGCILVELCSGEALF--QTHENLEHLAMME-----RVLGP 336
            +    D W +G ++ E+  G   F  Q HE L  L +ME     R LGP
Sbjct: 328 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGP 377

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 114/261 (43%), Gaps = 48/261 (18%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLARHDIG 151
           RY+ L  +G G  G V   +D      VAIK + R       A         + A  ++ 
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---------KRAYRELV 68
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYD------FLRKNSYRSFPIDLVRE----LGR 201
             +CV  +N     N      +K      D       +  N  +   ++L  E    L  
Sbjct: 69  LMKCVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 126
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           Q+L  +  +H   +IH DLKP NI++ S   +K+ D+  L+R++  G+ F   P      
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA--GTSFMMTP------ 177
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
                          YVV TR+YRAPEVILG+G+    D+WSVGCI+ E+   + LF   
Sbjct: 178 ---------------YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221
Query: 322 ENLEHL-AMMERVLGPLPHHM 341
           + ++    ++E++  P P  M
Sbjct: 222 DYIDQWNKVIEQLGTPCPEFM 242

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 114/267 (42%), Gaps = 52/267 (19%)
Query: 81  HYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV----------RSINK 130
           H      EN  P+      +G G    V  C      +  A+KI+            + +
Sbjct: 10  HSTHGFYENYEPK----EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQE 65
Query: 131 YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPS-LYDFLRKNSYR 189
            REA + E+D+L++++ H       +Q+++ ++      +VF+ +    L+D+L +    
Sbjct: 66  LREATLKEVDILRKVSGH----PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-- 119
Query: 190 SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249
           +      R++ R LLE +  +H+L ++H DLKPENILL     +K+ D+ F  +      
Sbjct: 120 TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ------ 173
Query: 250 YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVI-LGLGWNYP-----CDLWS 303
                        +D G      +    V  T  Y APE+I   +  N+P      D+WS
Sbjct: 174 -------------LDPG------EKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWS 214
Query: 304 VGCILVELCSGEALFQTHENLEHLAMM 330
            G I+  L +G   F   + +  L M+
Sbjct: 215 TGVIMYTLLAGSPPFWHRKQMLMLRMI 241

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 105/242 (43%), Gaps = 40/242 (16%)
Query: 86  IGENLTPRYRILSKMGEGTFGQVVEC---FDNEKKELVAIKIVRSIN-KYREAAMIEIDV 141
           +G N    +RI  K+G G F +V       D     L  ++I   ++ K R   + EID+
Sbjct: 26  MGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDL 85
Query: 142 LQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLR-----KNSYRSFPIDLV 196
           L++L   ++     ++    F   N + IV E       D  R     K   R  P   V
Sbjct: 86  LKQLNHPNV-----IKYYASFIEDNELNIVLELADAG--DLSRMIKHFKKQKRLIPERTV 138
Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256
            +   QL  ++  MH  R++H D+KP N+ + +   VK+ D          G +F +   
Sbjct: 139 WKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL-------GRFFSS--- 188
Query: 257 SSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 316
                      TT  H     +V T +Y +PE I   G+N+  D+WS+GC+L E+ + ++
Sbjct: 189 ----------KTTAAHS----LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 234
Query: 317 LF 318
            F
Sbjct: 235 PF 236

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 109/256 (42%), Gaps = 44/256 (17%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAA--MIEIDVLQRLARHD 149
           +  L  +G+GTFG+V+   +       A+KI++   I    E A  + E  VLQ  +RH 
Sbjct: 12  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHP 70
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                   ++  F   + +C V E   G  L+  L +   R F  D  R  G +++ ++ 
Sbjct: 71  F----LTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALD 124
Query: 209 FMH-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
           ++H E  +++ DLK EN++L    ++K+ D+       KDG+  K               
Sbjct: 125 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF------------- 171
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENLE 325
                        T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L 
Sbjct: 172 -----------CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 220
Query: 326 HLAMME-----RVLGP 336
            L +ME     R LGP
Sbjct: 221 ELILMEEIRFPRTLGP 236

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 109/256 (42%), Gaps = 44/256 (17%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAA--MIEIDVLQRLARHD 149
           +  L  +G+GTFG+V+   +       A+KI++   I    E A  + E  VLQ  +RH 
Sbjct: 11  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHP 69
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                   ++  F   + +C V E   G  L+  L +   R F  D  R  G +++ ++ 
Sbjct: 70  F----LTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALD 123
Query: 209 FMH-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
           ++H E  +++ DLK EN++L    ++K+ D+       KDG+  K               
Sbjct: 124 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF------------- 170
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENLE 325
                        T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L 
Sbjct: 171 -----------CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 219
Query: 326 HLAMME-----RVLGP 336
            L +ME     R LGP
Sbjct: 220 ELILMEEIRFPRTLGP 235

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 121/285 (42%), Gaps = 60/285 (21%)
Query: 87  GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRL 145
           G +L  RY  L  +G G  G V    DN+  + VAIK IV +  +  + A+ EI +++RL
Sbjct: 6   GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL 65
Query: 146 ARHDI---------GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLV 196
              +I          G++           N + IV E +   L + L +         L+
Sbjct: 66  DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP-------LL 118
Query: 197 RELGR----QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 252
            E  R    QLL  + ++H   ++H DLKP N+ + + + V                   
Sbjct: 119 EEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV------------------- 159
Query: 253 NLPKSSAIKLIDFG-----STTFEHQDH-SYVVSTRHYRAPEVILGLG-WNYPCDLWSVG 305
                  +K+ DFG        + H+ H S  + T+ YR+P ++L    +    D+W+ G
Sbjct: 160 -------LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG 212
Query: 306 CILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAE 350
           CI  E+ +G+ LF     LE    M+ +L  +P   V+  + R E
Sbjct: 213 CIFAEMLTGKTLFAGAHELEQ---MQLILESIP---VVHEEDRQE 251

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 109/256 (42%), Gaps = 44/256 (17%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAA--MIEIDVLQRLARHD 149
           +  L  +G+GTFG+V+   +       A+KI++   I    E A  + E  VLQ  +RH 
Sbjct: 10  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHP 68
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                   ++  F   + +C V E   G  L+  L +   R F  D  R  G +++ ++ 
Sbjct: 69  F----LTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALD 122
Query: 209 FMH-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
           ++H E  +++ DLK EN++L    ++K+ D+       KDG+  K               
Sbjct: 123 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF------------- 169
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENLE 325
                        T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L 
Sbjct: 170 -----------CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 218
Query: 326 HLAMME-----RVLGP 336
            L +ME     R LGP
Sbjct: 219 ELILMEEIRFPRTLGP 234

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 113/238 (47%), Gaps = 38/238 (15%)
Query: 94  YRILSK-MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR--HDI 150
           Y++ S+ +G G  G+V++ F+   +E  A+K+++   K R     E+++  R ++  H +
Sbjct: 33  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQCPHIV 88
Query: 151 GGTRCVQI-RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
              R V +  N +  R  + IV E L G  L+  ++    ++F      E+ + + E++ 
Sbjct: 89  ---RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 145
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-- 266
           ++H + + H D+KPEN+L  S    K P+                    + +KL DFG  
Sbjct: 146 YLHSINIAHRDVKPENLLYTS----KRPN--------------------AILKLTDFGFA 181
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
             T  H   +    T +Y APEV+    ++  CD+WS+G I+  L  G   F ++  L
Sbjct: 182 KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 239

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 113/238 (47%), Gaps = 38/238 (15%)
Query: 94  YRILSK-MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR--HDI 150
           Y++ S+ +G G  G+V++ F+   +E  A+K+++   K R     E+++  R ++  H +
Sbjct: 18  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQCPHIV 73
Query: 151 GGTRCVQI-RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
              R V +  N +  R  + IV E L G  L+  ++    ++F      E+ + + E++ 
Sbjct: 74  ---RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 130
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-- 266
           ++H + + H D+KPEN+L  S    K P+                    + +KL DFG  
Sbjct: 131 YLHSINIAHRDVKPENLLYTS----KRPN--------------------AILKLTDFGFA 166
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
             T  H   +    T +Y APEV+    ++  CD+WS+G I+  L  G   F ++  L
Sbjct: 167 KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 224

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 112/272 (41%), Gaps = 40/272 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-------NKYREAAMIEIDVLQRLA 146
           Y +  ++G G F  V +C      +  A K ++            RE    E+++L+ + 
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREI- 86
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
           RH       + + + F+ +  + ++ E + G  L+DFL +    S   D   +  +Q+L+
Sbjct: 87  RH----PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILD 140
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
            V ++H  R+ H DLKPENI+L+                       KN+P +  IKLIDF
Sbjct: 141 GVHYLHSKRIAHFDLKPENIMLLD----------------------KNVP-NPRIKLIDF 177
Query: 266 GSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
           G        + +  +  T  + APE++         D+WS+G I   L SG + F     
Sbjct: 178 GIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK 237
Query: 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRR 355
            E L  +  V               A+ + RR
Sbjct: 238 QETLTNISAVNYDFDEEYFSNTSELAKDFIRR 269

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 113/238 (47%), Gaps = 38/238 (15%)
Query: 94  YRILSK-MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR--HDI 150
           Y++ S+ +G G  G+V++ F+   +E  A+K+++   K R     E+++  R ++  H +
Sbjct: 17  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQCPHIV 72
Query: 151 GGTRCVQI-RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
              R V +  N +  R  + IV E L G  L+  ++    ++F      E+ + + E++ 
Sbjct: 73  ---RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 129
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-- 266
           ++H + + H D+KPEN+L  S    K P+                    + +KL DFG  
Sbjct: 130 YLHSINIAHRDVKPENLLYTS----KRPN--------------------AILKLTDFGFA 165
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
             T  H   +    T +Y APEV+    ++  CD+WS+G I+  L  G   F ++  L
Sbjct: 166 KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 223

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 113/238 (47%), Gaps = 38/238 (15%)
Query: 94  YRILSK-MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR--HDI 150
           Y++ S+ +G G  G+V++ F+   +E  A+K+++   K R     E+++  R ++  H +
Sbjct: 25  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQCPHIV 80
Query: 151 GGTRCVQI-RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
              R V +  N +  R  + IV E L G  L+  ++    ++F      E+ + + E++ 
Sbjct: 81  ---RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 137
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-- 266
           ++H + + H D+KPEN+L  S    K P+                    + +KL DFG  
Sbjct: 138 YLHSINIAHRDVKPENLLYTS----KRPN--------------------AILKLTDFGFA 173
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
             T  H   +    T +Y APEV+    ++  CD+WS+G I+  L  G   F ++  L
Sbjct: 174 KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 231

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 113/238 (47%), Gaps = 38/238 (15%)
Query: 94  YRILSK-MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR--HDI 150
           Y++ S+ +G G  G+V++ F+   +E  A+K+++   K R     E+++  R ++  H +
Sbjct: 23  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQCPHIV 78
Query: 151 GGTRCVQI-RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
              R V +  N +  R  + IV E L G  L+  ++    ++F      E+ + + E++ 
Sbjct: 79  ---RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 135
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-- 266
           ++H + + H D+KPEN+L  S    K P+                    + +KL DFG  
Sbjct: 136 YLHSINIAHRDVKPENLLYTS----KRPN--------------------AILKLTDFGFA 171
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
             T  H   +    T +Y APEV+    ++  CD+WS+G I+  L  G   F ++  L
Sbjct: 172 KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 229

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 113/238 (47%), Gaps = 38/238 (15%)
Query: 94  YRILSK-MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR--HDI 150
           Y++ S+ +G G  G+V++ F+   +E  A+K+++   K R     E+++  R ++  H +
Sbjct: 24  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQCPHIV 79
Query: 151 GGTRCVQI-RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
              R V +  N +  R  + IV E L G  L+  ++    ++F      E+ + + E++ 
Sbjct: 80  ---RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 136
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-- 266
           ++H + + H D+KPEN+L  S    K P+                    + +KL DFG  
Sbjct: 137 YLHSINIAHRDVKPENLLYTS----KRPN--------------------AILKLTDFGFA 172
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
             T  H   +    T +Y APEV+    ++  CD+WS+G I+  L  G   F ++  L
Sbjct: 173 KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 230

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 94/225 (41%), Gaps = 41/225 (18%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARHDIG--- 151
           L ++G+G+FG+V +  DN  KE+VAIKI+         E    EI VL +     I    
Sbjct: 24  LDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYF 83
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
           G+     + W        I+ E L G S  D L+        I  +    R++L+ + ++
Sbjct: 84  GSYLKSTKLW--------IIMEYLGGGSALDLLKPGPLEETYIATIL---REILKGLDYL 132
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H  R IH D+K  N+LL     VK+ D+                           G  T 
Sbjct: 133 HSERKIHRDIKAANVLLSEQGDVKLADFGVA------------------------GQLTD 168
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
                +  V T  + APEVI    +++  D+WS+G   +EL  GE
Sbjct: 169 TQIKRNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE 213

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 117/292 (40%), Gaps = 40/292 (13%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-------NKYREAAMIEIDVLQRLA 146
           Y +  ++G G F  V +C      +  A K ++            RE    E+++L+ + 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
             +I     + + + F+ +  + ++ E + G  L+DFL +    S   D   +  +Q+L+
Sbjct: 67  HPNI-----ITLHDIFENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILD 119
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
            V ++H  R+ H DLKPENI+L+                       KN+P +  IKLIDF
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLD----------------------KNVP-NPRIKLIDF 156
Query: 266 GSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
           G        + +  +  T  + APE++         D+WS+G I   L SG + F     
Sbjct: 157 GIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK 216
Query: 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVW 375
            E L  +  V               A+ + RR    D     T   S+   W
Sbjct: 217 QETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSW 268

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 113/238 (47%), Gaps = 38/238 (15%)
Query: 94  YRILSK-MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR--HDI 150
           Y++ S+ +G G  G+V++ F+   +E  A+K+++   K R     E+++  R ++  H +
Sbjct: 19  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQCPHIV 74
Query: 151 GGTRCVQI-RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
              R V +  N +  R  + IV E L G  L+  ++    ++F      E+ + + E++ 
Sbjct: 75  ---RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-- 266
           ++H + + H D+KPEN+L  S    K P+                    + +KL DFG  
Sbjct: 132 YLHSINIAHRDVKPENLLYTS----KRPN--------------------AILKLTDFGFA 167
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
             T  H   +    T +Y APEV+    ++  CD+WS+G I+  L  G   F ++  L
Sbjct: 168 KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 225

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 113/238 (47%), Gaps = 38/238 (15%)
Query: 94  YRILSK-MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR--HDI 150
           Y++ S+ +G G  G+V++ F+   +E  A+K+++   K R     E+++  R ++  H +
Sbjct: 69  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQCPHIV 124
Query: 151 GGTRCVQI-RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
              R V +  N +  R  + IV E L G  L+  ++    ++F      E+ + + E++ 
Sbjct: 125 ---RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 181
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-- 266
           ++H + + H D+KPEN+L  S    K P+                    + +KL DFG  
Sbjct: 182 YLHSINIAHRDVKPENLLYTS----KRPN--------------------AILKLTDFGFA 217
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
             T  H   +    T +Y APEV+    ++  CD+WS+G I+  L  G   F ++  L
Sbjct: 218 KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 275

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 113/238 (47%), Gaps = 38/238 (15%)
Query: 94  YRILSK-MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR--HDI 150
           Y++ S+ +G G  G+V++ F+   +E  A+K+++   K R     E+++  R ++  H +
Sbjct: 63  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQCPHIV 118
Query: 151 GGTRCVQI-RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
              R V +  N +  R  + IV E L G  L+  ++    ++F      E+ + + E++ 
Sbjct: 119 ---RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-- 266
           ++H + + H D+KPEN+L  S    K P+                    + +KL DFG  
Sbjct: 176 YLHSINIAHRDVKPENLLYTS----KRPN--------------------AILKLTDFGFA 211
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
             T  H   +    T +Y APEV+    ++  CD+WS+G I+  L  G   F ++  L
Sbjct: 212 KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 269

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 113/238 (47%), Gaps = 38/238 (15%)
Query: 94  YRILSK-MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR--HDI 150
           Y++ S+ +G G  G+V++ F+   +E  A+K+++   K R     E+++  R ++  H +
Sbjct: 19  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQCPHIV 74
Query: 151 GGTRCVQI-RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
              R V +  N +  R  + IV E L G  L+  ++    ++F      E+ + + E++ 
Sbjct: 75  ---RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-- 266
           ++H + + H D+KPEN+L  S    K P+                    + +KL DFG  
Sbjct: 132 YLHSINIAHRDVKPENLLYTS----KRPN--------------------AILKLTDFGFA 167
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
             T  H   +    T +Y APEV+    ++  CD+WS+G I+  L  G   F ++  L
Sbjct: 168 KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 225

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 113/238 (47%), Gaps = 38/238 (15%)
Query: 94  YRILSK-MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR--HDI 150
           Y++ S+ +G G  G+V++ F+   +E  A+K+++   K R     E+++  R ++  H +
Sbjct: 17  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQCPHIV 72
Query: 151 GGTRCVQI-RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
              R V +  N +  R  + IV E L G  L+  ++    ++F      E+ + + E++ 
Sbjct: 73  ---RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 129
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-- 266
           ++H + + H D+KPEN+L  S    K P+                    + +KL DFG  
Sbjct: 130 YLHSINIAHRDVKPENLLYTS----KRPN--------------------AILKLTDFGFA 165
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
             T  H   +    T +Y APEV+    ++  CD+WS+G I+  L  G   F ++  L
Sbjct: 166 KETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 223

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 95/222 (42%), Gaps = 35/222 (15%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARHDIGGTR 154
           L ++G+G+FG+V +  DN  +++VAIKI+         E    EI VL +        + 
Sbjct: 28  LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ-----CDSSY 82
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
             +    +   + + I+ E L G S  D LR   +  F I     + +++L+ + ++H  
Sbjct: 83  VTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQI---ATMLKEILKGLDYLHSE 139
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
           + IH D+K  N+LL     VK+ D+                           G  T    
Sbjct: 140 KKIHRDIKAANVLLSEQGDVKLADFGVA------------------------GQLTDTQI 175
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
             +  V T  + APEVI    ++   D+WS+G   +EL  GE
Sbjct: 176 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE 217

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 36/226 (15%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV-RSI---NKYREAAMIEIDVLQRLARHDIGGTRC 155
           +G+G F +  E  D + KE+ A KIV +S+      RE   +EI + + LA   + G   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG--- 81
Query: 156 VQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
                +F+  + + +V E     SL +  ++    + P    R   RQ++    ++H  R
Sbjct: 82  --FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP--EARYYLRQIVLGCQYLHRNR 137
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           +IH DLK  N+ L     VK+ D+   ++   DG   K L                    
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-------------------- 177
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320
                 T +Y APEV+   G ++  D+WS+GCI+  L  G+  F+T
Sbjct: 178 ----CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 219

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 36/226 (15%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV-RSI---NKYREAAMIEIDVLQRLARHDIGGTRC 155
           +G+G F +  E  D + KE+ A KIV +S+      RE   +EI + + LA   + G   
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG--- 85
Query: 156 VQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
                +F+  + + +V E     SL +  ++    + P    R   RQ++    ++H  R
Sbjct: 86  --FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP--EARYYLRQIVLGCQYLHRNR 141
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           +IH DLK  N+ L     VK+ D+   ++   DG   K L                    
Sbjct: 142 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-------------------- 181
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320
                 T +Y APEV+   G ++  D+WS+GCI+  L  G+  F+T
Sbjct: 182 ----CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 223

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 121/277 (43%), Gaps = 46/277 (16%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHD 149
           +Y  L K+GEG+FG+ +     E      IK   I R  +K RE +  E+ VL  +   +
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I     VQ R  F+    + IV +   G  L+  +       F  D + +   Q+  ++ 
Sbjct: 85  I-----VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK 139
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-- 266
            +H+ +++H D+K +NI L                 +KDG+          ++L DFG  
Sbjct: 140 HVHDRKILHRDIKSQNIFL-----------------TKDGT----------VQLGDFGIA 172
Query: 267 ---STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ--TH 321
              ++T E       + T +Y +PE+     +N   D+W++GC+L ELC+ +  F+  + 
Sbjct: 173 RVLNSTVELARA--CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM 230
Query: 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGAR 358
           +NL  L ++     P+  H          + F+R  R
Sbjct: 231 KNLV-LKIISGSFPPVSLHYSYDLRSLVSQLFKRNPR 266

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 36/226 (15%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV-RSI---NKYREAAMIEIDVLQRLARHDIGGTRC 155
           +G+G F +  E  D + KE+ A KIV +S+      RE   +EI + + LA   + G   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG--- 81
Query: 156 VQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
                +F+  + + +V E     SL +  ++    + P    R   RQ++    ++H  R
Sbjct: 82  --FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP--EARYYLRQIVLGCQYLHRNR 137
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           +IH DLK  N+ L     VK+ D+   ++   DG   K L                    
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-------------------- 177
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320
                 T +Y APEV+   G ++  D+WS+GCI+  L  G+  F+T
Sbjct: 178 ----CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 219

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 111/238 (46%), Gaps = 46/238 (19%)
Query: 87  GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAM-IEIDVLQR 144
            E++   Y     +G G F +V+   D   ++LVAIK I +   + +E +M  EI VL +
Sbjct: 13  AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHK 72
Query: 145 LARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGR-- 201
           +   +I     V + + ++   H+ ++ + + G  L+D + +  + +      R+  R  
Sbjct: 73  IKHPNI-----VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYT-----ERDASRLI 122
Query: 202 -QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+L++V ++H+L ++H DLKPEN+L                        + +L + S I
Sbjct: 123 FQVLDAVKYLHDLGIVHRDLKPENLL------------------------YYSLDEDSKI 158
Query: 261 KLIDFGSTTFEHQDHSYVVSTR----HYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
            + DFG +  E  D   V+ST      Y APEV+    ++   D WS+G I   L  G
Sbjct: 159 MISDFGLSKME--DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 111/238 (46%), Gaps = 46/238 (19%)
Query: 87  GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMI-EIDVLQR 144
            E++   Y     +G G F +V+   D   ++LVAIK I +   + +E +M  EI VL +
Sbjct: 13  AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHK 72
Query: 145 LARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGR-- 201
           +   +I     V + + ++   H+ ++ + + G  L+D + +  + +      R+  R  
Sbjct: 73  IKHPNI-----VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYT-----ERDASRLI 122
Query: 202 -QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+L++V ++H+L ++H DLKPEN+L                        + +L + S I
Sbjct: 123 FQVLDAVKYLHDLGIVHRDLKPENLL------------------------YYSLDEDSKI 158
Query: 261 KLIDFGSTTFEHQDHSYVVSTR----HYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
            + DFG +  E  D   V+ST      Y APEV+    ++   D WS+G I   L  G
Sbjct: 159 MISDFGLSKME--DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 111/238 (46%), Gaps = 46/238 (19%)
Query: 87  GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAM-IEIDVLQR 144
            E++   Y     +G G F +V+   D   ++LVAIK I +   + +E +M  EI VL +
Sbjct: 13  AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHK 72
Query: 145 LARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGR-- 201
           +   +I     V + + ++   H+ ++ + + G  L+D + +  + +      R+  R  
Sbjct: 73  IKHPNI-----VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYT-----ERDASRLI 122
Query: 202 -QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+L++V ++H+L ++H DLKPEN+L                        + +L + S I
Sbjct: 123 FQVLDAVKYLHDLGIVHRDLKPENLL------------------------YYSLDEDSKI 158
Query: 261 KLIDFGSTTFEHQDHSYVVSTR----HYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
            + DFG +  E  D   V+ST      Y APEV+    ++   D WS+G I   L  G
Sbjct: 159 MISDFGLSKME--DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 111/250 (44%), Gaps = 46/250 (18%)
Query: 70  SPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSI 128
           S  W+   +D   +F   E L          G G F +VV   +    +L A+K I +  
Sbjct: 10  SSSWKKQAEDIKKIFEFKETL----------GTGAFSEVVLAEEKATGKLFAVKCIPKKA 59
Query: 129 NKYREAAM-IEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKN 186
            K +E+++  EI VL+++   +I     V + + ++  NH+ +V + + G  L+D + + 
Sbjct: 60  LKGKESSIENEIAVLRKIKHENI-----VALEDIYESPNHLYLVMQLVSGGELFDRIVEK 114
Query: 187 SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246
            +  +       L RQ+L++V ++H + ++H DLKPEN+L  S +               
Sbjct: 115 GF--YTEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQD--------------- 157
Query: 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSV 304
                    + S I + DFG +  E +    S    T  Y APEV+    ++   D WS+
Sbjct: 158 ---------EESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSI 208
Query: 305 GCILVELCSG 314
           G I   L  G
Sbjct: 209 GVIAYILLCG 218

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 111/238 (46%), Gaps = 46/238 (19%)
Query: 87  GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAM-IEIDVLQR 144
            E++   Y     +G G F +V+   D   ++LVAIK I +   + +E +M  EI VL +
Sbjct: 13  AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHK 72
Query: 145 LARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGR-- 201
           +   +I     V + + ++   H+ ++ + + G  L+D + +  + +      R+  R  
Sbjct: 73  IKHPNI-----VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYT-----ERDASRLI 122
Query: 202 -QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+L++V ++H+L ++H DLKPEN+L                        + +L + S I
Sbjct: 123 FQVLDAVKYLHDLGIVHRDLKPENLL------------------------YYSLDEDSKI 158
Query: 261 KLIDFGSTTFEHQDHSYVVSTR----HYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
            + DFG +  E  D   V+ST      Y APEV+    ++   D WS+G I   L  G
Sbjct: 159 MISDFGLSKME--DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 121/270 (44%), Gaps = 49/270 (18%)
Query: 80  GHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR------------- 126
           G YV      +   Y  + K+G G +G+V+ C +       AIK+++             
Sbjct: 24  GMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDN 83
Query: 127 -SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLR 184
            +I K+ E    EI +L+ L   +I     +++ + F+ + +  +V E   G  L++ + 
Sbjct: 84  KNIEKFHEEIYNEISLLKSLDHPNI-----IKLFDVFEDKKYFYLVTEFYEGGELFEQII 138
Query: 185 KNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244
            N ++    D    + +Q+L  + ++H+  ++H D+KPENILL                 
Sbjct: 139 -NRHKFDECDAAN-IMKQILSGICYLHKHNIVHRDIKPENILL----------------- 179
Query: 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLW 302
                  +N      IK++DFG ++F  +D+     + T +Y APEV L   +N  CD+W
Sbjct: 180 -------ENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEV-LKKKYNEKCDVW 231
Query: 303 SVGCILVELCSGEALFQTHENLEHLAMMER 332
           S G I+  L  G   F    + + +  +E+
Sbjct: 232 SCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 129/307 (42%), Gaps = 64/307 (20%)
Query: 81  HYVFAIGENLTP-RYRILSKMGEGTFGQVV---ECFDNEKKELVAIKIVRSINKYREAAM 136
           H+V    E   P ++ +L  +G+G+FG+V    +   ++ ++L A+K+++      +A +
Sbjct: 12  HHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK------KATL 65
Query: 137 IEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLV 196
              D ++     DI     V++ + F  + H     E     + DFLR         DL 
Sbjct: 66  KVRDRVRTKMERDI----LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGG-------DLF 114
Query: 197 RELGRQLL---ESVAF-----------MHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242
             L ++++   E V F           +H L +I+ DLKPENILL    ++K+ D+  LS
Sbjct: 115 TRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG-LS 173
Query: 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVV-STRHYRAPEVILGLGWNYPCDL 301
           + S D                        H+  +Y    T  Y APEV+   G     D 
Sbjct: 174 KESID------------------------HEKKAYSFCGTVEYMAPEVVNRRGHTQSADW 209
Query: 302 WSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRR--GARL 359
           WS G ++ E+ +G   FQ  +  E + M+ +    +P  +   A       F+R    RL
Sbjct: 210 WSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRL 269
Query: 360 D-WPDGA 365
              PDG 
Sbjct: 270 GAGPDGV 276

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/252 (22%), Positives = 103/252 (40%), Gaps = 48/252 (19%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           L  +G+GTFG+V+   +       A+KI+R           E+ + +    H +  +R +
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRK----------EVIIAKDEVAHTVTESRVL 59
Query: 157 Q---------IRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
           Q         ++  F   + +C V E   G  L+  L +   R F  +  R  G +++ +
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSA 117
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           + ++H   +++ D+K EN++L    ++K+ D+        DG+  K              
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF------------ 165
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENL 324
                         T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L
Sbjct: 166 ------------CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213
Query: 325 EHLAMMERVLGP 336
             L +ME +  P
Sbjct: 214 FELILMEEIRFP 225

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/294 (22%), Positives = 123/294 (41%), Gaps = 44/294 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY-------REAAMIEIDVLQRLA 146
           Y I  ++G G F  V +C +       A K ++            RE    E+ +L+++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
             +I     + + + ++ R  + ++ E + G  L+DFL +    S   +      +Q+L+
Sbjct: 74  HPNI-----ITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILD 126
Query: 206 SVAFMHELRLIHTDLKPENILLVSAE----YVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
            V ++H  ++ H DLKPENI+L+       ++K+ D+  L+   +DG  FKN+       
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG-LAHEIEDGVEFKNI------- 178
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
              FG+  F               APE++         D+WS+G I   L SG + F   
Sbjct: 179 ---FGTPEF--------------VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221
Query: 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVW 375
              E LA +  V          +    A+ + R+    +     T ++++R  W
Sbjct: 222 TKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++  +  +  
Sbjct: 43  QFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDK-QKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V++   F   +++ +V E   G  ++  LR+    S P    R    Q++ +  ++H
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLH 159
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            L LI+ DLKPEN+L+    Y+KV D+ F  R                      G T   
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--------------------GRTW-- 197
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                 +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 198 -----XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/252 (22%), Positives = 103/252 (40%), Gaps = 48/252 (19%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           L  +G+GTFG+V+   +       A+KI+R           E+ + +    H +  +R +
Sbjct: 13  LKLLGKGTFGKVILVREKATGRYYAMKILRK----------EVIIAKDEVAHTVTESRVL 62
Query: 157 Q---------IRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
           Q         ++  F   + +C V E   G  L+  L +   R F  +  R  G +++ +
Sbjct: 63  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSA 120
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           + ++H   +++ D+K EN++L    ++K+ D+        DG+  K              
Sbjct: 121 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF------------ 168
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENL 324
                         T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L
Sbjct: 169 ------------CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 216
Query: 325 EHLAMMERVLGP 336
             L +ME +  P
Sbjct: 217 FELILMEEIRFP 228

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/252 (22%), Positives = 103/252 (40%), Gaps = 48/252 (19%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           L  +G+GTFG+V+   +       A+KI+R           E+ + +    H +  +R +
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRK----------EVIIAKDEVAHTVTESRVL 59
Query: 157 Q---------IRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
           Q         ++  F   + +C V E   G  L+  L +   R F  +  R  G +++ +
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSA 117
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           + ++H   +++ D+K EN++L    ++K+ D+        DG+  K              
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF------------ 165
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENL 324
                         T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L
Sbjct: 166 ------------CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213
Query: 325 EHLAMMERVLGP 336
             L +ME +  P
Sbjct: 214 FELILMEEIRFP 225

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 36/226 (15%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV-RSI---NKYREAAMIEIDVLQRLARHDIGGTRC 155
           +G+G F +  E  D + KE+ A KIV +S+      RE   +EI + + LA   + G   
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG--- 105
Query: 156 VQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
                +F+  + + +V E     SL +  ++    + P    R   RQ++    ++H  R
Sbjct: 106 --FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP--EARYYLRQIVLGCQYLHRNR 161
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           +IH DLK  N+ L     VK+ D+   ++   DG   K L                    
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-------------------- 201
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320
                 T +Y APEV+   G ++  D+WS+GCI+  L  G+  F+T
Sbjct: 202 ----CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 243

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 129/307 (42%), Gaps = 64/307 (20%)
Query: 81  HYVFAIGENLTP-RYRILSKMGEGTFGQVV---ECFDNEKKELVAIKIVRSINKYREAAM 136
           H+V    E   P ++ +L  +G+G+FG+V    +   ++ ++L A+K+++      +A +
Sbjct: 13  HHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK------KATL 66
Query: 137 IEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLV 196
              D ++     DI     V++ + F  + H     E     + DFLR         DL 
Sbjct: 67  KVRDRVRTKMERDI----LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGG-------DLF 115
Query: 197 RELGRQLL---ESVAF-----------MHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242
             L ++++   E V F           +H L +I+ DLKPENILL    ++K+ D+  LS
Sbjct: 116 TRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG-LS 174
Query: 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVV-STRHYRAPEVILGLGWNYPCDL 301
           + S D                        H+  +Y    T  Y APEV+   G     D 
Sbjct: 175 KESID------------------------HEKKAYSFCGTVEYMAPEVVNRRGHTQSADW 210
Query: 302 WSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRR--GARL 359
           WS G ++ E+ +G   FQ  +  E + M+ +    +P  +   A       F+R    RL
Sbjct: 211 WSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRL 270
Query: 360 D-WPDGA 365
              PDG 
Sbjct: 271 GAGPDGV 277

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 36/226 (15%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV-RSI---NKYREAAMIEIDVLQRLARHDIGGTRC 155
           +G+G F +  E  D + KE+ A KIV +S+      RE   +EI + + LA   + G   
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG--- 103
Query: 156 VQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
                +F+  + + +V E     SL +  ++    + P    R   RQ++    ++H  R
Sbjct: 104 --FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP--EARYYLRQIVLGCQYLHRNR 159
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           +IH DLK  N+ L     VK+ D+   ++   DG   K L                    
Sbjct: 160 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-------------------- 199
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320
                 T +Y APEV+   G ++  D+WS+GCI+  L  G+  F+T
Sbjct: 200 ----CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 241

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 36/226 (15%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV-RSI---NKYREAAMIEIDVLQRLARHDIGGTRC 155
           +G+G F +  E  D + KE+ A KIV +S+      RE   +EI + + LA   + G   
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG--- 79
Query: 156 VQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
                +F+  + + +V E     SL +  ++    + P    R   RQ++    ++H  R
Sbjct: 80  --FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP--EARYYLRQIVLGCQYLHRNR 135
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           +IH DLK  N+ L     VK+ D+   ++   DG   K L                    
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-------------------- 175
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320
                 T +Y APEV+   G ++  D+WS+GCI+  L  G+  F+T
Sbjct: 176 ----CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 217

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/252 (22%), Positives = 103/252 (40%), Gaps = 48/252 (19%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           L  +G+GTFG+V+   +       A+KI+R           E+ + +    H +  +R +
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRK----------EVIIAKDEVAHTVTESRVL 59
Query: 157 Q---------IRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
           Q         ++  F   + +C V E   G  L+  L +   R F  +  R  G +++ +
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSA 117
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           + ++H   +++ D+K EN++L    ++K+ D+        DG+  K              
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF------------ 165
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENL 324
                         T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L
Sbjct: 166 ------------CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213
Query: 325 EHLAMMERVLGP 336
             L +ME +  P
Sbjct: 214 FELILMEEIRFP 225

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/252 (22%), Positives = 103/252 (40%), Gaps = 48/252 (19%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           L  +G+GTFG+V+   +       A+KI+R           E+ + +    H +  +R +
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRK----------EVIIAKDEVAHTVTESRVL 59
Query: 157 Q---------IRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
           Q         ++  F   + +C V E   G  L+  L +   R F  +  R  G +++ +
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSA 117
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           + ++H   +++ D+K EN++L    ++K+ D+        DG+  K              
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF------------ 165
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENL 324
                         T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L
Sbjct: 166 ------------CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213
Query: 325 EHLAMMERVLGP 336
             L +ME +  P
Sbjct: 214 FELILMEEIRFP 225

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 129/307 (42%), Gaps = 64/307 (20%)
Query: 81  HYVFAIGENLTP-RYRILSKMGEGTFGQVV---ECFDNEKKELVAIKIVRSINKYREAAM 136
           H+V    E   P ++ +L  +G+G+FG+V    +   ++ ++L A+K+++      +A +
Sbjct: 12  HHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK------KATL 65
Query: 137 IEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLV 196
              D ++     DI     V++ + F  + H     E     + DFLR         DL 
Sbjct: 66  KVRDRVRTKMERDI----LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGG-------DLF 114
Query: 197 RELGRQLL---ESVAF-----------MHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242
             L ++++   E V F           +H L +I+ DLKPENILL    ++K+ D+  LS
Sbjct: 115 TRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG-LS 173
Query: 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVV-STRHYRAPEVILGLGWNYPCDL 301
           + S D                        H+  +Y    T  Y APEV+   G     D 
Sbjct: 174 KESID------------------------HEKKAYSFCGTVEYMAPEVVNRRGHTQSADW 209
Query: 302 WSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRR--GARL 359
           WS G ++ E+ +G   FQ  +  E + M+ +    +P  +   A       F+R    RL
Sbjct: 210 WSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRL 269
Query: 360 D-WPDGA 365
              PDG 
Sbjct: 270 GAGPDGV 276

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 103/230 (44%), Gaps = 36/230 (15%)
Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAM-IEIDVLQRLAR 147
           N+   +  +  +G G F +V         +L A+K ++    +R++++  EI VL+++  
Sbjct: 6   NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH 65
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYD-FLRKNSYRSFPIDLVRELGRQLLE 205
            +I     V + + ++   H  +V + + G  L+D  L +  Y      LV +   Q+L 
Sbjct: 66  ENI-----VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ---QVLS 117
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           +V ++HE  ++H DLKPEN+L ++ E                        ++S I + DF
Sbjct: 118 AVKYLHENGIVHRDLKPENLLYLTPE------------------------ENSKIMITDF 153
Query: 266 GSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           G +  E     S    T  Y APEV+    ++   D WS+G I   L  G
Sbjct: 154 GLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 36/226 (15%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV-RSI---NKYREAAMIEIDVLQRLARHDIGGTRC 155
           +G+G F +  E  D + KE+ A K+V +S+      +E    EI + + L    + G   
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVG--- 106
Query: 156 VQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
                +F+  + + +V E     SL +  ++    + P    R   RQ ++ V ++H  R
Sbjct: 107 --FHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEP--EARYFMRQTIQGVQYLHNNR 162
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           +IH DLK  N+ L     VK+ D+   ++   DG   K+L                    
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDL-------------------- 202
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320
                 T +Y APEV+   G ++  D+WS+GCIL  L  G+  F+T
Sbjct: 203 ----CGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 244

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +  
Sbjct: 42  QFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNF 100
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLH 158
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            L LI+ DLKPEN+L+    Y+KV D+ F  R                      G T   
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--------------------GRTW-- 196
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                 +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 197 -----XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/255 (22%), Positives = 104/255 (40%), Gaps = 48/255 (18%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           +  L  +G+GTFG+V+   +       A+KI+R           E+ + +    H +  +
Sbjct: 12  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRK----------EVIIAKDEVAHTVTES 61
Query: 154 RCVQ---------IRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQL 203
           R +Q         ++  F   + +C V E   G  L+  L +   R F  +  R  G ++
Sbjct: 62  RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEI 119
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
           + ++ ++H   +++ D+K EN++L    ++K+ D+        DG+  K           
Sbjct: 120 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF--------- 170
Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTH 321
                            T  Y APEV+    +    D W +G ++ E+  G   F  Q H
Sbjct: 171 ---------------CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 215
Query: 322 ENLEHLAMMERVLGP 336
           E L  L +ME +  P
Sbjct: 216 ERLFELILMEEIRFP 230

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/252 (22%), Positives = 103/252 (40%), Gaps = 48/252 (19%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           L  +G+GTFG+V+   +       A+KI+R           E+ + +    H +  +R +
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRK----------EVIIAKDEVAHTVTESRVL 59
Query: 157 Q---------IRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
           Q         ++  F   + +C V E   G  L+  L +   R F  +  R  G +++ +
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSA 117
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           + ++H   +++ D+K EN++L    ++K+ D+        DG+  K              
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF------------ 165
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENL 324
                         T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L
Sbjct: 166 ------------CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213
Query: 325 EHLAMMERVLGP 336
             L +ME +  P
Sbjct: 214 FELILMEEIRFP 225

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 36/226 (15%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV-RSI---NKYREAAMIEIDVLQRLARHDIGGTRC 155
           +G+G F +  E  D + KE+ A K+V +S+      +E    EI + + L    + G   
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVG--- 90
Query: 156 VQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
                +F+  + + +V E     SL +  ++    + P    R   RQ ++ V ++H  R
Sbjct: 91  --FHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEP--EARYFMRQTIQGVQYLHNNR 146
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           +IH DLK  N+ L     VK+ D+   ++   DG   K+L                    
Sbjct: 147 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDL-------------------- 186
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320
                 T +Y APEV+   G ++  D+WS+GCIL  L  G+  F+T
Sbjct: 187 ----CGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 228

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +  
Sbjct: 42  QFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNF 100
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLH 158
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            L LI+ DLKPEN+L+    Y+KV D+ F  R                      G T   
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--------------------GRTW-- 196
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                 +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 197 -----XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 31/219 (14%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +     V
Sbjct: 67  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLV 125
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           ++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H L L
Sbjct: 126 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLDL 183
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           I+ DLKPEN+L+    Y++V D+ F  R                      G+T       
Sbjct: 184 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GATW------ 217
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
             +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 218 -TLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 105/248 (42%), Gaps = 45/248 (18%)
Query: 91  TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE---------AAMIEIDV 141
           + +Y  +S +G G FG V    D EK + V +K ++      +            +EI +
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 142 LQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGR 201
           L R+   +I     +++ + F+ +    +V EK G  L  F   + +      L   + R
Sbjct: 83  LSRVEHANI-----IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR 137
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           QL+ +V ++    +IH D+K ENI++         D+                     IK
Sbjct: 138 QLVSAVGYLRLKDIIHRDIKDENIVIAE-------DF--------------------TIK 170
Query: 262 LIDFGSTTFEHQDHSYVV--STRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALF 318
           LIDFGS  +  +   +     T  Y APEV++G  +  P  ++WS+G  L  L   E  F
Sbjct: 171 LIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230
Query: 319 -QTHENLE 325
            +  E +E
Sbjct: 231 CELEETVE 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDK-QKVVKLKQIEHTLNEKRILQAVNF 100
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLH 158
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            L LI+ DLKPEN+L+    Y++V D+ F  R                      G T   
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW-- 196
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                 +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 197 -----XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDK-QKVVKLKQIEHTLNEKRILQAVNF 100
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLH 158
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            L LI+ DLKPEN+L+    Y++V D+ F  R                      G T   
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW-- 196
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                 +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 197 -----XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDK-QKVVKLKQIEHTLNEKRILQAVNF 100
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLH 158
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            L LI+ DLKPEN+L+    Y++V D+ F  R                      G T   
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW-- 196
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                 +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 197 -----XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 99/226 (43%), Gaps = 36/226 (15%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV-RSI---NKYREAAMIEIDVLQRLARHDIGGTRC 155
           +G+G F +  E  D + KE+ A K+V +S+      +E    EI + + L    + G   
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVG--- 106
Query: 156 VQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
                +F+  + + +V E     SL +  ++    + P    R   RQ ++ V ++H  R
Sbjct: 107 --FHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEP--EARYFMRQTIQGVQYLHNNR 162
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           +IH DLK  N+ L     VK+ D+   ++   DG   K L                    
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTL-------------------- 202
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320
                 T +Y APEV+   G ++  D+WS+GCIL  L  G+  F+T
Sbjct: 203 ----CGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 244

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +     V
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           ++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H L L
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLDL 162
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           I+ DLKPEN+L+    Y++V D+ F  R                      G T       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW------ 196
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
             +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 197 -XLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 127/289 (43%), Gaps = 49/289 (16%)
Query: 48  GNGGMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPR--YRILSKMGEGTF 105
           GN G+    C  +   ++P   S P +P +KD   +        PR   ++  K+G G F
Sbjct: 157 GNDGL----CQKL---SVPCMSSKPQKPWEKDAWEI--------PRESLKLEKKLGAGQF 201
Query: 106 GQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165
           G+V     N K   VA+K ++  +   EA + E +V++ L +HD    + V++      +
Sbjct: 202 GEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHD----KLVKLHAVVT-K 254
Query: 166 NHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPEN 224
             I I+ E +   SL DFL+ +     P+  + +   Q+ E +AF+ +   IH DL+  N
Sbjct: 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAAN 314
Query: 225 ILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHY 284
           IL+ ++   K+ D+  L+R  +D  Y         IK                      +
Sbjct: 315 ILVSASLVCKIADFG-LARVIEDNEYTAREGAKFPIK----------------------W 351
Query: 285 RAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
            APE I    +    D+WS G +L+E+ + G   +    N E +  +ER
Sbjct: 352 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 105/228 (46%), Gaps = 35/228 (15%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-EAAMIEIDVLQRLARHDIGG 152
           + I+ ++G+G FG+V +  + E   L A K++ + ++   E  ++EI++L       I  
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI-- 78
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
              V++   + +   + I+ E       D +     R      ++ + RQ+LE++ F+H 
Sbjct: 79  ---VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
            R+IH DLK  N+L+     +++ D+         G   KNL              T + 
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADF---------GVSAKNL-------------KTLQK 173
Query: 273 QDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGE 315
           +D    + T ++ APEV++        ++Y  D+WS+G  L+E+   E
Sbjct: 174 RDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 38/221 (17%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159
           +G G  G+V+ECF     +  A+K++    K R+    E+D   + +    GG   V I 
Sbjct: 18  LGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ----EVDHHWQAS----GGPHIVCIL 69
Query: 160 NWFDYRNH----ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
           + ++  +H    + I+ E + G  L+  +++   ++F      E+ R +  ++ F+H   
Sbjct: 70  DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN 129
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           + H D+KPEN+L  S E                        K + +KL DFG      Q+
Sbjct: 130 IAHRDVKPENLLYTSKE------------------------KDAVLKLTDFGFAKETTQN 165
Query: 275 HSYV-VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                  T +Y APEV+    ++  CD+WS+G I+  L  G
Sbjct: 166 ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 206

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +  
Sbjct: 63  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNF 121
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLH 179
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            L LI+ DLKPEN+L+    Y++V D+ F  R                      G T   
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW-- 217
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                 +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 218 -----XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +  
Sbjct: 35  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNF 93
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLH 151
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            L LI+ DLKPEN+L+    Y++V D+ F  R                      G T   
Sbjct: 152 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW-- 189
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                 +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 190 -----XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +  
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNF 101
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLH 159
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            L LI+ DLKPEN+L+    Y++V D+ F  R                      G T   
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW-- 197
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                 +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 198 -----XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 105/228 (46%), Gaps = 35/228 (15%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-EAAMIEIDVLQRLARHDIGG 152
           + I+ ++G+G FG+V +  + E   L A K++ + ++   E  ++EI++L       I  
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI-- 70
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
              V++   + +   + I+ E       D +     R      ++ + RQ+LE++ F+H 
Sbjct: 71  ---VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 127
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
            R+IH DLK  N+L+     +++ D+         G   KNL              T + 
Sbjct: 128 KRIIHRDLKAGNVLMTLEGDIRLADF---------GVSAKNL-------------KTLQK 165
Query: 273 QDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGE 315
           +D    + T ++ APEV++        ++Y  D+WS+G  L+E+   E
Sbjct: 166 RDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 211

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +  
Sbjct: 42  QFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNF 100
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLH 158
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            L LI+ DLKPEN+L+    Y+KV D+ F  R                      G T   
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--------------------GRTW-- 196
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                 +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 197 -----XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +  
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNF 101
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLH 159
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            L LI+ DLKPEN+L+    Y++V D+ F  R                      G T   
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW-- 197
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                 +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 198 -----XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 38/221 (17%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159
           +G G  G+V+ECF     +  A+K++    K R+    E+D   + +    GG   V I 
Sbjct: 37  LGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ----EVDHHWQAS----GGPHIVCIL 88
Query: 160 NWFDYRNH----ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
           + ++  +H    + I+ E + G  L+  +++   ++F      E+ R +  ++ F+H   
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN 148
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           + H D+KPEN+L  S E                        K + +KL DFG      Q+
Sbjct: 149 IAHRDVKPENLLYTSKE------------------------KDAVLKLTDFGFAKETTQN 184
Query: 275 HSYV-VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                  T +Y APEV+    ++  CD+WS+G I+  L  G
Sbjct: 185 ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +  
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNF 101
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLH 159
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            L LI+ DLKPEN+L+    Y++V D+ F  R                      G T   
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW-- 197
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                 +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 198 -----XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +     V
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           ++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H L L
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLDL 162
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           I+ DLKPEN+L+    Y++V D+ F  R                      G T       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW------ 196
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
             +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 197 -XLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 99/226 (43%), Gaps = 36/226 (15%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV-RSI---NKYREAAMIEIDVLQRLARHDIGGTRC 155
           +G+G F +  E  D + KE+ A K+V +S+      +E    EI + + L    + G   
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVG--- 106
Query: 156 VQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
                +F+  + + +V E     SL +  ++    + P    R   RQ ++ V ++H  R
Sbjct: 107 --FHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEP--EARYFMRQTIQGVQYLHNNR 162
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           +IH DLK  N+ L     VK+ D+   ++   DG   K L                    
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXL-------------------- 202
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320
                 T +Y APEV+   G ++  D+WS+GCIL  L  G+  F+T
Sbjct: 203 ----CGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 244

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 104/240 (43%), Gaps = 37/240 (15%)
Query: 86  IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL 145
           IG+ +  RY+I+ K+G G    V    D      VAIK +    + +E      + L+R 
Sbjct: 5   IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKE------ETLKRF 58
Query: 146 AR--HDIGGTRCVQIRNWFDYRNH---ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
            R  H+        I +  D         +V E + GP+L +++   S+    +D     
Sbjct: 59  EREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE--SHGPLSVDTAINF 116
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
             Q+L+ +   H++R++H D+KP+NIL+ S + +K+ D+      S+             
Sbjct: 117 TNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE------------- 163
Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
                   T+    +H  V+ T  Y +PE   G   +   D++S+G +L E+  GE  F 
Sbjct: 164 --------TSLTQTNH--VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN 213

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 31/223 (13%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +  
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNF 101
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V++   F   +++ +V E   G  ++  LR+    S P    R    Q++ +  ++H
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLH 159
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            L LI+ DLKPEN+++    Y+KV D+ F  R                      G T   
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--------------------GRTW-- 197
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                 +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 198 -----XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +     V
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           ++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H L L
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLDL 162
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           I+ DLKPEN+L+    Y++V D+ F  R                      G T       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW------ 196
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
             +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 197 -XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 101/230 (43%), Gaps = 31/230 (13%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +     V
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           ++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H L L
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLDL 162
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           I+ DLKPEN+L+    Y++V D+ F  R                      G T       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW------ 196
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
             +  T  Y APE+IL  G+N   D W++G ++ E+ +G   F   E ++
Sbjct: 197 -XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQ 245

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +     V
Sbjct: 33  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLV 91
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           ++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H L L
Sbjct: 92  KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLDL 149
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           I+ DLKPEN+L+    Y++V D+ F  R                      G T       
Sbjct: 150 IYRDLKPENLLIDEQGYIQVTDFGFAKRVK--------------------GRTW------ 183
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
             +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 184 -XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +     V
Sbjct: 47  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLV 105
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           ++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H L L
Sbjct: 106 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLDL 163
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           I+ DLKPEN+L+    Y++V D+ F  R                      G T       
Sbjct: 164 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW------ 197
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
             +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 198 -XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +     V
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           ++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H L L
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLDL 162
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           I+ DLKPEN+L+    Y++V D+ F  R                      G T       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW------ 196
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
             +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 197 -XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +     V
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           ++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H L L
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLDL 162
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           I+ DLKPEN+L+    Y++V D+ F  R                      G T       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW------ 196
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
             +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 197 -XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +     V
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           ++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H L L
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLDL 162
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           I+ DLKPEN+L+    Y++V D+ F  R                      G T       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW------ 196
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
             +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 197 -XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNF 100
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLH 158
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            L LI+ DLKPEN+L+    Y++V D+ F  R                      G T   
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW-- 196
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                 +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 197 -----XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +  
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNF 101
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLH 159
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            L LI+ DLKPEN+L+    Y++V D+ F  R                      G T   
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW-- 197
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                 +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 198 -----TLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +  
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNF 101
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLH 159
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            L LI+ DLKPEN+L+    Y++V D+ F  R                      G T   
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW-- 197
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                 +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 198 -----XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNF 100
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLH 158
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            L LI+ DLKPEN+L+    Y++V D+ F  R                      G T   
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW-- 196
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                 +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 197 -----XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNF 100
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLH 158
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            L LI+ DLKPEN+L+    Y++V D+ F  R                      G T   
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW-- 196
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                 +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 197 -----XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNF 100
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLH 158
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            L LI+ DLKPEN+L+    Y++V D+ F  R                      G T   
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW-- 196
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                 +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 197 -----XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 100/230 (43%), Gaps = 44/230 (19%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           +Y    K+G+G  G V    D    + VAI+ +    + ++  +I   ++ R  ++    
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP--- 77
Query: 153 TRCVQIRNWFD---YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                I N+ D     + + +V E L G SL D + +       I  V    R+ L+++ 
Sbjct: 78  ----NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALE 130
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-- 266
           F+H  ++IH D+K +NILL                   DGS          +KL DFG  
Sbjct: 131 FLHSNQVIHRDIKSDNILL-----------------GMDGS----------VKLTDFGFC 163
Query: 267 -STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
              T E    S +V T ++ APEV+    +    D+WS+G + +E+  GE
Sbjct: 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +  
Sbjct: 28  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNF 86
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLH 144
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            L LI+ DLKPEN+L+    Y++V D+ F  R                      G T   
Sbjct: 145 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW-- 182
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                 +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 183 -----TLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 102/230 (44%), Gaps = 29/230 (12%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           ++ +G+G FGQVV+  +       AIK +R   +     + E+ +L  L    +      
Sbjct: 11  IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 157 QIRNWFDYRNHI---------CIVFEKL----GPSLYDFLRKNSYRSFPIDLVRELGRQL 203
               W + RN +           +F ++      +LYD +   +      +  R L RQ+
Sbjct: 71  ----WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR-LFRQI 125
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
           LE+++++H   +IH DLKP NI +  +  VK+ D+             KN+ +S  I  +
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA----------KNVHRSLDILKL 175
Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELC 312
           D  +      + +  + T  Y A EV+ G G +N   D++S+G I  E+ 
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 100/230 (43%), Gaps = 44/230 (19%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           +Y    K+G+G  G V    D    + VAI+ +    + ++  +I   ++ R  ++    
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP--- 77
Query: 153 TRCVQIRNWFD---YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                I N+ D     + + +V E L G SL D + +       I  V    R+ L+++ 
Sbjct: 78  ----NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALE 130
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-- 266
           F+H  ++IH D+K +NILL                   DGS          +KL DFG  
Sbjct: 131 FLHSNQVIHRDIKSDNILL-----------------GMDGS----------VKLTDFGFC 163
Query: 267 -STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
              T E    S +V T ++ APEV+    +    D+WS+G + +E+  GE
Sbjct: 164 AQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 110/238 (46%), Gaps = 38/238 (15%)
Query: 94  YRILSK-MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR--HDI 150
           Y++ S+ +G G  G+V++ F+   +E  A+K ++   K R     E+++  R ++  H +
Sbjct: 63  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKXLQDCPKARR----EVELHWRASQCPHIV 118
Query: 151 GGTRCVQI-RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
              R V +  N +  R  + IV E L G  L+  ++    ++F      E+ + + E++ 
Sbjct: 119 ---RIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQ 175
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-- 266
           ++H + + H D+KPEN+L  S    K P+                    + +KL DFG  
Sbjct: 176 YLHSINIAHRDVKPENLLYTS----KRPN--------------------AILKLTDFGFA 211
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
             T  H   +    T +Y APEV+    ++  CD WS+G I   L  G   F ++  L
Sbjct: 212 KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGL 269

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 31/223 (13%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNF 100
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V++   F   +++ +V E   G  ++  LR+    S P    R    Q++ +  ++H
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLH 158
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            L LI+ DLKPEN+++    Y+KV D+ F  R                      G T   
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--------------------GRTW-- 196
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                 +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 197 -----XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 100/230 (43%), Gaps = 44/230 (19%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           +Y    K+G+G  G V    D    + VAI+ +    + ++  +I   ++ R  ++    
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP--- 78
Query: 153 TRCVQIRNWFD---YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                I N+ D     + + +V E L G SL D + +       I  V    R+ L+++ 
Sbjct: 79  ----NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALE 131
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-- 266
           F+H  ++IH D+K +NILL                   DGS          +KL DFG  
Sbjct: 132 FLHSNQVIHRDIKSDNILL-----------------GMDGS----------VKLTDFGFC 164
Query: 267 -STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
              T E    S +V T ++ APEV+    +    D+WS+G + +E+  GE
Sbjct: 165 AQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +     V
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           ++   F   +++ +V E + G  ++  LR+    + P    R    Q++ +  ++H L L
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEP--HARFYAAQIVLTFEYLHSLDL 162
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           I+ DLKPEN+L+    Y++V D+ F  R                      G T       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW------ 196
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
             +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 197 -XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 100/230 (43%), Gaps = 44/230 (19%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           +Y    K+G+G  G V    D    + VAI+ +    + ++  +I   ++ R  ++    
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP--- 77
Query: 153 TRCVQIRNWFD---YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                I N+ D     + + +V E L G SL D + +       I  V    R+ L+++ 
Sbjct: 78  ----NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALE 130
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-- 266
           F+H  ++IH D+K +NILL                   DGS          +KL DFG  
Sbjct: 131 FLHSNQVIHRDIKSDNILL-----------------GMDGS----------VKLTDFGFC 163
Query: 267 -STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
              T E    S +V T ++ APEV+    +    D+WS+G + +E+  GE
Sbjct: 164 AQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 118/276 (42%), Gaps = 39/276 (14%)
Query: 69  GSPPWRPDDKDGHYVFAIGENLT-----PRYRI--LSKMGEGTFGQVVECFDNEKKELVA 121
           GS P R   +  H  F     L      PR  +    K+GEG+ G V         +LVA
Sbjct: 1   GSSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVA 60
Query: 122 IKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLY 180
           +K +    + R   +    V+ R  +H+      V++ N +   + + +V E L G +L 
Sbjct: 61  VKKMDLRKQQRRELLFNEVVIMRDYQHE----NVVEMYNSYLVGDELWVVMEFLEGGALT 116
Query: 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240
           D +          + +  +   +L++++ +H   +IH D+K ++ILL     VK+ D+ F
Sbjct: 117 DIVTHTRMNE---EQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGF 173
Query: 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 300
            ++ SK+    K L                        V T ++ APE+I  L +    D
Sbjct: 174 CAQVSKEVPRRKXL------------------------VGTPYWMAPELISRLPYGPEVD 209
Query: 301 LWSVGCILVELCSGEALFQTHENLEHLAMMERVLGP 336
           +WS+G +++E+  GE  +     L+ + M+   L P
Sbjct: 210 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP 245

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 101/232 (43%), Gaps = 49/232 (21%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI   ++K +   + +I+       H +  
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKI---LDKQKVVKLKQIE-------HTLNE 92
Query: 153 TRCVQIRNW---------FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQ 202
            R +Q  N+         F   +++ +V E   G  ++  LR+    S P    R    Q
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP--HARFYAAQ 150
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           ++ +  ++H L LI+ DLKPEN+++    Y+KV D+ F  R                   
Sbjct: 151 IVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK----------------- 193
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
              G T         +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 194 ---GRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 101/232 (43%), Gaps = 49/232 (21%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI   ++K +   + +I+       H +  
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKI---LDKQKVVKLKQIE-------HTLNE 92
Query: 153 TRCVQIRNW---------FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQ 202
            R +Q  N+         F   +++ +V E   G  ++  LR+    S P    R    Q
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP--HARFYAAQ 150
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           ++ +  ++H L LI+ DLKPEN+++    Y+KV D+ F  R                   
Sbjct: 151 IVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK----------------- 193
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
              G T         +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 194 ---GRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 102/230 (44%), Gaps = 29/230 (12%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           ++ +G+G FGQVV+  +       AIK +R   +     + E+ +L  L    +      
Sbjct: 11  IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 157 QIRNWFDYRNHI---------CIVFEKL----GPSLYDFLRKNSYRSFPIDLVRELGRQL 203
               W + RN +           +F ++      +LYD +   +      +  R L RQ+
Sbjct: 71  ----WLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR-LFRQI 125
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
           LE+++++H   +IH DLKP NI +  +  VK+ D+             KN+ +S  I  +
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA----------KNVHRSLDILKL 175
Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELC 312
           D  +      + +  + T  Y A EV+ G G +N   D++S+G I  E+ 
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 122/248 (49%), Gaps = 42/248 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           Y+++ K+G G + +V E  +    E VA+KI++ + K +    I+  +L+ L     GG 
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIKREIK--ILENLR----GGP 92
Query: 154 RCVQIRNWFD--YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
             + + +           +VFE +  +  DF  K  Y++     +R    ++L+++ + H
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            + ++H D+KP N+L +  E+ K                         ++LID+G   F 
Sbjct: 149 SMGIMHRDVKPHNVL-IDHEHRK-------------------------LRLIDWGLAEFY 182
Query: 272 H--QDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELC-SGEALFQTHENLEHL 327
           H  Q+++  V++R+++ PE+++    ++Y  D+WS+GC+L  +    E  F  H+N + L
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242
Query: 328 AMMERVLG 335
             + +VLG
Sbjct: 243 VRIAKVLG 250

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +     V
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           ++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H L L
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLDL 162
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           I+ DLKPEN+L+    Y++V D+ F  R                      G T       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW------ 196
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
             +  T  Y APE+IL  G+N   D W++G ++ ++ +G
Sbjct: 197 -XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 96/234 (41%), Gaps = 36/234 (15%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           RY ++  +G G FG      D +  ELVA+K +    K  E    EI +  R  RH    
Sbjct: 20  RYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREI-INHRSLRH---- 74
Query: 153 TRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V+ +       H+ IV E   G  L++  R  +   F  D  R   +QL+  V++ H
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYAH 132
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG--STT 269
            +++ H DLK EN LL                   DGS       +  +K+ DFG    +
Sbjct: 133 AMQVAHRDLKLENTLL-------------------DGS------PAPRLKIADFGYSKAS 167
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALFQTHE 322
             H      V T  Y APEV+L   ++    D+WS G  L  +  G   F+  E
Sbjct: 168 VLHSQPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPE 221

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 116/266 (43%), Gaps = 63/266 (23%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIV-------RSINKYREAAMIEIDVLQRLA 146
           Y IL ++G G   +V +   NEKK++ AIK V       ++++ YR     EI  L +L 
Sbjct: 58  YSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRN----EIAYLNKLQ 112
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
           +H     + +++ ++     +I +V E     L  +L+K   +S      +   + +LE+
Sbjct: 113 QH---SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEA 167
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           V  +H+  ++H+DLKP N L+V                  DG           +KLIDFG
Sbjct: 168 VHTIHQHGIVHSDLKPANFLIV------------------DG----------MLKLIDFG 199
Query: 267 STTFEHQDHSYV-----VSTRHYRAPEVILGLGWN-----------YPCDLWSVGCILVE 310
                  D + V     V T +Y  PE I  +  +              D+WS+GCIL  
Sbjct: 200 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 259
Query: 311 LCSGEALFQTHENLEHLAMMERVLGP 336
           +  G+  FQ  + +  ++ +  ++ P
Sbjct: 260 MTYGKTPFQ--QIINQISKLHAIIDP 283

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 98/223 (43%), Gaps = 31/223 (13%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +  
Sbjct: 35  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNF 93
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V++   F   +++ +V E + G  ++  LR+     F     R    Q++ +  ++H
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLH 151
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            L LI+ DLKPEN+L+    Y++V D+ F  R                      G T   
Sbjct: 152 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW-- 189
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                 +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 190 -----XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 77/241 (31%), Positives = 109/241 (45%), Gaps = 25/241 (10%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIV-RSINKYREAAMI--EIDVLQRLARHDI 150
           Y I   +G G++G V   +D   ++ VAIK V R      +   I  EI +L RL    I
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 87
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV--- 207
                + I +     + + IV E     L    +       PI L  E  + +L ++   
Sbjct: 88  IRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT------PIFLTEEHIKTILYNLLLG 141
Query: 208 -AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS--RSSKDGSYFKNLPKSSAIKLID 264
             F+HE  +IH DLKP N LL     VKV D+       S KD +   +L ++       
Sbjct: 142 ENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP-- 199
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTHE 322
             +   + Q  S+VV TR YRAPE+IL L  NY    D+WS GCI  EL +   + Q+H 
Sbjct: 200 -HNKNLKKQLTSHVV-TRWYRAPELIL-LQENYTKSIDIWSTGCIFAELLN---MLQSHI 253
Query: 323 N 323
           N
Sbjct: 254 N 254

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 116/266 (43%), Gaps = 63/266 (23%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIV-------RSINKYREAAMIEIDVLQRLA 146
           Y IL ++G G   +V +   NEKK++ AIK V       ++++ YR     EI  L +L 
Sbjct: 58  YSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRN----EIAYLNKLQ 112
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
           +H     + +++ ++     +I +V E     L  +L+K   +S      +   + +LE+
Sbjct: 113 QH---SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEA 167
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           V  +H+  ++H+DLKP N L+V                  DG           +KLIDFG
Sbjct: 168 VHTIHQHGIVHSDLKPANFLIV------------------DG----------MLKLIDFG 199
Query: 267 STTFEHQDHSYV-----VSTRHYRAPEVILGLGWN-----------YPCDLWSVGCILVE 310
                  D + V     V T +Y  PE I  +  +              D+WS+GCIL  
Sbjct: 200 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 259
Query: 311 LCSGEALFQTHENLEHLAMMERVLGP 336
           +  G+  FQ  + +  ++ +  ++ P
Sbjct: 260 MTYGKTPFQ--QIINQISKLHAIIDP 283

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 116/266 (43%), Gaps = 63/266 (23%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIV-------RSINKYREAAMIEIDVLQRLA 146
           Y IL ++G G   +V +   NEKK++ AIK V       ++++ YR     EI  L +L 
Sbjct: 11  YSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRN----EIAYLNKLQ 65
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
           +H     + +++ ++     +I +V E     L  +L+K   +S      +   + +LE+
Sbjct: 66  QH---SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEA 120
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           V  +H+  ++H+DLKP N L+V                  DG           +KLIDFG
Sbjct: 121 VHTIHQHGIVHSDLKPANFLIV------------------DG----------MLKLIDFG 152
Query: 267 STTFEHQDHSYV-----VSTRHYRAPEVILGLGWN-----------YPCDLWSVGCILVE 310
                  D + V     V T +Y  PE I  +  +              D+WS+GCIL  
Sbjct: 153 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 212
Query: 311 LCSGEALFQTHENLEHLAMMERVLGP 336
           +  G+  FQ  + +  ++ +  ++ P
Sbjct: 213 MTYGKTPFQ--QIINQISKLHAIIDP 236

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 31/219 (14%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +     V
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           ++   F   +++ +V E + G  ++  LR+     F     R    Q++ +  ++H L L
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHSLDL 162
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           I+ DLKPEN+L+    Y++V D+ F  R                      G T       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW------ 196
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
             +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 197 -XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 31/219 (14%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +     V
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           ++   F   +++ +V E + G  ++  LR+     F     R    Q++ +  ++H L L
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHSLDL 162
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           I+ DLKPEN+L+    Y++V D+ F  R                      G T       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW------ 196
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
             +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 197 -XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 31/219 (14%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +     V
Sbjct: 67  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLV 125
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           ++   F   +++ +V E + G  ++  LR+     F     R    Q++ +  ++H L L
Sbjct: 126 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHSLDL 183
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           I+ DLKPEN+L+    Y++V D+ F  R                      G T       
Sbjct: 184 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW------ 217
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
             +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 218 -XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 97/234 (41%), Gaps = 36/234 (15%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           RY ++  +G G FG      D +  ELVA+K +    K  E    EI +  R  RH    
Sbjct: 19  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREI-INHRSLRH---- 73
Query: 153 TRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V+ +       H+ IV E   G  L++  R  +   F  D  R   +QL+  V++ H
Sbjct: 74  PNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCH 131
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG--STT 269
            +++ H DLK EN LL                   DGS       +  +K+ DFG   ++
Sbjct: 132 AMQVCHRDLKLENTLL-------------------DGS------PAPRLKICDFGYSKSS 166
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALFQTHE 322
             H      V T  Y APEV+L   ++    D+WS G  L  +  G   F+  E
Sbjct: 167 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPE 220

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 31/219 (14%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +     V
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           ++   F   +++ +V E + G  ++  LR+     F     R    Q++ +  ++H L L
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHSLDL 162
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           I+ DLKPEN+L+    Y++V D+ F  R                      G T       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW------ 196
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
             +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 197 -XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 31/219 (14%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +     V
Sbjct: 41  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLV 99
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           ++   F   +++ +V E + G  ++  LR+     F     R    Q++ +  ++H L L
Sbjct: 100 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHSLDL 157
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           I+ DLKPEN+L+    Y++V D+ F  R                      G T       
Sbjct: 158 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW------ 191
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
             +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 192 -XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 116/266 (43%), Gaps = 63/266 (23%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIV-------RSINKYREAAMIEIDVLQRLA 146
           Y IL ++G G   +V +   NEKK++ AIK V       ++++ YR     EI  L +L 
Sbjct: 14  YSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRN----EIAYLNKLQ 68
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
           +H     + +++ ++     +I +V E     L  +L+K   +S      +   + +LE+
Sbjct: 69  QH---SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEA 123
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           V  +H+  ++H+DLKP N L+V                  DG           +KLIDFG
Sbjct: 124 VHTIHQHGIVHSDLKPANFLIV------------------DG----------MLKLIDFG 155
Query: 267 STTFEHQDHSYV-----VSTRHYRAPEVILGLGWN-----------YPCDLWSVGCILVE 310
                  D + V     V T +Y  PE I  +  +              D+WS+GCIL  
Sbjct: 156 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 215
Query: 311 LCSGEALFQTHENLEHLAMMERVLGP 336
           +  G+  FQ  + +  ++ +  ++ P
Sbjct: 216 MTYGKTPFQ--QIINQISKLHAIIDP 239

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 106/232 (45%), Gaps = 38/232 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH-DIGG 152
           + ++  +G GT+GQV +    +  +L AIK++       E    EI++L++ + H +I  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 153 TRCVQIR-NWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                I+ N     + + +V E  G  S+ D ++     +   + +  + R++L  ++ +
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 145
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H+ ++IH D+K +N+LL                            +++ +KL+DFG +  
Sbjct: 146 HQHKVIHRDIKGQNVLLT---------------------------ENAEVKLVDFGVSAQ 178
Query: 271 EHQD---HSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSG 314
             +     +  + T ++ APEVI         +++  DLWS+G   +E+  G
Sbjct: 179 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 116/266 (43%), Gaps = 63/266 (23%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIV-------RSINKYREAAMIEIDVLQRLA 146
           Y IL ++G G   +V +   NEKK++ AIK V       ++++ YR     EI  L +L 
Sbjct: 30  YSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRN----EIAYLNKLQ 84
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
           +H     + +++ ++     +I +V E     L  +L+K   +S      +   + +LE+
Sbjct: 85  QH---SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEA 139
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           V  +H+  ++H+DLKP N L+V                  DG           +KLIDFG
Sbjct: 140 VHTIHQHGIVHSDLKPANFLIV------------------DG----------MLKLIDFG 171
Query: 267 STTFEHQDHSYV-----VSTRHYRAPEVILGLGWN-----------YPCDLWSVGCILVE 310
                  D + V     V T +Y  PE I  +  +              D+WS+GCIL  
Sbjct: 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 231
Query: 311 LCSGEALFQTHENLEHLAMMERVLGP 336
           +  G+  FQ  + +  ++ +  ++ P
Sbjct: 232 MTYGKTPFQ--QIINQISKLHAIIDP 255

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 107/241 (44%), Gaps = 35/241 (14%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+GEG+ G V    +    + VA+K +    + R   +    V+ R   HD      V +
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHD----NVVDM 107
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
            + +   + + +V E L G +L D +         I  V      +L +++++H   +IH
Sbjct: 108 YSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATV---CLSVLRALSYLHNQGVIH 164
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
            D+K ++ILL S   +K+ D+ F ++ SK+      +PK   +                 
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFGFCAQVSKE------VPKRKXL----------------- 201
Query: 278 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPL 337
            V T ++ APEVI  L +    D+WS+G +++E+  GE     + N   L  M R+   L
Sbjct: 202 -VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP---PYFNEPPLQAMRRIRDSL 257
Query: 338 P 338
           P
Sbjct: 258 P 258

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +     V
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           ++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H L L
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLDL 162
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           I+ DLKPEN+++    Y++V D+ F  R                      G T       
Sbjct: 163 IYRDLKPENLIIDQQGYIQVTDFGFAKRVK--------------------GRTW------ 196
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
             +  T  Y APE+I+  G+N   D W++G ++ E+ +G
Sbjct: 197 -XLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 116/266 (43%), Gaps = 63/266 (23%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIV-------RSINKYREAAMIEIDVLQRLA 146
           Y IL ++G G   +V +   NEKK++ AIK V       ++++ YR     EI  L +L 
Sbjct: 10  YSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRN----EIAYLNKLQ 64
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
           +H     + +++ ++     +I +V E     L  +L+K   +S      +   + +LE+
Sbjct: 65  QH---SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEA 119
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           V  +H+  ++H+DLKP N L+V                  DG           +KLIDFG
Sbjct: 120 VHTIHQHGIVHSDLKPANFLIV------------------DG----------MLKLIDFG 151
Query: 267 STTFEHQDHSYV-----VSTRHYRAPEVILGLGWN-----------YPCDLWSVGCILVE 310
                  D + V     V T +Y  PE I  +  +              D+WS+GCIL  
Sbjct: 152 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 211
Query: 311 LCSGEALFQTHENLEHLAMMERVLGP 336
           +  G+  FQ  + +  ++ +  ++ P
Sbjct: 212 MTYGKTPFQ--QIINQISKLHAIIDP 235

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 98/223 (43%), Gaps = 31/223 (13%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNF 100
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V++   F   +++ +V E   G  ++  LR+    S P    R    Q++ +  ++H
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLH 158
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            L LI+ DLKPEN+++    Y++V D+ F  R                      G T   
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVK--------------------GRTW-- 196
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                 +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 197 -----XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 98/223 (43%), Gaps = 31/223 (13%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNF 100
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V++   F   +++ +V E + G  ++  LR+     F     R    Q++ +  ++H
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLH 158
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            L LI+ DLKPEN+L+    Y++V D+ F  R                      G T   
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW-- 196
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                 +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 197 -----XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 98/223 (43%), Gaps = 31/223 (13%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +  
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNF 101
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V++   F   +++ +V E + G  ++  LR+     F     R    Q++ +  ++H
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLH 159
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            L LI+ DLKPEN+L+    Y++V D+ F  R                      G T   
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW-- 197
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                 +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 198 -----XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 109/239 (45%), Gaps = 32/239 (13%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+GEG+ G V         +LVA+K +    + R   +    V+ R  +H+      V++
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHE----NVVEM 213
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
            N +   + + +V E L G +L D +   ++     + +  +   +L++++ +H   +IH
Sbjct: 214 YNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQGVIH 270
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
            D+K ++ILL     VK+ D+ F ++ SK+    K L                       
Sbjct: 271 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL----------------------- 307
Query: 278 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGP 336
            V T ++ APE+I  L +    D+WS+G +++E+  GE  +     L+ + M+   L P
Sbjct: 308 -VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP 365

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 106/240 (44%), Gaps = 37/240 (15%)
Query: 84  FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV-RSINKYREAAMI---EI 139
            AI +     Y I   +GEG+FG+V      + ++ VA+K + R + K  +  M    EI
Sbjct: 1   MAISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREI 60
Query: 140 DVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVREL 199
             L +L RH       +++ +       I +V E  G  L+D++ +   +    D  R  
Sbjct: 61  SYL-KLLRH----PHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEK--KRMTEDEGRRF 113
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
            +Q++ ++ + H  +++H DLKPEN+LL     VK+ D+  LS    DG++ K       
Sbjct: 114 FQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFG-LSNIMTDGNFLKT------ 166
Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALF 318
                                + +Y APEVI G  +  P  D+WS G +L  +  G   F
Sbjct: 167 ------------------SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF 208

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 98/223 (43%), Gaps = 31/223 (13%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNF 100
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V++   F   +++ +V E + G  ++  LR+     F     R    Q++ +  ++H
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLH 158
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            L LI+ DLKPEN+L+    Y++V D+ F  R                      G T   
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW-- 196
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                 +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 197 -----XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 31/219 (14%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +     V
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           ++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H L L
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLDL 162
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           I+ DLKPEN+L+    Y++V D+ F  R                      G T       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW------ 196
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
             +  T  Y AP +IL  G+N   D W++G ++ E+ +G
Sbjct: 197 -XLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 109/239 (45%), Gaps = 32/239 (13%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+GEG+ G V         +LVA+K +    + R   +    V+ R  +H+      V++
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHE----NVVEM 136
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
            N +   + + +V E L G +L D +   ++     + +  +   +L++++ +H   +IH
Sbjct: 137 YNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQGVIH 193
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
            D+K ++ILL     VK+ D+ F ++ SK+    K L                       
Sbjct: 194 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL----------------------- 230
Query: 278 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGP 336
            V T ++ APE+I  L +    D+WS+G +++E+  GE  +     L+ + M+   L P
Sbjct: 231 -VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP 288

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 115/266 (43%), Gaps = 63/266 (23%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIV-------RSINKYREAAMIEIDVLQRLA 146
           Y IL ++G G   +V +   NEKK++ AIK V       ++++ YR     EI  L +L 
Sbjct: 30  YSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRN----EIAYLNKLQ 84
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
           +H     + +++ ++     +I +V E     L  +L+K   +S      +   + +LE+
Sbjct: 85  QH---SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEA 139
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           V  +H+  ++H+DLKP N L+V                  DG           +KLIDFG
Sbjct: 140 VHTIHQHGIVHSDLKPANFLIV------------------DG----------MLKLIDFG 171
Query: 267 STTFEHQDHSYV-----VSTRHYRAPEVILGLGWN-----------YPCDLWSVGCILVE 310
                  D   V     V T +Y  PE I  +  +              D+WS+GCIL  
Sbjct: 172 IANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 231
Query: 311 LCSGEALFQTHENLEHLAMMERVLGP 336
           +  G+  FQ  + +  ++ +  ++ P
Sbjct: 232 MTYGKTPFQ--QIINQISKLHAIIDP 255

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 100/232 (43%), Gaps = 49/232 (21%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI   ++K +   + EI+       H +  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKI---LDKQKVVKLKEIE-------HTLNE 91
Query: 153 TRCVQIRNW---------FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQ 202
            R +Q  N+         F   +++ +V E   G  ++  LR+    S P    R    Q
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP--HARFYAAQ 149
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           ++ +  ++H L LI+ DLKPEN+++    Y+KV D+    R                   
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVK----------------- 192
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
              G T         +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 193 ---GRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 107/239 (44%), Gaps = 32/239 (13%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+GEG+ G V         +LVA+K +    + R   +    V+ R  +H+      V++
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHE----NVVEM 86
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
            N +   + + +V E L G +L D +          + +  +   +L++++ +H   +IH
Sbjct: 87  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE---EQIAAVCLAVLQALSVLHAQGVIH 143
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
            D+K ++ILL     VK+ D+ F ++ SK+    K L                       
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL----------------------- 180
Query: 278 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGP 336
            V T ++ APE+I  L +    D+WS+G +++E+  GE  +     L+ + M+   L P
Sbjct: 181 -VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP 238

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 107/231 (46%), Gaps = 28/231 (12%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++R+  K+G G+FG++    + +  E VAIK+     K+ +  + E  + + L     GG
Sbjct: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL-LYESKIYRILQ----GG 62
Query: 153 TRCVQIRNWFDYR-NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
           T    +R WF    ++  +V + LGPSL D     S R   +  V  L  Q++  V F+H
Sbjct: 63  TGIPNVR-WFGVEGDYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVH 120
Query: 212 ELRLIHTDLKPENILLV---SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
               +H D+KP+N L+     A  V + D+  L++  +D S  +++P             
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFG-LAKKYRDTSTHQHIP------------- 166
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
              ++++  +  T  Y +    LG+  +   DL S+G +L+    G   +Q
Sbjct: 167 ---YRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 214

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 76/241 (31%), Positives = 105/241 (43%), Gaps = 22/241 (9%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIV-RSINKYREAAMI--EIDVLQRLARHDI 150
           Y I   +G G++G V   +D    + VAIK V R      +   I  EI +L RL    I
Sbjct: 30  YEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 89
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDL----VRELGRQLLES 206
                + I       + + IV E     L    +       PI L    V+ +   LL  
Sbjct: 90  IRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKT------PIFLTEQHVKTILYNLLLG 143
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS--RSSKDGSYFKNLPKSSAIKLID 264
             F+HE  +IH DLKP N LL     VK+ D+       S KD     +L +    +   
Sbjct: 144 EKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPG 203
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTHE 322
             +   + Q  S+VV TR YRAPE+IL L  NY    D+WS GCI  EL +   + ++H 
Sbjct: 204 PHNKNLKKQLTSHVV-TRWYRAPELIL-LQENYTNSIDIWSTGCIFAELLN---MMKSHI 258
Query: 323 N 323
           N
Sbjct: 259 N 259

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 45/227 (19%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARHDIG--- 151
           L K+G+G+FG+V +  DN  +++VAIKI+         E    EI VL +     +    
Sbjct: 27  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 86
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPID--LVRELGRQLLESVA 208
           G+     + W        I+ E L G S  D L        P+D   +  + R++L+ + 
Sbjct: 87  GSYLKDTKLW--------IIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLD 133
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H  + IH D+K  N+LL     VK+ D+                           G  
Sbjct: 134 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA------------------------GQL 169
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
           T      +  V T  + APEVI    ++   D+WS+G   +EL  GE
Sbjct: 170 TDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 107/239 (44%), Gaps = 32/239 (13%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+GEG+ G V         +LVA+K +    + R   +    V+ R  +H+      V++
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHE----NVVEM 91
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
            N +   + + +V E L G +L D +          + +  +   +L++++ +H   +IH
Sbjct: 92  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE---EQIAAVCLAVLQALSVLHAQGVIH 148
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
            D+K ++ILL     VK+ D+ F ++ SK+    K L                       
Sbjct: 149 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL----------------------- 185
Query: 278 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGP 336
            V T ++ APE+I  L +    D+WS+G +++E+  GE  +     L+ + M+   L P
Sbjct: 186 -VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP 243

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 31/223 (13%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNF 100
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V++   F   +++ +V E   G  ++  LR+     F     R    Q++ +  ++H
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLH 158
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            L LI+ DLKPEN+++    Y+KV D+ F  R                      G T   
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--------------------GRTW-- 196
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                 +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 197 -----XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 107/239 (44%), Gaps = 32/239 (13%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+GEG+ G V         +LVA+K +    + R   +    V+ R  +H+      V++
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHE----NVVEM 82
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
            N +   + + +V E L G +L D +          + +  +   +L++++ +H   +IH
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE---EQIAAVCLAVLQALSVLHAQGVIH 139
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
            D+K ++ILL     VK+ D+ F ++ SK+    K L                       
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL----------------------- 176
Query: 278 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGP 336
            V T ++ APE+I  L +    D+WS+G +++E+  GE  +     L+ + M+   L P
Sbjct: 177 -VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP 234

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 98/230 (42%), Gaps = 35/230 (15%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR--HDIG 151
           Y +   +G+G F  V  C + E  +  A+KIV  + K+  +  +  + L+R A   H + 
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIV-DVAKFTSSPGLSTEDLKREASICHMLK 86
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPID--LVRELGRQLLESVA 208
               V++   +     + +VFE + G  L   + K +   F     +     RQ+LE++ 
Sbjct: 87  HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 146
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           + H+  +IH D+KP  +LL S E                         S+ +KL  FG  
Sbjct: 147 YCHDNNIIHRDVKPHCVLLASKE------------------------NSAPVKLGGFG-V 181
Query: 269 TFEHQDHSYV----VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
             +  +   V    V T H+ APEV+    +  P D+W  G IL  L SG
Sbjct: 182 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 100/230 (43%), Gaps = 44/230 (19%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           +Y    K+G+G  G V    D    + VAI+ +    + ++  +I   ++ R  ++    
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP--- 78
Query: 153 TRCVQIRNWFD---YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                I N+ D     + + +V E L G SL D + +       I  V    R+ L+++ 
Sbjct: 79  ----NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALE 131
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-- 266
           F+H  ++IH ++K +NILL                   DGS          +KL DFG  
Sbjct: 132 FLHSNQVIHRNIKSDNILL-----------------GMDGS----------VKLTDFGFC 164
Query: 267 -STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
              T E    S +V T ++ APEV+    +    D+WS+G + +E+  GE
Sbjct: 165 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 45/227 (19%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARHDIG--- 151
           L K+G+G+FG+V +  DN  +++VAIKI+         E    EI VL +     +    
Sbjct: 12  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 71
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPID--LVRELGRQLLESVA 208
           G+     + W        I+ E L G S  D L        P+D   +  + R++L+ + 
Sbjct: 72  GSYLKDTKLW--------IIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLD 118
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H  + IH D+K  N+LL     VK+ D+                           G  
Sbjct: 119 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA------------------------GQL 154
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
           T      +  V T  + APEVI    ++   D+WS+G   +EL  GE
Sbjct: 155 TDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 201

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 87/171 (50%), Gaps = 34/171 (19%)
Query: 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228
            +VFE +  +  DF  K  Y++     +R    ++L+++ + H + ++H D+KP N++ +
Sbjct: 110 ALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-I 164
Query: 229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH--QDHSYVVSTRHYRA 286
             E+ K                         ++LID+G   F H  Q+++  V++R+++ 
Sbjct: 165 DHEHRK-------------------------LRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 287 PEVILGLG-WNYPCDLWSVGCILVELC-SGEALFQTHENLEHLAMMERVLG 335
           PE+++    ++Y  D+WS+GC+L  +    E  F  H+N + L  + +VLG
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 250

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 100/232 (43%), Gaps = 49/232 (21%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI   ++K +   + +I+       H +  
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKI---LDKQKVVKLKQIE-------HTLNE 92
Query: 153 TRCVQIRNW---------FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQ 202
            R +Q  N+         F   +++ +V E   G  ++  LR+     F     R    Q
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG--RFXEPHARFYAAQ 150
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           ++ +  ++H L LI+ DLKPEN+++    Y+KV D+ F  R                   
Sbjct: 151 IVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK----------------- 193
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
              G T         +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 194 ---GRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 102/248 (41%), Gaps = 37/248 (14%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           RY  +  +G G FG      D   KELVA+K +       E    EI +  R  RH    
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREI-INHRSLRH---- 75
Query: 153 TRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V+ +       H+ I+ E   G  LY+  R  +   F  D  R   +QLL  V++ H
Sbjct: 76  PNIVRFKEVILTPTHLAIIMEYASGGELYE--RICNAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG--STT 269
            +++ H DLK EN LL                   DGS       +  +K+ DFG   ++
Sbjct: 134 SMQICHRDLKLENTLL-------------------DGS------PAPRLKICDFGYSKSS 168
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALFQT-HENLEHL 327
             H      V T  Y APEV+L   ++    D+WS G  L  +  G   F+   E  ++ 
Sbjct: 169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR 228
Query: 328 AMMERVLG 335
             ++R+L 
Sbjct: 229 KTIQRILS 236

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 87/171 (50%), Gaps = 34/171 (19%)
Query: 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228
            +VFE +  +  DF  K  Y++     +R    ++L+++ + H + ++H D+KP N++ +
Sbjct: 110 ALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-I 164
Query: 229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH--QDHSYVVSTRHYRA 286
             E+ K                         ++LID+G   F H  Q+++  V++R+++ 
Sbjct: 165 DHEHRK-------------------------LRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 287 PEVILGLG-WNYPCDLWSVGCILVELC-SGEALFQTHENLEHLAMMERVLG 335
           PE+++    ++Y  D+WS+GC+L  +    E  F  H+N + L  + +VLG
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 250

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 87/171 (50%), Gaps = 34/171 (19%)
Query: 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228
            +VFE +  +  DF  K  Y++     +R    ++L+++ + H + ++H D+KP N++ +
Sbjct: 110 ALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-I 164
Query: 229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH--QDHSYVVSTRHYRA 286
             E+ K                         ++LID+G   F H  Q+++  V++R+++ 
Sbjct: 165 DHEHRK-------------------------LRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 287 PEVILGLG-WNYPCDLWSVGCILVELC-SGEALFQTHENLEHLAMMERVLG 335
           PE+++    ++Y  D+WS+GC+L  +    E  F  H+N + L  + +VLG
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 250

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 87/171 (50%), Gaps = 34/171 (19%)
Query: 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228
            +VFE +  +  DF  K  Y++     +R    ++L+++ + H + ++H D+KP N++ +
Sbjct: 109 ALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-I 163
Query: 229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH--QDHSYVVSTRHYRA 286
             E+ K                         ++LID+G   F H  Q+++  V++R+++ 
Sbjct: 164 DHEHRK-------------------------LRLIDWGLAEFYHPGQEYNVRVASRYFKG 198
Query: 287 PEVILGLG-WNYPCDLWSVGCILVELC-SGEALFQTHENLEHLAMMERVLG 335
           PE+++    ++Y  D+WS+GC+L  +    E  F  H+N + L  + +VLG
Sbjct: 199 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 249

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 87/171 (50%), Gaps = 34/171 (19%)
Query: 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228
            +VFE +  +  DF  K  Y++     +R    ++L+++ + H + ++H D+KP N++ +
Sbjct: 110 ALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-I 164
Query: 229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH--QDHSYVVSTRHYRA 286
             E+ K                         ++LID+G   F H  Q+++  V++R+++ 
Sbjct: 165 DHEHRK-------------------------LRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 287 PEVILGLG-WNYPCDLWSVGCILVELC-SGEALFQTHENLEHLAMMERVLG 335
           PE+++    ++Y  D+WS+GC+L  +    E  F  H+N + L  + +VLG
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 250

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 87/171 (50%), Gaps = 34/171 (19%)
Query: 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228
            +VFE +  +  DF  K  Y++     +R    ++L+++ + H + ++H D+KP N++ +
Sbjct: 110 ALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-I 164
Query: 229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH--QDHSYVVSTRHYRA 286
             E+ K                         ++LID+G   F H  Q+++  V++R+++ 
Sbjct: 165 DHEHRK-------------------------LRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 287 PEVILGLG-WNYPCDLWSVGCILVELC-SGEALFQTHENLEHLAMMERVLG 335
           PE+++    ++Y  D+WS+GC+L  +    E  F  H+N + L  + +VLG
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 250

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 87/171 (50%), Gaps = 34/171 (19%)
Query: 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228
            +VFE +  +  DF  K  Y++     +R    ++L+++ + H + ++H D+KP N++ +
Sbjct: 110 ALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-I 164
Query: 229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH--QDHSYVVSTRHYRA 286
             E+ K                         ++LID+G   F H  Q+++  V++R+++ 
Sbjct: 165 DHEHRK-------------------------LRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 287 PEVILGLG-WNYPCDLWSVGCILVELC-SGEALFQTHENLEHLAMMERVLG 335
           PE+++    ++Y  D+WS+GC+L  +    E  F  H+N + L  + +VLG
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 250

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 45/227 (19%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARHDIG--- 151
           L K+G+G+FG+V +  DN  +++VAIKI+         E    EI VL +     +    
Sbjct: 12  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 71
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPID--LVRELGRQLLESVA 208
           G+     + W        I+ E L G S  D L        P+D   +  + R++L+ + 
Sbjct: 72  GSYLKDTKLW--------IIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLD 118
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H  + IH D+K  N+LL     VK+ D+                           G  
Sbjct: 119 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA------------------------GQL 154
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
           T      +  V T  + APEVI    ++   D+WS+G   +EL  GE
Sbjct: 155 TDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 201

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 115/266 (43%), Gaps = 63/266 (23%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIV-------RSINKYREAAMIEIDVLQRLA 146
           Y IL ++G G   +V +   NEKK++ AIK V       ++++ YR     EI  L +L 
Sbjct: 58  YSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRN----EIAYLNKLQ 112
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
           +H     + +++ ++     +I +V E     L  +L+K   +S      +   + +LE+
Sbjct: 113 QH---SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEA 167
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           V  +H+  ++H+DLKP N L+V                  DG           +KLIDFG
Sbjct: 168 VHTIHQHGIVHSDLKPANFLIV------------------DG----------MLKLIDFG 199
Query: 267 STTFEHQDHSYVVSTR-----HYRAPEVILGLGWN-----------YPCDLWSVGCILVE 310
                  D + VV        +Y  PE I  +  +              D+WS+GCIL  
Sbjct: 200 IANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 259
Query: 311 LCSGEALFQTHENLEHLAMMERVLGP 336
           +  G+  FQ  + +  ++ +  ++ P
Sbjct: 260 MTYGKTPFQ--QIINQISKLHAIIDP 283

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 87/171 (50%), Gaps = 34/171 (19%)
Query: 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228
            +VFE +  +  DF  K  Y++     +R    ++L+++ + H + ++H D+KP N++ +
Sbjct: 108 ALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-I 162
Query: 229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH--QDHSYVVSTRHYRA 286
             E+ K                         ++LID+G   F H  Q+++  V++R+++ 
Sbjct: 163 DHEHRK-------------------------LRLIDWGLAEFYHPGQEYNVRVASRYFKG 197
Query: 287 PEVILGLG-WNYPCDLWSVGCILVELC-SGEALFQTHENLEHLAMMERVLG 335
           PE+++    ++Y  D+WS+GC+L  +    E  F  H+N + L  + +VLG
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 248

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 87/171 (50%), Gaps = 34/171 (19%)
Query: 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228
            +VFE +  +  DF  K  Y++     +R    ++L+++ + H + ++H D+KP N++ +
Sbjct: 110 ALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-I 164
Query: 229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH--QDHSYVVSTRHYRA 286
             E+ K                         ++LID+G   F H  Q+++  V++R+++ 
Sbjct: 165 DHEHRK-------------------------LRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 287 PEVILGLG-WNYPCDLWSVGCILVELC-SGEALFQTHENLEHLAMMERVLG 335
           PE+++    ++Y  D+WS+GC+L  +    E  F  H+N + L  + +VLG
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 250

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 98/230 (42%), Gaps = 35/230 (15%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR--HDIG 151
           Y +   +G+G F  V  C + E  +  A+KIV  + K+  +  +  + L+R A   H + 
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIV-DVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPID--LVRELGRQLLESVA 208
               V++   +     + +VFE + G  L   + K +   F     +     RQ+LE++ 
Sbjct: 85  HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           + H+  +IH D+KP  +LL S E                         S+ +KL  FG  
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKE------------------------NSAPVKLGGFG-V 179
Query: 269 TFEHQDHSYV----VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
             +  +   V    V T H+ APEV+    +  P D+W  G IL  L SG
Sbjct: 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 87/171 (50%), Gaps = 34/171 (19%)
Query: 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228
            +VFE +  +  DF  K  Y++     +R    ++L+++ + H + ++H D+KP N++ +
Sbjct: 109 ALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-I 163
Query: 229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH--QDHSYVVSTRHYRA 286
             E+ K                         ++LID+G   F H  Q+++  V++R+++ 
Sbjct: 164 DHEHRK-------------------------LRLIDWGLAEFYHPGQEYNVRVASRYFKG 198
Query: 287 PEVILGLG-WNYPCDLWSVGCILVELC-SGEALFQTHENLEHLAMMERVLG 335
           PE+++    ++Y  D+WS+GC+L  +    E  F  H+N + L  + +VLG
Sbjct: 199 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 249

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 87/171 (50%), Gaps = 34/171 (19%)
Query: 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228
            +VFE +  +  DF  K  Y++     +R    ++L+++ + H + ++H D+KP N++ +
Sbjct: 115 ALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-I 169
Query: 229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH--QDHSYVVSTRHYRA 286
             E+ K                         ++LID+G   F H  Q+++  V++R+++ 
Sbjct: 170 DHEHRK-------------------------LRLIDWGLAEFYHPGQEYNVRVASRYFKG 204
Query: 287 PEVILGLG-WNYPCDLWSVGCILVELC-SGEALFQTHENLEHLAMMERVLG 335
           PE+++    ++Y  D+WS+GC+L  +    E  F  H+N + L  + +VLG
Sbjct: 205 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 255

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 87/171 (50%), Gaps = 34/171 (19%)
Query: 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228
            +VFE +  +  DF  K  Y++     +R    ++L+++ + H + ++H D+KP N++ +
Sbjct: 110 ALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-I 164
Query: 229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH--QDHSYVVSTRHYRA 286
             E+ K                         ++LID+G   F H  Q+++  V++R+++ 
Sbjct: 165 DHEHRK-------------------------LRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 287 PEVILGLG-WNYPCDLWSVGCILVELC-SGEALFQTHENLEHLAMMERVLG 335
           PE+++    ++Y  D+WS+GC+L  +    E  F  H+N + L  + +VLG
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 250

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 45/227 (19%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARHDIG--- 151
           L K+G+G+FG+V +  DN  +++VAIKI+         E    EI VL +     +    
Sbjct: 32  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 91
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPID--LVRELGRQLLESVA 208
           G+     + W        I+ E L G S  D L        P+D   +  + R++L+ + 
Sbjct: 92  GSYLKDTKLW--------IIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLD 138
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H  + IH D+K  N+LL     VK+ D+                           G  
Sbjct: 139 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA------------------------GQL 174
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
           T      +  V T  + APEVI    ++   D+WS+G   +EL  GE
Sbjct: 175 TDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 221

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 129/289 (44%), Gaps = 59/289 (20%)
Query: 48  GNGGMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPR--YRILSKMGEGTF 105
           GN G+    C  +   ++P   S P +P +KD   +        PR   ++  K+G G F
Sbjct: 151 GNDGL----CQKL---SVPCMSSKPQKPWEKDAWEI--------PRESLKLEKKLGAGQF 195
Query: 106 GQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165
           G+V     N K   VA+K ++  +   EA + E +V++ L +HD    + V++      +
Sbjct: 196 GEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHD----KLVKLHAVVT-K 248
Query: 166 NHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPEN 224
             I I+ E +   SL DFL+ +     P+  + +   Q+ E +AF+ +   IH DL+  N
Sbjct: 249 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAAN 308
Query: 225 ILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHY 284
           IL+ ++   K+ D+      ++ G+ F    K +A + I+FGS T +             
Sbjct: 309 ILVSASLVCKIADFGL----ARVGAKFP--IKWTAPEAINFGSFTIK------------- 349
Query: 285 RAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                          D+WS G +L+E+ + G   +    N E +  +ER
Sbjct: 350 --------------SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 384

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 31/219 (14%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           +  +G G+FG+V+     E     A+KI+    K  +   IE  + ++     +     V
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           ++   F   +++ +V E + G  ++  LR+    S P    R    Q++ +  ++H L L
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLDL 162
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           I+ DLKPEN+L+    Y++V D+ F  R                      G T       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------------GRTW------ 196
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
             +  T    APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 197 -XLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 100/232 (43%), Gaps = 49/232 (21%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           ++  +  +G G+FG+V+     E     A+KI   ++K +   + EI+       H +  
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKI---LDKQKVVKLKEIE-------HTLNE 91
Query: 153 TRCVQIRNW---------FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQ 202
            R +Q  N+         F   +++ +V E   G  ++  LR+    S P    R    Q
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP--HARFYAAQ 149
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           ++ +  ++H L LI+ DLKPEN+++    Y++V D+    R                   
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVK----------------- 192
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
              G T         +  T  Y APE+IL  G+N   D W++G ++ E+ +G
Sbjct: 193 ---GRTW-------XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 96/234 (41%), Gaps = 36/234 (15%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           RY ++  +G G FG      D +  ELVA+K +    K       EI +  R  RH    
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREI-INHRSLRH---- 74
Query: 153 TRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V+ +       H+ IV E   G  L++  R  +   F  D  R   +QL+  V++ H
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCH 132
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG--STT 269
            +++ H DLK EN LL                   DGS       +  +K+ DFG   ++
Sbjct: 133 AMQVCHRDLKLENTLL-------------------DGS------PAPRLKICDFGYSKSS 167
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALFQTHE 322
             H      V T  Y APEV+L   ++    D+WS G  L  +  G   F+  E
Sbjct: 168 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPE 221

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 108/240 (45%), Gaps = 32/240 (13%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           ++  K+G G FG+V     N K   VA+K ++  +   EA + E +V++ L +HD    +
Sbjct: 18  KLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHD----K 71
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            V++      +  I I+ E +   SL DFL+ +     P+  + +   Q+ E +AF+ + 
Sbjct: 72  LVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 130
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             IH DL+  NIL+ ++   K+ D+  L+R  +D  Y         IK            
Sbjct: 131 NYIHRDLRAANILVSASLVCKIADFG-LARVIEDNEYTAREGAKFPIK------------ 177
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE I    +    D+WS G +L+E+ + G   +    N E +  +ER
Sbjct: 178 ----------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 227

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/237 (22%), Positives = 100/237 (42%), Gaps = 42/237 (17%)
Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH 148
             T  Y +   +G G++     C         A+KI   I+K +     EI++L R  +H
Sbjct: 19  QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKI---IDKSKRDPTEEIEILLRYGQH 75
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLL--- 204
                  + +++ +D   ++ +V E + G  L D + +  + S      RE    L    
Sbjct: 76  ----PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFS-----EREASAVLFTIT 126
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
           ++V ++H   ++H DLKP NIL                       Y        +I++ D
Sbjct: 127 KTVEYLHAQGVVHRDLKPSNIL-----------------------YVDESGNPESIRICD 163
Query: 265 FGSTTFEHQDHSYVVS---TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
           FG       ++  +++   T ++ APEV+   G++  CD+WS+G +L  + +G   F
Sbjct: 164 FGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF 220

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 94/232 (40%), Gaps = 32/232 (13%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           RY ++  +G G FG      D +  ELVA+K +    K  E    EI +  R  RH    
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREI-INHRSLRH---- 74
Query: 153 TRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V+ +       H+ IV E   G  L++  R  +   F  D  R   +QL+  V++ H
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCH 132
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
            +++ H DLK EN LL  +     P  K  +      S   + PKS+             
Sbjct: 133 AMQVCHRDLKLENTLLDGS---PAPRLKICAFGYSKSSVLHSQPKST------------- 176
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALFQTHE 322
                  V T  Y APEV+L   ++    D+WS G  L  +  G   F+  E
Sbjct: 177 -------VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPE 221

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 128/297 (43%), Gaps = 43/297 (14%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           +++ ++G G FG+V   + N   + VA+K ++  +   +A + E +++++L    +    
Sbjct: 26  KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 84
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            V  +        I I+ E +   SL DFL+  S     I+ + ++  Q+ E +AF+ E 
Sbjct: 85  AVVTQE------PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 138
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             IH DL+  NIL+      K+ D+  L+R  +D  Y         IK            
Sbjct: 139 NYIHRDLRAANILVSDTLSCKIADFG-LARLIEDNEYTAREGAKFPIK------------ 185
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE I    +    D+WS G +L E+ + G   +    N E +  +ER
Sbjct: 186 ----------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 235
Query: 333 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSAS 389
                  + ++R D   E+ ++   RL W +    R   R  +  LR  + D ++A+
Sbjct: 236 ------GYRMVRPDNCPEELYQL-MRLCWKE----RPEDRPTFDYLRSVLEDFFTAT 281

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 86/171 (50%), Gaps = 34/171 (19%)
Query: 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228
            +VFE +  + +  LR+    +     +R    ++L+++ + H + ++H D+KP N++ +
Sbjct: 110 ALVFEHVNNTDFKQLRQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-I 164
Query: 229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH--QDHSYVVSTRHYRA 286
             E+ K                         ++LID+G   F H  Q+++  V++R+++ 
Sbjct: 165 DHEHRK-------------------------LRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 287 PEVILGLG-WNYPCDLWSVGCILVELC-SGEALFQTHENLEHLAMMERVLG 335
           PE+++    ++Y  D+WS+GC+L  +    E  F  H+N + L  + +VLG
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 250

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 128/297 (43%), Gaps = 43/297 (14%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           +++ ++G G FG+V   + N   + VA+K ++  +   +A + E +++++L    +    
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            V  +        I I+ E +   SL DFL+  S     I+ + ++  Q+ E +AF+ E 
Sbjct: 75  AVVTQE------PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             IH DL+  NIL+      K+ D+  L+R  +D  Y         IK            
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFG-LARLIEDNEYTAREGAKFPIK------------ 175
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE I    +    D+WS G +L E+ + G   +    N E +  +ER
Sbjct: 176 ----------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
Query: 333 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSAS 389
                  + ++R D   E+ ++   RL W +    R   R  +  LR  + D ++A+
Sbjct: 226 ------GYRMVRPDNCPEELYQL-MRLCWKE----RPEDRPTFDYLRSVLEDFFTAT 271

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 99/228 (43%), Gaps = 29/228 (12%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           ++ +G+G FGQVV+  +       AIK +R   +     + E+ +L  L    +      
Sbjct: 11  IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRYYAA 70
Query: 157 QIRNWFDYRNHI---------CIVFEKL----GPSLYDFLRKNSYRSFPIDLVRELGRQL 203
               W + RN +           +F +       +LYD +   +      +  R L RQ+
Sbjct: 71  ----WLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWR-LFRQI 125
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
           LE+++++H   +IH +LKP NI +  +  VK+ D+             KN+ +S  I  +
Sbjct: 126 LEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLA----------KNVHRSLDILKL 175
Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVE 310
           D  +      + +  + T  Y A EV+ G G +N   D +S+G I  E
Sbjct: 176 DSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 96/234 (41%), Gaps = 36/234 (15%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           RY ++  +G G FG      D +  ELVA+K +    K  E    EI +  R  RH    
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREI-INHRSLRH---- 74
Query: 153 TRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              V+ +       H+ IV E   G  L++  R  +   F  D  R   +QL+  V++ H
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCH 132
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG--STT 269
            +++ H DLK EN LL                   DGS       +  +K+  FG   ++
Sbjct: 133 AMQVCHRDLKLENTLL-------------------DGS------PAPRLKICAFGYSKSS 167
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALFQTHE 322
             H      V T  Y APEV+L   ++    D+WS G  L  +  G   F+  E
Sbjct: 168 VLHSQPKDTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPE 221

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 108/239 (45%), Gaps = 37/239 (15%)
Query: 83  VFAIGENLT-PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV 141
           VF   E++    + IL  +G+G+FG+V     N+ K++ A+K    +NK +     E+  
Sbjct: 5   VFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKY---MNKQKCVERNEVRN 61
Query: 142 LQRLARHDIGGTRCVQIRNWFDYRNH---ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRE 198
           + +  +   G      +  W+ +++      +V   LG  L   L++N +  F  + V+ 
Sbjct: 62  VFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVH--FKEETVKL 119
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              +L+ ++ ++   R+IH D+KP+NILL    +V + D+   +           LP+ +
Sbjct: 120 FICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAM----------LPRET 169
Query: 259 AIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVI---LGLGWNYPCDLWSVGCILVELCSG 314
            I               + +  T+ Y APE+     G G+++  D WS+G    EL  G
Sbjct: 170 QI---------------TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRG 213

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 128/297 (43%), Gaps = 43/297 (14%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           +++ ++G G FG+V   + N   + VA+K ++  +   +A + E +++++L    +    
Sbjct: 22  KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 80
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            V  +        I I+ E +   SL DFL+  S     I+ + ++  Q+ E +AF+ E 
Sbjct: 81  AVVTQE------PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 134
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             IH DL+  NIL+      K+ D+  L+R  +D  Y         IK            
Sbjct: 135 NYIHRDLRAANILVSDTLSCKIADFG-LARLIEDNEYTAREGAKFPIK------------ 181
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE I    +    D+WS G +L E+ + G   +    N E +  +ER
Sbjct: 182 ----------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 231
Query: 333 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSAS 389
                  + ++R D   E+ ++   RL W +    R   R  +  LR  + D ++A+
Sbjct: 232 ------GYRMVRPDNCPEELYQL-MRLCWKE----RPEDRPTFDYLRSVLEDFFTAT 277

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/239 (22%), Positives = 99/239 (41%), Gaps = 34/239 (14%)
Query: 86  IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL 145
           IGE +   +++ + +G+G+F  V           VAIK++     Y+ A M++  V   +
Sbjct: 6   IGEKIED-FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYK-AGMVQ-RVQNEV 62
Query: 146 ARH-DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
             H  +     +++ N+F+  N++ +V E       +   KN  + F  +  R    Q++
Sbjct: 63  KIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII 122
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
             + ++H   ++H DL   N+LL                            ++  IK+ D
Sbjct: 123 TGMLYLHSHGILHRDLTLSNLLLT---------------------------RNMNIKIAD 155
Query: 265 FGSTT---FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320
           FG  T     H+ H  +  T +Y +PE+          D+WS+GC+   L  G   F T
Sbjct: 156 FGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT 214

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 128/297 (43%), Gaps = 43/297 (14%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           +++ ++G G FG+V   + N   + VA+K ++  +   +A + E +++++L    +    
Sbjct: 21  KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 79
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            V  +        I I+ E +   SL DFL+  S     I+ + ++  Q+ E +AF+ E 
Sbjct: 80  AVVTQE------PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 133
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             IH DL+  NIL+      K+ D+  L+R  +D  Y         IK            
Sbjct: 134 NYIHRDLRAANILVSDTLSCKIADFG-LARLIEDNEYTAREGAKFPIK------------ 180
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE I    +    D+WS G +L E+ + G   +    N E +  +ER
Sbjct: 181 ----------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 230
Query: 333 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSAS 389
                  + ++R D   E+ ++   RL W +    R   R  +  LR  + D ++A+
Sbjct: 231 ------GYRMVRPDNCPEELYQL-MRLCWKE----RPEDRPTFDYLRSVLEDFFTAT 276

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 115/268 (42%), Gaps = 63/268 (23%)
Query: 85  AIGENLTP---RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEID- 140
           A+G +  P    YR+L  +G+G F +V              K+ R I   RE A+  ID 
Sbjct: 2   AMGSDEQPHIGNYRLLKTIGKGNFAKV--------------KLARHILTGREVAIKIIDK 47
Query: 141 ------VLQRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSY 188
                  LQ+L R       +     V++    +    + ++ E   G  ++D+L   ++
Sbjct: 48  TQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLV--AH 105
Query: 189 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248
                   R   RQ++ +V + H+ R++H DLK EN+LL +   +K+ D+ F +  +  G
Sbjct: 106 GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 165
Query: 249 SYFKNLPKSSAIKLIDF-GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYP-CDLWSVGC 306
                       KL  F GS                Y APE+  G  ++ P  D+WS+G 
Sbjct: 166 ------------KLDTFCGSPP--------------YAAPELFQGKKYDGPEVDVWSLGV 199
Query: 307 ILVELCSGEALFQTHENLEHLAMMERVL 334
           IL  L SG   F   +NL+ L   ERVL
Sbjct: 200 ILYTLVSGSLPFDG-QNLKELR--ERVL 224

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 99/232 (42%), Gaps = 41/232 (17%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQ 157
           +G G FG V E  +       AIK +R  N+   RE  M E+  L +L    I     V+
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI-----VR 67
Query: 158 IRNWFDYRNHICIVFEKLGPS---LYDFLRKNSYRSFPID-------LVRELGR------ 201
             N +  +N      EKL PS   +Y +++    R   +         + E  R      
Sbjct: 68  YFNAWLEKNTT----EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 202 --QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
             Q+ E+V F+H   L+H DLKP NI     + VKV D+  ++   +D      L    A
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
                       +  H+  V T+ Y +PE I G  +++  D++S+G IL EL
Sbjct: 184 ------------YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 36/227 (15%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDV-LQRLARHDIG 151
           Y++  ++G+G F  V  C      +  A KI+ +     R+   +E +  + RL +H   
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKH--- 80
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
               V++ +      H  ++F+ + G  L++ +    Y S   D    + +Q+LE+V   
Sbjct: 81  -PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS-EADASHCI-QQILEAVLHC 137
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG---S 267
           H++ ++H DLKPEN+LL S                          K +A+KL DFG    
Sbjct: 138 HQMGVVHRDLKPENLLLASK------------------------LKGAAVKLADFGLAIE 173
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
              E Q       T  Y +PEV+    +  P DLW+ G IL  L  G
Sbjct: 174 VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 127/296 (42%), Gaps = 43/296 (14%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           +++ ++G G FG+V   + N   + VA+K ++  +   +A + E +++++L    +    
Sbjct: 11  KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 69
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            V  +        I I+ E +   SL DFL+  S     I+ + ++  Q+ E +AF+ E 
Sbjct: 70  AVVTQE------PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 123
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             IH DL+  NIL+      K+ D+  L+R  +D  Y         IK            
Sbjct: 124 NYIHRDLRAANILVSDTLSCKIADFG-LARLIEDNEYTAREGAKFPIK------------ 170
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE I    +    D+WS G +L E+ + G   +    N E +  +ER
Sbjct: 171 ----------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 220
Query: 333 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSA 388
                  + ++R D   E+ ++   RL W +    R   R  +  LR  + D ++A
Sbjct: 221 ------GYRMVRPDNCPEELYQL-MRLCWKE----RPEDRPTFDYLRSVLEDFFTA 265

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 105/244 (43%), Gaps = 26/244 (10%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           RYR+  K+G G+FG +    D    E VAIK+     K+ +     + +  ++ +   GG
Sbjct: 10  RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMMQGG 64
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
                IR      ++  +V E LGPSL D     S R F +  V  L  Q++  + ++H 
Sbjct: 65  VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS 123
Query: 213 LRLIHTDLKPENILL---VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
              IH D+KP+N L+        V + D+  L++  +D    +++P              
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFG-LAKKYRDARTHQHIP-------------- 168
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329
             ++++  +  T  Y +    LG+  +   DL S+G +L+    G   +Q  +       
Sbjct: 169 --YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 226
Query: 330 MERV 333
            ER+
Sbjct: 227 YERI 230

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 105/244 (43%), Gaps = 26/244 (10%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           RYR+  K+G G+FG +    D    E VAIK+     K+ +     + +  ++ +   GG
Sbjct: 8   RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMMQGG 62
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
                IR      ++  +V E LGPSL D     S R F +  V  L  Q++  + ++H 
Sbjct: 63  VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS 121
Query: 213 LRLIHTDLKPENILL---VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
              IH D+KP+N L+        V + D+  L++  +D    +++P              
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFG-LAKKYRDARTHQHIP-------------- 166
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329
             ++++  +  T  Y +    LG+  +   DL S+G +L+    G   +Q  +       
Sbjct: 167 --YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 224
Query: 330 MERV 333
            ER+
Sbjct: 225 YERI 228

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 97/238 (40%), Gaps = 44/238 (18%)
Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH 148
             T  Y +   +G G++     C         A+KI   I+K +     EI++L R  +H
Sbjct: 19  QFTDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKI---IDKSKRDPTEEIEILLRYGQH 75
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLL-- 204
                  + +++ +D   ++ +V E  K G  L   LR+  +        RE    L   
Sbjct: 76  ----PNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSE------REASAVLFTI 125
Query: 205 -ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
            ++V ++H   ++H DLKP NIL                       Y        +I++ 
Sbjct: 126 TKTVEYLHAQGVVHRDLKPSNIL-----------------------YVDESGNPESIRIC 162
Query: 264 DFGSTTFEHQDHSYVVS---TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
           DFG       ++  + +   T ++ APEV+   G++  CD+WS+G +L    +G   F
Sbjct: 163 DFGFAKQLRAENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPF 220

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/286 (22%), Positives = 108/286 (37%), Gaps = 58/286 (20%)
Query: 49  NGGMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQV 108
           N   P    +  F    P    P W           A  +    +Y     +G G    V
Sbjct: 62  NDAQPKGTENLYFQSMGPEDELPDW-----------AAAKEFYQKYDPKDVIGRGVSSVV 110
Query: 109 VECFDNEKKELVAIKIVR---------SINKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159
             C         A+KI+           + + REA   E  +L+++A H       + + 
Sbjct: 111 RRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH----PHIITLI 166
Query: 160 NWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHT 218
           + ++  + + +VF+ +    L+D+L +    +      R + R LLE+V+F+H   ++H 
Sbjct: 167 DSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANNIVHR 224
Query: 219 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV 278
           DLKPENILL     +++ D+ F S   + G   + L                        
Sbjct: 225 DLKPENILLDDNMQIRLSDFGF-SCHLEPGEKLREL------------------------ 259
Query: 279 VSTRHYRAPEVI------LGLGWNYPCDLWSVGCILVELCSGEALF 318
             T  Y APE++         G+    DLW+ G IL  L +G   F
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 99/218 (45%), Gaps = 32/218 (14%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+GEG+ G V    +      VA+K++    + R   +    V+ R  +H       V++
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH----FNVVEM 107
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
              +     + ++ E L G +L D + +       I  V E    +L+++A++H   +IH
Sbjct: 108 YKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCE---AVLQALAYLHAQGVIH 164
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
            D+K ++ILL     VK+ D+ F ++ SKD      +PK   +                 
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKD------VPKRKXL----------------- 201
Query: 278 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
            V T ++ APEVI    +    D+WS+G +++E+  GE
Sbjct: 202 -VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 128/297 (43%), Gaps = 43/297 (14%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           +++ ++G G FG+V   + N   + VA+K ++  +   +A + E +++++L    +    
Sbjct: 12  KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 70
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            V  +        I I+ E +   SL DFL+  S     I+ + ++  Q+ E +AF+ E 
Sbjct: 71  AVVTQE------PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 124
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             IH +L+  NIL+      K+ D+  L+R  +D  Y         IK            
Sbjct: 125 NYIHRNLRAANILVSDTLSCKIADFG-LARLIEDNEYTAREGAKFPIK------------ 171
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE I    +    D+WS G +L E+ + G   +    N E +  +ER
Sbjct: 172 ----------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 221
Query: 333 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSAS 389
                  + ++R D   E+ ++   RL W +    R   R  +  LR  + D ++A+
Sbjct: 222 ------GYRMVRPDNCPEELYQL-MRLCWKE----RPEDRPTFDYLRSVLEDFFTAT 267

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/231 (22%), Positives = 98/231 (42%), Gaps = 40/231 (17%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           Y +   +G G++ +   C         A+K+   I+K +     EI++L R  +H     
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKV---IDKSKRDPSEEIEILLRYGQH----P 81
Query: 154 RCVQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLV-RELGRQLLESVAFM 210
             + +++ +D   H+ +V E +  G  L   LR+  +       V   +G+    +V ++
Sbjct: 82  NIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGK----TVEYL 137
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H   ++H DLKP NIL                       Y         +++ DFG    
Sbjct: 138 HSQGVVHRDLKPSNIL-----------------------YVDESGNPECLRICDFGFAKQ 174
Query: 271 EHQDHSYVVS---TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
              ++  +++   T ++ APEV+   G++  CD+WS+G +L  + +G   F
Sbjct: 175 LRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPF 225

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 107/256 (41%), Gaps = 49/256 (19%)
Query: 84  FAIGENLTPRYRILSK-MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVL 142
           F   EN    Y + SK +G G F  V +C      +  A K ++   K R       ++L
Sbjct: 20  FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK---KRRRGQDCRAEIL 76
Query: 143 QRLARHDIGGT--RCVQIRNWFDYRNHICIVFEKLG---------PSLYDFLRKNSYRSF 191
             +A  ++  +  R + +   ++  + I ++ E            P L + + +N     
Sbjct: 77  HEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEN----- 131
Query: 192 PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251
             D++R L +Q+LE V ++H+  ++H DLKP+NILL S                      
Sbjct: 132 --DVIR-LIKQILEGVYYLHQNNIVHLDLKPQNILLSS---------------------- 166
Query: 252 KNLPKSSAIKLIDFG-STTFEHQ-DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309
             +     IK++DFG S    H  +   ++ T  Y APE++         D+W++G I  
Sbjct: 167 --IYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAY 224
Query: 310 ELCSGEALFQTHENLE 325
            L +  + F   +N E
Sbjct: 225 MLLTHTSPFVGEDNQE 240

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 95/226 (42%), Gaps = 31/226 (13%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           ++IL  +G G+FG+V            A+K+++     R    +E    +RL    +   
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHP 66
Query: 154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
             +++   F     I ++ + + G  L+  LRK+  + FP  + +    ++  ++ ++H 
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHS 124
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
             +I+ DLKPENILL                            K+  IK+ DFG   +  
Sbjct: 125 KDIIYRDLKPENILL---------------------------DKNGHIKITDFGFAKYVP 157
Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
                +  T  Y APEV+    +N   D WS G ++ E+ +G   F
Sbjct: 158 DVTYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 103/241 (42%), Gaps = 37/241 (15%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           + I+  +G G FG+V        + + A+KI   +NK+      E     R  R  +   
Sbjct: 76  FEIIKVIGRGAFGEVAVVKMKNTERIYAMKI---LNKWEMLKRAETACF-REERDVLVNG 131
Query: 154 RCVQIRNW---FDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
            C  I      F   NH+ +V +  +G  L   L K   +  P D+ R    +++ ++  
Sbjct: 132 DCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDK-LPEDMARFYIGEMVLAIDS 190
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
           +H+L  +H D+KP+N+LL    ++++ D+                   S +K+ D G+  
Sbjct: 191 IHQLHYVHRDIKPDNVLLDVNGHIRLADF------------------GSCLKMNDDGTVQ 232
Query: 270 FEHQDHSYVVSTRHYRAPEVIL----GLGWNYP-CDLWSVGCILVELCSGEALFQTHENL 324
                 S  V T  Y +PE++     G+G   P CD WS+G  + E+  GE  F     +
Sbjct: 233 -----SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 287
Query: 325 E 325
           E
Sbjct: 288 E 288

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 103/241 (42%), Gaps = 37/241 (15%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           + I+  +G G FG+V        + + A+KI   +NK+      E     R  R  +   
Sbjct: 92  FEIIKVIGRGAFGEVAVVKMKNTERIYAMKI---LNKWEMLKRAETACF-REERDVLVNG 147
Query: 154 RCVQIRNW---FDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
            C  I      F   NH+ +V +  +G  L   L K   +  P D+ R    +++ ++  
Sbjct: 148 DCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDK-LPEDMARFYIGEMVLAIDS 206
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
           +H+L  +H D+KP+N+LL    ++++ D+                   S +K+ D G+  
Sbjct: 207 IHQLHYVHRDIKPDNVLLDVNGHIRLADF------------------GSCLKMNDDGTVQ 248
Query: 270 FEHQDHSYVVSTRHYRAPEVIL----GLGWNYP-CDLWSVGCILVELCSGEALFQTHENL 324
                 S  V T  Y +PE++     G+G   P CD WS+G  + E+  GE  F     +
Sbjct: 249 -----SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 303
Query: 325 E 325
           E
Sbjct: 304 E 304

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 97/231 (41%), Gaps = 36/231 (15%)
Query: 90  LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDV-LQRLAR 147
            T  Y++  ++G+G F  V  C      +  A KI+ +     R+   +E +  + RL +
Sbjct: 29  FTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLK 88
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
           H       V++ +         +VF+ + G  L++ +    Y S   D    +  Q+LES
Sbjct: 89  H----PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYS-EADASHCI-HQILES 142
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           V  +H+  ++H DLKPEN+LL S                          K +A+KL DFG
Sbjct: 143 VNHIHQHDIVHRDLKPENLLLASK------------------------CKGAAVKLADFG 178
Query: 267 ---STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                  E Q       T  Y +PEV+    +  P D+W+ G IL  L  G
Sbjct: 179 LAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/231 (22%), Positives = 98/231 (42%), Gaps = 40/231 (17%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           Y +   +G G++ +   C         A+K+   I+K +     EI++L R  +H     
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKV---IDKSKRDPSEEIEILLRYGQH----P 81
Query: 154 RCVQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLV-RELGRQLLESVAFM 210
             + +++ +D   H+ +V E +  G  L   LR+  +       V   +G+    +V ++
Sbjct: 82  NIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGK----TVEYL 137
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H   ++H DLKP NIL                       Y         +++ DFG    
Sbjct: 138 HSQGVVHRDLKPSNIL-----------------------YVDESGNPECLRICDFGFAKQ 174
Query: 271 EHQDHSYVVS---TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
              ++  +++   T ++ APEV+   G++  CD+WS+G +L  + +G   F
Sbjct: 175 LRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPF 225

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 104/237 (43%), Gaps = 35/237 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAA--MIEIDVLQRLARHD 149
           +  L  +G+G+FG+V+      ++   A+K++  ++I K +E    M E +VL +  +H 
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                 V +   F   + +  V + + G  L+  L++   R F     R    ++  ++ 
Sbjct: 100 F----LVGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALG 153
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H L +++ DLKPENILL S  ++ + D+     +                  I+  ST
Sbjct: 154 YLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN------------------IEHNST 195
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
           T      S    T  Y APEV+    ++   D W +G +L E+  G   F +    E
Sbjct: 196 T------STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 246

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 108/255 (42%), Gaps = 58/255 (22%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEID-------VLQRLA 146
           YR+L  +G+G F +V              K+ R I   RE A+  ID        LQ+L 
Sbjct: 17  YRLLKTIGKGNFAKV--------------KLARHILTGREVAIKIIDKTQLNPTSLQKLF 62
Query: 147 RHD-----IGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELG 200
           R       +     V++    +    + ++ E   G  ++D+L   ++        R   
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLV--AHGRMKEKEARSKF 120
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
           RQ++ +V + H+ R++H DLK EN+LL +   +K+ D+ F +  +  G            
Sbjct: 121 RQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG------------ 168
Query: 261 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALFQ 319
           KL  F                  Y APE+  G  ++ P  D+WS+G IL  L SG   F 
Sbjct: 169 KLDAF-------------CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215
Query: 320 THENLEHLAMMERVL 334
             +NL+ L   ERVL
Sbjct: 216 G-QNLKELR--ERVL 227

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/269 (21%), Positives = 112/269 (41%), Gaps = 38/269 (14%)
Query: 86  IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY----REAAMIEIDV 141
           + +N   +YR+L   G+G FG+V  C      ++ A K +             A+ E  +
Sbjct: 181 VTKNTFRQYRVL---GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI 237
Query: 142 LQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELG 200
           L+++    +     V +   ++ ++ +C+V   + G  L   +       FP        
Sbjct: 238 LEKVNSRFV-----VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            ++   +  +H  R+++ DLKPENILL    ++++ D               ++P+   I
Sbjct: 293 AEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAV----------HVPEGQTI 342
Query: 261 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320
           K                 V T  Y APEV+    + +  D W++GC+L E+ +G++ FQ 
Sbjct: 343 K---------------GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387
Query: 321 HENLEHLAMMERVLGPLPHHMVIRADRRA 349
            +       +ER++  +P     R   +A
Sbjct: 388 RKKKIKREEVERLVKEVPEEYSERFSPQA 416

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 102/240 (42%), Gaps = 32/240 (13%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           R+  K+G+G FG+V     N     VAIK ++  N   EA + E  V+++L RH+    +
Sbjct: 188 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGNMSPEAFLQEAQVMKKL-RHE----K 241
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            VQ+         I IV E +   SL DFL+    +   +  + ++  Q+   +A++  +
Sbjct: 242 LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 300
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL+  NIL+      KV D+  L R  +D  Y         IK            
Sbjct: 301 NYVHRDLRAANILVGENLVCKVADFG-LGRLIEDNEYTARQGAKFPIK------------ 347
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE  L   +    D+WS G +L EL + G   +    N E L  +ER
Sbjct: 348 ----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 397

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/269 (21%), Positives = 112/269 (41%), Gaps = 38/269 (14%)
Query: 86  IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY----REAAMIEIDV 141
           + +N   +YR+L   G+G FG+V  C      ++ A K +             A+ E  +
Sbjct: 181 VTKNTFRQYRVL---GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI 237
Query: 142 LQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELG 200
           L+++    +     V +   ++ ++ +C+V   + G  L   +       FP        
Sbjct: 238 LEKVNSRFV-----VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            ++   +  +H  R+++ DLKPENILL    ++++ D               ++P+   I
Sbjct: 293 AEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAV----------HVPEGQTI 342
Query: 261 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320
           K                 V T  Y APEV+    + +  D W++GC+L E+ +G++ FQ 
Sbjct: 343 K---------------GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387
Query: 321 HENLEHLAMMERVLGPLPHHMVIRADRRA 349
            +       +ER++  +P     R   +A
Sbjct: 388 RKKKIKREEVERLVKEVPEEYSERFSPQA 416

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 127/297 (42%), Gaps = 43/297 (14%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           +++ ++G G FG+V   + N   + VA+K ++  +   +A + E +++++L    +    
Sbjct: 25  KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 83
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            V  +        I I+ E +   SL DFL+  S     I+ + ++  Q+ E +AF+ E 
Sbjct: 84  AVVTQE------PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 137
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             IH DL+  NIL+      K+ D+  L+R  +D            IK            
Sbjct: 138 NYIHRDLRAANILVSDTLSCKIADFG-LARLIEDNEXTAREGAKFPIK------------ 184
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE I    +    D+WS G +L E+ + G   +    N E +  +ER
Sbjct: 185 ----------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 234
Query: 333 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSAS 389
                  + ++R D   E+ ++   RL W +    R   R  +  LR  + D ++A+
Sbjct: 235 ------GYRMVRPDNCPEELYQL-MRLCWKE----RPEDRPTFDYLRSVLEDFFTAT 280

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 127/297 (42%), Gaps = 43/297 (14%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           +++ ++G G FG+V   + N   + VA+K ++  +   +A + E +++++L    +    
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            V  +        I I+ E +   SL DFL+  S     I+ + ++  Q+ E +AF+ E 
Sbjct: 75  AVVTQE------PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             IH DL+  NIL+      K+ D+  L+R  +D            IK            
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFG-LARLIEDNEXTAREGAKFPIK------------ 175
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE I    +    D+WS G +L E+ + G   +    N E +  +ER
Sbjct: 176 ----------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
Query: 333 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSAS 389
                  + ++R D   E+ ++   RL W +    R   R  +  LR  + D ++A+
Sbjct: 226 ------GYRMVRPDNCPEELYQL-MRLCWKE----RPEDRPTFDYLRSVLEDFFTAT 271

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 106/228 (46%), Gaps = 41/228 (17%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           +G+GT+G V    D   +  +AIK I    ++Y +    EI + + L   +I     VQ 
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI-----VQY 84
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPI-DLVRELG---RQLLESVAFMHEL 213
              F     I I  E++ G SL   LR    +  P+ D  + +G   +Q+LE + ++H+ 
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRS---KWGPLKDNEQTIGFYTKQILEGLKYLHDN 141
Query: 214 RLIHTDLKPENILLVS-AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
           +++H D+K +N+L+ + +  +K+ D+    R                +  I+  + TF  
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKR----------------LAGINPCTETF-- 183
Query: 273 QDHSYVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSGEALF 318
                   T  Y APE+I     G+    D+WS+GC ++E+ +G+  F
Sbjct: 184 ------TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 225

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 127/297 (42%), Gaps = 43/297 (14%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           +++ ++G G FG+V   + N   + VA+K ++  +   +A + E +++++L    +    
Sbjct: 18  KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 76
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            V  +        I I+ E +   SL DFL+  S     I+ + ++  Q+ E +AF+ E 
Sbjct: 77  AVVTQE------PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 130
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             IH DL+  NIL+      K+ D+  L+R  +D            IK            
Sbjct: 131 NYIHRDLRAANILVSDTLSCKIADFG-LARLIEDNEXTAREGAKFPIK------------ 177
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE I    +    D+WS G +L E+ + G   +    N E +  +ER
Sbjct: 178 ----------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 227
Query: 333 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSAS 389
                  + ++R D   E+ ++   RL W +    R   R  +  LR  + D ++A+
Sbjct: 228 ------GYRMVRPDNCPEELYQL-MRLCWKE----RPEDRPTFDYLRSVLEDFFTAT 273

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 127/297 (42%), Gaps = 43/297 (14%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           +++ ++G G FG+V   + N   + VA+K ++  +   +A + E +++++L    +    
Sbjct: 24  KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 82
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            V  +        I I+ E +   SL DFL+  S     I+ + ++  Q+ E +AF+ E 
Sbjct: 83  AVVTQE------PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 136
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             IH DL+  NIL+      K+ D+  L+R  +D            IK            
Sbjct: 137 NYIHRDLRAANILVSDTLSCKIADFG-LARLIEDNEXTAREGAKFPIK------------ 183
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE I    +    D+WS G +L E+ + G   +    N E +  +ER
Sbjct: 184 ----------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 233
Query: 333 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSAS 389
                  + ++R D   E+ ++   RL W +    R   R  +  LR  + D ++A+
Sbjct: 234 ------GYRMVRPDNCPEELYQL-MRLCWKE----RPEDRPTFDYLRSVLEDFFTAT 279

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 127/297 (42%), Gaps = 43/297 (14%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           +++ ++G G FG+V   + N   + VA+K ++  +   +A + E +++++L    +    
Sbjct: 22  KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 80
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            V  +        I I+ E +   SL DFL+  S     I+ + ++  Q+ E +AF+ E 
Sbjct: 81  AVVTQE------PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 134
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             IH DL+  NIL+      K+ D+  L+R  +D            IK            
Sbjct: 135 NYIHRDLRAANILVSDTLSCKIADFG-LARLIEDNEXTAREGAKFPIK------------ 181
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE I    +    D+WS G +L E+ + G   +    N E +  +ER
Sbjct: 182 ----------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 231
Query: 333 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSAS 389
                  + ++R D   E+ ++   RL W +    R   R  +  LR  + D ++A+
Sbjct: 232 ------GYRMVRPDNCPEELYQL-MRLCWKE----RPEDRPTFDYLRSVLEDFFTAT 277

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 103/240 (42%), Gaps = 32/240 (13%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           R+  K+G+G FG+V     N     VAIK ++      EA + E  V+++L RH+    +
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE----K 323
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            VQ+         I IV E +   SL DFL+  + +   +  + ++  Q+   +A++  +
Sbjct: 324 LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL+  NIL+      KV D+  L+R  +D  Y         IK            
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFG-LARLIEDNEYTARQGAKFPIK------------ 429
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE  L   +    D+WS G +L EL + G   +    N E L  +ER
Sbjct: 430 ----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 105/250 (42%), Gaps = 40/250 (16%)
Query: 96  ILSKM-GEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDI 150
           IL KM G+G+FG+V      +  +  AIK ++     ++   E  M+E  VL     H  
Sbjct: 20  ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 79
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                  +   F  + ++  V E L  G  +Y      S   F +        +++  + 
Sbjct: 80  ----LTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQ 132
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           F+H   +++ DLK +NILL    ++K+ D+         G   +N+       L D  + 
Sbjct: 133 FLHSKGIVYRDLKLDNILLDKDGHIKIADF---------GMCKENM-------LGDAKTN 176
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENLEH 326
            F          T  Y APE++LG  +N+  D WS G +L E+  G++ F  Q  E L H
Sbjct: 177 XF--------CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228
Query: 327 LAMMERVLGP 336
              M+    P
Sbjct: 229 SIRMDNPFYP 238

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 127/297 (42%), Gaps = 43/297 (14%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           +++ ++G G FG+V   + N   + VA+K ++  +   +A + E +++++L    +    
Sbjct: 17  KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 75
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            V  +        I I+ E +   SL DFL+  S     I+ + ++  Q+ E +AF+ E 
Sbjct: 76  AVVTQE------PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 129
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             IH DL+  NIL+      K+ D+  L+R  +D            IK            
Sbjct: 130 NYIHRDLRAANILVSDTLSCKIADFG-LARLIEDNEXTAREGAKFPIK------------ 176
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE I    +    D+WS G +L E+ + G   +    N E +  +ER
Sbjct: 177 ----------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 226
Query: 333 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSAS 389
                  + ++R D   E+ ++   RL W +    R   R  +  LR  + D ++A+
Sbjct: 227 ------GYRMVRPDNCPEELYQL-MRLCWKE----RPEDRPTFDYLRSVLEDFFTAT 272

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 127/297 (42%), Gaps = 43/297 (14%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           +++ ++G G FG+V   + N   + VA+K ++  +   +A + E +++++L    +    
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            V  +        I I+ E +   SL DFL+  S     I+ + ++  Q+ E +AF+ E 
Sbjct: 75  AVVTQE------PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             IH DL+  NIL+      K+ D+  L+R  +D            IK            
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFG-LARLIEDNEXTAREGAKFPIK------------ 175
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE I    +    D+WS G +L E+ + G   +    N E +  +ER
Sbjct: 176 ----------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
Query: 333 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSAS 389
                  + ++R D   E+ ++   RL W +    R   R  +  LR  + D ++A+
Sbjct: 226 ------GYRMVRPDNCPEELYQL-MRLCWKE----RPEDRPTFDYLRSVLEDFFTAT 271

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/251 (22%), Positives = 116/251 (46%), Gaps = 48/251 (19%)
Query: 94  YRILSKMGEGTFGQVVECFD---NEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150
           Y+++ K+G G + +V E  +   NE+  +  +K V+     RE  ++E         +  
Sbjct: 40  YQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILE---------NLR 90
Query: 151 GGTRCVQIRNWFD--YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           GGT  +++ +           +VFE +  +  DF  K  Y+      +R    +LL+++ 
Sbjct: 91  GGTNIIKLIDTVKDPVSKTPALVFEYINNT--DF--KQLYQILTDFDIRFYMYELLKALD 146
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           + H   ++H D+KP N+++                            +   ++LID+G  
Sbjct: 147 YCHSKGIMHRDVKPHNVMIDH--------------------------QQKKLRLIDWGLA 180
Query: 269 TFEH--QDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELC-SGEALFQTHENL 324
            F H  Q+++  V++R+++ PE+++    ++Y  D+WS+GC+L  +    E  F   +N 
Sbjct: 181 EFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNY 240
Query: 325 EHLAMMERVLG 335
           + L  + +VLG
Sbjct: 241 DQLVRIAKVLG 251

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 103/240 (42%), Gaps = 32/240 (13%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           R+  K+G+G FG+V     N     VAIK ++      EA + E  V+++L RH+    +
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE----K 240
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            VQ+         I IV E +   SL DFL+  + +   +  + ++  Q+   +A++  +
Sbjct: 241 LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL+  NIL+      KV D+  L+R  +D  Y         IK            
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFG-LARLIEDNEYTARQGAKFPIK------------ 346
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE  L   +    D+WS G +L EL + G   +    N E L  +ER
Sbjct: 347 ----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 106/228 (46%), Gaps = 41/228 (17%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           +G+GT+G V    D   +  +AIK I    ++Y +    EI + + L   +I     VQ 
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI-----VQY 70
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPI-DLVRELG---RQLLESVAFMHEL 213
              F     I I  E++ G SL   LR    +  P+ D  + +G   +Q+LE + ++H+ 
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLSALLRS---KWGPLKDNEQTIGFYTKQILEGLKYLHDN 127
Query: 214 RLIHTDLKPENILLVS-AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
           +++H D+K +N+L+ + +  +K+ D+                  S  +  I+  + TF  
Sbjct: 128 QIVHRDIKGDNVLINTYSGVLKISDFG----------------TSKRLAGINPCTETF-- 169
Query: 273 QDHSYVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSGEALF 318
                   T  Y APE+I     G+    D+WS+GC ++E+ +G+  F
Sbjct: 170 ------TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 211

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 103/240 (42%), Gaps = 32/240 (13%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           R+  K+G+G FG+V     N     VAIK ++      EA + E  V+++L RH+    +
Sbjct: 14  RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE----K 67
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            VQ+         I IV E +   SL DFL+  + +   +  + ++  Q+   +A++  +
Sbjct: 68  LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 126
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL+  NIL+      KV D+  L+R  +D  Y         IK            
Sbjct: 127 NYVHRDLRAANILVGENLVCKVADFG-LARLIEDNEYTARQGAKFPIK------------ 173
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE  L   +    D+WS G +L EL + G   +    N E L  +ER
Sbjct: 174 ----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 223

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 103/240 (42%), Gaps = 32/240 (13%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           R+  K+G+G FG+V     N     VAIK ++      EA + E  V+++L RH+    +
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE----K 240
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            VQ+         I IV E +   SL DFL+  + +   +  + ++  Q+   +A++  +
Sbjct: 241 LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL+  NIL+      KV D+  L+R  +D  Y         IK            
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFG-LARLIEDNEYTARQGAKFPIK------------ 346
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE  L   +    D+WS G +L EL + G   +    N E L  +ER
Sbjct: 347 ----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 46/226 (20%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRC 155
           +GEG+F  VV   +       AIKI+  R I K  +   +  E DV+ RL          
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-------DHP 92
Query: 156 VQIRNWFDYRN----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
             ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ ++ ++H
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNG-CLLKYIRKIG--SFDETCTRFYTAEIVSALEYLH 149
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
              +IH DLKPENILL    ++++ D+   K LS  SK                    + 
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR-----------------AN 192
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           +F        V T  Y +PE++     +   DLW++GCI+ +L +G
Sbjct: 193 SF--------VGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/251 (22%), Positives = 116/251 (46%), Gaps = 48/251 (19%)
Query: 94  YRILSKMGEGTFGQVVECFD---NEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150
           Y+++ K+G G + +V E  +   NE+  +  +K V+     RE  ++E         +  
Sbjct: 45  YQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILE---------NLR 95
Query: 151 GGTRCVQIRNWFD--YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           GGT  +++ +           +VFE +  +  DF  K  Y+      +R    +LL+++ 
Sbjct: 96  GGTNIIKLIDTVKDPVSKTPALVFEYINNT--DF--KQLYQILTDFDIRFYMYELLKALD 151
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           + H   ++H D+KP N+++                            +   ++LID+G  
Sbjct: 152 YCHSKGIMHRDVKPHNVMIDH--------------------------QQKKLRLIDWGLA 185
Query: 269 TFEH--QDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELC-SGEALFQTHENL 324
            F H  Q+++  V++R+++ PE+++    ++Y  D+WS+GC+L  +    E  F   +N 
Sbjct: 186 EFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNY 245
Query: 325 EHLAMMERVLG 335
           + L  + +VLG
Sbjct: 246 DQLVRIAKVLG 256

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 116/270 (42%), Gaps = 44/270 (16%)
Query: 94  YRILSKMGEGTFGQV-VECFDNEKKELVAIKI----VRSINKYREAAMIEIDVLQRLARH 148
           Y + + +G G++G+V +      +    A KI    V  ++++++    EI++++ L   
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ----EIEIMKSLDHP 66
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
           +I     +++   F+    I +V E   G  L++  R    R F       + + +L +V
Sbjct: 67  NI-----IRLYETFEDNTDIYLVMELCTGGELFE--RVVHKRVFRESDAARIMKDVLSAV 119
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
           A+ H+L + H DLKPEN L ++      PD                    S +KLIDFG 
Sbjct: 120 AYCHKLNVAHRDLKPENFLFLTDS----PD--------------------SPLKLIDFGL 155
Query: 267 STTFEHQDHSYV-VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
           +  F+        V T +Y +P+V+ GL +   CD WS G ++  L  G   F    + E
Sbjct: 156 AARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDXE 214
Query: 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRR 355
            +  +       P    +    +AE   RR
Sbjct: 215 VMLKIREGTFTFPEKDWLNVSPQAESLIRR 244

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 103/239 (43%), Gaps = 34/239 (14%)
Query: 94  YRILSKM-GEGTFGQVVECFDNEKKELVAIKIV-RSINKYREAAMIEIDVLQRLARHDIG 151
           Y++ S++ GEG + +V      +  +  A+KI+ +     R     E++ L +      G
Sbjct: 14  YKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQ----G 69
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
               +++  +F+      +VFEKL G S+   ++K  +  F       + R +  ++ F+
Sbjct: 70  NKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKH--FNEREASRVVRDVAAALDFL 127
Query: 211 HELRLIHTDLKPENILLVSAEY---VKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
           H   + H DLKPENIL  S E    VK+ D+                   S +KL +   
Sbjct: 128 HTKGIAHRDLKPENILCESPEKVSPVKICDFDL----------------GSGMKL-NNSC 170
Query: 268 TTFEHQDHSYVVSTRHYRAPEVI-----LGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
           T     + +    +  Y APEV+         ++  CDLWS+G +L  + SG   F  H
Sbjct: 171 TPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGH 229

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 98/231 (42%), Gaps = 36/231 (15%)
Query: 90  LTPRYRILSKMGEGTFGQVVECFDN-EKKELVAIKIVRSINKYREAAMIEIDV-LQRLAR 147
            T  Y++  ++G+G F  V  C      +E  A+ I       R+   +E +  + RL +
Sbjct: 9   FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK 68
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
           H       V++ +      H  ++F+ + G  L++ +    Y S   D    + +Q+LE+
Sbjct: 69  H----PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS-EADASHCI-QQILEA 122
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           V   H++ ++H +LKPEN+LL S                          K +A+KL DFG
Sbjct: 123 VLHCHQMGVVHRNLKPENLLLASK------------------------LKGAAVKLADFG 158
Query: 267 ---STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                  E Q       T  Y +PEV+    +  P DLW+ G IL  L  G
Sbjct: 159 LAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 106/241 (43%), Gaps = 34/241 (14%)
Query: 95  RILSKMGEGTFGQV-VECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           +++ ++G G FG+V +  ++   K  VAIK ++      E+ + E  ++++L +HD    
Sbjct: 12  QLIKRLGNGQFGEVWMGTWNGNTK--VAIKTLKPGTMSPESFLEEAQIMKKL-KHD---- 64
Query: 154 RCVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
           + VQ+         I IV E +   SL DFL+    R+  +  + ++  Q+   +A++  
Sbjct: 65  KLVQLYAVVS-EEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER 123
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
           +  IH DL+  NIL+ +    K+ D+  L+R  +D            IK           
Sbjct: 124 MNYIHRDLRSANILVGNGLICKIADFG-LARLIEDNEXTARQGAKFPIK----------- 171
Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMME 331
                      + APE  L   +    D+WS G +L EL + G   +    N E L  +E
Sbjct: 172 -----------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE 220
Query: 332 R 332
           R
Sbjct: 221 R 221

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 116/270 (42%), Gaps = 44/270 (16%)
Query: 94  YRILSKMGEGTFGQV-VECFDNEKKELVAIKI----VRSINKYREAAMIEIDVLQRLARH 148
           Y + + +G G++G+V +      +    A KI    V  ++++++    EI++++ L   
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ----EIEIMKSLDHP 83
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
           +I     +++   F+    I +V E   G  L++  R    R F       + + +L +V
Sbjct: 84  NI-----IRLYETFEDNTDIYLVMELCTGGELFE--RVVHKRVFRESDAARIMKDVLSAV 136
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
           A+ H+L + H DLKPEN L ++      PD                    S +KLIDFG 
Sbjct: 137 AYCHKLNVAHRDLKPENFLFLTDS----PD--------------------SPLKLIDFGL 172
Query: 267 STTFEHQDHSYV-VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
           +  F+        V T +Y +P+V+ GL +   CD WS G ++  L  G   F    + E
Sbjct: 173 AARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDXE 231
Query: 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRR 355
            +  +       P    +    +AE   RR
Sbjct: 232 VMLKIREGTFTFPEKDWLNVSPQAESLIRR 261

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 102/240 (42%), Gaps = 32/240 (13%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           R+  K+G+G FG+V     N     VAIK ++      EA + E  V+++L RH+    +
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE----K 74
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            VQ+         I IV E +   SL DFL+    +   +  + ++  Q+   +A++  +
Sbjct: 75  LVQLYAVVS-EEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL+  NIL+      KV D+  L+R  +D  Y         IK            
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFG-LARLIEDNEYTARQGAKFPIK------------ 180
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE  L   +    D+WS G +L EL + G   +    N E L  +ER
Sbjct: 181 ----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 103/240 (42%), Gaps = 32/240 (13%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           R+  K+G+G FG+V     N     VAIK ++      EA + E  V+++L RH+    +
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE----K 240
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            VQ+         I IV E +   SL DFL+  + +   +  + ++  Q+   +A++  +
Sbjct: 241 LVQLYAVVS-EEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL+  NIL+      KV D+  L+R  +D  Y         IK            
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFG-LARLIEDNEYTARQGAKFPIK------------ 346
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE  L   +    D+WS G +L EL + G   +    N E L  +ER
Sbjct: 347 ----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 98/232 (42%), Gaps = 36/232 (15%)
Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDV-LQRLA 146
           ++T  Y++   +G+G F  V  C         A KI+ +     R+   +E +  + RL 
Sbjct: 1   SMTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
           +H    +  V++ +         +VF+ + G  L++ +    Y S   D    + +Q+LE
Sbjct: 61  KH----SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYS-EADASHCI-QQILE 114
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           +V   H++ ++H DLKPEN+LL S                          K +A+KL DF
Sbjct: 115 AVLHCHQMGVVHRDLKPENLLLASK------------------------CKGAAVKLADF 150
Query: 266 GSTTFEHQDHSY---VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           G       D         T  Y +PEV+    +  P D+W+ G IL  L  G
Sbjct: 151 GLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 103/248 (41%), Gaps = 52/248 (20%)
Query: 78  KDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI 137
           K GHY+  +G+ L          G GTFG+V           VA+KI+    K R   ++
Sbjct: 14  KIGHYI--LGDTL----------GVGTFGKVKVGKHELTGHKVAVKILNR-QKIRSLDVV 60
Query: 138 -----EIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSF 191
                EI  L +L RH       +++       + I +V E + G  L+D++ KN     
Sbjct: 61  GKIRREIQNL-KLFRH----PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG--RL 113
Query: 192 PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251
                R L +Q+L  V + H   ++H DLKPEN+LL +    K+ D+  LS    DG + 
Sbjct: 114 DEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG-LSNMMSDGEFL 172
Query: 252 KNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVE 310
           +                            + +Y APEVI G  +  P  D+WS G IL  
Sbjct: 173 RX------------------------SCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYA 208
Query: 311 LCSGEALF 318
           L  G   F
Sbjct: 209 LLCGTLPF 216

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 95/232 (40%), Gaps = 36/232 (15%)
Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDV-LQRLA 146
           ++T  Y++  ++G+G F  V  C      +  A KI+ +     R+   +E +  + RL 
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
           +H       V++ +         +VF+ + G  L++ +    Y S          +Q+LE
Sbjct: 61  KH----PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEAD--ASHCIQQILE 114
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           SV   H   ++H DLKPEN+LL S                          K +A+KL DF
Sbjct: 115 SVNHCHLNGIVHRDLKPENLLLASKS------------------------KGAAVKLADF 150
Query: 266 GSTTFEHQDHSY---VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           G       D         T  Y +PEV+    +  P D+W+ G IL  L  G
Sbjct: 151 GLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 95/232 (40%), Gaps = 36/232 (15%)
Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDV-LQRLA 146
           ++T  Y++  ++G+G F  V  C      +  A KI+ +     R+   +E +  + RL 
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
           +H       V++ +         +VF+ + G  L++ +    Y S          +Q+LE
Sbjct: 61  KH----PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEAD--ASHCIQQILE 114
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           SV   H   ++H DLKPEN+LL S                          K +A+KL DF
Sbjct: 115 SVNHCHLNGIVHRDLKPENLLLASKS------------------------KGAAVKLADF 150
Query: 266 GSTTFEHQDHSY---VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           G       D         T  Y +PEV+    +  P D+W+ G IL  L  G
Sbjct: 151 GLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 111/248 (44%), Gaps = 42/248 (16%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREA-----AMIEID 140
           E L  +Y++   +G G FG V           VAIK V    I+ + E        +E+ 
Sbjct: 4   EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 63
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRE 198
           +L++++    G +  +++ +WF+  +   ++ E++ P   L+DF+ +    +   +L R 
Sbjct: 64  LLKKVSS---GFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERG--ALQEELARS 118
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              Q+LE+V   H   ++H D+K ENIL+             L+R               
Sbjct: 119 FFWQVLEAVRHCHNCGVLHRDIKDENILID------------LNRGE------------- 153
Query: 259 AIKLIDFGSTT-FEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEA 316
            +KLIDFGS    +   ++    TR Y  PE I    ++     +WS+G +L ++  G+ 
Sbjct: 154 -LKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 212
Query: 317 LFQTHENL 324
            F+  E +
Sbjct: 213 PFEHDEEI 220

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 103/240 (42%), Gaps = 32/240 (13%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           R+  K+G+G FG+V     N     VAIK ++      EA + E  V+++L RH+    +
Sbjct: 18  RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE----K 71
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            VQ+         I IV E +   SL DFL+  + +   +  + ++  Q+   +A++  +
Sbjct: 72  LVQLYAVVS-EEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERM 130
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL+  NIL+      KV D+  L+R  +D  Y         IK            
Sbjct: 131 NYVHRDLRAANILVGENLVCKVADFG-LARLIEDNEYTARQGAKFPIK------------ 177
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE  L   +    D+WS G +L EL + G   +    N E L  +ER
Sbjct: 178 ----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 227

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 46/226 (20%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRC 155
           +GEG+F  VV   +       AIKI+  R I K  +   +  E DV+ RL          
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-------DHP 92
Query: 156 VQIRNWFDYRN----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
             ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ ++ ++H
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNG-ELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH 149
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
              +IH DLKPENILL    ++++ D+   K LS  SK                      
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------------- 190
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                  +  V T  Y +PE++         DLW++GCI+ +L +G
Sbjct: 191 ------ANXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 105/243 (43%), Gaps = 41/243 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI----EIDVLQRLARHD 149
           + IL  +G G FG+V         ++ A+KI+      + A       E DVL       
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN----- 130
Query: 150 IGGTRCVQIRNW-FDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
            G ++ +   ++ F   N++ +V +  +G  L   L K   R  P ++ R    +++ ++
Sbjct: 131 -GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR-LPEEMARFYLAEMVIAI 188
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
             +H+L  +H D+KP+NIL+    ++++ D+                   S +KL++ G+
Sbjct: 189 DSVHQLHYVHRDIKPDNILMDMNGHIRLADF------------------GSCLKLMEDGT 230
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLG-----WNYPCDLWSVGCILVELCSGEALFQTHE 322
                   S  V T  Y +PE++  +      +   CD WS+G  + E+  GE  F    
Sbjct: 231 VQ-----SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 285
Query: 323 NLE 325
            +E
Sbjct: 286 LVE 288

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 87/178 (48%), Gaps = 44/178 (24%)
Query: 162 FDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLK 221
           F+Y N+    F+ L P+L D+             +R    +LL+++ + H   ++H D+K
Sbjct: 108 FEYVNNTD--FKVLYPTLTDYD------------IRYYIYELLKALDYCHSQGIMHRDVK 153
Query: 222 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH--QDHSYVV 279
           P N+++         D++                    ++LID+G   F H  ++++  V
Sbjct: 154 PHNVMI---------DHEL-----------------RKLRLIDWGLAEFYHPGKEYNVRV 187
Query: 280 STRHYRAPEVILGL-GWNYPCDLWSVGCILVELC-SGEALFQTHENLEHLAMMERVLG 335
           ++R+++ PE+++ L  ++Y  D+WS+GC+   +    E  F  H+N + L  + +VLG
Sbjct: 188 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 245

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/264 (21%), Positives = 106/264 (40%), Gaps = 27/264 (10%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           R+L K G G   QV +       ++ A+K+++     R A        +R    ++    
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            V +   F     + ++ E L G  L+  L +     F  D       ++  ++  +H+ 
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGI--FMEDTACFYLAEISMALGHLHQK 140
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
            +I+ DLKPENI+L    +VK+ D+     S  DG+                        
Sbjct: 141 GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV----------------------- 177
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 333
            H++   T  Y APE+++  G N   D WS+G ++ ++ +G   F      + +  + + 
Sbjct: 178 THTF-CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC 236
Query: 334 LGPLPHHMVIRADRRAEKYFRRGA 357
              LP ++   A    +K  +R A
Sbjct: 237 KLNLPPYLTQEARDLLKKLLKRNA 260

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 87/178 (48%), Gaps = 44/178 (24%)
Query: 162 FDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLK 221
           F+Y N+    F+ L P+L D+             +R    +LL+++ + H   ++H D+K
Sbjct: 108 FEYVNNTD--FKVLYPTLTDYD------------IRYYIYELLKALDYCHSQGIMHRDVK 153
Query: 222 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH--QDHSYVV 279
           P N+++         D++                    ++LID+G   F H  ++++  V
Sbjct: 154 PHNVMI---------DHEL-----------------RKLRLIDWGLAEFYHPGKEYNVRV 187
Query: 280 STRHYRAPEVILGL-GWNYPCDLWSVGCILVELC-SGEALFQTHENLEHLAMMERVLG 335
           ++R+++ PE+++ L  ++Y  D+WS+GC+   +    E  F  H+N + L  + +VLG
Sbjct: 188 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 245

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 87/178 (48%), Gaps = 44/178 (24%)
Query: 162 FDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLK 221
           F+Y N+    F+ L P+L D+             +R    +LL+++ + H   ++H D+K
Sbjct: 128 FEYVNNTD--FKVLYPTLTDYD------------IRYYIYELLKALDYCHSQGIMHRDVK 173
Query: 222 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH--QDHSYVV 279
           P N+++         D++                    ++LID+G   F H  ++++  V
Sbjct: 174 PHNVMI---------DHEL-----------------RKLRLIDWGLAEFYHPGKEYNVRV 207
Query: 280 STRHYRAPEVILGL-GWNYPCDLWSVGCILVELC-SGEALFQTHENLEHLAMMERVLG 335
           ++R+++ PE+++ L  ++Y  D+WS+GC+   +    E  F  H+N + L  + +VLG
Sbjct: 208 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 265

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/276 (19%), Positives = 108/276 (39%), Gaps = 39/276 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-----------EIDVL 142
           Y +   +  G++G V    D+E   +   ++  +++  R   ++           EI +L
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 143 QRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
                 +I G R + +       + + +V E +   L   +        P   ++     
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP-QHIQYFMYH 142
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  +  +HE  ++H DL P NILL     + + D+      + D               
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA-------------- 188
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTH 321
                      + ++ V+ R YRAPE+++   G+    D+WS GC++ E+ + +ALF+  
Sbjct: 189 -----------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237
Query: 322 ENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRG 356
                L  +  V+G P    +V+ +   A  Y R  
Sbjct: 238 TFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNS 273

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/276 (19%), Positives = 108/276 (39%), Gaps = 39/276 (14%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-----------EIDVL 142
           Y +   +  G++G V    D+E   +   ++  +++  R   ++           EI +L
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 143 QRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
                 +I G R + +       + + +V E +   L   +        P   ++     
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP-QHIQYFMYH 142
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  +  +HE  ++H DL P NILL     + + D+      + D               
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA-------------- 188
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTH 321
                      + ++ V+ R YRAPE+++   G+    D+WS GC++ E+ + +ALF+  
Sbjct: 189 -----------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237
Query: 322 ENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRG 356
                L  +  V+G P    +V+ +   A  Y R  
Sbjct: 238 TFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNS 273

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 87/178 (48%), Gaps = 44/178 (24%)
Query: 162 FDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLK 221
           F+Y N+    F+ L P+L D+             +R    +LL+++ + H   ++H D+K
Sbjct: 107 FEYVNNTD--FKVLYPTLTDYD------------IRYYIYELLKALDYCHSQGIMHRDVK 152
Query: 222 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH--QDHSYVV 279
           P N+++         D++                    ++LID+G   F H  ++++  V
Sbjct: 153 PHNVMI---------DHEL-----------------RKLRLIDWGLAEFYHPGKEYNVRV 186
Query: 280 STRHYRAPEVILGL-GWNYPCDLWSVGCILVELC-SGEALFQTHENLEHLAMMERVLG 335
           ++R+++ PE+++ L  ++Y  D+WS+GC+   +    E  F  H+N + L  + +VLG
Sbjct: 187 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 244

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 87/178 (48%), Gaps = 44/178 (24%)
Query: 162 FDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLK 221
           F+Y N+    F+ L P+L D+             +R    +LL+++ + H   ++H D+K
Sbjct: 107 FEYVNNTD--FKVLYPTLTDYD------------IRYYIYELLKALDYCHSQGIMHRDVK 152
Query: 222 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH--QDHSYVV 279
           P N+++         D++                    ++LID+G   F H  ++++  V
Sbjct: 153 PHNVMI---------DHEL-----------------RKLRLIDWGLAEFYHPGKEYNVRV 186
Query: 280 STRHYRAPEVILGL-GWNYPCDLWSVGCILVELC-SGEALFQTHENLEHLAMMERVLG 335
           ++R+++ PE+++ L  ++Y  D+WS+GC+   +    E  F  H+N + L  + +VLG
Sbjct: 187 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 244

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 87/178 (48%), Gaps = 44/178 (24%)
Query: 162 FDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLK 221
           F+Y N+    F+ L P+L D+             +R    +LL+++ + H   ++H D+K
Sbjct: 107 FEYVNNTD--FKVLYPTLTDYD------------IRYYIYELLKALDYCHSQGIMHRDVK 152
Query: 222 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH--QDHSYVV 279
           P N+++         D++                    ++LID+G   F H  ++++  V
Sbjct: 153 PHNVMI---------DHEL-----------------RKLRLIDWGLAEFYHPGKEYNVRV 186
Query: 280 STRHYRAPEVILGL-GWNYPCDLWSVGCILVELC-SGEALFQTHENLEHLAMMERVLG 335
           ++R+++ PE+++ L  ++Y  D+WS+GC+   +    E  F  H+N + L  + +VLG
Sbjct: 187 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 244

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 87/178 (48%), Gaps = 44/178 (24%)
Query: 162 FDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLK 221
           F+Y N+    F+ L P+L D+             +R    +LL+++ + H   ++H D+K
Sbjct: 109 FEYVNNTD--FKVLYPTLTDYD------------IRYYIYELLKALDYCHSQGIMHRDVK 154
Query: 222 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH--QDHSYVV 279
           P N+++         D++                    ++LID+G   F H  ++++  V
Sbjct: 155 PHNVMI---------DHEL-----------------RKLRLIDWGLAEFYHPGKEYNVRV 188
Query: 280 STRHYRAPEVILGL-GWNYPCDLWSVGCILVELC-SGEALFQTHENLEHLAMMERVLG 335
           ++R+++ PE+++ L  ++Y  D+WS+GC+   +    E  F  H+N + L  + +VLG
Sbjct: 189 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 246

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 87/178 (48%), Gaps = 44/178 (24%)
Query: 162 FDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLK 221
           F+Y N+    F+ L P+L D+             +R    +LL+++ + H   ++H D+K
Sbjct: 107 FEYVNNTD--FKVLYPTLTDYD------------IRYYIYELLKALDYCHSQGIMHRDVK 152
Query: 222 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH--QDHSYVV 279
           P N+++         D++                    ++LID+G   F H  ++++  V
Sbjct: 153 PHNVMI---------DHEL-----------------RKLRLIDWGLAEFYHPGKEYNVRV 186
Query: 280 STRHYRAPEVILGL-GWNYPCDLWSVGCILVELC-SGEALFQTHENLEHLAMMERVLG 335
           ++R+++ PE+++ L  ++Y  D+WS+GC+   +    E  F  H+N + L  + +VLG
Sbjct: 187 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 244

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 87/178 (48%), Gaps = 44/178 (24%)
Query: 162 FDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLK 221
           F+Y N+    F+ L P+L D+             +R    +LL+++ + H   ++H D+K
Sbjct: 107 FEYVNNTD--FKVLYPTLTDYD------------IRYYIYELLKALDYCHSQGIMHRDVK 152
Query: 222 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH--QDHSYVV 279
           P N+++         D++                    ++LID+G   F H  ++++  V
Sbjct: 153 PHNVMI---------DHEL-----------------RKLRLIDWGLAEFYHPGKEYNVRV 186
Query: 280 STRHYRAPEVILGL-GWNYPCDLWSVGCILVELC-SGEALFQTHENLEHLAMMERVLG 335
           ++R+++ PE+++ L  ++Y  D+WS+GC+   +    E  F  H+N + L  + +VLG
Sbjct: 187 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 244

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 87/178 (48%), Gaps = 44/178 (24%)
Query: 162 FDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLK 221
           F+Y N+    F+ L P+L D+             +R    +LL+++ + H   ++H D+K
Sbjct: 107 FEYVNNTD--FKVLYPTLTDYD------------IRYYIYELLKALDYCHSQGIMHRDVK 152
Query: 222 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH--QDHSYVV 279
           P N+++         D++                    ++LID+G   F H  ++++  V
Sbjct: 153 PHNVMI---------DHEL-----------------RKLRLIDWGLAEFYHPGKEYNVRV 186
Query: 280 STRHYRAPEVILGL-GWNYPCDLWSVGCILVELC-SGEALFQTHENLEHLAMMERVLG 335
           ++R+++ PE+++ L  ++Y  D+WS+GC+   +    E  F  H+N + L  + +VLG
Sbjct: 187 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 244

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 108/256 (42%), Gaps = 68/256 (26%)
Query: 78  KDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI 137
           K GHYV                +G GTFG+V           VA+KI+    K R     
Sbjct: 9   KIGHYVLG------------DTLGVGTFGKVKIGEHQLTGHKVAVKILNR-QKIRS---- 51
Query: 138 EIDVLQRLARHDIGGTRCVQIRNWFDYRN-HICIVFEKL--------------GPSLYDF 182
            +DV+ ++ R         +I+N   +R+ HI  +++ +              G  L+D+
Sbjct: 52  -LDVVGKIKR---------EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDY 101
Query: 183 LRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242
           + K+  R   ++  R L +Q+L +V + H   ++H DLKPEN+LL +    K+ D+  LS
Sbjct: 102 ICKHG-RVEEME-ARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG-LS 158
Query: 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLW 302
               DG + ++            GS  +   +   V+S R Y  PEV          D+W
Sbjct: 159 NMMSDGEFLRD----------SCGSPNYAAPE---VISGRLYAGPEV----------DIW 195
Query: 303 SVGCILVELCSGEALF 318
           S G IL  L  G   F
Sbjct: 196 SCGVILYALLCGTLPF 211

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 102/240 (42%), Gaps = 32/240 (13%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           R+  K+G+G FG+V     N     VAIK ++      EA + E  V+++L RH+    +
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE----K 74
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            VQ+         I IV E +   SL DFL+    +   +  + ++  Q+   +A++  +
Sbjct: 75  LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL+  NIL+      KV D+  L+R  +D  Y         IK            
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFG-LARLIEDNEYTARQGAKFPIK------------ 180
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE  L   +    D+WS G +L EL + G   +    N E L  +ER
Sbjct: 181 ----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 61/137 (44%), Gaps = 30/137 (21%)
Query: 190 SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249
             P  +V+ L  Q+L+ + ++H   ++H DLKP NIL++                     
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG------------------ 165
Query: 250 YFKNLPKSSAIKLIDFGSTTFEHQ------DHSYVVSTRHYRAPEVILGL-GWNYPCDLW 302
                P+   +K+ D G     +       D   VV T  YRAPE++LG   +    D+W
Sbjct: 166 -----PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW 220
Query: 303 SVGCILVELCSGEALFQ 319
           ++GCI  EL + E +F 
Sbjct: 221 AIGCIFAELLTSEPIFH 237

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 46/226 (20%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRC 155
           +GEG+F  VV   +       AIKI+  R I K  +   +  E DV+ RL          
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-------DHP 93
Query: 156 VQIRNWFDYRN----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
             ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ ++ ++H
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNG-ELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH 150
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
              +IH DLKPENILL    ++++ D+   K LS  SK                    + 
Sbjct: 151 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR-----------------AN 193
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           +F        V T  Y +PE++         DLW++GCI+ +L +G
Sbjct: 194 SF--------VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 46/226 (20%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRC 155
           +GEG+F  VV   +       AIKI+  R I K  +   +  E DV+ RL          
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-------DHP 90
Query: 156 VQIRNWFDYRN----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
             ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ ++ ++H
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNG-ELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH 147
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
              +IH DLKPENILL    ++++ D+   K LS  SK         +++A         
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA-------RANAF-------- 192
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                     V T  Y +PE++         DLW++GCI+ +L +G
Sbjct: 193 ----------VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 102/240 (42%), Gaps = 32/240 (13%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           R+  K+G+G FG+V     N     VAIK ++      EA + E  V+++L RH+    +
Sbjct: 10  RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE----K 63
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            VQ+         I IV E +   SL DFL+    +   +  + ++  Q+   +A++  +
Sbjct: 64  LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 122
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL+  NIL+      KV D+  L+R  +D  Y         IK            
Sbjct: 123 NYVHRDLRAANILVGENLVCKVADFG-LARLIEDNEYTARQGAKFPIK------------ 169
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE  L   +    D+WS G +L EL + G   +    N E L  +ER
Sbjct: 170 ----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 219

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 102/240 (42%), Gaps = 32/240 (13%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           R+  K+G+G FG+V     N     VAIK ++      EA + E  V+++L RH+    +
Sbjct: 12  RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE----K 65
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            VQ+         I IV E +   SL DFL+    +   +  + ++  Q+   +A++  +
Sbjct: 66  LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 124
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL+  NIL+      KV D+  L+R  +D  Y         IK            
Sbjct: 125 NYVHRDLRAANILVGENLVCKVADFG-LARLIEDNEYTARQGAKFPIK------------ 171
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE  L   +    D+WS G +L EL + G   +    N E L  +ER
Sbjct: 172 ----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 221

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 99/248 (39%), Gaps = 47/248 (18%)
Query: 78  KDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI 137
           +   ++       +  Y +  ++G+G F  V  C         A KI+ +    ++ +  
Sbjct: 15  RGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT----KKLSAR 70
Query: 138 EIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVR 197
           +   L+R AR       C ++++    R H  I  E     ++D +       F   + R
Sbjct: 71  DFQKLEREAR------ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL--FEDIVAR 122
Query: 198 ELG---------RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248
           E           +Q+LES+A+ H   ++H +LKPEN+LL S                   
Sbjct: 123 EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASK------------------ 164
Query: 249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGC 306
                  K +A+KL DFG     +   ++     T  Y +PEV+    ++ P D+W+ G 
Sbjct: 165 ------AKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218
Query: 307 ILVELCSG 314
           IL  L  G
Sbjct: 219 ILYILLVG 226

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/251 (23%), Positives = 104/251 (41%), Gaps = 39/251 (15%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHD 149
           + +   +G+G+FG+V      +  +  AIK ++     ++   E  M+E  VL     H 
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 79
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
                   +   F  + ++  V E L  G  +Y      S   F +        +++  +
Sbjct: 80  F----LTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGL 132
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
            F+H   +++ DLK +NILL    ++K+ D+         G   +N+       L D  +
Sbjct: 133 QFLHSKGIVYRDLKLDNILLDKDGHIKIADF---------GMCKENM-------LGDAKT 176
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENLE 325
             F          T  Y APE++LG  +N+  D WS G +L E+  G++ F  Q  E L 
Sbjct: 177 NEF--------CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 228
Query: 326 HLAMMERVLGP 336
           H   M+    P
Sbjct: 229 HSIRMDNPFYP 239

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 35/232 (15%)
Query: 86  IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQ 143
           +GE     +  +S++G G  G V +        ++A K++    K   R   + E+ VL 
Sbjct: 10  VGELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVL- 68
Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
               H+      V     F     I I  E +     D + K + R  P +++ ++   +
Sbjct: 69  ----HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR-IPEEILGKVSIAV 123
Query: 204 LESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           L  +A++ E  +++H D+KP NIL+ S   +K+ D+                    + +L
Sbjct: 124 LRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGV------------------SGQL 165
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           ID  + +F        V TR Y APE + G  ++   D+WS+G  LVEL  G
Sbjct: 166 IDSMANSF--------VGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVG 209

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 107/256 (41%), Gaps = 68/256 (26%)
Query: 78  KDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI 137
           K GHYV                +G GTFG+V           VA+KI+    K R     
Sbjct: 9   KIGHYVLG------------DTLGVGTFGKVKIGEHQLTGHKVAVKILNR-QKIRS---- 51
Query: 138 EIDVLQRLARHDIGGTRCVQIRNWFDYRN-HICIVFEKL--------------GPSLYDF 182
            +DV+ ++ R         +I+N   +R+ HI  +++ +              G  L+D+
Sbjct: 52  -LDVVGKIKR---------EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDY 101
Query: 183 LRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242
           + K+  R   ++  R L +Q+L +V + H   ++H DLKPEN+LL +    K+ D+  LS
Sbjct: 102 ICKHG-RVEEME-ARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG-LS 158
Query: 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLW 302
               DG + +             GS  +   +   V+S R Y  PEV          D+W
Sbjct: 159 NMMSDGEFLRT----------SCGSPNYAAPE---VISGRLYAGPEV----------DIW 195
Query: 303 SVGCILVELCSGEALF 318
           S G IL  L  G   F
Sbjct: 196 SCGVILYALLCGTLPF 211

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 46/226 (20%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRC 155
           +GEG+F  VV   +       AIKI+  R I K  +   +  E DV+ RL          
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-------DHP 93
Query: 156 VQIRNWFDYRN----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
             ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ ++ ++H
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNG-ELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH 150
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
              +IH DLKPENILL    ++++ D+   K LS  SK                      
Sbjct: 151 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------------- 191
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                  +  V T  Y +PE++         DLW++GCI+ +L +G
Sbjct: 192 ------ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 46/226 (20%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRC 155
           +GEG+F  VV   +       AIKI+  R I K  +   +  E DV+ RL          
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-------DHP 92
Query: 156 VQIRNWFDYRN----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
             ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ ++ ++H
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNG-ELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH 149
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
              +IH DLKPENILL    ++++ D+   K LS  SK                      
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------------- 190
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                  +  V T  Y +PE++         DLW++GCI+ +L +G
Sbjct: 191 ------ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 53/110 (48%), Gaps = 12/110 (10%)
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           Q+ E+V F+H   L+H DLKP NI     + VKV D+  ++   +D      L    A  
Sbjct: 172 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA-- 229
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
                     +  H   V T+ Y +PE I G  +++  D++S+G IL EL
Sbjct: 230 ----------YATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/264 (21%), Positives = 105/264 (39%), Gaps = 27/264 (10%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           R+L K G G   QV +       ++ A+K+++     R A        +R    ++    
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            V +   F     + ++ E L G  L+  L +     F  D       ++  ++  +H+ 
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGI--FMEDTACFYLAEISMALGHLHQK 140
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
            +I+ DLKPENI+L    +VK+ D+     S  DG+                        
Sbjct: 141 GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV----------------------- 177
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERV 333
            H +   T  Y APE+++  G N   D WS+G ++ ++ +G   F      + +  + + 
Sbjct: 178 THXF-CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC 236
Query: 334 LGPLPHHMVIRADRRAEKYFRRGA 357
              LP ++   A    +K  +R A
Sbjct: 237 KLNLPPYLTQEARDLLKKLLKRNA 260

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 46/226 (20%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRC 155
           +GEG+F  VV   +       AIKI+  R I K  +   +  E DV+ RL          
Sbjct: 43  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-------DHP 95
Query: 156 VQIRNWFDYRN----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
             ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ ++ ++H
Sbjct: 96  FFVKLYFTFQDDEKLYFGLSYAKNG-ELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH 152
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
              +IH DLKPENILL    ++++ D+   K LS  SK                      
Sbjct: 153 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------------- 193
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                  +  V T  Y +PE++         DLW++GCI+ +L +G
Sbjct: 194 ------ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 46/226 (20%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRC 155
           +GEG+F  VV   +       AIKI+  R I K  +   +  E DV+ RL          
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-------DHP 92
Query: 156 VQIRNWFDYRN----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
             ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ ++ ++H
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNG-ELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH 149
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
              +IH DLKPENILL    ++++ D+   K LS  SK                      
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------------- 190
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                  +  V T  Y +PE++         DLW++GCI+ +L +G
Sbjct: 191 ------ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 102/240 (42%), Gaps = 32/240 (13%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           R+  K+G+G FG+V     N     VAIK ++      EA + E  V+++L RH+    +
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE----K 74
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            VQ+         I IV E +   SL DFL+    +   +  + ++  Q+   +A++  +
Sbjct: 75  LVQLYAVVS-EEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL+  NIL+      KV D+  L+R  +D  Y         IK            
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFG-LARLIEDNEYTARQGAKFPIK------------ 180
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE  L   +    D+WS G +L EL + G   +    N E L  +ER
Sbjct: 181 ----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 41/219 (18%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159
           +G G FG V  C    + + VAIK + S ++ R+A ++E+  L R+   +I       ++
Sbjct: 17  VGRGAFGVV--CKAKWRAKDVAIKQIESESE-RKAFIVELRQLSRVNHPNI-------VK 66
Query: 160 NWFDYRNHICIVFE-KLGPSLYDFLR-KNSYRSFPIDLVRELGRQLLESVAFMHELR--- 214
            +    N +C+V E   G SLY+ L        +          Q  + VA++H ++   
Sbjct: 67  LYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 126
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           LIH DLKP N+LLV+                            + +K+ DFG+       
Sbjct: 127 LIHRDLKPPNLLLVAG--------------------------GTVLKICDFGTACDIQTH 160
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
            +    +  + APEV  G  ++  CD++S G IL E+ +
Sbjct: 161 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVIT 199

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 46/226 (20%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRC 155
           +GEG+F  VV   +       AIKI+  R I K  +   +  E DV+ RL          
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-------DHP 92
Query: 156 VQIRNWFDYRN----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
             ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ ++ ++H
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNG-ELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH 149
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
              +IH DLKPENILL    ++++ D+   K LS  SK                      
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------------- 190
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                  +  V T  Y +PE++         DLW++GCI+ +L +G
Sbjct: 191 ------ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 110/248 (44%), Gaps = 42/248 (16%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREA-----AMIEID 140
           E L  +Y++   +G G FG V           VAIK V    I+ + E        +E+ 
Sbjct: 39  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 98
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRE 198
           +L++++    G +  +++ +WF+  +   ++ E+  P   L+DF+ +    +   +L R 
Sbjct: 99  LLKKVSS---GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARS 153
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              Q+LE+V   H   ++H D+K ENIL+             L+R               
Sbjct: 154 FFWQVLEAVRHCHNCGVLHRDIKDENILID------------LNRGE------------- 188
Query: 259 AIKLIDFGSTT-FEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEA 316
            +KLIDFGS    +   ++    TR Y  PE I    ++     +WS+G +L ++  G+ 
Sbjct: 189 -LKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 247
Query: 317 LFQTHENL 324
            F+  E +
Sbjct: 248 PFEHDEEI 255

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 46/226 (20%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRC 155
           +GEG+F  VV   +       AIKI+  R I K  +   +  E DV+ RL          
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-------DHP 90
Query: 156 VQIRNWFDYRN----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
             ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ ++ ++H
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNG-ELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH 147
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
              +IH DLKPENILL    ++++ D+   K LS  SK                      
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------------- 188
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                  +  V T  Y +PE++         DLW++GCI+ +L +G
Sbjct: 189 ------ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 46/226 (20%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRC 155
           +GEG+F  VV   +       AIKI+  R I K  +   +  E DV+ RL          
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-------DHP 92
Query: 156 VQIRNWFDYRN----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
             ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ ++ ++H
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNG-ELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH 149
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
              +IH DLKPENILL    ++++ D+   K LS  SK                      
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------------- 190
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                  +  V T  Y +PE++         DLW++GCI+ +L +G
Sbjct: 191 ------ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 46/226 (20%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRC 155
           +GEG+F  VV   +       AIKI+  R I K  +   +  E DV+ RL          
Sbjct: 17  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-------DHP 69
Query: 156 VQIRNWFDYRN----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
             ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ ++ ++H
Sbjct: 70  FFVKLYFTFQDDEKLYFGLSYAKNG-ELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH 126
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
              +IH DLKPENILL    ++++ D+   K LS  SK                      
Sbjct: 127 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------------- 167
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                  +  V T  Y +PE++         DLW++GCI+ +L +G
Sbjct: 168 ------ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 46/226 (20%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRC 155
           +GEG+F  VV   +       AIKI+  R I K  +   +  E DV+ RL          
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-------DHP 90
Query: 156 VQIRNWFDYRN----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
             ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ ++ ++H
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNG-ELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH 147
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
              +IH DLKPENILL    ++++ D+   K LS  SK                      
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------------- 188
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                  +  V T  Y +PE++         DLW++GCI+ +L +G
Sbjct: 189 ------ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 41/219 (18%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159
           +G G FG V  C    + + VAIK + S ++ R+A ++E+  L R+   +I       ++
Sbjct: 16  VGRGAFGVV--CKAKWRAKDVAIKQIESESE-RKAFIVELRQLSRVNHPNI-------VK 65
Query: 160 NWFDYRNHICIVFE-KLGPSLYDFLR-KNSYRSFPIDLVRELGRQLLESVAFMHELR--- 214
            +    N +C+V E   G SLY+ L        +          Q  + VA++H ++   
Sbjct: 66  LYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           LIH DLKP N+LLV+                            + +K+ DFG+       
Sbjct: 126 LIHRDLKPPNLLLVAG--------------------------GTVLKICDFGTACDIQTH 159
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
            +    +  + APEV  G  ++  CD++S G IL E+ +
Sbjct: 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVIT 198

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 108/248 (43%), Gaps = 44/248 (17%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD---- 149
           YR+L  +G+G F +V         + VA+KI+       +   +    LQ+L R      
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKII-------DKTQLNSSSLQKLFREVRIMK 68
Query: 150 -IGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
            +     V++    +    + +V E   G  ++D+L   ++        R   RQ++ +V
Sbjct: 69  VLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV--AHGRMKEKEARAKFRQIVSAV 126
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
            + H+  ++H DLK EN+LL +   +K+ D+ F +                         
Sbjct: 127 QYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSN------------------------E 162
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALFQTHENLEH 326
            TF ++  ++  S   Y APE+  G  ++ P  D+WS+G IL  L SG   F   +NL+ 
Sbjct: 163 FTFGNKLDTFCGSP-PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKE 220
Query: 327 LAMMERVL 334
           L   ERVL
Sbjct: 221 LR--ERVL 226

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 95/231 (41%), Gaps = 37/231 (16%)
Query: 90  LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR-- 147
            +  Y +  ++G+G F  V  C         A KI+ +    ++ +  +   L+R AR  
Sbjct: 3   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT----KKLSARDFQKLEREARIC 58
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
             +     V++ +     +   +VF+ +  G    D + +  Y            +Q+LE
Sbjct: 59  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD---ASHCIQQILE 115
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           S+A+ H   ++H +LKPEN+LL S                          K +A+KL DF
Sbjct: 116 SIAYCHSNGIVHRNLKPENLLLASK------------------------AKGAAVKLADF 151
Query: 266 GSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           G     +   ++     T  Y +PEV+    ++ P D+W+ G IL  L  G
Sbjct: 152 GLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 46/226 (20%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRC 155
           +GEG+F  VV   +       AIKI+  R I K  +   +  E DV+ RL          
Sbjct: 18  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-------DHP 70
Query: 156 VQIRNWFDYRN----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
             ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ ++ ++H
Sbjct: 71  FFVKLYFTFQDDEKLYFGLSYAKNG-ELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH 127
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
              +IH DLKPENILL    ++++ D+   K LS  SK                      
Sbjct: 128 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------------- 168
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                  +  V T  Y +PE++         DLW++GCI+ +L +G
Sbjct: 169 ------ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 46/226 (20%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRC 155
           +GEG+F  VV   +       AIKI+  R I K  +   +  E DV+ RL          
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-------DHP 89
Query: 156 VQIRNWFDYRN----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
             ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ ++ ++H
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNG-ELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH 146
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
              +IH DLKPENILL    ++++ D+   K LS  SK                    + 
Sbjct: 147 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR-----------------AN 189
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           +F        V T  Y +PE++         DLW++GCI+ +L +G
Sbjct: 190 SF--------VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 110/248 (44%), Gaps = 42/248 (16%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREA-----AMIEID 140
           E L  +Y++   +G G FG V           VAIK V    I+ + E        +E+ 
Sbjct: 20  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 79
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRE 198
           +L++++    G +  +++ +WF+  +   ++ E+  P   L+DF+ +    +   +L R 
Sbjct: 80  LLKKVSS---GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARS 134
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              Q+LE+V   H   ++H D+K ENIL+             L+R               
Sbjct: 135 FFWQVLEAVRHCHNCGVLHRDIKDENILID------------LNRGE------------- 169
Query: 259 AIKLIDFGSTT-FEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEA 316
            +KLIDFGS    +   ++    TR Y  PE I    ++     +WS+G +L ++  G+ 
Sbjct: 170 -LKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 228
Query: 317 LFQTHENL 324
            F+  E +
Sbjct: 229 PFEHDEEI 236

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 110/248 (44%), Gaps = 42/248 (16%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREA-----AMIEID 140
           E L  +Y++   +G G FG V           VAIK V    I+ + E        +E+ 
Sbjct: 19  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 78
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRE 198
           +L++++    G +  +++ +WF+  +   ++ E+  P   L+DF+ +    +   +L R 
Sbjct: 79  LLKKVSS---GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARS 133
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              Q+LE+V   H   ++H D+K ENIL+             L+R               
Sbjct: 134 FFWQVLEAVRHCHNCGVLHRDIKDENILID------------LNRGE------------- 168
Query: 259 AIKLIDFGSTT-FEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEA 316
            +KLIDFGS    +   ++    TR Y  PE I    ++     +WS+G +L ++  G+ 
Sbjct: 169 -LKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 227
Query: 317 LFQTHENL 324
            F+  E +
Sbjct: 228 PFEHDEEI 235

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 110/248 (44%), Gaps = 42/248 (16%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREA-----AMIEID 140
           E L  +Y++   +G G FG V           VAIK V    I+ + E        +E+ 
Sbjct: 20  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 79
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRE 198
           +L++++    G +  +++ +WF+  +   ++ E+  P   L+DF+ +    +   +L R 
Sbjct: 80  LLKKVSS---GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARS 134
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              Q+LE+V   H   ++H D+K ENIL+             L+R               
Sbjct: 135 FFWQVLEAVRHCHNCGVLHRDIKDENILID------------LNRGE------------- 169
Query: 259 AIKLIDFGSTT-FEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEA 316
            +KLIDFGS    +   ++    TR Y  PE I    ++     +WS+G +L ++  G+ 
Sbjct: 170 -LKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 228
Query: 317 LFQTHENL 324
            F+  E +
Sbjct: 229 PFEHDEEI 236

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 110/248 (44%), Gaps = 42/248 (16%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREA-----AMIEID 140
           E L  +Y++   +G G FG V           VAIK V    I+ + E        +E+ 
Sbjct: 19  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 78
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRE 198
           +L++++    G +  +++ +WF+  +   ++ E+  P   L+DF+ +    +   +L R 
Sbjct: 79  LLKKVSS---GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARS 133
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              Q+LE+V   H   ++H D+K ENIL+             L+R               
Sbjct: 134 FFWQVLEAVRHCHNCGVLHRDIKDENILID------------LNRGE------------- 168
Query: 259 AIKLIDFGSTT-FEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEA 316
            +KLIDFGS    +   ++    TR Y  PE I    ++     +WS+G +L ++  G+ 
Sbjct: 169 -LKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 227
Query: 317 LFQTHENL 324
            F+  E +
Sbjct: 228 PFEHDEEI 235

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 101/240 (42%), Gaps = 32/240 (13%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           R+  K+G+G FG+V     N     VAIK ++      EA + E  V+++L RH+    +
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE----K 74
Query: 155 CVQIRNWFDYRNHICIVFEKLGPS-LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            VQ+         I IV E +    L DFL+    +   +  + ++  Q+   +A++  +
Sbjct: 75  LVQLYAVVS-EEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL+  NIL+      KV D+  L+R  +D  Y         IK            
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFG-LARLIEDNEYTARQGAKFPIK------------ 180
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE  L   +    D+WS G +L EL + G   +    N E L  +ER
Sbjct: 181 ----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 108/248 (43%), Gaps = 44/248 (17%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD---- 149
           YR+L  +G+G F +V         + VA+KI+       +   +    LQ+L R      
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKII-------DKTQLNSSSLQKLFREVRIMK 68
Query: 150 -IGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
            +     V++    +    + +V E   G  ++D+L   ++        R   RQ++ +V
Sbjct: 69  VLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV--AHGRMKEKEARAKFRQIVSAV 126
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
            + H+  ++H DLK EN+LL +   +K+ D+ F +                         
Sbjct: 127 QYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSN------------------------E 162
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALFQTHENLEH 326
            TF ++  ++  S   Y APE+  G  ++ P  D+WS+G IL  L SG   F   +NL+ 
Sbjct: 163 FTFGNKLDTFCGSP-PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKE 220
Query: 327 LAMMERVL 334
           L   ERVL
Sbjct: 221 LR--ERVL 226

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 95/231 (41%), Gaps = 37/231 (16%)
Query: 90  LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR-- 147
            +  Y +  ++G+G F  V  C         A KI+ +    ++ +  +   L+R AR  
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT----KKLSARDFQKLEREARIC 59
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
             +     V++ +     +   +VF+ +  G    D + +  Y            +Q+LE
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD---ASHCIQQILE 116
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           S+A+ H   ++H +LKPEN+LL S                          K +A+KL DF
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASK------------------------AKGAAVKLADF 152
Query: 266 GSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           G     +   ++     T  Y +PEV+    ++ P D+W+ G IL  L  G
Sbjct: 153 GLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 46/226 (20%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRC 155
           +GEG+F  VV   +       AIKI+  R I K  +   +  E DV+ RL          
Sbjct: 15  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-------DHP 67
Query: 156 VQIRNWFDYRN----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
             ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ ++ ++H
Sbjct: 68  FFVKLYFTFQDDEKLYFGLSYAKNG-ELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH 124
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
              +IH DLKPENILL    ++++ D+   K LS  SK                      
Sbjct: 125 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------------- 165
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                  +  V T  Y +PE++         DLW++GCI+ +L +G
Sbjct: 166 ------ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 102/240 (42%), Gaps = 32/240 (13%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           R+  K+G+G FG+V     N     VAIK ++      EA + E  V++++ RH+    +
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKI-RHE----K 74
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            VQ+         I IV E +   SL DFL+    +   +  + ++  Q+   +A++  +
Sbjct: 75  LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL+  NIL+      KV D+  L+R  +D  Y         IK            
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFG-LARLIEDNEYTARQGAKFPIK------------ 180
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE  L   +    D+WS G +L EL + G   +    N E L  +ER
Sbjct: 181 ----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 46/226 (20%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRC 155
           +GEG+F  VV   +       AIKI+  R I K  +   +  E DV+ RL          
Sbjct: 16  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-------DHP 68
Query: 156 VQIRNWFDYRN----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
             ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ ++ ++H
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNG-ELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH 125
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
              +IH DLKPENILL    ++++ D+   K LS  SK                      
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------------- 166
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                  +  V T  Y +PE++         DLW++GCI+ +L +G
Sbjct: 167 ------ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 101/226 (44%), Gaps = 33/226 (14%)
Query: 95  RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
           + L ++G+G FG V  C      +   E+VA+K ++ S  ++      EI++L+ L   +
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLG-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I   + V    +   R ++ ++ E L   SL D+L+K+  R   I L+ +   Q+ + + 
Sbjct: 73  IVKYKGV---CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQICKGME 128
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK-NLPKSSAIKLIDFGS 267
           ++   R IH DL   NIL+ +   VK+ D+       +D  +FK   P  S I       
Sbjct: 129 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI------- 181
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                           + APE +    ++   D+WS G +L EL +
Sbjct: 182 ---------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 101/240 (42%), Gaps = 32/240 (13%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           R+  K+G+G FG+V     N     VAIK ++      EA + E  V+++L RH+    +
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE----K 74
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            VQ+         I IV E +   SL DFL+    +   +  + ++  Q+   +A++  +
Sbjct: 75  LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL   NIL+      KV D+  L+R  +D  Y         IK            
Sbjct: 134 NYVHRDLAAANILVGENLVCKVADFG-LARLIEDNEYTARQGAKFPIK------------ 180
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE  L   +    D+WS G +L EL + G   +    N E L  +ER
Sbjct: 181 ----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 110/248 (44%), Gaps = 42/248 (16%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREA-----AMIEID 140
           E L  +Y++   +G G FG V           VAIK V    I+ + E        +E+ 
Sbjct: 20  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 79
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRE 198
           +L++++    G +  +++ +WF+  +   ++ E+  P   L+DF+ +    +   +L R 
Sbjct: 80  LLKKVSS---GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARS 134
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              Q+LE+V   H   ++H D+K ENIL+             L+R               
Sbjct: 135 FFWQVLEAVRHCHNCGVLHRDIKDENILID------------LNRGE------------- 169
Query: 259 AIKLIDFGSTT-FEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEA 316
            +KLIDFGS    +   ++    TR Y  PE I    ++     +WS+G +L ++  G+ 
Sbjct: 170 -LKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 228
Query: 317 LFQTHENL 324
            F+  E +
Sbjct: 229 PFEHDEEI 236

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 95/231 (41%), Gaps = 37/231 (16%)
Query: 90  LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR-- 147
            +  Y +  ++G+G F  V  C         A KI+ +    ++ +  +   L+R AR  
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT----KKLSARDFQKLEREARIC 59
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
             +     V++ +     +   +VF+ +  G    D + +  Y            +Q+LE
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD---ASHCIQQILE 116
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           S+A+ H   ++H +LKPEN+LL S                          K +A+KL DF
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASK------------------------AKGAAVKLADF 152
Query: 266 GSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           G     +   ++     T  Y +PEV+    ++ P D+W+ G IL  L  G
Sbjct: 153 GLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 110/248 (44%), Gaps = 42/248 (16%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREA-----AMIEID 140
           E L  +Y++   +G G FG V           VAIK V    I+ + E        +E+ 
Sbjct: 33  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRE 198
           +L++++    G +  +++ +WF+  +   ++ E+  P   L+DF+ +    +   +L R 
Sbjct: 93  LLKKVSS---GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARS 147
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              Q+LE+V   H   ++H D+K ENIL+             L+R               
Sbjct: 148 FFWQVLEAVRHCHNCGVLHRDIKDENILID------------LNRGE------------- 182
Query: 259 AIKLIDFGSTT-FEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEA 316
            +KLIDFGS    +   ++    TR Y  PE I    ++     +WS+G +L ++  G+ 
Sbjct: 183 -LKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 241
Query: 317 LFQTHENL 324
            F+  E +
Sbjct: 242 PFEHDEEI 249

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/239 (23%), Positives = 101/239 (42%), Gaps = 38/239 (15%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA-----MIEIDVLQRLARH 148
           ++ LS++G G++G+V +    E   L A+K  RS++ +R        + E+   +++ +H
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVK--RSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                 CV++   ++    + +  E  GPSL          S P   V    R  L ++A
Sbjct: 117 PC----CVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGA-SLPEAQVWGYLRDTLLALA 171
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
            +H   L+H D+KP NI L      K+ D+  L                  ++L   G+ 
Sbjct: 172 HLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLL------------------VELGTAGAG 213
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
             +  D  Y+       APE++ G  +    D++S+G  ++E+     L    E  + L
Sbjct: 214 EVQEGDPRYM-------APELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL 264

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 110/248 (44%), Gaps = 42/248 (16%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREA-----AMIEID 140
           E L  +Y++   +G G FG V           VAIK V    I+ + E        +E+ 
Sbjct: 52  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 111
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRE 198
           +L++++    G +  +++ +WF+  +   ++ E+  P   L+DF+ +    +   +L R 
Sbjct: 112 LLKKVSS---GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARS 166
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              Q+LE+V   H   ++H D+K ENIL+             L+R               
Sbjct: 167 FFWQVLEAVRHCHNCGVLHRDIKDENILID------------LNRGE------------- 201
Query: 259 AIKLIDFGSTT-FEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEA 316
            +KLIDFGS    +   ++    TR Y  PE I    ++     +WS+G +L ++  G+ 
Sbjct: 202 -LKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 260
Query: 317 LFQTHENL 324
            F+  E +
Sbjct: 261 PFEHDEEI 268

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 110/248 (44%), Gaps = 42/248 (16%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREA-----AMIEID 140
           E L  +Y++   +G G FG V           VAIK V    I+ + E        +E+ 
Sbjct: 33  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRE 198
           +L++++    G +  +++ +WF+  +   ++ E+  P   L+DF+ +    +   +L R 
Sbjct: 93  LLKKVSS---GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARS 147
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              Q+LE+V   H   ++H D+K ENIL+             L+R               
Sbjct: 148 FFWQVLEAVRHCHNCGVLHRDIKDENILID------------LNRGE------------- 182
Query: 259 AIKLIDFGSTT-FEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEA 316
            +KLIDFGS    +   ++    TR Y  PE I    ++     +WS+G +L ++  G+ 
Sbjct: 183 -LKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 241
Query: 317 LFQTHENL 324
            F+  E +
Sbjct: 242 PFEHDEEI 249

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 46/226 (20%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRC 155
           +GEG+F  VV   +       AIKI+  R I K  +   +  E DV+ RL          
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-------DHP 89
Query: 156 VQIRNWFDYRN----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
             ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ ++ ++H
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNG-ELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH 146
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
              +IH DLKPENILL    ++++ D+   K LS  SK                      
Sbjct: 147 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------------- 187
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                  +  V T  Y +PE++         DLW++GCI+ +L +G
Sbjct: 188 ------ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 110/248 (44%), Gaps = 42/248 (16%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREA-----AMIEID 140
           E L  +Y++   +G G FG V           VAIK V    I+ + E        +E+ 
Sbjct: 47  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 106
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRE 198
           +L++++    G +  +++ +WF+  +   ++ E+  P   L+DF+ +    +   +L R 
Sbjct: 107 LLKKVSS---GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARS 161
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              Q+LE+V   H   ++H D+K ENIL+             L+R               
Sbjct: 162 FFWQVLEAVRHCHNCGVLHRDIKDENILID------------LNRGE------------- 196
Query: 259 AIKLIDFGSTT-FEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEA 316
            +KLIDFGS    +   ++    TR Y  PE I    ++     +WS+G +L ++  G+ 
Sbjct: 197 -LKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 255
Query: 317 LFQTHENL 324
            F+  E +
Sbjct: 256 PFEHDEEI 263

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 103/240 (42%), Gaps = 32/240 (13%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           R+  K+G+G FG+V     N     VAIK ++      EA + E  V+++L RH+    +
Sbjct: 18  RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE----K 71
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            VQ+         I IV E +   SL DFL+  + +   +  + ++  Q+   +A++  +
Sbjct: 72  LVQLYAVVS-EEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERM 130
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL+  NIL+      KV D+  L+R  +D  +         IK            
Sbjct: 131 NYVHRDLRAANILVGENLVCKVADFG-LARLIEDNEWTARQGAKFPIK------------ 177
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE  L   +    D+WS G +L EL + G   +    N E L  +ER
Sbjct: 178 ----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 227

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 110/248 (44%), Gaps = 42/248 (16%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREA-----AMIEID 140
           E L  +Y++   +G G FG V           VAIK V    I+ + E        +E+ 
Sbjct: 32  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRE 198
           +L++++    G +  +++ +WF+  +   ++ E+  P   L+DF+ +    +   +L R 
Sbjct: 92  LLKKVSS---GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARS 146
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              Q+LE+V   H   ++H D+K ENIL+             L+R               
Sbjct: 147 FFWQVLEAVRHCHNCGVLHRDIKDENILID------------LNRGE------------- 181
Query: 259 AIKLIDFGSTT-FEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEA 316
            +KLIDFGS    +   ++    TR Y  PE I    ++     +WS+G +L ++  G+ 
Sbjct: 182 -LKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 240
Query: 317 LFQTHENL 324
            F+  E +
Sbjct: 241 PFEHDEEI 248

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 110/248 (44%), Gaps = 42/248 (16%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREA-----AMIEID 140
           E L  +Y++   +G G FG V           VAIK V    I+ + E        +E+ 
Sbjct: 5   EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 64
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRE 198
           +L++++    G +  +++ +WF+  +   ++ E+  P   L+DF+ +    +   +L R 
Sbjct: 65  LLKKVSS---GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARS 119
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              Q+LE+V   H   ++H D+K ENIL+             L+R               
Sbjct: 120 FFWQVLEAVRHCHNCGVLHRDIKDENILID------------LNRGE------------- 154
Query: 259 AIKLIDFGSTT-FEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEA 316
            +KLIDFGS    +   ++    TR Y  PE I    ++     +WS+G +L ++  G+ 
Sbjct: 155 -LKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 213
Query: 317 LFQTHENL 324
            F+  E +
Sbjct: 214 PFEHDEEI 221

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 108/248 (43%), Gaps = 44/248 (17%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD---- 149
           YR+L  +G+G F +V         + VA+KI+       +   +    LQ+L R      
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAVKII-------DKTQLNSSSLQKLFREVRIMK 61
Query: 150 -IGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
            +     V++    +    + +V E   G  ++D+L  + +        R   RQ++ +V
Sbjct: 62  VLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGW--MKEKEARAKFRQIVSAV 119
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
            + H+  ++H DLK EN+LL +   +K+ D+ F +                         
Sbjct: 120 QYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSN------------------------E 155
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALFQTHENLEH 326
            TF ++  ++  S   Y APE+  G  ++ P  D+WS+G IL  L SG   F   +NL+ 
Sbjct: 156 FTFGNKLDTFCGSP-PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKE 213
Query: 327 LAMMERVL 334
           L   ERVL
Sbjct: 214 LR--ERVL 219

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 110/248 (44%), Gaps = 42/248 (16%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREA-----AMIEID 140
           E L  +Y++   +G G FG V           VAIK V    I+ + E        +E+ 
Sbjct: 32  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRE 198
           +L++++    G +  +++ +WF+  +   ++ E+  P   L+DF+ +    +   +L R 
Sbjct: 92  LLKKVSS---GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARS 146
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              Q+LE+V   H   ++H D+K ENIL+             L+R               
Sbjct: 147 FFWQVLEAVRHCHNCGVLHRDIKDENILID------------LNRGE------------- 181
Query: 259 AIKLIDFGSTT-FEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEA 316
            +KLIDFGS    +   ++    TR Y  PE I    ++     +WS+G +L ++  G+ 
Sbjct: 182 -LKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 240
Query: 317 LFQTHENL 324
            F+  E +
Sbjct: 241 PFEHDEEI 248

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 110/248 (44%), Gaps = 42/248 (16%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREA-----AMIEID 140
           E L  +Y++   +G G FG V           VAIK V    I+ + E        +E+ 
Sbjct: 33  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRE 198
           +L++++    G +  +++ +WF+  +   ++ E+  P   L+DF+ +    +   +L R 
Sbjct: 93  LLKKVSS---GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARS 147
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              Q+LE+V   H   ++H D+K ENIL+             L+R               
Sbjct: 148 FFWQVLEAVRHCHNCGVLHRDIKDENILID------------LNRGE------------- 182
Query: 259 AIKLIDFGSTT-FEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEA 316
            +KLIDFGS    +   ++    TR Y  PE I    ++     +WS+G +L ++  G+ 
Sbjct: 183 -LKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 241
Query: 317 LFQTHENL 324
            F+  E +
Sbjct: 242 PFEHDEEI 249

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 110/248 (44%), Gaps = 42/248 (16%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREA-----AMIEID 140
           E L  +Y++   +G G FG V           VAIK V    I+ + E        +E+ 
Sbjct: 33  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRE 198
           +L++++    G +  +++ +WF+  +   ++ E+  P   L+DF+ +    +   +L R 
Sbjct: 93  LLKKVSS---GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARS 147
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              Q+LE+V   H   ++H D+K ENIL+             L+R               
Sbjct: 148 FFWQVLEAVRHCHNCGVLHRDIKDENILID------------LNRGE------------- 182
Query: 259 AIKLIDFGSTT-FEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEA 316
            +KLIDFGS    +   ++    TR Y  PE I    ++     +WS+G +L ++  G+ 
Sbjct: 183 -LKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 241
Query: 317 LFQTHENL 324
            F+  E +
Sbjct: 242 PFEHDEEI 249

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 110/248 (44%), Gaps = 42/248 (16%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREA-----AMIEID 140
           E L  +Y++   +G G FG V           VAIK V    I+ + E        +E+ 
Sbjct: 32  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRE 198
           +L++++    G +  +++ +WF+  +   ++ E+  P   L+DF+ +    +   +L R 
Sbjct: 92  LLKKVSS---GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARS 146
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              Q+LE+V   H   ++H D+K ENIL+             L+R               
Sbjct: 147 FFWQVLEAVRHCHNCGVLHRDIKDENILID------------LNRGE------------- 181
Query: 259 AIKLIDFGSTT-FEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEA 316
            +KLIDFGS    +   ++    TR Y  PE I    ++     +WS+G +L ++  G+ 
Sbjct: 182 -LKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 240
Query: 317 LFQTHENL 324
            F+  E +
Sbjct: 241 PFEHDEEI 248

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 46/226 (20%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRC 155
           +GEG+F  VV   +       AIKI+  R I K  +   +  E DV+ RL          
Sbjct: 22  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-------DHP 74
Query: 156 VQIRNWFDYRN----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
             ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ ++ ++H
Sbjct: 75  FFVKLYFTFQDDEKLYFGLSYAKNG-ELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH 131
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
              +IH DLKPENILL    ++++ D+   K LS  SK                      
Sbjct: 132 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------------- 172
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                  +  V T  Y +PE++         DLW++GCI+ +L +G
Sbjct: 173 ------ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 110/248 (44%), Gaps = 42/248 (16%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREA-----AMIEID 140
           E L  +Y++   +G G FG V           VAIK V    I+ + E        +E+ 
Sbjct: 5   EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 64
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRE 198
           +L++++    G +  +++ +WF+  +   ++ E+  P   L+DF+ +    +   +L R 
Sbjct: 65  LLKKVSS---GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARS 119
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              Q+LE+V   H   ++H D+K ENIL+             L+R               
Sbjct: 120 FFWQVLEAVRHCHNCGVLHRDIKDENILID------------LNRGE------------- 154
Query: 259 AIKLIDFGSTT-FEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEA 316
            +KLIDFGS    +   ++    TR Y  PE I    ++     +WS+G +L ++  G+ 
Sbjct: 155 -LKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 213
Query: 317 LFQTHENL 324
            F+  E +
Sbjct: 214 PFEHDEEI 221

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 111/257 (43%), Gaps = 62/257 (24%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           YR+L  +G+G F +V              K+ R I   +E A+  ID  Q  +       
Sbjct: 16  YRLLKTIGKGNFAKV--------------KLARHILTGKEVAVRIIDKTQLNSSSLQKLF 61
Query: 154 RCVQIRNWFDYRNHICIVFEKL--------------GPSLYDFLRKNSYRSFPIDLVREL 199
           R V+I    ++ N I  +FE +              G  ++D+L   ++        R  
Sbjct: 62  REVRIMKVLNHPN-IVKLFEVIETEKTLYLVMEYASGGEVFDYLV--AHGRMKEKEARAK 118
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
            RQ++ +V + H+  ++H DLK EN+LL +   +K+ D+ F +  +     F N      
Sbjct: 119 FRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT-----FGN------ 167
Query: 260 IKLIDF-GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEAL 317
            KL +F GS                Y APE+  G  ++ P  D+WS+G IL  L SG   
Sbjct: 168 -KLDEFCGSPP--------------YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212
Query: 318 FQTHENLEHLAMMERVL 334
           F   +NL+ L   ERVL
Sbjct: 213 FDG-QNLKELR--ERVL 226

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 110/248 (44%), Gaps = 42/248 (16%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREA-----AMIEID 140
           E L  +Y++   +G G FG V           VAIK V    I+ + E        +E+ 
Sbjct: 5   EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 64
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRE 198
           +L++++    G +  +++ +WF+  +   ++ E+  P   L+DF+ +    +   +L R 
Sbjct: 65  LLKKVSS---GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARS 119
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              Q+LE+V   H   ++H D+K ENIL+             L+R               
Sbjct: 120 FFWQVLEAVRHCHNCGVLHRDIKDENILID------------LNRGE------------- 154
Query: 259 AIKLIDFGSTT-FEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEA 316
            +KLIDFGS    +   ++    TR Y  PE I    ++     +WS+G +L ++  G+ 
Sbjct: 155 -LKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 213
Query: 317 LFQTHENL 324
            F+  E +
Sbjct: 214 PFEHDEEI 221

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 41/223 (18%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIV----RSINKYREAAMIEIDVLQRLARHDIGG 152
           L ++G G+FG V    D    E+VAIK +    +  N+  +  + E+  LQ+L RH    
Sbjct: 59  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RH---- 113
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
              +Q R  +   +   +V E    S  D L  +      +++   +    L+ +A++H 
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AVTHGALQGLAYLHS 172
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
             +IH D+K  NIL                           L +   +KL DFGS +   
Sbjct: 173 HNMIHRDVKAGNIL---------------------------LSEPGLVKLGDFGSASIMA 205
Query: 273 QDHSYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVELC 312
             + + V T ++ APEVIL +    ++   D+WS+G   +EL 
Sbjct: 206 PANXF-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 110/248 (44%), Gaps = 42/248 (16%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREA-----AMIEID 140
           E L  +Y++   +G G FG V           VAIK V    I+ + E        +E+ 
Sbjct: 4   EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 63
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRE 198
           +L++++    G +  +++ +WF+  +   ++ E+  P   L+DF+ +    +   +L R 
Sbjct: 64  LLKKVSS---GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARS 118
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              Q+LE+V   H   ++H D+K ENIL+             L+R               
Sbjct: 119 FFWQVLEAVRHCHNCGVLHRDIKDENILID------------LNRGE------------- 153
Query: 259 AIKLIDFGSTT-FEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEA 316
            +KLIDFGS    +   ++    TR Y  PE I    ++     +WS+G +L ++  G+ 
Sbjct: 154 -LKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 212
Query: 317 LFQTHENL 324
            F+  E +
Sbjct: 213 PFEHDEEI 220

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/244 (22%), Positives = 104/244 (42%), Gaps = 26/244 (10%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           +YR+  K+G G+FG +    +    E VAIK+     K+ +     + +  +  +   GG
Sbjct: 10  KYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQ-----LHIESKFYKMMQGG 64
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
                I+      ++  +V E LGPSL D     S R F +  V  L  Q++  + ++H 
Sbjct: 65  VGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS 123
Query: 213 LRLIHTDLKPENILL---VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
              IH D+KP+N L+        V + D+  L++  +D    +++P              
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFG-LAKKYRDARTHQHIP-------------- 168
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329
             ++++  +  T  Y +    LG+  +   DL S+G +L+    G   +Q  +       
Sbjct: 169 --YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 226
Query: 330 MERV 333
            ER+
Sbjct: 227 YERI 230

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 110/248 (44%), Gaps = 42/248 (16%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREA-----AMIEID 140
           E L  +Y++   +G G FG V           VAIK V    I+ + E        +E+ 
Sbjct: 32  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRE 198
           +L++++    G +  +++ +WF+  +   ++ E+  P   L+DF+ +    +   +L R 
Sbjct: 92  LLKKVSS---GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARS 146
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              Q+LE+V   H   ++H D+K ENIL+             L+R               
Sbjct: 147 FFWQVLEAVRHCHNCGVLHRDIKDENILID------------LNRGE------------- 181
Query: 259 AIKLIDFGSTT-FEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEA 316
            +KLIDFGS    +   ++    TR Y  PE I    ++     +WS+G +L ++  G+ 
Sbjct: 182 -LKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 240
Query: 317 LFQTHENL 324
            F+  E +
Sbjct: 241 PFEHDEEI 248

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 110/248 (44%), Gaps = 42/248 (16%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREA-----AMIEID 140
           E L  +Y++   +G G FG V           VAIK V    I+ + E        +E+ 
Sbjct: 47  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 106
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRE 198
           +L++++    G +  +++ +WF+  +   ++ E+  P   L+DF+ +    +   +L R 
Sbjct: 107 LLKKVSS---GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARS 161
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              Q+LE+V   H   ++H D+K ENIL+             L+R               
Sbjct: 162 FFWQVLEAVRHCHNCGVLHRDIKDENILID------------LNRGE------------- 196
Query: 259 AIKLIDFGSTT-FEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEA 316
            +KLIDFGS    +   ++    TR Y  PE I    ++     +WS+G +L ++  G+ 
Sbjct: 197 -LKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 255
Query: 317 LFQTHENL 324
            F+  E +
Sbjct: 256 PFEHDEEI 263

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 110/248 (44%), Gaps = 42/248 (16%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREA-----AMIEID 140
           E L  +Y++   +G G FG V           VAIK V    I+ + E        +E+ 
Sbjct: 27  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 86
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRE 198
           +L++++    G +  +++ +WF+  +   ++ E+  P   L+DF+ +    +   +L R 
Sbjct: 87  LLKKVSS---GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARS 141
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              Q+LE+V   H   ++H D+K ENIL+             L+R               
Sbjct: 142 FFWQVLEAVRHCHNCGVLHRDIKDENILID------------LNRGE------------- 176
Query: 259 AIKLIDFGSTT-FEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEA 316
            +KLIDFGS    +   ++    TR Y  PE I    ++     +WS+G +L ++  G+ 
Sbjct: 177 -LKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 235
Query: 317 LFQTHENL 324
            F+  E +
Sbjct: 236 PFEHDEEI 243

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 97/226 (42%), Gaps = 46/226 (20%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRC 155
           +GEG+F  VV   +       AIKI+  R I K  +   +  E DV+ RL          
Sbjct: 45  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-------DHP 97
Query: 156 VQIRNWF----DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
             ++ +F    D + +  + + K G  L  ++RK    SF     R    +++ ++ ++H
Sbjct: 98  FFVKLYFCFQDDEKLYFGLSYAKNG-ELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH 154
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
              +IH DLKPENILL    ++++ D+   K LS  SK                      
Sbjct: 155 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------------- 195
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                  +  V T  Y +PE++         DLW++GCI+ +L +G
Sbjct: 196 ------ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/231 (21%), Positives = 102/231 (44%), Gaps = 37/231 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAAMIEID--VLQRLARHD 149
           + +L  +G G++ +V+     +   + A+K+V+   +N   +   ++ +  V ++ + H 
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 150 --IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
             +G   C Q  +    R    I +   G  ++   R+   R  P +  R    ++  ++
Sbjct: 71  FLVGLHSCFQTES----RLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLAL 123
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
            ++HE  +I+ DLK +N+LL S  ++K+ DY       +                   G 
Sbjct: 124 NYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP------------------GD 165
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
           TT      S    T +Y APE++ G  + +  D W++G ++ E+ +G + F
Sbjct: 166 TT------SXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 210

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 101/240 (42%), Gaps = 32/240 (13%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           R+  K+G+G FG+V     N     VAIK ++      EA + E  V+++L RH+    +
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE----K 74
Query: 155 CVQIRNWFDYRNHICIVFEKLGPS-LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            VQ+         I IV E +    L DFL+    +   +  + ++  Q+   +A++  +
Sbjct: 75  LVQLYAVVS-EEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL+  NIL+      KV D+  L+R  +D  Y         IK            
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFG-LARLIEDNEYTARQGAKFPIK------------ 180
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE  L   +    D+WS G +L EL + G   +    N E L  +ER
Sbjct: 181 ----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 110/248 (44%), Gaps = 42/248 (16%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREA-----AMIEID 140
           E L  +Y++   +G G FG V           VAIK V    I+ + E        +E+ 
Sbjct: 3   EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 62
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRE 198
           +L++++    G +  +++ +WF+  +   ++ E+  P   L+DF+ +    +   +L R 
Sbjct: 63  LLKKVSS---GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARS 117
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              Q+LE+V   H   ++H D+K ENIL+             L+R               
Sbjct: 118 FFWQVLEAVRHCHNCGVLHRDIKDENILID------------LNRGE------------- 152
Query: 259 AIKLIDFGS-TTFEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEA 316
            +KLIDFGS    +   ++    TR Y  PE I    ++     +WS+G +L ++  G+ 
Sbjct: 153 -LKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 211
Query: 317 LFQTHENL 324
            F+  E +
Sbjct: 212 PFEHDEEI 219

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/297 (22%), Positives = 126/297 (42%), Gaps = 43/297 (14%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           +++ ++G G  G+V   + N   + VA+K ++  +   +A + E +++++L    +    
Sbjct: 16  KLVERLGAGQAGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            V  +        I I+ E +   SL DFL+  S     I+ + ++  Q+ E +AF+ E 
Sbjct: 75  AVVTQE------PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             IH DL+  NIL+      K+ D+  L+R  +D            IK            
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFG-LARLIEDAEXTAREGAKFPIK------------ 175
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE I    +    D+WS G +L E+ + G   +    N E +  +ER
Sbjct: 176 ----------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
Query: 333 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSAS 389
                  + ++R D   E+ ++   RL W +    R   R  +  LR  + D ++A+
Sbjct: 226 ------GYRMVRPDNCPEELYQL-MRLCWKE----RPEDRPTFDYLRSVLEDFFTAT 271

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/231 (21%), Positives = 102/231 (44%), Gaps = 37/231 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAAMIEID--VLQRLARHD 149
           + +L  +G G++ +V+     +   + A+K+V+   +N   +   ++ +  V ++ + H 
Sbjct: 7   FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 66
Query: 150 --IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
             +G   C Q  +    R    I +   G  ++   R+   R  P +  R    ++  ++
Sbjct: 67  FLVGLHSCFQTES----RLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLAL 119
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
            ++HE  +I+ DLK +N+LL S  ++K+ DY       +                   G 
Sbjct: 120 NYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP------------------GD 161
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
           TT      S    T +Y APE++ G  + +  D W++G ++ E+ +G + F
Sbjct: 162 TT------SXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 206

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 102/240 (42%), Gaps = 32/240 (13%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           R+  K+G+G FG+V     N     VAIK ++      EA + E  V+++L RH+    +
Sbjct: 11  RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE----K 64
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            VQ+         I IV E +   SL DFL+  + +   +  + ++  Q+   +A++  +
Sbjct: 65  LVQLYAVVS-EEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 123
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL+  NIL+      KV D+  L+R  +D            IK            
Sbjct: 124 NYVHRDLRAANILVGENLVCKVADFG-LARLIEDNEXTARQGAKFPIK------------ 170
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE  L   +    D+WS G +L EL + G   +    N E L  +ER
Sbjct: 171 ----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 220

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 107/248 (43%), Gaps = 44/248 (17%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD---- 149
           YR+L  +G+G F +V         + VA+KI+       +   +    LQ+L R      
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKII-------DKTQLNSSSLQKLFREVRIMK 68
Query: 150 -IGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
            +     V++    +    + +V E   G  ++D+L   ++        R   RQ++ +V
Sbjct: 69  VLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV--AHGRMKEKEARAKFRQIVSAV 126
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
            + H+  ++H DLK EN+LL +   +K+ D+ F +  +     F N       KL  F  
Sbjct: 127 QYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT-----FGN-------KLDAF-- 172
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALFQTHENLEH 326
                           Y APE+  G  ++ P  D+WS+G IL  L SG   F   +NL+ 
Sbjct: 173 -----------CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKE 220
Query: 327 LAMMERVL 334
           L   ERVL
Sbjct: 221 LR--ERVL 226

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 108/246 (43%), Gaps = 34/246 (13%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARHDIG 151
           Y +   +G G    V   +   KKE VAIK +         +  + EI  + +    +I 
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI- 70
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLR----KNSYRSFPID--LVRELGRQLL 204
               V     F  ++ + +V + L G S+ D ++    K  ++S  +D   +  + R++L
Sbjct: 71  ----VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 126
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
           E + ++H+   IH D+K  NILL     V++ D+   +  +  G   +N  +        
Sbjct: 127 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK------- 179
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHEN 323
               TF        V T  + APEV+  + G+++  D+WS G   +EL +G A +  +  
Sbjct: 180 ----TF--------VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP 227
Query: 324 LEHLAM 329
           ++ L +
Sbjct: 228 MKVLML 233

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 41/223 (18%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIV----RSINKYREAAMIEIDVLQRLARHDIGG 152
           L ++G G+FG V    D    E+VAIK +    +  N+  +  + E+  LQ+L RH    
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RH---- 74
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
              +Q R  +   +   +V E    S  D L  +      +++   +    L+ +A++H 
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AVTHGALQGLAYLHS 133
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
             +IH D+K  NIL                           L +   +KL DFGS +   
Sbjct: 134 HNMIHRDVKAGNIL---------------------------LSEPGLVKLGDFGSASIMA 166
Query: 273 QDHSYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVELC 312
             + + V T ++ APEVIL +    ++   D+WS+G   +EL 
Sbjct: 167 PANXF-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 208

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 103/230 (44%), Gaps = 34/230 (14%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR 147
           + L  +Y I   +G G FG V  C +   K+    K V+     +     EI +L  +AR
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILN-IAR 59
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
           H       + +   F+    + ++FE + G  +++ +  +++     ++V  +  Q+ E+
Sbjct: 60  H----RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYV-HQVCEA 114
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           + F+H   + H D++PENI+             + +R            +SS IK+I+FG
Sbjct: 115 LQFLHSHNIGHFDIRPENII-------------YQTR------------RSSTIKIIEFG 149
Query: 267 ST-TFEHQDHSYVVSTR-HYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                +  D+  ++ T   Y APEV      +   D+WS+G ++  L SG
Sbjct: 150 QARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 109/256 (42%), Gaps = 60/256 (23%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           YR+L  +G+G F +V              K+ R I   +E A+  ID  Q  +       
Sbjct: 16  YRLLKTIGKGNFAKV--------------KLARHILTGKEVAVRIIDKTQLNSSSLQKLF 61
Query: 154 RCVQIRNWFDYRNHICIVFEKL--------------GPSLYDFLRKNSYRSFPIDLVREL 199
           R V+I    ++ N I  +FE +              G  ++D+L   ++        R  
Sbjct: 62  REVRIMKVLNHPN-IVKLFEVIETEKTLYLVMEYASGGEVFDYLV--AHGRMKEKEARAK 118
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
            RQ++ +V + H+  ++H DLK EN+LL +   +K+ D+ F +                 
Sbjct: 119 FRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSN----------------- 161
Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALF 318
                    TF ++  ++  S   Y APE+  G  ++ P  D+WS+G IL  L SG   F
Sbjct: 162 -------EFTFGNKLDTFCGSP-PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213
Query: 319 QTHENLEHLAMMERVL 334
              +NL+ L   ERVL
Sbjct: 214 DG-QNLKELR--ERVL 226

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/231 (21%), Positives = 102/231 (44%), Gaps = 37/231 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAAMIEID--VLQRLARHD 149
           + +L  +G G++ +V+     +   + A+K+V+   +N   +   ++ +  V ++ + H 
Sbjct: 22  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 81
Query: 150 --IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
             +G   C Q  +    R    I +   G  ++   R+   R  P +  R    ++  ++
Sbjct: 82  FLVGLHSCFQTES----RLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLAL 134
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
            ++HE  +I+ DLK +N+LL S  ++K+ DY       +                   G 
Sbjct: 135 NYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP------------------GD 176
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
           TT      S    T +Y APE++ G  + +  D W++G ++ E+ +G + F
Sbjct: 177 TT------SXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 221

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 46/226 (20%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRC 155
           +GEG+F   V   +       AIKI+  R I K  +   +  E DV+ RL          
Sbjct: 38  LGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-------DHP 90
Query: 156 VQIRNWFDYRN----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
             ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ ++ ++H
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNG-ELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH 147
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
              +IH DLKPENILL    ++++ D+   K LS  SK                      
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------------- 188
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                  +  V T  Y +PE++         DLW++GCI+ +L +G
Sbjct: 189 ------ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 108/258 (41%), Gaps = 36/258 (13%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           L +MG GT GQV +    +   ++A+K +R      E   I +D+   L  HD      V
Sbjct: 30  LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDC--PYIV 87
Query: 157 QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR-L 215
           Q    F     + I  E +G +  + L+K      P  ++ ++   +++++ ++ E   +
Sbjct: 88  QCFGTFITNTDVFIAMELMG-TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGV 146
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           IH D+KP NILL     +K+ D+    R   D                       + +D 
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRLVDD-----------------------KAKDR 183
Query: 276 SYVVSTRHYRAPEVI-----LGLGWNYPCDLWSVGCILVELCSGEALFQT-HENLEHLAM 329
           S   +   Y APE I         ++   D+WS+G  LVEL +G+  ++    + E L  
Sbjct: 184 SAGCAA--YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTK 241
Query: 330 MERVLGP-LPHHMVIRAD 346
           + +   P LP HM    D
Sbjct: 242 VLQEEPPLLPGHMGFSGD 259

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 106/223 (47%), Gaps = 38/223 (17%)
Query: 100 MGEGTFGQV-VECFD---NEKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGG 152
           +GEG FG+V + C+D   +   E+VA+K +++    ++R     EID+L+ L   H I  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVREL--GRQLLESVAFM 210
             C + +   +    + + +  LG SL D+L ++S     I L + L   +Q+ E +A++
Sbjct: 82  KGCCEDQG--EKSLQLVMEYVPLG-SLRDYLPRHS-----IGLAQLLLFAQQICEGMAYL 133
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H    IH +L   N+LL +   VK+ D+  L+++  +G  +  + +       D  S  F
Sbjct: 134 HSQHYIHRNLAARNVLLDNDRLVKIGDFG-LAKAVPEGHEYYRVRE-------DGDSPVF 185
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                        + APE +    + Y  D+WS G  L EL +
Sbjct: 186 -------------WYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 106/252 (42%), Gaps = 42/252 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   LG ++Y  L+K S   F          +L  +
Sbjct: 68  ----PNILRLYGYFHDATRVYLILEYAPLG-TVYRELQKLS--KFDEQRTATYITELANA 120
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL SA  +K+ D+           +  + P S   +L    
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGELKIADF----------GWSVHAPSSRRTEL---- 166
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                         T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   E 
Sbjct: 167 ------------CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214
Query: 327 LAMMERVLGPLP 338
              + RV    P
Sbjct: 215 YKRISRVEFTFP 226

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 108/246 (43%), Gaps = 34/246 (13%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARHDIG 151
           Y +   +G G    V   +   KKE VAIK +         +  + EI  + +    +I 
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI- 75
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLR----KNSYRSFPID--LVRELGRQLL 204
               V     F  ++ + +V + L G S+ D ++    K  ++S  +D   +  + R++L
Sbjct: 76  ----VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
           E + ++H+   IH D+K  NILL     V++ D+   +  +  G   +N  +        
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK------- 184
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHEN 323
               TF        V T  + APEV+  + G+++  D+WS G   +EL +G A +  +  
Sbjct: 185 ----TF--------VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP 232
Query: 324 LEHLAM 329
           ++ L +
Sbjct: 233 MKVLML 238

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 106/223 (47%), Gaps = 38/223 (17%)
Query: 100 MGEGTFGQV-VECFD---NEKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGG 152
           +GEG FG+V + C+D   +   E+VA+K +++    ++R     EID+L+ L   H I  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVREL--GRQLLESVAFM 210
             C + +   +    + + +  LG SL D+L ++S     I L + L   +Q+ E +A++
Sbjct: 82  KGCCEDQG--EKSLQLVMEYVPLG-SLRDYLPRHS-----IGLAQLLLFAQQICEGMAYL 133
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H    IH +L   N+LL +   VK+ D+  L+++  +G  +  + +       D  S  F
Sbjct: 134 HAQHYIHRNLAARNVLLDNDRLVKIGDFG-LAKAVPEGHEYYRVRE-------DGDSPVF 185
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                        + APE +    + Y  D+WS G  L EL +
Sbjct: 186 -------------WYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 108/256 (42%), Gaps = 60/256 (23%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           YR+L  +G+G F +V              K+ R I   +E A+  ID  Q  +       
Sbjct: 16  YRLLKTIGKGNFAKV--------------KLARHILTGKEVAVKIIDKTQLNSSSLQKLF 61
Query: 154 RCVQIRNWFDYRNHICIVFEKL--------------GPSLYDFLRKNSYRSFPIDLVREL 199
           R V+I    ++ N I  +FE +              G  ++D+L   ++        R  
Sbjct: 62  REVRIXKVLNHPN-IVKLFEVIETEKTLYLVXEYASGGEVFDYLV--AHGRXKEKEARAK 118
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
            RQ++ +V + H+  ++H DLK EN+LL +   +K+ D+ F +  +     F N      
Sbjct: 119 FRQIVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFT-----FGN------ 167
Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALF 318
            KL  F                  Y APE+  G  ++ P  D+WS+G IL  L SG   F
Sbjct: 168 -KLDAF-------------CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213
Query: 319 QTHENLEHLAMMERVL 334
              +NL+ L   ERVL
Sbjct: 214 DG-QNLKEL--RERVL 226

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 109/246 (44%), Gaps = 42/246 (17%)
Query: 90  LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREA-----AMIEIDVL 142
           L  +Y++   +G G FG V           VAIK V    I+ + E        +E+ +L
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 143 QRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELG 200
           ++++    G +  +++ +WF+  +   ++ E+  P   L+DF+ +    +   +L R   
Sbjct: 62  KKVSS---GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFF 116
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+LE+V   H   ++H D+K ENIL+             L+R                +
Sbjct: 117 WQVLEAVRHCHNXGVLHRDIKDENILID------------LNRGE--------------L 150
Query: 261 KLIDFGS-TTFEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEALF 318
           KLIDFGS    +   ++    TR Y  PE I    ++     +WS+G +L ++  G+  F
Sbjct: 151 KLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210
Query: 319 QTHENL 324
           +  E +
Sbjct: 211 EHDEEI 216

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 101/240 (42%), Gaps = 32/240 (13%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           R+  K+G+G FG+V     N     VAIK ++      EA + E  V+++L RH+    +
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE----K 74
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            VQ+         I IV E +   SL DFL+    +   +  + ++  Q+   +A++  +
Sbjct: 75  LVQLYAVVS-EEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL+  NIL+      KV D+  L+R  +D            IK            
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFG-LARLIEDNEXTARQGAKFPIK------------ 180
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     + APE  L   +    D+WS G +L EL + G   +    N E L  +ER
Sbjct: 181 ----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 230

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 106/252 (42%), Gaps = 42/252 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    + ++K ++A+K++       E A +E  +     +Q   RH
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 64
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   LG ++Y  L+K S   F          +L  +
Sbjct: 65  ----PNILRLYGYFHDATRVYLILEYAPLG-TVYRELQKLS--KFDEQRTATYITELANA 117
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL SA  +K+ D+           +  + P S    L    
Sbjct: 118 LSYCHSKRVIHRDIKPENLLLGSAGELKIADF----------GWSVHAPSSRRTTL---- 163
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                         T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   E 
Sbjct: 164 ------------CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 211
Query: 327 LAMMERVLGPLP 338
              + RV    P
Sbjct: 212 YKRISRVEFTFP 223

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 109/246 (44%), Gaps = 42/246 (17%)
Query: 90  LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREA-----AMIEIDVL 142
           L  +Y++   +G G FG V           VAIK V    I+ + E        +E+ +L
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 143 QRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELG 200
           ++++    G +  +++ +WF+  +   ++ E+  P   L+DF+ +    +   +L R   
Sbjct: 62  KKVSS---GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFF 116
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+LE+V   H   ++H D+K ENIL+             L+R                +
Sbjct: 117 WQVLEAVRHCHNCGVLHRDIKDENILID------------LNRGE--------------L 150
Query: 261 KLIDFGSTT-FEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEALF 318
           KLIDFGS    +   ++    TR Y  PE I    ++     +WS+G +L ++  G+  F
Sbjct: 151 KLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210
Query: 319 QTHENL 324
           +  E +
Sbjct: 211 EHDEEI 216

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 105/239 (43%), Gaps = 61/239 (25%)
Query: 94  YRILSK-MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR--HDI 150
           Y++ S+ +G G  G+V++ F+   +E  A+K+++   K R     E+++  R ++  H +
Sbjct: 19  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQCPHIV 74
Query: 151 GGTRCVQI-RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
              R V +  N +  R  + IV E L G  L+  ++    ++F      E+ + + E++ 
Sbjct: 75  ---RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-- 266
           ++H + + H D+KPEN+L  S    K P+                    + +KL DFG  
Sbjct: 132 YLHSINIAHRDVKPENLLYTS----KRPN--------------------AILKLTDFGFA 167
Query: 267 -STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
             TT E  D S                      CD+WS+G I+  L  G   F ++  L
Sbjct: 168 KETTGEKYDKS----------------------CDMWSLGVIMYILLCGYPPFYSNHGL 204

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 101/234 (43%), Gaps = 51/234 (21%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTR 154
           L ++G G +G V +       +++A+K +RS    K ++  ++++DV+ R        + 
Sbjct: 27  LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMR-------SSD 79
Query: 155 CVQIRNWFD--YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRE--LGRQLLESVAFM 210
           C  I  ++   +R   C +  +L  + +D   K  Y S   D++ E  LG+  L +V  +
Sbjct: 80  CPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVY-SVLDDVIPEEILGKITLATVKAL 138
Query: 211 H----ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +     L++IH D+KP NILL                            +S  IKL DFG
Sbjct: 139 NHLKENLKIIHRDIKPSNILL---------------------------DRSGNIKLCDFG 171
Query: 267 --STTFEHQDHSYVVSTRHYRAPEVI----LGLGWNYPCDLWSVGCILVELCSG 314
                 +    +     R Y APE I       G++   D+WS+G  L EL +G
Sbjct: 172 ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 109/246 (44%), Gaps = 42/246 (17%)
Query: 90  LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREA-----AMIEIDVL 142
           L  +Y++   +G G FG V           VAIK V    I+ + E        +E+ +L
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 143 QRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELG 200
           ++++    G +  +++ +WF+  +   ++ E+  P   L+DF+ +    +   +L R   
Sbjct: 62  KKVSS---GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFF 116
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+LE+V   H   ++H D+K ENIL+             L+R                +
Sbjct: 117 WQVLEAVRHCHNCGVLHRDIKDENILID------------LNRGE--------------L 150
Query: 261 KLIDFGS-TTFEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEALF 318
           KLIDFGS    +   ++    TR Y  PE I    ++     +WS+G +L ++  G+  F
Sbjct: 151 KLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210
Query: 319 QTHENL 324
           +  E +
Sbjct: 211 EHDEEI 216

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 33/226 (14%)
Query: 95  RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
           + L ++G+G FG V  C      +   E+VA+K ++ S  ++      EI++L+ L   +
Sbjct: 14  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 73
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLG-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I   + V    +   R ++ ++ E L   SL D+L+K+  R   I L+ +   Q+ + + 
Sbjct: 74  IVKYKGV---CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQICKGME 129
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK-NLPKSSAIKLIDFGS 267
           ++   R IH +L   NIL+ +   VK+ D+       +D  Y+K   P  S I       
Sbjct: 130 YLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI------- 182
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                           + APE +    ++   D+WS G +L EL +
Sbjct: 183 ---------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 105/252 (41%), Gaps = 42/252 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH
Sbjct: 14  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 71
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   LG ++Y  L+K S   F          +L  +
Sbjct: 72  ----PNILRLYGYFHDATRVYLILEYAPLG-TVYRELQKLS--KFDEQRTATYITELANA 124
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL SA  +K+ D+           +  + P S    L    
Sbjct: 125 LSYCHSKRVIHRDIKPENLLLGSAGELKIADF----------GWSVHAPSSRRTTL---- 170
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                         T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   E 
Sbjct: 171 ------------CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 218
Query: 327 LAMMERVLGPLP 338
              + RV    P
Sbjct: 219 YKRISRVEFTFP 230

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 105/252 (41%), Gaps = 42/252 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   LG ++Y  L+K S   F          +L  +
Sbjct: 73  ----PNILRLYGYFHDATRVYLILEYAPLG-TVYRELQKLS--KFDEQRTATYITELANA 125
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL SA  +K+ D+           +  + P S    L    
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLGSAGELKIADF----------GWSVHAPSSRRTDL---- 171
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                         T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   E 
Sbjct: 172 ------------CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 219
Query: 327 LAMMERVLGPLP 338
              + RV    P
Sbjct: 220 YKRISRVEFTFP 231

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 38/223 (17%)
Query: 100 MGEGTFGQV-VECFD---NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGG 152
           +GEG FG+V + C+D   +   E+VA+K +++    ++R     EID+L+ L   H I  
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVREL--GRQLLESVAFM 210
             C +       +  + + +  LG SL D+L ++S     I L + L   +Q+ E +A++
Sbjct: 99  KGCCEDAGAASLQ--LVMEYVPLG-SLRDYLPRHS-----IGLAQLLLFAQQICEGMAYL 150
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H    IH DL   N+LL +   VK+ D+  L+++  +G     + +       D  S  F
Sbjct: 151 HAQHYIHRDLAARNVLLDNDRLVKIGDFG-LAKAVPEGHEXYRVRE-------DGDSPVF 202
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                        + APE +    + Y  D+WS G  L EL +
Sbjct: 203 -------------WYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/231 (20%), Positives = 103/231 (44%), Gaps = 37/231 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAAMIEID--VLQRLARHD 149
           + +L  +G G++ +V+     +   + A+++V+   +N   +   ++ +  V ++ + H 
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 150 --IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
             +G   C Q  +    R    I +   G  ++   R+   R  P +  R    ++  ++
Sbjct: 114 FLVGLHSCFQTES----RLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLAL 166
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
            ++HE  +I+ DLK +N+LL S  ++K+ DY       + G                  +
Sbjct: 167 NYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----------------T 210
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
           +TF          T +Y APE++ G  + +  D W++G ++ E+ +G + F
Sbjct: 211 STF--------CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 253

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 105/252 (41%), Gaps = 42/252 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   LG ++Y  L+K S   F          +L  +
Sbjct: 68  ----PNILRLYGYFHDATRVYLILEYAPLG-TVYRELQKLS--KFDEQRTATYITELANA 120
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL SA  +K+ D+           +  + P S    L    
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGELKIADF----------GWSVHAPSSRRTTL---- 166
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                         T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   E 
Sbjct: 167 ------------CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214
Query: 327 LAMMERVLGPLP 338
              + RV    P
Sbjct: 215 YKRISRVEFTFP 226

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 34/117 (29%), Positives = 51/117 (43%), Gaps = 25/117 (21%)
Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254
           L  EL  Q+ + V ++H  +LIH DLKP NI LV  + VK+ D+  ++    DG   ++ 
Sbjct: 137 LALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS- 195
Query: 255 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
                                     T  Y +PE I    +    DL+++G IL EL
Sbjct: 196 ------------------------KGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 228

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 106/243 (43%), Gaps = 45/243 (18%)
Query: 98  SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE---AAMIEIDVLQRLARHDIGGTR 154
           +++G G+FG V   +  +    VA+KI++ ++   E   A   E+ VL++        TR
Sbjct: 42  TRIGSGSFGTV---YKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRK--------TR 90
Query: 155 CVQIRNWFDY--RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
            V I  +  Y  ++++ IV +   G SLY  L     + F +  + ++ RQ  + + ++H
Sbjct: 91  HVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETK-FQMFQLIDIARQTAQGMDYLH 149
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK-DGSYFKNLPKSSAIKLIDFGSTTF 270
              +IH D+K  NI L     VK+ D+   +  S+  GS     P  S +          
Sbjct: 150 AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL---------- 199
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWN---YPCDLWSVGCILVELCSGEALFQTHENLEHL 327
                        + APEVI     N   +  D++S G +L EL +GE  +    N + +
Sbjct: 200 -------------WMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI 246
Query: 328 AMM 330
             M
Sbjct: 247 IFM 249

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 104/252 (41%), Gaps = 42/252 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   LG ++Y  L+K S   F          +L  +
Sbjct: 73  ----PNILRLYGYFHDATRVYLILEYAPLG-TVYRELQKLS--KFDEQRTATYITELANA 125
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL SA  +K+ D+           +  + P S    L    
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLGSAGELKIADF----------GWSVHAPSSRRTTL---- 171
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                         T  Y  PE I G   +   DLWS+G +  E   G+  F+ +   E 
Sbjct: 172 ------------CGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 219
Query: 327 LAMMERVLGPLP 338
              + RV    P
Sbjct: 220 YKRISRVEFTFP 231

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 105/252 (41%), Gaps = 42/252 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   LG ++Y  L+K S   F          +L  +
Sbjct: 68  ----PNILRLYGYFHDATRVYLILEYAPLG-TVYRELQKLS--KFDEQRTATYITELANA 120
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL SA  +K+ D+           +  + P S    L    
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGELKIADF----------GWSVHAPSSRRTDL---- 166
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                         T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   E 
Sbjct: 167 ------------CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214
Query: 327 LAMMERVLGPLP 338
              + RV    P
Sbjct: 215 YKRISRVEFTFP 226

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 104/253 (41%), Gaps = 44/253 (17%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 93
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   LG ++Y  L+K S   F          +L  +
Sbjct: 94  ----PNILRLYGYFHDATRVYLILEYAPLG-TVYRELQKLS--KFDEQRTATYITELANA 146
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL SA                             +K+ DFG
Sbjct: 147 LSYCHSKRVIHRDIKPENLLLGSA---------------------------GELKIADFG 179
Query: 267 -STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
            S        + +  T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   E
Sbjct: 180 WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 239
Query: 326 HLAMMERVLGPLP 338
               + RV    P
Sbjct: 240 TYKRISRVEFTFP 252

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 105/252 (41%), Gaps = 42/252 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   LG ++Y  L+K S   F          +L  +
Sbjct: 71  ----PNILRLYGYFHDATRVYLILEYAPLG-TVYRELQKLS--KFDEQRTATYITELANA 123
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL SA  +K+ D+           +  + P S    L    
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLGSAGELKIADF----------GWSVHAPSSRRTTL---- 169
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                         T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   E 
Sbjct: 170 ------------CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 217
Query: 327 LAMMERVLGPLP 338
              + RV    P
Sbjct: 218 YKRISRVEFTFP 229

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 105/252 (41%), Gaps = 42/252 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   LG ++Y  L+K S   F          +L  +
Sbjct: 68  ----PNILRLYGYFHDATRVYLILEYAPLG-TVYRELQKLS--KFDEQRTATYITELANA 120
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL SA  +K+ D+           +  + P S    L    
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGELKIADF----------GWSVHAPSSRRTXL---- 166
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                         T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   E 
Sbjct: 167 ------------CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214
Query: 327 LAMMERVLGPLP 338
              + RV    P
Sbjct: 215 YKRISRVEFTFP 226

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 90/225 (40%), Gaps = 46/225 (20%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           ++G G+FG+V    D +     A+K VR +  +R   +        +A   +   R V +
Sbjct: 100 RLGRGSFGEVHRMEDKQTGFQCAVKKVR-LEVFRAEEL--------MACAGLTSPRIVPL 150
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
                    + I  E L G SL   +++      P D       Q LE + ++H  R++H
Sbjct: 151 YGAVREGPWVNIFMELLEGGSLGQLVKEQG--CLPEDRALYYLGQALEGLEYLHSRRILH 208
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-- 275
            D+K +N+LL                 S DGS+           L DFG       D   
Sbjct: 209 GDVKADNVLL-----------------SSDGSH---------AALCDFGHAVCLQPDGLG 242
Query: 276 ------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                  Y+  T  + APEV+LG   +   D+WS  C+++ + +G
Sbjct: 243 KSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 90/225 (40%), Gaps = 46/225 (20%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           ++G G+FG+V    D +     A+K VR +  +R   +        +A   +   R V +
Sbjct: 81  RLGRGSFGEVHRMEDKQTGFQCAVKKVR-LEVFRAEEL--------MACAGLTSPRIVPL 131
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
                    + I  E L G SL   +++      P D       Q LE + ++H  R++H
Sbjct: 132 YGAVREGPWVNIFMELLEGGSLGQLVKEQG--CLPEDRALYYLGQALEGLEYLHSRRILH 189
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-- 275
            D+K +N+LL                 S DGS+           L DFG       D   
Sbjct: 190 GDVKADNVLL-----------------SSDGSH---------AALCDFGHAVCLQPDGLG 223
Query: 276 ------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                  Y+  T  + APEV+LG   +   D+WS  C+++ + +G
Sbjct: 224 KDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 105/252 (41%), Gaps = 42/252 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   LG ++Y  L+K S   F          +L  +
Sbjct: 71  ----PNILRLYGYFHDATRVYLILEYAPLG-TVYRELQKLS--KFDEQRTATYITELANA 123
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL SA  +K+ D+           +  + P S    L    
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLGSAGELKIADF----------GWSVHAPSSRRAAL---- 169
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                         T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   E 
Sbjct: 170 ------------CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 217
Query: 327 LAMMERVLGPLP 338
              + RV    P
Sbjct: 218 YKRISRVEFTFP 229

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 105/252 (41%), Gaps = 42/252 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH
Sbjct: 9   FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 66
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   LG ++Y  L+K S   F          +L  +
Sbjct: 67  ----PNILRLYGYFHDATRVYLILEYAPLG-TVYRELQKLS--KFDEQRTATYITELANA 119
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL SA  +K+ D+           +  + P S    L    
Sbjct: 120 LSYCHSKRVIHRDIKPENLLLGSAGELKIADF----------GWSVHAPSSRRTTL---- 165
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                         T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   E 
Sbjct: 166 ------------CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 213
Query: 327 LAMMERVLGPLP 338
              + RV    P
Sbjct: 214 YKRISRVEFTFP 225

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 105/252 (41%), Gaps = 42/252 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   LG ++Y  L+K S   F          +L  +
Sbjct: 73  ----PNILRLYGYFHDATRVYLILEYAPLG-TVYRELQKLS--KFDEQRTATYITELANA 125
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL SA  +K+ D+           +  + P S    L    
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLGSAGELKIADF----------GWSVHAPSSRRTTL---- 171
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                         T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   E 
Sbjct: 172 ------------CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 219
Query: 327 LAMMERVLGPLP 338
              + RV    P
Sbjct: 220 YKRISRVEFTFP 231

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 105/252 (41%), Gaps = 42/252 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   LG ++Y  L+K S   F          +L  +
Sbjct: 69  ----PNILRLYGYFHDATRVYLILEYAPLG-TVYRELQKLS--KFDEQRTATYITELANA 121
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL SA  +K+ D+           +  + P S    L    
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADF----------GWSVHAPSSRRTDL---- 167
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                         T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   E 
Sbjct: 168 ------------CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 215
Query: 327 LAMMERVLGPLP 338
              + RV    P
Sbjct: 216 YKRISRVEFTFP 227

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 105/252 (41%), Gaps = 42/252 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   LG ++Y  L+K S   F          +L  +
Sbjct: 68  ----PNILRLYGYFHDATRVYLILEYAPLG-TVYRELQKLS--KFDEQRTATYITELANA 120
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL SA  +K+ D+           +  + P S    L    
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGELKIADF----------GWSVHAPSSRRTDL---- 166
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                         T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   E 
Sbjct: 167 ------------CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214
Query: 327 LAMMERVLGPLP 338
              + RV    P
Sbjct: 215 YKRISRVEFTFP 226

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 105/252 (41%), Gaps = 42/252 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   LG ++Y  L+K S   F          +L  +
Sbjct: 71  ----PNILRLYGYFHDATRVYLILEYAPLG-TVYRELQKLS--KFDEQRTATYITELANA 123
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL SA  +K+ D+           +  + P S    L    
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLGSAGELKIADF----------GWSVHAPSSRRTTL---- 169
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                         T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   E 
Sbjct: 170 ------------CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 217
Query: 327 LAMMERVLGPLP 338
              + RV    P
Sbjct: 218 YKRISRVEFTFP 229

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 105/252 (41%), Gaps = 42/252 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   LG ++Y  L+K S   F          +L  +
Sbjct: 68  ----PNILRLYGYFHDATRVYLILEYAPLG-TVYRELQKLS--KFDEQRTATYITELANA 120
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL SA  +K+ D+           +  + P S    L    
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGELKIADF----------GWSVHAPSSRRXXL---- 166
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                         T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   E 
Sbjct: 167 ------------CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214
Query: 327 LAMMERVLGPLP 338
              + RV    P
Sbjct: 215 YKRISRVEFTFP 226

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 105/252 (41%), Gaps = 42/252 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   LG ++Y  L+K S   F          +L  +
Sbjct: 69  ----PNILRLYGYFHDATRVYLILEYAPLG-TVYRELQKLS--KFDEQRTATYITELANA 121
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL SA  +K+ D+ +   +          P S    L    
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHA----------PSSRRTTL---- 167
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                         T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   E 
Sbjct: 168 ------------SGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 215
Query: 327 LAMMERVLGPLP 338
              + RV    P
Sbjct: 216 YKRISRVEFTFP 227

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 105/252 (41%), Gaps = 42/252 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   LG ++Y  L+K S   F          +L  +
Sbjct: 68  ----PNILRLYGYFHDATRVYLILEYAPLG-TVYRELQKLS--KFDEQRTATYITELANA 120
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL SA  +K+ D+           +  + P S    L    
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGELKIADF----------GWSVHAPSSRRAAL---- 166
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                         T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   E 
Sbjct: 167 ------------CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214
Query: 327 LAMMERVLGPLP 338
              + RV    P
Sbjct: 215 YKRISRVEFTFP 226

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 105/252 (41%), Gaps = 42/252 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 69
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   LG ++Y  L+K S   F          +L  +
Sbjct: 70  ----PNILRLYGYFHDATRVYLILEYAPLG-TVYRELQKLS--KFDEQRTATYITELANA 122
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL SA  +K+ D+           +  + P S    L    
Sbjct: 123 LSYCHSKRVIHRDIKPENLLLGSAGELKIADF----------GWSVHAPSSRRXXL---- 168
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                         T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   E 
Sbjct: 169 ------------CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 216
Query: 327 LAMMERVLGPLP 338
              + RV    P
Sbjct: 217 YKRISRVEFTFP 228

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/276 (22%), Positives = 114/276 (41%), Gaps = 55/276 (19%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAM-------IEID 140
           E     YR+   +G+G FG V        +  VAIK++        + +       +E+ 
Sbjct: 27  EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVA 86
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPS--LYDFL-RKNSYRSFPIDLVR 197
           +L ++     G    +++ +WF+ +    +V E+  P+  L+D++  K      P    R
Sbjct: 87  LLWKVGAGG-GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP---SR 142
Query: 198 ELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 257
               Q++ ++   H   ++H D+K ENIL+                         +L + 
Sbjct: 143 CFFGQVVAAIQHCHSRGVVHRDIKDENILI-------------------------DLRRG 177
Query: 258 SAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGE 315
            A KLIDFGS    H + ++    TR Y  PE I    ++  P  +WS+G +L ++  G+
Sbjct: 178 CA-KLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
Query: 316 ALFQ-------------THENLEHLAMMERVLGPLP 338
             F+              H + +  A++ R L P P
Sbjct: 237 IPFERDQEILEAELHFPAHVSPDCCALIRRCLAPKP 272

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 105/252 (41%), Gaps = 42/252 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH
Sbjct: 27  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 84
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   LG ++Y  L+K S   F          +L  +
Sbjct: 85  ----PNILRLYGYFHDATRVYLILEYAPLG-TVYRELQKLS--KFDEQRTATYITELANA 137
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL SA  +K+ D+           +  + P S    L    
Sbjct: 138 LSYCHSKRVIHRDIKPENLLLGSAGELKIADF----------GWSVHAPSSRRTTL---- 183
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                         T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   E 
Sbjct: 184 ------------CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 231
Query: 327 LAMMERVLGPLP 338
              + RV    P
Sbjct: 232 YKRISRVEFTFP 243

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 105/252 (41%), Gaps = 42/252 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   LG ++Y  L+K S   F          +L  +
Sbjct: 71  ----PNILRLYGYFHDATRVYLILEYAPLG-TVYRELQKLS--KFDEQRTATYITELANA 123
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL SA  +K+ D+           +  + P S    L    
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLGSAGELKIADF----------GWSVHAPSSRRXXL---- 169
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                         T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   E 
Sbjct: 170 ------------CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 217
Query: 327 LAMMERVLGPLP 338
              + RV    P
Sbjct: 218 YKRISRVEFTFP 229

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 105/252 (41%), Gaps = 42/252 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   LG ++Y  L+K S   F          +L  +
Sbjct: 71  ----PNILRLYGYFHDATRVYLILEYAPLG-TVYRELQKLS--KFDEQRTATYITELANA 123
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL SA  +K+ D+           +  + P S    L    
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLGSAGELKIADF----------GWSVHAPSSRRDDL---- 169
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                         T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   E 
Sbjct: 170 ------------CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 217
Query: 327 LAMMERVLGPLP 338
              + RV    P
Sbjct: 218 YKRISRVEFTFP 229

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 103/253 (40%), Gaps = 44/253 (17%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   LG ++Y  L+K S   F          +L  +
Sbjct: 69  ----PNILRLYGYFHDATRVYLILEYAPLG-TVYRELQKLS--KFDEQRTATYITELANA 121
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL SA                             +K+ DFG
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSA---------------------------GELKIADFG 154
Query: 267 -STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
            S          +  T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   E
Sbjct: 155 WSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214
Query: 326 HLAMMERVLGPLP 338
               + RV    P
Sbjct: 215 TYKRISRVEFTFP 227

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 103/252 (40%), Gaps = 42/252 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   P   +Y  L+K S   F          +L  +
Sbjct: 73  ----PNILRLYGYFHDATRVYLILE-YAPRGEVYKELQKLS--KFDEQRTATYITELANA 125
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL SA  +K+ D+           +  + P S    L    
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLGSAGELKIADF----------GWSVHAPSSRRTTL---- 171
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                         T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   E 
Sbjct: 172 ------------CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 219
Query: 327 LAMMERVLGPLP 338
              + RV    P
Sbjct: 220 YKRISRVEFTFP 231

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 103/253 (40%), Gaps = 44/253 (17%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 93
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   LG ++Y  L+K S   F          +L  +
Sbjct: 94  ----PNILRLYGYFHDATRVYLILEYAPLG-TVYRELQKLS--KFDEQRTATYITELANA 146
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL SA                             +K+ DFG
Sbjct: 147 LSYCHSKRVIHRDIKPENLLLGSA---------------------------GELKIADFG 179
Query: 267 -STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
            S          +  T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   E
Sbjct: 180 WSVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 239
Query: 326 HLAMMERVLGPLP 338
               + RV    P
Sbjct: 240 TYKRISRVEFTFP 252

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 55/114 (48%), Gaps = 21/114 (18%)
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
           +++ F H+  +IH D+KP NIL+ +   VKV D+                    A  + D
Sbjct: 127 QALNFSHQNGIIHRDVKPANILISATNAVKVVDFGI------------------ARAIAD 168
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
            G++  +    + V+ T  Y +PE   G   +   D++S+GC+L E+ +GE  F
Sbjct: 169 SGNSVXQ---TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/242 (22%), Positives = 98/242 (40%), Gaps = 37/242 (15%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           + IL  +G G F +V      +  ++ A+KI   +NK+      E+   +      + G 
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKI---MNKWDMLKRGEVSCFREERDVLVNGD 119
Query: 154 R--CVQIRNWFDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
           R    Q+   F   N++ +V E  +G  L   L K   R  P ++ R    +++ ++  +
Sbjct: 120 RRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGER-IPAEMARFYLAEIVMAIDSV 178
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H L  +H D+KP+NILL    ++++ D+         GS  K     +   L+       
Sbjct: 179 HRLGYVHRDIKPDNILLDRCGHIRLADF---------GSCLKLRADGTVRSLV------- 222
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNY-------PCDLWSVGCILVELCSGEALFQTHEN 323
                   V T  Y +PE++  +G           CD W++G    E+  G+  F     
Sbjct: 223 -------AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST 275
Query: 324 LE 325
            E
Sbjct: 276 AE 277

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 99/232 (42%), Gaps = 35/232 (15%)
Query: 86  IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQ 143
           +GE     +  +S++G G  G V +        ++A K++    K   R   + E+ VL 
Sbjct: 62  VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL- 120
Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
               H+      V     F     I I  E +     D + K + R  P  ++ ++   +
Sbjct: 121 ----HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAV 175
Query: 204 LESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           ++ + ++ E  +++H D+KP NIL+ S   +K+ D+                    + +L
Sbjct: 176 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV------------------SGQL 217
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           ID  + +F        V TR Y +PE + G  ++   D+WS+G  LVE+  G
Sbjct: 218 IDSMANSF--------VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 261

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 98/239 (41%), Gaps = 42/239 (17%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA----MIEIDVLQRLARHD 149
           + I+  +G+G FG V    + + K ++A+K++      +E        EI++   L   +
Sbjct: 16  FDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
           I     +++ N+F  R  I ++ E   P   LY  L+K+    F          +L +++
Sbjct: 76  I-----LRMYNYFHDRKRIYLMLE-FAPRGELYKELQKHG--RFDEQRSATFMEELADAL 127
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
            + HE ++IH D+KPEN+L+          YK                    +K+ DFG 
Sbjct: 128 HYCHERKVIHRDIKPENLLM---------GYK------------------GELKIADFGW 160
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
           S          +  T  Y  PE+I G   +   DLW  G +  E   G   F +  + E
Sbjct: 161 SVHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 103/252 (40%), Gaps = 42/252 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   P   +Y  L+K S   F          +L  +
Sbjct: 73  ----PNILRLYGYFHDATRVYLILE-YAPRGEVYKELQKLS--KFDEQRTATYITELANA 125
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL SA  +K+ D+           +  + P S    L    
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLGSAGELKIADF----------GWSVHAPSSRRXXL---- 171
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                         T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   E 
Sbjct: 172 ------------XGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 219
Query: 327 LAMMERVLGPLP 338
              + RV    P
Sbjct: 220 YKRISRVEFTFP 231

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 68/144 (47%), Gaps = 23/144 (15%)
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
           +++ F H+  +IH D+KP NI++ +   VKV D+                    A  + D
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI------------------ARAIAD 168
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHE 322
            G++  +    + V+ T  Y +PE   G   +   D++S+GC+L E+ +GE  F   + +
Sbjct: 169 SGNSVTQ---TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPD 225
Query: 323 NLEHLAMMERVLGPLPHHMVIRAD 346
           ++ +  + E  + P   H  + AD
Sbjct: 226 SVAYQHVREDPIPPSARHEGLSAD 249

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 102/253 (40%), Gaps = 67/253 (26%)
Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARH--- 148
           R R+   + EG F  V E  D       A+K + S  + +  A+I E+  +++L+ H   
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 149 -------DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRS-FPIDLVRELG 200
                   IG       +  F     +C         L +FL+K   R     D V ++ 
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELC------KGQLVEFLKKMESRGPLSCDTVLKIF 142
Query: 201 RQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
            Q   +V  MH  +  +IH DLK EN+LL                 S  G+         
Sbjct: 143 YQTCRAVQHMHRQKPPIIHRDLKVENLLL-----------------SNQGT--------- 176
Query: 259 AIKLIDFGS-TTFEH-QDHSYVV-------------STRHYRAPEVILGLGWNYPC---- 299
            IKL DFGS TT  H  D+S+               +T  YR PE+I  L  N+P     
Sbjct: 177 -IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII-DLYSNFPIGEKQ 234
Query: 300 DLWSVGCILVELC 312
           D+W++GCIL  LC
Sbjct: 235 DIWALGCILYLLC 247

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 99/234 (42%), Gaps = 35/234 (14%)
Query: 84  FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDV 141
            A+GE     +  +S++G G  G V +        ++A K++    K   R   + E+ V
Sbjct: 1   MALGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQV 60
Query: 142 LQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGR 201
           L     H+      V     F     I I  E +     D + K + R  P  ++ ++  
Sbjct: 61  L-----HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSI 114
Query: 202 QLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            +++ + ++ E  +++H D+KP NIL+ S   +K+ D+                    + 
Sbjct: 115 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV------------------SG 156
Query: 261 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           +LID  +  F        V TR Y +PE + G  ++   D+WS+G  LVE+  G
Sbjct: 157 QLIDEMANEF--------VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 202

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 99/232 (42%), Gaps = 35/232 (15%)
Query: 86  IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQ 143
           +GE     +  +S++G G  G V +        ++A K++    K   R   + E+ VL 
Sbjct: 27  VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL- 85
Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
               H+      V     F     I I  E +     D + K + R  P  ++ ++   +
Sbjct: 86  ----HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAV 140
Query: 204 LESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           ++ + ++ E  +++H D+KP NIL+ S   +K+ D+                    + +L
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDF------------------GVSGQL 182
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           ID  + +F        V TR Y +PE + G  ++   D+WS+G  LVE+  G
Sbjct: 183 IDSMANSF--------VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 110/283 (38%), Gaps = 84/283 (29%)
Query: 90  LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKI-----VRSIN-KYREAAMIEIDVLQ 143
           L  +Y +   +G+G++G V    +N+ + + AIKI     +R IN K  E    E+ +++
Sbjct: 24  LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK 83
Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLR---KNSYRSFPIDLVR-- 197
           +L   +I      ++   ++   +IC+V E   G  L D L     +S     +D+V+  
Sbjct: 84  KLHHPNIA-----RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQ 138
Query: 198 ---------------------------------ELGRQLLESVAFMHELRLIHTDLKPEN 224
                                             + RQ+  ++ ++H   + H D+KPEN
Sbjct: 139 ICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPEN 198
Query: 225 ILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTF------EHQDHSY 277
            L  +                          KS  IKL+DFG S  F      E+   + 
Sbjct: 199 FLFSTN-------------------------KSFEIKLVDFGLSKEFYKLNNGEYYGMTT 233
Query: 278 VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALF 318
              T ++ APEV+     +Y   CD WS G +L  L  G   F
Sbjct: 234 KAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPF 276

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 93/231 (40%), Gaps = 37/231 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIG 151
           + +  ++G G FG V+     +  E VAIK  R     K RE   +EI ++++L   ++ 
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL--GPSLYDFLRK----NSYRSFPIDLVRELGRQLLE 205
             R V         N + ++  +   G  L  +L +       +  PI   R L   +  
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI---RTLLSDISS 132
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           ++ ++HE R+IH DLKPENI+L                           P+    K+ID 
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPG------------------------PQRLIHKIIDL 168
Query: 266 GSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           G      Q    +  V T  Y APE++    +    D WS G +  E  +G
Sbjct: 169 GYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 93/231 (40%), Gaps = 37/231 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIG 151
           + +  ++G G FG V+     +  E VAIK  R     K RE   +EI ++++L   ++ 
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL--GPSLYDFLRK----NSYRSFPIDLVRELGRQLLE 205
             R V         N + ++  +   G  L  +L +       +  PI   R L   +  
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI---RTLLSDISS 133
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           ++ ++HE R+IH DLKPENI+L                           P+    K+ID 
Sbjct: 134 ALRYLHENRIIHRDLKPENIVLQPG------------------------PQRLIHKIIDL 169
Query: 266 GSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           G      Q    +  V T  Y APE++    +    D WS G +  E  +G
Sbjct: 170 GYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 101/247 (40%), Gaps = 44/247 (17%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARHDIGGTR 154
           +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH      
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVL--FKTQLEKAGVEHQLRREVEIQSHLRH----PN 73
Query: 155 CVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
            +++  +F     + ++ E   LG ++Y  L+K S   F          +L  ++++ H 
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLG-TVYRELQKLS--RFDEQRTATYITELANALSYCHS 130
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFE 271
            R+IH D+KPEN+LL S                           +  +K+ DFG S    
Sbjct: 131 KRVIHRDIKPENLLLGS---------------------------NGELKIADFGWSVHAP 163
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 331
               + +  T  Y  PE+I G   +   DLWS+G +  E   G   F+ H   E    + 
Sbjct: 164 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRIS 223
Query: 332 RVLGPLP 338
           RV    P
Sbjct: 224 RVEFTFP 230

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 92/232 (39%), Gaps = 44/232 (18%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           ++ +  +G G FGQV +       +   IK V+  N   E A  E+  L +L   +I   
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNI--V 67
Query: 154 RCVQIRNWFDY----------RNHICIVFEKL----GPSLYDFLRKNSYRSFPIDLVREL 199
                 + FDY          R+    +F ++      +L  ++ K         L  EL
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
             Q+ + V ++H  +LI+ DLKP NI LV  + VK+ D+  ++    DG   ++      
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRS------ 181
Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
                                T  Y +PE I    +    DL+++G IL EL
Sbjct: 182 -------------------KGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 105/252 (41%), Gaps = 42/252 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   LG ++Y  L+K S   F          +L  +
Sbjct: 71  ----PNILRLYGYFHDATRVYLILEYAPLG-TVYRELQKLS--KFDEQRTATYITELANA 123
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL SA  +K+ ++           +  + P S    L    
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLGSAGELKIANF----------GWSVHAPSSRRTTL---- 169
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                         T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   E 
Sbjct: 170 ------------CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 217
Query: 327 LAMMERVLGPLP 338
              + RV    P
Sbjct: 218 YKRISRVEFTFP 229

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/232 (21%), Positives = 99/232 (42%), Gaps = 45/232 (19%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-LQRLARHDIGG 152
           + ++  +GEG +G+V    +   +E VA+KIV           I+ ++ + ++  H+   
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE--- 65
Query: 153 TRCVQIRNWFDYRNHICIVFEKL----GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                +  ++ +R    I +  L    G  L+D +  +     P    +    QL+  V 
Sbjct: 66  ----NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVV 119
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H + + H D+KPEN+LL   + +K+ D+                            +T
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGL--------------------------AT 153
Query: 269 TFEHQDHSYVVS----TRHYRAPEVILGLGWNY-PCDLWSVGCILVELCSGE 315
            F + +   +++    T  Y APE++    ++  P D+WS G +L  + +GE
Sbjct: 154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/114 (27%), Positives = 55/114 (48%), Gaps = 21/114 (18%)
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
           +++ F H+  +IH D+KP NI++ +   VKV D+                    A  + D
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI------------------ARAIAD 168
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
            G++  +    + V+ T  Y +PE   G   +   D++S+GC+L E+ +GE  F
Sbjct: 169 SGNSVTQ---TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 104/243 (42%), Gaps = 40/243 (16%)
Query: 74  RPDDKDGHYVFAIGENLTPR--YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY 131
           +P DKD   +        PR   +++ ++G G FG+V   + N   + VA+K ++     
Sbjct: 1   KPWDKDAWEI--------PRESIKLVKRLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMS 51
Query: 132 REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRS 190
            +A + E ++++ L +HD    + V++         I I+ E +   SL DFL+ +    
Sbjct: 52  VQAFLEEANLMKTL-QHD----KLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGK 106
Query: 191 FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250
             +  + +   Q+ E +A++     IH DL+  N+L+  +   K+ D+  L+R  +D  Y
Sbjct: 107 VLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFG-LARVIEDNEY 165
Query: 251 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310
                    IK                      + APE I    +    D+WS G +L E
Sbjct: 166 TAREGAKFPIK----------------------WTAPEAINFGCFTIKSDVWSFGILLYE 203
Query: 311 LCS 313
           + +
Sbjct: 204 IVT 206

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 100/234 (42%), Gaps = 49/234 (20%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREAAMIEIDVLQRLARHDI 150
           + ++  +GEG +G+V    +   +E VA+KIV   R+++   E    EI + + L   ++
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEIXINKMLNHENV 67
Query: 151 ----GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
               G  R   I+  F        +F+++ P +            P    +    QL+  
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----------GMPEPDAQRFFHQLMAG 117
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           V ++H + + H D+KPEN+LL   + +K+ D+                            
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGL-------------------------- 151
Query: 267 STTFEHQDHSYVVS----TRHYRAPEVILGLGWNY-PCDLWSVGCILVELCSGE 315
           +T F + +   +++    T  Y APE++    ++  P D+WS G +L  + +GE
Sbjct: 152 ATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 105/252 (41%), Gaps = 42/252 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 69
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   LG ++Y  L+K S   F          +L  +
Sbjct: 70  ----PNILRLYGYFHDATRVYLILEYAPLG-TVYRELQKLS--KFDEQRTATYITELANA 122
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL SA  +K+ ++           +  + P S    L    
Sbjct: 123 LSYCHSKRVIHRDIKPENLLLGSAGELKIANF----------GWSVHAPSSRRTTL---- 168
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                         T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   E 
Sbjct: 169 ------------CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 216
Query: 327 LAMMERVLGPLP 338
              + RV    P
Sbjct: 217 YKRISRVEFTFP 228

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/114 (27%), Positives = 55/114 (48%), Gaps = 21/114 (18%)
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
           +++ F H+  +IH D+KP NI++ +   VKV D+                    A  + D
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI------------------ARAIAD 168
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
            G++  +    + V+ T  Y +PE   G   +   D++S+GC+L E+ +GE  F
Sbjct: 169 SGNSVTQ---TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/114 (27%), Positives = 55/114 (48%), Gaps = 21/114 (18%)
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
           +++ F H+  +IH D+KP NI++ +   VKV D+                    A  + D
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI------------------ARAIAD 168
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
            G++  +    + V+ T  Y +PE   G   +   D++S+GC+L E+ +GE  F
Sbjct: 169 SGNSVTQ---TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 99/232 (42%), Gaps = 35/232 (15%)
Query: 86  IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQ 143
           +GE     +  +S++G G  G V +        ++A K++    K   R   + E+ VL 
Sbjct: 19  VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL- 77
Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
               H+      V     F     I I  E +     D + K + R  P  ++ ++   +
Sbjct: 78  ----HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAV 132
Query: 204 LESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           ++ + ++ E  +++H D+KP NIL+ S   +K+ D+                    + +L
Sbjct: 133 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV------------------SGQL 174
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           ID  + +F        V TR Y +PE + G  ++   D+WS+G  LVE+  G
Sbjct: 175 IDSMANSF--------VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 218

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/232 (21%), Positives = 99/232 (42%), Gaps = 45/232 (19%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-LQRLARHDIGG 152
           + ++  +GEG +G+V    +   +E VA+KIV           I+ ++ + ++  H+   
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE--- 64
Query: 153 TRCVQIRNWFDYRNHICIVFEKL----GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                +  ++ +R    I +  L    G  L+D +  +     P    +    QL+  V 
Sbjct: 65  ----NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVV 118
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H + + H D+KPEN+LL   + +K+ D+                            +T
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGL--------------------------AT 152
Query: 269 TFEHQDHSYVVS----TRHYRAPEVILGLGWNY-PCDLWSVGCILVELCSGE 315
            F + +   +++    T  Y APE++    ++  P D+WS G +L  + +GE
Sbjct: 153 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 100/234 (42%), Gaps = 49/234 (20%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREAAMIEIDVLQRLARHDI 150
           + ++  +GEG +G+V    +   +E VA+KIV   R+++   E    EI + + L   ++
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEIXINKMLNHENV 66
Query: 151 ----GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
               G  R   I+  F        +F+++ P +            P    +    QL+  
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----------GMPEPDAQRFFHQLMAG 116
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           V ++H + + H D+KPEN+LL   + +K+ D+                            
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGL-------------------------- 150
Query: 267 STTFEHQDHSYVVS----TRHYRAPEVILGLGWNY-PCDLWSVGCILVELCSGE 315
           +T F + +   +++    T  Y APE++    ++  P D+WS G +L  + +GE
Sbjct: 151 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/232 (21%), Positives = 99/232 (42%), Gaps = 45/232 (19%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-LQRLARHDIGG 152
           + ++  +GEG +G+V    +   +E VA+KIV           I+ ++ + ++  H+   
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE--- 65
Query: 153 TRCVQIRNWFDYRNHICIVFEKL----GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                +  ++ +R    I +  L    G  L+D +  +     P    +    QL+  V 
Sbjct: 66  ----NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVV 119
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H + + H D+KPEN+LL   + +K+ D+                            +T
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGL--------------------------AT 153
Query: 269 TFEHQDHSYVVS----TRHYRAPEVILGLGWNY-PCDLWSVGCILVELCSGE 315
            F + +   +++    T  Y APE++    ++  P D+WS G +L  + +GE
Sbjct: 154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/232 (21%), Positives = 99/232 (42%), Gaps = 45/232 (19%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-LQRLARHDIGG 152
           + ++  +GEG +G+V    +   +E VA+KIV           I+ ++ + ++  H+   
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE--- 65
Query: 153 TRCVQIRNWFDYRNHICIVFEKL----GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                +  ++ +R    I +  L    G  L+D +  +     P    +    QL+  V 
Sbjct: 66  ----NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVV 119
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H + + H D+KPEN+LL   + +K+ D+                            +T
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGL--------------------------AT 153
Query: 269 TFEHQDHSYVVS----TRHYRAPEVILGLGWNY-PCDLWSVGCILVELCSGE 315
            F + +   +++    T  Y APE++    ++  P D+WS G +L  + +GE
Sbjct: 154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/232 (21%), Positives = 99/232 (42%), Gaps = 45/232 (19%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-LQRLARHDIGG 152
           + ++  +GEG +G+V    +   +E VA+KIV           I+ ++ + ++  H+   
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE--- 65
Query: 153 TRCVQIRNWFDYRNHICIVFEKL----GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                +  ++ +R    I +  L    G  L+D +  +     P    +    QL+  V 
Sbjct: 66  ----NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVV 119
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H + + H D+KPEN+LL   + +K+ D+                            +T
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGL--------------------------AT 153
Query: 269 TFEHQDHSYVVS----TRHYRAPEVILGLGWNY-PCDLWSVGCILVELCSGE 315
            F + +   +++    T  Y APE++    ++  P D+WS G +L  + +GE
Sbjct: 154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/114 (27%), Positives = 55/114 (48%), Gaps = 21/114 (18%)
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
           +++ F H+  +IH D+KP NI++ +   VKV D+                    A  + D
Sbjct: 144 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI------------------ARAIAD 185
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
            G++  +    + V+ T  Y +PE   G   +   D++S+GC+L E+ +GE  F
Sbjct: 186 SGNSVTQ---TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 236

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 100/234 (42%), Gaps = 49/234 (20%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREAAMIEIDVLQRLARHDI 150
           + ++  +GEG +G+V    +   +E VA+KIV   R+++   E    EI + + L   ++
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEIXINKMLNHENV 66
Query: 151 ----GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
               G  R   I+  F        +F+++ P +            P    +    QL+  
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----------GMPEPDAQRFFHQLMAG 116
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           V ++H + + H D+KPEN+LL   + +K+ D+                            
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGL-------------------------- 150
Query: 267 STTFEHQDHSYVVS----TRHYRAPEVILGLGWNY-PCDLWSVGCILVELCSGE 315
           +T F + +   +++    T  Y APE++    ++  P D+WS G +L  + +GE
Sbjct: 151 ATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 105/255 (41%), Gaps = 58/255 (22%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEID-------VLQRLA 146
           YR+   +G+G F +V              K+ R +   RE A+  ID        LQ+L 
Sbjct: 17  YRLQKTIGKGNFAKV--------------KLARHVLTGREVAVKIIDKTQLNPTSLQKLF 62
Query: 147 RHD-----IGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELG 200
           R       +     V++    +    + +V E   G  ++D+L   ++        R   
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV--AHGRMKEKEARAKF 120
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
           RQ++ +V + H+  ++H DLK EN+LL     +K+ D+ F +              +   
Sbjct: 121 RQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEF------------TVGN 168
Query: 261 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALFQ 319
           KL  F               +  Y APE+  G  ++ P  D+WS+G IL  L SG   F 
Sbjct: 169 KLDTF-------------CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215
Query: 320 THENLEHLAMMERVL 334
             +NL+ L   ERVL
Sbjct: 216 G-QNLKELR--ERVL 227

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 33/226 (14%)
Query: 95  RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
           + L ++G+G FG V  C      +   E+VA+K ++ S  ++      EI++L+ L   +
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 103
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLG-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I   + V    +   R ++ ++ E L   SL D+L+K+  R   I L+ +   Q+ + + 
Sbjct: 104 IVKYKGV---CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQICKGME 159
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK-NLPKSSAIKLIDFGS 267
           ++   R IH DL   NIL+ +   VK+ D+       +D    K   P  S I       
Sbjct: 160 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------- 212
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                           + APE +    ++   D+WS G +L EL +
Sbjct: 213 ---------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/232 (21%), Positives = 99/232 (42%), Gaps = 45/232 (19%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-LQRLARHDIGG 152
           + ++  +GEG +G+V    +   +E VA+KIV           I+ ++ + ++  H+   
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE--- 63
Query: 153 TRCVQIRNWFDYRNHICIVFEKL----GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                +  ++ +R    I +  L    G  L+D +  +     P    +    QL+  V 
Sbjct: 64  ----NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVV 117
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H + + H D+KPEN+LL   + +K+ D+                            +T
Sbjct: 118 YLHGIGITHRDIKPENLLLDERDNLKISDFGL--------------------------AT 151
Query: 269 TFEHQDHSYVVS----TRHYRAPEVILGLGWNY-PCDLWSVGCILVELCSGE 315
            F + +   +++    T  Y APE++    ++  P D+WS G +L  + +GE
Sbjct: 152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 100/247 (40%), Gaps = 44/247 (17%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARHDIGGTR 154
           +G+G FG V    + + K ++A+K++       E A +E  +     +Q   RH      
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVL--FKTQLEKAGVEHQLRREVEIQSHLRH----PN 73
Query: 155 CVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
            +++  +F     + ++ E   LG ++Y  L+K S   F          +L  ++++ H 
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLG-TVYRELQKLS--RFDEQRTATYITELANALSYCHS 130
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFE 271
            R+IH D+KPEN+LL S                           +  +K+ DFG S    
Sbjct: 131 KRVIHRDIKPENLLLGS---------------------------NGELKIADFGWSVHAP 163
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMME 331
                 +  T  Y  PE+I G   +   DLWS+G +  E   G   F+ H   E    + 
Sbjct: 164 SSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRIS 223
Query: 332 RVLGPLP 338
           RV    P
Sbjct: 224 RVEFTFP 230

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 33/226 (14%)
Query: 95  RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
           + L ++G+G FG V  C      +   E+VA+K ++ S  ++      EI++L+ L   +
Sbjct: 31  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 90
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLG-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I   + V    +   R ++ ++ E L   SL D+L+K+  R   I L+ +   Q+ + + 
Sbjct: 91  IVKYKGV---CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQICKGME 146
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK-NLPKSSAIKLIDFGS 267
           ++   R IH DL   NIL+ +   VK+ D+       +D    K   P  S I       
Sbjct: 147 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------- 199
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                           + APE +    ++   D+WS G +L EL +
Sbjct: 200 ---------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/232 (21%), Positives = 99/232 (42%), Gaps = 45/232 (19%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-LQRLARHDIGG 152
           + ++  +GEG +G+V    +   +E VA+KIV           I+ ++ + ++  H+   
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE--- 65
Query: 153 TRCVQIRNWFDYRNHICIVFEKL----GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                +  ++ +R    I +  L    G  L+D +  +     P    +    QL+  V 
Sbjct: 66  ----NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVV 119
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H + + H D+KPEN+LL   + +K+ D+                            +T
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGL--------------------------AT 153
Query: 269 TFEHQDHSYVVS----TRHYRAPEVILGLGWNY-PCDLWSVGCILVELCSGE 315
            F + +   +++    T  Y APE++    ++  P D+WS G +L  + +GE
Sbjct: 154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/232 (21%), Positives = 99/232 (42%), Gaps = 45/232 (19%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-LQRLARHDIGG 152
           + ++  +GEG +G+V    +   +E VA+KIV           I+ ++ + ++  H+   
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE--- 64
Query: 153 TRCVQIRNWFDYRNHICIVFEKL----GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                +  ++ +R    I +  L    G  L+D +  +     P    +    QL+  V 
Sbjct: 65  ----NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVV 118
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H + + H D+KPEN+LL   + +K+ D+                            +T
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGL--------------------------AT 152
Query: 269 TFEHQDHSYVVS----TRHYRAPEVILGLGWNY-PCDLWSVGCILVELCSGE 315
            F + +   +++    T  Y APE++    ++  P D+WS G +L  + +GE
Sbjct: 153 VFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 33/226 (14%)
Query: 95  RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
           + L ++G+G FG V  C      +   E+VA+K ++ S  ++      EI++L+ L   +
Sbjct: 16  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLG-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I   + V    +   R ++ ++ E L   SL D+L+K+  R   I L+ +   Q+ + + 
Sbjct: 76  IVKYKGV---CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQICKGME 131
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK-NLPKSSAIKLIDFGS 267
           ++   R IH DL   NIL+ +   VK+ D+       +D    K   P  S I       
Sbjct: 132 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------- 184
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                           + APE +    ++   D+WS G +L EL +
Sbjct: 185 ---------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/259 (22%), Positives = 109/259 (42%), Gaps = 44/259 (16%)
Query: 86  IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR----EAAMIEIDV 141
           +GE+    +R+L   G G FG+V  C      +L A K +      +    + AM+E  +
Sbjct: 182 MGEDWFLDFRVL---GRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI 238
Query: 142 LQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPS-----LYDFLRKNSYRSFPIDLV 196
           L ++    I     V +   F+ +  +C+V   +        +Y+    N     P  + 
Sbjct: 239 LAKVHSRFI-----VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256
                Q++  +  +H+  +I+ DLKPEN+LL     V++ D                   
Sbjct: 294 YTA--QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL---------------- 335
Query: 257 SSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 316
             A++L    + T  +        T  + APE++LG  +++  D +++G  L E+ +   
Sbjct: 336 --AVELKAGQTKTKGY------AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387
Query: 317 LFQTH-ENLEHLAMMERVL 334
            F+   E +E+  + +RVL
Sbjct: 388 PFRARGEKVENKELKQRVL 406

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 33/226 (14%)
Query: 95  RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
           + L ++G+G FG V  C      +   E+VA+K ++ S  ++      EI++L+ L   +
Sbjct: 19  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 78
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLG-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I   + V    +   R ++ ++ E L   SL D+L+K+  R   I L+ +   Q+ + + 
Sbjct: 79  IVKYKGV---CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQICKGME 134
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK-NLPKSSAIKLIDFGS 267
           ++   R IH DL   NIL+ +   VK+ D+       +D    K   P  S I       
Sbjct: 135 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------- 187
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                           + APE +    ++   D+WS G +L EL +
Sbjct: 188 ---------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 33/226 (14%)
Query: 95  RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
           + L ++G+G FG V  C      +   E+VA+K ++ S  ++      EI++L+ L   +
Sbjct: 31  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 90
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLG-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I   + V    +   R ++ ++ E L   SL D+L+K+  R   I L+ +   Q+ + + 
Sbjct: 91  IVKYKGV---CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQICKGME 146
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK-NLPKSSAIKLIDFGS 267
           ++   R IH DL   NIL+ +   VK+ D+       +D    K   P  S I       
Sbjct: 147 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------- 199
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                           + APE +    ++   D+WS G +L EL +
Sbjct: 200 ---------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 33/226 (14%)
Query: 95  RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
           + L ++G+G FG V  C      +   E+VA+K ++ S  ++      EI++L+ L   +
Sbjct: 20  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 79
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLG-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I   + V    +   R ++ ++ E L   SL D+L+K+  R   I L+ +   Q+ + + 
Sbjct: 80  IVKYKGV---CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQICKGME 135
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK-NLPKSSAIKLIDFGS 267
           ++   R IH DL   NIL+ +   VK+ D+       +D    K   P  S I       
Sbjct: 136 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------- 188
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                           + APE +    ++   D+WS G +L EL +
Sbjct: 189 ---------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 33/226 (14%)
Query: 95  RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
           + L ++G+G FG V  C      +   E+VA+K ++ S  ++      EI++L+ L   +
Sbjct: 17  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 76
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLG-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I   + V    +   R ++ ++ E L   SL D+L+K+  R   I L+ +   Q+ + + 
Sbjct: 77  IVKYKGV---CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQICKGME 132
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK-NLPKSSAIKLIDFGS 267
           ++   R IH DL   NIL+ +   VK+ D+       +D    K   P  S I       
Sbjct: 133 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------- 185
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                           + APE +    ++   D+WS G +L EL +
Sbjct: 186 ---------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 33/226 (14%)
Query: 95  RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
           + L ++G+G FG V  C      +   E+VA+K ++ S  ++      EI++L+ L   +
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLG-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I   + V    +   R ++ ++ E L   SL D+L+K+  R   I L+ +   Q+ + + 
Sbjct: 73  IVKYKGV---CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQICKGME 128
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK-NLPKSSAIKLIDFGS 267
           ++   R IH DL   NIL+ +   VK+ D+       +D    K   P  S I       
Sbjct: 129 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------- 181
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                           + APE +    ++   D+WS G +L EL +
Sbjct: 182 ---------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/232 (21%), Positives = 99/232 (42%), Gaps = 45/232 (19%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-LQRLARHDIGG 152
           + ++  +GEG +G+V    +   +E VA+KIV           I+ ++ + ++  H+   
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE--- 64
Query: 153 TRCVQIRNWFDYRNHICIVFEKL----GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                +  ++ +R    I +  L    G  L+D +  +     P    +    QL+  V 
Sbjct: 65  ----NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVV 118
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H + + H D+KPEN+LL   + +K+ D+                            +T
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGL--------------------------AT 152
Query: 269 TFEHQDHSYVVS----TRHYRAPEVILGLGWNY-PCDLWSVGCILVELCSGE 315
            F + +   +++    T  Y APE++    ++  P D+WS G +L  + +GE
Sbjct: 153 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 33/226 (14%)
Query: 95  RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
           + L ++G+G FG V  C      +   E+VA+K ++ S  ++      EI++L+ L   +
Sbjct: 11  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 70
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLG-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I   + V    +   R ++ ++ E L   SL D+L+K+  R   I L+ +   Q+ + + 
Sbjct: 71  IVKYKGV---CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQICKGME 126
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK-NLPKSSAIKLIDFGS 267
           ++   R IH DL   NIL+ +   VK+ D+       +D    K   P  S I       
Sbjct: 127 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------- 179
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                           + APE +    ++   D+WS G +L EL +
Sbjct: 180 ---------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/259 (22%), Positives = 109/259 (42%), Gaps = 44/259 (16%)
Query: 86  IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR----EAAMIEIDV 141
           +GE+    +R+L   G G FG+V  C      +L A K +      +    + AM+E  +
Sbjct: 182 MGEDWFLDFRVL---GRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI 238
Query: 142 LQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPS-----LYDFLRKNSYRSFPIDLV 196
           L ++    I     V +   F+ +  +C+V   +        +Y+    N     P  + 
Sbjct: 239 LAKVHSRFI-----VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256
                Q++  +  +H+  +I+ DLKPEN+LL     V++ D                   
Sbjct: 294 YTA--QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL---------------- 335
Query: 257 SSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 316
             A++L    + T  +        T  + APE++LG  +++  D +++G  L E+ +   
Sbjct: 336 --AVELKAGQTKTKGY------AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387
Query: 317 LFQTH-ENLEHLAMMERVL 334
            F+   E +E+  + +RVL
Sbjct: 388 PFRARGEKVENKELKQRVL 406

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/262 (22%), Positives = 113/262 (43%), Gaps = 48/262 (18%)
Query: 66  PRTGSPPWRPDDKDGHYVFAIG--------ENLTPRYRILSKMGEGTFGQVVECFDNEKK 117
           P+T S P  P D D     +IG        ++L P    + ++G G +G V +       
Sbjct: 23  PQTSSTP--PRDLDSKACISIGNQNFEVKADDLEP----IMELGRGAYGVVEKMRHVPSG 76
Query: 118 ELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP 177
           +++A+K +R+    +E   + +D+   ++   +     V           + I  E +  
Sbjct: 77  QIMAVKRIRATVNSQEQKRLLMDL--DISMRTVDCPFTVTFYGALFREGDVWICMELMDT 134
Query: 178 SLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLVSAEYVK 234
           SL  F ++  +  ++ P D++ ++   +++++  +H +L +IH D+KP N+L+ +   VK
Sbjct: 135 SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVK 194
Query: 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVI---- 290
           + D+           Y  +    S  K ID G               + Y APE I    
Sbjct: 195 MCDFGI-------SGYLVD----SVAKTIDAG--------------CKPYMAPERINPEL 229
Query: 291 LGLGWNYPCDLWSVGCILVELC 312
              G++   D+WS+G  ++EL 
Sbjct: 230 NQKGYSVKSDIWSLGITMIELA 251

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 33/226 (14%)
Query: 95  RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
           + L ++G+G FG V  C      +   E+VA+K ++ S  ++      EI++L+ L   +
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLG-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I   + V    +   R ++ ++ E L   SL D+L+K+  R   I L+ +   Q+ + + 
Sbjct: 73  IVKYKGV---CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQICKGME 128
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK-NLPKSSAIKLIDFGS 267
           ++   R IH DL   NIL+ +   VK+ D+       +D    K   P  S I       
Sbjct: 129 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------- 181
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                           + APE +    ++   D+WS G +L EL +
Sbjct: 182 ---------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 33/226 (14%)
Query: 95  RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
           + L ++G+G FG V  C      +   E+VA+K ++ S  ++      EI++L+ L   +
Sbjct: 18  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 77
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLG-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I   + V    +   R ++ ++ E L   SL D+L+K+  R   I L+ +   Q+ + + 
Sbjct: 78  IVKYKGV---CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQICKGME 133
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK-NLPKSSAIKLIDFGS 267
           ++   R IH DL   NIL+ +   VK+ D+       +D    K   P  S I       
Sbjct: 134 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------- 186
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                           + APE +    ++   D+WS G +L EL +
Sbjct: 187 ---------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/232 (21%), Positives = 99/232 (42%), Gaps = 45/232 (19%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-LQRLARHDIGG 152
           + ++  +GEG +G+V    +   +E VA+KIV           I+ ++ + ++  H+   
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE--- 64
Query: 153 TRCVQIRNWFDYRNHICIVFEKL----GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                +  ++ +R    I +  L    G  L+D +  +     P    +    QL+  V 
Sbjct: 65  ----NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVV 118
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H + + H D+KPEN+LL   + +K+ D+                            +T
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGL--------------------------AT 152
Query: 269 TFEHQDHSYVVS----TRHYRAPEVILGLGWNY-PCDLWSVGCILVELCSGE 315
            F + +   +++    T  Y APE++    ++  P D+WS G +L  + +GE
Sbjct: 153 VFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 33/226 (14%)
Query: 95  RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
           + L ++G+G FG V  C      +   E+VA+K ++ S  ++      EI++L+ L   +
Sbjct: 12  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 71
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLG-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I   + V    +   R ++ ++ E L   SL D+L+K+  R   I L+ +   Q+ + + 
Sbjct: 72  IVKYKGV---CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQICKGME 127
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK-NLPKSSAIKLIDFGS 267
           ++   R IH DL   NIL+ +   VK+ D+       +D    K   P  S I       
Sbjct: 128 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------- 180
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                           + APE +    ++   D+WS G +L EL +
Sbjct: 181 ---------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/259 (22%), Positives = 109/259 (42%), Gaps = 44/259 (16%)
Query: 86  IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR----EAAMIEIDV 141
           +GE+    +R+L   G G FG+V  C      +L A K +      +    + AM+E  +
Sbjct: 182 MGEDWFLDFRVL---GRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI 238
Query: 142 LQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPS-----LYDFLRKNSYRSFPIDLV 196
           L ++    I     V +   F+ +  +C+V   +        +Y+    N     P  + 
Sbjct: 239 LAKVHSRFI-----VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256
                Q++  +  +H+  +I+ DLKPEN+LL     V++ D                   
Sbjct: 294 YTA--QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL---------------- 335
Query: 257 SSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 316
             A++L    + T  +        T  + APE++LG  +++  D +++G  L E+ +   
Sbjct: 336 --AVELKAGQTKTKGY------AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387
Query: 317 LFQTH-ENLEHLAMMERVL 334
            F+   E +E+  + +RVL
Sbjct: 388 PFRARGEKVENKELKQRVL 406

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/259 (22%), Positives = 109/259 (42%), Gaps = 44/259 (16%)
Query: 86  IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR----EAAMIEIDV 141
           +GE+    +R+L   G G FG+V  C      +L A K +      +    + AM+E  +
Sbjct: 182 MGEDWFLDFRVL---GRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI 238
Query: 142 LQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPS-----LYDFLRKNSYRSFPIDLV 196
           L ++    I     V +   F+ +  +C+V   +        +Y+    N     P  + 
Sbjct: 239 LAKVHSRFI-----VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256
                Q++  +  +H+  +I+ DLKPEN+LL     V++ D                   
Sbjct: 294 YTA--QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL---------------- 335
Query: 257 SSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 316
             A++L    + T  +        T  + APE++LG  +++  D +++G  L E+ +   
Sbjct: 336 --AVELKAGQTKTKGY------AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387
Query: 317 LFQTH-ENLEHLAMMERVL 334
            F+   E +E+  + +RVL
Sbjct: 388 PFRARGEKVENKELKQRVL 406

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/232 (21%), Positives = 99/232 (42%), Gaps = 45/232 (19%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-LQRLARHDIGG 152
           + ++  +GEG +G+V    +   +E VA+KIV           I+ ++ + ++  H+   
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE--- 64
Query: 153 TRCVQIRNWFDYRNHICIVFEKL----GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                +  ++ +R    I +  L    G  L+D +  +     P    +    QL+  V 
Sbjct: 65  ----NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVV 118
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H + + H D+KPEN+LL   + +K+ D+                            +T
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGL--------------------------AT 152
Query: 269 TFEHQDHSYVVS----TRHYRAPEVILGLGWNY-PCDLWSVGCILVELCSGE 315
            F + +   +++    T  Y APE++    ++  P D+WS G +L  + +GE
Sbjct: 153 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/232 (21%), Positives = 99/232 (42%), Gaps = 45/232 (19%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-LQRLARHDIGG 152
           + ++  +GEG +G+V    +   +E VA+KIV           I+ ++ + ++  H+   
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE--- 65
Query: 153 TRCVQIRNWFDYRNHICIVFEKL----GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                +  ++ +R    I +  L    G  L+D +  +     P    +    QL+  V 
Sbjct: 66  ----NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVV 119
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H + + H D+KPEN+LL   + +K+ D+                            +T
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGL--------------------------AT 153
Query: 269 TFEHQDHSYVVS----TRHYRAPEVILGLGWNY-PCDLWSVGCILVELCSGE 315
            F + +   +++    T  Y APE++    ++  P D+WS G +L  + +GE
Sbjct: 154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/232 (21%), Positives = 99/232 (42%), Gaps = 45/232 (19%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-LQRLARHDIGG 152
           + ++  +GEG +G+V    +   +E VA+KIV           I+ ++ + ++  H+   
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE--- 64
Query: 153 TRCVQIRNWFDYRNHICIVFEKL----GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                +  ++ +R    I +  L    G  L+D +  +     P    +    QL+  V 
Sbjct: 65  ----NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVV 118
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H + + H D+KPEN+LL   + +K+ D+                            +T
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGL--------------------------AT 152
Query: 269 TFEHQDHSYVVS----TRHYRAPEVILGLGWNY-PCDLWSVGCILVELCSGE 315
            F + +   +++    T  Y APE++    ++  P D+WS G +L  + +GE
Sbjct: 153 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 95/233 (40%), Gaps = 42/233 (18%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA----MIEIDVLQRLARHDIGGTRC 155
           +G+G FG V    + + K ++A+K++      +E        EI++   L   +I     
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNI----- 77
Query: 156 VQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
           +++ N+F  R  I ++ E   P   LY  L+K+    F          +L +++ + HE 
Sbjct: 78  LRMYNYFHDRKRIYLMLE-FAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHER 134
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEH 272
           ++IH D+KPEN+L+          YK                    +K+ DFG S     
Sbjct: 135 KVIHRDIKPENLLM---------GYK------------------GELKIADFGWSVHAPS 167
Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
                +  T  Y  PE+I G   +   DLW  G +  E   G   F +  + E
Sbjct: 168 LRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 220

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 99/238 (41%), Gaps = 37/238 (15%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHD 149
           +  L  +G+G+FG+V+       +EL AIKI++      +   E  M+E  VL  L +  
Sbjct: 21  FNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPP 80
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
                  Q+ + F   + +  V E +  G  +Y   +   ++  P  +      ++   +
Sbjct: 81  F----LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKE-PQAVF--YAAEISIGL 133
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
            F+H+  +I+ DLK +N++L S  ++K+ D+        D                  G 
Sbjct: 134 FFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMD------------------GV 175
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
           TT E         T  Y APE+I    +    D W+ G +L E+ +G+  F   +  E
Sbjct: 176 TTRE------FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 227

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 94/239 (39%), Gaps = 47/239 (19%)
Query: 100 MGEGTFGQVVEC--FDNEKKELV---AIKIVRSINKY--REAAMIEIDVLQRLARHD--- 149
           +G G FG+VVE   F   K++ V   A+K+++S      +EA M E+ ++  L +H+   
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 150 ------IGGTRCVQIRNWFDYRNHICIVFEK----LGPSLY-----DFLRKNSYRSFPID 194
                   G   + I  +  Y + +  +  K    LGPSL      + L K   R   + 
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELR 158
Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254
            +     Q+ + +AF+     IH D+   N+LL +    K+ D+        D +Y    
Sbjct: 159 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 218
Query: 255 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                +K                      + APE I    +    D+WS G +L E+ S
Sbjct: 219 NARLPVK----------------------WMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/232 (21%), Positives = 99/232 (42%), Gaps = 45/232 (19%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-LQRLARHDIGG 152
           + ++  +GEG +G+V    +   +E VA+KIV           I+ ++ + ++  H+   
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE--- 64
Query: 153 TRCVQIRNWFDYRNHICIVFEKL----GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                +  ++ +R    I +  L    G  L+D +  +     P    +    QL+  V 
Sbjct: 65  ----NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVV 118
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H + + H D+KPEN+LL   + +K+ D+                            +T
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGL--------------------------AT 152
Query: 269 TFEHQDHSYVVS----TRHYRAPEVILGLGWNY-PCDLWSVGCILVELCSGE 315
            F + +   +++    T  Y APE++    ++  P D+WS G +L  + +GE
Sbjct: 153 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 121/289 (41%), Gaps = 46/289 (15%)
Query: 100 MGEGTFGQVVEC-FDNE---KKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDIGGT 153
           +GEG FG+V  C +D E     E VA+K ++  +     A +  EI++L+ L   +I   
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL--GRQLLESVAFM 210
           + +      D  N I ++ E L   SL ++L KN  +   I+L ++L    Q+ + + ++
Sbjct: 89  KGICTE---DGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYL 142
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
              + +H DL   N+L+ S   VK+ D+                  + AI+      T  
Sbjct: 143 GSRQYVHRDLAARNVLVESEHQVKIGDFGL----------------TKAIETDKEXXTVK 186
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330
           + +D     S   + APE ++   +    D+WS G  L EL     L     +   +A+ 
Sbjct: 187 DDRD-----SPVFWYAPECLMQSKFYIASDVWSFGVTLHEL-----LTYCDSDSSPMALF 236
Query: 331 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR--DSMRAVWKL 377
            +++GP    M +    R     + G RL  P          MR  W+ 
Sbjct: 237 LKMIGPTHGQMTV---TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEF 282

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/232 (21%), Positives = 99/232 (42%), Gaps = 45/232 (19%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-LQRLARHDIGG 152
           + ++  +GEG +G+V    +   +E VA+KIV           I+ ++ + ++  H+   
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE--- 64
Query: 153 TRCVQIRNWFDYRNHICIVFEKL----GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                +  ++ +R    I +  L    G  L+D +  +     P    +    QL+  V 
Sbjct: 65  ----NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVV 118
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H + + H D+KPEN+LL   + +K+ D+                            +T
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGL--------------------------AT 152
Query: 269 TFEHQDHSYVVS----TRHYRAPEVILGLGWNY-PCDLWSVGCILVELCSGE 315
            F + +   +++    T  Y APE++    ++  P D+WS G +L  + +GE
Sbjct: 153 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/232 (21%), Positives = 99/232 (42%), Gaps = 45/232 (19%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-LQRLARHDIGG 152
           + ++  +GEG +G+V    +   +E VA+KIV           I+ ++ + ++  H+   
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE--- 64
Query: 153 TRCVQIRNWFDYRNHICIVFEKL----GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                +  ++ +R    I +  L    G  L+D +  +     P    +    QL+  V 
Sbjct: 65  ----NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVV 118
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H + + H D+KPEN+LL   + +K+ D+                            +T
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGL--------------------------AT 152
Query: 269 TFEHQDHSYVVS----TRHYRAPEVILGLGWNY-PCDLWSVGCILVELCSGE 315
            F + +   +++    T  Y APE++    ++  P D+WS G +L  + +GE
Sbjct: 153 VFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 32/221 (14%)
Query: 95  RILSKMGEGTFGQV-VECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           +++ K+G G FG+V +  ++N  K  VA+K ++      +A + E ++++ L +HD    
Sbjct: 15  KLVKKLGAGQFGEVWMGYYNNSTK--VAVKTLKPGTMSVQAFLEEANLMKTL-QHD---- 67
Query: 154 RCVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
           + V++         I I+ E +   SL DFL+ +      +  + +   Q+ E +A++  
Sbjct: 68  KLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER 127
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
              IH DL+  N+L+  +   K+ D+  L+R  +D  Y         IK           
Sbjct: 128 KNYIHRDLRAANVLVSESLMCKIADFG-LARVIEDNEYTAREGAKFPIK----------- 175
Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                      + APE I    +    ++WS G +L E+ +
Sbjct: 176 -----------WTAPEAINFGCFTIKSNVWSFGILLYEIVT 205

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 96/224 (42%), Gaps = 35/224 (15%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIG 151
           +  +S++G G  G V +        ++A K++    K   R   + E+ VL     H+  
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL-----HECN 62
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
               V     F     I I  E +     D + K + R  P  ++ ++   +++ + ++ 
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLR 121
Query: 212 EL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           E  +++H D+KP NIL+ S   +K+ D+                    + +LID  + +F
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGV------------------SGQLIDSMANSF 163
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                   V TR Y +PE + G  ++   D+WS+G  LVE+  G
Sbjct: 164 --------VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 121/289 (41%), Gaps = 46/289 (15%)
Query: 100 MGEGTFGQVVEC-FDNE---KKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDIGGT 153
           +GEG FG+V  C +D E     E VA+K ++  +     A +  EI++L+ L   +I   
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL--GRQLLESVAFM 210
           + +      D  N I ++ E L   SL ++L KN  +   I+L ++L    Q+ + + ++
Sbjct: 77  KGICTE---DGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYL 130
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
              + +H DL   N+L+ S   VK+ D+                  + AI+      T  
Sbjct: 131 GSRQYVHRDLAARNVLVESEHQVKIGDFGL----------------TKAIETDKEXXTVK 174
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330
           + +D     S   + APE ++   +    D+WS G  L EL     L     +   +A+ 
Sbjct: 175 DDRD-----SPVFWYAPECLMQSKFYIASDVWSFGVTLHEL-----LTYCDSDSSPMALF 224
Query: 331 ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR--DSMRAVWKL 377
            +++GP    M +    R     + G RL  P          MR  W+ 
Sbjct: 225 LKMIGPTHGQMTV---TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEF 270

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 98/238 (41%), Gaps = 37/238 (15%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           ++G G+FG V +   +    +  + +     +  +A   E+ VL++        TR V I
Sbjct: 31  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK--------TRHVNI 82
Query: 159 RNWFDYRN--HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
             +  Y     + IV +   G SLY  L  +  + F +  + ++ RQ    + ++H   +
Sbjct: 83  LLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLHAKSI 141
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           IH DLK  NI L     VK+ D+   +  S+                   GS  FE    
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS-----------------GSHQFEQLSG 184
Query: 276 SYVVSTRHYRAPEVILGLGWN---YPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330
           S +     + APEVI     N   +  D+++ G +L EL +G+  +    N + +  M
Sbjct: 185 SIL-----WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM 237

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 93/234 (39%), Gaps = 50/234 (21%)
Query: 100 MGEGTFGQVVEC--FDNEKKELV---AIKIVRSINKY--REAAMIEIDVLQRLARHDIGG 152
           +G G FG+VVE   F   K++ V   A+K+++S      +EA M E+ ++  L +H+   
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE--- 102
Query: 153 TRCVQIRNWFDYRNHICIVFEKLG-PSLYDFLRKNSYRSFPIDLVRELGR---------- 201
              V +     +   + ++ E      L +FLR    R    DL +E GR          
Sbjct: 103 -NIVNLLGACTHGGPVLVITEYCCYGDLLNFLR----RKAEADLDKEDGRPLELRDLLHF 157
Query: 202 --QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
             Q+ + +AF+     IH D+   N+LL +    K+ D+        D +Y         
Sbjct: 158 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 217
Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
           +K                      + APE I    +    D+WS G +L E+ S
Sbjct: 218 VK----------------------WMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 96/224 (42%), Gaps = 35/224 (15%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIG 151
           +  +S++G G  G V +        ++A K++    K   R   + E+ VL     H+  
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL-----HECN 62
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
               V     F     I I  E +     D + K + R  P  ++ ++   +++ + ++ 
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLR 121
Query: 212 EL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           E  +++H D+KP NIL+ S   +K+ D+                    + +LID  + +F
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGV------------------SGQLIDSMANSF 163
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                   V TR Y +PE + G  ++   D+WS+G  LVE+  G
Sbjct: 164 --------VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 96/224 (42%), Gaps = 35/224 (15%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIG 151
           +  +S++G G  G V +        ++A K++    K   R   + E+ VL     H+  
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL-----HECN 62
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
               V     F     I I  E +     D + K + R  P  ++ ++   +++ + ++ 
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLR 121
Query: 212 EL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           E  +++H D+KP NIL+ S   +K+ D+                    + +LID  + +F
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGV------------------SGQLIDSMANSF 163
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                   V TR Y +PE + G  ++   D+WS+G  LVE+  G
Sbjct: 164 --------VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 93/234 (39%), Gaps = 50/234 (21%)
Query: 100 MGEGTFGQVVEC--FDNEKKELV---AIKIVRSINKY--REAAMIEIDVLQRLARHDIGG 152
           +G G FG+VVE   F   K++ V   A+K+++S      +EA M E+ ++  L +H+   
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE--- 110
Query: 153 TRCVQIRNWFDYRNHICIVFEKLG-PSLYDFLRKNSYRSFPIDLVRELGR---------- 201
              V +     +   + ++ E      L +FLR    R    DL +E GR          
Sbjct: 111 -NIVNLLGACTHGGPVLVITEYCCYGDLLNFLR----RKAEADLDKEDGRPLELRDLLHF 165
Query: 202 --QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
             Q+ + +AF+     IH D+   N+LL +    K+ D+        D +Y         
Sbjct: 166 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 225
Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
           +K                      + APE I    +    D+WS G +L E+ S
Sbjct: 226 VK----------------------WMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 99/238 (41%), Gaps = 37/238 (15%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           ++G G+FG V +   +    +  + +     +  +A   E+ VL++        TR V I
Sbjct: 31  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK--------TRHVNI 82
Query: 159 RNWFDY--RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
             +  Y  +  + IV +   G SLY  L  +  + F +  + ++ RQ    + ++H   +
Sbjct: 83  LLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLHAKSI 141
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           IH DLK  NI L     VK+ D+   +  S+                   GS  FE    
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS-----------------GSHQFEQLSG 184
Query: 276 SYVVSTRHYRAPEVILGLGWN---YPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330
           S +     + APEVI     N   +  D+++ G +L EL +G+  +    N + +  M
Sbjct: 185 SIL-----WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM 237

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 96/224 (42%), Gaps = 35/224 (15%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIG 151
           +  +S++G G  G V +        ++A K++    K   R   + E+ VL     H+  
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL-----HECN 62
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
               V     F     I I  E +     D + K + R  P  ++ ++   +++ + ++ 
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLR 121
Query: 212 EL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           E  +++H D+KP NIL+ S   +K+ D+                    + +LID  + +F
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGV------------------SGQLIDSMANSF 163
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                   V TR Y +PE + G  ++   D+WS+G  LVE+  G
Sbjct: 164 --------VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 96/224 (42%), Gaps = 35/224 (15%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIG 151
           +  +S++G G  G V +        ++A K++    K   R   + E+ VL     H+  
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL-----HECN 62
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
               V     F     I I  E +     D + K + R  P  ++ ++   +++ + ++ 
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLR 121
Query: 212 EL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           E  +++H D+KP NIL+ S   +K+ D+                    + +LID  + +F
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGV------------------SGQLIDSMANSF 163
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                   V TR Y +PE + G  ++   D+WS+G  LVE+  G
Sbjct: 164 --------VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 109/253 (43%), Gaps = 41/253 (16%)
Query: 85  AIGENLTPR-----YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAA 135
            IG N + R     +  +  +G+G+FG+V+     E  +L A+K+++      +   E  
Sbjct: 11  GIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECT 70
Query: 136 MIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPID 194
           M E  +L     H        Q+   F   + +  V E + G  L   ++K+  R F   
Sbjct: 71  MTEKRILSLARNHPF----LTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEA 124
Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254
             R    +++ ++ F+H+  +I+ DLK +N+LL    + K+ D+       K+G      
Sbjct: 125 RARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGM----CKEG------ 174
Query: 255 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                   I  G TT      +    T  Y APE++  + +    D W++G +L E+  G
Sbjct: 175 --------ICNGVTT------ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220
Query: 315 EALFQTHENLEHL 327
            A F+  EN + L
Sbjct: 221 HAPFEA-ENEDDL 232

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/252 (23%), Positives = 104/252 (41%), Gaps = 42/252 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-----LQRLARH 148
           + I   +G+G FG V    +   K ++A+K++       E A +E  +     +Q   RH
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKNSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
                  +++  +F     + ++ E   LG ++Y  L+K S   F          +L  +
Sbjct: 68  ----PNILRLYGYFHDSTRVYLILEYAPLG-TVYRELQKLS--KFDEQRTATYITELANA 120
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  ++IH D+KPEN+LL SA  +K+ D+           +  + P S    L    
Sbjct: 121 LSYCHSKKVIHRDIKPENLLLGSAGELKIADF----------GWSVHAPSSRRAAL---- 166
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                         T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   + 
Sbjct: 167 ------------CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDT 214
Query: 327 LAMMERVLGPLP 338
              + RV    P
Sbjct: 215 YKRISRVEFTFP 226

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 90/225 (40%), Gaps = 46/225 (20%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           ++G G+FG+V    D +     A+K VR +  +R        V + +A   +   R V +
Sbjct: 79  RLGRGSFGEVHRMKDKQTGFQCAVKKVR-LEVFR--------VEELVACAGLSSPRIVPL 129
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
                    + I  E L G SL   +++      P D       Q LE + ++H  R++H
Sbjct: 130 YGAVREGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILH 187
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-- 275
            D+K +N+LL                 S DGS            L DFG       D   
Sbjct: 188 GDVKADNVLL-----------------SSDGSR---------AALCDFGHALCLQPDGLG 221
Query: 276 ------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                  Y+  T  + APEV++G   +   D+WS  C+++ + +G
Sbjct: 222 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 84/192 (43%), Gaps = 30/192 (15%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+G G FG +   F   K E  A  +V+   +       E+   QR+A+ D     C++ 
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKD-----CIKK 98
Query: 159 ---RNWFDY----------------RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVREL 199
              R   DY                R++  +V E+LG  L     +N   +F    V +L
Sbjct: 99  WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG--TFKKSTVLQL 156
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILL--VSAEYVKVPDYKFLSRSSKDGSY--FKNLP 255
           G ++L+ + ++HE   +H D+K  N+LL   + + V + DY    R   +G++  ++  P
Sbjct: 157 GIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENP 216
Query: 256 KSSAIKLIDFGS 267
           +      I+F S
Sbjct: 217 RKGHNGTIEFTS 228

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 108/252 (42%), Gaps = 43/252 (17%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVR-----SINKYREAAMIEIDVLQRLARHDIGGTR 154
           +G G FG+V   F     + VA+K  R      I++  E    E  +   L   +I   R
Sbjct: 15  IGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 155 CVQIRNWFDYRNHICIV--FEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
            V ++       ++C+V  F + GP      R  S +  P D++     Q+   + ++H+
Sbjct: 73  GVCLK-----EPNLCLVMEFARGGP----LNRVLSGKRIPPDILVNWAVQIARGMNYLHD 123
Query: 213 ---LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
              + +IH DLK  NIL++              +  ++G     +     +K+ DFG   
Sbjct: 124 EAIVPIIHRDLKSSNILIL--------------QKVENGDLSNKI-----LKITDFGLAR 164
Query: 270 FEHQDHSYVVSTRH-YRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL--EH 326
             H+      +  + + APEVI    ++   D+WS G +L EL +GE  F+  + L   +
Sbjct: 165 EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY 224
Query: 327 LAMMERVLGPLP 338
              M ++  P+P
Sbjct: 225 GVAMNKLALPIP 236

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/232 (21%), Positives = 98/232 (42%), Gaps = 45/232 (19%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-LQRLARHDIGG 152
           + ++  +GEG +G+V    +   +E VA+KIV           I+ ++ +  +  H+   
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE--- 65
Query: 153 TRCVQIRNWFDYRNHICIVFEKL----GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                +  ++ +R    I +  L    G  L+D +  +     P    +    QL+  V 
Sbjct: 66  ----NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVV 119
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H + + H D+KPEN+LL   + +K+ D+                            +T
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGL--------------------------AT 153
Query: 269 TFEHQDHSYVVS----TRHYRAPEVILGLGWNY-PCDLWSVGCILVELCSGE 315
            F + +   +++    T  Y APE++    ++  P D+WS G +L  + +GE
Sbjct: 154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 99/238 (41%), Gaps = 37/238 (15%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           ++G G+FG V +   +    +  + +     +  +A   E+ VL++        TR V I
Sbjct: 19  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK--------TRHVNI 70
Query: 159 RNWFDY--RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
             +  Y  +  + IV +   G SLY  L  +  + F +  + ++ RQ    + ++H   +
Sbjct: 71  LLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLHAKSI 129
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           IH DLK  NI L     VK+ D+   +  S+                   GS  FE    
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWS-----------------GSHQFEQLSG 172
Query: 276 SYVVSTRHYRAPEVILGLGWN---YPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330
           S +     + APEVI     N   +  D+++ G +L EL +G+  +    N + +  M
Sbjct: 173 SIL-----WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM 225

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 99/226 (43%), Gaps = 33/226 (14%)
Query: 95  RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
           + L ++G+G FG V  C      +   E+VA+K ++ S  ++      EI++L+ L   +
Sbjct: 16  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLG-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I   + V    +   R ++ ++ E L   SL D+L+ ++ R   I L+ +   Q+ + + 
Sbjct: 76  IVKYKGV---CYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLL-QYTSQICKGME 131
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK-NLPKSSAIKLIDFGS 267
           ++   R IH DL   NIL+ +   VK+ D+       +D    K   P  S I       
Sbjct: 132 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------- 184
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                           + APE +    ++   D+WS G +L EL +
Sbjct: 185 ---------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 90/225 (40%), Gaps = 46/225 (20%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           ++G G+FG+V    D +     A+K VR +  +R        V + +A   +   R V +
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVR-LEVFR--------VEELVACAGLSSPRIVPL 115
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
                    + I  E L G SL   +++      P D       Q LE + ++H  R++H
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILH 173
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-- 275
            D+K +N+LL                 S DGS            L DFG       D   
Sbjct: 174 GDVKADNVLL-----------------SSDGSR---------AALCDFGHALCLQPDGLG 207
Query: 276 ------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                  Y+  T  + APEV++G   +   D+WS  C+++ + +G
Sbjct: 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 90/225 (40%), Gaps = 46/225 (20%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           ++G G+FG+V    D +     A+K VR +  +R        V + +A   +   R V +
Sbjct: 81  RVGRGSFGEVHRMKDKQTGFQCAVKKVR-LEVFR--------VEELVACAGLSSPRIVPL 131
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
                    + I  E L G SL   +++      P D       Q LE + ++H  R++H
Sbjct: 132 YGAVREGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILH 189
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-- 275
            D+K +N+LL                 S DGS            L DFG       D   
Sbjct: 190 GDVKADNVLL-----------------SSDGSR---------AALCDFGHALCLQPDGLG 223
Query: 276 ------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                  Y+  T  + APEV++G   +   D+WS  C+++ + +G
Sbjct: 224 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 12/137 (8%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           Y++  ++GEG+FG + E  +    + VAIK      + R +   ++    R  +   G  
Sbjct: 11  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-----EPRRSDAPQLRDEYRTYKLLAG-- 63
Query: 154 RCVQIRNWFDYRN---HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
            C  I N + +     H  +V + LGPSL D L     R F +  V    +Q+L  V  +
Sbjct: 64  -CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSI 121
Query: 211 HELRLIHTDLKPENILL 227
           HE  L++ D+KP+N L+
Sbjct: 122 HEKSLVYRDIKPDNFLI 138

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/232 (21%), Positives = 98/232 (42%), Gaps = 45/232 (19%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDV-LQRLARHDIGG 152
           + ++  +GEG  G+V    +   +E VA+KIV           I+ ++ + ++  H+   
Sbjct: 8   WDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE--- 64
Query: 153 TRCVQIRNWFDYRNHICIVFEKL----GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                +  ++ +R    I +  L    G  L+D +  +     P    +    QL+  V 
Sbjct: 65  ----NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVV 118
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H + + H D+KPEN+LL   + +K+ D+                            +T
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGL--------------------------AT 152
Query: 269 TFEHQDHSYVVS----TRHYRAPEVILGLGWNY-PCDLWSVGCILVELCSGE 315
            F + +   +++    T  Y APE++    ++  P D+WS G +L  + +GE
Sbjct: 153 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 99/238 (41%), Gaps = 37/238 (15%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           ++G G+FG V +   +    +  + +     +  +A   E+ VL++        TR V I
Sbjct: 43  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK--------TRHVNI 94
Query: 159 RNWFDY--RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
             +  Y  +  + IV +   G SLY  L     +   I L+ ++ RQ  + + ++H   +
Sbjct: 95  LLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKSI 153
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           IH DLK  NI L     VK+ D+   +  S+                   GS  FE    
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWS-----------------GSHQFEQLSG 196
Query: 276 SYVVSTRHYRAPEVILGLGWN---YPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330
           S +     + APEVI     N   +  D+++ G +L EL +G+  +    N + +  M
Sbjct: 197 SIL-----WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM 249

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 99/238 (41%), Gaps = 37/238 (15%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           ++G G+FG V +   +    +  + +     +  +A   E+ VL++        TR V I
Sbjct: 35  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK--------TRHVNI 86
Query: 159 RNWFDY--RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
             +  Y  +  + IV +   G SLY  L     +   I L+ ++ RQ  + + ++H   +
Sbjct: 87  LLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKSI 145
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           IH DLK  NI L     VK+ D+   +  S+                   GS  FE    
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWS-----------------GSHQFEQLSG 188
Query: 276 SYVVSTRHYRAPEVILGLGWN---YPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330
           S +     + APEVI     N   +  D+++ G +L EL +G+  +    N + +  M
Sbjct: 189 SIL-----WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM 241

>pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 12/137 (8%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           Y++  ++GEG+FG + E  +    + VAIK      + R +   ++    R  +   G  
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-----EPRRSDAPQLRDEYRTYKLLAG-- 64
Query: 154 RCVQIRNWFDYRN---HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
            C  I N + +     H  +V + LGPSL D L     R F +  V    +Q+L  V  +
Sbjct: 65  -CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSI 122
Query: 211 HELRLIHTDLKPENILL 227
           HE  L++ D+KP+N L+
Sbjct: 123 HEKSLVYRDIKPDNFLI 139

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 115/274 (41%), Gaps = 42/274 (15%)
Query: 97  LSKMGEGTFGQV-VECFD---NEKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHD 149
           +  +GEG FG+V + C+D   +   E+VA+K ++     + R     EI++L+ L   H 
Sbjct: 14  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
           +    C + +   +    + + +  LG SL D+L ++      + L     +Q+ E +A+
Sbjct: 74  VKYKGCCEDQG--EKSVQLVMEYVPLG-SLRDYLPRHCVGLAQLLL---FAQQICEGMAY 127
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
           +H    IH  L   N+LL +   VK+ D+  L+++  +G  +  + +       D  S  
Sbjct: 128 LHAQHYIHRALAARNVLLDNDRLVKIGDFG-LAKAVPEGHEYYRVRE-------DGDSPV 179
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329
           F             + APE +    + Y  D+WS G  L EL     L     N      
Sbjct: 180 F-------------WYAPECLKECKFYYASDVWSFGVTLYEL-----LTYCDSNQSPHTK 221
Query: 330 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPD 363
              ++G     M +    R  +   RG RL  PD
Sbjct: 222 FTELIGHTQGQMTV---LRLTELLERGERLPRPD 252

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 99/238 (41%), Gaps = 37/238 (15%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           ++G G+FG V +   +    +  + +     +  +A   E+ VL++        TR V I
Sbjct: 15  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK--------TRHVNI 66
Query: 159 RNWFDY--RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
             +  Y  +  + IV +   G SLY  L     +   I L+ ++ RQ  + + ++H   +
Sbjct: 67  LLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKSI 125
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           IH DLK  NI L     VK+ D+   +  S+                   GS  FE    
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWS-----------------GSHQFEQLSG 168
Query: 276 SYVVSTRHYRAPEVILGLGWN---YPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330
           S +     + APEVI     N   +  D+++ G +L EL +G+  +    N + +  M
Sbjct: 169 SIL-----WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM 221

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 115/274 (41%), Gaps = 42/274 (15%)
Query: 97  LSKMGEGTFGQV-VECFD---NEKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHD 149
           +  +GEG FG+V + C+D   +   E+VA+K ++     + R     EI++L+ L   H 
Sbjct: 13  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
           +    C + +   +    + + +  LG SL D+L ++      + L     +Q+ E +A+
Sbjct: 73  VKYKGCCEDQG--EKSVQLVMEYVPLG-SLRDYLPRHCVGLAQLLL---FAQQICEGMAY 126
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
           +H    IH  L   N+LL +   VK+ D+  L+++  +G  +  + +       D  S  
Sbjct: 127 LHAQHYIHRALAARNVLLDNDRLVKIGDFG-LAKAVPEGHEYYRVRE-------DGDSPV 178
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329
           F             + APE +    + Y  D+WS G  L EL     L     N      
Sbjct: 179 F-------------WYAPECLKECKFYYASDVWSFGVTLYEL-----LTYCDSNQSPHTK 220
Query: 330 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPD 363
              ++G     M +    R  +   RG RL  PD
Sbjct: 221 FTELIGHTQGQMTV---LRLTELLERGERLPRPD 251

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/246 (22%), Positives = 105/246 (42%), Gaps = 35/246 (14%)
Query: 96  ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRC 155
            L ++G G FG VV+      +  VAIK+++  +   +  + E  V+  L+       + 
Sbjct: 28  FLKELGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE-----KL 81
Query: 156 VQIRNWFDYRNHICIVFEKLGPS-LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
           VQ+      +  I I+ E +    L ++LR+  +R F    + E+ + + E++ ++   +
Sbjct: 82  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
            +H DL   N L+     VKV D+  LSR   D  Y  ++     ++             
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFG-LSRYVLDDEYTSSVGSKFPVR------------- 186
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL----FQTHENLEHLAMM 330
                    +  PEV++   ++   D+W+ G ++ E+ S   +    F   E  EH+A  
Sbjct: 187 ---------WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 237
Query: 331 ERVLGP 336
            R+  P
Sbjct: 238 LRLYRP 243

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 47/99 (47%), Gaps = 24/99 (24%)
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           ++H DLKP N+ L   + VK+ D+      + D S+ K                TF    
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK----------------TF---- 176
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
               V T +Y +PE +  + +N   D+WS+GC+L ELC+
Sbjct: 177 ----VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/280 (22%), Positives = 113/280 (40%), Gaps = 43/280 (15%)
Query: 78  KDGHYVFAIGENLTPRYRILSKMGEGTFGQV---VECFDNEKKELVAIK-IVRSINKYRE 133
           KD   ++     L+  ++I  K+GEGTF  V           +E +A+K ++ + +  R 
Sbjct: 7   KDIEKLYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRI 66
Query: 134 AAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLG-PSLYDFLRKNSYRSFP 192
           AA  E+  L      D      + ++  F   +H+ I    L   S  D L   S++   
Sbjct: 67  AA--ELQCLTVAGGQD----NVMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQE-- 118
Query: 193 IDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 252
              VRE    L +++  +H+  ++H D+KP N L       ++  Y  +      G++  
Sbjct: 119 ---VREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNR----RLKKYALVDFGLAQGTH-- 169
Query: 253 NLPKSSAIKLIDFGSTTFEH---------------QDHSYVVSTRHYRAPEVILGL-GWN 296
                + I+L+ F  +  +                Q  +    T  +RAPEV+       
Sbjct: 170 ----DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQT 225
Query: 297 YPCDLWSVGCILVELCSGE-ALFQTHENLEHLAMMERVLG 335
              D+WS G I + L SG    ++  ++L  LA +  + G
Sbjct: 226 TAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRG 265

>pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 100/242 (41%), Gaps = 40/242 (16%)
Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH 148
           ++ P +R+  K+G G FG++    +    E VAIK+   I        +E    ++L+  
Sbjct: 1   SMGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL-EPIKSRAPQLHLEYRFYKQLS-- 57
Query: 149 DIGGTRCV-QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
               T  V Q+  +     +  +V E LGPSL D       R+F +  V  +  QL+  +
Sbjct: 58  ---ATEGVPQVYYFGPXGKYNAMVLELLGPSLEDLFDLCD-RTFTLKTVLMIAIQLITRM 113
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
            ++H   LI+ D+KPEN L      V  P  K                +  AI +IDFG 
Sbjct: 114 EYVHTKSLIYRDVKPENFL------VGRPGTK----------------RQHAIHIIDFGL 151
Query: 267 ------STTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317
                   T +H   ++H  +  T  Y +    LG   +   DL ++G + +    G   
Sbjct: 152 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 211
Query: 318 FQ 319
           +Q
Sbjct: 212 WQ 213

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/239 (21%), Positives = 95/239 (39%), Gaps = 39/239 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHD 149
           +  L  +G+G+FG+V+        EL A+KI++      +   E  M+E  VL    +  
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRS-FPIDLVRELGRQLLES 206
                  Q+ + F   + +  V E +  G  +Y   +   ++    +    E+   L   
Sbjct: 403 F----LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF-- 456
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
             F+    +I+ DLK +N++L S  ++K+ D+     +  DG   K              
Sbjct: 457 --FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXF------------ 502
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
                         T  Y APE+I    +    D W+ G +L E+ +G+A F+  +  E
Sbjct: 503 ------------CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 549

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 99/226 (43%), Gaps = 33/226 (14%)
Query: 95  RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
           + L ++G+G FG V  C      +   E+VA+K ++ S  ++      EI++L+ L   +
Sbjct: 16  KFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLG-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I   + V    +   R ++ ++ E L   SL ++L+K+  R   I L+ +   Q+ + + 
Sbjct: 76  IVKYKGV---CYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLL-QYTSQICKGME 131
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK-NLPKSSAIKLIDFGS 267
           ++   R IH DL   NIL+ +   VK+ D+       +D    K   P  S I       
Sbjct: 132 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------- 184
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                           + APE +    ++   D+WS G +L EL +
Sbjct: 185 ---------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/246 (22%), Positives = 105/246 (42%), Gaps = 35/246 (14%)
Query: 96  ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRC 155
            L ++G G FG VV+      +  VAIK+++  +   +  + E  V+  L+       + 
Sbjct: 19  FLKELGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE-----KL 72
Query: 156 VQIRNWFDYRNHICIVFEKLGPS-LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
           VQ+      +  I I+ E +    L ++LR+  +R F    + E+ + + E++ ++   +
Sbjct: 73  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQ 131
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
            +H DL   N L+     VKV D+  LSR   D  Y  ++     ++             
Sbjct: 132 FLHRDLAARNCLVNDQGVVKVSDFG-LSRYVLDDEYTSSVGSKFPVR------------- 177
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL----FQTHENLEHLAMM 330
                    +  PEV++   ++   D+W+ G ++ E+ S   +    F   E  EH+A  
Sbjct: 178 ---------WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 228
Query: 331 ERVLGP 336
            R+  P
Sbjct: 229 LRLYRP 234

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/246 (22%), Positives = 105/246 (42%), Gaps = 35/246 (14%)
Query: 96  ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRC 155
            L ++G G FG VV+      +  VAIK+++  +   +  + E  V+  L+       + 
Sbjct: 13  FLKELGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE-----KL 66
Query: 156 VQIRNWFDYRNHICIVFEKLGPS-LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
           VQ+      +  I I+ E +    L ++LR+  +R F    + E+ + + E++ ++   +
Sbjct: 67  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQ 125
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
            +H DL   N L+     VKV D+  LSR   D  Y  ++     ++             
Sbjct: 126 FLHRDLAARNCLVNDQGVVKVSDFG-LSRYVLDDEYTSSVGSKFPVR------------- 171
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL----FQTHENLEHLAMM 330
                    +  PEV++   ++   D+W+ G ++ E+ S   +    F   E  EH+A  
Sbjct: 172 ---------WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 222
Query: 331 ERVLGP 336
            R+  P
Sbjct: 223 LRLYRP 228

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 96/238 (40%), Gaps = 48/238 (20%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMI--EIDVLQRLARHD 149
           Y ++  +G G FG+V        +++ A+K++      K  ++A    E D++       
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF----- 130
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                 VQ+   F    ++ +V E + G  L + +   S    P    R    +++ ++ 
Sbjct: 131 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAEVVLALD 187
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
            +H +  IH D+KP+N+LL                            KS  +KL DFG+ 
Sbjct: 188 AIHSMGFIHRDVKPDNMLL---------------------------DKSGHLKLADFGTC 220
Query: 269 TFEHQDH----SYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVELCSGEALF 318
              +++        V T  Y +PEV+   G    +   CD WSVG  L E+  G+  F
Sbjct: 221 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 102/248 (41%), Gaps = 38/248 (15%)
Query: 95  RILSKMGEGTFGQVVEC---FDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHD 149
           +I   +G G FG+V         +++  VAIK ++S    K R   + E  ++ +    +
Sbjct: 36  KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPN 95
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           +     + +         + I+ E +   SL  FLR+N  +   I LV  L R +   + 
Sbjct: 96  V-----IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGML-RGIAAGMK 149
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           ++ ++  +H DL   NIL+ S    KV D+   +FL   + D +Y   L     I+    
Sbjct: 150 YLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR---- 205
Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL 324
                             + APE I    +    D+WS G ++ E+ S GE  +    N 
Sbjct: 206 ------------------WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 247
Query: 325 EHLAMMER 332
           + +  +E+
Sbjct: 248 DVINAIEQ 255

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/246 (22%), Positives = 105/246 (42%), Gaps = 35/246 (14%)
Query: 96  ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRC 155
            L ++G G FG VV+      +  VAIK+++  +   +  + E  V+  L+       + 
Sbjct: 12  FLKELGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE-----KL 65
Query: 156 VQIRNWFDYRNHICIVFEKLGPS-LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
           VQ+      +  I I+ E +    L ++LR+  +R F    + E+ + + E++ ++   +
Sbjct: 66  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQ 124
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
            +H DL   N L+     VKV D+  LSR   D  Y  ++     ++             
Sbjct: 125 FLHRDLAARNCLVNDQGVVKVSDFG-LSRYVLDDEYTSSVGSKFPVR------------- 170
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL----FQTHENLEHLAMM 330
                    +  PEV++   ++   D+W+ G ++ E+ S   +    F   E  EH+A  
Sbjct: 171 ---------WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 221
Query: 331 ERVLGP 336
            R+  P
Sbjct: 222 LRLYRP 227

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 96/238 (40%), Gaps = 48/238 (20%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMI--EIDVLQRLARHD 149
           Y ++  +G G FG+V        +++ A+K++      K  ++A    E D++       
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF----- 125
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                 VQ+   F    ++ +V E + G  L + +   S    P    R    +++ ++ 
Sbjct: 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAEVVLALD 182
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
            +H +  IH D+KP+N+LL                            KS  +KL DFG+ 
Sbjct: 183 AIHSMGFIHRDVKPDNMLL---------------------------DKSGHLKLADFGTC 215
Query: 269 TFEHQDH----SYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVELCSGEALF 318
              +++        V T  Y +PEV+   G    +   CD WSVG  L E+  G+  F
Sbjct: 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 99/238 (41%), Gaps = 37/238 (15%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           ++G G+FG V +   +    +  + +     +  +A   E+ VL++        TR V I
Sbjct: 43  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK--------TRHVNI 94
Query: 159 RNWFDY--RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
             +  Y  +  + IV +   G SLY  L     +   I L+ ++ RQ  + + ++H   +
Sbjct: 95  LLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKSI 153
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           IH DLK  NI L     VK+ D+   +  S+                   GS  FE    
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS-----------------GSHQFEQLSG 196
Query: 276 SYVVSTRHYRAPEVILGLGWN---YPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330
           S +     + APEVI     N   +  D+++ G +L EL +G+  +    N + +  M
Sbjct: 197 SIL-----WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM 249

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 45/99 (45%), Gaps = 24/99 (24%)
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           ++H DLKP N+ L   + VK+ D+      + D S+ K                      
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF-------------------- 176
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
               V T +Y +PE +  + +N   D+WS+GC+L ELC+
Sbjct: 177 ----VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 99/238 (41%), Gaps = 37/238 (15%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           ++G G+FG V +   +    +  + +     +  +A   E+ VL++        TR V I
Sbjct: 42  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK--------TRHVNI 93
Query: 159 RNWFDY--RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
             +  Y  +  + IV +   G SLY  L     +   I L+ ++ RQ  + + ++H   +
Sbjct: 94  LLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKSI 152
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           IH DLK  NI L     VK+ D+   +  S+                   GS  FE    
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS-----------------GSHQFEQLSG 195
Query: 276 SYVVSTRHYRAPEVILGLGWN---YPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330
           S +     + APEVI     N   +  D+++ G +L EL +G+  +    N + +  M
Sbjct: 196 SIL-----WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM 248

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 99/238 (41%), Gaps = 37/238 (15%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           ++G G+FG V +   +    +  + +     +  +A   E+ VL++        TR V I
Sbjct: 15  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK--------TRHVNI 66
Query: 159 RNWFDY--RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
             +  Y  +  + IV +   G SLY  L     +   I L+ ++ RQ  + + ++H   +
Sbjct: 67  LLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKSI 125
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           IH DLK  NI L     VK+ D+   +  S+                   GS  FE    
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS-----------------GSHQFEQLSG 168
Query: 276 SYVVSTRHYRAPEVILGLGWN---YPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330
           S +     + APEVI     N   +  D+++ G +L EL +G+  +    N + +  M
Sbjct: 169 SIL-----WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM 221

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 96/238 (40%), Gaps = 48/238 (20%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMI--EIDVLQRLARHD 149
           Y ++  +G G FG+V        +++ A+K++      K  ++A    E D++       
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF----- 130
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                 VQ+   F    ++ +V E + G  L + +   S    P    R    +++ ++ 
Sbjct: 131 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAEVVLALD 187
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
            +H +  IH D+KP+N+LL                            KS  +KL DFG+ 
Sbjct: 188 AIHSMGFIHRDVKPDNMLL---------------------------DKSGHLKLADFGTC 220
Query: 269 TFEHQDH----SYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVELCSGEALF 318
              +++        V T  Y +PEV+   G    +   CD WSVG  L E+  G+  F
Sbjct: 221 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 99/238 (41%), Gaps = 37/238 (15%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           ++G G+FG V +   +    +  + +     +  +A   E+ VL++        TR V I
Sbjct: 20  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK--------TRHVNI 71
Query: 159 RNWFDY--RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
             +  Y  +  + IV +   G SLY  L     +   I L+ ++ RQ  + + ++H   +
Sbjct: 72  LLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKSI 130
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           IH DLK  NI L     VK+ D+   +  S+                   GS  FE    
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS-----------------GSHQFEQLSG 173
Query: 276 SYVVSTRHYRAPEVILGLGWN---YPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330
           S +     + APEVI     N   +  D+++ G +L EL +G+  +    N + +  M
Sbjct: 174 SIL-----WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM 226

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/246 (22%), Positives = 105/246 (42%), Gaps = 35/246 (14%)
Query: 96  ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRC 155
            L ++G G FG VV+      +  VAIK+++  +   +  + E  V+  L+       + 
Sbjct: 8   FLKELGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE-----KL 61
Query: 156 VQIRNWFDYRNHICIVFEKLGPS-LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
           VQ+      +  I I+ E +    L ++LR+  +R F    + E+ + + E++ ++   +
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
            +H DL   N L+     VKV D+  LSR   D  Y  ++     ++             
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFG-LSRYVLDDEYTSSVGSKFPVR------------- 166
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL----FQTHENLEHLAMM 330
                    +  PEV++   ++   D+W+ G ++ E+ S   +    F   E  EH+A  
Sbjct: 167 ---------WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 217
Query: 331 ERVLGP 336
            R+  P
Sbjct: 218 LRLYRP 223

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 99/238 (41%), Gaps = 37/238 (15%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           ++G G+FG V +   +    +  + +     +  +A   E+ VL++        TR V I
Sbjct: 20  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK--------TRHVNI 71
Query: 159 RNWFDY--RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
             +  Y  +  + IV +   G SLY  L     +   I L+ ++ RQ  + + ++H   +
Sbjct: 72  LLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKSI 130
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           IH DLK  NI L     VK+ D+   +  S+                   GS  FE    
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS-----------------GSHQFEQLSG 173
Query: 276 SYVVSTRHYRAPEVILGLGWN---YPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330
           S +     + APEVI     N   +  D+++ G +L EL +G+  +    N + +  M
Sbjct: 174 SIL-----WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM 226

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 98/238 (41%), Gaps = 37/238 (15%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           ++G G+FG V +   +    +  + +     +  +A   E+ VL++        TR V I
Sbjct: 15  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK--------TRHVNI 66
Query: 159 RNWFDYRN--HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
             +  Y     + IV +   G SLY  L     +   I L+ ++ RQ  + + ++H   +
Sbjct: 67  LLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKSI 125
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           IH DLK  NI L     VK+ D+   +  S+                   GS  FE    
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS-----------------GSHQFEQLSG 168
Query: 276 SYVVSTRHYRAPEVILGLGWN---YPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330
           S +     + APEVI     N   +  D+++ G +L EL +G+  +    N + +  M
Sbjct: 169 SIL-----WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM 221

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 99/238 (41%), Gaps = 37/238 (15%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           ++G G+FG V +   +    +  + +     +  +A   E+ VL++        TR V I
Sbjct: 17  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK--------TRHVNI 68
Query: 159 RNWFDY--RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
             +  Y  +  + IV +   G SLY  L     +   I L+ ++ RQ  + + ++H   +
Sbjct: 69  LLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKSI 127
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           IH DLK  NI L     VK+ D+   +  S+                   GS  FE    
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS-----------------GSHQFEQLSG 170
Query: 276 SYVVSTRHYRAPEVILGLGWN---YPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330
           S +     + APEVI     N   +  D+++ G +L EL +G+  +    N + +  M
Sbjct: 171 SIL-----WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM 223

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/239 (21%), Positives = 95/239 (39%), Gaps = 39/239 (16%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHD 149
           +  L  +G+G+FG+V+        EL A+KI++      +   E  M+E  VL    +  
Sbjct: 22  FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRS-FPIDLVRELGRQLLES 206
                  Q+ + F   + +  V E +  G  +Y   +   ++    +    E+   L   
Sbjct: 82  F----LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF-- 135
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
             F+    +I+ DLK +N++L S  ++K+ D+     +  DG   K              
Sbjct: 136 --FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXF------------ 181
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
                         T  Y APE+I    +    D W+ G +L E+ +G+A F+  +  E
Sbjct: 182 ------------CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 228

>pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 100/233 (42%), Gaps = 28/233 (12%)
Query: 92  PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG 151
           P +R+  K+G G FG++    +    E VAIK+     +  ++   ++ +  R  +    
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL-----EPMKSRAPQLHLEYRFYKQLGS 63
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
           G    Q+  +     +  +V E LGPSL D       R+F +  V  +  QL+  + ++H
Sbjct: 64  GDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVH 122
Query: 212 ELRLIHTDLKPENILL-----VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
              LI+ D+KPEN L+      + + + + D+  L++   D    K++P           
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA-LAKEYIDPETKKHIP----------- 170
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
                +++H  +  T  Y +    LG   +   DL ++G + +    G   +Q
Sbjct: 171 -----YREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQ 218

>pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 100/233 (42%), Gaps = 28/233 (12%)
Query: 92  PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG 151
           P +R+  K+G G FG++    +    E VAIK+     +  ++   ++ +  R  +    
Sbjct: 30  PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL-----EPMKSRAPQLHLEYRFYKQLGS 84
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
           G    Q+  +     +  +V E LGPSL D       R+F +  V  +  QL+  + ++H
Sbjct: 85  GDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVH 143
Query: 212 ELRLIHTDLKPENILL-----VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
              LI+ D+KPEN L+      + + + + D+  L++   D    K++P           
Sbjct: 144 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA-LAKEYIDPETKKHIP----------- 191
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
                +++H  +  T  Y +    LG   +   DL ++G + +    G   +Q
Sbjct: 192 -----YREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQ 239

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 39/227 (17%)
Query: 95  RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
           + +S++G+G FG V  C      +    LVA+K ++ S    +     EI +L+ L    
Sbjct: 14  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 73
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPS--LYDFLRKNSYRSFPIDLVREL--GRQLLE 205
           I   R V   ++   R  + +V E L PS  L DFL+++  R   +D  R L    Q+ +
Sbjct: 74  IVKYRGV---SYGPGRQSLRLVMEYL-PSGCLRDFLQRHRAR---LDASRLLLYSSQICK 126
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF-KNLPKSSAIKLID 264
            + ++   R +H DL   NIL+ S  +VK+ D+        D  Y+    P  S I    
Sbjct: 127 GMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI---- 182
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
                              + APE +    ++   D+WS G +L EL
Sbjct: 183 ------------------FWYAPESLSDNIFSRQSDVWSFGVVLYEL 211

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/245 (22%), Positives = 104/245 (42%), Gaps = 32/245 (13%)
Query: 80  GHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEI 139
           G  V  +G    P +R+  K+G G FG++    +    E VAIK+     +  ++   ++
Sbjct: 1   GSGVLMVG----PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL-----EPMKSRAPQL 51
Query: 140 DVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVREL 199
            +  R  +    G    Q+  +     +  +V E LGPSL D       R+F +  V  +
Sbjct: 52  HLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCD-RTFSLKTVLMI 110
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILL-----VSAEYVKVPDYKFLSRSSKDGSYFKNL 254
             QL+  + ++H   LI+ D+KPEN L+      + + + + D+  L++   D    K++
Sbjct: 111 AIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFG-LAKEYIDPETKKHI 169
Query: 255 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           P                +++H  +  T  Y +    LG   +   DL ++G + +    G
Sbjct: 170 P----------------YREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRG 213
Query: 315 EALFQ 319
              +Q
Sbjct: 214 SLPWQ 218

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 39/227 (17%)
Query: 95  RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
           + +S++G+G FG V  C      +    LVA+K ++ S    +     EI +L+ L    
Sbjct: 13  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 72
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPS--LYDFLRKNSYRSFPIDLVREL--GRQLLE 205
           I   R V   ++   R  + +V E L PS  L DFL+++  R   +D  R L    Q+ +
Sbjct: 73  IVKYRGV---SYGPGRQSLRLVMEYL-PSGCLRDFLQRHRAR---LDASRLLLYSSQICK 125
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK-NLPKSSAIKLID 264
            + ++   R +H DL   NIL+ S  +VK+ D+        D  Y+    P  S I    
Sbjct: 126 GMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI---- 181
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
                              + APE +    ++   D+WS G +L EL
Sbjct: 182 ------------------FWYAPESLSDNIFSRQSDVWSFGVVLYEL 210

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 39/227 (17%)
Query: 95  RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
           + +S++G+G FG V  C      +    LVA+K ++ S    +     EI +L+ L    
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 85
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPS--LYDFLRKNSYRSFPIDLVREL--GRQLLE 205
           I   R V   ++   R  + +V E L PS  L DFL+++  R   +D  R L    Q+ +
Sbjct: 86  IVKYRGV---SYGPGRQSLRLVMEYL-PSGCLRDFLQRHRAR---LDASRLLLYSSQICK 138
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK-NLPKSSAIKLID 264
            + ++   R +H DL   NIL+ S  +VK+ D+        D  Y+    P  S I    
Sbjct: 139 GMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI---- 194
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
                              + APE +    ++   D+WS G +L EL
Sbjct: 195 ------------------FWYAPESLSDNIFSRQSDVWSFGVVLYEL 223

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 95/225 (42%), Gaps = 33/225 (14%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV-RSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           +GEG   +V  C +    +  A+KI+ +     R     E+++L +   H       +++
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH----RNVLEL 76
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
             +F+  +   +VFEK+ G S+   + K   R F       + + +  ++ F+H   + H
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAH 134
Query: 218 TDLKPENILLV---SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
            DLKPENIL         VK+ D+   S    +G      P S+   L   GS       
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS---PISTPELLTPCGSA------ 185
Query: 275 HSYVVSTRHYRAPEVILGLG-----WNYPCDLWSVGCILVELCSG 314
                    Y APEV+         ++  CDLWS+G IL  L SG
Sbjct: 186 --------EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 94/248 (37%), Gaps = 57/248 (22%)
Query: 93  RYRILSKMGEGTFGQVVEC--FDNEKK---ELVAIKIVRSINKYRE--AAMIEIDVLQRL 145
           R ++   +G G FGQV+E   F  +K      VA+K+++    + E  A M E+ +L  +
Sbjct: 30  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 89
Query: 146 ARHDIGGTRCVQIRNWFDYRNH------ICIVFEKLGPSLYDFLRKN-----SYRSFPID 194
             H       + + N             + + F K G +L  +LR        Y+  P D
Sbjct: 90  GHH-------LNVVNLLGACTKPGGPLMVIVEFCKFG-NLSTYLRSKRNEFVPYKEAPED 141
Query: 195 LVREL---------GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
           L ++            Q+ + + F+   + IH DL   NILL     VK+ D+       
Sbjct: 142 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 201
Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
           KD  Y +       +K                      + APE I    +    D+WS G
Sbjct: 202 KDPDYVRKGDARLPLK----------------------WMAPETIFDRVYTIQSDVWSFG 239
Query: 306 CILVELCS 313
            +L E+ S
Sbjct: 240 VLLWEIFS 247

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 99/231 (42%), Gaps = 32/231 (13%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           + ++G G FG +V       K+ VAIK +R      E  + E +V+ +L+       + V
Sbjct: 12  VQEIGSGQFG-LVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-----PKLV 65
Query: 157 QIRNWFDYRNHICIVFEKLGPS-LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           Q+      +  IC+VFE +    L D+LR      F  + +  +   + E +A++ E  +
Sbjct: 66  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEASV 124
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           IH DL   N L+   + +KV D+  ++R   D  Y  +      +K              
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFG-MTRFVLDDQYTSSTGTKFPVK-------------- 169
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 325
                   + +PEV     ++   D+WS G ++ E+ S G+  ++   N E
Sbjct: 170 --------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 212

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 55/246 (22%), Positives = 104/246 (42%), Gaps = 35/246 (14%)
Query: 96  ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRC 155
            L ++G G FG VV+      +  VAIK+++  +   +  + E  V+  L+       + 
Sbjct: 13  FLKELGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE-----KL 66
Query: 156 VQIRNWFDYRNHICIVFEKLGPS-LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
           VQ+      +  I I+ E +    L ++LR+  +R F    + E+ + + E++ ++   +
Sbjct: 67  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQ 125
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
            +H DL   N L+     VKV D+  LSR   D  Y  +      ++             
Sbjct: 126 FLHRDLAARNCLVNDQGVVKVSDFG-LSRYVLDDEYTSSRGSKFPVR------------- 171
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL----FQTHENLEHLAMM 330
                    +  PEV++   ++   D+W+ G ++ E+ S   +    F   E  EH+A  
Sbjct: 172 ---------WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 222
Query: 331 ERVLGP 336
            R+  P
Sbjct: 223 LRLYRP 228

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 95/225 (42%), Gaps = 33/225 (14%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV-RSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           +GEG   +V  C +    +  A+KI+ +     R     E+++L +   H       +++
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH----RNVLEL 76
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
             +F+  +   +VFEK+ G S+   + K   R F       + + +  ++ F+H   + H
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAH 134
Query: 218 TDLKPENILLV---SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
            DLKPENIL         VK+ D+   S    +G      P S+   L   GS       
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCS---PISTPELLTPCGSA------ 185
Query: 275 HSYVVSTRHYRAPEVILGLG-----WNYPCDLWSVGCILVELCSG 314
                    Y APEV+         ++  CDLWS+G IL  L SG
Sbjct: 186 --------EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 95/227 (41%), Gaps = 43/227 (18%)
Query: 98  SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEI---DVLQRLARHDIGGTR 154
           +KMGEG FG V + + N     VA+K        + AAM++I   ++ Q+  +      +
Sbjct: 37  NKMGEGGFGVVYKGYVNNTT--VAVK--------KLAAMVDITTEELKQQFDQEIKVMAK 86
Query: 155 C-----VQIRNWFDYRNHICIVFEKL-GPSLYDFLR-KNSYRSFPIDLVRELGRQLLESV 207
           C     V++  +    + +C+V+  +   SL D L   +        +  ++ +     +
Sbjct: 87  CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGI 146
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
            F+HE   IH D+K  NILL  A   K+ D+     S K                  F  
Sbjct: 147 NFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK------------------FAQ 188
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           T       S +V T  Y APE + G       D++S G +L+E+ +G
Sbjct: 189 TVMX----SRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITG 230

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 27/99 (27%), Positives = 44/99 (44%), Gaps = 24/99 (24%)
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           ++H DLKP N+ L   + VK+ D+      + D  + K                      
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEF-------------------- 176
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
               V T +Y +PE +  + +N   D+WS+GC+L ELC+
Sbjct: 177 ----VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 94/235 (40%), Gaps = 37/235 (15%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           R+  K+G G FG++    +    E VAIK+   I        +E    ++L      G  
Sbjct: 3   RVGKKIGCGNFGELRLGKNLYTNEYVAIKL-EPIKSRAPQLHLEYRFYKQLGS---AGEG 58
Query: 155 CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
             Q+  +     +  +V E LGPSL D       R+F +  V  +  QLL  + ++H   
Sbjct: 59  LPQVYYFGPXGKYNAMVLELLGPSLEDLFDLCD-RTFTLKTVLMIAIQLLSRMEYVHSKN 117
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-------S 267
           LI+ D+KPEN L+                  + G+      K   I +IDFG        
Sbjct: 118 LIYRDVKPENFLI-----------------GRQGN-----KKEHVIHIIDFGLAKEYIDP 155
Query: 268 TTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
            T +H   ++H  +  T  Y +    LG   +   DL ++G + +    G   +Q
Sbjct: 156 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQ 210

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 89/192 (46%), Gaps = 35/192 (18%)
Query: 137 IEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPID 194
           +E+ +L++++    G +  +++ +WF+  +   ++ E+  P   L+DF+ +    +   +
Sbjct: 103 MEVVLLKKVSS---GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEE 157
Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254
           L R    Q+LE+V   H   ++H D+K ENIL+             L+R           
Sbjct: 158 LARSFFWQVLEAVRHCHNCGVLHRDIKDENILID------------LNRGE--------- 196
Query: 255 PKSSAIKLIDFGS-TTFEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELC 312
                +KLIDFGS    +   ++    TR Y  PE I    ++     +WS+G +L ++ 
Sbjct: 197 -----LKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251
Query: 313 SGEALFQTHENL 324
            G+  F+  E +
Sbjct: 252 CGDIPFEHDEEI 263

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 97/240 (40%), Gaps = 52/240 (21%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMI--EIDVLQRLARHD 149
           Y ++  +G G FG+V        +++ A+K++      K  ++A    E D++       
Sbjct: 77  YDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF----- 131
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                 VQ+   F    ++ +V E + G  L + +   S    P    +    +++ ++ 
Sbjct: 132 ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM---SNYDVPEKWAKFYTAEVVLALD 188
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS- 267
            +H + LIH D+KP+N+L                           L K   +KL DFG+ 
Sbjct: 189 AIHSMGLIHRDVKPDNML---------------------------LDKHGHLKLADFGTC 221
Query: 268 -----TTFEHQDHSYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVELCSGEALF 318
                T   H D +  V T  Y +PEV+   G    +   CD WSVG  L E+  G+  F
Sbjct: 222 MKMDETGMVHCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 94/235 (40%), Gaps = 48/235 (20%)
Query: 100 MGEGTFGQVVEC--FDNEKKELV---AIKIVRSINKY--REAAMIEIDVLQRLARHDIGG 152
           +G G FG+VVE   F   K++ V   A+K+++S      +EA M E+ ++  L +H+   
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE--- 110
Query: 153 TRCVQIRNWFDYRNHICIVFEKLG-PSLYDFLRKNSYR-----SFPI--------DLVRE 198
              V +     +   + ++ E      L +FLR+ S       +F I        DL+  
Sbjct: 111 -NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH- 168
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              Q+ + +AF+     IH D+   N+LL +    K+ D+        D +Y        
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 259 AIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
            +K                      + APE I    +    D+WS G +L E+ S
Sbjct: 229 PVK----------------------WMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 94/248 (37%), Gaps = 57/248 (22%)
Query: 93  RYRILSKMGEGTFGQVVEC--FDNEKK---ELVAIKIVRSINKYRE--AAMIEIDVLQRL 145
           R ++   +G G FGQV+E   F  +K      VA+K+++    + E  A M E+ +L  +
Sbjct: 28  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 87
Query: 146 ARHDIGGTRCVQIRNWFDYRNH------ICIVFEKLGPSLYDFLRKN-----SYRSFPID 194
             H       + + N             + + F K G +L  +LR        Y+  P D
Sbjct: 88  GHH-------LNVVNLLGACTKPGGPLMVIVEFCKFG-NLSTYLRSKRNEFVPYKVAPED 139
Query: 195 LVREL---------GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
           L ++            Q+ + + F+   + IH DL   NILL     VK+ D+       
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
           KD  Y +       +K                      + APE I    +    D+WS G
Sbjct: 200 KDPDYVRKGDARLPLK----------------------WMAPETIFDRVYTIQSDVWSFG 237
Query: 306 CILVELCS 313
            +L E+ S
Sbjct: 238 VLLWEIFS 245

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 94/235 (40%), Gaps = 48/235 (20%)
Query: 100 MGEGTFGQVVEC--FDNEKKELV---AIKIVRSINKY--REAAMIEIDVLQRLARHDIGG 152
           +G G FG+VVE   F   K++ V   A+K+++S      +EA M E+ ++  L +H+   
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE--- 110
Query: 153 TRCVQIRNWFDYRNHICIVFEKLG-PSLYDFLRKNSYR-----SFPI--------DLVRE 198
              V +     +   + ++ E      L +FLR+ S       +F I        DL+  
Sbjct: 111 -NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLH- 168
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              Q+ + +AF+     IH D+   N+LL +    K+ D+        D +Y        
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 259 AIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
            +K                      + APE I    +    D+WS G +L E+ S
Sbjct: 229 PVK----------------------WMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 94/248 (37%), Gaps = 57/248 (22%)
Query: 93  RYRILSKMGEGTFGQVVEC--FDNEKK---ELVAIKIVRSINKYRE--AAMIEIDVLQRL 145
           R ++   +G G FGQV+E   F  +K      VA+K+++    + E  A M E+ +L  +
Sbjct: 65  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 124
Query: 146 ARHDIGGTRCVQIRNWFDYRNH------ICIVFEKLGPSLYDFLRKN-----SYRSFPID 194
             H       + + N             + + F K G +L  +LR        Y+  P D
Sbjct: 125 GHH-------LNVVNLLGACTKPGGPLMVIVEFCKFG-NLSTYLRSKRNEFVPYKVAPED 176
Query: 195 LVREL---------GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
           L ++            Q+ + + F+   + IH DL   NILL     VK+ D+       
Sbjct: 177 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 236
Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
           KD  Y +       +K                      + APE I    +    D+WS G
Sbjct: 237 KDPDYVRKGDARLPLK----------------------WMAPETIFDRVYTIQSDVWSFG 274
Query: 306 CILVELCS 313
            +L E+ S
Sbjct: 275 VLLWEIFS 282

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/255 (23%), Positives = 106/255 (41%), Gaps = 35/255 (13%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+G G +G+V E    +    VA+K ++      E  + E  V++ +   ++     V  
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHT 218
           R   +   +I I F   G +L D+LR+ + +     ++  +  Q+  ++ ++ +   IH 
Sbjct: 85  R---EPPFYIIIEFMTYG-NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 140
Query: 219 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV 278
           DL   N L+     VKV D+  LSR     +Y  +      IK                 
Sbjct: 141 DLAARNCLVGENHLVKVADFG-LSRLMTGDTYTAHAGAKFPIK----------------- 182
Query: 279 VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-------GEALFQTHENLEHLAMME 331
                + APE +    ++   D+W+ G +L E+ +       G  L Q +E LE    ME
Sbjct: 183 -----WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 237
Query: 332 RVLG-PLPHHMVIRA 345
           R  G P   + ++RA
Sbjct: 238 RPEGCPEKVYELMRA 252

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/255 (23%), Positives = 106/255 (41%), Gaps = 35/255 (13%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+G G +G+V E    +    VA+K ++      E  + E  V++ +   ++     V  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHT 218
           R   +   +I I F   G +L D+LR+ + +     ++  +  Q+  ++ ++ +   IH 
Sbjct: 80  R---EPPFYIIIEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 135
Query: 219 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV 278
           DL   N L+     VKV D+  LSR     +Y  +      IK                 
Sbjct: 136 DLAARNCLVGENHLVKVADFG-LSRLMTGDTYTAHAGAKFPIK----------------- 177
Query: 279 VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-------GEALFQTHENLEHLAMME 331
                + APE +    ++   D+W+ G +L E+ +       G  L Q +E LE    ME
Sbjct: 178 -----WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 232
Query: 332 RVLG-PLPHHMVIRA 345
           R  G P   + ++RA
Sbjct: 233 RPEGCPEKVYELMRA 247

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/255 (23%), Positives = 106/255 (41%), Gaps = 35/255 (13%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+G G +G+V E    +    VA+K ++      E  + E  V++ +   ++     V  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHT 218
           R   +   +I I F   G +L D+LR+ + +     ++  +  Q+  ++ ++ +   IH 
Sbjct: 80  R---EPPFYIIIEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 135
Query: 219 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV 278
           DL   N L+     VKV D+  LSR     +Y  +      IK                 
Sbjct: 136 DLAARNCLVGENHLVKVADFG-LSRLMTGDTYTAHAGAKFPIK----------------- 177
Query: 279 VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-------GEALFQTHENLEHLAMME 331
                + APE +    ++   D+W+ G +L E+ +       G  L Q +E LE    ME
Sbjct: 178 -----WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 232
Query: 332 RVLG-PLPHHMVIRA 345
           R  G P   + ++RA
Sbjct: 233 RPEGCPEKVYELMRA 247

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 74/318 (23%), Positives = 108/318 (33%), Gaps = 87/318 (27%)
Query: 92  PRYRIL--SKMGEGTFGQVVEC-----FDNEKKELVAIKIVRSINKY--REAAMIEIDVL 142
           PR R+     +G G FG+VVE        ++    VA+K+++       REA M E+ VL
Sbjct: 44  PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 103
Query: 143 QRLARH----------DIGGTRCV--------QIRNWFDYRNHICIVFEKLGPSLYDFLR 184
             L  H           IGG   V         + N F  R     +  K  P++ +   
Sbjct: 104 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN-FLRRKRDSFICSKTSPAIMEDDE 162
Query: 185 KNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244
                      +     Q+ + +AF+     IH DL   NILL      K+         
Sbjct: 163 LALDLE----DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKI--------- 209
Query: 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTR-----HYRAPEVILGLGWNYPC 299
                              DFG       D +YVV         + APE I    + +  
Sbjct: 210 ------------------CDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFES 251
Query: 300 DLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARL 359
           D+WS G  L EL S                    LG  P+   +  D +  K  + G R+
Sbjct: 252 DVWSYGIFLWELFS--------------------LGSSPYPG-MPVDSKFYKMIKEGFRM 290
Query: 360 DWPDGATSR--DSMRAVW 375
             P+ A +   D M+  W
Sbjct: 291 LSPEHAPAEMYDIMKTCW 308

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 102/248 (41%), Gaps = 38/248 (15%)
Query: 95  RILSKMGEGTFGQVVEC---FDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHD 149
           +I   +G G FG+V         +K+  VAIK ++     + R   + E  ++ +    +
Sbjct: 17  KIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPN 76
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I     +++         + I+ E +   +L  FLR N  +   I LV  L R +   + 
Sbjct: 77  I-----IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGML-RGIASGMR 130
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           ++ E+  +H DL   NIL+ S    KV D+   +FL  +S D +Y  +L     I+    
Sbjct: 131 YLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIR---- 186
Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL 324
                             + APE I    +    D WS G ++ E+ S GE  +    N 
Sbjct: 187 ------------------WTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQ 228
Query: 325 EHLAMMER 332
           + +  +E+
Sbjct: 229 DVINAIEQ 236

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 99/232 (42%), Gaps = 32/232 (13%)
Query: 96  ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRC 155
            + ++G G FG +V       K+ VAIK +R      E  + E +V+ +L+       + 
Sbjct: 14  FVQEIGSGQFG-LVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-----PKL 67
Query: 156 VQIRNWFDYRNHICIVFEKLGPS-LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
           VQ+      +  IC+VFE +    L D+LR      F  + +  +   + E +A++ E  
Sbjct: 68  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC 126
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           +IH DL   N L+   + +KV D+  ++R   D  Y  +      +K             
Sbjct: 127 VIHRDLAARNCLVGENQVIKVSDFG-MTRFVLDDQYTSSTGTKFPVK------------- 172
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 325
                    + +PEV     ++   D+WS G ++ E+ S G+  ++   N E
Sbjct: 173 ---------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 215

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 75/318 (23%), Positives = 112/318 (35%), Gaps = 87/318 (27%)
Query: 92  PRYRIL--SKMGEGTFGQVVEC-----FDNEKKELVAIKIVRSINKY--REAAMIEIDVL 142
           PR R+     +G G FG+VVE        ++    VA+K+++       REA M E+ VL
Sbjct: 44  PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 103
Query: 143 QRLARH----------DIGGTRCV--------QIRNWFDYRNHICIVFEKLGPSLYDFLR 184
             L  H           IGG   V         + N F  R     +  K  P++ +   
Sbjct: 104 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN-FLRRKRDSFICSKTSPAIMEDDE 162
Query: 185 KNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244
                      +     Q+ + +AF+     IH DL   NILL      K+ D+  L+R 
Sbjct: 163 LALDLE----DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG-LARD 217
Query: 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTR-----HYRAPEVILGLGWNYPC 299
            K+                          D +YVV         + APE I    + +  
Sbjct: 218 IKN--------------------------DSNYVVKGNARLPVKWMAPESIFNCVYTFES 251
Query: 300 DLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARL 359
           D+WS G  L EL S                    LG  P+   +  D +  K  + G R+
Sbjct: 252 DVWSYGIFLWELFS--------------------LGSSPYPG-MPVDSKFYKMIKEGFRM 290
Query: 360 DWPDGATSR--DSMRAVW 375
             P+ A +   D M+  W
Sbjct: 291 LSPEHAPAEMYDIMKTCW 308

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/255 (23%), Positives = 107/255 (41%), Gaps = 35/255 (13%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+G G +G+V E    +    VA+K ++      E  + E  V++ +   ++     V  
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHT 218
           R   +   +I I F   G +L D+LR+ + +     ++  +  Q+  ++ ++ +   IH 
Sbjct: 81  R---EPPFYIIIEFMTYG-NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 136
Query: 219 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV 278
           DL   N L+     VKV D+  LSR                   +  G T   H    + 
Sbjct: 137 DLAARNCLVGENHLVKVADFG-LSR-------------------LMTGDTXTAHAGAKFP 176
Query: 279 VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-------GEALFQTHENLEHLAMME 331
           +    + APE +    ++   D+W+ G +L E+ +       G  L Q +E LE    ME
Sbjct: 177 IK---WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 233
Query: 332 RVLG-PLPHHMVIRA 345
           R  G P   + ++RA
Sbjct: 234 RPEGCPEKVYELMRA 248

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 75/318 (23%), Positives = 112/318 (35%), Gaps = 87/318 (27%)
Query: 92  PRYRIL--SKMGEGTFGQVVEC-----FDNEKKELVAIKIVRSINKY--REAAMIEIDVL 142
           PR R+     +G G FG+VVE        ++    VA+K+++       REA M E+ VL
Sbjct: 21  PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 80
Query: 143 QRLARH----------DIGGTRCV--------QIRNWFDYRNHICIVFEKLGPSLYDFLR 184
             L  H           IGG   V         + N F  R     +  K  P++ +   
Sbjct: 81  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN-FLRRKRDSFICSKTSPAIMEDDE 139
Query: 185 KNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244
                      +     Q+ + +AF+     IH DL   NILL      K+ D+  L+R 
Sbjct: 140 LALDLE----DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG-LARD 194
Query: 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTR-----HYRAPEVILGLGWNYPC 299
            K+                          D +YVV         + APE I    + +  
Sbjct: 195 IKN--------------------------DSNYVVKGNARLPVKWMAPESIFNCVYTFES 228
Query: 300 DLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARL 359
           D+WS G  L EL S                    LG  P+   +  D +  K  + G R+
Sbjct: 229 DVWSYGIFLWELFS--------------------LGSSPYPG-MPVDSKFYKMIKEGFRM 267
Query: 360 DWPDGATSR--DSMRAVW 375
             P+ A +   D M+  W
Sbjct: 268 LSPEHAPAEMYDIMKTCW 285

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 94/246 (38%), Gaps = 53/246 (21%)
Query: 93  RYRILSKMGEGTFGQVVEC--FDNEKK---ELVAIKIVRSINKYRE--AAMIEIDVLQRL 145
           R ++   +G G FGQV+E   F  +K      VA+K+++    + E  A M E+ +L  +
Sbjct: 19  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 78
Query: 146 ARH----DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKN-----SYRSFPIDLV 196
             H    ++ G  C +           C    K G +L  +LR        Y+  P DL 
Sbjct: 79  GHHLNVVNLLGA-CTKPGGPLMVITEFC----KFG-NLSTYLRSKRNEFVPYKVAPEDLY 132
Query: 197 REL---------GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247
           ++            Q+ + + F+   + IH DL   NILL     VK+ D+       KD
Sbjct: 133 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 192
Query: 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCI 307
             Y +       +K                      + APE I    +    D+WS G +
Sbjct: 193 PDYVRKGDARLPLK----------------------WMAPETIFDRVYTIQSDVWSFGVL 230
Query: 308 LVELCS 313
           L E+ S
Sbjct: 231 LWEIFS 236

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 97/237 (40%), Gaps = 28/237 (11%)
Query: 99  KMGEGTFGQVVE-CFDNEKKEL-VAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           ++G G FG V +  +   KK++ VAIK+++      E A  E  + +    H +     V
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIV 73
Query: 157 QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLI 216
           ++         + ++    G  L+ FL        P+  V EL  Q+   + ++ E   +
Sbjct: 74  RLIGVCQAEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 217 HTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS 276
           H DL   N+LLV+  Y K+ D+        D SY+      SA K               
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY---TARSAGKW-------------- 175
Query: 277 YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                  + APE I    ++   D+WS G  + E  S G+  ++  +  E +A +E+
Sbjct: 176 ----PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 94/246 (38%), Gaps = 53/246 (21%)
Query: 93  RYRILSKMGEGTFGQVVEC--FDNEKK---ELVAIKIVRSINKYRE--AAMIEIDVLQRL 145
           R ++   +G G FGQV+E   F  +K      VA+K+++    + E  A M E+ +L  +
Sbjct: 19  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 78
Query: 146 ARH----DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKN-----SYRSFPIDLV 196
             H    ++ G  C +           C    K G +L  +LR        Y+  P DL 
Sbjct: 79  GHHLNVVNLLGA-CTKPGGPLMVITEFC----KFG-NLSTYLRSKRNEFVPYKVAPEDLY 132
Query: 197 REL---------GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247
           ++            Q+ + + F+   + IH DL   NILL     VK+ D+       KD
Sbjct: 133 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 192
Query: 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCI 307
             Y +       +K                      + APE I    +    D+WS G +
Sbjct: 193 PDYVRKGDARLPLK----------------------WMAPETIFDRVYTIQSDVWSFGVL 230
Query: 308 LVELCS 313
           L E+ S
Sbjct: 231 LWEIFS 236

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 43/227 (18%)
Query: 98  SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEI---DVLQRLARHDIGGTR 154
           +KMGEG FG V + + N     VA+K        + AAM++I   ++ Q+  +      +
Sbjct: 37  NKMGEGGFGVVYKGYVNNTT--VAVK--------KLAAMVDITTEELKQQFDQEIKVMAK 86
Query: 155 C-----VQIRNWFDYRNHICIVFEKL-GPSLYDFLR-KNSYRSFPIDLVRELGRQLLESV 207
           C     V++  +    + +C+V+  +   SL D L   +        +  ++ +     +
Sbjct: 87  CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGI 146
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
            F+HE   IH D+K  NILL  A   K+ D+     S K                  F  
Sbjct: 147 NFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK------------------FAQ 188
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           T    +    +V T  Y APE + G       D++S G +L+E+ +G
Sbjct: 189 TVMXXR----IVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITG 230

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 75/318 (23%), Positives = 112/318 (35%), Gaps = 87/318 (27%)
Query: 92  PRYRIL--SKMGEGTFGQVVEC-----FDNEKKELVAIKIVRSINKY--REAAMIEIDVL 142
           PR R+     +G G FG+VVE        ++    VA+K+++       REA M E+ VL
Sbjct: 39  PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 98
Query: 143 QRLARH----------DIGGTRCV--------QIRNWFDYRNHICIVFEKLGPSLYDFLR 184
             L  H           IGG   V         + N F  R     +  K  P++ +   
Sbjct: 99  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN-FLRRKRDSFICSKTSPAIMEDDE 157
Query: 185 KNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244
                      +     Q+ + +AF+     IH DL   NILL      K+ D+  L+R 
Sbjct: 158 LALDLE----DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG-LARD 212
Query: 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTR-----HYRAPEVILGLGWNYPC 299
            K+                          D +YVV         + APE I    + +  
Sbjct: 213 IKN--------------------------DSNYVVKGNARLPVKWMAPESIFNCVYTFES 246
Query: 300 DLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARL 359
           D+WS G  L EL S                    LG  P+   +  D +  K  + G R+
Sbjct: 247 DVWSYGIFLWELFS--------------------LGSSPYPG-MPVDSKFYKMIKEGFRM 285
Query: 360 DWPDGATSR--DSMRAVW 375
             P+ A +   D M+  W
Sbjct: 286 LSPEHAPAEMYDIMKTCW 303

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 99/231 (42%), Gaps = 32/231 (13%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           + ++G G FG +V       K+ VAIK +R      E  + E +V+ +L+       + V
Sbjct: 12  VQEIGSGQFG-LVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-----PKLV 65
Query: 157 QIRNWFDYRNHICIVFEKLGPS-LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           Q+      +  IC+VFE +    L D+LR      F  + +  +   + E +A++ E  +
Sbjct: 66  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACV 124
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           IH DL   N L+   + +KV D+  ++R   D  Y  +      +K              
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFG-MTRFVLDDQYTSSTGTKFPVK-------------- 169
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 325
                   + +PEV     ++   D+WS G ++ E+ S G+  ++   N E
Sbjct: 170 --------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 212

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 103/243 (42%), Gaps = 40/243 (16%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAM-----IEIDVLQRLARHDIGGT 153
           ++G G FG V + +   KK +  + +    N+  + A+      E +V+Q+L    I   
Sbjct: 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI--V 433
Query: 154 RCVQI---RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
           R + I    +W      + +   +LGP L  +L++N  R      + EL  Q+   + ++
Sbjct: 434 RMIGICEAESWM-----LVMEMAELGP-LNKYLQQN--RHVKDKNIIELVHQVSMGMKYL 485
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
            E   +H DL   N+LLV+  Y K+ D+        D +Y+K                  
Sbjct: 486 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA----------------- 528
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAM 329
             Q H        + APE I    ++   D+WS G ++ E  S G+  ++  +  E  AM
Sbjct: 529 --QTHGKWPVK--WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 584
Query: 330 MER 332
           +E+
Sbjct: 585 LEK 587

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 75/318 (23%), Positives = 112/318 (35%), Gaps = 87/318 (27%)
Query: 92  PRYRIL--SKMGEGTFGQVVEC-----FDNEKKELVAIKIVRSINKY--REAAMIEIDVL 142
           PR R+     +G G FG+VVE        ++    VA+K+++       REA M E+ VL
Sbjct: 37  PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 96
Query: 143 QRLARH----------DIGGTRCV--------QIRNWFDYRNHICIVFEKLGPSLYDFLR 184
             L  H           IGG   V         + N F  R     +  K  P++ +   
Sbjct: 97  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN-FLRRKRDSFICSKTSPAIMEDDE 155
Query: 185 KNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244
                      +     Q+ + +AF+     IH DL   NILL      K+ D+  L+R 
Sbjct: 156 LALDLE----DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG-LARD 210
Query: 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTR-----HYRAPEVILGLGWNYPC 299
            K+                          D +YVV         + APE I    + +  
Sbjct: 211 IKN--------------------------DSNYVVKGNARLPVKWMAPESIFNCVYTFES 244
Query: 300 DLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARL 359
           D+WS G  L EL S                    LG  P+   +  D +  K  + G R+
Sbjct: 245 DVWSYGIFLWELFS--------------------LGSSPYPG-MPVDSKFYKMIKEGFRM 283
Query: 360 DWPDGATSR--DSMRAVW 375
             P+ A +   D M+  W
Sbjct: 284 LSPEHAPAEMYDIMKTCW 301

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 103/243 (42%), Gaps = 40/243 (16%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAM-----IEIDVLQRLARHDIGGT 153
           ++G G FG V + +   KK +  + +    N+  + A+      E +V+Q+L    I   
Sbjct: 377 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI--V 434
Query: 154 RCVQI---RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
           R + I    +W      + +   +LGP L  +L++N  R      + EL  Q+   + ++
Sbjct: 435 RMIGICEAESWM-----LVMEMAELGP-LNKYLQQN--RHVKDKNIIELVHQVSMGMKYL 486
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
            E   +H DL   N+LLV+  Y K+ D+        D +Y+K                  
Sbjct: 487 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA----------------- 529
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAM 329
             Q H        + APE I    ++   D+WS G ++ E  S G+  ++  +  E  AM
Sbjct: 530 --QTHGKWPVK--WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 585
Query: 330 MER 332
           +E+
Sbjct: 586 LEK 588

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/214 (21%), Positives = 95/214 (44%), Gaps = 18/214 (8%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           +G+G FGQ ++    E  E++ +K ++R   + +   + E+ V++ L   ++     V  
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHT 218
           ++       +  + E +       + K+    +P        + +   +A++H + +IH 
Sbjct: 78  KD-----KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHR 132
Query: 219 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS-SAIKLIDFGSTTFEHQDHSY 277
           DL   N L+   + V V D+  L+R   D    K  P+   ++K  D        +    
Sbjct: 133 DLNSHNCLVRENKNVVVADFG-LARLMVDE---KTQPEGLRSLKKPD-------RKKRYT 181
Query: 278 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
           VV   ++ APE+I G  ++   D++S G +L E+
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEI 215

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 99/231 (42%), Gaps = 32/231 (13%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           + ++G G FG +V       K+ VAIK +R      E  + E +V+ +L+       + V
Sbjct: 10  VQEIGSGQFG-LVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-----PKLV 63
Query: 157 QIRNWFDYRNHICIVFEKLGPS-LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           Q+      +  IC+VFE +    L D+LR      F  + +  +   + E +A++ E  +
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACV 122
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           IH DL   N L+   + +KV D+  ++R   D  Y  +      +K              
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFG-MTRFVLDDQYTSSTGTKFPVK-------------- 167
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 325
                   + +PEV     ++   D+WS G ++ E+ S G+  ++   N E
Sbjct: 168 --------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/240 (20%), Positives = 101/240 (42%), Gaps = 36/240 (15%)
Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNE---KKELVAIKIVRSINKYREAAMI--EIDVLQ 143
            L  +Y +   +GEG++G+V E  D+E   ++ +  +K  +        A +  EI +L+
Sbjct: 2   KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61
Query: 144 RLARHDIGGTRCVQIRN--WFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGR 201
           RL   ++     +Q+ +  + + +  + +V E     + + L     + FP+        
Sbjct: 62  RLRHKNV-----IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFC 116
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           QL++ + ++H   ++H D+KP N+LL +   +K+                  L  + A+ 
Sbjct: 117 QLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKI----------------SALGVAEALH 160
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW--NYPCDLWSVGCILVELCSGEALFQ 319
                 T    Q       +  ++ PE+  GL     +  D+WS G  L  + +G   F+
Sbjct: 161 PFAADDTCRTSQ------GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 72/298 (24%), Positives = 115/298 (38%), Gaps = 72/298 (24%)
Query: 92  PRYRI-LSK-MGEGTFGQVVEC--FDNEKK---ELVAIKIVRSINKYRE--AAMIEIDVL 142
           PR R+ L K +G G FGQV+E   F  +K      VA+K+++    + E  A M E+ +L
Sbjct: 25  PRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKIL 84
Query: 143 QRLARH----DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLR---------KNSYR 189
             +  H    ++ G  C +          + + F K G +L  +LR         K+ Y+
Sbjct: 85  IHIGHHLNVVNLLGA-CTKPGGPL----MVIVEFCKFG-NLSTYLRSKRNEFVPYKDLYK 138
Query: 190 SF-PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248
            F  ++ +     Q+ + + F+   + IH DL   NILL     VK+ D+       KD 
Sbjct: 139 DFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDP 198
Query: 249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308
            Y +       +K                      + APE I    +    D+WS G +L
Sbjct: 199 DYVRKGDARLPLK----------------------WMAPETIFDRVYTIQSDVWSFGVLL 236
Query: 309 VELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGAT 366
            E+ S                    LG  P+  V + D    +  + G R+  PD  T
Sbjct: 237 WEIFS--------------------LGASPYPGV-KIDEEFXRRLKEGTRMRAPDYTT 273

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 40/233 (17%)
Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA----MIEIDVLQRLARHD 149
           + I   +G+G FG V    + +   +VA+K++      +E        EI++   L   +
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPN 84
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
           I     +++ N+F  R  I ++ E   P   LY  L+K+   +F       +  +L +++
Sbjct: 85  I-----LRLYNYFYDRRRIYLILE-YAPRGELYKELQKSC--TFDEQRTATIMEELADAL 136
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
            + H  ++IH D+KPEN+LL     +K+ D+ +         +  +L + +    +D   
Sbjct: 137 MYCHGKKVIHRDIKPENLLLGLKGELKIADFGW-------SVHAPSLRRKTMCGTLD--- 186
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320
                           Y  PE+I G   N   DLW +G +  EL  G   F++
Sbjct: 187 ----------------YLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFES 223

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/237 (23%), Positives = 97/237 (40%), Gaps = 28/237 (11%)
Query: 99  KMGEGTFGQVVE-CFDNEKKEL-VAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           ++G G FG V +  +   KK++ VAIK+++      E A  E  + +    H +     V
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIV 399
Query: 157 QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLI 216
           ++         + ++    G  L+ FL        P+  V EL  Q+   + ++ E   +
Sbjct: 400 RLIGVCQAEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 217 HTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS 276
           H +L   N+LLV+  Y K+ D+        D SY+      SA K               
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT---ARSAGKW-------------- 501
Query: 277 YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                  + APE I    ++   D+WS G  + E  S G+  ++  +  E +A +E+
Sbjct: 502 ----PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 554

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/246 (21%), Positives = 104/246 (42%), Gaps = 35/246 (14%)
Query: 96  ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRC 155
            L ++G G FG VV+      +  VAIK+++  +   +  + E  V+  L+       + 
Sbjct: 28  FLKELGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE-----KL 81
Query: 156 VQIRNWFDYRNHICIVFEKLGPS-LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
           VQ+      +  I I+ E +    L ++LR+  +R F    + E+ + + E++ ++   +
Sbjct: 82  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
            +H DL   N L+     VKV D+  LSR   D     ++     ++             
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFG-LSRYVLDDEETSSVGSKFPVR------------- 186
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL----FQTHENLEHLAMM 330
                    +  PEV++   ++   D+W+ G ++ E+ S   +    F   E  EH+A  
Sbjct: 187 ---------WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 237
Query: 331 ERVLGP 336
            R+  P
Sbjct: 238 LRLYRP 243

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 37/226 (16%)
Query: 95  RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
           + +S++G+G FG V  C      +    LVA+K ++ S    +     EI +L+ L    
Sbjct: 10  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 69
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPS--LYDFLRKNSYRSFPIDLVREL--GRQLLE 205
           I   R V   ++   R  + +V E L PS  L DFL+++  R   +D  R L    Q+ +
Sbjct: 70  IVKYRGV---SYGPGRPELRLVMEYL-PSGCLRDFLQRHRAR---LDASRLLLYSSQICK 122
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
            + ++   R +H DL   NIL+ S  +VK+ D+             K LP       +D 
Sbjct: 123 GMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA----------KLLP-------LDK 165
Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
                     S +     + APE +    ++   D+WS G +L EL
Sbjct: 166 DXXVVREPGQSPIF----WYAPESLSDNIFSRQSDVWSFGVVLYEL 207

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 101/248 (40%), Gaps = 38/248 (15%)
Query: 95  RILSKMGEGTFGQVVEC---FDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHD 149
           +I   +G G FG+V         +++  VAIK ++S    K R   + E  ++ +    +
Sbjct: 10  KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPN 69
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           +     + +         + I+ E +   SL  FLR+N  +   I LV  L R +   + 
Sbjct: 70  V-----IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGML-RGIAAGMK 123
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           ++ ++  +H  L   NIL+ S    KV D+   +FL   + D +Y   L     I+    
Sbjct: 124 YLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR---- 179
Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL 324
                             + APE I    +    D+WS G ++ E+ S GE  +    N 
Sbjct: 180 ------------------WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 221
Query: 325 EHLAMMER 332
           + +  +E+
Sbjct: 222 DVINAIEQ 229

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/233 (22%), Positives = 91/233 (39%), Gaps = 42/233 (18%)
Query: 100 MGEGTFGQVVEC--FDNEKKELV---AIKIVRSINKY--REAAMIEIDVLQRLARHD--- 149
           +G G FG+VVE   F   K++ V   A+K+++S      +EA M E+ ++  L +H+   
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 150 ------IGGTRCVQIRNWFDYRNHICIVFEKLGPSL---YDFLRKNSYRSFPIDLVRELG 200
                   G   + I  +  Y + +  +  K  P L   Y+       +    DL+    
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLH-FS 172
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
            Q+ + +AF+     IH D+   N+LL +    K+ D+        D +Y         +
Sbjct: 173 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 232
Query: 261 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
           K                      + APE I    +    D+WS G +L E+ S
Sbjct: 233 K----------------------WMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 103/243 (42%), Gaps = 40/243 (16%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAM-----IEIDVLQRLARHDIGGT 153
           ++G G FG V + +   KK +  + +    N+  + A+      E +V+Q+L    I   
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI--V 89
Query: 154 RCVQI---RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
           R + I    +W      + +   +LGP L  +L++N  R      + EL  Q+   + ++
Sbjct: 90  RMIGICEAESWM-----LVMEMAELGP-LNKYLQQN--RHVKDKNIIELVHQVSMGMKYL 141
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
            E   +H DL   N+LLV+  Y K+ D+        D +Y+K                  
Sbjct: 142 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK------------------ 183
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAM 329
             Q H        + APE I    ++   D+WS G ++ E  S G+  ++  +  E  AM
Sbjct: 184 -AQTHG--KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 240
Query: 330 MER 332
           +E+
Sbjct: 241 LEK 243

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 103/243 (42%), Gaps = 40/243 (16%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAM-----IEIDVLQRLARHDIGGT 153
           ++G G FG V + +   KK +  + +    N+  + A+      E +V+Q+L    I   
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI--V 75
Query: 154 RCVQI---RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
           R + I    +W      + +   +LGP L  +L++N  R      + EL  Q+   + ++
Sbjct: 76  RMIGICEAESWM-----LVMEMAELGP-LNKYLQQN--RHVKDKNIIELVHQVSMGMKYL 127
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
            E   +H DL   N+LLV+  Y K+ D+        D +Y+K                  
Sbjct: 128 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK------------------ 169
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAM 329
             Q H        + APE I    ++   D+WS G ++ E  S G+  ++  +  E  AM
Sbjct: 170 -AQTHG--KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 226
Query: 330 MER 332
           +E+
Sbjct: 227 LEK 229

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 103/243 (42%), Gaps = 40/243 (16%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAM-----IEIDVLQRLARHDIGGT 153
           ++G G FG V + +   KK +  + +    N+  + A+      E +V+Q+L    I   
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI--V 91
Query: 154 RCVQI---RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
           R + I    +W      + +   +LGP L  +L++N  R      + EL  Q+   + ++
Sbjct: 92  RMIGICEAESWM-----LVMEMAELGP-LNKYLQQN--RHVKDKNIIELVHQVSMGMKYL 143
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
            E   +H DL   N+LLV+  Y K+ D+        D +Y+K                  
Sbjct: 144 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK------------------ 185
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAM 329
             Q H        + APE I    ++   D+WS G ++ E  S G+  ++  +  E  AM
Sbjct: 186 -AQTHG--KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 242
Query: 330 MER 332
           +E+
Sbjct: 243 LEK 245

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 103/243 (42%), Gaps = 40/243 (16%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAM-----IEIDVLQRLARHDIGGT 153
           ++G G FG V + +   KK +  + +    N+  + A+      E +V+Q+L    I   
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI--V 91
Query: 154 RCVQI---RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
           R + I    +W      + +   +LGP L  +L++N  R      + EL  Q+   + ++
Sbjct: 92  RMIGICEAESWM-----LVMEMAELGP-LNKYLQQN--RHVKDKNIIELVHQVSMGMKYL 143
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
            E   +H DL   N+LLV+  Y K+ D+        D +Y+K                  
Sbjct: 144 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK------------------ 185
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAM 329
             Q H        + APE I    ++   D+WS G ++ E  S G+  ++  +  E  AM
Sbjct: 186 -AQTHG--KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 242
Query: 330 MER 332
           +E+
Sbjct: 243 LEK 245

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/255 (23%), Positives = 106/255 (41%), Gaps = 35/255 (13%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+G G +G+V E    +    VA+K ++      E  + E  V++ +   ++     V  
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHT 218
           R   +   +I   F   G +L D+LR+ + +     ++  +  Q+  ++ ++ +   IH 
Sbjct: 85  R---EPPFYIITEFMTYG-NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 140
Query: 219 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV 278
           DL   N L+     VKV D+  LSR                   +  G T   H    + 
Sbjct: 141 DLAARNCLVGENHLVKVADFG-LSR-------------------LMTGDTXTAHAGAKFP 180
Query: 279 VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-------GEALFQTHENLEHLAMME 331
           +    + APE +    ++   D+W+ G +L E+ +       G  L Q +E LE    ME
Sbjct: 181 IK---WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 237
Query: 332 RVLG-PLPHHMVIRA 345
           R  G P   + ++RA
Sbjct: 238 RPEGCPEKVYELMRA 252

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/255 (23%), Positives = 105/255 (41%), Gaps = 35/255 (13%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+G G +G+V E    +    VA+K ++      E  + E  V++ +   ++     V  
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHT 218
           R   +   +I   F   G +L D+LR+ + +     ++  +  Q+  ++ ++ +   IH 
Sbjct: 85  R---EPPFYIITEFMTYG-NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 140
Query: 219 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV 278
           DL   N L+     VKV D+  LSR     +Y  +      IK                 
Sbjct: 141 DLAARNCLVGENHLVKVADFG-LSRLMTGDTYTAHAGAKFPIK----------------- 182
Query: 279 VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-------GEALFQTHENLEHLAMME 331
                + APE +    ++   D+W+ G +L E+ +       G  L Q +E LE    ME
Sbjct: 183 -----WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 237
Query: 332 RVLG-PLPHHMVIRA 345
           R  G P   + ++RA
Sbjct: 238 RPEGCPEKVYELMRA 252

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/255 (23%), Positives = 105/255 (41%), Gaps = 35/255 (13%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+G G +G+V E    +    VA+K ++      E  + E  V++ +   ++     V  
Sbjct: 24  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHT 218
           R   +   +I   F   G +L D+LR+ + +     ++  +  Q+  ++ ++ +   IH 
Sbjct: 84  R---EPPFYIITEFMTYG-NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 139
Query: 219 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV 278
           DL   N L+     VKV D+  LSR     +Y  +      IK                 
Sbjct: 140 DLAARNCLVGENHLVKVADFG-LSRLMTGDTYTAHAGAKFPIK----------------- 181
Query: 279 VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-------GEALFQTHENLEHLAMME 331
                + APE +    ++   D+W+ G +L E+ +       G  L Q +E LE    ME
Sbjct: 182 -----WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 236
Query: 332 RVLG-PLPHHMVIRA 345
           R  G P   + ++RA
Sbjct: 237 RPEGCPEKVYELMRA 251

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/255 (23%), Positives = 105/255 (41%), Gaps = 35/255 (13%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+G G +G+V E    +    VA+K ++      E  + E  V++ +   ++     V  
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHT 218
           R   +   +I   F   G +L D+LR+ + +     ++  +  Q+  ++ ++ +   IH 
Sbjct: 85  R---EPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 140
Query: 219 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV 278
           DL   N L+     VKV D+  LSR     +Y  +      IK                 
Sbjct: 141 DLAARNCLVGENHLVKVADFG-LSRLMTGDTYTAHAGAKFPIK----------------- 182
Query: 279 VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-------GEALFQTHENLEHLAMME 331
                + APE +    ++   D+W+ G +L E+ +       G  L Q +E LE    ME
Sbjct: 183 -----WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 237
Query: 332 RVLG-PLPHHMVIRA 345
           R  G P   + ++RA
Sbjct: 238 RPEGCPEKVYELMRA 252

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 112/289 (38%), Gaps = 65/289 (22%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           ++L  +G+G FG V+    + +   VA+K +++ +   +A + E  V+ +L RH    + 
Sbjct: 196 KLLQTIGKGEFGDVM--LGDYRGNKVAVKCIKN-DATAQAFLAEASVMTQL-RH----SN 247
Query: 155 CVQIRNWF-DYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
            VQ+     + +  + IV E +   SL D+LR         D + +    + E++ ++  
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
              +H DL   N+L+      KV D+     +S      K LP                 
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-LPVK--------------- 351
Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 332
                      + APE +    ++   D+WS G +L E+ S                   
Sbjct: 352 -----------WTAPEALREKKFSTKSDVWSFGILLWEIYS------------------- 381
Query: 333 VLGPLPHHMVIRADR--RAEKYFRRGARLDWPDGA--TSRDSMRAVWKL 377
             G +P+  +   D   R EK    G ++D PDG      D M+  W L
Sbjct: 382 -FGRVPYPRIPLKDVVPRVEK----GYKMDAPDGCPPAVYDVMKNCWHL 425

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/255 (23%), Positives = 105/255 (41%), Gaps = 35/255 (13%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+G G +G+V E    +    VA+K ++      E  + E  V++ +   ++     V  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHT 218
           R   +   +I   F   G +L D+LR+ + +     ++  +  Q+  ++ ++ +   IH 
Sbjct: 80  R---EPPFYIITEFMTYG-NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 135
Query: 219 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV 278
           DL   N L+     VKV D+  LSR     +Y  +      IK                 
Sbjct: 136 DLAARNCLVGENHLVKVADFG-LSRLMTGDTYTAHAGAKFPIK----------------- 177
Query: 279 VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-------GEALFQTHENLEHLAMME 331
                + APE +    ++   D+W+ G +L E+ +       G  L Q +E LE    ME
Sbjct: 178 -----WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 232
Query: 332 RVLG-PLPHHMVIRA 345
           R  G P   + ++RA
Sbjct: 233 RPEGCPEKVYELMRA 247

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/255 (23%), Positives = 105/255 (41%), Gaps = 35/255 (13%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+G G +G+V E    +    VA+K ++      E  + E  V++ +   ++     V  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHT 218
           R   +   +I   F   G +L D+LR+ + +     ++  +  Q+  ++ ++ +   IH 
Sbjct: 80  R---EPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 135
Query: 219 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV 278
           DL   N L+     VKV D+  LSR     +Y  +      IK                 
Sbjct: 136 DLAARNCLVGENHLVKVADFG-LSRLMTGDTYTAHAGAKFPIK----------------- 177
Query: 279 VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-------GEALFQTHENLEHLAMME 331
                + APE +    ++   D+W+ G +L E+ +       G  L Q +E LE    ME
Sbjct: 178 -----WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 232
Query: 332 RVLG-PLPHHMVIRA 345
           R  G P   + ++RA
Sbjct: 233 RPEGCPEKVYELMRA 247

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/255 (23%), Positives = 105/255 (41%), Gaps = 35/255 (13%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+G G +G+V E    +    VA+K ++      E  + E  V++ +   ++     V  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHT 218
           R   +   +I   F   G +L D+LR+ + +     ++  +  Q+  ++ ++ +   IH 
Sbjct: 80  R---EPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 135
Query: 219 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV 278
           DL   N L+     VKV D+  LSR     +Y  +      IK                 
Sbjct: 136 DLAARNCLVGENHLVKVADFG-LSRLMTGDTYTAHAGAKFPIK----------------- 177
Query: 279 VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-------GEALFQTHENLEHLAMME 331
                + APE +    ++   D+W+ G +L E+ +       G  L Q +E LE    ME
Sbjct: 178 -----WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 232
Query: 332 RVLG-PLPHHMVIRA 345
           R  G P   + ++RA
Sbjct: 233 RPEGCPEKVYELMRA 247

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/221 (22%), Positives = 91/221 (41%), Gaps = 37/221 (16%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           ++L  +G+G FG V+    + +   VA+K +++ +   +A + E  V+ +L RH    + 
Sbjct: 15  KLLQTIGKGEFGDVM--LGDYRGNKVAVKCIKN-DATAQAFLAEASVMTQL-RH----SN 66
Query: 155 CVQIRNWF-DYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
            VQ+     + +  + IV E +   SL D+LR         D + +    + E++ ++  
Sbjct: 67  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 126
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
              +H DL   N+L+      KV D+     +S      K LP                 
Sbjct: 127 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-LPVK--------------- 170
Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                      + APE +    ++   D+WS G +L E+ S
Sbjct: 171 -----------WTAPEALREAAFSTKSDVWSFGILLWEIYS 200

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 103/243 (42%), Gaps = 40/243 (16%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAM-----IEIDVLQRLARHDIGGT 153
           ++G G FG V + +   KK +  + +    N+  + A+      E +V+Q+L    I   
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI--V 69
Query: 154 RCVQI---RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
           R + I    +W      + +   +LGP L  +L++N  R      + EL  Q+   + ++
Sbjct: 70  RMIGICEAESWM-----LVMEMAELGP-LNKYLQQN--RHVKDKNIIELVHQVSMGMKYL 121
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
            E   +H DL   N+LLV+  Y K+ D+        D +Y+K                  
Sbjct: 122 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK------------------ 163
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAM 329
             Q H        + APE I    ++   D+WS G ++ E  S G+  ++  +  E  AM
Sbjct: 164 -AQTHG--KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 220
Query: 330 MER 332
           +E+
Sbjct: 221 LEK 223

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 87/205 (42%), Gaps = 35/205 (17%)
Query: 132 REAAMIEIDVLQRLARHDIGGTRCVQI---RNWFDYRNHICIVFEKLGPSLYDFLRKNSY 188
           ++  + E +V+Q+L    I   R + I    +W      + +   +LGP L  +L++N  
Sbjct: 52  KDELLAEANVMQQLDNPYI--VRMIGICEAESWM-----LVMEMAELGP-LNKYLQQN-- 101
Query: 189 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248
           R      + EL  Q+   + ++ E   +H DL   N+LLV+  Y K+ D+        D 
Sbjct: 102 RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 161
Query: 249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308
           +Y+K                    Q H        + APE I    ++   D+WS G ++
Sbjct: 162 NYYK-------------------AQTHG--KWPVKWYAPECINYYKFSSKSDVWSFGVLM 200
Query: 309 VELCS-GEALFQTHENLEHLAMMER 332
            E  S G+  ++  +  E  AM+E+
Sbjct: 201 WEAFSYGQKPYRGMKGSEVTAMLEK 225

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 87/205 (42%), Gaps = 35/205 (17%)
Query: 132 REAAMIEIDVLQRLARHDIGGTRCVQI---RNWFDYRNHICIVFEKLGPSLYDFLRKNSY 188
           ++  + E +V+Q+L    I   R + I    +W      + +   +LGP L  +L++N  
Sbjct: 62  KDELLAEANVMQQLDNPYI--VRMIGICEAESWM-----LVMEMAELGP-LNKYLQQN-- 111
Query: 189 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248
           R      + EL  Q+   + ++ E   +H DL   N+LLV+  Y K+ D+        D 
Sbjct: 112 RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171
Query: 249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308
           +Y+K                    Q H        + APE I    ++   D+WS G ++
Sbjct: 172 NYYK-------------------AQTHG--KWPVKWYAPECINYYKFSSKSDVWSFGVLM 210
Query: 309 VELCS-GEALFQTHENLEHLAMMER 332
            E  S G+  ++  +  E  AM+E+
Sbjct: 211 WEAFSYGQKPYRGMKGSEVTAMLEK 235

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 105/240 (43%), Gaps = 33/240 (13%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR 147
           +NL    +IL   G G+ G VV     + +  VA+K  R +  + + A++EI +L     
Sbjct: 14  KNLVVSEKIL---GYGSSGTVVFQGSFQGRP-VAVK--RMLIDFCDIALMEIKLLTESDD 67
Query: 148 H-DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRE-----LGR 201
           H ++    C +  + F Y     I  E    +L D +   +     + L +E     L R
Sbjct: 68  HPNVIRYYCSETTDRFLY-----IALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI- 260
           Q+   VA +H L++IH DLKP+NIL+ ++        +F +         + L     + 
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSS-------RFTADQQTGAENLRILISDFGLC 175
Query: 261 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG-------WNYPCDLWSVGCILVELCS 313
           K +D G ++F   + +    T  +RAPE++                D++S+GC+   + S
Sbjct: 176 KKLDSGQSSF-RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/230 (22%), Positives = 97/230 (42%), Gaps = 36/230 (15%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRC 155
           +G G FG+V  C   +  ++ A+K +      + +    A+ E  +L  ++  D     C
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
           +     F   + +  + + + G  L+  L ++    F    +R    +++  +  MH   
Sbjct: 257 MSYA--FHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRF 312
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           +++ DLKP NILL    +V++ D            + K  P +S                
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLAC------DFSKKKPHAS---------------- 350
Query: 275 HSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
               V T  Y APEV+  G+ ++   D +S+GC+L +L  G + F+ H+ 
Sbjct: 351 ----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 97/230 (42%), Gaps = 46/230 (20%)
Query: 95  RILSKMGEGTFGQVVEC-FDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           R+L K+G+G+FG V    +D    + V++ +            ++ DVL +    D    
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAV----------KCLKPDVLSQPEAMD-DFI 69
Query: 154 RCVQIRNWFDYRNHICI----------VFEKLGP--SLYDFLRKNSYRSFPIDLVRELGR 201
           R V   +  D+RN I +          +  +L P  SL D LRK+    F +  +     
Sbjct: 70  REVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAV 128
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           Q+ E + ++   R IH DL   N+LL + + VK+ D+  +          + LP++    
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM----------RALPQNDDHX 178
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
           ++         Q+H  V     + APE +    +++  D W  G  L E+
Sbjct: 179 VM---------QEHRKVPFA--WCAPESLKTRTFSHASDTWMFGVTLWEM 217

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 100/231 (43%), Gaps = 32/231 (13%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           + ++G G FG +V       K+ VAIK ++  +   +  + E +V+ +L+       + V
Sbjct: 32  VQEIGSGQFG-LVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSH-----PKLV 85
Query: 157 QIRNWFDYRNHICIVFEKLGPS-LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           Q+      +  IC+VFE +    L D+LR      F  + +  +   + E +A++ E  +
Sbjct: 86  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACV 144
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           IH DL   N L+   + +KV D+  ++R   D  Y  +      +K              
Sbjct: 145 IHRDLAARNCLVGENQVIKVSDFG-MTRFVLDDQYTSSTGTKFPVK-------------- 189
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 325
                   + +PEV     ++   D+WS G ++ E+ S G+  ++   N E
Sbjct: 190 --------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 232

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/230 (22%), Positives = 97/230 (42%), Gaps = 36/230 (15%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRC 155
           +G G FG+V  C   +  ++ A+K +      + +    A+ E  +L  ++  D     C
Sbjct: 196 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 255
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
           +     F   + +  + + + G  L+  L ++    F    +R    +++  +  MH   
Sbjct: 256 MSYA--FHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRF 311
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           +++ DLKP NILL    +V++ D            + K  P +S                
Sbjct: 312 VVYRDLKPANILLDEHGHVRISDLGLAC------DFSKKKPHAS---------------- 349
Query: 275 HSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
               V T  Y APEV+  G+ ++   D +S+GC+L +L  G + F+ H+ 
Sbjct: 350 ----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 395

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/255 (23%), Positives = 105/255 (41%), Gaps = 35/255 (13%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+G G +G+V E    +    VA+K ++      E  + E  V++ +   ++     V  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHT 218
           R   +   +I   F   G +L D+LR+ + +     ++  +  Q+  ++ ++ +   IH 
Sbjct: 80  R---EPPFYIITEFMTYG-NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 135
Query: 219 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV 278
           DL   N L+     VKV D+  LSR     +Y  +      IK                 
Sbjct: 136 DLAARNCLVGENHLVKVADFG-LSRLMTGDTYTAHAGAKFPIK----------------- 177
Query: 279 VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-------GEALFQTHENLEHLAMME 331
                + APE +    ++   D+W+ G +L E+ +       G  L Q +E LE    ME
Sbjct: 178 -----WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 232
Query: 332 RVLG-PLPHHMVIRA 345
           R  G P   + ++RA
Sbjct: 233 RPEGCPEKVYELMRA 247

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/230 (22%), Positives = 97/230 (42%), Gaps = 36/230 (15%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRC 155
           +G G FG+V  C   +  ++ A+K +      + +    A+ E  +L  ++  D     C
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
           +     F   + +  + + + G  L+  L ++    F    +R    +++  +  MH   
Sbjct: 257 MSYA--FHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRF 312
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           +++ DLKP NILL    +V++ D            + K  P +S                
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLAC------DFSKKKPHAS---------------- 350
Query: 275 HSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
               V T  Y APEV+  G+ ++   D +S+GC+L +L  G + F+ H+ 
Sbjct: 351 ----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/230 (22%), Positives = 97/230 (42%), Gaps = 36/230 (15%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRC 155
           +G G FG+V  C   +  ++ A+K +      + +    A+ E  +L  ++  D     C
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
           +     F   + +  + + + G  L+  L ++    F    +R    +++  +  MH   
Sbjct: 257 MSYA--FHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRF 312
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
           +++ DLKP NILL    +V++ D            + K  P +S                
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLAC------DFSKKKPHAS---------------- 350
Query: 275 HSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
               V T  Y APEV+  G+ ++   D +S+GC+L +L  G + F+ H+ 
Sbjct: 351 ----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 93/248 (37%), Gaps = 57/248 (22%)
Query: 93  RYRILSKMGEGTFGQVVEC--FDNEKK---ELVAIKIVRSINKYRE--AAMIEIDVLQRL 145
           R ++   +G G FGQV+E   F  +K      VA+K+++    + E  A M E+ +L  +
Sbjct: 28  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 87
Query: 146 ARHDIGGTRCVQIRNWFDYRNH------ICIVFEKLGPSLYDFLRKN-----SYRSFPID 194
             H       + + N             + + F K G +L  +LR        Y+  P D
Sbjct: 88  GHH-------LNVVNLLGACTKPGGPLMVIVEFCKFG-NLSTYLRSKRNEFVPYKVAPED 139
Query: 195 LVREL---------GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
           L ++            Q+ + + F+   + IH DL   NILL     VK+ D+       
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIX 199
Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
           KD    +       +K                      + APE I    +    D+WS G
Sbjct: 200 KDPDXVRKGDARLPLK----------------------WMAPETIFDRVYTIQSDVWSFG 237
Query: 306 CILVELCS 313
            +L E+ S
Sbjct: 238 VLLWEIFS 245

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 70/319 (21%), Positives = 122/319 (38%), Gaps = 69/319 (21%)
Query: 78  KDGHYVFAIGENLTPRYRILSKMGEGTFGQVVE-----CFDNEKKELVAIKIVRSINKYR 132
           K GH+    GE    +  +L ++G+G+FG V E         E +  VA+K V      R
Sbjct: 2   KKGHHHHHHGEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR 61
Query: 133 EAA--MIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLG-PSLYDFLR----- 184
           E    + E  V++    H +     V++           +V E +    L  +LR     
Sbjct: 62  ERIEFLNEASVMKGFTCHHV-----VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPE 116
Query: 185 --KNSYRSFP-IDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241
              N  R  P +  + ++  ++ + +A+++  + +H DL   N ++     VK+ D+  +
Sbjct: 117 AENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFG-M 175
Query: 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDL 301
           +R   +  Y++   K                     ++  R + APE +    +    D+
Sbjct: 176 TRDIYETDYYRKGGKG--------------------LLPVR-WMAPESLKDGVFTTSSDM 214
Query: 302 WSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLD 360
           WS G +L E+ S  E  +Q   N       E+VL                K+   G  LD
Sbjct: 215 WSFGVVLWEITSLAEQPYQGLSN-------EQVL----------------KFVMDGGYLD 251
Query: 361 WPDGATSR--DSMRAVWKL 377
            PD    R  D MR  W+ 
Sbjct: 252 QPDNCPERVTDLMRMCWQF 270

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 103/236 (43%), Gaps = 29/236 (12%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR 147
           +NL    +IL   G G+ G VV     + +  VA+K  R +  + + A++EI +L     
Sbjct: 32  KNLVVSEKIL---GYGSSGTVVFQGSFQGRP-VAVK--RMLIDFCDIALMEIKLLTESDD 85
Query: 148 H-DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRE-----LGR 201
           H ++    C +  + F Y     I  E    +L D +   +     + L +E     L R
Sbjct: 86  HPNVIRYYCSETTDRFLY-----IALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLR 140
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI- 260
           Q+   VA +H L++IH DLKP+NIL+ ++        +F +         + L     + 
Sbjct: 141 QIASGVAHLHSLKIIHRDLKPQNILVSTSS-------RFTADQQTGAENLRILISDFGLC 193
Query: 261 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVI---LGLGWNYPCDLWSVGCILVELCS 313
           K +D G   F   + +    T  +RAPE++            D++S+GC+   + S
Sbjct: 194 KKLDSGQXXF-RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 103/236 (43%), Gaps = 29/236 (12%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR 147
           +NL    +IL   G G+ G VV     + +  VA+K  R +  + + A++EI +L     
Sbjct: 32  KNLVVSEKIL---GYGSSGTVVFQGSFQGRP-VAVK--RMLIDFCDIALMEIKLLTESDD 85
Query: 148 H-DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRE-----LGR 201
           H ++    C +  + F Y     I  E    +L D +   +     + L +E     L R
Sbjct: 86  HPNVIRYYCSETTDRFLY-----IALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLR 140
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI- 260
           Q+   VA +H L++IH DLKP+NIL+ ++        +F +         + L     + 
Sbjct: 141 QIASGVAHLHSLKIIHRDLKPQNILVSTSS-------RFTADQQTGAENLRILISDFGLC 193
Query: 261 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVI---LGLGWNYPCDLWSVGCILVELCS 313
           K +D G   F   + +    T  +RAPE++            D++S+GC+   + S
Sbjct: 194 KKLDSGQXXF-RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 93/248 (37%), Gaps = 57/248 (22%)
Query: 93  RYRILSKMGEGTFGQVVEC--FDNEKK---ELVAIKIVRSINKYRE--AAMIEIDVLQRL 145
           R ++   +G G FGQV+E   F  +K      VA+K+++    + E  A M E+ +L  +
Sbjct: 19  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 78
Query: 146 ARHDIGGTRCVQIRNWFDYRNH------ICIVFEKLGPSLYDFLRKN-----SYRSFPID 194
             H       + + N             + + F K G +L  +LR        Y+  P D
Sbjct: 79  GHH-------LNVVNLLGACTKPGGPLMVIVEFCKFG-NLSTYLRSKRNEFVPYKVAPED 130
Query: 195 LVREL---------GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
           L ++            Q+ + + F+   + IH DL   NILL     VK+ D+       
Sbjct: 131 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIX 190
Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
           KD    +       +K                      + APE I    +    D+WS G
Sbjct: 191 KDPDXVRKGDARLPLK----------------------WMAPETIFDRVYTIQSDVWSFG 228
Query: 306 CILVELCS 313
            +L E+ S
Sbjct: 229 VLLWEIFS 236

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 94/230 (40%), Gaps = 46/230 (20%)
Query: 95  RILSKMGEGTFGQVVEC-FDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           R+L K+G+G+FG V    +D    + V++ +            ++ DVL +    D    
Sbjct: 11  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAV----------KCLKPDVLSQPEAMD-DFI 59
Query: 154 RCVQIRNWFDYRNHICIVFEKLGP------------SLYDFLRKNSYRSFPIDLVRELGR 201
           R V   +  D+RN I +    L P            SL D LRK+    F +  +     
Sbjct: 60  REVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAV 118
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           Q+ E + ++   R IH DL   N+LL + + VK+ D+  +          + LP++    
Sbjct: 119 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM----------RALPQN---- 164
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
             D      EH+   +      + APE +    +++  D W  G  L E+
Sbjct: 165 --DDHXVMQEHRKVPFA-----WCAPESLKTRTFSHASDTWMFGVTLWEM 207

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/255 (23%), Positives = 105/255 (41%), Gaps = 35/255 (13%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+G G +G+V E    +    VA+K ++      E  + E  V++ +   ++     V  
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHT 218
           R   +   +I   F   G +L D+LR+ + +     ++  +  Q+  ++ ++ +   IH 
Sbjct: 85  R---EPPFYIITEFMTYG-NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 140
Query: 219 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV 278
           DL   N L+     VKV D+  LSR     +Y  +      IK                 
Sbjct: 141 DLAARNCLVGENHLVKVADFG-LSRLMTGDTYTAHAGAKFPIK----------------- 182
Query: 279 VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-------GEALFQTHENLEHLAMME 331
                + APE +    ++   D+W+ G +L E+ +       G  L Q +E LE    ME
Sbjct: 183 -----WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 237
Query: 332 RVLG-PLPHHMVIRA 345
           R  G P   + ++RA
Sbjct: 238 RPEGCPEKVYELMRA 252

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 97/245 (39%), Gaps = 51/245 (20%)
Query: 92  PRYRI-LSK-MGEGTFGQVVEC--FDNEKK---ELVAIKIVRSINKYRE--AAMIEIDVL 142
           PR R+ L K +G G FGQV+E   F  +K      VA+K+++    + E  A M E+ +L
Sbjct: 25  PRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKIL 84
Query: 143 QRLARH----DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI-DLVR 197
             +  H    ++ G  C +          + + F K G +L  +LR       P  DL +
Sbjct: 85  IHIGHHLNVVNLLGA-CTKPGGPL----MVIVEFCKFG-NLSTYLRSKRNEFVPYKDLYK 138
Query: 198 EL---------GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248
           +            Q+ + + F+   + IH DL   NILL     VK+ D+       KD 
Sbjct: 139 DFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 198
Query: 249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308
            Y +       +K                      + APE I    +    D+WS G +L
Sbjct: 199 DYVRKGDARLPLK----------------------WMAPETIFDRVYTIQSDVWSFGVLL 236
Query: 309 VELCS 313
            E+ S
Sbjct: 237 WEIFS 241

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/255 (23%), Positives = 105/255 (41%), Gaps = 35/255 (13%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+G G +G+V E    +    VA+K ++      E  + E  V++ +   ++     V  
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHT 218
           R   +   +I   F   G +L D+LR+ + +     ++  +  Q+  ++ ++ +   IH 
Sbjct: 82  R---EPPFYIITEFMTYG-NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 137
Query: 219 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV 278
           DL   N L+     VKV D+  LSR     +Y  +      IK                 
Sbjct: 138 DLAARNCLVGENHLVKVADFG-LSRLMTGDTYTAHAGAKFPIK----------------- 179
Query: 279 VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-------GEALFQTHENLEHLAMME 331
                + APE +    ++   D+W+ G +L E+ +       G  L Q +E LE    ME
Sbjct: 180 -----WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 234
Query: 332 RVLG-PLPHHMVIRA 345
           R  G P   + ++RA
Sbjct: 235 RPEGCPEKVYELMRA 249

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/255 (23%), Positives = 105/255 (41%), Gaps = 35/255 (13%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+G G +G+V E    +    VA+K ++      E  + E  V++ +   ++     V  
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHT 218
           R   +   +I   F   G +L D+LR+ + +     ++  +  Q+  ++ ++ +   IH 
Sbjct: 82  R---EPPFYIITEFMTYG-NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 137
Query: 219 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV 278
           DL   N L+     VKV D+  LSR     +Y  +      IK                 
Sbjct: 138 DLAARNCLVGENHLVKVADFG-LSRLMTGDTYTAHAGAKFPIK----------------- 179
Query: 279 VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-------GEALFQTHENLEHLAMME 331
                + APE +    ++   D+W+ G +L E+ +       G  L Q +E LE    ME
Sbjct: 180 -----WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 234
Query: 332 RVLG-PLPHHMVIRA 345
           R  G P   + ++RA
Sbjct: 235 RPEGCPEKVYELMRA 249

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 94/230 (40%), Gaps = 46/230 (20%)
Query: 95  RILSKMGEGTFGQVVEC-FDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           R+L K+G+G+FG V    +D    + V++ +            ++ DVL +    D    
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAV----------KCLKPDVLSQPEAMD-DFI 69
Query: 154 RCVQIRNWFDYRNHICIVFEKLGP------------SLYDFLRKNSYRSFPIDLVRELGR 201
           R V   +  D+RN I +    L P            SL D LRK+    F +  +     
Sbjct: 70  REVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAV 128
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           Q+ E + ++   R IH DL   N+LL + + VK+ D+  +          + LP++    
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM----------RALPQN---- 174
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
                   +  Q+H  V     + APE +    +++  D W  G  L E+
Sbjct: 175 -----DDHYVMQEHRKVPFA--WCAPESLKTRTFSHASDTWMFGVTLWEM 217

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/255 (23%), Positives = 105/255 (41%), Gaps = 35/255 (13%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+G G +G+V E    +    VA+K ++      E  + E  V++ +   ++     V  
Sbjct: 33  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHT 218
           R   +   +I   F   G +L D+LR+ + +     ++  +  Q+  ++ ++ +   IH 
Sbjct: 93  R---EPPFYIITEFMTYG-NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 148
Query: 219 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV 278
           DL   N L+     VKV D+  LSR     +Y  +      IK                 
Sbjct: 149 DLAARNCLVGENHLVKVADFG-LSRLMTGDTYTAHAGAKFPIK----------------- 190
Query: 279 VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-------GEALFQTHENLEHLAMME 331
                + APE +    ++   D+W+ G +L E+ +       G  L Q +E LE    ME
Sbjct: 191 -----WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 245
Query: 332 RVLG-PLPHHMVIRA 345
           R  G P   + ++RA
Sbjct: 246 RPEGCPEKVYELMRA 260

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 94/230 (40%), Gaps = 46/230 (20%)
Query: 95  RILSKMGEGTFGQVVEC-FDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           R+L K+G+G+FG V    +D    + V++ +            ++ DVL +    D    
Sbjct: 15  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAV----------KCLKPDVLSQPEAMD-DFI 63
Query: 154 RCVQIRNWFDYRNHICIVFEKLGP------------SLYDFLRKNSYRSFPIDLVRELGR 201
           R V   +  D+RN I +    L P            SL D LRK+    F +  +     
Sbjct: 64  REVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAV 122
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           Q+ E + ++   R IH DL   N+LL + + VK+ D+  +          + LP++    
Sbjct: 123 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM----------RALPQN---- 168
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
                   +  Q+H  V     + APE +    +++  D W  G  L E+
Sbjct: 169 -----DDHYVMQEHRKVPFA--WCAPESLKTRTFSHASDTWMFGVTLWEM 211

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 94/230 (40%), Gaps = 46/230 (20%)
Query: 95  RILSKMGEGTFGQVVEC-FDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           R+L K+G+G+FG V    +D    + V++ +            ++ DVL +    D    
Sbjct: 15  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAV----------KCLKPDVLSQPEAMD-DFI 63
Query: 154 RCVQIRNWFDYRNHICIVFEKLGP------------SLYDFLRKNSYRSFPIDLVRELGR 201
           R V   +  D+RN I +    L P            SL D LRK+    F +  +     
Sbjct: 64  REVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAV 122
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           Q+ E + ++   R IH DL   N+LL + + VK+ D+  +          + LP++    
Sbjct: 123 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM----------RALPQN---- 168
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
                   +  Q+H  V     + APE +    +++  D W  G  L E+
Sbjct: 169 -----DDHYVMQEHRKVPFA--WCAPESLKTRTFSHASDTWMFGVTLWEM 211

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 94/227 (41%), Gaps = 43/227 (18%)
Query: 98  SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEI---DVLQRLARHDIGGTR 154
           +KMGEG FG V + + N     VA+K        + AAM++I   ++ Q+  +      +
Sbjct: 31  NKMGEGGFGVVYKGYVNNTT--VAVK--------KLAAMVDITTEELKQQFDQEIKVMAK 80
Query: 155 C-----VQIRNWFDYRNHICIVFEKL-GPSLYDFLR-KNSYRSFPIDLVRELGRQLLESV 207
           C     V++  +    + +C+V+  +   SL D L   +        +  ++ +     +
Sbjct: 81  CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGI 140
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
            F+HE   IH D+K  NILL  A   K+ D+     S K                  F  
Sbjct: 141 NFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK------------------FAQ 182
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                +    +V T  Y APE + G       D++S G +L+E+ +G
Sbjct: 183 XVMXXR----IVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITG 224

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 95/232 (40%), Gaps = 46/232 (19%)
Query: 95  RILSKMGEGTFGQVVEC-FDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           R+L K+G+G+FG V    +D    + V++ +            ++ DVL +    D    
Sbjct: 11  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAV----------KCLKPDVLSQPEAMD-DFI 59
Query: 154 RCVQIRNWFDYRNHICIVFEKLGP------------SLYDFLRKNSYRSFPIDLVRELGR 201
           R V   +  D+RN I +    L P            SL D LRK+    F +  +     
Sbjct: 60  REVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAV 118
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           Q+ E + ++   R IH DL   N+LL + + VK+ D+  +          + LP++    
Sbjct: 119 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM----------RALPQN---- 164
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                   +  Q+H  V     + APE +    +++  D W  G  L E+ +
Sbjct: 165 -----DDHYVMQEHRKVPFA--WCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 93/246 (37%), Gaps = 53/246 (21%)
Query: 93  RYRILSKMGEGTFGQVVEC--FDNEKK---ELVAIKIVRSINKYRE--AAMIEIDVLQRL 145
           R ++   +G G FGQV+E   F  +K      VA+K+++    + E  A M E+ +L  +
Sbjct: 19  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 78
Query: 146 ARH----DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKN-----SYRSFPIDLV 196
             H    ++ G  C +           C    K G +L  +LR        Y+  P DL 
Sbjct: 79  GHHLNVVNLLGA-CTKPGGPLMVITEFC----KFG-NLSTYLRSKRNEFVPYKVAPEDLY 132
Query: 197 REL---------GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247
           ++            Q+ + + F+   + IH DL   NILL     VK+ D+       KD
Sbjct: 133 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 192
Query: 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCI 307
               +       +K                      + APE I    +    D+WS G +
Sbjct: 193 PDXVRKGDARLPLK----------------------WMAPETIFDRVYTIQSDVWSFGVL 230
Query: 308 LVELCS 313
           L E+ S
Sbjct: 231 LWEIFS 236

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 93/248 (37%), Gaps = 57/248 (22%)
Query: 93  RYRILSKMGEGTFGQVVEC--FDNEKK---ELVAIKIVRSINKYRE--AAMIEIDVLQRL 145
           R ++   +G G FGQV+E   F  +K      VA+K+++    + E  A M E+ +L  +
Sbjct: 28  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 87
Query: 146 ARHDIGGTRCVQIRNWFDYRNH------ICIVFEKLGPSLYDFLRKN-----SYRSFPID 194
             H       + + N             + + F K G +L  +LR        Y+  P D
Sbjct: 88  GHH-------LNVVNLLGACTKPGGPLMVIVEFCKFG-NLSTYLRSKRNEFVPYKVAPED 139
Query: 195 LVREL---------GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
           L ++            Q+ + + F+   + IH DL   NILL     VK+ D+       
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
           KD    +       +K                      + APE I    +    D+WS G
Sbjct: 200 KDPDXVRKGDARLPLK----------------------WMAPETIFDRVYTIQSDVWSFG 237
Query: 306 CILVELCS 313
            +L E+ S
Sbjct: 238 VLLWEIFS 245

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 95/232 (40%), Gaps = 46/232 (19%)
Query: 95  RILSKMGEGTFGQVVEC-FDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           R+L K+G+G+FG V    +D    + V++ +            ++ DVL +    D    
Sbjct: 11  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAV----------KCLKPDVLSQPEAMD-DFI 59
Query: 154 RCVQIRNWFDYRNHICIVFEKLGP------------SLYDFLRKNSYRSFPIDLVRELGR 201
           R V   +  D+RN I +    L P            SL D LRK+    F +  +     
Sbjct: 60  REVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAV 118
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           Q+ E + ++   R IH DL   N+LL + + VK+ D+  +          + LP++    
Sbjct: 119 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM----------RALPQN---- 164
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                   +  Q+H  V     + APE +    +++  D W  G  L E+ +
Sbjct: 165 -----DDHYVMQEHRKVPFA--WCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 59/255 (23%), Positives = 106/255 (41%), Gaps = 35/255 (13%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+G G +G+V E    +    VA+K ++      E  + E  V++ +   ++     V  
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHT 218
           R   +   +I I F   G +L D+LR+ + +     ++  +  Q+  ++ ++ +   IH 
Sbjct: 78  R---EPPFYIIIEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 133
Query: 219 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV 278
           DL   N L+     VKV D+  LSR                   +  G T   H    + 
Sbjct: 134 DLAARNCLVGENHLVKVADFG-LSR-------------------LMTGDTXTAHAGAKFP 173
Query: 279 VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-------GEALFQTHENLEHLAMME 331
           +    + APE +    ++   D+W+ G +L E+ +       G    Q +E LE    ME
Sbjct: 174 IK---WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRME 230
Query: 332 RVLG-PLPHHMVIRA 345
           R  G P   + ++RA
Sbjct: 231 RPEGCPEKVYELMRA 245

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 46/223 (20%), Positives = 98/223 (43%), Gaps = 34/223 (15%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           + ++G G +G V +       +++A+K +R+    +E   + +D+   ++   +     V
Sbjct: 12  IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDL--DISMRTVDCPFTV 69
Query: 157 QIRNWFDYRNHICIVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMH-EL 213
                      + I  E +  SL  F ++  +  ++ P D++ ++   +++++  +H +L
Sbjct: 70  TFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
            +IH D+KP N+L+ +   VK+ D+         G    ++ K      ID G       
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGI------SGYLVDDVAKD-----IDAG------- 171
Query: 274 DHSYVVSTRHYRAPEVI----LGLGWNYPCDLWSVGCILVELC 312
                   + Y APE I       G++   D+WS+G  ++EL 
Sbjct: 172 -------CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELA 207

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 58/244 (23%), Positives = 97/244 (39%), Gaps = 51/244 (20%)
Query: 93  RYRILSKMGEGTFGQVVEC--FDNEKK---ELVAIKIVRSINKYRE--AAMIEIDVLQRL 145
           R ++   +G G FGQV+E   F  +K      VA+K+++    + E  A M E+ +L  +
Sbjct: 30  RLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHI 89
Query: 146 ARH----DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLR--KNSYRSF-PIDLVRE 198
             H    ++ G  C +          + + F K G +L  +LR  +N +  + P DL ++
Sbjct: 90  GHHLNVVNLLGA-CTKPGGPL----MVIVEFCKFG-NLSTYLRSKRNEFVPYKPEDLYKD 143
Query: 199 L---------GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249
                       Q+ + + F+   + IH DL   NILL     VK+ D+       KD  
Sbjct: 144 FLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 203
Query: 250 YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309
             +       +K                      + APE I    +    D+WS G +L 
Sbjct: 204 XVRKGDARLPLK----------------------WMAPETIFDRVYTIQSDVWSFGVLLW 241
Query: 310 ELCS 313
           E+ S
Sbjct: 242 EIFS 245

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/255 (23%), Positives = 104/255 (40%), Gaps = 35/255 (13%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+G G +G+V E    +    VA+K ++      E  + E  V++ +   ++     V  
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHT 218
           R   +   +I   F   G +L D+LR+ + +     ++  +  Q+  ++ ++ +   IH 
Sbjct: 82  R---EPPFYIITEFMTYG-NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 137
Query: 219 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV 278
           DL   N L+     VKV D+  LSR     +Y         IK                 
Sbjct: 138 DLAARNCLVGENHLVKVADFG-LSRLMTGDTYTAPAGAKFPIK----------------- 179
Query: 279 VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-------GEALFQTHENLEHLAMME 331
                + APE +    ++   D+W+ G +L E+ +       G  L Q +E LE    ME
Sbjct: 180 -----WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 234
Query: 332 RVLG-PLPHHMVIRA 345
           R  G P   + ++RA
Sbjct: 235 RPEGCPEKVYELMRA 249

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/244 (23%), Positives = 100/244 (40%), Gaps = 34/244 (13%)
Query: 95  RILSKMGEGTFGQVVEC---FDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHD 149
           +I   +G G FG+V         +++  VAIK +++   +K R   + E  ++ +    +
Sbjct: 32  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPN 91
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I     + +         + I+ E +   SL  FLRKN  R   I LV  L R +   + 
Sbjct: 92  I-----IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGML-RGIGSGMK 145
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++ ++  +H DL   NIL+ S    KV D+  +SR  +D        +   I +      
Sbjct: 146 YLSDMSAVHRDLAARNILVNSNLVCKVSDFG-MSRVLEDDPEAAYTTRGGKIPI------ 198
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHL 327
                          + APE I    +    D+WS G ++ E+ S GE  +    N + +
Sbjct: 199 --------------RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI 244
Query: 328 AMME 331
             +E
Sbjct: 245 KAIE 248

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/255 (23%), Positives = 104/255 (40%), Gaps = 35/255 (13%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+G G +G+V E    +    VA+K ++      E  + E  V++ +   ++     V  
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHT 218
           R   +   +I   F   G +L D+LR+ + +     ++  +  Q+  ++ ++ +   IH 
Sbjct: 81  R---EPPFYIITEFMTYG-NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 136
Query: 219 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV 278
           DL   N L+     VKV D+  LSR     +Y         IK                 
Sbjct: 137 DLAARNCLVGENHLVKVADFG-LSRLMTGDTYTAPAGAKFPIK----------------- 178
Query: 279 VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-------GEALFQTHENLEHLAMME 331
                + APE +    ++   D+W+ G +L E+ +       G  L Q +E LE    ME
Sbjct: 179 -----WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 233
Query: 332 RVLG-PLPHHMVIRA 345
           R  G P   + ++RA
Sbjct: 234 RPEGCPEKVYELMRA 248

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/221 (22%), Positives = 91/221 (41%), Gaps = 37/221 (16%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           ++L  +G+G FG V+    + +   VA+K +++ +   +A + E  V+ +L RH    + 
Sbjct: 24  KLLQTIGKGEFGDVM--LGDYRGNKVAVKCIKN-DATAQAFLAEASVMTQL-RH----SN 75
Query: 155 CVQIRNWF-DYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
            VQ+     + +  + IV E +   SL D+LR         D + +    + E++ ++  
Sbjct: 76  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
              +H DL   N+L+      KV D+     +S      K LP                 
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-LPVK--------------- 179
Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                      + APE +    ++   D+WS G +L E+ S
Sbjct: 180 -----------WTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 71/153 (46%), Gaps = 18/153 (11%)
Query: 85  AIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR 144
           A+    T  +  L K+G G FG V +C       + AIK  RS  K    ++ E + L+ 
Sbjct: 2   AMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK--RS-KKPLAGSVDEQNALRE 58
Query: 145 LARHDIGGTRCVQIRNWFDYR--NHICIVFEKL-GPSLYDFLRKNSYRSFPI-------D 194
           +  H + G     +R +  +   +H+ I  E   G SL D + +N YR           D
Sbjct: 59  VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISEN-YRIMSYFKEAELKD 117
Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILL 227
           L+ ++GR L     ++H + L+H D+KP NI +
Sbjct: 118 LLLQVGRGL----RYIHSMSLVHMDIKPSNIFI 146

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/244 (23%), Positives = 100/244 (40%), Gaps = 34/244 (13%)
Query: 95  RILSKMGEGTFGQVVEC---FDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHD 149
           +I   +G G FG+V         +++  VAIK +++   +K R   + E  ++ +    +
Sbjct: 11  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPN 70
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I     + +         + I+ E +   SL  FLRKN  R   I LV  L R +   + 
Sbjct: 71  I-----IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGML-RGIGSGMK 124
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++ ++  +H DL   NIL+ S    KV D+  +SR  +D        +   I +      
Sbjct: 125 YLSDMSYVHRDLAARNILVNSNLVCKVSDFG-MSRVLEDDPEAAYTTRGGKIPI------ 177
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHL 327
                          + APE I    +    D+WS G ++ E+ S GE  +    N + +
Sbjct: 178 --------------RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI 223
Query: 328 AMME 331
             +E
Sbjct: 224 KAIE 227

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/255 (23%), Positives = 105/255 (41%), Gaps = 35/255 (13%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+G G FG+V E    +    VA+K ++      E  + E  V++ +   ++     V  
Sbjct: 18  KLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHT 218
           R   +   +I   F   G +L D+LR+ + +     ++  +  Q+  ++ ++ +   IH 
Sbjct: 78  R---EPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 133
Query: 219 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV 278
           DL   N L+     VKV D+  LSR                   +  G T   H    + 
Sbjct: 134 DLAARNCLVGENHLVKVADFG-LSR-------------------LMTGDTXTAHAGAKFP 173
Query: 279 VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-------GEALFQTHENLEHLAMME 331
           +    + APE +    ++   D+W+ G +L E+ +       G    Q +E LE    ME
Sbjct: 174 IK---WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRME 230
Query: 332 RVLG-PLPHHMVIRA 345
           R  G P   + ++RA
Sbjct: 231 RPEGCPEKVYELMRA 245

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 101/248 (40%), Gaps = 38/248 (15%)
Query: 95  RILSKMGEGTFGQVVEC---FDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHD 149
           +I   +G G FG+V         +K+  VAIK ++     + R   + E  ++ +    +
Sbjct: 19  KIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPN 78
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I     +++         + I+ E +   +L  FLR N  +   I LV  L R +   + 
Sbjct: 79  I-----IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGML-RGIASGMR 132
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           ++ E+  +H DL   NIL+ S    KV D+   +FL  +S D +   +L     I+    
Sbjct: 133 YLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIR---- 188
Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL 324
                             + APE I    +    D WS G ++ E+ S GE  +    N 
Sbjct: 189 ------------------WTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQ 230
Query: 325 EHLAMMER 332
           + +  +E+
Sbjct: 231 DVINAIEQ 238

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 103/240 (42%), Gaps = 33/240 (13%)
Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR 147
           +NL    +IL   G G+ G VV     + +  VA+K  R +  + + A++EI +L     
Sbjct: 14  KNLVVSEKIL---GYGSSGTVVFQGSFQGRP-VAVK--RMLIDFCDIALMEIKLLTESDD 67
Query: 148 H-DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRE-----LGR 201
           H ++    C +  + F Y     I  E    +L D +   +     + L +E     L R
Sbjct: 68  HPNVIRYYCSETTDRFLY-----IALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI- 260
           Q+   VA +H L++IH DLKP+NIL+ ++        +F +         + L     + 
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSS-------RFTADQQTGAENLRILISDFGLC 175
Query: 261 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG-------WNYPCDLWSVGCILVELCS 313
           K +D G   F   + +    T  +RAPE++                D++S+GC+   + S
Sbjct: 176 KKLDSGQXXF-RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/255 (23%), Positives = 104/255 (40%), Gaps = 35/255 (13%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+G G +G+V E    +    VA+K ++      E  + E  V++ +   ++     V  
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHT 218
           R    Y   I   F   G +L D+LR+ + +     ++  +  Q+  ++ ++ +   IH 
Sbjct: 287 REPPFY---IITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 342
Query: 219 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV 278
           +L   N L+     VKV D+  LSR     +Y  +      IK                 
Sbjct: 343 NLAARNCLVGENHLVKVADFG-LSRLMTGDTYTAHAGAKFPIK----------------- 384
Query: 279 VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-------GEALFQTHENLEHLAMME 331
                + APE +    ++   D+W+ G +L E+ +       G  L Q +E LE    ME
Sbjct: 385 -----WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 439
Query: 332 RVLG-PLPHHMVIRA 345
           R  G P   + ++RA
Sbjct: 440 RPEGCPEKVYELMRA 454

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 98/231 (42%), Gaps = 32/231 (13%)
Query: 97  LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
           + ++G G FG +V       K+ VAIK +R      E  + E +V+ +L+       + V
Sbjct: 13  VQEIGSGQFG-LVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-----PKLV 66
Query: 157 QIRNWFDYRNHICIVFEKLGPS-LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           Q+      +  IC+V E +    L D+LR      F  + +  +   + E +A++ E  +
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACV 125
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           IH DL   N L+   + +KV D+  ++R   D  Y  +      +K              
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFG-MTRFVLDDQYTSSTGTKFPVK-------------- 170
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 325
                   + +PEV     ++   D+WS G ++ E+ S G+  ++   N E
Sbjct: 171 --------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/221 (22%), Positives = 91/221 (41%), Gaps = 37/221 (16%)
Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           ++L  +G+G FG V+    + +   VA+K +++ +   +A + E  V+ +L RH    + 
Sbjct: 9   KLLQTIGKGEFGDVM--LGDYRGNKVAVKCIKN-DATAQAFLAEASVMTQL-RH----SN 60
Query: 155 CVQIRNWF-DYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
            VQ+     + +  + IV E +   SL D+LR         D + +    + E++ ++  
Sbjct: 61  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 120
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
              +H DL   N+L+      KV D+     +S      K LP                 
Sbjct: 121 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-LPVK--------------- 164
Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                      + APE +    ++   D+WS G +L E+ S
Sbjct: 165 -----------WTAPEALREKKFSTKSDVWSFGILLWEIYS 194

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/244 (23%), Positives = 100/244 (40%), Gaps = 34/244 (13%)
Query: 95  RILSKMGEGTFGQVVEC---FDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHD 149
           +I   +G G FG+V         +++  VAIK +++   +K R   + E  ++ +    +
Sbjct: 17  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPN 76
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I     + +         + I+ E +   SL  FLRKN  R   I LV  L R +   + 
Sbjct: 77  I-----IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGML-RGIGSGMK 130
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++ ++  +H DL   NIL+ S    KV D+  +SR  +D        +   I +      
Sbjct: 131 YLSDMSYVHRDLAARNILVNSNLVCKVSDFG-MSRVLEDDPEAAYTTRGGKIPI------ 183
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHL 327
                          + APE I    +    D+WS G ++ E+ S GE  +    N + +
Sbjct: 184 --------------RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI 229
Query: 328 AMME 331
             +E
Sbjct: 230 KAIE 233

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 69/147 (46%), Gaps = 18/147 (12%)
Query: 91  TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150
           T  +  L K+G G FG V +C       + AIK  RS  K    ++ E + L+ +  H +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK--RS-KKPLAGSVDEQNALREVYAHAV 66
Query: 151 GGTRCVQIRNWFDYR--NHICIVFEKL-GPSLYDFLRKNSYRSFPI-------DLVRELG 200
            G     +R +  +   +H+ I  E   G SL D + +N YR           DL+ ++G
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISEN-YRIMSYFKEAELKDLLLQVG 125
Query: 201 RQLLESVAFMHELRLIHTDLKPENILL 227
           R L     ++H + L+H D+KP NI +
Sbjct: 126 RGL----RYIHSMSLVHMDIKPSNIFI 148

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/244 (22%), Positives = 98/244 (40%), Gaps = 34/244 (13%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+G G +G+V E    +    VA+K ++      E  + E  V++ +   ++     V  
Sbjct: 266 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHT 218
           R    Y   I   F   G +L D+LR+ + +     ++  +  Q+  ++ ++ +   IH 
Sbjct: 326 REPPFY---IITEFMTYG-NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 381
Query: 219 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV 278
           +L   N L+     VKV D+  LSR     +Y  +      IK                 
Sbjct: 382 NLAARNCLVGENHLVKVADFG-LSRLMTGDTYTAHAGAKFPIK----------------- 423
Query: 279 VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-------GEALFQTHENLEHLAMME 331
                + APE +    ++   D+W+ G +L E+ +       G  L Q +E LE    ME
Sbjct: 424 -----WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 478
Query: 332 RVLG 335
           R  G
Sbjct: 479 RPEG 482

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 69/147 (46%), Gaps = 18/147 (12%)
Query: 91  TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150
           T  +  L K+G G FG V +C       + AIK  RS  K    ++ E + L+ +  H +
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK--RS-KKPLAGSVDEQNALREVYAHAV 64
Query: 151 GGTRCVQIRNWFDYR--NHICIVFEKL-GPSLYDFLRKNSYRSFPI-------DLVRELG 200
            G     +R +  +   +H+ I  E   G SL D + +N YR           DL+ ++G
Sbjct: 65  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISEN-YRIMSYFKEAELKDLLLQVG 123
Query: 201 RQLLESVAFMHELRLIHTDLKPENILL 227
           R L     ++H + L+H D+KP NI +
Sbjct: 124 RGL----RYIHSMSLVHMDIKPSNIFI 146

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 69/147 (46%), Gaps = 18/147 (12%)
Query: 91  TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150
           T  +  L K+G G FG V +C       + AIK  RS  K    ++ E + L+ +  H +
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK--RS-KKPLAGSVDEQNALREVYAHAV 62
Query: 151 GGTRCVQIRNWFDYR--NHICIVFEKL-GPSLYDFLRKNSYRSFPI-------DLVRELG 200
            G     +R +  +   +H+ I  E   G SL D + +N YR           DL+ ++G
Sbjct: 63  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISEN-YRIMSYFKEAELKDLLLQVG 121
Query: 201 RQLLESVAFMHELRLIHTDLKPENILL 227
           R L     ++H + L+H D+KP NI +
Sbjct: 122 RGL----RYIHSMSLVHMDIKPSNIFI 144

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 33/220 (15%)
Query: 100 MGEGTFGQVVEC---FDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTR 154
           +G G FG+V        ++K+  VAIK ++     K R   + E  ++ +    +I    
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI---- 108
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            +++         + IV E +   SL  FLRK+  +   I LV  L R +   + ++ ++
Sbjct: 109 -IRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGML-RGIASGMKYLSDM 166
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL   NIL+ S    KV D+  LSR  +D        +   I +           
Sbjct: 167 GAVHRDLAARNILINSNLVCKVSDFG-LSRVLEDDPEAAYTTRGGKIPI----------- 214
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                     + +PE I    +    D+WS G +L E+ S
Sbjct: 215 ---------RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/163 (22%), Positives = 70/163 (42%), Gaps = 38/163 (23%)
Query: 155 CVQIRNWFDYRNHIC-----IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
            VQI N+ ++ +        IV E +G      L+++  +  P+        ++L ++++
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQ---SLKRSKGQKLPVAEAIAYLLEILPALSY 197
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
           +H + L++ DLKPENI+L   +                            +KLID G+ +
Sbjct: 198 LHSIGLVYNDLKPENIMLTEEQ----------------------------LKLIDLGAVS 229
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312
                  Y+  T  ++APE++   G     D+++VG  L  L 
Sbjct: 230 -RINSFGYLYGTPGFQAPEIVR-TGPTVATDIYTVGRTLAALT 270

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 65/304 (21%), Positives = 117/304 (38%), Gaps = 69/304 (22%)
Query: 93  RYRILSKMGEGTFGQVVE-----CFDNEKKELVAIKIVRSINKYRE--AAMIEIDVLQRL 145
           +  +L ++G+G+FG V E         E +  VA+K V      RE    + E  V++  
Sbjct: 18  KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF 77
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKLG-PSLYDFLR-------KNSYRSFP-IDLV 196
             H +     V++           +V E +    L  +LR        N  R  P +  +
Sbjct: 78  TCHHV-----VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256
            ++  ++ + +A+++  + +H DL   N ++     VK+ D+  ++R   + +Y++   K
Sbjct: 133 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFG-MTRDIYETAYYRKGGK 191
Query: 257 SSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GE 315
                                ++  R + APE +    +    D+WS G +L E+ S  E
Sbjct: 192 G--------------------LLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 230
Query: 316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR--DSMRA 373
             +Q   N       E+VL                K+   G  LD PD    R  D MR 
Sbjct: 231 QPYQGLSN-------EQVL----------------KFVMDGGYLDQPDNCPERVTDLMRM 267
Query: 374 VWKL 377
            W+ 
Sbjct: 268 CWQF 271

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 33/220 (15%)
Query: 100 MGEGTFGQVVEC---FDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTR 154
           +G G FG+V        ++K+  VAIK ++     K R   + E  ++ +    +I    
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI---- 108
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            +++         + IV E +   SL  FLRK+  +   I LV  L R +   + ++ ++
Sbjct: 109 -IRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGML-RGIASGMKYLSDM 166
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL   NIL+ S    KV D+  LSR  +D        +   I +           
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFG-LSRVLEDDPEAAYTTRGGKIPI----------- 214
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                     + +PE I    +    D+WS G +L E+ S
Sbjct: 215 ---------RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 94/247 (38%), Gaps = 56/247 (22%)
Query: 93  RYRILSKMGEGTFGQVVEC--FDNEKK---ELVAIKIVRSINKYRE--AAMIEIDVLQRL 145
           R  +   +G G FGQV+E   F  +K      VA+K+++    + E  A M E+ +L  +
Sbjct: 29  RLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 88
Query: 146 ARHDIGGTRCVQIRNWFDYRNH------ICIVFEKLGPSLYDFLR--KNSYRSF--PIDL 195
             H       + + N             + + F K G +L  +LR  +N +  +  P DL
Sbjct: 89  GHH-------LNVVNLLGACTKPGGPLMVIVEFCKFG-NLSTYLRSKRNEFVPYKTPEDL 140
Query: 196 VREL---------GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246
            ++            Q+ + + F+   + IH DL   NILL     VK+ D+       K
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXK 200
Query: 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC 306
           D    +       +K                      + APE I    +    D+WS G 
Sbjct: 201 DPDXVRKGDARLPLK----------------------WMAPETIFDRVYTIQSDVWSFGV 238
Query: 307 ILVELCS 313
           +L E+ S
Sbjct: 239 LLWEIFS 245

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 33/220 (15%)
Query: 100 MGEGTFGQVVEC---FDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTR 154
           +G G FG+V        ++K+  VAIK ++     K R   + E  ++ +    +I    
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI---- 108
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            +++         + IV E +   SL  FLRK+  +   I LV  L R +   + ++ ++
Sbjct: 109 -IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML-RGIASGMKYLSDM 166
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL   NIL+ S    KV D+  LSR  +D        +   I +           
Sbjct: 167 GFVHRDLAARNILINSNLVCKVSDFG-LSRVLEDDPEAAYTTRGGKIPI----------- 214
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                     + +PE I    +    D+WS G +L E+ S
Sbjct: 215 ---------RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/232 (21%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 94  YRILSKMGEGTFGQVV---ECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR-LARHD 149
           + +L  +G G +G+V    +   ++  +L A+K+++     ++A   E    +R +  H 
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                 V +   F     + ++ + + G  L+  L +     F    V+    +++ ++ 
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALE 173
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
            +H+L +I+ D+K ENILL S  +V + D+             K        +  DF  T
Sbjct: 174 HLHKLGIIYRDIKLENILLDSNGHVVLTDF----------GLSKEFVADETERAYDFCGT 223
Query: 269 TFEHQDHSYVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSGEALF 318
                          Y AP+++ G   G +   D WS+G ++ EL +G + F
Sbjct: 224 I-------------EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 86/205 (41%), Gaps = 35/205 (17%)
Query: 132 REAAMIEIDVLQRLARHDIGGTRCVQI---RNWFDYRNHICIVFEKLGPSLYDFLRKNSY 188
           ++  + E +V+Q+L    I   R + I    +W      + +   +LGP L  +L++N  
Sbjct: 56  KDELLAEANVMQQLDNPYI--VRMIGICEAESWM-----LVMEMAELGP-LNKYLQQN-- 105
Query: 189 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248
           R      + EL  Q+   + ++ E   +H DL   N+LLV+  Y K+ D+        D 
Sbjct: 106 RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 165
Query: 249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308
           + +K                    Q H        + APE I    ++   D+WS G ++
Sbjct: 166 NXYK-------------------AQTHG--KWPVKWYAPECINYYKFSSKSDVWSFGVLM 204
Query: 309 VELCS-GEALFQTHENLEHLAMMER 332
            E  S G+  ++  +  E  AM+E+
Sbjct: 205 WEAFSYGQKPYRGMKGSEVTAMLEK 229

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 33/220 (15%)
Query: 100 MGEGTFGQVVEC---FDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTR 154
           +G G FG+V        ++K+  VAIK ++     K R   + E  ++ +    +I    
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI---- 108
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            +++         + IV E +   SL  FLRK+  +   I LV  L R +   + ++ ++
Sbjct: 109 -IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML-RGIASGMKYLSDM 166
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL   NIL+ S    KV D+  LSR  +D        +   I +           
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFG-LSRVLEDDPEAAYTTRGGKIPI----------- 214
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                     + +PE I    +    D+WS G +L E+ S
Sbjct: 215 ---------RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 65/304 (21%), Positives = 116/304 (38%), Gaps = 69/304 (22%)
Query: 93  RYRILSKMGEGTFGQVVE-----CFDNEKKELVAIKIVRSINKYRE--AAMIEIDVLQRL 145
           +  +L ++G+G+FG V E         E +  VA+K V      RE    + E  V++  
Sbjct: 18  KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF 77
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKLG-PSLYDFLR-------KNSYRSFP-IDLV 196
             H +     V++           +V E +    L  +LR        N  R  P +  +
Sbjct: 78  TCHHV-----VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256
            ++  ++ + +A+++  + +H DL   N ++     VK+ D+  ++R   +  Y++   K
Sbjct: 133 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFG-MTRDIYETDYYRKGGK 191
Query: 257 SSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GE 315
                                ++  R + APE +    +    D+WS G +L E+ S  E
Sbjct: 192 G--------------------LLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 230
Query: 316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR--DSMRA 373
             +Q   N       E+VL                K+   G  LD PD    R  D MR 
Sbjct: 231 QPYQGLSN-------EQVL----------------KFVMDGGYLDQPDNCPERVTDLMRM 267
Query: 374 VWKL 377
            W+ 
Sbjct: 268 CWQF 271

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 33/220 (15%)
Query: 100 MGEGTFGQVVEC---FDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTR 154
           +G G FG+V        ++K+  VAIK ++     K R   + E  ++ +    +I    
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI---- 79
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            +++         + IV E +   SL  FLRK+  +   I LV  L R +   + ++ ++
Sbjct: 80  -IRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGML-RGIASGMKYLSDM 137
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL   NIL+ S    KV D+  LSR  +D        +   I +           
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFG-LSRVLEDDPEAAYTTRGGKIPI----------- 185
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                     + +PE I    +    D+WS G +L E+ S
Sbjct: 186 ---------RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 33/220 (15%)
Query: 100 MGEGTFGQVVEC---FDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTR 154
           +G G FG+V        ++K+  VAIK ++     K R   + E  ++ +    +I    
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI---- 108
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            +++         + IV E +   SL  FLRK+  +   I LV  L R +   + ++ ++
Sbjct: 109 -IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML-RGIASGMKYLSDM 166
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL   NIL+ S    KV D+  LSR  +D        +   I +           
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFG-LSRVLEDDPEAAYTTRGGKIPI----------- 214
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                     + +PE I    +    D+WS G +L E+ S
Sbjct: 215 ---------RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 33/220 (15%)
Query: 100 MGEGTFGQVVEC---FDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTR 154
           +G G FG+V        ++K+  VAIK ++     K R   + E  ++ +    +I    
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI---- 108
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            +++         + IV E +   SL  FLRK+  +   I LV  L R +   + ++ ++
Sbjct: 109 -IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML-RGIASGMKYLSDM 166
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL   NIL+ S    KV D+  LSR  +D        +   I +           
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFG-LSRVLEDDPEAAYTTRGGKIPI----------- 214
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                     + +PE I    +    D+WS G +L E+ S
Sbjct: 215 ---------RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 33/220 (15%)
Query: 100 MGEGTFGQVVEC---FDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTR 154
           +G G FG+V        ++K+  VAIK ++     K R   + E  ++ +    +I    
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI---- 108
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            +++         + IV E +   SL  FLRK+  +   I LV  L R +   + ++ ++
Sbjct: 109 -IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML-RGIASGMKYLSDM 166
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL   NIL+ S    KV D+  LSR  +D        +   I +           
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFG-LSRVLEDDPEAAYTTRGGKIPI----------- 214
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                     + +PE I    +    D+WS G +L E+ S
Sbjct: 215 ---------RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 33/220 (15%)
Query: 100 MGEGTFGQVVEC---FDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTR 154
           +G G FG+V        ++K+  VAIK ++     K R   + E  ++ +    +I    
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI---- 106
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            +++         + IV E +   SL  FLRK+  +   I LV  L R +   + ++ ++
Sbjct: 107 -IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML-RGIASGMKYLSDM 164
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL   NIL+ S    KV D+  LSR  +D        +   I +           
Sbjct: 165 GYVHRDLAARNILINSNLVCKVSDFG-LSRVLEDDPEAAYTTRGGKIPI----------- 212
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                     + +PE I    +    D+WS G +L E+ S
Sbjct: 213 ---------RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 58/255 (22%), Positives = 105/255 (41%), Gaps = 35/255 (13%)
Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           K+G G +G+V E    +    VA+K ++      E  + E  V++ +   ++     V  
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHT 218
           R   +   +I   F   G +L D+LR+ + +     ++  +  Q+  ++ ++ +   IH 
Sbjct: 78  R---EPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 133
Query: 219 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV 278
           DL   N L+     VKV D+  LSR                   +  G T   H    + 
Sbjct: 134 DLAARNCLVGENHLVKVADFG-LSR-------------------LMTGDTFTAHAGAKFP 173
Query: 279 VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-------GEALFQTHENLEHLAMME 331
           +    + APE +    ++   D+W+ G +L E+ +       G    Q +E LE    ME
Sbjct: 174 IK---WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRME 230
Query: 332 RVLG-PLPHHMVIRA 345
           R  G P   + ++RA
Sbjct: 231 RPEGCPEKVYELMRA 245

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 33/220 (15%)
Query: 100 MGEGTFGQVVEC---FDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTR 154
           +G G FG+V        ++K+  VAIK ++     K R   + E  ++ +    +I    
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI---- 96
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            +++         + IV E +   SL  FLRK+  +   I LV  L R +   + ++ ++
Sbjct: 97  -IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML-RGIASGMKYLSDM 154
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL   NIL+ S    KV D+  LSR  +D        +   I +           
Sbjct: 155 GYVHRDLAARNILINSNLVCKVSDFG-LSRVLEDDPEAAYTTRGGKIPI----------- 202
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                     + +PE I    +    D+WS G +L E+ S
Sbjct: 203 ---------RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 33/220 (15%)
Query: 100 MGEGTFGQVVEC---FDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTR 154
           +G G FG+V        ++K+  VAIK ++     K R   + E  ++ +    +I    
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI---- 79
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            +++         + IV E +   SL  FLRK+  +   I LV  L R +   + ++ ++
Sbjct: 80  -IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML-RGIASGMKYLSDM 137
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL   NIL+ S    KV D+  LSR  +D        +   I +           
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFG-LSRVLEDDPEAAYTTRGGKIPI----------- 185
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                     + +PE I    +    D+WS G +L E+ S
Sbjct: 186 ---------RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 61/135 (45%), Gaps = 23/135 (17%)
Query: 179 LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
           L D +R+N  R    DL+     Q+ + ++++ ++RL+H DL   N+L+ S  +VK+ D+
Sbjct: 105 LLDHVRENRGRLGSQDLL-NWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDF 163
Query: 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYP 298
                                 +L+D   T + H D   V     + A E IL   + + 
Sbjct: 164 GL-------------------ARLLDIDETEY-HADGGKV--PIKWMALESILRRRFTHQ 201
Query: 299 CDLWSVGCILVELCS 313
            D+WS G  + EL +
Sbjct: 202 SDVWSYGVTVWELMT 216

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 73/324 (22%), Positives = 126/324 (38%), Gaps = 51/324 (15%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYR--EAAMIEIDVLQRLARHDIGGTRCVQ 157
           +G+G    V      +  +L AIK+  +I+  R  +  M E +VL++L   +I   +   
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI--VKLFA 74
Query: 158 IRNWFDYRNHICIVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           I      R+ + I+      SLY  L +  N+Y   P      + R ++  +  + E  +
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY-GLPESEFLIVLRDVVGGMNHLRENGI 133
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           +H ++KP NI+ V  E               DG         S  KL DFG+      D 
Sbjct: 134 VHRNIKPGNIMRVIGE---------------DG--------QSVYKLTDFGAARELEDDE 170
Query: 276 SYVV--STRHYRAPEV----IL----GLGWNYPCDLWSVGCILVELCSGEALFQTHEN-L 324
            +V    T  Y  P++    +L       +    DLWS+G       +G   F+  E   
Sbjct: 171 QFVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
Query: 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID 384
            +  +M +++   P    I   ++AE        +DW        S+    ++L  PV+ 
Sbjct: 231 RNKEVMYKIITGKPSG-AISGVQKAEN-----GPIDWSGDMPVSCSLSRGLQVLLTPVLA 284
Query: 385 --LYSASPNC--LCKFYAITHCLL 404
             L +    C    +F+A T  +L
Sbjct: 285 NILEADQEKCWGFDQFFAETSDIL 308

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 52/119 (43%), Gaps = 23/119 (19%)
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
           RQ+  ++   H     H D+KPENIL+ + ++  + D+   S ++ +             
Sbjct: 141 RQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE------------- 187
Query: 261 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
           KL   G+T          V T +Y APE        Y  D++++ C+L E  +G   +Q
Sbjct: 188 KLTQLGNT----------VGTLYYXAPERFSESHATYRADIYALTCVLYECLTGSPPYQ 236

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 96/239 (40%), Gaps = 34/239 (14%)
Query: 100 MGEGTFGQVVEC---FDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTR 154
           +G G FG+V         +++  VAIK ++     K R   + E  ++ +    +I    
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI---- 85
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            + +         + IV E +   SL  FL+KN  +   I LV  L R +   + ++ ++
Sbjct: 86  -IHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGML-RGISAGMKYLSDM 143
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL   NIL+ S    KV D+  LSR  +D        +   I +           
Sbjct: 144 GYVHRDLAARNILINSNLVCKVSDFG-LSRVLEDDPEAAYTTRGGKIPI----------- 191
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMME 331
                     + APE I    +    D+WS G ++ E+ S GE  +    N + +  +E
Sbjct: 192 ---------RWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVE 241

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 58/240 (24%), Positives = 95/240 (39%), Gaps = 39/240 (16%)
Query: 100 MGEGTFGQV---VECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDIGGTR 154
           +GEG FG V   +          VAIK  +  + +  RE  + E   +++     I    
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 155 CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVREL--GRQLLESVAFMHE 212
            V   N       +C + E     L  FL+    R F +DL   +    QL  ++A++  
Sbjct: 78  GVITENPVWIIMELCTLGE-----LRSFLQ---VRKFSLDLASLILYAYQLSTALAYLES 129
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
            R +H D+   N+L+ + + VK+ D+  LSR  +D +Y+K       IK           
Sbjct: 130 KRFVHRDIAARNVLVSATDCVKLGDFG-LSRYMEDSTYYKASKGKLPIK----------- 177
Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG-CILVELCSGEALFQTHENLEHLAMME 331
                      + APE I    +    D+W  G C+   L  G   FQ  +N + +  +E
Sbjct: 178 -----------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 226

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 70/330 (21%), Positives = 121/330 (36%), Gaps = 80/330 (24%)
Query: 93  RYRILSKMGEGTFGQVVE-----CFDNEKKELVAIKIVRSINKYREAA--MIEIDVLQRL 145
           +  +L ++G+G+FG V E         E +  VA+K V      RE    + E  V++  
Sbjct: 18  KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF 77
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKLG-PSLYDFLR-------KNSYRSFP-IDLV 196
             H +     V++           +V E +    L  +LR        N  R  P +  +
Sbjct: 78  TCHHV-----VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256
            ++  ++ + +A+++  + +H DL   N ++     VK+ D+  ++R             
Sbjct: 133 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFG-MTR------------- 178
Query: 257 SSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GE 315
                  D   T    +    ++  R + APE +    +    D+WS G +L E+ S  E
Sbjct: 179 -------DIXETDXXRKGGKGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 230
Query: 316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR--DSMRA 373
             +Q   N       E+VL                K+   G  LD PD    R  D MR 
Sbjct: 231 QPYQGLSN-------EQVL----------------KFVMDGGYLDQPDNCPERVTDLMRM 267
Query: 374 VWKLLRLPVIDLYSASPNCLCKFYAITHCL 403
            W+            +PN    F  I + L
Sbjct: 268 CWQF-----------NPNMRPTFLEIVNLL 286

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 33/220 (15%)
Query: 100 MGEGTFGQVVEC---FDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTR 154
           +G G FG+V        ++K+  VAIK ++     K R   + E  ++ +    +I    
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI---- 108
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            +++         + IV E +   SL  FLRK+  +   I LV  L R +   + ++ ++
Sbjct: 109 -IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML-RGIASGMKYLSDM 166
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL   NIL+ S    KV D+  L+R  +D        +   I +           
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFG-LARVLEDDPEAAYTTRGGKIPI----------- 214
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                     + +PE I    +    D+WS G +L E+ S
Sbjct: 215 ---------RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 69/330 (20%), Positives = 123/330 (37%), Gaps = 80/330 (24%)
Query: 93  RYRILSKMGEGTFGQVVE-----CFDNEKKELVAIKIVRSINKYREAA--MIEIDVLQRL 145
           +  +L ++G+G+FG V E         E +  VA+K V      RE    + E  V++  
Sbjct: 19  KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF 78
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKLG-PSLYDFLR-------KNSYRSFP-IDLV 196
             H +     V++           +V E +    L  +LR        N  R  P +  +
Sbjct: 79  TCHHV-----VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 133
Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256
            ++  ++ + +A+++  + +H +L   N ++     VK+ D+  ++R   +  Y++   K
Sbjct: 134 IQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFG-MTRDIYETDYYRKGGK 192
Query: 257 SSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GE 315
                                ++  R + APE +    +    D+WS G +L E+ S  E
Sbjct: 193 G--------------------LLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 231
Query: 316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR--DSMRA 373
             +Q   N       E+VL                K+   G  LD PD    R  D MR 
Sbjct: 232 QPYQGLSN-------EQVL----------------KFVMDGGYLDQPDNCPERVTDLMRM 268
Query: 374 VWKLLRLPVIDLYSASPNCLCKFYAITHCL 403
            W+            +PN    F  I + L
Sbjct: 269 CWQF-----------NPNMRPTFLEIVNLL 287

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 129/331 (38%), Gaps = 51/331 (15%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYR--EAAMIEIDVLQRLARHDIGGTRCVQ 157
           +G+G    V      +  +L AIK+  +I+  R  +  M E +VL++L   +I   +   
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI--VKLFA 74
Query: 158 IRNWFDYRNHICIVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           I      R+ + I+      SLY  L +  N+Y   P      + R ++  +  + E  +
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY-GLPESEFLIVLRDVVGGMNHLRENGI 133
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           +H ++KP NI+ V  E               DG         S  KL DFG+      D 
Sbjct: 134 VHRNIKPGNIMRVIGE---------------DG--------QSVYKLTDFGAARELEDDE 170
Query: 276 SYV--VSTRHYRAPEV----IL----GLGWNYPCDLWSVGCILVELCSGEALFQTHEN-L 324
            +V    T  Y  P++    +L       +    DLWS+G       +G   F+  E   
Sbjct: 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
Query: 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID 384
            +  +M +++   P    I   ++AE        +DW        S+    ++L  PV+ 
Sbjct: 231 RNKEVMYKIITGKPSG-AISGVQKAEN-----GPIDWSGDMPVSCSLSRGLQVLLTPVLA 284
Query: 385 --LYSASPNC--LCKFYAITHCLLCSILCYC 411
             L +    C    +F+A T  +L  ++ + 
Sbjct: 285 NILEADQEKCWGFDQFFAETSDILHRMVIHV 315

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 69/330 (20%), Positives = 123/330 (37%), Gaps = 80/330 (24%)
Query: 93  RYRILSKMGEGTFGQVVE-----CFDNEKKELVAIKIVRSINKYRE--AAMIEIDVLQRL 145
           +  +L ++G+G+FG V E         E +  VA+K V      RE    + E  V++  
Sbjct: 18  KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF 77
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKLG-PSLYDFLR-------KNSYRSFP-IDLV 196
             H +     V++           +V E +    L  +LR        N  R  P +  +
Sbjct: 78  TCHHV-----VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256
            ++  ++ + +A+++  + +H +L   N ++     VK+ D+  ++R   +  Y++   K
Sbjct: 133 IQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFG-MTRDIYETDYYRKGGK 191
Query: 257 SSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GE 315
                                ++  R + APE +    +    D+WS G +L E+ S  E
Sbjct: 192 G--------------------LLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 230
Query: 316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR--DSMRA 373
             +Q   N       E+VL                K+   G  LD PD    R  D MR 
Sbjct: 231 QPYQGLSN-------EQVL----------------KFVMDGGYLDQPDNCPERVTDLMRM 267
Query: 374 VWKLLRLPVIDLYSASPNCLCKFYAITHCL 403
            W+            +PN    F  I + L
Sbjct: 268 CWQF-----------NPNMRPTFLEIVNLL 286

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	411
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-174
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-162
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-161
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-133
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-132
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-120
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-103
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-43
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-42
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-41
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-40
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-40
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-40
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-39
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-39
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-39
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-38
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-38
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-38
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-38
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-37
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-37
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-37
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-37
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-37
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-37
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	9e-37
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-36
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-36
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-36
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	9e-36
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-35
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-35
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-35
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-35
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-35
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-35
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	9e-35
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-35
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-34
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-34
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-34
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-34
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-34
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-34
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-34
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-34
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-34
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-34
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-34
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-34
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-34
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	7e-34
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-34
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	8e-34
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-34
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-33
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-33
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-33
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-33
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-33
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-33
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-33
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	7e-33
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-32
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-32
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-32
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-32
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-31
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-31
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-31
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-31
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-31
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-31
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-31
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-30
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-30
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-30
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-30
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-30
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-30
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	7e-30
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	8e-30
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-29
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-29
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-29
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-29
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-29
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-29
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	8e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-28
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-28
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-28
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-28
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	6e-28
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-28
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-27
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-27
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-27
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-27
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-26
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-25
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-24
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-24
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-23
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-23
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-23
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-23
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-23
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-23
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-23
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	9e-23
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-22
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-22
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-22
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-22
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	9e-22
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-21
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-21
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-21
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-21
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-21
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-21
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-21
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-21
3an0_A	340	Dual specificity mitogen-activated protein kinase;	7e-21
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-21
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-21
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-20
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-20
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-20
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-20
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-20
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-20
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-20
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-20
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-20
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	9e-20
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-20
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-19
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-18
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-18
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-18
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-18
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-18
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	7e-18
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-17
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-17
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-17
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-17
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-17
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	9e-17
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-16
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-16
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-16
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-16
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-16
3q4u_A	301	Activin receptor type-1; structural genomics conso	7e-16
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-15
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-15
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-15
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-15
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-15
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-15
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-15
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-14
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-14
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-14
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-14
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	9e-14
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-13
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-13
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-12
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-12
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-12
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-12
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-12
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-12
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-12
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-11
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-11
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-11
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-10
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-10
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-10
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-10
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-10
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-10
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-10
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-10
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	8e-10
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-09
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-09
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-09
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-09
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-09
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-09
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-09
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-09
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-09
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-08
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-08
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-08
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-08
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-08
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-08
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-07
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-07
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-07
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-07
3pls_A	298	Macrophage-stimulating protein receptor; protein k	7e-07
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-06
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-06
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-06
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-06
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-06
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-05
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-05
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-05
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	5e-05
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-04
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-04
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-04

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  488 bits (1259), Expect = e-174
 Identities = 123/317 (38%), Positives = 194/317 (61%), Gaps = 4/317 (1%)

Query: 66  PRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV 125
               +  ++ DD+  H+ +  G  L   + ++ KMG+GTFG+V+ C   + K+  A+K+V
Sbjct: 9   SGRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV 68

Query: 126 RSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
           R+I KY  +A IE D+L+++   DI     V+    F Y +H+C++FE LGPSLY+ + +
Sbjct: 69  RNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITR 128

Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
           N+Y  F I+ ++    ++L+++ ++ ++ L HTDLKPENILL    + K           
Sbjct: 129 NNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188

Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
           K    ++   KS+ IKLIDFG  TF+   H  +++TR YRAPEVIL LGW+   D+WS G
Sbjct: 189 KKIQIYR--TKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFG 246

Query: 306 CILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRR-AEKYFRRGA-RLDWPD 363
           C+L EL +G  LF+THE++EHLAMME ++ P+P +M+  A +    KY  +   +L WP+
Sbjct: 247 CVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPE 306

Query: 364 GATSRDSMRAVWKLLRL 380
            A+S +S++ V K L L
Sbjct: 307 NASSINSIKHVKKCLPL 323

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  458 bits (1181), Expect = e-162
 Identities = 138/302 (45%), Positives = 197/302 (65%), Gaps = 13/302 (4%)

Query: 80  GHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSINKYREAAMIE 138
            H +   G+ L+ RY I+  +GEG FG+VVEC D++     VA+KIV+++++Y EAA  E
Sbjct: 2   MHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE 61

Query: 139 IDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVR 197
           I VL+ L   D   T RCVQ+  WF++  HICIVFE LG S YDF+++N +  F +D +R
Sbjct: 62  IQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIR 121

Query: 198 ELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 257
           ++  Q+ +SV F+H  +L HTDLKPENIL V ++Y +  + K            +    +
Sbjct: 122 KMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD--------ERTLIN 173

Query: 258 SAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317
             IK++DFGS T++ + HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E   G  +
Sbjct: 174 PDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTV 233

Query: 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL 377
           F TH++ EHLAMMER+LGPLP HM+ +  +R  KYF    RLDW + +++   +    K 
Sbjct: 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKR--KYFHHD-RLDWDEHSSAGRYVSRACKP 290

Query: 378 LR 379
           L+
Sbjct: 291 LK 292

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  455 bits (1173), Expect = e-161
 Identities = 139/306 (45%), Positives = 206/306 (67%), Gaps = 13/306 (4%)

Query: 76  DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEK-KELVAIKIVRSINKYREA 134
           DDK+GH V  IG+ L  RY I+  +GEGTFG+VVEC D+ + K  VA+KI+R++ KYREA
Sbjct: 3   DDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA 62

Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
           A +EI+VL+++   D      CV + +WF++  H+CI FE LG + ++FL++N+++ +P+
Sbjct: 63  ARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPL 122

Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
             VR +  QL  ++ F+HE +L HTDLKPENIL V++E+  + +           S  + 
Sbjct: 123 PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH--------KSCEEK 174

Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
             K+++I++ DFGS TF+H+ H+ +V+TRHYR PEVIL LGW  PCD+WS+GCIL E   
Sbjct: 175 SVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234

Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA 373
           G  LFQTHEN EHL MME++LGP+P HM+ R  ++  KYF +G  L W + ++    ++ 
Sbjct: 235 GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQ--KYFYKG-GLVWDENSSDGRYVKE 291

Query: 374 VWKLLR 379
             K L+
Sbjct: 292 NCKPLK 297

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  387 bits (997), Expect = e-133
 Identities = 106/313 (33%), Positives = 165/313 (52%), Gaps = 33/313 (10%)

Query: 76  DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA 135
           DD  G YV    +++  RY +L  +G+G+FGQVV+ +D++  + VA+K+VR+  ++   A
Sbjct: 81  DDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA 140

Query: 136 MIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
             EI +L+ L + D   T   + +   F +RNHIC+ FE L  +LY+ ++KN ++ F + 
Sbjct: 141 AEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLP 200

Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254
           LVR+    +L+ +  +H+ R+IH DLKPENILL                           
Sbjct: 201 LVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ------------------------- 235

Query: 255 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
              S IK+IDFGS+ +EHQ     + +R YRAPEVILG  +  P D+WS+GCIL EL +G
Sbjct: 236 QGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

Query: 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDW------PDGATSR 368
             L    +  + LA M  +LG     + + A +RA+ +        +       DG+   
Sbjct: 296 YPLLPGEDEGDQLACMIELLGMPSQKL-LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVL 354

Query: 369 DSMRAVWKLLRLP 381
           +  R+    LR P
Sbjct: 355 NGGRSRRGKLRGP 367

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  383 bits (986), Expect = e-132
 Identities = 105/307 (34%), Positives = 164/307 (53%), Gaps = 29/307 (9%)

Query: 76  DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA 135
           DD +  Y+   GE    RY I S +G+G+FGQVV+ +D  ++E VAIKI+++   +   A
Sbjct: 38  DDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA 97

Query: 136 MIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
            IE+ +L+ + +HD       V ++  F +RNH+C+VFE L  +LYD LR  ++R   ++
Sbjct: 98  QIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLN 157

Query: 195 LVRELGRQLLESVAFMH--ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 252
           L R+  +Q+  ++ F+   EL +IH DLKPENILL +                       
Sbjct: 158 LTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN----------------------- 194

Query: 253 NLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312
             PK SAIK++DFGS+    Q     + +R YR+PEV+LG+ ++   D+WS+GCILVE+ 
Sbjct: 195 --PKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMH 252

Query: 313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMR 372
           +GE LF     ++ +  +  VLG  P H+ +    +A K+F +     W    T      
Sbjct: 253 TGEPLFSGANEVDQMNKIVEVLGIPPAHI-LDQAPKARKFFEKLPDGTWNLKKTKDGKRE 311

Query: 373 AVWKLLR 379
                 R
Sbjct: 312 YKPPGTR 318

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  352 bits (906), Expect = e-120
 Identities = 86/298 (28%), Positives = 146/298 (48%), Gaps = 40/298 (13%)

Query: 76  DDKDGHYVFAIGENLT-PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA 134
               G++    GE     RY ++ K+G G F  V    D      VA+KIVR    Y EA
Sbjct: 2   YRPGGYHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA 61

Query: 135 AMIEIDVLQRLARHD------IGGTRCVQIRNWFDYRN----HICIVFEKLGPSLYDFLR 184
           A  EI +LQR+   D      +G    +++ + F+++     H+ +VFE LG +L   ++
Sbjct: 62  AEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK 121

Query: 185 KNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243
           K  +R  P+  V+++ +QLL  + +MH    +IHTD+KPEN+L+   +  +         
Sbjct: 122 KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE--------- 172

Query: 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWS 303
                           IK+ D G+  +  + ++  + TR YR+PEV+LG  W    D+WS
Sbjct: 173 ------------NLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWS 220

Query: 304 VGCILVELCSGEALFQTHE------NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRR 355
             C++ EL +G+ LF+  E      + +H+A +  +LG LP ++ +R  +    +F  
Sbjct: 221 TACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYL-LRNGKYTRTFFNS 277

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  310 bits (796), Expect = e-103
 Identities = 92/328 (28%), Positives = 162/328 (49%), Gaps = 36/328 (10%)

Query: 72  PWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY 131
                 K G+++  IG+    RY ++ K+G G F  V   +D + K+ VA+K+V+S   Y
Sbjct: 17  DPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHY 76

Query: 132 REAAMIEIDVLQRLARHDI---GGTRCVQIRNWFDYR----NHICIVFEKLGPSLYDFLR 184
            E A+ EI +L+ +   D         VQ+ + F        HIC+VFE LG  L  ++ 
Sbjct: 77  TETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWII 136

Query: 185 KNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLVSAEY------VKVPD 237
           K++Y+  P+  V+++ +Q+L+ + ++H + R+IHTD+KPENILL   E        +  +
Sbjct: 137 KSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATE 196

Query: 238 YKFLSRSSKDGSYFKNLP----------------KSSAIKLIDFGSTTFEHQDHSYVVST 281
           ++        GS     P                +   +K+ D G+  + H+  +  + T
Sbjct: 197 WQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQT 256

Query: 282 RHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE------HLAMMERVLG 335
           R YR+ EV++G G+N P D+WS  C+  EL +G+ LF+ H   E      H+A++  +LG
Sbjct: 257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG 316

Query: 336 PLPHHMVIRADRRAEKYFRRGARLDWPD 363
            +P  +++      E + ++G       
Sbjct: 317 KVPRKLIVAGKYSKEFFTKKGDLKHITK 344

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  152 bits (386), Expect = 4e-43
 Identities = 63/250 (25%), Positives = 108/250 (43%), Gaps = 53/250 (21%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHD 149
            Y IL ++G G   +V +   NEKK++ AIK V    + N+  ++   EI  L +L +  
Sbjct: 29  IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQ- 85

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
               + +++ ++     +I +V E     L  +L+K   +S      +   + +LE+V  
Sbjct: 86  -HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHT 142

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-ST 268
           +H+  ++H+DLKP N L+V                  DG           +KLIDFG + 
Sbjct: 143 IHQHGIVHSDLKPANFLIV------------------DGM----------LKLIDFGIAN 174

Query: 269 TFEHQDHSYVVSTR----HYRAPEVILGLGW-----------NYPCDLWSVGCILVELCS 313
             +    S V  ++    +Y  PE I  +             +   D+WS+GCIL  +  
Sbjct: 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234

Query: 314 GEALFQTHEN 323
           G+  FQ   N
Sbjct: 235 GKTPFQQIIN 244

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  150 bits (381), Expect = 4e-42
 Identities = 63/250 (25%), Positives = 108/250 (43%), Gaps = 53/250 (21%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHD 149
            Y IL ++G G   +V +   NEKK++ AIK V    + N+  ++   EI  L +L +  
Sbjct: 10  IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQ- 66

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
               + +++ ++     +I +V E     L  +L+K   +S      +   + +LE+V  
Sbjct: 67  -HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHT 123

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-ST 268
           +H+  ++H+DLKP N L+V                  DG           +KLIDFG + 
Sbjct: 124 IHQHGIVHSDLKPANFLIV------------------DGM----------LKLIDFGIAN 155

Query: 269 TFEHQDHSYVVSTR----HYRAPEVILGLG-----------WNYPCDLWSVGCILVELCS 313
             +    S V  ++    +Y  PE I  +             +   D+WS+GCIL  +  
Sbjct: 156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 215

Query: 314 GEALFQTHEN 323
           G+  FQ   N
Sbjct: 216 GKTPFQQIIN 225

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  146 bits (370), Expect = 6e-41
 Identities = 74/260 (28%), Positives = 125/260 (48%), Gaps = 47/260 (18%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARH 148
           +Y  + K+GEG++G V +C + +  ++VAIK     ++        A+ EI +L++L +H
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFL-ESEDDPVIKKIALREIRMLKQL-KH 61

Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
             +     V +   F  +  + +VFE    ++   L +   R  P  LV+ +  Q L++V
Sbjct: 62  PNL-----VNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAV 115

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
            F H+   IH D+KPENIL+                 +K             IKL DFG 
Sbjct: 116 NFCHKHNCIHRDVKPENILI-----------------TKHSV----------IKLCDFGF 148

Query: 267 STTFEHQDHSY--VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTHE 322
           +         Y   V+TR YR+PE+++G    Y  P D+W++GC+  EL SG  L+    
Sbjct: 149 ARLLTGPSDYYDDEVATRWYRSPELLVG-DTQYGPPVDVWAIGCVFAELLSGVPLWPGKS 207

Query: 323 NLEHLAMMERVLG-PLPHHM 341
           +++ L ++ + LG  +P H 
Sbjct: 208 DVDQLYLIRKTLGDLIPRHQ 227

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  147 bits (373), Expect = 1e-40
 Identities = 63/250 (25%), Positives = 108/250 (43%), Gaps = 53/250 (21%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHD 149
            Y IL ++G G   +V +   NEKK++ AIK V    + N+  ++   EI  L +L +  
Sbjct: 57  IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQ- 113

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
               + +++ ++     +I +V E     L  +L+K   +S      +   + +LE+V  
Sbjct: 114 -HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHT 170

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-ST 268
           +H+  ++H+DLKP N L+V                  DG           +KLIDFG + 
Sbjct: 171 IHQHGIVHSDLKPANFLIV------------------DGM----------LKLIDFGIAN 202

Query: 269 TFEHQDHSYVVSTR----HYRAPEVILGLGWN-----------YPCDLWSVGCILVELCS 313
             +    S V  ++    +Y  PE I  +  +              D+WS+GCIL  +  
Sbjct: 203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 262

Query: 314 GEALFQTHEN 323
           G+  FQ   N
Sbjct: 263 GKTPFQQIIN 272

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  145 bits (369), Expect = 1e-40
 Identities = 71/255 (27%), Positives = 119/255 (46%), Gaps = 46/255 (18%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARH 148
           +Y  L  +GEG++G V++C + +   +VAIK     +   +     AM EI +L++L RH
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL-ESDDDKMVKKIAMREIKLLKQL-RH 83

Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
           + +     V +      +    +VFE +  ++ D L           +V++   Q++  +
Sbjct: 84  ENL-----VNLLEVCKKKKRWYLVFEFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGI 137

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
            F H   +IH D+KPENIL+                 S+ G           +KL DFG 
Sbjct: 138 GFCHSHNIIHRDIKPENILV-----------------SQSGV----------VKLCDFGF 170

Query: 267 STTFEHQDHSY--VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTHE 322
           + T       Y   V+TR YRAPE+++G    Y    D+W++GC++ E+  GE LF    
Sbjct: 171 ARTLAAPGEVYDDEVATRWYRAPELLVG-DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229

Query: 323 NLEHLAMMERVLGPL 337
           +++ L  +   LG L
Sbjct: 230 DIDQLYHIMMCLGNL 244

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  144 bits (366), Expect = 2e-40
 Identities = 55/254 (21%), Positives = 93/254 (36%), Gaps = 39/254 (15%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
            ++ LS++G G++G+V +    E   L A+K   S     K R   + E+   +++ +H 
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
                CV++   ++    + +  E  GPSL          S P   V    R  L ++A 
Sbjct: 118 ----CCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAH 172

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-ST 268
           +H   L+H D+KP NI L                    G            KL DFG   
Sbjct: 173 LHSQGLVHLDVKPANIFL-----------------GPRGR----------CKLGDFGLLV 205

Query: 269 TFEHQDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
                           Y APE++ G  +    D++S+G  ++E+     L    E  + L
Sbjct: 206 ELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL 264

Query: 328 AMMERVLGPLPHHM 341
                +       +
Sbjct: 265 -RQGYLPPEFTAGL 277

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  144 bits (364), Expect = 1e-39
 Identities = 45/248 (18%), Positives = 92/248 (37%), Gaps = 36/248 (14%)

Query: 93  RYRILSKMGEGTFGQVVEC-----FDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLA 146
              +   +GEG F QV E       D + K+   +K+ +  N +        ++ L+   
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125

Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFL---RKNSYRSFPIDLVRELGRQ 202
           +H       ++  +   ++N   +V E     +L + +   +    +  P  LV     +
Sbjct: 126 QHMF-----MKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L  +  +H+  +IH D+KP+N +L                 +           S+ + L
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFIL----------------GNGFLEQDDEDDLSAGLAL 224

Query: 263 IDFG-STTFEHQDHSYVVS----TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317
           ID G S   +      + +    T  ++  E++    WNY  D + V   +  +  G  +
Sbjct: 225 IDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

Query: 318 FQTHENLE 325
              +E  E
Sbjct: 285 KVKNEGGE 292

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  140 bits (356), Expect = 7e-39
 Identities = 70/260 (26%), Positives = 109/260 (41%), Gaps = 50/260 (19%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA-------AMIEIDVLQRL 145
           RY  ++++G G +G V +  D      VA+K VR +              + E+ +L+RL
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR-VPNGGGGGGGLPISTVREVALLRRL 68

Query: 146 --ARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
               H  +     V   +  D    + +VFE +   L  +L K      P + +++L RQ
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 128

Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
            L  + F+H   ++H DLKPENIL+                 +  G           +KL
Sbjct: 129 FLRGLDFLHANCIVHRDLKPENILV-----------------TSGG----------TVKL 161

Query: 263 IDFG-------STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
            DFG                  VV T  YRAPEV+L   +  P D+WSVGCI  E+   +
Sbjct: 162 ADFGLARIYSYQMALTPV----VV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

Query: 316 ALFQTHENLEHLAMMERVLG 335
            LF  +   + L  +  ++G
Sbjct: 217 PLFCGNSEADQLGKIFDLIG 236

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  142 bits (359), Expect = 3e-38
 Identities = 81/321 (25%), Positives = 134/321 (41%), Gaps = 64/321 (19%)

Query: 66  PRTGSPPWRPDDKDGHYVFAI--------GENLTPRYRILSKMGEGTFGQVVECFDNEKK 117
           P          DKDG  V  +               Y     +G G+FG V +    +  
Sbjct: 20  PSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSG 79

Query: 118 ELVAIKIVRSINKY--REAAMIEIDVLQRLARHDIGGTRCVQIRNWF------DYRNHIC 169
           ELVAIK V    ++  RE     + ++++L  H       V++R +F          ++ 
Sbjct: 80  ELVAIKKVLQDKRFKNRE-----LQIMRKL-DHC----NIVRLRYFFYSSGEKKDEVYLN 129

Query: 170 IVFEKLGPSLYDFLR--KNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227
           +V + +  ++Y   R    + ++ P+  V+    QL  S+A++H   + H D+KP+N+LL
Sbjct: 130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 189

Query: 228 VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-TFEHQDH--SYVVSTRHY 284
                                    + P ++ +KL DFGS       +   SY+  +R+Y
Sbjct: 190 -------------------------D-PDTAVLKLCDFGSAKQLVRGEPNVSYIC-SRYY 222

Query: 285 RAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMV 342
           RAPE+I G   +Y    D+WS GC+L EL  G+ +F     ++ L  + +VLG  P    
Sbjct: 223 RAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT-PTREQ 280

Query: 343 IRA--DRRAEKYFRRGARLDW 361
           IR       E  F +     W
Sbjct: 281 IREMNPNYTEFKFPQIKAHPW 301

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  138 bits (350), Expect = 4e-38
 Identities = 58/246 (23%), Positives = 103/246 (41%), Gaps = 28/246 (11%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD---- 149
           +  ++ +G+G FGQVV+  +       AIK +R   +     + E+ +L  L  H     
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVR 66

Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQL 203
                +     V+       ++ + I  E     +LYD +   +  +   D    L RQ+
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQI 125

Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKL 262
           LE+++++H   +IH DLKP NI +  +  VK+ D  F L+++         L   +    
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD--FGLAKNVHRSLDILKLDSQNLPGS 183

Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQTH 321
            D  ++          + T  Y A EV+ G G  N   D++S+G I  E+      F T 
Sbjct: 184 SDNLTS---------AIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP---FSTG 231

Query: 322 ENLEHL 327
               ++
Sbjct: 232 MERVNI 237

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  138 bits (349), Expect = 5e-38
 Identities = 48/255 (18%), Positives = 90/255 (35%), Gaps = 22/255 (8%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHD 149
            +  L K+G G FG V +C       + AIK  +   + +   + A+ E+     L +H 
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLES 206
                 V+  + +   +H+ I  E   G SL D + +N      F    +++L  Q+   
Sbjct: 72  ----HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           + ++H + L+H D+KP NI +           +                     K+ D G
Sbjct: 128 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN--------KVMFKIGDLG 179

Query: 267 STTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
             T              + A EV+          D++++   +V     E L +  +   
Sbjct: 180 HVTRISSPQV-EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH 238

Query: 326 HLAMMERVLGPLPHH 340
            +      L  +P  
Sbjct: 239 EIRQGR--LPRIPQV 251

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  138 bits (351), Expect = 8e-38
 Identities = 53/252 (21%), Positives = 103/252 (40%), Gaps = 38/252 (15%)

Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR 147
              T  Y +   +G G++     C         A+KI   I+K +     EI++L R  +
Sbjct: 18  IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKI---IDKSKRDPTEEIEILLRYGQ 74

Query: 148 HD-IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
           H  I     + +++ +D   ++ +V E + G  L D + +  +  F       +   + +
Sbjct: 75  HPNI-----ITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF--FSEREASAVLFTITK 127

Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           +V ++H   ++H DLKP NIL V                              +I++ DF
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDES-----------------------GNPESIRICDF 164

Query: 266 G-STTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322
           G +     ++        T ++ APEV+   G++  CD+WS+G +L  + +G   F    
Sbjct: 165 GFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP 224

Query: 323 NLEHLAMMERVL 334
           +     ++ R+ 
Sbjct: 225 DDTPEEILARIG 236

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  140 bits (355), Expect = 2e-37
 Identities = 69/245 (28%), Positives = 113/245 (46%), Gaps = 38/245 (15%)

Query: 80  GHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREAAM 136
           G            RY I+  +G+G+FG+V++C D   ++  A+K++    + NK     +
Sbjct: 10  GRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL 69

Query: 137 IEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDL 195
            E+++L++L   +I     +++    +  +   IV E   G  L+D + K     F    
Sbjct: 70  REVELLKKLDHPNI-----MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHD 122

Query: 196 VRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 255
              + +Q+   + +MH+  ++H DLKPENILL S E                        
Sbjct: 123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE------------------------ 158

Query: 256 KSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
           K   IK+IDFG +T   Q+      + T +Y APEV+ G  ++  CD+WS G IL  L S
Sbjct: 159 KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLS 217

Query: 314 GEALF 318
           G   F
Sbjct: 218 GTPPF 222

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  137 bits (347), Expect = 3e-37
 Identities = 61/259 (23%), Positives = 112/259 (43%), Gaps = 44/259 (16%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
           +Y  L K+GEG+FG+ +     E      IK +       K RE +  E+ VL  + +H 
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHP 83

Query: 150 -IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
            I     VQ R  F+    + IV +   G  L+  +       F  D + +   Q+  ++
Sbjct: 84  NI-----VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLAL 138

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
             +H+ +++H D+K +NI L                 +KDG+          ++L DFG 
Sbjct: 139 KHVHDRKILHRDIKSQNIFL-----------------TKDGT----------VQLGDFGI 171

Query: 267 STTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
           +             + T +Y +PE+     +N   D+W++GC+L ELC+ +  F+   ++
Sbjct: 172 ARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA-GSM 230

Query: 325 EHLAM--MERVLGPLPHHM 341
           ++L +  +     P+  H 
Sbjct: 231 KNLVLKIISGSFPPVSLHY 249

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  136 bits (344), Expect = 4e-37
 Identities = 68/286 (23%), Positives = 115/286 (40%), Gaps = 49/286 (17%)

Query: 68  TGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS 127
              PP             +G N    +RI  K+G G F +V           VA+K V+ 
Sbjct: 8   MQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQI 67

Query: 128 IN----KYREAAMIEIDVLQRLARHD-IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYD 181
            +    K R   + EID+L++L  H  +     ++    F   N + IV E      L  
Sbjct: 68  FDLMDAKARADCIKEIDLLKQL-NHPNV-----IKYYASFIEDNELNIVLELADAGDLSR 121

Query: 182 FLR--KNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239
            ++  K   R  P   V +   QL  ++  MH  R++H D+KP N+ +            
Sbjct: 122 MIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI------------ 169

Query: 240 FLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEHQDH--SYVVSTRHYRAPEVILGLGWN 296
                +  G           +KL D G    F  +      +V T +Y +PE I   G+N
Sbjct: 170 -----TATGV----------VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 214

Query: 297 YPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG----PLP 338
           +  D+WS+GC+L E+ + ++ F   + +   ++ +++      PLP
Sbjct: 215 FKSDIWSLGCLLYEMAALQSPFYG-DKMNLYSLCKKIEQCDYPPLP 259

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  140 bits (354), Expect = 4e-37
 Identities = 63/247 (25%), Positives = 111/247 (44%), Gaps = 38/247 (15%)

Query: 78  KDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREA 134
             G ++ +   +L+  Y+ + K+G G +G+V+ C D       AIKI+            
Sbjct: 23  TPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK 82

Query: 135 AMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPI 193
            + E+ VL+ L   +I     +++ ++F+ + +  +V E   G  L+D +       F  
Sbjct: 83  LLEEVAVLKLLDHPNI-----MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK--FNE 135

Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
                + +Q+L  V ++H+  ++H DLKPEN+LL S E                      
Sbjct: 136 VDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKE---------------------- 173

Query: 254 LPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
             K + IK++DFG +            + T +Y APEV+    ++  CD+WS+G IL  L
Sbjct: 174 --KDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFIL 230

Query: 312 CSGEALF 318
            +G   F
Sbjct: 231 LAGYPPF 237

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  135 bits (341), Expect = 6e-37
 Identities = 53/263 (20%), Positives = 86/263 (32%), Gaps = 50/263 (19%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH---- 148
            ++ +  +G G FGQV +       +   IK    +    E A  E+  L +L  H    
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR---VKYNNEKAEREVKALAKL-DHVNIV 67

Query: 149 --------DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
                              +       + I  E     +L  ++ K         L  EL
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127

Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
             Q+ + V ++H  +LI+ DLKP NI L                                
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFL-----------------VDTKQ---------- 160

Query: 260 IKLIDFG-STTFEH-QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317
           +K+ DFG  T+ ++    +    T  Y +PE I    +    DL+++G IL EL     +
Sbjct: 161 VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL---HV 217

Query: 318 FQTHENLEHLAMMERVLGPLPHH 340
             T           R  G +   
Sbjct: 218 CDTAFETSKFFTDLR-DGIISDI 239

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  135 bits (343), Expect = 9e-37
 Identities = 67/253 (26%), Positives = 119/253 (47%), Gaps = 42/253 (16%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
           RYR ++K+GEGT+G+V +  D    E VAIK +R +    E     A+ E+ +L+ L +H
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR-LEHEEEGVPGTAIREVSLLKEL-QH 92

Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
             I     +++++   + + + ++FE     L  ++  +      + +++    QL+  V
Sbjct: 93  RNI-----IELKSVIHHNHRLHLIFEYAENDLKKYM--DKNPDVSMRVIKSFLYQLINGV 145

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
            F H  R +H DLKP+N+LL              S +S+             +K+ DFG 
Sbjct: 146 NFCHSRRCLHRDLKPQNLLLSV------------SDASETP----------VLKIGDFGL 183

Query: 267 --STTFEHQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTHE 322
             +     +  ++ + T  YR PE++LG   +Y    D+WS+ CI  E+     LF    
Sbjct: 184 ARAFGIPIRQFTHEIITLWYRPPEILLG-SRHYSTSVDIWSIACIWAEMLMKTPLFPGDS 242

Query: 323 NLEHLAMMERVLG 335
            ++ L  +  VLG
Sbjct: 243 EIDQLFKIFEVLG 255

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  139 bits (351), Expect = 9e-37
 Identities = 65/246 (26%), Positives = 115/246 (46%), Gaps = 39/246 (15%)

Query: 80  GHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI 137
           G +V       + RY+    +G+G+FG+V+ C D    +  A+K++  R + +  +   +
Sbjct: 14  GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL 73

Query: 138 --EIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPID 194
             E+ +L++L   +I     +++  +F+ + +  +V E   G  L+D +       F   
Sbjct: 74  LREVQLLKQLDHPNI-----MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEV 126

Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254
               + RQ+L  + +MH+ +++H DLKPEN+LL S                         
Sbjct: 127 DAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKS----------------------- 163

Query: 255 PKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312
            K + I++IDFG +T           + T +Y APEV+ G  ++  CD+WS G IL  L 
Sbjct: 164 -KDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILL 221

Query: 313 SGEALF 318
           SG   F
Sbjct: 222 SGCPPF 227

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  135 bits (341), Expect = 1e-36
 Identities = 73/258 (28%), Positives = 115/258 (44%), Gaps = 48/258 (18%)

Query: 93  RYRILSKMGEGTFGQVVECFD-NEKKELVAIKIVRSINKYRE----AAMIEIDVLQRL-- 145
           +Y  ++++GEG +G+V +  D       VA+K VR +    E    + + E+ VL+ L  
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIREVAVLRHLET 70

Query: 146 ARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
             H  +     V   +  D    + +VFE +   L  +L K      P + ++++  QLL
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 130

Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
             + F+H  R++H DLKP+NIL+                 +  G           IKL D
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILV-----------------TSSG----------QIKLAD 163

Query: 265 FG-------STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317
           FG                  VV T  YRAPEV+L   +  P DLWSVGCI  E+   + L
Sbjct: 164 FGLARIYSFQMALTSV----VV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 218

Query: 318 FQTHENLEHLAMMERVLG 335
           F+   +++ L  +  V+G
Sbjct: 219 FRGSSDVDQLGKILDVIG 236

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  135 bits (343), Expect = 2e-36
 Identities = 78/292 (26%), Positives = 129/292 (44%), Gaps = 57/292 (19%)

Query: 87  GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY--REAAMIEIDVLQR 144
           GE     Y     +G G+FG V +    E  E VAIK V    ++  RE     + +++ 
Sbjct: 35  GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRE-----LQIMRI 88

Query: 145 LARHDIGGTRCVQIRNWF------DYRNHICIVFEKLGPSLYDFLR--KNSYRSFPIDLV 196
           + +H       V ++ +F           + +V E +  ++Y   R      ++ P+ L+
Sbjct: 89  V-KHP----NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLI 143

Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256
           +    QLL S+A++H + + H D+KP+N+LL                         + P 
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLLL-------------------------D-PP 177

Query: 257 SSAIKLIDFGS--TTFEHQDH-SYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVEL 311
           S  +KLIDFGS       + + SY+  +R+YRAPE+I G   NY    D+WS GC++ EL
Sbjct: 178 SGVLKLIDFGSAKILIAGEPNVSYIC-SRYYRAPELIFG-ATNYTTNIDIWSTGCVMAEL 235

Query: 312 CSGEALFQTHENLEHLAMMERVLGPLPHHMVIRAD--RRAEKYFRRGARLDW 361
             G+ LF     ++ L  + +VLG  P    I+       E  F +     +
Sbjct: 236 MQGQPLFPGESGIDQLVEIIKVLGT-PSREQIKTMNPNYMEHKFPQIRPHPF 286

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  134 bits (339), Expect = 3e-36
 Identities = 64/284 (22%), Positives = 121/284 (42%), Gaps = 47/284 (16%)

Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH 148
                Y+++ K+G G + +V E  +    E V +KI++ + K +     EI +L+ L   
Sbjct: 33  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK--IKREIKILENLRGG 90

Query: 149 D--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
              I     V+            +VFE +  +  DF  K  Y++     +R    ++L++
Sbjct: 91  PNIITLADIVKDPVSRTP----ALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKA 142

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           + + H + ++H D+KP N+++                            +   ++LID+G
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMID--------------------------HEHRKLRLIDWG 176

Query: 267 STTFEHQDHSYV--VSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSG-EALFQTHE 322
              F H    Y   V++R+++ PE+++    ++Y  D+WS+GC+L  +    E  F  H+
Sbjct: 177 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 236

Query: 323 NLEHLAMMERVLGP-----LPHHMVIRADRRAEKYFRRGARLDW 361
           N + L  + +VLG            I  D R      R +R  W
Sbjct: 237 NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRW 280

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  131 bits (333), Expect = 9e-36
 Identities = 73/254 (28%), Positives = 116/254 (45%), Gaps = 49/254 (19%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
           +Y  L K+GEGT+G V +  +N   E  A+K +R + K  E      + EI +L+ L +H
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIR-LEKEDEGIPSTTIREISILKEL-KH 59

Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
             I     V++ +    +  + +VFE L   L   L             +    QLL  +
Sbjct: 60  SNI-----VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGI 113

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
           A+ H+ R++H DLKP+N+L+                 +++G           +K+ DFG 
Sbjct: 114 AYCHDRRVLHRDLKPQNLLI-----------------NREG----------ELKIADFGL 146

Query: 267 STTFEHQDHSY---VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTH 321
           +  F      Y   +V T  YRAP+V++G    Y    D+WSVGCI  E+ +G  LF   
Sbjct: 147 ARAFGIPVRKYTHEIV-TLWYRAPDVLMG-SKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204

Query: 322 ENLEHLAMMERVLG 335
              + L  + R+LG
Sbjct: 205 SEADQLMRIFRILG 218

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  131 bits (333), Expect = 2e-35
 Identities = 50/230 (21%), Positives = 94/230 (40%), Gaps = 34/230 (14%)

Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR 147
           + L  +Y I   +G G FG V  C +   K+    K V+     +     EI +L    R
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-R 59

Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
           H       + +   F+    + ++FE + G  +++ +  +++       +     Q+ E+
Sbjct: 60  HR----NILHLHESFESMEELVMIFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEA 114

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           + F+H   + H D++PENI+  +                          +SS IK+I+FG
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQT-------------------------RRSSTIKIIEFG 149

Query: 267 STTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                    ++  + +   Y APEV      +   D+WS+G ++  L SG
Sbjct: 150 QARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  134 bits (340), Expect = 3e-35
 Identities = 59/248 (23%), Positives = 108/248 (43%), Gaps = 49/248 (19%)

Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--------------SINKYRE 133
             +   Y  + K+G G +G+V+ C +       AIK+++              +I K+ E
Sbjct: 32  GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHE 91

Query: 134 AAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFP 192
               EI +L+ L   +I     +++ + F+ + +  +V E   G  L++ +       F 
Sbjct: 92  EIYNEISLLKSLDHPNI-----IKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FD 144

Query: 193 IDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 252
                 + +Q+L  + ++H+  ++H D+KPENILL +                       
Sbjct: 145 ECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN--------------------- 183

Query: 253 NLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310
                  IK++DFG ++F  +D+     + T +Y APEV+    +N  CD+WS G I+  
Sbjct: 184 ---SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYI 239

Query: 311 LCSGEALF 318
           L  G   F
Sbjct: 240 LLCGYPPF 247

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  130 bits (329), Expect = 4e-35
 Identities = 54/230 (23%), Positives = 103/230 (44%), Gaps = 34/230 (14%)

Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLA 146
            N+   +  +  +G G F +V         +L A+K ++    +R++++  EI VL+++ 
Sbjct: 5   TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK 64

Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
             +I     V + + ++   H  +V + + G  L+D + +     +       + +Q+L 
Sbjct: 65  HENI-----VTLEDIYESTTHYYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLS 117

Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           +V ++HE  ++H DLKPEN+L ++ E                        ++S I + DF
Sbjct: 118 AVKYLHENGIVHRDLKPENLLYLTPE------------------------ENSKIMITDF 153

Query: 266 G-STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           G S   ++   S    T  Y APEV+    ++   D WS+G I   L  G
Sbjct: 154 GLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  130 bits (330), Expect = 4e-35
 Identities = 76/254 (29%), Positives = 121/254 (47%), Gaps = 49/254 (19%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
           +Y+ L K+GEGT+G V +  D+ +  +VA+K +R ++   E     A+ EI +L+ L  H
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIR-LDAEDEGIPSTAIREISLLKEL-HH 78

Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
             I     V + +       + +VFE +   L   L +N         ++    QLL  V
Sbjct: 79  PNI-----VSLIDVIHSERCLTLVFEFMEKDLKKVLDENK-TGLQDSQIKIYLYQLLRGV 132

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
           A  H+ R++H DLKP+N+L+                 + DG+          +KL DFG 
Sbjct: 133 AHCHQHRILHRDLKPQNLLI-----------------NSDGA----------LKLADFGL 165

Query: 267 STTFEHQDHSY---VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTH 321
           +  F     SY   VV T  YRAP+V++G    Y    D+WS+GCI  E+ +G+ LF   
Sbjct: 166 ARAFGIPVRSYTHEVV-TLWYRAPDVLMG-SKKYSTSVDIWSIGCIFAEMITGKPLFPGV 223

Query: 322 ENLEHLAMMERVLG 335
            + + L  +  +LG
Sbjct: 224 TDDDQLPKIFSILG 237

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  131 bits (332), Expect = 5e-35
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 39/226 (17%)

Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRL 145
           + L+  + + S++G G    V  C     ++  A+K    + K  +  ++  EI VL RL
Sbjct: 49  DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALK---VLKKTVDKKIVRTEIGVLLRL 105

Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
           +  +I     ++++  F+    I +V E   G  L+D + +  Y  +      +  +Q+L
Sbjct: 106 SHPNI-----IKLKEIFETPTEISLVLELVTGGELFDRIVEKGY--YSERDAADAVKQIL 158

Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
           E+VA++HE  ++H DLKPEN+L  +                            + +K+ D
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPA------------------------PDAPLKIAD 194

Query: 265 FG-STTFEHQDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308
           FG S   EHQ     V  T  Y APE++ G  +    D+WSVG I 
Sbjct: 195 FGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  129 bits (328), Expect = 6e-35
 Identities = 72/254 (28%), Positives = 118/254 (46%), Gaps = 47/254 (18%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
           +Y  L K+GEGT+G V +  + E  E+VA+K VR ++   E    +A+ EI +L+ L +H
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALREICLLKEL-KH 60

Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
             I     V++ +       + +VFE     L  +    +      ++V+    QLL+ +
Sbjct: 61  KNI-----VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGL 114

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
            F H   ++H DLKP+N+L+                 +++G           +KL +FG 
Sbjct: 115 GFCHSRNVLHRDLKPQNLLI-----------------NRNGE----------LKLANFGL 147

Query: 267 STTFEHQDHSY--VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCS-GEALFQTH 321
           +  F      Y   V T  YR P+V+ G    Y    D+WS GCI  EL + G  LF  +
Sbjct: 148 ARAFGIPVRCYSAEVVTLWYRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206

Query: 322 ENLEHLAMMERVLG 335
           +  + L  + R+LG
Sbjct: 207 DVDDQLKRIFRLLG 220

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  131 bits (331), Expect = 9e-35
 Identities = 74/313 (23%), Positives = 124/313 (39%), Gaps = 68/313 (21%)

Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY--RE------------ 133
           E  + +Y +   +G G+FG V E FD E  +  A+K V    +Y  RE            
Sbjct: 3   ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNI 62

Query: 134 ----------------AAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP 177
                                 D  +   +++        +        ++ ++ E +  
Sbjct: 63  IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122

Query: 178 SLYDFLR--KNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
           +L+  L+    S RS P++L+     QL  +V F+H L + H D+KP+N+L+        
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV-------- 174

Query: 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS--TTFEHQDH-SYVVSTRHYRAPEVILG 292
                            N  K + +KL DFGS       +   +Y+  +R YRAPE++LG
Sbjct: 175 -----------------N-SKDNTLKLCDFGSAKKLIPSEPSVAYIC-SRFYRAPELMLG 215

Query: 293 LGWNYPC--DLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRA--DRR 348
               Y    DLWS+GC+  EL  G+ LF    +++ L  + +++G  P    +       
Sbjct: 216 -ATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGT-PTKEQMIRMNPHY 273

Query: 349 AEKYFRRGARLDW 361
            E  F      DW
Sbjct: 274 TEVRFPTLKAKDW 286

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  129 bits (326), Expect = 9e-35
 Identities = 62/245 (25%), Positives = 95/245 (38%), Gaps = 43/245 (17%)

Query: 80  GHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-- 137
           G         +   +    K+G G FG V    +        IK    INK R    +  
Sbjct: 10  GRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKT---INKDRSQVPMEQ 66

Query: 138 ---EIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFL--RKNSYRSF 191
              EI+VL+ L   +I     ++I   F+  +++ IV E   G  L + +   +   ++ 
Sbjct: 67  IEAEIEVLKSLDHPNI-----IKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKAL 121

Query: 192 PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251
               V EL +Q++ ++A+ H   ++H DLKPENIL                         
Sbjct: 122 SEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTS-------------------- 161

Query: 252 KNLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309
                 S IK+IDFG       D        T  Y APEV       + CD+WS G ++ 
Sbjct: 162 ----PHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMY 216

Query: 310 ELCSG 314
            L +G
Sbjct: 217 FLLTG 221

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  130 bits (328), Expect = 1e-34
 Identities = 54/235 (22%), Positives = 90/235 (38%), Gaps = 35/235 (14%)

Query: 87  GENLTPRYRILSK-MGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREAAMIEIDVL 142
            EN    Y + SK +G G F  V +C      +  A K +   R     R   + EI VL
Sbjct: 23  MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVL 82

Query: 143 QRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGR 201
           +          R + +   ++  + I ++ E   G  ++             + V  L +
Sbjct: 83  ELAKSCP----RVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK 138

Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           Q+LE V ++H+  ++H DLKP+NILL S                              IK
Sbjct: 139 QILEGVYYLHQNNIVHLDLKPQNILLSSIY------------------------PLGDIK 174

Query: 262 LIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           ++DFG +           ++ T  Y APE++         D+W++G I   L + 
Sbjct: 175 IVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  130 bits (328), Expect = 1e-34
 Identities = 56/241 (23%), Positives = 92/241 (38%), Gaps = 47/241 (19%)

Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR---------EAAMIEI 139
                Y +   +G+G F  V  C + E  +  A+KI   ++  +         E    E 
Sbjct: 21  LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKI---VDVAKFTSSPGLSTEDLKREA 77

Query: 140 DVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFL--RKNSYRSFPIDLV 196
            +   L    I     V++   +     + +VFE + G  L   +  R ++   +   + 
Sbjct: 78  SICHMLKHPHI-----VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132

Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256
               RQ+LE++ + H+  +IH D+KP  +LL S E                         
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKE------------------------N 168

Query: 257 SSAIKLIDFG-STTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
           S+ +KL  FG +             V T H+ APEV+    +  P D+W  G IL  L S
Sbjct: 169 SAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS 228

Query: 314 G 314
           G
Sbjct: 229 G 229

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  128 bits (324), Expect = 2e-34
 Identities = 68/243 (27%), Positives = 112/243 (46%), Gaps = 38/243 (15%)

Query: 78  KDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREA 134
             G            RY I+  +G+G+FG+V++C D   ++  A+K++    + NK    
Sbjct: 8   SSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST 67

Query: 135 AMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPI 193
            + E+++L++L   +I     +++    +  +   IV E   G  L+D + K     F  
Sbjct: 68  ILREVELLKKLDHPNI-----MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSE 120

Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
                + +Q+   + +MH+  ++H DLKPENILL S E                      
Sbjct: 121 HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE---------------------- 158

Query: 254 LPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
             K   IK+IDFG +T   Q+      + T +Y APEV+ G  ++  CD+WS G IL  L
Sbjct: 159 --KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYIL 215

Query: 312 CSG 314
            SG
Sbjct: 216 LSG 218

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  129 bits (326), Expect = 2e-34
 Identities = 73/258 (28%), Positives = 128/258 (49%), Gaps = 52/258 (20%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
           +++ L K+G GT+  V +  +      VA+K V+  ++  E     A+ EI +++ L +H
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKEL-KH 62

Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLR----KNSYRSFPIDLVRELGRQL 203
           + I     V++ +     N + +VFE +   L  ++      N+ R   ++LV+    QL
Sbjct: 63  ENI-----VRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117

Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
           L+ +AF HE +++H DLKP+N+L+                 +K G           +KL 
Sbjct: 118 LQGLAFCHENKILHRDLKPQNLLI-----------------NKRGQ----------LKLG 150

Query: 264 DFG-STTFEHQDHSY---VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEAL 317
           DFG +  F    +++   VV T  YRAP+V++G    Y    D+WS GCIL E+ +G+ L
Sbjct: 151 DFGLARAFGIPVNTFSSEVV-TLWYRAPDVLMG-SRTYSTSIDIWSCGCILAEMITGKPL 208

Query: 318 FQTHENLEHLAMMERVLG 335
           F    + E L ++  ++G
Sbjct: 209 FPGTNDEEQLKLIFDIMG 226

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  130 bits (328), Expect = 2e-34
 Identities = 55/253 (21%), Positives = 101/253 (39%), Gaps = 44/253 (17%)

Query: 66  PRTGSPPW-RPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKI 124
           P   S    +   +   ++       +  Y +  ++G+G F  V  C         A KI
Sbjct: 2   PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61

Query: 125 VRSINK----YREAAMI--EIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GP 177
              IN      R+   +  E  + ++L   +I     V++ +     +   +VF+ + G 
Sbjct: 62  ---INTKKLSARDFQKLEREARICRKLQHPNI-----VRLHDSIQEESFHYLVFDLVTGG 113

Query: 178 SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
            L++ +    +  +         +Q+LES+A+ H   ++H +LKPEN+LL S        
Sbjct: 114 ELFEDIVAREF--YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA------ 165

Query: 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGW 295
                             K +A+KL DFG     +   ++     T  Y +PEV+    +
Sbjct: 166 ------------------KGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207

Query: 296 NYPCDLWSVGCIL 308
           + P D+W+ G IL
Sbjct: 208 SKPVDIWACGVIL 220

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  128 bits (325), Expect = 3e-34
 Identities = 71/254 (27%), Positives = 113/254 (44%), Gaps = 49/254 (19%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
            Y  L K+GEGT+  V +        LVA+K +R  ++  E     A+ E+ +L+ L +H
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDL-KH 59

Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
             I     V + +       + +VFE L   L  +L  +      +  V+    QLL  +
Sbjct: 60  ANI-----VTLHDIIHTEKSLTLVFEYLDKDLKQYL-DDCGNIINMHNVKLFLFQLLRGL 113

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
           A+ H  +++H DLKP+N+L+                 ++ G           +KL DFG 
Sbjct: 114 AYCHRQKVLHRDLKPQNLLI-----------------NERG----------ELKLADFGL 146

Query: 267 STTFEHQDHSY---VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQTH 321
           +        +Y   VV T  YR P+++LG   +Y    D+W VGCI  E+ +G  LF   
Sbjct: 147 ARAKSIPTKTYDNEVV-TLWYRPPDILLG-STDYSTQIDMWGVGCIFYEMATGRPLFPGS 204

Query: 322 ENLEHLAMMERVLG 335
              E L  + R+LG
Sbjct: 205 TVEEQLHFIFRILG 218

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  129 bits (325), Expect = 3e-34
 Identities = 60/296 (20%), Positives = 105/296 (35%), Gaps = 84/296 (28%)

Query: 77  DKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR------SINK 130
            ++ ++       L  +Y +   +G+G++G V    +N+ + + AIKI+          K
Sbjct: 11  RENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPK 70

Query: 131 YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYR 189
             E    E+ ++++L   +I      ++   ++   +IC+V E   G  L D L      
Sbjct: 71  DVERIKTEVRLMKKLHHPNI-----ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125

Query: 190 --------------------------------------SFPIDLVRELGRQLLESVAFMH 211
                                                      L+  + RQ+  ++ ++H
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185

Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTF 270
              + H D+KPEN L  +                          KS  IKL+DFG S  F
Sbjct: 186 NQGICHRDIKPENFLFST-------------------------NKSFEIKLVDFGLSKEF 220

Query: 271 EHQDHSY------VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALF 318
              ++           T ++ APEV+     +Y   CD WS G +L  L  G   F
Sbjct: 221 YKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPF 276

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  129 bits (327), Expect = 4e-34
 Identities = 54/231 (23%), Positives = 96/231 (41%), Gaps = 35/231 (15%)

Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLA 146
            ++   Y IL ++G G FG V  C +     +   K +       +     EI ++ +L 
Sbjct: 47  GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL- 105

Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
            H     + + + + F+ +  + ++ E L G  L+D +    Y       V    RQ  E
Sbjct: 106 HHP----KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACE 160

Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
            +  MHE  ++H D+KPENI+  +                          K+S++K+IDF
Sbjct: 161 GLKHMHEHSIVHLDIKPENIMCET-------------------------KKASSVKIIDF 195

Query: 266 GSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           G  T  + D       +T  + APE++      +  D+W++G +   L SG
Sbjct: 196 GLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  128 bits (325), Expect = 4e-34
 Identities = 70/256 (27%), Positives = 116/256 (45%), Gaps = 49/256 (19%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA------AMIEIDVLQRLA 146
           RY  L  +GEG F  V +  D    ++VAIK ++  ++          A+ EI +LQ L 
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL- 69

Query: 147 RHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
            H  I     + + + F ++++I +VF+ +   L   ++ NS        ++      L+
Sbjct: 70  SHPNI-----IGLLDAFGHKSNISLVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQ 123

Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
            + ++H+  ++H DLKP N+LL                  ++G           +KL DF
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLL-----------------DENG----------VLKLADF 156

Query: 266 G-STTFEHQDHSY---VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEALFQ 319
           G + +F   + +Y   VV TR YRAPE++ G    Y    D+W+VGCIL EL        
Sbjct: 157 GLAKSFGSPNRAYTHQVV-TRWYRAPELLFG-ARMYGVGVDMWAVGCILAELLLRVPFLP 214

Query: 320 THENLEHLAMMERVLG 335
              +L+ L  +   LG
Sbjct: 215 GDSDLDQLTRIFETLG 230

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  129 bits (326), Expect = 4e-34
 Identities = 75/300 (25%), Positives = 122/300 (40%), Gaps = 56/300 (18%)

Query: 83  VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY--REAAMIEID 140
                     R+++    G+GTFG V    +      VAIK V    ++  RE   ++I 
Sbjct: 14  ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE---LQIM 70

Query: 141 VLQRLARHDIGGTRCVQIRNWF-----DYRNHIC--IVFEKLGPSLYDFLRKNSYR--SF 191
               +  H       VQ++++F       R  I   +V E +  +L+   R    R  + 
Sbjct: 71  QDLAVLHHP----NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAP 126

Query: 192 PIDLVRELGRQLLESVAFMHE--LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249
           P  L++    QL+ S+  +H   + + H D+KP N+L+                      
Sbjct: 127 PPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV---------------------- 164

Query: 250 YFKNLPKSSAIKLIDFGS--TTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPC--DLWSV 304
              N      +KL DFGS       + + +Y+  +R+YRAPE+I G   +Y    D+WSV
Sbjct: 165 ---N-EADGTLKLCDFGSAKKLSPSEPNVAYIC-SRYYRAPELIFGNQ-HYTTAVDIWSV 218

Query: 305 GCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADR--RAEKYFRRGARLDWP 362
           GCI  E+  GE +F+   +   L  + RVLG  P   V+R       +        + W 
Sbjct: 219 GCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC-PSREVLRKLNPSHTDVDLYNSKGIPWS 277

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  129 bits (327), Expect = 5e-34
 Identities = 59/347 (17%), Positives = 105/347 (30%), Gaps = 71/347 (20%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARHD- 149
            + +   +G+G    V      +  +L AIK+    S  +  +  M E +VL++L  H  
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKN 68

Query: 150 IGGTRCVQIRNWFDYRN--HICIVFEKL-GPSLYDFLRKN-SYRSFPIDLVRELGRQLLE 205
           I     V++    +     H  ++ E     SLY  L +  +    P      + R ++ 
Sbjct: 69  I-----VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123

Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
            +  + E  ++H ++KP NI+ V  E                          S  KL DF
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGE-----------------------DGQSVYKLTDF 160

Query: 266 G-STTFEHQDHSY-VVSTRHYRAPEVILGLGWNYP--------CDLWSVGCILVELCSGE 315
           G +   E  +    +  T  Y  P++                  DLWS+G       +G 
Sbjct: 161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

Query: 316 ALFQTHENLEHLA-MMERVL------------------------GPLPHHMVIRADRRAE 350
             F+  E       +M +++                         P+   +         
Sbjct: 221 LPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLT 280

Query: 351 KYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSASPNCLCKFY 397
                    D                +L   VI ++S       K Y
Sbjct: 281 PVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIY 327

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  130 bits (328), Expect = 6e-34
 Identities = 52/250 (20%), Positives = 99/250 (39%), Gaps = 45/250 (18%)

Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLA 146
           ++L         +G G+ G VV    + +   VA+K    +   + + A++EI +L    
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKR---MLIDFCDIALMEIKLLTESD 66

Query: 147 RHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG----- 200
            H  +     ++          + I  E    +L D +   +     + L +E       
Sbjct: 67  DHPNV-----IRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121

Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
           RQ+   VA +H L++IH DLKP+NIL+ +              SS+  +  +   ++  I
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVST--------------SSRFTADQQTGAENLRI 167

Query: 261 KLIDFG-STTFEHQDHSYVVSTRH------YRAPEVILGLGW-------NYPCDLWSVGC 306
            + DFG     +    S+  +  +      +RAPE++                D++S+GC
Sbjct: 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGC 227

Query: 307 IL-VELCSGE 315
           +    L  G+
Sbjct: 228 VFYYILSKGK 237

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  126 bits (320), Expect = 6e-34
 Identities = 54/234 (23%), Positives = 94/234 (40%), Gaps = 42/234 (17%)

Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR----EAAMIEIDVLQ 143
            ++   Y + + +G G++G+V        +   A K    I KY     +    EI++++
Sbjct: 5   GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKK---IPKYFVEDVDRFKQEIEIMK 61

Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQ 202
            L   +I     +++   F+    I +V E   G  L++ +       F       + + 
Sbjct: 62  SLDHPNI-----IRLYETFEDNTDIYLVMELCTGGELFERVVHKRV--FRESDAARIMKD 114

Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +L +VA+ H+L + H DLKPEN L ++                            S +KL
Sbjct: 115 VLSAVAYCHKLNVAHRDLKPENFLFLTDS------------------------PDSPLKL 150

Query: 263 IDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           IDFG              V T +Y +P+V+ G  +   CD WS G ++  L  G
Sbjct: 151 IDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCG 203

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  127 bits (321), Expect = 7e-34
 Identities = 52/289 (17%), Positives = 96/289 (33%), Gaps = 47/289 (16%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARHD- 149
            + +   +G+G    V      +  +L AIK+    S  +  +  M E +VL++L  H  
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKN 68

Query: 150 IGGTRCVQIRNWFDYRN--HICIVFEKL-GPSLYDFLRKN-SYRSFPIDLVRELGRQLLE 205
           I     V++    +     H  ++ E     SLY  L +  +    P      + R ++ 
Sbjct: 69  I-----VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123

Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
            +  + E  ++H ++KP NI+ V  E                          S  KL DF
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGE-----------------------DGQSVYKLTDF 160

Query: 266 G-STTFEHQDHSY-VVSTRHYRAPEVILGLGWNYP--------CDLWSVGCILVELCSGE 315
           G +   E  +    +  T  Y  P++                  DLWS+G       +G 
Sbjct: 161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

Query: 316 ALFQTHENLEHLA-MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPD 363
             F+  E       +M +++   P   +    +           +    
Sbjct: 221 LPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSC 269

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  127 bits (322), Expect = 7e-34
 Identities = 53/237 (22%), Positives = 96/237 (40%), Gaps = 40/237 (16%)

Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-------SINKYREAAMIEID 140
           EN+   Y    ++G G F  V +C +       A K ++            RE    E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66

Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
           +L+ +   ++     + +   ++ +  + ++ E + G  L+DFL +        +   E 
Sbjct: 67  ILKEIQHPNV-----ITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEF 119

Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
            +Q+L  V ++H L++ H DLKPENI+L+                               
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRN-----------------------VPKPR 156

Query: 260 IKLIDFG-STTFEH-QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           IK+IDFG +   +   +   +  T  + APE++         D+WS+G I   L SG
Sbjct: 157 IKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  130 bits (328), Expect = 8e-34
 Identities = 52/229 (22%), Positives = 96/229 (41%), Gaps = 38/229 (16%)

Query: 87  GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI-EIDVLQ 143
               T  Y++  ++G+G F  V  C      +  A  I+  + ++      +  E  + +
Sbjct: 6   CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65

Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQ 202
            L   +I     V++ +      H  ++F+ + G  L++ +    Y  +         +Q
Sbjct: 66  LLKHPNI-----VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQ 118

Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +LE+V   H++ ++H +LKPEN+LL S                          K +A+KL
Sbjct: 119 ILEAVLHCHQMGVVHRNLKPENLLLASKL------------------------KGAAVKL 154

Query: 263 IDFG-STTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308
            DFG +   E +  ++     T  Y +PEV+    +  P DLW+ G IL
Sbjct: 155 ADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  127 bits (321), Expect = 9e-34
 Identities = 65/244 (26%), Positives = 107/244 (43%), Gaps = 44/244 (18%)

Query: 101 GEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHD-IGGTRCVQI 158
           GEG+F    +C   +  +  A+KI   I+K  EA    EI  L+    H  I     V++
Sbjct: 20  GEGSFSICRKCVHKKSNQAFAVKI---ISKRMEANTQKEITALKLCEGHPNI-----VKL 71

Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
              F  + H  +V E L G  L++  R    + F       + R+L+ +V+ MH++ ++H
Sbjct: 72  HEVFHDQLHTFLVMELLNGGELFE--RIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVH 129

Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEHQDHS 276
            DLKPEN+L                              +  IK+IDFG +      +  
Sbjct: 130 RDLKPENLLFTDEN------------------------DNLEIKIIDFGFARLKPPDNQP 165

Query: 277 Y--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF----QTHENLEHLAMM 330
                 T HY APE++   G++  CDLWS+G IL  + SG+  F    ++      + +M
Sbjct: 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM 225

Query: 331 ERVL 334
           +++ 
Sbjct: 226 KKIK 229

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  127 bits (322), Expect = 1e-33
 Identities = 58/256 (22%), Positives = 105/256 (41%), Gaps = 42/256 (16%)

Query: 88  ENLTPRYRILSKM-GEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA 146
             +T  Y++  ++ G G  G+V+ECF     +  A+K+   +      A  E+D   + +
Sbjct: 24  YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKL---LYD-SPKARQEVDHHWQAS 79

Query: 147 RHD-IGGTRCVQIRNWFD----YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELG 200
               I     V I + ++     +  + I+ E + G  L+  +++   ++F      E+ 
Sbjct: 80  GGPHI-----VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIM 134

Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
           R +  ++ F+H   + H D+KPEN+L  S E                        K + +
Sbjct: 135 RDIGTAIQFLHSHNIAHRDVKPENLLYTSKE------------------------KDAVL 170

Query: 261 KLIDFG-STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
           KL DFG +             T +Y APEV+    ++  CD+WS+G I+  L  G   F 
Sbjct: 171 KLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFY 230

Query: 320 T-HENLEHLAMMERVL 334
           +         M  R+ 
Sbjct: 231 SNTGQAISPGMKRRIR 246

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  131 bits (331), Expect = 1e-33
 Identities = 61/231 (26%), Positives = 95/231 (41%), Gaps = 35/231 (15%)

Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY-REAAMIEIDVLQRLA 146
           +++   Y I  ++G G FG V    +       A K V + ++  +E    EI  +  L 
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL- 211

Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
           RH       V + + F+  N + +++E + G  L++ +          D   E  RQ+ +
Sbjct: 212 RHP----TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCK 266

Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
            +  MHE   +H DLKPENI+  +                          +S+ +KLIDF
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTT-------------------------KRSNELKLIDF 301

Query: 266 GSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           G T       S      T  + APEV  G    Y  D+WSVG +   L SG
Sbjct: 302 GLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  126 bits (318), Expect = 1e-33
 Identities = 56/236 (23%), Positives = 98/236 (41%), Gaps = 40/236 (16%)

Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-------SINKYREAAMIEIDV 141
            +   Y +  ++G G F  V +C      +  A K ++            RE    E+++
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 142 LQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELG 200
           L+ + RH       + + + F+ +  + ++ E + G  L+DFL +        D   +  
Sbjct: 62  LREI-RHP----NIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFL 114

Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
           +Q+L+ V ++H  R+ H DLKPENI+L+                            +  I
Sbjct: 115 KQILDGVHYLHSKRIAHFDLKPENIMLLDKN-----------------------VPNPRI 151

Query: 261 KLIDFG-STTFEH-QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           KLIDFG +   E   +   +  T  + APE++         D+WS+G I   L SG
Sbjct: 152 KLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  126 bits (320), Expect = 1e-33
 Identities = 56/238 (23%), Positives = 99/238 (41%), Gaps = 42/238 (17%)

Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-------SINKYREAAMIEID 140
           + +   Y I  ++G G F  V +C +       A K ++            RE    E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67

Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFL-RKNSYRSFPIDLVRE 198
           +L+++  H++     + + + ++ R  + ++ E + G  L+DFL +K S      +    
Sbjct: 68  ILRQVLHHNV-----ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---EEATS 119

Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
             +Q+L+ V ++H  ++ H DLKPENI+L+                              
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN-----------------------IPIP 156

Query: 259 AIKLIDFG-STTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
            IKLIDFG +   E       +  T  + APE++         D+WS+G I   L SG
Sbjct: 157 HIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  127 bits (322), Expect = 2e-33
 Identities = 54/237 (22%), Positives = 96/237 (40%), Gaps = 40/237 (16%)

Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-------SINKYREAAMIEID 140
           + +   Y I  ++G G F  V +C +       A K ++            RE    E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67

Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
           +L+++   +I     + + + ++ R  + ++ E + G  L+DFL +        +     
Sbjct: 68  ILRQVLHPNI-----ITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSF 120

Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
            +Q+L+ V ++H  ++ H DLKPENI+L+                               
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKN-----------------------IPIPH 157

Query: 260 IKLIDFG-STTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           IKLIDFG +   E       +  T  + APE++         D+WS+G I   L SG
Sbjct: 158 IKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  125 bits (316), Expect = 5e-33
 Identities = 54/263 (20%), Positives = 92/263 (34%), Gaps = 60/263 (22%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY-REAAMIEIDVLQRLARHD-I 150
            Y  + K+GEG F  V            A+K +    +  RE A  E D+ +    H  I
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNI 88

Query: 151 GGTRCVQIRNWF----DYRNHICIVFE--KLGPSLYDFL--RKNSYRSFPIDLVRELGRQ 202
                +++  +       ++   ++    K G +L++ +   K+       D +  L   
Sbjct: 89  -----LRLVAYCLRERGAKHEAWLLLPFFKRG-TLWNEIERLKDKGNFLTEDQILWLLLG 142

Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +   +  +H     H DLKP NILL                   +G             L
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILL-----------------GDEGQP----------VL 175

Query: 263 IDFGSTTFEH------------QDHSYVVSTRHYRAPEVI---LGLGWNYPCDLWSVGCI 307
           +D GS                 QD +    T  YRAPE+         +   D+WS+GC+
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235

Query: 308 LVELCSGEALFQ-THENLEHLAM 329
           L  +  GE  +    +  + +A+
Sbjct: 236 LYAMMFGEGPYDMVFQKGDSVAL 258

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  123 bits (312), Expect = 7e-33
 Identities = 55/268 (20%), Positives = 101/268 (37%), Gaps = 53/268 (19%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
            Y +L  +G G++G+  +       +++  K +   +     ++  + E+++L+ L +H 
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHP 65

Query: 150 -IGGTRCVQIRNWFDYR--NHICIVFEKL-GPSLYDFLR--KNSYRSFPIDLVRELGRQL 203
            I     V+  +    R    + IV E   G  L   +       +    + V  +  QL
Sbjct: 66  NI-----VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120

Query: 204 LESVAFMHELRL-----IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
             ++   H         +H DLKP N+ L                     +         
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFL-----------------DGKQN--------- 154

Query: 259 AIKLIDFG-STTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
            +KL DFG +    H        V T +Y +PE +  + +N   D+WS+GC+L ELC+  
Sbjct: 155 -VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213

Query: 316 ALFQTHENLEHLAM--MERVLGPLPHHM 341
             F    + + LA    E     +P+  
Sbjct: 214 PPFTA-FSQKELAGKIREGKFRRIPYRY 240

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  123 bits (312), Expect = 7e-33
 Identities = 54/236 (22%), Positives = 96/236 (40%), Gaps = 43/236 (18%)

Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR------EAAMIEIDV 141
              +  Y +  ++G+G F  V  C         A KI   IN  +      +    E  +
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI---INTKKLSARDFQKLEREARI 58

Query: 142 LQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELG 200
            ++L   +I     V++ +     +   +VF+ + G  L++ +    +  +         
Sbjct: 59  CRKLQHPNI-----VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCI 111

Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
           +Q+LES+A+ H   ++H +LKPEN+LL S                          K +A+
Sbjct: 112 QQILESIAYCHSNGIVHRNLKPENLLLASKA------------------------KGAAV 147

Query: 261 KLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
           KL DFG     +   ++     T  Y +PEV+    ++ P D+W+ G IL  L  G
Sbjct: 148 KLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  126 bits (317), Expect = 2e-32
 Identities = 52/260 (20%), Positives = 90/260 (34%), Gaps = 44/260 (16%)

Query: 70  SPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN 129
           SP    DD D      I   +   +     +G G  G +V          VA+K +  + 
Sbjct: 4   SPSLEQDDGDEETSVVIVGKI--SFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRI--LP 58

Query: 130 KYREAAMIEIDVLQRLARH-DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSY 188
           +    A  E+ +L+    H ++     ++       R    I  E    +L +++ +  +
Sbjct: 59  ECFSFADREVQLLRESDEHPNV-----IRYFCTEKDRQFQYIAIELCAATLQEYVEQKDF 113

Query: 189 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248
               ++    L +Q    +A +H L ++H DLKP NIL+                     
Sbjct: 114 AHLGLE-PITLLQQTTSGLAHLHSLNIVHRDLKPHNILISM------------------- 153

Query: 249 SYFKNLPKSSAIKLIDFG-STTFEHQDHSY-----VVSTRHYRAPEVILGL---GWNYPC 299
               N        + DFG         HS+     V  T  + APE++         Y  
Sbjct: 154 ---PNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTV 210

Query: 300 DLWSVGCILVE-LCSGEALF 318
           D++S GC+    +  G   F
Sbjct: 211 DIFSAGCVFYYVISEGSHPF 230

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  124 bits (312), Expect = 2e-32
 Identities = 53/232 (22%), Positives = 85/232 (36%), Gaps = 46/232 (19%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
                 ++G G+FG+V    D +     A+K VR         + E+     L       
Sbjct: 59  WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGL-SSP--- 110

Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
            R V +         + I  E L G SL   +++      P D       Q LE + ++H
Sbjct: 111 -RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLH 167

Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG----- 266
             R++H D+K +N+LL                 S DGS            L DFG     
Sbjct: 168 TRRILHGDVKADNVLL-----------------SSDGS---------RAALCDFGHALCL 201

Query: 267 ---STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
                        Y+  T  + APEV++G   +   D+WS  C+++ + +G 
Sbjct: 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  124 bits (314), Expect = 3e-32
 Identities = 63/288 (21%), Positives = 114/288 (39%), Gaps = 53/288 (18%)

Query: 29  PPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGE 88
           P P P P   P             P       F     ++G    +    D + V    +
Sbjct: 11  PVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVT--SQ 68

Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH 148
            L          G G  G+V++ F+   +E  A+K+++   K R     E+++  R ++ 
Sbjct: 69  VL----------GLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQC 114

Query: 149 D-IGGTRCVQIRNWFD----YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQ 202
             I     V+I + ++     R  + IV E L G  L+  ++    ++F      E+ + 
Sbjct: 115 PHI-----VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 169

Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           + E++ ++H + + H D+KPEN+L  S                           ++ +KL
Sbjct: 170 IGEAIQYLHSINIAHRDVKPENLLYTSKR------------------------PNAILKL 205

Query: 263 IDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308
            DFG        +S      T +Y APEV+    ++  CD+WS+G I+
Sbjct: 206 TDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  122 bits (308), Expect = 4e-32
 Identities = 55/234 (23%), Positives = 91/234 (38%), Gaps = 29/234 (12%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD- 149
            +  +  +G G FG V E  +       AIK +R  +    RE  M E+  L +L  H  
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPG 64

Query: 150 -------IGGTRCVQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFP-IDLVREL 199
                         +       + ++ I  + L    +L D++            +   +
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQ-LCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSS 258
             Q+ E+V F+H   L+H DLKP NI     + VKV D  F L  +       + +    
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD--FGLVTAMDQDEEEQTVLTPM 181

Query: 259 AIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312
                        +  H+  V T+ Y +PE I G  +++  D++S+G IL EL 
Sbjct: 182 P-----------AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  125 bits (316), Expect = 1e-31
 Identities = 53/230 (23%), Positives = 88/230 (38%), Gaps = 33/230 (14%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD- 149
            + +  ++G G FG V+     +  E VAIK  R     K RE   +EI ++++L  H  
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPN 73

Query: 150 -IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRS-FPIDLVRELGRQLLES 206
            +               +   +  E   G  L  +L +           +R L   +  +
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           + ++HE R+IH DLKPENI+L                            +    K+ID G
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGP------------------------QRLIHKIIDLG 169

Query: 267 -STTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
            +   +  +  +  V T  Y APE++    +    D WS G +  E  +G
Sbjct: 170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  121 bits (307), Expect = 1e-31
 Identities = 68/261 (26%), Positives = 120/261 (45%), Gaps = 50/261 (19%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARH 148
           +Y  L+K+G+GTFG+V +    +  + VA+K V  +   +E     A+ EI +LQ L +H
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-MENEKEGFPITALREIKILQLL-KH 75

Query: 149 D-IGGTRCV---QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
           + +     +   +   +   +  I +VF+     L   L  N    F +  ++ + + LL
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLL 134

Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
             + ++H  +++H D+K  N+L+                 ++DG           +KL D
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLI-----------------TRDGV----------LKLAD 167

Query: 265 FG-----STTFEHQDHSY---VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSG 314
           FG     S     Q + Y   VV T  YR PE++LG   +Y  P DLW  GCI+ E+ + 
Sbjct: 168 FGLARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTR 225

Query: 315 EALFQTHENLEHLAMMERVLG 335
             + Q +     LA++ ++ G
Sbjct: 226 SPIMQGNTEQHQLALISQLCG 246

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  121 bits (306), Expect = 2e-31
 Identities = 66/268 (24%), Positives = 98/268 (36%), Gaps = 56/268 (20%)

Query: 83  VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDV 141
              +GE    R R+   + EG F  V E  D       A+K + S  +    A + E+  
Sbjct: 22  TVELGEL---RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCF 78

Query: 142 LQRLARHD----IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYR-SFPIDLV 196
           +++L+ H           +        +    ++ E     L +FL+K   R     D V
Sbjct: 79  MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV 138

Query: 197 RELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254
            ++  Q   +V  MH  +  +IH DLK EN+LL                 S  G+     
Sbjct: 139 LKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL-----------------SNQGTI---- 177

Query: 255 PKSSAIKLIDFGSTTFEHQDHSYVVS-----------TRH----YRAPEVI---LGLGWN 296
                 KL DFGS T       Y  S           TR+    YR PE+I         
Sbjct: 178 ------KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIG 231

Query: 297 YPCDLWSVGCILVELCSGEALFQTHENL 324
              D+W++GCIL  LC  +  F+    L
Sbjct: 232 EKQDIWALGCILYLLCFRQHPFEDGAKL 259

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  122 bits (308), Expect = 2e-31
 Identities = 69/251 (27%), Positives = 105/251 (41%), Gaps = 37/251 (14%)

Query: 70  SPPWRPDDKDGHYVFAIGENLTPRYRILSK--MGEGTFGQVVECFDNEKKELVAIKIVR- 126
             P  P   D   V A    +   Y +     +G G FGQV +C +      +A KI++ 
Sbjct: 65  DIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT 124

Query: 127 SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRK 185
              K +E    EI V+ +L  H       +Q+ + F+ +N I +V E + G  L+D +  
Sbjct: 125 RGMKDKEEVKNEISVMNQL-DHA----NLIQLYDAFESKNDIVLVMEYVDGGELFDRIID 179

Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
            SY +          +Q+ E +  MH++ ++H DLKPENIL V+                
Sbjct: 180 ESY-NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN---------------- 222

Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWS 303
                      +  IK+IDFG                T  + APEV+     ++P D+WS
Sbjct: 223 ---------RDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWS 273

Query: 304 VGCILVELCSG 314
           VG I   L SG
Sbjct: 274 VGVIAYMLLSG 284

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  120 bits (304), Expect = 4e-31
 Identities = 72/274 (26%), Positives = 124/274 (45%), Gaps = 26/274 (9%)

Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLA 146
           N++  +++ S +GEG +G V         E+VAIK +   +K   A     EI +L+   
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF- 66

Query: 147 RHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
           +H+ I     +Q  + F+  N + I+ E +   L+  +          D ++    Q L 
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSD---DHIQYFIYQTLR 123

Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLID 264
           +V  +H   +IH DLKP N+L+ S   +KV D  F L+R   + +   + P      +++
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCD--FGLARIIDESAADNSEPTGQQSGMVE 181

Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHEN 323
                       +V  TR YRAPEV+L    ++   D+WS GCIL EL     +F   + 
Sbjct: 182 ------------FVA-TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228

Query: 324 LEHLAMMERVLG-PLPHHMVIR-ADRRAEKYFRR 355
              L ++  ++G P   + +      RA +Y + 
Sbjct: 229 RHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKS 262

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  119 bits (301), Expect = 6e-31
 Identities = 70/242 (28%), Positives = 110/242 (45%), Gaps = 50/242 (20%)

Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMI-----E 138
           + L   Y +   +G G  G+V   F+ +  + VAIKI+     +I   REA        E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65

Query: 139 IDVLQRLARH-DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLV 196
           I++L++L  H  I     ++I+N+FD  ++  IV E + G  L+D +  N          
Sbjct: 66  IEILKKL-NHPCI-----IKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKR--LKEATC 116

Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256
           +    Q+L +V ++HE  +IH DLKPEN+LL S E                        +
Sbjct: 117 KLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE------------------------E 152

Query: 257 SSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGL---GWNYPCDLWSVGCIL-VE 310
              IK+ DFG +    +      +  T  Y APEV++ +   G+N   D WS+G IL + 
Sbjct: 153 DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 212

Query: 311 LC 312
           L 
Sbjct: 213 LS 214

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  119 bits (301), Expect = 6e-31
 Identities = 63/294 (21%), Positives = 107/294 (36%), Gaps = 54/294 (18%)

Query: 89  NLTPRYRILSKM-GEGTFGQVVECFDNEKKELVAIKIV-RSINKYREAAMIEIDVLQRLA 146
                Y++   + GEG   +V  C +    +  A+KI+ +     R     E+++L +  
Sbjct: 9   RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ 68

Query: 147 RHD-IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
            H  +     +++  +F+  +   +VFEK+ G S+   + K   R F       + + + 
Sbjct: 69  GHRNV-----LELIEFFEEEDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVA 121

Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
            ++ F+H   + H DLKPENIL                             + S +K+ D
Sbjct: 122 SALDFLHNKGIAHRDLKPENILCEHPN------------------------QVSPVKICD 157

Query: 265 FG-STTFEHQDHSYVVSTR---------HYRAPEVILGLGW---NY--PCDLWSVGCILV 309
           F   +  +       +ST           Y APEV+         Y   CDLWS+G IL 
Sbjct: 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217

Query: 310 ELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPD 363
            L SG   F                 P   +M+  + +  +  F      DW  
Sbjct: 218 ILLSGYPPFV-GRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDK---DWAH 267

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  119 bits (301), Expect = 1e-30
 Identities = 65/318 (20%), Positives = 110/318 (34%), Gaps = 66/318 (20%)

Query: 10  PHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTG 69
             +++    R++ R         P            +  N   P    +  F    P   
Sbjct: 25  EIRHLPNLNREQRRAFIRSLRDDPSQSANLLA--EAKKLNDAQPKGTENLYFQSMGPEDE 82

Query: 70  SPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---- 125
            P W              +    +Y     +G G    V  C         A+KI+    
Sbjct: 83  LPDWAA-----------AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTA 131

Query: 126 -----RSINKYREAAMIEIDVLQRLARHD-IGGTRCVQIRNWFDYRNHICIVFEKL-GPS 178
                  + + REA   E  +L+++A H  I     + + + ++  + + +VF+ +    
Sbjct: 132 ERLSPEQLEEVREATRRETHILRQVAGHPHI-----ITLIDSYESSSFMFLVFDLMRKGE 186

Query: 179 LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
           L+D+L +           R + R LLE+V+F+H   ++H DLKPENILL           
Sbjct: 187 LFDYLTEKVA--LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDD--------- 235

Query: 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGL--- 293
                             +  I+L DFG +           +  T  Y APE++      
Sbjct: 236 ------------------NMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDE 277

Query: 294 ---GWNYPCDLWSVGCIL 308
              G+    DLW+ G IL
Sbjct: 278 THPGYGKEVDLWACGVIL 295

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  121 bits (304), Expect = 2e-30
 Identities = 71/263 (26%), Positives = 107/263 (40%), Gaps = 22/263 (8%)

Query: 66  PRTGSPPWRPDDKDGHYVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAI 122
            + G    +                  +  RY I   +G G++G V E +D  +K +VAI
Sbjct: 24  QQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAI 83

Query: 123 K-IVRSINKYREAAMI--EIDVLQRLARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPS 178
           K I+R      +   I  EI +L RL  HD +     + I    +  + + +V E     
Sbjct: 84  KKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD 142

Query: 179 LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
                R           ++ L   LL  V ++H   ++H DLKP N L+     VKV D 
Sbjct: 143 FKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCD- 199

Query: 239 KF-LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS-----YVVSTRHYRAPEVILG 292
            F L+R+        +    S  +      T    ++       +VV TR YRAPE+IL 
Sbjct: 200 -FGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVV-TRWYRAPELILL 257

Query: 293 LGWNY--PCDLWSVGCILVELCS 313
              NY    D+WS+GCI  EL +
Sbjct: 258 QE-NYTEAIDVWSIGCIFAELLN 279

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  118 bits (298), Expect = 2e-30
 Identities = 61/242 (25%), Positives = 100/242 (41%), Gaps = 48/242 (19%)

Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI-----EID 140
           E L  +Y++   +G G FG V           VAIK V    I+ + E         E+ 
Sbjct: 39  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 98

Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPS--LYDFLRKNSYRSFPIDLVRE 198
           +L+++      G   +++ +WF+  +   ++ E+  P   L+DF+ +    +   +L R 
Sbjct: 99  LLKKV-SSGFSG--VIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARS 153

Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
              Q+LE+V   H   ++H D+K ENIL+         D                     
Sbjct: 154 FFWQVLEAVRHCHNCGVLHRDIKDENILI---------DLNRGE---------------- 188

Query: 259 AIKLIDFGSTTFEHQDHSYVVS--TRHYRAPEVILGLGWNY---PCDLWSVGCILVELCS 313
            +KLIDFGS     +D  Y     TR Y  PE I      Y      +WS+G +L ++  
Sbjct: 189 -LKLIDFGSGAL-LKDTVYTDFDGTRVYSPPEWIRYHR--YHGRSAAVWSLGILLYDMVC 244

Query: 314 GE 315
           G+
Sbjct: 245 GD 246

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  117 bits (295), Expect = 3e-30
 Identities = 52/224 (23%), Positives = 97/224 (43%), Gaps = 41/224 (18%)

Query: 101 GEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGTRCVQIR 159
           G+GT+G V    D   +  +AIK +   +  Y +    EI + + L +H       VQ  
Sbjct: 31  GKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHK----NIVQYL 85

Query: 160 NWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPID--LVRELGRQLLESVAFMHELRLI 216
             F     I I  E++ G SL   L ++ +     +   +    +Q+LE + ++H+ +++
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144

Query: 217 HTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS---TTFEHQ 273
           H D+K +N+L+                ++  G           +K+ DFG+       + 
Sbjct: 145 HRDIKGDNVLI----------------NTYSGV----------LKISDFGTSKRLAGINP 178

Query: 274 DHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGE 315
                  T  Y APE+I     G+    D+WS+GC ++E+ +G+
Sbjct: 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  119 bits (301), Expect = 3e-30
 Identities = 67/242 (27%), Positives = 106/242 (43%), Gaps = 47/242 (19%)

Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV-------RSINKYREAAMI--E 138
           + L   Y +   +G G  G+V   F+ +  + VAI+I+        S  +   A  +  E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190

Query: 139 IDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVR 197
           I++L++L  H       ++I+N+FD      IV E + G  L+D +  N          +
Sbjct: 191 IEILKKL-NHP----CIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKR--LKEATCK 242

Query: 198 ELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 257
               Q+L +V ++HE  +IH DLKPEN+LL S E                        + 
Sbjct: 243 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE------------------------ED 278

Query: 258 SAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELC 312
             IK+ DFG +    +      +  T  Y APEV++ +   G+N   D WS+G IL    
Sbjct: 279 CLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 338

Query: 313 SG 314
           SG
Sbjct: 339 SG 340

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  118 bits (298), Expect = 5e-30
 Identities = 75/276 (27%), Positives = 125/276 (45%), Gaps = 21/276 (7%)

Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMI--EIDVLQRL 145
           ++  +Y ++ K+G+G +G V +  D    E+VA+K I  +     +A     EI +L  L
Sbjct: 6   HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTEL 65

Query: 146 ARHD-IGGTRCVQIRNWF--DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           + H+ I     V + N    D    + +VF+ +   L+  +R N          + +  Q
Sbjct: 66  SGHENI-----VNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEP---VHKQYVVYQ 117

Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIK 261
           L++ + ++H   L+H D+KP NILL +  +VKV D  F LSRS  +     N    S  +
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVAD--FGLSRSFVNIRRVTNNIPLSINE 175

Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQT 320
             +            YV  TR YRAPE++LG   +    D+WS+GCIL E+  G+ +F  
Sbjct: 176 NTENFDDDQPILTD-YVA-TRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233

Query: 321 HENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRR 355
              +  L  +  V+  P    +       A+     
Sbjct: 234 SSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIES 269

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  116 bits (292), Expect = 7e-30
 Identities = 60/247 (24%), Positives = 98/247 (39%), Gaps = 54/247 (21%)

Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV----------RSINKYREAAMI 137
                 Y     +G G    V  C      +  A+KI+            + + REA + 
Sbjct: 13  HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72

Query: 138 EIDVLQRLARHD-IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDL 195
           E+D+L++++ H  I     +Q+++ ++      +VF+ +    L+D+L +          
Sbjct: 73  EVDILRKVSGHPNI-----IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKE 125

Query: 196 VRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 255
            R++ R LLE +  +H+L ++H DLKPENILL                            
Sbjct: 126 TRKIMRALLEVICALHKLNIVHRDLKPENILLDD-------------------------- 159

Query: 256 KSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGL------GWNYPCDLWSVGCI 307
               IKL DFG +           V  T  Y APE+I         G+    D+WS G I
Sbjct: 160 -DMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218

Query: 308 LVELCSG 314
           +  L +G
Sbjct: 219 MYTLLAG 225

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  116 bits (293), Expect = 8e-30
 Identities = 64/291 (21%), Positives = 108/291 (37%), Gaps = 60/291 (20%)

Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK------YREAAMIEIDVL 142
           +L  RY  L  +G G  G V    DN+  + VAIK +   +        R     EI ++
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-----EIKII 62

Query: 143 QRLARHD--IG--------GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFP 192
           +RL  HD  +         G++           N + IV E +   L + L +       
Sbjct: 63  RRL-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE-- 119

Query: 193 IDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 252
            +  R    QLL  + ++H   ++H DLKP N+ + +                       
Sbjct: 120 -EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT----------------------- 155

Query: 253 NLPKSSAIKLIDFG--STTFEHQDHS-----YVVSTRHYRAPEVILGL-GWNYPCDLWSV 304
              +   +K+ DFG       H  H       +V T+ YR+P ++L    +    D+W+ 
Sbjct: 156 ---EDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAA 211

Query: 305 GCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRR 355
           GCI  E+ +G+ LF     LE + ++   +  +              Y R 
Sbjct: 212 GCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRN 262

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  118 bits (298), Expect = 1e-29
 Identities = 69/293 (23%), Positives = 117/293 (39%), Gaps = 44/293 (15%)

Query: 74  RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
           +    +  Y   +G++   +  RY+ L  +G G  G V   +D      VAIK + R   
Sbjct: 41  KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ 100

Query: 130 KYREA--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
               A  A  E+ +++ +  H   I        +   +    + +V E +  +L   ++ 
Sbjct: 101 NQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM 159

Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
                   + +  L  Q+L  +  +H   +IH DLKP NI++ S                
Sbjct: 160 E----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---------------- 199

Query: 246 KDGSYFKNLPKSSAIKLIDFG-STTFEHQDHS--YVVSTRHYRAPEVILGLGWNYPCDLW 302
                         +K++DFG + T         YVV TR+YRAPEVILG+G+    D+W
Sbjct: 200 -----------DCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIW 247

Query: 303 SVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRR 355
           SVGCI+ E+   + LF   + ++    +   LG      + +       Y   
Sbjct: 248 SVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 300

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  114 bits (288), Expect = 3e-29
 Identities = 62/244 (25%), Positives = 105/244 (43%), Gaps = 45/244 (18%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
           RY     +G+G F +  E  D + KE+ A KIV    + K  +   +  EI + + L  H
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AH 74

Query: 149 -DIGGTRCVQIRNWFDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
             +     V    +F+  + + +V E     SL +  ++   ++      R   RQ++  
Sbjct: 75  QHV-----VGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLG 127

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
             ++H  R+IH DLK  N+ L                 ++D            +K+ DFG
Sbjct: 128 CQYLHRNRVIHRDLKLGNLFL-----------------NEDLE----------VKIGDFG 160

Query: 267 -STTFEHQDHSYVVS--TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
            +T  E+      V   T +Y APEV+   G ++  D+WS+GCI+  L  G+  F+T   
Sbjct: 161 LATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SC 219

Query: 324 LEHL 327
           L+  
Sbjct: 220 LKET 223

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  114 bits (288), Expect = 3e-29
 Identities = 58/260 (22%), Positives = 99/260 (38%), Gaps = 46/260 (17%)

Query: 70  SPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RS 127
            PP  P            E     YR+   +G+G FG V        +  VAIK++    
Sbjct: 9   GPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNR 68

Query: 128 INKYREAAMI-----EIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPS--LY 180
           +  +   +       E+ +L ++     G    +++ +WF+ +    +V E+  P+  L+
Sbjct: 69  VLGWSPLSDSVTCPLEVALLWKV-GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLF 127

Query: 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240
           D++ +           R    Q++ ++   H   ++H D+K ENIL+             
Sbjct: 128 DYITEKGP--LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILI------------- 172

Query: 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVS--TRHYRAPEVILGLGWNY- 297
                + G            KLIDFGS      D  Y     TR Y  PE I      Y 
Sbjct: 173 ---DLRRGC----------AKLIDFGSGAL-LHDEPYTDFDGTRVYSPPEWISRHQ--YH 216

Query: 298 --PCDLWSVGCILVELCSGE 315
             P  +WS+G +L ++  G+
Sbjct: 217 ALPATVWSLGILLYDMVCGD 236

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  115 bits (290), Expect = 5e-29
 Identities = 78/287 (27%), Positives = 117/287 (40%), Gaps = 44/287 (15%)

Query: 81  HYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--E 138
             V     ++ PRY  LS +GEG +G V   +DN  K  VAIK +              E
Sbjct: 16  EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE 75

Query: 139 IDVLQRLARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVR 197
           I +L R  RH+ I G   +      +    + IV + +   LY  L+         D + 
Sbjct: 76  IKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHIC 131

Query: 198 ELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 257
               Q+L  + ++H   ++H DLKP N+LL +                           +
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT---------------------------T 164

Query: 258 SAIKLIDFG--STTFEHQDHS-----YVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILV 309
             +K+ DFG         DH+     YV  TR YRAPE++L   G+    D+WSVGCIL 
Sbjct: 165 CDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILA 223

Query: 310 ELCSGEALFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRR 355
           E+ S   +F     L+ L  +  +LG P    +    + +A  Y   
Sbjct: 224 EMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 270

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  114 bits (288), Expect = 5e-29
 Identities = 73/308 (23%), Positives = 118/308 (38%), Gaps = 69/308 (22%)

Query: 29  PPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGE 88
           P P  P K              G+P  A       A P    P    D +          
Sbjct: 2   PAPADPGK-------------AGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRR------- 41

Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQR 144
               RY     +G+G F +  E  D + KE+ A KIV    + K  +   +  EI + + 
Sbjct: 42  ----RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS 97

Query: 145 LARH-DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQ 202
           L  H  +     V    +F+  + + +V E     SL +  ++   ++      R   RQ
Sbjct: 98  L-AHQHV-----VGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQ 149

Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           ++    ++H  R+IH DLK  N+ L                 ++D            +K+
Sbjct: 150 IVLGCQYLHRNRVIHRDLKLGNLFL-----------------NEDLE----------VKI 182

Query: 263 IDFG-STTFEHQDHSYVVS--TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
            DFG +T  E+      V   T +Y APEV+   G ++  D+WS+GCI+  L  G+  F+
Sbjct: 183 GDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242

Query: 320 THENLEHL 327
           T   L+  
Sbjct: 243 T-SCLKET 249

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  115 bits (290), Expect = 5e-29
 Identities = 73/293 (24%), Positives = 118/293 (40%), Gaps = 44/293 (15%)

Query: 74  RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
           R    +  Y   IG++   +  RY+ L  +G G  G V   +D   +  VAIK + R   
Sbjct: 4   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 63

Query: 130 KYREA--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
               A  A  E+ +++ +  H   IG       +   +    + IV E +  +L   ++ 
Sbjct: 64  NQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM 122

Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
                     +  L  Q+L  +  +H   +IH DLKP NI++ S                
Sbjct: 123 ELDHER----MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---------------- 162

Query: 246 KDGSYFKNLPKSSAIKLIDFG---STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLW 302
                         +K++DFG   +         YVV TR+YRAPEVILG+G+    D+W
Sbjct: 163 -----------DCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIW 210

Query: 303 SVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRR 355
           SVGCI+ E+  G  LF   ++++    +   LG      + +       Y   
Sbjct: 211 SVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 263

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  114 bits (288), Expect = 8e-29
 Identities = 75/293 (25%), Positives = 122/293 (41%), Gaps = 43/293 (14%)

Query: 74  RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
            P  + G Y   + +    +   YR L  +G G +G V    D      VAIK + R   
Sbjct: 4   PPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ 63

Query: 130 KYREA--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
               A  A  E+ +L+ + RH+  IG           D      +V   +G  L   ++ 
Sbjct: 64  SELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH 122

Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
                   D ++ L  Q+L+ + ++H   +IH DLKP N+ +                  
Sbjct: 123 EKLGE---DRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE---------------- 163

Query: 246 KDGSYFKNLPKSSAIKLIDFG-STTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWS 303
                         +K++DFG +   + +   YVV TR YRAPEVIL    +    D+WS
Sbjct: 164 -----------DCELKILDFGLARQADSEMTGYVV-TRWYRAPEVILNWMRYTQTVDIWS 211

Query: 304 VGCILVELCSGEALFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRR 355
           VGCI+ E+ +G+ LF+  ++L+ L  + +V G P    +       A+ Y + 
Sbjct: 212 VGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 264

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  114 bits (287), Expect = 1e-28
 Identities = 31/278 (11%), Positives = 65/278 (23%), Gaps = 59/278 (21%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--------INKYREAAMIEIDVLQR 144
           + +++  +  G    V    D E+ E  A+K+           + +  EA      +L  
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 145 LARHDIGGTRCVQIRNWFDYRNH-----------------ICIVFEKLGPSLYDFLRKNS 187
                    R +   +    ++                    ++       L        
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 188 YRS-----FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242
           +         I  +  L  QL+   A +    L+H    P+N+ +               
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI--------------- 227

Query: 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNY--PCD 300
               DG           + L D  +                Y   E +      +    +
Sbjct: 228 --MPDGR----------LMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALN 275

Query: 301 LWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLP 338
            W +G  +  +      F         +     L    
Sbjct: 276 AWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPG 313

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  112 bits (282), Expect = 2e-28
 Identities = 48/244 (19%), Positives = 104/244 (42%), Gaps = 44/244 (18%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
            +++ + +G+G+F  V           VAIK++  +++ K      +  E+ +  +L +H
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KH 70

Query: 149 -DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
             I     +++ N+F+  N++ +V E      +  +L+    + F  +  R    Q++  
Sbjct: 71  PSI-----LELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITG 124

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           + ++H   ++H DL   N+LL                 +++ +          IK+ DFG
Sbjct: 125 MLYLHSHGILHRDLTLSNLLL-----------------TRNMN----------IKIADFG 157

Query: 267 -STTFEHQDHSYVVS--TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
            +T  +     +     T +Y +PE+          D+WS+GC+   L  G   F T + 
Sbjct: 158 LATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT-DT 216

Query: 324 LEHL 327
           +++ 
Sbjct: 217 VKNT 220

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  113 bits (284), Expect = 2e-28
 Identities = 72/289 (24%), Positives = 120/289 (41%), Gaps = 44/289 (15%)

Query: 78  KDGHYVFAIGENL---TPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYRE 133
           K G Y   + +        Y   + +G G +G V    D    E VAIK + R       
Sbjct: 7   KKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIF 66

Query: 134 A--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYR 189
           A  A  E+ +L+ + +H+  IG        +         +V   +   L   +      
Sbjct: 67  AKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK--- 122

Query: 190 SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249
            F  + ++ L  Q+L+ + ++H   ++H DLKP N+ +                      
Sbjct: 123 -FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE-------------------- 161

Query: 250 YFKNLPKSSAIKLIDFG-STTFEHQDHSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCI 307
                     +K++DFG +   + +   YVV TR YRAPEVIL     N   D+WSVGCI
Sbjct: 162 -------DCELKILDFGLARHADAEMTGYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCI 213

Query: 308 LVELCSGEALFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRR 355
           + E+ +G+ LF+  + L+ L  + +V G P    +    D+ A+ Y + 
Sbjct: 214 MAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQS 262

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  111 bits (280), Expect = 3e-28
 Identities = 54/254 (21%), Positives = 108/254 (42%), Gaps = 46/254 (18%)

Query: 74  RPDDKDGHYVFAIGENLTPRY-RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--- 129
           + DD +     A+G +   R+ +   ++G G+F  V +  D E    VA   ++      
Sbjct: 7   QQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK 66

Query: 130 KYREAAMIEIDVLQRLARHDIGGTRCVQ-IRNWFDY---RNHICIVFEKL-GPSLYDFLR 184
             R+    E ++L+ L +H       V+   +W      +  I +V E +   +L  +L+
Sbjct: 67  SERQRFKEEAEMLKGL-QHP----NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK 121

Query: 185 KNSYRSFPIDLVRELGRQLLESVAFMHE--LRLIHTDLKPENILLVSAEYVKVPDYKFLS 242
           +  ++   I ++R   RQ+L+ + F+H     +IH DLK +NI +               
Sbjct: 122 R--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI--------------- 164

Query: 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY-VVSTRHYRAPEVILGLGWNYPCDL 301
            +   GS          +K+ D G  T +    +  V+ T  + APE+     ++   D+
Sbjct: 165 -TGPTGS----------VKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDV 212

Query: 302 WSVGCILVELCSGE 315
           ++ G  ++E+ + E
Sbjct: 213 YAFGMCMLEMATSE 226

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  112 bits (282), Expect = 6e-28
 Identities = 63/299 (21%), Positives = 108/299 (36%), Gaps = 52/299 (17%)

Query: 78  KDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA 134
           K    +  +      +   Y +   +  G++G V    D+E    VAIK V +       
Sbjct: 5   KGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEG-IPVAIKRVFNTVSDGRT 63

Query: 135 AMI------------EIDVLQRLARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYD 181
             I            EI +L     H  I G R + +       + + +V E +   L  
Sbjct: 64  VNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQ 122

Query: 182 FLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241
            +            ++     +L  +  +HE  ++H DL P NILL              
Sbjct: 123 VIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD------------ 169

Query: 242 SRSSKDGSYFKNLPKSSAIKLIDFG-STTFEHQDHS--YVVSTRHYRAPEVILGL-GWNY 297
                          ++ I + DF  +       +   YV   R YRAPE+++   G+  
Sbjct: 170 ---------------NNDITICDFNLAREDTADANKTHYVT-HRWYRAPELVMQFKGFTK 213

Query: 298 PCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRR 355
             D+WS GC++ E+ + +ALF+       L  +  V+G P    +V+ +   A  Y R 
Sbjct: 214 LVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRN 272

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  113 bits (284), Expect = 6e-28
 Identities = 67/233 (28%), Positives = 103/233 (44%), Gaps = 12/233 (5%)

Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMI--EIDVLQRL 145
           ++   Y I   +G G++G V   +D   ++ VAIK + R      +   I  EI +L RL
Sbjct: 23  HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL 82

Query: 146 ARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
            + D I     + I +     + + IV E     L    +   + +   + ++ +   LL
Sbjct: 83  -KSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLT--EEHIKTILYNLL 139

Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLI 263
               F+HE  +IH DLKP N LL     VKV D  F L+R+         +      +  
Sbjct: 140 LGENFIHESGIIHRDLKPANCLLNQDCSVKVCD--FGLARTINSEKDTNIVNDLEENEEP 197

Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGE 315
              +   + Q  S+VV TR YRAPE+IL    +    D+WS GCI  EL +  
Sbjct: 198 GPHNKNLKKQLTSHVV-TRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  110 bits (278), Expect = 2e-27
 Identities = 70/280 (25%), Positives = 121/280 (43%), Gaps = 50/280 (17%)

Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--------YREAAMIEID 140
            +  RY+ LS +G G +G V   FD +    VA+K +    +        YRE     + 
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LR 80

Query: 141 VLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRE 198
           +L+ + +H+  IG           +  N + +V   +G  L + ++         D V+ 
Sbjct: 81  LLKHM-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQF 136

Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
           L  Q+L  + ++H   +IH DLKP N+ +                               
Sbjct: 137 LIYQILRGLKYIHSADIIHRDLKPSNLAVNE---------------------------DC 169

Query: 259 AIKLIDFG-STTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEA 316
            +K++DFG +     +   YV  TR YRAPE++L    +N   D+WSVGCI+ EL +G  
Sbjct: 170 ELKILDFGLARHTADEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

Query: 317 LFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRR 355
           LF   ++++ L ++ R++G P    +   +   A  Y + 
Sbjct: 229 LFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 268

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  108 bits (273), Expect = 3e-27
 Identities = 56/255 (21%), Positives = 105/255 (41%), Gaps = 60/255 (23%)

Query: 88  ENLTPRYRILSKM-GEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA 146
             +   Y++ S++ G G  G+V++ F+   +E  A+K+++   K R     E+++  R +
Sbjct: 13  NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRAS 68

Query: 147 RHD-IGGTRCVQIRNWFD----YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELG 200
           +   I     V+I + ++     R  + IV E L G  L+  ++    ++F      E+ 
Sbjct: 69  QCPHI-----VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 123

Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
           + + E++ ++H + + H D+KPEN+L  S                           ++ +
Sbjct: 124 KSIGEAIQYLHSINIAHRDVKPENLLYTSKR------------------------PNAIL 159

Query: 261 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ- 319
           KL DFG                   A E   G  ++  CD+WS+G I+  L  G   F  
Sbjct: 160 KLTDFG------------------FAKET-TGEKYDKSCDMWSLGVIMYILLCGYPPFYS 200

Query: 320 THENLEHLAMMERVL 334
            H       M  R+ 
Sbjct: 201 NHGLAISPGMKTRIR 215

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  109 bits (274), Expect = 4e-27
 Identities = 65/245 (26%), Positives = 102/245 (41%), Gaps = 56/245 (22%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR--EAAMI----------EID 140
           +Y  +S +G G FG V    D EK + V +K    I K +  E   I          EI 
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKF---IKKEKVLEDCWIEDPKLGKVTLEIA 81

Query: 141 VLQRLARH-DIGGTRCVQIRNWFDYRNHICIVFEKLGPS--LYDFLRKNSYRSFPIDLVR 197
           +L R+  H +I     +++ + F+ +    +V EK G    L+ F+ ++        L  
Sbjct: 82  ILSRV-EHANI-----IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLAS 133

Query: 198 ELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 257
            + RQL+ +V ++    +IH D+K ENI++            F                 
Sbjct: 134 YIFRQLVSAVGYLRLKDIIHRDIKDENIVI---------AEDF----------------- 167

Query: 258 SAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSG 314
             IKLIDFGS  +  +         T  Y APEV++G  +  P  ++WS+G  L  L   
Sbjct: 168 -TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFE 226

Query: 315 EALFQ 319
           E  F 
Sbjct: 227 ENPFC 231

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  108 bits (271), Expect = 5e-27
 Identities = 54/249 (21%), Positives = 102/249 (40%), Gaps = 45/249 (18%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
            + I   +G+G FG V    + + K ++A+K++    + K      +  E+++   L RH
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 68

Query: 149 -DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
            +I     +++  +F     + ++ E     ++Y  L+K     F          +L  +
Sbjct: 69  PNI-----LRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANA 121

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +++ H  R+IH D+KPEN+LL                    G           +K+ DFG
Sbjct: 122 LSYCHSKRVIHRDIKPENLLL-----------------GSAGE----------LKIADFG 154

Query: 267 -STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
            S        + +  T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +    
Sbjct: 155 WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---T 211

Query: 326 HLAMMERVL 334
           +    +R+ 
Sbjct: 212 YQETYKRIS 220

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  108 bits (271), Expect = 3e-26
 Identities = 66/320 (20%), Positives = 115/320 (35%), Gaps = 72/320 (22%)

Query: 93  RYRILS-KMGEGTFGQV--VECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD 149
            +     K+G GT+G V   +  D +  +  A+K +        +A  EI +L+ L +H 
Sbjct: 21  LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLREL-KHP 78

Query: 150 -IGGTRCVQIRNWFDYRNHICI--VFE-------KLGPSLYDFLRKNSYRSFPIDLVREL 199
            +     + ++  F       +  +F+        +                P  +V+ L
Sbjct: 79  NV-----ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133

Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
             Q+L+ + ++H   ++H DLKP NIL++                          P+   
Sbjct: 134 LYQILDGIHYLHANWVLHRDLKPANILVMGEG-----------------------PERGR 170

Query: 260 IKLIDFG-STTFEHQDHSY-----VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVEL 311
           +K+ D G +  F            VV T  YRAPE++LG   +Y    D+W++GCI  EL
Sbjct: 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAEL 229

Query: 312 CSGEALFQ---------THENLEHLAMMERVLGP-----------LPHHMVIRADRRAEK 351
            + E +F             + + L  +  V+G            +P H  +  D R   
Sbjct: 230 LTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNT 289

Query: 352 YFRRGARLDWPDGATSRDSM 371
           Y                DS 
Sbjct: 290 YTNCSLIKYMEKHKVKPDSK 309

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  103 bits (259), Expect = 3e-25
 Identities = 57/249 (22%), Positives = 99/249 (39%), Gaps = 45/249 (18%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
            + I   +G+G FG V    + + K ++A+K++    + K      +  EI++   L RH
Sbjct: 15  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RH 73

Query: 149 -DIGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
            +I     +++ N+F  R  I ++ E      LY  L+K+    F          +L ++
Sbjct: 74  PNI-----LRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADA 126

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           + + HE ++IH D+KPEN+L+                                +K+ DFG
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGE---------------------------LKIADFG 159

Query: 267 -STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
            S          +  T  Y  PE+I G   +   DLW  G +  E   G   F +     
Sbjct: 160 WSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP---S 216

Query: 326 HLAMMERVL 334
           H     R++
Sbjct: 217 HTETHRRIV 225

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  102 bits (256), Expect = 1e-24
 Identities = 43/204 (21%), Positives = 79/204 (38%), Gaps = 24/204 (11%)

Query: 127 SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRK 185
           S     +A  ++I  +   +  +      V        + ++ I  +     +L D++ +
Sbjct: 100 SSPSPMDAPSVKIRRMDPFSTKNT-----VGQLQPSSPKVYLYIQMQLCRKENLKDWMNR 154

Query: 186 NSYRSFP-IDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSR 243
                     +   +  Q+ E+V F+H   L+H DLKP NI     + VKV D  F L  
Sbjct: 155 RCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD--FGLVT 212

Query: 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWS 303
           +       + +            +    +  H+  V T+ Y +PE I G  +++  D++S
Sbjct: 213 AMDQDEEEQTVL-----------TPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFS 261

Query: 304 VGCILVELCSGEALFQTHENLEHL 327
           +G IL EL      F T      +
Sbjct: 262 LGLILFELLYS---FSTQMERVRI 282

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  102 bits (254), Expect = 3e-24
 Identities = 30/265 (11%), Positives = 74/265 (27%), Gaps = 70/265 (26%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY---------REAAMIEIDVLQ 143
                + +G+      +E  D E  E   + +     +           E   + +    
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 144 RLARHDIGGTRCVQIRNWFDYRNH-----------------ICIVFEKLGPSLYDFL--- 183
           +  +      R +   +                           ++ ++  +L  F    
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 184 --RKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241
               ++++S       +L  Q++  +A +H   L+HT L+P +I+L              
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL-------------- 239

Query: 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW------ 295
               + G           + L  F     +         +R +  PE+            
Sbjct: 240 ---DQRGG----------VFLTGFEHLVRDGARVV-SSVSRGFEPPELEARRATISYHRD 285

Query: 296 -----NYPCDLWSVGCILVELCSGE 315
                 +  D W++G ++  +   +
Sbjct: 286 RRTLMTFSFDAWALGLVIYWIWCAD 310

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  100 bits (251), Expect = 1e-23
 Identities = 64/227 (28%), Positives = 89/227 (39%), Gaps = 38/227 (16%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH-DIG 151
           RY  +  +G G FG      D   KELVA+K +       E    EI    R  RH +I 
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINH-RSLRHPNI- 78

Query: 152 GTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
               V+ +       H+ I+ E   G  LY+ +       F  D  R   +QLL  V++ 
Sbjct: 79  ----VRFKEVILTPTHLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYC 132

Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H +++ H DLK EN LL                   DGS          +K+ DFG +  
Sbjct: 133 HSMQICHRDLKLENTLL-------------------DGSPAPR------LKICDFGYSKS 167

Query: 271 EHQDH--SYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSG 314
                     V T  Y APEV+L   ++    D+WS G  L  +  G
Sbjct: 168 SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  100 bits (251), Expect = 1e-23
 Identities = 32/273 (11%), Positives = 75/273 (27%), Gaps = 70/273 (25%)

Query: 90  LTPRYRILSK---MGEGTFGQVVECFDNEKKELVAIKIVRSINK---------YREAAMI 137
           L  R R L +   +G+      +E  D E  E   + +     +           E   +
Sbjct: 73  LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRL 132

Query: 138 EIDVLQRLARHDIGGTRCVQIRNWFDYRNH-----------------ICIVFEKLGPSLY 180
            +    +  +      R +   +                           ++ ++  +L 
Sbjct: 133 RLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQ 192

Query: 181 DFL-----RKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
            F        ++++S       +L  Q++  +A +H   L+HT L+P +I+L        
Sbjct: 193 TFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL-------- 244

Query: 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVIL 291
                     + G           + L  F     +            +     A  ++ 
Sbjct: 245 ---------DQRGG----------VFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLP 285

Query: 292 GLG-----WNYPCDLWSVGCILVELCSGEALFQ 319
                     +  D W++G  +  +   +    
Sbjct: 286 FGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT 318

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 98.9 bits (247), Expect = 3e-23
 Identities = 63/260 (24%), Positives = 111/260 (42%), Gaps = 49/260 (18%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
            Y I   +GEG+FG+V      + ++ VA+K +  + + K      +  EI  L +L RH
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL-KLLRH 68

Query: 149 -DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
             I     +++ +       I +V E  G  L+D++ +   +    D  R   +Q++ ++
Sbjct: 69  PHI-----IKLYDVITTPTDIVMVIEYAGGELFDYIVEK--KRMTEDEGRRFFQQIICAI 121

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
            + H  +++H DLKPEN+LL         D               N      +K+ DFG 
Sbjct: 122 EYCHRHKIVHRDLKPENLLL---------DDN------------LN------VKIADFGL 154

Query: 268 TTFEHQDHSYVVS--TRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALFQTHENL 324
           +      +    S  + +Y APEVI G  +  P  D+WS G +L  +  G   F   E +
Sbjct: 155 SNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD-DEFI 213

Query: 325 EHLAMMERVLG---PLPHHM 341
               + ++V      +P  +
Sbjct: 214 P--NLFKKVNSCVYVMPDFL 231

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 98.2 bits (245), Expect = 3e-23
 Identities = 49/237 (20%), Positives = 101/237 (42%), Gaps = 44/237 (18%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD--- 149
            + ++  +G GT+GQV +    +  +L AIK++       E    EI++L++ + H    
Sbjct: 25  IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIA 84

Query: 150 --IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
              G       +N     + + +V E     S+ D ++     +   + +  + R++L  
Sbjct: 85  TYYG---AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           ++ +H+ ++IH D+K +N+LL                 +++            +KL+DFG
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLL-----------------TENAE----------VKLVDFG 174

Query: 267 ---STTFEHQDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGE 315
                       +  + T ++ APEVI         +++  DLWS+G   +E+  G 
Sbjct: 175 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 96.9 bits (242), Expect = 4e-23
 Identities = 54/245 (22%), Positives = 100/245 (40%), Gaps = 51/245 (20%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-----EIDVLQRLAR 147
            + ++  +GEG +G+V    +   +E VA+KI   ++  R          EI + + L  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKI---VDMKRAVDCPENIKKEICINKML-N 63

Query: 148 H-DIGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
           H ++     V+        N   +  E   G  L+D +  +     P    +    QL+ 
Sbjct: 64  HENV-----VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA 116

Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
            V ++H + + H D+KPEN+LL                   D     N      +K+ DF
Sbjct: 117 GVVYLHGIGITHRDIKPENLLL-------------------DER--DN------LKISDF 149

Query: 266 G-STTFEHQDHSYVVSTR----HYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEALFQ 319
           G +T F + +   +++       Y APE++    ++  P D+WS G +L  + +GE  + 
Sbjct: 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

Query: 320 THENL 324
              + 
Sbjct: 210 QPSDS 214

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 97.1 bits (242), Expect = 8e-23
 Identities = 50/233 (21%), Positives = 98/233 (42%), Gaps = 40/233 (17%)

Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLA 146
            +         K+GEG+ G V    +      VA+K++    + R   +  E+ +++   
Sbjct: 41  GDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ 100

Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
             ++     V++   +     + ++ E L G +L D + +       I  V      +L+
Sbjct: 101 HFNV-----VEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATV---CEAVLQ 152

Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           ++A++H   +IH D+K ++ILL                 + DG           +KL DF
Sbjct: 153 ALAYLHAQGVIHRDIKSDSILL-----------------TLDGR----------VKLSDF 185

Query: 266 G---STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
           G     + +      +V T ++ APEVI    +    D+WS+G +++E+  GE
Sbjct: 186 GFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 96.6 bits (241), Expect = 9e-23
 Identities = 61/233 (26%), Positives = 102/233 (43%), Gaps = 40/233 (17%)

Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLA 146
            +   +Y    K+G+G  G V    D    + VAI+ +    + ++  +I EI V++   
Sbjct: 16  GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 75

Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
             +I     V   + +   + + +V E L G SL D + +       I  V    R+ L+
Sbjct: 76  NPNI-----VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQ 127

Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           ++ F+H  ++IH D+K +NILL                   DGS          +KL DF
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILL-----------------GMDGS----------VKLTDF 160

Query: 266 GST---TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
           G     T E    S +V T ++ APEV+    +    D+WS+G + +E+  GE
Sbjct: 161 GFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 54/245 (22%), Positives = 100/245 (40%), Gaps = 51/245 (20%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-----EIDVLQRLAR 147
            + ++  +GEG +G+V    +   +E VA+KI   ++  R          EI + + L  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKI---VDMKRAVDCPENIKKEICINKML-N 63

Query: 148 H-DIGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
           H ++     V+        N   +  E   G  L+D +  +     P    +    QL+ 
Sbjct: 64  HENV-----VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA 116

Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
            V ++H + + H D+KPEN+LL                   D     N      +K+ DF
Sbjct: 117 GVVYLHGIGITHRDIKPENLLL-------------------DER--DN------LKISDF 149

Query: 266 G-STTFEHQDHSYVVSTR----HYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEALFQ 319
           G +T F + +   +++       Y APE++    ++  P D+WS G +L  + +GE  + 
Sbjct: 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

Query: 320 THENL 324
              + 
Sbjct: 210 QPSDS 214

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 96.3 bits (240), Expect = 2e-22
 Identities = 48/264 (18%), Positives = 93/264 (35%), Gaps = 63/264 (23%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI------------- 137
            YRI+  + +G F +++ C   +  +  A+K      + K R+                 
Sbjct: 32  DYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 138 ---EIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSY----- 188
              E+ ++  + +++     C+         + + I++E +   S+  F           
Sbjct: 90  FKNELQIITDI-KNE----YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY 144

Query: 189 -RSFPIDLVRELGRQLLESVAFMHELRLI-HTDLKPENILLVSAEYVKVPDYKFLSRSSK 246
               PI +++ + + +L S +++H  + I H D+KP NIL+                  K
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM-----------------DK 187

Query: 247 DGSYFKNLPKSSAIKLIDFG-STTFEHQDHSYVVSTRHYRAPEVILGLGW--NYPCDLWS 303
           +G           +KL DFG S     +       T  +  PE             D+WS
Sbjct: 188 NGR----------VKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWS 237

Query: 304 VGCILVELCSGEALFQTHENLEHL 327
           +G  L  +      F    +L  L
Sbjct: 238 LGICLYVMFYNVVPFSLKISLVEL 261

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 95.7 bits (238), Expect = 4e-22
 Identities = 53/227 (23%), Positives = 90/227 (39%), Gaps = 39/227 (17%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDIG 151
           +  +S++G G  G V +        ++A K++    K      I  E+ VL       I 
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI- 93

Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                     F     I I  E + G SL   L+K      P  ++ ++   +++ + ++
Sbjct: 94  -VGFYGA---FYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYL 147

Query: 211 H-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-ST 268
             + +++H D+KP NIL+                 +  G           IKL DFG S 
Sbjct: 148 REKHKIMHRDVKPSNILV-----------------NSRGE----------IKLCDFGVSG 180

Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
                  +  V TR Y +PE + G  ++   D+WS+G  LVE+  G 
Sbjct: 181 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 94.7 bits (236), Expect = 5e-22
 Identities = 57/229 (24%), Positives = 101/229 (44%), Gaps = 38/229 (16%)

Query: 91  TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150
              + +L K+GEG++G V +    E  ++VAIK V  +    +  + EI ++Q+     +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESDLQEIIKEISIMQQCDSPHV 86

Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
                V+    +     + IV E     S+ D +R  + ++   D +  + +  L+ + +
Sbjct: 87  -----VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEY 140

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST- 268
           +H +R IH D+K  NILL                 + +G            KL DFG   
Sbjct: 141 LHFMRKIHRDIKAGNILL-----------------NTEGH----------AKLADFGVAG 173

Query: 269 --TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
             T      + V+ T  + APEVI  +G+N   D+WS+G   +E+  G+
Sbjct: 174 QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 94.3 bits (235), Expect = 9e-22
 Identities = 69/269 (25%), Positives = 112/269 (41%), Gaps = 55/269 (20%)

Query: 87  GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR------EAAMIEID 140
            +     YR+L  +G+G F +V           VAIKI   I+K +      +    E+ 
Sbjct: 10  EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKI---IDKTQLNPTSLQKLFREVR 66

Query: 141 VLQRLARH-DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRE 198
           +++ L  H +I     V++    +    + ++ E   G  ++D+L  +          R 
Sbjct: 67  IMKIL-NHPNI-----VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARS 118

Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
             RQ++ +V + H+ R++H DLK EN+LL                   D +         
Sbjct: 119 KFRQIVSAVQYCHQKRIVHRDLKAENLLL-----------------DADMN--------- 152

Query: 259 AIKLIDFG-STTFEHQDH-SYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGE 315
            IK+ DFG S  F              Y APE+  G  ++ P  D+WS+G IL  L SG 
Sbjct: 153 -IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211

Query: 316 ALFQTHENLEHLAMMERVLG---PLPHHM 341
             F   +NL+   + ERVL     +P +M
Sbjct: 212 LPFD-GQNLK--ELRERVLRGKYRIPFYM 237

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 61/236 (25%), Positives = 97/236 (41%), Gaps = 42/236 (17%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARHDI 150
            +  L K+G+G+FG+V +  DN  +++VAIKI+         E    EI VL +     +
Sbjct: 23  LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82

Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
                 +    +     + I+ E L G S  D L         I  +    R++L+ + +
Sbjct: 83  -----TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATIL---REILKGLDY 134

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG--- 266
           +H  + IH D+K  N+LL                 S+ G           +KL DFG   
Sbjct: 135 LHSEKKIHRDIKAANVLL-----------------SEHGE----------VKLADFGVAG 167

Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA-LFQTH 321
             T      +  V T  + APEVI    ++   D+WS+G   +EL  GE    + H
Sbjct: 168 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 92.7 bits (231), Expect = 1e-21
 Identities = 68/263 (25%), Positives = 106/263 (40%), Gaps = 54/263 (20%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
            Y +   +G GTFG+V           VA+KI+  + I        I  EI  L +L RH
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL-KLFRH 70

Query: 149 -DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
             I     +++           +V E + G  L+D++ K+          R L +Q+L +
Sbjct: 71  PHI-----IKLYQVISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSA 123

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           V + H   ++H DLKPEN+LL         D               N       K+ DFG
Sbjct: 124 VDYCHRHMVVHRDLKPENVLL---------DAH------------MN------AKIADFG 156

Query: 267 STTFEHQDHSYVVSTR----HYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALFQTH 321
            +          + T     +Y APEVI G  +  P  D+WS G IL  L  G   F   
Sbjct: 157 LSNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD-D 213

Query: 322 ENLEHLAMMERVLG---PLPHHM 341
           E++    + +++ G    +P ++
Sbjct: 214 EHVP--TLFKKIRGGVFYIPEYL 234

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 93.2 bits (232), Expect = 1e-21
 Identities = 61/245 (24%), Positives = 94/245 (38%), Gaps = 51/245 (20%)

Query: 96  ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD-----I 150
           +   +G G FG V  C    + + VAIK + S    R+A ++E+  L R+  H       
Sbjct: 12  VEEVVGRGAFGVV--CKAKWRAKDVAIKQIES-ESERKAFIVELRQLSRV-NHPNIVKLY 67

Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRK-NSYRSFPIDLVRELGRQLLESVA 208
           G              N +C+V E   G SLY+ L        +          Q  + VA
Sbjct: 68  GACL-----------NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116

Query: 209 FMHELR---LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           ++H ++   LIH DLKP N+LLV+   V                          +K+ DF
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTV--------------------------LKICDF 150

Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
           G+        +    +  + APEV  G  ++  CD++S G IL E+ +    F       
Sbjct: 151 GTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA 210

Query: 326 HLAMM 330
              M 
Sbjct: 211 FRIMW 215

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 95.7 bits (238), Expect = 2e-21
 Identities = 69/342 (20%), Positives = 117/342 (34%), Gaps = 67/342 (19%)

Query: 18  PRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGSPPWRPDD 77
           P   P       P +P  K      C +  G         S    G  P  GSP      
Sbjct: 16  PDIDPLEALMTNPVVPESKRFCW-NCGRPVGRSDSETKGASE---GWCPYCGSPYSFLPQ 71

Query: 78  KDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFD-NEKKELVAIKIVRSIN--KYREA 134
                    G+ +  +Y +   +  G  G +    D N     V +K +      + +  
Sbjct: 72  ------LNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM 125

Query: 135 AMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC-----IVFEKL-GPSLYDFLRKNSY 188
           AM E   L  +    I     VQI N+ ++ +        IV E + G SL         
Sbjct: 126 AMAERQFLAEVVHPSI-----VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG---- 176

Query: 189 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248
           +  P+        ++L +++++H + L++ DLKPENI+L                 +++ 
Sbjct: 177 QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIML-----------------TEEQ 219

Query: 249 SYFKNLPKSSAIKLIDFG---STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
                      +KLID G             Y+  T  ++APE++   G     D+++VG
Sbjct: 220 -----------LKLIDLGAVSRIN----SFGYLYGTPGFQAPEIVRT-GPTVATDIYTVG 263

Query: 306 CILVELCSGEALFQTHENLEHLAMMERVLGPLP--HHMVIRA 345
             L  L            ++ L   + VL        ++ RA
Sbjct: 264 RTLAALTLDLPTR-NGRYVDGLPEDDPVLKTYDSYGRLLRRA 304

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 92.3 bits (230), Expect = 3e-21
 Identities = 44/242 (18%), Positives = 90/242 (37%), Gaps = 60/242 (24%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHD-I 150
              + ++G G +G V +       +++A+K +R+    +E   +  ++D+  R       
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68

Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI--DLVRELGRQLLESVA 208
                V           + I  E +  SL  F ++   +   I  D++ ++   +++++ 
Sbjct: 69  -----VTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123

Query: 209 FMH-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
            +H +L +IH D+KP N+L+                 +  G           +K+ DFG 
Sbjct: 124 HLHSKLSVIHRDVKPSNVLI-----------------NALGQ----------VKMCDFGI 156

Query: 267 ---------STTFEHQDHSYVVSTRHYRAPEVILG----LGWNYPCDLWSVGCILVELCS 313
                                   + Y APE I       G++   D+WS+G  ++EL  
Sbjct: 157 SGYLVDDVAKDID--------AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAI 208

Query: 314 GE 315
             
Sbjct: 209 LR 210

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 92.8 bits (231), Expect = 3e-21
 Identities = 56/234 (23%), Positives = 93/234 (39%), Gaps = 40/234 (17%)

Query: 92  PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG 151
           P +R+  K+G G FG++    +    E VAIK+    ++      +E    ++L      
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP-QLHLEYRFYKQL----GS 63

Query: 152 GTRCVQIRNWF-DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
           G    Q+  +F     +  +V E LGPSL D L     R+F +  V  +  QL+  + ++
Sbjct: 64  GDGIPQVY-YFGPCGKYNAMVLELLGPSLED-LFDLCDRTFSLKTVLMIAIQLISRMEYV 121

Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG---- 266
           H   LI+ D+KPEN L+                    G           I +IDF     
Sbjct: 122 HSKNLIYRDVKPENFLI--------------------GR--PGNKTQQVIHIIDFALAKE 159

Query: 267 ---STTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                T +H   ++H  +  T  Y +    LG   +   DL ++G + +    G
Sbjct: 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRG 213

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 91.2 bits (227), Expect = 6e-21
 Identities = 47/250 (18%), Positives = 90/250 (36%), Gaps = 67/250 (26%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           +Y +  ++G+G++G V   ++       A+K+   ++K +                    
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKV---LSKKKLIRQAGFPRRPPPRGTRPAP 70

Query: 153 TRCVQIRNWFD--YR-------------------------NHICIVFEKL-GPSLYDFLR 184
             C+Q R   +  Y+                         +H+ +VFE +    + +   
Sbjct: 71  GGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT 130

Query: 185 KNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244
                    D  R   + L++ + ++H  ++IH D+KP N+L+                 
Sbjct: 131 LKP---LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV----------------- 170

Query: 245 SKDGSYFKNLPKSSAIKLIDFG-STTFEHQDH--SYVVSTRHYRAPEVILGLGWNY---P 298
            +DG           IK+ DFG S  F+  D   S  V T  + APE +      +    
Sbjct: 171 GEDGH----------IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKA 220

Query: 299 CDLWSVGCIL 308
            D+W++G  L
Sbjct: 221 LDVWAMGVTL 230

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 91.7 bits (228), Expect = 7e-21
 Identities = 51/241 (21%), Positives = 91/241 (37%), Gaps = 60/241 (24%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD-I 150
              L +MG GT GQV +    +   ++A+K +R     +  +  ++++DV+ +      I
Sbjct: 27  LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86

Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                VQ    F     + I  E +G       ++      P  ++ ++   +++++ ++
Sbjct: 87  -----VQCFGTFITNTDVFIAMELMGTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYYL 140

Query: 211 H-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG--- 266
             +  +IH D+KP NILL                  + G           IKL DFG   
Sbjct: 141 KEKHGVIHRDVKPSNILL-----------------DERGQ----------IKLCDFGISG 173

Query: 267 -------STTFEHQDHSYVVSTRHYRAPEVI-----LGLGWNYPCDLWSVGCILVELCSG 314
                                   Y APE I         ++   D+WS+G  LVEL +G
Sbjct: 174 RLVDDKAKDRS--------AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225

Query: 315 E 315
           +
Sbjct: 226 Q 226

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 91.2 bits (227), Expect = 7e-21
 Identities = 54/233 (23%), Positives = 104/233 (44%), Gaps = 43/233 (18%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHDIG 151
            + I+ ++G+G FG+V +  + E   L A K++ + ++      I EI++L       I 
Sbjct: 20  VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI- 78

Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
               V++   + +   + I+ E   G ++   + +   R      ++ + RQ+LE++ F+
Sbjct: 79  ----VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFL 133

Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-- 268
           H  R+IH DLK  N+L+                 + +G           I+L DFG +  
Sbjct: 134 HSKRIIHRDLKAGNVLM-----------------TLEGD----------IRLADFGVSAK 166

Query: 269 -TFEHQDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGE 315
                Q     + T ++ APEV++        ++Y  D+WS+G  L+E+   E
Sbjct: 167 NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 91.7 bits (228), Expect = 9e-21
 Identities = 58/242 (23%), Positives = 95/242 (39%), Gaps = 55/242 (22%)

Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI----EIDVLQ 143
           ++    +  L ++G G+FG V    D    E+VAIK +    K           E+  LQ
Sbjct: 50  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109

Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
           +L   +      +Q R  +   +   +V E    S  D L  +  +      +  +    
Sbjct: 110 KLRHPNT-----IQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGA 163

Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
           L+ +A++H   +IH D+K  NILL                 S+ G           +KL 
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILL-----------------SEPGL----------VKLG 196

Query: 264 DFGS-------TTFEHQDHSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCS 313
           DFGS        +F        V T ++ APEVIL +    ++   D+WS+G   +EL  
Sbjct: 197 DFGSASIMAPANSF--------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 248

Query: 314 GE 315
            +
Sbjct: 249 RK 250

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 90.5 bits (225), Expect = 1e-20
 Identities = 43/137 (31%), Positives = 66/137 (48%), Gaps = 8/137 (5%)

Query: 92  PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG 151
            RYR+  K+G G+FG +    D    E VAIK+     K+ +  + E  + + +     G
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI-ESKIYKMMQ----G 63

Query: 152 GTRCVQIRNWF-DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
           G     IR W     ++  +V E LGPSL D L     R F +  V  L  Q++  + ++
Sbjct: 64  GVGIPTIR-WCGAEGDYNVMVMELLGPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYI 121

Query: 211 HELRLIHTDLKPENILL 227
           H    IH D+KP+N L+
Sbjct: 122 HSKNFIHRDVKPDNFLM 138

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 90.0 bits (224), Expect = 1e-20
 Identities = 57/255 (22%), Positives = 94/255 (36%), Gaps = 52/255 (20%)

Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-----EIDVLQRLARHD 149
            +   +G G FG+V   F    +  VA+K  R       +  I     E  +   L +H 
Sbjct: 10  TLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAML-KHP 66

Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQL 203
                 G   C++         ++C+V E   G  L   L     +  P D++     Q+
Sbjct: 67  NIIALRGV--CLK-------EPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQI 114

Query: 204 LESVAFMHE---LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
              + ++H+   + +IH DLK  NIL+                             +  +
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILI-------------------LQKVENGDLSNKIL 155

Query: 261 KLIDFGSTTFEHQDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
           K+ DFG     H+           + APEVI    ++   D+WS G +L EL +GE  F 
Sbjct: 156 KITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF- 214

Query: 320 THENLEHLAMMERVL 334
               ++ LA+   V 
Sbjct: 215 --RGIDGLAVAYGVA 227

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 54/234 (23%), Positives = 92/234 (39%), Gaps = 40/234 (17%)

Query: 92  PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG 151
             Y++  ++GEG+FG + E  +    + VAIK     +   +    E    + L     G
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD-EYRTYKLL----AG 64

Query: 152 GTRCVQIRNWF-DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
            T    +  +F     H  +V + LGPSL D L     R F +  V    +Q+L  V  +
Sbjct: 65  CTGIPNVY-YFGQEGLHNVLVIDLLGPSLED-LLDLCGRKFSVKTVAMAAKQMLARVQSI 122

Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG---- 266
           HE  L++ D+KP+N L+                         N   ++ I ++DFG    
Sbjct: 123 HEKSLVYRDIKPDNFLI----------------------GRPNSKNANMIYVVDFGMVKF 160

Query: 267 ---STTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
                T +H   ++   +  T  Y +    LG   +   DL ++G + +    G
Sbjct: 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 214

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 91.4 bits (227), Expect = 3e-20
 Identities = 68/261 (26%), Positives = 105/261 (40%), Gaps = 50/261 (19%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
            Y +   +G GTFG+V           VA+KI+  + I        I  EI  L +L RH
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL-KLFRH 75

Query: 149 -DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
             I     +++       + I +V E + G  L+D++ KN          R L +Q+L  
Sbjct: 76  PHI-----IKLYQVISTPSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSG 128

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           V + H   ++H DLKPEN+LL         D               N       K+ DFG
Sbjct: 129 VDYCHRHMVVHRDLKPENVLL---------DAH------------MN------AKIADFG 161

Query: 267 STTFEHQDHSYVVS--TRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALFQTHEN 323
            +           S  + +Y APEVI G  +  P  D+WS G IL  L  G   F   ++
Sbjct: 162 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD-DDH 220

Query: 324 LEHLAMMERVLG---PLPHHM 341
           +    + +++       P ++
Sbjct: 221 VP--TLFKKICDGIFYTPQYL 239

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 91.6 bits (227), Expect = 3e-20
 Identities = 41/137 (29%), Positives = 68/137 (49%), Gaps = 8/137 (5%)

Query: 92  PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG 151
            ++R+  K+G G+FG++    + +  E VAIK+     K+ +    E  + + L     G
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY-ESKIYRILQ----G 61

Query: 152 GTRCVQIRNWF-DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
           GT    +R WF    ++  +V + LGPSL D L     R   +  V  L  Q++  V F+
Sbjct: 62  GTGIPNVR-WFGVEGDYNVLVMDLLGPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFV 119

Query: 211 HELRLIHTDLKPENILL 227
           H    +H D+KP+N L+
Sbjct: 120 HSKSFLHRDIKPDNFLM 136

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 89.3 bits (222), Expect = 4e-20
 Identities = 54/235 (22%), Positives = 93/235 (39%), Gaps = 45/235 (19%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHD-I 150
            + L ++G G +G V +       +++A+K +RS    +E   +  ++DV+ R +    I
Sbjct: 24  LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83

Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK---NSYRSFPIDLVRELGRQLLESV 207
                VQ            I  E +  S   F +          P +++ ++    ++++
Sbjct: 84  -----VQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138

Query: 208 AFMH-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
             +   L++IH D+KP NILL                  + G+          IKL DFG
Sbjct: 139 NHLKENLKIIHRDIKPSNILL-----------------DRSGN----------IKLCDFG 171

Query: 267 -STTFEH-QDHSYVVSTRHYRAPEVI----LGLGWNYPCDLWSVGCILVELCSGE 315
            S         +     R Y APE I       G++   D+WS+G  L EL +G 
Sbjct: 172 ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 89.4 bits (222), Expect = 5e-20
 Identities = 39/192 (20%), Positives = 68/192 (35%), Gaps = 47/192 (24%)

Query: 92  PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG 151
            ++ +  K+G G FG +   F   K E  A  +V+   +       E+   QR+A+ D  
Sbjct: 37  NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96

Query: 152 GTRCVQIRN---------WF--------DYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
                + +                     YR    +V E+LG  L     +N   +F   
Sbjct: 97  KKWIERKQLDYLGIPLFYGSGLTEFKGRSYR---FMVMERLGIDLQKISGQN--GTFKKS 151

Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254
            V +LG ++L+ + ++HE   +H D+K  N+LL                           
Sbjct: 152 TVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL-------------------------GY 186

Query: 255 PKSSAIKLIDFG 266
                + L D+G
Sbjct: 187 KNPDQVYLADYG 198

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 88.5 bits (220), Expect = 5e-20
 Identities = 49/252 (19%), Positives = 83/252 (32%), Gaps = 56/252 (22%)

Query: 96  ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--------EIDVLQRLAR 147
              ++G+G FG V +    + K +VAIK +   +   E  MI        E+ ++  L  
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-N 81

Query: 148 HD-----IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGR 201
           H       G              N   +V E +    LY  L   +       +   L  
Sbjct: 82  HPNIVKLYGLMH-----------NPPRMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLML 129

Query: 202 QLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
            +   + +M      ++H DL+  NI L S                       +      
Sbjct: 130 DIALGIEYMQNQNPPIVHRDLRSPNIFLQS----------------------LDENAPVC 167

Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCSGEAL 317
            K+ DFG +       S ++    + APE I     +Y    D +S   IL  + +GE  
Sbjct: 168 AKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227

Query: 318 FQTHENLEHLAM 329
           F   +   +  +
Sbjct: 228 F---DEYSYGKI 236

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 88.5 bits (220), Expect = 7e-20
 Identities = 53/254 (20%), Positives = 106/254 (41%), Gaps = 57/254 (22%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAM---IEIDVLQRLAR 147
           +Y +   +GEG++G+V E  D+E     A+KI+  + + +          EI +L+RL R
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-R 64

Query: 148 H-DIGGTRCVQIRN--WFDYRNHICIVFE--KLGPS-LYDFLRKNSYRSFPIDLVRELGR 201
           H ++     +Q+ +  + + +  + +V E    G   + D + +   + FP+        
Sbjct: 65  HKNV-----IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE---KRFPVCQAHGYFC 116

Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           QL++ + ++H   ++H D+KP N+LL                 +  G+          +K
Sbjct: 117 QLIDGLEYLHSQGIVHKDIKPGNLLL-----------------TTGGT----------LK 149

Query: 262 LIDFG-STTFEHQDHSYVVSTR----HYRAPEVILGLGWNY---PCDLWSVGCILVELCS 313
           +   G +             T      ++ PE+  GL   +     D+WS G  L  + +
Sbjct: 150 ISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLD-TFSGFKVDIWSAGVTLYNITT 208

Query: 314 GEALFQTHENLEHL 327
           G   F+  +N+  L
Sbjct: 209 GLYPFE-GDNIYKL 221

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 89.0 bits (221), Expect = 9e-20
 Identities = 33/197 (16%), Positives = 65/197 (32%), Gaps = 54/197 (27%)

Query: 92  PRYRILSKMGEGTFGQV--------VECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQ 143
            ++++ S       G +        + C    +K+  ++K+     +       E +  Q
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRL----FNEQNFFQ 97

Query: 144 RLARHD-------IGGTRCVQIRN--WF-----DYRNHICIVFEKLGPSLYDFLRKNSYR 189
           R A+         +  T  + I     F      YR    +V   LG SL   L  +   
Sbjct: 98  RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYR---FLVLPSLGRSLQSALDVSPKH 154

Query: 190 SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249
                 V ++  +LL+++ F+HE   +H ++  ENI +                      
Sbjct: 155 VLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV---------------------- 192

Query: 250 YFKNLPKSSAIKLIDFG 266
              +    S + L  +G
Sbjct: 193 ---DPEDQSQVTLAGYG 206

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 88.1 bits (219), Expect = 9e-20
 Identities = 54/219 (24%), Positives = 89/219 (40%), Gaps = 34/219 (15%)

Query: 101 GEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHDIGGTRCV 156
           GEG+F  VV   +       AIKI+    I K  +      E DV+ RL  H       V
Sbjct: 39  GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPF----FV 93

Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
           ++   F     +           L  ++RK    SF     R    +++ ++ ++H   +
Sbjct: 94  KLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGI 151

Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           IH DLKPENILL    ++++ D+      S +    +              + +F     
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR--------------ANSF----- 192

Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG 314
              V T  Y +PE++         DLW++GCI+ +L +G
Sbjct: 193 ---VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 87.8 bits (218), Expect = 1e-19
 Identities = 47/228 (20%), Positives = 90/228 (39%), Gaps = 30/228 (13%)

Query: 96  ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHD----- 149
               +G+G FGQ ++    E  E++ +K +   ++  +   + E+ V++ L  H      
Sbjct: 14  HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLKF 72

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           IG     +          +  + E + G +L   ++      +P        + +   +A
Sbjct: 73  IGV--LYK-------DKRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMA 122

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFGS 267
           ++H + +IH DL   N L+   + V V D  F L+R   D        +S          
Sbjct: 123 YLHSMNIIHRDLNSHNCLVRENKNVVVAD--FGLARLMVDEKTQPEGLRSLKKPDRKKRY 180

Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE 315
           T         VV   ++ APE+I G  ++   D++S G +L E+    
Sbjct: 181 T---------VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRV 219

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 86.5 bits (214), Expect = 2e-18
 Identities = 51/249 (20%), Positives = 96/249 (38%), Gaps = 42/249 (16%)

Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SI--NKYREAAMIEIDVLQRLARHDI 150
            +   +G G FG+V  C   +  ++ A+K +    I   +    A+ E  +L       +
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL-----V 246

Query: 151 GGTRC---VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
               C   V +   F   + +  + + + G  L+  L ++    F    +R    +++  
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILG 304

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           +  MH   +++ DLKP NILL    +V++ D                     A       
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL------------------ACDFSKKK 346

Query: 267 STTFEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
                       V T  Y APEV+  G+ ++   D +S+GC+L +L  G + F+ H+  +
Sbjct: 347 PHAS--------VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 398

Query: 326 HLAMMERVL 334
              +    L
Sbjct: 399 KHEIDRMTL 407

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 84.4 bits (209), Expect = 3e-18
 Identities = 38/209 (18%), Positives = 71/209 (33%), Gaps = 58/209 (27%)

Query: 84  FAIGENLT----PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSINKYREA 134
           FA+GE +T      +++   +G+G FG +     N            +K+  S N     
Sbjct: 23  FAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLF- 81

Query: 135 AMIEIDVLQRLARHDIGGTRCVQIRN---------WF--------DYRNHICIVFEKLGP 177
              E+   QR A+ +         +                     YR    ++ ++ G 
Sbjct: 82  --TELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYR---FMIMDRFGS 136

Query: 178 SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
            L      N+ + F    V +L  ++L+ + ++HE   +H D+K  N+LL          
Sbjct: 137 DLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL---------- 185

Query: 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
                          N      + L+D+G
Sbjct: 186 ---------------NYKNPDQVYLVDYG 199

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 83.5 bits (207), Expect = 3e-18
 Identities = 56/242 (23%), Positives = 98/242 (40%), Gaps = 50/242 (20%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARHDI 150
            Y +   +G G    V   +   KKE VAIK +         +  + EI  + +    +I
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75

Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRE------LGRQL 203
                V     F  ++ + +V + L G S+ D ++    +      V +      + R++
Sbjct: 76  -----VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130

Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
           LE + ++H+   IH D+K  NILL                  +DGS          +++ 
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILL-----------------GEDGS----------VQIA 163

Query: 264 DFG-----STTFEHQDHSY---VVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSG 314
           DFG     +T  +   +      V T  + APEV+    G+++  D+WS G   +EL +G
Sbjct: 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223

Query: 315 EA 316
            A
Sbjct: 224 AA 225

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 85.2 bits (211), Expect = 4e-18
 Identities = 53/247 (21%), Positives = 101/247 (40%), Gaps = 39/247 (15%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHD 149
           YR+L   G+G FG+V  C      ++ A K +        K    A+ E  +L+++    
Sbjct: 189 YRVL---GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           +     V +   ++ ++ +C+V   + G  L   +       FP         ++   + 
Sbjct: 246 V-----VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
            +H  R+++ DLKPENILL    ++++ D   L+    +G                    
Sbjct: 301 DLHRERIVYRDLKPENILLDDHGHIRISDLG-LAVHVPEGQ----------------TIK 343

Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH-ENLEHL 327
                     V T  Y APEV+    + +  D W++GC+L E+ +G++ FQ   + ++  
Sbjct: 344 GR--------VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 395

Query: 328 AMMERVL 334
            +   V 
Sbjct: 396 EVERLVK 402

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 84.2 bits (208), Expect = 5e-18
 Identities = 57/326 (17%), Positives = 103/326 (31%), Gaps = 56/326 (17%)

Query: 94  YRILSKMGEG--TFGQVVECFDNEKKELVAIKIV---RSINKYREAAMIEIDVLQRLARH 148
           Y +L+ +G+G      V         E V ++ +      N+       E+ V +     
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86

Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
           +I     V  R  F   N + +V   +   S  D +  +         +  + + +L+++
Sbjct: 87  NI-----VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKAL 141

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
            ++H +  +H  +K  +IL+                 S DG           + L    S
Sbjct: 142 DYIHHMGYVHRSVKASHILI-----------------SVDGK----------VYLSGLRS 174

Query: 268 ----------TTFEHQDHSYVVSTRHYRAPEVI--LGLGWNYPCDLWSVGCILVELCSGE 315
                         H    Y V    + +PEV+     G++   D++SVG    EL +G 
Sbjct: 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

Query: 316 ALFQTHENLEHLAMMERVLGP-LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV 374
             F+     + L        P L     I A+       R  A     D  T+     + 
Sbjct: 235 VPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSN 294

Query: 375 WKLLRLPVIDLYSAS-----PNCLCK 395
                 P    +S         CL +
Sbjct: 295 GDSPSHPYHRTFSPHFHHFVEQCLQR 320

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 82.7 bits (205), Expect = 7e-18
 Identities = 57/253 (22%), Positives = 95/253 (37%), Gaps = 57/253 (22%)

Query: 96  ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD--- 149
           I  K+G G+FG V     +     VA+KI+   +   +     + E+ +++RL RH    
Sbjct: 41  IKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIV 97

Query: 150 --IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYR-SFPIDLVRELGRQLLE 205
             +G     Q         ++ IV E L   SLY  L K+  R          +   + +
Sbjct: 98  LFMGA--VTQ-------PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAK 148

Query: 206 SVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
            + ++H     ++H +LK  N+L+     VKV                            
Sbjct: 149 GMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKV---------------------------C 181

Query: 264 DFGSTTFEHQDHSYVVS---TRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 320
           DFG +  +        S   T  + APEV+     N   D++S G IL EL + +  +  
Sbjct: 182 DFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW-- 239

Query: 321 HENLEHLAMMERV 333
             NL    ++  V
Sbjct: 240 -GNLNPAQVVAAV 251

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 55/246 (22%), Positives = 103/246 (41%), Gaps = 57/246 (23%)

Query: 86  IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--------INKY-REAAM 136
           IG+ +  RY+I+ K+G G    V    D      VAIK +          + ++ RE   
Sbjct: 5   IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHN 64

Query: 137 IEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDL 195
                  +L+  +I     V + +  +  +   +V E + GP+L +++  +      +D 
Sbjct: 65  S-----SQLSHQNI-----VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--GPLSVDT 112

Query: 196 VRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 255
                 Q+L+ +   H++R++H D+KP+NIL+                   + +      
Sbjct: 113 AINFTNQILDGIKHAHDMRIVHRDIKPQNILI-----------------DSNKT------ 149

Query: 256 KSSAIKLIDFG------STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309
               +K+ DFG       T+    +H  V+ T  Y +PE   G   +   D++S+G +L 
Sbjct: 150 ----LKIFDFGIAKALSETSLTQTNH--VLGTVQYFSPEQAKGEATDECTDIYSIGIVLY 203

Query: 310 ELCSGE 315
           E+  GE
Sbjct: 204 EMLVGE 209

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 80.4 bits (199), Expect = 3e-17
 Identities = 53/245 (21%), Positives = 95/245 (38%), Gaps = 53/245 (21%)

Query: 95  RILSKMGEGTFGQVVE-CFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD- 149
            +  ++G G+FG V +  +  +    VA+K++       +  +A   E+ VL++  RH  
Sbjct: 27  TVGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVN 81

Query: 150 ----IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
               +G +              + IV +   G SLY  L  +    F +  + ++ RQ  
Sbjct: 82  ILLFMGYST----------APQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTA 130

Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLI 263
             + ++H   +IH DLK  NI L     VK+ D  F L+                     
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGD--FGLAT-------------------- 168

Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWN---YPCDLWSVGCILVELCSGEALFQT 320
              S          +  +  + APEVI     N   +  D+++ G +L EL +G+  +  
Sbjct: 169 -EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227

Query: 321 HENLE 325
             N +
Sbjct: 228 INNRD 232

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 82.1 bits (203), Expect = 4e-17
 Identities = 54/251 (21%), Positives = 102/251 (40%), Gaps = 44/251 (17%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHD 149
           +R+L   G G FG+V  C      +L A K +        K  + AM+E  +L ++    
Sbjct: 190 FRVL---GRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246

Query: 150 IGGTRCVQIRNWFDYRNHICIVFE-----KLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
           I     V +   F+ +  +C+V        +   +Y+    N    F          Q++
Sbjct: 247 I-----VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN--PGFQEPRAIFYTAQIV 299

Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
             +  +H+  +I+ DLKPEN+LL     V++ D       + +    +   K        
Sbjct: 300 SGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL----AVELKAGQTKTK-------- 347

Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH-EN 323
                +          T  + APE++LG  +++  D +++G  L E+ +    F+   E 
Sbjct: 348 ----GY--------AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK 395

Query: 324 LEHLAMMERVL 334
           +E+  + +RVL
Sbjct: 396 VENKELKQRVL 406

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 81.2 bits (201), Expect = 4e-17
 Identities = 58/256 (22%), Positives = 109/256 (42%), Gaps = 45/256 (17%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
           +  +  +G G+FG+V+     E     A+KI+    + K ++    + E  +LQ +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFP 101

Query: 150 IGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                 V++   F   +++ +V E   G  ++  LR+     F     R    Q++ +  
Sbjct: 102 F----LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFE 155

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H L LI+ DLKPEN+L+    Y++V D+ F                    K +   + 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF-------------------AKRVKGRTW 196

Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
           T           T    APE+IL  G+N   D W++G ++ E+ +G   F   +    + 
Sbjct: 197 TL--------CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF-FADQ--PIQ 245

Query: 329 MMERVL-GPL--PHHM 341
           + E+++ G +  P H 
Sbjct: 246 IYEKIVSGKVRFPSHF 261

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 80.4 bits (199), Expect = 5e-17
 Identities = 57/273 (20%), Positives = 93/273 (34%), Gaps = 65/273 (23%)

Query: 63  GAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAI 122
           G +PR        + ++G   F         YR+   +G G  G V E  D  ++ +VA+
Sbjct: 13  GLVPRGSHMDGTAESREG-TQFG-------PYRLRRLVGRGGMGDVYEAEDTVRERIVAL 64

Query: 123 KIVRS--------INKY-REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173
           K++            +  REA         RL    +     V I ++ +    + +   
Sbjct: 65  KLMSETLSSDPVFRTRMQREA-----RTAGRLQEPHV-----VPIHDFGEIDGQLYVDMR 114

Query: 174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY 232
            + G  L   LR+             + RQ+  ++   H     H D+KPENIL+     
Sbjct: 115 LINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV----- 167

Query: 233 VKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG------STTFEHQDHSYVVSTRHYRA 286
                       S D              L+DFG                  V T +Y A
Sbjct: 168 ------------SADD----------FAYLVDFGIASATTDEKLTQ--LGNTVGTLYYMA 203

Query: 287 PEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
           PE        Y  D++++ C+L E  +G   +Q
Sbjct: 204 PERFSESHATYRADIYALTCVLYECLTGSPPYQ 236

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 54/255 (21%), Positives = 93/255 (36%), Gaps = 69/255 (27%)

Query: 86  IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--------INKY-REAAM 136
              +L+ RY +   +G G   +V    D      VA+K++R+          ++ REA  
Sbjct: 6   TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREA-- 63

Query: 137 IEIDVLQRLAR---------HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKN 186
                 Q  A          +D G          +       IV E + G +L D +   
Sbjct: 64  ------QNAAALNHPAIVAVYDTGEAETPAGPLPY-------IVMEYVDGVTLRDIVHTE 110

Query: 187 SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246
                      E+     +++ F H+  +IH D+KP NI++                 S 
Sbjct: 111 --GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI-----------------SA 151

Query: 247 DGSYFKNLPKSSAIKLIDFG------STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 300
                       A+K++DFG       +       + V+ T  Y +PE   G   +   D
Sbjct: 152 TN----------AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSD 201

Query: 301 LWSVGCILVELCSGE 315
           ++S+GC+L E+ +GE
Sbjct: 202 VYSLGCVLYEVLTGE 216

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 57/249 (22%), Positives = 102/249 (40%), Gaps = 42/249 (16%)

Query: 96  ILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHDIG 151
           IL  +G G FG+V         ++ A+KI+    + K  E A    E DVL       I 
Sbjct: 78  ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWI- 136

Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                 +   F   N++ +V +   G  L   L K   R  P ++ R    +++ ++  +
Sbjct: 137 ----TTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR-LPEEMARFYLAEMVIAIDSV 191

Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H+L  +H D+KP+NIL+    ++++ D+    +  +DG                  S+  
Sbjct: 192 HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG---------------TVQSSVA 236

Query: 271 EHQDHSYVVSTRHYRAPEVILGL-----GWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
                   V T  Y +PE++  +      +   CD WS+G  + E+  GE  F   E+L 
Sbjct: 237 --------VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF-YAESLV 287

Query: 326 HLAMMERVL 334
                 +++
Sbjct: 288 --ETYGKIM 294

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 51/232 (21%), Positives = 97/232 (41%), Gaps = 40/232 (17%)

Query: 96  ILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHDIG 151
           ++  +G G FG+V        +++ A+K++    + K  ++A    E D++       + 
Sbjct: 73  VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV- 131

Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
               VQ+   F    ++ +V E + G  L + +        P    R    +++ ++  +
Sbjct: 132 ----VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAI 184

Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H +  IH D+KP+N+LL  + ++K+ D+    + +K+G                    T 
Sbjct: 185 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG---------------MVRCDTA 229

Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYP----CDLWSVGCILVELCSGEALF 318
                   V T  Y +PEV+   G +      CD WSVG  L E+  G+  F
Sbjct: 230 --------VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 78.2 bits (193), Expect = 5e-16
 Identities = 56/251 (22%), Positives = 99/251 (39%), Gaps = 44/251 (17%)

Query: 96  ILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHDIG 151
           IL  +G G F +V      +  ++ A+KI+    + K  E +    E DVL    R  I 
Sbjct: 65  ILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI- 123

Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
                Q+   F   N++ +V E   G  L   L K   R  P ++ R    +++ ++  +
Sbjct: 124 ----TQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGER-IPAEMARFYLAEIVMAIDSV 178

Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H L  +H D+KP+NILL    ++++ D+    +   DG                  S   
Sbjct: 179 HRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG---------------TVRSLVA 223

Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNY-------PCDLWSVGCILVELCSGEALFQTHEN 323
                   V T  Y +PE++  +G           CD W++G    E+  G+  F   ++
Sbjct: 224 --------VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF-YADS 274

Query: 324 LEHLAMMERVL 334
                   +++
Sbjct: 275 TA--ETYGKIV 283

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 77.1 bits (190), Expect = 7e-16
 Identities = 61/310 (19%), Positives = 115/310 (37%), Gaps = 70/310 (22%)

Query: 96  ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD-----I 150
           +   +G+G FG+V       + E VA+KI  S  +       EI     L RH+     I
Sbjct: 46  LQESIGKGRFGEV--WRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFI 102

Query: 151 GGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                            + +V +  + G SL+D+L + +     ++ + +L       +A
Sbjct: 103 AADNKDN-----GTWTQLWLVSDYHEHG-SLFDYLNRYT---VTVEGMIKLALSTASGLA 153

Query: 209 FMHELRL--------IHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSA 259
            +H   +         H DLK +NIL+       + D    L+               SA
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD--LGLAVR-----------HDSA 200

Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYP------CDLWSVGCILVELCS 313
              ID              V T+ Y APEV+               D++++G +  E+  
Sbjct: 201 TDTIDIAPNH--------RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 252

Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYF----RRGARLDWPDGATSRD 369
             ++   HE+ +           LP++ ++ +D   E+       +  R + P+   S +
Sbjct: 253 RCSIGGIHEDYQ-----------LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCE 301

Query: 370 SMRAVWKLLR 379
           ++R + K++R
Sbjct: 302 ALRVMAKIMR 311

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 76.6 bits (189), Expect = 7e-16
 Identities = 58/310 (18%), Positives = 108/310 (34%), Gaps = 70/310 (22%)

Query: 96  ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD-----I 150
           +L  +G+G +G+V     + + E VA+KI  S ++       E+     L RH+     I
Sbjct: 12  LLECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKSWFRETELYNTVML-RHENILGFI 68

Query: 151 GGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                 +          + ++    ++G SLYD+L+  +           +   +   +A
Sbjct: 69  ASDMTSR-----HSSTQLWLITHYHEMG-SLYDYLQLTT---LDTVSCLRIVLSIASGLA 119

Query: 209 FMHELRL--------IHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSA 259
            +H             H DLK +NIL+       + D    L+              S +
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD--LGLAVM-----------HSQS 166

Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYP------CDLWSVGCILVELCS 313
              +D G+           V T+ Y APEV+               D+W+ G +L E+  
Sbjct: 167 TNQLDVGNNP--------RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR 218

Query: 314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYF----RRGARLDWPDGATSRD 369
                   E+ +            P + V+  D   E           R + P+   S  
Sbjct: 219 RMVSNGIVEDYK-----------PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDP 267

Query: 370 SMRAVWKLLR 379
           ++ ++ KL++
Sbjct: 268 TLTSLAKLMK 277

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 55/251 (21%), Positives = 103/251 (41%), Gaps = 46/251 (18%)

Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD- 149
            IL  +G+G+FG+V     N+ K++ A+K +      +  E      E+ ++Q L  H  
Sbjct: 18  EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPF 76

Query: 150 IGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           +     V +   F     + +V +  LG  L   L++N    F  + V+    +L+ ++ 
Sbjct: 77  L-----VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALD 129

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-S 267
           ++   R+IH D+KP+NILL         D        + G           + + DF  +
Sbjct: 130 YLQNQRIIHRDMKPDNILL---------D--------EHGH----------VHITDFNIA 162

Query: 268 TTFEHQDHSYVVS-TRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGEALFQTHEN 323
                +     ++ T+ Y APE+     G G+++  D WS+G    EL  G   +    +
Sbjct: 163 AMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS 222

Query: 324 LEHLAMMERVL 334
                ++    
Sbjct: 223 TSSKEIVHTFE 233

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 51/237 (21%), Positives = 106/237 (44%), Gaps = 35/237 (14%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
           + +L  +G G++ +V+     +   + A+K+V+   +N   +      E  V ++ + H 
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                 V + + F   + +  V E + G  L   +++   R  P +  R    ++  ++ 
Sbjct: 71  F----LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALN 124

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++HE  +I+ DLK +N+LL S  ++K+ DY       K+G              +  G T
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM----CKEG--------------LRPGDT 166

Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
           T      S    T +Y APE++ G  + +  D W++G ++ E+ +G + F    + +
Sbjct: 167 T------STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 74.6 bits (184), Expect = 3e-15
 Identities = 35/254 (13%), Positives = 81/254 (31%), Gaps = 60/254 (23%)

Query: 96  ILSKMGEGTFGQVVE--CFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD- 149
            L+K+ E   G++ +     N+    + +K+++  +   +       E   L+    H  
Sbjct: 14  FLTKLNENHSGELWKGRWQGND----IVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPN 68

Query: 150 ----IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
               +G   C           H  ++   +   SLY+ L + +          +    + 
Sbjct: 69  VLPVLGA--CQS-----PPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMA 121

Query: 205 ESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
             +AF+H L   +    L   ++++                  +D +           ++
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMI-----------------DEDMT----------ARI 154

Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYP---CDLWSVGCILVELCSGEALFQ 319
                           +    + APE +     +      D+WS   +L EL + E  F 
Sbjct: 155 SMADVKFSFQSPG--RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF- 211

Query: 320 THENLEHLAMMERV 333
              +L ++ +  +V
Sbjct: 212 --ADLSNMEIGMKV 223

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 74.7 bits (184), Expect = 4e-15
 Identities = 49/257 (19%), Positives = 94/257 (36%), Gaps = 56/257 (21%)

Query: 96  ILSKMGEGTFGQVVE-CFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD-- 149
           I   +G+G FGQV    +  E    VAI+++          +A   E+   ++  RH+  
Sbjct: 37  IGELIGKGRFGQVYHGRWHGE----VAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENV 91

Query: 150 ---IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
              +G   C+          H+ I+     G +LY  +R        ++  R++ +++++
Sbjct: 92  VLFMGA--CMS-------PPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVK 141

Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLID 264
            + ++H   ++H DLK +N+       V + D  F L   S      +            
Sbjct: 142 GMGYLHAKGILHKDLKSKNV-FYDNGKVVITD--FGLFSISGVLQAGRR----------- 187

Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYP---------CDLWSVGCILVELCSGE 315
                              + APE+I  L  +            D++++G I  EL + E
Sbjct: 188 -------EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240

Query: 316 ALFQTHENLEHLAMMER 332
             F+T      +  M  
Sbjct: 241 WPFKTQPAEAIIWQMGT 257

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 75.5 bits (186), Expect = 4e-15
 Identities = 50/237 (21%), Positives = 106/237 (44%), Gaps = 35/237 (14%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
           + +L  +G G++ +V+     +   + A+++V+   +N   +      E  V ++ + H 
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                 V + + F   + +  V E + G  L   +++   R  P +  R    ++  ++ 
Sbjct: 114 F----LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALN 167

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++HE  +I+ DLK +N+LL S  ++K+ DY       K+G              +  G T
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM----CKEG--------------LRPGDT 209

Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
           T      S    T +Y APE++ G  + +  D W++G ++ E+ +G + F    + +
Sbjct: 210 T------STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 74.9 bits (185), Expect = 4e-15
 Identities = 57/263 (21%), Positives = 106/263 (40%), Gaps = 50/263 (19%)

Query: 92  PRYRI-----LSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVL 142
           P+Y +     L  +G G+FG+V            A+K+++   + + ++      E  +L
Sbjct: 1   PKYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 60

Query: 143 QRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGR 201
             +  H       +++   F     I ++ + + G  L+  LRK   + FP  + +    
Sbjct: 61  SIV-THPF----IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAA 113

Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           ++  ++ ++H   +I+ DLKPENILL    ++K+ D+ F                    K
Sbjct: 114 EVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGF-------------------AK 154

Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
            +   + T           T  Y APEV+    +N   D WS G ++ E+ +G   F   
Sbjct: 155 YVPDVTYTL--------CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF-YD 205

Query: 322 ENLEHLAMMERVL-GPL--PHHM 341
            N   +   E++L   L  P   
Sbjct: 206 SN--TMKTYEKILNAELRFPPFF 226

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 52/231 (22%), Positives = 94/231 (40%), Gaps = 35/231 (15%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHD 149
           +  L  +G+G+FG+V+        EL A+KI++      +   E  M+E  VL    +  
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                  Q+ + F   + +  V E + G  L   +++     F          ++   + 
Sbjct: 403 F----LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLF 456

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           F+    +I+ DLK +N++L S  ++K+ D+       K+               I  G T
Sbjct: 457 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM----CKEN--------------IWDGVT 498

Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
           T           T  Y APE+I    +    D W+ G +L E+ +G+A F+
Sbjct: 499 T------KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 74.0 bits (182), Expect = 7e-15
 Identities = 58/311 (18%), Positives = 110/311 (35%), Gaps = 72/311 (23%)

Query: 96  ILSKMGEGTFGQVVEC-FDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
           ++ ++G+G +G+V    +  EK   VA+K+  +  +       EI     + RH+     
Sbjct: 41  MVKQIGKGRYGEVWMGKWRGEK---VAVKVFFTTEEASWFRETEIYQTVLM-RHENILGF 96

Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
           I     ++          + ++ +  + G SLYD+L+  +        + +L    +  +
Sbjct: 97  IAA--DIKGTG---SWTQLYLITDYHENG-SLYDYLKSTT---LDAKSMLKLAYSSVSGL 147

Query: 208 AFMHELRL--------IHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSS 258
             +H             H DLK +NIL+       + D    L+               S
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD--LGLAVK-----------FIS 194

Query: 259 AIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYP------CDLWSVGCILVELC 312
               +D    T         V T+ Y  PEV+               D++S G IL E+ 
Sbjct: 195 DTNEVDIPPNT--------RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

Query: 313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYF----RRGARLDWPDGATSR 368
                    E  +           LP+H ++ +D   E        +  R  +P+  +S 
Sbjct: 247 RRCVSGGIVEEYQ-----------LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSD 295

Query: 369 DSMRAVWKLLR 379
           + +R + KL+ 
Sbjct: 296 ECLRQMGKLMT 306

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 68/302 (22%), Positives = 113/302 (37%), Gaps = 64/302 (21%)

Query: 95  RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
           + L ++G+G FG V  C      +   E+VA+K ++ S  ++      EI++L+ L +HD
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 102

Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
                 G   C         R ++ ++ E    G SL D+L+K+  R   I L+ +   Q
Sbjct: 103 NIVKYKG--VCYS-----AGRRNLKLIMEYLPYG-SLRDYLQKHKERIDHIKLL-QYTSQ 153

Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           + + + ++   R IH DL   NIL+ +   VK+                           
Sbjct: 154 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIG-------------------------- 187

Query: 263 IDFGSTTFEHQDHSYVVSTRHYR------APEVILGLGWNYPCDLWSVGCILVELCSGEA 316
            DFG T    QD  Y              APE +    ++   D+WS G +L EL +   
Sbjct: 188 -DFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 246

Query: 317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR--DSMRAV 374
             ++        +     G +    +I       +  +   RL  PDG        M   
Sbjct: 247 KSKSPPAEFMRMIGNDKQGQMIVFHLI-------ELLKNNGRLPRPDGCPDEIYMIMTEC 299

Query: 375 WK 376
           W 
Sbjct: 300 WN 301

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 66/299 (22%), Positives = 115/299 (38%), Gaps = 58/299 (19%)

Query: 95  RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
           + L ++G+G FG V  C      +   E+VA+K ++ S  ++      EI++L+ L +HD
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 71

Query: 150 IGGTRCVQIRN--WFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
                 V+ +   +   R ++ ++ E    G SL D+L+K+  R   I L+ +   Q+ +
Sbjct: 72  ----NIVKYKGVCYSAGRRNLKLIMEYLPYG-SLRDYLQKHKERIDHIKLL-QYTSQICK 125

Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
            + ++   R IH DL   NIL+ +   VK+                            DF
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVENENRVKIG---------------------------DF 158

Query: 266 GSTTFEHQDHSYVVSTRHYR------APEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
           G T    QD  +              APE +    ++   D+WS G +L EL +     +
Sbjct: 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 218

Query: 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR--DSMRAVWK 376
           +        +     G +    +I       +  +   RL  PDG        M   W 
Sbjct: 219 SPPAEFMRMIGNDKQGQMIVFHLI-------ELLKNNGRLPRPDGCPDEIYMIMTECWN 270

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 65/251 (25%), Positives = 109/251 (43%), Gaps = 39/251 (15%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
           +  L  +G+GTFG+V+   +       A+KI++   I    E A  + E  VLQ  +RH 
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHP 208

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                   ++  F   + +C V E   G  L+  L +   R F  D  R  G +++ ++ 
Sbjct: 209 F----LTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALD 262

Query: 209 FMHELR-LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
           ++H  + +++ DLK EN++L    ++K+ D+       K+G              I  G+
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGL----CKEG--------------IKDGA 304

Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHENLE 325
           T            T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L 
Sbjct: 305 TM------KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 358

Query: 326 HLAMMERVLGP 336
            L +ME +  P
Sbjct: 359 ELILMEEIRFP 369

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 72.6 bits (179), Expect = 2e-14
 Identities = 49/230 (21%), Positives = 96/230 (41%), Gaps = 35/230 (15%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
           + +   +G+G+FG+V      +  +  AIK ++   +    +    M+E  VL     H 
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                   +   F  + ++  V E L G  L   ++      F +        +++  + 
Sbjct: 79  F----LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQ 132

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           F+H   +++ DLK +NILL    ++K+ D+       K+               +   + 
Sbjct: 133 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGM----CKEN--------------MLGDAK 174

Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
           T     +++   T  Y APE++LG  +N+  D WS G +L E+  G++ F
Sbjct: 175 T-----NTF-CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 71.9 bits (177), Expect = 5e-14
 Identities = 64/258 (24%), Positives = 108/258 (41%), Gaps = 46/258 (17%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
           +  L  +G+GTFG+V+   +       A+KI+R   I    E A  + E  VLQ      
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN----- 61

Query: 150 IGGTRC---VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
              TR      ++  F   + +C V E   G  L+  L +   R F  +  R  G +++ 
Sbjct: 62  ---TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVS 116

Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           ++ ++H   +++ D+K EN++L    ++K+ D+       K+G              I  
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL----CKEG--------------ISD 158

Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF--QTHEN 323
           G+T            T  Y APEV+    +    D W +G ++ E+  G   F  Q HE 
Sbjct: 159 GATM------KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212

Query: 324 LEHLAMMERVLGPLPHHM 341
           L  L +ME +    P  +
Sbjct: 213 LFELILMEEI--RFPRTL 228

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 71.9 bits (177), Expect = 5e-14
 Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 35/224 (15%)

Query: 101 GEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHDIGGTRCV 156
           G+G+FG+V+      ++   A+K+++  +I K +E    M E +VL +  +H       V
Sbjct: 47  GKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF----LV 102

Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
            +   F   + +  V + + G  L+  L++   R F     R    ++  ++ ++H L +
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNI 160

Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
           ++ DLKPENILL S  ++ + D+       K+               I+  STT      
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGL----CKEN--------------IEHNSTT------ 196

Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
           S    T  Y APEV+    ++   D W +G +L E+  G   F 
Sbjct: 197 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY 240

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 71.5 bits (176), Expect = 5e-14
 Identities = 56/239 (23%), Positives = 101/239 (42%), Gaps = 36/239 (15%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
           +  +  +G+G+FG+V+     E  +L A+K+++   I +  +    M E  +L     H 
Sbjct: 25  FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                  Q+   F   + +  V E + G  L         R F     R    +++ ++ 
Sbjct: 85  F----LTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEIISALM 138

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           F+H+  +I+ DLK +N+LL    + K+ D+  +    K+G              I  G T
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDHEGHCKLADF-GM---CKEG--------------ICNGVT 180

Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
           T      +    T  Y APE++  + +    D W++G +L E+  G A F   EN + L
Sbjct: 181 T------ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF-EAENEDDL 232

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 71.5 bits (176), Expect = 5e-14
 Identities = 51/230 (22%), Positives = 91/230 (39%), Gaps = 35/230 (15%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
           +  L  +G+G+FG+V+        EL A+KI++   + +  +    M+E  VL    +  
Sbjct: 22  FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
                  Q+ + F   + +  V E + G  L           F          ++   + 
Sbjct: 82  F----LTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLF 135

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           F+    +I+ DLK +N++L S  ++K+ D+       K+               I  G T
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM----CKEN--------------IWDGVT 177

Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF 318
           T           T  Y APE+I    +    D W+ G +L E+ +G+A F
Sbjct: 178 T------KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 221

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 71.7 bits (176), Expect = 9e-14
 Identities = 49/247 (19%), Positives = 98/247 (39%), Gaps = 44/247 (17%)

Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
            +  K+G G +G+V E    +    VA+K ++      E  + E  V++ + +H      
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQL 281

Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
           +G   C +            I+ E    G +L D+LR+ + +     ++  +  Q+  ++
Sbjct: 282 LG--VCTR-------EPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQISSAM 331

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFG 266
            ++ +   IH +L   N L+     VKV D  F LSR     +Y  +      IK     
Sbjct: 332 EYLEKKNFIHRNLAARNCLVGENHLVKVAD--FGLSRLMTGDTYTAHAGAKFPIKWT--- 386

Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE 325
                              APE +    ++   D+W+ G +L E+ + G + +   +  +
Sbjct: 387 -------------------APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 427

Query: 326 HLAMMER 332
              ++E+
Sbjct: 428 VYELLEK 434

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 58/316 (18%), Positives = 107/316 (33%), Gaps = 72/316 (22%)

Query: 91  TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD- 149
           +   ++L     G FG V +       E VA+KI    +K       E+  L  + +H+ 
Sbjct: 23  SMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHEN 79

Query: 150 ----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
               IG     +  +       + ++    + G SL DFL+ N       + +  +   +
Sbjct: 80  ILQFIGA--EKRGTS---VDVDLWLITAFHEKG-SLSDFLKANV---VSWNELCHIAETM 130

Query: 204 LESVAFMHE----------LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
              +A++HE            + H D+K +N+LL                   + +    
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL-----------------KNNLT---- 169

Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVS-----TRHYRAPEVILG-LGWNYP----CDLWS 303
                   + DFG         S   +     TR Y APEV+ G + +        D+++
Sbjct: 170 ------ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYA 223

Query: 304 VGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPD 363
           +G +L EL S           E++   E  +G  P    ++     E    +  R    D
Sbjct: 224 MGLVLWELASRCTAA-DGPVDEYMLPFEEEIGQHPSLEDMQ-----EVVVHKKKRPVLRD 277

Query: 364 GATSRDSMRAVWKLLR 379
                  M  + + + 
Sbjct: 278 YWQKHAGMAMLCETIE 293

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 69.2 bits (170), Expect = 3e-13
 Identities = 55/257 (21%), Positives = 106/257 (41%), Gaps = 46/257 (17%)

Query: 101 GEGTFGQVV---ECFDNEKKELVAIKIVR-----SINKYREAAMIEIDVLQRLARHD-IG 151
           G G +G+V    +   ++  +L A+K+++        K  E    E  VL+ + +   + 
Sbjct: 63  GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL- 121

Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
               V +   F     + ++ + + G  L+  L +     F    V+    +++ ++  +
Sbjct: 122 ----VTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHL 175

Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H+L +I+ D+K ENILL S  +V + D+      SK+              + D      
Sbjct: 176 HKLGIIYRDIKLENILLDSNGHVVLTDFGL----SKEF-------------VADETERA- 217

Query: 271 EHQDHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGEALFQT-HENLEHL 327
               + +   T  Y AP+++ G   G +   D WS+G ++ EL +G + F    E     
Sbjct: 218 ----YDF-CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA 272

Query: 328 AMMERVLG---PLPHHM 341
            +  R+L    P P  M
Sbjct: 273 EISRRILKSEPPYPQEM 289

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 68.5 bits (168), Expect = 4e-13
 Identities = 62/304 (20%), Positives = 106/304 (34%), Gaps = 68/304 (22%)

Query: 95  RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARH 148
           + +  +GEG FG+V  C      +   E VA+K ++  S   +      EI++L+ L  H
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YH 82

Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
           +      G   C +     D  N I ++ E    G SL ++L KN  +      + +   
Sbjct: 83  ENIVKYKG--ICTE-----DGGNGIKLIMEFLPSG-SLKEYLPKNKNKINLKQQL-KYAV 133

Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
           Q+ + + ++   + +H DL   N+L+ S   VK+                          
Sbjct: 134 QICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIG------------------------- 168

Query: 262 LIDFGSTTFEHQDHSYVVSTRHYR------APEVILGLGWNYPCDLWSVGCILVELCS-G 314
             DFG T     D  Y              APE ++   +    D+WS G  L EL +  
Sbjct: 169 --DFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYC 226

Query: 315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR--DSMR 372
           ++          +       G +    ++          + G RL  P          MR
Sbjct: 227 DSDSSPMALFLKMIGPTH--GQMTVTRLV-------NTLKEGKRLPCPPNCPDEVYQLMR 277

Query: 373 AVWK 376
             W+
Sbjct: 278 KCWE 281

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 68.4 bits (166), Expect = 7e-13
 Identities = 55/259 (21%), Positives = 85/259 (32%), Gaps = 62/259 (23%)

Query: 91  TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---------SINKYREAAMIEIDV 141
           T + +   K+GEG FG+V +         VAIKI+          S  K  E  + EI +
Sbjct: 19  TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 142 LQRLARHDIG------------GTRCVQ-------IRNWFDYRN---------------- 166
            + L+                    CVQ       ++ W  Y +                
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 167 -HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPEN 224
             I + FE  G  L     K S     +   + +  QL  S+A     LR  H DL   N
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLS----SLATAKSILHQLTASLAVAEASLRFEHRDLHWGN 192

Query: 225 ILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHY 284
           +LL      K+  Y    +SS   S          + +ID+  +  E             
Sbjct: 193 VLLKKTSLKKL-HYTLNGKSSTIPSC------GLQVSIIDYTLSRLERDGIVVFCDV--S 243

Query: 285 RAPEVILGLGWNYPCDLWS 303
              ++  G G +Y  D++ 
Sbjct: 244 MDEDLFTGDG-DYQFDIYR 261

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 65/300 (21%), Positives = 109/300 (36%), Gaps = 61/300 (20%)

Query: 95  RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHD 149
           + +S++G+G FG V  C      +    LVA+K ++     ++     EI +L+ L   D
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSD 84

Query: 150 IGGTRCVQIRN--WFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
                 V+ R   +   R  + +V E    G  L DFL+++  R     L+     Q+ +
Sbjct: 85  ----FIVKYRGVSYGPGRQSLRLVMEYLPSG-CLRDFLQRHRARLDASRLL-LYSSQICK 138

Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
            + ++   R +H DL   NIL+ S  +VK+                            DF
Sbjct: 139 GMEYLGSRRCVHRDLAARNILVESEAHVKIA---------------------------DF 171

Query: 266 GSTTFEHQDHSYVVSTRHYR------APEVILGLGWNYPCDLWSVGCILVELCS-GEALF 318
           G       D  Y V     +      APE +    ++   D+WS G +L EL +  +   
Sbjct: 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC 231

Query: 319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR--DSMRAVWK 376
                 E L MM           ++       +    G RL  P    +   + M+  W 
Sbjct: 232 SPSA--EFLRMMGCERDVPALSRLL-------ELLEEGQRLPAPPACPAEVHELMKLCWA 282

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 67.2 bits (165), Expect = 1e-12
 Identities = 58/260 (22%), Positives = 115/260 (44%), Gaps = 48/260 (18%)

Query: 95  RILSKMGEGTFGQVV---ECFDNEKKELVAIKIVRS---INKYREAA--MIEIDVLQRLA 146
            +L  +G+G +G+V    +       ++ A+K+++    +   ++ A    E ++L+   
Sbjct: 20  ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE-V 78

Query: 147 RHD-IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
           +H  I     V +   F     + ++ E L G  L+  L +     F  D       ++ 
Sbjct: 79  KHPFI-----VDLIYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEIS 131

Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
            ++  +H+  +I+ DLKPENI+L    +VK+ D+       K+               I 
Sbjct: 132 MALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL----CKES--------------IH 173

Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
            G+ T     H++   T  Y APE+++  G N   D WS+G ++ ++ +G   F T EN 
Sbjct: 174 DGTVT-----HTFC-GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF-TGENR 226

Query: 325 EHLAMMERVLG---PLPHHM 341
           +    ++++L     LP ++
Sbjct: 227 K--KTIDKILKCKLNLPPYL 244

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 66/245 (26%), Positives = 103/245 (42%), Gaps = 42/245 (17%)

Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           R+  K+G+G FG+V     N     VAIK ++      EA + E  V+++L RH+    +
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE----K 240

Query: 155 CVQIRNWFDY----RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
            VQ+     Y       I IV E +   SL DFL+  + +   +  + ++  Q+   +A+
Sbjct: 241 LVQL-----YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           +  +  +H DL+  NIL+      KV D  F L+R  +D  Y         IK       
Sbjct: 296 VERMNYVHRDLRAANILVGENLVCKVAD--FGLARLIEDNEYTARQGAKFPIKWT----- 348

Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHL 327
                            APE  L   +    D+WS G +L EL + G   +    N E L
Sbjct: 349 -----------------APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 391

Query: 328 AMMER 332
             +ER
Sbjct: 392 DQVER 396

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 66.8 bits (164), Expect = 2e-12
 Identities = 63/258 (24%), Positives = 106/258 (41%), Gaps = 65/258 (25%)

Query: 96  ILSKMGEGTFGQVV---ECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHD 149
           +L  +G+G+FG+V    +   ++ ++L A+K+++      + R    +E D+L     H 
Sbjct: 28  LLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE-VNHP 86

Query: 150 -IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
            I     V++   F     + ++ + L G  L+  L K     F  + V+    +L  ++
Sbjct: 87  FI-----VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALAL 139

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
             +H L +I+ DLKPENILL                  ++G           IKL DFG 
Sbjct: 140 DHLHSLGIIYRDLKPENILL-----------------DEEGH----------IKLTDFGL 172

Query: 267 ----------STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 316
                     + +F          T  Y APEV+   G     D WS G ++ E+ +G  
Sbjct: 173 SKESIDHEKKAYSF--------CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224

Query: 317 LFQTHENLEHLAMMERVL 334
            FQ  +  E    M  +L
Sbjct: 225 PFQGKDRKE---TMTMIL 239

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 66.8 bits (163), Expect = 4e-12
 Identities = 66/245 (26%), Positives = 103/245 (42%), Gaps = 42/245 (17%)

Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           R+  K+G+G FG+V     N     VAIK ++      EA + E  V+++L RH+    +
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE----K 323

Query: 155 CVQIRNWFDY----RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
            VQ+     Y       I IV E +   SL DFL+  + +   +  + ++  Q+   +A+
Sbjct: 324 LVQL-----YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 378

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           +  +  +H DL+  NIL+      KV D  F L+R  +D  Y         IK       
Sbjct: 379 VERMNYVHRDLRAANILVGENLVCKVAD--FGLARLIEDNEYTARQGAKFPIKWT----- 431

Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHL 327
                            APE  L   +    D+WS G +L EL + G   +    N E L
Sbjct: 432 -----------------APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 474

Query: 328 AMMER 332
             +ER
Sbjct: 475 DQVER 479

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 65.2 bits (159), Expect = 4e-12
 Identities = 42/283 (14%), Positives = 66/283 (23%), Gaps = 81/283 (28%)

Query: 66  PRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV 125
             + +PP       G  +         RYR+L   G     Q  +  D      VA+  V
Sbjct: 11  RESSAPPDDVQLVPGARI------ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFV 64

Query: 126 RSINK---------YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL- 175
                                      RL+R  I      ++ +    R    +V E + 
Sbjct: 65  DPQGVLPDDVLQETLSRT--------LRLSR--IDKPGVARVLDVVHTRAGGLVVAEWIR 114

Query: 176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
           G SL +          P+  +R   + L  +    H   +  +   P  + +        
Sbjct: 115 GGSLQEVADT---SPSPVGAIR-AMQSLAAAADAAHRAGVALSIDHPSRVRV-------- 162

Query: 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW 295
                    S DG           + L                                 
Sbjct: 163 ---------SIDG----------DVVLAYPA-----------------TMPDA------- 179

Query: 296 NYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLP 338
           N   D+  +G  L  L               LA  ER     P
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 66.3 bits (162), Expect = 5e-12
 Identities = 46/159 (28%), Positives = 82/159 (51%), Gaps = 13/159 (8%)

Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           ++  K+G G FG+V     N+  + VA+K ++  +   EA + E +V++ L +HD    +
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTL-QHD----K 244

Query: 155 CVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
            V++      +  I I+ E    G SL DFL+ +     P+  + +   Q+ E +AF+ +
Sbjct: 245 LVKLHAVV-TKEPIYIITEFMAKG-SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302

Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 250
              IH DL+  NIL+ ++   K+ D  F L+R  +D  Y
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIAD--FGLARVIEDNEY 339

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 65.2 bits (159), Expect = 6e-12
 Identities = 51/259 (19%), Positives = 84/259 (32%), Gaps = 54/259 (20%)

Query: 96  ILSKMGEGTFGQVVEC-FDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
           +L  +G G +G V +   D      VA+K+    N+        I  +  +  HD     
Sbjct: 17  LLELIGRGRYGAVYKGSLDERP---VAVKVFSFANRQNFINEKNIYRVPLM-EHDNIARF 72

Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
           I G      R   D R    +V E    G SL  +L  ++           L   +   +
Sbjct: 73  IVGD----ERVTADGRMEYLLVMEYYPNG-SLXKYLSLHT---SDWVSSCRLAHSVTRGL 124

Query: 208 AFMHE---------LRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKS 257
           A++H            + H DL   N+L+ +     + D  F LS         +   + 
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD--FGLSMRLTGNRLVRPGEED 182

Query: 258 SAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-------GWNYPCDLWSVGCILVE 310
           +A                   V T  Y APEV+ G              D++++G I  E
Sbjct: 183 NA---------------AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227

Query: 311 LCSGEALFQTHENLEHLAM 329
           +          E++    M
Sbjct: 228 IFMRCTDLFPGESVPEYQM 246

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 67/287 (23%), Positives = 114/287 (39%), Gaps = 62/287 (21%)

Query: 95  RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARH 148
           + +  +GEG FG+V        ++   E+VA+K +++    ++R     EID+L+ L  H
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YH 92

Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
           +      G   C            + +V E   LG SL D+L ++S       L+    +
Sbjct: 93  EHIIKYKG--CCED-----AGAASLQLVMEYVPLG-SLRDYLPRHSIG--LAQLL-LFAQ 141

Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGS--YFKNLPKSS 258
           Q+ E +A++H    IH DL   N+LL +   VK+ D  F L+++  +G   Y       S
Sbjct: 142 QICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGD--FGLAKAVPEGHEYYRVREDGDS 199

Query: 259 AIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEAL 317
            +                       + APE +    + Y  D+WS G  L EL +  ++ 
Sbjct: 200 PVF----------------------WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSS 237

Query: 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDG 364
                    L  + +  G +    +        +   RG RL  PD 
Sbjct: 238 QSPPTKFLELIGIAQ--GQMTVLRLT-------ELLERGERLPRPDK 275

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 63.0 bits (154), Expect = 3e-11
 Identities = 38/166 (22%), Positives = 70/166 (42%), Gaps = 21/166 (12%)

Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
            +  K+G G +G+V E    +    VA+K ++      E  + E  V++ + +H      
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQL 74

Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
           +G   C +            I+ E    G +L D+LR+ + +     ++  +  Q+  ++
Sbjct: 75  LG--VCTR-------EPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQISSAM 124

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFK 252
            ++ +   IH DL   N L+     VKV D  F LSR     +Y  
Sbjct: 125 EYLEKKNFIHRDLAARNCLVGENHLVKVAD--FGLSRLMTGDTYTA 168

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 64.1 bits (156), Expect = 4e-11
 Identities = 59/252 (23%), Positives = 97/252 (38%), Gaps = 51/252 (20%)

Query: 95  RILSKMGEGTFGQVVE---CFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD 149
            +   +GEG FG V +            VAIK  +  + +  RE  + E   +++   H 
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHP 451

Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
                IG     +        N + I+ E   LG  L  FL+   +      L+     Q
Sbjct: 452 HIVKLIG--VITE--------NPVWIIMELCTLG-ELRSFLQVRKFSLDLASLI-LYAYQ 499

Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIK 261
           L  ++A++   R +H D+   N+L+ S + VK+ D  F LSR  +D +Y+K       IK
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGD--FGLSRYMEDSTYYKASKGKLPIK 557

Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQT 320
            +                      APE I    +    D+W  G  + E+   G   FQ 
Sbjct: 558 WM----------------------APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595

Query: 321 HENLEHLAMMER 332
            +N + +  +E 
Sbjct: 596 VKNNDVIGRIEN 607

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 47/198 (23%), Positives = 73/198 (36%), Gaps = 30/198 (15%)

Query: 63  GAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAI 122
               ++G    R   KD   +    E+L     +  ++G G FG+V          LVA+
Sbjct: 91  PLTKKSGVVLHRAVPKDKWVLNH--EDLV----LGEQIGRGNFGEVFSGRLRADNTLVAV 144

Query: 123 KIVR--SINKYREAAMIEIDVLQRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE-- 173
           K  R       +   + E  +L++   H      IG   C Q       +  I IV E  
Sbjct: 145 KSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIG--VCTQ-------KQPIYIVMELV 194

Query: 174 KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233
           + G     FLR    R     L+ ++       + ++     IH DL   N L+     +
Sbjct: 195 QGG-DFLTFLRTEGARLRVKTLL-QMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVL 252

Query: 234 KVPDYKF-LSRSSKDGSY 250
           K+ D  F +SR   DG Y
Sbjct: 253 KISD--FGMSREEADGVY 268

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 60.7 bits (148), Expect = 1e-10
 Identities = 60/256 (23%), Positives = 98/256 (38%), Gaps = 59/256 (23%)

Query: 95  RILSKMGEGTFGQVVE---CFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD 149
            +   +GEG FG V +            VAIK  +  + +  RE  + E   +++   H 
Sbjct: 18  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHP 76

Query: 150 IGGTRCVQIRNWFDY----RNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
                 V++           N + I+ E   LG  L  FL+   Y      L+     QL
Sbjct: 77  ----HIVKL-----IGVITENPVWIIMELCTLG-ELRSFLQVRKYSLDLASLI-LYAYQL 125

Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKL 262
             ++A++   R +H D+   N+L+ S + VK+ D  F LSR  +D +Y+K       IK 
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGD--FGLSRYMEDSTYYKASKGKLPIKW 183

Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNY-----PCDLWSVGCILVELCS-GEA 316
           +                      APE I     N+       D+W  G  + E+   G  
Sbjct: 184 M----------------------APESI-----NFRRFTSASDVWMFGVCMWEILMHGVK 216

Query: 317 LFQTHENLEHLAMMER 332
            FQ  +N + +  +E 
Sbjct: 217 PFQGVKNNDVIGRIEN 232

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 60.3 bits (147), Expect = 2e-10
 Identities = 44/170 (25%), Positives = 73/170 (42%), Gaps = 26/170 (15%)

Query: 95  RILSKMGEGTFGQVVE---CFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD 149
            +   +GEG FG+V E        +K  VA+K  +       +E  M E  +++ L  H 
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHP 73

Query: 150 IGGTRCVQIRNWFDY----RNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
                 V++               I+ E    G  L  +L +N      + LV     Q+
Sbjct: 74  ----HIVKL-----IGIIEEEPTWIIMELYPYG-ELGHYLERNKNSLKVLTLV-LYSLQI 122

Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFK 252
            +++A++  +  +H D+   NIL+ S E VK+ D  F LSR  +D  Y+K
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASPECVKLGD--FGLSRYIEDEDYYK 170

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 59.9 bits (146), Expect = 2e-10
 Identities = 46/163 (28%), Positives = 84/163 (51%), Gaps = 21/163 (12%)

Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
           +++ ++G G FG+V   + N   + VA+K ++  +   +A + E +++++L +H     R
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQL-QHQ----R 69

Query: 155 CVQIRNWFDY----RNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
            V++     Y    +  I I+ E  + G SL DFL+  S     I+ + ++  Q+ E +A
Sbjct: 70  LVRL-----YAVVTQEPIYIITEYMENG-SLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 250
           F+ E   IH DL+  NIL+      K+ D  F L+R  +D  Y
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIAD--FGLARLIEDNEY 164

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 59.5 bits (145), Expect = 3e-10
 Identities = 44/164 (26%), Positives = 72/164 (43%), Gaps = 23/164 (14%)

Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
             + ++G G FG V   +   K + VAIK +R      E  + E +V+ +L  H      
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQL 68

Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
            G   C++       +  IC+V E  + G  L D+LR          L+  +   + E +
Sbjct: 69  YG--VCLE-------QAPICLVTEFMEHG-CLSDYLRTQRGLFAAETLL-GMCLDVCEGM 117

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 250
           A++ E  +IH DL   N L+   + +KV D  F ++R   D  Y
Sbjct: 118 AYLEEACVIHRDLAARNCLVGENQVIKVSD--FGMTRFVLDDQY 159

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 56/256 (21%), Positives = 98/256 (38%), Gaps = 66/256 (25%)

Query: 99  KMGEGTFGQVVE-CFDNEKKEL-VAIKIVR--SINKYREAAMIEIDVLQRLARHDIGGTR 154
           ++G G FG V +  +   KK++ VAIK+++  +     E  M E  ++ +L  +      
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNP----Y 71

Query: 155 CVQIRNWFDY----RNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
            V++             + +V E    G  L+ FL          ++  EL  Q+   + 
Sbjct: 72  IVRL-----IGVCQAEALMLVMEMAGGG-PLHKFLVGKREEIPVSNVA-ELLHQVSMGMK 124

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++ E   +H DL   N+LLV+  Y K+                            DFG +
Sbjct: 125 YLEEKNFVHRDLAARNVLLVNRHYAKIS---------------------------DFGLS 157

Query: 269 TFEHQDHSYVVSTRHYR------APEVILGLGWNY-----PCDLWSVGCILVELCS-GEA 316
                D SY  +    +      APE I     N+       D+WS G  + E  S G+ 
Sbjct: 158 KALGADDSYYTARSAGKWPLKWYAPECI-----NFRKFSSRSDVWSYGVTMWEALSYGQK 212

Query: 317 LFQTHENLEHLAMMER 332
            ++  +  E +A +E+
Sbjct: 213 PYKKMKGPEVMAFIEQ 228

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 59.1 bits (144), Expect = 4e-10
 Identities = 56/252 (22%), Positives = 98/252 (38%), Gaps = 56/252 (22%)

Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
            +L ++G G FG V       + + VA+K+++  +   +    E   + +L  H      
Sbjct: 11  TLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKL-SHPKLVKF 68

Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
            G   C +          I IV E    G  L ++LR +     P  L+ E+   + E +
Sbjct: 69  YG--VCSK-------EYPIYIVTEYISNG-CLLNYLRSHGKGLEPSQLL-EMCYDVCEGM 117

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFG 266
           AF+   + IH DL   N L+     VKV D  F ++R   D  Y  ++     +K     
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRDLCVKVSD--FGMTRYVLDDQYVSSVGTKFPVK----- 170

Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNY-----PCDLWSVGCILVELCS-GEALFQT 320
                            + APEV      +Y       D+W+ G ++ E+ S G+  +  
Sbjct: 171 -----------------WSAPEVF-----HYFKYSSKSDVWAFGILMWEVFSLGKMPYDL 208

Query: 321 HENLEHLAMMER 332
           + N E +  + +
Sbjct: 209 YTNSEVVLKVSQ 220

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 58.8 bits (143), Expect = 7e-10
 Identities = 35/170 (20%), Positives = 76/170 (44%), Gaps = 29/170 (17%)

Query: 95  RILSKMGEGTFGQVVECF---DNEKKEL-VAIKIVR--SINKYREAAMIEIDVLQRLARH 148
           + +  +G G FG V +     + EK ++ VAIK +R  +  K  +  + E  V+  +  +
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DN 76

Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
                 +G   C+         + + ++ +    G  L D++R++        L+     
Sbjct: 77  PHVCRLLG--ICLT--------STVQLITQLMPFG-CLLDYVREHKDNIGSQYLL-NWCV 124

Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 250
           Q+ + + ++ + RL+H DL   N+L+ + ++VK+ D  F L++       
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITD--FGLAKLLGAEEK 172

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 58.4 bits (142), Expect = 8e-10
 Identities = 44/163 (26%), Positives = 72/163 (44%), Gaps = 28/163 (17%)

Query: 95  RILSKMGEGTFGQVVE---CFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLAR 147
           R+L K+G+G+FG V        + K   VA+K ++    S  +  +  + E++ +  L  
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-D 79

Query: 148 HDIGGTRCVQIRNWFDY----RNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
           H       +++     Y       + +V E   LG SL D LRK+        L      
Sbjct: 80  HR----NLIRL-----YGVVLTPPMKMVTELAPLG-SLLDRLRKHQGHFLLGTLS-RYAV 128

Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSR 243
           Q+ E + ++   R IH DL   N+LL + + VK+ D  F L R
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGD--FGLMR 169

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 58/261 (22%), Positives = 96/261 (36%), Gaps = 61/261 (23%)

Query: 95  RILSKMGEGTFGQVVE-------CFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLA 146
                +G+GTF ++ +        +    +  V +K++   +  Y E+      ++ +L 
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL- 69

Query: 147 RHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVREL 199
            H       G   CV         +   +V E  K G SL  +L+KN      +  + E+
Sbjct: 70  SHKHLVLNYG--VCVC-------GDENILVQEFVKFG-SLDTYLKKNKNCINILWKL-EV 118

Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
            +QL  ++ F+ E  LIH ++  +NILL+  E  K  +  F                   
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF------------------- 159

Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYR------APEVIL-GLGWNYPCDLWSVGCILVELC 312
           IKL D G +         V+     +       PE I      N   D WS G  L E+C
Sbjct: 160 IKLSDPGIS-------ITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC 212

Query: 313 S-GEALFQTHENLEHLAMMER 332
           S G+      ++   L   E 
Sbjct: 213 SGGDKPLSALDSQRKLQFYED 233

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 47/256 (18%), Positives = 81/256 (31%), Gaps = 30/256 (11%)

Query: 14  MDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGSPPW 73
           M        R    V   +  P+  P L  +          Y  +           +   
Sbjct: 7   MGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHI 66

Query: 74  RPDDKDGHYVFAIGENLTPRYR----ILSKMGEGTFGQVVECF---DNEKKELVAIKIVR 126
                +   V A+   +             +G G FG V       ++ KK   A+K + 
Sbjct: 67  DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 126

Query: 127 SINKYREAA--MIEIDVLQRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGP 177
            I    E +  + E  +++    H      +G                  +V    K G 
Sbjct: 127 RITDIGEVSQFLTEGIIMKDF-SHPNVLSLLG---IC-----LRSEGSPLVVLPYMKHG- 176

Query: 178 SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
            L +F+R  ++     DL+   G Q+ + + F+   + +H DL   N +L     VKV D
Sbjct: 177 DLRNFIRNETHNPTVKDLIG-FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVAD 235

Query: 238 YKF-LSRSSKDGSYFK 252
             F L+R   D  +  
Sbjct: 236 --FGLARDMYDKEFDS 249

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 57.2 bits (139), Expect = 2e-09
 Identities = 42/164 (25%), Positives = 72/164 (43%), Gaps = 23/164 (14%)

Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
             L ++G G FG V       + + VAIK+++  +   +  + E  V+  L  H+     
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQL 84

Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
            G   C +       +  I I+ E    G  L ++LR+  +R     L+ E+ + + E++
Sbjct: 85  YG--VCTK-------QRPIFIITEYMANG-CLLNYLREMRHRFQTQQLL-EMCKDVCEAM 133

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 250
            ++   + +H DL   N L+     VKV D  F LSR   D  Y
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSD--FGLSRYVLDDEY 175

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 41/169 (24%), Positives = 73/169 (43%), Gaps = 23/169 (13%)

Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
           ++L  +G+G FG V+       K  VA+K +++ +   +A + E  V+ +L RH      
Sbjct: 196 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKN-DATAQAFLAEASVMTQL-RHSNLVQL 251

Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
           +G    V+       +  + IV E    G SL D+LR         D + +    + E++
Sbjct: 252 LG--VIVE------EKGGLYIVTEYMAKG-SLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 302

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLP 255
            ++     +H DL   N+L+      KV D  F L++ +        LP
Sbjct: 303 EYLEGNNFVHRDLAARNVLVSEDNVAKVSD--FGLTKEASSTQDTGKLP 349

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 65/343 (18%), Positives = 116/343 (33%), Gaps = 62/343 (18%)

Query: 7   IEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIP 66
               + +    P      +    P      +    Y  +              M      
Sbjct: 257 SSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFE 316

Query: 67  RTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVE-CFDNEKKEL-VAIKI 124
              S P    DK    +F   +NL        ++G G FG V +  +   KK++ VAIK+
Sbjct: 317 SPFSDPEELKDKK---LFLKRDNLL---IADIELGCGNFGSVRQGVYRMRKKQIDVAIKV 370

Query: 125 VR--SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY----RNHICIVFE--KLG 176
           ++  +     E  M E  ++ +L  +       V++             + +V E    G
Sbjct: 371 LKQGTEKADTEEMMREAQIMHQL-DNP----YIVRL-----IGVCQAEALMLVMEMAGGG 420

Query: 177 PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236
             L+ FL          ++  EL  Q+   + ++ E   +H +L   N+LLV+  Y K+ 
Sbjct: 421 -PLHKFLVGKREEIPVSNVA-ELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKIS 478

Query: 237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYR------APEVI 290
                                      DFG +     D SY  +    +      APE I
Sbjct: 479 ---------------------------DFGLSKALGADDSYYTARSAGKWPLKWYAPECI 511

Query: 291 LGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
               ++   D+WS G  + E  S G+  ++  +  E +A +E+
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 554

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 56.9 bits (138), Expect = 2e-09
 Identities = 62/268 (23%), Positives = 107/268 (39%), Gaps = 71/268 (26%)

Query: 88  ENLTPRYRILSKMGEGTFGQVVE-CFDNEKKEL-VAIKIVR---SINKYREAAMIEIDVL 142
           + LT   + L   G G FG V +  +  +K    VA+KI++   +    ++  + E +V+
Sbjct: 16  KLLTLEDKEL---GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 72

Query: 143 QRLARHDIGGTRCVQIRNWFDY----RNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLV 196
           Q+L  +       V++               +V E  +LG  L  +L++N  R      +
Sbjct: 73  QQL-DNP----YIVRM-----IGICEAESWMLVMEMAELG-PLNKYLQQN--RHVKDKNI 119

Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256
            EL  Q+   + ++ E   +H DL   N+LLV+  Y K+                     
Sbjct: 120 IELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKIS-------------------- 159

Query: 257 SSAIKLIDFGSTTFEHQDHSYVVSTRHYR------APEVILGLGWNY-----PCDLWSVG 305
                  DFG +     D +Y  +  H +      APE I     NY       D+WS G
Sbjct: 160 -------DFGLSKALRADENYYKAQTHGKWPVKWYAPECI-----NYYKFSSKSDVWSFG 207

Query: 306 CILVELCS-GEALFQTHENLEHLAMMER 332
            ++ E  S G+  ++  +  E  AM+E+
Sbjct: 208 VLMWEAFSYGQKPYRGMKGSEVTAMLEK 235

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 56.9 bits (138), Expect = 3e-09
 Identities = 54/263 (20%), Positives = 93/263 (35%), Gaps = 70/263 (26%)

Query: 95  RILSKMGEGTFGQVVE---CFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD 149
            I   +G G  G+V         ++   VAIK ++     + R   + E  ++ +   H 
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHP 110

Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
                 G     +            IV E  + G SL  FLR +  +   + LV  + R 
Sbjct: 111 NIIRLEG--VVTR-------GRLAMIVTEYMENG-SLDTFLRTHDGQFTIMQLV-GMLRG 159

Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIK 261
           +   + ++ +L  +H DL   N+L+ S    KV D  F LSR  +D              
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSD--FGLSRVLEDDPD----------- 206

Query: 262 LIDFGSTTFEHQDHSYVVSTRHYR------APEVILGLGWNY-----PCDLWSVGCILVE 310
                             +T   +      APE I      +       D+WS G ++ E
Sbjct: 207 ---------------AAYTTTGGKIPIRWTAPEAI-----AFRTFSSASDVWSFGVVMWE 246

Query: 311 LCS-GEALFQTHENLEHLAMMER 332
           + + GE  +    N + ++ +E 
Sbjct: 247 VLAYGERPYWNMTNRDVISSVEE 269

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 56.2 bits (136), Expect = 7e-09
 Identities = 60/263 (22%), Positives = 97/263 (36%), Gaps = 70/263 (26%)

Query: 95  RILSKMGEGTFGQVVE---CFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD 149
            I   +G G FG+V        ++K+  VAIK ++     K R   + E  ++ +   H 
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHP 106

Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
                 G     +          + IV E  + G SL  FLRK+  +   I LV  + R 
Sbjct: 107 NIIRLEG--VVTK-------SKPVMIVTEYMENG-SLDSFLRKHDAQFTVIQLV-GMLRG 155

Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIK 261
           +   + ++ ++  +H DL   NIL+ S    KV D  F L R  +D              
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSD--FGLGRVLEDDPE----------- 202

Query: 262 LIDFGSTTFEHQDHSYVVSTRHYR------APEVILGLGWNY-----PCDLWSVGCILVE 310
                             +TR  +      +PE I      Y       D+WS G +L E
Sbjct: 203 ---------------AAYTTRGGKIPIRWTSPEAI-----AYRKFTSASDVWSYGIVLWE 242

Query: 311 LCS-GEALFQTHENLEHLAMMER 332
           + S GE  +    N + +  ++ 
Sbjct: 243 VMSYGERPYWEMSNQDVIKAVDE 265

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 55.7 bits (135), Expect = 7e-09
 Identities = 40/178 (22%), Positives = 68/178 (38%), Gaps = 26/178 (14%)

Query: 95  RILSKMGEGTFGQVVECF---DNEKKELVAIKIVRSINKYREAA--MIEIDVLQRLARHD 149
                +G G FG V       ++ KK   A+K +  I    E +  + E  +++    H 
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHP 86

Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
                +G                  +V    K G  L +F+R  ++     DL+   G Q
Sbjct: 87  NVLSLLG---IC-----LRSEGSPLVVLPYMKHG-DLRNFIRNETHNPTVKDLIG-FGLQ 136

Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSA 259
           + + + ++   + +H DL   N +L     VKV D  F L+R   D  Y+    K+ A
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVAD--FGLARDMYDKEYYSVHNKTGA 192

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 41/190 (21%), Positives = 71/190 (37%), Gaps = 41/190 (21%)

Query: 92  PRYRI--LSKMGEGTFGQVVEC-----FDNEKKELVAIKIVR--SINKYREAAMIEIDVL 142
           PR  +     +G G FG+VVE         +    VA+K+++  +    +EA M E+ ++
Sbjct: 44  PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIM 103

Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL 195
             L +H+     +G   C            + ++ E    G  L +FLR+ S        
Sbjct: 104 SHLGQHENIVNLLGA--CTH-------GGPVLVITEYCCYG-DLLNFLRRKSRVLETDPA 153

Query: 196 VRELGRQLLES------------VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LS 242
                                  +AF+     IH D+   N+LL +    K+ D  F L+
Sbjct: 154 FAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGD--FGLA 211

Query: 243 RSSKDGSYFK 252
           R   + S + 
Sbjct: 212 RDIMNDSNYI 221

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 35/170 (20%), Positives = 76/170 (44%), Gaps = 29/170 (17%)

Query: 95  RILSKMGEGTFGQVVECF---DNEKKEL-VAIKIVR--SINKYREAAMIEIDVLQRLARH 148
           + +  +G G FG V +     + EK ++ VAIK +R  +  K  +  + E  V+  +  +
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DN 76

Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
                 +G   C+         + + ++ +    G  L D++R++        L+     
Sbjct: 77  PHVCRLLG--ICLT--------STVQLITQLMPFG-CLLDYVREHKDNIGSQYLL-NWCV 124

Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 250
           Q+ + + ++ + RL+H DL   N+L+ + ++VK+ D  F L++       
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITD--FGLAKLLGAEEK 172

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 39/170 (22%), Positives = 71/170 (41%), Gaps = 29/170 (17%)

Query: 95  RILSKMGEGTFGQVVECF---DNEKKEL-VAIKIVR--SINKYREAAMIEIDVLQRLARH 148
           R L  +G G FG V +     + E  ++ V IK++   S  +  +A    +  +  L  H
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DH 74

Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
                 +G   C          + + +V +   LG SL D +R++     P  L+   G 
Sbjct: 75  AHIVRLLG--LCPG--------SSLQLVTQYLPLG-SLLDHVRQHRGALGPQLLL-NWGV 122

Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 250
           Q+ + + ++ E  ++H +L   N+LL S   V+V D  F ++        
Sbjct: 123 QIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVAD--FGVADLLPPDDK 170

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 54.5 bits (132), Expect = 1e-08
 Identities = 40/169 (23%), Positives = 73/169 (43%), Gaps = 23/169 (13%)

Query: 95  RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
           ++L  +G+G FG V+       K  VA+K +++ +   +A + E  V+ +L RH      
Sbjct: 24  KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKN-DATAQAFLAEASVMTQL-RHSNLVQL 79

Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
           +G    +      + +  + IV E    G SL D+LR         D + +    + E++
Sbjct: 80  LG---VI-----VEEKGGLYIVTEYMAKG-SLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 130

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLP 255
            ++     +H DL   N+L+      KV D  F L++ +        LP
Sbjct: 131 EYLEGNNFVHRDLAARNVLVSEDNVAKVSD--FGLTKEASSTQDTGKLP 177

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 53.8 bits (130), Expect = 3e-08
 Identities = 47/194 (24%), Positives = 71/194 (36%), Gaps = 45/194 (23%)

Query: 92  PRYRI--LSKMGEGTFGQVVEC-----FDNEKKELVAIKIVR--SINKYREAAMIEIDVL 142
           PR R+     +G G FG+VVE        ++    VA+K+++  +    REA M E+ VL
Sbjct: 21  PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 80

Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL 195
             L  H      +G   C              ++ E    G  L +FLR+          
Sbjct: 81  SYLGNHMNIVNLLG--ACTI-------GGPTLVITEYCCYG-DLLNFLRRKRDSFICSKT 130

Query: 196 VRELGRQLLESV----------------AFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239
              +      ++                AF+     IH DL   NILL      K+ D  
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD-- 188

Query: 240 F-LSRSSKDGSYFK 252
           F L+R  K+ S + 
Sbjct: 189 FGLARDIKNDSNYV 202

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 40/170 (23%), Positives = 67/170 (39%), Gaps = 28/170 (16%)

Query: 95  RILSKMGEGTFGQVVE----CFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARH 148
                +G G FG+V +        +K+  VAIK ++     K R   + E  ++ +   H
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SH 105

Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
                  G     +          + I+ E  + G +L  FLR+       + LV  + R
Sbjct: 106 HNIIRLEG--VISK-------YKPMMIITEYMENG-ALDKFLREKDGEFSVLQLV-GMLR 154

Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 250
            +   + ++  +  +H DL   NIL+ S    KV D  F LSR  +D   
Sbjct: 155 GIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSD--FGLSRVLEDDPE 202

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 45/182 (24%), Positives = 69/182 (37%), Gaps = 40/182 (21%)

Query: 92  PRYRI--LSKMGEGTFGQVVECF--DNEKKELVAIKIVRSINKYREAA--MIEIDVLQRL 145
               I     +GEG FGQV++     +  +   AIK ++      +      E++VL +L
Sbjct: 23  DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 82

Query: 146 ARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRE 198
             H      +G   C         R ++ +  E    G +L DFLRK+            
Sbjct: 83  GHHPNIINLLG--ACEH-------RGYLYLAIEYAPHG-NLLDFLRKSRVLETDPAFAIA 132

Query: 199 LG-------RQLLE---SVA----FMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSR 243
                    +QLL     VA    ++ + + IH DL   NIL+      K+ D  F LSR
Sbjct: 133 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD--FGLSR 190

Query: 244 SS 245
             
Sbjct: 191 GQ 192

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 51.1 bits (123), Expect = 3e-07
 Identities = 42/192 (21%), Positives = 68/192 (35%), Gaps = 42/192 (21%)

Query: 92  PRYRI--LSKMGEGTFGQVVECF-----DNEKKELVAIKIVRSINKYREAA--MIEIDVL 142
           PR R+     +G G FGQV+E              VA+K+++    + E    M E+ +L
Sbjct: 25  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 84

Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL 195
             +  H      +G                + ++ E  K G +L  +LR       P  +
Sbjct: 85  IHIGHHLNVVNLLG---AC-----TKPGGPLMVIVEFCKFG-NLSTYLRSKRNEFVPYKV 135

Query: 196 VRELGRQLLESV--------------AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF- 240
             E   +   ++               F+   + IH DL   NILL     VK+ D  F 
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICD--FG 193

Query: 241 LSRSSKDGSYFK 252
           L+R       + 
Sbjct: 194 LARDIYKDPDYV 205

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 50.4 bits (121), Expect = 4e-07
 Identities = 37/181 (20%), Positives = 65/181 (35%), Gaps = 27/181 (14%)

Query: 92  PRYRI--LSKMGEGTFGQVVECF---DNEKKELVAIKIVR---SINKYREAAMIEIDVLQ 143
           P  +      +G+G FG V E     ++     VA+K+++     +   E  + E   ++
Sbjct: 21  PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMK 80

Query: 144 RLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL- 195
               H      +G                  ++    K G  L+ FL  +     P +L 
Sbjct: 81  EF-DHPHVAKLVG---VSLRSRAKGRLPIPMVILPFMKHG-DLHAFLLASRIGENPFNLP 135

Query: 196 VREL---GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYF 251
           ++ L      +   + ++     IH DL   N +L     V V D  F LSR    G Y+
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVAD--FGLSRKIYSGDYY 193

Query: 252 K 252
           +
Sbjct: 194 R 194

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 50.0 bits (120), Expect = 5e-07
 Identities = 37/185 (20%), Positives = 68/185 (36%), Gaps = 36/185 (19%)

Query: 92  PRYRI--LSKMGEGTFGQVVEC-----FDNEKKELVAIKIVRSINKYREAA--MIEIDVL 142
            R +I    ++G+G+FG V E        +E +  VAIK V      RE    + E  V+
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82

Query: 143 QRLARHDIGGTR----CVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLV 196
           +    H +   R      Q            ++ E    G  L  +LR          ++
Sbjct: 83  KEFNCHHV--VRLLGVVSQ-------GQPTLVIMELMTRG-DLKSYLRSLRPAMANNPVL 132

Query: 197 RELGRQLLESVA--------FMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKD 247
                  +  +A        +++  + +H DL   N ++     VK+ D  F ++R   +
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD--FGMTRDIYE 190

Query: 248 GSYFK 252
             Y++
Sbjct: 191 TDYYR 195

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 49.6 bits (119), Expect = 7e-07
 Identities = 38/178 (21%), Positives = 65/178 (36%), Gaps = 26/178 (14%)

Query: 95  RILSKMGEGTFGQVVECF---DNEKKELVAIKIVRSINKYREAA--MIEIDVLQRLARHD 149
                +G+G FG V         + +   AIK +  I + ++    + E  +++ L  H 
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHP 82

Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
                IG    +             ++      G  L  F+R         DL+   G Q
Sbjct: 83  NVLALIG---IM-----LPPEGLPHVLLPYMCHG-DLLQFIRSPQRNPTVKDLI-SFGLQ 132

Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSA 259
           +   + ++ E + +H DL   N +L  +  VKV D  F L+R   D  Y+       A
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESFTVKVAD--FGLARDILDREYYSVQQHRHA 188

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 38/194 (19%), Positives = 75/194 (38%), Gaps = 45/194 (23%)

Query: 92  PRYRI--LSKMGEGTFGQVVEC-------FDNEKKELVAIKIVRSINKYREAA--MIEID 140
           PR R+     +GEG FGQVV             +   VA+K+++S    ++ +  + E++
Sbjct: 67  PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME 126

Query: 141 VLQRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPI 193
           +++ + +H      +G   C Q          + ++ E    G +L ++L+         
Sbjct: 127 MMKMIGKHKNIINLLG--ACTQ-------DGPLYVIVEYASKG-NLREYLQARRPPGLEY 176

Query: 194 DLVRELG-------RQLLESV-------AFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239
                         + L+           ++   + IH DL   N+L+     +K+ D  
Sbjct: 177 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD-- 234

Query: 240 F-LSRSSKDGSYFK 252
           F L+R      Y+K
Sbjct: 235 FGLARDIHHIDYYK 248

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 43/200 (21%), Positives = 74/200 (37%), Gaps = 52/200 (26%)

Query: 92  PRYRI--LSKMGEGTFGQVVEC-----FDNEKKELVAIKIVRSI--NKYREAAMIEIDVL 142
           PR  +     +G G FG+V+               VA+K+++    +  REA M E+ ++
Sbjct: 43  PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 102

Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL 195
            +L  H+     +G   C            I ++FE    G  L ++LR    +    ++
Sbjct: 103 TQLGSHENIVNLLGA--CTL-------SGPIYLIFEYCCYG-DLLNYLRSKREKFSEDEI 152

Query: 196 VRELGRQLLESV---------------------AFMHELRLIHTDLKPENILLVSAEYV- 233
             E  ++L E                        F+     +H DL   N+ LV+   V 
Sbjct: 153 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV-LVTHGKVV 211

Query: 234 KVPDYKF-LSRSSKDGSYFK 252
           K+ D  F L+R     S + 
Sbjct: 212 KICD--FGLARDIMSDSNYV 229

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 37/181 (20%), Positives = 68/181 (37%), Gaps = 28/181 (15%)

Query: 92  PRYRI--LSKMGEGTFGQVVECF---DNEKKELVAIKIVRSIN---KYREAAMIEIDVLQ 143
            R  +     +GEG FG V+E     ++     VA+K ++  N   +  E  + E   ++
Sbjct: 32  DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMK 91

Query: 144 RLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL- 195
               H      +G    V I           ++    K G  L+ +L  +   + P  + 
Sbjct: 92  DF-SHPNVIRLLG----VCIEMSSQGIPKPMVILPFMKYG-DLHTYLLYSRLETGPKHIP 145

Query: 196 VREL---GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYF 251
           ++ L      +   + ++     +H DL   N +L     V V D  F LS+    G Y+
Sbjct: 146 LQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVAD--FGLSKKIYSGDYY 203

Query: 252 K 252
           +
Sbjct: 204 R 204

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 42/190 (22%), Positives = 70/190 (36%), Gaps = 42/190 (22%)

Query: 92  PRYRI--LSKMGEGTFGQVVEC-----FDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQ 143
            R  I    ++GEG FG+V           + K LVA+K ++  +   R+    E ++L 
Sbjct: 39  KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLT 98

Query: 144 RLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLV 196
            L +H       G   C +          + +VFE  + G  L  FLR +   +  +   
Sbjct: 99  ML-QHQHIVRFFG--VCTE-------GRPLLMVFEYMRHG-DLNRFLRSHGPDAKLLAGG 147

Query: 197 RELGRQLLESVAFMH-------------ELRLIHTDLKPENILLVSAEYVKVPDYKF-LS 242
            ++    L     +               L  +H DL   N L+     VK+ D  F +S
Sbjct: 148 EDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGD--FGMS 205

Query: 243 RSSKDGSYFK 252
           R      Y++
Sbjct: 206 RDIYSTDYYR 215

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 47.7 bits (114), Expect = 3e-06
 Identities = 40/194 (20%), Positives = 81/194 (41%), Gaps = 45/194 (23%)

Query: 92  PRYRI--LSKMGEGTFGQVVEC-------FDNEKKELVAIKIVRSINKYREAA--MIEID 140
           PR ++     +GEG FGQVV            ++   VA+K+++     ++ +  + E++
Sbjct: 79  PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 138

Query: 141 VLQRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNS--YRSF 191
           +++ + +H      +G   C Q          + ++ E    G +L ++LR        +
Sbjct: 139 MMKMIGKHKNIINLLG--ACTQ-------DGPLYVIVEYASKG-NLREYLRARRPPGMEY 188

Query: 192 PIDLVRELGRQLLES--------VA----FMHELRLIHTDLKPENILLVSAEYVKVPDYK 239
             D+ R    Q+           +A    ++   + IH DL   N+L+     +K+ D  
Sbjct: 189 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIAD-- 246

Query: 240 F-LSRSSKDGSYFK 252
           F L+R   +  Y+K
Sbjct: 247 FGLARDINNIDYYK 260

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 37/194 (19%), Positives = 76/194 (39%), Gaps = 45/194 (23%)

Query: 92  PRYRI--LSKMGEGTFGQVVEC-------FDNEKKELVAIKIVRSINKYREAA--MIEID 140
           PR ++     +GEG FGQVV            ++   VA+K+++     ++ +  + E++
Sbjct: 33  PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 92

Query: 141 VLQRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPI 193
           +++ + +H      +G   C Q          + ++ E    G +L ++LR         
Sbjct: 93  MMKMIGKHKNIINLLG--ACTQ-------DGPLYVIVEYASKG-NLREYLRARRPPGMEY 142

Query: 194 DLVRELG-------RQLLESV-------AFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239
                         + L+           ++   + IH DL   N+L+     +K+ D  
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIAD-- 200

Query: 240 F-LSRSSKDGSYFK 252
           F L+R   +  Y+K
Sbjct: 201 FGLARDINNIDYYK 214

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.8 bits (110), Expect = 1e-05
 Identities = 53/428 (12%), Positives = 108/428 (25%), Gaps = 134/428 (31%)

Query: 10  PHKNMDKRPRKRPRLTWDVPPPLPP------PKVLP---ALYCVQE------FGNGG--- 51
           P         +R RL ++                L    AL  ++        G  G   
Sbjct: 105 PSMMTRMYIEQRDRL-YNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGK 163

Query: 52  --MPNYACSS-----MFYGAIPRTGSPPW-------RPDDKDGHYVFAIGENL----TPR 93
             +    C S          I       W        P+      V  + + L     P 
Sbjct: 164 TWVALDVCLSYKVQCKMDFKIF------WLNLKNCNSPET-----VLEMLQKLLYQIDPN 212

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
           +   S          +     E + L+  K       Y    ++ +         ++   
Sbjct: 213 WTSRSDHSSNIK-LRIHSIQAELRRLLKSK------PYENCLLV-LL--------NVQNA 256

Query: 154 RCVQIRNWFDYRNHIC-IVFEKLGPSLYDFLRKNSYRSFPID-----LVRELGRQLLESV 207
           +       F+     C I+       + DFL   +     +D     L  +  + LL   
Sbjct: 257 KAWNA---FNLS---CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKY 310

Query: 208 AFMHELRLIHTDLKPE----NILLVS--AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
                L     DL  E    N   +S  AE ++      L+        +K++       
Sbjct: 311 -----LDCRPQDLPREVLTTNPRRLSIIAESIR----DGLATWD----NWKHVNCDKLTT 357

Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRA----------PEVILGLGWNYPCDLWSVGCILVEL 311
           +I+   ++    + +     + +            P ++L L W        V  ++ +L
Sbjct: 358 IIE---SSLNVLEPAEY--RKMFDRLSVFPPSAHIPTILLSLIWFDV-IKSDVMVVVNKL 411

Query: 312 CSGEAL---------------FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRG 356
                +                +    LE+   +        H  ++      + +    
Sbjct: 412 HKYSLVEKQPKESTISIPSIYLELKVKLENEYAL--------HRSIVDHYNIPKTFDSDD 463

Query: 357 ARLDWPDG 364
               + D 
Sbjct: 464 LIPPYLDQ 471

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 37/192 (19%), Positives = 67/192 (34%), Gaps = 44/192 (22%)

Query: 92  PRYRI--LSKMGEGTFGQVVEC-----FDNEKKELVAIKIVR--SINKYREAAMIEIDVL 142
               +  + ++GE  FG+V +         E+ + VAIK ++  +    RE    E  + 
Sbjct: 7   SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLR 66

Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL 195
            RL +H      +G     +          + ++F     G  L++FL   S  S     
Sbjct: 67  ARL-QHPNVVCLLG--VVTK-------DQPLSMIFSYCSHG-DLHEFLVMRSPHSDVGST 115

Query: 196 VRELG-------RQLLESV-------AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF- 240
             +            +  V        ++    ++H DL   N+L+     VK+ D    
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISD--LG 173

Query: 241 LSRSSKDGSYFK 252
           L R      Y+K
Sbjct: 174 LFREVYAADYYK 185

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 45.3 bits (108), Expect = 1e-05
 Identities = 42/191 (21%), Positives = 70/191 (36%), Gaps = 43/191 (22%)

Query: 92  PRYRI--LSKMGEGTFGQVVEC-----FDNEKKELVAIKIVRSINKYREAA-MIEIDVLQ 143
            R  I    ++GEG FG+V           + K LVA+K ++            E ++L 
Sbjct: 13  KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLT 72

Query: 144 RLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLV 196
            L +H+      G   C          + + +VFE  K G  L  FLR +   +  +   
Sbjct: 73  NL-QHEHIVKFYG--VCGD-------GDPLIMVFEYMKHG-DLNKFLRAHGPDAMILVDG 121

Query: 197 RELGR-------QLLESV-------AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-L 241
           +           Q+L           ++     +H DL   N L+ +   VK+ D  F +
Sbjct: 122 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGD--FGM 179

Query: 242 SRSSKDGSYFK 252
           SR      Y++
Sbjct: 180 SRDVYSTDYYR 190

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 44.2 bits (105), Expect = 5e-05
 Identities = 47/227 (20%), Positives = 77/227 (33%), Gaps = 61/227 (26%)

Query: 66  PRTGSPPWRPDDKDGHYVFAIGENLTPRYRI--LSKMGEGTFGQVVEC-----FDNEKKE 118
           P     P   + K     +       PR  I  +  +GEG FG+V +         E   
Sbjct: 26  PMYQRMPLLLNPKLLSLEY-------PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFT 78

Query: 119 LVAIKIVRSI--NKYREAAMIEIDVLQRLARHD-----IGGTRCVQIRNWFDYRNHICIV 171
           +VA+K+++       +     E  ++     +      +G   C            +C++
Sbjct: 79  MVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLG--VCAV-------GKPMCLL 128

Query: 172 FE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV---------------------- 207
           FE    G  L +FLR  S  +       +L  +   S                       
Sbjct: 129 FEYMAYG-DLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGM 187

Query: 208 AFMHELRLIHTDLKPENILLVSAEY-VKVPDYKF-LSRSSKDGSYFK 252
           A++ E + +H DL   N  LV     VK+ D  F LSR+     Y+K
Sbjct: 188 AYLSERKFVHRDLATRNC-LVGENMVVKIAD--FGLSRNIYSADYYK 231

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258

 Score = 43.5 bits (102), Expect = 5e-05
 Identities = 21/130 (16%), Positives = 45/130 (34%), Gaps = 9/130 (6%)

Query: 99  KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
           ++    F ++ E    +++    ++ +    K       E   L+R       G    Q 
Sbjct: 83  RIETSEFDKMDEYLYGDER--FDMRRISPKEKVFIWTEKEFRNLERAKEA---GVSVPQP 137

Query: 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIH 217
              + Y  ++ ++       L         R      V  +   ++E+V  ++ E  L+H
Sbjct: 138 ---YTYMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVH 194

Query: 218 TDLKPENILL 227
            DL   NI+ 
Sbjct: 195 ADLSEYNIMY 204

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 42.6 bits (101), Expect = 1e-04
 Identities = 42/200 (21%), Positives = 70/200 (35%), Gaps = 52/200 (26%)

Query: 92  PRYRI--LSKMGEGTFGQVVECF-----DNEKKELVAIKIVRSINKYREAA--MIEIDVL 142
           PR  +     +GEG FG+VV+              VA+K+++      E    + E +VL
Sbjct: 21  PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVL 80

Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL 195
           +++  H       G   C Q          + ++ E  K G SL  FLR++         
Sbjct: 81  KQV-NHPHVIKLYGA--CSQ-------DGPLLLIVEYAKYG-SLRGFLRESRKVGPGYLG 129

Query: 196 VRELGRQLLESV----------------------AFMHELRLIHTDLKPENILLVSAEYV 233
                                              ++ E++L+H DL   NIL+     +
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKM 189

Query: 234 KVPDYKF-LSRSSKDGSYFK 252
           K+ D  F LSR   +   + 
Sbjct: 190 KISD--FGLSRDVYEEDSYV 207

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 41/187 (21%), Positives = 71/187 (37%), Gaps = 40/187 (21%)

Query: 92  PRYRI--LSKMGEGTFGQVVECF-----DNEKKELVAIKIVRSINKYREAA--MIEIDVL 142
           PR  I  +  +G G FG+V E       ++     VA+K +  +   ++    ++E  ++
Sbjct: 28  PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII 87

Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSF---- 191
            +   H      IG    +Q            I+ E    G  L  FLR+   R      
Sbjct: 88  SKF-NHQNIVRCIG--VSLQ-------SLPRFILMELMAGG-DLKSFLRETRPRPSQPSS 136

Query: 192 --PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY---VKVPDYKF-LSRSS 245
              +DL+  + R +     ++ E   IH D+   N LL         K+ D  F ++R  
Sbjct: 137 LAMLDLLH-VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD--FGMARDI 193

Query: 246 KDGSYFK 252
              SY++
Sbjct: 194 YRASYYR 200

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 40.8 bits (96), Expect = 5e-04
 Identities = 40/187 (21%), Positives = 70/187 (37%), Gaps = 40/187 (21%)

Query: 92  PRYRI--LSKMGEGTFGQVVECF-----DNEKKELVAIKIVRSINKYREAA--MIEIDVL 142
           PR  I  +  +G G FG+V E       ++     VA+K +  +   ++    ++E  ++
Sbjct: 69  PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII 128

Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSF---- 191
            +   H      IG    +Q            I+ E    G  L  FLR+   R      
Sbjct: 129 SKF-NHQNIVRCIG--VSLQ-------SLPRFILLELMAGG-DLKSFLRETRPRPSQPSS 177

Query: 192 --PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY---VKVPDYKF-LSRSS 245
              +DL+  + R +     ++ E   IH D+   N LL         K+ D  F ++R  
Sbjct: 178 LAMLDLLH-VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD--FGMARDI 234

Query: 246 KDGSYFK 252
               Y++
Sbjct: 235 YRAGYYR 241

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	411
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.89
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.79
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.41
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.32
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.22
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.19
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.86
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.73
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.53
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.47
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.39
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.34
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.26
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.19
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	98.02
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.88
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.74
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.71
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.64
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.54
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.49
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.43
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.36
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.3
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.3
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.22
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.12
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.88
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.48
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.03

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.8e-64  Score=470.52  Aligned_cols=255  Identities=24%  Similarity=0.331  Sum_probs=226.6

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++++.||+|+||+||+|+++.+++.||||++.+..    ...+.+.+|+++|++++||||     |+++++|++++.
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~l~~~~~~~~~  106 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF-----VKLYFTFQDDEK  106 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTB-----CCEEEEEECSSE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEEeCCE
Confidence            46999999999999999999999999999999997532    345678899999999988877     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +||||||| ||+|.+++.+.+  .+++..++.++.||+.||+|||++|||||||||+|||++.+|               
T Consensus       107 ~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g---------------  169 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM---------------  169 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS---------------
T ss_pred             EEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCC---------------
Confidence            99999999 999999998875  799999999999999999999999999999999999998776               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccC-----CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                                  .+||+|||+|+....     ...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.
T Consensus       170 ------------~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~  237 (311)
T 4aw0_A          170 ------------HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG  237 (311)
T ss_dssp             ------------CEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ------------CEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                        677788887765432     124568999999999999999999999999999999999999999999


Q ss_pred             ChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHH------HHhcCCCCcccccCC
Q 015222          322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA------VWKLLRLPVIDLYSA  388 (411)
Q Consensus       322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~------il~~~~~~~~~~~~~  388 (411)
                      +..+.+..+.+....+|.    .+++.+++||.+||..|    |++|+|++|      +++||||++++|...
T Consensus       238 ~~~~~~~~i~~~~~~~p~----~~s~~~~dli~~lL~~d----p~~R~t~~e~~~~~~i~~Hp~F~~idw~~l  302 (311)
T 4aw0_A          238 NEGLIFAKIIKLEYDFPE----KFFPKARDLVEKLLVLD----ATKRLGCEEMEGYGPLKAHPFFESVTWENL  302 (311)
T ss_dssp             SHHHHHHHHHHTCCCCCT----TCCHHHHHHHHHHSCSS----GGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred             CHHHHHHHHHcCCCCCCc----ccCHHHHHHHHHHccCC----HhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence            999999888887777765    46788999999999999    777877776      699999999987653

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.3e-62  Score=466.85  Aligned_cols=254  Identities=23%  Similarity=0.362  Sum_probs=223.6

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      +.|+++++||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+.+|++++|+||     |+++++|.+++.+||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnI-----V~l~~~~~~~~~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV-----VEMYNSYLVGDELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTB-----CCEEEEEEETTEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCC-----CcEEEEEEECCEEEE
Confidence            57999999999999999999999999999999997433 345668899999999988877     999999999999999


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      ||||| ||+|.+++.+.   .+++..++.++.||+.||+|||++|||||||||+||||+.+|                  
T Consensus       149 vmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g------------------  207 (346)
T 4fih_A          149 VMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG------------------  207 (346)
T ss_dssp             EECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC------------------
T ss_pred             EEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC------------------
Confidence            99999 99999999874   599999999999999999999999999999999999998776                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH  326 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~  326 (411)
                               .+||+|||+|......   ..+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.
T Consensus       208 ---------~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~  278 (346)
T 4fih_A          208 ---------RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA  278 (346)
T ss_dssp             ---------CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred             ---------CEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH
Confidence                     6788888887754332   3457899999999999999999999999999999999999999999888888


Q ss_pred             HHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       327 ~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      +..+...... ....+..+++.+++||.+||..|    |++|+|+.|+++||||++...
T Consensus       279 ~~~i~~~~~~-~~~~~~~~s~~~~dli~~~L~~d----P~~R~ta~e~l~Hp~~~~~~~  332 (346)
T 4fih_A          279 MKMIRDNLPP-RLKNLHKVSPSLKGFLDRLLVRD----PAQRATAAELLKHPFLAKAGP  332 (346)
T ss_dssp             HHHHHHSSCC-CCSCGGGSCHHHHHHHHHHSCSS----TTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHHHcCCCC-CCCccccCCHHHHHHHHHHcCCC----hhHCcCHHHHhcCHhhcCCCC
Confidence            8777664332 22234567889999999999999    999999999999999997654

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=6.7e-63  Score=469.52  Aligned_cols=254  Identities=22%  Similarity=0.348  Sum_probs=218.9

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      ++|+++++||+|+||+||+|+++.+|+.||||+++..   ....+.+.+|+.+|++++|+||     |+++++|++++.+
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnI-----V~~~~~~~~~~~~   98 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI-----VQYRESFEENGSL   98 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEEETTEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCC-----CcEEEEEEECCEE
Confidence            6899999999999999999999999999999999743   2445678899999999998887     9999999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      ||||||| ||+|.+++.......+++..++.|+.||+.||+|||++|||||||||+||||+.+|                
T Consensus        99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g----------------  162 (350)
T 4b9d_A           99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG----------------  162 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC----------------
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC----------------
Confidence            9999999 99999999877656789999999999999999999999999999999999998776                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                                 .+||+|||+|+.....   ....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..
T Consensus       163 -----------~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~  231 (350)
T 4b9d_A          163 -----------TVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK  231 (350)
T ss_dssp             -----------CEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             -----------CEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH
Confidence                       6788888888765433   23468999999999999999999999999999999999999999999888


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      +.+..+.....+.   ....+++.+++||.+||+.|    |.+|||+.|+++|+||..-.
T Consensus       232 ~~~~~i~~~~~~~---~~~~~s~~~~~li~~~L~~d----P~~R~s~~e~l~hp~~~~~~  284 (350)
T 4b9d_A          232 NLVLKIISGSFPP---VSLHYSYDLRSLVSQLFKRN----PRDRPSVNSILEKGFIAKRI  284 (350)
T ss_dssp             HHHHHHHHTCCCC---CCTTSCHHHHHHHHHHTCSS----GGGSCCHHHHHTSHHHHTTG
T ss_pred             HHHHHHHcCCCCC---CCccCCHHHHHHHHHHccCC----hhHCcCHHHHhcCHHhhcCC
Confidence            8888777654321   22457888999999999999    99999999999999997643

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.2e-62  Score=452.36  Aligned_cols=249  Identities=24%  Similarity=0.396  Sum_probs=210.4

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++++.||+|+||+||+|+++.+|+.||||++++..    ...+.+.+|+.++++++||||     +++++++++++.
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-----v~~~~~~~~~~~   87 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHI-----IKLYDVIKSKDE   87 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTB-----CCEEEEEECSSE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCC-----CeEEEEEEECCE
Confidence            57999999999999999999999999999999997432    334678899999999988877     999999999999


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          168 ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       168 ~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      +|+|||||+|+|.+++.+++  .+++..++.++.||+.||+|||++||+||||||+|||++.+|                
T Consensus        88 ~~ivmEy~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~----------------  149 (275)
T 3hyh_A           88 IIMVIEYAGNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHL----------------  149 (275)
T ss_dssp             EEEEEECCCEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTC----------------
T ss_pred             EEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCC----------------
Confidence            99999999999999998875  799999999999999999999999999999999999998766                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCC-CccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                                 .+||+|||+|+.....  ..+.+||+.|||||++.+..+ +.++|||||||++|||++|+.||.+.+..
T Consensus       150 -----------~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~  218 (275)
T 3hyh_A          150 -----------NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP  218 (275)
T ss_dssp             -----------CEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             -----------CEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH
Confidence                       6788888888764432  345689999999999998876 58999999999999999999999998888


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCc
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~  382 (411)
                      +.+..+......+|.    .+++.++++|.+||+.|    |++|+|++|+++||||+.
T Consensus       219 ~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~d----P~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          219 VLFKNISNGVYTLPK----FLSPGAAGLIKRMLIVN----PLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             HHHHHHHHTCCCCCT----TSCHHHHHHHHHHSCSS----GGGSCCHHHHHHCHHHHT
T ss_pred             HHHHHHHcCCCCCCC----CCCHHHHHHHHHHccCC----hhHCcCHHHHHcCccccc
Confidence            888888877666664    46788999999999999    999999999999999974

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=7.2e-62  Score=472.75  Aligned_cols=255  Identities=23%  Similarity=0.361  Sum_probs=223.8

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      .++|+++++||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+|+.++|+||     |+++++|.+++.+|
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnI-----V~l~~~~~~~~~~~  224 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV-----VEMYNSYLVGDELW  224 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTB-----CCEEEEEEETTEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCC-----CceEEEEEECCEEE
Confidence            357999999999999999999999999999999997433 345678899999999998887     99999999999999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      |||||| ||+|.+++...   .+++..++.|+.||+.||+|||++|||||||||+||||+.+|                 
T Consensus       225 iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g-----------------  284 (423)
T 4fie_A          225 VVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-----------------  284 (423)
T ss_dssp             EEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC-----------------
T ss_pred             EEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-----------------
Confidence            999999 99999999765   499999999999999999999999999999999999998777                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                                .+||+|||+|......   ..+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+
T Consensus       285 ----------~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~  354 (423)
T 4fie_A          285 ----------RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK  354 (423)
T ss_dssp             ----------CEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred             ----------CEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence                      6788888887654332   345789999999999999999999999999999999999999999988888


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      .+..+...... .......+++.+++||.+||..|    |.+|+|+.|+|+|+||++...
T Consensus       355 ~~~~i~~~~~~-~~~~~~~~s~~~~dli~~~L~~d----P~~R~ta~ell~Hp~~~~~~~  409 (423)
T 4fie_A          355 AMKMIRDNLPP-RLKNLHKVSPSLKGFLDRLLVRD----PAQRATAAELLKHPFLAKAGP  409 (423)
T ss_dssp             HHHHHHHSCCC-CCSCTTSSCHHHHHHHHHHSCSS----TTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHHHHcCCCC-CCcccccCCHHHHHHHHHHcCCC----hhHCcCHHHHhcCHHhcCCCC
Confidence            88777664322 22233567889999999999999    999999999999999997554

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.7e-62  Score=456.88  Aligned_cols=253  Identities=26%  Similarity=0.403  Sum_probs=215.5

Q ss_pred             CCeEEEeeeccccceEEEEEEeC---CCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~---~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      ++|++++.||+|+||+||+|++.   .+++.||||++++..   .....+.+|+.++++++||||     |+++++|+++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~l~~~~~~~   98 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI-----VKLHYAFQTE   98 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTE-----ECEEEEEEET
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCC-----CeEEEEEEEC
Confidence            47999999999999999999874   468899999997532   234467889999998887776     9999999999


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      +.+|+||||| ||+|.+++.+.+  .+++..++.++.||+.||+|||++|||||||||+|||++.+|             
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-------------  163 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-------------  163 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTS-------------
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCC-------------
Confidence            9999999999 999999998876  799999999999999999999999999999999999998777             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccC---CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                                    .+||+|||+|+....   ...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.
T Consensus       164 --------------~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~  229 (304)
T 3ubd_A          164 --------------HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK  229 (304)
T ss_dssp             --------------CEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             --------------CEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc
Confidence                          577788887765322   234568999999999999999999999999999999999999999999


Q ss_pred             ChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHH-----HHHHHhcCCCCccccc
Q 015222          322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS-----MRAVWKLLRLPVIDLY  386 (411)
Q Consensus       322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t-----~~~il~~~~~~~~~~~  386 (411)
                      +..+.+..+.+....+|.    .+++.++++|.+||+.|    |++|+|     ++|+++||||++++|.
T Consensus       230 ~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~d----P~~R~ta~~~~~~eil~Hp~f~~idw~  291 (304)
T 3ubd_A          230 DRKETMTMILKAKLGMPQ----FLSPEAQSLLRMLFKRN----PANRLGAGPDGVEEIKRHSFFSTIDWN  291 (304)
T ss_dssp             SHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSS----GGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             CHHHHHHHHHcCCCCCCC----cCCHHHHHHHHHHcccC----HHHCCCCCcCCHHHHHcCccccCCCHH
Confidence            998988888877666664    46788999999999999    666665     7899999999999864

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-60  Score=444.45  Aligned_cols=255  Identities=21%  Similarity=0.336  Sum_probs=214.0

Q ss_pred             CccCCCe-EEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee
Q 015222           88 ENLTPRY-RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        88 ~~~~~~y-~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~  163 (411)
                      ....++| ++.++||+|+||+||+|+++.+++.||+|++...   ....+.+.+|+.++++++||||     |+++++|+
T Consensus        21 ~~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnI-----V~~~~~~~   95 (290)
T 3fpq_A           21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI-----VRFYDSWE   95 (290)
T ss_dssp             ECTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEE
T ss_pred             cCCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEEe
Confidence            3344566 7888999999999999999999999999999643   2345678899999999998887     99999986


Q ss_pred             c----CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEec-Cccccc
Q 015222          164 Y----RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVS-AEYVKV  235 (411)
Q Consensus       164 ~----~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dikp~NIli~~-~~~~~l  235 (411)
                      +    ++.+||||||| ||+|.+++.+..  .+++..++.++.||+.||+|||++|  ||||||||+||||+. +|    
T Consensus        96 ~~~~~~~~~~lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g----  169 (290)
T 3fpq_A           96 STVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG----  169 (290)
T ss_dssp             EEETTEEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTS----
T ss_pred             eccCCCcEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCC----
Confidence            5    45789999999 999999998865  7999999999999999999999998  999999999999964 34    


Q ss_pred             CCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC-CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhC
Q 015222          236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG  314 (411)
Q Consensus       236 ~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg  314 (411)
                                             .+||+|||+|+..... ..+.+||+.|||||++.+ .|+.++|||||||+||||+||
T Consensus       170 -----------------------~vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg  225 (290)
T 3fpq_A          170 -----------------------SVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATS  225 (290)
T ss_dssp             -----------------------CEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHS
T ss_pred             -----------------------CEEEEeCcCCEeCCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHC
Confidence                                   6888888888764433 345689999999999876 699999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCc
Q 015222          315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       315 ~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~  382 (411)
                      +.||.+.+....+..... .+..|..+....++.++++|.+||..|    |++|||+.++++||||++
T Consensus       226 ~~Pf~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~~li~~~L~~d----P~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          226 EYPYSECQNAAQIYRRVT-SGVKPASFDKVAIPEVKEIIEGCIRQN----KDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             SCTTTTCSSHHHHHHHHT-TTCCCGGGGGCCCHHHHHHHHHHSCSS----GGGSCCHHHHHTSGGGC-
T ss_pred             CCCCCCCCcHHHHHHHHH-cCCCCCCCCccCCHHHHHHHHHHccCC----hhHCcCHHHHhcCccccC
Confidence            999987655443332221 234455566667788999999999999    999999999999999985

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.8e-60  Score=460.21  Aligned_cols=267  Identities=27%  Similarity=0.439  Sum_probs=228.7

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec--
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--  164 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~--  164 (411)
                      +.++|++++.||+|+||+||+|+++.+|+.||||++++..   ...+.+.+|+.+|+.++|+||     |++++++..  
T Consensus        52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnI-----v~l~~~~~~~~  126 (398)
T 4b99_A           52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNI-----IAIKDILRPTV  126 (398)
T ss_dssp             CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTB-----CCEEEECCCSS
T ss_pred             CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCc-----ceEeeeeeccc
Confidence            4578999999999999999999999999999999997533   344567899999999998887     999988653  


Q ss_pred             ----CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          165 ----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       165 ----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                          .+++|||||||+|+|.+++.+.+  .+++..++.++.||+.||+|||++|||||||||+|||++.+|         
T Consensus       127 ~~~~~~~~~ivmE~~~g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~---------  195 (398)
T 4b99_A          127 PYGEFKSVYVVLDLMESDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENC---------  195 (398)
T ss_dssp             CTTTCCCEEEEEECCSEEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC---------
T ss_pred             ccccCCEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCC---------
Confidence                46899999999889999998765  799999999999999999999999999999999999998777         


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccC-------CCcccccCCCccccceecCC-CCCccchhHHHHHHHHHHH
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-------DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELC  312 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell  312 (411)
                                        .+||+|||+|+....       ...+.+||+.|||||++.+. .++.++||||+||++|||+
T Consensus       196 ------------------~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell  257 (398)
T 4b99_A          196 ------------------ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML  257 (398)
T ss_dssp             ------------------CEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred             ------------------CEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHH
Confidence                              567777777654321       23456899999999999886 5799999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChhH---------------------------HHhhhhhhhhhhccCCccCCCCCC
Q 015222          313 SGEALFQTHENLEHLAMMERVLGPLPHHM---------------------------VIRADRRAEKYFRRGARLDWPDGA  365 (411)
Q Consensus       313 tg~~pf~~~~~~~~~~~i~~~~~~~p~~~---------------------------~~~~~~~~~~li~~~l~~~~~~rp  365 (411)
                      +|++||.+.+..+.+..|....+.++...                           .+..++.+.+||.+||..|    |
T Consensus       258 ~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~d----P  333 (398)
T 4b99_A          258 ARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFE----P  333 (398)
T ss_dssp             HTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSS----T
T ss_pred             HCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCC----h
Confidence            99999999999999999988877665432                           1235778999999999999    9


Q ss_pred             CcHHHHHHHHhcCCCCcccccCCCCCchh
Q 015222          366 TSRDSMRAVWKLLRLPVIDLYSASPNCLC  394 (411)
Q Consensus       366 ~~R~t~~~il~~~~~~~~~~~~~~~~~~~  394 (411)
                      .+|+|+.|+|+||||++...+...|.+..
T Consensus       334 ~~R~ta~e~L~Hp~f~~~~~p~~~p~~~~  362 (398)
T 4b99_A          334 SARISAAAALRHPFLAKYHDPDDEPDCAP  362 (398)
T ss_dssp             TTSCCHHHHTTSGGGTTTCCGGGSCCCSS
T ss_pred             hHCcCHHHHhcCHhhCcCCCCccccCCCC
Confidence            99999999999999999877766666544

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.7e-60  Score=451.00  Aligned_cols=252  Identities=23%  Similarity=0.286  Sum_probs=214.3

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      +.|++.++||+|+||+||+|+++.+|+.||||+++....    ..+|+.+++.++||||     |++++++.+++.+|||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnI-----V~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRI-----VPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTB-----CCEEEEEEETTEEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCC-----CcEEEEEEECCEEEEE
Confidence            569999999999999999999999999999999975432    2469999999988877     9999999999999999


Q ss_pred             EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      |||| ||+|.+++.+.+  .+++..++.++.||+.||+|||++|||||||||+||||+.+|                   
T Consensus       129 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-------------------  187 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDG-------------------  187 (336)
T ss_dssp             ECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTS-------------------
T ss_pred             EeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCC-------------------
Confidence            9999 999999998875  799999999999999999999999999999999999998765                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCC--------CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQD--------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE  322 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~  322 (411)
                             ..+||+|||+|+.....        ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+
T Consensus       188 -------~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~  260 (336)
T 4g3f_A          188 -------SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF  260 (336)
T ss_dssp             -------CCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC
T ss_pred             -------CEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence                   14788888877654321        123579999999999999999999999999999999999999999877


Q ss_pred             hHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHH-------------HhcCCCCcccc
Q 015222          323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV-------------WKLLRLPVIDL  385 (411)
Q Consensus       323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~i-------------l~~~~~~~~~~  385 (411)
                      ..+.+..+.....+ ...+...+++.+.++|.+||++|    |.+|||+.|+             ++|||+.....
T Consensus       261 ~~~~~~~i~~~~~~-~~~~~~~~s~~~~~li~~~L~~d----P~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~  331 (336)
T 4g3f_A          261 RGPLCLKIASEPPP-IREIPPSCAPLTAQAIQEGLRKE----PVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE  331 (336)
T ss_dssp             CSCCHHHHHHSCCG-GGGSCTTSCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred             HHHHHHHHHcCCCC-chhcCccCCHHHHHHHHHHccCC----HhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence            76666666553321 12344567889999999999999    8888889887             46899987654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.1e-57  Score=427.68  Aligned_cols=269  Identities=24%  Similarity=0.291  Sum_probs=197.4

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC---
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN---  166 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~---  166 (411)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++..  ....+.+.+|+.+|++++||||     |+++++|.+.+   
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnI-----V~~~~~~~~~~~~~   79 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI-----VRYFNAWLEKNTTE   79 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEEEC---
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEEecCccc
Confidence            4699999999999999999999999999999999643  2345678899999999988877     99999886543   


Q ss_pred             ---------eEEEEEccC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCccccc
Q 015222          167 ---------HICIVFEKL-GPSLYDFLRKNSY-RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV  235 (411)
Q Consensus       167 ---------~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l  235 (411)
                               ++|+||||| +|+|.+++..... ...++..++.++.||+.||+|||++|||||||||+||||+.+|.+||
T Consensus        80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl  159 (299)
T 4g31_A           80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV  159 (299)
T ss_dssp             -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred             cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEE
Confidence                     479999999 9999999987642 23456778999999999999999999999999999999988875544


Q ss_pred             CCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCC
Q 015222          236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE  315 (411)
Q Consensus       236 ~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~  315 (411)
                      +|||+++....+.....        ....    ..........+||+.|||||++.+..|+.++|||||||++|||++  
T Consensus       160 ~DFGla~~~~~~~~~~~--------~~~~----~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~--  225 (299)
T 4g31_A          160 GDFGLVTAMDQDEEEQT--------VLTP----MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--  225 (299)
T ss_dssp             CCCCCC--------------------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS--
T ss_pred             ccCccceecCCCccccc--------cccc----cccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc--
Confidence            44444433222110000        0000    000011233589999999999999999999999999999999996  


Q ss_pred             CCCCCCChHHHHHHHHHH-hCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          316 ALFQTHENLEHLAMMERV-LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       316 ~pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                       ||.+  ..+....+... ...+|+. ....++.+.++|.+||+.|    |.+|||+.|+++|+||++++++.
T Consensus       226 -Pf~~--~~~~~~~~~~~~~~~~p~~-~~~~~~~~~~li~~~L~~d----P~~Rps~~eil~h~~~~~~~~p~  290 (299)
T 4g31_A          226 -PFST--QMERVRTLTDVRNLKFPPL-FTQKYPCEYVMVQDMLSPS----PMERPEAINIIENAVFEDLDFPG  290 (299)
T ss_dssp             -CCSS--HHHHHHHHHHHHTTCCCHH-HHHHCHHHHHHHHHHTCSS----GGGSCCHHHHHTSGGGCCC----
T ss_pred             -CCCC--ccHHHHHHHHHhcCCCCCC-CcccCHHHHHHHHHHcCCC----hhHCcCHHHHhcCHhhCCCCCCC
Confidence             8864  33333333333 3455554 3455667789999999999    99999999999999999988644

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.8e-57  Score=436.14  Aligned_cols=270  Identities=23%  Similarity=0.335  Sum_probs=212.3

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeC---CCCcEEEEEEeccchhhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeec
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~  164 (411)
                      .+.++|++.++||+|+||+||+|+++   .+++.||||++.... ....+.+|+++|+.+ .|+||     ++++++|.+
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nI-----v~l~~~~~~   91 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNV-----MGVKYCFRK   91 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTB-----CCCSEEEEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCC-----ceEEEEEEE
Confidence            45678999999999999999999875   467899999986543 345678899999998 46666     999999999


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecC-cccccCCccccc
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA-EYVKVPDYKFLS  242 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~-~~~~l~df~~~~  242 (411)
                      .+++|+||||| +++|.+++.     .+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+++
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             CCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            99999999999 899999983     48999999999999999999999999999999999999876 777788887765


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCccc---------------ccCCCcccccCCCccccceecCC-CCCccchhHHHHH
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTF---------------EHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGC  306 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~---------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGv  306 (411)
                      ......           ..+.+|+.+..               ........+||+.|+|||++.+. .|+.++||||+||
T Consensus       167 ~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~  235 (361)
T 4f9c_A          167 GTHDTK-----------IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGV  235 (361)
T ss_dssp             ECTTCS-----------CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHH
T ss_pred             ccCCcc-----------ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHH
Confidence            443221           12222221111               01112345899999999999886 5899999999999


Q ss_pred             HHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCCh----------------------------------------------
Q 015222          307 ILVELCSGEALFQ-THENLEHLAMMERVLGPLPH----------------------------------------------  339 (411)
Q Consensus       307 il~elltg~~pf~-~~~~~~~~~~i~~~~~~~p~----------------------------------------------  339 (411)
                      ++|||++|+.||. +.++.+.+..|....+..+.                                              
T Consensus       236 il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~  315 (361)
T 4f9c_A          236 IFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGH  315 (361)
T ss_dssp             HHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------
T ss_pred             HHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccc
Confidence            9999999999985 45566666666554432110                                              


Q ss_pred             ----hHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          340 ----HMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       340 ----~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                          ..+..+++++.+||.+||..|    |++|+|++|+|+||||++++
T Consensus       316 ~~~~~~~~~is~~a~DLl~~lL~~d----P~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          316 ATNLEGWNEVPDEAYDLLDKLLDLN----PASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             ------CTTCCHHHHHHHHHHTCSC----TTTSCCHHHHHTSGGGTTC-
T ss_pred             cccccccccCCHHHHHHHHHHCcCC----hhHCcCHHHHhcCcccCCCC
Confidence                112245678999999999999    99999999999999999875

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.6e-56  Score=455.62  Aligned_cols=266  Identities=24%  Similarity=0.366  Sum_probs=237.7

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      .+.++|++++.||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+|+.++|+||     ++++++|++.+.
T Consensus       154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnI-----v~l~~~~~~~~~  228 (573)
T 3uto_A          154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL-----VNLHDAFEDDNE  228 (573)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTB-----CCEEEEEECSSE
T ss_pred             cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCC-----CeEEEEEEECCE
Confidence            34578999999999999999999999999999999997543 445678899999999998877     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +||||||| ||+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+.               
T Consensus       229 ~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~---------------  292 (573)
T 3uto_A          229 MVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR---------------  292 (573)
T ss_dssp             EEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS---------------
T ss_pred             EEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCC---------------
Confidence            99999999 999999997543 3699999999999999999999999999999999999997542               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                                ...+||+|||+|+......  ...+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..
T Consensus       293 ----------~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~  362 (573)
T 3uto_A          293 ----------SNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD  362 (573)
T ss_dssp             ----------CCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred             ----------CCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH
Confidence                      2378999999998765443  4468999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccCCC
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSAS  389 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~~  389 (411)
                      +.+..+......++...+..+++.+++||.+||..|    |.+|+++.|+|+||||+...+....
T Consensus       363 ~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----p~~R~t~~e~l~Hpw~~~~~~~~~~  423 (573)
T 3uto_A          363 ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLAD----PNTRMTIHQALEHPWLTPGNAPGRD  423 (573)
T ss_dssp             HHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSS----GGGSCCHHHHHHSTTTSCCCCTTTT
T ss_pred             HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCC----hhHCcCHHHHhcCcCcCCCCCCCch
Confidence            999988888778888888889999999999999999    9999999999999999987766543

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.4e-56  Score=418.24  Aligned_cols=245  Identities=20%  Similarity=0.298  Sum_probs=207.4

Q ss_pred             CCeEEEeeeccccceEEEEEEeC-----CCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      ++|.+.++||+|+||+||+|++.     .++..||||+++... ...+.+.+|+++|++++|+||     |++++++.++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnI-----V~l~g~~~~~   87 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI-----VKFYGVCVEG   87 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEECSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCC-----ccEEEEEeeC
Confidence            57999999999999999999875     357899999997543 446778999999999988887     9999999999


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNS-----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV  233 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~  233 (411)
                      +.+||||||| +|+|.++|...+           ...+++..+..|+.||+.||+|||+++||||||||+|||++.++  
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~--  165 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL--  165 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC--
Confidence            9999999999 999999997642           24699999999999999999999999999999999999998776  


Q ss_pred             ccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchhHHHHHHH
Q 015222          234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL  308 (411)
Q Consensus       234 ~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  308 (411)
                                               .+||+|||+|+......     ....||+.|||||++.+..|+.++|||||||+|
T Consensus       166 -------------------------~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl  220 (299)
T 4asz_A          166 -------------------------LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVL  220 (299)
T ss_dssp             -------------------------CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred             -------------------------cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHH
Confidence                                     67888888886543221     224689999999999999999999999999999


Q ss_pred             HHHHh-CCCCCCCCChHHHHHHHHHHhC-CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHh
Q 015222          309 VELCS-GEALFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK  376 (411)
Q Consensus       309 ~ellt-g~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~  376 (411)
                      |||+| |+.||.+.+..+.+..+..... ..|    ..+++.+.+++.+|++.|    |++|||+.++++
T Consensus       221 ~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p----~~~~~~~~~li~~cl~~d----P~~RPs~~~i~~  282 (299)
T 4asz_A          221 WEIFTYGKQPWYQLSNNEVIECITQGRVLQRP----RTCPQEVYELMLGCWQRE----PHMRKNIKGIHT  282 (299)
T ss_dssp             HHHHTTTCCTTTTSCHHHHHHHHHHTCCCCCC----TTCCHHHHHHHHHHTCSS----GGGSCCHHHHHH
T ss_pred             HHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCC----ccchHHHHHHHHHHcCCC----hhHCcCHHHHHH
Confidence            99999 9999999988888887776532 333    346778899999987777    999999999854

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.9e-56  Score=416.41  Aligned_cols=247  Identities=21%  Similarity=0.337  Sum_probs=199.0

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      .+++++.++||+|+||+||+|++..   .||||+++..   ....+.+.+|+.++++++|+||     |++++++.. +.
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNI-----V~l~g~~~~-~~  105 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNI-----LLFMGYMTK-DN  105 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEECS-SS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEC-Ce
Confidence            4678999999999999999998643   5999999743   3445778999999999998887     999998764 56


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +||||||| +|+|.+++.... ..+++..+..|+.||+.||+|||++|||||||||+||||+.++               
T Consensus       106 ~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~---------------  169 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGL---------------  169 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTE---------------
T ss_pred             EEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCC---------------
Confidence            89999999 999999998654 3699999999999999999999999999999999999998877               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccC-----CCcccccCCCccccceecCC---CCCccchhHHHHHHHHHHHhCCCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSGEALF  318 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlGvil~elltg~~pf  318 (411)
                                  .+||+|||+|+....     .....+||+.|||||++.+.   .|+.++|||||||+||||+||+.||
T Consensus       170 ------------~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf  237 (307)
T 3omv_A          170 ------------TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPY  237 (307)
T ss_dssp             ------------EEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ------------cEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCC
Confidence                        567777777765332     12346899999999999743   5899999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCC--ChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          319 QTHENLEHLAMMERVLGPL--PHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       319 ~~~~~~~~~~~i~~~~~~~--p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      .+.+....+..+.......  .......+++.+.+++.+|++.+    |++|||+.++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~d----P~~RPs~~ei~~~L  295 (307)
T 3omv_A          238 SHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKV----KEERPLFPQILSSI  295 (307)
T ss_dssp             TTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSS----STTSCCHHHHHHHH
T ss_pred             CCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCC----HhHCcCHHHHHHHH
Confidence            9877665555444332222  23344567788999999998888    88888888876553

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=9.6e-56  Score=419.60  Aligned_cols=247  Identities=22%  Similarity=0.304  Sum_probs=204.9

Q ss_pred             CCeEEEeeeccccceEEEEEEeC-----CCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      ++|.+.++||+|+||+||+|+++     .+++.||||+++... ...+.+.+|+.+|++++|+||     |++++++.+.
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnI-----V~l~g~~~~~  115 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI-----VRFFGVCTEG  115 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEECSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEEEEC
Confidence            57899999999999999999865     368899999997543 455778999999999988887     9999999999


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNS-------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE  231 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~  231 (411)
                      +.+||||||| +|+|.+++....             ...+++..+..|+.||+.||+|||+++||||||||+||||+.++
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~  195 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL  195 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence            9999999999 999999997643             13589999999999999999999999999999999999998776


Q ss_pred             ccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCCCccchhHHHHH
Q 015222          232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC  306 (411)
Q Consensus       232 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  306 (411)
                                                 .+||+|||+|+.....     .....||+.|||||++.+..|+.++|||||||
T Consensus       196 ---------------------------~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gv  248 (329)
T 4aoj_A          196 ---------------------------VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGV  248 (329)
T ss_dssp             ---------------------------EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHH
T ss_pred             ---------------------------cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHH
Confidence                                       5677777777643222     12357999999999999999999999999999


Q ss_pred             HHHHHHh-CCCCCCCCChHHHHHHHHHHh-CCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          307 ILVELCS-GEALFQTHENLEHLAMMERVL-GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       307 il~ellt-g~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      +||||+| |+.||.+.+..+.+..+.+.. ...|    ..+++.+.+++.+|++.|    |++|||+.++++++
T Consensus       249 vl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~~p----~~~~~~~~~li~~cl~~d----P~~RPs~~ei~~~L  314 (329)
T 4aoj_A          249 VLWEIFTYGKQPWYQLSNTEAIDCITQGRELERP----RACPPEVYAIMRGCWQRE----PQQRHSIKDVHARL  314 (329)
T ss_dssp             HHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCCCC----TTCCHHHHHHHHHHCCSS----TTTSCCHHHHHHHH
T ss_pred             HHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCc----ccccHHHHHHHHHHcCcC----hhHCcCHHHHHHHH
Confidence            9999999 999999988888887776643 2333    346778899999987777    99999999998764

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.4e-55  Score=447.28  Aligned_cols=257  Identities=21%  Similarity=0.297  Sum_probs=211.9

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++++.||+|+||+||+|+++.+|+.||||++++..    .......+|..++..+.+  ..|||||+++++|++.+.
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~--~~HP~IV~l~~~f~~~~~  266 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST--GDCPFIVCMSYAFHTPDK  266 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSS--SCCTTBCCEEEEEECSSE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhh--CCCCCEeEEEEEEEECCE
Confidence            67999999999999999999999999999999997532    223344556555554432  234556999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+||||| ||+|.++|.+.+  .+++..++.++.||+.||+|||++|||||||||+||||+.+|               
T Consensus       267 lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G---------------  329 (689)
T 3v5w_A          267 LSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG---------------  329 (689)
T ss_dssp             EEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTS---------------
T ss_pred             EEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCC---------------
Confidence            99999999 999999998876  799999999999999999999999999999999999998877               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccC-CCcccccCCCccccceecC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCh-
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHEN-  323 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~-  323 (411)
                                  .+||+|||+|..... ...+.+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+. 
T Consensus       330 ------------~vKL~DFGlA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~  397 (689)
T 3v5w_A          330 ------------HVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK  397 (689)
T ss_dssp             ------------CEEECCCTTCEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC
T ss_pred             ------------CEEecccceeeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence                        567777777765433 3345799999999999975 5799999999999999999999999976432 


Q ss_pred             --HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHH-----HHHHHhcCCCCcccccC
Q 015222          324 --LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS-----MRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       324 --~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t-----~~~il~~~~~~~~~~~~  387 (411)
                        .+....+......+|.    .+++.+++||.+||..|    |.+|++     ++++++||||++++|..
T Consensus       398 ~~~~i~~~i~~~~~~~p~----~~S~~a~dLI~~lL~~d----P~~Rl~~~~~ga~ei~~HpfF~~idW~~  460 (689)
T 3v5w_A          398 DKHEIDRMTLTMAVELPD----SFSPELRSLLEGLLQRD----VNRRLGCLGRGAQEVKESPFFRSLDWQM  460 (689)
T ss_dssp             CHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSC----GGGCTTCSSSTHHHHTTSGGGTTCCHHH
T ss_pred             HHHHHHHhhcCCCCCCCc----cCCHHHHHHHHHHccCC----HhHCCCCCCCCHHHHhcCccccCCCHHH
Confidence              3334444444444443    46888999999999999    777766     89999999999998754

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.3e-55  Score=414.99  Aligned_cols=248  Identities=20%  Similarity=0.255  Sum_probs=207.8

Q ss_pred             CCCeEEEeeeccccceEEEEEEeC-----CCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~  163 (411)
                      ...+++.++||+|+||+||+|+..     .+++.||||+++..  ....+.+.+|+.++++++|+||     |++++++.
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNI-----V~l~g~~~   99 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV-----VCLLGVVT   99 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTB-----CCEEEEEC
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCC-----CCcceEEE
Confidence            357899999999999999999863     46789999999743  2345779999999999998888     99999999


Q ss_pred             cCCeEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015222          164 YRNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV  228 (411)
Q Consensus       164 ~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~  228 (411)
                      +++.++|||||| +|+|.++|..+.              ...+++..+..|+.||+.||+|||+++||||||||+||||+
T Consensus       100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY  179 (308)
T ss_dssp             SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence            999999999999 999999997542              13589999999999999999999999999999999999998


Q ss_pred             cCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCCCccchhHH
Q 015222          229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWS  303 (411)
Q Consensus       229 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  303 (411)
                      +++                           .+||+|||+|+.....     .....||+.|||||++.++.|+.++||||
T Consensus       180 ~~~---------------------------~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwS  232 (308)
T 4gt4_A          180 DKL---------------------------NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWS  232 (308)
T ss_dssp             GGG---------------------------CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred             CCC---------------------------CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhh
Confidence            877                           6777888877654222     23457999999999999999999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC-CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          304 VGCILVELCS-GEALFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       304 lGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      |||+||||+| |..||.+.+..+.+..+..... +.|    ..++..+.+++.+|++.|    |++|||+.+|++++
T Consensus       233 fGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p----~~~~~~~~~li~~C~~~d----P~~RPs~~ei~~~L  301 (308)
T 4gt4_A          233 YGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCP----DDCPAWVYALMIECWNEF----PSRRPRFKDIHSRL  301 (308)
T ss_dssp             HHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCCCC----TTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCc----ccchHHHHHHHHHHcCCC----hhHCcCHHHHHHHH
Confidence            9999999998 8999999988888777765432 222    356777888888886666    99999999999874

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.1e-53  Score=410.44  Aligned_cols=300  Identities=39%  Similarity=0.706  Sum_probs=249.8

Q ss_pred             CCCCCceEEeeCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcce
Q 015222           76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRC  155 (411)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~i  155 (411)
                      +++...+.+..+..+.++|+++++||+|+||+||+|++..+++.||||+++...........|+.+++.+.+..+.|+||
T Consensus        19 ~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~i   98 (360)
T 3llt_A           19 DDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNI   98 (360)
T ss_dssp             -CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred             CccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence            44445667788889999999999999999999999999999999999999876677777889999999999887788899


Q ss_pred             EEEeeeeecCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCccccc
Q 015222          156 VQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV  235 (411)
Q Consensus       156 v~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l  235 (411)
                      +++++++...+..|+||||++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.....+-
T Consensus        99 v~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~  178 (360)
T 3llt_A           99 VKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKS  178 (360)
T ss_dssp             CCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEE
T ss_pred             ecccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccc
Confidence            99999999999999999999999999999876567999999999999999999999999999999999999975321100


Q ss_pred             CCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCC
Q 015222          236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE  315 (411)
Q Consensus       236 ~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~  315 (411)
                      . .. ...................+||+|||++...........||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus       179 ~-~~-~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  256 (360)
T 3llt_A          179 L-IT-VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS  256 (360)
T ss_dssp             E-EE-EECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred             c-cc-hhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCC
Confidence            0 00 000000000000001355799999999988776666778999999999999999999999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChhHHHhh------------------------------------------hhhhhhhh
Q 015222          316 ALFQTHENLEHLAMMERVLGPLPHHMVIRA------------------------------------------DRRAEKYF  353 (411)
Q Consensus       316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~------------------------------------------~~~~~~li  353 (411)
                      .||.+.+..+.+..+....+.+|.......                                          ++.+.++|
T Consensus       257 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  336 (360)
T 3llt_A          257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL  336 (360)
T ss_dssp             CSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred             CCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence            999999999999999888888887654332                                          14566999


Q ss_pred             ccCCccCCCCCCCcHHHHHHHHhcCCCC
Q 015222          354 RRGARLDWPDGATSRDSMRAVWKLLRLP  381 (411)
Q Consensus       354 ~~~l~~~~~~rp~~R~t~~~il~~~~~~  381 (411)
                      .+||+.|    |.+|||+.++++|+||+
T Consensus       337 ~~~L~~d----P~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          337 YSILQID----PTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHHCCSS----GGGSCCHHHHTTSGGGC
T ss_pred             HHHhcCC----hhhCCCHHHHhcCcccC
Confidence            9999999    99999999999999985

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.2e-53  Score=408.59  Aligned_cols=248  Identities=21%  Similarity=0.271  Sum_probs=202.3

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCC-----CcEEEEEEeccch--hhhHHHHHHHHHHHHHhc-CCCCCcceEEEeeee
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSIN--KYREAAMIEIDVLQRLAR-HDIGGTRCVQIRNWF  162 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~-----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~-~~i~~~~iv~~~~~~  162 (411)
                      .++|++.++||+|+||+||+|++..+     ++.||||+++...  ...+.+.+|+.+|+++.| +||     |++++++
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnI-----V~l~g~~  137 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV-----VNLLGAC  137 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEE
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcE-----EEEEEEE
Confidence            46899999999999999999997654     3689999997532  345678899999999987 455     9999988


Q ss_pred             ec-CCeEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015222          163 DY-RNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL  226 (411)
Q Consensus       163 ~~-~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIl  226 (411)
                      .. ++.+||||||| +|+|.++|+...              ...+++..+..++.||+.||+|||+++||||||||+|||
T Consensus       138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL  217 (353)
T 4ase_A          138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  217 (353)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence            65 46799999999 999999997542              235899999999999999999999999999999999999


Q ss_pred             EecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchh
Q 015222          227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDL  301 (411)
Q Consensus       227 i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di  301 (411)
                      ++.++                           .+||+|||+|+......     ....||+.|||||++.+..|+.++||
T Consensus       218 l~~~~---------------------------~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDV  270 (353)
T 4ase_A          218 LSEKN---------------------------VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV  270 (353)
T ss_dssp             ECGGG---------------------------CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHH
T ss_pred             eCCCC---------------------------CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccE
Confidence            98877                           56777777776443221     23578999999999999999999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCChHH-HHHHHHHHh-CCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          302 WSVGCILVELCS-GEALFQTHENLE-HLAMMERVL-GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       302 wSlGvil~ellt-g~~pf~~~~~~~-~~~~i~~~~-~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      |||||+||||+| |+.||.+.+..+ ....+.... ...|    ..+++.+.+++.+|++.|    |++|||+.++++|+
T Consensus       271 wS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p----~~~~~~~~~li~~c~~~d----P~~RPt~~eil~~L  342 (353)
T 4ase_A          271 WSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP----DYTTPEMYQTMLDCWHGE----PSQRPTFSELVEHL  342 (353)
T ss_dssp             HHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCC----TTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred             eehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCC----ccCCHHHHHHHHHHcCcC----hhHCcCHHHHHHHH
Confidence            999999999998 999998876444 334444332 2333    345778889998887776    99999999999884

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5.5e-52  Score=409.83  Aligned_cols=279  Identities=35%  Similarity=0.623  Sum_probs=242.6

Q ss_pred             CCceEEeeCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCC-CCCcceEE
Q 015222           79 DGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD-IGGTRCVQ  157 (411)
Q Consensus        79 ~~~~~~~~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~-i~~~~iv~  157 (411)
                      .+.+....++.+..+|++++.||+|+||+||+|.+..+++.||||+++........+.+|+.+++.+.|.. ..|+|++.
T Consensus        84 ~~~~~~~~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~  163 (429)
T 3kvw_A           84 QGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH  163 (429)
T ss_dssp             TSCBCCCTTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCC
T ss_pred             CCCccccCCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEE
Confidence            34445556677889999999999999999999999999999999999877777778889999999998764 35678899


Q ss_pred             EeeeeecCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCC
Q 015222          158 IRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD  237 (411)
Q Consensus       158 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~d  237 (411)
                      +++++...+++|+||||++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.     
T Consensus       164 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~-----  238 (429)
T 3kvw_A          164 MLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR-----  238 (429)
T ss_dssp             EEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTS-----
T ss_pred             EEeecccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCC-----
Confidence            999999999999999999889999999876667999999999999999999999999999999999999987651     


Q ss_pred             cccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCC
Q 015222          238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL  317 (411)
Q Consensus       238 f~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p  317 (411)
                                          ..+||+|||++...........||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus       239 --------------------~~vkL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~p  298 (429)
T 3kvw_A          239 --------------------SGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPL  298 (429)
T ss_dssp             --------------------CCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             --------------------cceEEeecccceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCC
Confidence                                248999999998777666777899999999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChhHHHh-----------------------------------------------------
Q 015222          318 FQTHENLEHLAMMERVLGPLPHHMVIR-----------------------------------------------------  344 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~~~p~~~~~~-----------------------------------------------------  344 (411)
                      |.+.+..+.+..+....+..+..+...                                                     
T Consensus       299 f~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  378 (429)
T 3kvw_A          299 LPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALK  378 (429)
T ss_dssp             SCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTT
T ss_pred             CCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhcc
Confidence            999999999988888877766654332                                                     


Q ss_pred             --hhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          345 --ADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       345 --~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                        .++.+.+||.+||..|    |.+|||+.|+++||||++....
T Consensus       379 ~~~~~~~~dli~~~L~~d----P~~Rpta~e~L~Hpw~~~~~~~  418 (429)
T 3kvw_A          379 GCDDPLFLDFLKQCLEWD----PAVRMTPGQALRHPWLRRRLPK  418 (429)
T ss_dssp             TCCCHHHHHHHHHHTCSS----TTTSCCHHHHHTSTTTC-----
T ss_pred             ccchHHHHHHHHHHCCCC----hhhCCCHHHHhCChhhccCCCC
Confidence              1455789999999999    9999999999999999976543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.1e-52  Score=403.26  Aligned_cols=264  Identities=24%  Similarity=0.420  Sum_probs=235.0

Q ss_pred             CccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchh-------hhHHHHHHHHHHHHHhcCCCCCcceEEEee
Q 015222           88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRLARHDIGGTRCVQIRN  160 (411)
Q Consensus        88 ~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~  160 (411)
                      ..+.++|++.+.||+|+||+||+|+++.+|+.||+|+++....       ..+.+.+|+.+++++.|+||     +++++
T Consensus         8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~l~~   82 (361)
T 2yab_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI-----ITLHD   82 (361)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTB-----CCEEE
T ss_pred             CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCC-----CcEEE
Confidence            4567889999999999999999999999999999999975432       24678899999999988776     99999


Q ss_pred             eeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcc
Q 015222          161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK  239 (411)
Q Consensus       161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~  239 (411)
                      ++.+.+.+|+||||+ |++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.       
T Consensus        83 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~-------  153 (361)
T 2yab_A           83 VYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNI-------  153 (361)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTS-------
T ss_pred             EEEeCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCC-------
Confidence            999999999999999 999999997754  7999999999999999999999999999999999999976541       


Q ss_pred             cccccCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCC
Q 015222          240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL  317 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p  317 (411)
                                      ....+||+|||++......  .....||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus       154 ----------------~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~P  217 (361)
T 2yab_A          154 ----------------PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP  217 (361)
T ss_dssp             ----------------SSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred             ----------------CccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence                            1236899999988765433  2446799999999999998999999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      |.+.+..+.+..+......++...+..++..++++|.+||..|    |.+|||+.++++||||..+++
T Consensus       218 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d----P~~R~t~~e~l~hp~~~~~~~  281 (361)
T 2yab_A          218 FLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKE----TRKRLTIQEALRHPWITPVDT  281 (361)
T ss_dssp             SCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSS----TTTSCCHHHHHTSTTTSCSSH
T ss_pred             CCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCC----hhHCcCHHHHhcCcCcCCCch
Confidence            9999988888888888888888888899999999999999999    999999999999999997664

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-52  Score=394.80  Aligned_cols=262  Identities=21%  Similarity=0.322  Sum_probs=234.7

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      .+.++|++.+.||+|+||+||+|.+..+++.||+|++.........+.+|+.+++.+.|+||     +++++++.+.+.+
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~~~~~~~~~~   76 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNI-----LHLHESFESMEEL   76 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTB-----CCEEEEEEETTEE
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCC-----CeEeEEEecCCEE
Confidence            45689999999999999999999999999999999998766666778899999999988877     9999999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      ++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++                
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~----------------  139 (321)
T 1tki_A           77 VMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR----------------  139 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS----------------
T ss_pred             EEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCC----------------
Confidence            9999999 889999997653 3699999999999999999999999999999999999997521                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                               +..+||+|||++.......  ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+
T Consensus       140 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  210 (321)
T 1tki_A          140 ---------SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ  210 (321)
T ss_dssp             ---------CCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             ---------CCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH
Confidence                     2378999999887654332  34679999999999999889999999999999999999999999999888


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      .+..+......++...+..++..+.++|.+||..|    |.+|||+.++++||||.+...
T Consensus       211 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d----p~~Rpt~~e~l~hp~~~~~~~  266 (321)
T 1tki_A          211 IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKE----RKSRMTASEALQHPWLKQKIE  266 (321)
T ss_dssp             HHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSS----GGGSCCHHHHHHSHHHHSCGG
T ss_pred             HHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCC----hhHCcCHHHHhcChhhccCcc
Confidence            88888888888888888889999999999999999    999999999999999987543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=7.7e-53  Score=396.39  Aligned_cols=246  Identities=22%  Similarity=0.238  Sum_probs=185.4

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC----
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN----  166 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~----  166 (411)
                      .++|.+.++||+|+||+||+|++  +|+.||||+++.........+.|+..+.+++|+||     |++++++.+++    
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNI-----v~l~g~~~~~~~~~~   74 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI-----LGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTB-----CCEEEEEEEECSSSE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCC-----CcEEEEEEecCCCce
Confidence            35799999999999999999987  58899999997654433334456666666777766     99999987643    


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCcEEEecCcccccCC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL--------RLIHTDLKPENILLVSAEYVKVPD  237 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------givH~Dikp~NIli~~~~~~~l~d  237 (411)
                      .+||||||| +|+|.+++...   .++++.+.+++.|++.||+|||++        +||||||||+||||+.++      
T Consensus        75 ~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~------  145 (303)
T 3hmm_A           75 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG------  145 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS------
T ss_pred             EEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC------
Confidence            689999999 99999999875   499999999999999999999987        999999999999998776      


Q ss_pred             cccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-------cccccCCCccccceecCC------CCCccchhHHH
Q 015222          238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-------SYVVSTRHYRAPEVILGL------GWNYPCDLWSV  304 (411)
Q Consensus       238 f~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~------~~~~~~DiwSl  304 (411)
                                           .+||+|||+|+......       ...+||+.|||||++.+.      .++.++|||||
T Consensus       146 ---------------------~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~  204 (303)
T 3hmm_A          146 ---------------------TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM  204 (303)
T ss_dssp             ---------------------CEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHH
T ss_pred             ---------------------CEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhH
Confidence                                 67777777776543221       235799999999999764      36789999999


Q ss_pred             HHHHHHHHhCCCCCCCCC--------------hHHHHHHHHHH---hCCCChhHH-HhhhhhhhhhhccCCccCCCCCCC
Q 015222          305 GCILVELCSGEALFQTHE--------------NLEHLAMMERV---LGPLPHHMV-IRADRRAEKYFRRGARLDWPDGAT  366 (411)
Q Consensus       305 Gvil~elltg~~pf~~~~--------------~~~~~~~i~~~---~~~~p~~~~-~~~~~~~~~li~~~l~~~~~~rp~  366 (411)
                      ||+||||+||..||....              ..+.+......   .+.+|.... ....+.+.+++.+|++.|    |+
T Consensus       205 Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~d----P~  280 (303)
T 3hmm_A          205 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN----GA  280 (303)
T ss_dssp             HHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSS----GG
T ss_pred             HHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccC----Hh
Confidence            999999999987664321              11222221111   123343321 123345677888876666    99


Q ss_pred             cHHHHHHHHhc
Q 015222          367 SRDSMRAVWKL  377 (411)
Q Consensus       367 ~R~t~~~il~~  377 (411)
                      +|||+.++++.
T Consensus       281 ~RPt~~ei~~~  291 (303)
T 3hmm_A          281 ARLTALRIKKT  291 (303)
T ss_dssp             GSCCHHHHHHH
T ss_pred             HCcCHHHHHHH
Confidence            99999999875

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.3e-51  Score=400.82  Aligned_cols=303  Identities=30%  Similarity=0.529  Sum_probs=243.8

Q ss_pred             CCCCCceEEeeCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCC---C
Q 015222           76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG---G  152 (411)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~---~  152 (411)
                      ...++.+++.+++.+.++|++.++||+|+||+||+|++..+++.||||+++......+.+.+|+.+++.+.|.+..   |
T Consensus        21 ~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~  100 (397)
T 1wak_A           21 YCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNR  100 (397)
T ss_dssp             -CC--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGG
T ss_pred             CCCCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCc
Confidence            3445677788999999999999999999999999999999999999999987777778889999999999986643   5


Q ss_pred             cceEEEeeeee----cCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEE
Q 015222          153 TRCVQIRNWFD----YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILL  227 (411)
Q Consensus       153 ~~iv~~~~~~~----~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dikp~NIli  227 (411)
                      +|++++++++.    ...++|+||||++++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|||+
T Consensus       101 ~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll  180 (397)
T 1wak_A          101 EMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILL  180 (397)
T ss_dssp             GGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEE
T ss_pred             ceeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeE
Confidence            67899999987    56789999999988998888876556799999999999999999999998 99999999999999


Q ss_pred             ecCcccccCCcccccccCCC-----------------C-----CccccCCCCCCeeEeecCCcccccCCCcccccCCCcc
Q 015222          228 VSAEYVKVPDYKFLSRSSKD-----------------G-----SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYR  285 (411)
Q Consensus       228 ~~~~~~~l~df~~~~~~~~~-----------------~-----~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~  285 (411)
                      +.++.....+++........                 +     ...........+||+|||++...........||+.|+
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~  260 (397)
T 1wak_A          181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYR  260 (397)
T ss_dssp             CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGC
T ss_pred             eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCccc
Confidence            87763222111110000000                 0     0000011234799999999988776666678999999


Q ss_pred             ccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCChhHH-----------------
Q 015222          286 APEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE------NLEHLAMMERVLGPLPHHMV-----------------  342 (411)
Q Consensus       286 aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~------~~~~~~~i~~~~~~~p~~~~-----------------  342 (411)
                      |||++.+..++.++|||||||++|||++|+.||.+.+      ..+.+..+....+..|..+.                 
T Consensus       261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  340 (397)
T 1wak_A          261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK  340 (397)
T ss_dssp             CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred             CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence            9999999999999999999999999999999998654      45666777777777665442                 


Q ss_pred             ---------------------HhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCc
Q 015222          343 ---------------------IRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       343 ---------------------~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~  382 (411)
                                           ...+..+.++|.+||..|    |.+|||+.++++||||.+
T Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d----P~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELI----PEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSS----GGGSCCHHHHHTSGGGGC
T ss_pred             cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccC----hhhcCCHHHHhhCccccC
Confidence                                 234566889999999999    999999999999999964

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2e-51  Score=400.08  Aligned_cols=277  Identities=35%  Similarity=0.618  Sum_probs=241.4

Q ss_pred             CCceEEeeCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHh-cCCCCCcceEE
Q 015222           79 DGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCVQ  157 (411)
Q Consensus        79 ~~~~~~~~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~iv~  157 (411)
                      ...+.+..++.+.++|++.+.||+|+||+||+|++..+++.||||+++........+..|+.+++.+. |+++.+++++.
T Consensus        41 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~  120 (382)
T 2vx3_A           41 NYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVH  120 (382)
T ss_dssp             TSCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCC
T ss_pred             CCcEEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEE
Confidence            34566778889999999999999999999999999999999999999876666777889999999997 56667778899


Q ss_pred             EeeeeecCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCcEEEecCccccc
Q 015222          158 IRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH--ELRLIHTDLKPENILLVSAEYVKV  235 (411)
Q Consensus       158 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~givH~Dikp~NIli~~~~~~~l  235 (411)
                      +++++...++.|+||||++++|.+++.......+++..++.++.||+.||.|||  +.||+||||||+|||++.+     
T Consensus       121 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~-----  195 (382)
T 2vx3_A          121 LKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP-----  195 (382)
T ss_dssp             EEEEEEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESST-----
T ss_pred             eeeeeccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecC-----
Confidence            999999999999999999889999998876557999999999999999999999  5799999999999999542     


Q ss_pred             CCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCC
Q 015222          236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE  315 (411)
Q Consensus       236 ~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~  315 (411)
                                          .+..+||+|||++...........||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       196 --------------------~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~  255 (382)
T 2vx3_A          196 --------------------KRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE  255 (382)
T ss_dssp             --------------------TSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             --------------------CCCcEEEEeccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence                                233689999999987766666678999999999999999999999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChhHHHhh--------------------------------------------------
Q 015222          316 ALFQTHENLEHLAMMERVLGPLPHHMVIRA--------------------------------------------------  345 (411)
Q Consensus       316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~--------------------------------------------------  345 (411)
                      .||.+.+..+.+..+....+..+.......                                                  
T Consensus       256 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  335 (382)
T 2vx3_A          256 PLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRR  335 (382)
T ss_dssp             CSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTT
T ss_pred             CCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccc
Confidence            999999998888888887776665443211                                                  


Q ss_pred             ----------hhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          346 ----------DRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       346 ----------~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                                ...+.+||.+||..|    |++|||+.++++||||.+..
T Consensus       336 ~~~~~~~~~~~~~~~dli~~mL~~d----P~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          336 AGESGHTVADYLKFKDLILRMLDYD----PKTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             TTCTTCCHHHHHHHHHHHHHHTCSC----TTTSCCHHHHTTSGGGCC--
T ss_pred             cccccccchhhHHHHHHHHHhcCCC----hhhCCCHHHHhcCcccccCC
Confidence                      135789999999999    99999999999999998754

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=5.2e-52  Score=399.49  Aligned_cols=255  Identities=22%  Similarity=0.316  Sum_probs=218.9

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeecC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .++|++++.||+|+||+||+|+++.+++.||||++++..    ...+...+|..+++.+ .|++|     +++++++.+.
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~I-----v~l~~~~~~~   96 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL-----TQLFCCFQTP   96 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTB-----CCEEEEEECS
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCce-----eeEEEEEEeC
Confidence            368999999999999999999999999999999997532    3445677899999987 46665     9999999999


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      +.+|+||||+ |++|.+++.+..  .+++..++.++.||+.||+|||++||+||||||+|||++.+|             
T Consensus        97 ~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g-------------  161 (353)
T 3txo_A           97 DRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG-------------  161 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-------------
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCC-------------
Confidence            9999999999 899999998765  699999999999999999999999999999999999998777             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCccccc---CCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                                    .+||+|||++....   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus       162 --------------~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~  227 (353)
T 3txo_A          162 --------------HCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE  227 (353)
T ss_dssp             --------------CEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             --------------CEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC
Confidence                          56777777776422   2234468999999999999889999999999999999999999999999


Q ss_pred             ChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHH------HHHHhcCCCCcccccC
Q 015222          322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSM------RAVWKLLRLPVIDLYS  387 (411)
Q Consensus       322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~------~~il~~~~~~~~~~~~  387 (411)
                      +..+.+..+......+|..    ++..+.++|.+||..+    |.+|+++      +++++||||++++|..
T Consensus       228 ~~~~~~~~i~~~~~~~p~~----~~~~~~~li~~lL~~d----P~~R~~~~~~~~~~~il~hp~f~~~~w~~  291 (353)
T 3txo_A          228 NEDDLFEAILNDEVVYPTW----LHEDATGILKSFMTKN----PTMRLGSLTQGGEHAILRHPFFKEIDWAQ  291 (353)
T ss_dssp             SHHHHHHHHHHCCCCCCTT----SCHHHHHHHHHHTCSS----GGGSTTSGGGTCTHHHHTSGGGTTCCHHH
T ss_pred             CHHHHHHHHHcCCCCCCCC----CCHHHHHHHHHHhhhC----HHHccCCcccCCHHHHhhCCcccCCCHHH
Confidence            9988888888776666643    5678999999999999    8888887      9999999999987643

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.4e-51  Score=390.71  Aligned_cols=291  Identities=45%  Similarity=0.826  Sum_probs=245.7

Q ss_pred             eEEeeCCccCCCeEEEeeeccccceEEEEEEe-CCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCC-CCcceEEEe
Q 015222           82 YVFAIGENLTPRYRILSKMGEGTFGQVVECFD-NEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI-GGTRCVQIR  159 (411)
Q Consensus        82 ~~~~~~~~~~~~y~i~~~lG~G~~g~V~~a~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i-~~~~iv~~~  159 (411)
                      .....|+.+.++|++.+.||+|+||+||+|.+ ..+++.||||+++......+.+.+|+.+++.+.|++. .++++++++
T Consensus         4 ~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~   83 (339)
T 1z57_A            4 LICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQML   83 (339)
T ss_dssp             GTCSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred             eeeecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence            34456788899999999999999999999998 5688999999998776777888999999999998764 356789999


Q ss_pred             eeeecCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcc
Q 015222          160 NWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK  239 (411)
Q Consensus       160 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~  239 (411)
                      +++...+..++||||++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++..+.....+.+
T Consensus        84 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           84 EWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             EEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             cccccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCc
Confidence            99999999999999999999999988765679999999999999999999999999999999999999875432221111


Q ss_pred             cccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 015222          240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ  319 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~  319 (411)
                      ....        .....+..+||+|||++...........||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus       164 ~~~~--------~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  235 (339)
T 1z57_A          164 IKRD--------ERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFP  235 (339)
T ss_dssp             --CE--------EEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccc--------cccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence            0000        00011457999999999887766667789999999999999999999999999999999999999999


Q ss_pred             CCChHHHHHHHHHHhCCCChhHHHh----------------------------------------hhhhhhhhhccCCcc
Q 015222          320 THENLEHLAMMERVLGPLPHHMVIR----------------------------------------ADRRAEKYFRRGARL  359 (411)
Q Consensus       320 ~~~~~~~~~~i~~~~~~~p~~~~~~----------------------------------------~~~~~~~li~~~l~~  359 (411)
                      +.+..+....+.+..+.+|..+...                                        .++.+.++|.+||..
T Consensus       236 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  315 (339)
T 1z57_A          236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY  315 (339)
T ss_dssp             CSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred             CCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence            9999888888888888887765432                                        245678999999999


Q ss_pred             CCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          360 DWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       360 ~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      |    |.+|||+.++++|+||..+.
T Consensus       316 d----P~~Rpt~~ell~hp~f~~~~  336 (339)
T 1z57_A          316 D----PAKRITLREALKHPFFDLLK  336 (339)
T ss_dssp             S----TTTSCCHHHHTTSGGGGGGG
T ss_pred             C----cccccCHHHHhcCHHHHHHh
Confidence            9    99999999999999999765

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.2e-51  Score=390.26  Aligned_cols=253  Identities=25%  Similarity=0.364  Sum_probs=222.5

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      .++|++.+.||+|+||.||+|++..+|+.||||++....   ...+.+.+|+.+++.++|+||     +++++++...+.
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~l~~~~~~~~~   88 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI-----VKLFEVIETEKT   88 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEECSSE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEECCE
Confidence            468999999999999999999999999999999997532   345667899999999988877     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+||||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++               
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~---------------  151 (328)
T 3fe3_A           89 LYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM---------------  151 (328)
T ss_dssp             EEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS---------------
T ss_pred             EEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCC---------------
Confidence            99999999 999999998765  699999999999999999999999999999999999997766               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCh
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEALFQTHEN  323 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~pf~~~~~  323 (411)
                                  .+||+|||++......  ....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+.
T Consensus       152 ------------~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  219 (328)
T 3fe3_A          152 ------------NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL  219 (328)
T ss_dssp             ------------CEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ------------CEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH
Confidence                        6788888887654332  3446899999999999988765 899999999999999999999999888


Q ss_pred             HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      .+....+......+|..    .+..+.+++.+||..|    |.+|||+.++++|+||.....
T Consensus       220 ~~~~~~i~~~~~~~p~~----~s~~~~~li~~~L~~d----P~~R~t~~eil~h~~~~~~~~  273 (328)
T 3fe3_A          220 KELRERVLRGKYRIPFY----MSTDCENLLKRFLVLN----PIKRGTLEQIMKDRWINAGHE  273 (328)
T ss_dssp             HHHHHHHHHCCCCCCTT----SCHHHHHHHHHHCCSS----TTTSCCHHHHTTCTTTTTTCT
T ss_pred             HHHHHHHHhCCCCCCCC----CCHHHHHHHHHHCCCC----hhHCcCHHHHhcCHhhcCCCc
Confidence            88888887766666643    5678899999999999    999999999999999986543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-51  Score=390.54  Aligned_cols=257  Identities=22%  Similarity=0.333  Sum_probs=224.2

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++++.||+|+||.||+|+++.+|+.||+|++++..    ...+.+.+|+.+++.+.|++|     +++++++.+.+.
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~I-----v~~~~~~~~~~~   80 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI-----IRMWGTFQDAQQ   80 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTB-----CCEEEEEECSSE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCC-----ceEeEEEEeCCE
Confidence            57999999999999999999999999999999997532    334667789999999888777     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+||||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+|               
T Consensus        81 ~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g---------------  143 (318)
T 1fot_A           81 IFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG---------------  143 (318)
T ss_dssp             EEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS---------------
T ss_pred             EEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC---------------
Confidence            99999999 899999998765  699999999999999999999999999999999999998766               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH  326 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~  326 (411)
                                  .+||+|||++..........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.
T Consensus       144 ------------~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  211 (318)
T 1fot_A          144 ------------HIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT  211 (318)
T ss_dssp             ------------CEEECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred             ------------CEEEeecCcceecCCccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence                        67888888887766555667899999999999999999999999999999999999999999888888


Q ss_pred             HHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcH-HHHHHHHhcCCCCccccc
Q 015222          327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR-DSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       327 ~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R-~t~~~il~~~~~~~~~~~  386 (411)
                      ...+......+|.    ..+..+.++|.+||..|+.+||... ++++++++||||.++++.
T Consensus       212 ~~~i~~~~~~~p~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~  268 (318)
T 1fot_A          212 YEKILNAELRFPP----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  268 (318)
T ss_dssp             HHHHHHCCCCCCT----TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             HHHHHhCCCCCCC----CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence            8877776555554    4577899999999999944444322 299999999999988764

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.8e-51  Score=392.36  Aligned_cols=299  Identities=44%  Similarity=0.835  Sum_probs=253.3

Q ss_pred             CCCCCceEEeeCCccCCCeEEEeeeccccceEEEEEEeCCCC-cEEEEEEeccchhhhHHHHHHHHHHHHHhcCCC-CCc
Q 015222           76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKK-ELVAIKIVRSINKYREAAMIEIDVLQRLARHDI-GGT  153 (411)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~-~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i-~~~  153 (411)
                      ++.++.+....|+.+.++|++.+.||+|+||+||+|.+..++ +.||||+++......+.+.+|+.+++.+.|++. .+.
T Consensus         3 ~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~   82 (355)
T 2eu9_A            3 DDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKF   82 (355)
T ss_dssp             BCTTSCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCS
T ss_pred             cccCCCcccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCce
Confidence            456677888899999999999999999999999999998777 789999998776777888899999999998764 345


Q ss_pred             ceEEEeeeeecCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCccc
Q 015222          154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV  233 (411)
Q Consensus       154 ~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~  233 (411)
                      +++.+++++...++.|+||||++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++..+..
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~  162 (355)
T 2eu9_A           83 LCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFE  162 (355)
T ss_dssp             CBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEE
T ss_pred             eEEEeeeeeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccc
Confidence            57899999999999999999998899999887765679999999999999999999999999999999999999765533


Q ss_pred             ccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh
Q 015222          234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS  313 (411)
Q Consensus       234 ~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt  313 (411)
                      .+.+.....        ....+....+||+|||++...........||+.|+|||++.+..++.++|||||||++|||++
T Consensus       163 ~~~~~~~~~--------~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  234 (355)
T 2eu9_A          163 TLYNEHKSC--------EEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR  234 (355)
T ss_dssp             EEECCC-CC--------CEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred             ccccccccc--------cccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHh
Confidence            332211100        001124568999999999887766667789999999999999999999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChhHHHhh----------------------------------------hhhhhhhh
Q 015222          314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRA----------------------------------------DRRAEKYF  353 (411)
Q Consensus       314 g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~----------------------------------------~~~~~~li  353 (411)
                      |..||.+.+..+.+..+.+..+.+|..+....                                        +..+.++|
T Consensus       235 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  314 (355)
T 2eu9_A          235 GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLM  314 (355)
T ss_dssp             SSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHH
Confidence            99999999988888888888888887654321                                        34677999


Q ss_pred             ccCCccCCCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          354 RRGARLDWPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       354 ~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                      .+||..|    |++|||+.++++|+||.++...
T Consensus       315 ~~~L~~d----P~~Rpt~~e~l~hp~f~~~~~~  343 (355)
T 2eu9_A          315 RRMLEFD----PAQRITLAEALLHPFFAGLTPE  343 (355)
T ss_dssp             HHHTCSS----TTTSCCHHHHTTSGGGGGCCHH
T ss_pred             HHHhcCC----hhhCcCHHHHhcChhhcCCChh
Confidence            9999999    9999999999999999987654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.5e-51  Score=392.22  Aligned_cols=253  Identities=21%  Similarity=0.341  Sum_probs=219.6

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++++.||+|+||+||+|+++.+++.||||++++..    .....+.+|+.+++.++|++|     +++++++.+.+.
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~l~~~~~~~~~   79 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL-----TALKYAFQTHDR   79 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTB-----CCEEEEEECSSE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcC-----cceEEEEEeCCE
Confidence            57999999999999999999999999999999997532    344567889999998877766     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+||||+ |++|.+++.+..  .+++..++.++.||+.||+|||++||+||||||+|||++.+|               
T Consensus        80 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g---------------  142 (337)
T 1o6l_A           80 LCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG---------------  142 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS---------------
T ss_pred             EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCC---------------
Confidence            99999999 899999998765  699999999999999999999999999999999999998777               


Q ss_pred             CCCccccCCCCCCeeEeecCCccccc---CCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN  323 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~  323 (411)
                                  .+||+|||++....   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus       143 ------------~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~  210 (337)
T 1o6l_A          143 ------------HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH  210 (337)
T ss_dssp             ------------CEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ------------CEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH
Confidence                        56777777765422   123446899999999999999999999999999999999999999998888


Q ss_pred             HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH-----HHHHHHhcCCCCccccc
Q 015222          324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-----SMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~-----t~~~il~~~~~~~~~~~  386 (411)
                      .+....+......+|.    .++..+.++|.+||..|    |.+|+     +++++++|+||.++++.
T Consensus       211 ~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~d----P~~R~g~~~~~~~ei~~h~~f~~~~~~  270 (337)
T 1o6l_A          211 ERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKD----PKQRLGGGPSDAKEVMEHRFFLSINWQ  270 (337)
T ss_dssp             HHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSS----TTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             HHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhhcC----HHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence            7777777765555554    46788999999999999    66666     89999999999988754

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.6e-51  Score=389.64  Aligned_cols=264  Identities=28%  Similarity=0.419  Sum_probs=221.0

Q ss_pred             eeCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeee
Q 015222           85 AIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNW  161 (411)
Q Consensus        85 ~~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~  161 (411)
                      ..++.+.++|+++++||+|+||+||+|++. +++.||+|+++...   .....+.+|+.++++++|+||     ++++++
T Consensus        14 ~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~   87 (311)
T 3niz_A           14 LYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI-----VSLIDV   87 (311)
T ss_dssp             -CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTB-----CCEEEE
T ss_pred             eeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCE-----eeeeeE
Confidence            345678899999999999999999999985 48899999997433   234667899999999988777     999999


Q ss_pred             eecCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccc
Q 015222          162 FDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL  241 (411)
Q Consensus       162 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~  241 (411)
                      +.+++.+++||||+.++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++          
T Consensus        88 ~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~----------  156 (311)
T 3niz_A           88 IHSERCLTLVFEFMEKDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG----------  156 (311)
T ss_dssp             ECCSSCEEEEEECCSEEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC----------
T ss_pred             EccCCEEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCC----------
Confidence            99999999999999889999988754 4699999999999999999999999999999999999998766          


Q ss_pred             cccCCCCCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecC-CCCCccchhHHHHHHHHHHHhCCCC
Q 015222          242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEAL  317 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p  317 (411)
                                       .+||+|||++......   .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus       157 -----------------~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p  219 (311)
T 3niz_A          157 -----------------ALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPL  219 (311)
T ss_dssp             -----------------CEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             -----------------CEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCC
Confidence                             6788888877654322   233578999999999987 4689999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChhH--------------------------HHhhhhhhhhhhccCCccCCCCCCCcHHHH
Q 015222          318 FQTHENLEHLAMMERVLGPLPHHM--------------------------VIRADRRAEKYFRRGARLDWPDGATSRDSM  371 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~~~p~~~--------------------------~~~~~~~~~~li~~~l~~~~~~rp~~R~t~  371 (411)
                      |.+.+..+.+..+....+..+...                          ....+..+.++|.+||..|    |.+|||+
T Consensus       220 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d----P~~Rpt~  295 (311)
T 3niz_A          220 FPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFD----PNKRISA  295 (311)
T ss_dssp             CCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSC----TTTSCCH
T ss_pred             CCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCC----hhHCCCH
Confidence            998888787777777655433221                          1234567889999999999    9999999


Q ss_pred             HHHHhcCCCCccccc
Q 015222          372 RAVWKLLRLPVIDLY  386 (411)
Q Consensus       372 ~~il~~~~~~~~~~~  386 (411)
                      .++++||||++++.+
T Consensus       296 ~ell~hp~f~~~~~~  310 (311)
T 3niz_A          296 RDAMNHPYFKDLDPQ  310 (311)
T ss_dssp             HHHHTSGGGTTSCTT
T ss_pred             HHHhcCcccccCCcc
Confidence            999999999998753

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.7e-51  Score=388.99  Aligned_cols=264  Identities=25%  Similarity=0.411  Sum_probs=233.6

Q ss_pred             CccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchh-------hhHHHHHHHHHHHHHhcCCCCCcceEEEee
Q 015222           88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRLARHDIGGTRCVQIRN  160 (411)
Q Consensus        88 ~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~  160 (411)
                      +.+.++|++.+.||+|+||.||+|.++.+++.||+|+++....       ..+.+.+|+.+++.+.|+||     +++++
T Consensus         7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~   81 (326)
T 2y0a_A            7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV-----ITLHE   81 (326)
T ss_dssp             SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred             CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCC-----CcEEE
Confidence            3456789999999999999999999999999999999975321       35678899999999988777     99999


Q ss_pred             eeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcc
Q 015222          161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK  239 (411)
Q Consensus       161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~  239 (411)
                      ++.+.+..++||||+ +++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.       
T Consensus        82 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~-------  152 (326)
T 2y0a_A           82 VYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNV-------  152 (326)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSS-------
T ss_pred             EEEeCCEEEEEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCC-------
Confidence            999999999999999 899999997654  7999999999999999999999999999999999999976541       


Q ss_pred             cccccCCCCCccccCCCCCCeeEeecCCcccccC--CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCC
Q 015222          240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL  317 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p  317 (411)
                                      ....+||+|||++.....  ......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus       153 ----------------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  216 (326)
T 2y0a_A          153 ----------------PKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP  216 (326)
T ss_dssp             ----------------SSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred             ----------------CCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCC
Confidence                            223689999998876542  23446799999999999988999999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      |.+.+..+.+..+......++.......+..+.++|.+||..|    |.+|||+.++++||||.....
T Consensus       217 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d----P~~Rpt~~e~l~hp~~~~~~~  280 (326)
T 2y0a_A          217 FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD----PKKRMTIQDSLQHPWIKPKDT  280 (326)
T ss_dssp             SCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSS----GGGSCCHHHHHHSTTTSCCSH
T ss_pred             CCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCC----hhhCCCHHHHhcCCCccCCcc
Confidence            9998888888888887788888888889999999999999999    999999999999999997654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=7e-51  Score=384.43  Aligned_cols=263  Identities=29%  Similarity=0.487  Sum_probs=216.5

Q ss_pred             eCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch------hhhHHHHHHHHHHHHHh---cCCCCCcceE
Q 015222           86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------KYREAAMIEIDVLQRLA---RHDIGGTRCV  156 (411)
Q Consensus        86 ~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~---~~~i~~~~iv  156 (411)
                      +|+.+.++|++.++||+|+||+||+|++..+++.||||+++...      .......+|+.+++.+.   |+||     +
T Consensus         3 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni-----v   77 (308)
T 3g33_A            3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV-----V   77 (308)
T ss_dssp             -------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTB-----C
T ss_pred             CCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCe-----E
Confidence            45667889999999999999999999999999999999997422      22356778888888887   6665     9


Q ss_pred             EEeeeeecCC-----eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCc
Q 015222          157 QIRNWFDYRN-----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE  231 (411)
Q Consensus       157 ~~~~~~~~~~-----~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~  231 (411)
                      ++++++....     .+++||||++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus        78 ~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~  157 (308)
T 3g33_A           78 RLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG  157 (308)
T ss_dssp             CEEEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS
T ss_pred             EeeeeeeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC
Confidence            9999987644     68999999988999999987655699999999999999999999999999999999999997766


Q ss_pred             ccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHH
Q 015222          232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV  309 (411)
Q Consensus       232 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  309 (411)
                                                 .+||+|||++......  .....||+.|+|||++.+..++.++|||||||++|
T Consensus       158 ---------------------------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  210 (308)
T 3g33_A          158 ---------------------------TVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFA  210 (308)
T ss_dssp             ---------------------------CEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHH
T ss_pred             ---------------------------CEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHH
Confidence                                       6788888877654332  24468999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCChh-----------------------HHHhhhhhhhhhhccCCccCCCCCCC
Q 015222          310 ELCSGEALFQTHENLEHLAMMERVLGPLPHH-----------------------MVIRADRRAEKYFRRGARLDWPDGAT  366 (411)
Q Consensus       310 elltg~~pf~~~~~~~~~~~i~~~~~~~p~~-----------------------~~~~~~~~~~~li~~~l~~~~~~rp~  366 (411)
                      +|++|+.||.+.+..+.+..+....+..+..                       .....++.+.++|.+||+.|    |.
T Consensus       211 ~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d----P~  286 (308)
T 3g33_A          211 EMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFN----PH  286 (308)
T ss_dssp             HTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSS----TT
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCC----Cc
Confidence            9999999999999988888887766544332                       12345678899999999999    99


Q ss_pred             cHHHHHHHHhcCCCCccc
Q 015222          367 SRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       367 ~R~t~~~il~~~~~~~~~  384 (411)
                      +|||+.++++|+||.+..
T Consensus       287 ~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          287 KRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             TSCCHHHHHTSTTC----
T ss_pred             cCCCHHHHhcCccccCCC
Confidence            999999999999999754

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.6e-51  Score=404.01  Aligned_cols=263  Identities=22%  Similarity=0.327  Sum_probs=231.5

Q ss_pred             CCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee
Q 015222           87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        87 ~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~  163 (411)
                      +..+.++|++.+.||+|+||+||+|.++.+|+.||+|++....   ...+.+.+|+.+++.++|+||     +++++++.
T Consensus         6 ~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~l~~~~~   80 (444)
T 3soa_A            6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI-----VRLHDSIS   80 (444)
T ss_dssp             -CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTB-----CCEEEEEE
T ss_pred             cccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCC-----CeEEEEEE
Confidence            3456788999999999999999999999999999999997533   345667899999999988877     99999999


Q ss_pred             cCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccc
Q 015222          164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                      +.+..|+||||+ +++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++           
T Consensus        81 ~~~~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~-----------  147 (444)
T 3soa_A           81 EEGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKL-----------  147 (444)
T ss_dssp             CSSEEEEEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSS-----------
T ss_pred             ECCEEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccC-----------
Confidence            999999999999 999999998875  699999999999999999999999999999999999997532           


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ  319 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~  319 (411)
                                   .+..+||+|||++.......   ....||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus       148 -------------~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~  214 (444)
T 3soa_A          148 -------------KGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW  214 (444)
T ss_dssp             -------------TTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             -------------CCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence                         23478999999987654332   34679999999999999899999999999999999999999999


Q ss_pred             CCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      +.+..+....+......++...+..+++.+.++|.+||..|    |.+|||+.++++||||.+..
T Consensus       215 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d----P~~Rpta~e~L~hp~~~~~~  275 (444)
T 3soa_A          215 DEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTIN----PSKRITAAEALKHPWISHRS  275 (444)
T ss_dssp             CSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSS----TTTSCCHHHHHHSCTTHHHH
T ss_pred             CccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCC----hhHCCCHHHHhcCccccCCc
Confidence            99988888888888777777777788999999999999999    99999999999999998654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.1e-51  Score=396.83  Aligned_cols=267  Identities=22%  Similarity=0.328  Sum_probs=233.0

Q ss_pred             EEeeCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEe
Q 015222           83 VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIR  159 (411)
Q Consensus        83 ~~~~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~  159 (411)
                      ....+..+.++|++.+.||+|+||.||+|.++.+++.||+|++....   ...+.+.+|+.+++.++|+||     ++++
T Consensus        20 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~~~   94 (362)
T 2bdw_A           20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI-----VRLH   94 (362)
T ss_dssp             ----CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTB-----CCEE
T ss_pred             eecCCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCC-----CeEE
Confidence            34445667789999999999999999999999999999999997532   344667899999999988877     9999


Q ss_pred             eeeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCc
Q 015222          160 NWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY  238 (411)
Q Consensus       160 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df  238 (411)
                      +++.+.+..|+||||+ +++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++       
T Consensus        95 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~-------  165 (362)
T 2bdw_A           95 DSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA-------  165 (362)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSS-------
T ss_pred             EEEEeCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC-------
Confidence            9999999999999999 899999998765  699999999999999999999999999999999999997654       


Q ss_pred             ccccccCCCCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCC
Q 015222          239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA  316 (411)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~  316 (411)
                                       ....+||+|||++.......  ....||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       166 -----------------~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  228 (362)
T 2bdw_A          166 -----------------KGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP  228 (362)
T ss_dssp             -----------------TTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             -----------------CCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCC
Confidence                             23468999999987654332  34689999999999999899999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      ||.+.+..+....+......++...+..++..+.++|.+||..|    |.+||++.++++|+||.+..
T Consensus       229 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~d----P~~R~t~~e~l~hp~~~~~~  292 (362)
T 2bdw_A          229 PFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVN----PKKRITADQALKVPWICNRE  292 (362)
T ss_dssp             SSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSS----GGGSCCHHHHTTSHHHHTHH
T ss_pred             CCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCC----hhhCcCHHHHhcCcccCCCc
Confidence            99998888888888887777777777788999999999999999    99999999999999998643

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4.5e-51  Score=392.59  Aligned_cols=253  Identities=23%  Similarity=0.364  Sum_probs=224.5

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++++.||+|+||.||+|+++.+|+.||||++++..    ...+.+.+|+.+++.+.|++|     +++++++.+.+.
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~~  115 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL-----VKLEFSFKDNSN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTB-----CCEEEEEECSSE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEEcCCE
Confidence            68999999999999999999999999999999997532    334667889999998877766     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+||||+ +++|.+++.+..  .+++..++.++.||+.||+|||++||+||||||+|||++.+|               
T Consensus       116 ~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g---------------  178 (350)
T 1rdq_E          116 LYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG---------------  178 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS---------------
T ss_pred             EEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCC---------------
Confidence            99999999 999999998765  699999999999999999999999999999999999998766               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH  326 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~  326 (411)
                                  .+||+|||++..........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.
T Consensus       179 ------------~~kL~DFg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~  246 (350)
T 1rdq_E          179 ------------YIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI  246 (350)
T ss_dssp             ------------CEEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             ------------CEEEcccccceeccCCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH
Confidence                        67888888887766555667899999999999999999999999999999999999999999888888


Q ss_pred             HHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHH-----HHHHHhcCCCCccccc
Q 015222          327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS-----MRAVWKLLRLPVIDLY  386 (411)
Q Consensus       327 ~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t-----~~~il~~~~~~~~~~~  386 (411)
                      ...+......+|.    .++..+.++|.+||..|    |.+|++     ++++++|+||.++++.
T Consensus       247 ~~~i~~~~~~~p~----~~~~~~~~li~~lL~~d----p~~R~~~~~~~~~ei~~h~~f~~~~w~  303 (350)
T 1rdq_E          247 YEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD----LTKRFGNLKNGVNDIKNHKWFATTDWI  303 (350)
T ss_dssp             HHHHHHCCCCCCT----TCCHHHHHHHHHHSCSC----TTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred             HHHHHcCCCCCCC----CCCHHHHHHHHHHhhcC----HHhccCCccCCHHHHHhCcCcCCCCHH
Confidence            8888776666654    45778999999999999    666666     9999999999998764

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1e-50  Score=404.36  Aligned_cols=267  Identities=26%  Similarity=0.431  Sum_probs=220.7

Q ss_pred             CCCceEEeeCC---ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCC
Q 015222           78 KDGHYVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIG  151 (411)
Q Consensus        78 ~~~~~~~~~~~---~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~  151 (411)
                      ....+.+.+++   .+.++|++++.||+|+||+||+|++..+++.||||++...   ....+.+.+|+.+++.++|+|| 
T Consensus        45 ~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-  123 (464)
T 3ttj_A           45 DNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI-  123 (464)
T ss_dssp             -CCEEEEEC--CEEEEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTB-
T ss_pred             cccceeeecCCcceeecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCC-
Confidence            34566776666   4568999999999999999999999999999999999753   3445677899999999988877 


Q ss_pred             CcceEEEeeeeecC------CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 015222          152 GTRCVQIRNWFDYR------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI  225 (411)
Q Consensus       152 ~~~iv~~~~~~~~~------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NI  225 (411)
                          +++++++...      ..+|+||||++++|.+.+..    .+++..++.++.||+.||+|||++||+||||||+||
T Consensus       124 ----v~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NI  195 (464)
T 3ttj_A          124 ----ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI  195 (464)
T ss_dssp             ----CCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             ----CcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhE
Confidence                9999988643      47899999997788888754    489999999999999999999999999999999999


Q ss_pred             EEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHH
Q 015222          226 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWS  303 (411)
Q Consensus       226 li~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  303 (411)
                      |++.++                           .+||+|||++......  ....+||+.|+|||++.+..++.++||||
T Consensus       196 ll~~~~---------------------------~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  248 (464)
T 3ttj_A          196 VVKSDC---------------------------TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWS  248 (464)
T ss_dssp             EECTTS---------------------------CEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHH
T ss_pred             EEeCCC---------------------------CEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHH
Confidence            998766                           6788888887765433  24468999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHh--------------------------------------h
Q 015222          304 VGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIR--------------------------------------A  345 (411)
Q Consensus       304 lGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~--------------------------------------~  345 (411)
                      |||++|||++|+.||.+.+..+.+..+.+..+..+......                                      .
T Consensus       249 lG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (464)
T 3ttj_A          249 VGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK  328 (464)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCccccccccccccccc
Confidence            99999999999999999999999988888777655443321                                      1


Q ss_pred             hhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          346 DRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       346 ~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      +..+.+||.+||..|    |.+|+|+.|+++||||....
T Consensus       329 s~~~~dLl~~mL~~d----P~~R~ta~e~L~Hp~~~~~~  363 (464)
T 3ttj_A          329 ASQARDLLSKMLVID----PAKRISVDDALQHPYINVWY  363 (464)
T ss_dssp             HHHHHHHHHHHSCSS----TTTSCCHHHHHTSTTTGGGC
T ss_pred             CHHHHHHHHHHcCCC----hhhCCCHHHHhcChhhhhcc
Confidence            556899999999999    99999999999999998643

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-51  Score=394.10  Aligned_cols=264  Identities=27%  Similarity=0.465  Sum_probs=220.6

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC-
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR-  165 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~-  165 (411)
                      +.++|++++.||+|+||.||+|.+..+|+.||||++...   ....+.+.+|+.+++.++|+||     +++++++... 
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~l~~~~~~~~   97 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV-----IGLLDVFTPDE   97 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTB-----CCCSEEECSCS
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCC-----CCceeeEecCC
Confidence            457899999999999999999999999999999999542   2345667899999999998877     9999988765 


Q ss_pred             -----CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          166 -----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       166 -----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                           ..+|+||||++++|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++.++         
T Consensus        98 ~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~---------  165 (367)
T 1cm8_A           98 TLDDFTDFYLVMPFMGTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC---------  165 (367)
T ss_dssp             STTTCCCCEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC---------
T ss_pred             ccccCceEEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC---------
Confidence                 356999999999999999874   599999999999999999999999999999999999997766         


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecC-CCCCccchhHHHHHHHHHHHhCCCCCC
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQ  319 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~pf~  319 (411)
                                        .+||+|||++..........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus       166 ------------------~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~  227 (367)
T 1cm8_A          166 ------------------ELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK  227 (367)
T ss_dssp             ------------------CEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ------------------CEEEEeeecccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCC
Confidence                              6788888888876666666789999999999987 589999999999999999999999999


Q ss_pred             CCChHHHHHHHHHHhCCCChhHHH---------------------------hhhhhhhhhhccCCccCCCCCCCcHHHHH
Q 015222          320 THENLEHLAMMERVLGPLPHHMVI---------------------------RADRRAEKYFRRGARLDWPDGATSRDSMR  372 (411)
Q Consensus       320 ~~~~~~~~~~i~~~~~~~p~~~~~---------------------------~~~~~~~~li~~~l~~~~~~rp~~R~t~~  372 (411)
                      +.+..+.+..+.+..+..+..+..                           ..+..+.++|.+||..|    |.+|+|+.
T Consensus       228 ~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~d----P~~R~t~~  303 (367)
T 1cm8_A          228 GSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLD----AEQRVTAG  303 (367)
T ss_dssp             CSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSS----TTTSCCHH
T ss_pred             CCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCC----hhHCCCHH
Confidence            999999999888888877665432                           33667899999999999    99999999


Q ss_pred             HHHhcCCCCcccccCCCCCc
Q 015222          373 AVWKLLRLPVIDLYSASPNC  392 (411)
Q Consensus       373 ~il~~~~~~~~~~~~~~~~~  392 (411)
                      ++++||||.+.......|.+
T Consensus       304 e~l~hp~f~~~~~~~~~~~~  323 (367)
T 1cm8_A          304 EALAHPYFESLHDTEDEPQV  323 (367)
T ss_dssp             HHHHSGGGTTTC------CC
T ss_pred             HHhcChHHHhhcCCccCCCC
Confidence            99999999988766554443

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.5e-51  Score=397.73  Aligned_cols=292  Identities=25%  Similarity=0.406  Sum_probs=216.5

Q ss_pred             eCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHh-cCCCCCcceEEEeee
Q 015222           86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNW  161 (411)
Q Consensus        86 ~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~  161 (411)
                      ++..+.++|++++.||+|+||.||+|.+..+++.||||++...   ........+|+.+++.+. |+||     ++++++
T Consensus         3 v~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~ni-----v~l~~~   77 (388)
T 3oz6_A            3 VDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENI-----VNLLNV   77 (388)
T ss_dssp             -CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTB-----CCEEEE
T ss_pred             ccCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCC-----CeeeeE
Confidence            3455678999999999999999999999999999999998642   344566778999999997 7766     999999


Q ss_pred             eecC--CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcc
Q 015222          162 FDYR--NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK  239 (411)
Q Consensus       162 ~~~~--~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~  239 (411)
                      +...  ..+|+||||++++|.+++...   .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        78 ~~~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG  154 (388)
T 3oz6_A           78 LRADNDRDVYLVFDYMETDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFG  154 (388)
T ss_dssp             EECTTSSCEEEEEECCSEEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EecCCCCEEEEEecccCcCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCc
Confidence            8754  479999999988999999875   59999999999999999999999999999999999999988866666666


Q ss_pred             cccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecC-CCCCccchhHHHHHHHHHHHhCCCCC
Q 015222          240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALF  318 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~pf  318 (411)
                      ++..................-....+.   .........+||+.|+|||++.+ ..++.++|||||||++|||++|++||
T Consensus       155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf  231 (388)
T 3oz6_A          155 LSRSFVNIRRVTNNIPLSINENTENFD---DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF  231 (388)
T ss_dssp             TCEESSSCCCCCCCGGGCCC------------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccccccccccccccccccccccccccc---cccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence            554332211100000000000000000   00111233589999999999987 57999999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCChhHHH-------------------------------------------hhhhhhhhhhcc
Q 015222          319 QTHENLEHLAMMERVLGPLPHHMVI-------------------------------------------RADRRAEKYFRR  355 (411)
Q Consensus       319 ~~~~~~~~~~~i~~~~~~~p~~~~~-------------------------------------------~~~~~~~~li~~  355 (411)
                      .+.+..+.+..+....+..+.....                                           ..++.+.++|.+
T Consensus       232 ~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~  311 (388)
T 3oz6_A          232 PGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDK  311 (388)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHH
Confidence            9999988888888766655443221                                           346788999999


Q ss_pred             CCccCCCCCCCcHHHHHHHHhcCCCCcccccCCCCCc
Q 015222          356 GARLDWPDGATSRDSMRAVWKLLRLPVIDLYSASPNC  392 (411)
Q Consensus       356 ~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~~~~~  392 (411)
                      ||..|    |.+|+|+.++++||||.........|.+
T Consensus       312 ~L~~d----P~~R~t~~e~l~Hp~~~~~~~~~~~~~~  344 (388)
T 3oz6_A          312 LLQFN----PNKRISANDALKHPFVSIFHNPNEEPNC  344 (388)
T ss_dssp             HCCSS----GGGSCCHHHHTTSTTTTTTCCGGGCCCC
T ss_pred             hhccC----cccCCCHHHHhCCHHHHHhcCCccCCCC
Confidence            99999    9999999999999999877655554443

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.2e-51  Score=391.82  Aligned_cols=254  Identities=22%  Similarity=0.332  Sum_probs=221.4

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeecC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .++|++.+.||+|+||.||+|+++.+++.||||++++..    ...+....|..++..+ .|++|     +++++++.+.
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~i-----v~l~~~~~~~   90 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL-----THMFCTFQTK   90 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTB-----CCEEEEEECS
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCC-----CcEEEEEEeC
Confidence            468999999999999999999999999999999997542    3445677899999887 67666     9999999999


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      +.+|+||||+ |++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+|             
T Consensus        91 ~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-------------  155 (345)
T 1xjd_A           91 ENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-------------  155 (345)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-------------
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC-------------
Confidence            9999999999 999999998765  699999999999999999999999999999999999998777             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCccccc---CCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                                    .+||+|||++....   ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus       156 --------------~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  221 (345)
T 1xjd_A          156 --------------HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ  221 (345)
T ss_dssp             --------------CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             --------------CEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC
Confidence                          56777777765432   2234568999999999999999999999999999999999999999998


Q ss_pred             ChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHH-HHHhcCCCCccccc
Q 015222          322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMR-AVWKLLRLPVIDLY  386 (411)
Q Consensus       322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~-~il~~~~~~~~~~~  386 (411)
                      +..+....+......+|.    .++..+.++|.+||..+    |++|+++. ++++||||.+++|.
T Consensus       222 ~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~d----p~~R~~~~~~i~~hp~f~~~~w~  279 (345)
T 1xjd_A          222 DEEELFHSIRMDNPFYPR----WLEKEAKDLLVKLFVRE----PEKRLGVRGDIRQHPLFREINWE  279 (345)
T ss_dssp             SHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHSCSS----GGGSBTTBSCGGGSGGGTTCCHH
T ss_pred             CHHHHHHHHHhCCCCCCc----ccCHHHHHHHHHHhcCC----HhHcCCChHHHHcCccccCCCHH
Confidence            888888877776555554    36788999999999999    88888887 99999999998764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.9e-51  Score=402.56  Aligned_cols=256  Identities=21%  Similarity=0.337  Sum_probs=219.5

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      .++|++++.||+|+||+||+|+++.+++.||+|++++..    ...+.+.+|+.+++.++|++|     +++++++.+.+
T Consensus        68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~I-----v~l~~~~~~~~  142 (410)
T 3v8s_A           68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV-----VQLFYAFQDDR  142 (410)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTB-----CCEEEEEECSS
T ss_pred             ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEEECC
Confidence            468999999999999999999999999999999997532    233457789999999988777     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      .+|+||||+ ||+|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++.+|              
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g--------------  205 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--------------  205 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--------------
T ss_pred             EEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCC--------------
Confidence            999999999 99999999875   499999999999999999999999999999999999998777              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCC----CcccccCCCccccceecCCC----CCccchhHHHHHHHHHHHhCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVELCSGEAL  317 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlGvil~elltg~~p  317 (411)
                                   .+||+|||++......    ....+||+.|+|||++.+..    ++.++|||||||++|||++|+.|
T Consensus       206 -------------~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~P  272 (410)
T 3v8s_A          206 -------------HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP  272 (410)
T ss_dssp             -------------CEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCT
T ss_pred             -------------CEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCC
Confidence                         5677777777654332    23468999999999998765    88999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHh--CCCChhHHHhhhhhhhhhhccCCccCCCCCCCc--HHHHHHHHhcCCCCcccccC
Q 015222          318 FQTHENLEHLAMMERVL--GPLPHHMVIRADRRAEKYFRRGARLDWPDGATS--RDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~--R~t~~~il~~~~~~~~~~~~  387 (411)
                      |.+.+..+....+....  ..+|.  ...++..++++|.+||..+    |.+  |++++++++|+||++++|..
T Consensus       273 f~~~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~~li~~lL~~~----~~rlgR~~~~ei~~Hp~f~~~~w~~  340 (410)
T 3v8s_A          273 FYADSLVGTYSKIMNHKNSLTFPD--DNDISKEAKNLICAFLTDR----EVRLGRNGVEEIKRHLFFKNDQWAW  340 (410)
T ss_dssp             TCCSSHHHHHHHHHTHHHHCCCCT--TCCCCHHHHHHHHHHSSCG----GGCTTSSCHHHHHTSGGGCCSSCCS
T ss_pred             CCCCChhhHHHHHHhccccccCCC--cccccHHHHHHHHHHccCh----hhhCCCCCHHHHhcCccccCCCHHH
Confidence            99988888888776543  33443  2356788999999999866    666  99999999999999988653

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=9.5e-51  Score=404.59  Aligned_cols=293  Identities=25%  Similarity=0.384  Sum_probs=212.6

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec-
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-  164 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~-  164 (411)
                      .+.++|++++.||+|+||+||+|+++.+++.||||++...   ....+.+.+|+.+|+.++|+||     +++++++.. 
T Consensus        50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~l~~~~~~~  124 (458)
T 3rp9_A           50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV-----VKVLDIVIPK  124 (458)
T ss_dssp             CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTB-----CCEEEECCCS
T ss_pred             ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCC-----CceEEEEecC
Confidence            3567999999999999999999999999999999998643   2345678899999999988877     999998843 


Q ss_pred             ----CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          165 ----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       165 ----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                          .+.+|+||||++++|.+++....  .+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+
T Consensus       125 ~~~~~~~~~lv~e~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGl  202 (458)
T 3rp9_A          125 DVEKFDELYVVLEIADSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGL  202 (458)
T ss_dssp             CTTTCCCEEEEECCCSEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CcccCceEEEEEeccccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeeccccc
Confidence                36799999999999999998764  799999999999999999999999999999999999999999999999988


Q ss_pred             ccccCCCCCccccC---CCCCCeeEeecCCcccccCCCcccccCCCccccceec-CCCCCccchhHHHHHHHHHHHh---
Q 015222          241 LSRSSKDGSYFKNL---PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCS---  313 (411)
Q Consensus       241 ~~~~~~~~~~~~~~---~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~ellt---  313 (411)
                      +.............   .......+.+|+.+..........+||+.|+|||++. +..++.++|||||||++|||++   
T Consensus       203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~  282 (458)
T 3rp9_A          203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK  282 (458)
T ss_dssp             CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred             chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence            77654332211100   1112234455554444444445578999999999874 5579999999999999999998   


Q ss_pred             --------CCCCCCCCC--------------------hHHHHHHHHHHhCCCChhHH-----------------------
Q 015222          314 --------GEALFQTHE--------------------NLEHLAMMERVLGPLPHHMV-----------------------  342 (411)
Q Consensus       314 --------g~~pf~~~~--------------------~~~~~~~i~~~~~~~p~~~~-----------------------  342 (411)
                              |+++|.+.+                    ..+.+..+....+..+....                       
T Consensus       283 ~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (458)
T 3rp9_A          283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDL  362 (458)
T ss_dssp             TTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCG
T ss_pred             ccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCH
Confidence                    778887654                    24566666666666654432                       


Q ss_pred             ----HhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccCCCCCc
Q 015222          343 ----IRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSASPNC  392 (411)
Q Consensus       343 ----~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~~~~~  392 (411)
                          +..+..+.+||.+||..|    |.+|+|++|+++||||.++.+....+.+
T Consensus       363 ~~~~~~~s~~~~dLl~~mL~~d----P~~R~t~~e~L~Hp~f~~~~~~~~e~~~  412 (458)
T 3rp9_A          363 AERFPASSADAIHLLKRMLVFN----PNKRITINECLAHPFFKEVRIAEVETNA  412 (458)
T ss_dssp             GGGSTTSCHHHHHHHHHHSCSS----TTTSCCHHHHHHSGGGTTTCCGGGCCCC
T ss_pred             HHHCCCCCHHHHHHHHHHhccC----ccccCCHHHHhcCHhhhhcCCCccCCCC
Confidence                234678899999999999    9999999999999999999877665543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.3e-50  Score=389.64  Aligned_cols=255  Identities=22%  Similarity=0.293  Sum_probs=219.1

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeecC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .++|++++.||+|+||.||+|+++.+++.||||++++..    ...+.+..|..++..+ .|+     +++++++++.+.
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp-----~iv~l~~~~~~~   93 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP-----FLTQLHSCFQTM   93 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCT-----TBCCEEEEEECS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCC-----EEeeEEEEEEcC
Confidence            368999999999999999999999999999999997532    3345667888888776 344     459999999999


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      +.+|+||||+ |++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+|             
T Consensus        94 ~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-------------  158 (353)
T 2i0e_A           94 DRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-------------  158 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-------------
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC-------------
Confidence            9999999999 899999998765  699999999999999999999999999999999999998777             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCccccc---CCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                                    .+||+|||++....   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus       159 --------------~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~  224 (353)
T 2i0e_A          159 --------------HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE  224 (353)
T ss_dssp             --------------CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             --------------cEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC
Confidence                          56777777765422   2234468999999999999999999999999999999999999999998


Q ss_pred             ChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH-----HHHHHHhcCCCCcccccC
Q 015222          322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-----SMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~-----t~~~il~~~~~~~~~~~~  387 (411)
                      +..+....+......+|.    .++..+.++|.+||..+    |.+|+     +++++++|+||.+++|..
T Consensus       225 ~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~d----P~~R~~~~~~~~~~i~~h~~f~~~~w~~  287 (353)
T 2i0e_A          225 DEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKH----PGKRLGCGPEGERDIKEHAFFRYIDWEK  287 (353)
T ss_dssp             SHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSC----TTSCTTCSTTHHHHHHTSGGGTTCCHHH
T ss_pred             CHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHHhhcC----HHHcCCCCCCCHHHHhcCccccCCCHHH
Confidence            888888888776666664    46788999999999999    55665     789999999999887643

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.7e-50  Score=392.38  Aligned_cols=257  Identities=19%  Similarity=0.309  Sum_probs=213.5

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeecCC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      ++|++++.||+|+||+||+|+++.+++.||||++++..    ...+.+.+|..++.++ +|++|     +++++++.+.+
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~I-----v~l~~~~~~~~  126 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL-----VGLHSCFQTES  126 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTB-----CCEEEEEECSS
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCc-----CeeEEEEEECC
Confidence            68999999999999999999999999999999997542    2334577899999887 56666     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      .+|+||||+ +++|.+++.+..  .+++..++.++.||+.||+|||++||+||||||+|||++.+|              
T Consensus       127 ~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g--------------  190 (396)
T 4dc2_A          127 RLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG--------------  190 (396)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--------------
T ss_pred             EEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCC--------------
Confidence            999999999 999999998765  799999999999999999999999999999999999998777              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccc---cCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE  322 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~  322 (411)
                                   .+||+|||++...   .......+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       191 -------------~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~  257 (396)
T 4dc2_A          191 -------------HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG  257 (396)
T ss_dssp             -------------CEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTT
T ss_pred             -------------CEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence                         5677777777642   122345689999999999999999999999999999999999999996432


Q ss_pred             ---------hHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcH--HHHHHHHhcCCCCccccc
Q 015222          323 ---------NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR--DSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       323 ---------~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R--~t~~~il~~~~~~~~~~~  386 (411)
                               .......+......+|.    .++..+.++|.+||..||.+||...  ..+.++++||||.+++|.
T Consensus       258 ~~~~~~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~  328 (396)
T 4dc2_A          258 SSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  328 (396)
T ss_dssp             C------CCHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHH
T ss_pred             cccccchhhHHHHHHHHhccccCCCC----cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHH
Confidence                     22234444444445554    4677899999999999955555432  347999999999998764

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.2e-50  Score=381.17  Aligned_cols=256  Identities=24%  Similarity=0.374  Sum_probs=219.9

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++.... ...+.+.+|+.+++.+.|+||     +++++++..++..
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~~~   92 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI-----VNYLDSYLVGDEL   92 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTB-----CCEEEEEEETTEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCC-----CeEeEEEEECCEE
Confidence            3468999999999999999999999999999999986433 345667899999999988877     9999999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      |+||||+ +++|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++.++                
T Consensus        93 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~----------------  153 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG----------------  153 (297)
T ss_dssp             EEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC----------------
T ss_pred             EEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCC----------------
Confidence            9999999 99999999876   499999999999999999999999999999999999998766                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                                 .+||+|||++......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..
T Consensus       154 -----------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  222 (297)
T 3fxz_A          154 -----------SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL  222 (297)
T ss_dssp             -----------CEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred             -----------CEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence                       5777888877654322   23457999999999999999999999999999999999999999988877


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      .....+...... .......++..+.++|.+||..|    |.+|||+.++++|+||+....
T Consensus       223 ~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~d----p~~Rps~~ell~h~~~~~~~~  278 (297)
T 3fxz_A          223 RALYLIATNGTP-ELQNPEKLSAIFRDFLNRCLEMD----VEKRGSAKELLQHQFLKIAKP  278 (297)
T ss_dssp             HHHHHHHHHCSC-CCSCGGGSCHHHHHHHHHHSCSS----TTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHHHHHhCCCC-CCCCccccCHHHHHHHHHHccCC----hhHCcCHHHHhhChhhcccCc
Confidence            766665544322 22223467788999999999999    999999999999999997654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=9.6e-51  Score=397.37  Aligned_cols=262  Identities=23%  Similarity=0.363  Sum_probs=209.0

Q ss_pred             CCCeEEE-eeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeec----
Q 015222           91 TPRYRIL-SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY----  164 (411)
Q Consensus        91 ~~~y~i~-~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~----  164 (411)
                      .++|.+. +.||+|+||+||+|.++.+++.||||+++..    ..+.+|+.++.++ .|+||     +++++++..    
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~i-----v~l~~~~~~~~~~  130 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHI-----VRIVDVYENLYAG  130 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTB-----CCEEEEEEEEETT
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCc-----ceEeEEEeecccC
Confidence            3567776 7899999999999999999999999999643    3466788887655 45555     999988765    


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                      .+++|+||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++            
T Consensus       131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~------------  198 (400)
T 1nxk_A          131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR------------  198 (400)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS------------
T ss_pred             CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCC------------
Confidence            67899999999 88999999876555799999999999999999999999999999999999997632            


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                                  .+..+||+|||++......  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus       199 ------------~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  266 (400)
T 1nxk_A          199 ------------PNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN  266 (400)
T ss_dssp             ------------TTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             ------------CCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence                        2347899999988765432  24468899999999999999999999999999999999999999865


Q ss_pred             ChHH----HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccCCC
Q 015222          322 ENLE----HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSAS  389 (411)
Q Consensus       322 ~~~~----~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~~  389 (411)
                      +...    ....+......++...+..++..+.++|.+||..|    |.+|||+.++++|+||.+.......
T Consensus       267 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d----P~~Rpt~~eil~hp~~~~~~~~~~~  334 (400)
T 1nxk_A          267 HGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTE----PTQRMTITEFMNHPWIMQSTKVPQT  334 (400)
T ss_dssp             TTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSS----GGGSCCHHHHHHSHHHHTTTTSCCC
T ss_pred             ccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCC----hhHCcCHHHHhcCccccCCCCCCCC
Confidence            4322    34445555555555555678889999999999999    9999999999999999875543333

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.3e-50  Score=389.87  Aligned_cols=263  Identities=25%  Similarity=0.328  Sum_probs=226.1

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch------hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeee
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF  162 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~  162 (411)
                      .+.++|++.+.||+|+||+||+|+++.+++.||||++....      ...+.+.+|+.+++.++|+||     +++++++
T Consensus        21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~~~~   95 (351)
T 3c0i_A           21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI-----VELLETY   95 (351)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTB-----CCEEEEE
T ss_pred             ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCC-----CcEEEEE
Confidence            34578999999999999999999999999999999996432      135678899999999988877     9999999


Q ss_pred             ecCCeEEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcc
Q 015222          163 DYRNHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK  239 (411)
Q Consensus       163 ~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~  239 (411)
                      .+.+.+|+||||+ +++|.+++...  ....+++..++.++.||+.||+|||++||+||||||+|||++.++        
T Consensus        96 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~--------  167 (351)
T 3c0i_A           96 SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKE--------  167 (351)
T ss_dssp             EETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSS--------
T ss_pred             EeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCC--------
Confidence            9999999999999 89999888643  223589999999999999999999999999999999999997654        


Q ss_pred             cccccCCCCCccccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCC
Q 015222          240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA  316 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~  316 (411)
                                      ....+||+|||++.......   ....||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       168 ----------------~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  231 (351)
T 3c0i_A          168 ----------------NSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCL  231 (351)
T ss_dssp             ----------------TTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ----------------CCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCC
Confidence                            23358999999887654332   34579999999999999999999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      ||.+. ..+....+.......+...+..++..+.++|.+||..|    |.+||++.++++|+||.+...
T Consensus       232 pf~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d----P~~R~s~~e~l~hp~~~~~~~  295 (351)
T 3c0i_A          232 PFYGT-KERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLD----PAERITVYEALNHPWLKERDR  295 (351)
T ss_dssp             SSCSS-HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSS----TTTSCCHHHHHTSHHHHTHHH
T ss_pred             CCCCc-HHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCC----hhHCcCHHHHhcChhhcCCcc
Confidence            99874 44556666666666777777788999999999999999    999999999999999987654

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.8e-50  Score=378.72  Aligned_cols=256  Identities=26%  Similarity=0.428  Sum_probs=215.6

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      ++|+++++||+|+||+||+|+++.+++.||||+++...   .....+.+|+.++++++|+||     +++++++.+++.+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI-----VRLHDVLHSDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEETTEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCE-----eeEEeEEEeCCEE
Confidence            58999999999999999999999999999999997432   334667889999999988776     9999999999999


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      ++||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++                 
T Consensus        77 ~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~-----------------  138 (292)
T 3o0g_A           77 TLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-----------------  138 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-----------------
T ss_pred             EEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-----------------
Confidence            9999999778888877643 4699999999999999999999999999999999999998766                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCC-CCccchhHHHHHHHHHHHhCCCC-CCCCCh
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEAL-FQTHEN  323 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p-f~~~~~  323 (411)
                                .+||+|||++......   .....||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+.
T Consensus       139 ----------~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~  208 (292)
T 3o0g_A          139 ----------ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV  208 (292)
T ss_dssp             ----------CEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH
T ss_pred             ----------CEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH
Confidence                      5777888877654322   23457899999999998775 89999999999999999987766 667777


Q ss_pred             HHHHHHHHHHhCCCChhHH-------------------------HhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          324 LEHLAMMERVLGPLPHHMV-------------------------IRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~~~-------------------------~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      .+.+..+.+..+..+...+                         ...+..+.++|.+||+.|    |.+|||++|+++||
T Consensus       209 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d----P~~R~t~~e~l~hp  284 (292)
T 3o0g_A          209 DDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCN----PVQRISAEEALQHP  284 (292)
T ss_dssp             HHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSS----GGGSCCHHHHHTSG
T ss_pred             HHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccC----hhhCCCHHHHhcCc
Confidence            7777777776654433221                         235677889999999999    99999999999999


Q ss_pred             CCCccc
Q 015222          379 RLPVID  384 (411)
Q Consensus       379 ~~~~~~  384 (411)
                      ||.++.
T Consensus       285 ~f~~~~  290 (292)
T 3o0g_A          285 YFSDFC  290 (292)
T ss_dssp             GGTTC-
T ss_pred             ccccCC
Confidence            999864

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-50  Score=395.35  Aligned_cols=262  Identities=24%  Similarity=0.312  Sum_probs=218.6

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      .++|++++.||+|+||+||+|+++.+++.||||++++..    ...+.+.+|..++..+.|++|     +++++++.+.+
T Consensus        60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~I-----v~l~~~~~~~~  134 (412)
T 2vd5_A           60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI-----TQLHFAFQDEN  134 (412)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTB-----CCEEEEEECSS
T ss_pred             hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCe-----eeEEEEEeeCC
Confidence            468999999999999999999999999999999997532    233457889999999887776     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      .+|+||||+ |++|.+++.+.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+|              
T Consensus       135 ~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g--------------  199 (412)
T 2vd5_A          135 YLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG--------------  199 (412)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--------------
T ss_pred             EEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCC--------------
Confidence            999999999 999999998753 3699999999999999999999999999999999999998777              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceec-------CCCCCccchhHHHHHHHHHHHhC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVIL-------GLGWNYPCDLWSVGCILVELCSG  314 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlGvil~elltg  314 (411)
                                   .+||+|||++.......    ...+||+.|+|||++.       +..++.++|||||||++|||++|
T Consensus       200 -------------~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG  266 (412)
T 2vd5_A          200 -------------HIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG  266 (412)
T ss_dssp             -------------CEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHS
T ss_pred             -------------CEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhC
Confidence                         56777777765543221    2358999999999997       35789999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHh--CCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccCC
Q 015222          315 EALFQTHENLEHLAMMERVL--GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSA  388 (411)
Q Consensus       315 ~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~  388 (411)
                      +.||.+.+..+....+....  ..+|. ....++..++++|.+||. ++.+|+. |++++++++|+||.+++|...
T Consensus       267 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~~s~~~~dli~~lL~-~p~~Rlg-r~~~~ei~~Hpff~~i~w~~l  339 (412)
T 2vd5_A          267 QTPFYADSTAETYGKIVHYKEHLSLPL-VDEGVPEEARDFIQRLLC-PPETRLG-RGGAGDFRTHPFFFGLDWDGL  339 (412)
T ss_dssp             SCTTCCSSHHHHHHHHHTHHHHCCCC-----CCCHHHHHHHHTTSS-CGGGCTT-TTTHHHHHTSGGGTTCCSTTS
T ss_pred             CCCCCCCCHHHHHHHHHhcccCcCCCc-cccCCCHHHHHHHHHHcC-ChhhcCC-CCCHHHHhcCCCcCCCCHHHH
Confidence            99999988888777776432  33332 234678899999999998 8444433 479999999999999987654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=9.8e-50  Score=382.62  Aligned_cols=257  Identities=19%  Similarity=0.311  Sum_probs=212.9

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeecCC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      ++|++++.||+|+||.||+|+++.+++.||||++++..    ...+.+.+|..+++++ +|++|     +++++++.+.+
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~i-----v~l~~~~~~~~   83 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL-----VGLHSCFQTES   83 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTB-----CCEEEEEECSS
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCcc-----CeEEEEEEeCC
Confidence            57999999999999999999999999999999997532    3345677899999887 66666     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      .+|+||||+ +++|.+++.+..  .+++..++.++.||+.||+|||++||+||||||+|||++.+|              
T Consensus        84 ~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--------------  147 (345)
T 3a8x_A           84 RLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG--------------  147 (345)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--------------
T ss_pred             EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC--------------
Confidence            999999999 899999998765  699999999999999999999999999999999999998777              


Q ss_pred             CCCCccccCCCCCCeeEeecCCccccc---CCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCC-
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH-  321 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~-  321 (411)
                                   .+||+|||++....   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||... 
T Consensus       148 -------------~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  214 (345)
T 3a8x_A          148 -------------HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG  214 (345)
T ss_dssp             -------------CEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTT
T ss_pred             -------------CEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcc
Confidence                         56667777665421   2234468999999999999999999999999999999999999999752 


Q ss_pred             --------ChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCc--HHHHHHHHhcCCCCccccc
Q 015222          322 --------ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATS--RDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       322 --------~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~--R~t~~~il~~~~~~~~~~~  386 (411)
                              ........+......+|.    .++..+.++|.+||..||.+||+.  +.++.++++||||.+++|.
T Consensus       215 ~~~~~~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~  285 (345)
T 3a8x_A          215 SSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  285 (345)
T ss_dssp             C-------CHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHH
T ss_pred             cccccccccHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHH
Confidence                    223334444444444543    467789999999999995555543  2346999999999998753

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.5e-50  Score=399.18  Aligned_cols=260  Identities=24%  Similarity=0.351  Sum_probs=219.7

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      .++|+++++||+|+||+||+|+++.+++.||+|++++..    .....+.+|..++..+.|++|     +++++++.+.+
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~I-----v~l~~~~~~~~  147 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWI-----TTLHYAFQDDN  147 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTB-----CCEEEEEECSS
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCE-----EEEEEEEeeCC
Confidence            468999999999999999999999999999999997532    223347889999999888777     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      .+|+||||+ +|+|.+++.+.. ..+++..++.++.||+.||+|||++|||||||||+|||++.+|              
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g--------------  212 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG--------------  212 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--------------
T ss_pred             EEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCC--------------
Confidence            999999999 999999998743 3699999999999999999999999999999999999998776              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceec-----CCCCCccchhHHHHHHHHHHHhCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGEA  316 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltg~~  316 (411)
                                   .+||+|||++.......    ...+||+.|+|||++.     +..++.++|||||||++|||++|+.
T Consensus       213 -------------~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~  279 (437)
T 4aw2_A          213 -------------HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET  279 (437)
T ss_dssp             -------------CEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSC
T ss_pred             -------------CEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCC
Confidence                         56777777775443221    2358999999999997     4578999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHH--hCCCChhHHHhhhhhhhhhhccCCccCCCCCCCc--HHHHHHHHhcCCCCcccccCC
Q 015222          317 LFQTHENLEHLAMMERV--LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATS--RDSMRAVWKLLRLPVIDLYSA  388 (411)
Q Consensus       317 pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~--R~t~~~il~~~~~~~~~~~~~  388 (411)
                      ||.+.+..+....+...  ...+|... ..+++.++++|.+||..+    |..  |++++++++||||.+++|...
T Consensus       280 Pf~~~~~~~~~~~i~~~~~~~~~p~~~-~~~s~~~~dLi~~lL~~~----~~r~~r~~~~eil~Hpff~~i~w~~l  350 (437)
T 4aw2_A          280 PFYAESLVETYGKIMNHKERFQFPTQV-TDVSENAKDLIRRLICSR----EHRLGQNGIEDFKKHPFFSGIDWDNI  350 (437)
T ss_dssp             TTCCSSHHHHHHHHHTHHHHCCCCSSC-CCSCHHHHHHHHTTSSCG----GGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred             CCCCCChhHHHHhhhhccccccCCccc-ccCCHHHHHHHHHHhccc----ccccCCCCHHHHhCCCccCCCCHHHH
Confidence            99998888888777643  23444332 346788999999999766    555  999999999999999887543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.1e-50  Score=386.03  Aligned_cols=265  Identities=23%  Similarity=0.355  Sum_probs=212.6

Q ss_pred             CccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        88 ~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      +.+.++|++.+.||+|+||.||+|++..+++.||||+++... ..+.+.+|+.+++++.|+||     +++++++...+.
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~  122 (349)
T 2w4o_A           49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNI-----IKLKEIFETPTE  122 (349)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTB-----CCEEEEEECSSE
T ss_pred             ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCC-----cceeeeEecCCe
Confidence            456788999999999999999999999999999999997543 34567889999999988777     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      .++||||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++..+               
T Consensus       123 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~---------------  185 (349)
T 2w4o_A          123 ISLVLELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPA---------------  185 (349)
T ss_dssp             EEEEECCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSS---------------
T ss_pred             EEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCC---------------
Confidence            99999999 899999998765  699999999999999999999999999999999999997521               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                               .+..+||+|||++......  .....||+.|+|||++.+..++.++|||||||++|||++|..||.+....
T Consensus       186 ---------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  256 (349)
T 2w4o_A          186 ---------PDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD  256 (349)
T ss_dssp             ---------TTCCEEECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH
T ss_pred             ---------CCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc
Confidence                     2347899999988765433  23467999999999999999999999999999999999999999876654


Q ss_pred             H-HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccCC
Q 015222          325 E-HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSA  388 (411)
Q Consensus       325 ~-~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~  388 (411)
                      + .+..+......++......++..+.++|.+||..|    |.+||++.++++|+||.+......
T Consensus       257 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~d----P~~Rpt~~e~l~hp~~~~~~~~~~  317 (349)
T 2w4o_A          257 QFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLD----PKKRLTTFQALQHPWVTGKAANFV  317 (349)
T ss_dssp             HHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSS----GGGSCCHHHHHHSTTTTSTTCCCS
T ss_pred             HHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCC----hhhCcCHHHHhcCcccCCCccchh
Confidence            4 45555555555555555678889999999999999    999999999999999998765443

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=9.7e-50  Score=388.08  Aligned_cols=261  Identities=23%  Similarity=0.378  Sum_probs=228.5

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      +.++|++.+.||+|+||.||+|.++.+++.||+|++.... .....+.+|+.+++.+.|+||     +++++++.+.+.+
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~~~~~~~~~~~~  123 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL-----INLHDAFEDKYEM  123 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTB-----CCEEEEEECSSEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCC-----CeEEEEEEeCCEE
Confidence            4578999999999999999999999999999999997543 344568899999999988776     9999999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      ++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++                
T Consensus       124 ~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~----------------  186 (387)
T 1kob_A          124 VLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKK----------------  186 (387)
T ss_dssp             EEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTT----------------
T ss_pred             EEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCC----------------
Confidence            9999999 999999987653 3699999999999999999999999999999999999996432                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                               ...+||+|||++.......  ....||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+
T Consensus       187 ---------~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~  257 (387)
T 1kob_A          187 ---------ASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE  257 (387)
T ss_dssp             ---------CCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred             ---------CCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH
Confidence                     2368999999887654332  34579999999999999999999999999999999999999999988888


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      .+..+......++......++..+.++|.+||..|    |.+|||+.++++|+||.+...
T Consensus       258 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d----P~~Rpt~~ell~hp~~~~~~~  313 (387)
T 1kob_A          258 TLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKE----PRKRLTVHDALEHPWLKGDHS  313 (387)
T ss_dssp             HHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSS----GGGSCCHHHHHTSTTTSSCCT
T ss_pred             HHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCC----hhHCcCHHHHhhCccccCCcc
Confidence            88888776666666666678889999999999999    999999999999999987654

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.4e-50  Score=405.22  Aligned_cols=274  Identities=24%  Similarity=0.385  Sum_probs=237.9

Q ss_pred             CCCCceEEeeCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--------------hhhHHHHHHHHHH
Q 015222           77 DKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--------------KYREAAMIEIDVL  142 (411)
Q Consensus        77 ~~~~~~~~~~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--------------~~~~~~~~E~~~l  142 (411)
                      -..+.+....+..+.++|+++++||+|+||+||+|+++.+++.||||++....              ...+.+.+|+.++
T Consensus        21 ~~~~~~~~~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l  100 (504)
T 3q5i_A           21 INPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL  100 (504)
T ss_dssp             CCGGGGCCEECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHH
T ss_pred             echhheeeccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHH
Confidence            34455556666778899999999999999999999999999999999997532              2346788999999


Q ss_pred             HHHhcCCCCCcceEEEeeeeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 015222          143 QRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLK  221 (411)
Q Consensus       143 ~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dik  221 (411)
                      +++.|+||     +++++++.+.+.+|+||||| +++|.+++....  .+++..++.++.||+.||+|||++||+|||||
T Consensus       101 ~~l~hpni-----v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlk  173 (504)
T 3q5i_A          101 KSLDHPNI-----IKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHNIVHRDIK  173 (504)
T ss_dssp             HTCCCTTB-----CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             HhCCCCCC-----CeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCc
Confidence            99988777     99999999999999999999 899999998765  69999999999999999999999999999999


Q ss_pred             CCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccc
Q 015222          222 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPC  299 (411)
Q Consensus       222 p~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~  299 (411)
                      |+|||++.++                        ....+||+|||++......  .....||+.|+|||++.+ .++.++
T Consensus       174 p~Nil~~~~~------------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~  228 (504)
T 3q5i_A          174 PENILLENKN------------------------SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKC  228 (504)
T ss_dssp             GGGEEESSTT------------------------CCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHH
T ss_pred             HHHEEEecCC------------------------CCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchH
Confidence            9999997654                        2336899999998765433  244679999999999875 699999


Q ss_pred             hhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCC
Q 015222          300 DLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR  379 (411)
Q Consensus       300 DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~  379 (411)
                      |||||||++|+|++|..||.+.+..+.+..+......++...+..++..+.++|.+||..|    |.+|||+.++++|||
T Consensus       229 DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d----p~~R~t~~e~l~h~~  304 (504)
T 3q5i_A          229 DVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYD----YNKRCTAEEALNSRW  304 (504)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSS----TTTSCCHHHHHTSHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCC----hhHCCCHHHHhcCHh
Confidence            9999999999999999999999999999988888777888888889999999999999999    999999999999999


Q ss_pred             CCccccc
Q 015222          380 LPVIDLY  386 (411)
Q Consensus       380 ~~~~~~~  386 (411)
                      |+.....
T Consensus       305 ~~~~~~~  311 (504)
T 3q5i_A          305 IKKYANN  311 (504)
T ss_dssp             HHHTCCC
T ss_pred             hhhchhc
Confidence            9875543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=9.2e-50  Score=379.11  Aligned_cols=264  Identities=24%  Similarity=0.423  Sum_probs=232.7

Q ss_pred             CccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchh-------hhHHHHHHHHHHHHHhcCCCCCcceEEEee
Q 015222           88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRLARHDIGGTRCVQIRN  160 (411)
Q Consensus        88 ~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~  160 (411)
                      +.+.++|++.+.||+|+||.||+|+++.+++.||+|+++....       ..+.+.+|+.+++++.|+|+     +++++
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~   82 (321)
T 2a2a_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV-----ITLHD   82 (321)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred             hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCc-----ceEEE
Confidence            4456789999999999999999999999999999999975321       35678899999999988877     99999


Q ss_pred             eeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcc
Q 015222          161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK  239 (411)
Q Consensus       161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~  239 (411)
                      ++.+.+..++||||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.       
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~-------  153 (321)
T 2a2a_A           83 VYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNI-------  153 (321)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTS-------
T ss_pred             EEecCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCC-------
Confidence            999999999999999 899999998754  6999999999999999999999999999999999999976541       


Q ss_pred             cccccCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCC
Q 015222          240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL  317 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p  317 (411)
                                      ....++|+|||++......  .....||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus       154 ----------------~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p  217 (321)
T 2a2a_A          154 ----------------PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP  217 (321)
T ss_dssp             ----------------SSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred             ----------------CcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCC
Confidence                            1226889999988765433  2345799999999999998999999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      |.+.+..+.+..+......++.......+..+.++|.+||..|    |.+|||+.++++||||..+..
T Consensus       218 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~d----p~~Rps~~e~l~hp~~~~~~~  281 (321)
T 2a2a_A          218 FLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKE----TRKRLTIQEALRHPWITPVDN  281 (321)
T ss_dssp             SCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSS----TTTSCCHHHHHHSTTTSCSSH
T ss_pred             CCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCC----hhhCcCHHHHhcCccccCCCc
Confidence            9998888888888877777888888888999999999999999    999999999999999997764

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5.1e-50  Score=388.17  Aligned_cols=258  Identities=22%  Similarity=0.339  Sum_probs=211.9

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchh----hhHHHHHHHHH-HHHHhcCCCCCcceEEEeeeeecCC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDV-LQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~-l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      ++|++++.||+|+||.||+|+++.+++.||||++++...    ....+..|..+ ++.+     .|+|++++++++.+.+
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-----~hp~Iv~l~~~~~~~~  112 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-----KHPFLVGLHFSFQTAD  112 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-----CCTTBCCEEEEEECSS
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-----CCCCCCCEEEEEEeCC
Confidence            579999999999999999999999999999999975432    22333445444 2334     4555699999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      .+|+||||+ |++|.+++.+..  .+++..++.++.||+.||+|||++||+||||||+|||++.+|              
T Consensus       113 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g--------------  176 (373)
T 2r5t_A          113 KLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG--------------  176 (373)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--------------
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC--------------
Confidence            999999999 899999998765  699999999999999999999999999999999999998777              


Q ss_pred             CCCCccccCCCCCCeeEeecCCccccc---CCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE  322 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~  322 (411)
                                   .+||+|||++....   ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+
T Consensus       177 -------------~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~  243 (373)
T 2r5t_A          177 -------------HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN  243 (373)
T ss_dssp             -------------CEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred             -------------CEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence                         56777777766422   22345689999999999999999999999999999999999999999988


Q ss_pred             hHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                      ..+....+......++.    .++..+.++|.+||..|+.+||..+..+.++++|+||.+++|..
T Consensus       244 ~~~~~~~i~~~~~~~~~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~  304 (373)
T 2r5t_A          244 TAEMYDNILNKPLQLKP----NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDD  304 (373)
T ss_dssp             HHHHHHHHHHSCCCCCS----SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHH
T ss_pred             HHHHHHHHHhcccCCCC----CCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHH
Confidence            88888877765555543    46778999999999999666666666678999999999987643

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.4e-50  Score=386.15  Aligned_cols=264  Identities=26%  Similarity=0.444  Sum_probs=216.8

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      ..++|+++++||+|+||+||+|++..+++.||||+++...   ...+.+.+|+.++++++|+||     +++++++.+++
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~  106 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNI-----IELKSVIHHNH  106 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTB-----CCEEEEEEETT
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCc-----ceEEEEEecCC
Confidence            3468999999999999999999999999999999997433   223456789999999988777     99999999999


Q ss_pred             eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          167 HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       167 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      .+++||||+.++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++               
T Consensus       107 ~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~---------------  169 (329)
T 3gbz_A          107 RLHLIFEYAENDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSD---------------  169 (329)
T ss_dssp             EEEEEEECCSEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----------------
T ss_pred             EEEEEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCC---------------
Confidence            999999999889999998875  699999999999999999999999999999999999997554               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHE  322 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~  322 (411)
                             .+....+||+|||++......   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+
T Consensus       170 -------~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  242 (329)
T 3gbz_A          170 -------ASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS  242 (329)
T ss_dssp             ----------CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             -------CCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence                   123446899999988765422   2345789999999999875 58999999999999999999999999998


Q ss_pred             hHHHHHHHHHHhCCCChhHH--------------------------HhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHh
Q 015222          323 NLEHLAMMERVLGPLPHHMV--------------------------IRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK  376 (411)
Q Consensus       323 ~~~~~~~i~~~~~~~p~~~~--------------------------~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~  376 (411)
                      ..+.+..+....+..+...+                          ...++.+.++|.+||..|    |.+|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d----P~~R~t~~e~l~  318 (329)
T 3gbz_A          243 EIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMD----PVKRISAKNALE  318 (329)
T ss_dssp             HHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSS----GGGSCCHHHHHT
T ss_pred             HHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCC----hhhCCCHHHHhC
Confidence            88888887776554332211                          125678889999999999    999999999999


Q ss_pred             cCCCCccccc
Q 015222          377 LLRLPVIDLY  386 (411)
Q Consensus       377 ~~~~~~~~~~  386 (411)
                      ||||++.++.
T Consensus       319 hp~f~~~~~~  328 (329)
T 3gbz_A          319 HPYFSHNDFD  328 (329)
T ss_dssp             SGGGSSSCSC
T ss_pred             CcccCCCCCC
Confidence            9999998763

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.6e-49  Score=392.66  Aligned_cols=282  Identities=23%  Similarity=0.339  Sum_probs=215.6

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .+.++|++.+.||+|+||.||+|+++.+++.||||++...   ....+.+.+|+.+++.++|+||     +++++++...
T Consensus        23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-----v~l~~~~~~~   97 (432)
T 3n9x_A           23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI-----IRLYDLIIPD   97 (432)
T ss_dssp             CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTB-----CCEEEECCCS
T ss_pred             eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCc-----ceEEEEEecC
Confidence            4568999999999999999999999999999999999753   2345678899999999988877     9999998765


Q ss_pred             -----CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          166 -----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       166 -----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                           +.+|+||||++++|.+++....  .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+
T Consensus        98 ~~~~~~~~~lv~e~~~~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGl  175 (432)
T 3n9x_A           98 DLLKFDELYIVLEIADSDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGL  175 (432)
T ss_dssp             CTTTCCCEEEEEECCSEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CCCcCCeEEEEEecCCcCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence                 6799999999889999998764  699999999999999999999999999999999999998887655555555


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCc-------ccccCCCcccccCCCccccceec-CCCCCccchhHHHHHHHHHHH
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGST-------TFEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELC  312 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a-------~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~ell  312 (411)
                      +.........         ....++...       ..........+||+.|+|||++. +..++.++|||||||++|||+
T Consensus       176 a~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell  246 (432)
T 3n9x_A          176 ARTINSEKDT---------NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL  246 (432)
T ss_dssp             CEEC----------------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred             cccccccccc---------cccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHH
Confidence            4433221100         000000000       00001124468999999999874 557999999999999999999


Q ss_pred             h-----------CCCCCCCCC-----------------hHHHHHHHHHHhCCCChhHH----------------------
Q 015222          313 S-----------GEALFQTHE-----------------NLEHLAMMERVLGPLPHHMV----------------------  342 (411)
Q Consensus       313 t-----------g~~pf~~~~-----------------~~~~~~~i~~~~~~~p~~~~----------------------  342 (411)
                      +           |.++|.+.+                 ..+.+..+....+..+....                      
T Consensus       247 ~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (432)
T 3n9x_A          247 NMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPIN  326 (432)
T ss_dssp             TTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCC
T ss_pred             hcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCC
Confidence            8           455555543                 24566666666666554332                      


Q ss_pred             -----HhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccCCCC
Q 015222          343 -----IRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSASP  390 (411)
Q Consensus       343 -----~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~~~  390 (411)
                           +.+++.+.++|.+||..|    |.+|+|++++++||||.++......+
T Consensus       327 ~~~~~~~~s~~~~dLl~~mL~~d----P~~R~ta~e~L~Hp~f~~~~~~~~e~  375 (432)
T 3n9x_A          327 LKQKYPSISDDGINLLESMLKFN----PNKRITIDQALDHPYLKDVRKKKLEN  375 (432)
T ss_dssp             HHHHSTTSCHHHHHHHHHHSCSS----TTTSCCHHHHHTCGGGTTTCCTTTC-
T ss_pred             HHHHCCCCCHHHHHHHHHHhcCC----cccCCCHHHHhcChhhhhccCcccCc
Confidence                 346788999999999999    99999999999999999998776654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.4e-49  Score=370.82  Aligned_cols=265  Identities=22%  Similarity=0.325  Sum_probs=232.3

Q ss_pred             CccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        88 ~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      ..+.++|++.+.||+|+||.||+|.++.+++.||+|++....   ...+.+.+|+.++++++|+|+     +++++++..
T Consensus         2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~   76 (284)
T 3kk8_A            2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI-----VRLHDSIQE   76 (284)
T ss_dssp             CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEEC
T ss_pred             chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCc-----CeEEEEEEc
Confidence            456789999999999999999999999999999999996533   334667889999999988777     999999999


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                      .+..++||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+||+++.++            
T Consensus        77 ~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~------------  142 (284)
T 3kk8_A           77 ESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA------------  142 (284)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSS------------
T ss_pred             CCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCC------------
Confidence            99999999999 889999988765  699999999999999999999999999999999999997654            


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                                  ....+||+|||++.......  ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.
T Consensus       143 ------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  210 (284)
T 3kk8_A          143 ------------KGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE  210 (284)
T ss_dssp             ------------TTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ------------CCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC
Confidence                        23458999999887654433  3457999999999999999999999999999999999999999998


Q ss_pred             ChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                      +..+....+.......+......+++.+.+++.+||+.+    |.+||++.++++|+||.+.....
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d----p~~Rps~~~~l~h~~~~~~~~~~  272 (284)
T 3kk8_A          211 DQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVN----PKKRITADQALKVPWICNRERVA  272 (284)
T ss_dssp             SHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSS----TTTSCCHHHHTTSHHHHSCCCGG
T ss_pred             chhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccC----hhhCCCHHHHhcCccccCChhHH
Confidence            888888888777766666666678889999999999999    99999999999999998765443

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6.1e-50  Score=374.47  Aligned_cols=254  Identities=27%  Similarity=0.456  Sum_probs=211.6

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      ++|++++.||+|+||+||+|++ .+++.||+|++....   ...+.+.+|+.++++++|+||     +++++++...+..
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~   75 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI-----VKLYDVIHTKKRL   75 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTB-----CCEEEEEECSSCE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCE-----eeeeeEEccCCeE
Confidence            5799999999999999999998 678899999996433   234667899999999988776     9999999999999


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      ++||||+.++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|                 
T Consensus        76 ~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-----------------  137 (288)
T 1ob3_A           76 VLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-----------------  137 (288)
T ss_dssp             EEEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-----------------
T ss_pred             EEEEEecCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-----------------
Confidence            9999999779999998654 3699999999999999999999999999999999999998766                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                                .+||+|||++......   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..
T Consensus       138 ----------~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  207 (288)
T 1ob3_A          138 ----------ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA  207 (288)
T ss_dssp             ----------CEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ----------CEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence                      5777777777654322   2335789999999999765 6899999999999999999999999998888


Q ss_pred             HHHHHHHHHhCCCChh-------------------------HHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCC
Q 015222          325 EHLAMMERVLGPLPHH-------------------------MVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR  379 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~-------------------------~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~  379 (411)
                      +.+..+.+..+..+..                         ....++..+.++|.+||..|    |++|||+.++++|+|
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d----P~~Rpt~~e~l~hp~  283 (288)
T 1ob3_A          208 DQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLD----PNQRITAKQALEHAY  283 (288)
T ss_dssp             HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSS----TTTSCCHHHHHTSGG
T ss_pred             HHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCC----cccCCCHHHHhcCcc
Confidence            8887777655433221                         11235677889999999999    999999999999999


Q ss_pred             CCcc
Q 015222          380 LPVI  383 (411)
Q Consensus       380 ~~~~  383 (411)
                      |++.
T Consensus       284 f~~~  287 (288)
T 1ob3_A          284 FKEN  287 (288)
T ss_dssp             GGC-
T ss_pred             hhhc
Confidence            9864

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.8e-50  Score=380.49  Aligned_cols=260  Identities=27%  Similarity=0.453  Sum_probs=206.4

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      .++|++++.||+|+||+||+|.++.+++.||||+++...  ...+.+.+|+.++++++|+||     +++++++.+++.+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~~~   78 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENI-----VRLYDVIHTENKL   78 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTB-----CCEEEEECCTTEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCc-----ceEEEEEEECCeE
Confidence            357999999999999999999999999999999997432  334678899999999988877     9999999999999


Q ss_pred             EEEEccCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          169 CIVFEKLGPSLYDFLRKNS----YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       169 ~lv~e~~~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      ++||||+.++|.+++....    ...+++..++.++.||+.||+|||++||+||||||+|||++.+|             
T Consensus        79 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-------------  145 (317)
T 2pmi_A           79 TLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG-------------  145 (317)
T ss_dssp             EEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-------------
T ss_pred             EEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCC-------------
Confidence            9999999889999987542    13589999999999999999999999999999999999998766             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQT  320 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~  320 (411)
                                    .+||+|||++......   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+
T Consensus       146 --------------~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  211 (317)
T 2pmi_A          146 --------------QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPG  211 (317)
T ss_dssp             --------------CEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             --------------CEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                          5777788877654322   2335789999999999874 689999999999999999999999999


Q ss_pred             CChHHHHHHHHHHhCCCChhHH------------------------------HhhhhhhhhhhccCCccCCCCCCCcHHH
Q 015222          321 HENLEHLAMMERVLGPLPHHMV------------------------------IRADRRAEKYFRRGARLDWPDGATSRDS  370 (411)
Q Consensus       321 ~~~~~~~~~i~~~~~~~p~~~~------------------------------~~~~~~~~~li~~~l~~~~~~rp~~R~t  370 (411)
                      .+..+.+..+....+..+...+                              ...+..+.++|.+||..|    |.+|||
T Consensus       212 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d----P~~Rpt  287 (317)
T 2pmi_A          212 TNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLN----PDMRLS  287 (317)
T ss_dssp             SSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSS----GGGSCC
T ss_pred             CChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCC----cccCCC
Confidence            9888888888776554332211                              134567889999999999    999999


Q ss_pred             HHHHHhcCCCCccccc
Q 015222          371 MRAVWKLLRLPVIDLY  386 (411)
Q Consensus       371 ~~~il~~~~~~~~~~~  386 (411)
                      +.++++||||.+....
T Consensus       288 ~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          288 AKQALHHPWFAEYYHH  303 (317)
T ss_dssp             HHHHTTSGGGGGGCC-
T ss_pred             HHHHhCChhhhcccch
Confidence            9999999999987654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1e-50  Score=387.73  Aligned_cols=254  Identities=24%  Similarity=0.353  Sum_probs=214.6

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      ...++|++.+.||+|+||.||+|++..+++.||||++....    .....+.+|+.+++.++|+||     +++++++..
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~l~~~~~~   80 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHI-----IKLYDVITT   80 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTB-----CCEEEEEEC
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCC-----CeEEEEEEe
Confidence            34578999999999999999999999999999999997432    234568899999999988777     999999999


Q ss_pred             CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          165 RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       165 ~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      .+..++||||++|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++             
T Consensus        81 ~~~~~lv~E~~~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-------------  145 (336)
T 3h4j_B           81 PTDIVMVIEYAGGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNL-------------  145 (336)
T ss_dssp             SSEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTC-------------
T ss_pred             CCEEEEEEECCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCC-------------
Confidence            99999999999999999998765  699999999999999999999999999999999999997765             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCC-CccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                                    .+||+|||++......  ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.
T Consensus       146 --------------~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~  211 (336)
T 3h4j_B          146 --------------NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE  211 (336)
T ss_dssp             --------------CEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred             --------------CEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence                          6788888887654332  244679999999999998876 78999999999999999999999876


Q ss_pred             ChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      ...+....+......+|.    .++..+.++|.+||..|    |.+|||+.++++||||....
T Consensus       212 ~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~d----P~~Rpt~~eil~hp~~~~~~  266 (336)
T 3h4j_B          212 FIPNLFKKVNSCVYVMPD----FLSPGAQSLIRRMIVAD----PMQRITIQEIRRDPWFNVNL  266 (336)
T ss_dssp             SSTTCBCCCCSSCCCCCT----TSCHHHHHHHHTTSCSS----GGGSCCHHHHTTCHHHHTTC
T ss_pred             cHHHHHHHHHcCCCCCcc----cCCHHHHHHHHHHcCCC----hhHCcCHHHHHhChhhccCC
Confidence            544333333222233333    35778999999999999    99999999999999997643

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-49  Score=375.92  Aligned_cols=260  Identities=23%  Similarity=0.280  Sum_probs=213.1

Q ss_pred             CceEEeeCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHH-hcCCCCCcce
Q 015222           80 GHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRL-ARHDIGGTRC  155 (411)
Q Consensus        80 ~~~~~~~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l-~~~~i~~~~i  155 (411)
                      +.++...++.+.++|++.++||+|+||+||+|++..+++.||||++....   ........|+..+.++ .|+|+     
T Consensus        45 ~~~p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~i-----  119 (311)
T 3p1a_A           45 GYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCC-----  119 (311)
T ss_dssp             TCCTTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTB-----
T ss_pred             CCCCCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcE-----
Confidence            44455567777889999999999999999999999999999999986432   2333445566666555 56655     


Q ss_pred             EEEeeeeecCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCccccc
Q 015222          156 VQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV  235 (411)
Q Consensus       156 v~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l  235 (411)
                      +++++++.+++.+|+||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++    
T Consensus       120 v~l~~~~~~~~~~~lv~e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~----  194 (311)
T 3p1a_A          120 VRLEQAWEEGGILYLQTELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG----  194 (311)
T ss_dssp             CCEEEEEEETTEEEEEEECCCCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGG----
T ss_pred             EEEEEEEEeCCEEEEEEeccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC----
Confidence            99999999999999999999999999988765 4699999999999999999999999999999999999998776    


Q ss_pred             CCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh
Q 015222          236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS  313 (411)
Q Consensus       236 ~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt  313 (411)
                                             .+||+|||++.......  ....||+.|+|||++.+ .++.++|||||||++|||++
T Consensus       195 -----------------------~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~  250 (311)
T 3p1a_A          195 -----------------------RCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVAC  250 (311)
T ss_dssp             -----------------------CEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHH
T ss_pred             -----------------------CEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHh
Confidence                                   56777777776543322  33468999999999887 79999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCc
Q 015222          314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       314 g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~  382 (411)
                      |..||.+.+.   ...+  ..+..+..+...+++.+.++|.+||..+    |.+|||+.++++||||++
T Consensus       251 g~~~~~~~~~---~~~~--~~~~~~~~~~~~~~~~l~~li~~~L~~d----P~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          251 NMELPHGGEG---WQQL--RQGYLPPEFTAGLSSELRSVLVMMLEPD----PKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             TCCCCSSHHH---HHHH--TTTCCCHHHHTTSCHHHHHHHHHHSCSS----TTTSCCHHHHHTSGGGSC
T ss_pred             CCCCCCCccH---HHHH--hccCCCcccccCCCHHHHHHHHHHcCCC----hhhCcCHHHHHhCccccC
Confidence            9777754322   2222  2345667777788999999999999999    999999999999999975

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=8.3e-50  Score=380.18  Aligned_cols=266  Identities=27%  Similarity=0.439  Sum_probs=208.7

Q ss_pred             cCCCeEEE---eeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHh-cCCCCCcceEEEeeeeecC
Q 015222           90 LTPRYRIL---SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        90 ~~~~y~i~---~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~~~~~  165 (411)
                      +.++|++.   +.||+|+||+||+|.++.+++.||||++...  ......+|+.+++.+. |+||     +++++++.++
T Consensus         6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~ni-----v~~~~~~~~~   78 (325)
T 3kn6_A            6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNI-----VKLHEVFHDQ   78 (325)
T ss_dssp             HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTB-----CCEEEEEECS
T ss_pred             chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCe-----eEEEEEEEcC
Confidence            34568876   7899999999999999999999999999653  3466788999999997 6665     9999999999


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      +..|+||||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++             
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~-------------  143 (325)
T 3kn6_A           79 LHTFLVMELLNGGELFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDEN-------------  143 (325)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC---------------
T ss_pred             CEEEEEEEccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCC-------------
Confidence            9999999999 889999998865  799999999999999999999999999999999999997654             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                                 ....+||+|||++......   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus       144 -----------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  212 (325)
T 3kn6_A          144 -----------DNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSH  212 (325)
T ss_dssp             -------------CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred             -----------CcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence                       2346899999988754332   23457899999999999999999999999999999999999999864


Q ss_pred             Ch-------HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccCCCCCc
Q 015222          322 EN-------LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSASPNC  392 (411)
Q Consensus       322 ~~-------~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~~~~~  392 (411)
                      +.       .+.+..+......++...+..+++.+.++|.+||..|    |.+||++.++++|+||++....+..|..
T Consensus       213 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d----P~~Rpt~~ell~h~w~~~~~~~~~~~~~  286 (325)
T 3kn6_A          213 DRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVD----PNKRLKMSGLRYNEWLQDGSQLSSNPLM  286 (325)
T ss_dssp             -----CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCC----TTTCCCTTTSTTCGGGCTTCCCCCSCCS
T ss_pred             ccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCC----hhHCCCHHHHhcChhhccCccCCCCCCC
Confidence            33       4555556655666777777889999999999999999    9999999999999999987666555543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.2e-49  Score=377.63  Aligned_cols=258  Identities=21%  Similarity=0.319  Sum_probs=212.7

Q ss_pred             CCCeEEEeeeccccceEEEEEEeC---CCCcEEEEEEeccch-----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeee
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF  162 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~---~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~  162 (411)
                      .++|++.+.||+|+||.||+|++.   .+++.||+|++++..     .....+.+|+.+++.++|+||     +++++++
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~   90 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI-----VDLIYAF   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTB-----CCEEEEE
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCc-----cceeEEE
Confidence            468999999999999999999985   688999999997532     234556789999999988777     9999999


Q ss_pred             ecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccc
Q 015222          163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL  241 (411)
Q Consensus       163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~  241 (411)
                      ...+.+|+||||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+|          
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~----------  158 (327)
T 3a62_A           91 QTGGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG----------  158 (327)
T ss_dssp             ECSSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS----------
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC----------
Confidence            9999999999999 899999998765  699999999999999999999999999999999999998766          


Q ss_pred             cccCCCCCccccCCCCCCeeEeecCCcccccC---CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCC
Q 015222          242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF  318 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf  318 (411)
                                       .+||+|||++.....   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus       159 -----------------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf  221 (327)
T 3a62_A          159 -----------------HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF  221 (327)
T ss_dssp             -----------------CEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             -----------------cEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCC
Confidence                             567777777654322   123457999999999999989999999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcH-HHHHHHHhcCCCCccccc
Q 015222          319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR-DSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R-~t~~~il~~~~~~~~~~~  386 (411)
                      .+.+..+.+..+......+|.    .++..+.++|.+||..++.+||+.+ +++.++++||||.++++.
T Consensus       222 ~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~  286 (327)
T 3a62_A          222 TGENRKKTIDKILKCKLNLPP----YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE  286 (327)
T ss_dssp             CCSSHHHHHHHHHHTCCCCCT----TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred             CCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence            998888888877776666654    3577899999999999944444333 389999999999988653

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=7.2e-50  Score=386.73  Aligned_cols=263  Identities=26%  Similarity=0.460  Sum_probs=207.6

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC-
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR-  165 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~-  165 (411)
                      +.++|++++.||+|+||.||+|.+..+|+.||||++...   ....+.+.+|+.+++.++|+||     +++++++... 
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~~~~~~~~  101 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV-----IGLLDVFTPAR  101 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTB-----CCCSEEECSCS
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEEecCC
Confidence            458999999999999999999999999999999999643   2345667899999999988877     8999888643 


Q ss_pred             -----CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          166 -----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       166 -----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                           +.+|+|||+++++|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++.++         
T Consensus       102 ~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~---------  169 (367)
T 2fst_X          102 SLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC---------  169 (367)
T ss_dssp             SGGGCCCCEEEEECCCEECC-----C---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC---------
T ss_pred             ccccCCeEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC---------
Confidence                 578999999999999998763   599999999999999999999999999999999999997765         


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecC-CCCCccchhHHHHHHHHHHHhCCCCCC
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQ  319 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~pf~  319 (411)
                                        .+||+|||++...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus       170 ------------------~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~  231 (367)
T 2fst_X          170 ------------------ELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP  231 (367)
T ss_dssp             ------------------CEEECC---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ------------------CEEEeeccccccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence                              6788888888766555566789999999999987 589999999999999999999999999


Q ss_pred             CCChHHHHHHHHHHhCCCChhHHH---------------------------hhhhhhhhhhccCCccCCCCCCCcHHHHH
Q 015222          320 THENLEHLAMMERVLGPLPHHMVI---------------------------RADRRAEKYFRRGARLDWPDGATSRDSMR  372 (411)
Q Consensus       320 ~~~~~~~~~~i~~~~~~~p~~~~~---------------------------~~~~~~~~li~~~l~~~~~~rp~~R~t~~  372 (411)
                      +.+..+.+..+.+..+..+.....                           ..+..+.++|.+||..|    |.+|+|+.
T Consensus       232 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~d----P~~R~t~~  307 (367)
T 2fst_X          232 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD----SDKRITAA  307 (367)
T ss_dssp             CSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSS----GGGSCCHH
T ss_pred             CCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCC----cccCcCHH
Confidence            999988888888877665443322                           23567899999999999    99999999


Q ss_pred             HHHhcCCCCcccccCCCCC
Q 015222          373 AVWKLLRLPVIDLYSASPN  391 (411)
Q Consensus       373 ~il~~~~~~~~~~~~~~~~  391 (411)
                      ++++||||.+.......|.
T Consensus       308 e~L~hp~~~~~~~~~~~~~  326 (367)
T 2fst_X          308 QALAHAYFAQYHDPDDEPV  326 (367)
T ss_dssp             HHHTSGGGTTTCCGGGCCC
T ss_pred             HHhcChhhhhccCCCCCCC
Confidence            9999999998766555443

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=385.89  Aligned_cols=262  Identities=27%  Similarity=0.379  Sum_probs=221.8

Q ss_pred             cCCCeEE--EeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           90 LTPRYRI--LSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        90 ~~~~y~i--~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      +.+.|.+  .+.||+|+||.||+|.+..+|+.||+|+++... ...+.+.+|+.++++++|+||     +++++++.+.+
T Consensus        85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~~~~~~~~  159 (373)
T 2x4f_A           85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANL-----IQLYDAFESKN  159 (373)
T ss_dssp             GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEECSS
T ss_pred             cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCC-----CeEEEEEEECC
Confidence            3345665  678999999999999999999999999997543 455678899999999988776     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      .+++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+..++              
T Consensus       160 ~~~lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--------------  224 (373)
T 2x4f_A          160 DIVLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRD--------------  224 (373)
T ss_dssp             EEEEEEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETT--------------
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCC--------------
Confidence            999999999 899999887643 3599999999999999999999999999999999999985432              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN  323 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~  323 (411)
                                 ...+||+|||++.......  ....||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.
T Consensus       225 -----------~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~  293 (373)
T 2x4f_A          225 -----------AKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND  293 (373)
T ss_dssp             -----------TTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred             -----------CCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence                       2368889999887654332  335799999999999988999999999999999999999999999988


Q ss_pred             HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                      .+.+..+......++......+++.+.++|.+||..+    |.+||++.++++||||.+....
T Consensus       294 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~d----p~~Rps~~e~l~hp~~~~~~~~  352 (373)
T 2x4f_A          294 AETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKE----KSWRISASEALKHPWLSDHKLH  352 (373)
T ss_dssp             HHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSS----GGGSCCHHHHHHSHHHHCHHHH
T ss_pred             HHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCC----hhhCCCHHHHhcCcCcCCCchh
Confidence            8888888877766766666778899999999999999    9999999999999999986543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3e-50  Score=385.74  Aligned_cols=259  Identities=22%  Similarity=0.367  Sum_probs=220.4

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeecCCe
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      .+.++|++.+.||+|+||.||+|.++.+++.||||++++...   ...+|++++.++ .|+||     +++++++.+++.
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~i-----v~~~~~~~~~~~   90 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNI-----ITLKDVYDDGKY   90 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTB-----CCEEEEEECSSE
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCc-----CeEEEEEEcCCE
Confidence            456789999999999999999999999999999999975432   245688899888 56666     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+||||+ |++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||+.+++               
T Consensus        91 ~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~---------------  153 (342)
T 2qr7_A           91 VYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDES---------------  153 (342)
T ss_dssp             EEEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSS---------------
T ss_pred             EEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCC---------------
Confidence            99999999 899999998765  699999999999999999999999999999999999985432               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCC--
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH--  321 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~--  321 (411)
                              .....+||+|||++......   ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.  
T Consensus       154 --------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~  225 (342)
T 2qr7_A          154 --------GNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD  225 (342)
T ss_dssp             --------CSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT
T ss_pred             --------CCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc
Confidence                    01235899999988765432   23467899999999999888999999999999999999999999863  


Q ss_pred             -ChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          322 -ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       322 -~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                       +..+.+..+......++...+..+++.+.++|.+||..|    |.+||++.++++|+||.+..
T Consensus       226 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d----P~~R~t~~~il~hp~~~~~~  285 (342)
T 2qr7_A          226 DTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVD----PHQRLTAALVLRHPWIVHWD  285 (342)
T ss_dssp             SCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSS----TTTSCCHHHHTTSHHHHTGG
T ss_pred             CCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCC----hhHCcCHHHHhcCCeecCcc
Confidence             445666666666666666666778899999999999999    99999999999999997644

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.8e-49  Score=375.84  Aligned_cols=266  Identities=23%  Similarity=0.328  Sum_probs=215.7

Q ss_pred             CccCCCeEEE-eeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeec
Q 015222           88 ENLTPRYRIL-SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        88 ~~~~~~y~i~-~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~  164 (411)
                      ..+.++|++. +.||+|+||+||+|++..+++.||||++.... ...+.+.+|+.++.++ .|+||     +++++++.+
T Consensus         8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i-----~~~~~~~~~   82 (316)
T 2ac3_A            8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNV-----LELIEFFEE   82 (316)
T ss_dssp             CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTB-----CCEEEEEEE
T ss_pred             cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCe-----eeEEEEEee
Confidence            3466789996 78999999999999999999999999997543 3456788999999885 46665     999999999


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                      .+.+|+||||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.           
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-----------  149 (316)
T 2ac3_A           83 EDRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQ-----------  149 (316)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSS-----------
T ss_pred             CCEEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCC-----------
Confidence            99999999999 899999998765  6999999999999999999999999999999999999987652           


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccCC----------CcccccCCCccccceecC-----CCCCccchhHHHHHHH
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCIL  308 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil  308 (411)
                                   ...+||+|||++......          .....||+.|+|||++.+     ..++.++|||||||++
T Consensus       150 -------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il  216 (316)
T 2ac3_A          150 -------------VSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL  216 (316)
T ss_dssp             -------------SCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHH
T ss_pred             -------------cCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHH
Confidence                         224788888877643211          123469999999999975     4588999999999999


Q ss_pred             HHHHhCCCCCCCCCh---------------HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHH
Q 015222          309 VELCSGEALFQTHEN---------------LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA  373 (411)
Q Consensus       309 ~elltg~~pf~~~~~---------------~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~  373 (411)
                      |||++|+.||.+...               ......+......+|......++..+.++|.+||..|    |.+||++.+
T Consensus       217 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~d----P~~Rps~~e  292 (316)
T 2ac3_A          217 YILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRD----AKQRLSAAQ  292 (316)
T ss_dssp             HHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSS----TTTSCCHHH
T ss_pred             HHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCC----hhhCCCHHH
Confidence            999999999987542               3345555565667777766778899999999999999    999999999


Q ss_pred             HHhcCCCCcccccCC
Q 015222          374 VWKLLRLPVIDLYSA  388 (411)
Q Consensus       374 il~~~~~~~~~~~~~  388 (411)
                      +++||||++..+...
T Consensus       293 ~l~hp~~~~~~~~~~  307 (316)
T 2ac3_A          293 VLQHPWVQGCAPENT  307 (316)
T ss_dssp             HHHSTTCC-------
T ss_pred             HhcChhhcCCCCccc
Confidence            999999998765443

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.5e-49  Score=398.75  Aligned_cols=263  Identities=28%  Similarity=0.443  Sum_probs=231.2

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .+.++|++.++||+|+||+||+|+++.+++.||||++...   ......+.+|+.+++++.|+||     +++++++.+.
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~   93 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI-----MKLFEILEDS   93 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTB-----CCEEEEEECS
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCc-----CeEEEEEEcC
Confidence            4567899999999999999999999999999999999643   2345678899999999988877     9999999999


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      +.+|+||||+ +++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++..+             
T Consensus        94 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~-------------  158 (486)
T 3mwu_A           94 SSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE-------------  158 (486)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSS-------------
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC-------------
Confidence            9999999999 999999998765  699999999999999999999999999999999999996543             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE  322 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~  322 (411)
                                 ....+||+|||++......  ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+
T Consensus       159 -----------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~  226 (486)
T 3mwu_A          159 -----------KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN  226 (486)
T ss_dssp             -----------TTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             -----------CCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                       3447899999998765433  234579999999999987 59999999999999999999999999999


Q ss_pred             hHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                      ..+.+..+......++...+..+++.++++|.+||..+    |.+|||+.++++||||+......
T Consensus       227 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d----p~~R~t~~~~l~hp~~~~~~~~~  287 (486)
T 3mwu_A          227 EYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFH----PSLRITATQCLEHPWIQKYSSET  287 (486)
T ss_dssp             HHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSS----TTTSCCHHHHHHCHHHHHTCCCC
T ss_pred             HHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCC----hhhCcCHHHHhcCHhhccCcccC
Confidence            98888888887777766666788999999999999999    99999999999999999866544

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.4e-50  Score=383.15  Aligned_cols=281  Identities=22%  Similarity=0.314  Sum_probs=236.8

Q ss_pred             CCCCCceEEeeCCccCCCeEEE-eeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCC
Q 015222           76 DDKDGHYVFAIGENLTPRYRIL-SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIG  151 (411)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~y~i~-~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~  151 (411)
                      ++.++...+..++.+.++|.+. +.||+|+||.||+|+++.+++.||||+++...   .....+.+|+.+++.+.++   
T Consensus        12 ~~~~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~---   88 (327)
T 3lm5_A           12 DLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSC---   88 (327)
T ss_dssp             ----CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTC---
T ss_pred             cccchhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCC---
Confidence            3444556677778899999998 89999999999999999999999999997533   3356788999999998641   


Q ss_pred             CcceEEEeeeeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecC
Q 015222          152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA  230 (411)
Q Consensus       152 ~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~  230 (411)
                       +|++++++++...+..++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++..
T Consensus        89 -~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~  167 (327)
T 3lm5_A           89 -PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSI  167 (327)
T ss_dssp             -TTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCB
T ss_pred             -CCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecC
Confidence             34499999999999999999999 8899999876544579999999999999999999999999999999999999762


Q ss_pred             cccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCCCccchhHHHHHHH
Q 015222          231 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL  308 (411)
Q Consensus       231 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  308 (411)
                      .                        ....+||+|||++.......  ....||+.|+|||++.+..++.++|||||||++
T Consensus       168 ~------------------------~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  223 (327)
T 3lm5_A          168 Y------------------------PLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA  223 (327)
T ss_dssp             T------------------------TBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred             C------------------------CCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHH
Confidence            1                        12368888888887654332  345799999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccCC
Q 015222          309 VELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSA  388 (411)
Q Consensus       309 ~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~  388 (411)
                      |+|++|+.||.+.+..+....+.......+......++..+.++|.+||..+    |.+|||+.++++|+||+++++...
T Consensus       224 ~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~d----P~~Rpt~~~ll~h~~~~~~~~~~~  299 (327)
T 3lm5_A          224 YMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKN----PEKRPTAEICLSHSWLQQWDFENL  299 (327)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSS----GGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred             HHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCC----hhhCcCHHHHhCCHhhcccccccc
Confidence            9999999999998888888888887777777777788899999999999999    999999999999999999887554

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.7e-49  Score=384.06  Aligned_cols=255  Identities=22%  Similarity=0.391  Sum_probs=216.0

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      .++|++++.||+|+||.||+|+++.+++.||+|++.+..    .....+.+|+.+++.++|+||     +++++++.+.+
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~I-----v~l~~~~~~~~   88 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL-----VNLWYSFQDEE   88 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTB-----CCEEEEEECSS
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEEEeCC
Confidence            468999999999999999999999999999999997532    334667889999999988777     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      .+|+||||+ |++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.+|              
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g--------------  152 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG--------------  152 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--------------
T ss_pred             EEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCC--------------
Confidence            999999999 999999998765  699999999999999999999999999999999999998776              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecC---CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCSGEALFQT  320 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~elltg~~pf~~  320 (411)
                                   .+||+|||++......  ....+||+.|+|||++.+   ..++.++|||||||++|||++|+.||..
T Consensus       153 -------------~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~  219 (384)
T 4fr4_A          153 -------------HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI  219 (384)
T ss_dssp             -------------CEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             -------------CEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCC
Confidence                         5777888877654322  345689999999999974   3589999999999999999999999975


Q ss_pred             CC---hHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHH-HHHHHhcCCCCcccccC
Q 015222          321 HE---NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS-MRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       321 ~~---~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t-~~~il~~~~~~~~~~~~  387 (411)
                      .+   ..+....+......+|.    .++..+.++|.+||..+    |.+|++ ++++++|+||.+++|..
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~p~----~~s~~~~~li~~lL~~d----P~~R~s~~~~l~~hp~f~~~~w~~  282 (384)
T 4fr4_A          220 RSSTSSKEIVHTFETTVVTYPS----AWSQEMVSLLKKLLEPN----PDQRFSQLSDVQNFPYMNDINWDA  282 (384)
T ss_dssp             CTTSCHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHSCSS----GGGSCCSHHHHHTSGGGTTCCHHH
T ss_pred             CCCccHHHHHHHHhhcccCCCC----cCCHHHHHHHHHHhcCC----HhHhcccHHHHHcChhhhcCCHHH
Confidence            43   33444444444444443    45778999999999999    777877 89999999999988743

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=7.5e-49  Score=380.10  Aligned_cols=280  Identities=31%  Similarity=0.524  Sum_probs=232.1

Q ss_pred             ceEEeeCCcc-CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCC------CCc
Q 015222           81 HYVFAIGENL-TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI------GGT  153 (411)
Q Consensus        81 ~~~~~~~~~~-~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i------~~~  153 (411)
                      .++...++.+ .++|++.+.||+|+||+||+|++..+++.||||++.......+.+.+|+.+++++.|.+.      .|+
T Consensus         7 ~~p~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~   86 (373)
T 1q8y_A            7 YHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN   86 (373)
T ss_dssp             CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred             ceeeecCCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccc
Confidence            3344445544 469999999999999999999999999999999998776677788999999999986532      245


Q ss_pred             ceEEEeeeeecCC----eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEe
Q 015222          154 RCVQIRNWFDYRN----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLV  228 (411)
Q Consensus       154 ~iv~~~~~~~~~~----~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dikp~NIli~  228 (411)
                      |++++++++...+    .+++|||+++++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|||++
T Consensus        87 ~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~  166 (373)
T 1q8y_A           87 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME  166 (373)
T ss_dssp             TBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred             hHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEe
Confidence            6699999987654    89999999999999999886655799999999999999999999998 999999999999997


Q ss_pred             cCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHH
Q 015222          229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL  308 (411)
Q Consensus       229 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  308 (411)
                      .++.                     .+....+||+|||++...........||+.|+|||++.+..++.++|||||||++
T Consensus       167 ~~~~---------------------~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il  225 (373)
T 1q8y_A          167 IVDS---------------------PENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLI  225 (373)
T ss_dssp             EEET---------------------TTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHH
T ss_pred             ccCC---------------------CcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHH
Confidence            6431                     0123368999999998776666667899999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCC------hHHHHHHHHHHhCCCChhHH--------------------------------------Hh
Q 015222          309 VELCSGEALFQTHE------NLEHLAMMERVLGPLPHHMV--------------------------------------IR  344 (411)
Q Consensus       309 ~elltg~~pf~~~~------~~~~~~~i~~~~~~~p~~~~--------------------------------------~~  344 (411)
                      |||++|+.||.+.+      ..+.+..+....+.+|..+.                                      ..
T Consensus       226 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (373)
T 1q8y_A          226 FELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD  305 (373)
T ss_dssp             HHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHH
T ss_pred             HHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcc
Confidence            99999999998654      45566666676777665432                                      24


Q ss_pred             hhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          345 ADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       345 ~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      .+..+.++|.+||..|    |.+|||+.++++||||.+...
T Consensus       306 ~~~~~~~li~~~L~~d----P~~Rpt~~ell~hp~f~~~~~  342 (373)
T 1q8y_A          306 EAKEISDFLSPMLQLD----PRKRADAGGLVNHPWLKDTLG  342 (373)
T ss_dssp             HHHHHHHHHGGGGCSS----TTTCBCHHHHHTCGGGTTCTT
T ss_pred             hHHHHHHHHHHHhccC----ccccCCHHHHhhChhhhcccC
Confidence            4677889999999999    999999999999999998644

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.4e-50  Score=381.32  Aligned_cols=259  Identities=27%  Similarity=0.431  Sum_probs=214.7

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhh--hHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY--REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      ++|+++++||+|+||+||+|++..+++.||||+++.....  ...+.+|+.+++.++|+||     +++++++.+.+..+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI-----VTLHDIIHTEKSLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTB-----CCEEEEEECSSCEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCC-----CeeeeEEeeCCEEE
Confidence            5799999999999999999999999999999999743321  2234579999999887776     99999999999999


Q ss_pred             EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      +||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++                  
T Consensus        77 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~------------------  137 (324)
T 3mtl_A           77 LVFEYLDKDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG------------------  137 (324)
T ss_dssp             EEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTC------------------
T ss_pred             EEecccccCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCC------------------
Confidence            999999889999998764 4699999999999999999999999999999999999998766                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecC-CCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                               .+||+|||++......   .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+
T Consensus       138 ---------~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  208 (324)
T 3mtl_A          138 ---------ELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE  208 (324)
T ss_dssp             ---------CEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ---------CEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                     5677777776644322   233478999999999987 478999999999999999999999999999988


Q ss_pred             HHHHHHHHhCCCChhHH--------------------------HhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCC
Q 015222          326 HLAMMERVLGPLPHHMV--------------------------IRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR  379 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~--------------------------~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~  379 (411)
                      .+..+.+..+..+...+                          ..++..+.++|.+||+.|    |.+|||+.|+++|||
T Consensus       209 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d----P~~R~t~~e~l~hp~  284 (324)
T 3mtl_A          209 QLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFE----GRNRISAEDAMKHPF  284 (324)
T ss_dssp             HHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSS----GGGSCCHHHHTTSGG
T ss_pred             HHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcC----cccCCCHHHHhcChh
Confidence            88888887665443222                          134667889999999999    999999999999999


Q ss_pred             CCcccccC
Q 015222          380 LPVIDLYS  387 (411)
Q Consensus       380 ~~~~~~~~  387 (411)
                      |.++....
T Consensus       285 f~~~~~~~  292 (324)
T 3mtl_A          285 FLSLGERI  292 (324)
T ss_dssp             GGGGCSTT
T ss_pred             hhhccccc
Confidence            99887543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.4e-49  Score=381.40  Aligned_cols=272  Identities=26%  Similarity=0.444  Sum_probs=226.7

Q ss_pred             CCCCCceEEeeCC---ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCC
Q 015222           76 DDKDGHYVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHD  149 (411)
Q Consensus        76 ~~~~~~~~~~~~~---~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~  149 (411)
                      ...++.+...+..   .+.++|++.+.||+|+||.||+|.++.+|+.||||++...   ......+.+|+.+++.++|+|
T Consensus        23 ~~~~g~~~~~~~~~~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  102 (371)
T 4exu_A           23 IRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN  102 (371)
T ss_dssp             SSCTTEEEEEETTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTT
T ss_pred             eccccceeeeeccceecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCC
Confidence            3456666666655   3678999999999999999999999999999999999753   234567789999999998887


Q ss_pred             CCCcceEEEeeeeecCCeE------EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 015222          150 IGGTRCVQIRNWFDYRNHI------CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPE  223 (411)
Q Consensus       150 i~~~~iv~~~~~~~~~~~~------~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~  223 (411)
                      |     +++++++...+..      |+||||++++|.+++..    .+++..++.++.||+.||+|||++||+||||||+
T Consensus       103 i-----v~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~  173 (371)
T 4exu_A          103 V-----IGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPG  173 (371)
T ss_dssp             B-----CCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             c-----hhhhhheeccCCcccceeEEEEEccccccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHH
Confidence            7     9999999876544      99999998899888743    4999999999999999999999999999999999


Q ss_pred             cEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecC-CCCCccchhH
Q 015222          224 NILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLW  302 (411)
Q Consensus       224 NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diw  302 (411)
                      |||++.++                           .+||+|||++...........||+.|+|||++.+ ..++.++|||
T Consensus       174 NIll~~~~---------------------------~~kL~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  226 (371)
T 4exu_A          174 NLAVNEDC---------------------------ELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIW  226 (371)
T ss_dssp             GEEECTTC---------------------------CEEECSTTCC--------CTTCCCTTSCHHHHSCCSCCCTTHHHH
T ss_pred             HeEECCCC---------------------------CEEEEecCcccccccCcCCcccCccccCHHHhcCCCCCCcHHhHH
Confidence            99997765                           6788888888776666666789999999999987 5899999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHH---------------------------Hhhhhhhhhhhcc
Q 015222          303 SVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMV---------------------------IRADRRAEKYFRR  355 (411)
Q Consensus       303 SlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~---------------------------~~~~~~~~~li~~  355 (411)
                      ||||++|+|++|+.||.+.+..+.+..+....+..+..+.                           ...+..+.++|.+
T Consensus       227 slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  306 (371)
T 4exu_A          227 SVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEK  306 (371)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHH
Confidence            9999999999999999999988888888777666554432                           2346789999999


Q ss_pred             CCccCCCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          356 GARLDWPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       356 ~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                      ||..|    |.+|||+.++++||||..+....
T Consensus       307 ~L~~d----P~~Rpt~~ell~hp~f~~~~~~~  334 (371)
T 4exu_A          307 MLELD----VDKRLTAAQALTHPFFEPFRDPE  334 (371)
T ss_dssp             HSCSC----TTTSCCHHHHHTSGGGTTTCCGG
T ss_pred             HCCCC----hhhcCCHHHHhcCcccccCCCcc
Confidence            99999    99999999999999999765443

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=9.7e-50  Score=403.10  Aligned_cols=256  Identities=23%  Similarity=0.353  Sum_probs=217.8

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      .++|++.+.||+|+||.||+|+++.+|+.||||++.+..    .....+.+|+.+++.++|++|     +++++++.+.+
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~I-----v~l~~~~~~~~  257 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFV-----VSLAYAYETKD  257 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTB-----CCEEEEEECSS
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCE-----eeEEEEEeeCC
Confidence            468999999999999999999999999999999997532    334567889999999988777     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      .+|+||||+ |++|.+++.......+++..++.++.||+.||+|||++||+||||||+||||+.+|              
T Consensus       258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g--------------  323 (576)
T 2acx_A          258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG--------------  323 (576)
T ss_dssp             EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--------------
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC--------------
Confidence            999999999 99999999876655699999999999999999999999999999999999998776              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN  323 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~  323 (411)
                                   .+||+|||++......  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus       324 -------------~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~  390 (576)
T 2acx_A          324 -------------HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK  390 (576)
T ss_dssp             -------------CEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS
T ss_pred             -------------CeEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccccc
Confidence                         5677777777654332  2345899999999999999999999999999999999999999987542


Q ss_pred             ----HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH-----HHHHHHhcCCCCccccc
Q 015222          324 ----LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-----SMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       324 ----~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~-----t~~~il~~~~~~~~~~~  386 (411)
                          .+....+......++    ..++..+.++|.+||..|    |.+|+     ++.++++|+||.++++.
T Consensus       391 ~~~~~~i~~~i~~~~~~~p----~~~s~~~~dLI~~lL~~d----P~~R~g~~~~sa~eil~HpfF~~i~w~  454 (576)
T 2acx_A          391 KIKREEVERLVKEVPEEYS----ERFSPQARSLCSQLLCKD----PAERLGCRGGSAREVKEHPLFKKLNFK  454 (576)
T ss_dssp             CCCHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSS----GGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred             chhHHHHHHHhhcccccCC----ccCCHHHHHHHHHhccCC----HHHcCCCCCCCHHHHHhChhhccCCHH
Confidence                333444444333343    456788999999999999    77777     99999999999998754

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.1e-50  Score=402.06  Aligned_cols=266  Identities=26%  Similarity=0.419  Sum_probs=233.1

Q ss_pred             EeeCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc----hhhhHHHHHHHHHHHHHhcCCCCCcceEEEe
Q 015222           84 FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIR  159 (411)
Q Consensus        84 ~~~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~  159 (411)
                      ...+..+.++|++.+.||+|+||.||+|+++.+++.||||++...    ....+.+.+|+.+++++.|+||     ++++
T Consensus        18 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~   92 (484)
T 3nyv_A           18 QHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI-----MKLY   92 (484)
T ss_dssp             -CCCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTB-----CCEE
T ss_pred             ccCCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCC-----CcEE
Confidence            344456778999999999999999999999999999999998643    2345778899999999988777     9999


Q ss_pred             eeeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCc
Q 015222          160 NWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY  238 (411)
Q Consensus       160 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df  238 (411)
                      +++.+.+.+|+||||+ +++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++..+       
T Consensus        93 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-------  163 (484)
T 3nyv_A           93 EFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKS-------  163 (484)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS-------
T ss_pred             EEEEeCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCC-------
Confidence            9999999999999999 999999998765  699999999999999999999999999999999999995432       


Q ss_pred             ccccccCCCCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCC
Q 015222          239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA  316 (411)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~  316 (411)
                                       .+..+||+|||++.......  ....||+.|+|||++.+ .++.++|||||||++|+|++|..
T Consensus       164 -----------------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~  225 (484)
T 3nyv_A          164 -----------------KDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCP  225 (484)
T ss_dssp             -----------------TTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             -----------------CCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCC
Confidence                             34478999999887654332  34579999999999987 69999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      ||.+.+..+.+..+......++...+..+++.++++|.+||..+    |.+|||+.++++||||+....
T Consensus       226 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d----p~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          226 PFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYV----PSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             SSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSS----GGGSCCHHHHHTSHHHHHHTC
T ss_pred             CCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCC----hhHCcCHHHHhhChhhccccc
Confidence            99999998888888887777776666788999999999999999    999999999999999987654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=6.7e-50  Score=386.27  Aligned_cols=255  Identities=27%  Similarity=0.367  Sum_probs=206.7

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      .++|++++.||+|+||+||+|+++.+++.||||++.......+.+.+|+.+++.++|+||     +++++++.+.+.+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~~~~~l   93 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNI-----VRFKEVILTPTHLAI   93 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTB-----CCEEEEEECSSEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCC-----CcEEEEEeeCCEEEE
Confidence            468999999999999999999999999999999998766666788999999999988877     999999999999999


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      ||||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++                  
T Consensus        94 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~------------------  153 (361)
T 3uc3_A           94 IMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSP------------------  153 (361)
T ss_dssp             EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSS------------------
T ss_pred             EEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC------------------
Confidence            99999 999999998765  699999999999999999999999999999999999997654                  


Q ss_pred             ccccCCCCCCeeEeecCCccccc--CCCcccccCCCccccceecCCCCCcc-chhHHHHHHHHHHHhCCCCCCCCCh---
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEH--QDHSYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSGEALFQTHEN---  323 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~pf~~~~~---  323 (411)
                             ...+||+|||++....  .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.   
T Consensus       154 -------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~  226 (361)
T 3uc3_A          154 -------APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD  226 (361)
T ss_dssp             -------SCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC
T ss_pred             -------CceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH
Confidence                   2258999999887432  22344679999999999998877655 8999999999999999999987543   


Q ss_pred             -HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcc
Q 015222          324 -LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVI  383 (411)
Q Consensus       324 -~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~  383 (411)
                       ...+..+......+|..  ..++..+.++|.+||..+    |.+|||+.++++|+||...
T Consensus       227 ~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~~L~~d----P~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          227 YRKTIQRILSVKYSIPDD--IRISPECCHLISRIFVAD----PATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             HHHHHHHHHTTCCCCCTT--SCCCHHHHHHHHHHSCSC----TTTSCCHHHHHTSHHHHTT
T ss_pred             HHHHHHHHhcCCCCCCCc--CCCCHHHHHHHHHHccCC----hhHCcCHHHHHhCcchhcC
Confidence             23333333333333332  246778999999999999    9999999999999999543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.8e-49  Score=383.43  Aligned_cols=265  Identities=28%  Similarity=0.448  Sum_probs=213.9

Q ss_pred             CCceEEeeCC---ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCC
Q 015222           79 DGHYVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGG  152 (411)
Q Consensus        79 ~~~~~~~~~~---~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~  152 (411)
                      +..+.+.+++   .+.++|++++.||+|+||.||+|.+..+++.||||++...   ....+.+.+|+.+++.+.|+||  
T Consensus         9 ~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni--   86 (371)
T 2xrw_A            9 NNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI--   86 (371)
T ss_dssp             GGEEEEEETTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTB--
T ss_pred             CcceEeecCCcccchhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCc--
Confidence            3556677776   3568999999999999999999999999999999999743   2344667899999999988877  


Q ss_pred             cceEEEeeeeecCC------eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015222          153 TRCVQIRNWFDYRN------HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL  226 (411)
Q Consensus       153 ~~iv~~~~~~~~~~------~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIl  226 (411)
                         +++++++...+      ..|+||||+.++|.+++..    .+++..+..++.||+.||+|||++||+||||||+|||
T Consensus        87 ---v~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl  159 (371)
T 2xrw_A           87 ---IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV  159 (371)
T ss_dssp             ---CCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             ---cceEEeeccccccccccceEEEEEcCCCCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEE
Confidence               99999887654      8999999998899998863    4899999999999999999999999999999999999


Q ss_pred             EecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHH
Q 015222          227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSV  304 (411)
Q Consensus       227 i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  304 (411)
                      ++.++                           .+||+|||++......  .....||+.|+|||++.+..++.++|||||
T Consensus       160 ~~~~~---------------------------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  212 (371)
T 2xrw_A          160 VKSDC---------------------------TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV  212 (371)
T ss_dssp             ECTTS---------------------------CEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHH
T ss_pred             EcCCC---------------------------CEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHH
Confidence            98766                           5777888877654432  234579999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHH--------------------------------------Hhhh
Q 015222          305 GCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMV--------------------------------------IRAD  346 (411)
Q Consensus       305 Gvil~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~--------------------------------------~~~~  346 (411)
                      ||++|+|++|+.||.+.+..+.+..+.+..+..+..+.                                      ...+
T Consensus       213 G~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (371)
T 2xrw_A          213 GCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKA  292 (371)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCccccccccccc
Confidence            99999999999999998887777776655443332221                                      2235


Q ss_pred             hhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcc
Q 015222          347 RRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVI  383 (411)
Q Consensus       347 ~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~  383 (411)
                      ..+.++|.+||..|    |.+|||++++++||||...
T Consensus       293 ~~~~~li~~mL~~d----P~~R~t~~e~l~hp~~~~~  325 (371)
T 2xrw_A          293 SQARDLLSKMLVID----ASKRISVDEALQHPYINVW  325 (371)
T ss_dssp             HHHHHHHHHHSCSS----GGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHHHCcCC----hhhCCCHHHHhCCcchhhh
Confidence            67899999999999    9999999999999999753

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.9e-49  Score=370.64  Aligned_cols=259  Identities=29%  Similarity=0.494  Sum_probs=214.2

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      .++|+++++||+|+||+||+|++..+++.||||++....   ...+.+.+|+.++++++|+||     +++++++...+.
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~   76 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNL-----VNLLEVFRRKRR   76 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEEETTE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCc-----cchhheeecCCe
Confidence            468999999999999999999999999999999986433   334667789999999988877     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      .++||||+ +++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++               
T Consensus        77 ~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~---------------  139 (311)
T 4agu_A           77 LHLVFEYCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS---------------  139 (311)
T ss_dssp             EEEEEECCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS---------------
T ss_pred             EEEEEEeCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC---------------
Confidence            99999999 777888777654  699999999999999999999999999999999999997766               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecC-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHE  322 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~  322 (411)
                                  .++|+|||++......   .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+
T Consensus       140 ------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  207 (311)
T 4agu_A          140 ------------VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS  207 (311)
T ss_dssp             ------------CEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ------------CEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence                        6788888877654422   233578999999999987 478999999999999999999999999998


Q ss_pred             hHHHHHHHHHHhCCCChhHH---------------------------HhhhhhhhhhhccCCccCCCCCCCcHHHHHHHH
Q 015222          323 NLEHLAMMERVLGPLPHHMV---------------------------IRADRRAEKYFRRGARLDWPDGATSRDSMRAVW  375 (411)
Q Consensus       323 ~~~~~~~i~~~~~~~p~~~~---------------------------~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il  375 (411)
                      ..+....+.+..+.......                           ..++..+.+++.+||..|    |.+|||+++++
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d----P~~Rpt~~ell  283 (311)
T 4agu_A          208 DVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMD----PTERLTCEQLL  283 (311)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSS----TTTSCCHHHHH
T ss_pred             HHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCC----hhhcCCHHHHh
Confidence            88888877776655443221                           235566889999999999    99999999999


Q ss_pred             hcCCCCcccccC
Q 015222          376 KLLRLPVIDLYS  387 (411)
Q Consensus       376 ~~~~~~~~~~~~  387 (411)
                      +||||+++....
T Consensus       284 ~hp~f~~~~~~~  295 (311)
T 4agu_A          284 HHPYFENIREIE  295 (311)
T ss_dssp             TSGGGTTCC---
T ss_pred             cChHHHhccCHH
Confidence            999999987544

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5.6e-49  Score=380.33  Aligned_cols=266  Identities=29%  Similarity=0.493  Sum_probs=222.6

Q ss_pred             eeCCcc--CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEee
Q 015222           85 AIGENL--TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRN  160 (411)
Q Consensus        85 ~~~~~~--~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~  160 (411)
                      ..|+.+  .++|++++.||+|+||.||+|.+..+++.||||++...  ....+.+.+|+.++++++|+||     +++++
T Consensus        18 ~~g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~   92 (364)
T 3qyz_A           18 VRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI-----IGIND   92 (364)
T ss_dssp             CC-CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTB-----CCCCE
T ss_pred             EccEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCC-----cccee
Confidence            344444  47999999999999999999999999999999999743  2344678899999999988877     89988


Q ss_pred             eeecC-----CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCccccc
Q 015222          161 WFDYR-----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV  235 (411)
Q Consensus       161 ~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l  235 (411)
                      ++...     ...|+||||++++|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++.++    
T Consensus        93 ~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~----  165 (364)
T 3qyz_A           93 IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC----  165 (364)
T ss_dssp             EECCSSTTTCCCEEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC----
T ss_pred             EEecCCccccceEEEEEcccCcCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCC----
Confidence            88654     479999999988999999875   499999999999999999999999999999999999997766    


Q ss_pred             CCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC------CcccccCCCccccceecCC-CCCccchhHHHHHHH
Q 015222          236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCIL  308 (411)
Q Consensus       236 ~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil  308 (411)
                                             .+||+|||++......      .....||+.|+|||++.+. .++.++|||||||++
T Consensus       166 -----------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il  222 (364)
T 3qyz_A          166 -----------------------DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCIL  222 (364)
T ss_dssp             -----------------------CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHH
T ss_pred             -----------------------CEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHH
Confidence                                   5777788877654322      1335799999999987654 589999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHH---------------------------HhhhhhhhhhhccCCccCC
Q 015222          309 VELCSGEALFQTHENLEHLAMMERVLGPLPHHMV---------------------------IRADRRAEKYFRRGARLDW  361 (411)
Q Consensus       309 ~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~---------------------------~~~~~~~~~li~~~l~~~~  361 (411)
                      |+|++|+.||.+.+..+.+..+....+..+....                           ...+..+.++|.+||..| 
T Consensus       223 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d-  301 (364)
T 3qyz_A          223 AEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFN-  301 (364)
T ss_dssp             HHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSS-
T ss_pred             HHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCC-
Confidence            9999999999999888888888777666554332                           235678899999999999 


Q ss_pred             CCCCCcHHHHHHHHhcCCCCcccccCCC
Q 015222          362 PDGATSRDSMRAVWKLLRLPVIDLYSAS  389 (411)
Q Consensus       362 ~~rp~~R~t~~~il~~~~~~~~~~~~~~  389 (411)
                         |.+|||+.++++||||.+.......
T Consensus       302 ---P~~R~t~~e~l~hp~~~~~~~~~~~  326 (364)
T 3qyz_A          302 ---PHKRIEVEQALAHPYLEQYYDPSDE  326 (364)
T ss_dssp             ---TTTSCCHHHHHTSGGGTTTCCGGGS
T ss_pred             ---hhhCCCHHHHhcCcchhhccCcccc
Confidence               9999999999999999987554433

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.2e-49  Score=380.02  Aligned_cols=260  Identities=25%  Similarity=0.409  Sum_probs=219.8

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec----
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY----  164 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~----  164 (411)
                      ++|+++++||+|+||+||+|++..+++.||||++....   .....+.+|+.+++.++|+||     +++++++..    
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~   91 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV-----VNLIEICRTKASP   91 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTB-----CCEEEEEEEC---
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCc-----ccHhheeeccccc
Confidence            68999999999999999999999999999999986432   234567889999999988877     899988876    


Q ss_pred             ----CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          165 ----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       165 ----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                          .+.+|+||||++++|.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++         
T Consensus        92 ~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~---------  161 (351)
T 3mi9_A           92 YNRCKGSIYLVFDFCEHDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG---------  161 (351)
T ss_dssp             -----CEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS---------
T ss_pred             cccCCceEEEEEeccCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC---------
Confidence                45799999999889998887654 3699999999999999999999999999999999999998776         


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccC-------CCcccccCCCccccceecCC-CCCccchhHHHHHHHHHHH
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-------DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELC  312 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell  312 (411)
                                        .+||+|||++.....       ......||+.|+|||++.+. .++.++|||||||++|+|+
T Consensus       162 ------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  223 (351)
T 3mi9_A          162 ------------------VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW  223 (351)
T ss_dssp             ------------------CEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHH
T ss_pred             ------------------CEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHH
Confidence                              567777776654321       12335789999999999874 6899999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChhHHHhh----------------------------hhhhhhhhccCCccCCCCC
Q 015222          313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRA----------------------------DRRAEKYFRRGARLDWPDG  364 (411)
Q Consensus       313 tg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~----------------------------~~~~~~li~~~l~~~~~~r  364 (411)
                      +|..||.+.+..+.+..+....+.++...+...                            ++.+.++|.+||..|    
T Consensus       224 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d----  299 (351)
T 3mi9_A          224 TRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD----  299 (351)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSS----
T ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCC----
Confidence            999999999999999988888777765544332                            456889999999999    


Q ss_pred             CCcHHHHHHHHhcCCCCcccccCC
Q 015222          365 ATSRDSMRAVWKLLRLPVIDLYSA  388 (411)
Q Consensus       365 p~~R~t~~~il~~~~~~~~~~~~~  388 (411)
                      |.+|||+.++++|+||.+......
T Consensus       300 P~~R~t~~e~l~hp~f~~~~~~~~  323 (351)
T 3mi9_A          300 PAQRIDSDDALNHDFFWSDPMPSD  323 (351)
T ss_dssp             GGGSCCHHHHHTSGGGGSSSCCCC
T ss_pred             hhhCCCHHHHhCCCCcCCCCCccc
Confidence            999999999999999987665443

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.9e-49  Score=393.84  Aligned_cols=256  Identities=21%  Similarity=0.335  Sum_probs=214.0

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      ..++|++++.||+|+||.||+|++..+++.||||+++...    .....+.+|+.+++.+.|+||     +++++++...
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~l~~~~~~~  220 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL-----TALKYSFQTH  220 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTS-----CCEEEEEEET
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeE-----eeEEEEEeeC
Confidence            3468999999999999999999999999999999997432    233456678888888877766     9999999999


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                      +.+|+||||+ +++|.+++....  .+++..++.++.||+.||+|||+ +||+||||||+||||+.++            
T Consensus       221 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~------------  286 (446)
T 4ejn_A          221 DRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG------------  286 (446)
T ss_dssp             TEEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS------------
T ss_pred             CEEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC------------
Confidence            9999999999 899999998765  79999999999999999999998 9999999999999998766            


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccC---CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT  320 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~  320 (411)
                                     .+||+|||++.....   .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus       287 ---------------~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  351 (446)
T 4ejn_A          287 ---------------HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  351 (446)
T ss_dssp             ---------------CEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ---------------CEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence                           577777777764322   22446899999999999999999999999999999999999999999


Q ss_pred             CChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH-----HHHHHHhcCCCCcccccC
Q 015222          321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-----SMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~-----t~~~il~~~~~~~~~~~~  387 (411)
                      .+..+....+......+|.    .+++.+.++|.+||..|    |.+|+     +++++++|+||.++++..
T Consensus       352 ~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~L~~d----P~~R~~~~~~t~~ell~hp~f~~~~~~~  415 (446)
T 4ejn_A          352 QDHEKLFELILMEEIRFPR----TLGPEAKSLLSGLLKKD----PKQRLGGGSEDAKEIMQHRFFAGIVWQH  415 (446)
T ss_dssp             SSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSS----TTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred             CCHHHHHHHHHhCCCCCCc----cCCHHHHHHHHHHcccC----HHHhCCCCCCCHHHHHhCccccCCCHHH
Confidence            8888888777766656654    35778999999999999    77887     999999999999987643

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.4e-49  Score=384.38  Aligned_cols=269  Identities=17%  Similarity=0.206  Sum_probs=211.2

Q ss_pred             CCeEEEeeeccc--cceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           92 PRYRILSKMGEG--TFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        92 ~~y~i~~~lG~G--~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      ++|+++++||+|  +||+||+|+++.+++.||||+++...   ...+.+.+|+.+++.++|+||     +++++++.+.+
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~   99 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNI-----VPYRATFIADN   99 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEEETT
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCC-----CcEeEEEEECC
Confidence            589999999999  99999999999999999999997543   344667889999999988877     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      .+|+||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++    
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~----  175 (389)
T 3gni_B          100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN----  175 (389)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGC----
T ss_pred             EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccc----
Confidence            999999999 899999998875557999999999999999999999999999999999999988886655555542    


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccc-cCCCcccccCCCccccceecC--CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFE-HQDHSYVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSGEALFQTHE  322 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~pf~~~~  322 (411)
                                    ..+.+.|..... ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||.+.+
T Consensus       176 --------------~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  241 (389)
T 3gni_B          176 --------------LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP  241 (389)
T ss_dssp             --------------EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             --------------eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence                          122222221111 111233478999999999988  579999999999999999999999998766


Q ss_pred             hHHHHHHHHHHhC------------------------------------------CCChhHHHhhhhhhhhhhccCCccC
Q 015222          323 NLEHLAMMERVLG------------------------------------------PLPHHMVIRADRRAEKYFRRGARLD  360 (411)
Q Consensus       323 ~~~~~~~i~~~~~------------------------------------------~~p~~~~~~~~~~~~~li~~~l~~~  360 (411)
                      ..+.+..+.....                                          .........++..+.++|.+||+.|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  321 (389)
T 3gni_B          242 ATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRN  321 (389)
T ss_dssp             STTHHHHC--------------------------------------------------------CCHHHHHHHHHHTCSC
T ss_pred             HHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcC
Confidence            5444332221110                                          0011133456778999999999999


Q ss_pred             CCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          361 WPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       361 ~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                          |.+|||+.++++||||+++....
T Consensus       322 ----P~~Rpta~ell~hp~f~~~~~~~  344 (389)
T 3gni_B          322 ----PDARPSASTLLNHSFFKQIKRRA  344 (389)
T ss_dssp             ----TTTSCCHHHHTTSGGGGGC---C
T ss_pred             ----cccCCCHHHHhcCHHHHHHhhcc
Confidence                99999999999999999876543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.9e-49  Score=377.34  Aligned_cols=256  Identities=22%  Similarity=0.317  Sum_probs=211.3

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      +.++|++.+.||+|+||+||+|++..+++.||||++....  ...+.+.+|+.+++.+.|+||     +++++++.+++.
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~~~~~~~~~   79 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV-----VKFYGHRREGNI   79 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTB-----CCEEEEEECSSE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCC-----CeEEEEEecCCe
Confidence            5578999999999999999999999999999999986432  334668899999999988877     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      .|+||||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++               
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~---------------  142 (323)
T 3tki_A           80 QYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD---------------  142 (323)
T ss_dssp             EEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC---------------
T ss_pred             EEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCC---------------
Confidence            99999999 889999987654  699999999999999999999999999999999999997766               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCC-CccchhHHHHHHHHHHHhCCCCCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQT  320 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~pf~~  320 (411)
                                  .+||+|||++......     .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+
T Consensus       143 ------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  210 (323)
T 3tki_A          143 ------------NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ  210 (323)
T ss_dssp             ------------CEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred             ------------CEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Confidence                        5778888877643221     234579999999999988765 7899999999999999999999987


Q ss_pred             CChHHH-HHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          321 HENLEH-LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       321 ~~~~~~-~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      .+.... ...........  .....++..+.++|.+||..|    |.+|||+.|+++|+||.+...
T Consensus       211 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~d----P~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          211 PSDSCQEYSDWKEKKTYL--NPWKKIDSAPLALLHKILVEN----PSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             SCTTSHHHHHHHTTCTTS--TTGGGSCHHHHHHHHHHSCSS----TTTSCCHHHHTTCTTTTCCCC
T ss_pred             CchHHHHHHHHhcccccC--CccccCCHHHHHHHHHHccCC----hhhCcCHHHHhhChhhccccc
Confidence            655322 22222221111  223567888999999999999    999999999999999986543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.6e-49  Score=399.29  Aligned_cols=261  Identities=27%  Similarity=0.433  Sum_probs=227.1

Q ss_pred             CCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee
Q 015222           87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        87 ~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~  163 (411)
                      ...+.++|+++++||+|+||+||+|+++.+++.||||++....   .....+.+|+.+++.+.|+||     +++++++.
T Consensus        32 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~  106 (494)
T 3lij_A           32 KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI-----MKLYDFFE  106 (494)
T ss_dssp             BCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTB-----CCEEEEEE
T ss_pred             CCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCC-----CeEEEEEE
Confidence            3445678999999999999999999999999999999997532   335678899999999988777     99999999


Q ss_pred             cCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccc
Q 015222          164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                      +.+.+|+||||+ +++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++..+           
T Consensus       107 ~~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-----------  173 (494)
T 3lij_A          107 DKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKE-----------  173 (494)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS-----------
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCC-----------
Confidence            999999999999 999999988765  699999999999999999999999999999999999997643           


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT  320 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~  320 (411)
                                   ....+||+|||++......  .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+
T Consensus       174 -------------~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~  239 (494)
T 3lij_A          174 -------------KDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGG  239 (494)
T ss_dssp             -------------TTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             -------------CCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence                         2346899999998765433  234679999999999864 799999999999999999999999999


Q ss_pred             CChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcc
Q 015222          321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVI  383 (411)
Q Consensus       321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~  383 (411)
                      .+..+.+..+......++...+..++..+.++|.+||..+    |.+|||+.++++||||++.
T Consensus       240 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d----p~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          240 QTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFD----SQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             SSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSS----TTTSCCHHHHHTCHHHHHH
T ss_pred             CCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCC----hhhCccHHHHhcCcccccC
Confidence            9999988888888777777777788999999999999999    9999999999999999875

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.7e-49  Score=366.74  Aligned_cols=261  Identities=23%  Similarity=0.344  Sum_probs=228.9

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc-hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      .+.++|++.+.||+|+||.||+|.+..++..||+|++... ....+.+.+|+.+++++.|+||     +++++++.+.+.
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~   80 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNI-----IRLYETFEDNTD   80 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTB-----CCEEEEEECSSE
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCE-----eeEEEEEecCCe
Confidence            3557899999999999999999999999999999998753 3445678899999999988776     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      .++||||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||+..++               
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~---------------  143 (277)
T 3f3z_A           81 IYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDS---------------  143 (277)
T ss_dssp             EEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS---------------
T ss_pred             EEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCC---------------
Confidence            99999999 889999998765  699999999999999999999999999999999999994321               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                               .+..++|+|||++......  .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..
T Consensus       144 ---------~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  213 (277)
T 3f3z_A          144 ---------PDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS  213 (277)
T ss_dssp             ---------TTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             ---------CCCcEEEEecccceeccCccchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH
Confidence                     2347889999988754432  234579999999999876 4899999999999999999999999998888


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      +....+......++......+++.+.++|.+||+.+    |.+||++.++++|+||++...
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d----p~~R~s~~~~l~h~~~~~~~~  270 (277)
T 3f3z_A          214 EVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKS----PKQRITSLQALEHEWFEKQLS  270 (277)
T ss_dssp             HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSS----TTTSCCHHHHTTSHHHHHHHC
T ss_pred             HHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCC----hhhCcCHHHHhcCHHHhcccc
Confidence            888888888778888877788999999999999999    999999999999999987543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.4e-49  Score=366.65  Aligned_cols=264  Identities=25%  Similarity=0.416  Sum_probs=229.5

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-------hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeee
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF  162 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~  162 (411)
                      +.++|++.+.||+|+||.||+|++..+++.||+|+++...       ...+.+.+|+.+++++.|+|+     +++++++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~   77 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI-----ITLHDIF   77 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTB-----CCEEEEE
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCe-----eehhhee
Confidence            3468999999999999999999999999999999987432       135678899999999988777     9999999


Q ss_pred             ecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccc
Q 015222          163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL  241 (411)
Q Consensus       163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~  241 (411)
                      .+.+..++||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+||+++.++          
T Consensus        78 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~----------  145 (283)
T 3bhy_A           78 ENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKN----------  145 (283)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS----------
T ss_pred             cCCCeEEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCC----------
Confidence            9999999999999 899999998765  699999999999999999999999999999999999997654          


Q ss_pred             cccCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 015222          242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ  319 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~  319 (411)
                                   .....++|+|||++......  .....||+.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus       146 -------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  212 (283)
T 3bhy_A          146 -------------VPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL  212 (283)
T ss_dssp             -------------SSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             -------------CCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCC
Confidence                         12346899999988765432  234578999999999999899999999999999999999999999


Q ss_pred             CCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                      +.+..+.+..+.......+.......+..+.+++.+||..+    |.+||++.++++|+||+.+....
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d----p~~Rps~~~~l~h~~~~~~~~~~  276 (283)
T 3bhy_A          213 GETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKD----PKRRMTIAQSLEHSWIKAIRRRN  276 (283)
T ss_dssp             CSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSS----GGGSCCHHHHHHCHHHHHHHHCC
T ss_pred             CcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCC----HhHCcCHHHHHhCHHHHHHHHHh
Confidence            98888888877777777777777888899999999999999    99999999999999999876544

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=7.6e-49  Score=407.11  Aligned_cols=261  Identities=21%  Similarity=0.281  Sum_probs=220.9

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      .++|++++.||+|+||.||+|+++.+++.||||++++..    ...+.+..|..++..+.+    |++++.+++++.+.+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~----~~~i~~l~~~~~~~~  415 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK----PPFLTQLHSCFQTMD  415 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTC----CTTBCCEEEECBCSS
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccC----CCeEEEEEEEEEeCC
Confidence            468999999999999999999999999999999997532    334567778888887642    244599999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      .+|+||||+ +++|.+++....  .+++..++.++.||+.||+|||++|||||||||+||||+.+|              
T Consensus       416 ~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g--------------  479 (674)
T 3pfq_A          416 RLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG--------------  479 (674)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSS--------------
T ss_pred             EEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCC--------------
Confidence            999999999 999999998865  699999999999999999999999999999999999998777              


Q ss_pred             CCCCccccCCCCCCeeEeecCCccccc---CCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE  322 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~  322 (411)
                                   .+||+|||++....   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus       480 -------------~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~  546 (674)
T 3pfq_A          480 -------------HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED  546 (674)
T ss_dssp             -------------CEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             -------------cEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC
Confidence                         56777777776422   22345689999999999999999999999999999999999999999999


Q ss_pred             hHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCc-HHHHHHHHhcCCCCcccccCC
Q 015222          323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATS-RDSMRAVWKLLRLPVIDLYSA  388 (411)
Q Consensus       323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~-R~t~~~il~~~~~~~~~~~~~  388 (411)
                      ..+.+..+......+|.    .++..+.++|.+||..|+.+|+.. ...++++++|+||.+++|...
T Consensus       547 ~~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l  609 (674)
T 3pfq_A          547 EDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL  609 (674)
T ss_dssp             HHHHHHHHHSSCCCCCT----TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHH
T ss_pred             HHHHHHHHHhCCCCCCc----cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHH
Confidence            88888888876666665    467889999999999994444332 223499999999999987543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.8e-49  Score=371.67  Aligned_cols=250  Identities=20%  Similarity=0.328  Sum_probs=206.4

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchh---------------------------hhHHHHHHHHHHH
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---------------------------YREAAMIEIDVLQ  143 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~---------------------------~~~~~~~E~~~l~  143 (411)
                      .++|++.+.||+|+||.||+|++..+++.||||++.....                           ..+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            3689999999999999999999999999999999964321                           1355788999999


Q ss_pred             HHhcCCCCCcceEEEeeeeec--CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 015222          144 RLARHDIGGTRCVQIRNWFDY--RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL  220 (411)
Q Consensus       144 ~l~~~~i~~~~iv~~~~~~~~--~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Di  220 (411)
                      +++|+||     +++++++.+  .+.+|+||||+ +++|.+++..   ..+++..++.++.||+.||+|||++||+||||
T Consensus        92 ~l~h~~i-----v~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl  163 (298)
T 2zv2_A           92 KLDHPNV-----VKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDI  163 (298)
T ss_dssp             TCCCTTB-----CCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             hCCCCCC-----CeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence            9988777     999999886  57899999999 8888876543   36999999999999999999999999999999


Q ss_pred             CCCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCCC---
Q 015222          221 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLG---  294 (411)
Q Consensus       221 kp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~---  294 (411)
                      ||+|||++.++                           .+||+|||++.......   ....||+.|+|||++.+..   
T Consensus       164 kp~Nil~~~~~---------------------------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  216 (298)
T 2zv2_A          164 KPSNLLVGEDG---------------------------HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIF  216 (298)
T ss_dssp             CGGGEEECTTS---------------------------CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCE
T ss_pred             CHHHEEECCCC---------------------------CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCC
Confidence            99999998766                           57778888776543322   3357999999999998764   


Q ss_pred             CCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHH
Q 015222          295 WNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV  374 (411)
Q Consensus       295 ~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~i  374 (411)
                      ++.++|||||||++|+|++|+.||.+.+.......+......++.  ...+++.+.++|.+||..|    |.+||++.++
T Consensus       217 ~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~d----p~~R~s~~e~  290 (298)
T 2zv2_A          217 SGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKN----PESRIVVPEI  290 (298)
T ss_dssp             ESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSC----TTTSCCHHHH
T ss_pred             CCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcC----hhhCCCHHHH
Confidence            478999999999999999999999987776666665554434332  2356788999999999999    9999999999


Q ss_pred             HhcCCCC
Q 015222          375 WKLLRLP  381 (411)
Q Consensus       375 l~~~~~~  381 (411)
                      ++||||.
T Consensus       291 l~hp~~~  297 (298)
T 2zv2_A          291 KLHPWVT  297 (298)
T ss_dssp             TTCHHHH
T ss_pred             hcCcccc
Confidence            9999985

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.3e-49  Score=379.82  Aligned_cols=264  Identities=22%  Similarity=0.315  Sum_probs=223.0

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc------hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeee
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF  162 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~  162 (411)
                      .+.++|++.+.||+|+||+||+|.+..+++.||+|++...      ....+.+.+|+.++++++|+||     +++++++
T Consensus        23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~   97 (345)
T 3hko_A           23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI-----ARLYEVY   97 (345)
T ss_dssp             HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTB-----CCEEEEE
T ss_pred             hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCc-----ceeehhh
Confidence            4567899999999999999999999999999999999643      2345678899999999988777     9999999


Q ss_pred             ecCCeEEEEEccC-CCCHHHHHHhcC--------------------------------------CCCCCHHHHHHHHHHH
Q 015222          163 DYRNHICIVFEKL-GPSLYDFLRKNS--------------------------------------YRSFPIDLVRELGRQL  203 (411)
Q Consensus       163 ~~~~~~~lv~e~~-~~~L~~~l~~~~--------------------------------------~~~l~~~~~~~i~~qi  203 (411)
                      .+.+..++||||+ +++|.+++....                                      ...+++..++.++.||
T Consensus        98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi  177 (345)
T 3hko_A           98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI  177 (345)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred             ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence            9999999999999 999999985210                                      1124678899999999


Q ss_pred             HHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC-------Cc
Q 015222          204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-------HS  276 (411)
Q Consensus       204 ~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~  276 (411)
                      +.||+|||++||+||||||+|||++.++                         ...+||+|||++......       ..
T Consensus       178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~~-------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~  232 (345)
T 3hko_A          178 FSALHYLHNQGICHRDIKPENFLFSTNK-------------------------SFEIKLVDFGLSKEFYKLNNGEYYGMT  232 (345)
T ss_dssp             HHHHHHHHHTTEECCCCCGGGEEESCSS-------------------------SCCEEECCCTTCEEGGGTTCC------
T ss_pred             HHHHHHHHHCCccccCCChhhEEEecCC-------------------------CceEEEeeccccccccccCcccccccc
Confidence            9999999999999999999999997644                         236888899888754321       23


Q ss_pred             ccccCCCccccceecC--CCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhc
Q 015222          277 YVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFR  354 (411)
Q Consensus       277 ~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~  354 (411)
                      ...||+.|+|||++.+  ..++.++|||||||++|||++|+.||.+.+..+....+......++......++..+.++|.
T Consensus       233 ~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  312 (345)
T 3hko_A          233 TKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLS  312 (345)
T ss_dssp             --CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHH
T ss_pred             ccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHH
Confidence            4578999999999976  57899999999999999999999999998888888877776666666666678889999999


Q ss_pred             cCCccCCCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          355 RGARLDWPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       355 ~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                      +||..+    |.+||++.++++||||++....
T Consensus       313 ~~l~~~----p~~Rps~~~~l~hp~~~~~~~~  340 (345)
T 3hko_A          313 NLLNRN----VDERFDAMRALQHPWISQFSDK  340 (345)
T ss_dssp             HHSCSC----TTTSCCHHHHHHSHHHHTTSSC
T ss_pred             HHcCCC----hhHCCCHHHHhcChhhccChHh
Confidence            999999    9999999999999999987643

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=8.9e-49  Score=369.31  Aligned_cols=262  Identities=22%  Similarity=0.340  Sum_probs=225.4

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      .+.++|++.+.||+|+||.||+|++..+++.||+|+++... ...+.+.+|+.+++.+.|+||     +++++++.+.+.
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~   80 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENI-----VTLEDIYESTTH   80 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTB-----CCEEEEEECSSE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCe-----eehhhhcccCCE
Confidence            45678999999999999999999999999999999997543 234567899999999988777     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      .++||||+ +++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||+...+               
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~---------------  143 (304)
T 2jam_A           81 YYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPE---------------  143 (304)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSS---------------
T ss_pred             EEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCC---------------
Confidence            99999999 899999998765  699999999999999999999999999999999999984211               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC-CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                               .+..++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+
T Consensus       144 ---------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  214 (304)
T 2jam_A          144 ---------ENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK  214 (304)
T ss_dssp             ---------TTCCEEBCSCSTTCCCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred             ---------CCCCEEEccCCcceecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence                     2346888888887754432 234579999999999999999999999999999999999999999988888


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      ....+......++......++..+.++|.+||..|    |.+||++.++++|+||.+...
T Consensus       215 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~d----p~~Rps~~~~l~h~~~~~~~~  270 (304)
T 2jam_A          215 LFEKIKEGYYEFESPFWDDISESAKDFICHLLEKD----PNERYTCEKALSHPWIDGNTA  270 (304)
T ss_dssp             HHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSS----TTTSCCHHHHHTSHHHHSSCS
T ss_pred             HHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCC----hhHCcCHHHHhcCccccCCCc
Confidence            88887776666666666678889999999999999    999999999999999987543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.9e-48  Score=379.12  Aligned_cols=257  Identities=28%  Similarity=0.473  Sum_probs=213.5

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee------
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD------  163 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~------  163 (411)
                      ..++|++.+.||+|+||+||+|++..+|+.||||++......   ..+|+.+++.++|+||     +++++++.      
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnI-----v~l~~~~~~~~~~~   76 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNI-----IKLVDYFYTTGDEE   76 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTB-----CCEEEEEEEC----
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCc-----cchhheeeecCccc
Confidence            457899999999999999999999999999999998654332   3469999999988777     99998873      


Q ss_pred             --------------------------------cCCeEEEEEccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHH
Q 015222          164 --------------------------------YRNHICIVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAF  209 (411)
Q Consensus       164 --------------------------------~~~~~~lv~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~  209 (411)
                                                      ...++++||||+.++|.+.+..  .....+++..++.++.||+.||+|
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                            3345899999998898888764  223479999999999999999999


Q ss_pred             HHhCCceecCCCCCcEEEec-CcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccC--CCcccccCCCccc
Q 015222          210 MHELRLIHTDLKPENILLVS-AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRA  286 (411)
Q Consensus       210 LH~~givH~Dikp~NIli~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~a  286 (411)
                      ||++||+||||||+|||++. ++                           .+||+|||++.....  ......||+.|+|
T Consensus       157 LH~~gi~H~Dikp~Nil~~~~~~---------------------------~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~a  209 (383)
T 3eb0_A          157 IHSLGICHRDIKPQNLLVNSKDN---------------------------TLKLCDFGSAKKLIPSEPSVAYICSRFYRA  209 (383)
T ss_dssp             HHTTTEECSCCCGGGEEEETTTT---------------------------EEEECCCTTCEECCTTSCCCCCCCCSSCCC
T ss_pred             HHHCcCccCccCHHHEEEcCCCC---------------------------cEEEEECCCCcccCCCCCCcCcccCCCccC
Confidence            99999999999999999973 34                           678888888875432  2344678999999


Q ss_pred             cceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHHH----------------------
Q 015222          287 PEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVI----------------------  343 (411)
Q Consensus       287 PE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~----------------------  343 (411)
                      ||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+.+..+..+.....                      
T Consensus       210 PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (383)
T 3eb0_A          210 PELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKI  289 (383)
T ss_dssp             HHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHH
T ss_pred             HHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhh
Confidence            9999876 58999999999999999999999999999988888888776655443221                      


Q ss_pred             ---hhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          344 ---RADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       344 ---~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                         ..+..+.++|.+||..+    |.+|||+.++++||||.++..
T Consensus       290 ~~~~~~~~~~~li~~~L~~d----P~~R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          290 LPEGTPSLAIDLLEQILRYE----PDLRINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             SCTTCCHHHHHHHHHHCCSS----GGGSCCHHHHHTSGGGHHHHH
T ss_pred             CCCCCCHHHHHHHHHHccCC----hhhCCCHHHHhcCHHHHHHHh
Confidence               24567899999999999    999999999999999987643

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.3e-48  Score=368.52  Aligned_cols=261  Identities=21%  Similarity=0.357  Sum_probs=219.2

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      .|...++||+|+||.||+|++..+|+.||||++.... ...+.+.+|+.++++++|+||     +++++++...+..++|
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~lv  120 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNV-----VEMYKSYLVGEELWVL  120 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTB-----CCEEEEEEETTEEEEE
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCc-----ceEEEEEEECCEEEEE
Confidence            4888999999999999999999999999999997433 345668899999999988777     9999999999999999


Q ss_pred             EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      |||+ +++|.+++...   .+++..+..++.||+.||+|||++||+||||||+|||++.++                   
T Consensus       121 ~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-------------------  178 (321)
T 2c30_A          121 MEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG-------------------  178 (321)
T ss_dssp             ECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-------------------
T ss_pred             EecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-------------------
Confidence            9999 99999998754   599999999999999999999999999999999999998766                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL  327 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~  327 (411)
                              .+||+|||++......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+..
T Consensus       179 --------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~  250 (321)
T 2c30_A          179 --------RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM  250 (321)
T ss_dssp             --------CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred             --------cEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence                    5777777777654332   23457999999999999989999999999999999999999999988877766


Q ss_pred             HHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccCCCCCchhhHH
Q 015222          328 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSASPNCLCKFY  397 (411)
Q Consensus       328 ~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~~~~~~~~~~  397 (411)
                      ..+.....+. ......++..+.+++.+||..|    |.+||++.++++|+||.+..    .|+++.++.
T Consensus       251 ~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~d----p~~Rps~~ell~hp~~~~~~----~~~~~~~~~  311 (321)
T 2c30_A          251 KRLRDSPPPK-LKNSHKVSPVLRDFLERMLVRD----PQERATAQELLDHPFLLQTG----LPECLVPLI  311 (321)
T ss_dssp             HHHHHSSCCC-CTTGGGSCHHHHHHHHHHSCSS----TTTSCCHHHHHTSGGGGGCC----CGGGGHHHH
T ss_pred             HHHhcCCCCC-cCccccCCHHHHHHHHHHccCC----hhhCcCHHHHhcChhhccCC----CcccchHHH
Confidence            6665543221 1223456778999999999999    99999999999999998654    344555433

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=7.5e-48  Score=361.59  Aligned_cols=261  Identities=25%  Similarity=0.379  Sum_probs=223.0

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----------hhhHHHHHHHHHHHHHh-cCCCCCcceEE
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----------KYREAAMIEIDVLQRLA-RHDIGGTRCVQ  157 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----------~~~~~~~~E~~~l~~l~-~~~i~~~~iv~  157 (411)
                      .+.++|++.+.||+|+||.||+|.++.+++.||||+++...          ...+.+.+|+.+++++. |+|+     ++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i-----~~   88 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI-----IQ   88 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB-----CC
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCE-----ee
Confidence            45679999999999999999999999999999999996432          23456788999999996 7766     99


Q ss_pred             EeeeeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccC
Q 015222          158 IRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP  236 (411)
Q Consensus       158 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~  236 (411)
                      +++++...+..++||||+ +++|.+++....  .+++..+..++.||+.||+|||++||+|+||||+||+++.++     
T Consensus        89 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-----  161 (298)
T 1phk_A           89 LKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-----  161 (298)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-----
T ss_pred             eeeeeccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCC-----
Confidence            999999999999999999 899999998765  699999999999999999999999999999999999998766     


Q ss_pred             CcccccccCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceec------CCCCCccchhHHHHHHH
Q 015222          237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVIL------GLGWNYPCDLWSVGCIL  308 (411)
Q Consensus       237 df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlGvil  308 (411)
                                            .++|+|||++......  .....||+.|+|||++.      ...++.++|||||||++
T Consensus       162 ----------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l  219 (298)
T 1phk_A          162 ----------------------NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM  219 (298)
T ss_dssp             ----------------------CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHH
T ss_pred             ----------------------cEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHH
Confidence                                  5777777777654322  23357899999999985      44688999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          309 VELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       309 ~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                      |+|++|..||.+.+..+....+......++......++..+.++|.+||..+    |.+||++.++++|+||.+.....
T Consensus       220 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d----p~~Rps~~~ll~h~~~~~~~~~~  294 (298)
T 1phk_A          220 YTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQ----PQKRYTAEEALAHPFFQQYVVEE  294 (298)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSS----GGGSCCHHHHTTSGGGCTTC---
T ss_pred             HHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCC----cccCCCHHHHHhChHhhhccchh
Confidence            9999999999988888777777776666665555677889999999999999    99999999999999999876543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.8e-48  Score=364.02  Aligned_cols=260  Identities=25%  Similarity=0.342  Sum_probs=214.6

Q ss_pred             CccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        88 ~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      ..+.++|++.++||+|+||.||+|.++.+++.||+|++....  ...+.+.+|+.++++++|+||     +++++++.+.
T Consensus        18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~   92 (285)
T 3is5_A           18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNI-----IKIFEVFEDY   92 (285)
T ss_dssp             SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTB-----CCEEEEEECS
T ss_pred             CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchH-----HhHHHheecC
Confidence            345678999999999999999999999999999999997543  345778899999999988777     9999999999


Q ss_pred             CeEEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                      +..++||||+ +++|.+++...  ....+++..++.++.||+.||+|||++||+||||||+|||++.++           
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~-----------  161 (285)
T 3is5_A           93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTS-----------  161 (285)
T ss_dssp             SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSS-----------
T ss_pred             CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCC-----------
Confidence            9999999999 88999998643  124699999999999999999999999999999999999995432           


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT  320 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~  320 (411)
                                   .+..+||+|||++......  .....||+.|+|||++. ..++.++|||||||++|+|++|+.||.+
T Consensus       162 -------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~  227 (285)
T 3is5_A          162 -------------PHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTG  227 (285)
T ss_dssp             -------------TTCCEEECCCCCCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             -------------CCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCC
Confidence                         3347899999988764332  23467899999999986 4789999999999999999999999998


Q ss_pred             CChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCc
Q 015222          321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~  382 (411)
                      .+..+....+.......+.. ....++.+.++|.+||..|    |.+||++.++++|+||++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~d----P~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          228 TSLEEVQQKATYKEPNYAVE-CRPLTPQAVDLLKQMLTKD----PERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             SSHHHHHHHHHHCCCCCCC---CCCCHHHHHHHHHHTCSC----TTTSCCHHHHHTSGGGGC
T ss_pred             CCHHHHHhhhccCCcccccc-cCcCCHHHHHHHHHHccCC----hhhCcCHHHHhcCHHhhc
Confidence            87776666555443333222 2235678899999999999    999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.1e-48  Score=390.96  Aligned_cols=260  Identities=20%  Similarity=0.297  Sum_probs=216.1

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      .++|++.+.||+|+||.||+|+++.+|+.||||++.+..    .....+.+|+.++++++|++|     +++++++.+.+
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~I-----v~l~~~~~~~~  258 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFI-----VSLAYAFETKT  258 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTB-----CCEEEEEECSS
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCE-----eeEEEEEeeCC
Confidence            368999999999999999999999999999999997532    234567889999999988777     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          167 HICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                      .+|+||||+ |++|.+++....  ...+++..++.++.||+.||+|||++||+||||||+|||++.+|            
T Consensus       259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g------------  326 (543)
T 3c4z_A          259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG------------  326 (543)
T ss_dssp             EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS------------
T ss_pred             EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCC------------
Confidence            999999999 999999998643  34699999999999999999999999999999999999998777            


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT  320 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~  320 (411)
                                     .+||+|||++......   ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus       327 ---------------~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~  391 (543)
T 3c4z_A          327 ---------------NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA  391 (543)
T ss_dssp             ---------------CEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ---------------CEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCC
Confidence                           5677777777654332   2235899999999999999999999999999999999999999987


Q ss_pred             CC----hHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH-HHHHHHhcCCCCccccc
Q 015222          321 HE----NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-SMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       321 ~~----~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~-t~~~il~~~~~~~~~~~  386 (411)
                      .+    ..+....+......+|    ..++..+.++|.+||..|+.+||+.+. ++.++++||||.+++|.
T Consensus       392 ~~~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~  458 (543)
T 3c4z_A          392 RGEKVENKELKQRVLEQAVTYP----DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR  458 (543)
T ss_dssp             TTCCCCHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred             CccchhHHHHHHHHhhcccCCC----cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence            53    3444455554444444    346788999999999999444433322 56999999999998754

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.1e-48  Score=389.53  Aligned_cols=254  Identities=24%  Similarity=0.330  Sum_probs=219.8

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      ...++|++.+.||+|+||.||+|++..+|+.||||++....    ...+.+.+|+.+++.++|+||     +++++++..
T Consensus        13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-----v~l~~~~~~   87 (476)
T 2y94_A           13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHI-----IKLYQVIST   87 (476)
T ss_dssp             CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTB-----CCEEEEEEC
T ss_pred             ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEEEE
Confidence            34578999999999999999999999999999999997532    234578899999999988776     999999999


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                      .+.+|+||||+ +++|.+++.+..  .+++..++.++.||+.||+|||++||+||||||+|||++.++            
T Consensus        88 ~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~------------  153 (476)
T 2y94_A           88 PSDIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHM------------  153 (476)
T ss_dssp             SSEEEEEEECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTC------------
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCC------------
Confidence            99999999999 999999998654  699999999999999999999999999999999999997766            


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCC-CccchhHHHHHHHHHHHhCCCCCCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQT  320 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~pf~~  320 (411)
                                     .+||+|||++......  ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+
T Consensus       154 ---------------~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~  218 (476)
T 2y94_A          154 ---------------NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD  218 (476)
T ss_dssp             ---------------CEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ---------------CeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC
Confidence                           6788888877654332  234689999999999998765 7899999999999999999999998


Q ss_pred             CChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      .+.......+.......|.    .++..+.++|.+||..|    |.+|||+.++++|+||....
T Consensus       219 ~~~~~~~~~i~~~~~~~p~----~~s~~~~~Li~~~L~~d----P~~Rpt~~eil~hp~~~~~~  274 (476)
T 2y94_A          219 DHVPTLFKKICDGIFYTPQ----YLNPSVISLLKHMLQVD----PMKRATIKDIREHEWFKQDL  274 (476)
T ss_dssp             SSSHHHHHHHHTTCCCCCT----TCCHHHHHHHHHHTCSS----TTTSCCHHHHHTCHHHHTTC
T ss_pred             CCHHHHHHHHhcCCcCCCc----cCCHHHHHHHHHHcCCC----chhCcCHHHHHhCHHhhhcC
Confidence            8887777777665555543    35678999999999999    99999999999999997643

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=8.8e-48  Score=372.02  Aligned_cols=256  Identities=24%  Similarity=0.391  Sum_probs=221.8

Q ss_pred             CccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---------hhhHHHHHHHHHHHHH-hcCCCCCcceEE
Q 015222           88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRL-ARHDIGGTRCVQ  157 (411)
Q Consensus        88 ~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l-~~~~i~~~~iv~  157 (411)
                      ..+.++|++.+.||+|+||.||+|+++.+|+.||||+++...         ...+.+.+|+.+++++ .|++|     ++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i-----v~  164 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHI-----IT  164 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTB-----CC
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCE-----eE
Confidence            345578999999999999999999999999999999986432         2245677899999999 67776     99


Q ss_pred             EeeeeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccC
Q 015222          158 IRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP  236 (411)
Q Consensus       158 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~  236 (411)
                      +++++...+..|+||||+ +++|.+++....  .+++..+..++.||+.||.|||+.||+|+||||+|||++.+|     
T Consensus       165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~-----  237 (365)
T 2y7j_A          165 LIDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM-----  237 (365)
T ss_dssp             EEEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-----
T ss_pred             EEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-----
Confidence            999999999999999999 889999998765  699999999999999999999999999999999999998766     


Q ss_pred             CcccccccCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecC------CCCCccchhHHHHHHH
Q 015222          237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILG------LGWNYPCDLWSVGCIL  308 (411)
Q Consensus       237 df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlGvil  308 (411)
                                            .++|+|||++......  .....||+.|+|||++.+      ..++.++|||||||++
T Consensus       238 ----------------------~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il  295 (365)
T 2y7j_A          238 ----------------------QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL  295 (365)
T ss_dssp             ----------------------CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHH
T ss_pred             ----------------------CEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHH
Confidence                                  5777777777654332  234679999999999863      3588999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCC
Q 015222          309 VELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP  381 (411)
Q Consensus       309 ~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~  381 (411)
                      |+|++|..||.+.+....+..+......++...+...+..+.++|.+||..|    |.+||++.++++||||+
T Consensus       296 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~d----P~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          296 FTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVD----PEARLTAEQALQHPFFE  364 (365)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSS----TTTSCCHHHHHHSGGGC
T ss_pred             HHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCC----hhHCcCHHHHhcCcccC
Confidence            9999999999988888887777776666666666678888999999999999    99999999999999996

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.2e-48  Score=361.99  Aligned_cols=254  Identities=24%  Similarity=0.378  Sum_probs=218.3

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      .++|++.+.||+|+||+||+|.+..+++.||||++....    .....+.+|+.+++++.|+||     +++++++.+.+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~   82 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI-----LRLYGYFHDAT   82 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTB-----CCEEEEEECSS
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCC-----cchhheEecCC
Confidence            368999999999999999999999999999999986432    234567889999999987776     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      ..++||||+ +++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++              
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~--------------  146 (279)
T 3fdn_A           83 RVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG--------------  146 (279)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTS--------------
T ss_pred             EEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCC--------------
Confidence            999999999 889999998765  699999999999999999999999999999999999998766              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCC-CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                                   .++|+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+..
T Consensus       147 -------------~~~l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~  213 (279)
T 3fdn_A          147 -------------ELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ  213 (279)
T ss_dssp             -------------CEEECSCCEESCC--------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred             -------------CEEEEeccccccCCcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH
Confidence                         5677777766543322 23457899999999999989999999999999999999999999998888


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                      +....+......+|..    .+..+.++|.+||..+    |.+||++.++++|+||.+....
T Consensus       214 ~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~~----p~~Rps~~e~l~h~~~~~~~~~  267 (279)
T 3fdn_A          214 ETYKRISRVEFTFPDF----VTEGARDLISRLLKHN----PSQRPMLREVLEHPWITANSSK  267 (279)
T ss_dssp             HHHHHHHHTCCCCCTT----SCHHHHHHHHHHCCSS----GGGSCCHHHHHHCHHHHHHCSS
T ss_pred             HHHHHHHhCCCCCCCc----CCHHHHHHHHHHhccC----hhhCCCHHHHhhCccccCCccC
Confidence            8888777766666543    5677899999999999    9999999999999999876543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.3e-48  Score=370.27  Aligned_cols=253  Identities=25%  Similarity=0.315  Sum_probs=201.9

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      .+.++|++.+.||+|+||.||+|+++.+++.||||+++..  ....+.+.+|+.++++++|+||     +++++++.+.+
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~~   77 (332)
T 3qd2_B            3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI-----VRYFNAWLETP   77 (332)
T ss_dssp             HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTB-----CCEEEEEEECC
T ss_pred             hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEEec
Confidence            3456899999999999999999999999999999999743  3455778899999999988777     99988875432


Q ss_pred             ---------------------------------------------------------eEEEEEccC-CCCHHHHHHhcCC
Q 015222          167 ---------------------------------------------------------HICIVFEKL-GPSLYDFLRKNSY  188 (411)
Q Consensus       167 ---------------------------------------------------------~~~lv~e~~-~~~L~~~l~~~~~  188 (411)
                                                                               +.++||||+ +++|.+++.....
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~  157 (332)
T 3qd2_B           78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS  157 (332)
T ss_dssp             SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS
T ss_pred             cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC
Confidence                                                                     489999999 9999999987542


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCC
Q 015222          189 -RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS  267 (411)
Q Consensus       189 -~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~  267 (411)
                       ...++..++.++.||+.||+|||++||+||||||+|||++.++.                           +||+|||+
T Consensus       158 ~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---------------------------~kL~DfG~  210 (332)
T 3qd2_B          158 LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV---------------------------VKVGDFGL  210 (332)
T ss_dssp             GGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---------------------------EEECCCTT
T ss_pred             ccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCC---------------------------EEEeecCc
Confidence             23566778999999999999999999999999999999987774                           55555555


Q ss_pred             cccccCC---------------CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 015222          268 TTFEHQD---------------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER  332 (411)
Q Consensus       268 a~~~~~~---------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~  332 (411)
                      +......               .....||+.|+|||++.+..++.++|||||||++|||++|..|+.     +....+..
T Consensus       211 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~  285 (332)
T 3qd2_B          211 VTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITD  285 (332)
T ss_dssp             CEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHH
T ss_pred             ccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHH
Confidence            5443221               223479999999999999999999999999999999999877652     22222222


Q ss_pred             H-hCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcc
Q 015222          333 V-LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVI  383 (411)
Q Consensus       333 ~-~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~  383 (411)
                      . ....|. .....++.+.++|.+||..+    |.+||++.++++|+||+++
T Consensus       286 ~~~~~~~~-~~~~~~~~~~~li~~~l~~~----p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          286 VRNLKFPL-LFTQKYPQEHMMVQDMLSPS----PTERPEATDIIENAIFENL  332 (332)
T ss_dssp             HHTTCCCH-HHHHHCHHHHHHHHHHHCSS----GGGSCCHHHHHHSTTCCCC
T ss_pred             hhccCCCc-ccccCChhHHHHHHHHccCC----CCcCCCHHHHhhchhhhcC
Confidence            2 234443 34556677899999999999    9999999999999999874

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.9e-48  Score=371.13  Aligned_cols=265  Identities=26%  Similarity=0.410  Sum_probs=217.5

Q ss_pred             eCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee
Q 015222           86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        86 ~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~  163 (411)
                      ++..+.++|++.+.||+|+||.||+|.+..+|+.||||++....  .....+.+|+.+++++.|+||     +++++++.
T Consensus         5 ~~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~   79 (353)
T 2b9h_A            5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI-----ITIFNIQR   79 (353)
T ss_dssp             CCCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTB-----CCEEEECC
T ss_pred             cccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCc-----CCeeeeec
Confidence            34567789999999999999999999999999999999997432  345567789999999988877     88888765


Q ss_pred             cC-----CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCc
Q 015222          164 YR-----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY  238 (411)
Q Consensus       164 ~~-----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df  238 (411)
                      ..     +..++||||++++|.+++...   .+++..+..++.||+.||+|||++||+||||||+|||++.++.      
T Consensus        80 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~------  150 (353)
T 2b9h_A           80 PDSFENFNEVYIIQELMQTDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD------  150 (353)
T ss_dssp             CSCSTTCCCEEEEECCCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC------
T ss_pred             ccccCccceEEEEEeccCccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc------
Confidence            43     689999999988999999874   5999999999999999999999999999999999999987774      


Q ss_pred             ccccccCCCCCccccCCCCCCeeEeecCCcccccCC-------------CcccccCCCccccceecC-CCCCccchhHHH
Q 015222          239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-------------HSYVVSTRHYRAPEVILG-LGWNYPCDLWSV  304 (411)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSl  304 (411)
                                           +||+|||++......             .....||+.|+|||++.+ ..++.++|||||
T Consensus       151 ---------------------~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl  209 (353)
T 2b9h_A          151 ---------------------LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSC  209 (353)
T ss_dssp             ---------------------EEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHH
T ss_pred             ---------------------EEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHH
Confidence                                 555555555433211             122478999999998865 578999999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC----------------------------hhHHHhhhhhhhhhhccC
Q 015222          305 GCILVELCSGEALFQTHENLEHLAMMERVLGPLP----------------------------HHMVIRADRRAEKYFRRG  356 (411)
Q Consensus       305 Gvil~elltg~~pf~~~~~~~~~~~i~~~~~~~p----------------------------~~~~~~~~~~~~~li~~~  356 (411)
                      ||++|+|++|+.||.+.+..+.+..+....+..+                            ......++..+.++|.+|
T Consensus       210 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  289 (353)
T 2b9h_A          210 GCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRM  289 (353)
T ss_dssp             HHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHh
Confidence            9999999999999999888777776665544322                            111235677889999999


Q ss_pred             CccCCCCCCCcHHHHHHHHhcCCCCcccccCCC
Q 015222          357 ARLDWPDGATSRDSMRAVWKLLRLPVIDLYSAS  389 (411)
Q Consensus       357 l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~~  389 (411)
                      |..|    |.+|||+.++++|+||+........
T Consensus       290 L~~d----P~~Rpt~~ell~hp~~~~~~~~~~~  318 (353)
T 2b9h_A          290 LVFD----PAKRITAKEALEHPYLQTYHDPNDE  318 (353)
T ss_dssp             SCSS----GGGSCCHHHHHTSGGGTTTCCTTSS
T ss_pred             cCcC----cccCCCHHHHhcCccccccCCcccc
Confidence            9999    9999999999999999987765543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=6e-48  Score=365.45  Aligned_cols=266  Identities=24%  Similarity=0.419  Sum_probs=211.6

Q ss_pred             CCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeee---
Q 015222           87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF---  162 (411)
Q Consensus        87 ~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~---  162 (411)
                      +..+.++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+.+|+.+++++.|+|+     +++++++   
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~   80 (320)
T 2i6l_A            6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNI-----VKVFEILGPS   80 (320)
T ss_dssp             CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEECTT
T ss_pred             cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCe-----eEEEEecccc
Confidence            4567789999999999999999999999999999999987443 445678899999999988877     8888876   


Q ss_pred             -----------ecCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCc
Q 015222          163 -----------DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE  231 (411)
Q Consensus       163 -----------~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~  231 (411)
                                 ...+..++||||++++|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus        81 ~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~  157 (320)
T 2i6l_A           81 GSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED  157 (320)
T ss_dssp             SCBCCC----CCSCSEEEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT
T ss_pred             ccccccccccccccCceeEEeeccCCCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC
Confidence                       345789999999988999998753   599999999999999999999999999999999999997432


Q ss_pred             ccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC------CcccccCCCccccceecC-CCCCccchhHHH
Q 015222          232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILG-LGWNYPCDLWSV  304 (411)
Q Consensus       232 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSl  304 (411)
                                                ..+||+|||++......      .....+|..|+|||++.+ ..++.++|||||
T Consensus       158 --------------------------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl  211 (320)
T 2i6l_A          158 --------------------------LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA  211 (320)
T ss_dssp             --------------------------TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHH
T ss_pred             --------------------------CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhH
Confidence                                      25677777777654321      233467999999999876 578999999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh--------------------------HHHhhhhhhhhhhccCCc
Q 015222          305 GCILVELCSGEALFQTHENLEHLAMMERVLGPLPHH--------------------------MVIRADRRAEKYFRRGAR  358 (411)
Q Consensus       305 Gvil~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~--------------------------~~~~~~~~~~~li~~~l~  358 (411)
                      ||++|||++|+.||.+.+..+.+..+..........                          ....++..+.++|.+||.
T Consensus       212 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  291 (320)
T 2i6l_A          212 GCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILT  291 (320)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSC
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcC
Confidence            999999999999999988877777666544332221                          112467789999999999


Q ss_pred             cCCCCCCCcHHHHHHHHhcCCCCcccccCCCC
Q 015222          359 LDWPDGATSRDSMRAVWKLLRLPVIDLYSASP  390 (411)
Q Consensus       359 ~~~~~rp~~R~t~~~il~~~~~~~~~~~~~~~  390 (411)
                      .|    |.+||++.++++|+||....+....|
T Consensus       292 ~d----P~~Rpt~~ell~hp~~~~~~~p~~~~  319 (320)
T 2i6l_A          292 FS----PMDRLTAEEALSHPYMSIYSFPMDEP  319 (320)
T ss_dssp             SS----GGGSCCHHHHHTSHHHHTTCC-----
T ss_pred             CC----ccccCCHHHHhCCcccccccCccCCC
Confidence            99    99999999999999999887765443

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=6.2e-49  Score=386.92  Aligned_cols=261  Identities=28%  Similarity=0.407  Sum_probs=213.6

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---------hhhHHHHHHHHHHHHHhcCCCCCcceEEEe
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLARHDIGGTRCVQIR  159 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~  159 (411)
                      .+.++|++.+.||+|+||+||+|.+..+++.||||++....         .....+.+|+.++++++|+||     ++++
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~l~  206 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI-----IKIK  206 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTB-----CCCC
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCE-----eeEE
Confidence            44678999999999999999999999999999999997532         122347789999999988877     9999


Q ss_pred             eeeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCc
Q 015222          160 NWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY  238 (411)
Q Consensus       160 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df  238 (411)
                      +++.. +..|+||||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++       
T Consensus       207 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~-------  276 (419)
T 3i6u_A          207 NFFDA-EDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE-------  276 (419)
T ss_dssp             EEEES-SEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS-------
T ss_pred             EEEec-CceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCC-------
Confidence            98864 5689999999 999999887654  799999999999999999999999999999999999997644       


Q ss_pred             ccccccCCCCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecC---CCCCccchhHHHHHHHHHHHh
Q 015222          239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCS  313 (411)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~ellt  313 (411)
                                       ....+||+|||++.......  ....||+.|+|||++.+   ..++.++|||||||++|+|++
T Consensus       277 -----------------~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~llt  339 (419)
T 3i6u_A          277 -----------------EDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS  339 (419)
T ss_dssp             -----------------SSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHH
T ss_pred             -----------------CcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHH
Confidence                             23468999999998754432  34679999999999864   578899999999999999999


Q ss_pred             CCCCCCCCChH-HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          314 GEALFQTHENL-EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       314 g~~pf~~~~~~-~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      |..||.+.... .....+......++...+..+++.+.++|.+||..|    |.+||++.++++||||++.++
T Consensus       340 g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~d----P~~Rps~~e~l~hp~~~~~~~  408 (419)
T 3i6u_A          340 GYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVD----PKARFTTEEALRHPWLQDEDM  408 (419)
T ss_dssp             SSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSS----TTTSCCHHHHHHSGGGCCHHH
T ss_pred             CCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCC----hhHCcCHHHHhCCcccCChhH
Confidence            99999865443 334444555556667777788999999999999999    999999999999999997654

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.2e-48  Score=369.96  Aligned_cols=260  Identities=25%  Similarity=0.373  Sum_probs=223.3

Q ss_pred             eCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeee
Q 015222           86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNW  161 (411)
Q Consensus        86 ~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~  161 (411)
                      ......++|++.+.||+|+||.||+|++..+++.||+|++....    ...+.+.+|+.+++.+.|+||     ++++++
T Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~  109 (335)
T 2owb_A           35 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV-----VGFHGF  109 (335)
T ss_dssp             EETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTB-----CCEEEE
T ss_pred             cCcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEE
Confidence            34455678999999999999999999999999999999986532    345678889999999988776     999999


Q ss_pred             eecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                      +.+.+..|+||||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++         
T Consensus       110 ~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~---------  178 (335)
T 2owb_A          110 FEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL---------  178 (335)
T ss_dssp             EECSSEEEEEECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC---------
T ss_pred             EecCCeEEEEEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCC---------
Confidence            99999999999999 899999988765  699999999999999999999999999999999999998766         


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccC---CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCC
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL  317 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p  317 (411)
                                        .++|+|||++.....   ......||+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus       179 ------------------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p  240 (335)
T 2owb_A          179 ------------------EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP  240 (335)
T ss_dssp             ------------------CEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             ------------------CEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCC
Confidence                              567777777765432   22335789999999999998999999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                      |......+....+......++.    .++..+.++|.+||..|    |.+||++.++++|+||.+.....
T Consensus       241 f~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~d----p~~Rps~~ell~~~~~~~~~~~~  302 (335)
T 2owb_A          241 FETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTD----PTARPTINELLNDEFFTSGYIPA  302 (335)
T ss_dssp             TCCSSHHHHHHHHHHTCCCCCT----TSCHHHHHHHHHHTCSS----GGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             CCCCCHHHHHHHHhcCCCCCCc----cCCHHHHHHHHHHccCC----hhHCcCHHHHhcCccccCCCccc
Confidence            9988877777776665555554    35677899999999998    99999999999999998765444

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-48  Score=373.61  Aligned_cols=259  Identities=26%  Similarity=0.412  Sum_probs=213.7

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchh------hhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK------YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      .++|++.+.||+|+||.||+|++..+|+.||||++.....      ....+.+|+.+++.++|+||     +++++++.+
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~   83 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI-----IGLLDAFGH   83 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTB-----CCEEEEECC
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCC-----CeEEEEEee
Confidence            4689999999999999999999999999999999974321      23467789999999988777     999999999


Q ss_pred             CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          165 RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       165 ~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      .+..++||||+.++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.+|             
T Consensus        84 ~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-------------  149 (346)
T 1ua2_A           84 KSNISLVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-------------  149 (346)
T ss_dssp             TTCCEEEEECCSEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-------------
T ss_pred             CCceEEEEEcCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCC-------------
Confidence            99999999999779999987654 4689999999999999999999999999999999999998766             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQT  320 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~  320 (411)
                                    .+||+|||++......   .....||+.|+|||++.+. .++.++|||||||++|||++|.+||.+
T Consensus       150 --------------~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~  215 (346)
T 1ua2_A          150 --------------VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG  215 (346)
T ss_dssp             --------------CEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             --------------CEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence                          5677777776654322   2335789999999999765 589999999999999999999999999


Q ss_pred             CChHHHHHHHHHHhCCCChh------------------------HHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHh
Q 015222          321 HENLEHLAMMERVLGPLPHH------------------------MVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK  376 (411)
Q Consensus       321 ~~~~~~~~~i~~~~~~~p~~------------------------~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~  376 (411)
                      .+..+.+..+....+..+..                        .....+..+.++|.+||..|    |.+|||+.|+++
T Consensus       216 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d----P~~Rpt~~ell~  291 (346)
T 1ua2_A          216 DSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFN----PCARITATQALK  291 (346)
T ss_dssp             SSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSS----TTTSCCHHHHHT
T ss_pred             CCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccC----hhhCCCHHHHhc
Confidence            98888888877765443222                        12345678999999999999    999999999999


Q ss_pred             cCCCCccccc
Q 015222          377 LLRLPVIDLY  386 (411)
Q Consensus       377 ~~~~~~~~~~  386 (411)
                      |+||.+....
T Consensus       292 h~~f~~~~~~  301 (346)
T 1ua2_A          292 MKYFSNRPGP  301 (346)
T ss_dssp             SGGGTSSSCC
T ss_pred             ChhhhcCCCC
Confidence            9999876544

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=6.9e-48  Score=379.58  Aligned_cols=258  Identities=27%  Similarity=0.434  Sum_probs=213.2

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec------C
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY------R  165 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~------~  165 (411)
                      .+|++.+.||+|+||.||+|++..+++.||||++.....   ...+|+++++.++|+||     +++++++..      .
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpni-----v~l~~~~~~~~~~~~~  125 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNI-----VRLRYFFYSSGEKKDE  125 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTB-----CCEEEEEEEEETTTTE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCc-----cceeeEEeccCCCCcc
Confidence            479999999999999999999999999999999865432   23469999999988877     888888743      2


Q ss_pred             CeEEEEEccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          166 NHICIVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       166 ~~~~lv~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                      .++++||||+.++|.+.+..  .....+++..++.++.||+.||+|||++||+||||||+||||+.++            
T Consensus       126 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~------------  193 (420)
T 1j1b_A          126 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT------------  193 (420)
T ss_dssp             EEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTT------------
T ss_pred             eeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCC------------
Confidence            35789999997788877653  2234799999999999999999999999999999999999998543            


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccC--CCcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQT  320 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~  320 (411)
                                    ..+||+|||+++....  ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+
T Consensus       194 --------------~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~  259 (420)
T 1j1b_A          194 --------------AVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG  259 (420)
T ss_dssp             --------------TEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             --------------CeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence                          2468888888875432  23346889999999999875 799999999999999999999999999


Q ss_pred             CChHHHHHHHHHHhCCCChhHH-------------------------HhhhhhhhhhhccCCccCCCCCCCcHHHHHHHH
Q 015222          321 HENLEHLAMMERVLGPLPHHMV-------------------------IRADRRAEKYFRRGARLDWPDGATSRDSMRAVW  375 (411)
Q Consensus       321 ~~~~~~~~~i~~~~~~~p~~~~-------------------------~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il  375 (411)
                      .+..+.+..+.+..+.......                         ...+..+.++|.+||..|    |.+|+++.+++
T Consensus       260 ~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~d----P~~R~t~~e~l  335 (420)
T 1j1b_A          260 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT----PTARLTPLEAC  335 (420)
T ss_dssp             SSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSS----GGGSCCHHHHH
T ss_pred             CCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCC----hhHCCCHHHHh
Confidence            9888888887776554433221                         234678999999999999    99999999999


Q ss_pred             hcCCCCcccccC
Q 015222          376 KLLRLPVIDLYS  387 (411)
Q Consensus       376 ~~~~~~~~~~~~  387 (411)
                      +|+||.++....
T Consensus       336 ~hp~f~~~~~~~  347 (420)
T 1j1b_A          336 AHSFFDELRDPN  347 (420)
T ss_dssp             TSGGGGGGGCTT
T ss_pred             CCHhhccccccc
Confidence            999998876543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=6.4e-49  Score=371.66  Aligned_cols=260  Identities=22%  Similarity=0.265  Sum_probs=213.1

Q ss_pred             CCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeee
Q 015222           87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF  162 (411)
Q Consensus        87 ~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~  162 (411)
                      ...+.++|++.+.||+|+||.||+|++..+++.||||+++...    .....+.+|+.++++++|+||     +++++++
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~   81 (311)
T 3ork_A            7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI-----VAVYDTG   81 (311)
T ss_dssp             CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTB-----CCEEEEE
T ss_pred             cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCc-----ceEEEee
Confidence            4567789999999999999999999999999999999997532    334567789988888877766     9999988


Q ss_pred             ecCC----eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCC
Q 015222          163 DYRN----HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD  237 (411)
Q Consensus       163 ~~~~----~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~d  237 (411)
                      ....    ..|+||||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++      
T Consensus        82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~------  153 (311)
T 3ork_A           82 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN------  153 (311)
T ss_dssp             EEEETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS------
T ss_pred             eccCCCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC------
Confidence            7643    459999999 899999998765  699999999999999999999999999999999999998776      


Q ss_pred             cccccccCCCCCccccCCCCCCeeEeecCCcccccCC------CcccccCCCccccceecCCCCCccchhHHHHHHHHHH
Q 015222          238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL  311 (411)
Q Consensus       238 f~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el  311 (411)
                                           .+||+|||++......      .....||+.|+|||++.+..++.++|||||||++|+|
T Consensus       154 ---------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~l  212 (311)
T 3ork_A          154 ---------------------AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV  212 (311)
T ss_dssp             ---------------------CEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred             ---------------------CEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHH
Confidence                                 5677777777643322      1235689999999999999999999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          312 CSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       312 ltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      ++|+.||.+.+..+....+.......+......++..+.++|.+||+.|    |.+||+..+++.|+|+....
T Consensus       213 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d----P~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          213 LTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKN----PENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSS----GGGSCSSHHHHHHHHHHHHT
T ss_pred             HhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcC----HhhChhhHHHHHHHHHHHhc
Confidence            9999999988877766666554444444445567888999999999999    88999899999999887543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.3e-47  Score=369.66  Aligned_cols=262  Identities=26%  Similarity=0.376  Sum_probs=210.3

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC----
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN----  166 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~----  166 (411)
                      .++|++.+.||+|+||+||+|++..+++.||||++...........+|+..+..+.|+||     +++++++...+    
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~ni-----v~~~~~~~~~~~~~~   96 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNI-----VQLQSYFYTLGERDR   96 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTB-----CCEEEEEEEECSSCT
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCc-----ccHHHhhhccccccc
Confidence            468999999999999999999999999999999997666656667788888898988877     99999886532    


Q ss_pred             ---eEEEEEccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCcEEEec-CcccccCCc
Q 015222          167 ---HICIVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMH--ELRLIHTDLKPENILLVS-AEYVKVPDY  238 (411)
Q Consensus       167 ---~~~lv~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH--~~givH~Dikp~NIli~~-~~~~~l~df  238 (411)
                         .+++||||+.++|.+.+..  .....+++..++.++.||+.||.|||  ++||+||||||+|||++. ++       
T Consensus        97 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~-------  169 (360)
T 3e3p_A           97 RDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-------  169 (360)
T ss_dssp             TCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT-------
T ss_pred             cceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC-------
Confidence               3899999997787766553  22347899999999999999999999  999999999999999985 44       


Q ss_pred             ccccccCCCCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCC
Q 015222          239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGE  315 (411)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~  315 (411)
                                          .+||+|||++.......  ....||+.|+|||++.+. .++.++|||||||++|+|++|+
T Consensus       170 --------------------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~  229 (360)
T 3e3p_A          170 --------------------TLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE  229 (360)
T ss_dssp             --------------------EEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred             --------------------cEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence                                67888888877544332  345789999999999765 4899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChhHHHh----------------------------hhhhhhhhhccCCccCCCCCCCc
Q 015222          316 ALFQTHENLEHLAMMERVLGPLPHHMVIR----------------------------ADRRAEKYFRRGARLDWPDGATS  367 (411)
Q Consensus       316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~----------------------------~~~~~~~li~~~l~~~~~~rp~~  367 (411)
                      .||.+.+..+.+..+.+..+..+......                            .+..+.++|.+||+.|    |.+
T Consensus       230 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d----P~~  305 (360)
T 3e3p_A          230 PIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL----PEE  305 (360)
T ss_dssp             CSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSS----GGG
T ss_pred             CCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccC----ccc
Confidence            99999999888888888777666554432                            3467899999999999    999


Q ss_pred             HHHHHHHHhcCCCCcccccCC
Q 015222          368 RDSMRAVWKLLRLPVIDLYSA  388 (411)
Q Consensus       368 R~t~~~il~~~~~~~~~~~~~  388 (411)
                      |||+.++++||||.++.....
T Consensus       306 Rpt~~e~l~hp~f~~~~~~~~  326 (360)
T 3e3p_A          306 RMKPYEALCHPYFDELHDPAT  326 (360)
T ss_dssp             SCCHHHHTTSGGGGGGGCTTC
T ss_pred             cCCHHHHhcCccccccCCccc
Confidence            999999999999998866544

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.3e-47  Score=357.16  Aligned_cols=257  Identities=22%  Similarity=0.346  Sum_probs=205.8

Q ss_pred             eeCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc----hhhhHHHHHHHHHHHHHhcCCCCCcceEEEee
Q 015222           85 AIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRN  160 (411)
Q Consensus        85 ~~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~  160 (411)
                      .+|+.+.++|++.+.||+|+||.||+|++..+++.||+|++...    ....+.+.+|+.++++++|+||     +++++
T Consensus         4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i-----v~~~~   78 (294)
T 4eqm_A            4 MIGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI-----VSMID   78 (294)
T ss_dssp             CCSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTB-----CCEEE
T ss_pred             chhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCC-----ceEEE
Confidence            35778889999999999999999999999999999999998532    2345678899999999988877     99999


Q ss_pred             eeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcc
Q 015222          161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK  239 (411)
Q Consensus       161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~  239 (411)
                      ++.+++..|+||||+ +++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++        
T Consensus        79 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~--------  148 (294)
T 4eqm_A           79 VDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK--------  148 (294)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--------
T ss_pred             eeeeCCeEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--------
Confidence            999999999999999 889999998775  699999999999999999999999999999999999998766        


Q ss_pred             cccccCCCCCccccCCCCCCeeEeecCCcccccCC----CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCC
Q 015222          240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE  315 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~  315 (411)
                                         .+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus       149 -------------------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~  209 (294)
T 4eqm_A          149 -------------------TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE  209 (294)
T ss_dssp             -------------------CEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred             -------------------CEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCC
Confidence                               6788888877654322    22357999999999999999999999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHh-CCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHH
Q 015222          316 ALFQTHENLEHLAMMERVL-GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVW  375 (411)
Q Consensus       316 ~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il  375 (411)
                      .||.+.+..+......... ...+......++..+.++|.+||+.++.+||..-..+.+.|
T Consensus       210 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l  270 (294)
T 4eqm_A          210 PPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDL  270 (294)
T ss_dssp             CSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred             CCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHH
Confidence            9999877665543332211 11122333457788999999999999444443333333333

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=7.9e-48  Score=376.11  Aligned_cols=262  Identities=27%  Similarity=0.456  Sum_probs=214.0

Q ss_pred             CCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC-
Q 015222           87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR-  165 (411)
Q Consensus        87 ~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~-  165 (411)
                      ++....+|++.+.||+|+||+||+|++..+++ ||+|++......   ..+|+.+++.++|+||     +++++++... 
T Consensus        35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~---~~~E~~il~~l~h~ni-----v~l~~~~~~~~  105 (394)
T 4e7w_A           35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF---KNRELQIMRIVKHPNV-----VDLKAFFYSNG  105 (394)
T ss_dssp             CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS---CCHHHHHHHTCCCTTB-----CCEEEEEEEES
T ss_pred             CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch---HHHHHHHHHhCCCCCc-----ceEEEEEEecC
Confidence            34455689999999999999999999988776 888877543322   2369999999988877     9999988543 


Q ss_pred             -----CeEEEEEccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe-cCcccccCC
Q 015222          166 -----NHICIVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV-SAEYVKVPD  237 (411)
Q Consensus       166 -----~~~~lv~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~-~~~~~~l~d  237 (411)
                           ..+++||||+.+++.+.+..  .....+++..++.++.||+.||+|||++||+||||||+|||++ .++      
T Consensus       106 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~------  179 (394)
T 4e7w_A          106 DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG------  179 (394)
T ss_dssp             SSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT------
T ss_pred             CCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCC------
Confidence                 34899999997777665542  1234799999999999999999999999999999999999997 454      


Q ss_pred             cccccccCCCCCccccCCCCCCeeEeecCCcccccC--CCcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhC
Q 015222          238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSG  314 (411)
Q Consensus       238 f~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg  314 (411)
                                           .+||+|||++.....  ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus       180 ---------------------~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g  238 (394)
T 4e7w_A          180 ---------------------VLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG  238 (394)
T ss_dssp             ---------------------EEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred             ---------------------cEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence                                 678888888865432  23346789999999999776 589999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChhHHH-------------------------hhhhhhhhhhccCCccCCCCCCCcHH
Q 015222          315 EALFQTHENLEHLAMMERVLGPLPHHMVI-------------------------RADRRAEKYFRRGARLDWPDGATSRD  369 (411)
Q Consensus       315 ~~pf~~~~~~~~~~~i~~~~~~~p~~~~~-------------------------~~~~~~~~li~~~l~~~~~~rp~~R~  369 (411)
                      +.||.+.+..+.+..+.+..+..+.....                         ..+..+.++|.+||..|    |.+||
T Consensus       239 ~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d----P~~R~  314 (394)
T 4e7w_A          239 QPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYT----PSARL  314 (394)
T ss_dssp             SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS----GGGSC
T ss_pred             CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCC----hhhCC
Confidence            99999999888888888776655443222                         25678999999999999    99999


Q ss_pred             HHHHHHhcCCCCcccccCC
Q 015222          370 SMRAVWKLLRLPVIDLYSA  388 (411)
Q Consensus       370 t~~~il~~~~~~~~~~~~~  388 (411)
                      |+.++++||||.++.....
T Consensus       315 t~~e~l~hp~f~~~~~~~~  333 (394)
T 4e7w_A          315 TAIEALCHPFFDELRTGEA  333 (394)
T ss_dssp             CHHHHHTSGGGSTTTSSCC
T ss_pred             CHHHHhcChhhhhhccccc
Confidence            9999999999998876543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.8e-48  Score=368.87  Aligned_cols=256  Identities=26%  Similarity=0.437  Sum_probs=213.9

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      .++|++++.||+|+||.||+|++..+++.||||++....   ...+.+.+|+.++++++|+||     +++++++.+.+.
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~   98 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENL-----VNLLEVCKKKKR   98 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEEETTE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCE-----eeEEEEeecCCE
Confidence            468999999999999999999999999999999986432   334567789999999988777     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      .++||||+ +++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++               
T Consensus        99 ~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~---------------  161 (331)
T 4aaa_A           99 WYLVFEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG---------------  161 (331)
T ss_dssp             EEEEEECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS---------------
T ss_pred             EEEEEecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC---------------
Confidence            99999999 667777665544  699999999999999999999999999999999999997766               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHE  322 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~  322 (411)
                                  .++|+|||++......   .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+
T Consensus       162 ------------~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  229 (331)
T 4aaa_A          162 ------------VVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS  229 (331)
T ss_dssp             ------------CEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ------------cEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                        6778888877654322   2335789999999999876 78999999999999999999999999998


Q ss_pred             hHHHHHHHHHHhCCCChhHH---------------------------HhhhhhhhhhhccCCccCCCCCCCcHHHHHHHH
Q 015222          323 NLEHLAMMERVLGPLPHHMV---------------------------IRADRRAEKYFRRGARLDWPDGATSRDSMRAVW  375 (411)
Q Consensus       323 ~~~~~~~i~~~~~~~p~~~~---------------------------~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il  375 (411)
                      ..+.+..+....+..+....                           ..+++.+.++|.+||..|    |.+|||+.+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d----P~~Rpt~~ell  305 (331)
T 4aaa_A          230 DIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHID----PDKRPFCAELL  305 (331)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSS----GGGSCCGGGGG
T ss_pred             cHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccC----cccCCCHHHHh
Confidence            88888777766655443322                           245678899999999999    99999999999


Q ss_pred             hcCCCCccc
Q 015222          376 KLLRLPVID  384 (411)
Q Consensus       376 ~~~~~~~~~  384 (411)
                      +|+||+...
T Consensus       306 ~hp~f~~~~  314 (331)
T 4aaa_A          306 HHDFFQMDG  314 (331)
T ss_dssp             GSHHHHGGG
T ss_pred             cCchhccCC
Confidence            999998643

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7.4e-48  Score=359.39  Aligned_cols=256  Identities=22%  Similarity=0.344  Sum_probs=220.7

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      .++|++.+.||+|+||.||+|++..+++.||||++....    .....+.+|+.+++.++|+|+     +++++++.+.+
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~   87 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNI-----LRMYNYFHDRK   87 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTB-----CCEEEEEECSS
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCE-----eeEEEEEEcCC
Confidence            368999999999999999999999999999999996432    234668889999999988776     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      ..++||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+||+++.++              
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--------------  151 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG--------------  151 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTC--------------
T ss_pred             EEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCC--------------
Confidence            999999999 889999998765  699999999999999999999999999999999999997766              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCC-CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                                   .++|+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+..
T Consensus       152 -------------~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  218 (284)
T 2vgo_A          152 -------------ELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT  218 (284)
T ss_dssp             -------------CEEECCCTTCEECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred             -------------CEEEecccccccCcccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh
Confidence                         5778888877554332 23457899999999999999999999999999999999999999988877


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccCC
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSA  388 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~  388 (411)
                      +....+......+|.    .++..+.++|.+||..+    |.+||++.++++|+||........
T Consensus       219 ~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~----p~~Rps~~~ll~h~~~~~~~~~~~  274 (284)
T 2vgo_A          219 ETHRRIVNVDLKFPP----FLSDGSKDLISKLLRYH----PPQRLPLKGVMEHPWVKANSRRVL  274 (284)
T ss_dssp             HHHHHHHTTCCCCCT----TSCHHHHHHHHHHSCSS----GGGSCCHHHHHTCHHHHHHCCCCC
T ss_pred             HHHHHHhccccCCCC----cCCHHHHHHHHHHhhcC----HhhCCCHHHHhhCHHHHhhccccC
Confidence            777666655445543    45778899999999999    999999999999999987665443

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=5.9e-48  Score=371.52  Aligned_cols=260  Identities=26%  Similarity=0.444  Sum_probs=216.2

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      +.++|.+.+.||+|+||.||+|+++.+|+.||||++...   ....+.+.+|+.+++.++|+||     +++++++...+
T Consensus        22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~   96 (353)
T 3coi_A           22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV-----IGLLDVFTPAS   96 (353)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTB-----CCCSEEECSCS
T ss_pred             cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCc-----ccHhheEeccc
Confidence            457899999999999999999999999999999999643   2335667899999999988877     99999987754


Q ss_pred             ------eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          167 ------HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       167 ------~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                            .+|+||||++++|.+++..    .+++..+..++.||+.||+|||++||+||||||+|||++.++         
T Consensus        97 ~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~---------  163 (353)
T 3coi_A           97 SLRNFYDFYLVMPFMQTDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC---------  163 (353)
T ss_dssp             SGGGCCCCEEEEECCSEEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC---------
T ss_pred             ccccceeEEEEeccccCCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC---------
Confidence                  3599999998888877643    599999999999999999999999999999999999997766         


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecC-CCCCccchhHHHHHHHHHHHhCCCCCC
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQ  319 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~pf~  319 (411)
                                        .+||+|||++...........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus       164 ------------------~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~  225 (353)
T 3coi_A          164 ------------------ELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK  225 (353)
T ss_dssp             ------------------CEEECSTTCTTC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSB
T ss_pred             ------------------cEEEeecccccCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence                              6788888888766555555688999999999987 578999999999999999999999999


Q ss_pred             CCChHHHHHHHHHHhCCCChhHH---------------------------HhhhhhhhhhhccCCccCCCCCCCcHHHHH
Q 015222          320 THENLEHLAMMERVLGPLPHHMV---------------------------IRADRRAEKYFRRGARLDWPDGATSRDSMR  372 (411)
Q Consensus       320 ~~~~~~~~~~i~~~~~~~p~~~~---------------------------~~~~~~~~~li~~~l~~~~~~rp~~R~t~~  372 (411)
                      +.+..+.+..+.+..+..+..+.                           ...+..+.++|.+||..|    |.+|||+.
T Consensus       226 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d----p~~Rpt~~  301 (353)
T 3coi_A          226 GKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELD----VDKRLTAA  301 (353)
T ss_dssp             SSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSC----TTTSCCHH
T ss_pred             CCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCC----cccCCCHH
Confidence            98888888877776655443322                           234678899999999999    99999999


Q ss_pred             HHHhcCCCCcccccCCC
Q 015222          373 AVWKLLRLPVIDLYSAS  389 (411)
Q Consensus       373 ~il~~~~~~~~~~~~~~  389 (411)
                      ++++|+||.........
T Consensus       302 e~l~hp~f~~~~~~~~~  318 (353)
T 3coi_A          302 QALTHPFFEPFRDPEEE  318 (353)
T ss_dssp             HHHTSGGGTTTCCGGGC
T ss_pred             HHhcCcchhhccCcccc
Confidence            99999999987654433

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4.2e-48  Score=371.77  Aligned_cols=256  Identities=23%  Similarity=0.282  Sum_probs=215.7

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      ..++|++++.||+|+||+||+|++..+++.||||++....    ...+.+.+|+.++++++|+||     +++++++..+
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~  126 (348)
T 1u5q_A           52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT-----IQYRGCYLRE  126 (348)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEEET
T ss_pred             hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEEC
Confidence            3457999999999999999999999999999999996432    334567899999999988877     9999999999


Q ss_pred             CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          166 NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       166 ~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      +..++||||+.|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++              
T Consensus       127 ~~~~lv~e~~~g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--------------  191 (348)
T 1u5q_A          127 HTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--------------  191 (348)
T ss_dssp             TEEEEEEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT--------------
T ss_pred             CeEEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC--------------
Confidence            9999999999889999887543 3699999999999999999999999999999999999998776              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceec---CCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSGEALFQTHE  322 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltg~~pf~~~~  322 (411)
                                   .+||+|||++...... ....||+.|+|||++.   +..++.++|||||||++|||++|+.||.+.+
T Consensus       192 -------------~~kL~DfG~a~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  257 (348)
T 1u5q_A          192 -------------LVKLGDFGSASIMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN  257 (348)
T ss_dssp             -------------EEEECCCTTCBSSSSB-CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             -------------CEEEeeccCceecCCC-CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                         5677778877654432 3457999999999985   4578999999999999999999999999888


Q ss_pred             hHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      ..+.+..+.....  +......+++.+.++|.+||..+    |.+|||+.++++|+|+.....
T Consensus       258 ~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~d----P~~Rps~~~ll~h~~~~~~~~  314 (348)
T 1u5q_A          258 AMSALYHIAQNES--PALQSGHWSEYFRNFVDSCLQKI----PQDRPTSEVLLKHRFVLRERP  314 (348)
T ss_dssp             HHHHHHHHHHSCC--CCCCCTTSCHHHHHHHHHHTCSS----GGGSCCHHHHTTCHHHHSCCC
T ss_pred             hHHHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHcccC----hhhCcCHHHHhhChhhhccCC
Confidence            7776665554322  22223456778999999999988    999999999999999986544

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.1e-47  Score=361.11  Aligned_cols=265  Identities=28%  Similarity=0.471  Sum_probs=218.3

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeC-CCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee--
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDN-EKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD--  163 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~--  163 (411)
                      ..++|++.+.||+|+||.||+|++. .+++.||||+++...   .....+.+|+.+++.+..  +.|+|++++++++.  
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~h~~i~~~~~~~~~~   86 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET--FEHPNVVRLFDVCTVS   86 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHH--TCCTTBCCEEEEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhc--cCCCCeEeeeeeeeec
Confidence            3478999999999999999999995 678999999997432   223456788888888842  12344499999886  


Q ss_pred             ---cCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          164 ---YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       164 ---~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                         .....++||||++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++         
T Consensus        87 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~---------  157 (326)
T 1blx_A           87 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG---------  157 (326)
T ss_dssp             ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC---------
T ss_pred             ccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC---------
Confidence               56789999999988999999887655699999999999999999999999999999999999998766         


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCC
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF  318 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf  318 (411)
                                        .+||+|||++......  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus       158 ------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf  219 (326)
T 1blx_A          158 ------------------QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF  219 (326)
T ss_dssp             ------------------CEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ------------------CEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCC
Confidence                              5778888877654322  23457899999999999999999999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCChh-----------------------HHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHH
Q 015222          319 QTHENLEHLAMMERVLGPLPHH-----------------------MVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVW  375 (411)
Q Consensus       319 ~~~~~~~~~~~i~~~~~~~p~~-----------------------~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il  375 (411)
                      .+.+..+.+..+....+..+..                       +...++..+.++|.+||..+    |.+||++.+++
T Consensus       220 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d----P~~Rpt~~e~l  295 (326)
T 1blx_A          220 RGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN----PAKRISAYSAL  295 (326)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSS----TTTSCCHHHHH
T ss_pred             CCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCC----cccCCCHHHHh
Confidence            9988888887777654432211                       12345677889999999999    99999999999


Q ss_pred             hcCCCCcccccC
Q 015222          376 KLLRLPVIDLYS  387 (411)
Q Consensus       376 ~~~~~~~~~~~~  387 (411)
                      +|+||.++....
T Consensus       296 ~hp~~~~~~~~~  307 (326)
T 1blx_A          296 SHPYFQDLERCK  307 (326)
T ss_dssp             TSGGGTTCCCCC
T ss_pred             cCccccccchhh
Confidence            999999876543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.7e-47  Score=362.17  Aligned_cols=253  Identities=23%  Similarity=0.459  Sum_probs=208.3

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHh-cCCCCCcceEEEeeeeec--CCe
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDY--RNH  167 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~~~~--~~~  167 (411)
                      .++|++.+.||+|+||+||+|++..+++.||||+++..  ..+.+.+|+.+++++. |+||     +++++++.+  ...
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i-----~~~~~~~~~~~~~~  107 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNI-----ITLADIVKDPVSRT  107 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTB-----CCEEEEEECTTTCC
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCE-----EEeeeeeccCCCCc
Confidence            46899999999999999999999999999999999753  3466889999999997 6666     999999987  678


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      .++||||+ +++|.+++..     +++..++.++.||+.||+|||++||+||||||+|||++.++               
T Consensus       108 ~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~---------------  167 (330)
T 3nsz_A          108 PALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH---------------  167 (330)
T ss_dssp             EEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT---------------
T ss_pred             eEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCC---------------
Confidence            99999999 8999988753     88999999999999999999999999999999999997654               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecC-CCCCccchhHHHHHHHHHHHhCCCCCCC-CC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQT-HE  322 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~pf~~-~~  322 (411)
                                 ..+||+|||++......  .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+
T Consensus       168 -----------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~  236 (330)
T 3nsz_A          168 -----------RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD  236 (330)
T ss_dssp             -----------TEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred             -----------CEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence                       25788888888654322  234578999999999987 5799999999999999999999999954 34


Q ss_pred             hHHHHHHHHHHhCC-------------CChhH--------------------HHhhhhhhhhhhccCCccCCCCCCCcHH
Q 015222          323 NLEHLAMMERVLGP-------------LPHHM--------------------VIRADRRAEKYFRRGARLDWPDGATSRD  369 (411)
Q Consensus       323 ~~~~~~~i~~~~~~-------------~p~~~--------------------~~~~~~~~~~li~~~l~~~~~~rp~~R~  369 (411)
                      ..+.+..+....+.             .+..+                    ...++..+.++|.+||..|    |.+||
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d----P~~Rp  312 (330)
T 3nsz_A          237 NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD----HQSRL  312 (330)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSS----GGGSC
T ss_pred             hHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCC----cccCC
Confidence            44444444333221             11111                    1125788999999999999    99999


Q ss_pred             HHHHHHhcCCCCcccc
Q 015222          370 SMRAVWKLLRLPVIDL  385 (411)
Q Consensus       370 t~~~il~~~~~~~~~~  385 (411)
                      |+.++++||||+++..
T Consensus       313 ta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          313 TAREAMEHPYFYTVVK  328 (330)
T ss_dssp             CHHHHHTSGGGTTCC-
T ss_pred             CHHHHhcCccHhhhcc
Confidence            9999999999998764

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.4e-47  Score=359.23  Aligned_cols=259  Identities=25%  Similarity=0.373  Sum_probs=221.7

Q ss_pred             CCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc----hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeee
Q 015222           87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF  162 (411)
Q Consensus        87 ~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~  162 (411)
                      .....++|++.+.||+|+||.||+|.+..+++.||+|++...    ....+.+.+|+.+++.+.|+||     +++++++
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~   84 (294)
T 2rku_A           10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV-----VGFHGFF   84 (294)
T ss_dssp             ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEE
T ss_pred             CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCE-----eeeeeee
Confidence            445667899999999999999999999999999999998643    2345677889999999987776     9999999


Q ss_pred             ecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccc
Q 015222          163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL  241 (411)
Q Consensus       163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~  241 (411)
                      .+.+..++||||+ +++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++          
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~----------  152 (294)
T 2rku_A           85 EDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL----------  152 (294)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC----------
T ss_pred             ccCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCC----------
Confidence            9999999999999 899999988765  699999999999999999999999999999999999998766          


Q ss_pred             cccCCCCCccccCCCCCCeeEeecCCcccccC---CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCC
Q 015222          242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF  318 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf  318 (411)
                                       .++|+|||++.....   ......||+.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus       153 -----------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  215 (294)
T 2rku_A          153 -----------------EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF  215 (294)
T ss_dssp             -----------------CEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             -----------------CEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence                             567777777765432   223357899999999999988999999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                      .+....+....+.......|.    ..+..+.+++.+||..+    |.+||++.++++|+||.+.....
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~----p~~Rps~~~ll~~~~~~~~~~~~  276 (294)
T 2rku_A          216 ETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTD----PTARPTINELLNDEFFTSGYIPA  276 (294)
T ss_dssp             CCSSHHHHHHHHHTTCCCCCT----TSCHHHHHHHHHHTCSS----GGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             CCCCHHHHHHHHhhccCCCcc----ccCHHHHHHHHHHcccC----hhhCcCHHHHhhChheecCCcCC
Confidence            988877766666554444443    45678899999999988    99999999999999998765544

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=5.8e-48  Score=366.81  Aligned_cols=262  Identities=28%  Similarity=0.408  Sum_probs=217.8

Q ss_pred             CccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---------hhhHHHHHHHHHHHHHhcCCCCCcceEEE
Q 015222           88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLARHDIGGTRCVQI  158 (411)
Q Consensus        88 ~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~~~~i~~~~iv~~  158 (411)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||||++....         .....+.+|+.+++++.|+||     +++
T Consensus         6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~   80 (322)
T 2ycf_A            6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI-----IKI   80 (322)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTB-----CCE
T ss_pred             hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCC-----ceE
Confidence            345678999999999999999999999999999999986432         123457789999999988877     999


Q ss_pred             eeeeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCC
Q 015222          159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD  237 (411)
Q Consensus       159 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~d  237 (411)
                      ++++..++ .|+||||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++      
T Consensus        81 ~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~------  151 (322)
T 2ycf_A           81 KNFFDAED-YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE------  151 (322)
T ss_dssp             EEEEESSS-EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS------
T ss_pred             eeEEcCCc-eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCC------
Confidence            99987655 89999999 889999987654  799999999999999999999999999999999999997654      


Q ss_pred             cccccccCCCCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceec---CCCCCccchhHHHHHHHHHHH
Q 015222          238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELC  312 (411)
Q Consensus       238 f~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~ell  312 (411)
                                        ....+||+|||++.......  ....||+.|+|||++.   +..++.++|||||||++|+|+
T Consensus       152 ------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~  213 (322)
T 2ycf_A          152 ------------------EDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL  213 (322)
T ss_dssp             ------------------SSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHH
T ss_pred             ------------------CCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHH
Confidence                              23468999999987654432  3357899999999974   457899999999999999999


Q ss_pred             hCCCCCCCCChH-HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          313 SGEALFQTHENL-EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       313 tg~~pf~~~~~~-~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      +|..||...... .....+..............++..+.++|.+||..|    |.+||++.++++|+||.+...
T Consensus       214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d----P~~Rps~~~~l~h~~~~~~~~  283 (322)
T 2ycf_A          214 SGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVD----PKARFTTEEALRHPWLQDEDM  283 (322)
T ss_dssp             HSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSS----TTTSCCHHHHHTSGGGCCHHH
T ss_pred             hCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccC----HhhCCCHHHHhhCcCcCCHHH
Confidence            999999765433 334445555555666666778899999999999999    999999999999999987553

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.7e-47  Score=355.14  Aligned_cols=257  Identities=23%  Similarity=0.323  Sum_probs=211.4

Q ss_pred             CccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee
Q 015222           88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        88 ~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~  163 (411)
                      ....++|++.+.||+|+||.||+|.+..+++.||||++....    ...+.+.+|+.+++.+.|+||     +++++++.
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~   81 (276)
T 2h6d_A            7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHI-----IKLYQVIS   81 (276)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTB-----CCEEEEEE
T ss_pred             cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCE-----eEEEEEEe
Confidence            344578999999999999999999999999999999996432    234577889999999987776     99999999


Q ss_pred             cCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccc
Q 015222          164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                      ..+..++||||+ +++|.+++....  .+++..+..++.||+.||+|||++||+|+||||+|||++.++           
T Consensus        82 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-----------  148 (276)
T 2h6d_A           82 TPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM-----------  148 (276)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTS-----------
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCC-----------
Confidence            999999999999 889999998765  699999999999999999999999999999999999998766           


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCC-CccchhHHHHHHHHHHHhCCCCCC
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQ  319 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~pf~  319 (411)
                                      .++|+|||++.......  ....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.
T Consensus       149 ----------------~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  212 (276)
T 2h6d_A          149 ----------------NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD  212 (276)
T ss_dssp             ----------------CEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ----------------CEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence                            56777777766543322  33578999999999988765 689999999999999999999999


Q ss_pred             CCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                      ..+..+....+.......|.    ..+..+.++|.+||..+    |.+||++.++++|+||++....
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~----p~~Rps~~~~l~h~~~~~~~~~  271 (276)
T 2h6d_A          213 DEHVPTLFKKIRGGVFYIPE----YLNRSVATLLMHMLQVD----PLKRATIKDIREHEWFKQDLPS  271 (276)
T ss_dssp             CSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSS----GGGSCCHHHHHHSHHHHTTCCG
T ss_pred             CCcHHHHHHHhhcCcccCch----hcCHHHHHHHHHHccCC----hhhCCCHHHHHhChhhccCchh
Confidence            88777777766665544543    35677899999999999    9999999999999999875443

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-48  Score=372.52  Aligned_cols=253  Identities=23%  Similarity=0.359  Sum_probs=207.5

Q ss_pred             CCeEEEeeeccccceEEEEEEeC---CCCcEEEEEEeccch-----hhhHHHHHHHHHHHHHh-cCCCCCcceEEEeeee
Q 015222           92 PRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWF  162 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~---~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~~  162 (411)
                      ++|++.+.||+|+||.||+|++.   .+++.||||+++...     ...+.+.+|+.+++.+. |++|     +++++++
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----v~~~~~~  128 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL-----VTLHYAF  128 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTB-----CCEEEEE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCce-----eEEEEEE
Confidence            68999999999999999999984   588999999997432     33456778999999995 6665     9999999


Q ss_pred             ecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccc
Q 015222          163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL  241 (411)
Q Consensus       163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~  241 (411)
                      ...+.+++||||+ +++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++          
T Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~----------  196 (355)
T 1vzo_A          129 QTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG----------  196 (355)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS----------
T ss_pred             eeCceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC----------
Confidence            9999999999999 899999998765  699999999999999999999999999999999999998766          


Q ss_pred             cccCCCCCccccCCCCCCeeEeecCCcccccCC----CcccccCCCccccceecCC--CCCccchhHHHHHHHHHHHhCC
Q 015222          242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGE  315 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~  315 (411)
                                       .+||+|||++......    .....||+.|+|||++.+.  .++.++|||||||++|||++|+
T Consensus       197 -----------------~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~  259 (355)
T 1vzo_A          197 -----------------HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA  259 (355)
T ss_dssp             -----------------CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSS
T ss_pred             -----------------cEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCC
Confidence                             5677777777543221    2235799999999999863  5789999999999999999999


Q ss_pred             CCCCCCCh----HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH-----HHHHHHhcCCCCccccc
Q 015222          316 ALFQTHEN----LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-----SMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       316 ~pf~~~~~----~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~-----t~~~il~~~~~~~~~~~  386 (411)
                      .||.....    ......+.......+    ..++..+.++|.+||..|    |.+||     ++.++++|+||..+++.
T Consensus       260 ~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~d----P~~R~~~~~~s~~ell~h~~f~~~~~~  331 (355)
T 1vzo_A          260 SPFTVDGEKNSQAEISRRILKSEPPYP----QEMSALAKDLIQRLLMKD----PKKRLGCGPRDADEIKEHLFFQKINWD  331 (355)
T ss_dssp             CTTSCTTSCCCHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSS----GGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred             CCCccCCccchHHHHHHHHhccCCCCC----cccCHHHHHHHHHHhhhC----HHHhcCCCCCCHHHHHcCcchhcCChh
Confidence            99975432    233333333333333    345778899999999999    88887     99999999999987653

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.7e-48  Score=379.89  Aligned_cols=266  Identities=23%  Similarity=0.405  Sum_probs=203.6

Q ss_pred             ccCCCeEEE-eeeccccceEEEEEEeC--CCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee--
Q 015222           89 NLTPRYRIL-SKMGEGTFGQVVECFDN--EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD--  163 (411)
Q Consensus        89 ~~~~~y~i~-~~lG~G~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~--  163 (411)
                      .+.+.|++. ++||+|+||+||+|+++  .+++.||||++.... ....+.+|+.++++++|+||     +++++++.  
T Consensus        17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~   90 (405)
T 3rgf_A           17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNV-----ISLQKVFLSH   90 (405)
T ss_dssp             CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTB-----CCCCEEEEET
T ss_pred             hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCe-----eeEeeEEecC
Confidence            445678874 48999999999999966  568899999997543 33567889999999988877     99999984  


Q ss_pred             cCCeEEEEEccCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccC
Q 015222          164 YRNHICIVFEKLGPSLYDFLRKNS-------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP  236 (411)
Q Consensus       164 ~~~~~~lv~e~~~~~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~  236 (411)
                      ....+|+||||++++|.+++....       ...+++..++.++.||+.||+|||++||+||||||+||||..++     
T Consensus        91 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~-----  165 (405)
T 3rgf_A           91 ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG-----  165 (405)
T ss_dssp             TTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSS-----
T ss_pred             CCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCC-----
Confidence            467999999999889999886321       12499999999999999999999999999999999999995432     


Q ss_pred             CcccccccCCCCCccccCCCCCCeeEeecCCcccccCC------CcccccCCCccccceecCC-CCCccchhHHHHHHHH
Q 015222          237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILV  309 (411)
Q Consensus       237 df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~  309 (411)
                                        +.+..+||+|||++......      ....+||+.|+|||++.+. .++.++|||||||++|
T Consensus       166 ------------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~  227 (405)
T 3rgf_A          166 ------------------PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA  227 (405)
T ss_dssp             ------------------TTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHH
T ss_pred             ------------------CCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHH
Confidence                              23447899999988765432      2346789999999999885 5899999999999999


Q ss_pred             HHHhCCCCCCCCCh---------HHHHHHHHHHhCCCChhHHHhh----------------------------------h
Q 015222          310 ELCSGEALFQTHEN---------LEHLAMMERVLGPLPHHMVIRA----------------------------------D  346 (411)
Q Consensus       310 elltg~~pf~~~~~---------~~~~~~i~~~~~~~p~~~~~~~----------------------------------~  346 (411)
                      ||++|+.||.+...         .+.+..+....+..+...+...                                  +
T Consensus       228 ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (405)
T 3rgf_A          228 ELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD  307 (405)
T ss_dssp             HHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTT
T ss_pred             HHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCC
Confidence            99999999986554         3566666666665443322211                                  5


Q ss_pred             hhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          347 RRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       347 ~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                      ..+.+||.+||..|    |.+|||+.++++||||.+.....
T Consensus       308 ~~~~~Ll~~~L~~d----P~~R~ta~e~L~hp~f~~~~~~~  344 (405)
T 3rgf_A          308 SKAFHLLQKLLTMD----PIKRITSEQAMQDPYFLEDPLPT  344 (405)
T ss_dssp             SHHHHHHHHHSCSS----GGGSCCHHHHHTSGGGTSSSCCC
T ss_pred             HHHHHHHHHHccCC----cccCCCHHHHhcChhhccCCCCc
Confidence            67889999999999    99999999999999999865543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=8.4e-48  Score=368.04  Aligned_cols=274  Identities=23%  Similarity=0.342  Sum_probs=194.5

Q ss_pred             CccCCCeEEEe-eeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec--
Q 015222           88 ENLTPRYRILS-KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--  164 (411)
Q Consensus        88 ~~~~~~y~i~~-~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~--  164 (411)
                      ..+.++|++.+ .||+|+||+||+|+++.+++.||||++.........   ....++.+.|+|+     +++++++..  
T Consensus        24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e---~~~~~~~~~h~~i-----~~~~~~~~~~~   95 (336)
T 3fhr_A           24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE---VDHHWQASGGPHI-----VCILDVYENMH   95 (336)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHH---HHHHHHHTTSTTB-----CCEEEEEEEEE
T ss_pred             ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHH---HHHHHHhcCCCCh-----HHHHHHHhhcc
Confidence            34667899966 599999999999999999999999999764332222   2233455556655     888888865  


Q ss_pred             --CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccc
Q 015222          165 --RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL  241 (411)
Q Consensus       165 --~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~  241 (411)
                        ++.+++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++          
T Consensus        96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~----------  165 (336)
T 3fhr_A           96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKE----------  165 (336)
T ss_dssp             TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS----------
T ss_pred             CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecC----------
Confidence              55699999999 88999999987656799999999999999999999999999999999999997643          


Q ss_pred             cccCCCCCccccCCCCCCeeEeecCCcccccCC-CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 015222          242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT  320 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~  320 (411)
                                    ....+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus       166 --------------~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  231 (336)
T 3fhr_A          166 --------------KDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYS  231 (336)
T ss_dssp             --------------TTCCEEECCCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             --------------CCceEEEeccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence                          2346899999998765433 2446789999999999888999999999999999999999999987


Q ss_pred             CChHHH----HHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccCCCCCchhhH
Q 015222          321 HENLEH----LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSASPNCLCKF  396 (411)
Q Consensus       321 ~~~~~~----~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~~~~~~~~~  396 (411)
                      ......    ...+......++......++..+.++|.+||..|    |.+|||+.++++||||.+.......|....++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d----P~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~  307 (336)
T 3fhr_A          232 NTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTD----PTERLTITQFMNHPWINQSMVVPQTPLHTARV  307 (336)
T ss_dssp             -------------------CCCTTTSTTCCHHHHHHHHHHSCSS----GGGSCCHHHHHHSHHHHTGGGSCCCBCSHHHH
T ss_pred             ccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCC----hhHCcCHHHHhcCccccccccCCCCccccccc
Confidence            654433    2222333334444444567888999999999999    99999999999999999876666555544444


Q ss_pred             H
Q 015222          397 Y  397 (411)
Q Consensus       397 ~  397 (411)
                      .
T Consensus       308 ~  308 (336)
T 3fhr_A          308 L  308 (336)
T ss_dssp             H
T ss_pred             c
Confidence            3

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8e-48  Score=359.82  Aligned_cols=263  Identities=27%  Similarity=0.440  Sum_probs=225.9

Q ss_pred             CCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee
Q 015222           87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        87 ~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~  163 (411)
                      ...+.++|++.+.||+|+||.||+|++..+++.||||++....   ...+.+.+|+.++++++|++|     +++++++.
T Consensus        17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~   91 (287)
T 2wei_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI-----MKLFEILE   91 (287)
T ss_dssp             THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTB-----CCEEEEEE
T ss_pred             HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCc-----cEEEEEEe
Confidence            3456679999999999999999999999999999999996432   345678899999999987776     99999999


Q ss_pred             cCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccc
Q 015222          164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                      +.+..++||||+ +++|.+++....  .+++..++.++.||+.||.|||++||+||||||+||+++.++           
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~-----------  158 (287)
T 2wei_A           92 DSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE-----------  158 (287)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS-----------
T ss_pred             CCCeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCC-----------
Confidence            999999999999 899999988765  699999999999999999999999999999999999997643           


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT  320 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~  320 (411)
                                   ....+||+|||++.......  ....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+
T Consensus       159 -------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~  224 (287)
T 2wei_A          159 -------------KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG  224 (287)
T ss_dssp             -------------TTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             -------------CcccEEEeccCcceeecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCC
Confidence                         23468999999887654332  33468999999999876 589999999999999999999999999


Q ss_pred             CChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      .+..+....+......++......++..+.++|.+||..+    |.+||++.++++|+||.+...
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d----p~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          225 KNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFH----PSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             SSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSS----GGGSCCHHHHHHSHHHHHHCC
T ss_pred             CCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccC----hhhCcCHHHHhcCHHHhcccc
Confidence            8888777777766555554445567888999999999999    999999999999999987643

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.9e-48  Score=373.03  Aligned_cols=265  Identities=23%  Similarity=0.339  Sum_probs=217.9

Q ss_pred             eCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee
Q 015222           86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        86 ~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~  163 (411)
                      +++...++|++.+.||+|+||+||+|.+..+++.||+|++...  ....+.+.+|+.+++.++|+||     +++++++.
T Consensus        27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~  101 (360)
T 3eqc_A           27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI-----VGFYGAFY  101 (360)
T ss_dssp             CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTB-----CCEEEEEE
T ss_pred             ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCE-----EEEeEEEE
Confidence            4555678999999999999999999999999999999999753  3445678899999999887776     99999999


Q ss_pred             cCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEecCcccccCCcccc
Q 015222          164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFL  241 (411)
Q Consensus       164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dikp~NIli~~~~~~~l~df~~~  241 (411)
                      .++..++||||+ +++|.+++....  .+++..+..++.||+.||.|||++ ||+||||||+|||++.++          
T Consensus       102 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~----------  169 (360)
T 3eqc_A          102 SDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG----------  169 (360)
T ss_dssp             ETTEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC----------
T ss_pred             ECCEEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC----------
Confidence            999999999999 889999998765  699999999999999999999996 999999999999997765          


Q ss_pred             cccCCCCCccccCCCCCCeeEeecCCccccc-CCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 015222          242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH-QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT  320 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~  320 (411)
                                       .++|+|||++.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus       170 -----------------~~kl~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  232 (360)
T 3eqc_A          170 -----------------EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP  232 (360)
T ss_dssp             -----------------CEEECCCCCCHHHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred             -----------------CEEEEECCCCcccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                             67888888876432 223446899999999999999999999999999999999999999987


Q ss_pred             CChHHHHHHHHH---------------------------------------H-hCCCChhHHHhhhhhhhhhhccCCccC
Q 015222          321 HENLEHLAMMER---------------------------------------V-LGPLPHHMVIRADRRAEKYFRRGARLD  360 (411)
Q Consensus       321 ~~~~~~~~~i~~---------------------------------------~-~~~~p~~~~~~~~~~~~~li~~~l~~~  360 (411)
                      .+..+....+..                                       . ....+......++..+.++|.+||..|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  312 (360)
T 3eqc_A          233 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN  312 (360)
T ss_dssp             CCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSS
T ss_pred             CCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcC
Confidence            765543322210                                       0 011111111235678999999999999


Q ss_pred             CCCCCCcHHHHHHHHhcCCCCcccccCC
Q 015222          361 WPDGATSRDSMRAVWKLLRLPVIDLYSA  388 (411)
Q Consensus       361 ~~~rp~~R~t~~~il~~~~~~~~~~~~~  388 (411)
                          |.+|||+.++++||||++......
T Consensus       313 ----P~~Rpt~~ell~hp~~~~~~~~~~  336 (360)
T 3eqc_A          313 ----PAERADLKQLMVHAFIKRSDAEEV  336 (360)
T ss_dssp             ----TTTSCCHHHHHTSHHHHHHHHSCC
T ss_pred             ----hhhCCCHHHHhhChHhhcchHhhh
Confidence                999999999999999998776543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2e-47  Score=362.59  Aligned_cols=259  Identities=21%  Similarity=0.291  Sum_probs=209.7

Q ss_pred             CccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        88 ~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      ..+.++|++.+.||+|+||+||+|++..+++.||||+++...  ...+.+.+|+.++++++|+||     +++++++...
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~   79 (319)
T 4euu_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI-----VKLFAIEEET   79 (319)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTB-----CCEEEEEECT
T ss_pred             cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCc-----ceEEEEeecC
Confidence            345678999999999999999999999999999999997533  334667899999999988777     9999988765


Q ss_pred             C--eEEEEEccC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccc
Q 015222          166 N--HICIVFEKL-GPSLYDFLRKNSY-RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL  241 (411)
Q Consensus       166 ~--~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~  241 (411)
                      +  ..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||+....          
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~----------  149 (319)
T 4euu_A           80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE----------  149 (319)
T ss_dssp             TTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECT----------
T ss_pred             CCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccC----------
Confidence            4  889999999 8999999986542 2399999999999999999999999999999999999983221          


Q ss_pred             cccCCCCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceec--------CCCCCccchhHHHHHHHHHH
Q 015222          242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVIL--------GLGWNYPCDLWSVGCILVEL  311 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlGvil~el  311 (411)
                                   +.+..+||+|||++.......  ....||+.|+|||++.        +..++.++|||||||++|||
T Consensus       150 -------------~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el  216 (319)
T 4euu_A          150 -------------DGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA  216 (319)
T ss_dssp             -------------TSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHH
T ss_pred             -------------CCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHH
Confidence                         123368899999887654332  3457999999999986        56889999999999999999


Q ss_pred             HhCCCCCCCCC----hHHHHHHHHHHhC---------------------CCChhHHHhhhhhhhhhhccCCccCCCCCCC
Q 015222          312 CSGEALFQTHE----NLEHLAMMERVLG---------------------PLPHHMVIRADRRAEKYFRRGARLDWPDGAT  366 (411)
Q Consensus       312 ltg~~pf~~~~----~~~~~~~i~~~~~---------------------~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~  366 (411)
                      ++|+.||....    ..+.+..+.....                     +.+..+....+..+.++|.+||+.|    |+
T Consensus       217 ~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d----P~  292 (319)
T 4euu_A          217 ATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD----QE  292 (319)
T ss_dssp             HHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCC----TT
T ss_pred             HhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCC----hh
Confidence            99999997543    2344444443322                     1112334566778999999999999    99


Q ss_pred             cHHHHHHHHhcC
Q 015222          367 SRDSMRAVWKLL  378 (411)
Q Consensus       367 ~R~t~~~il~~~  378 (411)
                      +|+|++|+++|+
T Consensus       293 ~R~s~~ell~h~  304 (319)
T 4euu_A          293 KCWGFDQFFAET  304 (319)
T ss_dssp             TSCCHHHHHHHH
T ss_pred             hhccHHHhhhcc
Confidence            999999999987

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.4e-47  Score=366.55  Aligned_cols=262  Identities=23%  Similarity=0.354  Sum_probs=212.1

Q ss_pred             CccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch------------hhhHHHHHHHHHHHHHhcCCCCCcce
Q 015222           88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------------KYREAAMIEIDVLQRLARHDIGGTRC  155 (411)
Q Consensus        88 ~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~------------~~~~~~~~E~~~l~~l~~~~i~~~~i  155 (411)
                      ..+.++|++.+.||+|+||.||+|.+.. ++.||||++....            ...+.+.+|+.++++++|+||     
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----   91 (362)
T 3pg1_A           18 HAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI-----   91 (362)
T ss_dssp             HHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB-----
T ss_pred             HHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc-----
Confidence            4567899999999999999999999865 8899999986422            123678899999999988877     


Q ss_pred             EEEeeeee-----cCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecC
Q 015222          156 VQIRNWFD-----YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA  230 (411)
Q Consensus       156 v~~~~~~~-----~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~  230 (411)
                      +++++++.     ....+|+||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~  170 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN  170 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred             cceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCC
Confidence            89998874     345799999999889999988654 469999999999999999999999999999999999999776


Q ss_pred             cccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecC-CCCCccchhHHHHHH
Q 015222          231 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCI  307 (411)
Q Consensus       231 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvi  307 (411)
                      +                           .+||+|||++......  .....||+.|+|||++.+ ..++.++|||||||+
T Consensus       171 ~---------------------------~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  223 (362)
T 3pg1_A          171 N---------------------------DITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCV  223 (362)
T ss_dssp             C---------------------------CEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHH
T ss_pred             C---------------------------CEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHH
Confidence            6                           5788888877643322  234578999999999987 579999999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH----------------------------HHhhhhhhhhhhccCCcc
Q 015222          308 LVELCSGEALFQTHENLEHLAMMERVLGPLPHHM----------------------------VIRADRRAEKYFRRGARL  359 (411)
Q Consensus       308 l~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~----------------------------~~~~~~~~~~li~~~l~~  359 (411)
                      +|+|++|+.||.+.+..+.+..+....+..+...                            ....++.+.++|.+||..
T Consensus       224 l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  303 (362)
T 3pg1_A          224 MAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEF  303 (362)
T ss_dssp             HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcC
Confidence            9999999999999988888888777665544322                            123456788999999999


Q ss_pred             CCCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          360 DWPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       360 ~~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                      |    |.+|||+.++++||||+.+....
T Consensus       304 d----P~~Rpt~~ell~hp~f~~~~~~~  327 (362)
T 3pg1_A          304 N----PQRRISTEQALRHPYFESLFDPL  327 (362)
T ss_dssp             S----GGGSCCHHHHHTSGGGTTTCCGG
T ss_pred             C----hhhCCCHHHHHcCchhhhccCcc
Confidence            9    99999999999999999875443

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-47  Score=363.14  Aligned_cols=259  Identities=21%  Similarity=0.378  Sum_probs=212.4

Q ss_pred             CccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeec--
Q 015222           88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY--  164 (411)
Q Consensus        88 ~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~--  164 (411)
                      ....++|++.+.||+|+||.||+|++..+++.||||++.......+.+.+|+.+++++ .|+||     +++++++..  
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i-----~~~~~~~~~~~   94 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNI-----ATYYGAFIKKN   94 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTB-----CCEEEEEEECC
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCe-----eeeeeEEeecc
Confidence            3456899999999999999999999999999999999987666677889999999999 57666     999999876  


Q ss_pred             ----CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcc
Q 015222          165 ----RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK  239 (411)
Q Consensus       165 ----~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~  239 (411)
                          .+.+++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+|+||||+|||++.++        
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~--------  166 (326)
T 2x7f_A           95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA--------  166 (326)
T ss_dssp             --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC--------
T ss_pred             CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC--------
Confidence                56899999999 78999999876445799999999999999999999999999999999999997766        


Q ss_pred             cccccCCCCCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceec-----CCCCCccchhHHHHHHHHHH
Q 015222          240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVEL  311 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~el  311 (411)
                                         .++|+|||++......   .....||+.|+|||++.     +..++.++|||||||++|+|
T Consensus       167 -------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l  227 (326)
T 2x7f_A          167 -------------------EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM  227 (326)
T ss_dssp             -------------------CEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHH
T ss_pred             -------------------CEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHH
Confidence                               5777788777654322   23457899999999997     45789999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          312 CSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       312 ltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      ++|..||.+.+....+..+...  ..+......++..+.++|.+||..+    |.+||++.++++|+||.+..
T Consensus       228 ~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~d----p~~Rps~~~ll~hp~~~~~~  294 (326)
T 2x7f_A          228 AEGAPPLCDMHPMRALFLIPRN--PAPRLKSKKWSKKFQSFIESCLVKN----HSQRPATEQLMKHPFIRDQP  294 (326)
T ss_dssp             HHSSCTTTTSCHHHHHHHHHHS--CCCCCSCSCSCHHHHHHHHHHCCSS----GGGSCCHHHHHTSHHHHCCT
T ss_pred             HhCCCCCCCCcHHHHHHHhhcC--ccccCCccccCHHHHHHHHHHhccC----hhhCCCHHHHhhChHHhhCc
Confidence            9999999887776665554443  2222223456778999999999999    99999999999999998754

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=356.59  Aligned_cols=252  Identities=21%  Similarity=0.342  Sum_probs=188.6

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++.+.||+|+||.||+|++..+++.||||++....    ...+.+.+|+.++++++|+|+     +++++++.+.+.
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~   85 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSI-----LELYNYFEDSNY   85 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTB-----CCEEEEEECSSE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCe-----EeEEEEEccCCe
Confidence            57999999999999999999999999999999997432    223668889999999987776     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      .++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++.++               
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~---------------  149 (278)
T 3cok_A           86 VYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM---------------  149 (278)
T ss_dssp             EEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTC---------------
T ss_pred             EEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC---------------
Confidence            99999999 889999998653 4699999999999999999999999999999999999997766               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN  323 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~  323 (411)
                                  .++|+|||++......   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus       150 ------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  217 (278)
T 3cok_A          150 ------------NIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV  217 (278)
T ss_dssp             ------------CEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC
T ss_pred             ------------CEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH
Confidence                        5777888877654322   2235789999999999998999999999999999999999999987665


Q ss_pred             HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      .+.+..+.......|    ..++..+.++|.+||..|    |.+||++.++++|+||.+..
T Consensus       218 ~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~d----p~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          218 KNTLNKVVLADYEMP----SFLSIEAKDLIHQLLRRN----PADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             C-----CCSSCCCCC----TTSCHHHHHHHHHHSCSS----GGGSCCHHHHTTSTTTC---
T ss_pred             HHHHHHHhhcccCCc----cccCHHHHHHHHHHcccC----HhhCCCHHHHhcCccccCCC
Confidence            444433222122222    345678899999999999    99999999999999998644

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.7e-47  Score=361.81  Aligned_cols=253  Identities=24%  Similarity=0.310  Sum_probs=206.3

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeecCCeE
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      +.++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.+++++ .|+++     +++++++..++..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i-----~~~~~~~~~~~~~   80 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGI-----PQVYYFGPCGKYN   80 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTS-----CCEEEEEEETTEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCC-----CEEEEEEecCCcc
Confidence            4578999999999999999999999999999999987543 235688899999999 77777     9999999999999


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      ++||||++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.                
T Consensus        81 ~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~----------------  143 (330)
T 2izr_A           81 AMVLELLGPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGN----------------  143 (330)
T ss_dssp             EEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGG----------------
T ss_pred             EEEEEeCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCC----------------
Confidence            9999999999999998753 47999999999999999999999999999999999999987762                


Q ss_pred             CccccCCCCCCeeEeecCCcccccCC----------CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCC
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF  318 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf  318 (411)
                            .....+||+|||++......          .....||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       144 ------~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf  217 (330)
T 2izr_A          144 ------KTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPW  217 (330)
T ss_dssp             ------TCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ------CCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCc
Confidence                  12234788888887654322          13467999999999999999999999999999999999999999


Q ss_pred             CCCC---hHHHHHHHHHHhCCCChhHHH-hhhhhhhhhhccCCccCCCCCCCcHHHHHHHHh
Q 015222          319 QTHE---NLEHLAMMERVLGPLPHHMVI-RADRRAEKYFRRGARLDWPDGATSRDSMRAVWK  376 (411)
Q Consensus       319 ~~~~---~~~~~~~i~~~~~~~p~~~~~-~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~  376 (411)
                      .+.+   ..+.+..+.......+..... ..+ .+.+++..|+..+    |.+||++.++++
T Consensus       218 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~----p~~RP~~~~l~~  274 (330)
T 2izr_A          218 QGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLD----FFEKPDYDYLRK  274 (330)
T ss_dssp             TTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCC----TTCCCCHHHHHH
T ss_pred             cccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCC----CCCCCCHHHHHH
Confidence            8743   334445554444444443322 234 8999999999999    666666666665

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-47  Score=365.42  Aligned_cols=254  Identities=25%  Similarity=0.350  Sum_probs=202.6

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      ..++|++++.||+|+||.||+|.+. +++.||||++....   ...+.+.+|+.+++.+.|+   ++|++++++++...+
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~---~~~iv~~~~~~~~~~   82 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH---SDKIIRLYDYEITDQ   82 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTT---CTTBCCEEEEEECSS
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhc---CCceEEEeeeEeeCC
Confidence            3568999999999999999999874 68889999996432   3446778999999999873   145599999999999


Q ss_pred             eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          167 HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       167 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      .+|+|||+.+++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++ ++               
T Consensus        83 ~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~---------------  144 (343)
T 3dbq_A           83 YIYMVMECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG---------------  144 (343)
T ss_dssp             EEEEEECCCSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TT---------------
T ss_pred             EEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CC---------------
Confidence            999999977999999998865  799999999999999999999999999999999999996 33               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecC-----------CCCCccchhHHHHHHHHH
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILG-----------LGWNYPCDLWSVGCILVE  310 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlGvil~e  310 (411)
                                  .+||+|||++.......     ....||+.|+|||++.+           ..++.++|||||||++||
T Consensus       145 ------------~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~e  212 (343)
T 3dbq_A          145 ------------MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY  212 (343)
T ss_dssp             ------------EEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHH
T ss_pred             ------------cEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHH
Confidence                        47888888876543322     24579999999999864           578999999999999999


Q ss_pred             HHhCCCCCCCCChH-HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcc
Q 015222          311 LCSGEALFQTHENL-EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVI  383 (411)
Q Consensus       311 lltg~~pf~~~~~~-~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~  383 (411)
                      |++|+.||...... ..+..+..  ......+....+..+.+++.+||..|    |.+|||+.++++||||+..
T Consensus       213 ll~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~L~~d----p~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          213 MTYGKTPFQQIINQISKLHAIID--PNHEIEFPDIPEKDLQDVLKCCLKRD----PKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             HHHSSCTTTTCCSHHHHHHHHHC--TTSCCCCCCCSCHHHHHHHHHHTCSS----TTTSCCHHHHHTSHHHHSC
T ss_pred             HHhCCCcchhhhhHHHHHHHHhc--CCcccCCcccCCHHHHHHHHHHcCCC----hhHCCCHHHHHhCcccccc
Confidence            99999999875432 22222221  11222222334567899999999999    9999999999999999753

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5.2e-48  Score=369.34  Aligned_cols=248  Identities=24%  Similarity=0.387  Sum_probs=208.8

Q ss_pred             CccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchh---------hhHHHHHHHHHHHHHhcCCCCCcceEEE
Q 015222           88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---------YREAAMIEIDVLQRLARHDIGGTRCVQI  158 (411)
Q Consensus        88 ~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~~~~i~~~~iv~~  158 (411)
                      ..+.++|++.+.||+|+||.||+|+++.+++.||||+++....         ..+.+.+|+.++++++|+||     +++
T Consensus        20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~I-----v~~   94 (335)
T 3dls_A           20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI-----IKV   94 (335)
T ss_dssp             THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTB-----CCE
T ss_pred             cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCE-----eeE
Confidence            3456799999999999999999999999999999999975431         33456789999999988777     999


Q ss_pred             eeeeecCCeEEEEEccC-CC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccC
Q 015222          159 RNWFDYRNHICIVFEKL-GP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP  236 (411)
Q Consensus       159 ~~~~~~~~~~~lv~e~~-~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~  236 (411)
                      ++++.+.+.+++||||+ ++ +|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++     
T Consensus        95 ~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-----  167 (335)
T 3dls_A           95 LDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF-----  167 (335)
T ss_dssp             EEEEECSSEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-----
T ss_pred             EEEEeeCCEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC-----
Confidence            99999999999999998 55 9999998765  699999999999999999999999999999999999997766     


Q ss_pred             CcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCC-CccchhHHHHHHHHHHHh
Q 015222          237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCS  313 (411)
Q Consensus       237 df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt  313 (411)
                                            .+||+|||++.......  ....||+.|+|||++.+..+ +.++|||||||++|+|++
T Consensus       168 ----------------------~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~  225 (335)
T 3dls_A          168 ----------------------TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF  225 (335)
T ss_dssp             ----------------------CEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHH
T ss_pred             ----------------------cEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHh
Confidence                                  67888888877654332  34579999999999998876 889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcc
Q 015222          314 GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVI  383 (411)
Q Consensus       314 g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~  383 (411)
                      |..||......      .......|    ..++..+.++|.+||..+    |.+||++.++++|+||.+.
T Consensus       226 g~~pf~~~~~~------~~~~~~~~----~~~~~~l~~li~~~L~~d----P~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          226 EENPFCELEET------VEAAIHPP----YLVSKELMSLVSGLLQPV----PERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             SSCSCSSGGGG------TTTCCCCS----SCCCHHHHHHHHHHTCSS----GGGSCCHHHHHHCTTTTCC
T ss_pred             CCCchhhHHHH------HhhccCCC----cccCHHHHHHHHHHccCC----hhhCcCHHHHhcCccccCC
Confidence            99999763221      11111122    235678999999999999    9999999999999999864

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.3e-46  Score=352.11  Aligned_cols=252  Identities=21%  Similarity=0.327  Sum_probs=209.5

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec----
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY----  164 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~----  164 (411)
                      ..|++.+.||+|+||+||+|.+..++..||+|++...   ....+.+.+|+.++++++|+||     +++++++..    
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~  100 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI-----VRFYDSWESTVKG  100 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEEESSS
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCe-----eeeeeeeccccCC
Confidence            4689999999999999999999999999999998743   3345667889999999988777     999988765    


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEe-cCcccccCCccc
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLV-SAEYVKVPDYKF  240 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dikp~NIli~-~~~~~~l~df~~  240 (411)
                      .+.+++||||+ +++|.+++....  .+++..++.++.||+.||.|||++|  |+||||||+|||++ .++         
T Consensus       101 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~---------  169 (290)
T 1t4h_A          101 KKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG---------  169 (290)
T ss_dssp             CEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS---------
T ss_pred             CceEEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCC---------
Confidence            46799999999 889999998765  6999999999999999999999999  99999999999996 343         


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccCCC-cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ  319 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~  319 (411)
                                        .++|+|||++....... ....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.
T Consensus       170 ------------------~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~  230 (290)
T 1t4h_A          170 ------------------SVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS  230 (290)
T ss_dssp             ------------------CEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             ------------------CEEEeeCCCcccccccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCC
Confidence                              67888888886544332 34579999999998875 58999999999999999999999998


Q ss_pred             CCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcc
Q 015222          320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVI  383 (411)
Q Consensus       320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~  383 (411)
                      +............ .+..+.......++.+.++|.+||..+    |.+||++.++++|+||++.
T Consensus       231 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~d----p~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          231 ECQNAAQIYRRVT-SGVKPASFDKVAIPEVKEIIEGCIRQN----KDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             TCSSHHHHHHHHT-TTCCCGGGGGCCCHHHHHHHHHHSCSS----GGGSCCHHHHHTSGGGC--
T ss_pred             CcCcHHHHHHHHh-ccCCccccCCCCCHHHHHHHHHHccCC----hhhCCCHHHHhhCcccccC
Confidence            7655443332221 233444555566678999999999999    9999999999999999863

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.8e-47  Score=353.64  Aligned_cols=273  Identities=19%  Similarity=0.218  Sum_probs=209.0

Q ss_pred             CccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeee
Q 015222           88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        88 ~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~  163 (411)
                      ..+.++|++.+.||+|+||+||+|.+..+++.||||+++..   ......+.+|+.++..+ .|+||     +++++++.
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~i-----v~~~~~~~   81 (289)
T 1x8b_A            7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV-----VRYFSAWA   81 (289)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTB-----CCEEEEEE
T ss_pred             ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCe-----eeeeeeee
Confidence            44567899999999999999999999999999999999743   23456677899999988 67766     99999999


Q ss_pred             cCCeEEEEEccC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          164 YRNHICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       164 ~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                      +.+..++||||+ +++|.+++....  ...+++..++.++.||+.||+|||++||+||||||+|||++.++...+.+...
T Consensus        82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~  161 (289)
T 1x8b_A           82 EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEG  161 (289)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------
T ss_pred             cCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccc
Confidence            999999999999 889999998642  13699999999999999999999999999999999999999877554443321


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCC
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQ  319 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~  319 (411)
                      ....        ..+....++|+|||.+....... ...||+.|+|||++.+. .++.++|||||||++|+|++|.+++.
T Consensus       162 ~~~~--------~~~~~~~~kl~Dfg~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~  232 (289)
T 1x8b_A          162 DEDD--------WASNKVMFKIGDLGHVTRISSPQ-VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR  232 (289)
T ss_dssp             ----------------CCCEEECCCTTCEETTCSC-CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred             cccc--------ccCCceEEEEcccccccccCCcc-ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence            1110        01245579999999988765433 34699999999999876 67789999999999999999998876


Q ss_pred             CCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      ....   ...+...  .. ......++..+.++|.+||..|    |.+||++.++++|+||.+..
T Consensus       233 ~~~~---~~~~~~~--~~-~~~~~~~~~~~~~li~~~l~~d----p~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          233 NGDQ---WHEIRQG--RL-PRIPQVLSQEFTELLKVMIHPD----PERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             SSHH---HHHHHTT--CC-CCCSSCCCHHHHHHHHHHTCSS----GGGSCCHHHHHTCTTC----
T ss_pred             chhH---HHHHHcC--CC-CCCCcccCHHHHHHHHHHhCCC----cccCCCHHHHhhChHhhhhc
Confidence            5432   2222221  11 1122346788999999999999    99999999999999998743

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.3e-46  Score=351.34  Aligned_cols=258  Identities=22%  Similarity=0.280  Sum_probs=211.0

Q ss_pred             CCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeecC
Q 015222           87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        87 ~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~~  165 (411)
                      ++.+.++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.+++.+ .|+++     +++++++...
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i-----~~~~~~~~~~   78 (298)
T 1csn_A            5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGI-----PNVYYFGQEG   78 (298)
T ss_dssp             -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTC-----CCEEEEEEET
T ss_pred             CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCC-----CeEEeecCCC
Confidence            4567789999999999999999999999999999999986433 345678899999999 55655     8888999999


Q ss_pred             CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          166 NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       166 ~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      ...++||||++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.             
T Consensus        79 ~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~-------------  144 (298)
T 1csn_A           79 LHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNS-------------  144 (298)
T ss_dssp             TEEEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSS-------------
T ss_pred             ceeEEEEEecCCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCC-------------
Confidence            9999999999999999998754 36999999999999999999999999999999999999987651             


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCC----------CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE  315 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~  315 (411)
                               .....+||+|||++......          .....||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       145 ---------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~  215 (298)
T 1csn_A          145 ---------KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS  215 (298)
T ss_dssp             ---------TTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             ---------CCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCC
Confidence                     23345888888888754432          23357999999999999999999999999999999999999


Q ss_pred             CCCCCCC---hHHHHHHHHHHhC-CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          316 ALFQTHE---NLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       316 ~pf~~~~---~~~~~~~i~~~~~-~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      .||.+.+   ..+.+..+..... .........+++.+.+++.+|+..+    |.+||++.++++.
T Consensus       216 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d----p~~RP~~~~l~~~  277 (298)
T 1csn_A          216 LPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLA----FDATPDYDYLQGL  277 (298)
T ss_dssp             CTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCC----TTCCCCHHHHHHH
T ss_pred             CCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCC----cccCCCHHHHHHH
Confidence            9998743   3444444443332 2223334467888999999999999    7777777777654

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.2e-47  Score=357.72  Aligned_cols=258  Identities=20%  Similarity=0.351  Sum_probs=213.4

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeee--
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF--  162 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~--  162 (411)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|+++...     ...+.+.+|+.++++++|+||     +++++++  
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~   77 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV-----IQLVDVLYN   77 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEC
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCe-----eEEEEEEEc
Confidence            4578999999999999999999999999999999997532     345678899999999987776     9999988  


Q ss_pred             ecCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccc
Q 015222          163 DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       163 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                      ...+..++||||+.++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++           
T Consensus        78 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~-----------  146 (305)
T 2wtk_C           78 EEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG-----------  146 (305)
T ss_dssp             C---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-----------
T ss_pred             CCCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCC-----------
Confidence            445689999999966688888876656799999999999999999999999999999999999998766           


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCC--CCccchhHHHHHHHHHHHhCC
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLG--WNYPCDLWSVGCILVELCSGE  315 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~elltg~  315 (411)
                                      .++|+|||.+......     .....||+.|+|||++.+..  ++.++|||||||++|+|++|+
T Consensus       147 ----------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~  210 (305)
T 2wtk_C          147 ----------------TLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL  210 (305)
T ss_dssp             ----------------CEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSS
T ss_pred             ----------------cEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCC
Confidence                            5677777776543221     12346899999999998754  478999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                      .||.+.+..+....+......++.    ..+..+.++|.+||..|    |.+||++.++++|+||.+.....
T Consensus       211 ~p~~~~~~~~~~~~i~~~~~~~~~----~~~~~l~~li~~~l~~d----p~~Rps~~~ll~~~~~~~~~~~~  274 (305)
T 2wtk_C          211 YPFEGDNIYKLFENIGKGSYAIPG----DCGPPLSDLLKGMLEYE----PAKRFSIRQIRQHSWFRKKHPPA  274 (305)
T ss_dssp             CSCCCSSHHHHHHHHHHCCCCCCS----SSCHHHHHHHHHHTCSS----TTTSCCHHHHHHSHHHHSCCCC-
T ss_pred             CCCCCchHHHHHHHHhcCCCCCCC----ccCHHHHHHHHHHccCC----hhhCCCHHHHhcCcccccCCCCc
Confidence            999988877777777665544443    45677899999999999    99999999999999998766544

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=7.7e-47  Score=355.39  Aligned_cols=263  Identities=22%  Similarity=0.366  Sum_probs=215.0

Q ss_pred             eeCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee
Q 015222           85 AIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        85 ~~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~  163 (411)
                      ..+....++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.+.|+|+     +++++++.
T Consensus        12 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~   86 (302)
T 2j7t_A           12 RRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI-----VKLLGAYY   86 (302)
T ss_dssp             BSSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTB-----CCEEEEEE
T ss_pred             ccccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCE-----eeeeeeee
Confidence            334456689999999999999999999999999999999987433 345678899999999988776     99999999


Q ss_pred             cCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccc
Q 015222          164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                      ..+..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++           
T Consensus        87 ~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-----------  154 (302)
T 2j7t_A           87 HDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG-----------  154 (302)
T ss_dssp             CC-CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTS-----------
T ss_pred             eCCeEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCC-----------
Confidence            999999999999 889999987643 3699999999999999999999999999999999999997766           


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCccccc---CCCcccccCCCccccceec-----CCCCCccchhHHHHHHHHHHHhC
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSG  314 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltg  314 (411)
                                      .++|+|||++....   .......||+.|+|||++.     +..++.++|||||||++|+|++|
T Consensus       155 ----------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g  218 (302)
T 2j7t_A          155 ----------------DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI  218 (302)
T ss_dssp             ----------------CEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHS
T ss_pred             ----------------CEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcC
Confidence                            57778887664321   1223357899999999984     56789999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       315 ~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      ..||...+.......+....... ......++..+.++|.+||..+    |.+|||+.++++|+||.++..
T Consensus       219 ~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~d----p~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          219 EPPHHELNPMRVLLKIAKSDPPT-LLTPSKWSVEFRDFLKIALDKN----PETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             SCTTTTSCHHHHHHHHHHSCCCC-CSSGGGSCHHHHHHHHHHSCSC----TTTSCCHHHHTTSTTTTTCCC
T ss_pred             CCCCccCCHHHHHHHHhccCCcc-cCCccccCHHHHHHHHHHcccC----hhhCCCHHHHhcChHHhhhcc
Confidence            99999888776666555433221 1123456778999999999999    999999999999999998764

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=6.1e-47  Score=351.33  Aligned_cols=255  Identities=22%  Similarity=0.320  Sum_probs=211.1

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....  ...+.+.+|+.+++.+.|+|+     +++++++.+++..
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~   80 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV-----VKFYGHRREGNIQ   80 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTB-----CCEEEEEEETTEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCc-----eeeeeEEEcCCEE
Confidence            467999999999999999999999999999999996432  345678899999999987776     9999999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      ++||||+ +++|.+++....  .+++..+..++.||+.||+|||++||+|+||||+||+++.++                
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~----------------  142 (276)
T 2yex_A           81 YLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD----------------  142 (276)
T ss_dssp             EEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC----------------
T ss_pred             EEEEEecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCC----------------
Confidence            9999999 889999987654  699999999999999999999999999999999999998766                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCC-CccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                                 .++|+|||.+......     .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.
T Consensus       143 -----------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  211 (276)
T 2yex_A          143 -----------NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP  211 (276)
T ss_dssp             -----------CEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCS
T ss_pred             -----------CEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Confidence                       5677777777543221     233578999999999988765 78999999999999999999999876


Q ss_pred             ChH-HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          322 ENL-EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       322 ~~~-~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      +.. .....+.......  .....++..+.++|.+||..|    |.+|||+.++++|+||++...
T Consensus       212 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~----p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          212 SDSCQEYSDWKEKKTYL--NPWKKIDSAPLALLHKILVEN----PSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             CTTSHHHHHHHTTCTTS--TTGGGSCHHHHHHHHHHSCSS----TTTSCCHHHHTTCTTTTCCCC
T ss_pred             chHHHHHHHhhhccccc--CchhhcCHHHHHHHHHHCCCC----chhCCCHHHHhcCccccChhh
Confidence            543 2222222221112  123457788999999999999    999999999999999997644

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.5e-49  Score=384.55  Aligned_cols=250  Identities=15%  Similarity=0.141  Sum_probs=198.1

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc----hhhhHHHHHHHHHHHHHhcCCCCCcceEEEe-------
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIR-------  159 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~-------  159 (411)
                      .++|++.+.||+|+||+||+|++..+|+.||||++...    ....+.+.+|+.+++.+.  .+.|+||++++       
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR--GIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGST--TCCSHHHHHHHHCBCCCS
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhcc--ccCCHHHHHHHhhhhhhh
Confidence            46899999999999999999999999999999999632    234567889996666553  22456668887       


Q ss_pred             eeeecCC-----------------eEEEEEccCCCCHHHHHHhcCCCCCC-------HHHHHHHHHHHHHHHHHHHhCCc
Q 015222          160 NWFDYRN-----------------HICIVFEKLGPSLYDFLRKNSYRSFP-------IDLVRELGRQLLESVAFMHELRL  215 (411)
Q Consensus       160 ~~~~~~~-----------------~~~lv~e~~~~~L~~~l~~~~~~~l~-------~~~~~~i~~qi~~aL~~LH~~gi  215 (411)
                      +++++.+                 ..|+||||++|+|.+++....  .++       +..+..++.||+.||+|||++||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~--~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i  227 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL--SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL  227 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHH--HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhcc--ccccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence            5555443                 389999999889999998653  344       48888899999999999999999


Q ss_pred             eecCCCCCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCC--
Q 015222          216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL--  293 (411)
Q Consensus       216 vH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~--  293 (411)
                      +||||||+|||++.+|                           .+||+|||++...........| +.|+|||++.+.  
T Consensus       228 vHrDikp~NIll~~~~---------------------------~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~  279 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRG---------------------------GVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRAT  279 (377)
T ss_dssp             ECSCCCGGGEEECTTC---------------------------CEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTS
T ss_pred             ecCCCCHHHEEEcCCC---------------------------CEEEEechhheecCCcccCCCC-cCccChhhhccccc
Confidence            9999999999998766                           6788888888765555555678 999999999987  


Q ss_pred             ---------CCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCC
Q 015222          294 ---------GWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDG  364 (411)
Q Consensus       294 ---------~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~r  364 (411)
                               .++.++|||||||++|||++|+.||.+.+..+....+....        ..+++.+.++|.+||..|    
T Consensus       280 ~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~--------~~~~~~~~~li~~~L~~d----  347 (377)
T 3byv_A          280 ISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSC--------KNIPQPVRALLEGFLRYP----  347 (377)
T ss_dssp             THHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGSSC--------CCCCHHHHHHHHHHTCSS----
T ss_pred             ccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhhhc--------cCCCHHHHHHHHHHcCCC----
Confidence                     89999999999999999999999997655433222221111        345678899999999999    


Q ss_pred             CCcHHHHHHHHhcCCCCccc
Q 015222          365 ATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       365 p~~R~t~~~il~~~~~~~~~  384 (411)
                      |.+||++.++++|+||.++.
T Consensus       348 p~~Rpt~~e~l~hp~f~~~~  367 (377)
T 3byv_A          348 KEDRLLPLQAMETPEYEQLR  367 (377)
T ss_dssp             GGGCCCHHHHHTSHHHHHHH
T ss_pred             chhCCCHHHHhhChHHHHHH
Confidence            99999999999999998754

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.3e-48  Score=378.75  Aligned_cols=257  Identities=12%  Similarity=0.046  Sum_probs=195.5

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHh--cCCCCCcceEEEe------
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLA--RHDIGGTRCVQIR------  159 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~--~~~i~~~~iv~~~------  159 (411)
                      ..|++.+.||+|+||+||+|++..+++.||||++....    ...+.+.+|+.+++.+.  |+|+     ++++      
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~i-----v~~~~~~~~p  136 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE-----ARDRRRLLLP  136 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC---------------CBCCC
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhh-----hhhceeEEee
Confidence            35999999999999999999999999999999998633    44566778887777776  5554     6544      


Q ss_pred             -eeeecC-----------------CeEEEEEccCCCCHHHHHHhcCCCCCCHHHH------HHHHHHHHHHHHHHHhCCc
Q 015222          160 -NWFDYR-----------------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLV------RELGRQLLESVAFMHELRL  215 (411)
Q Consensus       160 -~~~~~~-----------------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~------~~i~~qi~~aL~~LH~~gi  215 (411)
                       +++...                 ..+|+||||++++|.+++.... ..+++...      ..++.||+.||+|||++||
T Consensus       137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~i  215 (371)
T 3q60_A          137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKGL  215 (371)
T ss_dssp             CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             ehheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCC
Confidence             333322                 4589999999999999998653 13455555      6777999999999999999


Q ss_pred             eecCCCCCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecC--C
Q 015222          216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG--L  293 (411)
Q Consensus       216 vH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~--~  293 (411)
                      +||||||+|||++.+|                           .+||+|||++...........+|+.|+|||++.+  .
T Consensus       216 vHrDikp~NIll~~~~---------------------------~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~  268 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDG---------------------------RLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTA  268 (371)
T ss_dssp             EETTCSGGGEEECTTS---------------------------CEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEE
T ss_pred             ccCcCCHHHEEECCCC---------------------------CEEEEecceeeecCCCccCccCCcCCcChhhccCCCC
Confidence            9999999999998766                           6788888888766554445677899999999987  6


Q ss_pred             CCCccchhHHHHHHHHHHHhCCCCCCCCChHHH--HHH---HHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcH
Q 015222          294 GWNYPCDLWSVGCILVELCSGEALFQTHENLEH--LAM---MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR  368 (411)
Q Consensus       294 ~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~--~~~---i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R  368 (411)
                      .++.++|||||||++|||++|+.||.+......  ...   ...............+++.+.++|.+||..|    |++|
T Consensus       269 ~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d----P~~R  344 (371)
T 3q60_A          269 TFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFD----RRRR  344 (371)
T ss_dssp             ECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSS----TTTC
T ss_pred             CcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCC----hhhC
Confidence            799999999999999999999999987633210  000   0000111111122356788999999999999    9999


Q ss_pred             HHHHHHHhcCCCCcccc
Q 015222          369 DSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       369 ~t~~~il~~~~~~~~~~  385 (411)
                      ||+.++++||||.++.+
T Consensus       345 pt~~e~l~hp~f~~~~~  361 (371)
T 3q60_A          345 LLPLEAMETPEFLQLQN  361 (371)
T ss_dssp             CCHHHHTTSHHHHHHHH
T ss_pred             CCHHHHhcCHHHHHHHH
Confidence            99999999999987654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=8.7e-47  Score=368.17  Aligned_cols=254  Identities=25%  Similarity=0.362  Sum_probs=204.0

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      .++|++.+.||+|+||.||+|.+.. ++.||||++...   ....+.+.+|+.+++++.|+   |+||+++++++...+.
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~---~~~iv~~~~~~~~~~~  130 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH---SDKIIRLYDYEITDQY  130 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTT---CTTBCCEEEEEECSSE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccC---CCeEEEEEEEEecCCE
Confidence            3569999999999999999999865 889999999643   23456788999999999862   2455999999999999


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          168 ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       168 ~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      +|+|||+.+++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++ ++                
T Consensus       131 ~~lv~E~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~----------------  191 (390)
T 2zmd_A          131 IYMVMECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG----------------  191 (390)
T ss_dssp             EEEEEECCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SS----------------
T ss_pred             EEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CC----------------
Confidence            99999966999999998865  789999999999999999999999999999999999994 33                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecC-----------CCCCccchhHHHHHHHHHH
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILG-----------LGWNYPCDLWSVGCILVEL  311 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlGvil~el  311 (411)
                                 .+||+|||++.......     ...+||+.|+|||++.+           ..++.++|||||||++|||
T Consensus       192 -----------~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~el  260 (390)
T 2zmd_A          192 -----------MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM  260 (390)
T ss_dssp             -----------CEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHH
T ss_pred             -----------eEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHH
Confidence                       57888888887543321     33579999999999975           3689999999999999999


Q ss_pred             HhCCCCCCCCCh-HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          312 CSGEALFQTHEN-LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       312 ltg~~pf~~~~~-~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      ++|+.||.+... ...+..+.......  .+....+..+.++|.+||..|    |.+||++.++++|+||+...
T Consensus       261 l~G~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~d----P~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          261 TYGKTPFQQIINQISKLHAIIDPNHEI--EFPDIPEKDLQDVLKCCLKRD----PKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             HHSSCTTTTCCCHHHHHHHHHCTTSCC--CCCCCSCHHHHHHHHHHTCSS----TTTSCCHHHHHTSHHHHSCC
T ss_pred             HHCCCcchhhhHHHHHHHHHhCccccC--CCCccchHHHHHHHHHHcccC----hhhCCCHHHHhhCcCccccC
Confidence            999999987543 23333332211111  112233567899999999999    99999999999999997543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=5e-47  Score=356.17  Aligned_cols=273  Identities=25%  Similarity=0.341  Sum_probs=205.1

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec-----
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-----  164 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~-----  164 (411)
                      +.++|++.+.||+|+||.||+|++..+++.||||++.......+.+.+|+.++++++|+|+     +++++++.+     
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~   78 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV-----VRYYAAWLERRNFV   78 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEECCCCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHH-----HHHHHHHHhhcchh
Confidence            4468999999999999999999999999999999998766667788899999999988777     888887643     


Q ss_pred             --------CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCccccc
Q 015222          165 --------RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV  235 (411)
Q Consensus       165 --------~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l  235 (411)
                              .+..|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|
T Consensus        79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             C------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEE
T ss_pred             hhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEE
Confidence                    46789999999 889999998654 35888999999999999999999999999999999999988775555


Q ss_pred             CCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhC
Q 015222          236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSG  314 (411)
Q Consensus       236 ~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg  314 (411)
                      +|||++.........         ..+ +...............||+.|+|||++.+. .++.++|||||||++|+|++ 
T Consensus       158 ~dfg~~~~~~~~~~~---------~~~-~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-  226 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDI---------LKL-DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-  226 (303)
T ss_dssp             CCCCCCSCTTC-----------------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS-
T ss_pred             eeCcchhhcccccch---------hcc-ccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh-
Confidence            454443322211100         000 000000000112335789999999999875 68999999999999999998 


Q ss_pred             CCCCCCC-ChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          315 EALFQTH-ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       315 ~~pf~~~-~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                        ||... +..+....+......+|..+....+..+.++|.+||..|    |.+|||+.++++|+||.....
T Consensus       227 --p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d----p~~Rps~~~ll~h~~~~~~~~  292 (303)
T 1zy4_A          227 --PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHD----PNKRPGARTLLNSGWLPVKHQ  292 (303)
T ss_dssp             --CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSS----GGGSCCHHHHHHSSCSCCCCH
T ss_pred             --ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcC----cccCcCHHHHhCCCCcCCCCh
Confidence              66432 233444444444556666666667778999999999999    999999999999999986543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.6e-46  Score=355.40  Aligned_cols=261  Identities=23%  Similarity=0.356  Sum_probs=212.2

Q ss_pred             CccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        88 ~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      +...++|++.+.||+|+||.||+|.+..+|+.||||++.... ..+.+.+|+.+++.+.|+|+     +++++++...+.
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~   98 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHV-----VKYYGSYFKNTD   98 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTB-----CCEEEEEEETTE
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCC-----ccEEEEEEeCCE
Confidence            445678999999999999999999999999999999997543 34668889999999987776     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      .++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++               
T Consensus        99 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~---------------  162 (314)
T 3com_A           99 LWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG---------------  162 (314)
T ss_dssp             EEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC---------------
T ss_pred             EEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCC---------------
Confidence            99999999 789999997443 3699999999999999999999999999999999999998766               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN  323 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~  323 (411)
                                  .++|+|||++......   .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus       163 ------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  230 (314)
T 3com_A          163 ------------HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP  230 (314)
T ss_dssp             ------------CEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred             ------------CEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh
Confidence                        5777777777654322   2335789999999999998999999999999999999999999998777


Q ss_pred             HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccC
Q 015222          324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~  387 (411)
                      ......+...... .......++..+.++|.+||..+    |.+||++.++++|+||.+.....
T Consensus       231 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~d----p~~Rpt~~~ll~~~~~~~~~~~~  289 (314)
T 3com_A          231 MRAIFMIPTNPPP-TFRKPELWSDNFTDFVKQCLVKS----PEQRATATQLLQHPFVRSAKGVS  289 (314)
T ss_dssp             HHHHHHHHHSCCC-CCSSGGGSCHHHHHHHHHHTCSC----TTTSCCHHHHTTSHHHHTCCCGG
T ss_pred             HHHHHHHhcCCCc-ccCCcccCCHHHHHHHHHHccCC----hhhCcCHHHHHhCHHHhcCCcch
Confidence            6655544433221 11223446778999999999999    99999999999999999876543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3e-46  Score=348.91  Aligned_cols=255  Identities=19%  Similarity=0.188  Sum_probs=208.0

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhh--------hHHHHHHHHHHHHHhcCCCCCcceEEEee
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY--------REAAMIEIDVLQRLARHDIGGTRCVQIRN  160 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--------~~~~~~E~~~l~~l~~~~i~~~~iv~~~~  160 (411)
                      ...++|++.+.||+|+||+||+|++..+++.||||++......        .+.+.+|+.++++++|+||     +++++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~   90 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI-----VKLYG   90 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTB-----CCEEE
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCc-----hhhhe
Confidence            3457899999999999999999999999999999998643211        1668899999999987776     99999


Q ss_pred             eeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEecCcccccCC
Q 015222          161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPD  237 (411)
Q Consensus       161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dikp~NIli~~~~~~~l~d  237 (411)
                      ++.+..  ++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++|  |+||||||+|||++.++      
T Consensus        91 ~~~~~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~------  161 (287)
T 4f0f_A           91 LMHNPP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLD------  161 (287)
T ss_dssp             EETTTT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCC------
T ss_pred             eecCCC--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccC------
Confidence            987665  6999999 899999987654 46999999999999999999999999  99999999999997655      


Q ss_pred             cccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceec--CCCCCccchhHHHHHHHHHHHhCC
Q 015222          238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL--GLGWNYPCDLWSVGCILVELCSGE  315 (411)
Q Consensus       238 f~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlGvil~elltg~  315 (411)
                                      .+....+||+|||++...........||+.|+|||++.  +..++.++|||||||++|+|++|+
T Consensus       162 ----------------~~~~~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~  225 (287)
T 4f0f_A          162 ----------------ENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE  225 (287)
T ss_dssp             ----------------TTCSCCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSS
T ss_pred             ----------------CCCceeEEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCC
Confidence                            12334589999999987666666678999999999994  446789999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      .||...+......................+++.+.+++.+||..|    |.+||++.++++.
T Consensus       226 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d----p~~Rps~~~ll~~  283 (287)
T 4f0f_A          226 GPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGD----PKKRPHFSYIVKE  283 (287)
T ss_dssp             CTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSS----GGGSCCHHHHHHH
T ss_pred             CCCccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCC----hhhCcCHHHHHHH
Confidence            999876543332222222223333334567788999999999998    9999999999864

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.1e-46  Score=346.76  Aligned_cols=246  Identities=24%  Similarity=0.351  Sum_probs=210.0

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      ++|++.+.||+|+||+||+|.+. +++.||+|++.......+.+.+|+.++++++|+||     +++++++.+.+..++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv   83 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKL-----VQLYGVCLEQAPICLV   83 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTB-----CCEEEEECSSSSEEEE
T ss_pred             hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCE-----eeEEEEEecCCceEEE
Confidence            58999999999999999999987 46779999998766667789999999999988776     9999999999999999


Q ss_pred             EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      |||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++                   
T Consensus        84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-------------------  143 (269)
T 4hcu_A           84 FEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-------------------  143 (269)
T ss_dssp             EECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG-------------------
T ss_pred             EEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCC-------------------
Confidence            9999 889999997654 3699999999999999999999999999999999999998766                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCC----CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE  325 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~  325 (411)
                              .++|+|||++......    .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+
T Consensus       144 --------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~  215 (269)
T 4hcu_A          144 --------VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE  215 (269)
T ss_dssp             --------CEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             --------CEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH
Confidence                    5788888877654322    223456778999999998899999999999999999999 999999988877


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ....+........   ....+..+.+++.+||..+    |.+||++.+++++.
T Consensus       216 ~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~----p~~Rps~~~ll~~l  261 (269)
T 4hcu_A          216 VVEDISTGFRLYK---PRLASTHVYQIMNHCWRER----PEDRPAFSRLLRQL  261 (269)
T ss_dssp             HHHHHHTTCCCCC---CTTSCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred             HHHHHhcCccCCC---CCcCCHHHHHHHHHHccCC----cccCcCHHHHHHHH
Confidence            7776655432222   2335678899999999988    99999999999874

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.7e-46  Score=352.48  Aligned_cols=253  Identities=21%  Similarity=0.261  Sum_probs=202.0

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      ..++|++.+.||+|+||+||+|++  +++.||||++....   ...+.+.+|+.++++++|+||     +++++++.+.+
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~  107 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI-----VLFMGAVTQPP  107 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEECSTT
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEECC
Confidence            346899999999999999999976  57889999997533   334567899999999988777     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEecCcccccCCccccc
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSY-RSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                      ..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||++|  |+||||||+|||++.++           
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~-----------  176 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY-----------  176 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC-----------
T ss_pred             ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC-----------
Confidence            999999999 8899999986541 13899999999999999999999999  99999999999997766           


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ  319 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~  319 (411)
                                      .+||+|||++......   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus       177 ----------------~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~  240 (309)
T 3p86_A          177 ----------------TVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG  240 (309)
T ss_dssp             ----------------CEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTT
T ss_pred             ----------------cEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence                            6778888877654332   234579999999999999999999999999999999999999999


Q ss_pred             CCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc--CCCCc
Q 015222          320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL--LRLPV  382 (411)
Q Consensus       320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~--~~~~~  382 (411)
                      +.+..+....+.......  .....++..+.++|.+||..+    |.+||++.++++.  .+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~d----P~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          241 NLNPAQVVAAVGFKCKRL--EIPRNLNPQVAAIIEGCWTNE----PWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             TSCHHHHHHHHHHSCCCC--CCCTTSCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHHHHHC-
T ss_pred             CCCHHHHHHHHHhcCCCC--CCCccCCHHHHHHHHHHccCC----hhhCcCHHHHHHHHHHHHHh
Confidence            888777666554332221  222456778999999999888    9999999999873  34444

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.7e-46  Score=357.37  Aligned_cols=250  Identities=21%  Similarity=0.269  Sum_probs=206.3

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCc---EEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~---~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~  163 (411)
                      ...++|++.+.||+|+||.||+|.+..+++   .||||+++..  ....+.+.+|+.++++++|+||     +++++++.
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~  120 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI-----IRLEGVVT  120 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEC
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEEE
Confidence            345789999999999999999999986554   5999999753  3445678899999999987776     99999999


Q ss_pred             cCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccc
Q 015222          164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                      +++..|+||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++           
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-----------  188 (325)
T 3kul_A          121 RGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL-----------  188 (325)
T ss_dssp             GGGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-----------
T ss_pred             eCCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC-----------
Confidence            999999999999 889999997653 3699999999999999999999999999999999999997766           


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCcccccCCC------cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CC
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GE  315 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~  315 (411)
                                      .++|+|||++.......      ....+|+.|+|||++.+..++.++|||||||++|||++ |.
T Consensus       189 ----------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~  252 (325)
T 3kul_A          189 ----------------VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE  252 (325)
T ss_dssp             ----------------CEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred             ----------------CEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCC
Confidence                            56777777776543321      12345778999999998899999999999999999999 99


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      .||.+.+..+....+.......   ....++..+.+++.+|+..+    |.+||++.++++.+
T Consensus       253 ~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~d----p~~Rps~~eil~~L  308 (325)
T 3kul_A          253 RPYWNMTNRDVISSVEEGYRLP---APMGCPHALHQLMLDCWHKD----RAQRPRFSQIVSVL  308 (325)
T ss_dssp             CTTTTSCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred             CCcccCCHHHHHHHHHcCCCCC---CCCCcCHHHHHHHHHHccCC----hhhCcCHHHHHHHH
Confidence            9999888877777666542211   12356778999999999888    88888898888653

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=8.7e-47  Score=365.32  Aligned_cols=258  Identities=18%  Similarity=0.248  Sum_probs=213.5

Q ss_pred             ccCCCeEEEeeeccccceEEEEEE-----eCCCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeee
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECF-----DNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW  161 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~-----~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~  161 (411)
                      ...++|++.+.||+|+||+||+|+     +..+++.||||+++..  ......+.+|+.++++++|+||     ++++++
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~~~  142 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI-----VRCIGV  142 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEE
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCC-----CeEEEE
Confidence            345789999999999999999999     4557789999999643  3445567889999999988877     999999


Q ss_pred             eecCCeEEEEEccC-CCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCccccc
Q 015222          162 FDYRNHICIVFEKL-GPSLYDFLRKNSY-----RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV  235 (411)
Q Consensus       162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l  235 (411)
                      +.+.+..++||||+ +++|.+++.....     ..+++..++.++.||+.||+|||++||+||||||+|||++.+|    
T Consensus       143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~----  218 (367)
T 3l9p_A          143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG----  218 (367)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS----
T ss_pred             EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCC----
Confidence            99999999999999 8899999986531     3589999999999999999999999999999999999998655    


Q ss_pred             CCcccccccCCCCCccccCCCCCCeeEeecCCccccc-----CCCcccccCCCccccceecCCCCCccchhHHHHHHHHH
Q 015222          236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH-----QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE  310 (411)
Q Consensus       236 ~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e  310 (411)
                                          ....+||+|||++....     .......||+.|+|||++.+..++.++|||||||++||
T Consensus       219 --------------------~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~e  278 (367)
T 3l9p_A          219 --------------------PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE  278 (367)
T ss_dssp             --------------------TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             --------------------CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHH
Confidence                                23468999999886432     12233568999999999999899999999999999999


Q ss_pred             HHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCc
Q 015222          311 LCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       311 llt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~  382 (411)
                      |++ |..||.+.+..+....+.......+   ...++..+.+++.+||+.+    |.+||++.+++++++...
T Consensus       279 llt~g~~pf~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~~li~~~l~~d----P~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          279 IFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNCPGPVYRIMTQCWQHQ----PEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             HHTTSCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHHHHH
T ss_pred             HHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCCC----HhHCcCHHHHHHHHHHHh
Confidence            998 9999999888777776665432221   2345677899999998888    999999999999987643

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=6.6e-47  Score=353.64  Aligned_cols=259  Identities=17%  Similarity=0.290  Sum_probs=194.4

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhh---hHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY---REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++.....   .+...++...++.+.|+     |++++++++.+++
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~-----~iv~~~~~~~~~~   79 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP-----FTVTFYGALFREG   79 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCT-----TBCCEEEEEECSS
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCC-----eEEEEeeeeeccC
Confidence            357899999999999999999999999999999999754222   22222333334444454     5599999999999


Q ss_pred             eEEEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEecCcccccCCcccccc
Q 015222          167 HICIVFEKLGPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       167 ~~~lv~e~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                      ..++||||++++|.+++...  ....+++..++.++.||+.||+|||++ ||+||||||+|||++.++            
T Consensus        80 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~------------  147 (290)
T 3fme_A           80 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG------------  147 (290)
T ss_dssp             SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC------------
T ss_pred             CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC------------
Confidence            99999999977998887642  234799999999999999999999998 999999999999997766            


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCcccccee----cCCCCCccchhHHHHHHHHHHHhCCCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVI----LGLGWNYPCDLWSVGCILVELCSGEAL  317 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlGvil~elltg~~p  317 (411)
                                     .+||+|||++.......  ....||+.|+|||++    .+..++.++|||||||++|+|++|+.|
T Consensus       148 ---------------~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  212 (290)
T 3fme_A          148 ---------------QVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP  212 (290)
T ss_dssp             ---------------CEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCS
T ss_pred             ---------------CEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCC
Confidence                           56777777766543322  234789999999996    455789999999999999999999999


Q ss_pred             CCCCC-hHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          318 FQTHE-NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       318 f~~~~-~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                      |.... ....+......  ..+......++..+.+++.+||+.+    |.+|||+.++++||||......
T Consensus       213 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~----p~~Rpt~~e~l~hp~f~~~~~~  276 (290)
T 3fme_A          213 YDSWGTPFQQLKQVVEE--PSPQLPADKFSAEFVDFTSQCLKKN----SKERPTYPELMQHPFFTLHESK  276 (290)
T ss_dssp             SCCCSCHHHHHHHHHHS--CCCCCCTTTSCHHHHHHHHHHTCSS----GGGSCCHHHHTTSHHHHHHHHS
T ss_pred             ccccCchHHHHHHHhcc--CCCCcccccCCHHHHHHHHHHhhcC----hhhCcCHHHHHhCcccccCccc
Confidence            98643 33333333222  2222222456788999999999999    9999999999999999875543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.7e-46  Score=362.18  Aligned_cols=248  Identities=17%  Similarity=0.265  Sum_probs=205.5

Q ss_pred             CCCeEEEeeeccccceEEEEEEeC-------CCCcEEEEEEeccc--hhhhHHHHHHHHHHHHH-hcCCCCCcceEEEee
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDN-------EKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRN  160 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~-------~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~  160 (411)
                      .++|++.+.||+|+||.||+|++.       .++..||||+++..  ....+.+.+|+.+++.+ +|+||     +++++
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI-----v~~~~  154 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI-----INLLG  154 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTB-----CCEEE
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCE-----eeEEE
Confidence            468999999999999999999874       34568999999753  23456788999999999 67776     99999


Q ss_pred             eeecCCeEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 015222          161 WFDYRNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI  225 (411)
Q Consensus       161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NI  225 (411)
                      ++.+.+.+|+||||+ +++|.+++....              ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI  234 (370)
T 2psq_A          155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  234 (370)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence            999999999999999 889999998753              13589999999999999999999999999999999999


Q ss_pred             EEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCCCccch
Q 015222          226 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCD  300 (411)
Q Consensus       226 li~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~D  300 (411)
                      |++.+|                           .+||+|||++......     .....+|+.|+|||++.+..++.++|
T Consensus       235 ll~~~~---------------------------~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D  287 (370)
T 2psq_A          235 LVTENN---------------------------VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD  287 (370)
T ss_dssp             EECTTC---------------------------CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHH
T ss_pred             EECCCC---------------------------CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHH
Confidence            998766                           5677777777643322     12245688999999999999999999


Q ss_pred             hHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          301 LWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       301 iwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ||||||++|||++ |..||.+.+..+....+......   .....++..+.+++.+|+..+    |.+||++.+++++
T Consensus       288 vwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~d----P~~Rpt~~ell~~  358 (370)
T 2psq_A          288 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM---DKPANCTNELYMMMRDCWHAV----PSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCCTTSCHHHHHHHHHHTCSS----GGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCC----hhhCcCHHHHHHH
Confidence            9999999999999 99999988776666555443221   122346778999999998888    8999999999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.6e-46  Score=344.16  Aligned_cols=247  Identities=20%  Similarity=0.273  Sum_probs=209.4

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      .++|++.+.||+|+||.||+|.+. ++..||+|+++......+.+.+|+.++++++|+||     +++++++.+.+..++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~l   80 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKL-----VKFYGVCSKEYPIYI   80 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTB-----CCEEEEECSSSSEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCE-----eeEEEEEccCCceEE
Confidence            468999999999999999999876 56679999998766667788999999999988777     999999999999999


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      ||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++                  
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~------------------  141 (268)
T 3sxs_A           81 VTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL------------------  141 (268)
T ss_dssp             EEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTC------------------
T ss_pred             EEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCC------------------
Confidence            99999 899999998754 3599999999999999999999999999999999999997766                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL  324 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~  324 (411)
                               .++|+|||++.......    ....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..
T Consensus       142 ---------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~  212 (268)
T 3sxs_A          142 ---------CVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS  212 (268)
T ss_dssp             ---------CEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             ---------CEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH
Confidence                     56777777776543322    12345678999999998899999999999999999999 99999988887


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      +....+.........   ...++.+.+++.+|+..+    |.+|||+.+++++.
T Consensus       213 ~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~----p~~Rps~~~ll~~L  259 (268)
T 3sxs_A          213 EVVLKVSQGHRLYRP---HLASDTIYQIMYSCWHEL----PEKRPTFQQLLSSI  259 (268)
T ss_dssp             HHHHHHHTTCCCCCC---TTSCHHHHHHHHHTTCSS----GGGSCCHHHHHHHH
T ss_pred             HHHHHHHcCCCCCCC---CcChHHHHHHHHHHcCCC----hhhCcCHHHHHHHH
Confidence            776666554333222   235677899999999988    99999999999875

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.1e-46  Score=351.66  Aligned_cols=252  Identities=23%  Similarity=0.358  Sum_probs=215.3

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      .++|++.+.||+|+||.||+|++..+++.||||++...  ....+.+.+|+.+++.+.|+++     +++++++...+..
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~   95 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV-----TKYYGSYLKDTKL   95 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTB-----CCEEEEEEETTEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCE-----eEEEEEEecCCeE
Confidence            45799999999999999999999999999999999743  2345778899999999988776     9999999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      ++||||+ +++|.+++...   .+++..+..++.||+.||.|||++||+||||||+||+++.++                
T Consensus        96 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~----------------  156 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG----------------  156 (303)
T ss_dssp             EEEEECCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS----------------
T ss_pred             EEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCC----------------
Confidence            9999999 88999998764   599999999999999999999999999999999999997766                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                                 .++|+|||++......   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus       157 -----------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~  225 (303)
T 3a7i_A          157 -----------EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM  225 (303)
T ss_dssp             -----------CEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred             -----------CEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH
Confidence                       5777777777654332   23457899999999999999999999999999999999999999987776


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      +....+.....   ......++..+.+++.+||..+    |.+||++.++++|+||....
T Consensus       226 ~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~d----p~~Rps~~~ll~~~~~~~~~  278 (303)
T 3a7i_A          226 KVLFLIPKNNP---PTLEGNYSKPLKEFVEACLNKE----PSFRPTAKELLKHKFILRNA  278 (303)
T ss_dssp             HHHHHHHHSCC---CCCCSSCCHHHHHHHHHHCCSS----GGGSCCHHHHTTCHHHHHHC
T ss_pred             HHHHHhhcCCC---CCCccccCHHHHHHHHHHcCCC----hhhCcCHHHHhhChhhhcCC
Confidence            66655544322   1223456778999999999998    99999999999999997654

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4.1e-46  Score=347.29  Aligned_cols=247  Identities=20%  Similarity=0.313  Sum_probs=207.3

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      .++|++++.||+|+||+||+|.+. ++..||||+++......+.+.+|+.+++++.|+||     +++++++.+.+..++
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~l   96 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKL-----VQLYGVCTKQRPIFI   96 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTB-----CCEEEEECSSSSEEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCE-----eeEEEEEecCCCeEE
Confidence            368999999999999999999876 56789999998766667788999999999988776     999999999999999


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      ||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++                  
T Consensus        97 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~------------------  157 (283)
T 3gen_A           97 ITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG------------------  157 (283)
T ss_dssp             EECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTS------------------
T ss_pred             EEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCC------------------
Confidence            99999 999999998643 3699999999999999999999999999999999999997766                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCC----CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL  324 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~  324 (411)
                               .++|+|||++......    .....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...+..
T Consensus       158 ---------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~  228 (283)
T 3gen_A          158 ---------VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS  228 (283)
T ss_dssp             ---------CEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             ---------CEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh
Confidence                     6788888877654322    122356788999999998899999999999999999998 99999988887


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      +....+.........   ...++.+.+++.+||+.+    |.+||++.+++++.
T Consensus       229 ~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~----p~~Rps~~~ll~~L  275 (283)
T 3gen_A          229 ETAEHIAQGLRLYRP---HLASEKVYTIMYSCWHEK----ADERPTFKILLSNI  275 (283)
T ss_dssp             HHHHHHHTTCCCCCC---TTCCHHHHHHHHHTTCSS----GGGSCCHHHHHHHH
T ss_pred             HHHHHHhcccCCCCC---CcCCHHHHHHHHHHccCC----hhHCcCHHHHHHHH
Confidence            777766654333222   235677899999999998    99999999999875

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=9.3e-46  Score=357.73  Aligned_cols=255  Identities=16%  Similarity=0.227  Sum_probs=193.7

Q ss_pred             CccCCCeEEEeeeccccceEEEEEEeCCC-----CcEEEEEEeccchhhhHHHHHHHHHHHHHhc----------CCCCC
Q 015222           88 ENLTPRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSINKYREAAMIEIDVLQRLAR----------HDIGG  152 (411)
Q Consensus        88 ~~~~~~y~i~~~lG~G~~g~V~~a~~~~~-----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~----------~~i~~  152 (411)
                      +...++|++.+.||+|+||+||+|.+..+     ++.||||++....   ....+|+.+++++.+          ..+.|
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h  107 (364)
T 3op5_A           31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN---GPLFTELKFYQRAAKPEQIQKWIRTRKLKY  107 (364)
T ss_dssp             CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC---HHHHHHHHHHHHHCCHHHHHHHHHHTTCSC
T ss_pred             ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc---hhHHHHHHHHHhhhhhHHHHHHHHHhhccC
Confidence            34556899999999999999999998765     5789999986543   234556666665544          45567


Q ss_pred             cceEEEeeeeecC----CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015222          153 TRCVQIRNWFDYR----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV  228 (411)
Q Consensus       153 ~~iv~~~~~~~~~----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~  228 (411)
                      +||+++++++...    .+.|+||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus       108 ~~iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~  186 (364)
T 3op5_A          108 LGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLN  186 (364)
T ss_dssp             CCSCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEE
T ss_pred             CCCCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEe
Confidence            7779999998764    5689999999999999998753 4699999999999999999999999999999999999998


Q ss_pred             --cCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC----------CcccccCCCccccceecCCCCC
Q 015222          229 --SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWN  296 (411)
Q Consensus       229 --~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~  296 (411)
                        .++                           .+||+|||++......          .....||+.|+|||++.+..++
T Consensus       187 ~~~~~---------------------------~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  239 (364)
T 3op5_A          187 YKNPD---------------------------QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPS  239 (364)
T ss_dssp             SSCTT---------------------------CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCC
T ss_pred             cCCCC---------------------------eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCC
Confidence              444                           6777777777543221          1234599999999999999999


Q ss_pred             ccchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhHH------HhhhhhhhhhhccCCccCCCCCCCcHH
Q 015222          297 YPCDLWSVGCILVELCSGEALFQTHENL-EHLAMMERVLGPLPHHMV------IRADRRAEKYFRRGARLDWPDGATSRD  369 (411)
Q Consensus       297 ~~~DiwSlGvil~elltg~~pf~~~~~~-~~~~~i~~~~~~~p~~~~------~~~~~~~~~li~~~l~~~~~~rp~~R~  369 (411)
                      .++|||||||++|||++|+.||.+.... ................+.      ...+..+.+++..|+..+    |.+||
T Consensus       240 ~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~----p~~RP  315 (364)
T 3op5_A          240 RRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLD----YTEKP  315 (364)
T ss_dssp             HHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCC----TTCCC
T ss_pred             chhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCC----CCCCC
Confidence            9999999999999999999999864332 222222211111111111      234678899999998888    66677


Q ss_pred             HHHHHHhc
Q 015222          370 SMRAVWKL  377 (411)
Q Consensus       370 t~~~il~~  377 (411)
                      ++.++++.
T Consensus       316 ~~~~l~~~  323 (364)
T 3op5_A          316 LYENLRDI  323 (364)
T ss_dssp             CHHHHHHH
T ss_pred             CHHHHHHH
Confidence            77766653

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=9e-47  Score=362.18  Aligned_cols=264  Identities=19%  Similarity=0.296  Sum_probs=218.4

Q ss_pred             eeCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhh------------------hHHHHHHHHHHHHHh
Q 015222           85 AIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY------------------REAAMIEIDVLQRLA  146 (411)
Q Consensus        85 ~~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~------------------~~~~~~E~~~l~~l~  146 (411)
                      ..++...++|++.+.||+|+||.||+|.+  +++.||||++......                  .+.+.+|+.++++++
T Consensus        24 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  101 (348)
T 2pml_X           24 KEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK  101 (348)
T ss_dssp             SSSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC
T ss_pred             hhcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC
Confidence            33455668999999999999999999998  8999999999743321                  177889999999998


Q ss_pred             cCCCCCcceEEEeeeeecCCeEEEEEccC-CCCHHHH------HHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceec
Q 015222          147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDF------LRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHT  218 (411)
Q Consensus       147 ~~~i~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~------l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~  218 (411)
                      |+|+     +++++++.+.+..++||||+ +++|.++      +.......+++..++.++.||+.||.|||+ +||+||
T Consensus       102 h~~i-----~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~  176 (348)
T 2pml_X          102 NEYC-----LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHR  176 (348)
T ss_dssp             CTTB-----CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECC
T ss_pred             CCCc-----ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeec
Confidence            7776     99999999999999999999 8899998      665434579999999999999999999999 999999


Q ss_pred             CCCCCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC-CcccccCCCccccceecCC-CCC
Q 015222          219 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGL-GWN  296 (411)
Q Consensus       219 Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~  296 (411)
                      ||||+|||++.++                           .++|+|||.+...... .....||+.|+|||++.+. .++
T Consensus       177 dl~p~Nil~~~~~---------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  229 (348)
T 2pml_X          177 DVKPSNILMDKNG---------------------------RVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYN  229 (348)
T ss_dssp             CCCGGGEEECTTS---------------------------CEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEE
T ss_pred             CCChHhEEEcCCC---------------------------cEEEeccccccccccccccCCCCCcCccCchhhcCCCCCC
Confidence            9999999997766                           6788888877654332 2345789999999999987 676


Q ss_pred             c-cchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCChh---------------HHHhhhhhhhhhhccCCcc
Q 015222          297 Y-PCDLWSVGCILVELCSGEALFQTHEN-LEHLAMMERVLGPLPHH---------------MVIRADRRAEKYFRRGARL  359 (411)
Q Consensus       297 ~-~~DiwSlGvil~elltg~~pf~~~~~-~~~~~~i~~~~~~~p~~---------------~~~~~~~~~~~li~~~l~~  359 (411)
                      . ++|||||||++|+|++|..||.+.+. .+....+......+|..               ....++..+.++|.+||..
T Consensus       230 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  309 (348)
T 2pml_X          230 GAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRK  309 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCS
T ss_pred             cchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccC
Confidence            6 99999999999999999999988766 56665555443344421               1145678899999999999


Q ss_pred             CCCCCCCcHHHHHHHHhcCCCCccccc
Q 015222          360 DWPDGATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       360 ~~~~rp~~R~t~~~il~~~~~~~~~~~  386 (411)
                      |    |.+||++.++++|+||.+..+.
T Consensus       310 d----P~~Rps~~e~l~hp~f~~~~~~  332 (348)
T 2pml_X          310 N----PAERITSEDALKHEWLADTNIE  332 (348)
T ss_dssp             S----GGGSCCHHHHHTSGGGTTCCHH
T ss_pred             C----hhhCCCHHHHhcCccccCCCHH
Confidence            9    9999999999999999987643

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.8e-46  Score=356.36  Aligned_cols=258  Identities=24%  Similarity=0.384  Sum_probs=209.5

Q ss_pred             eEEeeCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchh-------hhHHHHHHHHHHHHHhcCCCCCcc
Q 015222           82 YVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRLARHDIGGTR  154 (411)
Q Consensus        82 ~~~~~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~~~~i~~~~  154 (411)
                      .+...++.+.++|++.+.||+|+||.||+|++..+++.||||+++....       ....+.+|+.+++++.|   .|+|
T Consensus        33 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~---~~~~  109 (320)
T 3a99_A           33 APGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS---GFSG  109 (320)
T ss_dssp             -------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS---SSCS
T ss_pred             CcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhcc---CCCC
Confidence            3455667788999999999999999999999999999999999975431       23456789999999976   2345


Q ss_pred             eEEEeeeeecCCeEEEEEccC-C-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe-cCc
Q 015222          155 CVQIRNWFDYRNHICIVFEKL-G-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV-SAE  231 (411)
Q Consensus       155 iv~~~~~~~~~~~~~lv~e~~-~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~-~~~  231 (411)
                      ++++++++...+..++|||++ + ++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++ .++
T Consensus       110 i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~  187 (320)
T 3a99_A          110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG  187 (320)
T ss_dssp             BCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT
T ss_pred             ceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCC
Confidence            599999999999999999999 4 89999998765  699999999999999999999999999999999999997 444


Q ss_pred             ccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC-CcccccCCCccccceecCCCC-CccchhHHHHHHHH
Q 015222          232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILV  309 (411)
Q Consensus       232 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~  309 (411)
                                                 .+||+|||++...... .....||+.|+|||++.+..+ +.++|||||||++|
T Consensus       188 ---------------------------~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~  240 (320)
T 3a99_A          188 ---------------------------ELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLY  240 (320)
T ss_dssp             ---------------------------EEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHH
T ss_pred             ---------------------------CEEEeeCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHH
Confidence                                       5788888877655433 234578999999999987765 78899999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          310 ELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       310 elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      ||++|+.||...+.      +.......+    ..+++.+.++|.+||..+    |.+||++.++++|+||.+...
T Consensus       241 el~~g~~pf~~~~~------~~~~~~~~~----~~~~~~~~~li~~~l~~d----p~~Rps~~~ll~hp~~~~~~~  302 (320)
T 3a99_A          241 DMVCGDIPFEHDEE------IIRGQVFFR----QRVSSECQHLIRWCLALR----PSDRPTFEEIQNHPWMQDVLL  302 (320)
T ss_dssp             HHHHSSCSCCSHHH------HHHCCCCCS----SCCCHHHHHHHHHHTCSS----GGGSCCHHHHHTSGGGSSCCC
T ss_pred             HHHHCCCCCCChhh------hhccccccc----ccCCHHHHHHHHHHccCC----hhhCcCHHHHhcCHhhcCccC
Confidence            99999999975321      112222222    345678899999999988    999999999999999998654

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4e-46  Score=348.28  Aligned_cols=254  Identities=23%  Similarity=0.302  Sum_probs=210.8

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCC-------cEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeee
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKK-------ELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNW  161 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~-------~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~  161 (411)
                      ..++|++.+.||+|+||+||+|++..++       ..||+|++.... ...+.+.+|+.++++++|+||     ++++++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~   80 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL-----VLNYGV   80 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTB-----CCEEEE
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCE-----eEEEEE
Confidence            4578999999999999999999998877       479999996543 455778899999999988777     999999


Q ss_pred             eecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                      +.+.+..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++..++.+++ 
T Consensus        81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~-  158 (289)
T 4fvq_A           81 CVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPP-  158 (289)
T ss_dssp             ECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCC-
T ss_pred             EEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccc-
Confidence            99999999999999 899999998764 349999999999999999999999999999999999999998876666654 


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecC-CCCCccchhHHHHHHHHHHHhC-CCCC
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSG-EALF  318 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg-~~pf  318 (411)
                                        .+||+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|||++| .+||
T Consensus       159 ------------------~~kl~Dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~  219 (289)
T 4fvq_A          159 ------------------FIKLSDPGISITVLPK-DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL  219 (289)
T ss_dssp             ------------------EEEECCCCSCTTTSCH-HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             ------------------eeeeccCcccccccCc-cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCc
Confidence                              5899999998755332 33568999999999988 6799999999999999999995 5556


Q ss_pred             CCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ...+...... ........+.    ..+..+.+++.+||+.|    |.+|||+.+++++.
T Consensus       220 ~~~~~~~~~~-~~~~~~~~~~----~~~~~l~~li~~~l~~d----p~~Rps~~~ll~~l  270 (289)
T 4fvq_A          220 SALDSQRKLQ-FYEDRHQLPA----PKAAELANLINNCMDYE----PDHRPSFRAIIRDL  270 (289)
T ss_dssp             TTSCHHHHHH-HHHTTCCCCC----CSSCTTHHHHHHHSCSS----GGGSCCHHHHHHHH
T ss_pred             cccchHHHHH-HhhccCCCCC----CCCHHHHHHHHHHcCCC----hhHCcCHHHHHHHH
Confidence            5544444333 3333333333    24677899999999998    99999999999875

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.5e-46  Score=346.15  Aligned_cols=253  Identities=23%  Similarity=0.350  Sum_probs=211.9

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee--cCC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD--YRN  166 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~--~~~  166 (411)
                      ++|++.+.||+|+||.||+|.++.+++.||+|++...   ....+.+.+|+.++++++|+||     +++++++.  ..+
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~   80 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI-----VRYYDRIIDRTNT   80 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEEEGGGT
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCC-----CeEEEEEecCCCc
Confidence            6899999999999999999999999999999999743   2445678899999999988777     99999774  467


Q ss_pred             eEEEEEccC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCcEEEecCcccccCCc
Q 015222          167 HICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELR-----LIHTDLKPENILLVSAEYVKVPDY  238 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g-----ivH~Dikp~NIli~~~~~~~l~df  238 (411)
                      ..++||||+ +++|.+++....  ...+++..++.++.||+.||+|||++|     |+||||||+|||++.++       
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~-------  153 (279)
T 2w5a_A           81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-------  153 (279)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS-------
T ss_pred             eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC-------
Confidence            899999999 889999997542  235999999999999999999999999     99999999999997766       


Q ss_pred             ccccccCCCCCccccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCC
Q 015222          239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE  315 (411)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~  315 (411)
                                          .+||+|||++.......   ....||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus       154 --------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  213 (279)
T 2w5a_A          154 --------------------NVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM  213 (279)
T ss_dssp             --------------------CEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSS
T ss_pred             --------------------CEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCC
Confidence                                67888888776544332   2357899999999999999999999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhC-CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          316 ALFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       316 ~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      .||...+..+....+..... .++    ..++..+.++|.+||..+    |.+||++.++++|+|+..-.
T Consensus       214 ~p~~~~~~~~~~~~i~~~~~~~~~----~~~~~~l~~li~~~l~~~----p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          214 PPFTAFSQKELAGKIREGKFRRIP----YRYSDELNEIITRMLNLK----DYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             CSSCCSSHHHHHHHHHHTCCCCCC----TTSCHHHHHHHHHHTCSS----GGGSCCHHHHHTSTTCCGGG
T ss_pred             CCCcccCHHHHHHHHhhcccccCC----cccCHHHHHHHHHHcCCC----cccCCCHHHHHhChhhhhhc
Confidence            99998887776666655433 222    346778999999999998    99999999999999998643

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4.2e-46  Score=348.00  Aligned_cols=249  Identities=18%  Similarity=0.275  Sum_probs=213.7

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.......+.+.+|+.++++++|+|+     +++++++.+.+..+
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~   85 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL-----VQLLGVCTREPPFY   85 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTB-----CCEEEEECSSSSEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEccCCCEE
Confidence            4578999999999999999999999999999999998777777889999999999988777     99999999999999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+||+++.++                 
T Consensus        86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-----------------  148 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-----------------  148 (288)
T ss_dssp             EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG-----------------
T ss_pred             EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC-----------------
Confidence            999999 89999999886656799999999999999999999999999999999999998776                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCh
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHEN  323 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~  323 (411)
                                .++|+|||++.......    ....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+.
T Consensus       149 ----------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~  218 (288)
T 3kfa_A          149 ----------LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL  218 (288)
T ss_dssp             ----------CEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             ----------CEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence                      56777777776544322    22456888999999998899999999999999999999 9999998877


Q ss_pred             HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      .+....+......   .....+++.+.+++.+||..+    |.+||++.++++.
T Consensus       219 ~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~d----p~~Rps~~~~~~~  265 (288)
T 3kfa_A          219 SQVYELLEKDYRM---ERPEGCPEKVYELMRACWQWN----PSDRPSFAEIHQA  265 (288)
T ss_dssp             GGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHH
T ss_pred             HHHHHHHhccCCC---CCCCCCCHHHHHHHHHHhCCC----hhhCcCHHHHHHH
Confidence            6666655543221   122356778999999999999    8888999998764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=354.60  Aligned_cols=243  Identities=18%  Similarity=0.276  Sum_probs=198.6

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEecc-chhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS-INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++.. .....+.+.+|+.++++++|+||     +++++++.+++..++
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~~~~l   84 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV-----LKFIGVLYKDKRLNF   84 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEETTEEEE
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCc-----ccEEEEEecCCeeEE
Confidence            689999999999999999999999999999998864 34556778899999999987776     999999999999999


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      ||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.                 
T Consensus        85 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~-----------------  146 (310)
T 3s95_A           85 ITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN-----------------  146 (310)
T ss_dssp             EEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC-----------------
T ss_pred             EEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC-----------------
Confidence            99999 899999998754 36999999999999999999999999999999999999988774                 


Q ss_pred             ccccCCCCCCeeEeecCCcccccCC-----------------CcccccCCCccccceecCCCCCccchhHHHHHHHHHHH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQD-----------------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC  312 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~-----------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell  312 (411)
                                +||+|||++......                 .....||+.|+|||++.+..++.++|||||||++|||+
T Consensus       147 ----------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~  216 (310)
T 3s95_A          147 ----------VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII  216 (310)
T ss_dssp             ----------EEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred             ----------EEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHh
Confidence                      455555555432211                 11457999999999999999999999999999999999


Q ss_pred             hCCCCCCCCChHH-----HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          313 SGEALFQTHENLE-----HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       313 tg~~pf~~~~~~~-----~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      +|..||.......     .......  ...+    ..+++.+.+++.+|++.+    |.+||++.++++.
T Consensus       217 ~g~~~~~~~~~~~~~~~~~~~~~~~--~~~~----~~~~~~l~~li~~~l~~d----P~~Rps~~~l~~~  276 (310)
T 3s95_A          217 GRVNADPDYLPRTMDFGLNVRGFLD--RYCP----PNCPPSFFPITVRCCDLD----PEKRPSFVKLEHW  276 (310)
T ss_dssp             HTCCSSTTTSCBCTTSSBCHHHHHH--HTCC----TTCCTTHHHHHHHHTCSS----GGGSCCHHHHHHH
T ss_pred             cCCCCCcchhhhHHHHhhhhhcccc--ccCC----CCCCHHHHHHHHHHccCC----hhhCcCHHHHHHH
Confidence            9999987532211     0111111  1111    345677889999999888    8889999998863

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.3e-46  Score=353.69  Aligned_cols=261  Identities=23%  Similarity=0.344  Sum_probs=187.7

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....  ...+.+.+|+.+++++.|+||     +++++++...+.
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~   87 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI-----VSYYTSFVVKDE   87 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTB-----CCEEEEEESSSC
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCE-----eeEEEEEeecCC
Confidence            3578999999999999999999999999999999986432  334567788888888877766     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          168 ICIVFEKL-GPSLYDFLRKN------SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                      .++||||+ +++|.+++...      ....+++..+..++.||+.||.|||++||+||||||+|||++.++.        
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--------  159 (303)
T 2vwi_A           88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS--------  159 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--------
T ss_pred             cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC--------
Confidence            99999999 99999998741      2246999999999999999999999999999999999999987774        


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccC--------CCcccccCCCccccceecC-CCCCccchhHHHHHHHHHH
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--------DHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVEL  311 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~el  311 (411)
                                         ++|+|||++.....        ......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus       160 -------------------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l  220 (303)
T 2vwi_A          160 -------------------VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL  220 (303)
T ss_dssp             -------------------EEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHH
T ss_pred             -------------------EEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHH
Confidence                               55566655543221        1123578999999999876 4689999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCC-CCh-----hHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          312 CSGEALFQTHENLEHLAMMERVLGP-LPH-----HMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       312 ltg~~pf~~~~~~~~~~~i~~~~~~-~p~-----~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      ++|+.||.+................ .+.     .....++..+.+++.+||..|    |.+||++.++++|+||.+...
T Consensus       221 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d----p~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          221 ATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKD----PEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             HHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSS----GGGSCCHHHHHTSTTC-----
T ss_pred             HhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCC----hhhCcCHHHHhhChhhhcCCC
Confidence            9999999887665544333222111 111     112345677899999999988    999999999999999998654


Q ss_pred             c
Q 015222          386 Y  386 (411)
Q Consensus       386 ~  386 (411)
                      .
T Consensus       297 ~  297 (303)
T 2vwi_A          297 K  297 (303)
T ss_dssp             -
T ss_pred             C
Confidence            3

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.5e-45  Score=342.19  Aligned_cols=255  Identities=24%  Similarity=0.301  Sum_probs=201.8

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      .+.++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.+++.+.|+++    +..+..++...+..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~----i~~~~~~~~~~~~~   80 (296)
T 3uzp_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVG----IPTIRWCGAEGDYN   80 (296)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTT----CCCEEEEEEETTEE
T ss_pred             eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCC----CCccccccCCCCce
Confidence            45689999999999999999999999999999999986543 23568899999999998875    23334445667889


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      ++||||++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++                 
T Consensus        81 ~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~-----------------  142 (296)
T 3uzp_A           81 VMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK-----------------  142 (296)
T ss_dssp             EEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGG-----------------
T ss_pred             EEEEEecCCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCC-----------------
Confidence            9999999999999998544 3699999999999999999999999999999999999995211                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCC----------CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCC
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF  318 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf  318 (411)
                             .+..+||+|||++......          .....||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       143 -------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf  215 (296)
T 3uzp_A          143 -------KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW  215 (296)
T ss_dssp             -------GTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             -------CCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence                   1236777777777654332          23457999999999999999999999999999999999999999


Q ss_pred             CCCC---hHHHHHHHHHHhCCCC-hhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          319 QTHE---NLEHLAMMERVLGPLP-HHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       319 ~~~~---~~~~~~~i~~~~~~~p-~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      .+.+   ..+.+..+.......+ ......+++.+.+++.+|++.+    |.+||++.++++.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d----p~~Rps~~~l~~~  274 (296)
T 3uzp_A          216 QGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLR----FDDKPDYSYLRQL  274 (296)
T ss_dssp             SSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSC----TTCCCCHHHHHHH
T ss_pred             CCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcC----cCcCCCHHHHHHH
Confidence            8643   2233333333322222 2333456788999999999999    7777777777654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=7.5e-46  Score=352.22  Aligned_cols=260  Identities=15%  Similarity=0.184  Sum_probs=191.3

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCc---EEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~---~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~  163 (411)
                      ..++|++.+.||+|+||.||+|++..++.   .||||+++..   ....+.+.+|+.++++++|+||     +++++++.
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~   95 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV-----AKLVGVSL   95 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTB-----CCCCEEEE
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCce-----ehhhceee
Confidence            45789999999999999999999887775   8999999753   3445678899999999988777     99999988


Q ss_pred             cCCeE------EEEEccC-CCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcc
Q 015222          164 YRNHI------CIVFEKL-GPSLYDFLRKNS----YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY  232 (411)
Q Consensus       164 ~~~~~------~lv~e~~-~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~  232 (411)
                      ..+..      ++||||+ +++|.+++....    ...+++..++.++.||+.||+|||++||+||||||+|||++.++ 
T Consensus        96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~-  174 (323)
T 3qup_A           96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM-  174 (323)
T ss_dssp             CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-
T ss_pred             ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC-
Confidence            76554      9999999 889999997532    12589999999999999999999999999999999999998766 


Q ss_pred             cccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchhHHHHHH
Q 015222          233 VKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCI  307 (411)
Q Consensus       233 ~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  307 (411)
                                                .+||+|||++.......     ....+|+.|+|||++.+..++.++|||||||+
T Consensus       175 --------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i  228 (323)
T 3qup_A          175 --------------------------TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVT  228 (323)
T ss_dssp             --------------------------CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred             --------------------------CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHH
Confidence                                      56777777776543221     22356788999999999999999999999999


Q ss_pred             HHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHH-------HHHHHhcCC
Q 015222          308 LVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS-------MRAVWKLLR  379 (411)
Q Consensus       308 l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t-------~~~il~~~~  379 (411)
                      +|+|++ |..||.+.+..+....+......   .....++..+.+++.+||..|    |.+||+       ++++++|+|
T Consensus       229 l~ell~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~d----p~~Rps~~~l~~~l~~~l~~~~  301 (323)
T 3qup_A          229 MWEIMTRGQTPYAGIENAEIYNYLIGGNRL---KQPPECMEEVYDLMYQCWSAD----PKQRPSFTCLRMELENILGHLS  301 (323)
T ss_dssp             HHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHTTCSS----GGGSCCHHHHHHHHHHHHHC--
T ss_pred             HHHHHhCCCCCccccChHHHHHHHhcCCCC---CCCCccCHHHHHHHHHHccCC----hhhCcCHHHHHHHHHHHHHHhh
Confidence            999999 99999988877766655543221   112346778999999999999    777777       888999999


Q ss_pred             CCcccccCC
Q 015222          380 LPVIDLYSA  388 (411)
Q Consensus       380 ~~~~~~~~~  388 (411)
                      +........
T Consensus       302 ~~~~~~~pl  310 (323)
T 3qup_A          302 VLSTSQDPL  310 (323)
T ss_dssp             ---------
T ss_pred             hcCCCCCCC
Confidence            998665443

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.5e-45  Score=342.80  Aligned_cols=252  Identities=23%  Similarity=0.303  Sum_probs=196.8

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      .+.++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.+.|+++    +..+..++...+..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~----i~~~~~~~~~~~~~   80 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVG----IPTIRWCGAEGDYN   80 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTT----CCCEEEEEEETTEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCC----CCeeeeecCCCCce
Confidence            45678999999999999999999999999999999876433 23457889999999998875    23444455677899


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---ecCcccccCCcccccccC
Q 015222          169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL---VSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli---~~~~~~~l~df~~~~~~~  245 (411)
                      ++||||++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++              
T Consensus        81 ~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~--------------  145 (296)
T 4hgt_A           81 VMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN--------------  145 (296)
T ss_dssp             EEEEECCCCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT--------------
T ss_pred             EEEEEccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC--------------
Confidence            9999999999999998543 369999999999999999999999999999999999999   4444              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCC----------CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE  315 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~  315 (411)
                                   .+||+|||++......          .....||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus       146 -------------~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  212 (296)
T 4hgt_A          146 -------------LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS  212 (296)
T ss_dssp             -------------CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             -------------eEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCC
Confidence                         5777777777654332          12457899999999999999999999999999999999999


Q ss_pred             CCCCCCChH---HHHHHHHHHhCCCC-hhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          316 ALFQTHENL---EHLAMMERVLGPLP-HHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       316 ~pf~~~~~~---~~~~~i~~~~~~~p-~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      .||.+.+..   +.+..+.......+ ......+++.+.+++.+|++.+    |.+||++.++++.
T Consensus       213 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~----p~~Rpt~~~l~~~  274 (296)
T 4hgt_A          213 LPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLR----FDDKPDYSYLRQL  274 (296)
T ss_dssp             CTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSC----TTCCCCHHHHHHH
T ss_pred             CCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcC----CCCCCCHHHHHHH
Confidence            999865332   23333333222222 2233456788999999999999    7777788877763

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.2e-45  Score=355.95  Aligned_cols=251  Identities=20%  Similarity=0.266  Sum_probs=201.6

Q ss_pred             cCCCeEEEeeeccccceEEEEEE-----eCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHH-hcCCCCCcceEEEeee
Q 015222           90 LTPRYRILSKMGEGTFGQVVECF-----DNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNW  161 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~-----~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~  161 (411)
                      ..++|++.+.||+|+||.||+|+     +..+++.||||+++...  ...+.+.+|+.+++++ .|+||     ++++++
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni-----v~~~~~   94 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV-----VNLLGA   94 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEEE
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce-----eeeeee
Confidence            34789999999999999999998     56677999999997532  3446788999999999 55666     999999


Q ss_pred             eecC-CeEEEEEccC-CCCHHHHHHhcCC---------------------------------------------------
Q 015222          162 FDYR-NHICIVFEKL-GPSLYDFLRKNSY---------------------------------------------------  188 (411)
Q Consensus       162 ~~~~-~~~~lv~e~~-~~~L~~~l~~~~~---------------------------------------------------  188 (411)
                      +.+. +.+++||||+ +++|.+++.....                                                   
T Consensus        95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (359)
T 3vhe_A           95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS  174 (359)
T ss_dssp             ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred             eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence            8775 4599999999 8999999986542                                                   


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccCC
Q 015222          189 -------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP  255 (411)
Q Consensus       189 -------------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~  255 (411)
                                   ..+++..++.++.||+.||.|||++||+||||||+|||++.++                        
T Consensus       175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~------------------------  230 (359)
T 3vhe_A          175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN------------------------  230 (359)
T ss_dssp             ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG------------------------
T ss_pred             hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC------------------------
Confidence                         1289999999999999999999999999999999999998777                        


Q ss_pred             CCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 015222          256 KSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAM  329 (411)
Q Consensus       256 ~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~  329 (411)
                         .+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..
T Consensus       231 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  307 (359)
T 3vhe_A          231 ---VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR  307 (359)
T ss_dssp             ---CEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred             ---cEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHH
Confidence               4666666666543221     123467899999999999899999999999999999998 9999988765444433


Q ss_pred             HHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          330 MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       330 i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ........+  .....++.+.+++.+||+.+    |.+||++.++++|+
T Consensus       308 ~~~~~~~~~--~~~~~~~~l~~li~~~l~~d----P~~Rps~~ell~~L  350 (359)
T 3vhe_A          308 RLKEGTRMR--APDYTTPEMYQTMLDCWHGE----PSQRPTFSELVEHL  350 (359)
T ss_dssp             HHHHTCCCC--CCTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred             HHHcCCCCC--CCCCCCHHHHHHHHHHccCC----hhhCCCHHHHHHHH
Confidence            333222111  12346678999999999998    99999999999874

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=354.01  Aligned_cols=261  Identities=18%  Similarity=0.246  Sum_probs=202.2

Q ss_pred             CCccCCCeEEEeeeccccceEEEEEEeCC---CCcEEEEEEeccchh------------hhHHHHHHHHHHHHHhcCCCC
Q 015222           87 GENLTPRYRILSKMGEGTFGQVVECFDNE---KKELVAIKIVRSINK------------YREAAMIEIDVLQRLARHDIG  151 (411)
Q Consensus        87 ~~~~~~~y~i~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~~~------------~~~~~~~E~~~l~~l~~~~i~  151 (411)
                      .+...++|++.+.||+|+||.||+|.+..   ++..||||++.....            ....+.+|+.+++.+.|+|| 
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni-  110 (345)
T 2v62_A           32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGI-  110 (345)
T ss_dssp             ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCC-
T ss_pred             ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCc-
Confidence            34456789999999999999999999987   788999999875421            11234456666776666666 


Q ss_pred             CcceEEEeeeeec----CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 015222          152 GTRCVQIRNWFDY----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL  227 (411)
Q Consensus       152 ~~~iv~~~~~~~~----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli  227 (411)
                          +++++++..    .+..|+||||++++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus       111 ----~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  184 (345)
T 2v62_A          111 ----PLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL  184 (345)
T ss_dssp             ----CCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             ----ceeecccccccCCCcEEEEEEeccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEE
Confidence                999999877    78999999999999999998765  79999999999999999999999999999999999999


Q ss_pred             ecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC----------CcccccCCCccccceecCCCCCc
Q 015222          228 VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNY  297 (411)
Q Consensus       228 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~  297 (411)
                      +.++                         ...+||+|||++......          .....||+.|+|||++.+..++.
T Consensus       185 ~~~~-------------------------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  239 (345)
T 2v62_A          185 GYKN-------------------------PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSR  239 (345)
T ss_dssp             ESSS-------------------------TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCH
T ss_pred             ccCC-------------------------CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCc
Confidence            8765                         125777777777543211          13357999999999999999999


Q ss_pred             cchhHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHHhCCCChhHHH-----hhhhhhhhhhccCCccCCCCCCCcHHH
Q 015222          298 PCDLWSVGCILVELCSGEALFQTH--ENLEHLAMMERVLGPLPHHMVI-----RADRRAEKYFRRGARLDWPDGATSRDS  370 (411)
Q Consensus       298 ~~DiwSlGvil~elltg~~pf~~~--~~~~~~~~i~~~~~~~p~~~~~-----~~~~~~~~li~~~l~~~~~~rp~~R~t  370 (411)
                      ++|||||||++|||++|+.||.+.  +..............++.....     ..+..+.++|.+|+..+    |.+||+
T Consensus       240 ~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d----p~~Rps  315 (345)
T 2v62_A          240 RSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLA----YDEKPN  315 (345)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCC----TTCCCC
T ss_pred             hhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcC----cccCCC
Confidence            999999999999999999999652  3333344444445566655443     56778999999999998    888999


Q ss_pred             HHHHHhcCCCCcc
Q 015222          371 MRAVWKLLRLPVI  383 (411)
Q Consensus       371 ~~~il~~~~~~~~  383 (411)
                      +.++++...-..+
T Consensus       316 ~~~l~~~L~~~~~  328 (345)
T 2v62_A          316 YQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHHHHCTTCC
T ss_pred             HHHHHHHHhccCC
Confidence            9999887654443

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-45  Score=355.68  Aligned_cols=250  Identities=18%  Similarity=0.251  Sum_probs=207.6

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCC-------CcEEEEEEeccch--hhhHHHHHHHHHHHHH-hcCCCCCcceEEEe
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEK-------KELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIR  159 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~-------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~  159 (411)
                      ..++|++.+.||+|+||+||+|++..+       +..||||+++...  .....+.+|+.+++++ +|+||     ++++
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI-----v~~~  141 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI-----INLL  141 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEE
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchh-----hhhe
Confidence            346899999999999999999997543       3579999997542  3446788999999999 77776     9999


Q ss_pred             eeeecCCeEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 015222          160 NWFDYRNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPEN  224 (411)
Q Consensus       160 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~N  224 (411)
                      +++...+..++||||+ +++|.+++....              ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus       142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  221 (382)
T 3tt0_A          142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN  221 (382)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence            9999999999999999 889999998754              1359999999999999999999999999999999999


Q ss_pred             EEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCCCccc
Q 015222          225 ILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPC  299 (411)
Q Consensus       225 Ili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~  299 (411)
                      ||++.++                           .+||+|||++......     .....||+.|+|||++.+..++.++
T Consensus       222 Ill~~~~---------------------------~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~  274 (382)
T 3tt0_A          222 VLVTEDN---------------------------VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS  274 (382)
T ss_dssp             EEECTTC---------------------------CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHH
T ss_pred             EEEcCCC---------------------------cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchh
Confidence            9998766                           5677777777654322     2234567889999999999999999


Q ss_pred             hhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          300 DLWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       300 DiwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      |||||||++|+|++ |..||.+.+..+....+.......   ....++..+.+++.+||..+    |.+||++.++++++
T Consensus       275 DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~d----P~~Rps~~ell~~L  347 (382)
T 3tt0_A          275 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD---KPSNCTNELYMMMRDCWHAV----PSQRPTFKQLVEDL  347 (382)
T ss_dssp             HHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC---CCSSCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCccCCHHHHHHHHHHcCCC----hhhCcCHHHHHHHH
Confidence            99999999999999 999999888777666665442211   12346778999999999988    88888999988764

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=349.22  Aligned_cols=251  Identities=23%  Similarity=0.404  Sum_probs=196.5

Q ss_pred             CCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchh-------hhHHHHHHHHHHHHH----hcCCCCCcce
Q 015222           87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRL----ARHDIGGTRC  155 (411)
Q Consensus        87 ~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l----~~~~i~~~~i  155 (411)
                      ++.+.++|++.+.||+|+||.||+|++..+++.||||++.....       ....+.+|+.++.++    .|+||     
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i-----  100 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGV-----  100 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSB-----
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCe-----
Confidence            35567899999999999999999999999999999999965432       223456799999999    45555     


Q ss_pred             EEEeeeeecCCeEEEEEcc-C-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe-cCcc
Q 015222          156 VQIRNWFDYRNHICIVFEK-L-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV-SAEY  232 (411)
Q Consensus       156 v~~~~~~~~~~~~~lv~e~-~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~-~~~~  232 (411)
                      +++++++...+..++|||+ + +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++ .++ 
T Consensus       101 ~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-  177 (312)
T 2iwi_A          101 IRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG-  177 (312)
T ss_dssp             CCEEEEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT-
T ss_pred             eeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC-
Confidence            9999999999999999999 5 889999998765  699999999999999999999999999999999999998 444 


Q ss_pred             cccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC-CcccccCCCccccceecCCCC-CccchhHHHHHHHHH
Q 015222          233 VKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVE  310 (411)
Q Consensus       233 ~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~e  310 (411)
                                                .++|+|||++...... .....||..|+|||++.+..+ +.++|||||||++|+
T Consensus       178 --------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~  231 (312)
T 2iwi_A          178 --------------------------CAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYD  231 (312)
T ss_dssp             --------------------------EEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHH
T ss_pred             --------------------------eEEEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHH
Confidence                                      5788888877654433 234578999999999987665 469999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          311 LCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       311 lltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      |++|+.||....      .+......++    ..++..+.++|.+||..+    |.+||++.++++|+||.....
T Consensus       232 l~~g~~pf~~~~------~~~~~~~~~~----~~~~~~~~~li~~~l~~~----p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          232 MVCGDIPFERDQ------EILEAELHFP----AHVSPDCCALIRRCLAPK----PSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             HHHSSCSCCSHH------HHHHTCCCCC----TTSCHHHHHHHHHHTCSS----TTTSCCHHHHHHSTTTCC---
T ss_pred             HHHCCCCCCChH------HHhhhccCCc----ccCCHHHHHHHHHHccCC----hhhCcCHHHHhcChhhcCchh
Confidence            999999997532      1222223333    345778899999999998    999999999999999997543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.3e-45  Score=344.52  Aligned_cols=248  Identities=22%  Similarity=0.315  Sum_probs=196.2

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      .++|++.+.||+|+||.||+|++..+++.||||++....    ...+.+.+|+.+++++.|+||     +++++++..++
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i-----v~~~~~~~~~~  107 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV-----VPIHDFGEIDG  107 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEETT
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCe-----eEEEEEEeeCC
Confidence            368999999999999999999999999999999997542    234667889999999987776     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      ..|+||||+ +++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++              
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~--------------  171 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD--------------  171 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--------------
T ss_pred             eEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC--------------
Confidence            999999999 889999998765  699999999999999999999999999999999999998766              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCC----CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                                   .++|+|||++......    .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.
T Consensus       172 -------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  238 (309)
T 2h34_A          172 -------------FAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD  238 (309)
T ss_dssp             -------------CEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred             -------------CEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence                         5677777776554322    12347899999999999989999999999999999999999999876


Q ss_pred             ChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH-HHHHHHhc
Q 015222          322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-SMRAVWKL  377 (411)
Q Consensus       322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~-t~~~il~~  377 (411)
                      +.. .+..........+......++..+.++|.+||..+    |.+|| +++++++.
T Consensus       239 ~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d----P~~Rp~s~~~l~~~  290 (309)
T 2h34_A          239 QLS-VMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKN----PEDRYVTCGDLSAA  290 (309)
T ss_dssp             HHH-HHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSS----GGGSCSSHHHHHHH
T ss_pred             hHH-HHHHHhccCCCCccccCCCCCHHHHHHHHHhccCC----HHHHHHhHHHHHHH
Confidence            554 33333333333344455667888999999999999    66666 66666543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-45  Score=350.70  Aligned_cols=250  Identities=20%  Similarity=0.287  Sum_probs=208.0

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeC-----CCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeee
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW  161 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~  161 (411)
                      ...++|++.+.||+|+||.||+|++.     .+++.||||+++..  ....+.+.+|+.++++++|+||     ++++++
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~  118 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI-----VKLLGV  118 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEE
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCE-----EEEEEE
Confidence            34578999999999999999999987     35589999999753  2345678899999999988776     999999


Q ss_pred             eecCCeEEEEEccC-CCCHHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 015222          162 FDYRNHICIVFEKL-GPSLYDFLRKNSY----------------------RSFPIDLVRELGRQLLESVAFMHELRLIHT  218 (411)
Q Consensus       162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~----------------------~~l~~~~~~~i~~qi~~aL~~LH~~givH~  218 (411)
                      +.+.+..++||||+ +++|.+++.....                      ..+++..++.++.||+.||+|||++||+||
T Consensus       119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~  198 (343)
T 1luf_A          119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR  198 (343)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            99999999999999 8899999987421                      469999999999999999999999999999


Q ss_pred             CCCCCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCC
Q 015222          219 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGL  293 (411)
Q Consensus       219 Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~  293 (411)
                      ||||+|||++.++                           .+||+|||++......     .....||+.|+|||++.+.
T Consensus       199 Dlkp~NIl~~~~~---------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~  251 (343)
T 1luf_A          199 DLATRNCLVGENM---------------------------VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN  251 (343)
T ss_dssp             CCSGGGEEECGGG---------------------------CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC
T ss_pred             CCCcceEEECCCC---------------------------eEEEeecCCCcccccCccccccCCCcccceecChhhhccC
Confidence            9999999998776                           5677777777543221     2234678899999999988


Q ss_pred             CCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC-CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHH
Q 015222          294 GWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSM  371 (411)
Q Consensus       294 ~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~  371 (411)
                      .++.++|||||||++|||++ |..||.+.+..+....+..... ..|    ..++..+.+++.+|+..+    |.+||++
T Consensus       252 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~----p~~Rps~  323 (343)
T 1luf_A          252 RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACP----ENCPLELYNLMRLCWSKL----PADRPSF  323 (343)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC----TTCCHHHHHHHHHHTCSS----GGGSCCH
T ss_pred             CcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCC----CCCCHHHHHHHHHHcccC----cccCCCH
Confidence            99999999999999999999 9999998887777666554332 222    346778999999999888    8888999


Q ss_pred             HHHHhcC
Q 015222          372 RAVWKLL  378 (411)
Q Consensus       372 ~~il~~~  378 (411)
                      .+++++.
T Consensus       324 ~~~~~~L  330 (343)
T 1luf_A          324 CSIHRIL  330 (343)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9988764

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.1e-45  Score=336.19  Aligned_cols=246  Identities=24%  Similarity=0.338  Sum_probs=208.4

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++.......+.+.+|+.++++++|+|+     +++++++.+.+..++|
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv   81 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKL-----VQLYGVCLEQAPICLV   81 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTB-----CCEEEEECSSSSCEEE
T ss_pred             hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCE-----eeEEEEEccCCCeEEE
Confidence            58999999999999999999986 56789999998766666788999999999987776     9999999999999999


Q ss_pred             EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      |||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++                   
T Consensus        82 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~-------------------  141 (267)
T 3t9t_A           82 TEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-------------------  141 (267)
T ss_dssp             ECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGG-------------------
T ss_pred             EeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCC-------------------
Confidence            9999 899999998754 3689999999999999999999999999999999999998776                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCC----CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE  325 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~  325 (411)
                              .++|+|||++......    .....+|..|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+
T Consensus       142 --------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~  213 (267)
T 3t9t_A          142 --------VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE  213 (267)
T ss_dssp             --------CEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             --------CEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH
Confidence                    5677777777654321    122456788999999998899999999999999999999 999999888777


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ....+........   ....+..+.+++.+|+..+    |.+||++.+++++.
T Consensus       214 ~~~~i~~~~~~~~---~~~~~~~l~~li~~~l~~~----p~~Rps~~~ll~~L  259 (267)
T 3t9t_A          214 VVEDISTGFRLYK---PRLASTHVYQIMNHCWRER----PEDRPAFSRLLRQL  259 (267)
T ss_dssp             HHHHHHTTCCCCC---CTTSCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred             HHHHHhcCCcCCC---CccCcHHHHHHHHHHccCC----hhhCcCHHHHHHHH
Confidence            7666655432221   2245678899999999988    99999999998753

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.6e-45  Score=345.36  Aligned_cols=258  Identities=25%  Similarity=0.342  Sum_probs=203.0

Q ss_pred             CCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee
Q 015222           87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        87 ~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~  163 (411)
                      .....++|++.+.||+|+||.||+|.+. +++.||||++...   ....+.+.+|+.+++++.|+   ++|++++++++.
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~---~~~iv~~~~~~~   98 (313)
T 3cek_A           23 MSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH---SDKIIRLYDYEI   98 (313)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGG---CTTBCCEEEEEE
T ss_pred             eeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhcccc---CCceEEEEEEee
Confidence            3445578999999999999999999985 4888999999643   33456788999999999862   235599999999


Q ss_pred             cCCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          164 YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       164 ~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                      ..+..++|||+.+++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||+++ +            
T Consensus        99 ~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~------------  163 (313)
T 3cek_A           99 TDQYIYMVMECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G------------  163 (313)
T ss_dssp             CSSEEEEEECCCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T------------
T ss_pred             cCCEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-C------------
Confidence            999999999977999999998765  7999999999999999999999999999999999999953 4            


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecC-----------CCCCccchhHHHHHH
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILG-----------LGWNYPCDLWSVGCI  307 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlGvi  307 (411)
                                     .+||+|||++.......     ....||+.|+|||++.+           ..++.++|||||||+
T Consensus       164 ---------------~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~i  228 (313)
T 3cek_A          164 ---------------MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI  228 (313)
T ss_dssp             ---------------EEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHH
T ss_pred             ---------------eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHH
Confidence                           57788888776543322     23468999999999876           468899999999999


Q ss_pred             HHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          308 LVELCSGEALFQTHENL-EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       308 l~elltg~~pf~~~~~~-~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      +|+|++|+.||...... ..+..+..  ......+....+..+.++|.+||..+    |.+||++.++++|+||....
T Consensus       229 l~el~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~d----p~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          229 LYYMTYGKTPFQQIINQISKLHAIID--PNHEIEFPDIPEKDLQDVLKCCLKRD----PKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             HHHHHHSSCTTTTCCSHHHHHHHHHC--TTSCCCCCCCSCHHHHHHHHHHTCSS----TTTSCCHHHHHTSHHHHCC-
T ss_pred             HHHHHhCCCchhhHHHHHHHHHHHHh--cccccCCcccchHHHHHHHHHHccCC----cccCcCHHHHhcCccccCCC
Confidence            99999999999875432 22222221  11111122234667899999999988    99999999999999998644

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1e-45  Score=359.06  Aligned_cols=246  Identities=20%  Similarity=0.322  Sum_probs=204.3

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      .++|++.+.||+|+||.||+|+++.+++.||||+++..  ....+.+.+|+.+++++.|+||     +++++++...+..
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~~~~  187 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI-----VRLIGVCTQKQPI  187 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTB-----CCEEEEECSSSSC
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCE-----EEEEEEEecCCCc
Confidence            36899999999999999999999999999999998753  2334567889999999988776     9999999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      |+||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++                
T Consensus       188 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~----------------  250 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN----------------  250 (377)
T ss_dssp             EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC----------------
T ss_pred             EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCC----------------
Confidence            9999999 899999998654 3589999999999999999999999999999999999998776                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTH  321 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~  321 (411)
                                 .+||+|||++.......     ....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus       251 -----------~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~  319 (377)
T 3cbl_A          251 -----------VLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL  319 (377)
T ss_dssp             -----------CEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred             -----------cEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                       56666666665433221     11235678999999998899999999999999999998 99999988


Q ss_pred             ChHHHHHHHHHHhC-CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          322 ENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       322 ~~~~~~~~i~~~~~-~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      +..+....+..... +.|    ..+++.+.+++.+|++.+    |.+|||+.++++.
T Consensus       320 ~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~d----P~~Rps~~~i~~~  368 (377)
T 3cbl_A          320 SNQQTREFVEKGGRLPCP----ELCPDAVFRLMEQCWAYE----PGQRPSFSTIYQE  368 (377)
T ss_dssp             CHHHHHHHHHTTCCCCCC----TTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHcCCCCCCC----CCCCHHHHHHHHHHcCCC----chhCcCHHHHHHH
Confidence            87776665554321 222    345677889999998888    8899999998864

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.4e-45  Score=368.70  Aligned_cols=249  Identities=18%  Similarity=0.278  Sum_probs=211.2

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      .++|++.++||+|+||.||+|.++.++..||||+++......+.+.+|+.++++++|+||     +++++++...+.+|+
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~l~~~~~~~~~~~l  293 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL-----VQLLGVCTREPPFYI  293 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECSSSSCEE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCE-----eeEEEEEecCCcEEE
Confidence            467999999999999999999999999999999998766667889999999999988877     999999999999999


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      ||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++                  
T Consensus       294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~------------------  355 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH------------------  355 (495)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG------------------
T ss_pred             EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCC------------------
Confidence            99999 89999999876556799999999999999999999999999999999999998776                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL  324 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~  324 (411)
                               .+||+|||++.......    ....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..
T Consensus       356 ---------~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~  426 (495)
T 1opk_A          356 ---------LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS  426 (495)
T ss_dssp             ---------CEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             ---------cEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence                     56777777766543221    12345778999999998899999999999999999999 99999988776


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      +....+......   .....++..+.+++.+|++.+    |.+||++.++++..
T Consensus       427 ~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~d----P~~RPs~~el~~~L  473 (495)
T 1opk_A          427 QVYELLEKDYRM---ERPEGCPEKVYELMRACWQWN----PSDRPSFAEIHQAF  473 (495)
T ss_dssp             GHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred             HHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCcC----hhHCcCHHHHHHHH
Confidence            666655443211   122346778899999998888    99999999998753

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=8.1e-45  Score=343.11  Aligned_cols=253  Identities=25%  Similarity=0.369  Sum_probs=195.8

Q ss_pred             CccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc----hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee
Q 015222           88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        88 ~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~  163 (411)
                      ....++|++.+.||+|+||.||+|.+..+++.||||+++..    ......+.+|+.++++++|+|+     +++++++.
T Consensus        28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~  102 (310)
T 2wqm_A           28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV-----IKYYASFI  102 (310)
T ss_dssp             TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEE
T ss_pred             cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEE
Confidence            33456899999999999999999999999999999999742    3445678899999999988776     99999999


Q ss_pred             cCCeEEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          164 YRNHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       164 ~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                      ..+..++||||+ +++|.+++...  ....+++..++.++.||+.||.|||++||+||||||+|||++.+|         
T Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~---------  173 (310)
T 2wqm_A          103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG---------  173 (310)
T ss_dssp             ETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS---------
T ss_pred             cCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC---------
Confidence            999999999999 88999998742  234699999999999999999999999999999999999998766         


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCC
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL  317 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p  317 (411)
                                        .++|+|||++......   .....||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus       174 ------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p  235 (310)
T 2wqm_A          174 ------------------VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP  235 (310)
T ss_dssp             ------------------CEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             ------------------CEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence                              5677777776554322   1234789999999999999999999999999999999999999


Q ss_pred             CCCCCh--HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          318 FQTHEN--LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       318 f~~~~~--~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      |.+...  ......+..  ...+......++..+.+++.+||..|    |.+||++.+++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~d----p~~Rps~~~il~~l  292 (310)
T 2wqm_A          236 FYGDKMNLYSLCKKIEQ--CDYPPLPSDHYSEELRQLVNMCINPD----PEKRPDVTYVYDVA  292 (310)
T ss_dssp             TC---CCHHHHHHHHHT--TCSCCCCTTTSCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred             CcccchhHHHHHHHhhc--ccCCCCcccccCHHHHHHHHHHcCCC----hhhCCCHHHHHHHH
Confidence            976432  233333322  22222223456788999999999998    99999999988753

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.6e-45  Score=343.06  Aligned_cols=252  Identities=22%  Similarity=0.277  Sum_probs=196.7

Q ss_pred             ccCCCeEEEeeeccccceEEEEEE----eCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~----~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~  163 (411)
                      ...++|+++++||+|+||+||+|+    +..+++.||||++.... ...+.+.+|+.++++++|+||     +++++++.
T Consensus         7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~   81 (295)
T 3ugc_A            7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI-----VKYKGVCY   81 (295)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEC
T ss_pred             CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEe
Confidence            345789999999999999999998    66789999999997543 445678899999999988777     99999875


Q ss_pred             c--CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          164 Y--RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       164 ~--~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                      .  ...+++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++         
T Consensus        82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~---------  151 (295)
T 3ugc_A           82 SAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN---------  151 (295)
T ss_dssp             HHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT---------
T ss_pred             cCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC---------
Confidence            4  45689999999 999999998764 3599999999999999999999999999999999999998877         


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccCCC------cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhC
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG  314 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg  314 (411)
                                        .+||+|||++.......      ....+|..|+|||++.+..++.++|||||||++|||++|
T Consensus       152 ------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g  213 (295)
T 3ugc_A          152 ------------------RVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY  213 (295)
T ss_dssp             ------------------EEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHT
T ss_pred             ------------------eEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhc
Confidence                              46666777665443221      223467789999999999999999999999999999999


Q ss_pred             CCCCCCCChH-------------HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          315 EALFQTHENL-------------EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       315 ~~pf~~~~~~-------------~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ..||......             .....+..............+++.+.+++.+|+..+    |.+|||+.++++.
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d----p~~Rps~~el~~~  285 (295)
T 3ugc_A          214 IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNN----VNQRPSFRDLALR  285 (295)
T ss_dssp             TCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSS----GGGSCCHHHHHHH
T ss_pred             ccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCC----hhhCCCHHHHHHH
Confidence            9998643211             001111111111111122356778999999998888    8899999998864

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=7.2e-45  Score=361.19  Aligned_cols=244  Identities=21%  Similarity=0.311  Sum_probs=203.7

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC-eEE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN-HIC  169 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~-~~~  169 (411)
                      .++|++.+.||+|+||.||+|.+.  ++.||||+++... ..+.+.+|+.++++++|+||     +++++++...+ .+|
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~~  263 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNL-----VQLLGVIVEEKGGLY  263 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTB-----CCEEEEEECTTSCEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCE-----EEEEEEEEcCCCceE
Confidence            368999999999999999999875  6789999998654 45778999999999988877     99999876554 899


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++                 
T Consensus       264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-----------------  326 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-----------------  326 (450)
T ss_dssp             EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTS-----------------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCC-----------------
Confidence            999999 89999999987645589999999999999999999999999999999999998766                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHL  327 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~  327 (411)
                                .+||+|||++...........+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+..
T Consensus       327 ----------~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~  396 (450)
T 1k9a_A          327 ----------VAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV  396 (450)
T ss_dssp             ----------CEEECCCTTCEECC------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH
T ss_pred             ----------CEEEeeCCCcccccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence                      6788888887755444444567889999999999999999999999999999998 99999987776666


Q ss_pred             HHHHHHhC-CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          328 AMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       328 ~~i~~~~~-~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ..+..... ..|    ..++..+.+++.+|+..+    |.+|||+.++++.
T Consensus       397 ~~i~~~~~~~~p----~~~~~~l~~li~~cl~~d----p~~Rpt~~~l~~~  439 (450)
T 1k9a_A          397 PRVEKGYKMDAP----DGCPPAVYDVMKNCWHLD----AATRPTFLQLREQ  439 (450)
T ss_dssp             HHHHTTCCCCCC----TTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHH
T ss_pred             HHHHcCCCCCCC----CcCCHHHHHHHHHHcCCC----hhHCcCHHHHHHH
Confidence            66554321 222    356778899999998888    8889999988754

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=8.3e-46  Score=352.12  Aligned_cols=245  Identities=23%  Similarity=0.211  Sum_probs=192.4

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC----Ce
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR----NH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~----~~  167 (411)
                      ++|++.+.||+|+||+||+|++.  ++.||||++...........+|+.++++++|+||     +++++++...    ..
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~~~~~~~   96 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENI-----LQFIGAEKRGTSVDVD   96 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTB-----CCEEEEEEEECSSSEE
T ss_pred             hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCc-----hhhcceeccCCCCCce
Confidence            58999999999999999999875  7899999998766666667778888888877776     9999998774    35


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CceecCCCCCcEEEecCcccccC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL----------RLIHTDLKPENILLVSAEYVKVP  236 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----------givH~Dikp~NIli~~~~~~~l~  236 (411)
                      +++||||+ +++|.+++...   .+++..++.++.||+.||+|||+.          ||+||||||+|||++.++     
T Consensus        97 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~-----  168 (322)
T 3soc_A           97 LWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL-----  168 (322)
T ss_dssp             EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC-----
T ss_pred             EEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC-----
Confidence            89999999 88999999875   499999999999999999999999          999999999999997766     


Q ss_pred             CcccccccCCCCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCC-----CCCccchhHHHHH
Q 015222          237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGL-----GWNYPCDLWSVGC  306 (411)
Q Consensus       237 df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlGv  306 (411)
                                            .+||+|||++......     .....||+.|+|||++.+.     .++.++|||||||
T Consensus       169 ----------------------~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~  226 (322)
T 3soc_A          169 ----------------------TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGL  226 (322)
T ss_dssp             ----------------------CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHH
T ss_pred             ----------------------eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHH
Confidence                                  6777777777553322     2235789999999999873     4667899999999


Q ss_pred             HHHHHHhCCCCCCCCCh---------------HHHHHHHHHHhC---CCChhHH-HhhhhhhhhhhccCCccCCCCCCCc
Q 015222          307 ILVELCSGEALFQTHEN---------------LEHLAMMERVLG---PLPHHMV-IRADRRAEKYFRRGARLDWPDGATS  367 (411)
Q Consensus       307 il~elltg~~pf~~~~~---------------~~~~~~i~~~~~---~~p~~~~-~~~~~~~~~li~~~l~~~~~~rp~~  367 (411)
                      ++|||++|+.||.+...               ...+........   .++..+. ...+..+.+++.+|++.|    |.+
T Consensus       227 il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d----P~~  302 (322)
T 3soc_A          227 VLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHD----AEA  302 (322)
T ss_dssp             HHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSS----GGG
T ss_pred             HHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCC----hhh
Confidence            99999999999976432               111111111111   1111111 123445889999998888    889


Q ss_pred             HHHHHHHHhc
Q 015222          368 RDSMRAVWKL  377 (411)
Q Consensus       368 R~t~~~il~~  377 (411)
                      |||+.++++.
T Consensus       303 Rps~~ell~~  312 (322)
T 3soc_A          303 RLSAGCVGER  312 (322)
T ss_dssp             SCCHHHHHHH
T ss_pred             CcCHHHHHHH
Confidence            9999998865

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=364.04  Aligned_cols=258  Identities=20%  Similarity=0.194  Sum_probs=198.9

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeecCCeEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      .+|++.+.||+|+||+||. ....+++.||||++....  ...+.+|+.+++.+ .|+||     +++++++.+.+..|+
T Consensus        24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnI-----v~l~~~~~~~~~~~l   95 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC--FSFADREVQLLRESDEHPNV-----IRYFCTEKDRQFQYI   95 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT--EEECHHHHHHHHHSCCCTTB-----CCEEEEEEETTEEEE
T ss_pred             EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhccCCCCc-----CeEEEEEecCCEEEE
Confidence            3699999999999999763 345678999999986532  23456799999998 57766     999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       171 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      ||||++++|.+++.... ..+.+..+..++.||+.||+|||++||+||||||+|||++.++                   
T Consensus        96 v~E~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~-------------------  155 (432)
T 3p23_A           96 AIELCAATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPN-------------------  155 (432)
T ss_dssp             EEECCSEEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCB-------------------
T ss_pred             EEECCCCCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCC-------------------
Confidence            99999889999998765 2455566789999999999999999999999999999996543                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCC------CcccccCCCccccceecC---CCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCS-GEALFQT  320 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~ellt-g~~pf~~  320 (411)
                         .+....+||+|||++......      .....||+.|+|||++.+   ..++.++|||||||++|||++ |..||..
T Consensus       156 ---~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~  232 (432)
T 3p23_A          156 ---AHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK  232 (432)
T ss_dssp             ---TTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBS
T ss_pred             ---CCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcch
Confidence               123446889999988765422      233579999999999984   467889999999999999999 9999976


Q ss_pred             CChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      .........+.. ............+..+.++|.+||+.|    |.+||++.++++||||.++.+
T Consensus       233 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~d----P~~Rps~~evl~hp~f~~~~~  292 (432)
T 3p23_A          233 SLQRQANILLGA-CSLDCLHPEKHEDVIARELIEKMIAMD----PQKRPSAKHVLKHPFFWSLEK  292 (432)
T ss_dssp             TTTHHHHHHTTC-CCCTTSCTTCHHHHHHHHHHHHHSCSS----GGGSCCHHHHHTSTTTCCHHH
T ss_pred             hhHHHHHHHhcc-CCccccCccccccHHHHHHHHHHHhCC----HhhCCCHHHHHhCccccChHH
Confidence            544332221111 111111111234566889999999999    999999999999999987654

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6.9e-45  Score=336.71  Aligned_cols=253  Identities=24%  Similarity=0.307  Sum_probs=198.4

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .++|++.+.||+|+||.||+|.+.  ++.||||+++...     ...+.+.+|+.+++.++|+||     +++++++.+.
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~   78 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI-----IALRGVCLKE   78 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTB-----CCEEEEECCC
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCE-----eeEEEEEecC
Confidence            468999999999999999999875  7889999987432     234678899999999988877     9999999999


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCcEEEecCcccccCCcccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR---LIHTDLKPENILLVSAEYVKVPDYKFL  241 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dikp~NIli~~~~~~~l~df~~~  241 (411)
                      +..++||||+ +++|.+++...   .+++..++.++.||+.||+|||++|   |+||||||+|||++..+..        
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~--------  147 (271)
T 3dtc_A           79 PNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVEN--------  147 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSS--------
T ss_pred             CceEEEEEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccc--------
Confidence            9999999999 89999998653   5999999999999999999999999   8999999999999763200        


Q ss_pred             cccCCCCCccccCCCCCCeeEeecCCcccccCC-CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 015222          242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT  320 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~  320 (411)
                                 ....+..++|+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+
T Consensus       148 -----------~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  216 (271)
T 3dtc_A          148 -----------GDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG  216 (271)
T ss_dssp             -----------SCCSSCCEEECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTT
T ss_pred             -----------ccccCcceEEccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                       0012457899999998764433 2345789999999999998999999999999999999999999998


Q ss_pred             CChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      .+.......+.....  ........++.+.+++.+|+..+    |.+||++.+++++.
T Consensus       217 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~----p~~Rps~~e~l~~L  268 (271)
T 3dtc_A          217 IDGLAVAYGVAMNKL--ALPIPSTCPEPFAKLMEDCWNPD----PHSRPSFTNILDQL  268 (271)
T ss_dssp             SCHHHHHHHHHTSCC--CCCCCTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred             CCHHHHHHhhhcCCC--CCCCCcccCHHHHHHHHHHhcCC----cccCcCHHHHHHHH
Confidence            777665554443322  22223456778999999999888    99999999999864

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4.6e-45  Score=341.93  Aligned_cols=255  Identities=22%  Similarity=0.324  Sum_probs=203.1

Q ss_pred             eEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEE
Q 015222           94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF  172 (411)
Q Consensus        94 y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~  172 (411)
                      |.....||+|+||.||+|.+..+++.||||++.... ...+.+.+|+.+++.+.|+||     +++++++...+..++||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~~lv~   98 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI-----VQYLGSFSENGFIKIFM   98 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTB-----CCEEEEEEETTEEEEEE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCE-----eeEeeEEEeCCcEEEEE
Confidence            334458999999999999999999999999987543 345678899999999988776     99999999999999999


Q ss_pred             ccC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec-CcccccCCcccccccCCCCC
Q 015222          173 EKL-GPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS-AEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       173 e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~-~~~~~l~df~~~~~~~~~~~  249 (411)
                      ||+ +++|.+++.... ...+++..+..++.||+.||+|||++||+|+||||+|||++. ++                  
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~------------------  160 (295)
T 2clq_A           99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSG------------------  160 (295)
T ss_dssp             ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTC------------------
T ss_pred             EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCC------------------
Confidence            999 899999998753 235679999999999999999999999999999999999976 44                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCC--CCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLG--WNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                               .++|+|||++......   .....||+.|+|||++.+..  ++.++|||||||++|+|++|+.||......
T Consensus       161 ---------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  231 (295)
T 2clq_A          161 ---------VLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP  231 (295)
T ss_dssp             ---------CEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH
T ss_pred             ---------CEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch
Confidence                     6788888877654322   23457899999999997653  889999999999999999999999765443


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      .......... .....+...++..+.++|.+||..+    |.+||++.++++|+||.....
T Consensus       232 ~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~d----p~~Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          232 QAAMFKVGMF-KVHPEIPESMSAEAKAFILKCFEPD----PDKRACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             HHHHHHHHHH-CCCCCCCTTSCHHHHHHHHHTTCSS----TTTSCCHHHHHTSGGGCC---
T ss_pred             hHHHHhhccc-cccccccccCCHHHHHHHHHHccCC----hhhCCCHHHHhcChhhhhccc
Confidence            3222111111 1122223456788999999999999    999999999999999986543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=5.3e-45  Score=347.30  Aligned_cols=247  Identities=19%  Similarity=0.258  Sum_probs=196.2

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcE----EEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKEL----VAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~----vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      .++|++.+.||+|+||+||+|++..+++.    ||+|.++..  ....+.+.+|+.++++++|+||     +++++++..
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~   88 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV-----CRLLGICLT   88 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTB-----CCEEEEEES
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCE-----eEEEEEEec
Confidence            36899999999999999999999888765    577777532  2445678899999999998877     999999987


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                      .+ .++|+||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++            
T Consensus        89 ~~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~------------  154 (327)
T 3poz_A           89 ST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ------------  154 (327)
T ss_dssp             SS-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT------------
T ss_pred             CC-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC------------
Confidence            55 77889998 999999998754 4699999999999999999999999999999999999998877            


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEAL  317 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p  317 (411)
                                     .+||+|||++.......     ....||+.|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus       155 ---------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p  219 (327)
T 3poz_A          155 ---------------HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP  219 (327)
T ss_dssp             ---------------EEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             ---------------CEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCC
Confidence                           46677777665433221     22356789999999999999999999999999999999 9999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      |.+.+..+....+.......   .....+..+.+++.+|+..+    |.+||++.+++++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~----p~~Rps~~ell~~l  273 (327)
T 3poz_A          220 YDGIPASEISSILEKGERLP---QPPICTIDVYMIMVKCWMID----ADSRPKFRELIIEF  273 (327)
T ss_dssp             TTTCCGGGHHHHHHTTCCCC---CCTTBCHHHHHHHHHHTCSC----GGGSCCHHHHHHHH
T ss_pred             ccCCCHHHHHHHHHcCCCCC---CCccCCHHHHHHHHHHcCCC----hhhCCCHHHHHHHH
Confidence            99877766655554432211   12345677889999998888    88888899988763

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.6e-45  Score=345.78  Aligned_cols=249  Identities=18%  Similarity=0.283  Sum_probs=205.7

Q ss_pred             CCCeEEEeeeccccceEEEEEEeC-----CCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~  163 (411)
                      .++|++.+.||+|+||.||+|.+.     .+++.||||+++..  ....+.+.+|+.++++++|+||     +++++++.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~   96 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV-----IKLYGACS   96 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCce-----eeEEEEEe
Confidence            468999999999999999999883     45689999999753  2344678899999999987776     99999999


Q ss_pred             cCCeEEEEEccC-CCCHHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 015222          164 YRNHICIVFEKL-GPSLYDFLRKNSY----------------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDL  220 (411)
Q Consensus       164 ~~~~~~lv~e~~-~~~L~~~l~~~~~----------------------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Di  220 (411)
                      +.+..++||||+ +++|.+++.....                      ..+++..++.++.||+.||+|||++||+||||
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di  176 (314)
T 2ivs_A           97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL  176 (314)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccccc
Confidence            999999999999 8999999987542                      23899999999999999999999999999999


Q ss_pred             CCCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCC
Q 015222          221 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGW  295 (411)
Q Consensus       221 kp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~  295 (411)
                      ||+|||++.++                           .+||+|||++.......     ....+|+.|+|||++.+..+
T Consensus       177 kp~NIli~~~~---------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  229 (314)
T 2ivs_A          177 AARNILVAEGR---------------------------KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY  229 (314)
T ss_dssp             SGGGEEEETTT---------------------------EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE
T ss_pred             chheEEEcCCC---------------------------CEEEccccccccccccccceeccCCCCcccccChhhhcCCCc
Confidence            99999998776                           46777777665443221     22356788999999999899


Q ss_pred             CccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHH
Q 015222          296 NYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV  374 (411)
Q Consensus       296 ~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~i  374 (411)
                      +.++|||||||++|||++ |..||.+.+..+....+.....   ......++..+.+++.+||..+    |.+||++.++
T Consensus       230 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~d----p~~Rps~~~l  302 (314)
T 2ivs_A          230 TTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHR---MERPDNCSEEMYRLMLQCWKQE----PDKRPVFADI  302 (314)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSS----GGGSCCHHHH
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCc---CCCCccCCHHHHHHHHHHccCC----hhhCcCHHHH
Confidence            999999999999999999 9999998877666555544321   1122356788999999999999    8899999999


Q ss_pred             HhcC
Q 015222          375 WKLL  378 (411)
Q Consensus       375 l~~~  378 (411)
                      +++.
T Consensus       303 ~~~l  306 (314)
T 2ivs_A          303 SKDL  306 (314)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8763

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1e-44  Score=342.43  Aligned_cols=250  Identities=24%  Similarity=0.322  Sum_probs=203.7

Q ss_pred             CCCeEEEeeeccccceEEEEEEe-----CCCCcEEEEEEeccch--hhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeee
Q 015222           91 TPRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWF  162 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~-----~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~  162 (411)
                      .++|++.+.||+|+||.||+|++     ..+++.||||+++...  ...+.+.+|+.+++++ .|+||     +++++++
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----~~~~~~~   96 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI-----VNLLGAC   96 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEE
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCe-----eeEEEEE
Confidence            46899999999999999999985     4577899999997543  3456788999999999 77777     9999999


Q ss_pred             ecCCeEEEEEccC-CCCHHHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 015222          163 DYRNHICIVFEKL-GPSLYDFLRKNSY----------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI  225 (411)
Q Consensus       163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NI  225 (411)
                      .+.+..++||||+ +++|.+++.....                ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni  176 (313)
T 1t46_A           97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI  176 (313)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence            9999999999999 8899999987542                2489999999999999999999999999999999999


Q ss_pred             EEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccch
Q 015222          226 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCD  300 (411)
Q Consensus       226 li~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~D  300 (411)
                      |++.++.                           +||+|||++.......     ....||+.|+|||++.+..++.++|
T Consensus       177 l~~~~~~---------------------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  229 (313)
T 1t46_A          177 LLTHGRI---------------------------TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESD  229 (313)
T ss_dssp             EEETTTE---------------------------EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHH
T ss_pred             EEcCCCC---------------------------EEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHH
Confidence            9988774                           5666666555433221     2245788899999999889999999


Q ss_pred             hHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          301 LWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       301 iwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ||||||++|+|++ |..||.+.................+  .....+..+.+++.+||..+    |.+||++.+++++.
T Consensus       230 i~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~d----p~~Rps~~ell~~L  302 (313)
T 1t46_A          230 VWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML--SPEHAPAEMYDIMKTCWDAD----PLKRPTFKQIVQLI  302 (313)
T ss_dssp             HHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCC--CcccCCHHHHHHHHHHcCCC----chhCcCHHHHHHHH
Confidence            9999999999999 9999988765444444333222111  12346778999999999999    88999999998763

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.8e-45  Score=349.09  Aligned_cols=259  Identities=19%  Similarity=0.251  Sum_probs=210.0

Q ss_pred             CccCCCeEEEeeeccccceEEEEEE-----eCCCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEee
Q 015222           88 ENLTPRYRILSKMGEGTFGQVVECF-----DNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRN  160 (411)
Q Consensus        88 ~~~~~~y~i~~~lG~G~~g~V~~a~-----~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~  160 (411)
                      +...++|++.+.||+|+||.||+|+     +..+++.||||++...  ......+.+|+.+++++.|+||     +++++
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~  100 (327)
T 2yfx_A           26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI-----VRCIG  100 (327)
T ss_dssp             BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred             cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCC-----CeEEE
Confidence            3445789999999999999999999     5567889999999643  3445678889999999988777     99999


Q ss_pred             eeecCCeEEEEEccC-CCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccc
Q 015222          161 WFDYRNHICIVFEKL-GPSLYDFLRKNSY-----RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK  234 (411)
Q Consensus       161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~  234 (411)
                      ++...+..|+||||+ +++|.+++.....     ..+++..++.++.||+.||.|||++||+||||||+|||++.++   
T Consensus       101 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~---  177 (327)
T 2yfx_A          101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG---  177 (327)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS---
T ss_pred             EEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCC---
Confidence            999999999999999 9999999987542     3489999999999999999999999999999999999998644   


Q ss_pred             cCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCCCccchhHHHHHHHH
Q 015222          235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV  309 (411)
Q Consensus       235 l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  309 (411)
                                           ....++|+|||++......     .....||+.|+|||++.+..++.++|||||||++|
T Consensus       178 ---------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  236 (327)
T 2yfx_A          178 ---------------------PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLW  236 (327)
T ss_dssp             ---------------------TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred             ---------------------CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHH
Confidence                                 2346889999987643222     23356789999999999889999999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCc
Q 015222          310 ELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       310 ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~  382 (411)
                      +|++ |..||.+.+..+....+.......+   ...++..+.++|.+||..+    |.+||++.++++++|...
T Consensus       237 ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~d----p~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          237 EIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNCPGPVYRIMTQCWQHQ----PEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             HHHTTSCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCCcCHHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHhcCC----hhhCcCHHHHHHHHHHHh
Confidence            9998 9999998877776665554322211   2346778899999999998    999999999999987653

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5.3e-45  Score=339.64  Aligned_cols=249  Identities=22%  Similarity=0.276  Sum_probs=196.8

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCC---CcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~---~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~  163 (411)
                      ...++|++.+.||+|+||.||+|.+..+   +..||+|+++..  ....+.+.+|+.+++++.|+||     +++++++.
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~   86 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI-----VKLIGVIT   86 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEC
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCcc-----ceEEEEEc
Confidence            3457899999999999999999998654   457999998753  3345678899999999987776     99999885


Q ss_pred             cCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccc
Q 015222          164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                       ++..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++           
T Consensus        87 -~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-----------  153 (281)
T 1mp8_A           87 -ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-----------  153 (281)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-----------
T ss_pred             -cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC-----------
Confidence             46789999999 889999998654 3699999999999999999999999999999999999998877           


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCC
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEAL  317 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p  317 (411)
                                      .+||+|||++.......    ....+|+.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus       154 ----------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p  217 (281)
T 1mp8_A          154 ----------------CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP  217 (281)
T ss_dssp             ----------------EEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             ----------------CEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCC
Confidence                            45666666665443221    22356788999999998899999999999999999997 9999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      |.+.+..+....+......   .....++..+.+++.+||..+    |.+||++.+++++.
T Consensus       218 f~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~~li~~~l~~~----p~~Rps~~~l~~~l  271 (281)
T 1mp8_A          218 FQGVKNNDVIGRIENGERL---PMPPNCPPTLYSLMTKCWAYD----PSRRPRFTELKAQL  271 (281)
T ss_dssp             TTTCCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred             CCcCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHccCC----hhhCcCHHHHHHHH
Confidence            9988777766665543221   122356778999999999999    88999999988753

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.1e-45  Score=348.57  Aligned_cols=247  Identities=20%  Similarity=0.255  Sum_probs=199.3

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcE----EEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKEL----VAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~----vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      .++|++.+.||+|+||+||+|++..+++.    ||+|++....  .....+.+|+.++++++|+||     +++++++. 
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~-   85 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI-----VRLLGLCP-   85 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTB-----CCEEEEEC-
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCc-----CeEEEEEc-
Confidence            46899999999999999999999888875    7777775322  233556789999999988777     99999886 


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                      ++..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++            
T Consensus        86 ~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~------------  152 (325)
T 3kex_A           86 GSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS------------  152 (325)
T ss_dssp             BSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSS------------
T ss_pred             CCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCC------------
Confidence            46789999999 899999998653 3689999999999999999999999999999999999997766            


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEAL  317 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p  317 (411)
                                     .+||+|||++.......     ....||..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus       153 ---------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p  217 (325)
T 3kex_A          153 ---------------QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP  217 (325)
T ss_dssp             ---------------CEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             ---------------eEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCC
Confidence                           56777777776543221     23467889999999998899999999999999999999 9999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      |.+....+....+........   ....+..+.+++.+|+..+    |.+||++.+++++.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~d----p~~Rps~~el~~~l  271 (325)
T 3kex_A          218 YAGLRLAEVPDLLEKGERLAQ---PQICTIDVYMVMVKCWMID----ENIRPTFKELANEF  271 (325)
T ss_dssp             TTTSCTTHHHHHHHTTCBCCC---CTTBCTTTTHHHHHHTCSC----TTTSCCHHHHHHHH
T ss_pred             ccccCHHHHHHHHHcCCCCCC---CCcCcHHHHHHHHHHcCCC----hhhCcCHHHHHHHH
Confidence            998877666666554432211   1235678899999999888    88888888888763

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.6e-45  Score=358.56  Aligned_cols=259  Identities=20%  Similarity=0.277  Sum_probs=203.3

Q ss_pred             CCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        87 ~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      +..+.++|++.+.||+|+||+||+|++..+++.||||+++...  ...+.+.+|+.++++++|+||     +++++++..
T Consensus         4 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~~~~~~   78 (396)
T 4eut_A            4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI-----VKLFAIEEE   78 (396)
T ss_dssp             EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTB-----CCEEEEEEC
T ss_pred             CCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCC-----CeEEEeecc
Confidence            3456779999999999999999999999999999999997533  334667899999999988877     999999876


Q ss_pred             CC--eEEEEEccC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          165 RN--HICIVFEKL-GPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       165 ~~--~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                      .+  ..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||+....         
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~---------  149 (396)
T 4eut_A           79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE---------  149 (396)
T ss_dssp             TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECT---------
T ss_pred             CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecC---------
Confidence            54  889999999 899999997643 22399999999999999999999999999999999999983221         


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecC--------CCCCccchhHHHHHHHHH
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILG--------LGWNYPCDLWSVGCILVE  310 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~e  310 (411)
                                    +.+..+||+|||++.......  ....||+.|+|||++.+        ..++.++|||||||++||
T Consensus       150 --------------~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~e  215 (396)
T 4eut_A          150 --------------DGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYH  215 (396)
T ss_dssp             --------------TSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHH
T ss_pred             --------------CCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHH
Confidence                          123368888888887654332  34579999999999875        467889999999999999


Q ss_pred             HHhCCCCCCCC----ChHHHHHHHHHHhCC---------------------CChhHHHhhhhhhhhhhccCCccCCCCCC
Q 015222          311 LCSGEALFQTH----ENLEHLAMMERVLGP---------------------LPHHMVIRADRRAEKYFRRGARLDWPDGA  365 (411)
Q Consensus       311 lltg~~pf~~~----~~~~~~~~i~~~~~~---------------------~p~~~~~~~~~~~~~li~~~l~~~~~~rp  365 (411)
                      |++|+.||...    ...+.+..+......                     .+..+....+..+.++|.+||..|    |
T Consensus       216 l~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~d----P  291 (396)
T 4eut_A          216 AATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD----Q  291 (396)
T ss_dssp             HHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCC----T
T ss_pred             HHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccC----h
Confidence            99999999753    233444444332210                     111233556778899999999999    6


Q ss_pred             CcHHHHHHHHhc
Q 015222          366 TSRDSMRAVWKL  377 (411)
Q Consensus       366 ~~R~t~~~il~~  377 (411)
                      ++|+++.+++++
T Consensus       292 ~~R~s~~e~l~~  303 (396)
T 4eut_A          292 EKCWGFDQFFAE  303 (396)
T ss_dssp             TTSCCHHHHHHH
T ss_pred             hhhccHHHHHHH
Confidence            666666666543

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.1e-45  Score=348.13  Aligned_cols=251  Identities=20%  Similarity=0.280  Sum_probs=202.5

Q ss_pred             CCCeEEEeeeccccceEEEEEEe-----CCCCcEEEEEEeccc--hhhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeee
Q 015222           91 TPRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWF  162 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~-----~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~  162 (411)
                      .++|++.+.||+|+||.||+|++     ..+++.||||+++..  ....+.+.+|+.+++++ .|+||     +++++++
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i-----v~~~~~~  118 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI-----VNLLGAC  118 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTB-----CCEEEEE
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCe-----eeEEEEE
Confidence            46899999999999999999997     345678999999743  23456788999999999 78777     9999999


Q ss_pred             ecCCeEEEEEccC-CCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 015222          163 DYRNHICIVFEKL-GPSLYDFLRKNSY---------------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDL  220 (411)
Q Consensus       163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Di  220 (411)
                      ...+..++||||+ +++|.+++.....                     ..+++..++.++.||+.||+|||++||+||||
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di  198 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL  198 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence            9999999999999 8999999986542                     23799999999999999999999999999999


Q ss_pred             CCCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCC
Q 015222          221 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGW  295 (411)
Q Consensus       221 kp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~  295 (411)
                      ||+|||++.++                           .++|+|||++.......     ....||+.|+|||++.+..+
T Consensus       199 kp~NIll~~~~---------------------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  251 (344)
T 1rjb_A          199 AARNVLVTHGK---------------------------VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY  251 (344)
T ss_dssp             SGGGEEEETTT---------------------------EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred             ChhhEEEcCCC---------------------------cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC
Confidence            99999998877                           45666666665432221     22457889999999998899


Q ss_pred             CccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHH
Q 015222          296 NYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV  374 (411)
Q Consensus       296 ~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~i  374 (411)
                      +.++|||||||++|+|++ |..||.+......+..+.......  ......++.+.+++.+||..+    |.+||++.++
T Consensus       252 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~d----p~~Rps~~~l  325 (344)
T 1rjb_A          252 TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM--DQPFYATEEIYIIMQSCWAFD----SRKRPSFPNL  325 (344)
T ss_dssp             CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSS----GGGSCCHHHH
T ss_pred             ChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcCCC----chhCcCHHHH
Confidence            999999999999999998 999998876544444333322111  122345778999999999988    9999999999


Q ss_pred             HhcCC
Q 015222          375 WKLLR  379 (411)
Q Consensus       375 l~~~~  379 (411)
                      ++++.
T Consensus       326 ~~~l~  330 (344)
T 1rjb_A          326 TSFLG  330 (344)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            98764

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5.8e-46  Score=352.86  Aligned_cols=255  Identities=21%  Similarity=0.229  Sum_probs=203.5

Q ss_pred             CccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        88 ~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      +...++|++.+.||+|+||.||+|++. +++.||||++.... ...+.+.+|+.+++.++|+||     +++++++...+
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~  108 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHL-----VSLIGFCDERN  108 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTB-----CCEEEECCCTT
T ss_pred             HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEcCCC
Confidence            445689999999999999999999964 68899999987543 345678899999998887776     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          167 HICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                      ..++||||+ +++|.+++....  ...+++..+..++.||+.||+|||++||+||||||+|||++.++            
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~------------  176 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF------------  176 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC------------
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC------------
Confidence            999999999 899999987543  23589999999999999999999999999999999999997766            


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF  318 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf  318 (411)
                                     .+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       177 ---------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~  241 (321)
T 2qkw_B          177 ---------------VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI  241 (321)
T ss_dssp             ---------------CEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTC
T ss_pred             ---------------CEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcc
Confidence                           5677777776543221     12346899999999999889999999999999999999999999


Q ss_pred             CCCChHHHHHHH-----HHHh--------CCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCC
Q 015222          319 QTHENLEHLAMM-----ERVL--------GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR  379 (411)
Q Consensus       319 ~~~~~~~~~~~i-----~~~~--------~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~  379 (411)
                      .+....+.....     ....        ...........+..+.+++.+||..|    |.+||++.++++++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d----P~~Rps~~ell~~L~  311 (321)
T 2qkw_B          242 VQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALS----SEDRPSMGDVLWKLE  311 (321)
T ss_dssp             SCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSS----GGGSCCHHHHHHHHH
T ss_pred             cccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCC----cccCcCHHHHHHHHH
Confidence            765432211110     0001        11222233456677889999999988    999999999998753

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1e-44  Score=339.15  Aligned_cols=252  Identities=22%  Similarity=0.328  Sum_probs=193.8

Q ss_pred             eeCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeee
Q 015222           85 AIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW  161 (411)
Q Consensus        85 ~~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~  161 (411)
                      ..++...++|++.++||+|+||+||+|++..   .||+|+++..   ....+.+.+|+.++++++|+|+     +.++++
T Consensus        17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~   88 (289)
T 3og7_A           17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI-----LLFMGY   88 (289)
T ss_dssp             -CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEE
T ss_pred             CCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcE-----EEEEee
Confidence            3456677899999999999999999998643   4999999743   2345678899999999988877     888885


Q ss_pred             eecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                      . ..+..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++         
T Consensus        89 ~-~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~---------  157 (289)
T 3og7_A           89 S-TAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN---------  157 (289)
T ss_dssp             E-CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT---------
T ss_pred             c-cCCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC---------
Confidence            5 456789999999 899999997554 4699999999999999999999999999999999999998877         


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccC-----CCcccccCCCccccceec---CCCCCccchhHHHHHHHHHHH
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELC  312 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~ell  312 (411)
                                        .++|+|||++.....     ......||+.|+|||++.   +..++.++|||||||++|+|+
T Consensus       158 ------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~  219 (289)
T 3og7_A          158 ------------------TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM  219 (289)
T ss_dssp             ------------------EEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHH
T ss_pred             ------------------CEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHH
Confidence                              466677776654321     112357899999999987   557899999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhC--CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          313 SGEALFQTHENLEHLAMMERVLG--PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       313 tg~~pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      +|+.||.+....+.+........  .........+++.+.+++.+||+.+    |.+||++.++++.
T Consensus       220 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~----p~~Rps~~ell~~  282 (289)
T 3og7_A          220 TGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKK----RDERPSFPRILAE  282 (289)
T ss_dssp             HSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSS----GGGSCCHHHHHHH
T ss_pred             HCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCC----hhhCCCHHHHHHH
Confidence            99999988766555444433222  1222233456788999999999999    8888899998864

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5.7e-45  Score=345.90  Aligned_cols=263  Identities=18%  Similarity=0.251  Sum_probs=212.9

Q ss_pred             CccCCCeEEEeeeccccceEEEEEEeC-----CCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEee
Q 015222           88 ENLTPRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRN  160 (411)
Q Consensus        88 ~~~~~~y~i~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~  160 (411)
                      +...++|++.+.||+|+||.||+|.+.     .+++.||||++....  .....+.+|+.+++.+.|+||     +++++
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~   95 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV-----VRLLG   95 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTB-----CCEEE
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCE-----eeeEE
Confidence            344578999999999999999999876     457889999997533  344567889999999988776     99999


Q ss_pred             eeecCCeEEEEEccC-CCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCc
Q 015222          161 WFDYRNHICIVFEKL-GPSLYDFLRKNS--------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE  231 (411)
Q Consensus       161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~  231 (411)
                      ++.+.+..++||||+ +++|.+++....        ...+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence            999999999999999 889999997532        13579999999999999999999999999999999999998766


Q ss_pred             ccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchhHHHHH
Q 015222          232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGC  306 (411)
Q Consensus       232 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  306 (411)
                                                 .+||+|||++.......     ....||+.|+|||++.+..++.++|||||||
T Consensus       176 ---------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  228 (322)
T 1p4o_A          176 ---------------------------TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV  228 (322)
T ss_dssp             ---------------------------CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred             ---------------------------eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHH
Confidence                                       67888888776543221     2245788999999999889999999999999


Q ss_pred             HHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc------CC
Q 015222          307 ILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL------LR  379 (411)
Q Consensus       307 il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~------~~  379 (411)
                      ++|+|++ |..||.+.+..+....+.......   ....++..+.+++.+||..+    |.+||++.+++++      ++
T Consensus       229 il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~d----p~~Rps~~e~l~~L~~~~~~~  301 (322)
T 1p4o_A          229 VLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD---KPDNCPDMLFELMRMCWQYN----PKMRPSFLEIISSIKEEMEPG  301 (322)
T ss_dssp             HHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHGGGSCTT
T ss_pred             HHHHHHhcCCCccccCCHHHHHHHHHcCCcCC---CCCCCCHHHHHHHHHHcCCC----cccCcCHHHHHHHHHHhhccC
Confidence            9999999 899999888777666555432211   12346778999999999999    8889999999887      45


Q ss_pred             CCcccccCCC
Q 015222          380 LPVIDLYSAS  389 (411)
Q Consensus       380 ~~~~~~~~~~  389 (411)
                      +..+.+....
T Consensus       302 ~~~~~~~~~~  311 (322)
T 1p4o_A          302 FREVSFYYSE  311 (322)
T ss_dssp             HHHHCSTTST
T ss_pred             Cccccccccc
Confidence            5555444433

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.6e-45  Score=342.35  Aligned_cols=248  Identities=20%  Similarity=0.258  Sum_probs=192.1

Q ss_pred             CCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHH--HhcCCCCCcceEEEeeeeec
Q 015222           87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR--LARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        87 ~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~~~~i~~~~iv~~~~~~~~  164 (411)
                      +..+.++|++.+.||+|+||+||+|++  +++.||||++....  ...+..|.+++..  ++|+||     +++++++..
T Consensus         3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~ni-----v~~~~~~~~   73 (301)
T 3q4u_A            3 QRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENI-----LGFIASDMT   73 (301)
T ss_dssp             -CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTB-----CCEEEEEEE
T ss_pred             cccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCe-----eeEEEeecc
Confidence            456678999999999999999999987  68899999997543  3445667777766  556655     888887543


Q ss_pred             ----CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCcEEEecCc
Q 015222          165 ----RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH--------ELRLIHTDLKPENILLVSAE  231 (411)
Q Consensus       165 ----~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~givH~Dikp~NIli~~~~  231 (411)
                          ...+++||||+ +++|.+++...   .+++..+..++.||+.||+|||        ++||+||||||+|||++.++
T Consensus        74 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~  150 (301)
T 3q4u_A           74 SRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG  150 (301)
T ss_dssp             EETTEEEEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred             ccCCCceeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC
Confidence                45799999999 88999999654   5999999999999999999999        99999999999999998766


Q ss_pred             ccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-------cccccCCCccccceecCC------CCCcc
Q 015222          232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-------SYVVSTRHYRAPEVILGL------GWNYP  298 (411)
Q Consensus       232 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~------~~~~~  298 (411)
                                                 .+||+|||++.......       ....||+.|+|||++.+.      .++.+
T Consensus       151 ---------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~  203 (301)
T 3q4u_A          151 ---------------------------QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKR  203 (301)
T ss_dssp             ---------------------------CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHH
T ss_pred             ---------------------------CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCch
Confidence                                       56777777775433222       224799999999999887      45579


Q ss_pred             chhHHHHHHHHHHHhC----------CCCCCCCC----hHHHHHHHHHHh---CCCChh-HHHhhhhhhhhhhccCCccC
Q 015222          299 CDLWSVGCILVELCSG----------EALFQTHE----NLEHLAMMERVL---GPLPHH-MVIRADRRAEKYFRRGARLD  360 (411)
Q Consensus       299 ~DiwSlGvil~elltg----------~~pf~~~~----~~~~~~~i~~~~---~~~p~~-~~~~~~~~~~~li~~~l~~~  360 (411)
                      +|||||||++|||++|          ..||....    ....+.......   ...+.. .....+..+.+++.+|++.|
T Consensus       204 ~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  283 (301)
T 3q4u_A          204 VDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQN  283 (301)
T ss_dssp             HHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSS
T ss_pred             hhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcC
Confidence            9999999999999999          88986532    222333222221   123322 22345677899999998888


Q ss_pred             CCCCCCcHHHHHHHHhc
Q 015222          361 WPDGATSRDSMRAVWKL  377 (411)
Q Consensus       361 ~~~rp~~R~t~~~il~~  377 (411)
                          |.+|||+.++++.
T Consensus       284 ----P~~Rps~~~i~~~  296 (301)
T 3q4u_A          284 ----PSARLTALRIKKT  296 (301)
T ss_dssp             ----GGGSCCHHHHHHH
T ss_pred             ----hhhCCCHHHHHHH
Confidence                9999999999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.3e-44  Score=340.23  Aligned_cols=250  Identities=21%  Similarity=0.299  Sum_probs=197.1

Q ss_pred             CCCeEEEeeeccccceEEEEEE----eCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           91 TPRYRILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~----~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      .++|++.+.||+|+||.||+|+    +..+++.||||+++...  ...+.+.+|+.+++.++|+|+     +++++++.+
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~   94 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI-----VKYKGICTE   94 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTB-----CCEEEEEEC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCe-----eeeeeEEec
Confidence            4679999999999999999998    67789999999997433  344678899999999988776     999999887


Q ss_pred             C--CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccc
Q 015222          165 R--NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL  241 (411)
Q Consensus       165 ~--~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~  241 (411)
                      .  +.+++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++          
T Consensus        95 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~----------  163 (302)
T 4e5w_A           95 DGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH----------  163 (302)
T ss_dssp             ---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT----------
T ss_pred             CCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC----------
Confidence            6  6799999999 889999996654 3699999999999999999999999999999999999998877          


Q ss_pred             cccCCCCCccccCCCCCCeeEeecCCcccccCCC------cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCC
Q 015222          242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE  315 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~  315 (411)
                                       .++|+|||++.......      ....||..|+|||++.+..++.++|||||||++|+|++|.
T Consensus       164 -----------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  226 (302)
T 4e5w_A          164 -----------------QVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYC  226 (302)
T ss_dssp             -----------------EEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTT
T ss_pred             -----------------CEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHcc
Confidence                             46677777665543221      2346788899999999989999999999999999999999


Q ss_pred             CCCCCCC------------hHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          316 ALFQTHE------------NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       316 ~pf~~~~------------~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      .|+....            ......................+++.+.+++.+||+.+    |.+|||+.++++.
T Consensus       227 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d----p~~Rps~~~ll~~  296 (302)
T 4e5w_A          227 DSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQ----PSNRTSFQNLIEG  296 (302)
T ss_dssp             CGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSS----GGGSCCHHHHHHH
T ss_pred             CCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCC----CCCCCCHHHHHHH
Confidence            9864321            11111111112121122223456778999999999999    9999999998864

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.6e-45  Score=362.43  Aligned_cols=247  Identities=24%  Similarity=0.372  Sum_probs=207.6

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      ..++|++.+.||+|+||.||+|.+.. +..||||+++......+.+.+|+.++++++|+||     +++++++. .+..+
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~l~~~~~-~~~~~  258 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKL-----VKLHAVVT-KEPIY  258 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTB-----CCEEEEEC-SSSCE
T ss_pred             chHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCE-----eeEEEEEe-CCccE
Confidence            34689999999999999999999864 6779999998766667889999999999988877     99999886 56789


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++                 
T Consensus       259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-----------------  321 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-----------------  321 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC-----------------
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC-----------------
Confidence            999999 99999999865333689999999999999999999999999999999999997766                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCC----CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCh
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHEN  323 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~  323 (411)
                                .+||+|||++......    .....+|..|+|||++.+..++.++|||||||++|||++ |+.||.+.+.
T Consensus       322 ----------~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~  391 (454)
T 1qcf_A          322 ----------VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN  391 (454)
T ss_dssp             ----------CEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             ----------cEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH
Confidence                      6788888877654322    122346778999999998899999999999999999999 9999999888


Q ss_pred             HHHHHHHHHHhC-CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          324 LEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       324 ~~~~~~i~~~~~-~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      .+....+..... +.|    ..+++.+.+++.+|+..+    |.+|||+.++++.+
T Consensus       392 ~~~~~~i~~~~~~~~~----~~~~~~l~~li~~cl~~d----p~~RPt~~~i~~~L  439 (454)
T 1qcf_A          392 PEVIRALERGYRMPRP----ENCPEELYNIMMRCWKNR----PEERPTFEYIQSVL  439 (454)
T ss_dssp             HHHHHHHHHTCCCCCC----TTSCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred             HHHHHHHHcCCCCCCC----CCCCHHHHHHHHHHccCC----hhHCcCHHHHHHHH
Confidence            887777665432 222    346778899999998888    88999999887643

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1e-44  Score=337.65  Aligned_cols=250  Identities=24%  Similarity=0.324  Sum_probs=204.8

Q ss_pred             eCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec-
Q 015222           86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-  164 (411)
Q Consensus        86 ~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~-  164 (411)
                      ++..+.++|++.+.||+|+||.||+|.+..+++.||+|+++...   +.+.+|+.+++++.|+|+     +++++++.. 
T Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~   76 (284)
T 2a19_B            5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNI-----VHYNGCWDGF   76 (284)
T ss_dssp             CCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTB-----CCEEEEEEEE
T ss_pred             ccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCE-----EEEeeeEecc
Confidence            45567789999999999999999999999999999999997543   356789999999988877     888887754 


Q ss_pred             ---------------CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015222          165 ---------------RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV  228 (411)
Q Consensus       165 ---------------~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~  228 (411)
                                     ...+++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~  156 (284)
T 2a19_B           77 DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV  156 (284)
T ss_dssp             EEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred             ccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc
Confidence                           45689999999 88999999876445799999999999999999999999999999999999998


Q ss_pred             cCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHH
Q 015222          229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC  306 (411)
Q Consensus       229 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  306 (411)
                      .++                           .++|+|||++......  .....||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~---------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  209 (284)
T 2a19_B          157 DTK---------------------------QVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGL  209 (284)
T ss_dssp             ETT---------------------------EEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHH
T ss_pred             CCC---------------------------CEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHH
Confidence            876                           5677777776554322  23357899999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCc
Q 015222          307 ILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       307 il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~  382 (411)
                      ++|+|++|..||...  ......+.  ....+    ..++..+.++|.+||..|    |.+||++.+++++++...
T Consensus       210 il~~l~~~~~~~~~~--~~~~~~~~--~~~~~----~~~~~~~~~li~~~l~~d----p~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          210 ILAELLHVCDTAFET--SKFFTDLR--DGIIS----DIFDKKEKTLLQKLLSKK----PEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             HHHHHHSCCSSHHHH--HHHHHHHH--TTCCC----TTSCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHHHHT
T ss_pred             HHHHHHhcCCcchhH--HHHHHHhh--ccccc----ccCCHHHHHHHHHHccCC----hhhCcCHHHHHHHHHHHh
Confidence            999999999988531  12222221  12222    235677889999999998    999999999999987654

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.3e-44  Score=355.94  Aligned_cols=269  Identities=21%  Similarity=0.213  Sum_probs=202.4

Q ss_pred             CCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeecC
Q 015222           87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        87 ~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .+.+.+.|.+.+.||+|+||+||.+ ...+|+.||||++...  ..+.+.+|+.+++++ .|+||     +++++++.++
T Consensus        10 ~~~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnI-----v~~~~~~~~~   81 (434)
T 2rio_A           10 EQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNV-----IRYYCSETTD   81 (434)
T ss_dssp             SCSCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTB-----CCEEEEEECS
T ss_pred             hhhhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCc-----CeEEEEEecC
Confidence            3456678888999999999999875 4567899999998653  235678899999987 67766     9999999999


Q ss_pred             CeEEEEEccCCCCHHHHHHhcCCCC-----CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          166 NHICIVFEKLGPSLYDFLRKNSYRS-----FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       166 ~~~~lv~e~~~~~L~~~l~~~~~~~-----l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                      +.+|+||||++++|.+++.......     .++..+..++.||+.||+|||++||+||||||+|||++.+|.......  
T Consensus        82 ~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~--  159 (434)
T 2rio_A           82 RFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQ--  159 (434)
T ss_dssp             SEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCT--
T ss_pred             CeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccc--
Confidence            9999999999889999998754211     123346789999999999999999999999999999987653211100  


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccCCC-------cccccCCCccccceecC-------CCCCccchhHHHHH
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-------SYVVSTRHYRAPEVILG-------LGWNYPCDLWSVGC  306 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGv  306 (411)
                                  ..+.+..+||+|||++.......       ....||+.|+|||++.+       ..++.++|||||||
T Consensus       160 ------------~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~  227 (434)
T 2rio_A          160 ------------TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGC  227 (434)
T ss_dssp             ------------TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHH
T ss_pred             ------------cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHH
Confidence                        01244578999999987654332       23579999999999976       56899999999999


Q ss_pred             HHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC---hhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCc
Q 015222          307 ILVELCS-GEALFQTHENLEHLAMMERVLGPLP---HHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       307 il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p---~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~  382 (411)
                      ++|||++ |..||.+....+  ..+.......+   ......++..+.++|.+||..|    |.+||++.++++||||+.
T Consensus       228 il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d----P~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          228 VFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHD----PLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             HHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSS----GGGSCCHHHHHTSGGGSC
T ss_pred             HHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCC----hhhCCCHHHHHhCCccCC
Confidence            9999999 999997655433  22223222221   1112345678999999999999    999999999999999975


Q ss_pred             c
Q 015222          383 I  383 (411)
Q Consensus       383 ~  383 (411)
                      .
T Consensus       302 ~  302 (434)
T 2rio_A          302 K  302 (434)
T ss_dssp             H
T ss_pred             c
Confidence            4

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-44  Score=336.75  Aligned_cols=248  Identities=24%  Similarity=0.293  Sum_probs=203.2

Q ss_pred             CCCeEEEe-eeccccceEEEEEEeC--CCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           91 TPRYRILS-KMGEGTFGQVVECFDN--EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        91 ~~~y~i~~-~lG~G~~g~V~~a~~~--~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .++|.+.+ .||+|+||.||+|.+.  .+++.||||+++..  ....+.+.+|+.+++++.|+||     +++++++. .
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~-~   81 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI-----VRLIGVCQ-A   81 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEE-S
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCE-----eEEEEEec-C
Confidence            35788887 9999999999999864  46788999999753  3456778899999999988777     99999984 5


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      +..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++             
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-------------  147 (287)
T 1u59_A           82 EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-------------  147 (287)
T ss_dssp             SSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-------------
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC-------------
Confidence            6799999999 889999997543 4699999999999999999999999999999999999998877             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCCC------cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEAL  317 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p  317 (411)
                                    .++|+|||++.......      ....||+.|+|||++.+..++.++|||||||++|+|++ |+.|
T Consensus       148 --------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p  213 (287)
T 1u59_A          148 --------------YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP  213 (287)
T ss_dssp             --------------EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             --------------CEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence                          45666666665433221      22356889999999998889999999999999999998 9999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCC
Q 015222          318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR  379 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~  379 (411)
                      |.+.+..+....+......   .....++..+.++|.+|+..+    |.+||++.+++++++
T Consensus       214 ~~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~~li~~~l~~~----p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          214 YKKMKGPEVMAFIEQGKRM---ECPPECPPELYALMSDCWIYK----WEDRPDFLTVEQRMR  268 (287)
T ss_dssp             TTTCCTHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHTTCSS----GGGSCCHHHHHHHHH
T ss_pred             cccCCHHHHHHHHhcCCcC---CCCCCcCHHHHHHHHHHcCCC----hhhCcCHHHHHHHHH
Confidence            9988877766665543211   122356788999999999998    889999999998753

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.6e-44  Score=357.77  Aligned_cols=255  Identities=21%  Similarity=0.310  Sum_probs=201.9

Q ss_pred             CccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        88 ~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ..+.++|++.++||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.+.|++.    +..+..++...+.
T Consensus         3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~----i~~i~~~~~~~~~   77 (483)
T 3sv0_A            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTG----IPNVRWFGVEGDY   77 (483)
T ss_dssp             CEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTT----CCCEEEEEEETTE
T ss_pred             CCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCC----CCeEEEEEeeCCE
Confidence            3467899999999999999999999999999999999864332 3457889999999988654    2445556667889


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          168 ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       168 ~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      .++||||++++|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+.                
T Consensus        78 ~~lvme~~g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~----------------  140 (483)
T 3sv0_A           78 NVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR----------------  140 (483)
T ss_dssp             EEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGG----------------
T ss_pred             EEEEEECCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCC----------------
Confidence            99999999999999998643 3699999999999999999999999999999999999994211                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCCC----------cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCC
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH----------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL  317 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p  317 (411)
                              ....+||+|||++.......          ....||+.|+|||++.+..++.++|||||||+||||++|+.|
T Consensus       141 --------~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~P  212 (483)
T 3sv0_A          141 --------RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP  212 (483)
T ss_dssp             --------GTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             --------CCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence                    22367777777776543322          246799999999999999999999999999999999999999


Q ss_pred             CCCCCh---HHHHHHHHHH-hCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHh
Q 015222          318 FQTHEN---LEHLAMMERV-LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK  376 (411)
Q Consensus       318 f~~~~~---~~~~~~i~~~-~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~  376 (411)
                      |.+...   .+.+..+... .......+...++..+.+++..|+..+    |.+||++.++++
T Consensus       213 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~d----P~~RPs~~el~~  271 (483)
T 3sv0_A          213 WQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLR----FDDKPDYSYLKR  271 (483)
T ss_dssp             TSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCC----TTCCCCHHHHHH
T ss_pred             CccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCC----hhhCcCHHHHHH
Confidence            987543   3333333332 223334444667888999999999999    666666665544

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.1e-44  Score=336.85  Aligned_cols=247  Identities=23%  Similarity=0.343  Sum_probs=205.0

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      ..++|++.+.||+|+||.||+|.+. +++.||||+++......+.+.+|+.+++++.|+|+     +++++++.. +..+
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~-~~~~   83 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRL-----VRLYAVVTQ-EPIY   83 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECS-SSCE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCc-----ceEEEEEcC-CCcE
Confidence            3468999999999999999999975 56789999998766667788999999999988877     899988764 5689


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++                 
T Consensus        84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-----------------  146 (279)
T 1qpc_A           84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-----------------  146 (279)
T ss_dssp             EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-----------------
T ss_pred             EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCC-----------------
Confidence            999999 89999999754323599999999999999999999999999999999999997766                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCh
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHEN  323 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~  323 (411)
                                .++|+|||++.......    ....+|..|+|||++.+..++.++|||||||++|||++ |+.||.+.+.
T Consensus       147 ----------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  216 (279)
T 1qpc_A          147 ----------SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN  216 (279)
T ss_dssp             ----------CEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred             ----------CEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH
Confidence                      56777777776543322    22356788999999998889999999999999999999 9999998887


Q ss_pred             HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      .+....+.......   ....++..+.+++.+|+..+    |.+||++.++++.
T Consensus       217 ~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~----p~~Rps~~~l~~~  263 (279)
T 1qpc_A          217 PEVIQNLERGYRMV---RPDNCPEELYQLMRLCWKER----PEDRPTFDYLRSV  263 (279)
T ss_dssp             HHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHH
T ss_pred             HHHHHHHhcccCCC---CcccccHHHHHHHHHHhccC----hhhCCCHHHHHHH
Confidence            77666655432211   12356778999999999999    8888888888763

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.7e-45  Score=351.91  Aligned_cols=254  Identities=16%  Similarity=0.157  Sum_probs=196.5

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCC--------CcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCC----------C
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEK--------KELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG----------G  152 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~----------~  152 (411)
                      .++|++.+.||+|+||.||+|++..+        ++.||||++...    +.+.+|+.+++++.|+|+.          +
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            57899999999999999999999874        889999998754    4577899999999887762          2


Q ss_pred             cceEEEeeeeec-CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCc
Q 015222          153 TRCVQIRNWFDY-RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE  231 (411)
Q Consensus       153 ~~iv~~~~~~~~-~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~  231 (411)
                      .+++.+++++.. ++..|+||||++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~  196 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPED  196 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTE
T ss_pred             cCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCC
Confidence            344557777765 6899999999999999999976334799999999999999999999999999999999999998776


Q ss_pred             ccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccC----------CCcccccCCCccccceecCCCCCccchh
Q 015222          232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ----------DHSYVVSTRHYRAPEVILGLGWNYPCDL  301 (411)
Q Consensus       232 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Di  301 (411)
                      .                         ..+||+|||++.....          ......||+.|+|||++.+..++.++||
T Consensus       197 ~-------------------------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  251 (352)
T 2jii_A          197 Q-------------------------SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDL  251 (352)
T ss_dssp             E-------------------------EEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHH
T ss_pred             C-------------------------ceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhH
Confidence            1                         1345555555543221          1123479999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCChhH-----HHhhhhhhhhhhccCCccCCCCCCCcHHHHHHH
Q 015222          302 WSVGCILVELCSGEALFQTHE--NLEHLAMMERVLGPLPHHM-----VIRADRRAEKYFRRGARLDWPDGATSRDSMRAV  374 (411)
Q Consensus       302 wSlGvil~elltg~~pf~~~~--~~~~~~~i~~~~~~~p~~~-----~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~i  374 (411)
                      |||||++|||++|+.||.+..  ...............+...     ...++..+.+++.+||..|    |.+||++.++
T Consensus       252 ~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d----p~~Rps~~~l  327 (352)
T 2jii_A          252 QSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALT----YEEKPPYAML  327 (352)
T ss_dssp             HHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCC----TTCCCCHHHH
T ss_pred             HHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCC----hhhCCCHHHH
Confidence            999999999999999998763  3333333332222221111     1234678999999999999    7777778777


Q ss_pred             Hhc
Q 015222          375 WKL  377 (411)
Q Consensus       375 l~~  377 (411)
                      ++.
T Consensus       328 ~~~  330 (352)
T 2jii_A          328 RNN  330 (352)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            654

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.5e-44  Score=343.58  Aligned_cols=249  Identities=17%  Similarity=0.262  Sum_probs=204.7

Q ss_pred             CCCeEEEeeeccccceEEEEEEeC-------CCCcEEEEEEeccch--hhhHHHHHHHHHHHHH-hcCCCCCcceEEEee
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDN-------EKKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRN  160 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~-------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~  160 (411)
                      .++|++.+.||+|+||.||+|++.       .+++.||||+++...  ...+.+.+|+.+++++ .|+||     +++++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i-----v~~~~  108 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI-----INLLG  108 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCE-----eeEEE
Confidence            468999999999999999999976       456789999997532  3456788999999999 77776     99999


Q ss_pred             eeecCCeEEEEEccC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 015222          161 WFDYRNHICIVFEKL-GPSLYDFLRKNSY--------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI  225 (411)
Q Consensus       161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NI  225 (411)
                      ++...+..++||||+ +++|.+++.....              ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus       109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  188 (334)
T 2pvf_A          109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  188 (334)
T ss_dssp             EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence            999999999999999 8899999986541              2489999999999999999999999999999999999


Q ss_pred             EEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCCCccch
Q 015222          226 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCD  300 (411)
Q Consensus       226 li~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~D  300 (411)
                      |++.++                           .+||+|||++......     .....+|+.|+|||++.+..++.++|
T Consensus       189 ll~~~~---------------------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  241 (334)
T 2pvf_A          189 LVTENN---------------------------VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD  241 (334)
T ss_dssp             EECTTC---------------------------CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHH
T ss_pred             EEcCCC---------------------------CEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHH
Confidence            998766                           5677777777654322     12235678899999999888999999


Q ss_pred             hHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          301 LWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       301 iwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ||||||++|+|++ |..||.+.+..+....+.......   ....++..+.+++.+|+..+    |.+||++.++++++
T Consensus       242 i~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~d----p~~Rps~~ell~~L  313 (334)
T 2pvf_A          242 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD---KPANCTNELYMMMRDCWHAV----PSQRPTFKQLVEDL  313 (334)
T ss_dssp             HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCC---CCccCCHHHHHHHHHHccCC----hhhCcCHHHHHHHH
Confidence            9999999999999 999999888777766665543211   12346778899999999888    88888999988763

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.1e-45  Score=353.60  Aligned_cols=247  Identities=22%  Similarity=0.305  Sum_probs=195.4

Q ss_pred             CCCeEEEeeeccccceEEEEEEeC---CCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~---~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .++|++.+.||+|+||.||+|+++   .++..||||+++..  ....+.+.+|+.+++++.|+||     +++++++...
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~  118 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI-----IRLEGVVTKS  118 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEECSS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEeeC
Confidence            358999999999999999999887   46778999999753  3445678899999999988776     9999999999


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      +..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++             
T Consensus       119 ~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-------------  184 (373)
T 2qol_A          119 KPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL-------------  184 (373)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-------------
T ss_pred             CceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC-------------
Confidence            9999999999 999999998654 4699999999999999999999999999999999999998766             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCCC------cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEAL  317 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p  317 (411)
                                    .+||+|||++.......      ....+|+.|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus       185 --------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P  250 (373)
T 2qol_A          185 --------------VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP  250 (373)
T ss_dssp             --------------CEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CT
T ss_pred             --------------CEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCC
Confidence                          56777777666543221      11245778999999999899999999999999999998 9999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      |.+.+..+....+.......+   ...++..+.+++.+|++.+    |.+||++.++++.
T Consensus       251 ~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~~li~~cl~~d----p~~RPs~~~i~~~  303 (373)
T 2qol_A          251 YWEMSNQDVIKAVDEGYRLPP---PMDCPAALYQLMLDCWQKD----RNNRPKFEQIVSI  303 (373)
T ss_dssp             TTTCCHHHHHHHHHTTEECCC---CTTCBHHHHHHHHHHTCSS----GGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHHHcCCCCCC---CccccHHHHHHHHHHhCcC----hhhCcCHHHHHHH
Confidence            998887777666654322211   1245678899999999888    8888888887764

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=9.6e-45  Score=343.46  Aligned_cols=256  Identities=23%  Similarity=0.313  Sum_probs=189.4

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchh--h-hHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--Y-REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~-~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      .++|++++.||+|+||.||+|+++.+++.||||++.....  . .+.+.++..+++.+.|+||     +++++++...+.
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i-----~~~~~~~~~~~~   98 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI-----VQCFGTFITNTD   98 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTB-----CCEEEEEECSSE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCce-----eeEEEEEecCCc
Confidence            3689999999999999999999999999999999975432  1 2223334445665666655     999999999999


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      .++||||+++.+..+..... ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++               
T Consensus        99 ~~lv~e~~~~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~---------------  162 (318)
T 2dyl_A           99 VFIAMELMGTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG---------------  162 (318)
T ss_dssp             EEEEECCCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS---------------
T ss_pred             EEEEEeccCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC---------------
Confidence            99999999777776665433 4699999999999999999999996 999999999999998766               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceec-----CCCCCccchhHHHHHHHHHHHhCCCCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGEALFQ  319 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltg~~pf~  319 (411)
                                  .+||+|||++......  .....||+.|+|||++.     +..++.++|||||||++|+|++|+.||.
T Consensus       163 ------------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  230 (318)
T 2dyl_A          163 ------------QIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK  230 (318)
T ss_dssp             ------------CEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             ------------CEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCC
Confidence                        5777788777544322  23357899999999995     4568899999999999999999999998


Q ss_pred             CC-ChHHHHHHHHHHhCC-CChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          320 TH-ENLEHLAMMERVLGP-LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       320 ~~-~~~~~~~~i~~~~~~-~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      .. ...+.+..+...... .+.  ...++..+.++|.+||..|    |.+||++.++++|+||.+...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~d----p~~Rps~~~ll~h~~~~~~~~  292 (318)
T 2dyl_A          231 NCKTDFEVLTKVLQEEPPLLPG--HMGFSGDFQSFVKDCLTKD----HRKRPKYNKLLEHSFIKRYET  292 (318)
T ss_dssp             TCCSHHHHHHHHHHSCCCCCCS--SSCCCHHHHHHHHHHTCSC----TTTSCCHHHHTTSHHHHHHHH
T ss_pred             CCCccHHHHHHHhccCCCCCCc--cCCCCHHHHHHHHHHccCC----hhHCcCHHHHhhCHHHHhccc
Confidence            74 344444444443222 111  1245778999999999998    999999999999999987654

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2e-44  Score=358.23  Aligned_cols=253  Identities=24%  Similarity=0.337  Sum_probs=206.1

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      .++|++.++||+|+||.||+|.+..+ ..||||+++......+.+.+|+.++++++|+||     +++++++.+ +..++
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~-~~~~i  255 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKL-----VQLYAVVSE-EPIYI  255 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECS-SSCEE
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCC-ceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCE-----eeEEEEEcC-CceEE
Confidence            46899999999999999999998754 569999998766566789999999999988877     999998876 67899


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      ||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++                  
T Consensus       256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~------------------  317 (452)
T 1fmk_A          256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL------------------  317 (452)
T ss_dssp             EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG------------------
T ss_pred             EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCC------------------
Confidence            99999 89999999764334699999999999999999999999999999999999998776                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL  324 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~  324 (411)
                               .+||+|||++.......    ....+|..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..
T Consensus       318 ---------~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~  388 (452)
T 1fmk_A          318 ---------VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR  388 (452)
T ss_dssp             ---------CEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             ---------CEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence                     56777777776543221    22356788999999998899999999999999999999 99999998887


Q ss_pred             HHHHHHHHHhC-CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc--CCCCcccc
Q 015222          325 EHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL--LRLPVIDL  385 (411)
Q Consensus       325 ~~~~~i~~~~~-~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~--~~~~~~~~  385 (411)
                      +.+..+..... +.|    ..+++.+.+++.+|+..+    |.+|||+.++++.  .++.....
T Consensus       389 ~~~~~i~~~~~~~~~----~~~~~~l~~li~~cl~~d----P~~Rpt~~~l~~~L~~~~~~~~~  444 (452)
T 1fmk_A          389 EVLDQVERGYRMPCP----PECPESLHDLMCQCWRKE----PEERPTFEYLQAFLEDYFTSTEP  444 (452)
T ss_dssp             HHHHHHHTTCCCCCC----TTSCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHHTTTSCSCC
T ss_pred             HHHHHHHcCCCCCCC----CCCCHHHHHHHHHHccCC----hhhCcCHHHHHHHHHHHhccCCc
Confidence            77776654322 222    346778899999998888    9999999998874  45554433

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.5e-44  Score=333.96  Aligned_cols=245  Identities=13%  Similarity=0.150  Sum_probs=201.5

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC--
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--  165 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~--  165 (411)
                      .++|++.+.||+|+||.||+|++.  ++.||||+++...   ...+.+.+|+.++++++|+||     +++++++.+.  
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~   81 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV-----LPVLGACQSPPA   81 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTE-----ECEEEEECTTTS
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCch-----hheEEEEccCCC
Confidence            368999999999999999999885  7889999997532   345668889999988877766     9999999876  


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEecCcccccCCccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                      +..++||||+ +++|.+++.......+++..+..++.||+.||+|||++|  |+||||||+|||++.++           
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~-----------  150 (271)
T 3kmu_A           82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM-----------  150 (271)
T ss_dssp             SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTS-----------
T ss_pred             CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCc-----------
Confidence            7899999999 889999998876556999999999999999999999999  99999999999998766           


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCc---cchhHHHHHHHHHHHhCCCCCC
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNY---PCDLWSVGCILVELCSGEALFQ  319 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwSlGvil~elltg~~pf~  319 (411)
                                      .++|+|||++....  .....||+.|+|||++.+..++.   ++|||||||++|||++|+.||.
T Consensus       151 ----------------~~~l~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  212 (271)
T 3kmu_A          151 ----------------TARISMADVKFSFQ--SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA  212 (271)
T ss_dssp             ----------------CEEEEGGGSCCTTS--CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTT
T ss_pred             ----------------ceeEEeccceeeec--ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence                            45666666554322  22347899999999998875544   8999999999999999999999


Q ss_pred             CCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      +.+..+....+.....  .......++..+.+++.+||..+    |.+|||+.++++.
T Consensus       213 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~----p~~Rps~~~il~~  264 (271)
T 3kmu_A          213 DLSNMEIGMKVALEGL--RPTIPPGISPHVSKLMKICMNED----PAKRPKFDMIVPI  264 (271)
T ss_dssp             TSCHHHHHHHHHHSCC--CCCCCTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHH
T ss_pred             ccChHHHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHcCCC----hhhCcCHHHHHHH
Confidence            8887766555544322  22223456788999999999988    8899999998864

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=342.64  Aligned_cols=246  Identities=20%  Similarity=0.265  Sum_probs=197.1

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEE----EEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELV----AIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~v----avK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      .++|++++.||+|+||+||+|++..+++.|    |+|.+...  ....+.+.+|+.++++++|+||     +++++++..
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~   88 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV-----CRLLGICLT   88 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTB-----CCCCEEEES
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCe-----eEEEEEEec
Confidence            478999999999999999999998888755    66666432  2455778899999999988877     999999887


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                      .+ .++|||++ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++            
T Consensus        89 ~~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~------------  154 (327)
T 3lzb_A           89 ST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ------------  154 (327)
T ss_dssp             SS-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT------------
T ss_pred             CC-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC------------
Confidence            55 78889998 999999998754 3699999999999999999999999999999999999998877            


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEAL  317 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p  317 (411)
                                     .+||+|||++.......     ....||+.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus       155 ---------------~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p  219 (327)
T 3lzb_A          155 ---------------HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP  219 (327)
T ss_dssp             ---------------EEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             ---------------CEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCC
Confidence                           46677777665433221     22356788999999999999999999999999999999 9999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      |.+.+..+....+.......   .....+..+.+++.+||..+    |.+||++.++++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~d----p~~Rps~~ell~~  272 (327)
T 3lzb_A          220 YDGIPASEISSILEKGERLP---QPPICTIDVYMIMRKCWMID----ADSRPKFRELIIE  272 (327)
T ss_dssp             TTTCCGGGHHHHHHTTCCCC---CCTTBCHHHHHHHHHHTCSS----GGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHHHcCCCCC---CCccCCHHHHHHHHHHcCCC----hhHCcCHHHHHHH
Confidence            99887776666555433211   12346778899999999998    8888888888864

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.7e-44  Score=342.85  Aligned_cols=262  Identities=24%  Similarity=0.290  Sum_probs=179.5

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc-hhhhHHHHHHHHHHHHHh-cCCCCCcceEEEeeee------
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWF------  162 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~~------  162 (411)
                      ..+|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++++. |+||     +++++++      
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~i-----v~~~~~~~~~~~~  101 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI-----VQFCSAASIGKEE  101 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTB-----CCEEEEEEECTTT
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCCh-----hhccccccccccc
Confidence            35899999999999999999999999999999988543 344567789999999996 7776     8888887      


Q ss_pred             --ecCCeEEEEEccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEecCcccccCC
Q 015222          163 --DYRNHICIVFEKLGPSLYDFLRKN-SYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPD  237 (411)
Q Consensus       163 --~~~~~~~lv~e~~~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dikp~NIli~~~~~~~l~d  237 (411)
                        .....+++||||++|+|.+++... ....+++..++.++.||+.||+|||++|  |+||||||+|||++.++.+||+|
T Consensus       102 ~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          102 SDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             STTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             cccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEec
Confidence              345579999999988999998752 2236999999999999999999999999  99999999999998877555555


Q ss_pred             cccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCcccccee---cCCCCCccchhHHHHHHHHHHHhC
Q 015222          238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVI---LGLGWNYPCDLWSVGCILVELCSG  314 (411)
Q Consensus       238 f~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlGvil~elltg  314 (411)
                      ||++..........          .  ...............||+.|+|||++   .+..++.++|||||||++|+|++|
T Consensus       182 fg~~~~~~~~~~~~----------~--~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g  249 (337)
T 3ll6_A          182 FGSATTISHYPDYS----------W--SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR  249 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHS
T ss_pred             CccceeccccCccc----------c--cccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhC
Confidence            55433222111000          0  00000000111234689999999998   456789999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCC
Q 015222          315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR  379 (411)
Q Consensus       315 ~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~  379 (411)
                      +.||..........   . ....+.  ....+..+.+++.+||+.+    |.+||++.+++++++
T Consensus       250 ~~p~~~~~~~~~~~---~-~~~~~~--~~~~~~~~~~li~~~l~~~----p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          250 QHPFEDGAKLRIVN---G-KYSIPP--HDTQYTVFHSLIRAMLQVN----PEERLSIAEVVHQLQ  304 (337)
T ss_dssp             SCCC----------------CCCCT--TCCSSGGGHHHHHHHSCSS----GGGSCCHHHHHHHHH
T ss_pred             CCCCcchhHHHhhc---C-cccCCc--ccccchHHHHHHHHHccCC----hhhCcCHHHHHHHHH
Confidence            99997654433221   1 111111  2344567889999999999    889999999998864

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.1e-45  Score=349.82  Aligned_cols=262  Identities=21%  Similarity=0.318  Sum_probs=185.1

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHH-HHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEID-VLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~-~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      .++|++.+.||+|+||.||+|.++.+++.||||+++...  .....+..|+. +++.+.|+     |++++++++.+.+.
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~-----niv~~~~~~~~~~~   95 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP-----YIVQFYGALFREGD   95 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCT-----TBCCEEEEEECSSE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCC-----cEeeeeeEEEeCCc
Confidence            478999999999999999999999999999999997532  23334445554 44444555     45999999999999


Q ss_pred             EEEEEccCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEecCcccccCCcccccc
Q 015222          168 ICIVFEKLGPSLYDFLRK---NSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       168 ~~lv~e~~~~~L~~~l~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                      .++||||+.++|.+++..   .....+++..+..++.|++.||.|||++ ||+||||||+|||++.++            
T Consensus        96 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~------------  163 (327)
T 3aln_A           96 CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG------------  163 (327)
T ss_dssp             EEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT------------
T ss_pred             eEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC------------
Confidence            999999997799888763   2234799999999999999999999999 999999999999998776            


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCcccccee----cCCCCCccchhHHHHHHHHHHHhCCCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVI----LGLGWNYPCDLWSVGCILVELCSGEAL  317 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlGvil~elltg~~p  317 (411)
                                     .+||+|||++.......  ....||+.|+|||++    .+..++.++|||||||++|+|++|+.|
T Consensus       164 ---------------~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  228 (327)
T 3aln_A          164 ---------------NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP  228 (327)
T ss_dssp             ---------------EEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCC
T ss_pred             ---------------CEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCC
Confidence                           56777777776543222  234789999999999    455789999999999999999999999


Q ss_pred             CCCCChH-HHHHHHHHH-hCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccCC
Q 015222          318 FQTHENL-EHLAMMERV-LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSA  388 (411)
Q Consensus       318 f~~~~~~-~~~~~i~~~-~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~  388 (411)
                      |.+.... +.+..+... ...++......++..+.+++.+||..|    |.+||++.++++|+||........
T Consensus       229 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d----p~~Rps~~ell~hp~~~~~~~~~~  297 (327)
T 3aln_A          229 YPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKD----ESKRPKYKELLKHPFILMYEERAV  297 (327)
T ss_dssp             SSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSS----GGGSCCHHHHTTSHHHHHHHHSCC
T ss_pred             CCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCC----hhhCcCHHHHHhChHHHHhHhhHH
Confidence            9865432 111111111 111222222346778999999999988    999999999999999987665443

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.7e-44  Score=342.92  Aligned_cols=251  Identities=22%  Similarity=0.296  Sum_probs=202.3

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCc-----EEEEEEeccch--hhhHHHHHHHHHHHHH-hcCCCCCcceEEEeee
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKE-----LVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNW  161 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~-----~vavK~~~~~~--~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~  161 (411)
                      ..++|++.+.||+|+||.||+|.+..+++     .||+|+++...  ...+.+.+|+.+++++ .|+||     ++++++
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----v~~~~~  118 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI-----VNLLGA  118 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEEE
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCe-----eeEEEE
Confidence            34789999999999999999999877664     79999997543  3456788999999999 78777     999999


Q ss_pred             eecCCeEEEEEccC-CCCHHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015222          162 FDYRNHICIVFEKL-GPSLYDFLRKNS------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV  228 (411)
Q Consensus       162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~  228 (411)
                      +.+.+..++||||+ +++|.+++....            ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus       119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT  198 (333)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred             EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence            99999999999999 889999997542            23589999999999999999999999999999999999999


Q ss_pred             cCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCCCccchhHH
Q 015222          229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWS  303 (411)
Q Consensus       229 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  303 (411)
                      .++.+                           ||+|||++......     .....||+.|+|||++.+..++.++||||
T Consensus       199 ~~~~~---------------------------kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  251 (333)
T 2i1m_A          199 NGHVA---------------------------KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS  251 (333)
T ss_dssp             GGGEE---------------------------EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHH
T ss_pred             CCCeE---------------------------EECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHH
Confidence            88755                           55555554432211     12235688899999999889999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          304 VGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       304 lGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      |||++|||++ |..||.+.........+.......+  .....+..+.+++.+||..+    |.+||++.++++++
T Consensus       252 lG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~----p~~Rps~~~l~~~L  321 (333)
T 2i1m_A          252 YGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMA--QPAFAPKNIYSIMQACWALE----PTHRPTFQQICSFL  321 (333)
T ss_dssp             HHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCC--CCTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHhccC----hhhCcCHHHHHHHH
Confidence            9999999998 9999988765554444443322221  11235677899999999888    99999999998753

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.6e-44  Score=340.19  Aligned_cols=250  Identities=21%  Similarity=0.310  Sum_probs=200.1

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCC----cEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeee
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKK----ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF  162 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~----~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~  162 (411)
                      ...++|++.+.||+|+||.||+|.+..++    ..||||+++..  ......+.+|+.+++++.|+||     +++++++
T Consensus        41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~  115 (333)
T 1mqb_A           41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI-----IRLEGVI  115 (333)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEE
T ss_pred             CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEE
Confidence            34578999999999999999999987653    46999999753  2345568899999999988776     9999999


Q ss_pred             ecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccc
Q 015222          163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL  241 (411)
Q Consensus       163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~  241 (411)
                      ...+..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++          
T Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~----------  184 (333)
T 1mqb_A          116 SKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL----------  184 (333)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC----------
T ss_pred             ecCCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC----------
Confidence            9999999999999 889999998753 3699999999999999999999999999999999999998766          


Q ss_pred             cccCCCCCccccCCCCCCeeEeecCCcccccCCC------cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-C
Q 015222          242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-G  314 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g  314 (411)
                                       .+||+|||++.......      ....+|+.|+|||++.+..++.++|||||||++|||++ |
T Consensus       185 -----------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g  247 (333)
T 1mqb_A          185 -----------------VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG  247 (333)
T ss_dssp             -----------------CEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             -----------------cEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCC
Confidence                             56777777766543221      12345778999999999899999999999999999999 9


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          315 EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       315 ~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      +.||.+.+..+....+..... .+  ....++..+.+++.+|++.+    |.+||++.+++++.
T Consensus       248 ~~pf~~~~~~~~~~~~~~~~~-~~--~~~~~~~~l~~li~~~l~~~----p~~Rps~~~l~~~L  304 (333)
T 1mqb_A          248 ERPYWELSNHEVMKAINDGFR-LP--TPMDCPSAIYQLMMQCWQQE----RARRPKFADIVSIL  304 (333)
T ss_dssp             CCTTTTCCHHHHHHHHHTTCC-CC--CCTTCBHHHHHHHHHHTCSS----TTTSCCHHHHHHHH
T ss_pred             CCCcccCCHHHHHHHHHCCCc-CC--CcccCCHHHHHHHHHHcCCC----hhhCcCHHHHHHHH
Confidence            999998887776666554321 11  12346778899999998888    88888888887764

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.8e-44  Score=342.15  Aligned_cols=248  Identities=21%  Similarity=0.272  Sum_probs=202.1

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEE--EEEEeccc--hhhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeecCC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELV--AIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~v--avK~~~~~--~~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      ++|++.+.||+|+||.||+|++..++..+  |+|.++..  ....+.+.+|+.+++++ .|+||     +++++++.+.+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i-----v~~~~~~~~~~   99 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI-----INLLGACEHRG   99 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTB-----CCEEEEEEETT
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCch-----hhhceeeeeCC
Confidence            68999999999999999999999888765  99998742  23456688899999998 67766     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCc
Q 015222          167 HICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE  231 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~  231 (411)
                      ..++||||+ +++|.+++....              ...+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence            999999999 889999998643              23699999999999999999999999999999999999998776


Q ss_pred             ccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHH
Q 015222          232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV  309 (411)
Q Consensus       232 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  309 (411)
                                                 .+||+|||++......  .....+|+.|+|||++.+..++.++|||||||++|
T Consensus       180 ---------------------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  232 (327)
T 1fvr_A          180 ---------------------------VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW  232 (327)
T ss_dssp             ---------------------------CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred             ---------------------------eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHH
Confidence                                       5677777776533221  22345688999999999888999999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          310 ELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       310 ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      +|++ |..||.+.+..+....+.....   ......++..+.++|.+||..+    |.+||++.+++++.
T Consensus       233 ellt~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~d----p~~Rps~~ell~~L  295 (327)
T 1fvr_A          233 EIVSLGGTPYCGMTCAELYEKLPQGYR---LEKPLNCDDEVYDLMRQCWREK----PYERPSFAQILVSL  295 (327)
T ss_dssp             HHHTTSCCTTTTCCHHHHHHHGGGTCC---CCCCTTBCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred             HHHcCCCCCCCCCcHHHHHHHhhcCCC---CCCCCCCCHHHHHHHHHHccCC----hhhCcCHHHHHHHH
Confidence            9998 9999998877666655443321   1122356778999999999999    88888898888764

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=7.1e-44  Score=331.90  Aligned_cols=247  Identities=22%  Similarity=0.270  Sum_probs=200.6

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCC---CCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNE---KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .++|++.+.||+|+||+||+|.+..   ++..||+|++...  ....+.+.+|+.+++.++|+|+     +++++++.+ 
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~-   84 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI-----VKLIGIIEE-   84 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTB-----CCEEEEECS-
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCc-----ceEEEEEcC-
Confidence            3689999999999999999998654   3456999999753  2445778899999999988877     999998875 


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      +..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++             
T Consensus        85 ~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-------------  150 (281)
T 3cc6_A           85 EPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE-------------  150 (281)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT-------------
T ss_pred             CCCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC-------------
Confidence            4568999999 899999998754 3599999999999999999999999999999999999998877             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQ  319 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~  319 (411)
                                    .++|+|||++.......    ....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.
T Consensus       151 --------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~  216 (281)
T 3cc6_A          151 --------------CVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFF  216 (281)
T ss_dssp             --------------EEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             --------------cEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcc
Confidence                          45666666665433221    22356788999999998899999999999999999998 999998


Q ss_pred             CCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ..+..+....+........   ...+++.+.+++.+||..+    |.+||++.+++++.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~----p~~Rps~~ell~~L  268 (281)
T 3cc6_A          217 WLENKDVIGVLEKGDRLPK---PDLCPPVLYTLMTRCWDYD----PSDRPRFTELVCSL  268 (281)
T ss_dssp             TSCGGGHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred             cCChHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHccCC----chhCcCHHHHHHHH
Confidence            7777666665554432211   1245678999999999998    99999999998763

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.3e-44  Score=336.06  Aligned_cols=243  Identities=27%  Similarity=0.372  Sum_probs=191.4

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      ++|++.+.||+|+||+||+|++.  ++.||||++... ...+.+.+|+.++++++|+||     +++++++.+  ..++|
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~--~~~lv   77 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNI-----VKLYGACLN--PVCLV   77 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTB-----CCEEEBCTT--TTEEE
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCc-----CeEEEEEcC--CcEEE
Confidence            58999999999999999999874  688999999753 345678899999999988877     999998774  47999


Q ss_pred             EccC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          172 FEKL-GPSLYDFLRKNSY-RSFPIDLVRELGRQLLESVAFMHE---LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       172 ~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      |||+ +++|.+++..... ..+++..+..++.||++||+|||+   +||+||||||+|||++.++.              
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~--------------  143 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT--------------  143 (307)
T ss_dssp             EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT--------------
T ss_pred             EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC--------------
Confidence            9999 8999999986542 247899999999999999999999   89999999999999987652              


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH-
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE-  325 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~-  325 (411)
                                  .+||+|||++...........||+.|+|||++.+..++.++|||||||++|||++|+.||....... 
T Consensus       144 ------------~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~  211 (307)
T 2eva_A          144 ------------VLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF  211 (307)
T ss_dssp             ------------EEEECCCCC------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH
T ss_pred             ------------EEEEcccccccccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH
Confidence                        3688888888765554555679999999999999999999999999999999999999998643322 


Q ss_pred             -HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          326 -HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       326 -~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                       ....+.  .+.. ......++..+.+++.+||..+    |.+||++.+++++
T Consensus       212 ~~~~~~~--~~~~-~~~~~~~~~~l~~li~~~l~~d----p~~Rps~~ell~~  257 (307)
T 2eva_A          212 RIMWAVH--NGTR-PPLIKNLPKPIESLMTRCWSKD----PSQRPSMEEIVKI  257 (307)
T ss_dssp             HHHHHHH--TTCC-CCCBTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHH
T ss_pred             HHHHHHh--cCCC-CCcccccCHHHHHHHHHHhcCC----hhhCcCHHHHHHH
Confidence             222222  1222 2223456778999999999988    8888899998874

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.1e-44  Score=338.78  Aligned_cols=248  Identities=21%  Similarity=0.288  Sum_probs=199.9

Q ss_pred             CCCeEEEeeeccccceEEEEEEe-----CCCCcEEEEEEeccch--hhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeee
Q 015222           91 TPRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWF  162 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~-----~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~  162 (411)
                      .++|++.+.||+|+||+||+|++     ..+++.||||+++...  ...+.+.+|+.+++++ .|+||     +++++++
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i-----v~~~~~~  100 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV-----VNLLGAC  100 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEE
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCe-----eeEEEEE
Confidence            46899999999999999999985     4577899999997533  3445788999999999 45665     9999988


Q ss_pred             ecC-CeEEEEEccC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015222          163 DYR-NHICIVFEKL-GPSLYDFLRKNSY--------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL  226 (411)
Q Consensus       163 ~~~-~~~~lv~e~~-~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIl  226 (411)
                      ... +.+++||||+ +++|.+++.....              ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil  180 (316)
T 2xir_A          101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  180 (316)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence            764 4699999999 8899999987642              12889999999999999999999999999999999999


Q ss_pred             EecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchh
Q 015222          227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDL  301 (411)
Q Consensus       227 i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di  301 (411)
                      ++.++                           .+||+|||++.......     ....||+.|+|||++.+..++.++||
T Consensus       181 ~~~~~---------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di  233 (316)
T 2xir_A          181 LSEKN---------------------------VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV  233 (316)
T ss_dssp             ECGGG---------------------------CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHH
T ss_pred             ECCCC---------------------------CEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHH
Confidence            98777                           46666666665432221     23467889999999999899999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCChHHHH-HHHHHHhC-CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          302 WSVGCILVELCS-GEALFQTHENLEHL-AMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       302 wSlGvil~ellt-g~~pf~~~~~~~~~-~~i~~~~~-~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      |||||++|+|++ |..||.+....+.+ ..+..... ..+    ...+..+.+++.+||..+    |.+||++.++++|+
T Consensus       234 ~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~d----p~~Rps~~ell~~L  305 (316)
T 2xir_A          234 WSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP----DYTTPEMYQTMLDCWHGE----PSQRPTFSELVEHL  305 (316)
T ss_dssp             HHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCC----TTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCC----CCCCHHHHHHHHHHcCCC----hhhCcCHHHHHHHH
Confidence            999999999998 99999876644333 33333221 222    335678899999999888    99999999999874

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=6.5e-44  Score=333.93  Aligned_cols=244  Identities=23%  Similarity=0.299  Sum_probs=198.6

Q ss_pred             CCeEEEe-eeccccceEEEEEE--eCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           92 PRYRILS-KMGEGTFGQVVECF--DNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        92 ~~y~i~~-~lG~G~~g~V~~a~--~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      ++|++.+ .||+|+||+||+|.  +..+++.||||+++...   ...+.+.+|+.+++.+.|+||     +++++++ ..
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~-~~   89 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI-----VRMIGIC-EA   89 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTB-----CCEEEEE-ES
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCE-----EEEEEEE-CC
Confidence            5799998 99999999999995  45678899999997542   335678899999999988776     9999988 45


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      +..++||||+ +++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++             
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~-------------  154 (291)
T 1xbb_A           90 ESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-------------  154 (291)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-------------
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC-------------
Confidence            7789999999 899999998765  699999999999999999999999999999999999998877             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCCC------cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEAL  317 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p  317 (411)
                                    .++|+|||++.......      ....+|+.|+|||++.+..++.++||||||+++|+|++ |+.|
T Consensus       155 --------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p  220 (291)
T 1xbb_A          155 --------------YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP  220 (291)
T ss_dssp             --------------EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             --------------cEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCC
Confidence                          45666666665433221      12346788999999998889999999999999999999 9999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      |.+.+..+....+......   .....++..+.+++.+|+..+    |.+||++.++++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~d----p~~Rps~~~l~~~  273 (291)
T 1xbb_A          221 YRGMKGSEVTAMLEKGERM---GCPAGCPREMYDLMNLCWTYD----VENRPGFAAVELR  273 (291)
T ss_dssp             STTCCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSS----TTTSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCC----hhhCcCHHHHHHH
Confidence            9988877766655543211   122356788999999999999    8888888888753

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-44  Score=344.28  Aligned_cols=255  Identities=19%  Similarity=0.241  Sum_probs=193.7

Q ss_pred             EEeeCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeee
Q 015222           83 VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF  162 (411)
Q Consensus        83 ~~~~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~  162 (411)
                      +...+..+.++|++.+.||+|+||.||+|++.  ++.||||++.....  .....|.+++..+   ...|+|++++++++
T Consensus        28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~---~~~h~~i~~~~~~~  100 (337)
T 3mdy_A           28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTV---LMRHENILGFIAAD  100 (337)
T ss_dssp             CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTST---TCCCTTBCCEEEEE
T ss_pred             CcccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHH---hhcCCCeeeEEEEE
Confidence            34455667789999999999999999999875  88999999865433  3344455555443   12344459999998


Q ss_pred             ecC----CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCcEEEec
Q 015222          163 DYR----NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL--------RLIHTDLKPENILLVS  229 (411)
Q Consensus       163 ~~~----~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------givH~Dikp~NIli~~  229 (411)
                      ...    +.+++||||+ +++|.+++...   .+++..++.++.|++.||+|||++        ||+||||||+|||++.
T Consensus       101 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~  177 (337)
T 3mdy_A          101 IKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK  177 (337)
T ss_dssp             EESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred             ccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECC
Confidence            776    7899999999 88999999775   499999999999999999999999        9999999999999987


Q ss_pred             CcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-------cccccCCCccccceecCCCCCcc----
Q 015222          230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-------SYVVSTRHYRAPEVILGLGWNYP----  298 (411)
Q Consensus       230 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~----  298 (411)
                      ++                           .+||+|||++.......       ....||+.|+|||++.+...+..    
T Consensus       178 ~~---------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~  230 (337)
T 3mdy_A          178 NG---------------------------TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSY  230 (337)
T ss_dssp             TS---------------------------CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHH
T ss_pred             CC---------------------------CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCc
Confidence            66                           56777777765432221       23579999999999988766654    


Q ss_pred             --chhHHHHHHHHHHHhC----------CCCCCCCC----hHHHHHHHHHH---hCCCChhHH-HhhhhhhhhhhccCCc
Q 015222          299 --CDLWSVGCILVELCSG----------EALFQTHE----NLEHLAMMERV---LGPLPHHMV-IRADRRAEKYFRRGAR  358 (411)
Q Consensus       299 --~DiwSlGvil~elltg----------~~pf~~~~----~~~~~~~i~~~---~~~~p~~~~-~~~~~~~~~li~~~l~  358 (411)
                        +|||||||++|||++|          ..||....    ...........   ...++..+. ..+++.+.+++.+||.
T Consensus       231 ~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  310 (337)
T 3mdy_A          231 IMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWA  310 (337)
T ss_dssp             HHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSC
T ss_pred             cccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhh
Confidence              9999999999999999          77776432    12222222211   223333222 2456778999999998


Q ss_pred             cCCCCCCCcHHHHHHHHhcC
Q 015222          359 LDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       359 ~~~~~rp~~R~t~~~il~~~  378 (411)
                      .|    |.+||++.++++++
T Consensus       311 ~d----P~~Rps~~ell~~L  326 (337)
T 3mdy_A          311 HN----PASRLTALRVKKTL  326 (337)
T ss_dssp             SS----GGGSCCHHHHHHHH
T ss_pred             hC----hhhCCCHHHHHHHH
Confidence            88    99999999999874

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-43  Score=363.11  Aligned_cols=244  Identities=24%  Similarity=0.299  Sum_probs=197.6

Q ss_pred             CCCeEEEe-eeccccceEEEEEEeC--CCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           91 TPRYRILS-KMGEGTFGQVVECFDN--EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        91 ~~~y~i~~-~lG~G~~g~V~~a~~~--~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .+++.+.+ +||+|+||.||+|.++  .++..||||+++..  ....+.+.+|+.++++++|+||     +++++++.. 
T Consensus       334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpni-----v~l~~~~~~-  407 (613)
T 2ozo_A          334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI-----VRLIGVCQA-  407 (613)
T ss_dssp             TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTB-----CCEEEEEES-
T ss_pred             ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCE-----eeEEEEecc-
Confidence            35667766 8999999999999875  35677999999753  2356778999999999988777     999999876 


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      +.+++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||||+.++             
T Consensus       408 ~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-------------  473 (613)
T 2ozo_A          408 EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH-------------  473 (613)
T ss_dssp             SSEEEEEECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-------------
T ss_pred             CCeEEEEEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC-------------
Confidence            5699999999 999999997653 4699999999999999999999999999999999999998877             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCCC------cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEAL  317 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p  317 (411)
                                    .+||+|||++.......      ....+|+.|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus       474 --------------~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~P  539 (613)
T 2ozo_A          474 --------------YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP  539 (613)
T ss_dssp             --------------EEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             --------------cEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence                          45666666665432221      12245689999999998899999999999999999998 9999


Q ss_pred             CCCCChHHHHHHHHHHhC-CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHh
Q 015222          318 FQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK  376 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~  376 (411)
                      |.+.+..+....+..... ..|    ..++..+.+++.+|+..+    |.+||++.++++
T Consensus       540 f~~~~~~~~~~~i~~~~~~~~p----~~~~~~l~~li~~cl~~d----P~~RPs~~~l~~  591 (613)
T 2ozo_A          540 YKKMKGPEVMAFIEQGKRMECP----PECPPELYALMSDCWIYK----WEDRPDFLTVEQ  591 (613)
T ss_dssp             TTTCCSHHHHHHHHTTCCCCCC----TTCCHHHHHHHHHTTCSS----TTTSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHcCCCCCCC----CcCCHHHHHHHHHHcCCC----hhHCcCHHHHHH
Confidence            999888887776665432 222    346778899999998888    888888888754

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.2e-43  Score=333.48  Aligned_cols=249  Identities=22%  Similarity=0.374  Sum_probs=198.7

Q ss_pred             cCCCeEEE-eeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHH-HhcCCCCCcceEEEeeeeec---
Q 015222           90 LTPRYRIL-SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR-LARHDIGGTRCVQIRNWFDY---  164 (411)
Q Consensus        90 ~~~~y~i~-~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~-l~~~~i~~~~iv~~~~~~~~---  164 (411)
                      +.++|.+. +.||+|+||.||+|.+..+++.||||+++..    ....+|+.++.+ +.|+||     +++++++..   
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i-----~~~~~~~~~~~~   85 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHI-----VRIVDVYENLYA   85 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTB-----CCEEEEEEEEET
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCc-----hhHHhhhhhhcC
Confidence            34567777 7899999999999999999999999999653    446678888844 456655     999998876   


Q ss_pred             -CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccc
Q 015222          165 -RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       165 -~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                       .+.+++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++..+           
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-----------  154 (299)
T 3m2w_A           86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-----------  154 (299)
T ss_dssp             TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS-----------
T ss_pred             CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCC-----------
Confidence             67899999999 88999999987656799999999999999999999999999999999999997632           


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE  322 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~  322 (411)
                                   .+..++|+|||++....                   +..++.++|||||||++|||++|+.||.+.+
T Consensus       155 -------------~~~~~kl~Dfg~a~~~~-------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~  202 (299)
T 3m2w_A          155 -------------PNAILKLTDFGFAKETT-------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNH  202 (299)
T ss_dssp             -------------TTCCEEECCCTTCEECT-------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--
T ss_pred             -------------CCCcEEEeccccccccc-------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence                         23478999999876432                   3467889999999999999999999998755


Q ss_pred             hHHHHHH----HHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccCCCCCchh
Q 015222          323 NLEHLAM----MERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSASPNCLC  394 (411)
Q Consensus       323 ~~~~~~~----i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~~~~~~~  394 (411)
                      .......    +.......+......++..+.++|.+||..|    |.+||++.++++|+||.+.......+....
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d----P~~Rps~~e~l~hp~~~~~~~~~~~~~~~~  274 (299)
T 3m2w_A          203 GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTE----PTQRMTITEFMNHPWIMQSTKVPQTPLHTS  274 (299)
T ss_dssp             -----CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSS----TTTSCCHHHHHTSHHHHTGGGSCCCBCSHH
T ss_pred             chhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccC----hhhCCCHHHHhcChhhcccccCCCCCCccc
Confidence            4332211    1122234455555678899999999999999    999999999999999998776665555433

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.1e-44  Score=341.82  Aligned_cols=255  Identities=22%  Similarity=0.264  Sum_probs=200.2

Q ss_pred             CCccC-CCeEEEeeeccccceEEEEEE----eCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEee
Q 015222           87 GENLT-PRYRILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRN  160 (411)
Q Consensus        87 ~~~~~-~~y~i~~~lG~G~~g~V~~a~----~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~  160 (411)
                      .+.+. ++|++.+.||+|+||.||+|+    +..+++.||||++.... ...+.+.+|+.+++++.|+||     +++++
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~   91 (327)
T 3lxl_A           17 PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI-----VKYRG   91 (327)
T ss_dssp             CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTB-----CCEEE
T ss_pred             hhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCce-----eEEEE
Confidence            34443 689999999999999999998    57789999999997543 445668899999999988776     99988


Q ss_pred             eee--cCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCC
Q 015222          161 WFD--YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD  237 (411)
Q Consensus       161 ~~~--~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~d  237 (411)
                      ++.  ..+..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.     
T Consensus        92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~-----  165 (327)
T 3lxl_A           92 VSYGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH-----  165 (327)
T ss_dssp             EEECSSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE-----
T ss_pred             EEecCCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC-----
Confidence            875  457899999999 999999998743 25999999999999999999999999999999999999988774     


Q ss_pred             cccccccCCCCCccccCCCCCCeeEeecCCcccccCCC------cccccCCCccccceecCCCCCccchhHHHHHHHHHH
Q 015222          238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL  311 (411)
Q Consensus       238 f~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el  311 (411)
                                            +||+|||++.......      ....||+.|+|||++.+..++.++|||||||++|+|
T Consensus       166 ----------------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l  223 (327)
T 3lxl_A          166 ----------------------VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL  223 (327)
T ss_dssp             ----------------------EEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred             ----------------------EEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHH
Confidence                                  5666666655432221      224578889999999998999999999999999999


Q ss_pred             HhCCCCCCCCChHHH------------HHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          312 CSGEALFQTHENLEH------------LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       312 ltg~~pf~~~~~~~~------------~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ++|..||........            ..................+++.+.+++.+||+.+    |.+||++.++++++
T Consensus       224 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d----P~~Rps~~ell~~L  298 (327)
T 3lxl_A          224 FTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPS----PQDRPSFSALGPQL  298 (327)
T ss_dssp             HTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred             HhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCC----hhhCcCHHHHHHHH
Confidence            999999965332110            0111111111111223456778999999999999    88999999996553

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.4e-44  Score=336.06  Aligned_cols=245  Identities=21%  Similarity=0.298  Sum_probs=194.6

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec-CCeEE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-RNHIC  169 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~-~~~~~  169 (411)
                      .++|++.+.||+|+||.||+|.+.  ++.||||+++... ..+.+.+|+.++++++|+|+     +++++++.. .+..+
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~~   91 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNL-----VQLLGVIVEEKGGLY   91 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTB-----CCEEEEECCC--CCE
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCE-----eeEEEEEEcCCCceE
Confidence            368999999999999999999874  7899999997543 45678899999999987776     999998654 45799


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+||+++.++                 
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-----------------  154 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-----------------  154 (278)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-----------------
T ss_pred             EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC-----------------
Confidence            999999 78999999875433489999999999999999999999999999999999997766                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHL  327 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~  327 (411)
                                .++|+|||++...........+++.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+..
T Consensus       155 ----------~~~l~Dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~  224 (278)
T 1byg_A          155 ----------VAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV  224 (278)
T ss_dssp             ----------CEEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH
T ss_pred             ----------cEEEeeccccccccccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence                      6788888887765555455578899999999998899999999999999999998 99999887766655


Q ss_pred             HHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          328 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       328 ~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ..+....   .......+++.+.+++.+|+..+    |.+||++.++++.
T Consensus       225 ~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~----p~~Rps~~~l~~~  267 (278)
T 1byg_A          225 PRVEKGY---KMDAPDGCPPAVYEVMKNCWHLD----AAMRPSFLQLREQ  267 (278)
T ss_dssp             HHHTTTC---CCCCCTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHH
T ss_pred             HHHhcCC---CCCCcccCCHHHHHHHHHHhcCC----hhhCCCHHHHHHH
Confidence            5544322   11222456778999999999988    8888899888764

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.2e-44  Score=362.22  Aligned_cols=252  Identities=24%  Similarity=0.339  Sum_probs=209.2

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      ++|++.++||+|+||.||+|.+..+ ..||||+++......+.+.+|+.++++++|+||     +++++++.+ +.+|+|
T Consensus       267 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~-~~~~lv  339 (535)
T 2h8h_A          267 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKL-----VQLYAVVSE-EPIYIV  339 (535)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTT-EEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECS-SSCEEE
T ss_pred             hhhhhheecccCCCeEEEEEEECCC-ceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCE-----eeEEEEEee-ccceEe
Confidence            5799999999999999999998754 569999998766666789999999999988877     999998876 678999


Q ss_pred             EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      |||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+||||+.++                   
T Consensus       340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-------------------  400 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-------------------  400 (535)
T ss_dssp             ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-------------------
T ss_pred             eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC-------------------
Confidence            9999 88999999764334699999999999999999999999999999999999998766                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCC----CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE  325 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~  325 (411)
                              .+||+|||++......    .....++..|+|||++.+..++.++|||||||+||||++ |+.||.+....+
T Consensus       401 --------~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~  472 (535)
T 2h8h_A          401 --------VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE  472 (535)
T ss_dssp             --------CEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH
T ss_pred             --------cEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence                    5788888877654322    122356788999999998899999999999999999999 999999988877


Q ss_pred             HHHHHHHHhC-CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc--CCCCcccc
Q 015222          326 HLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL--LRLPVIDL  385 (411)
Q Consensus       326 ~~~~i~~~~~-~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~--~~~~~~~~  385 (411)
                      .+..+..... ..+    ..++..+.++|.+|+..+    |.+||++.++++.  .++.....
T Consensus       473 ~~~~i~~~~~~~~~----~~~~~~l~~li~~cl~~d----P~~RPt~~~l~~~L~~~~~~~~~  527 (535)
T 2h8h_A          473 VLDQVERGYRMPCP----PECPESLHDLMCQCWRKE----PEERPTFEYLQAFLEDYFTSTEP  527 (535)
T ss_dssp             HHHHHHTTCCCCCC----TTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHHTSSCCCSC
T ss_pred             HHHHHHcCCCCCCC----CCCCHHHHHHHHHHcCCC----hhHCcCHHHHHHHHHHHhhccCc
Confidence            7776654322 222    346778899999998888    9999999998875  34544433

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.9e-44  Score=339.90  Aligned_cols=250  Identities=24%  Similarity=0.341  Sum_probs=196.9

Q ss_pred             ccCCCe-EEEeeeccccceEEEEEE----eCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeee
Q 015222           89 NLTPRY-RILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNW  161 (411)
Q Consensus        89 ~~~~~y-~i~~~lG~G~~g~V~~a~----~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~  161 (411)
                      .+.++| +++++||+|+||+||++.    +..+++.||||+++...  ...+.+.+|+.++++++|+||     ++++++
T Consensus        27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~  101 (318)
T 3lxp_A           27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI-----IKYKGC  101 (318)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEE
T ss_pred             eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcch-----hhEEEE
Confidence            455666 999999999999998775    34578999999997543  445678899999999988777     999999


Q ss_pred             eec--CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCc
Q 015222          162 FDY--RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY  238 (411)
Q Consensus       162 ~~~--~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df  238 (411)
                      +.+  ...+++||||+ +++|.+++....   +++..++.++.||+.||+|||++||+||||||+|||++.++       
T Consensus       102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~-------  171 (318)
T 3lxp_A          102 CEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR-------  171 (318)
T ss_dssp             EEETTTTEEEEEECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-------
T ss_pred             EecCCCceEEEEEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCC-------
Confidence            887  46899999999 889999998754   99999999999999999999999999999999999998766       


Q ss_pred             ccccccCCCCCccccCCCCCCeeEeecCCcccccCCC------cccccCCCccccceecCCCCCccchhHHHHHHHHHHH
Q 015222          239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC  312 (411)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell  312 (411)
                                          .++|+|||++.......      ....||..|+|||++.+..++.++|||||||++|+|+
T Consensus       172 --------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll  231 (318)
T 3lxp_A          172 --------------------LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL  231 (318)
T ss_dssp             --------------------CEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred             --------------------CEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence                                56777777666543321      2245788899999999989999999999999999999


Q ss_pred             hCCCCCCCCChH------------HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          313 SGEALFQTHENL------------EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       313 tg~~pf~~~~~~------------~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      +|..||......            ....................++..+.++|.+||..+    |.+||++.++++.
T Consensus       232 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d----P~~Rps~~ell~~  304 (318)
T 3lxp_A          232 THCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETE----ASFRPTFENLIPI  304 (318)
T ss_dssp             TTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHH
T ss_pred             hCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCC----cccCcCHHHHHHH
Confidence            999999753221            111111111111122223456778999999999988    8899999998864

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=5.7e-44  Score=338.24  Aligned_cols=250  Identities=20%  Similarity=0.262  Sum_probs=196.2

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc-hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee----cC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD----YR  165 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~----~~  165 (411)
                      .++|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++.+.|+||     +++++++.    ..
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~  102 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI-----LRLVAYCLRERGAK  102 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTB-----CCCCEEEEEEETTE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCe-----eeEEEEEEeccCCC
Confidence            46899999999999999999999999999999998643 3456678899999999988776     99999886    34


Q ss_pred             CeEEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                      +..++||||+ +++|.+++...  ....+++..++.++.||+.||+|||++||+||||||+|||++.++           
T Consensus       103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~-----------  171 (317)
T 2buj_A          103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG-----------  171 (317)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-----------
T ss_pred             ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC-----------
Confidence            5899999999 88999999763  224699999999999999999999999999999999999997766           


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCcccccCC------------CcccccCCCccccceecCCC---CCccchhHHHHHH
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------------HSYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCI  307 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------------~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlGvi  307 (411)
                                      .++|+|||++......            .....||+.|+|||++.+..   ++.++|||||||+
T Consensus       172 ----------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~i  235 (317)
T 2buj_A          172 ----------------QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV  235 (317)
T ss_dssp             ----------------CEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHH
T ss_pred             ----------------CEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHH
Confidence                            5677777766543211            11245799999999998654   6899999999999


Q ss_pred             HHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCC
Q 015222          308 LVELCSGEALFQTHEN--LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR  379 (411)
Q Consensus       308 l~elltg~~pf~~~~~--~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~  379 (411)
                      +|+|++|+.||.....  ......+.. ....+.  ....+..+.++|.+||..+    |.+||++.+++++..
T Consensus       236 l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~l~~li~~~l~~d----p~~Rps~~~ll~~L~  302 (317)
T 2buj_A          236 LYAMMFGEGPYDMVFQKGDSVALAVQN-QLSIPQ--SPRHSSALWQLLNSMMTVD----PHQRPHIPLLLSQLE  302 (317)
T ss_dssp             HHHHHHSSCTTHHHHHTTSCHHHHHHC-C--CCC--CTTSCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHH
T ss_pred             HHHHHhCCCChhhhhcccchhhHHhhc-cCCCCc--cccCCHHHHHHHHHHhhcC----hhhCCCHHHHHHHhh
Confidence            9999999999953110  011111111 111221  2346778999999999999    999999999998763

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=342.08  Aligned_cols=257  Identities=19%  Similarity=0.222  Sum_probs=192.6

Q ss_pred             cCCCeEEEeeeccccceEEEEE-----EeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           90 LTPRYRILSKMGEGTFGQVVEC-----FDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a-----~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      ..++|++.+.||+|+||+||+|     .+..+++.||||+++..  ....+..|+.+++.+.+.  .|++++.+++++..
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~--~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPS--MQHMFMKFYSAHLF  138 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGG--GGGGBCCEEEEEEC
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhh--hhhhhhhhheeeec
Confidence            3578999999999999999999     46778999999999754  345678889999888632  34667999999999


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKN---SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                      .+..|+||||+ +++|.+++...   ....+++..++.++.||+.||+|||++|||||||||+|||++.+....      
T Consensus       139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~------  212 (365)
T 3e7e_A          139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQ------  212 (365)
T ss_dssp             SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------
T ss_pred             CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCc------
Confidence            99999999999 89999999752   234699999999999999999999999999999999999997621000      


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccC-----CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCC
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE  315 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~  315 (411)
                         .       ...+.+..+||+|||+|.....     .....+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       213 ---~-------~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~  282 (365)
T 3e7e_A          213 ---D-------DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT  282 (365)
T ss_dssp             ----------------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSS
T ss_pred             ---c-------ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCC
Confidence               0       0011245789999999865321     123457999999999999999999999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHH
Q 015222          316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV  374 (411)
Q Consensus       316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~i  374 (411)
                      .||........     .....++..   ..++...+++.+||+.++.+|+..-..+.+.
T Consensus       283 ~pf~~~~~~~~-----~~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~  333 (365)
T 3e7e_A          283 YMKVKNEGGEC-----KPEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK  333 (365)
T ss_dssp             CCCEEEETTEE-----EECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred             CccccCCCCce-----eechhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence            99965332110     000111111   1245678899999999976665553333333

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.6e-43  Score=332.17  Aligned_cols=246  Identities=15%  Similarity=0.194  Sum_probs=196.3

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCC---cEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeee-ecC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKK---ELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF-DYR  165 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~-~~~  165 (411)
                      .+|++.+.||+|+||+||+|++..++   ..||+|.+....  ...+.+.+|+.++++++|+|+     +++++++ ..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~   99 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV-----LSLLGICLRSE   99 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTB-----CCCCEEECCSS
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCE-----eeeeeEEEcCC
Confidence            47999999999999999999975443   468999987532  345678899999999988777     9999984 556


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      +..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++             
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~-------------  165 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF-------------  165 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-------------
T ss_pred             CceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC-------------
Confidence            7899999999 889999997644 4689999999999999999999999999999999999998776             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCC-------CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEA  316 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~  316 (411)
                                    .+||+|||++......       .....||+.|+|||++.+..++.++|||||||++|+|++ |.+
T Consensus       166 --------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~  231 (298)
T 3f66_A          166 --------------TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP  231 (298)
T ss_dssp             --------------CEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             --------------CEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence                          4566666666543221       123467889999999999899999999999999999999 778


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ||.+.+..+....+.........   ..++..+.+++.+||..+    |.+||++.++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~----p~~Rps~~ell~~  285 (298)
T 3f66_A          232 PYPDVNTFDITVYLLQGRRLLQP---EYCPDPLYEVMLKCWHPK----AEMRPSFSELVSR  285 (298)
T ss_dssp             SSTTSCTTTHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHH
T ss_pred             CCccCCHHHHHHHHhcCCCCCCC---ccCCHHHHHHHHHHcCCC----hhhCcCHHHHHHH
Confidence            88877766665555544333222   235677899999999988    8888889888864

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.9e-43  Score=334.09  Aligned_cols=249  Identities=14%  Similarity=0.180  Sum_probs=195.4

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCC---CCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNE---KKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      .++|++.+.||+|+||.||+|.+..   +++.||+|+++..   ....+.+.+|+.++++++|+||     +++++++..
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~  107 (313)
T 3brb_A           33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV-----IRLLGVCIE  107 (313)
T ss_dssp             GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTB-----CCCCEEEEC
T ss_pred             HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCe-----eeeeEEEee
Confidence            4689999999999999999998765   5568999999743   2344668889999999988777     999998876


Q ss_pred             CC-----eEEEEEccC-CCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccc
Q 015222          165 RN-----HICIVFEKL-GPSLYDFLRKN----SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK  234 (411)
Q Consensus       165 ~~-----~~~lv~e~~-~~~L~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~  234 (411)
                      .+     ..++||||+ +++|.+++...    ....+++..++.++.||+.||.|||++||+||||||+|||++.++   
T Consensus       108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~---  184 (313)
T 3brb_A          108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM---  184 (313)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS---
T ss_pred             ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC---
Confidence            44     459999999 89999998532    234699999999999999999999999999999999999998766   


Q ss_pred             cCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCCCccchhHHHHHHHH
Q 015222          235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV  309 (411)
Q Consensus       235 l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  309 (411)
                                              .+||+|||++......     .....+++.|+|||++.+..++.++|||||||++|
T Consensus       185 ------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  240 (313)
T 3brb_A          185 ------------------------TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMW  240 (313)
T ss_dssp             ------------------------CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHH
T ss_pred             ------------------------cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHH
Confidence                                    5677777776544322     12245688899999999999999999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          310 ELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       310 ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      +|++ |..||.+.+..+....+......   .....++..+.+++.+||..+    |.+||++.+++++.
T Consensus       241 el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~d----p~~Rps~~~l~~~L  303 (313)
T 3brb_A          241 EIATRGMTPYPGVQNHEMYDYLLHGHRL---KQPEDCLDELYEIMYSCWRTD----PLDRPTFSVLRLQL  303 (313)
T ss_dssp             HHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCBTTCCHHHHHHHHHTTCSS----GGGSCCHHHHHHHH
T ss_pred             HHHhcCCCCCccCCHHHHHHHHHcCCCC---CCCccccHHHHHHHHHHcCCC----hhhCcCHHHHHHHH
Confidence            9999 99999988776666655443221   122356778999999999998    99999999998764

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-43  Score=329.25  Aligned_cols=245  Identities=18%  Similarity=0.230  Sum_probs=196.9

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCc---EEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~---~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      .|++.+.||+|+||+||+|.+..+++   .||+|++....  ...+.+.+|+.+++.++|+||     +++++++.+.+.
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~   96 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV-----LALIGIMLPPEG   96 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTB-----CCCCEEECCSSS
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCe-----eeEEEEEecCCC
Confidence            57788999999999999999765544   79999997533  345678899999999988777     999999976654


Q ss_pred             -EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          168 -ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       168 -~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                       .++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++              
T Consensus        97 ~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~--------------  161 (298)
T 3pls_A           97 LPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF--------------  161 (298)
T ss_dssp             CCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC--------------
T ss_pred             CcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC--------------
Confidence             49999999 999999998643 4689999999999999999999999999999999999997766              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccC-------CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQ-------DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEAL  317 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p  317 (411)
                                   .+||+|||++.....       ......+|+.|+|||.+.+..++.++|||||||++|+|++ |.+|
T Consensus       162 -------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~  228 (298)
T 3pls_A          162 -------------TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP  228 (298)
T ss_dssp             -------------CEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred             -------------cEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence                         567777777754322       1223467889999999999999999999999999999999 5566


Q ss_pred             CCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      |...+..+....+.......   .....++.+.+++.+||..+    |.+|||+.++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~----p~~Rps~~~ll~~  281 (298)
T 3pls_A          229 YRHIDPFDLTHFLAQGRRLP---QPEYCPDSLYQVMQQCWEAD----PAVRPTFRVLVGE  281 (298)
T ss_dssp             TTTSCGGGHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHH
T ss_pred             CccCCHHHHHHHhhcCCCCC---CCccchHHHHHHHHHHccCC----hhhCcCHHHHHHH
Confidence            66666655555554433221   12345678999999999999    8888888888764

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5.2e-45  Score=348.60  Aligned_cols=266  Identities=19%  Similarity=0.212  Sum_probs=202.3

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---------hhhHHHHHHHHHHHHHh---------cCCCC--
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLA---------RHDIG--  151 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~---------~~~i~--  151 (411)
                      ++|++.+.||+|+||+||+|++  +|+.||||++....         ...+.+.+|+.+++.++         |+|+.  
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            5799999999999999999987  68999999997532         22367889999999997         77763  


Q ss_pred             ----------CcceEEEeeeeec-------------CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Q 015222          152 ----------GTRCVQIRNWFDY-------------RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV  207 (411)
Q Consensus       152 ----------~~~iv~~~~~~~~-------------~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL  207 (411)
                                |+||++++++|.+             .+.+|+||||+ +|++.+.+.+   ..+++..++.++.||+.||
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence                      6777888888775             78999999999 8866666644   2589999999999999999


Q ss_pred             HHHH-hCCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccc
Q 015222          208 AFMH-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRA  286 (411)
Q Consensus       208 ~~LH-~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~a  286 (411)
                      +||| ++||+||||||+|||++.+|... .+++.....      .........+||+|||+|+.....  ..+||+.|+|
T Consensus       175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~-~~~~~~~~~------~~~~~~~~~vkL~DFG~a~~~~~~--~~~gt~~y~a  245 (336)
T 2vuw_A          175 AVAEASLRFEHRDLHWGNVLLKKTSLKK-LHYTLNGKS------STIPSCGLQVSIIDYTLSRLERDG--IVVFCDVSMD  245 (336)
T ss_dssp             HHHHHHHCCBCSCCCGGGEEEEECSCSE-EEEEETTEE------EEEECTTEEEEECCCTTCBEEETT--EEECCCCTTC
T ss_pred             HHHHHhCCEeECCCCHHHEEEeccCCcc-eeeeccCcc------ccccCCCceEEEeeccccEecCCC--cEEEeecccC
Confidence            9999 99999999999999999875210 111110000      000012237899999999876543  4589999999


Q ss_pred             cceecCCCCCccchhHHHHHH-HHHHHhCCCCCCCCCh-HHHHHHHHH---HhCCCChhHHHhhhhhhhhhhccCCccCC
Q 015222          287 PEVILGLGWNYPCDLWSVGCI-LVELCSGEALFQTHEN-LEHLAMMER---VLGPLPHHMVIRADRRAEKYFRRGARLDW  361 (411)
Q Consensus       287 PE~~~~~~~~~~~DiwSlGvi-l~elltg~~pf~~~~~-~~~~~~i~~---~~~~~p~~~~~~~~~~~~~li~~~l~~~~  361 (411)
                      ||++.+.. +.++||||||++ .+++++|..||.+... ......+..   .....+......+++.+.+||.+||..+ 
T Consensus       246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-  323 (336)
T 2vuw_A          246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-  323 (336)
T ss_dssp             SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-
T ss_pred             hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-
Confidence            99999876 999999998777 7888899999954211 111222221   1123344566778999999999999865 


Q ss_pred             CCCCCcHHHHHHHH-hcCCCC
Q 015222          362 PDGATSRDSMRAVW-KLLRLP  381 (411)
Q Consensus       362 ~~rp~~R~t~~~il-~~~~~~  381 (411)
                              |+.+++ +||||+
T Consensus       324 --------sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          324 --------SATDLLCQHSLFK  336 (336)
T ss_dssp             --------SHHHHHHHCGGGC
T ss_pred             --------CHHHHHhcCCCcC
Confidence                    899999 999985

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.4e-44  Score=342.33  Aligned_cols=261  Identities=18%  Similarity=0.223  Sum_probs=204.4

Q ss_pred             CCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        87 ~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      .+...++|++.+.||+|+||.||+|++. +++.||||++....  .....+.+|+.+++.+.|+||     +++++++..
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~   98 (326)
T 3uim_A           25 LQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL-----LRLRGFCMT   98 (326)
T ss_dssp             HHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTB-----CCCCEEECC
T ss_pred             HHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCc-----cceEEEEec
Confidence            3455689999999999999999999754 68889999997543  223367889999998887776     999999999


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCcEEEecCcccccCCc
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHEL---RLIHTDLKPENILLVSAEYVKVPDY  238 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dikp~NIli~~~~~~~l~df  238 (411)
                      .+..++||||+ +++|.+++....  ...+++..+..++.||+.||+|||++   ||+||||||+|||++.++       
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~-------  171 (326)
T 3uim_A           99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF-------  171 (326)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC-------
T ss_pred             CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC-------
Confidence            99999999999 889999998654  23499999999999999999999999   999999999999997765       


Q ss_pred             ccccccCCCCCccccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhC
Q 015222          239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG  314 (411)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg  314 (411)
                                          .+||+|||++.......    ....||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus       172 --------------------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  231 (326)
T 3uim_A          172 --------------------EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG  231 (326)
T ss_dssp             --------------------CEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHC
T ss_pred             --------------------CEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhC
Confidence                                67788888776543222    224589999999999988999999999999999999999


Q ss_pred             CCCCCCC-----ChHHHHHHHHHHhC----------CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCC
Q 015222          315 EALFQTH-----ENLEHLAMMERVLG----------PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR  379 (411)
Q Consensus       315 ~~pf~~~-----~~~~~~~~i~~~~~----------~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~  379 (411)
                      +.||...     ........+.....          ..........+..+.+++.+||..+    |.+|||+.++++|++
T Consensus       232 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d----P~~Rps~~ell~~L~  307 (326)
T 3uim_A          232 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSS----PMERPKMSEVVRMLE  307 (326)
T ss_dssp             CCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSC----GGGSCCHHHHHHHHH
T ss_pred             CCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcC----CccCCCHHHHHHHhc
Confidence            9999521     11111111111100          1111223345577889999998888    999999999999987


Q ss_pred             CCccc
Q 015222          380 LPVID  384 (411)
Q Consensus       380 ~~~~~  384 (411)
                      -..+.
T Consensus       308 ~~~~~  312 (326)
T 3uim_A          308 GDGLA  312 (326)
T ss_dssp             TSSCS
T ss_pred             Ccchh
Confidence            65444

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=339.14  Aligned_cols=254  Identities=19%  Similarity=0.202  Sum_probs=181.0

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee-----cC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD-----YR  165 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~-----~~  165 (411)
                      .++|++.+.||+|+||.||+|++  +++.||||++............|+..+..+.|+||     +++++.+.     ..
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i-----~~~~~~~~~~~~~~~   84 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNI-----ARFIVGDERVTADGR   84 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTB-----CCEEEEEEEECTTSC
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcch-----hhheecccccccCCC
Confidence            36899999999999999999976  68899999997544332222333333334555555     88876432     24


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCcEEEecCccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL---------RLIHTDLKPENILLVSAEYVKV  235 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---------givH~Dikp~NIli~~~~~~~l  235 (411)
                      ..+++||||+ +++|.+++....   .++..+..++.||+.||+|||++         ||+||||||+|||++.++    
T Consensus        85 ~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~----  157 (336)
T 3g2f_A           85 MEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG----  157 (336)
T ss_dssp             EEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS----
T ss_pred             ceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC----
Confidence            4789999999 999999998764   68999999999999999999999         999999999999998776    


Q ss_pred             CCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC-----------CcccccCCCccccceecC-------CCCCc
Q 015222          236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----------HSYVVSTRHYRAPEVILG-------LGWNY  297 (411)
Q Consensus       236 ~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----------~~~~~gt~~y~aPE~~~~-------~~~~~  297 (411)
                                             .+||+|||++......           .....||+.|+|||++.+       ..++.
T Consensus       158 -----------------------~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~  214 (336)
T 3g2f_A          158 -----------------------TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALK  214 (336)
T ss_dssp             -----------------------CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHH
T ss_pred             -----------------------cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCccccccccccc
Confidence                                   5666666666543211           123479999999999987       35678


Q ss_pred             cchhHHHHHHHHHHHhCCCCCCCCCh-----------------HHHHHHHHHH---hCCCChhHH--Hhhhhhhhhhhcc
Q 015222          298 PCDLWSVGCILVELCSGEALFQTHEN-----------------LEHLAMMERV---LGPLPHHMV--IRADRRAEKYFRR  355 (411)
Q Consensus       298 ~~DiwSlGvil~elltg~~pf~~~~~-----------------~~~~~~i~~~---~~~~p~~~~--~~~~~~~~~li~~  355 (411)
                      ++|||||||++|||++|..||.....                 .+........   ...+|..+.  ...++.+.++|.+
T Consensus       215 ~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  294 (336)
T 3g2f_A          215 QVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED  294 (336)
T ss_dssp             HHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHH
T ss_pred             ccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHH
Confidence            99999999999999999766533211                 1111111111   112222111  1244578999999


Q ss_pred             CCccCCCCCCCcHHHHHHH------HhcCCCCcccc
Q 015222          356 GARLDWPDGATSRDSMRAV------WKLLRLPVIDL  385 (411)
Q Consensus       356 ~l~~~~~~rp~~R~t~~~i------l~~~~~~~~~~  385 (411)
                      ||..|    |.+|||+.++      +.+.|.++-..
T Consensus       295 cl~~d----P~~Rps~~e~l~~L~~ll~~~~~~~~~  326 (336)
T 3g2f_A          295 CWDQD----AEARLTAQXAEERMAELMMIWERNKSV  326 (336)
T ss_dssp             HSCSS----GGGSCCHHHHHHHHHHHHHCCCC----
T ss_pred             HhcCC----hhhCcchHHHHHHHHHHHHHHHhcccC
Confidence            99998    8888888888      44667776543

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.2e-43  Score=329.93  Aligned_cols=248  Identities=21%  Similarity=0.287  Sum_probs=194.9

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCC-CC--cEEEEEEeccc----hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNE-KK--ELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~-~~--~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~  163 (411)
                      .++|++.+.||+|+||+||+|++.. ++  ..||||+++..    ....+.+.+|+.+++++.|+|+     +++++++.
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~   91 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL-----IRLYGVVL   91 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEC
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCc-----ccEEEEEc
Confidence            3689999999999999999998643 33  36999998743    2345678899999999988776     99999988


Q ss_pred             cCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccc
Q 015222          164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                      ..+ .++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++           
T Consensus        92 ~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~-----------  158 (291)
T 1u46_A           92 TPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-----------  158 (291)
T ss_dssp             SSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-----------
T ss_pred             cCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC-----------
Confidence            755 88999999 899999998653 3599999999999999999999999999999999999998877           


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCcccccCCC------cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CC
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GE  315 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~  315 (411)
                                      .++|+|||++.......      ....+|..|+|||++.+..++.++||||||+++|+|++ |+
T Consensus       159 ----------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~  222 (291)
T 1u46_A          159 ----------------LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ  222 (291)
T ss_dssp             ----------------EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSC
T ss_pred             ----------------CEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence                            45666666665443221      22356788999999998889999999999999999999 99


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      .||.+.+..+....+.......+  ....++..+.+++.+||..+    |.+||++.+++++.
T Consensus       223 ~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~----p~~Rps~~~l~~~l  279 (291)
T 1u46_A          223 EPWIGLNGSQILHKIDKEGERLP--RPEDCPQDIYNVMVQCWAHK----PEDRPTFVALRDFL  279 (291)
T ss_dssp             CTTTTCCHHHHHHHHHTSCCCCC--CCTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred             CCcccCCHHHHHHHHHccCCCCC--CCcCcCHHHHHHHHHHccCC----cccCcCHHHHHHHH
Confidence            99998888777666654332222  22356788999999999999    89999999998753

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-43  Score=343.59  Aligned_cols=247  Identities=16%  Similarity=0.189  Sum_probs=192.1

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCC---cEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee-cC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKK---ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD-YR  165 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~---~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~-~~  165 (411)
                      ..|++.+.||+|+||+||+|++..++   ..||+|.++..  ....+.+.+|+.++++++|+||     +++++++. .+
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~~~~~~~~~~  163 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV-----LSLLGICLRSE  163 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTB-----CCCCEEECCCS
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEEcCC
Confidence            35899999999999999999875432   46899998643  2345678899999999987776     99999754 45


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      +..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++             
T Consensus       164 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-------------  229 (373)
T 3c1x_A          164 GSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-------------  229 (373)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-------------
T ss_pred             CCeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC-------------
Confidence            6889999999 889999997654 4689999999999999999999999999999999999998766             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCC-------CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEA  316 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~  316 (411)
                                    .+||+|||++......       .....+|+.|+|||++.+..++.++|||||||++|||++ |.+
T Consensus       230 --------------~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~  295 (373)
T 3c1x_A          230 --------------TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP  295 (373)
T ss_dssp             --------------CEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             --------------CEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCC
Confidence                          5666777766543221       122456788999999999899999999999999999999 788


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ||.+.+..+....+........   ...++..+.+++.+|+..+    |.+||++.+++++.
T Consensus       296 p~~~~~~~~~~~~~~~~~~~~~---p~~~~~~l~~li~~cl~~d----p~~RPs~~ell~~L  350 (373)
T 3c1x_A          296 PYPDVNTFDITVYLLQGRRLLQ---PEYCPDPLYEVMLKCWHPK----AEMRPSFSELVSRI  350 (373)
T ss_dssp             SCTTSCSSCHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHHcCCC----hhhCcCHHHHHHHH
Confidence            9987766555555444322221   1345677899999998888    88889999988764

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.2e-43  Score=333.32  Aligned_cols=250  Identities=22%  Similarity=0.275  Sum_probs=195.4

Q ss_pred             CCCeEEEeeeccccceEEEEEE----eCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           91 TPRYRILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~----~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .++|++++.||+|+||.||+|+    +..+++.||||++.... ...+.+.+|+.++++++|+||     +++++++...
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~  114 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI-----VKYKGVCYSA  114 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTB-----CCEEEEECC-
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCe-----eeEEEEEEec
Confidence            4579999999999999999998    46789999999997543 445678899999999988776     9999987654


Q ss_pred             --CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccc
Q 015222          166 --NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       166 --~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                        +.+++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++           
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~-----------  182 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-----------  182 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-----------
T ss_pred             CCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC-----------
Confidence              3789999999 889999998764 3699999999999999999999999999999999999998877           


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCcccccCCC------cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCC
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA  316 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~  316 (411)
                                      .++|+|||++.......      ....++..|+|||++.+..++.++|||||||++|||++|..
T Consensus       183 ----------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~  246 (326)
T 2w1i_A          183 ----------------RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE  246 (326)
T ss_dssp             ----------------EEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTC
T ss_pred             ----------------cEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCC
Confidence                            45666666665443221      12356778999999998889999999999999999999999


Q ss_pred             CCCCCCh------------HHHHHHH-HHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          317 LFQTHEN------------LEHLAMM-ERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       317 pf~~~~~------------~~~~~~i-~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ||.....            ......+ ..............++..+.++|.+|+..+    |.+||++.++++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d----P~~Rps~~el~~~  316 (326)
T 2w1i_A          247 KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNN----VNQRPSFRDLALR  316 (326)
T ss_dssp             GGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSS----GGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCC----hhhCcCHHHHHHH
Confidence            9864211            0001111 111111111112346778999999999888    8888899988864

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=7e-43  Score=360.03  Aligned_cols=241  Identities=24%  Similarity=0.327  Sum_probs=196.1

Q ss_pred             eEEE-eeeccccceEEEEEEe--CCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           94 YRIL-SKMGEGTFGQVVECFD--NEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        94 y~i~-~~lG~G~~g~V~~a~~--~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      +.+. ++||+|+||.||+|.+  +.+++.||||+++...   ...+.+.+|+.++++++|+||     +++++++.. +.
T Consensus       370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~l~~~~~~-~~  443 (635)
T 4fl3_A          370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI-----VRMIGICEA-ES  443 (635)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTB-----CCEEEEEES-SS
T ss_pred             ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEec-CC
Confidence            4443 4899999999999954  5667899999997533   335778999999999988877     999999875 55


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      .++||||+ +++|.+++....  .+++..+..++.||+.||+|||++||+||||||+||||+.++               
T Consensus       444 ~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~---------------  506 (635)
T 4fl3_A          444 WMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH---------------  506 (635)
T ss_dssp             EEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT---------------
T ss_pred             EEEEEEccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC---------------
Confidence            88999999 899999998765  799999999999999999999999999999999999999877               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCC------cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQ  319 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~  319 (411)
                                  .+||+|||++.......      ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus       507 ------------~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~  574 (635)
T 4fl3_A          507 ------------YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR  574 (635)
T ss_dssp             ------------EEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             ------------CEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                        45666666655432211      22356788999999999899999999999999999998 999999


Q ss_pred             CCChHHHHHHHHHHhC-CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          320 THENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       320 ~~~~~~~~~~i~~~~~-~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      +.+..+....+..... ..|    ..++..+.+++.+|+..+    |.+||++.++++.
T Consensus       575 ~~~~~~~~~~i~~~~~~~~p----~~~~~~l~~li~~cl~~d----P~~RPs~~~l~~~  625 (635)
T 4fl3_A          575 GMKGSEVTAMLEKGERMGCP----AGCPREMYDLMNLCWTYD----VENRPGFAAVELR  625 (635)
T ss_dssp             TCCHHHHHHHHHTTCCCCCC----TTCCHHHHHHHHHHTCSS----TTTSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHcCCCCCCC----CCCCHHHHHHHHHHcCCC----HhHCcCHHHHHHH
Confidence            9888877777665432 222    346778999999998888    8888889988754

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.4e-44  Score=369.30  Aligned_cols=261  Identities=25%  Similarity=0.346  Sum_probs=208.1

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec----
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY----  164 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~----  164 (411)
                      .++|++.+.||+|+||.||+|.+..+|+.||||+++..  ....+.+.+|+.++++++|+||     +++++++..    
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnI-----V~l~~v~~~~~~~   87 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV-----VSAREVPDGLQKL   87 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTB-----CCEEECCTTTCCC
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCC-----Cceeeeecccccc
Confidence            47899999999999999999999999999999998743  3445678899999999988877     888888765    


Q ss_pred             --CCeEEEEEccC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          165 --RNHICIVFEKL-GPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       165 --~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                        ++..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++         
T Consensus        88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g---------  158 (676)
T 3qa8_A           88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGP---------  158 (676)
T ss_dssp             CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCS---------
T ss_pred             cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCC---------
Confidence              67889999999 999999998643 23589999999999999999999999999999999999998765         


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCC
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF  318 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf  318 (411)
                                     ....++|+|||.+.......  ....||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       159 ---------------~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf  223 (676)
T 3qa8_A          159 ---------------QRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF  223 (676)
T ss_dssp             ---------------SSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSC
T ss_pred             ---------------CceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence                           23358899999887654332  3457999999999999999999999999999999999999999


Q ss_pred             CCCChHHHHHH------HHH------H--------hCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          319 QTHENLEHLAM------MER------V--------LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       319 ~~~~~~~~~~~------i~~------~--------~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      .+.........      ...      .        ..+.|......++..+.++|.+||..|    |.+|||+.++++|+
T Consensus       224 ~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~D----P~kRPTa~elL~hp  299 (676)
T 3qa8_A          224 LPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWH----QRQRGTDPQNPNVG  299 (676)
T ss_dssp             CSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSS----CC---CCTTCCCCT
T ss_pred             CcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCC----HhhCcCHHHHhcCH
Confidence            76533221100      000      0        012233344557788999999999999    99999999999999


Q ss_pred             CCCccc
Q 015222          379 RLPVID  384 (411)
Q Consensus       379 ~~~~~~  384 (411)
                      ||..+.
T Consensus       300 ~F~~l~  305 (676)
T 3qa8_A          300 CFQALD  305 (676)
T ss_dssp             THHHHH
T ss_pred             HHHHHH
Confidence            988654

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-44  Score=353.93  Aligned_cols=253  Identities=14%  Similarity=0.092  Sum_probs=194.6

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCC-----------CCCcceE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHD-----------IGGTRCV  156 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~-----------i~~~~iv  156 (411)
                      ..|++.+.||+|+||+||+|++..+|+.||||+++...    ...+.+.+|+.+++.+.|..           +....++
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            35889999999999999999999999999999997322    23567889999999887621           1001111


Q ss_pred             EE------eeeeec-----CCeEEEEEccCCCCHHHHHH-----hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 015222          157 QI------RNWFDY-----RNHICIVFEKLGPSLYDFLR-----KNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL  220 (411)
Q Consensus       157 ~~------~~~~~~-----~~~~~lv~e~~~~~L~~~l~-----~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Di  220 (411)
                      .+      ..++..     ...++++|++++++|.+++.     ......+++..+..++.||+.||+|||++||+||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi  237 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL  237 (413)
T ss_dssp             ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence            11      111111     23578999999999999985     222235788899999999999999999999999999


Q ss_pred             CCCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCcccccee----------
Q 015222          221 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVI----------  290 (411)
Q Consensus       221 kp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~----------  290 (411)
                      ||+||||+.++                           .+||+|||++..........+| +.|+|||++          
T Consensus       238 Kp~NILl~~~~---------------------------~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~  289 (413)
T 3dzo_A          238 RPVDIVLDQRG---------------------------GVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQH  289 (413)
T ss_dssp             CGGGEEECTTC---------------------------CEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGG
T ss_pred             ccceEEEecCC---------------------------eEEEEeccceeecCCccccCCC-CceeCchhhhccccccccc
Confidence            99999998776                           5788888887766555555678 999999999          


Q ss_pred             cCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHH
Q 015222          291 LGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS  370 (411)
Q Consensus       291 ~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t  370 (411)
                      .+..++.++|||||||++|||++|+.||.+.+..+....+....        ..+++.+.++|.+||+.+    |.+||+
T Consensus       290 ~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~--------~~~~~~~~~li~~~l~~d----P~~Rpt  357 (413)
T 3dzo_A          290 HPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSC--------KNIPQPVRALLEGFLRYP----KEDRLL  357 (413)
T ss_dssp             CCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGSSC--------CCCCHHHHHHHHHHTCSS----GGGSCC
T ss_pred             cCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHhhc--------ccCCHHHHHHHHHHccCC----hhhCcC
Confidence            55568899999999999999999999998765433222221111        135677899999999998    999999


Q ss_pred             HHHHHhcCCCCccc
Q 015222          371 MRAVWKLLRLPVID  384 (411)
Q Consensus       371 ~~~il~~~~~~~~~  384 (411)
                      +.++++|+||.++.
T Consensus       358 ~~~~l~~~~~~~~~  371 (413)
T 3dzo_A          358 PLQAMETPEYEQLR  371 (413)
T ss_dssp             HHHHTTSHHHHHHH
T ss_pred             HHHHHhCHHHHHHH
Confidence            99999999998754

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.8e-43  Score=335.30  Aligned_cols=255  Identities=20%  Similarity=0.263  Sum_probs=199.2

Q ss_pred             ceEEeeCCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHH--HhcCCCCCcceEEE
Q 015222           81 HYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR--LARHDIGGTRCVQI  158 (411)
Q Consensus        81 ~~~~~~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~~~~i~~~~iv~~  158 (411)
                      ..++..+..+.++|++.+.||+|+||.||+|.+  +++.||||++...  ....+.+|.+++..  +.|+||     +++
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni-----~~~  101 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENI-----LGF  101 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTB-----CCE
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcE-----EEE
Confidence            445566677788999999999999999999987  4889999999653  34567788888887  556555     999


Q ss_pred             eeeeecCC----eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCcE
Q 015222          159 RNWFDYRN----HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH--------ELRLIHTDLKPENI  225 (411)
Q Consensus       159 ~~~~~~~~----~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~givH~Dikp~NI  225 (411)
                      ++++...+    ..++||||+ +++|.+++.+.   .+++..++.++.||+.||.|||        +.||+||||||+||
T Consensus       102 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NI  178 (342)
T 1b6c_B          102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI  178 (342)
T ss_dssp             EEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGE
T ss_pred             EeeecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHE
Confidence            99988765    899999999 88999999875   4999999999999999999999        89999999999999


Q ss_pred             EEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-------cccccCCCccccceecCC-----
Q 015222          226 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-------SYVVSTRHYRAPEVILGL-----  293 (411)
Q Consensus       226 li~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~-----  293 (411)
                      |++.++                           .+||+|||++.......       ....||+.|+|||++.+.     
T Consensus       179 ll~~~~---------------------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  231 (342)
T 1b6c_B          179 LVKKNG---------------------------TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH  231 (342)
T ss_dssp             EECTTS---------------------------CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTC
T ss_pred             EECCCC---------------------------CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccc
Confidence            998766                           56777777775543322       334789999999999876     


Q ss_pred             -CCCccchhHHHHHHHHHHHhC----------CCCCCCCCh----HHHHH-HHHHH--hCCCChhH-HHhhhhhhhhhhc
Q 015222          294 -GWNYPCDLWSVGCILVELCSG----------EALFQTHEN----LEHLA-MMERV--LGPLPHHM-VIRADRRAEKYFR  354 (411)
Q Consensus       294 -~~~~~~DiwSlGvil~elltg----------~~pf~~~~~----~~~~~-~i~~~--~~~~p~~~-~~~~~~~~~~li~  354 (411)
                       .++.++|||||||++|||++|          ..||.....    .+.+. .+...  ...++..+ .....+.+.+++.
T Consensus       232 ~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  311 (342)
T 1b6c_B          232 FESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR  311 (342)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHH
T ss_pred             cccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHH
Confidence             234789999999999999999          789876421    22222 22111  12333322 1244567888999


Q ss_pred             cCCccCCCCCCCcHHHHHHHHhcC
Q 015222          355 RGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       355 ~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      +|+..+    |++||++.+++++.
T Consensus       312 ~cl~~d----p~~Rps~~~i~~~L  331 (342)
T 1b6c_B          312 ECWYAN----GAARLTALRIKKTL  331 (342)
T ss_dssp             HHCCSS----GGGSCCHHHHHHHH
T ss_pred             HHhccC----hhhCCCHHHHHHHH
Confidence            998888    99999999999874

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.1e-42  Score=327.84  Aligned_cols=246  Identities=23%  Similarity=0.331  Sum_probs=193.8

Q ss_pred             eEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc-----hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        94 y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      |...+.||+|+||.||+|.+  +++.||||++...     ....+.+.+|+.++++++|+|+     +++++++.+.+..
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~  105 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL-----VELLGFSSDGDDL  105 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB-----CCEEEEECSSSSC
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe-----EEEEEEEecCCce
Confidence            44458999999999999976  5788999998642     2345678899999999988777     9999999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      ++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.++               
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~---------------  170 (307)
T 2nru_A          106 CLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF---------------  170 (307)
T ss_dssp             EEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC---------------
T ss_pred             EEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC---------------
Confidence            9999999 999999997432 24699999999999999999999999999999999999997766               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                                  .++|+|||++......     .....||+.|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus       171 ------------~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~  237 (307)
T 2nru_A          171 ------------TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEH  237 (307)
T ss_dssp             ------------CEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTT
T ss_pred             ------------cEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccC
Confidence                        5677777776654322     123478999999999876 5899999999999999999999999875


Q ss_pred             ChHHHHHHHHHHh-----------CCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          322 ENLEHLAMMERVL-----------GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       322 ~~~~~~~~i~~~~-----------~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ...+.+..+....           ...........+..+.+++.+|+..+    |.+||++.++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~----p~~Rps~~~l~~~L  301 (307)
T 2nru_A          238 REPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEK----KNKRPDIKKVQQLL  301 (307)
T ss_dssp             BSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSS----TTTSCCHHHHHHHH
T ss_pred             cchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCC----cccCcCHHHHHHHH
Confidence            4432222221111           00011112344567888999998888    88888999988764

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=4.1e-43  Score=327.93  Aligned_cols=229  Identities=16%  Similarity=0.069  Sum_probs=185.2

Q ss_pred             eeCC-ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEe
Q 015222           85 AIGE-NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIR  159 (411)
Q Consensus        85 ~~~~-~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~  159 (411)
                      ..|+ .+.++|++.+.||+|+||.||+|++..+++.||||++....    ...+.+.+|+.++.++.|+||     ++++
T Consensus        23 ~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i-----v~~~   97 (286)
T 3uqc_A           23 VPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGV-----ARVL   97 (286)
T ss_dssp             CTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTB-----CCEE
T ss_pred             CCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCc-----ceee
Confidence            4455 66789999999999999999999999999999999997542    334678899999998888776     9999


Q ss_pred             eeeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCc
Q 015222          160 NWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY  238 (411)
Q Consensus       160 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df  238 (411)
                      +++.+.+..|+||||+ |++|.+++...    .....+..++.||+.||+|||++||+||||||+|||++.+|       
T Consensus        98 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g-------  166 (286)
T 3uqc_A           98 DVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG-------  166 (286)
T ss_dssp             EEEEETTEEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTS-------
T ss_pred             EEEEECCcEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCC-------
Confidence            9999999999999999 89999998542    45667899999999999999999999999999999998877       


Q ss_pred             ccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCC
Q 015222          239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF  318 (411)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf  318 (411)
                                          .+||+++|                 |++       .++.++|||||||++|||++|+.||
T Consensus       167 --------------------~~kl~~~~-----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf  202 (286)
T 3uqc_A          167 --------------------DVVLAYPA-----------------TMP-------DANPQDDIRGIGASLYALLVNRWPL  202 (286)
T ss_dssp             --------------------CEEECSCC-----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECS
T ss_pred             --------------------CEEEEecc-----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCC
Confidence                                45665433                 444       3789999999999999999999999


Q ss_pred             CCCChHHHHH---HHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          319 QTHENLEHLA---MMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       319 ~~~~~~~~~~---~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      .+.+..+.+.   .........+......++..+.++|.+||+.|    |.+| |+.++++.+
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d----P~~R-s~~el~~~L  260 (286)
T 3uqc_A          203 PEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGD----GGIR-SASTLLNLM  260 (286)
T ss_dssp             CCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTT----SSCC-CHHHHHHHH
T ss_pred             CcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccC----CccC-CHHHHHHHH
Confidence            8765432111   00111112223444567888999999999999    8888 888888754

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=8.3e-42  Score=353.30  Aligned_cols=246  Identities=22%  Similarity=0.303  Sum_probs=202.4

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCC---CcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~---~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      ..++|++.+.||+|+||.||+|.+..+   +..||||+++..  ....+.+.+|+.++++++|+||     +++++++. 
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~l~~~~~-  461 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI-----VKLIGVIT-  461 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEC-
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEe-
Confidence            346899999999999999999998654   467999998743  3345678899999999988877     99999885 


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                      ++..|+||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++            
T Consensus       462 ~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~------------  528 (656)
T 2j0j_A          462 ENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND------------  528 (656)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT------------
T ss_pred             cCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC------------
Confidence            46689999999 899999998654 3689999999999999999999999999999999999998877            


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALF  318 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf  318 (411)
                                     .+||+|||++.......    ....+|+.|+|||++.+..++.++|||||||++|||++ |..||
T Consensus       529 ---------------~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf  593 (656)
T 2j0j_A          529 ---------------CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF  593 (656)
T ss_dssp             ---------------EEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             ---------------CEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCC
Confidence                           46677777665543221    22356789999999998899999999999999999997 99999


Q ss_pred             CCCChHHHHHHHHHHhC-CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          319 QTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       319 ~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      .+.+..+.+..+..... ..|    ..++..+.+++.+|+..+    |.+||++.++++.
T Consensus       594 ~~~~~~~~~~~i~~~~~~~~~----~~~~~~l~~li~~~l~~d----P~~RPs~~el~~~  645 (656)
T 2j0j_A          594 QGVKNNDVIGRIENGERLPMP----PNCPPTLYSLMTKCWAYD----PSRRPRFTELKAQ  645 (656)
T ss_dssp             TTCCHHHHHHHHHHTCCCCCC----TTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHcCCCCCCC----ccccHHHHHHHHHHcCCC----hhHCcCHHHHHHH
Confidence            99888887777765432 222    346778999999999988    8889999998864

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=7.2e-43  Score=330.84  Aligned_cols=247  Identities=19%  Similarity=0.269  Sum_probs=197.8

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      ...++|++.+.||+|+||.||+|.+..   .||+|+++...   ...+.+.+|+.++++++|+|+     +++++++.+.
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~  101 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENV-----VLFMGACMSP  101 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTB-----CCCCEEEECS
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCE-----eEEEEEEecC
Confidence            345789999999999999999998864   39999987432   233556779999998887776     9999999999


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      +..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++ ++             
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~-------------  166 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG-------------  166 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----------------
T ss_pred             CceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC-------------
Confidence            9999999999 899999997654 4699999999999999999999999999999999999996 34             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCccccc--------CCCcccccCCCccccceecC---------CCCCccchhHHHHHH
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEH--------QDHSYVVSTRHYRAPEVILG---------LGWNYPCDLWSVGCI  307 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~--------~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwSlGvi  307 (411)
                                    .++|+|||++....        .......||+.|+|||++.+         ..++.++|||||||+
T Consensus       167 --------------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~i  232 (319)
T 2y4i_B          167 --------------KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI  232 (319)
T ss_dssp             --------------CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHH
T ss_pred             --------------CEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHH
Confidence                          46777777655432        11223468999999999975         357899999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          308 LVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       308 l~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      +|||++|+.||.+.+.......+.....  +......++..+.+++.+|+..+    |.+||++.++++..
T Consensus       233 l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~----p~~Rpt~~~l~~~l  297 (319)
T 2y4i_B          233 WYELHAREWPFKTQPAEAIIWQMGTGMK--PNLSQIGMGKEISDILLFCWAFE----QEERPTFTKLMDML  297 (319)
T ss_dssp             HHHHHHSSCSSSSCCHHHHHHHHHTTCC--CCCCCSSCCTTHHHHHHHHHCSS----TTTSCCHHHHHHHH
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHhccCCC--CCCCcCCCCHHHHHHHHHHhcCC----hhhCcCHHHHHHHH
Confidence            9999999999998887766665544322  22122246778999999999999    88888888888754

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.1e-42  Score=359.08  Aligned_cols=243  Identities=23%  Similarity=0.303  Sum_probs=193.8

Q ss_pred             eeCCccCCCeEEEeeeccccceEEEEEEeCC-CCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeee
Q 015222           85 AIGENLTPRYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW  161 (411)
Q Consensus        85 ~~~~~~~~~y~i~~~lG~G~~g~V~~a~~~~-~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~  161 (411)
                      ..|+.+.++|++.+.||+|+||+||+|.+.. +++.||||++...  ......+.+|+.++++++|+||     ++++++
T Consensus        73 ~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~  147 (681)
T 2pzi_A           73 NPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI-----VQIFNF  147 (681)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTB-----CCEEEE
T ss_pred             CCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCc-----CeEeee
Confidence            4567788999999999999999999999976 7899999998643  2445667889999999987776     999999


Q ss_pred             eecCCe-----EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCccccc
Q 015222          162 FDYRNH-----ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV  235 (411)
Q Consensus       162 ~~~~~~-----~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l  235 (411)
                      +...+.     .|+||||+ |++|.+++..    .+++..++.++.||+.||.|||++|||||||||+|||++.+     
T Consensus       148 ~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-----  218 (681)
T 2pzi_A          148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-----  218 (681)
T ss_dssp             EEEECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-----
T ss_pred             EeecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-----
Confidence            887554     79999999 8899887654    59999999999999999999999999999999999999642     


Q ss_pred             CCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCC
Q 015222          236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE  315 (411)
Q Consensus       236 ~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~  315 (411)
                                             .+||+|||++...... ....||+.|+|||++.+. ++.++|||||||++|+|++|.
T Consensus       219 -----------------------~~kl~DFG~a~~~~~~-~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~  273 (681)
T 2pzi_A          219 -----------------------QLKLIDLGAVSRINSF-GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDL  273 (681)
T ss_dssp             -----------------------CEEECCCTTCEETTCC-SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCC
T ss_pred             -----------------------cEEEEecccchhcccC-CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCC
Confidence                                   5789999988765543 446799999999998775 489999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      .||.+....          ...........++.+.++|.+||..|    |.+|++..+.+.+.|+
T Consensus       274 ~~~~~~~~~----------~~~~~~~~~~~~~~l~~li~~~l~~d----P~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          274 PTRNGRYVD----------GLPEDDPVLKTYDSYGRLLRRAIDPD----PRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             CEETTEECS----------SCCTTCHHHHHCHHHHHHHHHHTCSS----GGGSCSSHHHHHHHHH
T ss_pred             CCCcccccc----------cccccccccccCHHHHHHHhhhccCC----hhhCCCHHHHHHHHHH
Confidence            998753211          00111122335677899999999999    6666665555555443

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=2.8e-34  Score=291.89  Aligned_cols=181  Identities=20%  Similarity=0.128  Sum_probs=127.7

Q ss_pred             EeeeccccceEEEEEEeCCCCcEEEEEEeccc-----------hhhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeec
Q 015222           97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-----------NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        97 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----------~~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~  164 (411)
                      ....+.|++|.+..++....|+.||+|++.+.           ....+.+.+|+++|+++ .|+||     +++++++++
T Consensus       239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i-----~~~~~~~ed  313 (569)
T 4azs_A          239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDA-----PAVLAHGEN  313 (569)
T ss_dssp             ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCC-----CCEEEEEEC
T ss_pred             hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCe-----eEEEEEEEE
Confidence            34577888888888888889999999999642           23446788999999998 45555     999999999


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                      ++.+||||||+ |++|.++|.+.+  .+++.   .|+.||+.||+|||++|||||||||+||||+.+|            
T Consensus       314 ~~~~yLVMEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg------------  376 (569)
T 4azs_A          314 AQSGWLVMEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ------------  376 (569)
T ss_dssp             SSEEEEEEECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS------------
T ss_pred             CCEEEEEEecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCC------------
Confidence            99999999999 999999998865  67664   5889999999999999999999999999998777            


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE  315 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~  315 (411)
                                     .+||+|||+|+.....   ..+.+||+.|+|||++.+ .+..++|+||+|+++++|.++.
T Consensus       377 ---------------~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          377 ---------------HARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             ---------------CEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred             ---------------CEEEeecccCeeCCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence                           5777777777654332   345689999999999987 4678899999999988776553

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=7.2e-29  Score=250.77  Aligned_cols=179  Identities=19%  Similarity=0.180  Sum_probs=138.7

Q ss_pred             EEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---------hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        95 ~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      ...+.||+|+||+||+|  ...++.+|+|+.....         ...+.+.+|+.++++++|+||     +.+..++...
T Consensus       339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nI-----v~~~~~~~~~  411 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGI-----PAPYIFDVDL  411 (540)
T ss_dssp             ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTC-----CCCCEEEEET
T ss_pred             CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCc-----CceEEEEEeC
Confidence            45679999999999999  4457789999864311         123457899999999999988     6444444456


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      +..|+||||+ +++|.+++..          +..++.||+.||+|||++||+||||||+|||++.               
T Consensus       412 ~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~---------------  466 (540)
T 3en9_A          412 DNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK---------------  466 (540)
T ss_dssp             TTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---------------
T ss_pred             CccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---------------
Confidence            6679999999 8999999865          5689999999999999999999999999999853               


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCCC----------cccccCCCccccceecC--CCCCccchhHHHHHHHHHHH
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----------SYVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELC  312 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----------~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell  312 (411)
                                    .+||+|||+++......          ....||+.|+|||++.+  ..|+..+|+||..+-..+.+
T Consensus       467 --------------~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v  532 (540)
T 3en9_A          467 --------------DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDV  532 (540)
T ss_dssp             --------------SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHH
T ss_pred             --------------eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHH
Confidence                          57999999988765432          24689999999999987  57888999999999998888


Q ss_pred             hCCCCCC
Q 015222          313 SGEALFQ  319 (411)
Q Consensus       313 tg~~pf~  319 (411)
                      .++.+|.
T Consensus       533 ~~r~rY~  539 (540)
T 3en9_A          533 ERRARYV  539 (540)
T ss_dssp             HTCSCCC
T ss_pred             HhccccC
Confidence            8877764

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=5.7e-26  Score=211.06  Aligned_cols=144  Identities=24%  Similarity=0.320  Sum_probs=113.5

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-------------------hhhHHHHHHHHHHHHHhcCCCCC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------------------KYREAAMIEIDVLQRLARHDIGG  152 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-------------------~~~~~~~~E~~~l~~l~~~~i~~  152 (411)
                      ..|.+.+.||+|+||.||+|.+ .+|+.||||+++...                   .....+.+|+.+++++.|  +  
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~--~--  164 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG--L--  164 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT--S--
T ss_pred             eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC--C--
Confidence            3466779999999999999999 889999999996422                   134567899999999972  2  


Q ss_pred             cceEEEeeeeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCc
Q 015222          153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE  231 (411)
Q Consensus       153 ~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~  231 (411)
                          ++.+++.. +..|+||||+ |++|.+ +.      .  .....++.||+.||.|||++||+||||||+|||++ +|
T Consensus       165 ----~v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~  229 (282)
T 1zar_A          165 ----AVPKVYAW-EGNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE  229 (282)
T ss_dssp             ----SSCCEEEE-ETTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT
T ss_pred             ----CcCeEEec-cceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC
Confidence                23333333 4569999999 889987 32      1  23557999999999999999999999999999998 66


Q ss_pred             ccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecC
Q 015222          232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG  292 (411)
Q Consensus       232 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~  292 (411)
                                                 .++|+|||++.          .+..++|||++..
T Consensus       230 ---------------------------~vkl~DFG~a~----------~~~~~~a~e~l~r  253 (282)
T 1zar_A          230 ---------------------------GIWIIDFPQSV----------EVGEEGWREILER  253 (282)
T ss_dssp             ---------------------------EEEECCCTTCE----------ETTSTTHHHHHHH
T ss_pred             ---------------------------cEEEEECCCCe----------ECCCCCHHHHHHH
Confidence                                       67889999875          3456899998864

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.89  E-value=5.1e-23  Score=188.77  Aligned_cols=138  Identities=19%  Similarity=0.170  Sum_probs=109.8

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcE--EEEEEeccchh-------------------------hhHHHHHHHHHHHHH
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKEL--VAIKIVRSINK-------------------------YREAAMIEIDVLQRL  145 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~--vavK~~~~~~~-------------------------~~~~~~~E~~~l~~l  145 (411)
                      -|++.+.||+|+||.||+|.+..+|+.  ||||+++....                         ....+.+|+.++.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            378999999999999999998778988  99999754311                         113578899999999


Q ss_pred             hcCCCCCcceEEEeeeeecCCeEEEEEccCC--C----CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceec
Q 015222          146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKLG--P----SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHT  218 (411)
Q Consensus       146 ~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~~--~----~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~givH~  218 (411)
                      .|+++..|.++..       +..++||||++  |    +|.++...     .++..+..++.||+.||.||| +.||+||
T Consensus       128 ~~~~i~~p~~~~~-------~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHr  195 (258)
T 1zth_A          128 KEAGVSVPQPYTY-------MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHA  195 (258)
T ss_dssp             HHTTCCCCCEEEE-------ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECS
T ss_pred             HhCCCCCCeEEEc-------CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence            9998766655432       34689999994  3    77776433     234567899999999999999 9999999


Q ss_pred             CCCCCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccc
Q 015222          219 DLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE  271 (411)
Q Consensus       219 Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~  271 (411)
                      ||||+|||++.                             .++|+|||+|...
T Consensus       196 Dlkp~NILl~~-----------------------------~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID-----------------------------KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS-----------------------------SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC-----------------------------cEEEEECcccccC
Confidence            99999999843                             5789999988654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.79  E-value=3.5e-19  Score=170.22  Aligned_cols=146  Identities=19%  Similarity=0.191  Sum_probs=104.1

Q ss_pred             eEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchh-----------------------hhHHHHHHHHHHHHHhcCCC
Q 015222           94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-----------------------YREAAMIEIDVLQRLARHDI  150 (411)
Q Consensus        94 y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~E~~~l~~l~~~~i  150 (411)
                      |++.+.||+|+||.||+|.+. +|+.||||+++....                       ..-...+|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            999999999999999999975 688999999753110                       01123568889999988776


Q ss_pred             CCcceEEEeeeeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q 015222          151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS  229 (411)
Q Consensus       151 ~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~  229 (411)
                      ..+..+   +.   . ..+|||||+ |++|.++.        ....+..++.||+.+|.+||+.|||||||||.|||++.
T Consensus       176 ~vp~p~---~~---~-~~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~  240 (397)
T 4gyi_A          176 PVPEPI---AQ---S-RHTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIRE  240 (397)
T ss_dssp             SCCCEE---EE---E-TTEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEE
T ss_pred             CCCeee---ec---c-CceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeC
Confidence            333222   21   1 237999999 77765432        12345678899999999999999999999999999998


Q ss_pred             CcccccCCcccccccCCCCCccccCCCCCCeeEeecCCccccc
Q 015222          230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH  272 (411)
Q Consensus       230 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~  272 (411)
                      +|...-.+                 .....+.|+||+.+....
T Consensus       241 dgd~~d~~-----------------~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          241 EKDAEDPS-----------------SITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             EECSSCTT-----------------SEEEEEEECCCTTCEETT
T ss_pred             CCCccccc-----------------ccccceEEEEeCCcccCC
Confidence            77321100                 011247899999776543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.41  E-value=1.5e-12  Score=118.93  Aligned_cols=108  Identities=11%  Similarity=0.094  Sum_probs=82.6

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      +.|++...++.|+.+.||++...  ++.+++|+..... .....+.+|+.+++.+.. .+   .+.++++++.+.+..|+
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~-~~---~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEG-KL---PVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTT-TS---CCCCEEEEEEETTEEEE
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhc-CC---CCCeEEEEEecCCceEE
Confidence            46999999999999999999743  6789999986422 233468889999999965 23   34567777777889999


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE  212 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  212 (411)
                      |||++ |.+|.+.+.       +......++.+++.+|..||+
T Consensus        88 v~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~  123 (263)
T 3tm0_A           88 LMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHS  123 (263)
T ss_dssp             EEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHH
T ss_pred             EEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhC
Confidence            99999 878876521       122345788999999999998

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.32  E-value=7.2e-12  Score=113.91  Aligned_cols=107  Identities=13%  Similarity=0.087  Sum_probs=74.0

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      ..|.+....+.|..+.||++.. .+|+.+++|+....  ....+..|+.+++.+.+.++.   +.+++.+...++..++|
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~---vP~~~~~~~~~~~~~~v   93 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVP---CAAVLDVVTEAGRDWLL   93 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCC---BCCEEEEEECSSCEEEE
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCC---CCeEEEeccCCCCCEEE
Confidence            3466655555667799999964 45677999997653  235678899999999876542   34566666777789999


Q ss_pred             EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 015222          172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR  214 (411)
Q Consensus       172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g  214 (411)
                      ||++ |.+|.  ..     ..+   ...++.+++..|..||+..
T Consensus        94 ~e~i~G~~l~--~~-----~~~---~~~~~~~l~~~l~~lh~~~  127 (264)
T 1nd4_A           94 LGEVPGQDLL--SS-----HLA---PAEKVSIMADAMRRLHTLD  127 (264)
T ss_dssp             EECCSSEETT--TS-----CCC---HHHHHHHHHHHHHHHTTSC
T ss_pred             EEecCCcccC--cC-----cCC---HhHHHHHHHHHHHHHhCCC
Confidence            9999 76763  11     122   2356677778888888643

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.22  E-value=1.6e-11  Score=114.76  Aligned_cols=102  Identities=17%  Similarity=0.140  Sum_probs=72.0

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHh-cCCCCCcceEEEeeeeecC---CeEEEEEc
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYR---NHICIVFE  173 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~~~~~---~~~~lv~e  173 (411)
                      +.++.|..+.||++.     ..+++|+.... .....+.+|..+++.+. +..+..|.++   ......   ...|+||+
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~---~~~~~~~~~~~~~~vm~   96 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVV---FTGMPSETYQMSFAGFT   96 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEE---EECCCCSSCSCSCEEEE
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceE---eecCCCCCCCcceEEEc
Confidence            458999999999873     45899986543 34567889999999984 4444444433   332222   24589999


Q ss_pred             cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 015222          174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE  212 (411)
Q Consensus       174 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  212 (411)
                      ++ |.+|.+....    .++.++...++.|++..|..||+
T Consensus        97 ~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~  132 (304)
T 3sg8_A           97 KIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHS  132 (304)
T ss_dssp             CCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHc
Confidence            99 7777654332    47788888899999999999986

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.19  E-value=6.7e-11  Score=113.13  Aligned_cols=108  Identities=14%  Similarity=0.151  Sum_probs=76.3

Q ss_pred             EEeeeccccceEEEEEEeCCCCcEEEEEEec--cch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC---CeE
Q 015222           96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR---NHI  168 (411)
Q Consensus        96 i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~--~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~---~~~  168 (411)
                      .++.|+.|.++.||++...  +..+++|+..  ...  .....+.+|+.+++.+...++.   +.+++.++.+.   +..
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vp---vP~~~~~~~~~~~~g~~  116 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVP---VAKMYALCEDESVIGRA  116 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSC---CCCEEEEECCTTTTSSC
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCC---CCcEEEECCCCCccCCe
Confidence            4678899999999998754  4578899876  322  2345678899999999876553   35555555554   458


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE  212 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  212 (411)
                      |+|||++ |..+.+.    ....++......++.+++..|..||+
T Consensus       117 ~~vme~v~G~~l~~~----~~~~l~~~~~~~~~~~l~~~La~LH~  157 (359)
T 3dxp_A          117 FYIMEFVSGRVLWDQ----SLPGMSPAERTAIYDEMNRVIAAMHT  157 (359)
T ss_dssp             EEEEECCCCBCCCCT----TCTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEecCCeecCCC----ccccCCHHHHHHHHHHHHHHHHHHhC
Confidence            9999999 6665331    11247788889999999999999997

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.73  E-value=1.7e-07  Score=87.31  Aligned_cols=103  Identities=17%  Similarity=0.112  Sum_probs=67.3

Q ss_pred             EeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcC-CCCCcceEEEeeee-ecCCeEEEEEcc
Q 015222           97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH-DIGGTRCVQIRNWF-DYRNHICIVFEK  174 (411)
Q Consensus        97 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~-~i~~~~iv~~~~~~-~~~~~~~lv~e~  174 (411)
                      ++.++.|....||+.     +..+++|+... ......+.+|..+|+.+.+. .+..|   .++.+. ...+..++|||+
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP---~~~~~~~~~~g~~~~v~e~   94 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIP---QYVYIGKRSDGNPFVGYRK   94 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCC---CEEEEEECTTSCEEEEEEC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCC---CeEeecccCCCceEEEEec
Confidence            356788888999988     45688998543 33456788999999999864 33223   333333 235667899999


Q ss_pred             C-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 015222          175 L-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE  212 (411)
Q Consensus       175 ~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  212 (411)
                      + |.+|.+....    .++......++.++...|..||+
T Consensus        95 i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~  129 (306)
T 3tdw_A           95 VQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSA  129 (306)
T ss_dssp             CCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhc
Confidence            9 7777653221    24555555666666666666664

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.53  E-value=1.9e-06  Score=78.44  Aligned_cols=101  Identities=12%  Similarity=0.145  Sum_probs=69.4

Q ss_pred             eccccce-EEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC-CC
Q 015222          100 MGEGTFG-QVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GP  177 (411)
Q Consensus       100 lG~G~~g-~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~-~~  177 (411)
                      +..|..| .||+......+..+++|+-...  ....+.+|..+|+.+.. .+.   +.+++.+..+.+..++|||++ |.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~-~vP---VP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTA-FMP---LPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTT-TSC---CCCEEEEEEETTEEEEEEECCCSE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhcc-CCC---cCeEEEEEEECCeEEEEEEeeCCc
Confidence            3445444 7999888777888999986543  34567889999999963 453   456666777788999999999 77


Q ss_pred             CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 015222          178 SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE  212 (411)
Q Consensus       178 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  212 (411)
                      ++.+......      .....+..++...|..||+
T Consensus       106 ~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~  134 (272)
T 4gkh_A          106 TAFQVLEEYP------DSGENIVDALAVFLRRLHS  134 (272)
T ss_dssp             EHHHHHHHCG------GGHHHHHHHHHHHHHHHHT
T ss_pred             cccccccCCH------HHHHHHHHHHHHHHHHhcC
Confidence            8777654321      2233455666666666663

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.39  E-value=2e-06  Score=83.06  Aligned_cols=77  Identities=21%  Similarity=0.224  Sum_probs=48.8

Q ss_pred             EEeeeccccceEEEEEEeCCCCcEEEEEEeccch--------hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        96 i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--------~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      -.+.||.|..+.||++....+++.|+||......        ...+....|..+++.+....  ...+..++.+  +.+.
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~--~~~vP~~~~~--d~~~  109 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV--PHLVPRVFYS--DTEM  109 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTC--GGGSCCEEEE--ETTT
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhC--CCCcCeEEEE--cCCc
Confidence            3568999999999999876667889999864321        12345678999999886531  0122344433  2344


Q ss_pred             EEEEEccCC
Q 015222          168 ICIVFEKLG  176 (411)
Q Consensus       168 ~~lv~e~~~  176 (411)
                      .++|||++.
T Consensus       110 ~~lvmE~l~  118 (397)
T 2olc_A          110 AVTVMEDLS  118 (397)
T ss_dssp             TEEEECCCT
T ss_pred             cEEEEEeCC
Confidence            689999993

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.34  E-value=7.7e-06  Score=76.88  Aligned_cols=77  Identities=12%  Similarity=0.214  Sum_probs=46.7

Q ss_pred             EeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEe-e--eeecCCeEEEEEc
Q 015222           97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR-N--WFDYRNHICIVFE  173 (411)
Q Consensus        97 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~-~--~~~~~~~~~lv~e  173 (411)
                      ++.|+.|..+.||++... + ..+++|+....   ......|..+++.|...++..|.++... +  +....+..+++|+
T Consensus        37 ~~~l~gG~~n~~~~v~~~-~-~~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD-S-GAVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EEECC----CEEEEEEET-T-EEEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeeccccccCcEEEEEeC-C-CCEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            456676778899998753 3 34899998752   2345567888888876665334433311 1  1234677899999


Q ss_pred             cC-CCC
Q 015222          174 KL-GPS  178 (411)
Q Consensus       174 ~~-~~~  178 (411)
                      ++ |.+
T Consensus       112 ~i~G~~  117 (346)
T 2q83_A          112 WIEGRP  117 (346)
T ss_dssp             CCCCBC
T ss_pred             eecCcc
Confidence            99 543

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.26  E-value=2.2e-06  Score=81.48  Aligned_cols=82  Identities=7%  Similarity=0.068  Sum_probs=54.7

Q ss_pred             EEEeee-ccccceEEEEEEeC---C---CCcEEEEEEeccch---h-hhHHHHHHHHHHHHHhcC-CCCCcceEEEeeee
Q 015222           95 RILSKM-GEGTFGQVVECFDN---E---KKELVAIKIVRSIN---K-YREAAMIEIDVLQRLARH-DIGGTRCVQIRNWF  162 (411)
Q Consensus        95 ~i~~~l-G~G~~g~V~~a~~~---~---~~~~vavK~~~~~~---~-~~~~~~~E~~~l~~l~~~-~i~~~~iv~~~~~~  162 (411)
                      ...+.| +.|..+.+|+....   .   +++.+++|+.....   . ....+.+|+.+++.+... .+..|   +++.+.
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP---~v~~~~   99 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVP---RVRWIE   99 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCC---CEEEEE
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCC---cEEEEc
Confidence            445778 88989999988653   1   15678999875432   1 135678899999999765 55334   444444


Q ss_pred             ecC---CeEEEEEccC-CCCH
Q 015222          163 DYR---NHICIVFEKL-GPSL  179 (411)
Q Consensus       163 ~~~---~~~~lv~e~~-~~~L  179 (411)
                      .+.   +..++|||++ |..+
T Consensus       100 ~~~~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          100 TTGDVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             CSSTTTSSCEEEEECCCCBCC
T ss_pred             cCCCccCCceEEEEecCCCCh
Confidence            443   4568999999 5443

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=98.02  E-value=3e-05  Score=71.78  Aligned_cols=69  Identities=10%  Similarity=-0.019  Sum_probs=46.8

Q ss_pred             EeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC-
Q 015222           97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-  175 (411)
Q Consensus        97 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~-  175 (411)
                      ++.|+.|....+|++      +.+++|+............+|+.+++.+...++. |.++   ...  .+.-++|+||+ 
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~-P~~~---~~~--~~~~~~v~e~i~   90 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVS-PEVL---HVD--PATGVMVTRYIA   90 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSS-CCEE---EEC--TTTCCEEEECCT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCC-CceE---EEE--CCCCEEEEeecC
Confidence            578888999999998      4489999865332223346799999999888774 4443   332  22346899999 


Q ss_pred             CC
Q 015222          176 GP  177 (411)
Q Consensus       176 ~~  177 (411)
                      +|
T Consensus        91 ~g   92 (301)
T 3dxq_A           91 GA   92 (301)
T ss_dssp             TC
T ss_pred             CC
Confidence            65

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.88  E-value=0.00012  Score=67.94  Aligned_cols=76  Identities=22%  Similarity=0.232  Sum_probs=57.3

Q ss_pred             EEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcC-CCCCcceEEEeeeeecCCeEEEEEcc
Q 015222           96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH-DIGGTRCVQIRNWFDYRNHICIVFEK  174 (411)
Q Consensus        96 i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~-~i~~~~iv~~~~~~~~~~~~~lv~e~  174 (411)
                      -.+.|+.|....+|+...  ++..+++|+....  ....+..|...|+.|... .+   .+.+++.+....+..++|||+
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v---~VP~vl~~~~~~g~~~lvme~  112 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSI---NVPLVYGIGNSQGHSFLLLEA  112 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSS---BCCCEEEEEECSSEEEEEEEC
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCC---CcceEEEEeecCCceEEEEEe
Confidence            357889999999999874  4567889987543  356688899999999764 23   345666666667889999999


Q ss_pred             C-CCC
Q 015222          175 L-GPS  178 (411)
Q Consensus       175 ~-~~~  178 (411)
                      + |..
T Consensus       113 l~G~~  117 (312)
T 3jr1_A          113 LNKSK  117 (312)
T ss_dssp             CCCCC
T ss_pred             ccCCC
Confidence            9 654

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.74  E-value=0.00031  Score=65.37  Aligned_cols=81  Identities=10%  Similarity=0.064  Sum_probs=50.3

Q ss_pred             EEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEee---eeecCCeEEEE
Q 015222           95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN---WFDYRNHICIV  171 (411)
Q Consensus        95 ~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~---~~~~~~~~~lv  171 (411)
                      .-++.|+.|....+|++... ++ .+++|+.... ...+.+..|+.+++.+...++..|.++...+   +....+..+++
T Consensus        25 ~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l  101 (322)
T 2ppq_A           25 TSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL  101 (322)
T ss_dssp             EEEEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred             eEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence            34567888888999998753 33 5889998652 2234567799999999877764444443211   11234678999


Q ss_pred             EccC-CCC
Q 015222          172 FEKL-GPS  178 (411)
Q Consensus       172 ~e~~-~~~  178 (411)
                      |+++ |..
T Consensus       102 ~~~l~G~~  109 (322)
T 2ppq_A          102 ISFLEGMW  109 (322)
T ss_dssp             EECCCCBC
T ss_pred             EEeCCCcC
Confidence            9999 543

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.71  E-value=0.00015  Score=70.43  Aligned_cols=76  Identities=17%  Similarity=0.253  Sum_probs=43.5

Q ss_pred             EEeeeccccceEEEEEEeCCCCcEEEEEEeccc-----hh---hhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-----NK---YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        96 i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-----~~---~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      -++.||.|..+.||++..  +++.++||.....     ..   .......|.+++..+....  ...+.+++.+.  .+.
T Consensus        38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~--~~~vP~v~~~~--~~~  111 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLS--PDHVPEVYHFD--RTM  111 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHS--GGGSCCEEEEE--TTT
T ss_pred             EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhC--CCCCCeEEEEC--CCc
Confidence            356789999999999954  4677999943210     11   0122333444444443211  11234444443  456


Q ss_pred             EEEEEccC-CC
Q 015222          168 ICIVFEKL-GP  177 (411)
Q Consensus       168 ~~lv~e~~-~~  177 (411)
                      .++|||++ ++
T Consensus       112 ~~lv~e~l~~g  122 (420)
T 2pyw_A          112 ALIGMRYLEPP  122 (420)
T ss_dssp             TEEEECCCCTT
T ss_pred             cEEEEeecCCc
Confidence            78999999 76

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.64  E-value=0.00024  Score=66.56  Aligned_cols=78  Identities=10%  Similarity=0.036  Sum_probs=41.5

Q ss_pred             eeeccccceE-EEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC-
Q 015222           98 SKMGEGTFGQ-VVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-  175 (411)
Q Consensus        98 ~~lG~G~~g~-V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~-  175 (411)
                      +.|+.|.... +|+... .+++.+++|......  ...+..|+.+++.+...++..|.++   .+....+  +++||++ 
T Consensus        24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~---~~d~~~g--~ll~e~l~   95 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIY---AEEHARG--LLLIEDLG   95 (333)
T ss_dssp             CC--------CCEEEEC-TTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEE---EEETTTT--EEEECCCC
T ss_pred             eECCCCCCCceEEEEEc-CCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCcee---eecCCCC--EEEEeeCC
Confidence            3555554443 667653 225567777654321  1345678999999987666444444   3322333  6899999 


Q ss_pred             CCCHHHHH
Q 015222          176 GPSLYDFL  183 (411)
Q Consensus       176 ~~~L~~~l  183 (411)
                      +..+.+.+
T Consensus        96 ~~~l~~~l  103 (333)
T 3csv_A           96 DALFTEVI  103 (333)
T ss_dssp             SCBHHHHH
T ss_pred             CcchHHHh
Confidence            55665544

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.54  E-value=0.0012  Score=60.34  Aligned_cols=78  Identities=10%  Similarity=0.006  Sum_probs=54.3

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcC-CCCCcceEEEeeeeecCCeEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARH-DIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~-~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      .+..-++.+|.|..+.||+.+. .+|+.|++|+..... .....+..|...|+.|... .+..|.++   .+.    .-+
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~---~~~----~~~   86 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVA---GWD----DRT   86 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEE---EEE----TTE
T ss_pred             CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEE---ecc----Cce
Confidence            4566788999999999999975 467889999865332 2335578899999999653 34334333   321    236


Q ss_pred             EEEccC-CC
Q 015222          170 IVFEKL-GP  177 (411)
Q Consensus       170 lv~e~~-~~  177 (411)
                      +|||++ ++
T Consensus        87 lv~e~l~~~   95 (288)
T 3f7w_A           87 LAMEWVDER   95 (288)
T ss_dssp             EEEECCCCC
T ss_pred             EEEEeeccc
Confidence            899998 44

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.49  E-value=0.00074  Score=62.89  Aligned_cols=78  Identities=14%  Similarity=0.181  Sum_probs=50.7

Q ss_pred             eeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEee--eeecCCeEEEEEccC
Q 015222           98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN--WFDYRNHICIVFEKL  175 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~--~~~~~~~~~lv~e~~  175 (411)
                      ..|+ |....||++.. .+|+.+++|+..........+..|..+++.+...++.-|.++..-+  +...++..+++|+++
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            3456 77789998754 3455799999874333456677899999999876653333332211  122356778999999


Q ss_pred             CC
Q 015222          176 GP  177 (411)
Q Consensus       176 ~~  177 (411)
                      .|
T Consensus       110 ~G  111 (328)
T 1zyl_A          110 GG  111 (328)
T ss_dssp             CC
T ss_pred             CC
Confidence            43

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.43  E-value=0.00034  Score=66.76  Aligned_cols=73  Identities=14%  Similarity=0.176  Sum_probs=45.9

Q ss_pred             eeeccccceEEEEEEeCC-------CCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           98 SKMGEGTFGQVVECFDNE-------KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~~-------~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      +.|..|-...+|++....       +++.|++|+............+|..+++.|...++. |   +++..+..    .+
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~-P---~ll~~~~~----g~  127 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLG-P---QLYGVFPE----GR  127 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSS-C---CEEEEETT----EE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCC-C---eEEEEcCC----cc
Confidence            567678888899987642       357899999744333455667899999999888773 3   44455543    28


Q ss_pred             EEccC-CCC
Q 015222          171 VFEKL-GPS  178 (411)
Q Consensus       171 v~e~~-~~~  178 (411)
                      ||||+ |.+
T Consensus       128 v~e~i~G~~  136 (379)
T 3feg_A          128 LEQYIPSRP  136 (379)
T ss_dssp             EEECCSEEE
T ss_pred             EEEEecCcc
Confidence            99999 543

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.36  E-value=0.00049  Score=59.58  Aligned_cols=97  Identities=14%  Similarity=0.006  Sum_probs=61.8

Q ss_pred             CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEecCcccccCCcccccccCCCCCccccCCC
Q 015222          178 SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK  256 (411)
Q Consensus       178 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~  256 (411)
                      +|.+.|...+ .+++++++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+|.+                       
T Consensus        34 SL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V-----------------------   89 (229)
T 2yle_A           34 SLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAV-----------------------   89 (229)
T ss_dssp             EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCE-----------------------
T ss_pred             cHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCce-----------------------
Confidence            7999998776 589999999999999999876622 221233345688888877733                       


Q ss_pred             CCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh
Q 015222          257 SSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS  313 (411)
Q Consensus       257 ~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt  313 (411)
                          .+.+ +.+.         .....+.|||... ...+.+.=|||||+++|.-+-
T Consensus        90 ----~f~~-~~s~---------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           90 ----TLAP-AADD---------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ----EECC-C---------------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             ----eccc-cccc---------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence                2221 1100         1123467888763 345678889999999999986

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.30  E-value=0.0036  Score=60.83  Aligned_cols=71  Identities=14%  Similarity=0.187  Sum_probs=49.3

Q ss_pred             EEeeeccccceEEEEEEeCC-------CCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           96 ILSKMGEGTFGQVVECFDNE-------KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        96 i~~~lG~G~~g~V~~a~~~~-------~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      -++.|+.|....||++....       .++.+++|+.... ...+.+..|..+++.+...++. |   ++++.+..    
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~-P---~l~~~~~~----  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLG-P---KLYGIFSG----  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSS-S---CEEEEETT----
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCC-C---cEEEEeCC----
Confidence            45678888889999998653       2578999998432 1114556899999999887762 3   34444432    


Q ss_pred             EEEEccC
Q 015222          169 CIVFEKL  175 (411)
Q Consensus       169 ~lv~e~~  175 (411)
                      .+||||+
T Consensus       148 g~v~e~l  154 (429)
T 1nw1_A          148 GRLEEYI  154 (429)
T ss_dssp             EEEECCC
T ss_pred             CEEEEEe
Confidence            2899998

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.30  E-value=0.00093  Score=63.48  Aligned_cols=73  Identities=19%  Similarity=0.188  Sum_probs=45.1

Q ss_pred             EeeeccccceEEEEEEeCC--------CCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           97 LSKMGEGTFGQVVECFDNE--------KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        97 ~~~lG~G~~g~V~~a~~~~--------~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      ++.|+.|....+|++....        .++.+++|+.............|..+++.+...++ .|.   ++..+  .+  
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~-~P~---~~~~~--~~--  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKI-APQ---LLNTF--NG--  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTS-SCC---EEEEE--TT--
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCC-CCc---eEEec--CC--
Confidence            4577888888999997643        13679999976533222234679999999987765 333   33333  22  


Q ss_pred             EEEEccC-CC
Q 015222          169 CIVFEKL-GP  177 (411)
Q Consensus       169 ~lv~e~~-~~  177 (411)
                      ++||||+ |.
T Consensus       110 ~~v~e~i~G~  119 (369)
T 3c5i_A          110 GRIEEWLYGD  119 (369)
T ss_dssp             EEEEECCCSE
T ss_pred             cEEEEEecCC
Confidence            6899999 53

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.22  E-value=0.0036  Score=58.76  Aligned_cols=75  Identities=13%  Similarity=0.129  Sum_probs=47.3

Q ss_pred             eee--ccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCC-CcceEEEe-e--eeecCCeEEEE
Q 015222           98 SKM--GEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG-GTRCVQIR-N--WFDYRNHICIV  171 (411)
Q Consensus        98 ~~l--G~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~-~~~iv~~~-~--~~~~~~~~~lv  171 (411)
                      +.+  |.|....||++... +| .+++|+.....     ...|+.+++.|...++. -|..+... +  +....+..+++
T Consensus        27 ~~l~~G~g~~N~vy~v~~~-~g-~~vLK~~~~~~-----~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l   99 (339)
T 3i1a_A           27 QFIQGGADTNAFAYQADSE-SK-SYFIKLKYGYH-----DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIA   99 (339)
T ss_dssp             EEETTTSCSSCEEEEEECS-SC-EEEEEEEECSS-----CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEE
T ss_pred             EEeeccCccccceEEEEeC-CC-CEEEEEecCcc-----chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEE
Confidence            445  34446899999743 34 79999876543     24688889888876664 23323221 1  12345788999


Q ss_pred             EccC-CCCH
Q 015222          172 FEKL-GPSL  179 (411)
Q Consensus       172 ~e~~-~~~L  179 (411)
                      |+|+ |..+
T Consensus       100 ~~~i~G~~~  108 (339)
T 3i1a_A          100 YPFIHAPNG  108 (339)
T ss_dssp             EECCCCCBT
T ss_pred             EeccCCCcC
Confidence            9999 6544

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.12  E-value=0.0061  Score=59.63  Aligned_cols=73  Identities=16%  Similarity=0.128  Sum_probs=47.8

Q ss_pred             EEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC
Q 015222           96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL  175 (411)
Q Consensus        96 i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~  175 (411)
                      -++.|+.|-...+|++.....+..+++|+........-...+|..+++.|...++.    .++++.+.  +  .+||||+
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~----P~ll~~~~--~--G~v~e~I  183 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIA----KKIYVFFT--N--GRIEEFM  183 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSB----CCEEEEET--T--EEEEECC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCC----CCEEEEeC--C--eEEEEee
Confidence            35678888889999998765457899999854322222235799999999877652    34555553  2  2599998


Q ss_pred             -C
Q 015222          176 -G  176 (411)
Q Consensus       176 -~  176 (411)
                       |
T Consensus       184 ~G  185 (458)
T 2qg7_A          184 DG  185 (458)
T ss_dssp             CS
T ss_pred             CC
Confidence             5

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.48  E-value=0.0093  Score=57.66  Aligned_cols=75  Identities=16%  Similarity=0.121  Sum_probs=49.6

Q ss_pred             EEeeeccccceEEEEEEeCCC-------CcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           96 ILSKMGEGTFGQVVECFDNEK-------KELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        96 i~~~lG~G~~g~V~~a~~~~~-------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      -++.|..|-...+|++.....       ++.|++|+........-...+|..+++.+...++ .|   ++++.+.  +  
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi-~P---~l~~~~~--~--  145 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINI-AP---NIIADFP--E--  145 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTS-SC---CEEEEET--T--
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCC-CC---CEEEEcC--C--
Confidence            345677788889999986531       5779999975433323345679999999987776 23   3333332  2  


Q ss_pred             EEEEccC-CCC
Q 015222          169 CIVFEKL-GPS  178 (411)
Q Consensus       169 ~lv~e~~-~~~  178 (411)
                      ++||||+ |.+
T Consensus       146 ~~I~efI~G~~  156 (424)
T 3mes_A          146 GRIEEFIDGEP  156 (424)
T ss_dssp             EEEEECCCSEE
T ss_pred             CEEEEEeCCcc
Confidence            6899999 544

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.03  E-value=0.068  Score=51.15  Aligned_cols=71  Identities=17%  Similarity=0.226  Sum_probs=39.7

Q ss_pred             EeeeccccceEEEEEEeCC-------CCcEEEEEEeccchh-------------------hhHHHHHHHHHHHHHhcCCC
Q 015222           97 LSKMGEGTFGQVVECFDNE-------KKELVAIKIVRSINK-------------------YREAAMIEIDVLQRLARHDI  150 (411)
Q Consensus        97 ~~~lG~G~~g~V~~a~~~~-------~~~~vavK~~~~~~~-------------------~~~~~~~E~~~l~~l~~~~i  150 (411)
                      ++.|+.|-.-.+|++....       ..+.|++++.-....                   .......|..++..+...++
T Consensus        57 v~~lsGG~SN~~y~v~~~~~~~~~~~~~~~~llRi~g~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~e~~~~~~ls~~g~  136 (401)
T 3g15_A           57 ISVIRGGLSNMLFQCSLPDTTATLGDEPRKVLLRLYGAILQMRSCNKEGSEQAQKENEFQGAEAMVLESVMFAILAERSL  136 (401)
T ss_dssp             EEEEECSSEEEEEEEECCTTCCCSSSCCSEEEEEEEEC-----------------------CHHHHHHHHHHHHHHHTTS
T ss_pred             EEEeCCccccceEEEEECCCCcccccCCCeEEEEeCCCCccchhhhhHHHHHHHHHHhccCCCCCcchhHHHHHHHhCCC
Confidence            4566667778899997643       235688887632110                   00112246666777766665


Q ss_pred             CCcceEEEeeeeecCCeEEEEEccC
Q 015222          151 GGTRCVQIRNWFDYRNHICIVFEKL  175 (411)
Q Consensus       151 ~~~~iv~~~~~~~~~~~~~lv~e~~  175 (411)
                      +    .++++.+..    .++++|+
T Consensus       137 ~----p~l~~~f~~----g~i~e~i  153 (401)
T 3g15_A          137 G----PKLYGIFPQ----GRLEQFI  153 (401)
T ss_dssp             S----CCEEEEETT----EEEEECC
T ss_pred             C----CEEEEEECC----cEEEEec
Confidence            2    345555543    3566666

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	411
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-43
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-42
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-42
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	7e-42
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-41
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-40
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-40
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-40
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	8e-40
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-39
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-38
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-38
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-38
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-37
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-37
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-37
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-37
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-36
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-36
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-36
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-36
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-36
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-35
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-35
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-35
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-34
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-33
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	8e-33
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	9e-33
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-32
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	6e-32
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-32
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-32
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-31
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-31
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	7e-31
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-30
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-30
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-29
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-29
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-29
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-27
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-27
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	8e-27
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-27
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	9e-27
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-26
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-25
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-25
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-25
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-25
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-24
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-24
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-24
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-24
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-23
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-23
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-23
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-22
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-22
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-20
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-13

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  152 bits (385), Expect = 3e-43
 Identities = 60/267 (22%), Positives = 109/267 (40%), Gaps = 35/267 (13%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIG 151
            Y IL ++G G FG V  C +     +   K + +     +     EI ++ +L  H   
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHP-- 86

Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
             + + + + F+ +  + ++ E L G  L+D +    Y+      V    RQ  E +  M
Sbjct: 87  --KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHM 143

Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           HE  ++H D+KPENI+                             K+S++K+IDFG  T 
Sbjct: 144 HEHSIVHLDIKPENIMC-------------------------ETKKASSVKIIDFGLATK 178

Query: 271 EHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
            + D       +T  + APE++      +  D+W++G +   L SG + F   ++LE L 
Sbjct: 179 LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ 238

Query: 329 MMERVLGPLPHHMVIRADRRAEKYFRR 355
            ++R                A+ + + 
Sbjct: 239 NVKRCDWEFDEDAFSSVSPEAKDFIKN 265

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 1e-42
 Identities = 55/255 (21%), Positives = 100/255 (39%), Gaps = 40/255 (15%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARH 148
            + I   +G+G FG V    + + K ++A+K++                E+++   L   
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66

Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
           +I     +++  +F     + ++ E     ++Y  L+K     F          +L  ++
Sbjct: 67  NI-----LRLYGYFHDATRVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANAL 119

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
           ++ H  R+IH D+KPEN+LL SA  +K                           + DFG 
Sbjct: 120 SYCHSKRVIHRDIKPENLLLGSAGELK---------------------------IADFGW 152

Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
           S        + +  T  Y  PE+I G   +   DLWS+G +  E   G+  F+ +   E 
Sbjct: 153 SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 212

Query: 327 LAMMERVLGPLPHHM 341
              + RV    P  +
Sbjct: 213 YKRISRVEFTFPDFV 227

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  150 bits (380), Expect = 2e-42
 Identities = 65/267 (24%), Positives = 104/267 (38%), Gaps = 35/267 (13%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIG 151
            Y I  ++G G FG V    +       A K V + +   +E    EI  +  L RH   
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHP-- 83

Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
               V + + F+  N + +++E + G  L++ +    +     D   E  RQ+ + +  M
Sbjct: 84  --TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHM 140

Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           HE   +H DLKPENI+  +                          +S+ +KLIDFG T  
Sbjct: 141 HENNYVHLDLKPENIMFTT-------------------------KRSNELKLIDFGLTAH 175

Query: 271 --EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
               Q       T  + APEV  G    Y  D+WSVG +   L SG + F    + E L 
Sbjct: 176 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR 235

Query: 329 MMERVLGPLPHHMVIRADRRAEKYFRR 355
            ++     +            + + R+
Sbjct: 236 NVKSCDWNMDDSAFSGISEDGKDFIRK 262

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 7e-42
 Identities = 58/248 (23%), Positives = 110/248 (44%), Gaps = 40/248 (16%)

Query: 93  RYRILSKM-GEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG 151
            Y++ S++ G G  G+V++ F+   +E  A+K+++   K R     E+++  R ++    
Sbjct: 12  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQCP-- 65

Query: 152 GTRCVQIRNWFDY----RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
               V+I + ++     R  + IV E L G  L+  ++    ++F      E+ + + E+
Sbjct: 66  --HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           + ++H + + H D+KPEN+L  S     +                        +KL DFG
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAI------------------------LKLTDFG 159

Query: 267 STTF--EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
                  H   +    T +Y APEV+    ++  CD+WS+G I+  L  G   F ++  L
Sbjct: 160 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 219

Query: 325 EHLAMMER 332
                M+ 
Sbjct: 220 AISPGMKT 227

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (373), Expect = 1e-41
 Identities = 59/294 (20%), Positives = 100/294 (34%), Gaps = 39/294 (13%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDI 150
            +  +S++G G  G V +        ++A K++        R   + E+ VL        
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSP- 64

Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
                V     F     I I  E + G SL   L+K      P  ++ ++   +++ + +
Sbjct: 65  ---YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTY 119

Query: 210 MHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           + E  +++H D+KP NIL+                 +  G           IKL DFG +
Sbjct: 120 LREKHKIMHRDVKPSNILV-----------------NSRGE----------IKLCDFGVS 152

Query: 269 TFEHQDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
                  +   V TR Y +PE + G  ++   D+WS+G  LVE+  G       +  E  
Sbjct: 153 GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212

Query: 328 AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP 381
            M    +         R           G     P                +LP
Sbjct: 213 LMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP 266

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 2e-40
 Identities = 50/271 (18%), Positives = 99/271 (36%), Gaps = 34/271 (12%)

Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR 147
           + L  +Y I   +G G FG V  C +   K+    K V+     +     EI +L     
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60

Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
            +I     + +   F+    + ++FE + G  +++ +  +++       +     Q+ E+
Sbjct: 61  RNI-----LHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEA 114

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           + F+H   + H D++PENI+  +     +                         K+I+FG
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTI-------------------------KIIEFG 149

Query: 267 STTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
                    ++  + +   Y APEV      +   D+WS+G ++  L SG   F    N 
Sbjct: 150 QARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ 209

Query: 325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRR 355
           + +  +                  A  +  R
Sbjct: 210 QIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 3e-40
 Identities = 59/253 (23%), Positives = 111/253 (43%), Gaps = 41/253 (16%)

Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLAR 147
           N    + I+ ++G+G FG+V +  + E   L A K++ + + +  E  M+EID+L     
Sbjct: 9   NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68

Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
            +I     V++ + F Y N++ I+ E       D +     R      ++ + +Q L+++
Sbjct: 69  PNI-----VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDAL 123

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
            ++H+ ++IH DLK  NIL                  + DG           IKL DFG 
Sbjct: 124 NYLHDNKIIHRDLKAGNILF-----------------TLDGD----------IKLADFGV 156

Query: 268 TTFEHQDHSY---VVSTRHYRAPEVILGL-----GWNYPCDLWSVGCILVELCSGEALFQ 319
           +    +        + T ++ APEV++        ++Y  D+WS+G  L+E+   E    
Sbjct: 157 SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH 216

Query: 320 THENLEHLAMMER 332
               +  L  + +
Sbjct: 217 ELNPMRVLLKIAK 229

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  142 bits (359), Expect = 3e-40
 Identities = 63/265 (23%), Positives = 106/265 (40%), Gaps = 52/265 (19%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----------SINKYREAAMIEIDVL 142
            Y     +G G    V  C      +  A+KI+            + + REA + E+D+L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 143 QRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGR 201
           ++++ H       +Q+++ ++      +VF+ +    L+D+L +    +      R++ R
Sbjct: 64  RKVSGHP----NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMR 117

Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
            LLE +  +H+L ++H DLKPENILL                   D +          IK
Sbjct: 118 ALLEVICALHKLNIVHRDLKPENILL-----------------DDDMN----------IK 150

Query: 262 LIDFGSTTFEHQDHSY--VVSTRHYRAPEVILG------LGWNYPCDLWSVGCILVELCS 313
           L DFG +           V  T  Y APE+I         G+    D+WS G I+  L +
Sbjct: 151 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 210

Query: 314 GEALFQTHENLEHLAMMERVLGPLP 338
           G   F   + +  L M+        
Sbjct: 211 GSPPFWHRKQMLMLRMIMSGNYQFG 235

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 8e-40
 Identities = 69/256 (26%), Positives = 111/256 (43%), Gaps = 27/256 (10%)

Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLA 146
           ++ PRY  LS +GEG +G V   +DN  K  VAIK +       Y +  + EI +L R  
Sbjct: 5   DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64

Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
             +I G   +      +    + +V   +G  LY  L+    +    D +     Q+L  
Sbjct: 65  HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRG 121

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           + ++H   ++H DLKP N+LL +   +K+ D+     +  D  +                
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH---------------- 165

Query: 267 STTFEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
                    +  V+TR YRAPE++L   G+    D+WSVGCIL E+ S   +F     L+
Sbjct: 166 -----TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220

Query: 326 HLAMMERVLGPLPHHM 341
            L  +  +LG      
Sbjct: 221 QLNHILGILGSPSQED 236

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 1e-39
 Identities = 69/278 (24%), Positives = 117/278 (42%), Gaps = 32/278 (11%)

Query: 93  RYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSIN---KYREAAMIEIDVLQRLARH 148
           +Y  ++++GEG +G+V +  D +     VA+K VR          + + E+ VL+ L   
Sbjct: 8   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67

Query: 149 D---IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
           +   +     V   +  D    + +VFE +   L  +L K      P + ++++  QLL 
Sbjct: 68  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127

Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
            + F+H  R++H DLKP+NIL+ S+  +K+ D                            
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD-------------------------FGL 162

Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
                     + VV T  YRAPEV+L   +  P DLWSVGCI  E+   + LF+   +++
Sbjct: 163 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 222

Query: 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPD 363
            L  +  V+G        R      + F   +      
Sbjct: 223 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEK 260

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  138 bits (348), Expect = 2e-38
 Identities = 60/274 (21%), Positives = 110/274 (40%), Gaps = 36/274 (13%)

Query: 87  GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQR 144
            E++   Y     +G G F +V+   D   ++LVAIK +   ++     +   EI VL +
Sbjct: 4   AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHK 63

Query: 145 LARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQL 203
           + +H       V + + ++   H+ ++ + + G  L+D + +  +  +       L  Q+
Sbjct: 64  I-KHP----NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQV 116

Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
           L++V ++H+L ++H DLKPEN+L  S                        L + S I + 
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYS------------------------LDEDSKIMIS 152

Query: 264 DFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH 321
           DFG +  E           T  Y APEV+    ++   D WS+G I   L  G   F   
Sbjct: 153 DFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 212

Query: 322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRR 355
            + +    + +                A+ + R 
Sbjct: 213 NDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 246

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 3e-38
 Identities = 55/242 (22%), Positives = 104/242 (42%), Gaps = 34/242 (14%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIG 151
           +Y    K+G+G  G V    D    + VAI+ +       +E  + EI V++   ++   
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNP-- 77

Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
               V   + +   + + +V E L G SL D + +          +  + R+ L+++ F+
Sbjct: 78  --NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQALEFL 132

Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
           H  ++IH D+K +NILL     VK+ D+ F ++ + + S                     
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-------------------- 172

Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330
                S +V T ++ APEV+    +    D+WS+G + +E+  GE  +     L  L ++
Sbjct: 173 ----RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228

Query: 331 ER 332
             
Sbjct: 229 AT 230

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  137 bits (346), Expect = 6e-38
 Identities = 62/258 (24%), Positives = 106/258 (41%), Gaps = 41/258 (15%)

Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQ 143
           ++    +  L ++G G+FG V    D    E+VAIK +       N+  +  + E+  LQ
Sbjct: 11  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
           +L RH       +Q R  +   +   +V E    S  D L  +  +      +  +    
Sbjct: 71  KL-RHP----NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGA 124

Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
           L+ +A++H   +IH D+K  NILL                 S+ G           +KL 
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILL-----------------SEPGL----------VKLG 157

Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVELCSGEALFQT 320
           DFGS +     +S+ V T ++ APEVIL +    ++   D+WS+G   +EL   +     
Sbjct: 158 DFGSASIMAPANSF-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216

Query: 321 HENLEHLAMMERVLGPLP 338
              +  L  + +   P  
Sbjct: 217 MNAMSALYHIAQNESPAL 234

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 2e-37
 Identities = 59/263 (22%), Positives = 114/263 (43%), Gaps = 28/263 (10%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
           +Y  L+K+G+GTFG+V +    +  + VA+K V   N    +   A+ EI +LQ L   +
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70

Query: 150 IG---GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
           +         +   +   +  I +VF+     L   L  N    F +  ++ + + LL  
Sbjct: 71  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNG 129

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           + ++H  +++H D+K  N+L+     +K+ D+                      +     
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGL-------------------ARAFSLA 170

Query: 267 STTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
             +  ++  + VV T  YR PE++LG   +  P DLW  GCI+ E+ +   + Q +    
Sbjct: 171 KNSQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 229

Query: 326 HLAMMERVLGPLPHHMVIRADRR 348
            LA++ ++ G +   +    D  
Sbjct: 230 QLALISQLCGSITPEVWPNVDNY 252

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  134 bits (337), Expect = 7e-37
 Identities = 52/252 (20%), Positives = 92/252 (36%), Gaps = 38/252 (15%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
            Y++  ++GEG+FG + E  +    + VAIK              E    + LA      
Sbjct: 6   HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTG-- 62

Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
                +  +     H  +V + LGPSL D L     R F +  V    +Q+L  V  +HE
Sbjct: 63  --IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHE 119

Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG------ 266
             L++ D+KP+N L+                             ++ I ++DFG      
Sbjct: 120 KSLVYRDIKPDNFLIGRPNS----------------------KNANMIYVVDFGMVKFYR 157

Query: 267 ----STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE 322
                    +++   +  T  Y +    LG   +   DL ++G + +    G   +Q  +
Sbjct: 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217

Query: 323 NLEHLAMMERVL 334
              +    ER+ 
Sbjct: 218 AATNKQKYERIG 229

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 7e-37
 Identities = 67/253 (26%), Positives = 118/253 (46%), Gaps = 33/253 (13%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
            ++ + K+GEGT+G V +  +    E+VA+K +R           A+ EI +L+ L   +
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
           I     V++ +     N + +VFE L   L  F+  ++    P+ L++    QLL+ +AF
Sbjct: 63  I-----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
            H  R++H DLKP+N+L+ +   +K+ D+                               
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT------------------- 158

Query: 270 FEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
                +++ V T  YRAPE++LG   ++   D+WS+GCI  E+ +  ALF     ++ L 
Sbjct: 159 -----YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 213

Query: 329 MMERVLGPLPHHM 341
            + R LG     +
Sbjct: 214 RIFRTLGTPDEVV 226

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  133 bits (336), Expect = 8e-37
 Identities = 55/240 (22%), Positives = 92/240 (38%), Gaps = 20/240 (8%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
           RYR+  K+G G+FG +    D    E VAIK+   +        IE  + + +       
Sbjct: 8   RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-VKTKHPQLHIESKIYKMMQGGVG-- 64

Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
                IR      ++  +V E LGPSL D     S R F +  V  L  Q++  + ++H 
Sbjct: 65  --IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS 121

Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
              IH D+KP+N L+   +   +           D    K    +              +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYII-------DFGLAKKYRDAR-------THQHIPY 167

Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 332
           +++  +  T  Y +    LG+  +   DL S+G +L+    G   +Q  +        ER
Sbjct: 168 RENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER 227

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 3e-36
 Identities = 63/278 (22%), Positives = 108/278 (38%), Gaps = 40/278 (14%)

Query: 88  ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEID 140
           EN+   Y    ++G G F  V +C +       A K ++            RE    E+ 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65

Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
           +L+ + +H       + +   ++ +  + ++ E + G  L+DFL +    S   +   E 
Sbjct: 66  ILKEI-QHP----NVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 118

Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
            +Q+L  V ++H L++ H DLKPENI+L+                               
Sbjct: 119 LKQILNGVYYLHSLQIAHFDLKPENIMLLD-----------------------RNVPKPR 155

Query: 260 IKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317
           IK+IDFG        + +  +  T  + APE++         D+WS+G I   L SG + 
Sbjct: 156 IKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

Query: 318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRR 355
           F      E LA +  V               A+ + RR
Sbjct: 216 FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 253

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  133 bits (335), Expect = 4e-36
 Identities = 83/295 (28%), Positives = 134/295 (45%), Gaps = 39/295 (13%)

Query: 86  IGENLTP-RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR 144
            GE     RY ++ K+G G F  V    D      VA+KIVR    Y EAA  EI +LQR
Sbjct: 6   KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQR 65

Query: 145 LARHDIGGTRCVQIRN----------WFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
           +   D      +   +                H+ +VFE LG +L   ++K  +R  P+ 
Sbjct: 66  VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI 125

Query: 195 LVRELGRQLLESVAFMHELR-LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
            V+++ +QLL  + +MH    +IHTD+KPEN+L+   +                      
Sbjct: 126 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP-------------------- 165

Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                 IK+ D G+  +  + ++  + TR YR+PEV+LG  W    D+WS  C++ EL +
Sbjct: 166 -ENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 224

Query: 314 GEALFQTHE------NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWP 362
           G+ LF+  E      + +H+A +  +LG LP +++         +  RG   +  
Sbjct: 225 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNIS 279

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 4e-36
 Identities = 50/251 (19%), Positives = 96/251 (38%), Gaps = 33/251 (13%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDI 150
            + ++  +GEG +G+V    +   +E VA+KIV         E    EI + + L  H+ 
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHE- 63

Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
                V+        N   +  E   G  L+D +  +     P    +    QL+  V +
Sbjct: 64  ---NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVY 118

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
           +H + + H D+KPEN+LL   + +K+ D+   +    +                      
Sbjct: 119 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN--------------------- 157

Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
              +  + +  T  Y APE++    ++  P D+WS G +L  + +GE  +    +     
Sbjct: 158 -RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 216

Query: 329 MMERVLGPLPH 339
              +      +
Sbjct: 217 SDWKEKKTYLN 227

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (329), Expect = 5e-36
 Identities = 52/255 (20%), Positives = 107/255 (41%), Gaps = 46/255 (18%)

Query: 85  AIGENLTPRY-RILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEID 140
           A+G +   R+ +   ++G G+F  V +  D E    VA   ++        R+    E +
Sbjct: 1   AVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAE 60

Query: 141 VLQRLARHDIGGTRCVQIRNWF----DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDL 195
           +L+ L +H       V+  + +      +  I +V E +   +L  +L++   +   I +
Sbjct: 61  MLKGL-QHP----NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKV 113

Query: 196 VRELGRQLLESVAFMHEL--RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
           +R   RQ+L+ + F+H     +IH DLK +NI +                +   GS    
Sbjct: 114 LRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI----------------TGPTGS---- 153

Query: 254 LPKSSAIKLIDFGSTTFEHQDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312
                 +K+ D G  T +    +  V+ T  + APE+     ++   D+++ G  ++E+ 
Sbjct: 154 ------VKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMA 206

Query: 313 SGEALFQTHENLEHL 327
           + E  +   +N   +
Sbjct: 207 TSEYPYSECQNAAQI 221

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 6e-36
 Identities = 75/327 (22%), Positives = 130/327 (39%), Gaps = 50/327 (15%)

Query: 65  IPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKI 124
           +   G  P RP +                Y     +G G+FG V +    +  ELVAIK 
Sbjct: 7   VATPGQGPDRPQEVS--------------YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK 52

Query: 125 VRSINKYREAAMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFL 183
           V    +++     E+ ++++L   +I   R             ++ +V + +  ++Y   
Sbjct: 53  VLQDKRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109

Query: 184 RK--NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241
           R    + ++ P+  V+    QL  S+A++H   + H D+KP+N+LL              
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD------------- 156

Query: 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTF--EHQDHSYVVSTRHYRAPEVILG-LGWNYP 298
                        P ++ +KL DFGS       + +   + +R+YRAPE+I G   +   
Sbjct: 157 -------------PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSS 203

Query: 299 CDLWSVGCILVELCSGEALFQTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGA 357
            D+WS GC+L EL  G+ +F     ++ L  + +VLG P    +        E  F +  
Sbjct: 204 IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 263

Query: 358 RLDWPDGATSRDSMRAVWKLLRLPVID 384
              W      R    A+    RL    
Sbjct: 264 AHPWTKVFRPRTPPEAIALCSRLLEYT 290

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 2e-35
 Identities = 54/257 (21%), Positives = 96/257 (37%), Gaps = 41/257 (15%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARH 148
            + +   +G+G+FG+V      +  +  AIK ++     ++   E  M+E  VL     H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
                    +   F  + ++  V E L G  L   ++      F +        +++  +
Sbjct: 63  PF----LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGL 116

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
            F+H   +++ DLK +NIL                   KDG            K+ DFG 
Sbjct: 117 QFLHSKGIVYRDLKLDNIL-----------------LDKDGHI----------KIADFGM 149

Query: 268 TTF---EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL 324
                      +    T  Y APE++LG  +N+  D WS G +L E+  G++ F   +  
Sbjct: 150 CKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE 209

Query: 325 EHLAMMERVLGPLPHHM 341
           E    +       P  +
Sbjct: 210 ELFHSIRMDNPFYPRWL 226

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 4e-35
 Identities = 53/254 (20%), Positives = 93/254 (36%), Gaps = 34/254 (13%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARH 148
            ++    +GEG+F  VV   +       AIKI+                E DV+ RL  H
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 67

Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
                  V++   F     +           L  ++RK    SF     R    +++ ++
Sbjct: 68  P----FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSAL 121

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
            ++H   +IH DLKPENILL    ++++ D+      S +                    
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES------------------- 162

Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
              +    +  V T  Y +PE++         DLW++GCI+ +L +G   F+        
Sbjct: 163 ---KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 219

Query: 328 AMMERVLGPLPHHM 341
             + ++    P   
Sbjct: 220 QKIIKLEYDFPEKF 233

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 7e-35
 Identities = 55/265 (20%), Positives = 102/265 (38%), Gaps = 49/265 (18%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
           Y +L  +G G++G+  +       +++  K +         ++  + E+++L+ L   +I
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 151 GGTRCVQIRNWFDYR--NHICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLE 205
                V+  +    R    + IV E   G  L   + K +   +    + V  +  QL  
Sbjct: 66  -----VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 206 SVAFMHEL-----RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
           ++   H        ++H DLKP N+ L                     +          +
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFL-----------------DGKQN----------V 153

Query: 261 KLIDFGSTTFEHQDHSY---VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL 317
           KL DFG     + D S+    V T +Y +PE +  + +N   D+WS+GC+L ELC+    
Sbjct: 154 KLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 213

Query: 318 FQTHENLEHL-AMMERVLGPLPHHM 341
           F      E    + E     +P+  
Sbjct: 214 FTAFSQKELAGKIREGKFRRIPYRY 238

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (316), Expect = 4e-34
 Identities = 52/241 (21%), Positives = 92/241 (38%), Gaps = 38/241 (15%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEIDVLQRL 145
           +Y++   +G G FG V           VAIK V                  +E+ +L+++
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
           +    G    +++ +WF+  +   ++ E+  P    F       +   +L R    Q+LE
Sbjct: 65  SSGFSG---VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121

Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
           +V   H   ++H D+K ENIL+                                +KLIDF
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDL--------------------------NRGELKLIDF 155

Query: 266 G-STTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHEN 323
           G     +   ++    TR Y  PE I           +WS+G +L ++  G+  F+  E 
Sbjct: 156 GSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 215

Query: 324 L 324
           +
Sbjct: 216 I 216

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 1e-33
 Identities = 69/287 (24%), Positives = 119/287 (41%), Gaps = 38/287 (13%)

Query: 78  KDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KY 131
           + G Y   + +    +   YR L  +G G +G V    D      VAIK +        +
Sbjct: 1   RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60

Query: 132 REAAMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRS 190
            + A  E+ +L+ +   ++ G           D      +V   +G  L   ++      
Sbjct: 61  AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH---EK 117

Query: 191 FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250
              D ++ L  Q+L+ + ++H   +IH DLKP N+                         
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA------------------------ 153

Query: 251 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILV 309
              + +   +K++DFG       + +  V TR YRAPEVIL  + +    D+WSVGCI+ 
Sbjct: 154 ---VNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA 210

Query: 310 ELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRG 356
           E+ +G+ LF+  ++L+ L  + +V G  P   V R      K + +G
Sbjct: 211 EMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 257

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 8e-33
 Identities = 48/240 (20%), Positives = 93/240 (38%), Gaps = 37/240 (15%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
             ++L  +G+G FG V+      +   VA+K +++ +   +A + E  V+ +L   ++  
Sbjct: 8   ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNL-- 62

Query: 153 TRCVQIRNWF-DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
              VQ+     + +  + IV E +   SL D+LR         D + +    + E++ ++
Sbjct: 63  ---VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119

Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
                +H DL   N+L+                 S+D             K+ DFG T  
Sbjct: 120 EGNNFVHRDLAARNVLV-----------------SEDNV----------AKVSDFGLTKE 152

Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330
                        + APE +    ++   D+WS G +L E+ S   +      L+ +   
Sbjct: 153 ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 212

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 9e-33
 Identities = 64/253 (25%), Positives = 114/253 (45%), Gaps = 43/253 (16%)

Query: 96  ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK------YREAAMIEIDVLQRLARHD 149
            L  +GEG F  V +  D    ++VAIK ++  ++          A+ EI +LQ L+  +
Sbjct: 2   KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
           I     + + + F ++++I +VF+ +   L   ++ NS    P   ++      L+ + +
Sbjct: 62  I-----IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTP-SHIKAYMLMTLQGLEY 115

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
           +H+  ++H DLKP N+LL                  ++G           +KL DFG   
Sbjct: 116 LHQHWILHRDLKPNNLLL-----------------DENGV----------LKLADFGLAK 148

Query: 270 F---EHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
                ++ +++ V TR YRAPE++ G   +    D+W+VGCIL EL           +L+
Sbjct: 149 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD 208

Query: 326 HLAMMERVLGPLP 338
            L  +   LG   
Sbjct: 209 QLTRIFETLGTPT 221

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  121 bits (304), Expect = 5e-32
 Identities = 55/300 (18%), Positives = 118/300 (39%), Gaps = 44/300 (14%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
            Y+++ K+G G + +V E  +    E V +KI++ + K +     EI +L+ L       
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK--IKREIKILENLRGGP--- 90

Query: 153 TRCVQIRNWF--DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
              + + +           +VFE +         +           +R    ++L+++ +
Sbjct: 91  -NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDY 144

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
            H + ++H D+KP N+++                            +   ++LID+G   
Sbjct: 145 CHSMGIMHRDVKPHNVMIDH--------------------------EHRKLRLIDWGLAE 178

Query: 270 FEH--QDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGE-ALFQTHENLE 325
           F H  Q+++  V++R+++ PE+++    ++Y  D+WS+GC+L  +   +   F  H+N +
Sbjct: 179 FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 238

Query: 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL 385
            L  + +VLG    +  I                        R        L+    +D 
Sbjct: 239 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 298

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  122 bits (307), Expect = 6e-32
 Identities = 51/254 (20%), Positives = 101/254 (39%), Gaps = 38/254 (14%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARH 148
            + +   +G G FG+V  C   +  ++ A+K +      + +    A+ E  +L  ++  
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
           D      V +   F   + +  + + + G  L+  L ++    F    +R    +++  +
Sbjct: 65  DC--PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGL 120

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
             MH   +++ DLKP NILL    +V                           ++ D G 
Sbjct: 121 EHMHNRFVVYRDLKPANILLDEHGHV---------------------------RISDLGL 153

Query: 267 STTFEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
           +  F  +     V T  Y APEV+  G+ ++   D +S+GC+L +L  G + F+ H+  +
Sbjct: 154 ACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 213

Query: 326 HLAMMERVLGPLPH 339
              +    L     
Sbjct: 214 KHEIDRMTLTMAVE 227

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 6e-32
 Identities = 60/267 (22%), Positives = 104/267 (38%), Gaps = 33/267 (12%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
           RY+ L  +G G  G V   +D      VAIK +        + + A  E+ +++ +   +
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77

Query: 150 IGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I         +   +    + +V E +  +L   ++         + +  L  Q+L  + 
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCGIK 133

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
            +H   +IH DLKP NI++ S   +K+ D                              T
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTLKILD-------------------------FGLART 168

Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
                  +  V TR+YRAPEVILG+G+    D+WSVGCI+ E+   + LF   + ++   
Sbjct: 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228

Query: 329 MMERVLGPLPHHMVIRADRRAEKYFRR 355
            +   LG      + +       Y   
Sbjct: 229 KVIEQLGTPCPEFMKKLQPTVRNYVEN 255

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  121 bits (305), Expect = 6e-32
 Identities = 54/253 (21%), Positives = 98/253 (38%), Gaps = 37/253 (14%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARH 148
           ++  +  +G G+FG+V+     E     A+KI+        K  E  + E  +LQ +   
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
            +         ++ D  N   ++    G  ++  LR+     F     R    Q++ +  
Sbjct: 102 FL----VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFE 155

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H L LI+ DLKPEN+L+                  + G           I++ DFG  
Sbjct: 156 YLHSLDLIYRDLKPENLLI-----------------DQQGY----------IQVTDFGFA 188

Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLA 328
                    +  T    APE+IL  G+N   D W++G ++ E+ +G   F   + ++   
Sbjct: 189 KRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

Query: 329 MMERVLGPLPHHM 341
            +       P H 
Sbjct: 249 KIVSGKVRFPSHF 261

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  120 bits (302), Expect = 1e-31
 Identities = 54/252 (21%), Positives = 96/252 (38%), Gaps = 37/252 (14%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHD 149
           ++IL  +G G+FG+V            A+K+++       K  E    E  +L  +    
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
           I     +++   F     I ++ + +       L + S R FP  + +    ++  ++ +
Sbjct: 66  I-----IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEY 119

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
           +H   +I+ DLKPENILL                  K+G           IK+ DFG   
Sbjct: 120 LHSKDIIYRDLKPENILL-----------------DKNGH----------IKITDFGFAK 152

Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAM 329
           +       +  T  Y APEV+    +N   D WS G ++ E+ +G   F     ++    
Sbjct: 153 YVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK 212

Query: 330 MERVLGPLPHHM 341
           +       P   
Sbjct: 213 ILNAELRFPPFF 224

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 3e-31
 Identities = 62/272 (22%), Positives = 121/272 (44%), Gaps = 35/272 (12%)

Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRL 145
            +  RY+ LS +G G +G V   FD +    VA+K +        + +    E+ +L+ +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74

Query: 146 ARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
              ++ G           +  N + +V   +G  L + ++    +    D V+ L  Q+L
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQIL 131

Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
             + ++H   +IH DLKP N+                            + +   +K++D
Sbjct: 132 RGLKYIHSADIIHRDLKPSNLA---------------------------VNEDCELKILD 164

Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHEN 323
           FG       + +  V+TR YRAPE++L    +N   D+WSVGCI+ EL +G  LF   ++
Sbjct: 165 FGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224

Query: 324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRR 355
           ++ L ++ R++G     ++ +    + + + +
Sbjct: 225 IDQLKLILRLVGTPGAELLKKISSESARNYIQ 256

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  117 bits (294), Expect = 6e-31
 Identities = 67/294 (22%), Positives = 116/294 (39%), Gaps = 41/294 (13%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
           +Y  L K+GEGT+G V +  +N  +   A+K +R            + EI +L+ L   +
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
           I     V++ +    +  + +VFE L   L   L             +    QLL  +A+
Sbjct: 62  I-----VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAY 115

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
            H+ R++H DLKP+N+L+                            +   +K+ DFG   
Sbjct: 116 CHDRRVLHRDLKPQNLLI---------------------------NREGELKIADFGLAR 148

Query: 270 FEHQD---HSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENLE 325
                   +++ + T  YRAP+V++G   ++   D+WSVGCI  E+ +G  LF      +
Sbjct: 149 AFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208

Query: 326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 379
            L  + R+LG              +           P  +  +    +   LL 
Sbjct: 209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS 262

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  117 bits (293), Expect = 7e-31
 Identities = 53/276 (19%), Positives = 94/276 (34%), Gaps = 37/276 (13%)

Query: 89  NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQR 144
           +L+ RY +   +G G   +V    D      VA+K++R        +      E      
Sbjct: 4   HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63

Query: 145 LARHDIGGTRCVQIRNWFDYRNH----ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
           L    I     V + +  +          IV E + G +L D +              E+
Sbjct: 64  LNHPAI-----VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEV 116

Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
                +++ F H+  +IH D+KP NI++ +   VKV D+      +  G+          
Sbjct: 117 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS--------- 167

Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ 319
                           + V+ T  Y +PE   G   +   D++S+GC+L E+ +GE  F 
Sbjct: 168 ------------VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 215

Query: 320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRR 355
               +       R     P           +    +
Sbjct: 216 GDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLK 251

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 2e-30
 Identities = 54/256 (21%), Positives = 97/256 (37%), Gaps = 42/256 (16%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHD 149
           +  L  +G+GTFG+V+   +       A+KI+R             + E  VLQ      
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           +       ++  F   + +C V E   G  L+  L +   R F  +  R  G +++ ++ 
Sbjct: 67  L-----TALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALE 119

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H   +++ D+K EN++L                  KDG           IK+ DFG  
Sbjct: 120 YLHSRDVVYRDIKLENLML-----------------DKDGH----------IKITDFGLC 152

Query: 269 TFEHQDHS---YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE 325
                D +       T  Y APEV+    +    D W +G ++ E+  G   F   ++  
Sbjct: 153 KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212

Query: 326 HLAMMERVLGPLPHHM 341
              ++       P  +
Sbjct: 213 LFELILMEEIRFPRTL 228

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 5e-30
 Identities = 53/236 (22%), Positives = 100/236 (42%), Gaps = 31/236 (13%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
             +++ ++G G FG+V   + N   + VA+K ++  +   +A + E +++++L +H    
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQL-QHQ--- 68

Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
            R V++      +  I I+ E +   SL DFL+  S     I+ + ++  Q+ E +AF+ 
Sbjct: 69  -RLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
           E   IH DL+  NIL+      K+ D+  L+R  +D  Y                     
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFG-LARLIEDNEYTA------------------- 166

Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
                       + APE I    +    D+WS G +L E+ +   +         +
Sbjct: 167 ---REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 219

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (285), Expect = 1e-29
 Identities = 54/266 (20%), Positives = 106/266 (39%), Gaps = 49/266 (18%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHD 149
           +  +  ++G G+FG V +   +     VA+K++       +  +A   E+ VL++    +
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
           I     +    +      + IV +   G SLY  L     + F +  + ++ RQ  + + 
Sbjct: 66  I-----LLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMD 118

Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
           ++H   +IH DLK  NI L                  +D +          +K+ DFG  
Sbjct: 119 YLHAKSIIHRDLKSNNIFL-----------------HEDLT----------VKIGDFGLA 151

Query: 269 TFEHQDHSY-----VVSTRHYRAPEVILGLGWN---YPCDLWSVGCILVELCSGEALFQT 320
           T + +         +  +  + APEVI     N   +  D+++ G +L EL +G+  +  
Sbjct: 152 TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 211

Query: 321 HENLEHLAMMERVLGPLPHHMVIRAD 346
             N + +  M       P    +R++
Sbjct: 212 INNRDQIIFMVGRGYLSPDLSKVRSN 237

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 4e-29
 Identities = 62/253 (24%), Positives = 107/253 (42%), Gaps = 35/253 (13%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
           +Y  L K+GEGT+G V +  + E  E+VA+K VR  +       +A+ EI +L+ L   +
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62

Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
           I     V++ +       + +VFE            +       ++V+    QLL+ + F
Sbjct: 63  I-----VRLHDVLHSDKKLTLVFEFCDQD-LKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116

Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
            H   ++H DLKP+N+L+     +K+ ++                               
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--------------------- 155

Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEA-LFQTHENLEHL 327
              + +S  V T  YR P+V+ G    +   D+WS GCI  EL +    LF  ++  + L
Sbjct: 156 ---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212

Query: 328 AMMERVLGPLPHH 340
             + R+LG     
Sbjct: 213 KRIFRLLGTPTEE 225

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 6e-29
 Identities = 56/245 (22%), Positives = 93/245 (37%), Gaps = 30/245 (12%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
             R+  K+G+G FG+V     N     VAIK ++      EA + E  V+++L    +  
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKL-- 74

Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
              VQ+           +       SL DFL+  + +   +  + ++  Q+   +A++  
Sbjct: 75  ---VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131

Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
           +  +H DL+  NIL+      KV D+  L+R  +D  Y                      
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFG-LARLIEDNEYTA-------------------- 170

Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL-CSGEALFQTHENLEHLAMME 331
                      + APE  L   +    D+WS G +L EL   G   +    N E L  +E
Sbjct: 171 --RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 228

Query: 332 RVLGP 336
           R    
Sbjct: 229 RGYRM 233

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  107 bits (269), Expect = 2e-27
 Identities = 43/260 (16%), Positives = 95/260 (36%), Gaps = 39/260 (15%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
              +  K+G G +G+V E    +    VA+K ++      E  + E  V++ +   ++  
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL-- 75

Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
              VQ+           I+ E +   +L D+LR+ + +     ++  +  Q+  ++ ++ 
Sbjct: 76  ---VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132

Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
           +   IH DL   N L+                  ++            +K+ DFG +   
Sbjct: 133 KKNFIHRDLAARNCLV-----------------GENHL----------VKVADFGLSRLM 165

Query: 272 HQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
             D    H+       + APE +    ++   D+W+ G +L E+ +         +L  +
Sbjct: 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 225

Query: 328 --AMMERVLGPLPHHMVIRA 345
              + +      P     + 
Sbjct: 226 YELLEKDYRMERPEGCPEKV 245

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 7e-27
 Identities = 45/268 (16%), Positives = 88/268 (32%), Gaps = 56/268 (20%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKEL-----VAIKIVR--SINKYREAAMIEIDVLQRL 145
                  +G G FG+V+        +      VA+K+++  + +  REA M E+ ++ +L
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97

Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYR--------------- 189
             H+      V +         I ++FE      L ++LR    +               
Sbjct: 98  GSHE----NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 190 ------SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243
                     + +     Q+ + + F+     +H DL   N+L+   + VK+ D+     
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWS 303
              D +Y                                 + APE +    +    D+WS
Sbjct: 214 IMSDSNYVV----------------------RGNARLPVKWMAPESLFEGIYTIKSDVWS 251

Query: 304 VGCILVELCS-GEALFQTHENLEHLAMM 330
            G +L E+ S G   +       +   +
Sbjct: 252 YGILLWEIFSLGVNPYPGIPVDANFYKL 279

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 8e-27
 Identities = 53/261 (20%), Positives = 87/261 (33%), Gaps = 50/261 (19%)

Query: 93  RYRILSKMGEGTFGQVVEC-----FDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRL 145
           R      +G G FG+VVE        ++    VA+K+++  +    REA M E+ VL  L
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83

Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRK----------------NSY 188
             H       V +           ++ E      L +FLR+                +  
Sbjct: 84  GNHM----NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 189 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248
            +  ++ +     Q+ + +AF+     IH DL   NILL      K+ D+        D 
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308
           +Y                                 + APE I    + +  D+WS G  L
Sbjct: 200 NYVV----------------------KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFL 237

Query: 309 VELCSGEALFQTHENLEHLAM 329
            EL S  +       ++    
Sbjct: 238 WELFSLGSSPYPGMPVDSKFY 258

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (264), Expect = 8e-27
 Identities = 51/287 (17%), Positives = 102/287 (35%), Gaps = 35/287 (12%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
               + ++G G FG V   +    K+ VAIK +R      E  + E +V+ +L  H    
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHP--- 60

Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
            + VQ+      +  IC+VFE +         +     F  + +  +   + E +A++ E
Sbjct: 61  -KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119

Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
             +IH DL   N L+   + +KV D+        D                       ++
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-----------------------QY 156

Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMMER 332
              +       + +PEV     ++   D+WS G ++ E+ S   +   + +   +     
Sbjct: 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-- 214

Query: 333 VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 379
               +     +   R A  +  +     W +    R +   + + L 
Sbjct: 215 ----ISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 9e-27
 Identities = 54/299 (18%), Positives = 101/299 (33%), Gaps = 42/299 (14%)

Query: 93  RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
              +   +G+G FG+V       + E VA+KI  S  +       EI     L   +I G
Sbjct: 4   TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61

Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSY-----RSFPIDLVRELGRQLLES 206
                 ++   +   + +V +     SL+D+L + +          +     L    +E 
Sbjct: 62  FIAADNKDNGTW-TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           V    +  + H DLK +NIL+       + D     R           P           
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH--------- 171

Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYP------CDLWSVGCILVELCSGEALFQT 320
                       V T+ Y APEV+               D++++G +  E+    ++   
Sbjct: 172 -----------RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220

Query: 321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR 379
           HE+ +          P    M        +    +  R + P+   S +++R + K++R
Sbjct: 221 HEDYQLPYYDLVPSDPSVEEM-------RKVVCEQKLRPNIPNRWQSCEALRVMAKIMR 272

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  106 bits (265), Expect = 1e-26
 Identities = 50/257 (19%), Positives = 98/257 (38%), Gaps = 30/257 (11%)

Query: 88  ENLTPRYRILSKMGEGTFGQVVECFD---NEKKELVAIKIVRS--INKYREAAMIEIDVL 142
           E      +I   +G G FG+V         +++  VAIK ++S    K R   + E  ++
Sbjct: 22  EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 81

Query: 143 QRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
            +    ++     + +         + I+ E +     D   + +   F +  +  + R 
Sbjct: 82  GQFDHPNV-----IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRG 136

Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
           +   + ++ ++  +H DL   NIL+ S    KV D+  LSR  +D +       +   K+
Sbjct: 137 IAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFG-LSRFLEDDTSDPTYTSALGGKI 195

Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTH 321
                                + APE I    +    D+WS G ++ E+ S GE  +   
Sbjct: 196 ------------------PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237

Query: 322 ENLEHLAMMERVLGPLP 338
            N + +  +E+     P
Sbjct: 238 TNQDVINAIEQDYRLPP 254

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 1e-25
 Identities = 45/254 (17%), Positives = 85/254 (33%), Gaps = 48/254 (18%)

Query: 93  RYRILSKMGEGTFGQVVECFDNE--KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARH 148
             +    +GEG FGQV++    +   +   AIK ++             E++VL +L  H
Sbjct: 11  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70

Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSY--------------RSFPI 193
                  + +    ++R ++ +  E     +L DFLRK+                 +   
Sbjct: 71  P----NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126

Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
             +      +   + ++ + + IH DL   NIL+      K+ D+  LSR  +       
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF-GLSRGQEV------ 179

Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
                             +   +       + A E +    +    D+WS G +L E+ S
Sbjct: 180 ------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 221

Query: 314 GEALFQTHENLEHL 327
                        L
Sbjct: 222 LGGTPYCGMTCAEL 235

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 4e-25
 Identities = 44/261 (16%), Positives = 86/261 (32%), Gaps = 34/261 (13%)

Query: 93  RYRILSKMGEGTFGQVVECF----DNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLA 146
                  +G G FG+V +        +K+  VAIK ++     K R   + E  ++ + +
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
            H+I     +++         + I+ E +     D   +     F +  +  + R +   
Sbjct: 68  HHNI-----IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 122

Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
           + ++  +  +H DL   NIL+ S    KV D+        D                   
Sbjct: 123 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT------------ 170

Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH 326
                    S       + APE I    +    D+WS G ++ E+ +         +   
Sbjct: 171 ---------SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 221

Query: 327 L--AMMERVLGPLPHHMVIRA 345
           +  A+ +    P P       
Sbjct: 222 VMKAINDGFRLPTPMDCPSAI 242

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (251), Expect = 5e-25
 Identities = 48/250 (19%), Positives = 95/250 (38%), Gaps = 30/250 (12%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
              L ++G G FG V       + + VAIK+++  +   +  + E  V+  L+   +   
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKL--- 61

Query: 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
             VQ+      +  I I+ E +         +     F    + E+ + + E++ ++   
Sbjct: 62  --VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119

Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
           + +H DL   N L+     VKV D+  LSR   D  Y  +                    
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFG-LSRYVLDDEYTSS-------------------- 158

Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMER 332
                     +  PEV++   ++   D+W+ G ++ E+ S G+  ++   N E    + +
Sbjct: 159 --VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 216

Query: 333 VLGPLPHHMV 342
            L     H+ 
Sbjct: 217 GLRLYRPHLA 226

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (250), Expect = 9e-25
 Identities = 50/240 (20%), Positives = 104/240 (43%), Gaps = 34/240 (14%)

Query: 99  KMGEGTFGQVVECFDNEKK--ELVAIKIVR---SINKYREAAMIEIDVLQRLARHDIGGT 153
           ++G G FG V + +   KK  + VA+KI++   +    ++  + E +V+Q+L  +     
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNP---- 68

Query: 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
             V++    +  + + ++       L  +L++N  R      + EL  Q+   + ++ E 
Sbjct: 69  YIVRMIGICEAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES 126

Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL   N+LLV+  Y K+ D+  LS+                       +    ++
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDF-GLSK--------------------ALRADENYYK 165

Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE-LCSGEALFQTHENLEHLAMMER 332
             ++      + APE I    ++   D+WS G ++ E    G+  ++  +  E  AM+E+
Sbjct: 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 225

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (250), Expect = 1e-24
 Identities = 63/296 (21%), Positives = 105/296 (35%), Gaps = 43/296 (14%)

Query: 99  KMGEGTFGQVVECFDNEKKE--LVAIKIVR--SINKYREAAMIEIDVLQRLARHDIGGTR 154
           ++G G FG V +     +K+   VAIK+++  +     E  M E  ++ +L    I    
Sbjct: 16  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI---- 71

Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
            V++         + +V E   G  L+ FL        P+  V EL  Q+   + ++ E 
Sbjct: 72  -VRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK 128

Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
             +H DL   N+LLV+  Y K+ D+        D SY                     + 
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY---------------------YT 167

Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE-LCSGEALFQTHENLEHLAMMER 332
             S       + APE I    ++   D+WS G  + E L  G+  ++  +  E +A +E+
Sbjct: 168 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227

Query: 333 VL-GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYS 387
                 P                      W      R     V + +R     L S
Sbjct: 228 GKRMECPPEC--------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  100 bits (250), Expect = 1e-24
 Identities = 47/268 (17%), Positives = 87/268 (32%), Gaps = 57/268 (21%)

Query: 93  RYRILSKMGEGTFGQVVEC-----FDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRL 145
               +  +GEG FG+V +         E   +VA+K+++  +    +     E  ++   
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73

Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRS-------------- 190
                     V++         +C++FE +    L +FLR  S  +              
Sbjct: 74  DNP-----NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128

Query: 191 --------FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242
                           + RQ+   +A++ E + +H DL   N L+     VK+ D+  LS
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF-GLS 187

Query: 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLW 302
           R+     Y+K                               +  PE I    +    D+W
Sbjct: 188 RNIYSADYYKA---------------------DGNDAIPIRWMPPESIFYNRYTTESDVW 226

Query: 303 SVGCILVELCSGEALFQTHENLEHLAMM 330
           + G +L E+ S           E +   
Sbjct: 227 AYGVVLWEIFSYGLQPYYGMAHEEVIYY 254

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.5 bits (247), Expect = 2e-24
 Identities = 47/243 (19%), Positives = 84/243 (34%), Gaps = 34/243 (13%)

Query: 93  RYRILSKMGEGTFGQVVECFD---NEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLAR 147
           R  +   +GEG FG V +            VAIK  ++   +  RE  + E   +++   
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-D 66

Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
           H       V++       N + I+ E           +    S  +  +     QL  ++
Sbjct: 67  HP----HIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 121

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
           A++   R +H D+   N+L+ S + VK+ D+  LSR  +D +Y+K               
Sbjct: 122 AYLESKRFVHRDIAARNVLVSSNDCVKLGDF-GLSRYMEDSTYYK--------------- 165

Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
                   S       + APE I    +    D+W  G  + E+               +
Sbjct: 166 -------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 218

Query: 328 AMM 330
              
Sbjct: 219 IGR 221

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.1 bits (246), Expect = 3e-24
 Identities = 43/254 (16%), Positives = 95/254 (37%), Gaps = 35/254 (13%)

Query: 93  RYRILSKMGEGTFGQVVECF---DNEKKELVAIKIVR----SINKYREAAMIEIDVLQRL 145
             R+L K+G+G+FG V        + K   VA+K ++    S  +  +  + E++ +  L
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68

Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
              ++     +++         + +V E           +     F +  +     Q+ E
Sbjct: 69  DHRNL-----IRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122

Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
            + ++   R IH DL   N+LL + + VK+ D+  +    ++  +               
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH--------------- 167

Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL 324
                 +    +      + APE +    +++  D W  G  L E+ + G+  +      
Sbjct: 168 ------YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 221

Query: 325 EHLAMMERVLGPLP 338
           + L  +++    LP
Sbjct: 222 QILHKIDKEGERLP 235

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.3 bits (244), Expect = 1e-23
 Identities = 40/237 (16%), Positives = 77/237 (32%), Gaps = 29/237 (12%)

Query: 99  KMGEGTFGQVVECFD---NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGT 153
            +G G FG V        + KK   A+K +  I         + E  +++  +  ++   
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV--- 90

Query: 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
               +           +V   +         +N   +  +  +   G Q+ + + F+   
Sbjct: 91  -LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149

Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
           + +H DL   N +L     VKV D+  L+R   D  +     K+                
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADF-GLARDMYDKEFDSVHNKTG--------------- 193

Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHLAMM 330
                     + A E +    +    D+WS G +L EL +  A      N   + + 
Sbjct: 194 ----AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 246

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.4 bits (244), Expect = 1e-23
 Identities = 48/251 (19%), Positives = 100/251 (39%), Gaps = 40/251 (15%)

Query: 93  RYRILSKMGEGTFGQV---VECFDNEKKELVAIKIVRSIN-----KYREAAMIEIDVLQR 144
            + +L  +G G +G+V    +   ++  +L A+K+++        K  E    E  VL+ 
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 145 LARHDIGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
           + +        V +   F     + ++ +   G  L+  L +     F    V+    ++
Sbjct: 85  IRQSPF----LVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEI 138

Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
           + ++  +H+L +I+ D+K ENILL S  +V + D+                    + + +
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL------------------SKEFV 180

Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGEALFQTH 321
              +        +       Y AP+++ G   G +   D WS+G ++ EL +G + F   
Sbjct: 181 ADETERAYDFCGTI-----EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 235

Query: 322 ENLEHLAMMER 332
                 A + R
Sbjct: 236 GEKNSQAEISR 246

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.1 bits (238), Expect = 5e-23
 Identities = 43/275 (15%), Positives = 91/275 (33%), Gaps = 52/275 (18%)

Query: 93  RYRILSKMGEGTFGQVVECFD-------NEKKELVAIKIVR--SINKYREAAMIEIDVLQ 143
           R  +   +GEG FGQVV             +   VA+K+++  +  K     + E+++++
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73

Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLR--------------KNSY 188
            + +H       + +         + ++ E     +L ++L+               N  
Sbjct: 74  MIGKHKN----IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 189 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248
                  +     Q+   + ++   + IH DL   N+L+     +K+ D+          
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308
            Y K                       +       + APE +    + +  D+WS G +L
Sbjct: 190 YYKK----------------------TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 227

Query: 309 VELCSGEALFQTHENLEHL--AMMERVLGPLPHHM 341
            E+ +          +E L   + E      P + 
Sbjct: 228 WEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNC 262

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.9 bits (235), Expect = 1e-22
 Identities = 44/267 (16%), Positives = 95/267 (35%), Gaps = 45/267 (16%)

Query: 93  RYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVR--SINKYREAAMIEIDVLQRL 145
           +  +  ++G+G+FG V E        +E +  VAIK V   +  + R   + E  V++  
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80

Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKN--------SYRSFPIDLV 196
             H +     V++           ++ E +    L  +LR                +  +
Sbjct: 81  NCHHV-----VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135

Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256
            ++  ++ + +A+++  + +H DL   N ++     VK+ D+       +   Y K    
Sbjct: 136 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK---- 191

Query: 257 SSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEA 316
                                 +    + +PE +    +    D+WS G +L E+ +   
Sbjct: 192 ------------------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 233

Query: 317 LFQTHENLEHL--AMMERVLGPLPHHM 341
                 + E +   +ME  L   P + 
Sbjct: 234 QPYQGLSNEQVLRFVMEGGLLDKPDNC 260

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.7 bits (232), Expect = 5e-22
 Identities = 40/243 (16%), Positives = 86/243 (35%), Gaps = 34/243 (13%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKEL----VAIKIVRSIN--KYREAAMIEIDVLQRLAR 147
           ++ +  +G G FG V +     + E     VAIK +R     K  +  + E  V+  +  
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
             +      ++           I        L D++R++   +     +     Q+ + +
Sbjct: 71  PHV-----CRLLGICLTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGM 124

Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
            ++ + RL+H DL   N+L+ + ++VK+ D+  L++                        
Sbjct: 125 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFG-LAKLLGAEEK----------------- 166

Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEHL 327
                           + A E IL   + +  D+WS G  + EL +  +          +
Sbjct: 167 ----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 222

Query: 328 AMM 330
           + +
Sbjct: 223 SSI 225

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.4 bits (218), Expect = 3e-20
 Identities = 50/269 (18%), Positives = 87/269 (32%), Gaps = 49/269 (18%)

Query: 93  RYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVR--SINKYREAAMIEIDVLQRL 145
           R ++   +G G FGQV+E              VA+K+++  + +    A M E+ +L  +
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73

Query: 146 ARHDIGGTRCVQIRN-WFDYRNHICIVFEKL-GPSLYDFLRKN--------------SYR 189
             H       V +          + ++ E     +L  +LR                   
Sbjct: 74  GHHLN----VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129

Query: 190 SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249
              ++ +     Q+ + + F+   + IH DL   NILL     VK+ D+       KD  
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 250 YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309
           Y +                               + APE I    +    D+WS G +L 
Sbjct: 190 YVR----------------------KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 227

Query: 310 ELCSGEALFQTHENLEHLAMMERVLGPLP 338
           E+ S  A       ++         G   
Sbjct: 228 EIFSLGASPYPGVKIDEEFCRRLKEGTRM 256

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 66.3 bits (161), Expect = 2e-13
 Identities = 28/219 (12%), Positives = 60/219 (27%), Gaps = 31/219 (14%)

Query: 94  YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD-IG 151
             I   MGEG    V  C+  +  E   +K  +     +++            +      
Sbjct: 2   DAIGKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
                +            +   +    L + +         ++   E+   +LE VA  +
Sbjct: 61  ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
              ++H DL   N+L+                                I +IDF  +   
Sbjct: 121 HRGIVHGDLSQYNVLVSEEG----------------------------IWIIDFPQSVEV 152

Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310
            ++    +  R  R         +    D+ S    +++
Sbjct: 153 GEEGWREILERDVRNIITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	411
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.5
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.14
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.0
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.83
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.32
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.08

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-60  Score=438.02  Aligned_cols=249  Identities=24%  Similarity=0.393  Sum_probs=222.4

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++.+.||+|+||+||+|+++.+++.||+|++.+..    ...+.+.+|+.++++++|+||     +++++++.+++.
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~~~~~~~~~~~   80 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI-----LRLYGYFHDATR   80 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTB-----CCEEEEEECSSE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCC-----CeEEEEEEECCE
Confidence            57999999999999999999999999999999996432    345678899999999988877     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+||||| +|+|.+++.+..  .+++..++.++.||+.||+|||++|||||||||+|||++.+|               
T Consensus        81 ~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~---------------  143 (263)
T d2j4za1          81 VYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG---------------  143 (263)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS---------------
T ss_pred             EEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCC---------------
Confidence            99999999 899999998765  699999999999999999999999999999999999998766               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC-CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                                  .+||+|||+|...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+
T Consensus       144 ------------~~kl~DFG~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~  211 (263)
T d2j4za1         144 ------------ELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE  211 (263)
T ss_dssp             ------------CEEECCCCSCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             ------------CEeecccceeeecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH
Confidence                        6788888887665433 345689999999999999999999999999999999999999999988888


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCc
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~  382 (411)
                      .+..+.+....+|.    .+++.++++|.+||+.|    |++|||++|+++||||..
T Consensus       212 ~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~d----p~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         212 TYKRISRVEFTFPD----FVTEGARDLISRLLKHN----PSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             HHHHHHTTCCCCCT----TSCHHHHHHHHHHTCSS----GGGSCCHHHHHTCHHHHH
T ss_pred             HHHHHHcCCCCCCc----cCCHHHHHHHHHHccCC----HhHCcCHHHHHcCcCcCC
Confidence            88888776666664    46788999999999999    999999999999999864

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-60  Score=440.80  Aligned_cols=267  Identities=25%  Similarity=0.402  Sum_probs=235.7

Q ss_pred             CccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-------hhhHHHHHHHHHHHHHhcCCCCCcceEEEee
Q 015222           88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEIDVLQRLARHDIGGTRCVQIRN  160 (411)
Q Consensus        88 ~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~  160 (411)
                      +.+.++|++.+.||+|+||+||+|+++.+|+.||||++++..       ...+.+.+|+.+|++++|+||     +++++
T Consensus         6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~~   80 (293)
T d1jksa_           6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV-----ITLHE   80 (293)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred             CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCC-----CcEEE
Confidence            346788999999999999999999999999999999996422       235678899999999988877     99999


Q ss_pred             eeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcc
Q 015222          161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK  239 (411)
Q Consensus       161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~  239 (411)
                      ++.+.+.+|+||||| +|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.       
T Consensus        81 ~~~~~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~-------  151 (293)
T d1jksa_          81 VYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNV-------  151 (293)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSS-------
T ss_pred             EEEECCEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCC-------
Confidence            999999999999999 999999998765  7999999999999999999999999999999999999987652       


Q ss_pred             cccccCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCC
Q 015222          240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL  317 (411)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p  317 (411)
                                      ....+||+|||+|......  .....||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       152 ----------------~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~P  215 (293)
T d1jksa_         152 ----------------PKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP  215 (293)
T ss_dssp             ----------------SSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ----------------cccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCC
Confidence                            2346899999999876433  3446899999999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccCC
Q 015222          318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSA  388 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~  388 (411)
                      |.+.+..+.+..+......++......++..++++|.+||..|    |++|||++++++||||+..++...
T Consensus       216 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d----P~~R~s~~eil~hp~~~~~~~~~~  282 (293)
T d1jksa_         216 FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD----PKKRMTIQDSLQHPWIKPKDTQQA  282 (293)
T ss_dssp             SCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSS----GGGSCCHHHHHHSTTTCC------
T ss_pred             CCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCC----hhHCcCHHHHhcCcccCCCChhHh
Confidence            9999999988888888888888888889999999999999999    999999999999999998776543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.3e-60  Score=445.84  Aligned_cols=263  Identities=24%  Similarity=0.364  Sum_probs=218.7

Q ss_pred             CCccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        87 ~~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      .+.+.++|++.+.||+|+||+||+|+++.+++.||||++....  .....+.+|+.++++++||||     +++++++.+
T Consensus         4 ~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnI-----v~l~~~~~~   78 (307)
T d1a06a_           4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNI-----VALDDIYES   78 (307)
T ss_dssp             CSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTB-----CCEEEEEEC
T ss_pred             CCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCC-----CcEEEEEEE
Confidence            4567788999999999999999999999999999999997533  334567789999999988877     999999999


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                      ++.+|+||||| ||+|.+++...+  .+++..+..++.||+.||+|||++||+||||||+|||+...             
T Consensus        79 ~~~~~lvmE~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~-------------  143 (307)
T d1a06a_          79 GGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL-------------  143 (307)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS-------------
T ss_pred             CCEEEEEEeccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeeccc-------------
Confidence            99999999999 899999998765  79999999999999999999999999999999999999642             


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                                 +++..+||+|||+|......  ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.
T Consensus       144 -----------~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~  212 (307)
T d1a06a_         144 -----------DEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE  212 (307)
T ss_dssp             -----------STTCCEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             -----------CCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC
Confidence                       13457899999998765433  34568999999999999999999999999999999999999999998


Q ss_pred             ChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      +..+....+.+....++......+++.+.++|.+||..|    |++|||+.|+++||||++..
T Consensus       213 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d----P~~R~s~~eil~hp~~~~~~  271 (307)
T d1a06a_         213 NDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKD----PEKRFTCEQALQHPWIAGDT  271 (307)
T ss_dssp             SHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSS----GGGSCCHHHHHHSTTTTSSC
T ss_pred             CHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCC----HhHCcCHHHHhcCHhhCCCC
Confidence            888888888877777776677788999999999999999    99999999999999998644

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-60  Score=441.05  Aligned_cols=254  Identities=24%  Similarity=0.369  Sum_probs=221.4

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      .++|+++++||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+.++++++|+||     +++++++.+++.+|
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~~~~~~~~~~~   93 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI-----VNYLDSYLVGDELW   93 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTB-----CCEEEEEEETTEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCE-----eeEeEEEEECCEEE
Confidence            468999999999999999999999999999999997543 345678999999999988877     99999999999999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +||||| ||+|.+++.+.   .+++..++.++.||+.||+|||++|||||||||+|||++.+|                 
T Consensus        94 ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-----------------  153 (293)
T d1yhwa1          94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-----------------  153 (293)
T ss_dssp             EEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-----------------
T ss_pred             EEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC-----------------
Confidence            999999 99999988765   499999999999999999999999999999999999998766                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                                .+||+|||+|......   ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+
T Consensus       154 ----------~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~  223 (293)
T d1yhwa1         154 ----------SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR  223 (293)
T ss_dssp             ----------CEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred             ----------cEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH
Confidence                      6788888887754322   244679999999999999999999999999999999999999999888877


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      .+..+..... .+......+++.++++|.+||..|    |.+|||+.|+++||||+...
T Consensus       224 ~~~~~~~~~~-~~~~~~~~~s~~~~~li~~~L~~d----P~~R~s~~eil~Hp~~~~~~  277 (293)
T d1yhwa1         224 ALYLIATNGT-PELQNPEKLSAIFRDFLNRCLDMD----VEKRGSAKELLQHQFLKIAK  277 (293)
T ss_dssp             HHHHHHHHCS-CCCSSGGGSCHHHHHHHHHHTCSS----TTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHhCCC-CCCCCcccCCHHHHHHHHHHccCC----hhHCcCHHHHhcCHhhCCCC
Confidence            7766655432 222334567889999999999999    99999999999999998543

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-60  Score=439.33  Aligned_cols=254  Identities=22%  Similarity=0.310  Sum_probs=212.2

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      +.++|++++.||+|+||+||+|+++.+|+.||||+++...  ...+.+.+|+.++++++|+||     +++++++.+++.
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnI-----v~~~~~~~~~~~   77 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV-----VKFYGHRREGNI   77 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTB-----CCEEEEEEETTE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCE-----eeEeeeeccCce
Confidence            3468999999999999999999999999999999997532  334568899999999988877     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+||||| +|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+|               
T Consensus        78 ~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~---------------  140 (271)
T d1nvra_          78 QYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD---------------  140 (271)
T ss_dssp             EEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC---------------
T ss_pred             eEEEEeccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCC---------------
Confidence            99999999 889999997654  799999999999999999999999999999999999998766               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCC-CccchhHHHHHHHHHHHhCCCCCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALFQT  320 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~pf~~  320 (411)
                                  .+||+|||+|......     ....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+
T Consensus       141 ------------~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~  208 (271)
T d1nvra_         141 ------------NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ  208 (271)
T ss_dssp             ------------CEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred             ------------CEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCC
Confidence                        6788888888754322     234689999999999998876 6789999999999999999999987


Q ss_pred             CChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCc
Q 015222          321 HENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       321 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~  382 (411)
                      .+.............. .......+++.+.++|.+||..|    |++|||++|+++||||+.
T Consensus       209 ~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~d----P~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         209 PSDSCQEYSDWKEKKT-YLNPWKKIDSAPLALLHKILVEN----PSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             SSTTSHHHHHHHTTCT-TSTTGGGSCHHHHHHHHHHSCSS----TTTSCCHHHHTTCTTTTC
T ss_pred             CChHHHHHHHHhcCCC-CCCccccCCHHHHHHHHHHcCCC----hhHCcCHHHHhcCHhhCc
Confidence            6543333322222222 22234567889999999999999    999999999999999975

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-60  Score=439.06  Aligned_cols=254  Identities=24%  Similarity=0.340  Sum_probs=222.4

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++.+.||+|+||+||+|+++.+++.||||++++..    ...+.+.+|+.++++++|+||     +++++++.+++.
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~l~~~~~~~~~   82 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF-----VKLYFTFQDDEK   82 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTB-----CCEEEEEECSSE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCe-----eEEEEEEEECCE
Confidence            46999999999999999999999999999999997432    344678899999999988877     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+||||| ||+|.+++...+  .+++..++.++.||+.||+|||++|||||||||+|||++.+|               
T Consensus        83 ~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~---------------  145 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM---------------  145 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS---------------
T ss_pred             EEEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCc---------------
Confidence            99999999 899999998776  799999999999999999999999999999999999998776               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                                  .+||+|||+|......     ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus       146 ------------~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~  213 (288)
T d1uu3a_         146 ------------HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG  213 (288)
T ss_dssp             ------------CEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ------------eEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence                        6788888887654322     23457999999999999999999999999999999999999999998


Q ss_pred             ChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHH------HHhcCCCCcccccC
Q 015222          322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRA------VWKLLRLPVIDLYS  387 (411)
Q Consensus       322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~------il~~~~~~~~~~~~  387 (411)
                      +..+.+..+.+....+|.    .+++.++++|.+||+.|    |.+|+|++|      +++||||++++|..
T Consensus       214 ~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~d----P~~R~t~~e~~~~~~i~~Hpff~~i~w~~  277 (288)
T d1uu3a_         214 NEYLIFQKIIKLEYDFPE----KFFPKARDLVEKLLVLD----ATKRLGCEEMEGYGPLKAHPFFESVTWEN  277 (288)
T ss_dssp             SHHHHHHHHHTTCCCCCT----TCCHHHHHHHHTTSCSS----GGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred             CHHHHHHHHHcCCCCCCc----cCCHHHHHHHHHHccCC----HhHCcCHHHHcCCHHHHcCCccCCCCHHH
Confidence            888888888776666664    46788999999999999    888888776      68999999998654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2e-59  Score=446.93  Aligned_cols=265  Identities=25%  Similarity=0.366  Sum_probs=235.7

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      +.++|++++.||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+|++++|+||     +++++++.+++.+
T Consensus        24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~~~~~~~~~~   98 (350)
T d1koaa2          24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL-----VNLHDAFEDDNEM   98 (350)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTB-----CCEEEEEEETTEE
T ss_pred             CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCC-----CcEEEEEEECCEE
Confidence            3468999999999999999999999999999999997543 345678899999999998877     9999999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      |+||||| ||+|.+++.+.. ..+++..++.++.||+.||+|||++|||||||||+|||++.++                
T Consensus        99 ~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~----------------  161 (350)
T d1koaa2          99 VMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR----------------  161 (350)
T ss_dssp             EEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTT----------------
T ss_pred             EEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCC----------------
Confidence            9999999 999999996543 3699999999999999999999999999999999999996432                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                               +..+||+|||+|.......  ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+
T Consensus       162 ---------~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~  232 (350)
T d1koaa2         162 ---------SNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE  232 (350)
T ss_dssp             ---------SCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             ---------CCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH
Confidence                     3478999999988755433  34689999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccCCC
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSAS  389 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~~  389 (411)
                      .+..+......++......+++.+++||.+||..|    |++|||+.|+++||||.+.......
T Consensus       233 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d----P~~R~t~~eil~hp~~~~~~~~~~~  292 (350)
T d1koaa2         233 TLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLAD----PNTRMTIHQALEHPWLTPGNAPGRD  292 (350)
T ss_dssp             HHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSS----GGGSCCHHHHHHSTTTSCTTCCSCC
T ss_pred             HHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCC----hhHCcCHHHHhcCcccCCCCCCCch
Confidence            99988888878887777888999999999999999    9999999999999999987665443

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2e-59  Score=441.22  Aligned_cols=257  Identities=22%  Similarity=0.336  Sum_probs=231.4

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++++.||+|+||+||+|+++.+|+.||||++++..    ...+.+.+|+.++++++||||     +++++++.+.+.
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~~~~~~~~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI-----IRMWGTFQDAQQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTB-----CCEEEEEECSSE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcCh-----hheeeeEeeCCe
Confidence            46999999999999999999999999999999997432    345678899999999998887     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+||||| |++|.+++....  .+++..++.++.||+.||+|||++||+||||||+||||+.+|               
T Consensus        79 ~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g---------------  141 (316)
T d1fota_          79 IFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG---------------  141 (316)
T ss_dssp             EEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS---------------
T ss_pred             eeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCC---------------
Confidence            99999999 999999998776  689999999999999999999999999999999999998766               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH  326 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~  326 (411)
                                  .+||+|||+|..........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.
T Consensus       142 ------------~vkL~DFG~a~~~~~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~  209 (316)
T d1fota_         142 ------------HIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT  209 (316)
T ss_dssp             ------------CEEECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred             ------------CEEEecCccceEeccccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH
Confidence                        68899999988877777778999999999999999999999999999999999999999999998888


Q ss_pred             HHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCC-CcHHHHHHHHhcCCCCccccc
Q 015222          327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGA-TSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       327 ~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp-~~R~t~~~il~~~~~~~~~~~  386 (411)
                      +..+......+|.    .+++.++++|.+||..||.+|+ ..|+|++++++||||+++++.
T Consensus       210 ~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~  266 (316)
T d1fota_         210 YEKILNAELRFPP----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  266 (316)
T ss_dssp             HHHHHHCCCCCCT----TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             HHHHHcCCCCCCC----CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence            8888877666654    3577899999999999988884 567899999999999998754

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.1e-59  Score=445.03  Aligned_cols=257  Identities=22%  Similarity=0.360  Sum_probs=231.7

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..    ...+.+.+|+.+|+.++|+||     +++++++.+.+.
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~~~~~~~~~~~  115 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL-----VKLEFSFKDNSN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTB-----CCEEEEEECSSE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcE-----eecccccccccc
Confidence            58999999999999999999999999999999996432    334668899999999988877     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +++||||+ +|+|.+++.+..  .+++..++.++.||+.||.|||++|||||||||+|||++.+|               
T Consensus       116 ~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g---------------  178 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG---------------  178 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS---------------
T ss_pred             cccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC---------------
Confidence            99999999 999999998876  699999999999999999999999999999999999998766               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH  326 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~  326 (411)
                                  .+||+|||+|+..........||+.|||||++.+..++.++|||||||++|||++|+.||.+.+....
T Consensus       179 ------------~ikL~DFG~a~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~  246 (350)
T d1rdqe_         179 ------------YIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI  246 (350)
T ss_dssp             ------------CEEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             ------------CEEeeeceeeeecccccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH
Confidence                        67889999888877666778999999999999999999999999999999999999999999888888


Q ss_pred             HHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCC-CCcHHHHHHHHhcCCCCccccc
Q 015222          327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDG-ATSRDSMRAVWKLLRLPVIDLY  386 (411)
Q Consensus       327 ~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~r-p~~R~t~~~il~~~~~~~~~~~  386 (411)
                      +..+......+|.    .+++.+.++|.+||..||.+| ++.|+|++++++||||+++++.
T Consensus       247 ~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~  303 (350)
T d1rdqe_         247 YEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI  303 (350)
T ss_dssp             HHHHHHCCCCCCT----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred             HHHHhcCCCCCCc----cCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHH
Confidence            8888776666654    467889999999999998888 4678999999999999998764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.3e-58  Score=441.66  Aligned_cols=259  Identities=23%  Similarity=0.384  Sum_probs=231.4

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      .++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+|+.+|++++|+||     ++++++|.+++.+|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnI-----v~~~~~~~~~~~~~  102 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL-----INLHDAFEDKYEMV  102 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTB-----CCEEEEEECSSEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCC-----CcEEEEEEECCEEE
Confidence            367999999999999999999999999999999997543 345667889999999988777     99999999999999


Q ss_pred             EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +||||| ||+|.+++.... ..+++..++.++.||+.||+|||++|||||||||+||||+..                  
T Consensus       103 ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~------------------  163 (352)
T d1koba_         103 LILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK------------------  163 (352)
T ss_dssp             EEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST------------------
T ss_pred             EEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccccc------------------
Confidence            999999 999999876554 469999999999999999999999999999999999999642                  


Q ss_pred             CccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHHH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLEH  326 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~  326 (411)
                             ....+||+|||+|.......  ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.
T Consensus       164 -------~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~  236 (352)
T d1koba_         164 -------KASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET  236 (352)
T ss_dssp             -------TCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred             -------CCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                   23478999999998765443  346899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          327 LAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       327 ~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      +..+.+....++......+++.+.+||.+||..|    |.+|||+.|+++||||++..
T Consensus       237 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d----p~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         237 LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKE----PRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             HHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSS----GGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHHhCCCCCCcccccCCCHHHHHHHHHHccCC----hhHCcCHHHHhcCHhhCCCc
Confidence            9988888878887777788999999999999999    99999999999999998643

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-58  Score=437.24  Aligned_cols=260  Identities=22%  Similarity=0.333  Sum_probs=236.2

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      .+-++|++++.||+|+||+||+|+++.+++.||||+++........+.+|+.+|+.++|+||     ++++++|++++.+
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnI-----v~~~~~~~~~~~~   76 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNI-----LHLHESFESMEEL   76 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTB-----CCEEEEEEETTEE
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCC-----CeEEEEEEECCEE
Confidence            35689999999999999999999999999999999998776666778899999999998877     9999999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      |+||||| |++|.+++...+ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++                
T Consensus        77 ~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~----------------  139 (321)
T d1tkia_          77 VMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR----------------  139 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS----------------
T ss_pred             EEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCC----------------
Confidence            9999999 899999997654 3699999999999999999999999999999999999997543                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                               ...+||+|||++.......  ....||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+
T Consensus       140 ---------~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~  210 (321)
T d1tkia_         140 ---------SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ  210 (321)
T ss_dssp             ---------CCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             ---------ceEEEEcccchhhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH
Confidence                     3478999999988754433  44678999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcc
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVI  383 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~  383 (411)
                      .+..+.+....++...+..+++.+++||.+||..|    |.+|||+.|+++||||++-
T Consensus       211 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d----p~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         211 IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKE----RKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSS----GGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCC----hhHCcCHHHHhcCHhhccC
Confidence            99999988888898888889999999999999999    9999999999999999753

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-59  Score=432.44  Aligned_cols=253  Identities=24%  Similarity=0.416  Sum_probs=219.2

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc-hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      +.|+++++||+|+||+||+|+++.+++.||||+++.. ....+.+.+|++++++++|+||     +++++++.+.+.+|+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnI-----v~l~~~~~~~~~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI-----VKLLDAFYYENNLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTB-----CCEEEEEEETTEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEeeCCeEEE
Confidence            4699999999999999999999999999999999753 3455778899999999988877     999999999999999


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      ||||| +|+|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|                  
T Consensus        87 vmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~------------------  147 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG------------------  147 (288)
T ss_dssp             EEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS------------------
T ss_pred             EEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCC------------------
Confidence            99999 999999987654 3699999999999999999999999999999999999998766                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceec-----CCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                               .+||+|||+|......   .....||+.|+|||++.     +..|+.++|||||||++|||++|+.||.+.
T Consensus       148 ---------~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~  218 (288)
T d2jfla1         148 ---------DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL  218 (288)
T ss_dssp             ---------CEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             ---------CEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC
Confidence                     6788889988654322   23468999999999984     446899999999999999999999999998


Q ss_pred             ChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCc
Q 015222          322 ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       322 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~  382 (411)
                      +..+.+..+.+...+.. .....+++.+.++|.+||+.|    |.+|||+.|+++||||+.
T Consensus       219 ~~~~~~~~i~~~~~~~~-~~~~~~s~~~~~li~~~L~~d----p~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         219 NPMRVLLKIAKSEPPTL-AQPSRWSSNFKDFLKKCLEKN----VDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             CGGGHHHHHHHSCCCCC-SSGGGSCHHHHHHHHHHSCSS----TTTSCCHHHHTTSGGGCC
T ss_pred             CHHHHHHHHHcCCCCCC-CccccCCHHHHHHHHHHccCC----hhHCcCHHHHhcCcccCC
Confidence            88887777766543221 223467889999999999999    999999999999999974

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-58  Score=424.88  Aligned_cols=252  Identities=21%  Similarity=0.356  Sum_probs=212.3

Q ss_pred             cCCCe-EEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec-
Q 015222           90 LTPRY-RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-  164 (411)
Q Consensus        90 ~~~~y-~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~-  164 (411)
                      .++|| ++.++||+|+||+||+|+++.+++.||+|++....   ...+.+.+|++++++++|+||     +++++++++ 
T Consensus         6 ~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~~~~~~~   80 (270)
T d1t4ha_           6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI-----VRFYDSWEST   80 (270)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEEE
T ss_pred             CCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCe-----eeEEEEEeec
Confidence            34556 77889999999999999999999999999986432   345668899999999988877     999999865 


Q ss_pred             ---CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEecCcccccCCc
Q 015222          165 ---RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDY  238 (411)
Q Consensus       165 ---~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dikp~NIli~~~~~~~l~df  238 (411)
                         ++.+|+||||+ +|+|.+++.+..  .+++..++.++.||+.||+|||++|  |+||||||+|||++++        
T Consensus        81 ~~~~~~~~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~--------  150 (270)
T d1t4ha_          81 VKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP--------  150 (270)
T ss_dssp             SSSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESST--------
T ss_pred             cccCCEEEEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCC--------
Confidence               45789999999 999999998765  7999999999999999999999998  9999999999999531        


Q ss_pred             ccccccCCCCCccccCCCCCCeeEeecCCcccccCC-CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCC
Q 015222          239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL  317 (411)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p  317 (411)
                                        +..+||+|||+|+..... ....+||+.|+|||++.+ .++.++|||||||++|||++|+.|
T Consensus       151 ------------------~~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~P  211 (270)
T d1t4ha_         151 ------------------TGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYP  211 (270)
T ss_dssp             ------------------TSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             ------------------CCCEEEeecCcceeccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCC
Confidence                              236889999988765443 345689999999999876 699999999999999999999999


Q ss_pred             CCCCChHHHH-HHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCC
Q 015222          318 FQTHENLEHL-AMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP  381 (411)
Q Consensus       318 f~~~~~~~~~-~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~  381 (411)
                      |.+......+ ..+.  .+..|..+....++.++++|.+||..|    |++|||+.|+++||||+
T Consensus       212 f~~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~~~li~~~l~~d----p~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         212 YSECQNAAQIYRRVT--SGVKPASFDKVAIPEVKEIIEGCIRQN----KDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             TTTCSSHHHHHHHHT--TTCCCGGGGGCCCHHHHHHHHHHSCSS----GGGSCCHHHHHTSGGGC
T ss_pred             CCCcccHHHHHHHHH--cCCCCcccCccCCHHHHHHHHHHccCC----HhHCcCHHHHhCCcccC
Confidence            9876554433 3332  234455566667888999999999999    99999999999999986

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-58  Score=436.83  Aligned_cols=256  Identities=21%  Similarity=0.328  Sum_probs=224.0

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++++.||+|+||+||+|+++.+|+.||||++++..    ...+.+.+|+.+|++++|+||     ++++++|.+.+.
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~I-----v~l~~~~~~~~~   79 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL-----TALKYAFQTHDR   79 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTB-----CCEEEEEECSSE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCE-----EEEEeeeccccc
Confidence            57999999999999999999999999999999997532    345668899999999988877     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+||||| ||+|.+++.+..  .+++..++.++.||+.||+|||++|||||||||+|||++.+|               
T Consensus        80 ~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g---------------  142 (337)
T d1o6la_          80 LCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG---------------  142 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS---------------
T ss_pred             cccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC---------------
Confidence            99999999 999999999876  799999999999999999999999999999999999998777               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccC---CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCCh
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHEN  323 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~  323 (411)
                                  .+||+|||+|+....   .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.
T Consensus       143 ------------~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~  210 (337)
T d1o6la_         143 ------------HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH  210 (337)
T ss_dssp             ------------CEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ------------CEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH
Confidence                        677888887765432   23446899999999999999999999999999999999999999999998


Q ss_pred             HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcH-HHHHHHHhcCCCCcccc
Q 015222          324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSR-DSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R-~t~~~il~~~~~~~~~~  385 (411)
                      .+....+......+|.    .+++.+++||.+||+.||.+|+..+ .+++++++||||.++++
T Consensus       211 ~~~~~~i~~~~~~~p~----~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~  269 (337)
T d1o6la_         211 ERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             HHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             HHHHHHHhcCCCCCCc----cCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence            8888888877666665    4678899999999999944444422 25999999999998764

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-59  Score=443.31  Aligned_cols=260  Identities=23%  Similarity=0.320  Sum_probs=214.3

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ..++|+++++||+|+||+||+|+++.+|+.||+|+++..  ....+.+.+|+.+|++++|+||     |+++++|.+.++
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnI-----v~l~~~~~~~~~   78 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI-----VGFYGAFYSDGE   78 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTB-----CCEEEEEECSSE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEEEECCE
Confidence            457899999999999999999999999999999999743  3445678899999999988777     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      +|+||||+ ||+|.+++.+.+  .+++..++.++.||+.||+|||++ ||+||||||+||||+.+|              
T Consensus        79 ~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~--------------  142 (322)
T d1s9ja_          79 ISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG--------------  142 (322)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC--------------
T ss_pred             EEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC--------------
Confidence            99999999 899999998775  699999999999999999999974 999999999999998766              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccC-CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                                   .+||+|||+|..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..
T Consensus       143 -------------~vkl~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~  209 (322)
T d1s9ja_         143 -------------EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK  209 (322)
T ss_dssp             -------------CEEECCCCCCHHHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT
T ss_pred             -------------CEEEeeCCCccccCCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence                         688899998876433 334578999999999999999999999999999999999999999876543


Q ss_pred             HHHHH-HHHHh--------------------------------------CC-CChhHHHhhhhhhhhhhccCCccCCCCC
Q 015222          325 EHLAM-MERVL--------------------------------------GP-LPHHMVIRADRRAEKYFRRGARLDWPDG  364 (411)
Q Consensus       325 ~~~~~-i~~~~--------------------------------------~~-~p~~~~~~~~~~~~~li~~~l~~~~~~r  364 (411)
                      +.... .....                                      .. .|.......+.++.++|.+||..|    
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----  285 (322)
T d1s9ja_         210 ELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN----  285 (322)
T ss_dssp             HHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSS----
T ss_pred             HHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCC----
Confidence            22111 00000                                      00 000011124678999999999999    


Q ss_pred             CCcHHHHHHHHhcCCCCcccccC
Q 015222          365 ATSRDSMRAVWKLLRLPVIDLYS  387 (411)
Q Consensus       365 p~~R~t~~~il~~~~~~~~~~~~  387 (411)
                      |.+|||++|+|+||||++.+...
T Consensus       286 P~~R~ta~e~L~Hpf~~~~~~~~  308 (322)
T d1s9ja_         286 PAERADLKQLMVHAFIKRSDAEE  308 (322)
T ss_dssp             TTTSCCHHHHHTSHHHHHHHHSC
T ss_pred             hhHCcCHHHHhhCHhhCcCCccc
Confidence            99999999999999999876543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-58  Score=424.83  Aligned_cols=250  Identities=22%  Similarity=0.343  Sum_probs=204.0

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec--CC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--RN  166 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~--~~  166 (411)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++...   ...+.+.+|++++++++|+||     +++++++.+  .+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~~~~~~~~~~   78 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI-----VRYYDRIIDRTNT   78 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTB-----CCEEEEEEC----
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCE-----eeEEEEEEeCCCC
Confidence            57999999999999999999999999999999997533   344667899999999988877     999998865  46


Q ss_pred             eEEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCcEEEecCcccccCCc
Q 015222          167 HICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELR-----LIHTDLKPENILLVSAEYVKVPDY  238 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g-----ivH~Dikp~NIli~~~~~~~l~df  238 (411)
                      .+|+||||| +|+|.+++.+.  ....+++..++.++.||+.||+|||++|     ||||||||+||||+.+|       
T Consensus        79 ~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~-------  151 (269)
T d2java1          79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-------  151 (269)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS-------
T ss_pred             EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC-------
Confidence            789999999 99999998642  2346999999999999999999999976     99999999999998776       


Q ss_pred             ccccccCCCCCccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCC
Q 015222          239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGE  315 (411)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~  315 (411)
                                          .+||+|||+|......   .....||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       152 --------------------~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~  211 (269)
T d2java1         152 --------------------NVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM  211 (269)
T ss_dssp             --------------------CEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             --------------------cEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCC
Confidence                                5677777777654322   23468999999999999999999999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCC
Q 015222          316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRL  380 (411)
Q Consensus       316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~  380 (411)
                      .||.+.+..+....+.......   +...+++.+.++|.+||+.|    |.+|||+.|+++|||+
T Consensus       212 ~Pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~l~~li~~~L~~d----p~~Rps~~ell~hp~i  269 (269)
T d2java1         212 PPFTAFSQKELAGKIREGKFRR---IPYRYSDELNEIITRMLNLK----DYHRPSVEEILENPLI  269 (269)
T ss_dssp             CSCCCSSHHHHHHHHHHTCCCC---CCTTSCHHHHHHHHHHTCSS----GGGSCCHHHHHTSTTC
T ss_pred             CCCCCCCHHHHHHHHHcCCCCC---CCcccCHHHHHHHHHHcCCC----hhHCcCHHHHHhCCcC
Confidence            9999988888777776643321   22356788999999999999    9999999999999996

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.5e-57  Score=418.94  Aligned_cols=255  Identities=25%  Similarity=0.392  Sum_probs=225.5

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----------hhhHHHHHHHHHHHHHh-cCCCCCcceEEE
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----------KYREAAMIEIDVLQRLA-RHDIGGTRCVQI  158 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----------~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~  158 (411)
                      |.++|++.+.||+|+||+||+|+++.+|+.||||++++..          ...+.+.+|+.+++++. |+||     +++
T Consensus         1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI-----v~~   75 (277)
T d1phka_           1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI-----IQL   75 (277)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB-----CCE
T ss_pred             CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCe-----EEE
Confidence            3578999999999999999999999999999999986432          22346788999999997 7777     999


Q ss_pred             eeeeecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCC
Q 015222          159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD  237 (411)
Q Consensus       159 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~d  237 (411)
                      ++++.+++++|+||||+ +++|.+++..++  .+++..++.++.||+.||+|||++||+||||||+|||++.++      
T Consensus        76 ~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~------  147 (277)
T d1phka_          76 KDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM------  147 (277)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC------
T ss_pred             EeecccCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCC------
Confidence            99999999999999999 899999998766  799999999999999999999999999999999999998766      


Q ss_pred             cccccccCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecC------CCCCccchhHHHHHHHH
Q 015222          238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILG------LGWNYPCDLWSVGCILV  309 (411)
Q Consensus       238 f~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlGvil~  309 (411)
                                           .+||+|||++......  .....||+.|+|||++.+      ..++.++||||+||++|
T Consensus       148 ---------------------~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvily  206 (277)
T d1phka_         148 ---------------------NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY  206 (277)
T ss_dssp             ---------------------CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHH
T ss_pred             ---------------------CeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhh
Confidence                                 6788888888765432  344679999999999863      35788999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCc
Q 015222          310 ELCSGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPV  382 (411)
Q Consensus       310 elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~  382 (411)
                      ||++|+.||.+.+..+....+......++......+++.++++|.+||..+    |++||+++|+++|+||+.
T Consensus       207 eml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~----p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         207 TLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQ----PQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSS----GGGSCCHHHHTTSGGGCT
T ss_pred             hhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCC----hhHCcCHHHHHcCHHHHH
Confidence            999999999999988888888877766676667789999999999999999    999999999999999985

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.2e-58  Score=428.29  Aligned_cols=251  Identities=22%  Similarity=0.284  Sum_probs=215.0

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|+++++||+|+||+||+|+++.+++.||||+++...    ...+.+.+|+.++++++|+||     |++++++.+++.
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-----v~~~~~~~~~~~   89 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT-----IQYRGCYLREHT   89 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEETTE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCE-----eeEEEEEEECCE
Confidence            46999999999999999999999999999999997432    334568899999999988877     999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+||||| +++|..++....  .+++..++.++.||+.||+|||++|||||||||+|||++.+|               
T Consensus        90 ~~iv~E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~---------------  152 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG---------------  152 (309)
T ss_dssp             EEEEEECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT---------------
T ss_pred             EEEEEEecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCC---------------
Confidence            99999999 777776666554  799999999999999999999999999999999999998776               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecC---CCCCccchhHHHHHHHHHHHhCCCCCCCCCh
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCSGEALFQTHEN  323 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~elltg~~pf~~~~~  323 (411)
                                  .+||+|||+|...... ....||+.|+|||++.+   ..|+.++|||||||++|||++|+.||.+.+.
T Consensus       153 ------------~~Kl~DFG~a~~~~~~-~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~  219 (309)
T d1u5ra_         153 ------------LVKLGDFGSASIMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA  219 (309)
T ss_dssp             ------------EEEECCCTTCBSSSSB-CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred             ------------CEEEeecccccccCCC-CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH
Confidence                        5788888887765433 34589999999999975   3589999999999999999999999998888


Q ss_pred             HHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcc
Q 015222          324 LEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVI  383 (411)
Q Consensus       324 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~  383 (411)
                      .+.+..+.....+.  .....+++.+.+||.+||..|    |.+|||+.++++||||..-
T Consensus       220 ~~~~~~i~~~~~~~--~~~~~~s~~~~~li~~~L~~d----P~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         220 MSALYHIAQNESPA--LQSGHWSEYFRNFVDSCLQKI----PQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             HHHHHHHHHSCCCC--CSCTTSCHHHHHHHHHHTCSS----GGGSCCHHHHTTCHHHHSC
T ss_pred             HHHHHHHHhCCCCC--CCCCCCCHHHHHHHHHHCcCC----hhHCcCHHHHHhCHHhcCC
Confidence            77776665543322  223457889999999999999    9999999999999999753

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-57  Score=423.94  Aligned_cols=252  Identities=22%  Similarity=0.340  Sum_probs=219.5

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHH-HHhcCCCCCcceEEEeeeeecCC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQ-RLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~-~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      ++|++++.||+|+||+||+|+++.+++.||||++++..    ...+.+..|..++. .++|+||     +++++++.+++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~I-----v~~~~~~~~~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL-----THMFCTFQTKE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTB-----CCEEEEEECSS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcE-----EEEEEEEccCC
Confidence            57999999999999999999999999999999997532    33455667777765 5677776     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      .+|+||||+ +|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+|              
T Consensus        77 ~~yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~--------------  140 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG--------------  140 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--------------
T ss_pred             ceeEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCC--------------
Confidence            999999999 999999998776  799999999999999999999999999999999999998776              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccC---CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQTHE  322 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~  322 (411)
                                   .+||+|||++.....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus       141 -------------~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~  207 (320)
T d1xjda_         141 -------------HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD  207 (320)
T ss_dssp             -------------CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             -------------ceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC
Confidence                         567777777764332   2234689999999999999999999999999999999999999999999


Q ss_pred             hHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHH-HHHhcCCCCcccc
Q 015222          323 NLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMR-AVWKLLRLPVIDL  385 (411)
Q Consensus       323 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~-~il~~~~~~~~~~  385 (411)
                      ..+.+..+......+|.    .+++.+.++|.+||..|    |++||++. ++++||||+++++
T Consensus       208 ~~~~~~~i~~~~~~~p~----~~s~~~~dli~~~L~~d----P~~R~s~~~~l~~hpff~~~~~  263 (320)
T d1xjda_         208 EEELFHSIRMDNPFYPR----WLEKEAKDLLVKLFVRE----PEKRLGVRGDIRQHPLFREINW  263 (320)
T ss_dssp             HHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHSCSS----GGGSBTTBSCGGGSGGGTTCCH
T ss_pred             HHHHHHHHHcCCCCCCc----cCCHHHHHHHHHhcccC----CCCCcCHHHHHHhCchhccCCH
Confidence            88888888776655554    46788999999999999    99999995 8999999998764

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-56  Score=426.02  Aligned_cols=274  Identities=26%  Similarity=0.456  Sum_probs=228.2

Q ss_pred             CCceEEeeCCc---cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCC
Q 015222           79 DGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGG  152 (411)
Q Consensus        79 ~~~~~~~~~~~---~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~  152 (411)
                      .|++...+++.   +.++|+++++||+|+||+||+|+++.+|+.||||+++...   ...+.+.+|+.+|++++|+|+  
T Consensus         2 ~~~~~~~~~~~~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpni--   79 (346)
T d1cm8a_           2 SGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV--   79 (346)
T ss_dssp             CSBCCEECSSSEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTB--
T ss_pred             CCcEEEeccCceeecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCe--
Confidence            35666677765   7899999999999999999999999999999999997432   345678899999999998887  


Q ss_pred             cceEEEeeeeecCC------eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015222          153 TRCVQIRNWFDYRN------HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL  226 (411)
Q Consensus       153 ~~iv~~~~~~~~~~------~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIl  226 (411)
                         ++++++|...+      ++|+||||++.+|..++...   .+++..++.++.||+.||+|||++||+||||||+|||
T Consensus        80 ---v~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL  153 (346)
T d1cm8a_          80 ---IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA  153 (346)
T ss_dssp             ---CCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             ---eEEEEEeccCccccccceEEEEEecccccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhh
Confidence               99999987644      67999999988998887764   5999999999999999999999999999999999999


Q ss_pred             EecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCC-CCCccchhHHHH
Q 015222          227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVG  305 (411)
Q Consensus       227 i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG  305 (411)
                      ++.++                           .+||+|||+|...........||+.|+|||++.+. .++.++||||||
T Consensus       154 ~~~~~---------------------------~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG  206 (346)
T d1cm8a_         154 VNEDC---------------------------ELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVG  206 (346)
T ss_dssp             ECTTC---------------------------CEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHH
T ss_pred             ccccc---------------------------ccccccccceeccCCccccccccccccCHHHHcCCCCCCccchhhcch
Confidence            97766                           67889999988877777778999999999999875 578999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHHH---------------------------hhhhhhhhhhccCCc
Q 015222          306 CILVELCSGEALFQTHENLEHLAMMERVLGPLPHHMVI---------------------------RADRRAEKYFRRGAR  358 (411)
Q Consensus       306 vil~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~---------------------------~~~~~~~~li~~~l~  358 (411)
                      |++|+|++|+.||.+.+..+.+..+....+..+..+..                           ..++.+.+||.+||.
T Consensus       207 vil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~  286 (346)
T d1cm8a_         207 CIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLV  286 (346)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSC
T ss_pred             HHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCc
Confidence            99999999999999999888888888877776655432                           345678899999999


Q ss_pred             cCCCCCCCcHHHHHHHHhcCCCCcccccCCCCC
Q 015222          359 LDWPDGATSRDSMRAVWKLLRLPVIDLYSASPN  391 (411)
Q Consensus       359 ~~~~~rp~~R~t~~~il~~~~~~~~~~~~~~~~  391 (411)
                      .|    |.+|||+.|+|+||||+++......|.
T Consensus       287 ~d----P~~R~ta~eiL~Hp~f~~~~~~~~~~~  315 (346)
T d1cm8a_         287 LD----AEQRVTAGEALAHPYFESLHDTEDEPQ  315 (346)
T ss_dssp             SS----TTTSCCHHHHHHSGGGTTTC------C
T ss_pred             CC----hhHCcCHHHHhcChhhCcCCCcccccc
Confidence            99    999999999999999998775554444

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-56  Score=419.15  Aligned_cols=259  Identities=30%  Similarity=0.475  Sum_probs=220.4

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      ++|+++++||+|+||+||+|+++.+|+.||||+++...   ...+.+.+|+.++++++|+||     +++++++.+++.+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~I-----v~~~~~~~~~~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI-----VKLLDVIHTENKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTB-----CCEEEEEEETTEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcE-----EEeccccccccce
Confidence            58999999999999999999999999999999996433   235678899999999988877     9999999999999


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      |+||||+++++.+++.......+++..++.++.||+.||+|||++|||||||||+|||++.++                 
T Consensus        77 ~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~-----------------  139 (298)
T d1gz8a_          77 YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-----------------  139 (298)
T ss_dssp             EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-----------------
T ss_pred             eEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccC-----------------
Confidence            999999987888887766556799999999999999999999999999999999999997766                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCCC-CCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                                .+||+|||.|......   .....||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..
T Consensus       140 ----------~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~  209 (298)
T d1gz8a_         140 ----------AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI  209 (298)
T ss_dssp             ----------CEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ----------cceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH
Confidence                      6788888877654432   23358999999999988775 589999999999999999999999998888


Q ss_pred             HHHHHHHHHhCCCChhH-------------------------HHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCC
Q 015222          325 EHLAMMERVLGPLPHHM-------------------------VIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR  379 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~-------------------------~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~  379 (411)
                      +.+..+.+..+......                         ...++..+.+||.+||..|    |++|||++|+++|+|
T Consensus       210 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~d----P~~R~t~~ell~H~f  285 (298)
T d1gz8a_         210 DQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYD----PNKRISAKAALAHPF  285 (298)
T ss_dssp             HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSS----TTTSCCHHHHHTSGG
T ss_pred             HHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCC----hhHCcCHHHHhCCHh
Confidence            88887776655433221                         1234577899999999999    999999999999999


Q ss_pred             CCccccc
Q 015222          380 LPVIDLY  386 (411)
Q Consensus       380 ~~~~~~~  386 (411)
                      |+++..+
T Consensus       286 f~~~~~p  292 (298)
T d1gz8a_         286 FQDVTKP  292 (298)
T ss_dssp             GTTCCCC
T ss_pred             hccCCCC
Confidence            9988765

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-57  Score=427.33  Aligned_cols=264  Identities=23%  Similarity=0.377  Sum_probs=218.0

Q ss_pred             cCCCeEEEe-eeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeec---
Q 015222           90 LTPRYRILS-KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY---  164 (411)
Q Consensus        90 ~~~~y~i~~-~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~---  164 (411)
                      +.++|++++ .||+|+||+||+|+++.+++.||||+++..    ..+.+|+.++.++ +|+||     ++++++|++   
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnI-----v~l~~~~~~~~~   79 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHI-----VRIVDVYENLYA   79 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTB-----CCEEEEEEEEET
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCC-----CeEEEEEeeccc
Confidence            446899986 599999999999999999999999999753    4467799987766 56666     999999875   


Q ss_pred             -CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccc
Q 015222          165 -RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       165 -~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                       ++++|+||||| ||+|.+++.+.+...+++..++.++.||+.||+|||++||+||||||+|||++..+           
T Consensus        80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~-----------  148 (335)
T d2ozaa1          80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-----------  148 (335)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSS-----------
T ss_pred             CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccc-----------
Confidence             46899999999 89999999876656799999999999999999999999999999999999997643           


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT  320 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~  320 (411)
                                   ....+||+|||+|+.....  .....||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+
T Consensus       149 -------------~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~  215 (335)
T d2ozaa1         149 -------------PNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS  215 (335)
T ss_dssp             -------------TTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEE
T ss_pred             -------------ccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCC
Confidence                         3447899999999765433  3456899999999999999999999999999999999999999987


Q ss_pred             CChHHHHHHHHH----HhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccccCCCC
Q 015222          321 HENLEHLAMMER----VLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDLYSASP  390 (411)
Q Consensus       321 ~~~~~~~~~i~~----~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~~~~~~  390 (411)
                      .+..+....+..    ....+|......+++.+.+||.+||..|    |++|||+.|+++||||.+.......|
T Consensus       216 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d----P~~R~s~~eil~hp~~~~~~~~~~~~  285 (335)
T d2ozaa1         216 NHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTE----PTQRMTITEFMNHPWIMQSTKVPQTP  285 (335)
T ss_dssp             TTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSS----TTTSCCHHHHHHSHHHHTTTSSCCCE
T ss_pred             CCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCC----hhHCcCHHHHHcCHHhhCCCCCCCCC
Confidence            765444433332    2335666667788999999999999999    99999999999999997654443333

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.9e-56  Score=428.67  Aligned_cols=259  Identities=19%  Similarity=0.288  Sum_probs=211.7

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..    .....+.+|..+++.+.+.  .||||+++++++.+.+.
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~--~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG--DCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS--CCTTBCCEEEEEECSSE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC--CCCcEEEEEEEEEECCE
Confidence            57999999999999999999999999999999996432    2233455565555555432  34556999999999999


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +|+||||| ||+|.+++.+..  .+++..++.++.||+.||+|||++|||||||||+|||++.+|               
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g---------------  144 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG---------------  144 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSS---------------
T ss_pred             EEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCC---------------
Confidence            99999999 999999998775  799999999999999999999999999999999999998776               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC-CcccccCCCccccceecC-CCCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                                  .+||+|||+|...... .....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..
T Consensus       145 ------------~iKl~DFGla~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~  212 (364)
T d1omwa3         145 ------------HVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK  212 (364)
T ss_dssp             ------------CEEECCCTTCEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS
T ss_pred             ------------cEEEeeeceeeecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH
Confidence                        6788888887754433 344689999999999975 47899999999999999999999999876544


Q ss_pred             HHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHH-----HHHHHhcCCCCccccc
Q 015222          325 EHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS-----MRAVWKLLRLPVIDLY  386 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t-----~~~il~~~~~~~~~~~  386 (411)
                      +...... .....+..+...+++.++++|.+||..|    |.+|+|     ++++++||||+++++.
T Consensus       213 ~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~d----P~~R~t~~~~~a~eil~Hp~f~~i~~~  274 (364)
T d1omwa3         213 DKHEIDR-MTLTMAVELPDSFSPELRSLLEGLLQRD----VNRRLGCLGRGAQEVKESPFFRSLDWQ  274 (364)
T ss_dssp             CHHHHHH-HSSSCCCCCCSSSCHHHHHHHHHHTCSS----TTTSTTTSSSTHHHHHTSGGGTTCCHH
T ss_pred             HHHHHHH-hcccCCCCCCCCCCHHHHHHHHHHcccC----HHHhCCCcccCHHHHHcCccccCCCHH
Confidence            3333222 2233333334467889999999999999    777777     8999999999998753

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-56  Score=418.18  Aligned_cols=253  Identities=26%  Similarity=0.409  Sum_probs=210.0

Q ss_pred             EEeeeccccceEEEEEEeCCCCcEEEEEEeccchh------hhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK------YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        96 i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      .+++||+|+||+||+|+++.+|+.||||+++....      ..+.+.+|+.++++++|+||     +++++++.+++++|
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-----v~~~~~~~~~~~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI-----IGLLDAFGHKSNIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTB-----CCEEEEECCTTCCE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCE-----eEEEeeeccCCcee
Confidence            46899999999999999999999999999964322      23467899999999998877     99999999999999


Q ss_pred             EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      +||||+.+++...+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++                  
T Consensus        77 ivmE~~~~~~~~~~~~~~-~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~------------------  137 (299)
T d1ua2a_          77 LVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG------------------  137 (299)
T ss_dssp             EEEECCSEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC------------------
T ss_pred             ehhhhhcchHHhhhhhcc-cCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCC------------------
Confidence            999999444444444332 4799999999999999999999999999999999999998776                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCChHH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENLE  325 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~  325 (411)
                               .+||+|||+|......   ....+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+
T Consensus       138 ---------~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~  208 (299)
T d1ua2a_         138 ---------VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD  208 (299)
T ss_dssp             ---------CEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             ---------ccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH
Confidence                     5677777777654332   2345799999999998765 68999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCChh------------------------HHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCC
Q 015222          326 HLAMMERVLGPLPHH------------------------MVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP  381 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~------------------------~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~  381 (411)
                      .+..+.+..+..+..                        .....++.+.+||.+||..|    |++|||++|+|+||||+
T Consensus       209 ~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~d----P~~R~sa~e~L~Hp~f~  284 (299)
T d1ua2a_         209 QLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFN----PCARITATQALKMKYFS  284 (299)
T ss_dssp             HHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSS----TTTSCCHHHHHTSGGGT
T ss_pred             HHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCC----hhhCcCHHHHhCCHhhC
Confidence            998888776543321                        22345678999999999999    99999999999999999


Q ss_pred             cccc
Q 015222          382 VIDL  385 (411)
Q Consensus       382 ~~~~  385 (411)
                      +...
T Consensus       285 ~~p~  288 (299)
T d1ua2a_         285 NRPG  288 (299)
T ss_dssp             SSSC
T ss_pred             CCCC
Confidence            7654

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-55  Score=412.16  Aligned_cols=262  Identities=28%  Similarity=0.481  Sum_probs=214.5

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCC-CcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec--
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEK-KELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--  164 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~--  164 (411)
                      .++|+++++||+|+||+||+|++..+ ++.||||+++...   .....+.+|+.+++.|...  .|+||++++++|..  
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~--~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF--EHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHT--CCTTBCCEEEEEEEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhc--CCCCcceeeeeecccc
Confidence            46899999999999999999999765 6789999986432   2334567899998888521  23444999998853  


Q ss_pred             ---CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccc
Q 015222          165 ---RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL  241 (411)
Q Consensus       165 ---~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~  241 (411)
                         ..+++++||++.+.+..+........+++..++.++.||+.||+|||++|||||||||+|||++.+|          
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~----------  153 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG----------  153 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC----------
T ss_pred             cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCC----------
Confidence               4589999999955555555555556799999999999999999999999999999999999998766          


Q ss_pred             cccCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 015222          242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ  319 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~  319 (411)
                                       .+||+|||++......  .....||+.|+|||++.+..|+.++|||||||++|||++|+.||.
T Consensus       154 -----------------~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~  216 (305)
T d1blxa_         154 -----------------QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR  216 (305)
T ss_dssp             -----------------CEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             -----------------CeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCC
Confidence                             5677777777654322  345689999999999999999999999999999999999999999


Q ss_pred             CCChHHHHHHHHHHhCCCChh-----------------------HHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHh
Q 015222          320 THENLEHLAMMERVLGPLPHH-----------------------MVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK  376 (411)
Q Consensus       320 ~~~~~~~~~~i~~~~~~~p~~-----------------------~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~  376 (411)
                      +.+..+.+..+.+..+..+..                       +....++.+.+||.+||..|    |++|||+.|+|+
T Consensus       217 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~d----P~~R~sa~e~L~  292 (305)
T d1blxa_         217 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN----PAKRISAYSALS  292 (305)
T ss_dssp             CSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSS----TTTSCCHHHHHT
T ss_pred             CCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCC----hhHCcCHHHHhc
Confidence            999988888887765543322                       22345678899999999999    999999999999


Q ss_pred             cCCCCcccc
Q 015222          377 LLRLPVIDL  385 (411)
Q Consensus       377 ~~~~~~~~~  385 (411)
                      ||||++++.
T Consensus       293 Hpff~~i~~  301 (305)
T d1blxa_         293 HPYFQDLER  301 (305)
T ss_dssp             SGGGTTCCC
T ss_pred             ChhhcCchh
Confidence            999998864

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-55  Score=407.08  Aligned_cols=251  Identities=24%  Similarity=0.410  Sum_probs=209.6

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-------hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeee
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF  162 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~  162 (411)
                      +.++|++.+.||+|+||+||+|+++.+|+.||||++++..       .....+.+|+.+++++++   .|+||+++++++
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~---~h~nIv~~~~~~   78 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS---GFSGVIRLLDWF   78 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS---SSCSBCCEEEEE
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhcc---CCCCccEEEEEE
Confidence            4679999999999999999999999999999999997432       122345689999999973   234559999999


Q ss_pred             ecCCeEEEEEccC-C-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          163 DYRNHICIVFEKL-G-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       163 ~~~~~~~lv~e~~-~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                      .+.+..++||||+ + +++.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++         
T Consensus        79 ~~~~~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~---------  147 (273)
T d1xwsa_          79 ERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR---------  147 (273)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT---------
T ss_pred             eeCCeEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC---------
Confidence            9999999999999 4 58888888765  799999999999999999999999999999999999997532         


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccCC-CcccccCCCccccceecCCCC-CccchhHHHHHHHHHHHhCCCCC
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSGEALF  318 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~pf  318 (411)
                                       ..+||+|||+|...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||
T Consensus       148 -----------------~~vkl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf  210 (273)
T d1xwsa_         148 -----------------GELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF  210 (273)
T ss_dssp             -----------------TEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             -----------------CeEEECccccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCC
Confidence                             26788888888765433 345689999999999987765 67899999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCcccc
Q 015222          319 QTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       319 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~~  385 (411)
                      .+.+      .+.+....++.    .+++.++++|.+||..|    |++|||++|+++||||+++..
T Consensus       211 ~~~~------~i~~~~~~~~~----~~s~~~~~li~~~L~~d----p~~R~s~~eil~hp~~~~~~~  263 (273)
T d1xwsa_         211 EHDE------EIIRGQVFFRQ----RVSSECQHLIRWCLALR----PSDRPTFEEIQNHPWMQDVLL  263 (273)
T ss_dssp             CSHH------HHHHCCCCCSS----CCCHHHHHHHHHHTCSS----GGGSCCHHHHHTSGGGSSCCC
T ss_pred             CCch------HHhhcccCCCC----CCCHHHHHHHHHHccCC----HhHCcCHHHHhcCHhhCCCCC
Confidence            7532      23333333433    46788999999999999    999999999999999998653

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=8.1e-55  Score=403.15  Aligned_cols=250  Identities=22%  Similarity=0.277  Sum_probs=206.1

Q ss_pred             CccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch----hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee
Q 015222           88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        88 ~~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~  163 (411)
                      ..+.++|++.+.||+|+||+||+|+++.+|+.||||+++...    ...+.+.+|+.+++.++|+||     +++++++.
T Consensus         3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpni-----v~~~~~~~   77 (277)
T d1o6ya_           3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI-----VAVYDTGE   77 (277)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEE
T ss_pred             cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCC-----Ccccceee
Confidence            356789999999999999999999999999999999997432    334568899999999988887     99999887


Q ss_pred             cCC----eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCc
Q 015222          164 YRN----HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY  238 (411)
Q Consensus       164 ~~~----~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df  238 (411)
                      ..+    .+|+||||+ |++|.+++...+  .+++..++.++.||+.||+|||++||+||||||+|||++.++       
T Consensus        78 ~~~~~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~-------  148 (277)
T d1o6ya_          78 AETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-------  148 (277)
T ss_dssp             EECSSSEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS-------
T ss_pred             eccCCCceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccc-------
Confidence            643    589999999 899999998775  799999999999999999999999999999999999998877       


Q ss_pred             ccccccCCCCCccccCCCCCCeeEeecCCcccccC------CCcccccCCCccccceecCCCCCccchhHHHHHHHHHHH
Q 015222          239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ------DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC  312 (411)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell  312 (411)
                                          .++|+|||.+.....      .....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus       149 --------------------~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyell  208 (277)
T d1o6ya_         149 --------------------AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL  208 (277)
T ss_dssp             --------------------CEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             --------------------cceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHH
Confidence                                456666665543221      223457999999999999999999999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH-HHHHHH
Q 015222          313 SGEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-SMRAVW  375 (411)
Q Consensus       313 tg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~-t~~~il  375 (411)
                      ||+.||.+.+..+.+..+.+.....+......+++.+.++|.+||..|    |.+|| |+++++
T Consensus       209 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~d----p~~R~~sa~~l~  268 (277)
T d1o6ya_         209 TGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKN----PENRYQTAAEMR  268 (277)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSS----GGGSCSSHHHHH
T ss_pred             hCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCC----HhHCHhHHHHHH
Confidence            999999998888877777766556666666778899999999999999    77776 555554

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.1e-55  Score=404.92  Aligned_cols=247  Identities=18%  Similarity=0.268  Sum_probs=210.1

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      ++|++.++||+|+||+||+|+++.+++.||||+++......+.+.+|+.++++++|+||     +++++++.+++.+++|
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~~~~~~~~~~~iv   91 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL-----VQLLGVCTREPPFYII   91 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECSSSSCEEE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCE-----ecCCccEeeCCeeEEE
Confidence            57999999999999999999999999999999998776677889999999999988877     9999999999999999


Q ss_pred             EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      |||| +|+|.+++.......+++..+..++.||+.||+|||++||+||||||+||||+.++                   
T Consensus        92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~-------------------  152 (287)
T d1opja_          92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-------------------  152 (287)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-------------------
T ss_pred             eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCC-------------------
Confidence            9999 99999999877666899999999999999999999999999999999999998876                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCC-CCCCChHH
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEAL-FQTHENLE  325 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p-f~~~~~~~  325 (411)
                              .+||+|||+|+......    ....||+.|+|||++.+..++.++|||||||++|||++|..| |.+.+..+
T Consensus       153 --------~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~  224 (287)
T d1opja_         153 --------LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ  224 (287)
T ss_dssp             --------CEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             --------cEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH
Confidence                    67888888877654332    224588999999999999999999999999999999996655 44545544


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ....+....   .......+++.+.+++.+||..|    |.+|||+.++++.
T Consensus       225 ~~~~i~~~~---~~~~~~~~~~~l~~li~~cl~~d----P~~Rps~~ei~~~  269 (287)
T d1opja_         225 VYELLEKDY---RMERPEGCPEKVYELMRACWQWN----PSDRPSFAEIHQA  269 (287)
T ss_dssp             HHHHHHTTC---CCCCCTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHH
T ss_pred             HHHHHhcCC---CCCCCccchHHHHHHHHHHcCCC----HhHCcCHHHHHHH
Confidence            444443321   12223456788999999998888    9999999999763

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-54  Score=396.17  Aligned_cols=245  Identities=24%  Similarity=0.344  Sum_probs=203.1

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      ++|++.++||+|+||+||+|+++ +++.||||+++......+.+.+|+.++++++|+||     +++++++..++.+++|
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnI-----v~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKL-----VQLYGVCLEQAPICLV   78 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECSSSSCEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCc-----ccccceeccCCceEEE
Confidence            57999999999999999999986 46779999998777777889999999999998887     9999999999999999


Q ss_pred             EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      |||+ +|+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++                   
T Consensus        79 ~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~-------------------  138 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-------------------  138 (263)
T ss_dssp             EECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGG-------------------
T ss_pred             EEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCC-------------------
Confidence            9999 999999987654 4689999999999999999999999999999999999998877                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCC----CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE  325 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~  325 (411)
                              .+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||+| |.+||...+..+
T Consensus       139 --------~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~  210 (263)
T d1sm2a_         139 --------VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE  210 (263)
T ss_dssp             --------CEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH
T ss_pred             --------CeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH
Confidence                    5677777777654322    123578999999999999999999999999999999999 677787777777


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      .+..+........   ....++.+.+++.+|++.|    |++|||+++++++
T Consensus       211 ~~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~~----p~~Rps~~~il~~  255 (263)
T d1sm2a_         211 VVEDISTGFRLYK---PRLASTHVYQIMNHCWKER----PEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHHHTCCCCC---CTTSCHHHHHHHHHHTCSS----GGGSCCHHHHHHH
T ss_pred             HHHHHHhcCCCCC---ccccCHHHHHHHHHHccCC----HhHCcCHHHHHHH
Confidence            7777766433221   1345678899999998888    9999999999987

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.4e-54  Score=403.40  Aligned_cols=253  Identities=27%  Similarity=0.461  Sum_probs=210.7

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      ++|+++++||+|+||+||+|+++ +|+.||||+++...   ...+.+.+|+.++++++|+||     +++++++.+.+..
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~~~~~~~~~~~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI-----VKLYDVIHTKKRL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTB-----CCEEEEEECSSCE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcE-----EeeeeecccCCce
Confidence            58999999999999999999986 77899999996532   335678899999999988877     9999999999999


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      +++||++++.+...+.... ..+++..++.++.||+.||+|||++|||||||||+|||++.++                 
T Consensus        76 ~i~~e~~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~-----------------  137 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-----------------  137 (286)
T ss_dssp             EEEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-----------------
T ss_pred             eEEEEeehhhhHHHHHhhc-CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCC-----------------
Confidence            9999999555555554433 4799999999999999999999999999999999999998776                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCC---CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCChH
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHENL  324 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~  324 (411)
                                .+||+|||.+......   .....|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..
T Consensus       138 ----------~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~  207 (286)
T d1ob3a_         138 ----------ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA  207 (286)
T ss_dssp             ----------CEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ----------CEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH
Confidence                      6788888877654332   2335789999999999865 5799999999999999999999999998888


Q ss_pred             HHHHHHHHHhCCCChhH-------------------------HHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCC
Q 015222          325 EHLAMMERVLGPLPHHM-------------------------VIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLR  379 (411)
Q Consensus       325 ~~~~~i~~~~~~~p~~~-------------------------~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~  379 (411)
                      +.+..+.+..+..+...                         ....++.+.+||++||..|    |++|||++|+++|||
T Consensus       208 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----P~~R~s~~ell~Hp~  283 (286)
T d1ob3a_         208 DQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLD----PNQRITAKQALEHAY  283 (286)
T ss_dssp             HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSS----TTTSCCHHHHHTSGG
T ss_pred             HHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCC----hhHCcCHHHHhcCcc
Confidence            88888777665433221                         2234567889999999999    999999999999999


Q ss_pred             CCc
Q 015222          380 LPV  382 (411)
Q Consensus       380 ~~~  382 (411)
                      |++
T Consensus       284 f~~  286 (286)
T d1ob3a_         284 FKE  286 (286)
T ss_dssp             GGC
T ss_pred             cCc
Confidence            974

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-54  Score=398.50  Aligned_cols=247  Identities=21%  Similarity=0.321  Sum_probs=200.4

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCe
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH  167 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~  167 (411)
                      .++|++.++||+|+||+||+|+.+   ..||||+++..   ....+.+.+|+.++++++|+||     +++++++. ++.
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~~~~~~~-~~~   77 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI-----LLFMGYST-APQ   77 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTB-----CCEEEEEC-SSS
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCE-----eeeeEEEe-ccE
Confidence            467999999999999999999754   35999999643   3455778899999999988877     99999865 456


Q ss_pred             EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCC
Q 015222          168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK  246 (411)
Q Consensus       168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~  246 (411)
                      +++||||| +|+|.+++.... ..+++..+..++.||++||+|||++|||||||||+|||++.++               
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~---------------  141 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL---------------  141 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTS---------------
T ss_pred             EEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCC---------------
Confidence            89999999 899999998654 3699999999999999999999999999999999999998776               


Q ss_pred             CCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCC---CCCccchhHHHHHHHHHHHhCCCCC
Q 015222          247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSGEALF  318 (411)
Q Consensus       247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlGvil~elltg~~pf  318 (411)
                                  .+||+|||+|......     .....||+.|||||++.+.   .|+.++|||||||++|||+||+.||
T Consensus       142 ------------~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf  209 (276)
T d1uwha_         142 ------------TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY  209 (276)
T ss_dssp             ------------SEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ------------CEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCC
Confidence                        6677777777654322     2345799999999999753   5899999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCC--hhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          319 QTHENLEHLAMMERVLGPLP--HHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       319 ~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      .+.+....+..........|  ......+++.+.+++.+|+..+    |++|||+.++++++
T Consensus       210 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~d----p~~RPt~~~il~~L  267 (276)
T d1uwha_         210 SNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKK----RDERPLFPQILASI  267 (276)
T ss_dssp             TTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred             CCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCC----HhHCcCHHHHHHHH
Confidence            98776655544443322222  3344567788999999998888    99999999999875

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-53  Score=406.24  Aligned_cols=256  Identities=27%  Similarity=0.449  Sum_probs=213.9

Q ss_pred             CeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec------CC
Q 015222           93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY------RN  166 (411)
Q Consensus        93 ~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~------~~  166 (411)
                      +|+.+++||+|+||+||+|+++.+|+.||||+++.....   ..+|+.+|++++|+||     ++++++|..      ..
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~ni-----v~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNI-----VRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTB-----CCEEEEEEEC--CCSCC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCC-----CcEEEEEEecCccCCce
Confidence            699999999999999999999999999999999764432   3469999999988877     999888743      34


Q ss_pred             eEEEEEccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          167 HICIVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       167 ~~~lv~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      ++|+|||||++++.+.+..  .....+++..++.++.||+.||+|||++||+||||||+|||++.++             
T Consensus        93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~-------------  159 (350)
T d1q5ka_          93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT-------------  159 (350)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTT-------------
T ss_pred             EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCC-------------
Confidence            6899999997666555532  2334799999999999999999999999999999999999997654             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccC--CCcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTH  321 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~  321 (411)
                                   ..+||+|||++.....  .....+||+.|+|||.+.+. .++.++|||||||++|||++|+.||.+.
T Consensus       160 -------------~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~  226 (350)
T d1q5ka_         160 -------------AVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD  226 (350)
T ss_dssp             -------------CCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred             -------------CceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC
Confidence                         2578899998876533  23456899999999998765 7899999999999999999999999999


Q ss_pred             ChHHHHHHHHHHhCCCChhHHH-------------------------hhhhhhhhhhccCCccCCCCCCCcHHHHHHHHh
Q 015222          322 ENLEHLAMMERVLGPLPHHMVI-------------------------RADRRAEKYFRRGARLDWPDGATSRDSMRAVWK  376 (411)
Q Consensus       322 ~~~~~~~~i~~~~~~~p~~~~~-------------------------~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~  376 (411)
                      +..+.+..+.+..+..+.....                         ..++.+.+||.+||..|    |.+|||+.|+++
T Consensus       227 ~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~d----P~~R~ta~e~L~  302 (350)
T d1q5ka_         227 SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT----PTARLTPLEACA  302 (350)
T ss_dssp             SHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSS----GGGSCCHHHHHT
T ss_pred             CHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCC----hhHCcCHHHHhc
Confidence            9888888887776655443332                         24567889999999999    999999999999


Q ss_pred             cCCCCccccc
Q 015222          377 LLRLPVIDLY  386 (411)
Q Consensus       377 ~~~~~~~~~~  386 (411)
                      ||||+++...
T Consensus       303 Hp~f~~~~~~  312 (350)
T d1q5ka_         303 HSFFDELRDP  312 (350)
T ss_dssp             SGGGGGGGCT
T ss_pred             CHhhccccCC
Confidence            9999987543

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-53  Score=405.02  Aligned_cols=265  Identities=26%  Similarity=0.415  Sum_probs=213.6

Q ss_pred             CceEEeeCC-c--cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCc
Q 015222           80 GHYVFAIGE-N--LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGT  153 (411)
Q Consensus        80 ~~~~~~~~~-~--~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~  153 (411)
                      .++++.+|+ .  +.++|+++++||+|+||+||+|+++.+|+.||||++...   ......+.+|+.++++++|+||   
T Consensus         2 ~~~~~~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnI---   78 (355)
T d2b1pa1           2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI---   78 (355)
T ss_dssp             CEEEEEETTEEEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTB---
T ss_pred             CCEEEEeCCcceeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCe---
Confidence            568899999 3  348999999999999999999999999999999999753   2344567899999999988877   


Q ss_pred             ceEEEeeeeec------CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 015222          154 RCVQIRNWFDY------RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL  227 (411)
Q Consensus       154 ~iv~~~~~~~~------~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli  227 (411)
                        ++++++|..      ..++|+|||||.+++.+.+..    .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        79 --v~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~~----~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~  152 (355)
T d2b1pa1          79 --ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV  152 (355)
T ss_dssp             --CCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             --eEEEEEEecccccccCceeEEEEeccchHHHHhhhc----CCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc
Confidence              999998853      478999999997777776643    58999999999999999999999999999999999999


Q ss_pred             ecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC--CcccccCCCccccceecCCCCCccchhHHHH
Q 015222          228 VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVG  305 (411)
Q Consensus       228 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  305 (411)
                      +.++                           .++++|||.+......  .....||+.|+|||++.+..++.++||||+|
T Consensus       153 ~~~~---------------------------~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG  205 (355)
T d2b1pa1         153 KSDC---------------------------TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG  205 (355)
T ss_dssp             CTTC---------------------------CEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHH
T ss_pred             cccc---------------------------ceeeechhhhhccccccccccccccccccChhhhcCCCCCCCccccccc
Confidence            8776                           5677777766554332  2445799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH--------------------------------------HHhhhh
Q 015222          306 CILVELCSGEALFQTHENLEHLAMMERVLGPLPHHM--------------------------------------VIRADR  347 (411)
Q Consensus       306 vil~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~--------------------------------------~~~~~~  347 (411)
                      |++|+|++|+.||.+.+.......+.......+...                                      ....+.
T Consensus       206 ~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  285 (355)
T d2b1pa1         206 CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKAS  285 (355)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHH
T ss_pred             chHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCH
Confidence            999999999999999888877777665544332221                                      223466


Q ss_pred             hhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          348 RAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       348 ~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      .+.+||.+||..|    |++|||++|+|+||||+...
T Consensus       286 ~~~dll~~mL~~d----P~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         286 QARDLLSKMLVID----PAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHHHHHHHSCSS----TTTSCCHHHHHTSTTTGGGC
T ss_pred             HHHHHHHHHCcCC----hhHCcCHHHHhcCcccCCCC
Confidence            7899999999999    99999999999999998643

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-53  Score=404.74  Aligned_cols=263  Identities=30%  Similarity=0.511  Sum_probs=213.8

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC--
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--  165 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~--  165 (411)
                      +.++|+++++||+|+||+||+|+++.+|+.||||++++..  ...+.+.+|+.+|++++|+++     +++++++...  
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~i-----v~~~~~~~~~~~   80 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI-----IGINDIIRAPTI   80 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTB-----CCCCEEECCSST
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCC-----CcEEEEEeeccc
Confidence            4578999999999999999999999999999999997533  345678899999999998887     8888877543  


Q ss_pred             ---CeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccc
Q 015222          166 ---NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS  242 (411)
Q Consensus       166 ---~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~  242 (411)
                         .++|++|++++++|.+++...   .+++..++.++.||+.||+|||++|||||||||+|||++.+|           
T Consensus        81 ~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~-----------  146 (345)
T d1pmea_          81 EQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-----------  146 (345)
T ss_dssp             TTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-----------
T ss_pred             cccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC-----------
Confidence               356777776699999999875   499999999999999999999999999999999999998776           


Q ss_pred             ccCCCCCccccCCCCCCeeEeecCCcccccCC------CcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCC
Q 015222          243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGE  315 (411)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~  315 (411)
                                      .+||+|||++......      ....+||+.|+|||++... .++.++||||+||++|||++|+
T Consensus       147 ----------------~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~  210 (345)
T d1pmea_         147 ----------------DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR  210 (345)
T ss_dssp             ----------------CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSS
T ss_pred             ----------------CEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCC
Confidence                            5677777776543221      2335799999999998554 6789999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChh---------------------------HHHhhhhhhhhhhccCCccCCCCCCCcH
Q 015222          316 ALFQTHENLEHLAMMERVLGPLPHH---------------------------MVIRADRRAEKYFRRGARLDWPDGATSR  368 (411)
Q Consensus       316 ~pf~~~~~~~~~~~i~~~~~~~p~~---------------------------~~~~~~~~~~~li~~~l~~~~~~rp~~R  368 (411)
                      .||.+.+..+...............                           ....++..+.+||.+||..|    |.+|
T Consensus       211 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d----P~~R  286 (345)
T d1pmea_         211 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFN----PHKR  286 (345)
T ss_dssp             CSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSS----TTTS
T ss_pred             CCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCC----hhHC
Confidence            9999888777776666554433322                           12245567899999999999    9999


Q ss_pred             HHHHHHHhcCCCCcccccCCCCC
Q 015222          369 DSMRAVWKLLRLPVIDLYSASPN  391 (411)
Q Consensus       369 ~t~~~il~~~~~~~~~~~~~~~~  391 (411)
                      ||+.++|+||||.........+.
T Consensus       287 ~ta~e~L~hpf~~~~~~~~~~~~  309 (345)
T d1pmea_         287 IEVEQALAHPYLEQYYDPSDEPI  309 (345)
T ss_dssp             CCHHHHHTSGGGTTTCCGGGSCC
T ss_pred             cCHHHHhcCHhhccCCCCccCcc
Confidence            99999999999997766655544

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-53  Score=402.02  Aligned_cols=257  Identities=25%  Similarity=0.411  Sum_probs=209.4

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec----
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY----  164 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~----  164 (411)
                      ++|+++++||+|+||+||+|+++.+|+.||||++....   .....+.+|+.+|++++|+|+     +++++++..    
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~ni-----i~~~~~~~~~~~~   84 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV-----VNLIEICRTKASP   84 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTB-----CCEEEEEEC----
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCc-----cceEeeeeccccc
Confidence            68999999999999999999999999999999986432   344668899999999999887     777777644    


Q ss_pred             ----CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccc
Q 015222          165 ----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF  240 (411)
Q Consensus       165 ----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~  240 (411)
                          ++++|+||||+++.+........ ..+++..++.++.||+.||+|||++||+||||||+|||++.++         
T Consensus        85 ~~~~~~~~~iv~e~~~~~~~~~~~~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~---------  154 (318)
T d3blha1          85 YNRCKGSIYLVFDFCEHDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG---------  154 (318)
T ss_dssp             ------CEEEEEECCCEEHHHHHTCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS---------
T ss_pred             ccccCceEEEEEeccCCCccchhhhcc-cccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCC---------
Confidence                45789999999666655544333 4799999999999999999999999999999999999998877         


Q ss_pred             ccccCCCCCccccCCCCCCeeEeecCCcccccC-------CCcccccCCCccccceecCC-CCCccchhHHHHHHHHHHH
Q 015222          241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-------DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELC  312 (411)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell  312 (411)
                                        .+||+|||++.....       .....+||+.|+|||++.+. .++.++|||||||++|||+
T Consensus       155 ------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~  216 (318)
T d3blha1         155 ------------------VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW  216 (318)
T ss_dssp             ------------------CEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred             ------------------cEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHh
Confidence                              456666666543221       12235799999999999876 6899999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChhHHH----------------------------hhhhhhhhhhccCCccCCCCC
Q 015222          313 SGEALFQTHENLEHLAMMERVLGPLPHHMVI----------------------------RADRRAEKYFRRGARLDWPDG  364 (411)
Q Consensus       313 tg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~----------------------------~~~~~~~~li~~~l~~~~~~r  364 (411)
                      +|+.||.+.+..+.+..+.+..+.++.....                            ..+..+.+||.+||+.|    
T Consensus       217 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~d----  292 (318)
T d3blha1         217 TRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD----  292 (318)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSS----
T ss_pred             hCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCC----
Confidence            9999999999989888888877665543221                            12556789999999999    


Q ss_pred             CCcHHHHHHHHhcCCCCcccc
Q 015222          365 ATSRDSMRAVWKLLRLPVIDL  385 (411)
Q Consensus       365 p~~R~t~~~il~~~~~~~~~~  385 (411)
                      |++|+|++|+++||||++...
T Consensus       293 P~~R~sa~elL~Hpff~~~p~  313 (318)
T d3blha1         293 PAQRIDSDDALNHDFFWSDPM  313 (318)
T ss_dssp             TTTSCCHHHHHHSGGGSSSSC
T ss_pred             hhHCcCHHHHHcChhhccCCC
Confidence            999999999999999996433

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-54  Score=392.06  Aligned_cols=246  Identities=20%  Similarity=0.314  Sum_probs=212.4

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      ++|++.++||+|+||+||+|+++ +++.||||+++......+.+.+|+.++++++|+||     +++++++.+++.+++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnI-----v~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKL-----VQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTB-----CCEEEEECCSSSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCce-----eeEEEEEeeCCceEEE
Confidence            57899999999999999999985 77889999998877777889999999999988877     9999999999999999


Q ss_pred             EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      |||+ +|+|.+++.... ..+++..+..++.||++||+|||++||+||||||+|||+++++                   
T Consensus        78 ~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~-------------------  137 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-------------------  137 (258)
T ss_dssp             EECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC-------------------
T ss_pred             EEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCC-------------------
Confidence            9999 899999977654 3689999999999999999999999999999999999998766                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE  325 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~  325 (411)
                              .+||+|||++.......    ....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+
T Consensus       138 --------~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~  209 (258)
T d1k2pa_         138 --------VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE  209 (258)
T ss_dssp             --------CEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH
T ss_pred             --------cEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH
Confidence                    67778888776543322    22568999999999999999999999999999999998 899999999888


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      ....+........   +...++.+.+++.+|++.+    |++|||++++++|+
T Consensus       210 ~~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~d----P~~RPt~~eil~~L  255 (258)
T d1k2pa_         210 TAEHIAQGLRLYR---PHLASEKVYTIMYSCWHEK----ADERPTFKILLSNI  255 (258)
T ss_dssp             HHHHHHTTCCCCC---CTTCCHHHHHHHHHTTCSS----GGGSCCHHHHHHHH
T ss_pred             HHHHHHhCCCCCC---cccccHHHHHHHHHHccCC----HhHCcCHHHHHHHh
Confidence            8777766433222   2356778999999997777    99999999999984

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-53  Score=407.03  Aligned_cols=261  Identities=26%  Similarity=0.465  Sum_probs=219.0

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec---
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY---  164 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~---  164 (411)
                      .+||+++++||+|+||+||+|+++.+|+.||||++++..   ...+.+.+|+.+|++++|+|+     +++++++..   
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~i-----v~~~~~~~~~~~   91 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV-----IGLLDVFTPARS   91 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTB-----CCCSEEECSCSS
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCe-----eeEEEEEeeccc
Confidence            578999999999999999999999999999999997533   344567899999999998887     888888753   


Q ss_pred             ---CCeEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccc
Q 015222          165 ---RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL  241 (411)
Q Consensus       165 ---~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~  241 (411)
                         .+.+++++++++++|.+++..+   .+++..++.++.||+.||+|||++||+||||||+|||++.+|          
T Consensus        92 ~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~----------  158 (348)
T d2gfsa1          92 LEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC----------  158 (348)
T ss_dssp             TTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC----------
T ss_pred             cccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccc----------
Confidence               2345555554599999998654   599999999999999999999999999999999999998766          


Q ss_pred             cccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 015222          242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQT  320 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~  320 (411)
                                       .+|++|||.+...........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+
T Consensus       159 -----------------~~kl~dfg~a~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~  221 (348)
T d2gfsa1         159 -----------------ELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG  221 (348)
T ss_dssp             -----------------CEEECCC----CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             -----------------cccccccchhcccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCC
Confidence                             67888888888776666777899999999998776 468999999999999999999999999


Q ss_pred             CChHHHHHHHHHHhCCCChhHH---------------------------HhhhhhhhhhhccCCccCCCCCCCcHHHHHH
Q 015222          321 HENLEHLAMMERVLGPLPHHMV---------------------------IRADRRAEKYFRRGARLDWPDGATSRDSMRA  373 (411)
Q Consensus       321 ~~~~~~~~~i~~~~~~~p~~~~---------------------------~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~  373 (411)
                      .+.......+.+..+..+....                           ...++.+.+||.+||..|    |.+|+|+.|
T Consensus       222 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~d----P~~R~ta~e  297 (348)
T d2gfsa1         222 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD----SDKRITAAQ  297 (348)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSS----GGGSCCHHH
T ss_pred             CCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCC----hhhCcCHHH
Confidence            9988888888877766554432                           235678899999999999    999999999


Q ss_pred             HHhcCCCCcccccCCCC
Q 015222          374 VWKLLRLPVIDLYSASP  390 (411)
Q Consensus       374 il~~~~~~~~~~~~~~~  390 (411)
                      +|+||||++.......|
T Consensus       298 lL~Hp~f~~~~~~~~~~  314 (348)
T d2gfsa1         298 ALAHAYFAQYHDPDDEP  314 (348)
T ss_dssp             HHTSGGGTTTCCTTSCC
T ss_pred             HhcCHhhCCCCCCccCC
Confidence            99999999876655544

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-54  Score=397.17  Aligned_cols=248  Identities=23%  Similarity=0.332  Sum_probs=207.1

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      ++|++.++||+|+||+||+|+++ +++.||||+++......+.+.+|+.++++++|+||     +++++++.+ +.+++|
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~~~g~~~~-~~~~iv   85 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRL-----VRLYAVVTQ-EPIYII   85 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECS-SSCEEE
T ss_pred             HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCE-----eEEEeeecc-CCeEEE
Confidence            58999999999999999999975 56789999998776677889999999999998887     999998764 567999


Q ss_pred             EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      |||+ +|+|.+++.......+++..+..|+.||+.||+|||++||+||||||+||||+.++                   
T Consensus        86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~-------------------  146 (272)
T d1qpca_          86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-------------------  146 (272)
T ss_dssp             EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-------------------
T ss_pred             EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeeccc-------------------
Confidence            9999 99999987655444699999999999999999999999999999999999998766                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCCC----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLE  325 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~  325 (411)
                              .+||+|||+|+......    ....||+.|+|||++.+..++.++|||||||++|||+| |.+||...+..+
T Consensus       147 --------~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~  218 (272)
T d1qpca_         147 --------SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE  218 (272)
T ss_dssp             --------CEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred             --------ceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH
Confidence                    67888888877654322    33578999999999998899999999999999999999 566677767767


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHh--cCCC
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK--LLRL  380 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~--~~~~  380 (411)
                      .+..+.......   ....+++.+.+++.+|++.+    |++|||+.++++  ++||
T Consensus       219 ~~~~i~~~~~~~---~p~~~~~~l~~li~~cl~~~----P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         219 VIQNLERGYRMV---RPDNCPEELYQLMRLCWKER----PEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             HHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHhcCCCC---CcccChHHHHHHHHHHcCCC----HhHCcCHHHHHHHhhhhh
Confidence            666665532221   12356778999999998888    999999999987  4444

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-53  Score=398.29  Aligned_cols=246  Identities=22%  Similarity=0.313  Sum_probs=198.2

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCc---EEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~---~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      ++|++.+.||+|+||+||+|+++.+++   .||||.+...  ....+.+.+|+.+|++++|+||     |++++++.+++
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~l~g~~~~~~  100 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV-----IHLEGVVTKST  100 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEECSSS
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCC-----ccEEEEEeeCC
Confidence            579999999999999999999987664   6899988643  3445678999999999988877     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      .+++||||| +|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||||+.++              
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~--------------  165 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL--------------  165 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--------------
T ss_pred             EEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCC--------------
Confidence            999999999 999999888654 3699999999999999999999999999999999999998776              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCCC--------cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEA  316 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~  316 (411)
                                   .+||+|||+|+......        ....||+.|+|||++.+..++.++|||||||++|||+| |+.
T Consensus       166 -------------~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~  232 (299)
T d1jpaa_         166 -------------VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER  232 (299)
T ss_dssp             -------------CEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             -------------cEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCC
Confidence                         56777777766543221        12357899999999999999999999999999999998 899


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ||.+.+..+.+..+.......   ....+++.+.+++.+|++.+    |.+|||+.+++++
T Consensus       233 Pf~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~li~~cl~~~----P~~RPs~~ei~~~  286 (299)
T d1jpaa_         233 PYWDMTNQDVINAIEQDYRLP---PPMDCPSALHQLMLDCWQKD----RNHRPKFGQIVNT  286 (299)
T ss_dssp             TTTTCCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSS----TTTSCCHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHcCCCCC---CCccchHHHHHHHHHHcCCC----HhHCcCHHHHHHH
Confidence            999988888777766543211   12356778899999998888    8888888888876

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-53  Score=402.99  Aligned_cols=249  Identities=20%  Similarity=0.286  Sum_probs=204.6

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCc-----EEEEEEeccc--hhhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeee
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKE-----LVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~-----~vavK~~~~~--~~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~  163 (411)
                      ++|++.++||+|+||+||+|++..+++     .||+|++...  ......+.+|+.++.++ +|+||     |++++++.
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnI-----v~l~~~~~  111 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI-----VNLLGACT  111 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTB-----CCEEEEEC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcE-----eEEEEEEe
Confidence            579999999999999999999876553     6999998643  34456788999999999 67777     99999999


Q ss_pred             cCCeEEEEEccC-CCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 015222          164 YRNHICIVFEKL-GPSLYDFLRKNSY---------------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLK  221 (411)
Q Consensus       164 ~~~~~~lv~e~~-~~~L~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dik  221 (411)
                      +.+.+|+||||| +|+|.+++.....                     ..+++..++.++.||+.||+|||++||||||||
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK  191 (325)
T d1rjba_         112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA  191 (325)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence            999999999999 9999999976531                     248999999999999999999999999999999


Q ss_pred             CCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCC
Q 015222          222 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWN  296 (411)
Q Consensus       222 p~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~  296 (411)
                      |+|||++.++                           .+||+|||+|+......     ....||+.|||||++.+..++
T Consensus       192 p~Nill~~~~---------------------------~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~  244 (325)
T d1rjba_         192 ARNVLVTHGK---------------------------VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT  244 (325)
T ss_dssp             GGGEEEETTT---------------------------EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred             hhccccccCC---------------------------eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC
Confidence            9999998877                           56777777766543322     234689999999999999999


Q ss_pred             ccchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHH
Q 015222          297 YPCDLWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVW  375 (411)
Q Consensus       297 ~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il  375 (411)
                      .++|||||||++|||+| |+.||.+.+..+.+..+.+....+  .....+++.+.++|.+|++.+    |++|||++||+
T Consensus       245 ~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~--~~p~~~~~~l~~li~~cl~~d----P~~RPt~~ei~  318 (325)
T d1rjba_         245 IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM--DQPFYATEEIYIIMQSCWAFD----SRKRPSFPNLT  318 (325)
T ss_dssp             HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSS----GGGSCCHHHHH
T ss_pred             cceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC--CCCCcCCHHHHHHHHHHcCCC----hhHCcCHHHHH
Confidence            99999999999999998 899999877665555554432222  222456788999999998888    99999999999


Q ss_pred             hcC
Q 015222          376 KLL  378 (411)
Q Consensus       376 ~~~  378 (411)
                      +|+
T Consensus       319 ~~L  321 (325)
T d1rjba_         319 SFL  321 (325)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-53  Score=400.03  Aligned_cols=256  Identities=23%  Similarity=0.349  Sum_probs=210.6

Q ss_pred             CCeEEEeeeccccceEEEEEEe---CCCCcEEEEEEeccch-----hhhHHHHHHHHHHHHHhcC-CCCCcceEEEeeee
Q 015222           92 PRYRILSKMGEGTFGQVVECFD---NEKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLARH-DIGGTRCVQIRNWF  162 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~---~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~~~-~i~~~~iv~~~~~~  162 (411)
                      ++|++++.||+|+||+||+|++   +.+|+.||||++++..     ...+.+.+|+.++++++|+ ||     +++++++
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnI-----v~~~~~~   98 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL-----VTLHYAF   98 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTB-----CCEEEEE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeE-----EEeeeee
Confidence            6799999999999999999987   4578999999986432     3456678899999999984 55     9999999


Q ss_pred             ecCCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccc
Q 015222          163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL  241 (411)
Q Consensus       163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~  241 (411)
                      ++.+.+++||||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+|          
T Consensus        99 ~~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~----------  166 (322)
T d1vzoa_          99 QTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG----------  166 (322)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS----------
T ss_pred             ccCCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCC----------
Confidence            9999999999999 999999998876  689999999999999999999999999999999999998776          


Q ss_pred             cccCCCCCccccCCCCCCeeEeecCCcccccCC----CcccccCCCccccceecCC--CCCccchhHHHHHHHHHHHhCC
Q 015222          242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSGE  315 (411)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~  315 (411)
                                       .+||+|||++......    .....||+.|+|||.+.+.  .++.++|||||||+||||++|+
T Consensus       167 -----------------~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~  229 (322)
T d1vzoa_         167 -----------------HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA  229 (322)
T ss_dssp             -----------------CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSS
T ss_pred             -----------------CEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCC
Confidence                             5777788877654322    2345799999999999865  4688999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHH-----HHHHHHhcCCCCcccc
Q 015222          316 ALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRD-----SMRAVWKLLRLPVIDL  385 (411)
Q Consensus       316 ~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~-----t~~~il~~~~~~~~~~  385 (411)
                      .||.+.+..+....+.+........+...+++.+.++|.+||..|    |.+|+     |++|+++||||+++++
T Consensus       230 ~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~d----P~~R~s~~~~t~~eil~Hpff~~i~~  300 (322)
T d1vzoa_         230 SPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKD----PKKRLGCGPRDADEIKEHLFFQKINW  300 (322)
T ss_dssp             CTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSS----GGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             CCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccC----HHHcCCCCcccHHHHHcCHhhcCCCH
Confidence            999877654444444433222222223457889999999999999    66665     6999999999998774

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=389.06  Aligned_cols=247  Identities=24%  Similarity=0.294  Sum_probs=202.3

Q ss_pred             CCeEEEe-eeccccceEEEEEEeCC--CCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC
Q 015222           92 PRYRILS-KMGEGTFGQVVECFDNE--KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        92 ~~y~i~~-~lG~G~~g~V~~a~~~~--~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      ++|.+.+ +||+|+||+||+|.++.  ++..||||+++..  ....+.+.+|+.++++++|+||     +++++++.. +
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~l~g~~~~-~   81 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI-----VRLIGVCQA-E   81 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEES-S
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCE-----eeEeeeecc-C
Confidence            4688888 59999999999998764  4558999999743  3445778999999999988877     999999875 5


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS  245 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~  245 (411)
                      .+|+||||+ +|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++              
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~--------------  146 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH--------------  146 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT--------------
T ss_pred             eEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCC--------------
Confidence            689999999 899999986543 3699999999999999999999999999999999999998877              


Q ss_pred             CCCCccccCCCCCCeeEeecCCcccccCC------CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCC
Q 015222          246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALF  318 (411)
Q Consensus       246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf  318 (411)
                                   .+||+|||+|+.....      .....||+.|+|||++.+..++.++|||||||++|||+| |+.||
T Consensus       147 -------------~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf  213 (285)
T d1u59a_         147 -------------YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY  213 (285)
T ss_dssp             -------------EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             -------------ceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCC
Confidence                         4566666666543322      123468999999999999899999999999999999998 99999


Q ss_pred             CCCChHHHHHHHHHHhC-CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHH---HhcCCC
Q 015222          319 QTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV---WKLLRL  380 (411)
Q Consensus       319 ~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~i---l~~~~~  380 (411)
                      .+.+..+....+.+... ..|    ..+++.+.+++.+|++.+    |++|||+.++   |+++|+
T Consensus       214 ~~~~~~~~~~~i~~~~~~~~p----~~~~~~l~~li~~cl~~~----p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         214 KKMKGPEVMAFIEQGKRMECP----PECPPELYALMSDCWIYK----WEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             TTCCTHHHHHHHHTTCCCCCC----TTCCHHHHHHHHHTTCSS----GGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHcCCCCCCC----CcCCHHHHHHHHHHcCCC----HhHCcCHHHHHHHHHHHHH
Confidence            99888777777665432 222    456788999999998888    8888888777   455554

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.9e-52  Score=396.61  Aligned_cols=252  Identities=21%  Similarity=0.450  Sum_probs=206.8

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHh-cCCCCCcceEEEeeeeec--CCeE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDY--RNHI  168 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~iv~~~~~~~~--~~~~  168 (411)
                      ++|+++++||+|+||+||+|+++.+|+.||||+++...  .+.+.+|+.+|+.+. |+||     ++++++|..  .+.+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnI-----v~~~~~~~~~~~~~~  107 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNI-----ITLADIVKDPVSRTP  107 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTB-----CCEEEEEECTTTCSE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCC-----cEEEEEEEecCCCce
Confidence            68999999999999999999999999999999997543  466889999999996 6666     999999874  4579


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      ++||||| +++|.++.     ..+++..++.++.||+.||+|||++|||||||||+||||+.++                
T Consensus       108 ~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~----------------  166 (328)
T d3bqca1         108 ALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH----------------  166 (328)
T ss_dssp             EEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT----------------
T ss_pred             eEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCC----------------
Confidence            9999999 78876552     3699999999999999999999999999999999999998654                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccC--CCcccccCCCccccceecCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCh-
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSGEALFQTHEN-  323 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~-  323 (411)
                                ..+||+|||+|.....  ......||+.|+|||++.+. .++.++||||+||++|||++|+.||..... 
T Consensus       167 ----------~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~  236 (328)
T d3bqca1         167 ----------RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN  236 (328)
T ss_dssp             ----------TEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred             ----------CeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchh
Confidence                      2478888888876543  23456789999999998876 579999999999999999999999976543 


Q ss_pred             HHHHHHHHHHhCC---------------------------------CChhHHHhhhhhhhhhhccCCccCCCCCCCcHHH
Q 015222          324 LEHLAMMERVLGP---------------------------------LPHHMVIRADRRAEKYFRRGARLDWPDGATSRDS  370 (411)
Q Consensus       324 ~~~~~~i~~~~~~---------------------------------~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t  370 (411)
                      .+....+....+.                                 .+......+++++.+||++||..|    |.+|+|
T Consensus       237 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~d----P~~R~t  312 (328)
T d3bqca1         237 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD----HQSRLT  312 (328)
T ss_dssp             HHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSS----GGGSCC
T ss_pred             HHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCC----hhHCcC
Confidence            3333333333221                                 111112335677899999999999    999999


Q ss_pred             HHHHHhcCCCCcccc
Q 015222          371 MRAVWKLLRLPVIDL  385 (411)
Q Consensus       371 ~~~il~~~~~~~~~~  385 (411)
                      ++|+|+||||+++.+
T Consensus       313 a~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         313 AREAMEHPYFYTVVK  327 (328)
T ss_dssp             HHHHHTSGGGTTSCC
T ss_pred             HHHHhcCcccCCCCC
Confidence            999999999999875

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-52  Score=389.51  Aligned_cols=256  Identities=27%  Similarity=0.411  Sum_probs=214.3

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch---hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      ++|+++++||+|+||+||+|+++.+++.||||+++...   .....+.+|+.+++.++|+||     +++++++.+.+..
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~ni-----v~~~~~~~~~~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI-----VRLHDVLHSDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTB-----CCEEEEEECSSEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCE-----Eeeccccccccce
Confidence            58999999999999999999999999999999996432   345778899999999988877     9999999999999


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      ++||+++ +++|..++....  .+++..++.++.|++.||+|||++||+||||||+|||++.++                
T Consensus        77 ~iv~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~----------------  138 (292)
T d1unla_          77 TLVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG----------------  138 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC----------------
T ss_pred             eEEeeecccccccccccccc--ccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCC----------------
Confidence            9999999 777777776554  789999999999999999999999999999999999997765                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCCC---cccccCCCccccceecCCC-CCccchhHHHHHHHHHHHhCCCCC-CCCC
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSGEALF-QTHE  322 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~pf-~~~~  322 (411)
                                 .+||+|||.+.......   ....+++.|+|||++.+.. ++.++|||||||++|||++|+.|| .+.+
T Consensus       139 -----------~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~  207 (292)
T d1unla_         139 -----------ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND  207 (292)
T ss_dssp             -----------CEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS
T ss_pred             -----------ceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC
Confidence                       67888888877654332   2346788999999998764 699999999999999999999885 5556


Q ss_pred             hHHHHHHHHHHhCCCChh-------------------------HHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          323 NLEHLAMMERVLGPLPHH-------------------------MVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       323 ~~~~~~~i~~~~~~~p~~-------------------------~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ..+.+..+....+..+..                         .....++.+.+||.+||+.|    |.+|||++|+|+|
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~d----P~~R~sa~e~L~H  283 (292)
T d1unla_         208 VDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCN----PVQRISAEEALQH  283 (292)
T ss_dssp             HHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSS----GGGSCCHHHHTTS
T ss_pred             HHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCC----hhHCcCHHHHhcC
Confidence            667777776665543321                         12234567889999999999    9999999999999


Q ss_pred             CCCCcccc
Q 015222          378 LRLPVIDL  385 (411)
Q Consensus       378 ~~~~~~~~  385 (411)
                      |||++..+
T Consensus       284 p~f~~~~~  291 (292)
T d1unla_         284 PYFSDFCP  291 (292)
T ss_dssp             GGGSSCSC
T ss_pred             hhhcCCCC
Confidence            99987543

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-53  Score=389.59  Aligned_cols=240  Identities=24%  Similarity=0.328  Sum_probs=195.8

Q ss_pred             eeeccccceEEEEEEeC--CCCcEEEEEEeccc---hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEE
Q 015222           98 SKMGEGTFGQVVECFDN--EKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF  172 (411)
Q Consensus        98 ~~lG~G~~g~V~~a~~~--~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~  172 (411)
                      ++||+|+||+||+|.++  .+++.||||+++..   ....+.+.+|+.++++++|+||     ++++++++. +..++||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~g~~~~-~~~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI-----VRMIGICEA-ESWMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEES-SSEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCC-----ceEEEEecc-CCEEEEE
Confidence            47999999999999864  45678999999643   2345678999999999988877     999999865 4578999


Q ss_pred             ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCcc
Q 015222          173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF  251 (411)
Q Consensus       173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~~  251 (411)
                      ||+ +|+|.+++.+..  .+++..+..++.||+.||+|||++|||||||||+|||++.++                    
T Consensus        87 E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~--------------------  144 (277)
T d1xbba_          87 EMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH--------------------  144 (277)
T ss_dssp             ECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--------------------
T ss_pred             EcCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccC--------------------
Confidence            999 999999998765  799999999999999999999999999999999999999887                    


Q ss_pred             ccCCCCCCeeEeecCCcccccCC------CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChH
Q 015222          252 KNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENL  324 (411)
Q Consensus       252 ~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~  324 (411)
                             .+||+|||+++.....      .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..
T Consensus       145 -------~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~  217 (277)
T d1xbba_         145 -------YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS  217 (277)
T ss_dssp             -------EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             -------cccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH
Confidence                   4566666666543222      122468999999999999999999999999999999998 99999998887


Q ss_pred             HHHHHHHHHh-CCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHH---hcCCC
Q 015222          325 EHLAMMERVL-GPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVW---KLLRL  380 (411)
Q Consensus       325 ~~~~~i~~~~-~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il---~~~~~  380 (411)
                      +....+.+.. ...|    ..+++.+.+++.+|++.+    |++|||+.+++   +++|+
T Consensus       218 ~~~~~i~~~~~~~~p----~~~~~~~~~li~~cl~~d----p~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         218 EVTAMLEKGERMGCP----AGCPREMYDLMNLCWTYD----VENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             HHHHHHHTTCCCCCC----TTCCHHHHHHHHHHTCSS----TTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCCCCC----cccCHHHHHHHHHHcCCC----HhHCcCHHHHHHHhhCHHh
Confidence            7777666532 2223    356788999999998888    88888888874   45443

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=388.47  Aligned_cols=254  Identities=23%  Similarity=0.299  Sum_probs=209.0

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV  171 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv  171 (411)
                      ++|++.+.||+|+||+||+|+++.+ +.||||+++......+.+.+|+.++++++|+||     +++++++.+ +.+++|
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nI-----v~~~g~~~~-~~~~lv   89 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKL-----VQLYAVVSE-EPIYIV   89 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECS-SSCEEE
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCE-----eEEEEEEec-CCeEEE
Confidence            5799999999999999999998766 569999998777677889999999999999887     999999865 557899


Q ss_pred             EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCCc
Q 015222          172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY  250 (411)
Q Consensus       172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~~  250 (411)
                      |||+ +|+|.+++.......+++..+..++.||+.||+|||++||+||||||+||||+.++                   
T Consensus        90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~-------------------  150 (285)
T d1fmka3          90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-------------------  150 (285)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-------------------
T ss_pred             EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCC-------------------
Confidence            9999 99999998765444699999999999999999999999999999999999998877                   


Q ss_pred             cccCCCCCCeeEeecCCcccccCC----CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhC-CCCCCCCChHH
Q 015222          251 FKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG-EALFQTHENLE  325 (411)
Q Consensus       251 ~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg-~~pf~~~~~~~  325 (411)
                              .+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++| .+||.+....+
T Consensus       151 --------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~  222 (285)
T d1fmka3         151 --------VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE  222 (285)
T ss_dssp             --------CEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred             --------cEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH
Confidence                    5777778877654322    2235789999999999999999999999999999999995 55566666666


Q ss_pred             HHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHh--cCCCCccccc
Q 015222          326 HLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK--LLRLPVIDLY  386 (411)
Q Consensus       326 ~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~--~~~~~~~~~~  386 (411)
                      .+..+.+... .  .....+++.+.+++.+|++.+    |++||++++|++  +.||.+....
T Consensus       223 ~~~~i~~~~~-~--~~~~~~~~~l~~li~~cl~~d----P~~Rps~~~i~~~L~~~~~~~~p~  278 (285)
T d1fmka3         223 VLDQVERGYR-M--PCPPECPESLHDLMCQCWRKE----PEERPTFEYLQAFLEDYFTSTEPQ  278 (285)
T ss_dssp             HHHHHHTTCC-C--CCCTTSCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred             HHHHHHhcCC-C--CCCcccCHHHHHHHHHHcccC----HhHCcCHHHHHHHHhhhhcCCCCC
Confidence            6666654322 1  123456788999999998888    999999999988  8899887643

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-51  Score=380.05  Aligned_cols=247  Identities=20%  Similarity=0.285  Sum_probs=196.4

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCC----cEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKK----ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~----~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      +.|++.+.||+|+||+||+|.++.++    ..||||+++..  ......+.+|+.++++++|+||     |++++++.+.
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nI-----v~~~g~~~~~   81 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI-----IRLEGVISKY   81 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEECSS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCE-----eeeeEEEecC
Confidence            57999999999999999999987655    47999999643  3345568899999999988877     9999999999


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      +..++||||+ ++++.+++.... ..+++..+..++.||+.||+|||++||+||||||+||||+.++             
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~-------------  147 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-------------  147 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-------------
T ss_pred             CceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCC-------------
Confidence            9999999999 889998887654 4699999999999999999999999999999999999998766             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCCC------cccccCCCccccceecCCCCCccchhHHHHHHHHHHHhC-CCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSG-EAL  317 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg-~~p  317 (411)
                                    .+||+|||+|+......      ....||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus       148 --------------~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~  213 (283)
T d1mqba_         148 --------------VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP  213 (283)
T ss_dssp             --------------CEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             --------------eEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCc
Confidence                          67777777776543221      224689999999999999999999999999999999995 555


Q ss_pred             CCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          318 FQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       318 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      |.+.+..+.+..+......   .....++..+.+++.+|++.+    |++||++.++++.+
T Consensus       214 ~~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~~li~~cl~~~----p~~RPt~~eil~~L  267 (283)
T d1mqba_         214 YWELSNHEVMKAINDGFRL---PTPMDCPSAIYQLMMQCWQQE----RARRPKFADIVSIL  267 (283)
T ss_dssp             TTTCCHHHHHHHHHTTCCC---CCCTTCBHHHHHHHHHHTCSS----TTTSCCHHHHHHHH
T ss_pred             cccCCHHHHHHHHhccCCC---CCchhhHHHHHHHHHHHCcCC----HhHCcCHHHHHHHH
Confidence            6666666666555443221   122346778899999998777    88888899988743

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-52  Score=383.29  Aligned_cols=247  Identities=22%  Similarity=0.286  Sum_probs=199.1

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCC---cEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKK---ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~---~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .++|++.+.||+|+||+||+|++..++   ..||||+++..  ....+.+.+|+.++++++||||     +++++++. +
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~l~~~~~-~   79 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI-----VKLIGVIT-E   79 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEC-S
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEe-c
Confidence            368999999999999999999986543   56899998643  3445678899999999988877     99999986 4


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      +.+|+||||+ +|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++             
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~-------------  145 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-------------  145 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-------------
T ss_pred             CeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCC-------------
Confidence            6789999999 899999887654 4699999999999999999999999999999999999998877             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCC----CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQ  319 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~  319 (411)
                                    .+||+|||+|+.....    .....||+.|+|||++.+..++.++|||||||++|||++ |.+||.
T Consensus       146 --------------~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~  211 (273)
T d1mp8a_         146 --------------CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ  211 (273)
T ss_dssp             --------------EEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             --------------cEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCC
Confidence                          5677777776653322    223468999999999999999999999999999999998 899999


Q ss_pred             CCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          320 THENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       320 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      +.+..+.+..+......   .....+++.+.++|.+|+..|    |.+|||+.++++++
T Consensus       212 ~~~~~~~~~~i~~~~~~---~~~~~~~~~~~~li~~cl~~d----p~~Rps~~ei~~~L  263 (273)
T d1mp8a_         212 GVKNNDVIGRIENGERL---PMPPNCPPTLYSLMTKCWAYD----PSRRPRFTELKAQL  263 (273)
T ss_dssp             TCCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred             CCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCC----HhHCcCHHHHHHHH
Confidence            98888777776654321   123457888999999998888    99999999998773

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-51  Score=384.33  Aligned_cols=245  Identities=20%  Similarity=0.288  Sum_probs=199.2

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCc----EEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKE----LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR  165 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~----~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~  165 (411)
                      .+|++++.||+|+||+||+|++..+|+    .||+|.++..  ....+.+.+|+.++++++|+||     +++++++.++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~l~g~~~~~   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV-----CRLLGICLTS   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTB-----CCEEEEEESS
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEecC
Confidence            469999999999999999999988876    5888888643  3456778999999999988887     9999999865


Q ss_pred             CeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCccccccc
Q 015222          166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS  244 (411)
Q Consensus       166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~  244 (411)
                      + .+++||++ +++|.+++.... ..+++..+..++.||+.||+|||++|||||||||+|||++.++             
T Consensus        84 ~-~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~-------------  148 (317)
T d1xkka_          84 T-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-------------  148 (317)
T ss_dssp             S-EEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-------------
T ss_pred             C-eeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCC-------------
Confidence            4 56677777 999999888754 4799999999999999999999999999999999999998877             


Q ss_pred             CCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCC
Q 015222          245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALF  318 (411)
Q Consensus       245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf  318 (411)
                                    .+||+|||+|.......     ....||+.|+|||++.++.++.++|||||||++|||+| |..||
T Consensus       149 --------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~  214 (317)
T d1xkka_         149 --------------HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY  214 (317)
T ss_dssp             --------------EEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             --------------CeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCC
Confidence                          55667777665543221     22468999999999999999999999999999999998 89999


Q ss_pred             CCCChHHHHHHHHHHhC-CCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          319 QTHENLEHLAMMERVLG-PLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       319 ~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      .+.+..+....+.+... +.|    ..++..+.+++.+|+..+    |.+|||+.++++|+
T Consensus       215 ~~~~~~~~~~~i~~~~~~~~p----~~~~~~~~~li~~cl~~d----P~~RPs~~eil~~l  267 (317)
T d1xkka_         215 DGIPASEISSILEKGERLPQP----PICTIDVYMIMVKCWMID----ADSRPKFRELIIEF  267 (317)
T ss_dssp             TTSCGGGHHHHHHHTCCCCCC----TTBCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred             CCCCHHHHHHHHHcCCCCCCC----cccCHHHHHHHHHhCCCC----hhhCcCHHHHHHHH
Confidence            98887777666665432 233    346778899999998888    99999999998874

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3e-50  Score=386.58  Aligned_cols=278  Identities=30%  Similarity=0.508  Sum_probs=227.6

Q ss_pred             eEEeeCCccC-CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCC------CCcc
Q 015222           82 YVFAIGENLT-PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI------GGTR  154 (411)
Q Consensus        82 ~~~~~~~~~~-~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i------~~~~  154 (411)
                      +++.+|+.+. +||+++++||+|+||+||+|+++.+|+.||||++++.....+.+.+|+.+++.+.|+++      .|+|
T Consensus         2 ~p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~   81 (362)
T d1q8ya_           2 HPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANH   81 (362)
T ss_dssp             CCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred             CCCCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCc
Confidence            5677899886 57999999999999999999999999999999998877667788999999999999886      3678


Q ss_pred             eEEEeeeeecC--CeEEEEEccC--CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEec
Q 015222          155 CVQIRNWFDYR--NHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVS  229 (411)
Q Consensus       155 iv~~~~~~~~~--~~~~lv~e~~--~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dikp~NIli~~  229 (411)
                      ++++++++...  ...+++|+++  +++............+++..++.++.||+.||+|||+ .||+||||||+||||+.
T Consensus        82 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~  161 (362)
T d1q8ya_          82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI  161 (362)
T ss_dssp             BCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred             eEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeec
Confidence            99999988653  4566666665  5556666655555689999999999999999999998 89999999999999987


Q ss_pred             CcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHH
Q 015222          230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV  309 (411)
Q Consensus       230 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  309 (411)
                      ++..                     .....++++|||.+..........+||+.|+|||++.+..++.++||||+||+++
T Consensus       162 ~~~~---------------------~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~  220 (362)
T d1q8ya_         162 VDSP---------------------ENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIF  220 (362)
T ss_dssp             EETT---------------------TTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHH
T ss_pred             cCcc---------------------cccceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHH
Confidence            6521                     1122589999999988777777788999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCC------hHHHHHHHHHHhCCCChhHH--------------------------------------Hhh
Q 015222          310 ELCSGEALFQTHE------NLEHLAMMERVLGPLPHHMV--------------------------------------IRA  345 (411)
Q Consensus       310 elltg~~pf~~~~------~~~~~~~i~~~~~~~p~~~~--------------------------------------~~~  345 (411)
                      +|++|+.||...+      ..+.+.......+..+....                                      ...
T Consensus       221 el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (362)
T d1q8ya_         221 ELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE  300 (362)
T ss_dssp             HHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHH
T ss_pred             HHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCccc
Confidence            9999999997543      23444445555555544432                                      234


Q ss_pred             hhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCCccc
Q 015222          346 DRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLPVID  384 (411)
Q Consensus       346 ~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~~~~  384 (411)
                      ++.+.+||.+||..|    |.+|||++|+|+||||++..
T Consensus       301 ~~~~~dll~~mL~~d----P~~Rpta~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         301 AKEISDFLSPMLQLD----PRKRADAGGLVNHPWLKDTL  335 (362)
T ss_dssp             HHHHHHHHGGGGCSS----TTTCBCHHHHHTCGGGTTCT
T ss_pred             CHHHHHHHHHHCCCC----hhHCcCHHHHhcCcccCCCC
Confidence            577899999999999    99999999999999999664

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-52  Score=379.78  Aligned_cols=244  Identities=22%  Similarity=0.311  Sum_probs=198.2

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec-CCeEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-RNHICI  170 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~-~~~~~l  170 (411)
                      ++|++.+.||+|+||.||+|+++  |..||||+++.. ...+.+.+|+.++++++|+||     +++++++.+ .+.+|+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnI-----v~~~g~~~~~~~~~~l   78 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNL-----VQLLGVIVEEKGGLYI   78 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTB-----CCEEEEECCC--CCEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEecCCcEEE
Confidence            57999999999999999999874  678999999754 345678999999999988877     999998854 567899


Q ss_pred             EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      ||||+ +|+|.+++.+.....+++..++.++.||+.||.|||+++|+||||||+|||++.+|                  
T Consensus        79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~------------------  140 (262)
T d1byga_          79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN------------------  140 (262)
T ss_dssp             EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS------------------
T ss_pred             EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCC------------------
Confidence            99999 99999999765434589999999999999999999999999999999999998766                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCCCcccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEALFQTHENLEHLA  328 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~  328 (411)
                               .+||+|||+++..........+|..|+|||++.+..++.++|||||||++|||+| |++||...+..+...
T Consensus       141 ---------~~kl~dfg~s~~~~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~  211 (262)
T d1byga_         141 ---------VAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP  211 (262)
T ss_dssp             ---------CEEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH
T ss_pred             ---------CEeecccccceecCCCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence                     6788888888876666666788999999999999999999999999999999998 799998887777776


Q ss_pred             HHHHH-hCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          329 MMERV-LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       329 ~i~~~-~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      .+.+. ..++|    ...++.+.++|.+|+..|    |.+|||+.++++++
T Consensus       212 ~i~~~~~~~~~----~~~~~~~~~li~~cl~~d----P~~Rps~~~l~~~L  254 (262)
T d1byga_         212 RVEKGYKMDAP----DGCPPAVYEVMKNCWHLD----AAMRPSFLQLREQL  254 (262)
T ss_dssp             HHTTTCCCCCC----TTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred             HHHcCCCCCCC----ccCCHHHHHHHHHHcccC----HhHCcCHHHHHHHH
Confidence            66542 22333    356778999999998888    99999999998763

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-50  Score=379.52  Aligned_cols=261  Identities=24%  Similarity=0.311  Sum_probs=203.5

Q ss_pred             cCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEE
Q 015222           90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC  169 (411)
Q Consensus        90 ~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~  169 (411)
                      +.++|++.++||+|+||+||+|++..+|+.||||++.... ..+.+..|+++++.+.|+++    ++.+..++.+++..+
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~----i~~~~~~~~~~~~~~   79 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVG----IPTIRWCGAEGDYNV   79 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTT----CCCEEEEEEETTEEE
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCc----ccEEEEEEecCCEEE
Confidence            4568999999999999999999999999999999987543 33557889999999988764    356667777888999


Q ss_pred             EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCCC
Q 015222          170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS  249 (411)
Q Consensus       170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~~  249 (411)
                      +||||++++|.+.+.... ..+++..+..++.|++.||+|||++|||||||||+|||++..+                  
T Consensus        80 ivme~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~------------------  140 (299)
T d1ckia_          80 MVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK------------------  140 (299)
T ss_dssp             EEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGG------------------
T ss_pred             EEEEEcCCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccC------------------
Confidence            999999889888876544 4799999999999999999999999999999999999986543                  


Q ss_pred             ccccCCCCCCeeEeecCCcccccCC----------CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 015222          250 YFKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQ  319 (411)
Q Consensus       250 ~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~  319 (411)
                            .+..++|+|||+|+.....          .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       141 ------~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~  214 (299)
T d1ckia_         141 ------KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ  214 (299)
T ss_dssp             ------GTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             ------CCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCccc
Confidence                  3446888899988764322          234579999999999999999999999999999999999999998


Q ss_pred             CCChHHHHHHHHHH----hCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcCCCC
Q 015222          320 THENLEHLAMMERV----LGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLLRLP  381 (411)
Q Consensus       320 ~~~~~~~~~~i~~~----~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~~~~  381 (411)
                      ..........+.+.    ...........+++.+.+++.+|+..++.+||+. ..+.++++++|..
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~-~~i~~~l~~~~~~  279 (299)
T d1ckia_         215 GLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDY-SYLRQLFRNLFHR  279 (299)
T ss_dssp             CCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCH-HHHHHHHHHHHHH
T ss_pred             ccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCH-HHHHHHHHHHHHH
Confidence            76654443333221    1222334445678889999999999994444422 2234566776543

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=379.22  Aligned_cols=250  Identities=20%  Similarity=0.256  Sum_probs=192.2

Q ss_pred             CCeEEEeeeccccceEEEEEEeCC-----CCcEEEEEEeccc--hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      ++|++.++||+|+||.||+|++..     +++.||||+++..  ....+.+.+|..++.++.|+    +|++.+++++..
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h----~~iv~~~~~~~~   88 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH----LNVVNLLGACTK   88 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCC----TTBCCEEEEECS
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCC----CeEEEeeeeecc
Confidence            579999999999999999999754     4578999999743  23456677888889888654    334888887654


Q ss_pred             -CCeEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 015222          165 -RNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV  228 (411)
Q Consensus       165 -~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~  228 (411)
                       ++.+++||||| +|+|.+++....              ...+++..+..++.||+.||+|||++|||||||||+||||+
T Consensus        89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  168 (299)
T ss_dssp             TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC
Confidence             56799999999 999999997542              13589999999999999999999999999999999999998


Q ss_pred             cCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCCCccchhHH
Q 015222          229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWS  303 (411)
Q Consensus       229 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  303 (411)
                      .++                           .+||+|||+|+.....     .....||+.|+|||++.+..++.++||||
T Consensus       169 ~~~---------------------------~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS  221 (299)
T d1ywna1         169 EKN---------------------------VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS  221 (299)
T ss_dssp             GGG---------------------------CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHH
T ss_pred             CCC---------------------------cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceee
Confidence            877                           5677777776543221     22357899999999999999999999999


Q ss_pred             HHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhcC
Q 015222          304 VGCILVELCSG-EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKLL  378 (411)
Q Consensus       304 lGvil~elltg-~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~~  378 (411)
                      |||++|||++| ..||.+.+..+.+.........+  .....+++.+.+++.+|++.|    |++|||+.++++|+
T Consensus       222 ~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~d----P~~Rpt~~eil~~L  291 (299)
T d1ywna1         222 FGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--RAPDYTTPEMYQTMLDCWHGE----PSQRPTFSELVEHL  291 (299)
T ss_dssp             HHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCC--CCCTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred             hHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC--CCCccCCHHHHHHHHHHcCCC----hhHCcCHHHHHHHH
Confidence            99999999986 67898766544444333322111  122346778999999998888    99999999999884

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=6.8e-50  Score=372.68  Aligned_cols=250  Identities=22%  Similarity=0.287  Sum_probs=202.1

Q ss_pred             ccCCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        89 ~~~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      .+.++|++.++||+|+||+||+|++..+|+.||||++.... ....+.+|+++++.+.|+    +|++.+++++..+...
T Consensus         2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~----~~i~~~~~~~~~~~~~   76 (293)
T d1csna_           2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGC----TGIPNVYYFGQEGLHN   76 (293)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTC----TTCCCEEEEEEETTEE
T ss_pred             CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCC----CCCCEEEEEeecCCcc
Confidence            45689999999999999999999999999999999986533 335577899999999873    2348888999999999


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCCC
Q 015222          169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG  248 (411)
Q Consensus       169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~~  248 (411)
                      ++||||++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++...                 
T Consensus        77 ~~vme~~~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~-----------------  138 (293)
T d1csna_          77 VLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPN-----------------  138 (293)
T ss_dssp             EEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSS-----------------
T ss_pred             EEEEEecCCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcc-----------------
Confidence            9999999999999987654 4699999999999999999999999999999999999997532                 


Q ss_pred             CccccCCCCCCeeEeecCCcccccCC----------CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCC
Q 015222          249 SYFKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALF  318 (411)
Q Consensus       249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf  318 (411)
                           ......+||+|||+|+.....          ....+||+.|||||++.+..++.++|||||||++|||++|+.||
T Consensus       139 -----~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf  213 (293)
T d1csna_         139 -----SKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW  213 (293)
T ss_dssp             -----STTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             -----cccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcC
Confidence                 113346889999988764321          23357999999999999999999999999999999999999999


Q ss_pred             CCCCh---HHHHHHHHHHh-CCCChhHHHhhhhhhhhhhccCCccCCCCCCC
Q 015222          319 QTHEN---LEHLAMMERVL-GPLPHHMVIRADRRAEKYFRRGARLDWPDGAT  366 (411)
Q Consensus       319 ~~~~~---~~~~~~i~~~~-~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~  366 (411)
                      .+...   .+....+.... ...+......+++++.+++..|+..++.+||+
T Consensus       214 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~  265 (293)
T d1csna_         214 QGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPD  265 (293)
T ss_dssp             SSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCC
T ss_pred             CCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcC
Confidence            86543   33333333322 23334444567788999999999999666554

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-50  Score=374.02  Aligned_cols=245  Identities=21%  Similarity=0.282  Sum_probs=195.1

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCC-C--cEEEEEEeccc----hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEK-K--ELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY  164 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~-~--~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~  164 (411)
                      ++|++++.||+|+||+||+|+.... +  ..||||++++.    ....+.+.+|+.++++++|+||     +++++++.+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-----v~~~g~~~~   82 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL-----IRLYGVVLT   82 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTB-----CCEEEEECS
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCE-----EEEEEEEee
Confidence            5799999999999999999986433 3  46899998643    2345678999999999988887     999999976


Q ss_pred             CCeEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccc
Q 015222          165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR  243 (411)
Q Consensus       165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~  243 (411)
                       +..++||||+ +++|.+++..+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++            
T Consensus        83 -~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~------------  148 (273)
T d1u46a_          83 -PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD------------  148 (273)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT------------
T ss_pred             -cchheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc------------
Confidence             4678999999 999999887654 3699999999999999999999999999999999999998876            


Q ss_pred             cCCCCCccccCCCCCCeeEeecCCcccccCCC------cccccCCCccccceecCCCCCccchhHHHHHHHHHHHh-CCC
Q 015222          244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-GEA  316 (411)
Q Consensus       244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~  316 (411)
                                     .+||+|||++.......      ....||..|+|||++.+..++.++|||||||++|||+| |+.
T Consensus       149 ---------------~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~  213 (273)
T d1u46a_         149 ---------------LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE  213 (273)
T ss_dssp             ---------------EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ---------------ceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCC
Confidence                           56777777776543322      22457889999999999999999999999999999998 899


Q ss_pred             CCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHh
Q 015222          317 LFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWK  376 (411)
Q Consensus       317 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~  376 (411)
                      ||.+.+..+.+..+.+....++  ....++..+.+++.+|++.|    |++|||+.++++
T Consensus       214 Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~l~~li~~cl~~d----p~~RPt~~ei~~  267 (273)
T d1u46a_         214 PWIGLNGSQILHKIDKEGERLP--RPEDCPQDIYNVMVQCWAHK----PEDRPTFVALRD  267 (273)
T ss_dssp             TTTTCCHHHHHHHHHTSCCCCC--CCTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHH
T ss_pred             CCCCcCHHHHHHHHHhCCCCCC--CcccccHHHHHHHHHHcCCC----hhHCcCHHHHHH
Confidence            9999988888777765433222  23456788999999998888    999999999875

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-50  Score=378.92  Aligned_cols=248  Identities=19%  Similarity=0.258  Sum_probs=205.9

Q ss_pred             CCCeEEEeeeccccceEEEEEEeC-----CCCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~  163 (411)
                      .++|+++++||+|+||+||+|+++     .+++.||||+++...  ...+.+.+|+.++++++|+|+     +++++++.
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~ni-----v~~~~~~~   86 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI-----VKLLGVCA   86 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEC
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCc-----ccceeeec
Confidence            357999999999999999999875     356789999997432  345678999999999988887     99999999


Q ss_pred             cCCeEEEEEccC-CCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 015222          164 YRNHICIVFEKL-GPSLYDFLRKNS----------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDL  220 (411)
Q Consensus       164 ~~~~~~lv~e~~-~~~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Di  220 (411)
                      ..+..++||||+ +|+|.+++....                      ...+++..+..++.||+.||+|||++|||||||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl  166 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL  166 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence            999999999999 999999997532                      124889999999999999999999999999999


Q ss_pred             CCCcEEEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCC-----CcccccCCCccccceecCCCC
Q 015222          221 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGW  295 (411)
Q Consensus       221 kp~NIli~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~  295 (411)
                      ||+|||++.++                           .+||+|||+|+.....     .....||+.|+|||.+.+..+
T Consensus       167 Kp~NILld~~~---------------------------~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  219 (301)
T d1lufa_         167 ATRNCLVGENM---------------------------VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY  219 (301)
T ss_dssp             SGGGEEECGGG---------------------------CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC
T ss_pred             cccceEECCCC---------------------------cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCC
Confidence            99999998776                           6788888877643222     223568899999999999999


Q ss_pred             CccchhHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHH
Q 015222          296 NYPCDLWSVGCILVELCSG-EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAV  374 (411)
Q Consensus       296 ~~~~DiwSlGvil~elltg-~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~i  374 (411)
                      +.++|||||||++|||++| .+||.+.+..+.+..+.+....   .....+++.+.+++.+|++.+    |++|||+.+|
T Consensus       220 t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~---~~p~~~~~~~~~li~~cl~~~----P~~RPt~~ev  292 (301)
T d1lufa_         220 TTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL---ACPENCPLELYNLMRLCWSKL----PADRPSFCSI  292 (301)
T ss_dssp             CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSS----GGGSCCHHHH
T ss_pred             ChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCC---CCCccchHHHHHHHHHHcCCC----hhHCcCHHHH
Confidence            9999999999999999998 4789988888887776654321   122356678889999998888    9999999999


Q ss_pred             Hhc
Q 015222          375 WKL  377 (411)
Q Consensus       375 l~~  377 (411)
                      ++.
T Consensus       293 ~~~  295 (301)
T d1lufa_         293 HRI  295 (301)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            764

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-50  Score=378.55  Aligned_cols=247  Identities=20%  Similarity=0.250  Sum_probs=203.2

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcE--EEEEEeccc--hhhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeeecCC
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKEL--VAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRN  166 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~--vavK~~~~~--~~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~~~~  166 (411)
                      ++|++.++||+|+||+||+|+++.++..  ||||.++..  ....+.+.+|+.+|+++ +|+||     +++++++.+++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnI-----v~~~~~~~~~~   84 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI-----INLLGACEHRG   84 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTB-----CCEEEEEEETT
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCE-----eeEEEEEecCC
Confidence            5799999999999999999999888864  677877532  23456789999999998 57776     99999999999


Q ss_pred             eEEEEEccC-CCCHHHHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCc
Q 015222          167 HICIVFEKL-GPSLYDFLRKN--------------SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE  231 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~  231 (411)
                      .+++||||+ +|+|.+++...              ....+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence            999999999 99999999754              234799999999999999999999999999999999999998776


Q ss_pred             ccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC--cccccCCCccccceecCCCCCccchhHHHHHHHH
Q 015222          232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV  309 (411)
Q Consensus       232 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  309 (411)
                                                 .+||+|||++.......  ....||..|+|||.+.+..++.++|||||||++|
T Consensus       165 ---------------------------~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~  217 (309)
T d1fvra_         165 ---------------------------VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW  217 (309)
T ss_dssp             ---------------------------CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred             ---------------------------ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHH
Confidence                                       67888888876543322  3356899999999999999999999999999999


Q ss_pred             HHHhC-CCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          310 ELCSG-EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       310 elltg-~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ||++| .+||.+.+..+....+.+...   ......+++.+.++|.+|++.|    |++|||+.+++++
T Consensus       218 ell~~~~~p~~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~~li~~cl~~d----P~~RPs~~eil~~  279 (309)
T d1fvra_         218 EIVSLGGTPYCGMTCAELYEKLPQGYR---LEKPLNCDDEVYDLMRQCWREK----PYERPSFAQILVS  279 (309)
T ss_dssp             HHHTTSCCTTTTCCHHHHHHHGGGTCC---CCCCTTBCHHHHHHHHHHTCSS----GGGSCCHHHHHHH
T ss_pred             HHHhcCCCCCCCCCHHHHHHHHHhcCC---CCCCccCCHHHHHHHHHHcCCC----hhHCcCHHHHHHH
Confidence            99996 567888887777766654321   1223457788999999998888    9999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=371.92  Aligned_cols=248  Identities=18%  Similarity=0.260  Sum_probs=201.0

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCC-------cEEEEEEeccch--hhhHHHHHHHHHHHHH-hcCCCCCcceEEEee
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKK-------ELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRN  160 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~-------~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~  160 (411)
                      .++|++.+.||+|+||.||+|++..++       ..||||+++...  .....+.+|+..+.++ +|+||     +++++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnI-----v~~~~   86 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI-----INLLG   86 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeE-----Eeccc
Confidence            368999999999999999999976654       479999996533  3456788899999998 57766     99999


Q ss_pred             eeecCCeEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 015222          161 WFDYRNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI  225 (411)
Q Consensus       161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NI  225 (411)
                      ++.+++.+++||||+ +|+|.+++....              ...+++..++.++.||+.||+|||++|||||||||+||
T Consensus        87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~Ni  166 (299)
T d1fgka_          87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  166 (299)
T ss_dssp             EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccce
Confidence            999999999999999 999999997553              23589999999999999999999999999999999999


Q ss_pred             EEecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccch
Q 015222          226 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCD  300 (411)
Q Consensus       226 li~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~D  300 (411)
                      |++.++                           .+||+|||++.......     ....||+.|+|||.+.++.|+.++|
T Consensus       167 Ll~~~~---------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~D  219 (299)
T d1fgka_         167 LVTEDN---------------------------VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD  219 (299)
T ss_dssp             EECTTC---------------------------CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHH
T ss_pred             eecCCC---------------------------CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhh
Confidence            998776                           56777777766543322     2356889999999999999999999


Q ss_pred             hHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          301 LWSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       301 iwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ||||||++|||++ |.+||.+.+..+....+......   .....+++.+.++|.+|++.+    |++|||+.|+++.
T Consensus       220 iwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~~---~~p~~~~~~l~~li~~cl~~d----P~~Rps~~eil~~  290 (299)
T d1fgka_         220 VWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM---DKPSNCTNELYMMMRDCWHAV----PSQRPTFKQLVED  290 (299)
T ss_dssp             HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC---CCCSSCCHHHHHHHHHHTCSS----GGGSCCHHHHHHH
T ss_pred             hHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCCC---CCCccchHHHHHHHHHHccCC----HhHCcCHHHHHHH
Confidence            9999999999998 79999988887766665543211   122456788999999998888    9999999999874

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-49  Score=369.29  Aligned_cols=248  Identities=24%  Similarity=0.318  Sum_probs=201.7

Q ss_pred             CCeEEEeeeccccceEEEEEEeC-----CCCcEEEEEEeccch--hhhHHHHHHHHHHHHH-hcCCCCCcceEEEeeeee
Q 015222           92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~~~~i~~~~iv~~~~~~~  163 (411)
                      ++|++.++||+|+||.||+|++.     .+++.||||+++...  .....+.+|+.+++++ +|+||     +++++++.
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnI-----v~~~g~~~   97 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI-----VNLLGACT   97 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCE-----EEEEEEEe
Confidence            68999999999999999999863     466799999997533  4455688999999999 46666     99999999


Q ss_pred             cCCeEEEEEccC-CCCHHHHHHhcC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 015222          164 YRNHICIVFEKL-GPSLYDFLRKNS----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL  226 (411)
Q Consensus       164 ~~~~~~lv~e~~-~~~L~~~l~~~~----------------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIl  226 (411)
                      +.+..++||||| +|+|.+++.+..                ...+++..+..++.||+.||+|||++|||||||||+|||
T Consensus        98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl  177 (311)
T d1t46a_          98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL  177 (311)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccc
Confidence            999999999999 999999997643                125899999999999999999999999999999999999


Q ss_pred             EecCcccccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchh
Q 015222          227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDL  301 (411)
Q Consensus       227 i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di  301 (411)
                      ++.++.                           ++|+|||.++......     ....||+.|+|||++.+..++.++||
T Consensus       178 ~~~~~~---------------------------~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DI  230 (311)
T d1t46a_         178 LTHGRI---------------------------TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV  230 (311)
T ss_dssp             EETTTE---------------------------EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHH
T ss_pred             ccccCc---------------------------ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccc
Confidence            988774                           5556666555433221     22578999999999999999999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          302 WSVGCILVELCS-GEALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       302 wSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      |||||++|||+| |.+||.+.+..+.+..+.+.....  ......++.+.++|.+|++.|    |.+|||+.++++.
T Consensus       231 wS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~Li~~cl~~d----P~~RPs~~~il~~  301 (311)
T d1t46a_         231 WSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM--LSPEHAPAEMYDIMKTCWDAD----PLKRPTFKQIVQL  301 (311)
T ss_dssp             HHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC--CCCTTSCHHHHHHHHHHTCSS----GGGSCCHHHHHHH
T ss_pred             cchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC--CCcccccHHHHHHHHHHcCCC----hhHCcCHHHHHHH
Confidence            999999999998 777787776656555544332211  122346788999999998888    9999999999863

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-49  Score=369.73  Aligned_cols=248  Identities=18%  Similarity=0.242  Sum_probs=206.4

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCC-----CCcEEEEEEeccch--hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeee
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD  163 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~-----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~  163 (411)
                      .++|++.++||+|+||+||+|.++.     ++..||||+++...  .....+.+|+.+++++.|+||     +++++++.
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nI-----v~~~~~~~   93 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV-----VRLLGVVS   93 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTB-----CCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCE-----eeeeeEEe
Confidence            3789999999999999999998753     35789999997533  334567899999999988877     99999999


Q ss_pred             cCCeEEEEEccC-CCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccc
Q 015222          164 YRNHICIVFEKL-GPSLYDFLRKNS--------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK  234 (411)
Q Consensus       164 ~~~~~~lv~e~~-~~~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~  234 (411)
                      .++..++||||+ +|+|.+++....        ...+++..+..++.|+++||.|||+++|+||||||+|||++.++   
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~---  170 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF---  170 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC---
T ss_pred             cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc---
Confidence            999999999999 999999986431        13478999999999999999999999999999999999997665   


Q ss_pred             cCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCC-----cccccCCCccccceecCCCCCccchhHHHHHHHH
Q 015222          235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV  309 (411)
Q Consensus       235 l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  309 (411)
                                              ++||+|||+|+......     ....||+.|+|||.+.+..++.++|||||||++|
T Consensus       171 ------------------------~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~  226 (308)
T d1p4oa_         171 ------------------------TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW  226 (308)
T ss_dssp             ------------------------CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred             ------------------------eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHH
Confidence                                    67888888887543322     2246899999999999999999999999999999


Q ss_pred             HHHhC-CCCCCCCChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          310 ELCSG-EALFQTHENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       310 elltg-~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      ||+|| ..||.+.+..+.+..+.+.....   ....++..+.+++.+|++.+    |.+|||+.+++++
T Consensus       227 El~t~~~~p~~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~~li~~cl~~~----P~~RPs~~~il~~  288 (308)
T d1p4oa_         227 EIATLAEQPYQGLSNEQVLRFVMEGGLLD---KPDNCPDMLFELMRMCWQYN----PKMRPSFLEIISS  288 (308)
T ss_dssp             HHHHTSCCTTTTSCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHH
T ss_pred             HHHhCCCCCCCCCCHHHHHHHHHhCCCCC---CcccchHHHHHHHHHHcCCC----hhHCcCHHHHHHH
Confidence            99997 68898888888877766533211   12346678999999998777    9999999999984

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-48  Score=362.94  Aligned_cols=247  Identities=22%  Similarity=0.238  Sum_probs=184.5

Q ss_pred             CCCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCC----
Q 015222           91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN----  166 (411)
Q Consensus        91 ~~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~----  166 (411)
                      ..+|.+.++||+|+||+||+|++  +|+.||||+++.........+.|+..+.+++|+||     +++++++.+.+    
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnI-----v~~~~~~~~~~~~~~   74 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI-----LGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTB-----CCEEEEEEEECSSSE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcC-----cceEEEEEeCCCcce
Confidence            35799999999999999999985  58899999997654433333344444455666655     99999987643    


Q ss_pred             eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceecCCCCCcEEEecCcccccCC
Q 015222          167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE--------LRLIHTDLKPENILLVSAEYVKVPD  237 (411)
Q Consensus       167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--------~givH~Dikp~NIli~~~~~~~l~d  237 (411)
                      .+|+||||+ +|+|.+++++.   .+++..+..++.|++.||+|||+        +|||||||||+||||+.++      
T Consensus        75 ~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~------  145 (303)
T d1vjya_          75 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG------  145 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS------
T ss_pred             EEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC------
Confidence            689999999 99999999876   49999999999999999999996        5999999999999998776      


Q ss_pred             cccccccCCCCCccccCCCCCCeeEeecCCcccccCC-------CcccccCCCccccceecCCC------CCccchhHHH
Q 015222          238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-------HSYVVSTRHYRAPEVILGLG------WNYPCDLWSV  304 (411)
Q Consensus       238 f~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSl  304 (411)
                                           .+||+|||++......       .....||+.|+|||++.+..      ++.++|||||
T Consensus       146 ---------------------~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~  204 (303)
T d1vjya_         146 ---------------------TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM  204 (303)
T ss_dssp             ---------------------CEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHH
T ss_pred             ---------------------CeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhh
Confidence                                 6677777777654322       22357999999999987642      6789999999


Q ss_pred             HHHHHHHHhCCCCCCCCC--------------hHHHHHHHHHHh---CCCChhHH-HhhhhhhhhhhccCCccCCCCCCC
Q 015222          305 GCILVELCSGEALFQTHE--------------NLEHLAMMERVL---GPLPHHMV-IRADRRAEKYFRRGARLDWPDGAT  366 (411)
Q Consensus       305 Gvil~elltg~~pf~~~~--------------~~~~~~~i~~~~---~~~p~~~~-~~~~~~~~~li~~~l~~~~~~rp~  366 (411)
                      ||+||||+||..||....              ..+.+.......   ..+|.... ......+.+++.+|++.|    |.
T Consensus       205 Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~d----p~  280 (303)
T d1vjya_         205 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN----GA  280 (303)
T ss_dssp             HHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSS----GG
T ss_pred             HHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccC----Hh
Confidence            999999999998874321              112222221111   12333321 223345778888887777    99


Q ss_pred             cHHHHHHHHhcC
Q 015222          367 SRDSMRAVWKLL  378 (411)
Q Consensus       367 ~R~t~~~il~~~  378 (411)
                      +|||+.|+++++
T Consensus       281 ~Rps~~ei~~~L  292 (303)
T d1vjya_         281 ARLTALRIKKTL  292 (303)
T ss_dssp             GSCCHHHHHHHH
T ss_pred             HCcCHHHHHHHH
Confidence            999999998753

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=359.75  Aligned_cols=243  Identities=16%  Similarity=0.165  Sum_probs=190.5

Q ss_pred             EEEeeeccccceEEEEEEeCCCC---cEEEEEEecc--chhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeec-CCeE
Q 015222           95 RILSKMGEGTFGQVVECFDNEKK---ELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-RNHI  168 (411)
Q Consensus        95 ~i~~~lG~G~~g~V~~a~~~~~~---~~vavK~~~~--~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~-~~~~  168 (411)
                      ...++||+|+||+||+|++..++   ..||||+++.  .....+.+.+|++++++++|+||     +++++++.. ++..
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~~~g~~~~~~~~~  104 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV-----LSLLGICLRSEGSP  104 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTB-----CCCCEEEEETTTEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCE-----eEEeEEEEecCCce
Confidence            34678999999999999987653   3699999964  33455778999999999988877     999998764 5689


Q ss_pred             EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCcccccCCcccccccCCC
Q 015222          169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD  247 (411)
Q Consensus       169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~~l~df~~~~~~~~~  247 (411)
                      ++||||| +++|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+|||+++++                
T Consensus       105 ~lv~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~----------------  167 (311)
T d1r0pa_         105 LVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF----------------  167 (311)
T ss_dssp             EEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC----------------
T ss_pred             EEEEEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCC----------------
Confidence            9999999 999999987654 4688899999999999999999999999999999999998766                


Q ss_pred             CCccccCCCCCCeeEeecCCcccccCC-------CcccccCCCccccceecCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 015222          248 GSYFKNLPKSSAIKLIDFGSTTFEHQD-------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT  320 (411)
Q Consensus       248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~pf~~  320 (411)
                                 .+||+|||+++.....       .....||+.|+|||.+.+..++.++|||||||++|||++|..||..
T Consensus       168 -----------~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~  236 (311)
T d1r0pa_         168 -----------TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP  236 (311)
T ss_dssp             -----------CEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred             -----------CEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence                       5566666666543221       1224689999999999999999999999999999999997777754


Q ss_pred             C-ChHHHHHHHHHHhCCCChhHHHhhhhhhhhhhccCCccCCCCCCCcHHHHHHHHhc
Q 015222          321 H-ENLEHLAMMERVLGPLPHHMVIRADRRAEKYFRRGARLDWPDGATSRDSMRAVWKL  377 (411)
Q Consensus       321 ~-~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~li~~~l~~~~~~rp~~R~t~~~il~~  377 (411)
                      . +..+....+.......   ....+++.+.+++.+|++.|    |++||++.|++++
T Consensus       237 ~~~~~~~~~~i~~g~~~~---~p~~~~~~l~~li~~cl~~d----P~~RPs~~ei~~~  287 (311)
T d1r0pa_         237 DVNTFDITVYLLQGRRLL---QPEYCPDPLYEVMLKCWHPK----AEMRPSFSELVSR  287 (311)
T ss_dssp             ------CHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHcCCCCC---CcccCcHHHHHHHHHHcCCC----HhHCcCHHHHHHH
Confidence            3 3333344443332211   12346678899999998887    9999999999988

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=1.1e-26  Score=201.39  Aligned_cols=162  Identities=21%  Similarity=0.234  Sum_probs=115.3

Q ss_pred             eEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-------------------hhhHHHHHHHHHHHHHhcCCCCCcc
Q 015222           94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------------------KYREAAMIEIDVLQRLARHDIGGTR  154 (411)
Q Consensus        94 y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-------------------~~~~~~~~E~~~l~~l~~~~i~~~~  154 (411)
                      +.+.++||+|+||+||+|++. +|+.||||+++...                   .......+|...+.++.+.++    
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v----   76 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAV----   76 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSS----
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCc----
Confidence            467899999999999999985 68899999875311                   112334568888888877766    


Q ss_pred             eEEEeeeeecCCeEEEEEccCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecCccc
Q 015222          155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV  233 (411)
Q Consensus       155 iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dikp~NIli~~~~~~  233 (411)
                       +..+++..    .+++|||+++ .+.         .++...+..++.||+.||+|||++||+||||||+|||++.++  
T Consensus        77 -~~~~~~~~----~~lvme~~~~~~~~---------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~--  140 (191)
T d1zara2          77 -PKVYAWEG----NAVLMELIDAKELY---------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG--  140 (191)
T ss_dssp             -CCEEEEET----TEEEEECCCCEEGG---------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE--
T ss_pred             -ceEEEecC----CEEEEEeecccccc---------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC--
Confidence             55544322    2799999944 321         255566788999999999999999999999999999997543  


Q ss_pred             ccCCcccccccCCCCCccccCCCCCCeeEeecCCcccccCCCcccccCCCccc------cceecCCCCCccchhHHHHHH
Q 015222          234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRA------PEVILGLGWNYPCDLWSVGCI  307 (411)
Q Consensus       234 ~l~df~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~DiwSlGvi  307 (411)
                                                ++|+|||.|.........     .|..      .|.+ ...|+.++|+||+.--
T Consensus       141 --------------------------~~liDFG~a~~~~~~~~~-----~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         141 --------------------------IWIIDFPQSVEVGEEGWR-----EILERDVRNIITYF-SRTYRTEKDINSAIDR  188 (191)
T ss_dssp             --------------------------EEECCCTTCEETTSTTHH-----HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred             --------------------------EEEEECCCcccCCCCCcH-----HHHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence                                      788899988655432211     0111      1111 2468899999998644


Q ss_pred             H
Q 015222          308 L  308 (411)
Q Consensus       308 l  308 (411)
                      +
T Consensus       189 ~  189 (191)
T d1zara2         189 I  189 (191)
T ss_dssp             H
T ss_pred             H
Confidence            3

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.50  E-value=3.3e-07  Score=80.88  Aligned_cols=85  Identities=12%  Similarity=0.084  Sum_probs=59.2

Q ss_pred             CCeEEEeeeccccceEEEEEEeCCCCcEEEEEEeccch-hhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEE
Q 015222           92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI  170 (411)
Q Consensus        92 ~~y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~l  170 (411)
                      +.|++.+..+.++.+.||+..  .+++.++||+..... .....+.+|...+..+.. .+.   +.+++.+..+++..++
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~-~vp---vP~vl~~~~~~~~~~l   87 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEG-KLP---VPKVLHFERHDGWSNL   87 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTT-TSC---CCCEEEEEEETTEEEE
T ss_pred             hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhc-cCC---CCcEEEEEecCCceEE
Confidence            467887776666667999885  455667888875432 334457789999988853 332   2455666677788999


Q ss_pred             EEccC-CCCHHHH
Q 015222          171 VFEKL-GPSLYDF  182 (411)
Q Consensus       171 v~e~~-~~~L~~~  182 (411)
                      ||+++ |.++.+.
T Consensus        88 v~~~l~G~~~~~~  100 (263)
T d1j7la_          88 LMSEADGVLCSEE  100 (263)
T ss_dssp             EEECCSSEEHHHH
T ss_pred             EEEeccccccccc
Confidence            99999 7676544

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.14  E-value=4.2e-06  Score=78.40  Aligned_cols=75  Identities=21%  Similarity=0.228  Sum_probs=47.1

Q ss_pred             EeeeccccceEEEEEEeCCCCcEEEEEEeccc--------hhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        97 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~--------~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      .+.||.|....||++.+..+++.|+||.-...        ....+....|...|+.+....  ...+.+++.+  +.+..
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~--p~~vP~v~~~--d~~~~  106 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV--PHLVPRVFYS--DTEMA  106 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTC--GGGSCCEEEE--ETTTT
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhC--CCCcceEEEE--cCCCC
Confidence            45789999999999998888889999975321        112344567888888775431  1123444443  33445


Q ss_pred             EEEEccC
Q 015222          169 CIVFEKL  175 (411)
Q Consensus       169 ~lv~e~~  175 (411)
                      ++|||++
T Consensus       107 ~lvmE~L  113 (392)
T d2pula1         107 VTVMEDL  113 (392)
T ss_dssp             EEEECCC
T ss_pred             EEEEecc
Confidence            7899999

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.00  E-value=9e-06  Score=70.92  Aligned_cols=75  Identities=15%  Similarity=0.126  Sum_probs=52.5

Q ss_pred             eecccc-ceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeEEEEEccC-C
Q 015222           99 KMGEGT-FGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-G  176 (411)
Q Consensus        99 ~lG~G~-~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~~lv~e~~-~  176 (411)
                      .+..|. .+.||+... .++..+++|......  ...+..|...++.+....+.   +.+++.+..+.+..++||+++ |
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvp---vP~v~~~~~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVP---CAAVLDVVTEAGRDWLLLGEVPG   90 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCC---BCCEEEEEECSSCEEEEEECCSS
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCC---CCceeeecccccceEEEEEeeec
Confidence            334444 468999875 446668899865433  34578899999999887764   345556666778899999999 6


Q ss_pred             CCH
Q 015222          177 PSL  179 (411)
Q Consensus       177 ~~L  179 (411)
                      .++
T Consensus        91 ~~~   93 (255)
T d1nd4a_          91 QDL   93 (255)
T ss_dssp             EET
T ss_pred             ccc
Confidence            554

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.83  E-value=3.1e-05  Score=70.34  Aligned_cols=71  Identities=15%  Similarity=0.195  Sum_probs=51.4

Q ss_pred             ceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEe--eeeecCCeEEEEEccCC
Q 015222          105 FGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR--NWFDYRNHICIVFEKLG  176 (411)
Q Consensus       105 ~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~--~~~~~~~~~~lv~e~~~  176 (411)
                      -..||+++. .+|+.|++|+.+......+.+..|...+..|...++..+..+..-  ..+..++..+.++++++
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~  107 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  107 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             cceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence            358999975 567789999998766667778899999999998877443323221  12344677899999983

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.32  E-value=0.00044  Score=64.15  Aligned_cols=73  Identities=12%  Similarity=0.132  Sum_probs=51.4

Q ss_pred             EEeeeccccceEEEEEEeCC-------CCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEeeeeecCCeE
Q 015222           96 ILSKMGEGTFGQVVECFDNE-------KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI  168 (411)
Q Consensus        96 i~~~lG~G~~g~V~~a~~~~-------~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~~~~~~~~~  168 (411)
                      -++.|+.|-.-.+|++....       ..+.|++++.-.. .......+|..+++.+...++    ..+++.++..    
T Consensus        46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~~idr~~E~~i~~~ls~~gl----~Pkll~~~~~----  116 (395)
T d1nw1a_          46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHL----GPKLYGIFSG----  116 (395)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTS----SSCEEEEETT----
T ss_pred             EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-chhhHHHHHHHHHHHHHhCCC----CCeEEEEcCC----
Confidence            34678888889999998653       3456888887633 233456789999999988776    2455666643    


Q ss_pred             EEEEccC-CC
Q 015222          169 CIVFEKL-GP  177 (411)
Q Consensus       169 ~lv~e~~-~~  177 (411)
                      .+||||+ |.
T Consensus       117 g~I~efi~g~  126 (395)
T d1nw1a_         117 GRLEEYIPSR  126 (395)
T ss_dssp             EEEECCCCEE
T ss_pred             ceEEEEeccc
Confidence            5789998 53

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.08  E-value=0.0017  Score=57.95  Aligned_cols=79  Identities=9%  Similarity=0.070  Sum_probs=46.6

Q ss_pred             eEEEeeeccccceEEEEEEeCCCCcEEEEEEeccchhhhHHHHHHHHHHHHHhcCCCCCcceEEEee---eeecCCeEEE
Q 015222           94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN---WFDYRNHICI  170 (411)
Q Consensus        94 y~i~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~iv~~~~---~~~~~~~~~l  170 (411)
                      ..-.+.|..|---+.|+.... +|+ +++|++... ...+.+..|+.++..|...++..|..+...+   +....+....
T Consensus        20 ~~~~~~i~~G~~N~ny~v~t~-~g~-yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~   96 (316)
T d2ppqa1          20 LTSYKGIAEGVENSNFLLHTT-KDP-LILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA   96 (316)
T ss_dssp             EEEEEEECC---EEEEEEEES-SCC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred             ceEeecCCCCcccCeEEEEEC-CCc-EEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccce
Confidence            344566777877889998754 344 899998653 2345667789999999988875554333221   1122345556


Q ss_pred             EEccC
Q 015222          171 VFEKL  175 (411)
Q Consensus       171 v~e~~  175 (411)
                      ++.+.
T Consensus        97 ~~~~~  101 (316)
T d2ppqa1          97 LISFL  101 (316)
T ss_dssp             EEECC
T ss_pred             eeeec
Confidence            66655